Citrus Sinensis ID: 005617
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 688 | 2.2.26 [Sep-21-2011] | |||||||
| Q8GUH1 | 834 | U-box domain-containing p | yes | no | 0.943 | 0.778 | 0.396 | 1e-131 | |
| Q94A51 | 805 | U-box domain-containing p | no | no | 0.928 | 0.793 | 0.331 | 8e-94 | |
| Q9FKG5 | 796 | U-box domain-containing p | no | no | 0.655 | 0.566 | 0.396 | 6e-92 | |
| Q8S8S7 | 801 | U-box domain-containing p | no | no | 0.633 | 0.544 | 0.411 | 7e-92 | |
| Q9LU47 | 819 | Putative U-box domain-con | no | no | 0.777 | 0.653 | 0.363 | 5e-89 | |
| Q9SW11 | 835 | U-box domain-containing p | no | no | 0.651 | 0.536 | 0.408 | 1e-88 | |
| Q9FKG6 | 845 | U-box domain-containing p | no | no | 0.655 | 0.533 | 0.378 | 6e-87 | |
| Q0DR28 | 518 | U-box domain-containing p | no | no | 0.587 | 0.779 | 0.375 | 6e-79 | |
| Q9FGD7 | 765 | Putative U-box domain-con | no | no | 0.686 | 0.616 | 0.325 | 1e-59 | |
| C0LGU1 | 959 | Probable LRR receptor-lik | no | no | 0.408 | 0.293 | 0.394 | 1e-50 |
| >sp|Q8GUH1|PUB33_ARATH U-box domain-containing protein 33 OS=Arabidopsis thaliana GN=PUB33 PE=2 SV=2 | Back alignment and function desciption |
|---|
Score = 471 bits (1211), Expect = e-131, Method: Compositional matrix adjust.
Identities = 281/709 (39%), Positives = 396/709 (55%), Gaps = 60/709 (8%)
Query: 5 GIQKLVMGAFPDNCMKVKMG---SRKASYAAKNAPMFCEIWFVNKGKHVWTKEASESPNS 61
GI+KLVMGA D +M SRKA + + AP C+IWF KG + T+EA+
Sbjct: 154 GIRKLVMGAAADRHYSRRMTDLKSRKAIFVRREAPTLCQIWFTCKGYLIHTREAT----- 208
Query: 62 FLPFCGAETRSAKMLRSRSLENCNGTSLFNPESILSRSATTLTHVGITDWVQSDPVHMVF 121
E+ A S S + T PES ++ V TD VQ +V
Sbjct: 209 ---MDDTESEYASPRPSISASDLLQT-FSTPES----EHQHISRVQSTDSVQ----QLVS 256
Query: 122 PSSPT-----ISCSDMNLFSPRSSSAGS------GYMSEKRESTDSDSKVEEDPLYVQHR 170
S T +S +N S GS MS S S +D V+ R
Sbjct: 257 NGSSTEQSGRVSDGSLNTDEEERESDGSEVTGSATVMSSGHSSPSSFPDGVDDSFNVKIR 316
Query: 171 EVSIKAEELRNSAFAEFLRRKKLESEAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQ 230
+ + +A + AFAE LRR+K E A++AI + K ESAY+ E+ RK+ E A+ +
Sbjct: 317 KATSEAHSSKQEAFAETLRRQKAEKNALDAIRRAKQSESAYSEELKRRKDTEIAVAKEKE 376
Query: 231 DQEKLKQEKAFVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQR 290
+K E+ + +EL M A+L S+ +++ ++ +L + + L+ E++
Sbjct: 377 RFITIKNEQEVIMEELQSAMAQKAMLESQIAKSDGTMEKLNQKLDIAVKLLQKLRDEREE 436
Query: 291 IRRQKVEAVRWLERWRSRGQAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKV 350
++ ++ A+R E RS + + +FS ++++ AT +F + K+
Sbjct: 437 LQTERDRALREAEELRSHAETSTLQLPQYF---------TDFSFSEIEEATNHFDSTLKI 487
Query: 351 GQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAW 410
G+GG+G +Y G + VAIKML ++ QG +E+QQEV VLSK++HP+++TL+GACPE W
Sbjct: 488 GEGGYGSIYVGLLRHTQVAIKMLNPNSSQGPVEYQQEVDVLSKMRHPNIITLIGACPEGW 547
Query: 411 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQ 470
SLVYEYLP GSL+DRL K N PL W++R RIA EI + L FLHS+K +VHGDLKP
Sbjct: 548 SLVYEYLPGGSLEDRLTCKDNSPPLSWQNRVRIATEICAALVFLHSNKAHSLVHGDLKPA 607
Query: 471 NILLDSELSSKICDFGICRLVTEDTLYLPSFHRS--TAPKGSFPYADPEYHRTGVLTPKS 528
NILLDS L SK+ DFG C L+ P+ +S T G+ Y DPE +G LTPKS
Sbjct: 608 NILLDSNLVSKLSDFGTCSLLH------PNGSKSVRTDVTGTVAYLDPEASSSGELTPKS 661
Query: 529 DSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQC 588
D YSFG+I+L+LLTGR + ++ EV+ A+ G L+ +LDPLAGDWP A +L L L+C
Sbjct: 662 DVYSFGIILLRLLTGRPALRISNEVKYALDNGTLNDLLDPLAGDWPFVQAEQLARLALRC 721
Query: 589 CELYGRERPDITPSLVKELEQLHVA------------EERPVPSFFLCPILQEIMHDPQV 636
CE RPD+ + + LE + + E R P +F+CPI QE+M DP V
Sbjct: 722 CETVSENRPDLGTEVWRVLEPMRASSGGSSSFHLGRNEHRIAPPYFICPIFQEVMQDPHV 781
Query: 637 AADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDWL 685
AADGFTYE +AIR WL++ +TSPMTN++LSH L NHALR AIQ+WL
Sbjct: 782 AADGFTYEAEAIRAWLDSEHDTSPMTNVKLSHTSLIANHALRSAIQEWL 830
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: - |
| >sp|Q94A51|PUB32_ARATH U-box domain-containing protein 32 OS=Arabidopsis thaliana GN=PUB32 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 345 bits (884), Expect = 8e-94, Method: Compositional matrix adjust.
Identities = 239/721 (33%), Positives = 371/721 (51%), Gaps = 82/721 (11%)
Query: 4 HGIQKLVMGAFPDNCMKVKM---GSRKASYAAKNAPMFCEIWFVNKGKHVWTKEASESPN 60
H I+ LVMGA D KM S+KA + K AP C IWF+ KG ++T+ +++ N
Sbjct: 123 HKIKWLVMGAASDKHYSWKMTDLKSKKAIFVCKKAPDSCHIWFLCKGYLIFTRASNDDSN 182
Query: 61 ---SFLPFC----GAETRSAKMLRS----------RSLENCNG---TSLFNPESILSRSA 100
+ P ETR ++ L S RSL +G T E + R+
Sbjct: 183 NRQTMPPLVQLDSDNETRKSEKLESSYMRRRLRYWRSLLEQDGEKDTGQLEREKVEPRAP 242
Query: 101 TTLTHVGITDWVQSDPVHMVFPSSPTISCSDMNLFSPRSSSAGSGYMSEKRESTDSDSKV 160
+ + +PV P SP + SD + + + EK D KV
Sbjct: 243 PLFSSGSSS--SFGEPVGPE-PVSPELVDSD---------TLNTSNVEEKEREGDVARKV 290
Query: 161 EEDPLYVQHREVSIKAEELRNSAFAEFLRRKKLESEAMEAIGKVKAFESAYAREMHLRKE 220
++ + + + + E ++ + ++ EA+ K KA E +E RK
Sbjct: 291 H------RYDKAMHDIGQSDRTVYGEAGKKWEEDASTTEALCKAKALEGLCIKESSQRKR 344
Query: 221 AEDALQTTIQDQEKLKQEKAFVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLIQAS 280
E+ L+ + + + ++ +EL L S+ ++ E +
Sbjct: 345 LEELLEKEKLEVKMVIEQNNGFMKELQMVQGRNLKLESQMRKLQDLEKEHGEKFDTAMEL 404
Query: 281 IATLQQEKQRIRRQKVEAVRWLERWRS--RGQAGAANYDGFIGLVEDLPESAEFSLADLQ 338
+ + +Q++ IR AV+ + R +G+ G ++ E ++S ++
Sbjct: 405 LKSFRQKRDEIRIDHENAVKEVNALRRLVKGETGESSGS----------EMLDYSFMEIN 454
Query: 339 TATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPH 398
AT F S+K+G+G +G VYKG + VA+KML S+ EF++ V +LS+++HP+
Sbjct: 455 EATNEFDPSWKLGEGKYGSVYKGNLQHLQVAVKMLPSYGSLNHFEFERRVEILSRVRHPN 514
Query: 399 LVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
LVTL+GACPE+ SL+Y+Y+PNGSL+D ++NV L W+ R RIA+EI S L FLHS+
Sbjct: 515 LVTLMGACPESRSLIYQYIPNGSLEDCFSSENNVPALSWESRIRIASEICSALLFLHSNI 574
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 518
P I+HG+LKP ILLDS L +KI D+GI +L+ D L S P+ DP Y
Sbjct: 575 P-CIIHGNLKPSKILLDSNLVTKINDYGISQLIPIDGL-----------DKSDPHVDPHY 622
Query: 519 HRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVA 578
+ +T +SD Y+FG+I+LQLLT R G+ +V+ A+ +S++LD AGDWP
Sbjct: 623 FVSREMTLESDIYAFGIILLQLLTRRPVSGILRDVKCALENDNISAVLDNSAGDWPVARG 682
Query: 579 RRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAE---------------ERPVPSFFL 623
++L ++ ++CC+ RPD+ +++ ++++ E RP PS +L
Sbjct: 683 KKLANVAIRCCKKNPMNRPDLA-VVLRFIDRMKAPEVPSSETSSYANQNVPRRP-PSHYL 740
Query: 624 CPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQD 683
CPI QE+M DP +AADGFTYE +AIR+WL NG +TSPMTNL++ +L PNHAL AIQD
Sbjct: 741 CPIFQEVMKDPLIAADGFTYEAEAIREWLANGHDTSPMTNLKMEDCNLIPNHALHLAIQD 800
Query: 684 W 684
W
Sbjct: 801 W 801
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 6 EC: . EC: 3 EC: . EC: 2 EC: . EC: - |
| >sp|Q9FKG5|PUB51_ARATH U-box domain-containing protein 51 OS=Arabidopsis thaliana GN=PUB51 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 338 bits (868), Expect = 6e-92, Method: Compositional matrix adjust.
Identities = 195/492 (39%), Positives = 280/492 (56%), Gaps = 41/492 (8%)
Query: 233 EKLKQEKAFVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLIQA------SIATLQQ 286
EKLK E + V + + Q+ N+RR E LK + + +++
Sbjct: 300 EKLKIELRHIKGMYAVAQSEVIDASKKMQDLNQRRSEEATRLKNLTIREEEADEVVEMER 359
Query: 287 EKQRIRRQKVEAVR-WLERW---RSRGQAGAANYDGFIGLVEDLPESA--------EFSL 334
E+Q + E VR +ER R +A A +ED E +F
Sbjct: 360 ERQEDAENEAELVRECIERETEERLEAEARAEEVRKEKQRLEDALEGGPLQRQQYMKFEW 419
Query: 335 ADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKL 394
++ AT +FS+ K+G GG+G VY+ + TVA+K+L+S +F QE+ +LSK+
Sbjct: 420 EEIVEATSSFSDELKIGVGGYGSVYRCNLHHTTVAVKVLHSDKSSLTKQFHQELEILSKI 479
Query: 395 QHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLF-RKSNVS-----PLLWKDRARIAAEIA 448
+HPHL+ LLGACPE SLVYEY+ NGSL++RL R+ NV PL W +R RIA EIA
Sbjct: 480 RHPHLLLLLGACPERGSLVYEYMHNGSLEERLMKRRPNVDTPQPPPLRWFERFRIAWEIA 539
Query: 449 SGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK 508
S L FLH+++P IVH DLKP NILLD SKI D G+ ++V D + + T P
Sbjct: 540 SALYFLHTNEPRPIVHRDLKPANILLDRNNVSKIGDVGLSKMVNLDPSHASTVFNETGPV 599
Query: 509 GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAV--SCGKLSSIL 566
G+F Y DPEY RTGV+TP+SD Y+FG+I+LQL+T R +GLA + +A+ GK + IL
Sbjct: 600 GTFFYIDPEYQRTGVVTPESDIYAFGIILLQLVTARSAMGLAHSIEKALRDQTGKFTEIL 659
Query: 567 DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH--------------V 612
D AGDWP A+ +V +GL+C E+ R+RPD+ ++ LE+L +
Sbjct: 660 DKTAGDWPVKEAKEMVMIGLRCAEMRKRDRPDLGKEILPVLERLKEVASIARNMFADNLI 719
Query: 613 AEERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLT 672
P+ F CPI +++M +P VA+DG+TYE +AI++WL+ + SPMT+L L
Sbjct: 720 DHHHNAPTHFYCPITKDVMENPCVASDGYTYEKRAIKEWLQKNHK-SPMTDLPFPSDSLL 778
Query: 673 PNHALRHAIQDW 684
PNH+L AI++W
Sbjct: 779 PNHSLLSAIKEW 790
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q8S8S7|PUB34_ARATH U-box domain-containing protein 34 OS=Arabidopsis thaliana GN=PUB34 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 338 bits (868), Expect = 7e-92, Method: Compositional matrix adjust.
Identities = 190/462 (41%), Positives = 265/462 (57%), Gaps = 26/462 (5%)
Query: 244 QELHRTMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVR-WL 302
+EL T V +L++ ++R + A E + +Q + A L++E+ ++VE + L
Sbjct: 334 EELFSTQNKVKMLSTEYLNESKRVNNAV-EKEELQRNTAALEKERYMKAVKEVETAKALL 392
Query: 303 ERWRSRGQAGAAN-----------YDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVG 351
R + Q N D +G ++++ ++ TAT FS +G
Sbjct: 393 AREFCQRQIAEVNALRTYLEKKKVIDQLLGTDH---RYRKYTIEEIVTATEGFSPEKVIG 449
Query: 352 QGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWS 411
+GG+G VY+ + A+K++ + + EF +EV VLS+L+HPH+V LLGACPE
Sbjct: 450 EGGYGKVYQCSLDSTPAAVKVVRLDTPEKKQEFLKEVEVLSQLRHPHVVLLLGACPENGC 509
Query: 412 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQN 471
LVYEYL NGSL++ +F + N PL W R R+ E+A GL FLHSSKPE IVH DLKP N
Sbjct: 510 LVYEYLENGSLEEYIFHRKNKPPLPWFIRFRVIFEVACGLAFLHSSKPEPIVHRDLKPGN 569
Query: 472 ILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSY 531
ILL+ SKI D G+ +LVT+ + +R++ G+ Y DPEYHRTG + PKSD Y
Sbjct: 570 ILLNRNYVSKIADVGLAKLVTDVAPDNVTMYRNSVLAGTLHYIDPEYHRTGTIRPKSDLY 629
Query: 532 SFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCEL 591
+FG+IILQLLT R P G+ V AV G L+ +LD DWP L +GL+C E
Sbjct: 630 AFGIIILQLLTARNPSGIVPAVENAVKKGTLTEMLDKSVTDWPLAETEELARIGLKCAEF 689
Query: 592 YGRERPDITPSLVKELEQLHVAEERPV---------PSFFLCPILQEIMHDPQVAADGFT 642
R+RPD+ ++ L++L V PS + CPIL+EIM +P++AADGFT
Sbjct: 690 RCRDRPDLKSEVIPVLKRLVETANSKVKKEGSNLRAPSHYFCPILREIMEEPEIAADGFT 749
Query: 643 YEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDW 684
YE KAI WLE SP+T +L H LTPNH LR AI+DW
Sbjct: 750 YERKAILAWLEK-HNISPVTRQKLDHFKLTPNHTLRSAIRDW 790
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9LU47|PUB53_ARATH Putative U-box domain-containing protein 53 OS=Arabidopsis thaliana GN=PUB53 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 329 bits (843), Expect = 5e-89, Method: Compositional matrix adjust.
Identities = 214/588 (36%), Positives = 318/588 (54%), Gaps = 53/588 (9%)
Query: 142 AGSGYMSEKRES---TDSDSKVEEDPLYVQHREVSIKAEELRNSAFAEFLRRKKLESEAM 198
A S MS +S T S+ +++ P V R VS+ E ++ E KK S+A
Sbjct: 235 ANSDVMSNALKSNPHTLSNKRMQNLPTIV--RGVSVPME----TSSTESDETKKRSSDAA 288
Query: 199 EAIGKVKAFESAYA-------REMHLRKEAEDALQTTIQ-------------DQEKLKQE 238
E K + E++ + R+ RK+A ++ + + D + E
Sbjct: 289 EEASKRSSPETSRSVSWNPQFRDFDERKDAMSSMSSNFEYGNVVTPLGHYFTDNQDTLNE 348
Query: 239 KAFVTQELHRTMRNVALLNSRAQEANRRRDEAT-GELKLIQ---ASIATLQQEK--QRIR 292
+ + EL A+ +A+R+ +E EL L++ IA + EK Q+ R
Sbjct: 349 ISKLRAELRHAHEMYAVAQVETLDASRKLNELKFEELTLLEHETKGIAKKETEKFEQKRR 408
Query: 293 RQKVEAVRWLERWRSRGQAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQ 352
++ A R ++ +A LV + EF+ ++ AT +FSE K+G
Sbjct: 409 EEREAAQRREAEMKATHEAKEKEKLEESSLVAPKLQYQEFTWEEIINATSSFSEDLKIGM 468
Query: 353 GGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSL 412
G +G VYK + A+K+L+S +F QE+ +LSK++HPHLV LLGACP+ +L
Sbjct: 469 GAYGDVYKCNLHHTIAAVKVLHSAESSLSKQFDQELEILSKIRHPHLVLLLGACPDHGAL 528
Query: 413 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNI 472
VYEY+ NGSL+DRLF+ ++ P+ W R RIA E+AS L FLH SKP I+H DLKP NI
Sbjct: 529 VYEYMENGSLEDRLFQVNDSQPIPWFVRLRIAWEVASALVFLHKSKPTPIIHRDLKPANI 588
Query: 473 LLDSELSSKICDFGICRLV-TEDTLYLP-SFHRSTAPKGSFPYADPEYHRTGVLTPKSDS 530
LL+ SK+ D G+ ++ D L + ++ T+P G+ Y DPEY RTG ++PKSD
Sbjct: 589 LLNHNFVSKVGDVGLSTMIQAADPLSTKFTMYKQTSPVGTLCYIDPEYQRTGRISPKSDV 648
Query: 531 YSFGLIILQLLTGRLPVGLAGEVRRAVSCG---KLSSILDPLAGDWPTFVARRLVDLGLQ 587
Y+FG+IILQLLTG+ + L V A+ +L ILD AG+WP R+L L LQ
Sbjct: 649 YAFGMIILQLLTGQQAMALTYTVETAMENNNDDELIQILDEKAGNWPIEETRQLAALALQ 708
Query: 588 CCELYGRERPDITPSLVKELEQLH-----------VAEERPVPSFFLCPILQEIMHDPQV 636
C EL ++RPD+ ++ LE L A +P PS F CP+L+++M +P +
Sbjct: 709 CTELRSKDRPDLEDQILPVLESLKKVADKARNSLSAAPSQP-PSHFFCPLLKDVMKEPCI 767
Query: 637 AADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDW 684
AADG+TY+ +AI +W+EN R TSP+TN L +++L PNH L AI +W
Sbjct: 768 AADGYTYDRRAIEEWMENHR-TSPVTNSPLQNVNLLPNHTLYAAIVEW 814
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9SW11|PUB35_ARATH U-box domain-containing protein 35 OS=Arabidopsis thaliana GN=PUB35 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 328 bits (840), Expect = 1e-88, Method: Compositional matrix adjust.
Identities = 197/482 (40%), Positives = 276/482 (57%), Gaps = 34/482 (7%)
Query: 233 EKLKQEKAFVTQELHRTMRNVALLNSRA-QEANRRR-DEATG--ELKLIQASIATL-QQE 287
EKL+ E V QE++ + SR E N+RR +EA ELKL + L ++E
Sbjct: 354 EKLRAELRHV-QEMYAVAQTETFDASRKLGELNQRRLEEAIKLEELKLKEYEARELAEKE 412
Query: 288 KQRIRRQKVEAV-------------RWLERWRSRGQAGAANYDGFIGLVEDLPESAEFSL 334
KQ + + +A R ER +R +G +G + + F+
Sbjct: 413 KQNFEKARRDAESMRERAEREIAQRREAERKSARDTKEKEKLEGTLGSPQ--LQYQHFAW 470
Query: 335 ADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKL 394
++ AT +FSE K+G G +G VYK + T +K+L S Q +FQQE+ +LSK+
Sbjct: 471 EEIMAATSSFSEELKIGMGAYGAVYKCNLHHTTAVVKVLQSAENQLSKQFQQELEILSKI 530
Query: 395 QHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFL 454
+HPHLV LLGACPE +LVYEY+ NGSL+DRLF+ +N PL W +R RIA E+A+ L FL
Sbjct: 531 RHPHLVLLLGACPEQGALVYEYMENGSLEDRLFQVNNSPPLPWFERFRIAWEVAAALVFL 590
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP-SFHRSTAPKGSFPY 513
H SKP+ I+H DLKP NILLD SK+ D G+ +V D L + ++ T+P G+ Y
Sbjct: 591 HKSKPKPIIHRDLKPANILLDHNFVSKVGDVGLSTMVQVDPLSTKFTIYKQTSPVGTLCY 650
Query: 514 ADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAV-SCGKLSSILDPLAGD 572
DPEY RTG ++ KSD YSFG+I+LQLLT + + L V A+ S + ILD AG+
Sbjct: 651 IDPEYQRTGRISSKSDIYSFGMILLQLLTAKPAIALTHFVESAMDSNDEFLKILDQKAGN 710
Query: 573 WPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEERPVPSF----------F 622
WP R L L L C EL G++RPD+ ++ LE L E+ SF F
Sbjct: 711 WPIEETRELAALALCCTELRGKDRPDLKDQILPALENLKKVAEKARNSFSGVSTQPPTHF 770
Query: 623 LCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQ 682
+CP+L+++M++P VAADG+TY+ AI +WL+ TSPMT+ L +L PN+ L AI
Sbjct: 771 ICPLLKDVMNEPCVAADGYTYDRHAIEEWLKE-HNTSPMTDSPLHSKNLLPNYTLYTAIM 829
Query: 683 DW 684
+W
Sbjct: 830 EW 831
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q9FKG6|PUB52_ARATH U-box domain-containing protein 52 OS=Arabidopsis thaliana GN=PUB52 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 322 bits (825), Expect = 6e-87, Method: Compositional matrix adjust.
Identities = 181/478 (37%), Positives = 268/478 (56%), Gaps = 27/478 (5%)
Query: 233 EKLKQEKAFVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLI----QASIATLQQEK 288
EKL+ E V + + + E N+RR E + +L + + + T +EK
Sbjct: 364 EKLRAELKHVQEMYAMAQTETVGASKKLTELNQRRFEESEKLVELKEKEEVAKDTASKEK 423
Query: 289 QRIRR-----QKVEAVRWLERWRSRGQAGAANYDGF------IGLVEDLPESAEFSLADL 337
QR +KV+ + E R A D LV + ++ ++
Sbjct: 424 QRYEEAMKEAEKVKELMMKEALHRREAEFKAERDAREKDKLQASLVSPGVQYQHYTWEEI 483
Query: 338 QTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHP 397
AT +F+E+ K+G G +G VYK + T A+K+L++ Q +F QE+ +LSK++HP
Sbjct: 484 AAATSDFAENLKIGIGAYGSVYKCNLHHTTGAVKVLHAGETQLSKQFDQELEILSKIRHP 543
Query: 398 HLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
HLV LLGACPE LVYEY+ NGSL DRL ++ P+ W +R RIA E+AS L FLH S
Sbjct: 544 HLVLLLGACPERGCLVYEYMDNGSLDDRLMLVNDTPPIPWFERFRIALEVASALVFLHKS 603
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 517
KP I+H DLKP NILLD SK+ D G+ +V +D + + + T+P G+ Y DPE
Sbjct: 604 KPRPIIHRDLKPGNILLDHNFVSKLGDVGLSTMVNQDDVSSRTIFKQTSPVGTLCYIDPE 663
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAV-SCGKLSSILDPLAGDWPTF 576
Y RTG+++PKSD YS G++ILQL+T + + + V A+ + +ILD AG WP
Sbjct: 664 YQRTGIISPKSDVYSLGVVILQLITAKPAIAITHMVEEAIGDDAEFMAILDKKAGSWPIS 723
Query: 577 VARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEERPV----------PSFFLCPI 626
R L LGL C E+ R+RPD+ ++ LE+L ++ PS F+CP+
Sbjct: 724 DTRELAALGLCCTEMRRRDRPDLKDQIIPALERLRKVADKAQNLLSRTPSGPPSHFICPL 783
Query: 627 LQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDW 684
L+ +M++P VAADG+TY+ +AI +WL ++TSP+TNL L + +L N+ L AI +W
Sbjct: 784 LKGVMNEPCVAADGYTYDREAIEEWLRQ-KDTSPVTNLPLPNKNLIANYTLYSAIMEW 840
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q0DR28|PUB57_ORYSJ U-box domain-containing protein 57 OS=Oryza sativa subsp. japonica GN=PUB57 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 295 bits (756), Expect = 6e-79, Method: Compositional matrix adjust.
Identities = 165/440 (37%), Positives = 247/440 (56%), Gaps = 36/440 (8%)
Query: 264 NRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVRWLERWRSRGQAGAANYDGFIGLV 323
+R+ E ++ +++ I TL+ + QK +AV ++ + D + V
Sbjct: 81 DRKTYEEVRKVHILEEEIVTLKHQADTYLVQKEKAVTAYDQLKHER-------DNAVQQV 133
Query: 324 EDLPESA-----EFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNM 378
+L + + +FS D++ AT +F + +VG +G YKG + V IK+ S +
Sbjct: 134 NELRDQSTHIILDFSRKDMEQATEHFKNAREVGDTEYGHTYKGMIHNMKVLIKLSSSQKL 193
Query: 379 QGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWK 438
FQQEV +L + +HP+++T +G C E +LVYE+LPNG+L+DR+ +N +PL W
Sbjct: 194 -----FQQEVSILRQWRHPNIITFIGVCSEVSALVYEWLPNGNLEDRIICTNNSAPLSWY 248
Query: 439 DRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498
+R +I EI L FLHS+K +VHGDL+P NIL+D+ SKIC+FG+ L + +
Sbjct: 249 NRTQIIGEICCALLFLHSNKSTALVHGDLRPCNILIDANYRSKICNFGMSNLFLQLGTFP 308
Query: 499 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS 558
P+ PY DPE++ TG LT SD YS G+IIL+LLTG P+ L+ +V A+
Sbjct: 309 PNL------TARLPYMDPEFNTTGELTTLSDVYSLGVIILRLLTGMPPLTLSEKVAEALG 362
Query: 559 CGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL-------- 610
L ++D AGDWP A++L +GL C + ++RPD+ + +E L
Sbjct: 363 SDSLHLLIDKSAGDWPYIEAKQLALIGLSCTGMTRKKRPDLLNEVWIVIEPLTRKPPAAT 422
Query: 611 -----HVAEERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLR 665
+ + VP+ F+CPI EIM DPQVA+DGFTYE +AIR W + G SPMTNL
Sbjct: 423 WPYLQSASGDSSVPAAFICPISMEIMKDPQVASDGFTYEAEAIRCWFDRGISRSPMTNLA 482
Query: 666 LSHLHLTPNHALRHAIQDWL 685
L +L+L PN LR I +L
Sbjct: 483 LPNLNLVPNRVLRSFIHGYL 502
|
Possesses E3 ubiquitin-protein ligase in vitro. May be involved in cell death signaling. Oryza sativa subsp. japonica (taxid: 39947) EC: 6 EC: . EC: 3 EC: . EC: 2 EC: . EC: - |
| >sp|Q9FGD7|PUB50_ARATH Putative U-box domain-containing protein 50 OS=Arabidopsis thaliana GN=PUB50 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 231 bits (589), Expect = 1e-59, Method: Compositional matrix adjust.
Identities = 184/565 (32%), Positives = 284/565 (50%), Gaps = 93/565 (16%)
Query: 159 KVEEDPLYV--QHREVSIKAEELRNSAFAEFLRRKKLESEAMEAIGKVKAFESAYAREMH 216
KV E L + + REV + AE + +A L ++ FE A+ +E
Sbjct: 251 KVNEAKLMIDEKSREVKVNAERSNRAEWAISL-----------CNSRIGEFE-AWIKEES 298
Query: 217 LRKEAEDALQTTIQ-DQEKLKQEKAFVTQ---ELHRTMRNVALLNSRAQEANRRRDEATG 272
R+E LQ T+ D+E +++ K +V + +LH +L+S+ + + +A
Sbjct: 299 ERREK---LQATLDSDKECIEEAKNYVEKGKTKLHSLAELQEVLSSKVKTMMEAKSQAEV 355
Query: 273 ELKLIQASIATLQQEKQRIRRQKVEAVRWLERWRSRGQAGAANYDGFIGLVEDLPESAEF 332
EL+ + + E +++R Q+ R +E + R G+ + + E E+
Sbjct: 356 ELERVVLQRGEMITEIEKLRSQRDVFNRRIEFCKEREVIGSVSKE------EVKCGYREY 409
Query: 333 SLADLQTATCNFSESFKVGQGG-FGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVL 391
D++ AT +S+ ++ GG + VY+G + TVA+K++ + F +V++L
Sbjct: 410 VAEDIRLATETYSDRLRLKSGGNWTNVYRGRIKHTTVAVKVI--GDSLSDEAFGAKVKLL 467
Query: 392 SKLQHPHLVTLLGACPE-AWSLVYEYLPNGSLQDRLF---RKSNVSPLL-WKDRARIAAE 446
++++HP+LV + G C + L++EY+ NG+L+D LF RKS S +L W DR RIA +
Sbjct: 468 NEIRHPNLVAIAGFCSQRPKCLLFEYMHNGNLRDNLFTSQRKSRRSKILKWHDRIRIAHQ 527
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTA 506
+ SGL FLHS KP+ IVHG L P ILLD L KI FG L + S T
Sbjct: 528 VCSGLGFLHSVKPKPIVHGRLTPSKILLDRNLVPKITGFG---------LIMHSDQSDTK 578
Query: 507 PKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSI- 565
P D +FG+++L LLTGR GL +A+S + S +
Sbjct: 579 P---------------------DVMAFGVLLLHLLTGRNWHGLL----KAMSMNQTSILR 613
Query: 566 -LDPLAGDWPTFVARRLVDLGLQCCELYGRERPDI-TPSLVKELEQL------------- 610
LD AG WP +A+ L ++C + D T +++EL ++
Sbjct: 614 DLDQTAGKWPLELAKEFGALAVKCSSVNRGGNMDFSTKEIMEELGKIREKADEFKTKGGY 673
Query: 611 ------HVAEERP--VPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMT 662
++ E P +PS F+CPILQE+M +P VAADGF+YE +AI++WL G +TSPMT
Sbjct: 674 EEATNSNMDEGDPNDIPSVFMCPILQEVMKNPHVAADGFSYELEAIQEWLSMGHDTSPMT 733
Query: 663 NLRLSHLHLTPNHALRHAIQDWLCK 687
NLRL + LTPNH LR IQDW K
Sbjct: 734 NLRLDYQMLTPNHTLRSLIQDWHSK 758
|
Functions as an E3 ubiquitin ligase. Arabidopsis thaliana (taxid: 3702) EC: 6 EC: . EC: 3 EC: . EC: 2 EC: . EC: - |
| >sp|C0LGU1|Y5374_ARATH Probable LRR receptor-like serine/threonine-protein kinase At5g37450 OS=Arabidopsis thaliana GN=At5g37450 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 202 bits (513), Expect = 1e-50, Method: Compositional matrix adjust.
Identities = 118/299 (39%), Positives = 178/299 (59%), Gaps = 18/299 (6%)
Query: 332 FSLADLQTATCNFSESFKVGQGGFGCVYKGEMLG-RTVAIKMLYSHNMQGQLEFQQEVRV 390
++ +L +AT +FS+ ++G+GG+G VYKG + G VA+K ++QGQ EF E+ +
Sbjct: 619 YNFTELDSATSSFSDLSQIGRGGYGKVYKGHLPGGLVVAVKRAEQGSLQGQKEFFTEIEL 678
Query: 391 LSKLQHPHLVTLLGACPEAWS--LVYEYLPNGSLQDRL---FRKSNVSPLLWKDRARIAA 445
LS+L H +LV+LLG C + LVYEY+PNGSLQD L FR+ PL R RIA
Sbjct: 679 LSRLHHRNLVSLLGYCDQKGEQMLVYEYMPNGSLQDALSARFRQ----PLSLALRLRIAL 734
Query: 446 EIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST 505
A G+ +LH+ I+H D+KP NILLDS+++ K+ DFGI +L+ D + H +T
Sbjct: 735 GSARGILYLHTEADPPIIHRDIKPSNILLDSKMNPKVADFGISKLIALDGGGVQRDHVTT 794
Query: 506 APKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPV----GLAGEVRRAVSCGK 561
KG+ Y DPEY+ + LT KSD YS G++ L++LTG P+ + EV A G
Sbjct: 795 IVKGTPGYVDPEYYLSHRLTEKSDVYSLGIVFLEILTGMRPISHGRNIVREVNEACDAGM 854
Query: 562 LSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH---VAEERP 617
+ S++D G + +R ++L ++CC+ RP + +V+ELE ++ EE+P
Sbjct: 855 MMSVIDRSMGQYSEECVKRFMELAIRCCQDNPEARPWML-EIVRELENIYGLIPKEEKP 912
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 688 | ||||||
| 255587037 | 673 | receptor protein kinase, putative [Ricin | 0.968 | 0.989 | 0.694 | 0.0 | |
| 359478641 | 836 | PREDICTED: U-box domain-containing prote | 0.981 | 0.807 | 0.671 | 0.0 | |
| 297746091 | 820 | unnamed protein product [Vitis vinifera] | 0.957 | 0.803 | 0.661 | 0.0 | |
| 356547247 | 659 | PREDICTED: U-box domain-containing prote | 0.954 | 0.996 | 0.639 | 0.0 | |
| 356557439 | 780 | PREDICTED: U-box domain-containing prote | 0.972 | 0.857 | 0.630 | 0.0 | |
| 224059500 | 736 | predicted protein [Populus trichocarpa] | 0.797 | 0.745 | 0.749 | 0.0 | |
| 356541238 | 776 | PREDICTED: U-box domain-containing prote | 0.962 | 0.853 | 0.593 | 0.0 | |
| 224106491 | 439 | predicted protein [Populus trichocarpa] | 0.638 | 1.0 | 0.806 | 0.0 | |
| 449450906 | 671 | PREDICTED: U-box domain-containing prote | 0.954 | 0.979 | 0.561 | 0.0 | |
| 449496721 | 650 | PREDICTED: U-box domain-containing prote | 0.924 | 0.978 | 0.549 | 0.0 |
| >gi|255587037|ref|XP_002534109.1| receptor protein kinase, putative [Ricinus communis] gi|223525841|gb|EEF28277.1| receptor protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 946 bits (2445), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 469/675 (69%), Positives = 543/675 (80%), Gaps = 9/675 (1%)
Query: 17 NCMKVKMGSRKASYAAKNAPMFCEIWFVNKGKHVWTKEASESPNSFLPFCGAETRSAKML 76
+CMKVK S KA Y AK+AP FCEIWF+NKGKH+WTKEA E + + S L
Sbjct: 5 SCMKVKKSSDKADYVAKSAPYFCEIWFINKGKHIWTKEAFERSSH------SGGASDDTL 58
Query: 77 RSRSLENCNGTSLFNPESILSRSATTLTHVGITDWVQSDPVHMVFPSSPTISCSDMNLF- 135
S+SL PE + S SAT + ++DWVQ + + P T S + F
Sbjct: 59 GSKSLRYSKNIMPLYPEYLQSTSATGIPCASVSDWVQIESNNSEEPVLHTRSSTTNGCFP 118
Query: 136 --SPRSSSAGSGYMSEKRESTDSDSKVEEDPLYVQHREVSIKAEELRNSAFAEFLRRKKL 193
+ S+S+ S +E+R S DSDSKVEE+ LY Q E I+AE RN AF E LRRKK+
Sbjct: 119 QSAFSSTSSSSRASTERRVSLDSDSKVEEESLYCQLAEARIEAEASRNEAFEELLRRKKI 178
Query: 194 ESEAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQDQEKLKQEKAFVTQELHRTMRNV 253
E + +EAI KVK FESAY E+ LRKEAEDAL+ TI++Q KL +EK VT+EL RTMRN+
Sbjct: 179 EFQTLEAISKVKIFESAYENEVKLRKEAEDALRITIEEQVKLLKEKEEVTRELQRTMRNL 238
Query: 254 ALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVRWLERWRSRGQAGA 313
ALL++R +EANRR+DEA GELKLIQ SIA+L+QEKQRI+RQK+EAVRWLERWR+RG AGA
Sbjct: 239 ALLDNRGKEANRRQDEAAGELKLIQTSIASLRQEKQRIQRQKMEAVRWLERWRNRGPAGA 298
Query: 314 ANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKML 373
N +GF+G VE+LPE AEF L+DL+TATCNFSESFK+GQGG+GCVYKGEMLGRTVAIK L
Sbjct: 299 PNCNGFLGFVEELPELAEFLLSDLETATCNFSESFKLGQGGYGCVYKGEMLGRTVAIKKL 358
Query: 374 YSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVS 433
+ HNMQGQ EFQ+EV+VL KLQHPHLVTLLG+CPEAWSLVYEYLPNGSL + LFR+SN+S
Sbjct: 359 HPHNMQGQSEFQKEVQVLGKLQHPHLVTLLGSCPEAWSLVYEYLPNGSLHECLFRRSNIS 418
Query: 434 PLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493
PL WK RARI AEI+S +CFLHSS PEKIVHGDLKPQNILLDSELS KIC+FGICRLVT+
Sbjct: 419 PLTWKVRARIIAEISSAVCFLHSSNPEKIVHGDLKPQNILLDSELSCKICEFGICRLVTD 478
Query: 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV 553
DTLY P FHR PKG+FPY DPE+HR GVLT KSD YSFG+IILQLLTGR PVGL GEV
Sbjct: 479 DTLYCPRFHRGNEPKGAFPYTDPEFHRVGVLTTKSDIYSFGVIILQLLTGRPPVGLVGEV 538
Query: 554 RRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVA 613
RR + CGKL+SILDP AG+WPTF+A RLVDLGLQ CEL RERP++TP+LV+ELEQLHV+
Sbjct: 539 RRTMLCGKLASILDPSAGEWPTFIASRLVDLGLQFCELNSRERPELTPALVRELEQLHVS 598
Query: 614 EERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTP 673
EERPVPSFFLCPILQEIMHDPQVAADGFTYEG+A+R WLENGRETSPMTNL+LSHL+LTP
Sbjct: 599 EERPVPSFFLCPILQEIMHDPQVAADGFTYEGEAMRGWLENGRETSPMTNLKLSHLYLTP 658
Query: 674 NHALRHAIQDWLCKS 688
NHALR AIQDWLCKS
Sbjct: 659 NHALRFAIQDWLCKS 673
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359478641|ref|XP_003632149.1| PREDICTED: U-box domain-containing protein 33-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 923 bits (2386), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 467/695 (67%), Positives = 552/695 (79%), Gaps = 20/695 (2%)
Query: 1 MNIHGIQKLVMGA-FPDNCMKVKMGSRKASYAAKNAPMFCEIWFVNKGKHVWTKEASESP 59
+N HGI+KLVMG P+NCMKVKM S KA+YAAK AP FCEIWF++KGKHVWTKEA ++P
Sbjct: 155 VNRHGIRKLVMGGTVPENCMKVKMSSSKANYAAKKAPEFCEIWFIHKGKHVWTKEAFKAP 214
Query: 60 NSFLPFCGAETRSAKMLRSRSLENCNGTSLFNPESILSRSA-TTLTHVGITDWVQSDPVH 118
P +T + + L F PE + S S+ ++ G + V+S+ V
Sbjct: 215 GFLPPISHPKTETGEDLG------------FQPECLPSGSSPVSVLSGGDRNGVESELVR 262
Query: 119 MVFPSSPTISCSD-----MNLFSPRSSSAGSGYMSEKRESTDSDSKVEEDPLYVQHREVS 173
SSP +S S + S+ +G G +EKR S DS SK EE+ LY Q E +
Sbjct: 263 TRVTSSPALSDSTSRNDPQFSPTSSSTFSGYGSSAEKR-SMDSYSKTEEESLYYQLAEAT 321
Query: 174 IKAEELRNSAFAEFLRRKKLESEAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQDQE 233
I+AE RN AF E L+R+KLESEAMEAI KVKAFESA+ARE+ LRK+AEDAL++TIQ+Q+
Sbjct: 322 IEAEASRNEAFLELLKRQKLESEAMEAIAKVKAFESAHAREVELRKDAEDALRSTIQEQD 381
Query: 234 KLKQEKAFVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRR 293
KL +E+ +T+E+ +TMRNVALL+SRAQEANRR DEAT ELKLIQASIATLQ EKQ+IRR
Sbjct: 382 KLLEEREKLTREIQKTMRNVALLDSRAQEANRRCDEATEELKLIQASIATLQYEKQKIRR 441
Query: 294 QKVEAVRWLERWRSRGQAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQG 353
QK+EA+ WL+RWRSRGQAG ++ +GFIG+ EDLPE AEFSL+DL+TATCNFSESFK+GQG
Sbjct: 442 QKMEAMHWLDRWRSRGQAGTSHCNGFIGVFEDLPELAEFSLSDLETATCNFSESFKIGQG 501
Query: 354 GFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLV 413
G G VYKGEML +TVAIK L+ HNMQGQ EFQ+EV+VL K+QHPHLVTL+GA PEAWSLV
Sbjct: 502 GNGSVYKGEMLDKTVAIKKLHPHNMQGQSEFQREVQVLGKIQHPHLVTLIGASPEAWSLV 561
Query: 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNIL 473
YEYLPNGSLQDRLFRKSN SPL WK RARI EI+S L FLHS KPEKIVHG+L+P+NIL
Sbjct: 562 YEYLPNGSLQDRLFRKSNNSPLTWKVRARIITEISSALLFLHSCKPEKIVHGNLRPENIL 621
Query: 474 LDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSF 533
L S+L KICDFGICRLV+++TL PSF R+ PKG+FPY DPE +RTGVLT KSD YSF
Sbjct: 622 LGSDLRCKICDFGICRLVSDETLRCPSFRRNAEPKGAFPYEDPELYRTGVLTTKSDIYSF 681
Query: 534 GLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYG 593
G+IILQLLTGR PVGLA EVR+AVSCGKL+SILD AG WPT VA RL DL L+CCEL
Sbjct: 682 GVIILQLLTGRPPVGLASEVRKAVSCGKLASILDSSAGVWPTHVASRLADLALRCCELNS 741
Query: 594 RERPDITPSLVKELEQLHVAEERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLE 653
R+RP++ P+LV+ELEQLHV+EE+PVPSFFLCPILQ+IMHDP VAADGFTYE +A+ WLE
Sbjct: 742 RDRPELKPTLVRELEQLHVSEEQPVPSFFLCPILQDIMHDPHVAADGFTYEKEALLGWLE 801
Query: 654 NGRETSPMTNLRLSHLHLTPNHALRHAIQDWLCKS 688
NGRETSPMTNLRLSHLHLTPNH+LR IQDWLCKS
Sbjct: 802 NGRETSPMTNLRLSHLHLTPNHSLRSTIQDWLCKS 836
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297746091|emb|CBI16147.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 900 bits (2326), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 460/695 (66%), Positives = 541/695 (77%), Gaps = 36/695 (5%)
Query: 1 MNIHGIQKLVMGA-FPDNCMKVKMGSRKASYAAKNAPMFCEIWFVNKGKHVWTKEASESP 59
+N HGI+KLVMG P+NCMKVKM S KA+YAAK AP FCEIWF++KGKHVWTKEA ++P
Sbjct: 155 VNRHGIRKLVMGGTVPENCMKVKMSSSKANYAAKKAPEFCEIWFIHKGKHVWTKEAFKAP 214
Query: 60 NSFLPFCGAETRSAKMLRSRSLENCNGTSLFNPESILSRSA-TTLTHVGITDWVQSDPVH 118
P +T + + L F PE + S S+ ++ G + V+S+ V
Sbjct: 215 GFLPPISHPKTETGEDLG------------FQPECLPSGSSPVSVLSGGDRNGVESELVR 262
Query: 119 MVFPSSPTISCSD-----MNLFSPRSSSAGSGYMSEKRESTDSDSKVEEDPLYVQHREVS 173
SSP +S S + S+ +G G +EKR S DS SK EE+ LY Q E +
Sbjct: 263 TRVTSSPALSDSTSRNDPQFSPTSSSTFSGYGSSAEKR-SMDSYSKTEEESLYYQLAEAT 321
Query: 174 IKAEELRNSAFAEFLRRKKLESEAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQDQE 233
I+AE RN AF E L+R+KLESEAMEAI KVKAFESA+ARE+ LRK+AEDAL++TIQ+Q+
Sbjct: 322 IEAEASRNEAFLELLKRQKLESEAMEAIAKVKAFESAHAREVELRKDAEDALRSTIQEQD 381
Query: 234 KLKQEKAFVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRR 293
KL +E+ +T+E+ +TMRNVALL+SRAQEANRR DEAT ELKLIQASIATLQ EKQ+IRR
Sbjct: 382 KLLEEREKLTREIQKTMRNVALLDSRAQEANRRCDEATEELKLIQASIATLQYEKQKIRR 441
Query: 294 QKVEAVRWLERWRSRGQAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQG 353
QK+EA+ WL+RWRSRGQAG ++ +GFIG+ EDLPE AEFSL+DL+TATCNFSESFK+GQG
Sbjct: 442 QKMEAMHWLDRWRSRGQAGTSHCNGFIGVFEDLPELAEFSLSDLETATCNFSESFKIGQG 501
Query: 354 GFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLV 413
G G VYKGEML +TVAIK L+ HNMQGQ EFQ+EV+VL K+QHPHLVTL+GA PEAWSLV
Sbjct: 502 GNGSVYKGEMLDKTVAIKKLHPHNMQGQSEFQREVQVLGKIQHPHLVTLIGASPEAWSLV 561
Query: 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNIL 473
YEYLPNGSLQDRLFRKSN SPL WK RARI EI+S L FLHS KPEKIVHG+L+P+NIL
Sbjct: 562 YEYLPNGSLQDRLFRKSNNSPLTWKVRARIITEISSALLFLHSCKPEKIVHGNLRPENIL 621
Query: 474 LDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSF 533
L S+L KICDFGICRL PKG+FPY DPE +RTGVLT KSD YSF
Sbjct: 622 LGSDLRCKICDFGICRL----------------PKGAFPYEDPELYRTGVLTTKSDIYSF 665
Query: 534 GLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYG 593
G+IILQLLTGR PVGLA EVR+AVSCGKL+SILD AG WPT VA RL DL L+CCEL
Sbjct: 666 GVIILQLLTGRPPVGLASEVRKAVSCGKLASILDSSAGVWPTHVASRLADLALRCCELNS 725
Query: 594 RERPDITPSLVKELEQLHVAEERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLE 653
R+RP++ P+LV+ELEQLHV+EE+PVPSFFLCPILQ+IMHDP VAADGFTYE +A+ WLE
Sbjct: 726 RDRPELKPTLVRELEQLHVSEEQPVPSFFLCPILQDIMHDPHVAADGFTYEKEALLGWLE 785
Query: 654 NGRETSPMTNLRLSHLHLTPNHALRHAIQDWLCKS 688
NGRETSPMTNLRLSHLHLTPNH+LR IQDWLCKS
Sbjct: 786 NGRETSPMTNLRLSHLHLTPNHSLRSTIQDWLCKS 820
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356547247|ref|XP_003542027.1| PREDICTED: U-box domain-containing protein 33-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 866 bits (2237), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 430/672 (63%), Positives = 509/672 (75%), Gaps = 15/672 (2%)
Query: 19 MKVKMGSRKASYAAKNAPMFCEIWFVNKGKHVWTKEASESPNSFLPFCGAETRSAKMLRS 78
MKVK S KA+Y AKNAP FCE+WF+ KGKH+WT+EASE+P S E + + LR
Sbjct: 1 MKVKRNSSKANYTAKNAPPFCEVWFIYKGKHIWTREASETPCSSSSCTQPEIATTESLRC 60
Query: 79 RSLENCNGTSLFNPESILSRSATTLTHVGITDWVQSDPVHM--VFPSSPTISCSDMNLFS 136
RS + LF+ E + SA T GI WVQ + + F S + CS S
Sbjct: 61 RSFQY-GKNELFDSEYLWPNSARTTAVSGIRSWVQGEIIETEATFSSKASSCCSHC---S 116
Query: 137 PRSSSAGSGYMSEKRESTDSDSKVEEDPLYVQHREVSIKAEELRNSAFAEFLRRKKLESE 196
P++SS R D+ +V E+ + Q E +AE + + AF E L+ +KLE E
Sbjct: 117 PQNSS---------RAYFDTYLEVMEERINKQLIETKREAEAVTDEAFTELLKCEKLEVE 167
Query: 197 AMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQDQEKLKQEKAFVTQELHRTMRNVALL 256
AMEAI KV FESA+ RE+ LRKEA+DAL+ T+Q+Q+KL E + EL TMRN+ALL
Sbjct: 168 AMEAIRKVNLFESAHVREVKLRKEADDALRDTVQEQQKLLNESEEIAGELQMTMRNIALL 227
Query: 257 NSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVRWLERWRSRGQAGAANY 316
+SRAQEANRRRDEA EL LIQ SI+TL QE+Q+IRRQK EA+RWLERWRSRGQ GAA+
Sbjct: 228 DSRAQEANRRRDEAADELSLIQESISTLWQERQQIRRQKTEALRWLERWRSRGQVGAAHC 287
Query: 317 DGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSH 376
+G IG E+LPE AEFSL+DLQ ATCNFS SFK+ QGG+ C+YKGEMLGRTVAIK + H
Sbjct: 288 NGVIGFAEELPELAEFSLSDLQNATCNFSNSFKIEQGGYSCIYKGEMLGRTVAIKKFHQH 347
Query: 377 NMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLL 436
NMQG LEF+QEV+VL LQHPHL+TLLG CPEAWS+VYEYLPNG+LQD LFRKSN SPL
Sbjct: 348 NMQGPLEFRQEVQVLGSLQHPHLITLLGVCPEAWSIVYEYLPNGTLQDYLFRKSNNSPLT 407
Query: 437 WKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496
W RAR+ AEIAS LCFLHS KPE I+HGDLKP+ +LLDS L K+C FG+CRLV+E++L
Sbjct: 408 WNTRARMIAEIASALCFLHSFKPETIIHGDLKPETVLLDSSLGCKMCGFGLCRLVSEESL 467
Query: 497 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA 556
PSF ST PKG+F Y DPE+ RTG+LT KSD YSFGLIILQLLTGR PVGLA VR A
Sbjct: 468 LRPSFRLSTEPKGAFTYTDPEFQRTGILTTKSDIYSFGLIILQLLTGRTPVGLAVLVRNA 527
Query: 557 VSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEER 616
VSCGKLSSILD AG+WP+ VA +LV+LGLQCC+ Y R+RP++TP+LV+ELEQLH +EER
Sbjct: 528 VSCGKLSSILDSSAGEWPSAVAMQLVELGLQCCQQYHRDRPELTPTLVRELEQLHASEER 587
Query: 617 PVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHA 676
PVPSFF CPILQEIMHDPQVAADGFTYEG AIR+WLENG +TSPMTNL+LSHL LTPN+A
Sbjct: 588 PVPSFFSCPILQEIMHDPQVAADGFTYEGDAIREWLENGHDTSPMTNLKLSHLFLTPNYA 647
Query: 677 LRHAIQDWLCKS 688
LR AIQDWLCKS
Sbjct: 648 LRLAIQDWLCKS 659
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356557439|ref|XP_003547023.1| PREDICTED: U-box domain-containing protein 33-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 865 bits (2236), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 431/684 (63%), Positives = 514/684 (75%), Gaps = 15/684 (2%)
Query: 4 HGIQKLVMGAFPDNCMKVKMGSRKASYAAKNAPMFCEIWFVNKGKHVWTKEASESPNSFL 63
H I+KLV+GA P+NCMKVK S KA+Y AKNAP FCE+WF+ KGKH+WT+EASE+P
Sbjct: 111 HNIEKLVIGAIPENCMKVKRNSGKANYTAKNAPPFCEVWFIYKGKHIWTREASETPCYSS 170
Query: 64 PFCGAETRSAKMLRSRSLENCNGTSLFNPESILSRSATTLTHVGITDWVQSDPVHMVFPS 123
E + + LR RS + G LF+ E + SA T T G WVQ + + +
Sbjct: 171 SCTQPEIATRESLRCRSFQY--GNELFDSEYLQPNSARTTTGSGSRSWVQGE----IIET 224
Query: 124 SPTISCSDMNLFSPRSSSAGSGYMSEKRESTDSDSKVEEDPLYVQHREVSIKAEELRNSA 183
S S + SP++SS R D+ + E+ + Q E +AE + + A
Sbjct: 225 EAIFSSSCSSHCSPQNSS---------RAYLDTYLEAMEERINKQLIETKREAEAVTDEA 275
Query: 184 FAEFLRRKKLESEAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQDQEKLKQEKAFVT 243
FAE L+ +KLE EAMEAI KV FESA+ RE+ LRKEAEDAL T+Q+Q+KL +
Sbjct: 276 FAELLKCEKLEVEAMEAIRKVNLFESAHVREVKLRKEAEDALTDTVQEQQKLLNASEEIA 335
Query: 244 QELHRTMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVRWLE 303
EL TMRN+ALL+SRAQEA+RR DEA EL LIQ SI+TL QE+Q+IRRQK+EA+RWLE
Sbjct: 336 GELQMTMRNIALLDSRAQEAHRRCDEAADELSLIQESISTLWQERQQIRRQKMEALRWLE 395
Query: 304 RWRSRGQAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEM 363
RWRSRG+ GAA+ +G IG E+LPE AEFSL+DLQ ATCNFS SF + QGG+ C+YKGEM
Sbjct: 396 RWRSRGKVGAAHCNGVIGFAEELPELAEFSLSDLQNATCNFSNSFIIEQGGYVCIYKGEM 455
Query: 364 LGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQ 423
LGRTVAIK + HNMQG LEF+QEV+VL LQHPHL+TLLG CPEAWS+VYEYLPNG+LQ
Sbjct: 456 LGRTVAIKKFHQHNMQGPLEFRQEVQVLGSLQHPHLITLLGVCPEAWSIVYEYLPNGTLQ 515
Query: 424 DRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKIC 483
D LFRKSN SPL W RAR+ AEIAS LCFLHS +PE I+HGDLKP+ +LLDS L K+C
Sbjct: 516 DYLFRKSNNSPLTWNTRARMIAEIASALCFLHSFRPESIIHGDLKPETVLLDSSLGCKMC 575
Query: 484 DFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTG 543
FG CRLV+E++L PSF ST PKG+F Y DPE+ RTG+LT KSD YSFGLIILQLLTG
Sbjct: 576 GFGFCRLVSEESLLRPSFRLSTEPKGAFTYTDPEFQRTGILTTKSDIYSFGLIILQLLTG 635
Query: 544 RLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603
R PVGLA VR A+SCGKLSSILD AG+WP+ VA RLV+LGLQCC+ Y R+RP++TP+L
Sbjct: 636 RTPVGLAVLVRNAISCGKLSSILDSSAGEWPSAVAMRLVELGLQCCQQYRRDRPELTPTL 695
Query: 604 VKELEQLHVAEERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTN 663
V+ELEQLH +EERPVPSFF C IL EIMHDPQVAADGFTYEG AIR+WLENG +TSPMTN
Sbjct: 696 VRELEQLHASEERPVPSFFSCQILLEIMHDPQVAADGFTYEGDAIREWLENGHDTSPMTN 755
Query: 664 LRLSHLHLTPNHALRHAIQDWLCK 687
L+LSHL LTPNHALR AIQDWLCK
Sbjct: 756 LKLSHLFLTPNHALRLAIQDWLCK 779
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224059500|ref|XP_002299877.1| predicted protein [Populus trichocarpa] gi|222847135|gb|EEE84682.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 837 bits (2163), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 415/554 (74%), Positives = 463/554 (83%), Gaps = 5/554 (0%)
Query: 135 FSPRSSSAGSGYMS-EKRESTDSDSKVEEDPLYVQHREVSIKAEELRNSAFAEFLRRKKL 193
FS SS SG S E R S+ SD KVEE+ Y EVS++AE L N AF E L+ K L
Sbjct: 186 FSSTISSCASGCTSTEMRVSSGSDPKVEEESSYSHIEEVSLEAEALGNEAFEELLKCKTL 245
Query: 194 ESEAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQDQEKLKQEKAFVTQELHRTMRNV 253
E EAMEA KVK +ESA E+ LRKEAEDAL TIQDQEKL +EK V ++L RTMRNV
Sbjct: 246 ELEAMEAFSKVKIYESALVHEVKLRKEAEDALNNTIQDQEKLLKEKDEVARKLERTMRNV 305
Query: 254 ALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVRWLERWRSRGQAGA 313
ALL+ RAQEANRR +EA+GELKLIQ SI +L+QE+QRIRRQK+EAV WLERWRS GQAG
Sbjct: 306 ALLDIRAQEANRRCEEASGELKLIQTSILSLRQEEQRIRRQKMEAVHWLERWRSPGQAGT 365
Query: 314 ANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKML 373
AN +GF+G+ E+LPE AEFSL+DLQTATCNFSESFK+GQGG G VYKGEMLGRTVAIK L
Sbjct: 366 ANCNGFLGITEELPELAEFSLSDLQTATCNFSESFKLGQGGCGQVYKGEMLGRTVAIKRL 425
Query: 374 YSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVS 433
+ +NMQGQ EFQ+EV+VL KLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLF+K+N++
Sbjct: 426 HPNNMQGQSEFQKEVQVLGKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLFQKNNIA 485
Query: 434 PLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493
PL WK R RI AEI+S LCFLHSSKPEKIVHGDLKPQNILL+SELS KIC+FGICRLVTE
Sbjct: 486 PLTWKIRTRIIAEISSALCFLHSSKPEKIVHGDLKPQNILLNSELSCKICEFGICRLVTE 545
Query: 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV 553
D+LY PSFH ST PKGSFPY DPE+ R GVLTPKSD Y+FG+IILQLLTG+ P GL GEV
Sbjct: 546 DSLYQPSFHWSTIPKGSFPYTDPEFQRIGVLTPKSDIYAFGVIILQLLTGKPPAGLVGEV 605
Query: 554 RRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVA 613
RR KL+SILDP + +WP VARRLVDL LQ CEL R RPD+TP+LV+ELE LHV+
Sbjct: 606 RRT---RKLTSILDP-SAEWPMIVARRLVDLALQFCELSSRGRPDLTPTLVRELEHLHVS 661
Query: 614 EERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTP 673
EERPVPSFFLCPILQEIMHDPQVAADGFTYEG+A+R WL NGRETSPMTNLRL HLHLTP
Sbjct: 662 EERPVPSFFLCPILQEIMHDPQVAADGFTYEGEALRGWLANGRETSPMTNLRLDHLHLTP 721
Query: 674 NHALRHAIQDWLCK 687
NHALR AIQDWLCK
Sbjct: 722 NHALRLAIQDWLCK 735
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356541238|ref|XP_003539086.1| PREDICTED: U-box domain-containing protein 33-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 799 bits (2064), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 408/688 (59%), Positives = 494/688 (71%), Gaps = 26/688 (3%)
Query: 1 MNIHGIQKLVMGAFPDNCMKVKMGSRKASYAAKNAPMFCEIWFVNKGKHVWTKEASESPN 60
+ +H ++KLV+GA P+NCMK+K S KA+YAAKNAP FCEIWFV GKH+WT+EASE+P
Sbjct: 115 VTVHNVRKLVIGAIPENCMKIKRNSSKANYAAKNAPPFCEIWFVYNGKHIWTREASETPR 174
Query: 61 SFLPFCGAETRSAKMLRSRSLENCNGTSLFNPESILSRSATTLTHVGITDWVQSDPVHMV 120
S ET +A+ L RS + GT L ++T T VQS+ +
Sbjct: 175 SLSSRAQPETTTAESLSCRSFHD--GTKELLHSECLQLNSTKTTR----SMVQSE----I 224
Query: 121 FPSSPTISCSDMNLFSPRSSSAGSGYMSEKRESTDSDSKVEEDPLYVQHREVSIKAEELR 180
+ T S + S S +G+ D+ S+ EE+ + Q E +A+
Sbjct: 225 IEAEATFSSKSSSCNSHCSPQHSAGWY------LDTHSEFEEETIDSQLIETKREAKAAT 278
Query: 181 NSAFAEFLRRKKLESEAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQDQEKLKQEKA 240
+ A AE L+ K+LE +A+EAI KV FESA+A E+ LRKEAEDAL+ TIQ+Q+ EK
Sbjct: 279 DKALAELLKSKRLEVKAIEAISKVNFFESAHAHEVKLRKEAEDALRATIQEQQMFLDEKE 338
Query: 241 FVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVR 300
+ +EL RT+R+++LL + A E N +RDEA EL LIQASI+ L EKQ+IR+QK+EA+
Sbjct: 339 EIARELERTVRSISLLGNCAHETNHKRDEAENELSLIQASISNLWHEKQQIRQQKMEALH 398
Query: 301 WLERWRSRGQAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYK 360
WLERW+S GQ GA + +G IG E+ PE AEFSL+DLQ ATCNFSESFKV +GG+G +YK
Sbjct: 399 WLERWKSCGQVGADHCNGVIGFAEEFPELAEFSLSDLQNATCNFSESFKVMEGGYGSIYK 458
Query: 361 GEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNG 420
GEMLGRTVAI+ L+ HNMQG EF QE ++L LQHPHLVTLLG CPEAWS VYEYLP+G
Sbjct: 459 GEMLGRTVAIRKLHPHNMQGSSEFHQEAQILGSLQHPHLVTLLGVCPEAWSFVYEYLPSG 518
Query: 421 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS 480
SLQD LFRKS+ PL RA+ AEIA+ LCFLHSSKPE I+HG L + +LLDS LS
Sbjct: 519 SLQDYLFRKSSFLPLTRNIRAQWIAEIATALCFLHSSKPETIIHGGLTLETVLLDSALSC 578
Query: 481 KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQL 540
KIC+FG RLV ED T PKGSF Y DPE+ RTGVLTPKSD YSFG+IILQL
Sbjct: 579 KICEFGFSRLVKED----------TEPKGSFTYTDPEFQRTGVLTPKSDIYSFGIIILQL 628
Query: 541 LTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDIT 600
LTGR PVGL GEVRRAVSCGKL ILD AG+W + +A RL +LGLQCC+L R RP++T
Sbjct: 629 LTGRTPVGLVGEVRRAVSCGKLYPILDSSAGEWNSTMATRLAELGLQCCQLNSRVRPELT 688
Query: 601 PSLVKELEQLHVAEERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSP 660
PSLV+EL+QL V EERPVPSFFLCPI QEIMHDPQVAADGFTYEGKAI +WLENG ETSP
Sbjct: 689 PSLVRELKQLLVLEERPVPSFFLCPIFQEIMHDPQVAADGFTYEGKAISEWLENGHETSP 748
Query: 661 MTNLRLSHLHLTPNHALRHAIQDWLCKS 688
MTNL+L+HL+LTPNHALR AIQ WLCKS
Sbjct: 749 MTNLKLTHLNLTPNHALRLAIQGWLCKS 776
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224106491|ref|XP_002314184.1| predicted protein [Populus trichocarpa] gi|222850592|gb|EEE88139.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 752 bits (1942), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 354/439 (80%), Positives = 397/439 (90%)
Query: 250 MRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVRWLERWRSRG 309
MRNVALL+SRAQEANRR +EA GELKLIQ SI++L+QEKQRIR+QK+EAV WLERWRS G
Sbjct: 1 MRNVALLDSRAQEANRRSEEAAGELKLIQTSISSLRQEKQRIRQQKIEAVHWLERWRSHG 60
Query: 310 QAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVA 369
QAGA+N +G +G+ E+LPE AEFSL+DLQTATCNFSESFK+GQGG GCVYKGEMLGRTVA
Sbjct: 61 QAGASNCNGILGITEELPELAEFSLSDLQTATCNFSESFKLGQGGCGCVYKGEMLGRTVA 120
Query: 370 IKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLFRK 429
IK L+ +N QGQLEFQ+EV+VL KLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLF+K
Sbjct: 121 IKRLHPNNTQGQLEFQKEVQVLGKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLFQK 180
Query: 430 SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
SN+SPL WK R RI AEI+S LCFLHSSKPEKIVHGDLKPQNILL+SELS KIC+FGICR
Sbjct: 181 SNISPLTWKIRTRIIAEISSTLCFLHSSKPEKIVHGDLKPQNILLNSELSCKICEFGICR 240
Query: 490 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGL 549
LVTED+LY PS HRS PKGSFPY DPE+ R GVLTPKSD Y+FG+IILQLLTG+ PVGL
Sbjct: 241 LVTEDSLYCPSIHRSNEPKGSFPYTDPEFQRIGVLTPKSDIYAFGVIILQLLTGKPPVGL 300
Query: 550 AGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609
G+VRR +SCGKL+SILDP AG+WP FVAR+LV L LQ CEL R+RPD+TP+LV+ELEQ
Sbjct: 301 VGKVRRTLSCGKLASILDPSAGEWPMFVARQLVYLSLQFCELRSRDRPDLTPTLVRELEQ 360
Query: 610 LHVAEERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHL 669
LHV+EERPVPS FLCPILQEIMHDPQVAADGFTYEG+A+R+WL NGRETSPMTNLRLSHL
Sbjct: 361 LHVSEERPVPSIFLCPILQEIMHDPQVAADGFTYEGEALREWLANGRETSPMTNLRLSHL 420
Query: 670 HLTPNHALRHAIQDWLCKS 688
LTPNHALR AIQDWLC++
Sbjct: 421 LLTPNHALRLAIQDWLCQT 439
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449450906|ref|XP_004143203.1| PREDICTED: U-box domain-containing protein 33-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 747 bits (1928), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 383/682 (56%), Positives = 491/682 (71%), Gaps = 25/682 (3%)
Query: 19 MKVKMGSRKASYAAKNAPMFCEIWFVNKGKHVWTKEASESPNSFLPFCGAETRSAKMLRS 78
MKVK S KA YAA+N P+ CEIWFV+KG H+WT+EA E G+ + S +LR
Sbjct: 1 MKVKKSSSKADYAARNIPLPCEIWFVDKGNHIWTREAVE---------GSCSASPSLLRE 51
Query: 79 RSL--ENCNGTSL------FNPESILSRSATTLTHVGITDWVQSDPVHM--VFPSSPTIS 128
++ ENC+ +SL FN + S SA + + + + +P H+ V SS I
Sbjct: 52 LAITKENCSQSSLVDNSHSFNQQYSHSSSANGI--IEGFNCIDKEPFHVEGVMSSSLDIH 109
Query: 129 CS---DMNLFSPRSSSAGSGYMSEKRESTDSDSKVEEDPLYVQHREVSIKAEELRNSAFA 185
+ ++ S +SS E RE T SDSKVEE L + ++ ++ E RN A A
Sbjct: 110 FTYPLRISSSSASTSSDSGYSSVEGREPTSSDSKVEERGLNGELKDAILETEASRNEAIA 169
Query: 186 EFLRRKKLESEAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQDQEKLKQEKAFVTQE 245
L +K+E EA E+I K K F+ E+ LR+E E+ L+T I+ ++ L +E+ + +E
Sbjct: 170 MHLICRKMEQEAAESIKKFKVFKCVNEHEIDLRRETEELLRTIIEKKQTLSEERTEIHEE 229
Query: 246 LHRTMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVRWLERW 305
L TM+ +ALL+S+AQE N++ +EAT EL+ IQASIA L++EKQ ++ QK+ A+ WL +W
Sbjct: 230 LESTMKTLALLDSQAQEVNQKHEEATAELRNIQASIAALKKEKQTMQSQKMNALNWLSQW 289
Query: 306 RSRGQAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLG 365
+S+ +A NY+ I ++E + EF+ +LQ ATC+FSESFK+ GG+GC+YKGEMLG
Sbjct: 290 KSQ-EASLENYNASIRVMEHQTQLIEFTFLELQMATCDFSESFKISHGGYGCLYKGEMLG 348
Query: 366 RTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDR 425
+TVAI+ L+ H + G EF++EV VL KLQHPHLVTLLG C EAWSL+YEYLP+G+LQ
Sbjct: 349 KTVAIRKLHPHYILGPAEFREEVEVLGKLQHPHLVTLLGVCTEAWSLIYEYLPHGNLQSH 408
Query: 426 LFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDF 485
LF+K N PL WK RARI AEI S LCFLHSSKPEKIVHGDLKP+NILLDSE SKICDF
Sbjct: 409 LFQKGNTPPLTWKTRARIIAEIGSALCFLHSSKPEKIVHGDLKPENILLDSEFISKICDF 468
Query: 486 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRL 545
GI RLV+E+TLY PSF RST PKG+F + DPE R GVLTPKSD YSFGLIILQLL+G+
Sbjct: 469 GIYRLVSEETLYCPSFRRSTEPKGAFSHTDPECQRDGVLTPKSDIYSFGLIILQLLSGKP 528
Query: 546 PVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 605
VGL E+R+A+S G+L S+LD AG+WP VARRLVD+GLQCCEL G +RP++TP++V+
Sbjct: 529 IVGLVIELRKAISFGRLESVLDLSAGEWPIDVARRLVDIGLQCCELKGSDRPELTPTIVR 588
Query: 606 ELEQLHVAEERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLR 665
EL+QL EERPVPS+FLCPILQEIM DPQVAADGFTYEG+AIR+W NGRETSPMTNL+
Sbjct: 589 ELKQLQNFEERPVPSYFLCPILQEIMQDPQVAADGFTYEGEAIREWFNNGRETSPMTNLK 648
Query: 666 LSHLHLTPNHALRHAIQDWLCK 687
LSHLHLTPNHA+R AIQDWLC+
Sbjct: 649 LSHLHLTPNHAVRLAIQDWLCR 670
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449496721|ref|XP_004160207.1| PREDICTED: U-box domain-containing protein 33-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 720 bits (1859), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 375/682 (54%), Positives = 480/682 (70%), Gaps = 46/682 (6%)
Query: 19 MKVKMGSRKASYAAKNAPMFCEIWFVNKGKHVWTKEASESPNSFLPFCGAETRSAKMLRS 78
MKVK S KA YAA+N P+ CEIWFV+KG H+WT+EA E G+ + S +LR
Sbjct: 1 MKVKKSSSKADYAARNIPLPCEIWFVDKGNHIWTREAVE---------GSCSASPSLLRE 51
Query: 79 RSL--ENCNGTSL------FNPESILSRSATTLTHVGITDWVQSDPVHM--VFPSSPTIS 128
++ ENC+ +SL FN + S SA + + + + +P H+ V SS I
Sbjct: 52 LAITKENCSQSSLVDNSHSFNQQYSHSSSANGI--IEGFNCIDKEPFHVEGVMSSSLDIH 109
Query: 129 CS---DMNLFSPRSSSAGSGYMSEKRESTDSDSKVEEDPLYVQHREVSIKAEELRNSAFA 185
+ ++ S +SS E RE T SDSKVEE L + ++ ++ E RN
Sbjct: 110 FTYPLRISSSSASTSSDSGYSSVEGREPTSSDSKVEERGLNGELKDAILETEASRN---- 165
Query: 186 EFLRRKKLESEAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQDQEKLKQEKAFVTQE 245
EF K F+ E+ LR+E E+ L+T I+ ++ L +E+ + +E
Sbjct: 166 EF-----------------KVFKCVNEHEIDLRRETEELLRTIIEKKQTLSEERTEIHEE 208
Query: 246 LHRTMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVRWLERW 305
L TM+ +ALL+S+AQE N++ +EAT EL+ IQASIA L++EKQ ++ QK+ A+ WL +W
Sbjct: 209 LESTMKTLALLDSQAQEVNQKHEEATAELRNIQASIAALKKEKQTMQSQKMNALNWLSQW 268
Query: 306 RSRGQAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLG 365
+S+ +A NY+ I ++E + EF+ +LQ ATC+FSESFK+ GG+GC+YKGEMLG
Sbjct: 269 KSQ-EASLENYNASIRVMEHQTQLIEFTFLELQMATCDFSESFKISHGGYGCLYKGEMLG 327
Query: 366 RTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDR 425
+TVAI+ L+ H + G EF++EV VL KLQHPHLVTLLG C EAWSL+YEYLP+G+LQ
Sbjct: 328 KTVAIRKLHPHYILGPAEFREEVEVLGKLQHPHLVTLLGVCTEAWSLIYEYLPHGNLQSH 387
Query: 426 LFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDF 485
LF+K N PL WK RARI AEI S LCFLHSSKPEKIVHGDLKP+NILLDSE SKICDF
Sbjct: 388 LFQKGNTPPLTWKTRARIIAEIGSALCFLHSSKPEKIVHGDLKPENILLDSEFISKICDF 447
Query: 486 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRL 545
GI RLV+E+TLY PSF RST PKG+F + DPE R GVLTPKSD YSFGLIILQLL+G+
Sbjct: 448 GIYRLVSEETLYCPSFRRSTEPKGAFSHTDPECQRDGVLTPKSDIYSFGLIILQLLSGKP 507
Query: 546 PVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 605
VGL E+R+A+S G+L S+LD AG+WP VARRLVD+GLQCCEL G +RP++TP++V+
Sbjct: 508 IVGLVIELRKAISFGRLESVLDLSAGEWPIDVARRLVDIGLQCCELKGSDRPELTPTIVR 567
Query: 606 ELEQLHVAEERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLR 665
EL+QL EERPVPS+FLCPILQEIM DPQVAADGFTYEG+AIR+W NGRETSPMTNL+
Sbjct: 568 ELKQLQNFEERPVPSYFLCPILQEIMQDPQVAADGFTYEGEAIREWFNNGRETSPMTNLK 627
Query: 666 LSHLHLTPNHALRHAIQDWLCK 687
LSHLHLTPNHA+R AIQDWLC+
Sbjct: 628 LSHLHLTPNHAVRLAIQDWLCR 649
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 688 | ||||||
| TAIR|locus:2050669 | 834 | AT2G45910 [Arabidopsis thalian | 0.954 | 0.787 | 0.396 | 2.8e-121 | |
| TAIR|locus:2101353 | 805 | AT3G49060 [Arabidopsis thalian | 0.933 | 0.797 | 0.353 | 1.9e-90 | |
| TAIR|locus:2117343 | 835 | AT4G25160 [Arabidopsis thalian | 0.940 | 0.774 | 0.345 | 3.5e-88 | |
| TAIR|locus:2047605 | 801 | AT2G19410 [Arabidopsis thalian | 0.683 | 0.586 | 0.400 | 9.1e-88 | |
| TAIR|locus:2176177 | 819 | AT5G51270 [Arabidopsis thalian | 0.658 | 0.553 | 0.402 | 2.4e-85 | |
| TAIR|locus:2151641 | 796 | AT5G61560 [Arabidopsis thalian | 0.949 | 0.820 | 0.330 | 3.4e-84 | |
| TAIR|locus:504954932 | 789 | AT5G57035 [Arabidopsis thalian | 0.699 | 0.609 | 0.381 | 2.9e-80 | |
| TAIR|locus:2061012 | 788 | AT2G24370 [Arabidopsis thalian | 0.590 | 0.515 | 0.392 | 1.8e-75 | |
| TAIR|locus:2143094 | 701 | AT5G12000 [Arabidopsis thalian | 0.511 | 0.502 | 0.423 | 5.9e-74 | |
| TAIR|locus:2015656 | 758 | AT1G16760 [Arabidopsis thalian | 0.920 | 0.835 | 0.323 | 1.1e-73 |
| TAIR|locus:2050669 AT2G45910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1193 (425.0 bits), Expect = 2.8e-121, P = 2.8e-121
Identities = 278/701 (39%), Positives = 400/701 (57%)
Query: 5 GIQKLVMGAFPDNCMKVKMG---SRKASYAAKNAPMFCEIWFVNKGKHVWTKEAS-ESPN 60
GI+KLVMGA D +M SRKA + + AP C+IWF KG + T+EA+ +
Sbjct: 154 GIRKLVMGAAADRHYSRRMTDLKSRKAIFVRREAPTLCQIWFTCKGYLIHTREATMDDTE 213
Query: 61 SFLPFCGAETRSAKMLRSRSLENCNGTSLFNPESILSRSATTLTHVGITDWVQSDPVHMV 120
S ++ +L++ S + +S + S L G + QS V
Sbjct: 214 SEYASPRPSISASDLLQTFSTPESEHQHISRVQS--TDSVQQLVSNG-SSTEQSGRV--- 267
Query: 121 FPSSPTISCSDMNLFSPRSSSAGSG-YMSEKRESTDSDSKVEEDPLYVQHREVSIKAEEL 179
S +++ + S S GS MS S S +D V+ R+ + +A
Sbjct: 268 --SDGSLNTDEEERESDGSEVTGSATVMSSGHSSPSSFPDGVDDSFNVKIRKATSEAHSS 325
Query: 180 RNSAFAEFLRRKKLESEAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQDQEKLKQEK 239
+ AFAE LRR+K E A++AI + K ESAY+ E+ RK+ E A+ + +K E+
Sbjct: 326 KQEAFAETLRRQKAEKNALDAIRRAKQSESAYSEELKRRKDTEIAVAKEKERFITIKNEQ 385
Query: 240 AFVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAV 299
+ +EL M A+L S+ +++ ++ +L + + L+ E++ ++ ++ A+
Sbjct: 386 EVIMEELQSAMAQKAMLESQIAKSDGTMEKLNQKLDIAVKLLQKLRDEREELQTERDRAL 445
Query: 300 RWLERWRSRGQAGAANYDGFIGLVEDLPES-AEFSLADLQTATCNFSESFKVGQGGFGCV 358
R E RS + LP+ +FS ++++ AT +F + K+G+GG+G +
Sbjct: 446 REAEELRSHAETSTLQ----------LPQYFTDFSFSEIEEATNHFDSTLKIGEGGYGSI 495
Query: 359 YKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLP 418
Y G + VAIKML ++ QG +E+QQEV VLSK++HP+++TL+GACPE WSLVYEYLP
Sbjct: 496 YVGLLRHTQVAIKMLNPNSSQGPVEYQQEVDVLSKMRHPNIITLIGACPEGWSLVYEYLP 555
Query: 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL 478
GSL+DRL K N PL W++R RIA EI + L FLHS+K +VHGDLKP NILLDS L
Sbjct: 556 GGSLEDRLTCKDNSPPLSWQNRVRIATEICAALVFLHSNKAHSLVHGDLKPANILLDSNL 615
Query: 479 SSKICDFGICRLVTEDTLYLPSFHRS--TAPKGSFPYADPEYHRTGVLTPKSDSYSFGLI 536
SK+ DFG C L+ P+ +S T G+ Y DPE +G LTPKSD YSFG+I
Sbjct: 616 VSKLSDFGTCSLLH------PNGSKSVRTDVTGTVAYLDPEASSSGELTPKSDVYSFGII 669
Query: 537 ILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRER 596
+L+LLTGR + ++ EV+ A+ G L+ +LDPLAGDWP A +L L L+CCE R
Sbjct: 670 LLRLLTGRPALRISNEVKYALDNGTLNDLLDPLAGDWPFVQAEQLARLALRCCETVSENR 729
Query: 597 PDITPSLVKELEQL----------HVA--EERPVPSFFLCPILQEIMHDPQVAADGFTYE 644
PD+ + + LE + H+ E R P +F+CPI QE+M DP VAADGFTYE
Sbjct: 730 PDLGTEVWRVLEPMRASSGGSSSFHLGRNEHRIAPPYFICPIFQEVMQDPHVAADGFTYE 789
Query: 645 GKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDWL 685
+AIR WL++ +TSPMTN++LSH L NHALR AIQ+WL
Sbjct: 790 AEAIRAWLDSEHDTSPMTNVKLSHTSLIANHALRSAIQEWL 830
|
|
| TAIR|locus:2101353 AT3G49060 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 902 (322.6 bits), Expect = 1.9e-90, P = 1.9e-90
Identities = 254/718 (35%), Positives = 377/718 (52%)
Query: 4 HGIQKLVMGAFPDNCMKVKMG---SRKASYAAKNAPMFCEIWFVNKGKHVWTKEASESPN 60
H I+ LVMGA D KM S+KA + K AP C IWF+ KG ++T+ +++ N
Sbjct: 123 HKIKWLVMGAASDKHYSWKMTDLKSKKAIFVCKKAPDSCHIWFLCKGYLIFTRASNDDSN 182
Query: 61 S---FLPFCGAETRSAKMLRSRSLENCNGTSLFNPESILSRSATTLTHVGITDWVQSDPV 117
+ P ++ + + +S LE+ S RS L G D Q +
Sbjct: 183 NRQTMPPLVQLDSDN-ETRKSEKLES----SYMRRRLRYWRSL--LEQDGEKDTGQLER- 234
Query: 118 HMVFPSSPTISCSDMNLFSPRSSSA-GSGYMSE--KRESTDSD----SKVEE-----DPL 165
V P +P LFS SSS+ G E E DSD S VEE D
Sbjct: 235 EKVEPRAPP-------LFSSGSSSSFGEPVGPEPVSPELVDSDTLNTSNVEEKEREGDVA 287
Query: 166 YVQHREVSIKAE--ELRNSAFAEFLRRKKLESEAMEAIGKVKAFESAYAREMHLRKEAED 223
HR + + + + E ++ + ++ EA+ K KA E +E RK E+
Sbjct: 288 RKVHRYDKAMHDIGQSDRTVYGEAGKKWEEDASTTEALCKAKALEGLCIKESSQRKRLEE 347
Query: 224 ALQTT-IQDQEKLKQEKAFVTQELHRTM-RNVALLNSRAQEANRRRDEATGELKLIQASI 281
L+ ++ + ++Q F+ +EL RN+ L S+ ++ E + +
Sbjct: 348 LLEKEKLEVKMVIEQNNGFM-KELQMVQGRNLKL-ESQMRKLQDLEKEHGEKFDTAMELL 405
Query: 282 ATLQQEKQRIRRQKVEAVRWLERWRS--RGQAGAANYDGFIGLVEDLPESAEFSLADLQT 339
+ +Q++ IR AV+ + R +G+ G ++ G E ++S ++
Sbjct: 406 KSFRQKRDEIRIDHENAVKEVNALRRLVKGETGESS-----G-----SEMLDYSFMEINE 455
Query: 340 ATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHL 399
AT F S+K+G+G +G VYKG + VA+KML S+ EF++ V +LS+++HP+L
Sbjct: 456 ATNEFDPSWKLGEGKYGSVYKGNLQHLQVAVKMLPSYGSLNHFEFERRVEILSRVRHPNL 515
Query: 400 VTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 459
VTL+GACPE+ SL+Y+Y+PNGSL+D ++NV L W+ R RIA+EI S L FLHS+ P
Sbjct: 516 VTLMGACPESRSLIYQYIPNGSLEDCFSSENNVPALSWESRIRIASEICSALLFLHSNIP 575
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 519
I+HG+LKP ILLDS L +KI D+GI +L+ D L S P+ DP Y
Sbjct: 576 -CIIHGNLKPSKILLDSNLVTKINDYGISQLIPIDGL-----------DKSDPHVDPHYF 623
Query: 520 RTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVAR 579
+ +T +SD Y+FG+I+LQLLT R G+ +V+ A+ +S++LD AGDWP +
Sbjct: 624 VSREMTLESDIYAFGIILLQLLTRRPVSGILRDVKCALENDNISAVLDNSAGDWPVARGK 683
Query: 580 RLVDLGLQCCELYGRERPDITPSL----------VKELEQLHVAEE---RPVPSFFLCPI 626
+L ++ ++CC+ RPD+ L V E A + R PS +LCPI
Sbjct: 684 KLANVAIRCCKKNPMNRPDLAVVLRFIDRMKAPEVPSSETSSYANQNVPRRPPSHYLCPI 743
Query: 627 LQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDW 684
QE+M DP +AADGFTYE +AIR+WL NG +TSPMTNL++ +L PNHAL AIQDW
Sbjct: 744 FQEVMKDPLIAADGFTYEAEAIREWLANGHDTSPMTNLKMEDCNLIPNHALHLAIQDW 801
|
|
| TAIR|locus:2117343 AT4G25160 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 860 (307.8 bits), Expect = 3.5e-88, Sum P(2) = 3.5e-88
Identities = 241/698 (34%), Positives = 359/698 (51%)
Query: 25 SRKA---SYAAKNAPMFCEIWFVNKGKHVWTKEASESPNSFLPFCGAETRSAKMLRSRSL 81
SRKA S + P FC ++ V+KGK + + N+ + G+E ++ S
Sbjct: 147 SRKADICSVISALMPNFCTVYVVSKGKLSCVRPSDSDGNATIREDGSERTNSSSGSSGPT 206
Query: 82 ENCNG--TSLFNPESI-LSRSATTLTHVGITDWVQSDPVHMVFPSSPTISCSDMNLFSPR 138
+ + +S + +S LS + H S P+ S C ++ R
Sbjct: 207 SDSSDVMSSAHDSQSRPLSLPVRRMQHFPAIAGQASVPMETSSVGSDETRCMSLDAEEAR 266
Query: 139 SSSAGSGYMSEKRESTDSDSKVEEDPLYVQHREVSIKAEELRNSAFAEFLRRKKLESEAM 198
S S R STD+ S+ + R+ ++ + N + F R +
Sbjct: 267 DVS------SINRSSTDTTSRWTPRRRDYEERKEAMSSSS-SNREYGNFGTRFSWSGMGV 319
Query: 199 EAIGKVKAFESAYAREMHLRKEAEDALQTTIQ-DQEKLKQEKAFVTQELHRTMRNVALLN 257
+ +A + A L +++ Q + + EKL+ E V QE++ +
Sbjct: 320 DTTHS-RASQQASNMSDALSEQSYTDNQVNLNFEVEKLRAELRHV-QEMYAVAQTETFDA 377
Query: 258 SRAQ-EANRRR-DEATG--ELKLIQASIATL-QQEKQRIR--RQKVEAVRW--------- 301
SR E N+RR +EA ELKL + L ++EKQ R+ E++R
Sbjct: 378 SRKLGELNQRRLEEAIKLEELKLKEYEARELAEKEKQNFEKARRDAESMRERAEREIAQR 437
Query: 302 --LERWRSRGQAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVY 359
ER +R +G +G + + F+ ++ AT +FSE K+G G +G VY
Sbjct: 438 REAERKSARDTKEKEKLEGTLGSPQ--LQYQHFAWEEIMAATSSFSEELKIGMGAYGAVY 495
Query: 360 KGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPN 419
K + T +K+L S Q +FQQE+ +LSK++HPHLV LLGACPE +LVYEY+ N
Sbjct: 496 KCNLHHTTAVVKVLQSAENQLSKQFQQELEILSKIRHPHLVLLLGACPEQGALVYEYMEN 555
Query: 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELS 479
GSL+DRLF+ +N PL W +R RIA E+A+ L FLH SKP+ I+H DLKP NILLD
Sbjct: 556 GSLEDRLFQVNNSPPLPWFERFRIAWEVAAALVFLHKSKPKPIIHRDLKPANILLDHNFV 615
Query: 480 SKICDFGICRLVTEDTLYLP-SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIIL 538
SK+ D G+ +V D L + ++ T+P G+ Y DPEY RTG ++ KSD YSFG+I+L
Sbjct: 616 SKVGDVGLSTMVQVDPLSTKFTIYKQTSPVGTLCYIDPEYQRTGRISSKSDIYSFGMILL 675
Query: 539 QLLTGRLPVGLAGEVRRAV-SCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERP 597
QLLT + + L V A+ S + ILD AG+WP R L L L C EL G++RP
Sbjct: 676 QLLTAKPAIALTHFVESAMDSNDEFLKILDQKAGNWPIEETRELAALALCCTELRGKDRP 735
Query: 598 DITPSLVKELEQLH-VAEE----------RPVPSFFLCPILQEIMHDPQVAADGFTYEGK 646
D+ ++ LE L VAE+ +P P+ F+CP+L+++M++P VAADG+TY+
Sbjct: 736 DLKDQILPALENLKKVAEKARNSFSGVSTQP-PTHFICPLLKDVMNEPCVAADGYTYDRH 794
Query: 647 AIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDW 684
AI +WL+ TSPMT+ L +L PN+ L AI +W
Sbjct: 795 AIEEWLKE-HNTSPMTDSPLHSKNLLPNYTLYTAIMEW 831
|
|
| TAIR|locus:2047605 AT2G19410 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 855 (306.0 bits), Expect = 9.1e-88, Sum P(2) = 9.1e-88
Identities = 198/494 (40%), Positives = 287/494 (58%)
Query: 209 SAYAREMHLRKEAEDALQTTIQDQEKLKQEKAFVTQELHRTMRNVALLNSRAQEANRRRD 268
S ++++ + +E E L+ +Q K ++A +EL T V +L++ ++R +
Sbjct: 303 SRKSKKVEIEEEVE-RLKNELQSTV-FKYKQA--CEELFSTQNKVKMLSTEYLNESKRVN 358
Query: 269 EATGELKLIQASIATLQQEKQRIRRQKVEAVR-WLERWRSRGQAGAAN----YDGFIGLV 323
A E + +Q + A L++E+ ++VE + L R + Q N Y ++
Sbjct: 359 NAV-EKEELQRNTAALEKERYMKAVKEVETAKALLAREFCQRQIAEVNALRTYLEKKKVI 417
Query: 324 EDLPES----AEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQ 379
+ L + ++++ ++ TAT FS +G+GG+G VY+ + A+K++ +
Sbjct: 418 DQLLGTDHRYRKYTIEEIVTATEGFSPEKVIGEGGYGKVYQCSLDSTPAAVKVVRLDTPE 477
Query: 380 GQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKD 439
+ EF +EV VLS+L+HPH+V LLGACPE LVYEYL NGSL++ +F + N PL W
Sbjct: 478 KKQEFLKEVEVLSQLRHPHVVLLLGACPENGCLVYEYLENGSLEEYIFHRKNKPPLPWFI 537
Query: 440 RARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499
R R+ E+A GL FLHSSKPE IVH DLKP NILL+ SKI D G+ +LVT+
Sbjct: 538 RFRVIFEVACGLAFLHSSKPEPIVHRDLKPGNILLNRNYVSKIADVGLAKLVTDVAPDNV 597
Query: 500 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC 559
+ +R++ G+ Y DPEYHRTG + PKSD Y+FG+IILQLLT R P G+ V AV
Sbjct: 598 TMYRNSVLAGTLHYIDPEYHRTGTIRPKSDLYAFGIIILQLLTARNPSGIVPAVENAVKK 657
Query: 560 GKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL------HVA 613
G L+ +LD DWP L +GL+C E R+RPD+ ++ L++L V
Sbjct: 658 GTLTEMLDKSVTDWPLAETEELARIGLKCAEFRCRDRPDLKSEVIPVLKRLVETANSKVK 717
Query: 614 EERP---VPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLH 670
+E PS + CPIL+EIM +P++AADGFTYE KAI WLE SP+T +L H
Sbjct: 718 KEGSNLRAPSHYFCPILREIMEEPEIAADGFTYERKAILAWLEK-HNISPVTRQKLDHFK 776
Query: 671 LTPNHALRHAIQDW 684
LTPNH LR AI+DW
Sbjct: 777 LTPNHTLRSAIRDW 790
|
|
| TAIR|locus:2176177 AT5G51270 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 823 (294.8 bits), Expect = 2.4e-85, Sum P(2) = 2.4e-85
Identities = 191/475 (40%), Positives = 279/475 (58%)
Query: 231 DQEKLKQEKAFVTQELHRTMRNVALLNSRAQEANRRRDEAT-GELKLIQ---ASIATLQQ 286
D + E + + EL A+ +A+R+ +E EL L++ IA +
Sbjct: 341 DNQDTLNEISKLRAELRHAHEMYAVAQVETLDASRKLNELKFEELTLLEHETKGIAKKET 400
Query: 287 EK-QRIRRQKVEAVRWLE-RWRSRGQAGAANYDGFIGLVEDLPESAEFSLADLQTATCNF 344
EK ++ RR++ EA + E ++ +A LV + EF+ ++ AT +F
Sbjct: 401 EKFEQKRREEREAAQRREAEMKATHEAKEKEKLEESSLVAPKLQYQEFTWEEIINATSSF 460
Query: 345 SESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLG 404
SE K+G G +G VYK + A+K+L+S +F QE+ +LSK++HPHLV LLG
Sbjct: 461 SEDLKIGMGAYGDVYKCNLHHTIAAVKVLHSAESSLSKQFDQELEILSKIRHPHLVLLLG 520
Query: 405 ACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
ACP+ +LVYEY+ NGSL+DRLF+ ++ P+ W R RIA E+AS L FLH SKP I+H
Sbjct: 521 ACPDHGALVYEYMENGSLEDRLFQVNDSQPIPWFVRLRIAWEVASALVFLHKSKPTPIIH 580
Query: 465 GDLKPQNILLDSELSSKICDFGICRLV-TEDTLYLP-SFHRSTAPKGSFPYADPEYHRTG 522
DLKP NILL+ SK+ D G+ ++ D L + ++ T+P G+ Y DPEY RTG
Sbjct: 581 RDLKPANILLNHNFVSKVGDVGLSTMIQAADPLSTKFTMYKQTSPVGTLCYIDPEYQRTG 640
Query: 523 VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCG---KLSSILDPLAGDWPTFVAR 579
++PKSD Y+FG+IILQLLTG+ + L V A+ +L ILD AG+WP R
Sbjct: 641 RISPKSDVYAFGMIILQLLTGQQAMALTYTVETAMENNNDDELIQILDEKAGNWPIEETR 700
Query: 580 RLVDLGLQCCELYGRERPDITPSLVKELEQLH-VAEER-------PV--PSFFLCPILQE 629
+L L LQC EL ++RPD+ ++ LE L VA++ P PS F CP+L++
Sbjct: 701 QLAALALQCTELRSKDRPDLEDQILPVLESLKKVADKARNSLSAAPSQPPSHFFCPLLKD 760
Query: 630 IMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDW 684
+M +P +AADG+TY+ +AI +W+EN R TSP+TN L +++L PNH L AI +W
Sbjct: 761 VMKEPCIAADGYTYDRRAIEEWMENHR-TSPVTNSPLQNVNLLPNHTLYAAIVEW 814
|
|
| TAIR|locus:2151641 AT5G61560 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 843 (301.8 bits), Expect = 3.4e-84, P = 3.4e-84
Identities = 234/709 (33%), Positives = 371/709 (52%)
Query: 4 HGIQKLVMGAFPDNCMKVKMG-SRKASYAAKNAPMFCEIWFVNKGKHVWTKEASESPNSF 62
HGI +LV+GA K+ S +S A P FC + ++KGK + +++ +
Sbjct: 110 HGISELVIGASSSIIFSWKLKRSNLSSRIADATPRFCSVHVISKGKLLNVRKSDMDTETS 169
Query: 63 LPFCGAETRSAKMLRSRSLENCNGTSLFNPESILSRSATTLTHVGITDWVQSDPVHMVFP 122
+ +E+R + S ++ + + F+ +L + LT V V
Sbjct: 170 IADDRSESRFSSDSHSGTVSSTSSHQ-FSSTPLLFQRIQALTTVN----------QKVGT 218
Query: 123 SSPTISCSDMNLFSPRSSSAG---SGYMSEKRESTDSDSKVEEDPLYVQHREVSIKAEEL 179
+ + + R+ S S +++K S S + + S E
Sbjct: 219 NIGKQNNEPHHHHHNRAGSLDVDESKLLNQKGFYRTSSSGIGYGGSDISSWRSSQMEEAS 278
Query: 180 RNSAFAEFLRRKKLESEAMEAIGKVKAFESAYAREMHLRKEAE--DALQTTIQDQEKLKQ 237
+S +++ + E + K+K E + + M+ ++E DA + +QD + +
Sbjct: 279 SSSTYSDPTSSSSQIHKDFE-LEKLK-IELRHIKGMYAVAQSEVIDASKK-MQDLNQRRS 335
Query: 238 EKAFVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVE 297
E+A T+ + T+R + + R+++A E +L++ I +R +++E
Sbjct: 336 EEA--TRLKNLTIREEEA-DEVVEMERERQEDAENEAELVRECI-------ERETEERLE 385
Query: 298 AVRWLERWRSRGQAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGC 357
A E R Q +G G ++ + +F ++ AT +FS+ K+G GG+G
Sbjct: 386 AEARAEEVRKEKQRLEDALEG--GPLQR-QQYMKFEWEEIVEATSSFSDELKIGVGGYGS 442
Query: 358 VYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYL 417
VY+ + TVA+K+L+S +F QE+ +LSK++HPHL+ LLGACPE SLVYEY+
Sbjct: 443 VYRCNLHHTTVAVKVLHSDKSSLTKQFHQELEILSKIRHPHLLLLLGACPERGSLVYEYM 502
Query: 418 PNGSLQDRLF-RKSNVS-----PLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQN 471
NGSL++RL R+ NV PL W +R RIA EIAS L FLH+++P IVH DLKP N
Sbjct: 503 HNGSLEERLMKRRPNVDTPQPPPLRWFERFRIAWEIASALYFLHTNEPRPIVHRDLKPAN 562
Query: 472 ILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSY 531
ILLD SKI D G+ ++V D + + T P G+F Y DPEY RTGV+TP+SD Y
Sbjct: 563 ILLDRNNVSKIGDVGLSKMVNLDPSHASTVFNETGPVGTFFYIDPEYQRTGVVTPESDIY 622
Query: 532 SFGLIILQLLTGRLPVGLAGEVRRAV--SCGKLSSILDPLAGDWPTFVARRLVDLGLQCC 589
+FG+I+LQL+T R +GLA + +A+ GK + ILD AGDWP A+ +V +GL+C
Sbjct: 623 AFGIILLQLVTARSAMGLAHSIEKALRDQTGKFTEILDKTAGDWPVKEAKEMVMIGLRCA 682
Query: 590 ELYGRERPDITPSLVKELEQL-HVAE-------------ERPVPSFFLCPILQEIMHDPQ 635
E+ R+RPD+ ++ LE+L VA P+ F CPI +++M +P
Sbjct: 683 EMRKRDRPDLGKEILPVLERLKEVASIARNMFADNLIDHHHNAPTHFYCPITKDVMENPC 742
Query: 636 VAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDW 684
VA+DG+TYE +AI++WL+ + SPMT+L L PNH+L AI++W
Sbjct: 743 VASDGYTYEKRAIKEWLQKNHK-SPMTDLPFPSDSLLPNHSLLSAIKEW 790
|
|
| TAIR|locus:504954932 AT5G57035 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 806 (288.8 bits), Expect = 2.9e-80, P = 2.9e-80
Identities = 189/496 (38%), Positives = 281/496 (56%)
Query: 204 VKAFESAYAREMH-LRKEAEDALQTTIQDQEKLKQEKAFVTQELHRTMRNVALLNSRAQE 262
+K +S E+ LRKE + L Q E+L ++ V ++ + + ++
Sbjct: 287 LKTPKSGVRAEVEQLRKEVQTTLSMYKQACEELVHKQTQVQSLSSECIKETERVITALEK 346
Query: 263 ANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEA-VRWLERWRSRGQAGAANYDGFIG 321
RR A E + ++ +++ K + ++ E + L+ + + F+
Sbjct: 347 EEMRRKAAAEEKEKHLKAVKEVEEAKSMLAKEFCERQLAELDALKQSIEKQKVIEQLFL- 405
Query: 322 LVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQ 381
D +++ ++ AT NFS +G+GG+G VYK + VA+K+L +++ +
Sbjct: 406 --RD-GRYRKYTKEEIAAATDNFSSRKIIGEGGYGKVYKCSLDHTPVALKVLKPDSVEKK 462
Query: 382 LEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRA 441
EF +E+ VLS+L+HPH+V LLGACPE LVYEY+ NGSL + K L W R
Sbjct: 463 EEFLKEISVLSQLRHPHVVLLLGACPENGCLVYEYMENGSLDCHISPKKGKPSLSWFIRF 522
Query: 442 RIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 501
RI E A GL FLH+SKPE IVH DLKP NILLD SKI D G+ +L++++ +
Sbjct: 523 RIIYETACGLAFLHNSKPEPIVHRDLKPGNILLDRNFVSKIGDVGLAKLMSDEAPDSVTV 582
Query: 502 HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGK 561
+R++ G+ Y DPEY RTG + PKSD Y+FG+IILQLLT R P GL V AV G
Sbjct: 583 YRNSIIAGTLYYMDPEYQRTGTIRPKSDLYAFGIIILQLLTARHPNGLLFCVEDAVKRGC 642
Query: 562 LSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDIT----PSLVKELEQLH--VAEE 615
+LD DWP A+ L + ++C +L R+RPD++ P+L + LE + + E
Sbjct: 643 FEDMLDGSVKDWPIAEAKELARIAIRCSQLKCRDRPDLSTQVLPALKRILESANSRLKTE 702
Query: 616 RP---VPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLT 672
+ P+ + CPIL+EIM DPQ+AADGFTYE KAI++W++ ++ SP+T RL H LT
Sbjct: 703 QANARAPTHYYCPILKEIMEDPQIAADGFTYERKAIKEWIQKHQDVSPVTKHRLKHSDLT 762
Query: 673 PNHALRHAIQDWLCKS 688
PNH LR AI++W +S
Sbjct: 763 PNHTLRSAIREWRSRS 778
|
|
| TAIR|locus:2061012 AT2G24370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 691 (248.3 bits), Expect = 1.8e-75, Sum P(3) = 1.8e-75
Identities = 168/428 (39%), Positives = 243/428 (56%)
Query: 195 SEAMEAIGKVKA------FESAYAREMHLRKEAEDALQTTIQDQEKLKQEKAFVTQELHR 248
S A ++I V+A E EM+ ++AL T Q +L++ K ++L
Sbjct: 340 SSASQSIDDVEAEMRRLKLELKQTMEMY-STACKEAL-TAKQKATELQRWKLEEERKLEE 397
Query: 249 TMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVRWLERWRSR 308
RN E + + +A E IA L+ +K R+ + ++A++ E +++
Sbjct: 398 A-RNAEEAALAIAEKEKAKSKAAMEAAEAAQRIAELEAKK-RVNAE-MKALKESEE-KTK 453
Query: 309 GQAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTV 368
AN D ++S+ D++ AT F+E +K+G+GG+G VYK + V
Sbjct: 454 ALTALANSD---------VRYRKYSIEDIELATEFFAEKYKIGEGGYGPVYKCYLDHTPV 504
Query: 369 AIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLFR 428
A+K+L QG+ +FQQEV VLS ++HP++V LLGACPE LVYE++ NGSL+DRLFR
Sbjct: 505 AVKVLRPDAAQGRSQFQQEVEVLSCIRHPNMVLLLGACPECGCLVYEFMANGSLEDRLFR 564
Query: 429 KSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 488
N PL W+ R RIAAEI +GL FLH +KPE +VH DLKP NILLD SKI D G+
Sbjct: 565 LGNSPPLSWQMRFRIAAEIGTGLLFLHQAKPEPLVHRDLKPGNILLDRNFVSKISDVGLA 624
Query: 489 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVG 548
RLV + +R T+ G+F Y DPEY +TG+L KSD YS G++ LQL+T + P+G
Sbjct: 625 RLVPPTVADTVTQYRMTSTAGTFCYIDPEYQQTGMLGVKSDIYSLGIMFLQLITAKPPMG 684
Query: 549 LAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608
L V RA+ G L +LDP+ DWP L L+C EL ++RPD+ ++ EL
Sbjct: 685 LTHYVERALEKGTLVDLLDPVVSDWPMEDTEEFAKLALKCAELRRKDRPDLAKVILPELN 744
Query: 609 QLH-VAEE 615
+L +A+E
Sbjct: 745 RLRTLADE 752
|
|
| TAIR|locus:2143094 AT5G12000 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 703 (252.5 bits), Expect = 5.9e-74, Sum P(2) = 5.9e-74
Identities = 155/366 (42%), Positives = 217/366 (59%)
Query: 256 LNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRR-----QKVEAVRWLERWRSRGQ 310
LN E RR +EA +A++A + EK + R +K + + LE R +
Sbjct: 326 LNQWKMEEARRFEEARNAE---EAALAVAEMEKAKCRAALEAAEKAQRMAELEGQRRKQA 382
Query: 311 AGAANYDG------FIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEML 364
A + LV++ ++S+ +++ AT F+ + K+G+GG+G VY G +
Sbjct: 383 EMKARRESQEKDRALSALVQNDVRYRKYSIDEIEVATERFANNRKIGEGGYGPVYHGTLD 442
Query: 365 GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQD 424
VAIK+L QG+ +FQQEV VLS ++HPH+V LLGACPE LVYE++ NGSL+D
Sbjct: 443 HTPVAIKVLRPDAAQGKKQFQQEVEVLSSIRHPHMVLLLGACPEYGCLVYEFMDNGSLED 502
Query: 425 RLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICD 484
RLFR+ N PL W+ R +IAAEIA+ L FLH +KPE +VH DLKP NILLD SKI D
Sbjct: 503 RLFRRGNSPPLSWRKRFQIAAEIATALSFLHQAKPEPLVHRDLKPANILLDKNYVSKISD 562
Query: 485 FGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 544
G+ RLV + + T+ G+F Y DPEY +TG LT KSD +S G+++LQ++T +
Sbjct: 563 VGLARLVPASVANTVTQYHMTSAAGTFCYIDPEYQQTGKLTTKSDIFSLGIMLLQIITAK 622
Query: 545 LPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 604
P+GLA V RA+ G +LDP+ DWP A L L+C EL R+RPD+ +V
Sbjct: 623 SPMGLAHHVSRAIDKGTFKDMLDPVVPDWPVEEALNFAKLCLRCAELRKRDRPDLGKEIV 682
Query: 605 KELEQL 610
EL +L
Sbjct: 683 PELLRL 688
|
|
| TAIR|locus:2015656 AT1G16760 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 744 (267.0 bits), Expect = 1.1e-73, P = 1.1e-73
Identities = 216/667 (32%), Positives = 331/667 (49%)
Query: 1 MNIHGIQKLVMGAFPDNCMKVKMGSRKASYAAKNAPMFCEIWFVNKGKHVWTKEASE-SP 59
+ + I+ LV+GA N + + + +K AP FC ++ ++KGK + AS +P
Sbjct: 111 VTVSAIENLVLGAPSRNSFMRRFKTDLPTSVSKAAPDFCNVYVISKGKISSLRNASRLAP 170
Query: 60 NSFLPFCGAETRSAKMLR-SRSLENCNGTSLFNPESILSRSATTLTHVGITDWVQSDPVH 118
+ P +E + + R + N +L P+ S + +T +G+ + H
Sbjct: 171 --YHPSVLSEVDDHETIAIERKHKTANTPAL--PKGRRSIDSD-VTRLGLP---KPPHGH 222
Query: 119 MVFPSSPTISCSDMNLFSP-RSSSAGSGYMSEKRESTDSDSKVEEDPLYVQHREVSIKAE 177
M + S S+ + S + S+ ++S R S D S + P + +S +E
Sbjct: 223 MKLMGDFSDSESEFSFISASQQESSDLSFISSGRPSVDRSSFTYDLPESARTSRMSTSSE 282
Query: 178 ELRNSAFAEFLRRKKLESEAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQDQEKLKQ 237
+ S + L K + + V ES + D + + +LKQ
Sbjct: 283 Q---SIGSHRLGIKFTDLSYLNGSSSVSD-ESGRTSCSFSSQSLNDVEAQMKRLRLELKQ 338
Query: 238 EKAFVTQELHR--TMRNVALLNSRAQEANRRRDEATGELKLIQA---SIATLQQEKQRIR 292
+ T RN A + + RR E ELK+ + SI ++ K +
Sbjct: 339 TMDMYSSACREALTARNEATELQKLRTEEERRLE---ELKMTEETAMSIVENERAKAKTA 395
Query: 293 RQKVEAVRWLERWRSRGQAGAA-----NYDGFIGLVEDLPESAEFSLADLQTATCNFSES 347
+ EA L ++ + A D F + ++S+ +++ T NF+ES
Sbjct: 396 LEAAEAANRLAEVEAKRRVHAEMKVLKESDSFSR--HSIVRYRKYSVQEIEEGTANFAES 453
Query: 348 FKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
KVG+GG+G V++G + +VA+K+L QG+ +F +EV VLS ++HP++V LLGACP
Sbjct: 454 RKVGEGGYGPVFRGHLDHTSVAVKVLRPDAAQGRSQFHKEVEVLSCIRHPNMVLLLGACP 513
Query: 408 EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDL 467
E LVYEY+ GSL DRLFR+ N P+ W+ R RIAAEIA+GL FLH +KPE IVH DL
Sbjct: 514 EYGILVYEYMARGSLDDRLFRRGNTPPISWQLRFRIAAEIATGLLFLHQTKPEPIVHRDL 573
Query: 468 KPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPK 527
KP N+LLD SKI D G+ RLV + + R T+ G+F Y DPEY +TG+L K
Sbjct: 574 KPGNVLLDHNYVSKISDVGLARLVPAVAENVTQY-RVTSAAGTFCYIDPEYQQTGMLGVK 632
Query: 528 SDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQ 587
SD YS G+++LQLLT + P+GLA V +A+ G L +LDP DWP A L L LQ
Sbjct: 633 SDVYSLGIMLLQLLTAKQPMGLAYYVEQAIEEGTLKDMLDPAVPDWPLEEALSLAKLSLQ 692
Query: 588 CCELYGRERPDITPSLVKELEQLHVAEERPVPSFFLCPILQEIMHDPQVAADGF-TYEGK 646
C EL ++RPD+ ++ EL +L E + S + + H QV+ + GK
Sbjct: 693 CAELRRKDRPDLGKEVMPELSRLREIGEESLDSVYYAGQGRS-SHPSQVSYTSVRVFNGK 751
Query: 647 AIR-DWL 652
+ DW+
Sbjct: 752 TLTSDWM 758
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 6.3.2 | 0.691 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00024341001 | SubName- Full=Chromosome chr6 scaffold_3, whole genome shotgun sequence; (820 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 688 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-49 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-44 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-43 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 6e-42 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 9e-42 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-41 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-37 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-35 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 5e-33 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-31 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 5e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-29 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-28 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-27 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 7e-26 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 5e-25 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-24 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-24 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 3e-24 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-24 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-23 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-23 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 2e-22 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-22 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-22 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-21 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-21 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-21 | |
| smart00504 | 63 | smart00504, Ubox, Modified RING finger domain | 7e-21 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-20 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-20 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 1e-20 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-20 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-20 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 3e-20 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-20 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-19 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 1e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-19 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 4e-19 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 5e-19 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-18 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 3e-18 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-18 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-18 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 3e-18 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-18 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 6e-18 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-18 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 7e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 8e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-17 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-17 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-17 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-17 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-17 | |
| pfam04564 | 73 | pfam04564, U-box, U-box domain | 3e-17 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-17 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 3e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-17 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 4e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-17 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-17 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-16 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-16 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-16 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-16 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-16 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-16 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 3e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 4e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 4e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-16 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-16 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 4e-16 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 4e-16 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-16 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-16 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 6e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 7e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-16 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-15 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-15 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-15 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-15 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-15 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 3e-15 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-15 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-15 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-15 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-14 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-14 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-14 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 1e-14 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-14 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-14 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 3e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-14 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-14 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-14 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 6e-14 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 6e-14 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-14 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 1e-13 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-13 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-13 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-13 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 2e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-13 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 5e-13 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 5e-13 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 5e-13 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 7e-13 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 7e-13 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-13 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 9e-13 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 1e-12 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-12 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-12 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-12 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-12 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-12 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-12 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-12 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-12 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 3e-12 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-12 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 4e-12 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 5e-12 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-12 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-12 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 7e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 8e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 9e-12 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-11 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-11 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-11 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-11 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-11 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-11 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 2e-11 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-11 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-11 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 7e-11 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-10 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-10 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-10 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-10 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 3e-10 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-10 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-10 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-10 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-10 | |
| cd01989 | 146 | cd01989, STK_N, The N-terminal domain of Eukaryoti | 7e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 7e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 9e-10 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-09 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-09 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-09 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-09 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 3e-09 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 3e-09 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-09 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-09 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-09 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-09 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-09 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 8e-09 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 9e-09 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 9e-09 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-08 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-08 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-08 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-08 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-08 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 2e-08 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-08 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-08 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-08 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 3e-08 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 4e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-08 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-08 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 5e-08 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 5e-08 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 6e-08 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 9e-08 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-07 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 1e-07 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-07 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-07 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-07 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-07 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-07 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-07 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-07 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 4e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 4e-07 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-07 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 6e-07 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-07 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 9e-07 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 1e-06 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-06 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-06 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-06 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-06 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 2e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-06 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 3e-06 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-06 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 4e-06 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 5e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-06 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 5e-06 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-05 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 1e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-05 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-05 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-05 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-05 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 6e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-05 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 1e-04 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 1e-04 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-04 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-04 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-04 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 2e-04 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-04 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-04 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-04 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 5e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 5e-04 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 8e-04 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 0.001 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 0.001 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 0.001 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.001 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.001 | |
| TIGR02168 | 1179 | TIGR02168, SMC_prok_B, chromosome segregation prot | 0.002 | |
| pfam13445 | 55 | pfam13445, zf-RING_LisH, RING-type zinc-finger, Li | 0.002 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.002 | |
| PRK01156 | 895 | PRK01156, PRK01156, chromosome segregation protein | 0.002 | |
| COG1196 | 1163 | COG1196, Smc, Chromosome segregation ATPases [Cell | 0.003 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 0.003 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.003 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 171 bits (436), Expect = 2e-49
Identities = 75/198 (37%), Positives = 104/198 (52%), Gaps = 18/198 (9%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGAC 406
+G+GGFG VY G+ VAIK++ + LE +E+ +L KL HP++V L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 407 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
LV EY GSL+D L K N L + RI +I GL +LHS I+H
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLL--KENEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 465 GDLKPQNILLDSELSS-KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR-TG 522
DLKP+NILLDS+ K+ DFG+ +L+T D L + G+ Y PE G
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI------VGTPAYMAPEVLLGKG 169
Query: 523 VLTPKSDSYSFGLIILQL 540
+ KSD +S G+I+ +L
Sbjct: 170 YYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 4e-44
Identities = 67/203 (33%), Positives = 100/203 (49%), Gaps = 18/203 (8%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGA 405
K+G+G FG VY G+ VAIK++ ++ E +E+++L KL+HP++V L
Sbjct: 6 KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDV 65
Query: 406 C--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
+ LV EY G L D L ++ +S + +I S L +LHS + IV
Sbjct: 66 FEDEDKLYLVMEYCEGGDLFDLLKKRGRLSE---DEARFYLRQILSALEYLHS---KGIV 119
Query: 464 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV 523
H DLKP+NILLD + K+ DFG+ R + T G+ Y PE
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKL-------TTFVGTPEYMAPEVLLGKG 172
Query: 524 LTPKSDSYSFGLIILQLLTGRLP 546
D +S G+I+ +LLTG+ P
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPP 195
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 1e-43
Identities = 76/211 (36%), Positives = 107/211 (50%), Gaps = 25/211 (11%)
Query: 349 KVGQGGFGCVYKGEMLGR------TVAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVT 401
K+G+G FG VYKG + G VA+K L + + EF +E ++ KL HP++V
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 402 LLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 459
LLG C E +V EY+P G L D L + + L KD ++A +IA G+ +L S
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLESKN- 122
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADP 516
VH DL +N L+ L KI DFG+ R + ED Y G P A P
Sbjct: 123 --FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYR------KRGGGKLPIKWMA-P 173
Query: 517 EYHRTGVLTPKSDSYSFGLIILQLLT-GRLP 546
E + G T KSD +SFG+++ ++ T G P
Sbjct: 174 ESLKDGKFTSKSDVWSFGVLLWEIFTLGEQP 204
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 2e-43
Identities = 82/262 (31%), Positives = 122/262 (46%), Gaps = 25/262 (9%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSH--NMQGQLEFQQEVRVLSKLQHPHLVTLLG 404
K+G G FG VYK + G+ VA+K+L + ++E+R+L +L HP++V L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 405 AC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
A + LV EY G L D L R +S + +IA +I GL +LHS I
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSRGGPLS---EDEAKKIALQILRGLEYLHS---NGI 119
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 522
+H DLKP+NILLD KI DFG+ + + + + T G+ Y PE G
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKLLKSS------SSLTTFVGTPWYMAPEVLLGG 173
Query: 523 VL-TPKSDSYSFGLIILQLLTGRLPVGLAGEVR-RAVSCGKLSSILDPLAGDWPTF--VA 578
PK D +S G+I+ +LLTG+ P + + L L+ D P + +
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEF---DEPKWSSGS 230
Query: 579 RRLVDLGLQCCELYGRERPDIT 600
DL +C +RP
Sbjct: 231 EEAKDLIKKCLNKDPSKRPTAE 252
|
Length = 260 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 6e-42
Identities = 75/210 (35%), Positives = 107/210 (50%), Gaps = 23/210 (10%)
Query: 349 KVGQGGFGCVYKGEMLGR------TVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVT 401
K+G+G FG VYKG + G+ VA+K L + Q EF +E R++ KL HP++V
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 402 LLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 459
LLG C E +V EY+P G L D L RK+ L D A +IA G+ +L S
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYL-RKNRPKELSLSDLLSFALQIARGMEYLES--- 121
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA--DPE 517
+ +H DL +N L+ L KI DFG+ R + +D Y + P PE
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGK-------LPIRWMAPE 174
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLT-GRLP 546
+ G T KSD +SFG+++ ++ T G P
Sbjct: 175 SLKEGKFTSKSDVWSFGVLLWEIFTLGEEP 204
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 9e-42
Identities = 98/280 (35%), Positives = 136/280 (48%), Gaps = 39/280 (13%)
Query: 349 KVGQGGFGCVYKGEMLG-----RTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVTL 402
K+G+G FG VYKG++ G VA+K L + + + +F +E RV+ KL HP++V L
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 403 LGACPEA--WSLVYEYLPNGSLQDRL------FRKSNVSPLLWKDRARIAAEIASGLCFL 454
LG C E LV EY+ G L D L F S L KD A +IA G+ +L
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP-- 512
S +K VH DL +N L+ +L KI DFG+ R V +D Y G P
Sbjct: 122 AS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYY------RKKTGGKLPIR 172
Query: 513 -YADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGL-AGEVRRAVSCGKLSSILDP 568
A PE + G+ T KSD +SFG+++ ++ T G P GL EV + G L
Sbjct: 173 WMA-PESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYR---LPK 228
Query: 569 LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608
P + L +L L C +L +RP + LV+ LE
Sbjct: 229 -----PEYCPDELYELMLSCWQLDPEDRPTFS-ELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 2e-41
Identities = 73/210 (34%), Positives = 105/210 (50%), Gaps = 24/210 (11%)
Query: 349 KVGQGGFGCVYKGEMLGR------TVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVT 401
K+G+G FG VYKG++ G+ VA+K L + Q EF +E R++ KL HP++V
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVK 65
Query: 402 LLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 459
LLG C E +V EY+ G L L + N L D A +IA G+ +L S
Sbjct: 66 LLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLES--- 120
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA--DPE 517
+ +H DL +N L+ L KI DFG+ R + +D Y G P PE
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY-------RKRGGKLPIRWMAPE 173
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLT-GRLP 546
+ G T KSD +SFG+++ ++ T G P
Sbjct: 174 SLKEGKFTSKSDVWSFGVLLWEIFTLGEQP 203
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 3e-37
Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 18/206 (8%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTLLG 404
+G+G FG VY G +A+K + + ++E+R+LS LQHP++V G
Sbjct: 7 LLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYG 66
Query: 405 AC----PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460
+ ++ EY+ GSL L + + + + R +I GL +LHS
Sbjct: 67 SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTR---QILEGLAYLHS---N 120
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 520
IVH D+K NIL+DS+ K+ DFG + + D + +G+ + PE R
Sbjct: 121 GIVHRDIKGANILVDSDGVVKLADFGCAKRL-GDIETGEGTG---SVRGTPYWMAPEVIR 176
Query: 521 TGVLTPKSDSYSFGLIILQLLTGRLP 546
+D +S G ++++ TG+ P
Sbjct: 177 GEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 2e-35
Identities = 76/277 (27%), Positives = 124/277 (44%), Gaps = 20/277 (7%)
Query: 349 KVGQGGFGCVYKGEMLGRTVAIKML---YSHNMQGQLEFQQEVRVLSKLQHP-HLVTLLG 404
K+G+G FG VY + VA+K+L + F +E+++L+ L HP ++V L
Sbjct: 7 KLGEGSFGEVYLAR-DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 405 AC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
+ LV EY+ GSL+D L + PL + I A+I S L +LHS I
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---I 122
Query: 463 VHGDLKPQNILLDSELS-SKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
+H D+KP+NILLD + K+ DFG+ +L+ + + G+ Y PE
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182
Query: 522 GVL---TPKSDSYSFGLIILQLLTGRLPV------GLAGEVRRAVSCGKLSSILDPLAGD 572
L + SD +S G+ + +LLTG P + + + S+ PL+
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPS 242
Query: 573 WPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609
P +++ DL + + R + L +L
Sbjct: 243 NPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279
|
Length = 384 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 5e-33
Identities = 65/203 (32%), Positives = 104/203 (51%), Gaps = 18/203 (8%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGA- 405
K+G+GGFG VYK G+ VAIK++ + + + + E+++L K +HP++V G+
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSY 66
Query: 406 -CP-EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
E W +V E+ GSL+D L KS L A + E+ GL +LHS I+
Sbjct: 67 LKKDELW-IVMEFCSGGSLKDLL--KSTNQTLTESQIAYVCKELLKGLEYLHS---NGII 120
Query: 464 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV 523
H D+K NILL S+ K+ DFG+ ++ + R+T G+ + PE
Sbjct: 121 HRDIKAANILLTSDGEVKLIDFGLSAQLS------DTKARNT-MVGTPYWMAPEVINGKP 173
Query: 524 LTPKSDSYSFGLIILQLLTGRLP 546
K+D +S G+ ++L G+ P
Sbjct: 174 YDYKADIWSLGITAIELAEGKPP 196
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 82/221 (37%), Positives = 114/221 (51%), Gaps = 22/221 (9%)
Query: 349 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC- 406
K+G G FG V+ G G T VA+K L M + F QE +++ KL+H LV L C
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE-AFLQEAQIMKKLRHDKLVQLYAVCS 71
Query: 407 -PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 465
E +V EY+ GSL D L + L +AA+IA G+ +L S +H
Sbjct: 72 EEEPIYIVTEYMSKGSLLDFL-KSGEGKKLRLPQLVDMAAQIAEGMAYLES---RNYIHR 127
Query: 466 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS-FP--YADPEYHRTG 522
DL +NIL+ L KI DFG+ RL+ ED Y TA +G+ FP + PE G
Sbjct: 128 DLAARNILVGENLVCKIADFGLARLI-EDDEY-------TAREGAKFPIKWTAPEAANYG 179
Query: 523 VLTPKSDSYSFGLIILQLLT-GRLPV-GLAG-EVRRAVSCG 560
T KSD +SFG+++ +++T GR+P G+ EV V G
Sbjct: 180 RFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG 220
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 5e-30
Identities = 79/234 (33%), Positives = 118/234 (50%), Gaps = 39/234 (16%)
Query: 331 EFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLG-------RTVAIKMLY-SHNMQGQL 382
E L+ ++ F E ++G+G FG VYKGE+ G +VAIK L + + Q
Sbjct: 1 EIPLSAVR-----FLE--ELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQ 53
Query: 383 EFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVS------- 433
EF+QE ++S LQHP++V LLG C + +++EYL +G L + L R S S
Sbjct: 54 EFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESG 113
Query: 434 ------PLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 487
L D IA +IA+G+ +L S VH DL +N L+ L+ KI DFG+
Sbjct: 114 DETVKSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTVKISDFGL 170
Query: 488 CRLV-TEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQL 540
R + + D Y +S P P PE G T +SD +SFG+++ ++
Sbjct: 171 SRDIYSAD--YYRVQSKSLLPVRWMP---PEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 61/212 (28%), Positives = 101/212 (47%), Gaps = 34/212 (16%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKMLY-SHNMQGQLEFQQEVRVLSKLQHPHLVTLLGA 405
+GQG G VYK + G+ A+K ++ + + + + +E++ L + P++V GA
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 406 C--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
S+V EY+ GSL D L + + A IA +I GL +LH+ + I+
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLLKKVGKIPE---PVLAYIARQILKGLDYLHTKR--HII 122
Query: 464 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF----PYADPEYH 519
H D+KP N+L++S+ KI DFGI +++ + +F Y PE
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVLE----------NTLDQCNTFVGTVTYMSPE-- 170
Query: 520 RTGVLTPKSDSY-----SFGLIILQLLTGRLP 546
R + +S SY S GL +L+ G+ P
Sbjct: 171 R---IQGESYSYAADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-28
Identities = 69/206 (33%), Positives = 113/206 (54%), Gaps = 22/206 (10%)
Query: 349 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
K+G G FG V++G R VAIK+L S ++ Q +FQ+EV+ L +L+H HL++L C
Sbjct: 13 KLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS 72
Query: 408 --EAWSLVYEYLPNGSLQDRLF----RKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
E ++ E + GSL L + V+ L+ +A ++A G+ +L +
Sbjct: 73 VGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLID-----MACQVAEGMAYLEE---QN 124
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
+H DL +NIL+ +L K+ DFG+ RL+ ED +YL S K + + PE
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKED-VYLSSDK-----KIPYKWTAPEAASH 178
Query: 522 GVLTPKSDSYSFGLIILQLLT-GRLP 546
G + KSD +SFG+++ ++ T G++P
Sbjct: 179 GTFSTKSDVWSFGILLYEMFTYGQVP 204
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 68/219 (31%), Positives = 107/219 (48%), Gaps = 25/219 (11%)
Query: 350 VGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEA 409
+G+G FG V G+ G+ VA+K L + Q F E V++ L+HP+LV LLG +
Sbjct: 14 IGKGEFGDVMLGDYRGQKVAVKCLKDDSTAAQ-AFLAEASVMTTLRHPNLVQLLGVVLQG 72
Query: 410 WSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDL 467
L V EY+ GSL D L R + + + A ++ G+ +L + VH DL
Sbjct: 73 NPLYIVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDL 128
Query: 468 KPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP--YADPEYHRTGVLT 525
+N+L+ +L +K+ DFG L E + S G P + PE R +
Sbjct: 129 AARNVLVSEDLVAKVSDFG---LAKEASQGQDS--------GKLPVKWTAPEALREKKFS 177
Query: 526 PKSDSYSFGLIILQLLT-GRLP---VGLAGEVRRAVSCG 560
KSD +SFG+++ ++ + GR+P + L +V V G
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVPYPRIPLK-DVVPHVEKG 215
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 1e-27
Identities = 62/211 (29%), Positives = 100/211 (47%), Gaps = 20/211 (9%)
Query: 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQL-EFQQEVRVLSKLQHPH 398
N+ +G+G FG VYKG L G VAIK + + + L QE+ +L L+HP+
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 399 LVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 456
+V +G+ + SL + EY NGSL+ + + L A ++ GL +LH
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESL---VAVYVYQVLQGLAYLHE 117
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY-AD 515
+ ++H D+K NIL + K+ DFG+ + + + + G+ PY
Sbjct: 118 ---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS------KDDASVVGT-PYWMA 167
Query: 516 PEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PE + SD +S G +++LLTG P
Sbjct: 168 PEVIEMSGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 72/214 (33%), Positives = 104/214 (48%), Gaps = 18/214 (8%)
Query: 349 KVGQGGFGCVYKGE---MLGRT--VAIKMLYSHNMQG-QLEFQQEVRVLSKLQHPHLVTL 402
K+G G FG V +GE G+ VA+K L S + +F +E ++ L H +L+ L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 403 LGAC-PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
G +V E P GSL DRL RK + L A +IA+G+ +L S +
Sbjct: 62 YGVVLTHPLMMVTELAPLGSLLDRL-RKDALGHFLISTLCDYAVQIANGMRYLESKR--- 117
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICR-LVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 520
+H DL +NILL S+ KI DFG+ R L + Y+ H K F + PE R
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHL----KVPFAWCAPESLR 173
Query: 521 TGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAGE 552
T + SD + FG+ + ++ T G P GL+G
Sbjct: 174 TRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGS 207
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 64/207 (30%), Positives = 99/207 (47%), Gaps = 25/207 (12%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKML-----YSHNMQGQLEFQQEVRVLSKLQHPHLVTL 402
+G+G FG V + + G+ A+K+L E +LS++ HP +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHT--LTERNILSRINHPFIVKL 58
Query: 403 LGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKP 459
A E LV EY P G L L ++ S +RAR AAEI L +LHS
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSE----ERARFYAAEIVLALEYLHS--- 111
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 519
I++ DLKP+NILLD++ K+ DFG+ + ++ + R+ G+ Y PE
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSE------GSRTNTFCGTPEYLAPEVL 165
Query: 520 RTGVLTPKSDSYSFGLIILQLLTGRLP 546
D +S G+++ ++LTG+ P
Sbjct: 166 LGKGYGKAVDWWSLGVLLYEMLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 69/207 (33%), Positives = 110/207 (53%), Gaps = 23/207 (11%)
Query: 349 KVGQGGFGCVYK------GEMLGRTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVT 401
++G+G FG V G+ G VA+K L +S Q + +F++E+ +L L H ++V
Sbjct: 11 QLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVK 70
Query: 402 LLGACPEAWS----LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
G C + L+ EYLP+GSL+D L R + + K +++I G+ +L S
Sbjct: 71 YKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD--QINLKRLLLFSSQICKGMDYLGS- 127
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS--FPYAD 515
++ +H DL +NIL++SE KI DFG+ +++ ED Y + P S F YA
Sbjct: 128 --QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDY----YYVKEPGESPIFWYA- 180
Query: 516 PEYHRTGVLTPKSDSYSFGLIILQLLT 542
PE RT + SD +SFG+ + +L T
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-25
Identities = 70/210 (33%), Positives = 105/210 (50%), Gaps = 23/210 (10%)
Query: 350 VGQGGFGCVYKGEMLGR-----TVAIKMLY-SHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
+G G FG V KG L + VA+K L H G+ EF +E V+++L HP +V L+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 404 GAC-PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
G C E LV E P G L L ++ + D +A ++A G+ +L S
Sbjct: 63 GVCKGEPLMLVMELAPLGPLLKYLKKRREIPV---SDLKELAHQVAMGMAYLESK---HF 116
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPEYH 519
VH DL +N+LL + +KI DFG+ R + + Y +R+T G +P YA PE
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY----YRATT-AGRWPLKWYA-PECI 170
Query: 520 RTGVLTPKSDSYSFGLIILQLLT-GRLPVG 548
G + KSD +S+G+ + + + G P G
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFSYGAKPYG 200
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 28/211 (13%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEF-QQEVRVLSKLQHPHLVTLLG 404
++G+G FG VY G+ +K + NM + + E EV++L KL HP+++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 405 ACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRA-RIAAEIASGLCFLHSSKPEK 461
+ E L V EY G L ++ ++ +++ ++ L +LHS K
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS---RK 123
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE---- 517
I+H D+KPQNI L S K+ DFGI ++++ + G+ Y PE
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV------VGTPYYLSPELCQN 177
Query: 518 --YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
Y KSD +S G ++ +L T + P
Sbjct: 178 KPY------NYKSDIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-24
Identities = 65/205 (31%), Positives = 108/205 (52%), Gaps = 20/205 (9%)
Query: 349 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
K+G G FG V++G T VA+K L M + +F E +++ KL+HP L+ L C
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPK-DFLAEAQIMKKLRHPKLIQLYAVCT 71
Query: 408 --EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 465
E +V E + GSL + L + L +AA++ASG+ +L + + +H
Sbjct: 72 LEEPIYIVTELMKYGSLLEYL-QGGAGRALKLPQLIDMAAQVASGMAYLEA---QNYIHR 127
Query: 466 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS-FP--YADPEYHRTG 522
DL +N+L+ K+ DFG+ R++ ED +Y A +G+ FP + PE
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKED-IY-------EAREGAKFPIKWTAPEAALYN 179
Query: 523 VLTPKSDSYSFGLIILQLLT-GRLP 546
+ KSD +SFG+++ +++T GR+P
Sbjct: 180 RFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 76/204 (37%), Positives = 108/204 (52%), Gaps = 19/204 (9%)
Query: 349 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
K+G G FG V+ G G T VAIK L +M + F E ++ +LQHP LV L
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE-AFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 408 -EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGD 466
E ++ EY+ NGSL D L + L +AA+IA G+ F+ + +H D
Sbjct: 72 QEPIYIITEYMENGSLVDFL-KTPEGIKLTINKLIDMAAQIAEGMAFIER---KNYIHRD 127
Query: 467 LKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS-FP--YADPEYHRTGV 523
L+ NIL+ L KI DFG+ RL+ ED Y TA +G+ FP + PE G
Sbjct: 128 LRAANILVSETLCCKIADFGLARLI-EDNEY-------TAREGAKFPIKWTAPEAINYGT 179
Query: 524 LTPKSDSYSFGLIILQLLT-GRLP 546
T KSD +SFG+++ +++T GR+P
Sbjct: 180 FTIKSDVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 81/270 (30%), Positives = 126/270 (46%), Gaps = 39/270 (14%)
Query: 350 VGQGGFGCVYKGEMLG-------RTVAIKMLY-SHNMQGQLEFQQEVRVLSKLQHPHLVT 401
+GQG FG VY+G G VAIK + + +M+ ++EF E V+ + H+V
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 402 LLGACPEAWS--LVYEYLPNGSLQDRLFRK-------SNVSPLLWKDRARIAAEIASGLC 452
LLG +V E + G L+ L + + P + ++AAEIA G+
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133
Query: 453 FLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP 512
+L + +K VH DL +N ++ +L+ KI DFG+ R + E Y KG P
Sbjct: 134 YLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKG------GKGLLP 184
Query: 513 --YADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAGE-VRRAVSCGKLSSILD 567
+ PE + GV T KSD +SFG+++ ++ T P GL+ E V + V G LD
Sbjct: 185 VRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGG---HLD 241
Query: 568 PLAGDWPTFVARRLVDLGLQCCELYGRERP 597
P +L++L C + + RP
Sbjct: 242 L-----PENCPDKLLELMRMCWQYNPKMRP 266
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-23
Identities = 94/256 (36%), Positives = 123/256 (48%), Gaps = 27/256 (10%)
Query: 349 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
K+GQG FG V+ G G T VAIK L M + F QE +V+ KL+H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 408 E-AWSLVYEYLPNGSLQDRLFRKSNVSPLL-WKDRARIAAEIASGLCFLHSSKPEKIVHG 465
E +V EY+ GSL D F K + L +AA+IASG+ ++ VH
Sbjct: 72 EEPIYIVTEYMSKGSLLD--FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 126
Query: 466 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS-FP--YADPEYHRTG 522
DL+ NIL+ L K+ DFG+ RL+ ED Y TA +G+ FP + PE G
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLI-EDNEY-------TARQGAKFPIKWTAPEAALYG 178
Query: 523 VLTPKSDSYSFGLIILQLLT-GRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRL 581
T KSD +SFG+++ +L T GR+P G V R V L + P L
Sbjct: 179 RFTIKSDVWSFGILLTELTTKGRVP--YPGMVNREV----LDQVERGYRMPCPPECPESL 232
Query: 582 VDLGLQCCELYGRERP 597
DL QC ERP
Sbjct: 233 HDLMCQCWRKEPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 4e-23
Identities = 69/251 (27%), Positives = 111/251 (44%), Gaps = 36/251 (14%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG--QLEFQQEVRVLSKLQHPHLVTLLG 404
++G+G G V+K + G TVA+K + ++G + +E++ L QHP++V LL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 405 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
+ LV EY+P L + L + PL + G+ ++H+ I
Sbjct: 67 VFPHGSGFVLVMEYMP-SDLSEVLRDEER--PLPEAQVKSYMRMLLKGVAYMHA---NGI 120
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST----APKGSFPYADPEY 518
+H DLKP N+L+ ++ KI DFG+ RL +E+ L S +T AP+ Y +Y
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE--LLYGARKY 178
Query: 519 HRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILD----PLAGDWP 574
P D ++ G I +LL G P+ GE +L+ + P WP
Sbjct: 179 ------DPGVDLWAVGCIFAELLNGS-PL-FPGENDIE----QLAIVFRTLGTPNEETWP 226
Query: 575 TFVARRLVDLG 585
L D
Sbjct: 227 GL--TSLPDYN 235
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 2e-22
Identities = 76/272 (27%), Positives = 124/272 (45%), Gaps = 27/272 (9%)
Query: 343 NFSESFKVGQGGFGCVYKG--EMLGRTVAIKM--LYSHNMQGQLEFQQEVRVLSKLQHPH 398
+F K+G+G FG V+K + R A+K L N + + E E RVL+KL +
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 399 LVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 456
++ + + L V EY NG L L + PL R +I GL LHS
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLL-KMQRGRPLPEDQVWRFFIQILLGLAHLHS 119
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 516
+KI+H D+K N+ LD+ + KI D G+ +L++++T F + G+ Y P
Sbjct: 120 ---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN----FANTIV--GTPYYLSP 170
Query: 517 EYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTF 576
E KSD ++ G+++ + TG+ P + A+ + + P++ +
Sbjct: 171 ELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG--ALILKIIRGVFPPVSQMY--- 225
Query: 577 VARRLVDLGLQCCELYGRERPDIT-----PSL 603
+++L L QC R+RPD PSL
Sbjct: 226 -SQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 4e-22
Identities = 63/222 (28%), Positives = 99/222 (44%), Gaps = 34/222 (15%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIKML-----YSHNMQGQLEFQQEVRVLSKL-QHPHLVT 401
+G+G F V + + AIK+L + + E VL++L HP ++
Sbjct: 9 IGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYV--KIEKEVLTRLNGHPGIIK 66
Query: 402 LLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSK 458
L + +L V EY PNG L + + ++ + R AAEI L +LHS
Sbjct: 67 LYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLD----EKCTRFYAAEILLALEYLHS-- 120
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF----------HRSTAPK 508
+ I+H DLKP+NILLD ++ KI DFG +++ ++ + ++
Sbjct: 121 -KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179
Query: 509 GSF----PYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
SF Y PE SD ++ G II Q+LTG+ P
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 9e-22
Identities = 63/201 (31%), Positives = 106/201 (52%), Gaps = 20/201 (9%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
K+G G +G VY+G + TVA+K L M+ + EF +E V+ +++HP+LV LLG C
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 71
Query: 407 PE--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
+ ++ E++ G+L D L R+ N + +A +I+S + +L + +H
Sbjct: 72 TREPPFYIITEFMTYGNLLDYL-RECNRQEVNAVVLLYMATQISSAMEYLEK---KNFIH 127
Query: 465 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS-FP--YADPEYHRT 521
DL +N L+ K+ DFG+ RL+T DT TA G+ FP + PE
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY--------TAHAGAKFPIKWTAPESLAY 179
Query: 522 GVLTPKSDSYSFGLIILQLLT 542
+ KSD ++FG+++ ++ T
Sbjct: 180 NKFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 69/223 (30%), Positives = 113/223 (50%), Gaps = 29/223 (13%)
Query: 350 VGQGGFGCVYKGEMLG-RTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE 408
+G G FG V+ G+ G VAIKM+ M + +F +E +V+ KL HP+LV L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMS-EDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 409 AWSL--VYEYLPNGSLQDRLFR---KSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
+ V EY+ NG L + L K LL + +++ + +L S+ +
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEWLL-----DMCSDVCEAMEYLESN---GFI 122
Query: 464 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS-FP--YADPEYHR 520
H DL +N L+ + K+ DFG+ R V +D + T+ +G+ FP +A PE
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLARYVLDD--------QYTSSQGTKFPVKWAPPEVFD 174
Query: 521 TGVLTPKSDSYSFGLIILQLLT-GRLPVG--LAGEVRRAVSCG 560
+ KSD +SFG+++ ++ + G++P EV +VS G
Sbjct: 175 YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAG 217
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 3e-21
Identities = 60/202 (29%), Positives = 102/202 (50%), Gaps = 15/202 (7%)
Query: 349 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
++G G FG V+ G L + VAIK + M + +F +E +V+ KL HP LV L G C
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE-DFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 408 E--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 465
E LV+E++ +G L D + ++ + + ++ G+ +L SS ++H
Sbjct: 70 ERSPICLVFEFMEHGCLSD--YLRAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHR 124
Query: 466 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLT 525
DL +N L+ K+ DFG+ R V +D + ST K ++ PE +
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDD-----QYTSSTGTKFPVKWSSPEVFSFSKYS 179
Query: 526 PKSDSYSFGLIILQLLT-GRLP 546
KSD +SFG+++ ++ + G+ P
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTP 201
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 4e-21
Identities = 80/215 (37%), Positives = 113/215 (52%), Gaps = 21/215 (9%)
Query: 349 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
K+GQG FG V+ G G T VAIK L M + F QE +++ KL+H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPE-AFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 408 E-AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGD 466
E +V E++ GSL D L ++ + L +AA+IA G+ ++ +H D
Sbjct: 72 EEPIYIVTEFMGKGSLLDFL-KEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRD 127
Query: 467 LKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS-FP--YADPEYHRTGV 523
L+ NIL+ L KI DFG+ RL+ ED Y TA +G+ FP + PE G
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLI-EDNEY-------TARQGAKFPIKWTAPEAALYGR 179
Query: 524 LTPKSDSYSFGLIILQLLT-GRLPVGLAGEVRRAV 557
T KSD +SFG+++ +L+T GR+P G V R V
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVP--YPGMVNREV 212
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 6e-21
Identities = 89/257 (34%), Positives = 127/257 (49%), Gaps = 29/257 (11%)
Query: 349 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
K+G G FG V+ G G T VA+K L M + F +E +++ KL+H LV L
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE-SFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 408 E-AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGD 466
E +V EY+ GSL D L + L + +AA++A+G+ ++ +H D
Sbjct: 72 EEPIYIVTEYMSKGSLLDFL-KDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRD 127
Query: 467 LKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS-FP--YADPEYHRTGV 523
L+ NIL+ L KI DFG+ RL+ ED Y TA +G+ FP + PE G
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLI-EDNEY-------TARQGAKFPIKWTAPEAALYGR 179
Query: 524 LTPKSDSYSFGLIILQLLT-GRLPV-GLAG-EVRRAVSCGKLSSILDPLAGDWPTFVARR 580
T KSD +SFG+++ +L+T GR+P G+ EV V G P D P
Sbjct: 180 FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM----PCPQDCPI----S 231
Query: 581 LVDLGLQCCELYGRERP 597
L +L LQC + ERP
Sbjct: 232 LHELMLQCWKKDPEERP 248
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|128780 smart00504, Ubox, Modified RING finger domain | Back alignment and domain information |
|---|
Score = 86.1 bits (214), Expect = 7e-21
Identities = 31/63 (49%), Positives = 38/63 (60%), Gaps = 1/63 (1%)
Query: 622 FLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAI 681
FLCPI E+M DP + G TYE AI WL + T P+T L+H L PN AL+ AI
Sbjct: 2 FLCPISLEVMKDPVILPSGQTYERSAIEKWLLS-HGTDPVTGQPLTHEDLIPNLALKSAI 60
Query: 682 QDW 684
Q+W
Sbjct: 61 QEW 63
|
Modified RING finger domain, without the full complement of Zn2+-binding ligands. Probable involvement in E2-dependent ubiquitination. Length = 63 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 1e-20
Identities = 65/202 (32%), Positives = 100/202 (49%), Gaps = 30/202 (14%)
Query: 363 MLGRTVAIKMLYSHNMQGQLE---FQQEVRVLSKLQHPHLVTLL--GACPEAWSL-VYEY 416
M G VAIK+L + + + + F++E + ++L HP++V LL G P V+EY
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL-- 474
+P +L++ L + L + R+ ++ L H+ + IVH DLKPQNI++
Sbjct: 61 VPGRTLREVL---AADGALPAGETGRLMLQVLDALACAHN---QGIVHRDLKPQNIMVSQ 114
Query: 475 -DSELSSKICDFGICRLVTEDTLYLPSFH--------RSTAPKGSFPYADPEYHRTGVLT 525
+K+ DFGI L LP R+T G+ Y PE R +T
Sbjct: 115 TGVRPHAKVLDFGIGTL-------LPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVT 167
Query: 526 PKSDSYSFGLIILQLLTGRLPV 547
P SD Y++GLI L+ LTG+ V
Sbjct: 168 PNSDLYAWGLIFLECLTGQRVV 189
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 92.6 bits (231), Expect = 1e-20
Identities = 72/214 (33%), Positives = 102/214 (47%), Gaps = 42/214 (19%)
Query: 350 VGQGGFGCVYKGEML------GRTVAIKMLYSHNM--QGQLE-FQQEVRVLSKLQHPHLV 400
+G G FG V ML G+ A+K+L + Q+E E R+L ++HP LV
Sbjct: 9 LGTGSFGRV----MLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLV 64
Query: 401 TLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSS 457
L G+ + +L V EY+P G L L RKS P AR AA++ L +LHS
Sbjct: 65 NLYGSFQDDSNLYLVMEYVPGGELFSHL-RKSGRFPE---PVARFYAAQVVLALEYLHS- 119
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 517
IV+ DLKP+N+LLDS+ KI DFG + V T L G+ Y PE
Sbjct: 120 --LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC---------GTPEYLAPE 168
Query: 518 YHRTGVLTPK-----SDSYSFGLIILQLLTGRLP 546
++ K D ++ G++I ++L G P
Sbjct: 169 -----IILSKGYGKAVDWWALGILIYEMLAGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 91.6 bits (228), Expect = 1e-20
Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 349 KVGQGGFGCVYKGEML----GRTVAIK-MLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
++G G G V K +L G+ +A+K + N Q + +E+ +L K P++V
Sbjct: 8 ELGAGNSGVVSK--VLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFY 65
Query: 404 GAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
GA S+ EY+ GSL K + + +IA + GL +LH K
Sbjct: 66 GAFYNNGDISICMEYMDGGSLDK--ILKEVQGRIPERILGKIAVAVLKGLTYLHEKH--K 121
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
I+H D+KP NIL++S K+CDFG+ + + G+ Y PE +
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL--------AKTFVGTSSYMAPERIQG 173
Query: 522 GVLTPKSDSYSFGLIILQLLTGRLPVG 548
+ KSD +S GL +++L TGR P
Sbjct: 174 NDYSVKSDIWSLGLSLIELATGRFPYP 200
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 2e-20
Identities = 63/219 (28%), Positives = 101/219 (46%), Gaps = 29/219 (13%)
Query: 350 VGQGGFGCVYKGEMLG-------RTVAIKMLY-SHNMQGQLEFQQEVRVLSKLQHPHLVT 401
+G+G FG V+ GE VA+K L + + + +F++E +L+ QH ++V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 402 LLGACPE--AWSLVYEYLPNGSLQDRLFR-----------KSNVSPLLWKDRARIAAEIA 448
G C E +V+EY+ +G L L S + L +IA +IA
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 449 SGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK 508
SG+ +L S + VH DL +N L+ +L KI DFG+ R V Y H +
Sbjct: 133 SGMVYLAS---QHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIR 189
Query: 509 GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP 546
+ PE T +SD +SFG+++ ++ T G+ P
Sbjct: 190 ----WMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 3e-20
Identities = 61/210 (29%), Positives = 105/210 (50%), Gaps = 19/210 (9%)
Query: 350 VGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLE---------FQQEVRVLSKLQHPH 398
+G G FG VY G G +A+K + ++ + +E+ +L +LQH +
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 399 LVTLLGACPEAWSLVY--EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 456
+V LG+ +A L EY+P GS+ L L ++ R +I GL +LH+
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVR---QILKGLNYLHN 124
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 516
I+H D+K NIL+D++ KI DFGI + + ++L + + +GS + P
Sbjct: 125 ---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAP 181
Query: 517 EYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
E + T K+D +S G +++++LTG+ P
Sbjct: 182 EVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 3e-20
Identities = 84/300 (28%), Positives = 135/300 (45%), Gaps = 56/300 (18%)
Query: 350 VGQGGFGCVYKG---EMLGR----TVAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVT 401
+G+G FG V K + GR TVA+KML + +L + E +L ++ HPH++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 402 LLGACP--EAWSLVYEYLPNGSLQD--RLFRK-------------------SNVSPLLWK 438
L GAC L+ EY GSL+ R RK + L
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 439 DRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498
D A +I+ G+ +L K +VH DL +N+L+ KI DFG+ R V E+ Y+
Sbjct: 128 DLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184
Query: 499 PSFHRSTAPKGSFP--YADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA 556
RS KG P + E + T +SD +SFG+++ +++T L G
Sbjct: 185 ---KRS---KGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT------LGGNPYPG 232
Query: 557 VSCGKLSSILDP-LAGDWPTFVARRLVDLGLQCCELYGRERPDITPS---LVKELEQLHV 612
++ +L ++L + P + + +L L C ++ PD P+ + KELE++ V
Sbjct: 233 IAPERLFNLLKTGYRMERPENCSEEMYNLMLTCW----KQEPDKRPTFADISKELEKMMV 288
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 91.0 bits (226), Expect = 3e-20
Identities = 70/213 (32%), Positives = 106/213 (49%), Gaps = 38/213 (17%)
Query: 350 VGQGGFG----CVYK--GEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
+G+G FG C Y + G VA+K L + +F++E+ +L LQH ++V
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 404 GACPEA----WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI--------AAEIASGL 451
G C A LV EYLP GSL+D L K R R+ A++I G+
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRD----------YLQKHRERLDHRKLLLYASQICKGM 121
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS- 510
+L S ++ VH DL +NIL++SE KI DFG+ +++ +D Y ++ P S
Sbjct: 122 EYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEY----YKVREPGESP 174
Query: 511 -FPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 542
F YA PE + SD +SFG+++ +L T
Sbjct: 175 IFWYA-PESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 7e-20
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 18/205 (8%)
Query: 351 GQGGFGCVYKG------EMLGRTVAIKMLY-SHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
G G FG VYKG E + VAIK+L + + E E V++ + HPH+V LL
Sbjct: 16 GSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLL 75
Query: 404 GACP-EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
G C L+ + +P G L D + +++ + + +IA G+ +L +++
Sbjct: 76 GICLSSQVQLITQLMPLGCLLDYV--RNHKDNIGSQYLLNWCVQIAKGMSYLEE---KRL 130
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 522
VH DL +N+L+ + KI DFG+ +L+ D + + K + E
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE----KEYHAEGGKVPIKWMALESILHR 186
Query: 523 VLTPKSDSYSFGLIILQLLT-GRLP 546
+ T KSD +S+G+ + +L+T G P
Sbjct: 187 IYTHKSDVWSYGVTVWELMTFGAKP 211
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 62/202 (30%), Positives = 104/202 (51%), Gaps = 16/202 (7%)
Query: 350 VGQGGFGCVYKGEMLG-----RTVAIKMLYS-HNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
+G+G FGCVY G ++ A+K L +++ +F +E ++ HP++++LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 404 GAC--PEAWSLV-YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460
G C E LV Y+ +G L++ R +P + KD ++A G+ +L S +
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRN-FIRSETHNPTV-KDLIGFGLQVAKGMEYLAS---K 117
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 520
K VH DL +N +LD + K+ DFG+ R + + Y S H T K + E +
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY--SVHNHTGAKLPVKWMALESLQ 175
Query: 521 TGVLTPKSDSYSFGLIILQLLT 542
T T KSD +SFG+++ +L+T
Sbjct: 176 TQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-19
Identities = 62/199 (31%), Positives = 98/199 (49%), Gaps = 13/199 (6%)
Query: 349 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGAC 406
K+G+G FG VYKG + G T VA+K S F QE +L + HP++V L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 407 PEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
+ + V E +P GSL L +K N + K +++ + A+G+ +L S + +H
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFLRKKKNRLTV--KKLLQMSLDAAAGMEYLES---KNCIH 116
Query: 465 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVL 524
DL +N L+ KI DFG+ R E +Y S P + PE G
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR-EEEGGIYTVSDGLKQIP---IKWTAPEALNYGRY 172
Query: 525 TPKSDSYSFGLIILQLLTG 543
T +SD +S+G+++ + +
Sbjct: 173 TSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 4e-19
Identities = 64/215 (29%), Positives = 94/215 (43%), Gaps = 42/215 (19%)
Query: 350 VGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQLEFQ------QEVRVLSKLQHPHLVT 401
+G+G FG C+ + + A+K + N Q +E E R+L +L HP LV
Sbjct: 8 IGKGAFGKVCIVQKRDTKKMFAMKYM---NKQKCVEKGSVRNVLNERRILQELNHPFLVN 64
Query: 402 LLGACPEAWS---------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGL 451
L W LV + L G L+ L +K S +++ + EI L
Sbjct: 65 L-------WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFS----EEQVKFWICEIVLAL 113
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 511
+LHS + I+H D+KP NILLD + I DF I VT DTL +T+ G+
Sbjct: 114 EYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL-------TTSTSGTP 163
Query: 512 PYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
Y PE + D +S G+ + L G+ P
Sbjct: 164 GYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (218), Expect = 4e-19
Identities = 65/218 (29%), Positives = 100/218 (45%), Gaps = 49/218 (22%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEFQQ----EVRVLSKLQHPHLVTL 402
K+G+G +G VYK + G VA+K + + E+ +L +L+HP++V L
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 403 LG--ACPEAWSLVYEYLPN--GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
L LV+EY D+ R +SP L K I ++ GL + HS
Sbjct: 64 LDVIHTERKLYLVFEYCDMDLKKYLDK--RPGPLSPNLIK---SIMYQLLRGLAYCHS-- 116
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED---------TLYLPSFHRSTAPK- 508
+I+H DLKPQNIL++ + K+ DFG+ R TL+ +R AP+
Sbjct: 117 -HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLW----YR--APEI 169
Query: 509 --GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 544
GS Y+ T V D +S G I +++TG+
Sbjct: 170 LLGSKHYS------TAV-----DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 5e-19
Identities = 71/206 (34%), Positives = 105/206 (50%), Gaps = 22/206 (10%)
Query: 349 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
K+G G FG V+ G T VA+K L M Q F +E ++ LQH LV L
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQ-AFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 408 --EAWSLVYEYLPNGSLQDRLFRKSNV-SPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
E ++ EY+ GSL D F KS+ +L +A+IA G+ ++ + +H
Sbjct: 72 KEEPIYIITEYMAKGSLLD--FLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIH 126
Query: 465 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS-FP--YADPEYHRT 521
DL+ N+L+ L KI DFG+ R V ED Y TA +G+ FP + PE
Sbjct: 127 RDLRAANVLVSESLMCKIADFGLAR-VIEDNEY-------TAREGAKFPIKWTAPEAINF 178
Query: 522 GVLTPKSDSYSFGLIILQLLT-GRLP 546
G T KSD +SFG+++ +++T G++P
Sbjct: 179 GSFTIKSDVWSFGILLYEIVTYGKIP 204
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 29/217 (13%)
Query: 350 VGQGGFGCVYKGEMLGRT-------VAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVT 401
+G G FG VY+G GR VA+K L S + Q + +F E ++SK H ++V
Sbjct: 14 LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVR 73
Query: 402 LLGACPEA--WSLVYEYLPNGSLQDRLF----RKSNVSPLLWKDRARIAAEIASGLCFLH 455
L+G E ++ E + G L+ L R S L KD A ++A G +L
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLE 133
Query: 456 SSKPEKIVHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHRSTAPKGSFP 512
+ +H D+ +N LL + KI DFG+ R +Y S++R + P
Sbjct: 134 EN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMAR-----DIYRASYYRKGG-RAMLP 184
Query: 513 --YADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP 546
+ PE G+ T K+D +SFG+++ ++ + G +P
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 66/211 (31%), Positives = 101/211 (47%), Gaps = 25/211 (11%)
Query: 349 KVGQGGFGCVYKGE----MLGRTVAIKMLY-SHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
++G G FG V GE M V +K L S QL F QEV+ +L HP+++ L
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 404 GACPEA--WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDR---ARIAAEIASGLCFLHSSK 458
G C E+ + LV E+ P G L++ L R + + R+A E+ASGL +LH +
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYL-RSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA- 119
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGI--CR-----LVTEDTLYLPSFHRSTAPKGSF 511
+H DL +N L ++LS KI D+G+ + +T+D +P R AP+
Sbjct: 120 --DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPL--RWLAPELVE 175
Query: 512 PYADPEYHRTGVLTPKSDSYSFGLIILQLLT 542
T KS+ +S G+ + +L T
Sbjct: 176 IRGQD--LLPKDQTKKSNIWSLGVTMWELFT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 3e-18
Identities = 62/205 (30%), Positives = 106/205 (51%), Gaps = 21/205 (10%)
Query: 349 KVGQGGFGCVYKGEMLGR-TVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
++G G FG V G+ G+ VAIKM+ +M + EF +E +V+ KL H LV L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 408 EAWSL--VYEYLPNGSLQDRL---FRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
+ + V EY+ NG L + L ++ S LL + ++ G+ +L S ++
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLL-----EMCKDVCEGMAYLES---KQF 121
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 522
+H DL +N L+D + K+ DFG+ R V +D + S K ++ PE
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDD-----EYTSSVGSKFPVRWSPPEVLLYS 176
Query: 523 VLTPKSDSYSFGLIILQLLT-GRLP 546
+ KSD ++FG+++ ++ + G++P
Sbjct: 177 KFSSKSDVWAFGVLMWEVYSLGKMP 201
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 65/216 (30%), Positives = 96/216 (44%), Gaps = 35/216 (16%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTLLG 404
+ +G +G V+ K + G AIK++ +M + + Q E +LS+ Q P++V L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 405 ACPEAWS--------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLH 455
+S LV EYLP G L L +D ARI AEI L +LH
Sbjct: 60 -----YSFQGKKNLYLVMEYLPGGDLA-SLLENVGSLD---EDVARIYIAEIVLALEYLH 110
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL-VTEDTLYLPSFHRSTAPK----GS 510
S+ I+H DLKP NIL+DS K+ DFG+ ++ + + L G+
Sbjct: 111 SNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLND---DEKEDKRIVGT 164
Query: 511 FPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
Y PE + D +S G I+ + L G P
Sbjct: 165 PDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPP 200
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 3e-18
Identities = 80/261 (30%), Positives = 121/261 (46%), Gaps = 34/261 (13%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIK--MLYSHNMQGQL---EFQQEVRVLSKLQHPHLVTL 402
+G G FG VY+G L G A+K L GQ + +QE+ +LSKLQHP++V
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 403 LGACPEAWSL-VY-EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460
LG E +L ++ E +P GSL L + + + + R +I GL +LH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTR---QILLGLEYLHD---R 121
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY-H 519
VH D+K NIL+D+ K+ DFG+ + V E SF +S KGS + PE
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF-----SFAKSF--KGSPYWMAPEVIA 174
Query: 520 RTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR---RAVSCGKLSSILDPLAGDWPTF 576
+ G +D +S G +L++ TG+ P V + +L I D L+ + F
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDF 234
Query: 577 VARRLVDLGLQCCELYGRERP 597
+ L+C + RP
Sbjct: 235 I--------LKCLQRDPSLRP 247
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-18
Identities = 85/297 (28%), Positives = 131/297 (44%), Gaps = 39/297 (13%)
Query: 350 VGQGGFGCVY------KGEMLGRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTL 402
+G+G FG V + G VA+K L Q +++E+ +L L H ++V
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 403 LGACPE----AWSLVYEYLPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSS 457
G C E L+ EY+P GSL+D L + N++ LL A +I G+ +LHS
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLL-----FAQQICEGMAYLHS- 125
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 517
+ +H DL +N+LLD++ KI DFG+ + V E Y +P F YA E
Sbjct: 126 --QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP--VFWYA-VE 180
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFV 577
+ + SD +SFG+ + +LLT + K ++ P G
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLTHCDS--------KQSPPKKFEEMIGPKQG---QMT 229
Query: 578 ARRLVDLGLQCCELYGRERPDITPSLVKEL-EQLHVAEERPVPSF-FLCPILQEIMH 632
RL++L + L P P V L + E + P+F L PIL+E+ H
Sbjct: 230 VVRLIELLERGMRL---PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 79/298 (26%), Positives = 132/298 (44%), Gaps = 43/298 (14%)
Query: 349 KVGQGGFGCVYKGEMLGRT-------VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVT 401
++G+G FG V+ E + VA+K L + + +FQ+E +L+ LQH H+V
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 71
Query: 402 LLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKD--------------RARIAA 445
G C + L V+EY+ +G L ++ R ++ D IA+
Sbjct: 72 FYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 130
Query: 446 EIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST 505
+IASG+ +L S + VH DL +N L+ + L KI DFG+ R V Y H +
Sbjct: 131 QIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGH-TM 186
Query: 506 APKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEVRRAVSCGKLSS 564
P P PE T +SD +SFG+I+ ++ T G+ P + C
Sbjct: 187 LPIRWMP---PESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT-EVIECITQGR 242
Query: 565 ILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEERPVPSFF 622
+L+ P + + D+ L C + ++R +I KE+ ++ A + P +
Sbjct: 243 VLER-----PRVCPKEVYDIMLGCWQREPQQRLNI-----KEIYKILHALGKATPIYL 290
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 43/151 (28%), Positives = 69/151 (45%), Gaps = 12/151 (7%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIK-MLYSHNMQGQLEF-QQEVRVLSKLQHPHLVTLLG 404
VG+G +G V K G VAIK S + + + +EV+VL +L+H ++V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKE 67
Query: 405 ACPEA--WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
A LV+EY+ L+ + P + ++ + + HS I
Sbjct: 68 AFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVR---SYIWQLLQAIAYCHS---HNI 121
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTE 493
+H D+KP+NIL+ K+CDFG R +
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFARALRA 152
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 6e-18
Identities = 68/270 (25%), Positives = 115/270 (42%), Gaps = 39/270 (14%)
Query: 350 VGQGGFGCVY------KGEMLGRTVAIKML---------YSHNMQGQLE-FQQEVRVLSK 393
+G+G +G VY GEM+ A+K + + + ++ + E+ L
Sbjct: 9 IGKGTYGRVYLALNVTTGEMM----AVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD 64
Query: 394 LQHPHLVTLLG--ACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGL 451
L H ++V LG E S+ EY+P GS+ L L + ++ GL
Sbjct: 65 LDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTE---QVLEGL 121
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 511
+LHS + I+H DLK N+L+D++ KI DFGI + D +Y ++ + +GS
Sbjct: 122 AYLHS---KGILHRDLKADNLLVDADGICKISDFGISK--KSDDIY--DNDQNMSMQGSV 174
Query: 512 PYADPE----YHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILD 567
+ PE Y + + K D +S G ++L++ GR P + G S
Sbjct: 175 FWMAPEVIHSYSQG--YSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRS-AP 231
Query: 568 PLAGDWPTFVARRLVDLGLQCCELYGRERP 597
P+ D ++ +D C + RP
Sbjct: 232 PIPPDVSMNLSPVALDFLNACFTINPDNRP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 7e-18
Identities = 54/176 (30%), Positives = 80/176 (45%), Gaps = 34/176 (19%)
Query: 343 NFSESFKVGQGGFGCVYKGEMLG------------------RTVAIKMLY-SHNMQGQLE 383
NF E K+G+G FG V+ E G VA+K+L + + +
Sbjct: 8 NFVE--KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED 65
Query: 384 FQQEVRVLSKLQHPHLVTLLGACPEAWSL--VYEYLPNGSLQDRLFR--------KSNVS 433
F +EV++LS+L P++ LLG C L + EY+ NG L L + N
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 434 PLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
L + +A +IASG+ +L S VH DL +N L+ + KI DFG+ R
Sbjct: 126 SLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 8e-18
Identities = 61/206 (29%), Positives = 106/206 (51%), Gaps = 29/206 (14%)
Query: 349 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC-P 407
+G+G FG V +GE G+ VA+K + ++ Q F +E V++KL H +LV LLG
Sbjct: 13 IIGEGEFGAVLQGEYTGQKVAVKNIKC-DVTAQ-AFLEETAVMTKLHHKNLVRLLGVILH 70
Query: 408 EAWSLVYEYLPNGSLQDRLFRKS----NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
+V E + G+L + L + +V LL + + ++A G+ +L S +K+V
Sbjct: 71 NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLL-----QFSLDVAEGMEYLES---KKLV 122
Query: 464 HGDLKPQNILLDSELSSKICDFGICRLVTE--DTLYLPSFHRSTAPKGSFPYADPEYHRT 521
H DL +NIL+ + +K+ DFG+ R+ + D LP + PE +
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP-----------VKWTAPEALKH 171
Query: 522 GVLTPKSDSYSFGLIILQLLT-GRLP 546
+ KSD +S+G+++ ++ + GR P
Sbjct: 172 KKFSSKSDVWSYGVLLWEVFSYGRAP 197
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 70/225 (31%), Positives = 104/225 (46%), Gaps = 37/225 (16%)
Query: 348 FKVGQGGFGCVYKGE----------MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHP 397
+++G+G FG V+ E ML VA+K L + + +FQ+E +L+ LQH
Sbjct: 11 WELGEGAFGKVFLAECHNLLPEQDKML---VAVKALKEASESARQDFQREAELLTVLQHQ 67
Query: 398 HLVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSN-------------VSPLLWKDRAR 442
H+V G C E L V+EY+ +G L +R R L
Sbjct: 68 HIVRFYGVCTEGRPLLMVFEYMRHGDL-NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA 126
Query: 443 IAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 502
IA++IASG+ +L S VH DL +N L+ L KI DFG+ R + T Y
Sbjct: 127 IASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS-TDYYRVGG 182
Query: 503 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP 546
R+ P P PE T +SD +SFG+++ ++ T G+ P
Sbjct: 183 RTMLPIRWMP---PESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 60/217 (27%), Positives = 94/217 (43%), Gaps = 33/217 (15%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTLL 403
+G+G FG V K G+ + K + NM + E QQ EV +L +L+HP++V
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEK-EKQQLVSEVNILRELKHPNIVRYY 65
Query: 404 GAC--PEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIA--------AEIASGL 451
+L V EY G L +L +K K+R I ++ L
Sbjct: 66 DRIIDRSNQTLYIVMEYCEGGDLA-QLIQKCK------KERKYIEEEFIWRILTQLLLAL 118
Query: 452 --CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKG 509
C S ++H DLKP NI LD+ + K+ DFG+ +++ D+ + ++ G
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTY------VG 172
Query: 510 SFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ Y PE KSD +S G +I +L P
Sbjct: 173 TPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 2e-17
Identities = 67/209 (32%), Positives = 101/209 (48%), Gaps = 31/209 (14%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEFQ---QEVRVLSKLQHPHLVTLL 403
K+GQG G VY G+ VAIK + N+Q Q + + E+ V+ + +HP++V L
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQM---NLQQQPKKELIINEILVMRENKHPNIVNYL 82
Query: 404 GA---CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA---EIASGLCFLHSS 457
+ E W +V EYL GSL D V D +IAA E L FLHS+
Sbjct: 83 DSYLVGDELW-VVMEYLAGGSLTD-------VVTETCMDEGQIAAVCRECLQALEFLHSN 134
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 517
+ ++H D+K NILL + S K+ DFG C +T P + + G+ + PE
Sbjct: 135 Q---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT------PEQSKRSTMVGTPYWMAPE 185
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PK D +S G++ ++++ G P
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 68/219 (31%), Positives = 106/219 (48%), Gaps = 34/219 (15%)
Query: 349 KVGQGGFGCVYKGEML------GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVT 401
++G+ FG +YKG + + VAIK L N Q EFQQE ++++L HP++V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 402 LLGACPEAWS--LVYEYLPNGSLQDRLFRKSN--------------VSPLLWKDRARIAA 445
LLG + +++EYL G L + L +S S L D IA
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 446 EIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST 505
+IA+G+ +L S VH DL +NIL+ +L KI D G+ R +Y ++R
Sbjct: 132 QIAAGMEYLSS---HFFVHKDLAARNILIGEQLHVKISDLGLSR-----EIYSADYYR-V 182
Query: 506 APKGSFP--YADPEYHRTGVLTPKSDSYSFGLIILQLLT 542
PK P + PE G + SD +SFG+++ ++ +
Sbjct: 183 QPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 82/294 (27%), Positives = 141/294 (47%), Gaps = 44/294 (14%)
Query: 349 KVGQGGFGCVY--------KGEMLGRTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHL 399
++GQG FG VY KGE R VA+K + S +++ ++EF E V+ H+
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETR-VAVKTVNESASLRERIEFLNEASVMKGFTCHHV 71
Query: 400 VTLLGACPEAWS--LVYEYLPNGSLQD--RLFRKSNVS-----PLLWKDRARIAAEIASG 450
V LLG + +V E + +G L+ R R + P ++ ++AAEIA G
Sbjct: 72 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 131
Query: 451 LCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS 510
+ +L++ +K VH DL +N ++ + + KI DFG+ R + E Y KG
Sbjct: 132 MAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY------RKGGKGL 182
Query: 511 FP--YADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGK-LSSILD 567
P + PE + GV T SD +SFG+++ ++ + LA + + +S + L ++D
Sbjct: 183 LPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPYQGLSNEQVLKFVMD 236
Query: 568 PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEERPVPSF 621
D P R+ DL ++ C + P + P+ ++ + L ++ PSF
Sbjct: 237 GGYLDQPDNCPERVTDL-MRMCWQFN---PKMRPTFLEIVNLL---KDDLHPSF 283
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|203049 pfam04564, U-box, U-box domain | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 3e-17
Identities = 26/70 (37%), Positives = 34/70 (48%)
Query: 618 VPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHAL 677
+P FL PI E+M DP + G TY+ I L + T P T L+H L PN L
Sbjct: 1 IPDEFLDPITLELMKDPVILPSGITYDRSTIERHLLSVDPTDPFTREPLTHDQLIPNLEL 60
Query: 678 RHAIQDWLCK 687
+ I WL +
Sbjct: 61 KEKIDAWLEE 70
|
This domain is related to the Ring finger pfam00097 but lacks the zinc binding residues. Length = 73 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 59/208 (28%), Positives = 100/208 (48%), Gaps = 28/208 (13%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKM--LYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLG 404
K+G+G G VYK G+ VAIK L N + + E+ ++ +HP++V
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEILIMKDCKHPNIVDYYD 82
Query: 405 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDR--ARIAAEIASGLCFLHSSKPE 460
+ + +V EY+ GSL D + + + + A + E+ GL +LHS +
Sbjct: 83 SYLVGDELWVVMEYMDGGSLTDII----TQNFVRMNEPQIAYVCREVLQGLEYLHS---Q 135
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY--ADPEY 518
++H D+K NILL + S K+ DFG +T++ R++ G+ PY A PE
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-----SKRNSV-VGT-PYWMA-PEV 187
Query: 519 HRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ PK D +S G++ +++ G P
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 3e-17
Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 28/213 (13%)
Query: 349 KVGQGGFGCVYKGEMLG-------RTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLV 400
++GQG FG VY+G G VAIK + + +M+ ++EF E V+ + H+V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 401 TLLGACPEAWS--LVYEYLPNG-------SLQDRLFRKSNVSPLLWKDRARIAAEIASGL 451
LLG + ++ E + G SL+ + +P K ++A EIA G+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 511
+L+++K VH DL +N ++ + + KI DFG+ R + E Y KG
Sbjct: 133 AYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY------RKGGKGLL 183
Query: 512 P--YADPEYHRTGVLTPKSDSYSFGLIILQLLT 542
P + PE + GV T SD +SFG+++ ++ T
Sbjct: 184 PVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 29/207 (14%)
Query: 350 VGQGGFGCVYKGEMLGR-----TVAIKML---YSHNMQGQLEFQQEVRVLSKLQHPHLVT 401
+G G FG V +G + VAIK L S + L+F E ++ + HP+++
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQR--LDFLTEASIMGQFDHPNIIR 69
Query: 402 LLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 459
L G ++ + + EY+ NGSL D+ R+ N + IASG+ +L
Sbjct: 70 LEGVVTKSRPVMIITEYMENGSL-DKFLRE-NDGKFTVGQLVGMLRGIASGMKYLSEMN- 126
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLV--TEDTLYLPSFHRSTAPKGSFP--YAD 515
VH DL +NIL++S L K+ DFG+ R + +E T T G P +
Sbjct: 127 --YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY--------TTKGGKIPIRWTA 176
Query: 516 PEYHRTGVLTPKSDSYSFGLIILQLLT 542
PE T SD +SFG+++ ++++
Sbjct: 177 PEAIAYRKFTSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 3e-17
Identities = 65/204 (31%), Positives = 104/204 (50%), Gaps = 19/204 (9%)
Query: 350 VGQGGFG----CVY--KGEMLGRTVAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVTL 402
+G+G FG C Y +G+ G VA+K L + + + ++E+ +L L H ++V
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 403 LGACPE----AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
G C E L+ E+LP+GSL++ L R N + + K + + A +I G+ +L S
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYLPR--NKNKINLKQQLKYAVQICKGMDYLGS-- 127
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 518
+ VH DL +N+L++SE KI DFG+ + + D Y +P F YA PE
Sbjct: 128 -RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSP--VFWYA-PEC 183
Query: 519 HRTGVLTPKSDSYSFGLIILQLLT 542
SD +SFG+ + +LLT
Sbjct: 184 LIQSKFYIASDVWSFGVTLYELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 61/204 (29%), Positives = 104/204 (50%), Gaps = 25/204 (12%)
Query: 350 VGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEA 409
+G+G FG V G+ G VA+K + ++ Q F E V+++L+H +LV LLG E
Sbjct: 14 IGKGEFGDVMLGDYRGNKVAVKCI-KNDATAQ-AFLAEASVMTQLRHSNLVQLLGVIVEE 71
Query: 410 WS---LVYEYLPNGSLQDRLFRKSNVSPLLWKDR-ARIAAEIASGLCFLHSSKPEKIVHG 465
+V EY+ GSL D L +S +L D + + ++ + +L ++ VH
Sbjct: 72 KGGLYIVTEYMAKGSLVDYL--RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 466 DLKPQNILLDSELSSKICDFGICRLV--TEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV 523
DL +N+L+ + +K+ DFG+ + T+DT LP + PE R
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-----------VKWTAPEALREKK 175
Query: 524 LTPKSDSYSFGLIILQLLT-GRLP 546
+ KSD +SFG+++ ++ + GR+P
Sbjct: 176 FSTKSDVWSFGILLWEIYSFGRVP 199
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-17
Identities = 69/260 (26%), Positives = 121/260 (46%), Gaps = 45/260 (17%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIKMLY---SHNMQGQLEFQQEVRVLSKLQHPHLVTLLG 404
+G G G V K + + G +A K+++ +++ Q+ +E++++ + + P++V+ G
Sbjct: 13 LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQI--LRELQIMHECRSPYIVSFYG 70
Query: 405 AC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
A + E++ GSL DR+++K P+ + +IA + GL +L++ +
Sbjct: 71 AFLNENNI-CMCMEFMDCGSL-DRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNV--HR 124
Query: 462 IVHGDLKPQNILLDSELSSKICDFGIC-RLVTE--DTLYLPSFHRSTAPKGSFPYADPEY 518
I+H D+KP NIL++S K+CDFG+ L+ DT G+ Y PE
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV-----------GTSTYMSPER 173
Query: 519 HRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPL--------- 569
+ G T KSD +S G+ I++L G+ P + ILD L
Sbjct: 174 IQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD--DPMGILDLLQQIVQEPPP 231
Query: 570 ---AGDWPTFVARRLVDLGL 586
+ D+P R VD L
Sbjct: 232 RLPSSDFPE-DLRDFVDACL 250
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 5e-17
Identities = 72/237 (30%), Positives = 104/237 (43%), Gaps = 35/237 (14%)
Query: 387 EVRVLSKLQHPHLVTLLGAC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI 443
E+ + KLQHP++V L+G C A+ L++EY+ +L + L N+S W+ R +I
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAY-LIHEYIEGKNLSEVL---RNLS---WERRRKI 785
Query: 444 AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS-FH 502
A IA L FLH +V G+L P+ I++D + + L LP
Sbjct: 786 AIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR------------LSLPGLLC 833
Query: 503 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--------R 554
T S Y PE T +T KSD Y FGLI+++LLTG+ P V R
Sbjct: 834 TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWAR 893
Query: 555 RAVSCGKLSSILDPLAGDWPTFVARRLV---DLGLQCCELYGRERPDITPSLVKELE 608
S L +DP + +V +L L C RP ++K LE
Sbjct: 894 YCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARP-CANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 7e-17
Identities = 67/231 (29%), Positives = 110/231 (47%), Gaps = 34/231 (14%)
Query: 336 DLQTATCNFSESFKVGQGGFGCVYKGEMLG-------RTVAIKMLYSHNMQGQL--EFQQ 386
++ +T F E ++G+ FG VYKG + G + VAIK L +G L EF+
Sbjct: 1 EINLSTVRFME--ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKAEGPLREEFKH 57
Query: 387 EVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-- 442
E + S+LQHP++V LLG + S+++ Y + L + L +S S + D +
Sbjct: 58 EAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117
Query: 443 -----------IAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491
I +IA+G+ FL S +VH DL +N+L+ +L+ KI D G+ R V
Sbjct: 118 KSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISDLGLFREV 174
Query: 492 TEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 542
Y S P + PE G + SD +S+G+++ ++ +
Sbjct: 175 YAAD-YYKLMGNSLLP---IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 9e-17
Identities = 67/207 (32%), Positives = 99/207 (47%), Gaps = 29/207 (14%)
Query: 350 VGQGGFGCVYKG------EMLGRTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVTL 402
+G G FG VYKG E + VAIK+L + + +EF E +++ + HPHLV L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 403 LGAC-PEAWSLVYEYLPNGSLQDRLFR-KSNVSPLL---WKDRARIAAEIASGLCFLHSS 457
LG C LV + +P+G L D + K N+ L W +IA G+ +L
Sbjct: 75 LGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLEE- 127
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP--YAD 515
++VH DL +N+L+ S KI DFG+ RL+ D A G P +
Sbjct: 128 --RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE------KEYNADGGKMPIKWMA 179
Query: 516 PEYHRTGVLTPKSDSYSFGLIILQLLT 542
E T +SD +S+G+ I +L+T
Sbjct: 180 LECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 1e-16
Identities = 62/208 (29%), Positives = 98/208 (47%), Gaps = 27/208 (12%)
Query: 350 VGQGGFGCVYKGEMLG-------RTVAIKMLYSHNMQGQLE-FQQEVRVLSKL-QHPHLV 400
+G G FG V + G VA+KML + E E++++S L H ++V
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIV 102
Query: 401 TLLGACPEAWS--LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
LLGAC ++ EY G L + L RK L D + ++A G+ FL S
Sbjct: 103 NLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLE-DLLSFSYQVAKGMAFLAS-- 159
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS--FP--YA 514
+ +H DL +N+LL KICDFG+ R + D+ Y+ KG+ P +
Sbjct: 160 -KNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV--------VKGNARLPVKWM 210
Query: 515 DPEYHRTGVLTPKSDSYSFGLIILQLLT 542
PE V T +SD +S+G+++ ++ +
Sbjct: 211 APESIFNCVYTFESDVWSYGILLWEIFS 238
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 2e-16
Identities = 62/227 (27%), Positives = 105/227 (46%), Gaps = 33/227 (14%)
Query: 338 QTATCNFSESFKV---GQGGFGCVYK--GEMLGRTVAIKMLY-SHNMQGQLEFQQEVRVL 391
+A + SE +V G G G VYK GR A+K++Y +H + + +E+ +L
Sbjct: 67 PSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEIL 126
Query: 392 SKLQHPHLVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDR--ARIAAEI 447
+ HP++V + + E++ GSL+ + ++ A +A +I
Sbjct: 127 RDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH---------IADEQFLADVARQI 177
Query: 448 ASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAP 507
SG+ +LH IVH D+KP N+L++S + KI DFG+ R++ + + +
Sbjct: 178 LSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ------TMDPCNSS 228
Query: 508 KGSFPYADPEYHRTGVLTPKSDSY-----SFGLIILQLLTGRLPVGL 549
G+ Y PE T + D Y S G+ IL+ GR P G+
Sbjct: 229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275
|
Length = 353 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 60/199 (30%), Positives = 104/199 (52%), Gaps = 22/199 (11%)
Query: 349 KVGQGGFGCVYKG--EML--GRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTL 402
++G G FG V KG +M +TVA+K+L + N L E +E V+ +L +P++V +
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 403 LGACP-EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
+G C E+W LV E G L L + +V+ K+ + +++ G+ +L +
Sbjct: 62 IGICEAESWMLVMELAELGPLNKFLQKNKHVTE---KNITELVHQVSMGMKYLEETN--- 115
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE---Y 518
VH DL +N+LL ++ +KI DFG+ + + D Y + T K + PE Y
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENY---YKAKTHGKWPVKWYAPECMNY 172
Query: 519 HRTGVLTPKSDSYSFGLII 537
++ + KSD +SFG+++
Sbjct: 173 YK---FSSKSDVWSFGVLM 188
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 2e-16
Identities = 65/214 (30%), Positives = 98/214 (45%), Gaps = 23/214 (10%)
Query: 343 NFSESFKVGQGGFGCVYKGEM--LGRTVAIK-MLYSHNMQGQLEFQQEVRVLSKLQHPHL 399
E ++G+G G V K + G A+K + N Q + +E+ + + P++
Sbjct: 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYI 61
Query: 400 VTLLGAC-PEAWSLVY---EYLPNGSLQDRLFRK--SNVSPLLWKDRARIAAEIASGLCF 453
V GA E+ S + EY GSL D +++K + K +IA + GL +
Sbjct: 62 VKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 454 LHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC-RLVTEDTLYLPSFHRSTAPKGSFP 512
LHS KI+H D+KP NILL + K+CDFG+ LV S T SF
Sbjct: 121 LHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN-------SL-AGTFTGTSF- 168
Query: 513 YADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
Y PE + + SD +S GL +L++ R P
Sbjct: 169 YMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFP 202
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 50/161 (31%), Positives = 74/161 (45%), Gaps = 28/161 (17%)
Query: 350 VGQGGFGCVYKG--EMLGRTVAIK-MLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGA 405
+G+G +G VYK + G+ VAIK M + + E ++E +L K HP++ T GA
Sbjct: 14 IGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEE--EIKEEYNILRKYSNHPNIATFYGA 71
Query: 406 C---------PEAWSLVYEYLPNGSLQD--RLFRKSNVS---PLLWKDRARIAAEIASGL 451
+ W LV E GS+ D + RK + A I E GL
Sbjct: 72 FIKKNPPGNDDQLW-LVMELCGGGSVTDLVKGLRKKGKRLKEEWI----AYILRETLRGL 126
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 492
+LH +K ++H D+K QNILL K+ DFG+ +
Sbjct: 127 AYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLD 164
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 79.4 bits (195), Expect = 3e-16
Identities = 65/209 (31%), Positives = 102/209 (48%), Gaps = 20/209 (9%)
Query: 344 FSESFKVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLV 400
F++ K+G+G FG V+KG + VAIK++ + ++E QQE+ VLS+ P++
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 401 TLLGAC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
G+ + W ++ EYL GS D L PL A I EI GL +LHS
Sbjct: 66 KYYGSYLKDTKLW-IIMEYLGGGSALDLL----EPGPLDETQIATILREILKGLDYLHS- 119
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 517
EK +H D+K N+LL K+ DFG+ +T+ + +F G+ + PE
Sbjct: 120 --EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF------VGTPFWMAPE 171
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ K+D +S G+ ++L G P
Sbjct: 172 VIKQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 3e-16
Identities = 71/235 (30%), Positives = 113/235 (48%), Gaps = 39/235 (16%)
Query: 350 VGQGGFGCVYKGEM----LGRTVAIKMLYSHNMQG-QLEFQQEVRVLSKL-QHPHLVTLL 403
+G+G FG V + + L AIKML + +F E+ VL KL HP+++ LL
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 404 GACPEAWSL--VYEYLPNGSLQDRLFRKSNV--------------SPLLWKDRARIAAEI 447
GAC L EY P G+L D L RKS V S L + + A+++
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFL-RKSRVLETDPAFAKEHGTASTLTSQQLLQFASDV 128
Query: 448 ASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAP 507
A+G+ +L ++ +H DL +N+L+ L+SKI DFG+ R + +Y+ + T
Sbjct: 129 ATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYV----KKTMG 178
Query: 508 KGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKL 562
+ + E V T KSD +SFG+++ ++ V L G ++C +L
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEI------VSLGGTPYCGMTCAEL 227
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.2 bits (196), Expect = 3e-16
Identities = 63/210 (30%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 344 FSESFKVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEF-QQEVRVLSKLQHPHLV 400
F+ +G+G FG VYK + + VAIK++ + ++E QQE++ LS+ + P++
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62
Query: 401 TLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
G+ + L + EY GS D L K L A I E+ GL +LH
Sbjct: 63 KYYGSFLKGSKLWIIMEYCGGGSCLDLL--KP--GKLDETYIAFILREVLLGLEYLHE-- 116
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY--ADP 516
E +H D+K NILL E K+ DFG+ +T +F G+ P+ A P
Sbjct: 117 -EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF------VGT-PFWMA-P 167
Query: 517 EYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
E + K+D +S G+ ++L G P
Sbjct: 168 EVIKQSGYDEKADIWSLGITAIELAKGEPP 197
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 59/206 (28%), Positives = 99/206 (48%), Gaps = 20/206 (9%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKM--LYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLG 404
K+G+G +G VYK + L + A+K L S + + + + E+R+L+ + HP++++
Sbjct: 7 KLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKE 66
Query: 405 ACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRA--RIAAEIASGLCFLHSSKPE 460
A + L V EY P G L + K L ++ RI ++ GL LH +
Sbjct: 67 AFLDGNKLCIVMEYAPFGDLS-KAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHE---Q 122
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 520
KI+H DLK NILL + KI D GI +++ ++ G+ Y PE +
Sbjct: 123 KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK--------TQIGTPHYMAPEVWK 174
Query: 521 TGVLTPKSDSYSFGLIILQLLTGRLP 546
+ KSD +S G ++ ++ T P
Sbjct: 175 GRPYSYKSDIWSLGCLLYEMATFAPP 200
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (195), Expect = 4e-16
Identities = 56/211 (26%), Positives = 92/211 (43%), Gaps = 35/211 (16%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIK-MLYSHNMQGQLEFQQ----EVRVLSKLQHPHLVT 401
K+G+G +G VYK + G VAIK + +G + E+++L +L HP+++
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEG---IPKTALREIKLLKELNHPNIIK 62
Query: 402 LLGACPE--AWSLVYEYLPNGSLQ-----DRLFRKSNVSPLLWKDRARIAAEIASGLCFL 454
LL LV+E++ + R +S + L+ ++ GL F
Sbjct: 63 LLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLY--------QLLQGLAFC 114
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 514
HS I+H DLKP+N+L+++E K+ DFG+ R T + Y
Sbjct: 115 HSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPY------THYVVTRWYR 165
Query: 515 DPE-YHRTGVLTPKSDSYSFGLIILQLLTGR 544
PE + D +S G I +LL+ R
Sbjct: 166 APELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 4e-16
Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 31/208 (14%)
Query: 350 VGQGGFGCVYKG------EMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLV 400
+G G FG V+KG + + VAIK + + G+ FQ+ + + L H ++V
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTI--QDRSGRQTFQEITDHMLAMGSLDHAYIV 72
Query: 401 TLLGACPEA-WSLVYEYLPNGSLQDRLF-RKSNVSP---LLWKDRARIAAEIASGLCFLH 455
LLG CP A LV + P GSL D + + ++ P L W +IA G+ +L
Sbjct: 73 RLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYYLE 126
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV-TEDTLYLPSFHRSTAPKGSFPYA 514
++VH +L +NILL S+ +I DFG+ L+ +D Y S H K +
Sbjct: 127 E---HRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEH-----KTPIKWM 178
Query: 515 DPEYHRTGVLTPKSDSYSFGLIILQLLT 542
E G T +SD +S+G+ + ++++
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 4e-16
Identities = 66/221 (29%), Positives = 109/221 (49%), Gaps = 23/221 (10%)
Query: 349 KVGQGGFGCVYKGEMLGR-TVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
++G G FG V+ G+ + VAIK + M + +F +E +V+ KL HP LV L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE-DFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 408 EAWSL--VYEYLPNGSLQDRLF-RKSNVSP--LLWKDRARIAAEIASGLCFLHSSKPEKI 462
+ L V E++ NG L + L R+ +S LL + ++ G+ +L +
Sbjct: 70 QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLL-----SMCQDVCEGMEYLERN---SF 121
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 522
+H DL +N L+ S K+ DFG+ R V +D + S+ K ++ PE
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDD-----EYTSSSGAKFPVKWSPPEVFNFS 176
Query: 523 VLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCG 560
+ KSD +SFG+++ ++ T G++P EV +S G
Sbjct: 177 KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRG 217
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 4e-16
Identities = 64/216 (29%), Positives = 98/216 (45%), Gaps = 33/216 (15%)
Query: 350 VGQGGFGCVYKGEMLG--------RTVAIKMLY-SHNMQGQLEFQQEVRVLSKLQHPHLV 400
+G G FG VY+G VA+K L Q + EF +E ++S HP++V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 401 TLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNV----SPLL-WKDRARIAAEIASGLCF 453
LLG C E ++ E + G L L R + V PLL K+ I ++A G +
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYL-RDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 454 LHSSKPEKIVHGDLKPQNILLDSELSS-----KICDFGICRLVTEDTLYLPSFHRSTAPK 508
L +H DL +N L+ + KI DFG+ R +Y ++R +
Sbjct: 122 LEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR-----DIYKSDYYRKEG-E 172
Query: 509 GSFP--YADPEYHRTGVLTPKSDSYSFGLIILQLLT 542
G P + PE G T +SD +SFG+++ ++LT
Sbjct: 173 GLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-16
Identities = 64/208 (30%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 344 FSESFKVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLV 400
F++ ++G+G FG VYKG VAIK++ + ++E QQE+ VLS+ P++
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 401 TLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
G+ + L + EYL GS D L PL A I EI GL +LHS
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGSALDLL----KPGPLEETYIATILREILKGLDYLHS-- 119
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 518
E+ +H D+K N+LL + K+ DFG+ +T+ + +F G+ + PE
Sbjct: 120 -ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF------VGTPFWMAPEV 172
Query: 519 HRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ K+D +S G+ ++L G P
Sbjct: 173 IKQSAYDFKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 6e-16
Identities = 54/161 (33%), Positives = 86/161 (53%), Gaps = 23/161 (14%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIK-MLYSHNMQG-QLEFQQEVRVLSKLQ---HPHLVTL 402
+G+G +G VYK L GR VA+K + + +G L +E+ +L +L+ HP++V L
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRL 66
Query: 403 LGAC--PEAW-----SLVYEYLPNGSLQD-RLFRKSNVSPLLWKDRAR-IAAEIASGLCF 453
L C P +LV+E++ QD + P L + + + ++ G+ F
Sbjct: 67 LDVCHGPRTDRELKLTLVFEHVD----QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDF 122
Query: 454 LHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494
LHS +IVH DLKPQNIL+ S+ KI DFG+ R+ + +
Sbjct: 123 LHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFE 160
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 6e-16
Identities = 63/208 (30%), Positives = 102/208 (49%), Gaps = 29/208 (13%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQ---QEVRVLSKLQHPHLVTLL 403
K+GQG G V+ G+ VAIK + N+Q Q + + E+ V+ +L++P++V L
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQI---NLQKQPKKELIINEILVMKELKNPNIVNFL 82
Query: 404 GA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA---EIASGLCFLHSSK 458
+ + +V EYL GSL D V D A+IAA E L FLH+++
Sbjct: 83 DSFLVGDELFVVMEYLAGGSLTD-------VVTETCMDEAQIAAVCRECLQALEFLHANQ 135
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 518
++H D+K N+LL + S K+ DFG C +T P + + G+ + PE
Sbjct: 136 ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQIT------PEQSKRSTMVGTPYWMAPEV 186
Query: 519 HRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PK D +S G++ ++++ G P
Sbjct: 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 6e-16
Identities = 60/226 (26%), Positives = 106/226 (46%), Gaps = 44/226 (19%)
Query: 350 VGQGGFGCVYKGEMLG-------RTVAIKMLYSH-NMQGQLEFQQEVRVLSKLQHPHLVT 401
+GQG FG V++ G VA+KML + Q +FQ+E ++++ HP++V
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 402 LLGACPEA--WSLVYEYLPNGSLQDRLFRKS-------------------NVSPLLWKDR 440
LLG C L++EY+ G L + L +S N PL ++
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 441 ARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 500
IA ++A+G+ +L K VH DL +N L+ + KI DFG+ R +Y
Sbjct: 133 LCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSR-----NIYSAD 184
Query: 501 FHRSTA----PKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 542
+++++ P P Y+R T +SD +++G+++ ++ +
Sbjct: 185 YYKASENDAIPIRWMPPESIFYNR---YTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 6e-16
Identities = 73/258 (28%), Positives = 114/258 (44%), Gaps = 24/258 (9%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGA 405
VG+G FG V+ + + + V IK + M +L Q E +VL L HP+++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 406 CPE--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
E A +V EY P G+L + + ++ N LL D I L LH + I+
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCN--SLL--DEDTILHFFVQILLALHHVHTKLIL 123
Query: 464 HGDLKPQNILLDS-ELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 522
H DLK QNILLD ++ KI DFGI ++ L S ++ G+ Y PE
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKI-------LSSKSKAYTVVGTPCYISPELCEGK 176
Query: 523 VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLV 582
KSD ++ G ++ +L + L A+ +S P+ D + R+L+
Sbjct: 177 PYNQKSDIWALGCVLYELAS--LKRAFEAANLPALVLKIMSGTFAPI-SDRYSPDLRQLI 233
Query: 583 DLGLQCCELYGRERPDIT 600
L L +RP ++
Sbjct: 234 ---LSMLNLDPSKRPQLS 248
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 7e-16
Identities = 68/235 (28%), Positives = 108/235 (45%), Gaps = 39/235 (16%)
Query: 350 VGQGGFGCVY----KGEMLGRTVAIKMLYSHNMQG-QLEFQQEVRVLSKL-QHPHLVTLL 403
+G+G FG V K + L AIK + + + +F E+ VL KL HP+++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 404 GACPEAWSL--VYEYLPNGSLQDRLFRKSNV--------------SPLLWKDRARIAAEI 447
GAC L EY P+G+L D L RKS V S L + AA++
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 448 ASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAP 507
A G+ +L ++ +H DL +NIL+ +KI DFG+ R +Y+ + T
Sbjct: 122 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV----KKTMG 171
Query: 508 KGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKL 562
+ + E V T SD +S+G+++ ++ V L G ++C +L
Sbjct: 172 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI------VSLGGTPYCGMTCAEL 220
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 8e-16
Identities = 80/287 (27%), Positives = 127/287 (44%), Gaps = 37/287 (12%)
Query: 343 NFSESFKVGQGGFGCVYKGEMLG-------RTVAIKMLYSHNMQG-QLEFQQEVRVLSKL 394
N E +G+G FG V+ + G V +K L + Q EF++E+ + KL
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 395 QHPHLVTLLGACPEA--WSLVYEYLPNGSLQDRL------FRKSNVSPLLWKDRARIAAE 446
H ++V LLG C EA ++ EY G L+ L K PL K + + +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST- 505
IA G+ L ++ + VH DL +N L+ S+ K+ + + V Y R+
Sbjct: 126 IALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYK---LRNAL 179
Query: 506 APKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPV-GLAG-EVRRAVSCGKL 562
P PE + + KSD +SFG+++ ++ T G LP GL+ EV + GKL
Sbjct: 180 IPLRWLA---PEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL 236
Query: 563 SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609
P+ P+ RL L +C + ++RP + LV L +
Sbjct: 237 EL---PVPEGCPS----RLYKLMTRCWAVNPKDRPSFS-ELVSALGE 275
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 57/227 (25%), Positives = 95/227 (41%), Gaps = 64/227 (28%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQ--QEVRVLSKLQHPHLVTLLG 404
++G+G +G VYK G VA+K + N + +E+++L KL+HP++V L
Sbjct: 6 QIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKE 65
Query: 405 ACPEAWS----LVYEYLP---NGSLQDRLFR------KSNVSPLLWKDRARIAAEIASGL 451
+V+EY+ G L + K ++ GL
Sbjct: 66 IVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKC------------YMKQLLEGL 113
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED----------TL-YLPS 500
+LHS+ I+H D+K NIL++++ K+ DFG+ R T+ TL Y P
Sbjct: 114 QYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRP- 169
Query: 501 FHRSTAPK---GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 544
P+ G+ Y P+ D +S G I+ +L G+
Sbjct: 170 ------PELLLGATRY-----------GPEVDMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 1e-15
Identities = 61/207 (29%), Positives = 95/207 (45%), Gaps = 17/207 (8%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTLLG 404
K+G G FG VY L G +A+K + + + E E++VL L+HP+LV G
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 405 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
E + EY G+L++ L + + + ++ GL +LHS I
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIR---VYTLQLLEGLAYLHSHG---I 120
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 522
VH D+KP NI LD K+ DFG + +T + +S A G+ Y PE G
Sbjct: 121 VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA--GTPAYMAPEVITGG 178
Query: 523 VLTPK---SDSYSFGLIILQLLTGRLP 546
+D +S G ++L++ TG+ P
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRP 205
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 77.1 bits (190), Expect = 2e-15
Identities = 65/219 (29%), Positives = 102/219 (46%), Gaps = 35/219 (15%)
Query: 350 VGQGGFGCVYKGEMLG-------RTVAIKMLYSHNMQGQL-EFQQEVRVLSKL-QHPHLV 400
+G+G FG V K E +G TVA+KML + L + E+ ++ + +H +++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 401 TLLGACPEAWSL--VYEYLPNGSLQDRLFRK-------------SNVSPLLWKDRARIAA 445
LLG C + L V EY +G+L+D L + L KD A
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 446 EIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST 505
++A G+ FL S +K +H DL +N+L+ + KI DFG+ R + Y R T
Sbjct: 140 QVARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY-----RKT 191
Query: 506 APKGSFPYA--DPEYHRTGVLTPKSDSYSFGLIILQLLT 542
G P PE V T +SD +SFG+++ ++ T
Sbjct: 192 T-NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 2e-15
Identities = 64/224 (28%), Positives = 108/224 (48%), Gaps = 39/224 (17%)
Query: 349 KVGQGGFG----CVYKG--EMLGRT----------VAIKMLYSH-NMQGQLEFQQEVRVL 391
K+G+G FG C +G E LG VA+KML + + +F +E++++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 392 SKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRL--------FRKSNVSPLL-WKDR 440
S+L++P+++ LLG C + ++ EY+ NG L L F +N P + +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 441 ARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 500
+A +IASG+ +L S VH DL +N L+ + + KI DFG+ R LY
Sbjct: 132 LYMAVQIASGMKYLASL---NFVHRDLATRNCLVGNHYTIKIADFGMSR-----NLYSGD 183
Query: 501 FHRSTAPKGSFP--YADPEYHRTGVLTPKSDSYSFGLIILQLLT 542
++R + P + E G T SD ++FG+ + ++ T
Sbjct: 184 YYRIQG-RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 77/223 (34%), Positives = 115/223 (51%), Gaps = 27/223 (12%)
Query: 349 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
K+G G FG V+ T VA+K + +M + F E V+ LQH LV L
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE-AFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 408 -EAWSLVYEYLPNGSLQDRLFRKS---NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
E ++ E++ GSL D F KS + PL +A+IA G+ F+ +
Sbjct: 72 KEPIYIITEFMAKGSLLD--FLKSDEGSKQPL--PKLIDFSAQIAEGMAFIEQ---RNYI 124
Query: 464 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS-FP--YADPEYHR 520
H DL+ NIL+ + L KI DFG+ R++ ED Y TA +G+ FP + PE
Sbjct: 125 HRDLRAANILVSASLVCKIADFGLARVI-EDNEY-------TAREGAKFPIKWTAPEAIN 176
Query: 521 TGVLTPKSDSYSFGLIILQLLT-GRLPV-GLAG-EVRRAVSCG 560
G T KSD +SFG+++++++T GR+P G++ EV RA+ G
Sbjct: 177 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 219
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 62/208 (29%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 344 FSESFKVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLV 400
F++ ++G+G FG V+KG + VAIK++ + ++E QQE+ VLS+ P++
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 401 TLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
G+ + L + EYL GS D L P A + EI GL +LHS
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGSALDLL----RAGPFDEFQIATMLKEILKGLDYLHS-- 119
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 518
EK +H D+K N+LL + K+ DFG+ +T+ + +F G+ + PE
Sbjct: 120 -EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF------VGTPFWMAPEV 172
Query: 519 HRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ K+D +S G+ ++L G P
Sbjct: 173 IQQSAYDSKADIWSLGITAIELAKGEPP 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 4e-15
Identities = 60/217 (27%), Positives = 100/217 (46%), Gaps = 20/217 (9%)
Query: 350 VGQGGFGCVYKGEMLG--RTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
+G+G +G VY L +AIK + + + +E+ + S L+H ++V LG+
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 408 EA--WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI--AAEIASGLCFLHSSKPEKIV 463
E + + E +P GSL L +S PL ++ I +I GL +LH +IV
Sbjct: 76 ENGFFKIFMEQVPGGSLSALL--RSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIV 130
Query: 464 HGDLKPQNILLDSELSS-KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 522
H D+K N+L+++ KI DFG + + +F G+ Y PE G
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETF------TGTLQYMAPEVIDKG 184
Query: 523 V--LTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAV 557
+D +S G I+++ TG+ P GE + A+
Sbjct: 185 PRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAM 221
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 5e-15
Identities = 57/197 (28%), Positives = 99/197 (50%), Gaps = 14/197 (7%)
Query: 350 VGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQG-QLEFQQEVRVLSKLQHPHLVTLLGACP 407
+G+G FG V+KG + +T VA+K Q +++F E R+L + HP++V L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 408 EAWS--LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 465
+ +V E +P G L +K + L K + A + A+G+ +L S + +H
Sbjct: 63 QRQPIYIVMELVPGGDFLSFLRKKKD--ELKTKQLVKFALDAAAGMAYLES---KNCIHR 117
Query: 466 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLT 525
DL +N L+ KI DFG+ R +D +Y S + K + PE G +
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQ-EDDGIYSSSGLKQIPIK----WTAPEALNYGRYS 172
Query: 526 PKSDSYSFGLIILQLLT 542
+SD +S+G+++ + +
Sbjct: 173 SESDVWSYGILLWETFS 189
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 9e-15
Identities = 65/218 (29%), Positives = 98/218 (44%), Gaps = 27/218 (12%)
Query: 349 KVGQGGFGCVYKGEMLGRT-------VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVT 401
++G+G FG V+ E VA+K L + + +F +E +L+ LQH H+V
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVK 71
Query: 402 LLGACPEAWSL--VYEYLPNGSLQ--------DRLFRKSNVSP--LLWKDRARIAAEIAS 449
G C E L V+EY+ +G L D + P L IA +IA+
Sbjct: 72 FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131
Query: 450 GLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKG 509
G+ +L S + VH DL +N L+ L KI DFG+ R V Y H + P
Sbjct: 132 GMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGH-TMLPIR 187
Query: 510 SFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP 546
P PE T +SD +S G+++ ++ T G+ P
Sbjct: 188 WMP---PESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 222
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 9e-15
Identities = 49/160 (30%), Positives = 81/160 (50%), Gaps = 35/160 (21%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKML----YSHNMQGQLEFQ--QEVRVLSKLQHPHLV 400
K+G+G + VYK GR VAIK + G + F +E+++L +L+HP+++
Sbjct: 7 KLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDG-INFTALREIKLLQELKHPNII 65
Query: 401 TLLGACPE--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI--AAEIAS------- 449
LL +LV+E++ L+ + KD++ + A+I S
Sbjct: 66 GLLDVFGHKSNINLVFEFME-TDLE-----------KVIKDKSIVLTPADIKSYMLMTLR 113
Query: 450 GLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
GL +LHS+ I+H DLKP N+L+ S+ K+ DFG+ R
Sbjct: 114 GLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLAR 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 63/215 (29%), Positives = 91/215 (42%), Gaps = 33/215 (15%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEF-QQEVRVLSKLQHPHLVTLLGA 405
+G G VY L VAIK + Q ++ ++EV+ +S+ HP++V +
Sbjct: 8 VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTS 67
Query: 406 CPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA---EIASGLCFLHSSKPE 460
L V YL GSL D + L D A IA E+ GL +LHS
Sbjct: 68 FVVGDELWLVMPYLSGGSLLDIMKSSYPRGGL---DEAIIATVLKEVLKGLEYLHS---N 121
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK---GSFPYADPE 517
+H D+K NILL + S KI DFG+ +L K G+ + PE
Sbjct: 122 GQIHRDIKAGNILLGEDGSVKIADFGV-----SASLADGGDRTRKVRKTFVGTPCWMAPE 176
Query: 518 YHRTGVLTP------KSDSYSFGLIILQLLTGRLP 546
V+ K+D +SFG+ ++L TG P
Sbjct: 177 -----VMEQVHGYDFKADIWSFGITAIELATGAAP 206
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 36/215 (16%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE-----FQQEVRVLSKLQHPHLVTL 402
+GQG FG VY + GR +A+K + + + + E+++L LQH +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 403 LGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460
G E S+ EY+P GS++D+L ++ + + R +I G+ +LHS+
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTR---QILEGVEYLHSNM-- 124
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGIC-RLVT--EDTLYLPSFHRSTAPKGSFPYADPE 517
IVH D+K NIL DS + K+ DFG RL T + S G+ + PE
Sbjct: 125 -IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVT------GTPYWMSPE 177
Query: 518 ------YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
Y R K+D +S G ++++LT + P
Sbjct: 178 VISGEGYGR------KADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 63/211 (29%), Positives = 108/211 (51%), Gaps = 32/211 (15%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQ----LEFQQEVRVLSKLQH---PHLV 400
+G+G +G VY+G+ + GR VA+K++ N+ + Q+EV +LS+L+ P++
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKII---NLDTPDDDVSDIQREVALLSQLRQSQPPNIT 65
Query: 401 TLLGAC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
G+ P W ++ EY GS+ R K+ P+ K + I E+ L ++H
Sbjct: 66 KYYGSYLKGPRLW-IIMEYAEGGSV--RTLMKA--GPIAEKYISVIIREVLVALKYIHKV 120
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY-ADP 516
++H D+K NIL+ + + K+CDFG+ L+ +++ RST G+ PY P
Sbjct: 121 G---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS-----KRSTF-VGT-PYWMAP 170
Query: 517 EYHRTGVL-TPKSDSYSFGLIILQLLTGRLP 546
E G K+D +S G+ I ++ TG P
Sbjct: 171 EVITEGKYYDTKADIWSLGITIYEMATGNPP 201
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 74.8 bits (183), Expect = 1e-14
Identities = 66/209 (31%), Positives = 102/209 (48%), Gaps = 31/209 (14%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQ---QEVRVLSKLQHPHLVTLL 403
K+GQG G VY + G+ VAIK + N+Q Q + + E+ V+ + ++P++V L
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQM---NLQQQPKKELIINEILVMRENKNPNIVNYL 82
Query: 404 GAC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA---EIASGLCFLHSS 457
+ E W +V EYL GSL D V D +IAA E L FLHS+
Sbjct: 83 DSYLVGDELW-VVMEYLAGGSLTD-------VVTETCMDEGQIAAVCRECLQALDFLHSN 134
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 517
+ ++H D+K NILL + S K+ DFG C +T P + + G+ + PE
Sbjct: 135 Q---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT------PEQSKRSTMVGTPYWMAPE 185
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PK D +S G++ ++++ G P
Sbjct: 186 VVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 48/145 (33%), Positives = 79/145 (54%), Gaps = 15/145 (10%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVTLLGA 405
K+G+G +G VYK + G+ VAIK++ ++ L E +E+ +L + P++V G+
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVVAIKVV---PVEEDLQEIIKEISILKQCDSPYIVKYYGS 66
Query: 406 C---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
+ W +V EY GS+ D + K L ++ A I + GL +LHS+K
Sbjct: 67 YFKNTDLW-IVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLHSNK---K 120
Query: 463 VHGDLKPQNILLDSELSSKICDFGI 487
+H D+K NILL+ E +K+ DFG+
Sbjct: 121 IHRDIKAGNILLNEEGQAKLADFGV 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-14
Identities = 55/168 (32%), Positives = 85/168 (50%), Gaps = 21/168 (12%)
Query: 349 KVGQGGFGCVYKGEML-----GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
++G G FG V GE+ + V ++ S ++Q Q++F +E + LQH +L+ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 404 GACPEA--WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDR---ARIAAEIASGLCFLHSSK 458
G C E + LV E+ P G L+ R + L+ D R+A EIA GL LH +
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLK-GYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRL-------VTEDTLYLP 499
+H DL +N LL ++L+ KI D+G+ VT D L++P
Sbjct: 121 ---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVP 165
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 64/222 (28%), Positives = 100/222 (45%), Gaps = 44/222 (19%)
Query: 343 NFSESFKVGQGGFGCVY--KGEMLGRTVAIKMLYSHNMQGQLEFQQ------EVRVLSKL 394
+ VG G FG V+ + + A+K++ + + +Q E RVL ++
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVM---AIPEVIRLKQEQHVHNEKRVLKEV 58
Query: 395 QHPHLVTLLGACPEAWSL--VYEYLPNGSLQDRLF---RKSNVSPLLWKDRARIAAEIAS 449
HP ++ L + L + EY+P G L L R SN + L + A+EI
Sbjct: 59 SHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFY------ASEIVC 112
Query: 450 GLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKG 509
L +LHS ++IV+ DLKP+NILLD E K+ DFG + + + T L G
Sbjct: 113 ALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLC---------G 160
Query: 510 SFPYADPEY-----HRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ Y PE H V D ++ G++I ++L G P
Sbjct: 161 TPEYLAPEVIQSKGHNKAV-----DWWALGILIYEMLVGYPP 197
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 3e-14
Identities = 65/209 (31%), Positives = 101/209 (48%), Gaps = 31/209 (14%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQ---QEVRVLSKLQHPHLVTLL 403
K+GQG G VY G+ VAI+ + N+Q Q + + E+ V+ + ++P++V L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQM---NLQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 404 GAC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA---EIASGLCFLHSS 457
+ E W +V EYL GSL D V D +IAA E L FLHS+
Sbjct: 84 DSYLVGDELW-VVMEYLAGGSLTD-------VVTETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 517
+ ++H D+K NILL + S K+ DFG C +T P + + G+ + PE
Sbjct: 136 Q---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT------PEQSKRSTMVGTPYWMAPE 186
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PK D +S G++ ++++ G P
Sbjct: 187 VVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 55/203 (27%), Positives = 103/203 (50%), Gaps = 20/203 (9%)
Query: 349 KVGQGGFGCVYKG--EMLGRT--VAIKMLYSHNMQG-QLEFQQEVRVLSKLQHPHLVTLL 403
++G G FGCV KG +M + VAIK+L + N + + E +E ++ +L +P++V ++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 404 GAC-PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
G C EA LV E G L L K + + + + +++ G+ +L +
Sbjct: 62 GVCEAEALMLVMEMASGGPLNKFLSGKKDEITV--SNVVELMHQVSMGMKYLEG---KNF 116
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE---YH 519
VH DL +N+LL ++ +KI DFG+ + + D Y + +A K + PE +
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY---YKARSAGKWPLKWYAPECINFR 173
Query: 520 RTGVLTPKSDSYSFGLIILQLLT 542
+ + +SD +S+G+ + + +
Sbjct: 174 K---FSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 3e-14
Identities = 64/205 (31%), Positives = 98/205 (47%), Gaps = 21/205 (10%)
Query: 350 VGQGGFGCV--YKGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTLLG 404
+G+G FG V + + G+ A+K+L + + E E RVL +HP L +L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 405 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 461
+ + V EY+ G L L R+ S +DR R AEI S L +LHS K
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRERVFS----EDRTRFYGAEIVSALDYLHSGK--- 115
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
IV+ DLK +N++LD + KI DFG+C+ D + +F G+ Y PE
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFC------GTPEYLAPEVLED 169
Query: 522 GVLTPKSDSYSFGLIILQLLTGRLP 546
D + G+++ +++ GRLP
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 4e-14
Identities = 64/259 (24%), Positives = 111/259 (42%), Gaps = 21/259 (8%)
Query: 350 VGQGGFGCVYKGE--MLGRTVAIKML-YSHNMQGQLE-----FQQEVRVLSKLQHPHLVT 401
+G G F Y+ G +A+K + Y N + E ++E+R++++L HPH++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 402 LLGACPEA--WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 459
+LGA E ++L E++ GS+ L S ++ GL +LH +
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLL---SKYGAFKEAVIINYTEQLLRGLSYLHEN-- 122
Query: 460 EKIVHGDLKPQNILLDSELSS-KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 518
+I+H D+K N+L+DS +I DFG + F G+ + PE
Sbjct: 123 -QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLL--GTIAFMAPEV 179
Query: 519 HRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVA 578
R D +S G +I+++ T + P K++S P ++
Sbjct: 180 LRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA--PSIPEHLS 237
Query: 579 RRLVDLGLQCCELYGRERP 597
L D+ L+C EL +RP
Sbjct: 238 PGLRDVTLRCLELQPEDRP 256
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 72.6 bits (178), Expect = 6e-14
Identities = 64/225 (28%), Positives = 105/225 (46%), Gaps = 40/225 (17%)
Query: 349 KVGQGGFGCVYKGEMLGRT------------------VAIKMLYSH-NMQGQLEFQQEVR 389
K+G+G FG V+ E G VA+KML N + +F +E++
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 390 VLSKLQHPHLVTLLGACPEAWSL--VYEYLPNGSLQDRLFR--------KSNVSPLLWKD 439
++S+L+ P+++ LL C + L + EY+ NG L L R K++V + +
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 440 RARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499
+A +IASG+ +L S VH DL +N L+ + KI DFG+ R LY
Sbjct: 132 LIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSR-----NLYSG 183
Query: 500 SFHRSTAPKGSFP--YADPEYHRTGVLTPKSDSYSFGLIILQLLT 542
++R + P + E G T SD ++FG+ + ++LT
Sbjct: 184 DYYRIQG-RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 6e-14
Identities = 66/212 (31%), Positives = 95/212 (44%), Gaps = 34/212 (16%)
Query: 350 VGQGGFGCVYKGEMLG--RTVAIKMLYSH--NMQGQLEF-QQEVRVLSKL-QHPHLVTLL 403
+G+G FG V E+ G A+K+L +E E RVL+ +HP L L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 404 GAC---PEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARI-AAEIASGLCFL 454
+C + V EY+ G L + F + RAR AAEI GL FL
Sbjct: 63 -SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEP---------RARFYAAEIVLGLQFL 112
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 514
H I++ DLK N+LLDSE KI DFG+C+ E L ++ G+ Y
Sbjct: 113 HE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCK---EGILG---GVTTSTFCGTPDYI 163
Query: 515 DPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PE P D ++ G+++ ++L G+ P
Sbjct: 164 APEILSYQPYGPAVDWWALGVLLYEMLAGQSP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 7e-14
Identities = 59/207 (28%), Positives = 105/207 (50%), Gaps = 26/207 (12%)
Query: 350 VGQGGFGCVYKGEM--LGR---TVAIKMLYS-HNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
+G G FG V +G + G+ VAIK L S + + + +F E ++ + HP+++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 404 G----ACPEAWSLVYEYLPNGSLQDRLFRKSN----VSPLLWKDRARIAAEIASGLCFLH 455
G + P ++ E++ NG+L D R+++ V L+ R IA+G+ +L
Sbjct: 72 GVVTKSRPVM--IITEFMENGAL-DSFLRQNDGQFTVIQLVGMLRG-----IAAGMKYLS 123
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 515
VH DL +NIL++S L K+ DFG+ R + +DT P++ S K +
Sbjct: 124 EMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD-PTYTSSLGGKIPIRWTA 179
Query: 516 PEYHRTGVLTPKSDSYSFGLIILQLLT 542
PE T SD +S+G+++ ++++
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 1e-13
Identities = 66/205 (32%), Positives = 98/205 (47%), Gaps = 20/205 (9%)
Query: 350 VGQGGFGCV--YKGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTLLG 404
+G+G FG V K + GR A+K+L + + E E RVL +HP L L
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 405 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 461
+ + V EY G L L R+ S +DRAR AEI S L +LHS K
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFS----EDRARFYGAEIVSALDYLHSEK--N 116
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
+V+ DLK +N++LD + KI DFG+C+ +D + +F G+ Y PE
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC------GTPEYLAPEVLED 170
Query: 522 GVLTPKSDSYSFGLIILQLLTGRLP 546
D + G+++ +++ GRLP
Sbjct: 171 NDYGRAVDWWGLGVVMYEMMCGRLP 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 1e-13
Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 21/205 (10%)
Query: 350 VGQGGFGCV--YKGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTLLG 404
+G+G FG V + + GR A+K+L + + E E RVL +HP L L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 405 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 461
A + V EY G L L R+ + ++RAR AEI S L +LHS
Sbjct: 63 AFQTHDRLCFVMEYANGGELFFHLSRERVFT----EERARFYGAEIVSALEYLHS---RD 115
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
+V+ D+K +N++LD + KI DFG+C+ D + +F G+ Y PE
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC------GTPEYLAPEVLED 169
Query: 522 GVLTPKSDSYSFGLIILQLLTGRLP 546
D + G+++ +++ GRLP
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 60/206 (29%), Positives = 99/206 (48%), Gaps = 19/206 (9%)
Query: 349 KVGQGGFGCVY--KGEMLGRTVAIKMLYSHNMQGQLE--FQQEVRVLSKLQHPHLVTLLG 404
K+G+G FG +Y K + IK + M + + ++EV +L+K++HP++VT
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 405 ACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 461
+ E L V EY G L R+ R+ V L +D+ +I+ GL +H K
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGV--LFSEDQILSWFVQISLGLKHIHD---RK 121
Query: 462 IVHGDLKPQNILLDSE-LSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 520
I+H D+K QNI L + +K+ DFGI R + + + G+ Y PE +
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM----ELAYTCV--GTPYYLSPEICQ 175
Query: 521 TGVLTPKSDSYSFGLIILQLLTGRLP 546
K+D +S G ++ +L T + P
Sbjct: 176 NRPYNNKTDIWSLGCVLYELCTLKHP 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.0 bits (175), Expect = 2e-13
Identities = 51/155 (32%), Positives = 67/155 (43%), Gaps = 27/155 (17%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKM----LYSHNMQGQLEFQQEVRVLSKLQ-HPHLVT 401
++G G FG VY G VAIK YS L +EV+ L KL HP++V
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL---REVKSLRKLNEHPNIVK 62
Query: 402 LLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSK 458
L E L V+EY+ G+L K + R I +I GL +H
Sbjct: 63 LKEVFRENDELYFVFEYM-EGNLYQ--LMKDRKGKPFSESVIRSIIYQILQGLAHIHK-- 117
Query: 459 PEKIVHG----DLKPQNILLDSELSSKICDFGICR 489
HG DLKP+N+L+ KI DFG+ R
Sbjct: 118 -----HGFFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 85/292 (29%), Positives = 130/292 (44%), Gaps = 47/292 (16%)
Query: 350 VGQGGFGCVYKGEM----LGRTVAIKMLYSHNMQG-QLEFQQEVRVLSKL-QHPHLVTLL 403
+G+G FG V K + L AIK + + + +F E+ VL KL HP+++ LL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 404 GACPEA--WSLVYEYLPNGSLQDRLFRKSNV--------------SPLLWKDRARIAAEI 447
GAC L EY P+G+L D L RKS V S L + AA++
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133
Query: 448 ASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAP 507
A G+ +L ++ +H DL +NIL+ +KI DFG+ R +Y+ + T
Sbjct: 134 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV----KKTMG 183
Query: 508 KGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILD 567
+ + E V T SD +S+G+++ ++ V L G ++C +L L
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEI------VSLGGTPYCGMTCAELYEKL- 236
Query: 568 PLAG--DWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL-HVAEER 616
P + P + DL QC RE+P PS + L L + EER
Sbjct: 237 PQGYRLEKPLNCDDEVYDLMRQCW----REKPYERPSFAQILVSLNRMLEER 284
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 62/209 (29%), Positives = 98/209 (46%), Gaps = 33/209 (15%)
Query: 350 VGQGGFGCVYKG------EMLGRTVAIKMLY-SHNMQGQLEFQQEVRVLSKLQHPHLVTL 402
+G G FG VYKG E + VAIK L + + + E E V++ + +PH+ L
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 403 LGAC-PEAWSLVYEYLPNGSLQDRLFR-KSNVSP---LLWKDRARIAAEIASGLCFLHSS 457
LG C L+ + +P G L D + K N+ L W +IA G+ +L
Sbjct: 75 LGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEE- 127
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA--- 514
++VH DL +N+L+ + KI DFG+ +L+ D +H A G P
Sbjct: 128 --RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE---KEYH---AEGGKVPIKWMA 179
Query: 515 -DPEYHRTGVLTPKSDSYSFGLIILQLLT 542
+ HR T +SD +S+G+ + +L+T
Sbjct: 180 LESILHRI--YTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 3e-13
Identities = 67/212 (31%), Positives = 104/212 (49%), Gaps = 33/212 (15%)
Query: 350 VGQGGFGCVY-----KGEMLGRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTL 402
+GQG FG V+ G G+ A+K+L ++ ++ + E +L+++ HP +V L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 403 LGA--CPEAWSLVYEYLPNGSLQDRL-----FRKSNVSPLLWKDRARIAAEIASGLCFLH 455
A L+ ++L G L RL F + +V L AE+A L LH
Sbjct: 64 HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL--------AELALALDHLH 115
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 515
S I++ DLKP+NILLD E K+ DFG+ + + SF G+ Y
Sbjct: 116 SLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFC------GTVEYMA 166
Query: 516 PE-YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PE +R G T +D +SFG+++ ++LTG LP
Sbjct: 167 PEVVNRRG-HTQSADWWSFGVLMFEMLTGSLP 197
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 4e-13
Identities = 55/180 (30%), Positives = 84/180 (46%), Gaps = 30/180 (16%)
Query: 349 KVGQGGFGCV-----YKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
++G G FG V Y + R V ++ + + + Q EF Q+ LQHP+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 404 GACPEA--WSLVYEYLPNGSL------QDRLFRKSNVSPLLWKDRARIAAEIASGLCFLH 455
G C EA + LV+EY G L + R S + L R+A EIA+G+ +H
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLL-----QRMACEIAAGVTHMH 116
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGIC-------RLVTEDTLYLPSFHRSTAPK 508
+H DL +N L S+L+ K+ D+GI + TED +P R AP+
Sbjct: 117 K---HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPL--RWLAPE 171
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 50/157 (31%), Positives = 80/157 (50%), Gaps = 31/157 (19%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQ---------QEVRVLSKLQHP 397
K+G+G +G VYK G VA+K + +LE + +E+ +L +L HP
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKI-------RLETEDEGVPSTAIREISLLKELNHP 58
Query: 398 HLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA---EIASGLC 452
++V LL LV+E+L D L + + SPL D I + ++ G+
Sbjct: 59 NIVRLLDVVHSENKLYLVFEFLD----LD-LKKYMDSSPLTGLDPPLIKSYLYQLLQGIA 113
Query: 453 FLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
+ HS +++H DLKPQN+L+D E + K+ DFG+ R
Sbjct: 114 YCHS---HRVLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 69.5 bits (170), Expect = 5e-13
Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 22/206 (10%)
Query: 350 VGQGGFGCVYKGEM--LGRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLG 404
+G+GGFG V ++ G+ A K L + +G+ E ++L K+ +V+L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 405 A--CPEAWSLVYEYLPNGSLQDRLFRKSNV-SPLLWKDRARI-AAEIASGLCFLHSSKPE 460
A + LV + G L+ + NV P + RA AA+I GL LH
Sbjct: 61 AFETKDDLCLVMTLMNGGDLK---YHIYNVGEPGFPEARAIFYAAQIICGLEHLHQ---R 114
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 520
+IV+ DLKP+N+LLD + +I D G+ + L + G+ Y PE +
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGL-------AVELKGGKKIKGRAGTPGYMAPEVLQ 167
Query: 521 TGVLTPKSDSYSFGLIILQLLTGRLP 546
V D ++ G + +++ GR P
Sbjct: 168 GEVYDFSVDWFALGCTLYEMIAGRSP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 5e-13
Identities = 59/219 (26%), Positives = 104/219 (47%), Gaps = 33/219 (15%)
Query: 350 VGQGGFGCVYKGEMLG---------RTVAIKMLYSHNMQGQL-EFQQEVRVLSKL-QHPH 398
+G+G FG V E LG TVA+KML + L + E+ ++ + +H +
Sbjct: 23 LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82
Query: 399 LVTLLGACPEAWSL--VYEYLPNGSLQDRL-----------FRKSNVS--PLLWKDRARI 443
++ LLGAC + L + EY G+L++ L + + V + +KD
Sbjct: 83 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142
Query: 444 AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHR 503
++A G+ +L S +K +H DL +N+L+ KI DFG+ R D + + +
Sbjct: 143 TYQVARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLAR----DVNNIDYYKK 195
Query: 504 STAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 542
+T + + PE V T +SD +SFG+++ ++ T
Sbjct: 196 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 234
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 7e-13
Identities = 53/222 (23%), Positives = 97/222 (43%), Gaps = 38/222 (17%)
Query: 350 VGQGGFGCVYKGEM-----LGRTVAIKMLYSHNM-QGQLE-FQQEVRVLSKLQHPHLVTL 402
+G+G FG V +G++ VA+K + ++E F E + HP+++ L
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 403 LGACPEAWSL--------VYEYLPNGSLQDRLFR--------KSNVSPLLWKDRARIAAE 446
+G C EA SL + ++ +G L L K + LL + +
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLL-----KFMVD 121
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST- 505
IA G+ +L + +H DL +N +L +++ + DFG+ + +Y ++R
Sbjct: 122 IALGMEYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSK-----KIYSGDYYRQGR 173
Query: 506 APKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP 546
K + E V T KSD ++FG+ + ++ T G+ P
Sbjct: 174 IAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 7e-13
Identities = 66/214 (30%), Positives = 99/214 (46%), Gaps = 38/214 (17%)
Query: 350 VGQGGFGCVYKGEMLG--RTVAIKMLYSHNMQGQLEFQQ--------EVRVLSKLQHPHL 399
+G+G FG V E G AIK+L + + Q E RVL+ P
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKIL-----KKDVIIQDDDVECTMVEKRVLALPGKPPF 62
Query: 400 VTLLGAC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 456
+T L +C + V EY+ G L ++ V AAEIA GL FLHS
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGKFKEPHAVFYAAEIAIGLFFLHS 119
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 516
+ I++ DLK N++LD+E KI DFG+C+ + ++ R+ G+ Y P
Sbjct: 120 ---KGIIYRDLKLDNVMLDAEGHIKIADFGMCK----ENIFGGKTTRTFC--GTPDYIAP 170
Query: 517 E---YHRTGVLTPKS-DSYSFGLIILQLLTGRLP 546
E Y G KS D ++FG+++ ++L G+ P
Sbjct: 171 EIIAYQPYG----KSVDWWAFGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 8e-13
Identities = 54/149 (36%), Positives = 80/149 (53%), Gaps = 16/149 (10%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSK-LQHPHLVTLL 403
+G+G FG V K + G+ A+K+L + + E + E VL K ++HP LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 404 GA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPE 460
+ + V +Y+ G L L R+ + + RAR AAEIAS L +LHS
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFP----EPRARFYAAEIASALGYLHS---L 115
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICR 489
I++ DLKP+NILLDS+ + DFG+C+
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 9e-13
Identities = 49/161 (30%), Positives = 76/161 (47%), Gaps = 36/161 (22%)
Query: 349 KVGQGGFGCVYK--GEMLGRTVAIKMLYS---HNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
VG+G +G V K + G+ VAIK M ++ + E+R+L +L+H +LV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMR-EIRMLKQLRHENLVNLI 66
Query: 404 GAC--PEAWSLVYEYL-----------PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASG 450
+ LV+E++ PNG L + RK L+ +I G
Sbjct: 67 EVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-LDESRVRK-----YLF--------QILRG 112
Query: 451 LCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491
+ F HS I+H D+KP+NIL+ K+CDFG R +
Sbjct: 113 IEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTL 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 57/206 (27%), Positives = 94/206 (45%), Gaps = 29/206 (14%)
Query: 349 KVGQGGFGCVYKGEMLGR-----TVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTL 402
+G+G FG VY+G + VA+K + E F QE ++ + HPH+V L
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKL 72
Query: 403 LGACPE--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460
+G E W +V E P G L+ L L + ++++ L +L S +
Sbjct: 73 IGVITENPVW-IVMELAPLGELRSYLQVNKYSLDLA--SLILYSYQLSTALAYLESKR-- 127
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP--YADPE- 517
VH D+ +N+L+ S K+ DFG+ R + +++ Y A KG P + PE
Sbjct: 128 -FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY-------KASKGKLPIKWMAPES 179
Query: 518 --YHRTGVLTPKSDSYSFGLIILQLL 541
+ R T SD + FG+ + ++L
Sbjct: 180 INFRR---FTSASDVWMFGVCMWEIL 202
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 62/205 (30%), Positives = 97/205 (47%), Gaps = 25/205 (12%)
Query: 350 VGQGGFGCVYKG------EMLGRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTL 402
+G G FG VYKG E + VAIK+L + + E E V++ + P++ L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 403 LGAC-PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
LG C LV + +P G L D + + N + +D +IA G+ +L +
Sbjct: 75 LGICLTSTVQLVTQLMPYGCLLDYV--RENKDRIGSQDLLNWCVQIAKGMSYLEEVR--- 129
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA----DPE 517
+VH DL +N+L+ S KI DFG+ RL+ D +H A G P +
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE---TEYH---ADGGKVPIKWMALESI 183
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLT 542
HR T +SD +S+G+ + +L+T
Sbjct: 184 LHRR--FTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 1e-12
Identities = 77/275 (28%), Positives = 129/275 (46%), Gaps = 34/275 (12%)
Query: 350 VGQGGFGCVYKG--EMLGR---TVAIKMLYSHNMQGQ-LEFQQEVRVLSKLQHPHLVTLL 403
+G G FG V++G +M GR VAIK L + Q +F E ++ + H +++ L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 404 GACPE--AWSLVYEYLPNGSLQDRLFRKSN--VSPLLWKDRARIAAEIASGLCFLHSSKP 459
G + ++ EY+ NG+L D+ R + S R IA+G+ +L
Sbjct: 73 GVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLR---GIAAGMKYLSDMN- 127
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 519
VH DL +NIL++S L K+ DFG+ R++ +D + ++ K + PE
Sbjct: 128 --YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP---EGTYTTSGGKIPIRWTAPEAI 182
Query: 520 RTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCG-KLSSILDPLAGDWPT 575
T SD +SFG+++ ++++ G P EV +A++ G +L P D P+
Sbjct: 183 AYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRL-----PAPMDCPS 237
Query: 576 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610
V + L LQC + RP +V L++L
Sbjct: 238 AVYQ----LMLQCWQQDRARRPRF-VDIVNLLDKL 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 49/165 (29%), Positives = 78/165 (47%), Gaps = 46/165 (27%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQ---------EVRVLSKLQHP 397
K+G+G +G VYKG G+ VA+K + +LE ++ E+ +L +LQHP
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKI-------RLESEEEGVPSTAIREISLLKELQHP 59
Query: 398 HLVTLLGAC--PEAWSLVYEYL-----------PNGSLQDRLFRKSNVSPLLWKDRARIA 444
++V L L++E+L P G D KS +
Sbjct: 60 NIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLY----------- 108
Query: 445 AEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
+I G+ F HS +++H DLKPQN+L+D++ K+ DFG+ R
Sbjct: 109 -QILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 1e-12
Identities = 57/206 (27%), Positives = 100/206 (48%), Gaps = 15/206 (7%)
Query: 350 VGQGGFGCVYKGEM-LGRTVAIKMLY---SHNMQGQLEF---QQEVRVLSKLQHPHLVTL 402
+G+G +G VY G G+ +A+K + S+ + + E+ Q+EV +L L+H ++V
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 403 LGACPE--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460
LG C + S+ E++P GS+ L R PL + +I G+ +LH++
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNN--- 121
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 520
+VH D+K N++L K+ DFG R + L+ + + G+ + PE
Sbjct: 122 CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVIN 181
Query: 521 TGVLTPKSDSYSFGLIILQLLTGRLP 546
KSD +S G + ++ TG+ P
Sbjct: 182 ESGYGRKSDIWSIGCTVFEMATGKPP 207
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 60/230 (26%), Positives = 104/230 (45%), Gaps = 35/230 (15%)
Query: 327 PESAEFSLADLQTATCNFSESFKVGQGGFG----CVYKGEMLGRTVAIKMLYSHN---MQ 379
P+++ + L+D + +G G FG +KG G AIK L M+
Sbjct: 10 PDTSSWKLSDFEMGE-------TLGTGSFGRVRIAKHKGT--GEYYAIKCLKKREILKMK 60
Query: 380 GQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLW 437
QE +L +L HP +V ++ + + + + E++ G L L RK+ P
Sbjct: 61 QVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHL-RKAGRFP--- 116
Query: 438 KDRARI-AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496
D A+ AE+ +LHS + I++ DLKP+N+LLD++ K+ DFG + V + T
Sbjct: 117 NDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF 173
Query: 497 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
L G+ Y PE ++ D ++ G+++ + + G P
Sbjct: 174 TLC---------GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214
|
Length = 329 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 69/208 (33%), Positives = 101/208 (48%), Gaps = 26/208 (12%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLYSH---NMQGQLEFQQEVRVLSK-LQHPHLVTLL 403
+G+G FG V K ++ G+ A+K+L N + Q E VL K ++HP LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 404 GA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPE 460
+ E V +++ G L L R+ + + RAR AAEIAS L +LHS
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFP----EPRARFYAAEIASALGYLHSIN-- 116
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICR--LVTEDTLYLPSFHRSTAPKGSFPYADPEY 518
IV+ DLKP+NILLDS+ + DFG+C+ + DT +T G+ Y PE
Sbjct: 117 -IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT--------TTTFCGTPEYLAPEV 167
Query: 519 HRTGVLTPKSDSYSFGLIILQLLTGRLP 546
R D + G ++ ++L G P
Sbjct: 168 IRKQPYDNTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-12
Identities = 63/215 (29%), Positives = 101/215 (46%), Gaps = 33/215 (15%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEFQQ--------EVRVLSKLQHPH 398
++G+G +G VYK G T+A+K + +LE + E+ +L K P+
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEI-------RLELDESKFNQIIMELDILHKAVSPY 60
Query: 399 LVTLLGACPEAWSLVY--EYLPNGSLQDRLFRKSNVSPLLWKDR-ARIAAEIASGLCFLH 455
+V GA ++ EY+ GSL D+L+ + + +D RI + GL FL
Sbjct: 61 IVDFYGAFFIEGAVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFL- 118
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGIC-RLV---TEDTLYLPSFHRSTAPKGSF 511
+ I+H D+KP N+L++ K+CDFG+ LV + + S+ K
Sbjct: 119 -KEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGG 177
Query: 512 PYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
P +P Y T +SD +S GL IL++ GR P
Sbjct: 178 PNQNPTY------TVQSDVWSLGLSILEMALGRYP 206
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 68.7 bits (169), Expect = 2e-12
Identities = 47/165 (28%), Positives = 73/165 (44%), Gaps = 36/165 (21%)
Query: 350 VGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEFQ---------QEVRVLSKLQHPH 398
+G G +G V + GR VAIK + F +E+++L L+H +
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKI-------SNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 399 LVTLLGAC-PEAWS------LVYEYLPNGSLQD--RLFRKSNVSPLLWKDRARIAAEIAS 449
++ LL P + +V E + D ++ + PL +I
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELMET----DLHKVIKSPQ--PLTDDHIQYFLYQILR 114
Query: 450 GLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494
GL +LHS+ ++H DLKP NIL++S KICDFG+ R V D
Sbjct: 115 GLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 2e-12
Identities = 68/215 (31%), Positives = 96/215 (44%), Gaps = 41/215 (19%)
Query: 351 GQGGFGCV----YKGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVL---SKLQHPHLV 400
G+G FG V YK G AIK L ++ + E + E R+ + +HP LV
Sbjct: 8 GRGHFGKVLLAEYKKT--GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 401 TLLGACPEAWSLVY---EYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHS 456
L AC + V EY G L + P RA AA + GL +LH
Sbjct: 66 NLF-ACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP-----RAVFYAACVVLGLQYLHE 119
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 516
+K IV+ DLK N+LLD+E KI DFG+C+ E + R++ G+ P
Sbjct: 120 NK---IVYRDLKLDNLLLDTEGFVKIADFGLCK---EGMGF---GDRTSTFCGT-----P 165
Query: 517 EYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 546
E+ VLT S D + G++I ++L G P
Sbjct: 166 EFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 59/214 (27%), Positives = 92/214 (42%), Gaps = 33/214 (15%)
Query: 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQ---QEVRVLSKLQHP 397
NF K+G+G F VYK L GR VA+K + M Q +E+ +L +L HP
Sbjct: 3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHP 62
Query: 398 HLVTLLGACPEAWSL--VYEYLPNGSL---------QDRLFRKSNVSPLLWKDRARIAAE 446
+++ L + E L V E G L Q RL + +WK +
Sbjct: 63 NVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPE----RTIWK----YFVQ 114
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTA 506
+ S L +HS ++I+H D+KP N+ + + K+ D G+ R + T S
Sbjct: 115 LCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL----- 166
Query: 507 PKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQL 540
G+ Y PE KSD +S G ++ ++
Sbjct: 167 -VGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 64/232 (27%), Positives = 107/232 (46%), Gaps = 48/232 (20%)
Query: 349 KVGQGGFGCVYKGEML----------------GRT--VAIKMLYSH-NMQGQLEFQQEVR 389
K+G+G FG V+ E++ GR VA+K+L N + +F +EV+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 390 VLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLF------RKSNVSPLLWKDRA 441
+LS+L+ P+++ LLG C + ++ EY+ NG L L ++ N + +
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 442 ----------RIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491
+A +IASG+ +L S VH DL +N L+ L+ KI DFG+ R
Sbjct: 132 LPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSR-- 186
Query: 492 TEDTLYLPSFHRSTAPKGSFP--YADPEYHRTGVLTPKSDSYSFGLIILQLL 541
LY ++R + P + E G T SD ++FG+ + ++L
Sbjct: 187 ---NLYAGDYYRIQG-RAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 3e-12
Identities = 57/202 (28%), Positives = 93/202 (46%), Gaps = 23/202 (11%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGA- 405
+G G G VYK L R +A+K++ ++ Q + E+ +L K P+++ GA
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68
Query: 406 -CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
S+ E++ GSL ++RK +L RIA + GL +L S K I+H
Sbjct: 69 FVENRISICTEFMDGGSLD--VYRKIP-EHVL----GRIAVAVVKGLTYLWSLK---ILH 118
Query: 465 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVL 524
D+KP N+L+++ K+CDFG+ + + G+ Y PE
Sbjct: 119 RDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI--------AKTYVGTNAYMAPERISGEQY 170
Query: 525 TPKSDSYSFGLIILQLLTGRLP 546
SD +S G+ ++L GR P
Sbjct: 171 GIHSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 47/175 (26%), Positives = 82/175 (46%), Gaps = 30/175 (17%)
Query: 339 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEF--QQEVRVLSKL 394
+ ++ K+G+G FG VYK + GR VA+K + HN + +E+++L KL
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKL 64
Query: 395 QHPHLVTLLGACPEAWSLVYEYLPNGSLQDRL-------FRKSNVSPLLWKDRAR----- 442
+HP++V L+ + E P+ S + R + ++S LL +
Sbjct: 65 KHPNVVPLI-------DMAVER-PDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQ 116
Query: 443 ---IAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494
++ G+ +LH + I+H D+K NIL+D++ KI DFG+ R
Sbjct: 117 IKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGP 168
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 63/205 (30%), Positives = 96/205 (46%), Gaps = 20/205 (9%)
Query: 350 VGQGGFGCVYKGEMLG--RTVAIKMLYSHNMQGQLEFQ---QEVRVLSKLQHPHLVTLLG 404
+G+G FG V E G AIK+L + + + E RVL+ P +T L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLH 67
Query: 405 ACPEAWSLVY---EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
+C + +Y EY+ G L +++ V AAEIA GL FLHS +
Sbjct: 68 SCFQTMDRLYFVMEYVNGGDL---MYQIQQVGRFKEPHAVFYAAEIAIGLFFLHS---KG 121
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
I++ DLK N++LDSE KI DFG+C+ D + +F G+ Y PE
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFC------GTPDYIAPEIIAY 175
Query: 522 GVLTPKSDSYSFGLIILQLLTGRLP 546
D ++FG+++ ++L G+ P
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQAP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 48/147 (32%), Positives = 75/147 (51%), Gaps = 17/147 (11%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEF---QQEVRVLSKLQHPHLVTLL 403
++G G +G VYK + G VAIK++ ++ +F QQE+ +L + +HP++V
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECRHPNIVAYF 66
Query: 404 GA---CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460
G+ + W +V EY GSLQD + PL A + E GL +LH +
Sbjct: 67 GSYLRRDKLW-IVMEYCGGGSLQDIY--QVTRGPLSELQIAYVCRETLKGLAYLHETG-- 121
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGI 487
+H D+K NILL + K+ DFG+
Sbjct: 122 -KIHRDIKGANILLTEDGDVKLADFGV 147
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 50/171 (29%), Positives = 84/171 (49%), Gaps = 29/171 (16%)
Query: 386 QEVRVLSKLQHPHLVTLLGACPEAW-----SLVYEYLPNGSLQDRLFRKSNVSP--LLWK 438
+E++VL + P++V GA + S+ E++ GSL D++ +K+ P +L
Sbjct: 48 RELKVLHECNSPYIVGFYGA---FYSDGEISICMEHMDGGSL-DQVLKKAGRIPENIL-- 101
Query: 439 DRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498
+I+ + GL +L KI+H D+KP NIL++S K+CDFG+
Sbjct: 102 --GKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVS---------- 147
Query: 499 PSFHRSTAPK--GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPV 547
S A G+ Y PE + T +SD +S GL ++++ GR P+
Sbjct: 148 GQLIDSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 66/210 (31%), Positives = 97/210 (46%), Gaps = 31/210 (14%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTLLG 404
+G+G FG V + + G+ A+K+L + + E E RVL +HP L L
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 405 ACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 461
+ L V EY G L L R+ S +DRAR AEI S L +LHS
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRERVFS----EDRARFYGAEIVSALGYLHS---CD 115
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
+V+ DLK +N++LD + KI DFG+C+ E S + +F PEY
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCK---EGI----SDGATMK---TF-CGTPEYLAP 164
Query: 522 GVLTPKS-----DSYSFGLIILQLLTGRLP 546
VL D + G+++ +++ GRLP
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 194
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 5e-12
Identities = 69/256 (26%), Positives = 107/256 (41%), Gaps = 52/256 (20%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQ--QEVRVLSKLQ---HPHLVT 401
++G G +G VYK G VA+K + + L +EV +L +L+ HP++V
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 402 LLGACPEAWS-------LVYEYLPNGSLQD-RLFRKSNVSPLLWKDRAR-IAAEIASGLC 452
L+ C + + LV+E++ QD R + P L + + + + GL
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVD----QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122
Query: 453 FLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAP-KGSF 511
FLH++ IVH DLKP+NIL+ S K+ DFG+ R+ S + P +
Sbjct: 123 FLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY--------SCQMALTPVVVTL 171
Query: 512 PYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCG-----KLSSIL 566
Y PE D +S G I ++ R+ + CG +L I
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEMFR-----------RKPLFCGNSEADQLGKIF 220
Query: 567 D----PLAGDWPTFVA 578
D P DWP V
Sbjct: 221 DLIGLPPEDDWPRDVT 236
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 6e-12
Identities = 63/223 (28%), Positives = 102/223 (45%), Gaps = 37/223 (16%)
Query: 350 VGQGGFGCVYKGEML-----GRTVAIKMLYS----HNMQGQLEFQQEVRVLSKLQHPHLV 400
+G+GG+G V++ + G+ A+K+L N + + E +L ++HP +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 401 TLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSS 457
L+ A L + EYL G L L R+ + +D A +EI+ L LH
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREG----IFMEDTACFYLSEISLALEHLHQ- 118
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 517
+ I++ DLKP+NILLD++ K+ DFG+C+ + +F G+ Y PE
Sbjct: 119 --QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC------GTIEYMAPE 170
Query: 518 Y-----HRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR 555
H V D +S G ++ +LTG P E R+
Sbjct: 171 ILMRSGHGKAV-----DWWSLGALMYDMLTGAPP--FTAENRK 206
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 6e-12
Identities = 59/219 (26%), Positives = 107/219 (48%), Gaps = 33/219 (15%)
Query: 350 VGQGGFGCVYKGEMLG---------RTVAIKMLYSHNMQGQL-EFQQEVRVLSKL-QHPH 398
+G+G FG V E +G VA+KML S + L + E+ ++ + +H +
Sbjct: 26 LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85
Query: 399 LVTLLGACPEAWSL--VYEYLPNGSLQDRL-----------FRKSNV--SPLLWKDRARI 443
++ LLGAC + L + EY G+L++ L + + V L +KD
Sbjct: 86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145
Query: 444 AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHR 503
A ++A G+ +L S +K +H DL +N+L+ + KI DFG+ R D ++ + +
Sbjct: 146 AYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYYKK 198
Query: 504 STAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 542
+T + + PE + T +SD +SFG+++ ++ T
Sbjct: 199 TTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 7e-12
Identities = 60/205 (29%), Positives = 101/205 (49%), Gaps = 24/205 (11%)
Query: 350 VGQGGFGCVYKGEML--GR---TVAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVTLL 403
+G G FG V G + G+ VAIK L + + Q +F E ++ + HP+++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 404 GACPEAWS--LVYEYLPNGSLQDRLFRKSN----VSPLLWKDRARIAAEIASGLCFLHSS 457
G ++ +V EY+ NGSL D RK + V L+ R IASG+ +L
Sbjct: 72 GVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRG-----IASGMKYLSDM 125
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 517
VH DL +NIL++S L K+ DFG+ R++ +D + + + K + PE
Sbjct: 126 G---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP---EAAYTTRGGKIPIRWTAPE 179
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLT 542
T SD +S+G+++ ++++
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 8e-12
Identities = 58/219 (26%), Positives = 102/219 (46%), Gaps = 33/219 (15%)
Query: 350 VGQGGFGCVYKGEMLG---------RTVAIKMLYSHNMQGQL-EFQQEVRVLSKL-QHPH 398
+G+G FG V + E G TVA+KML + L + E+ ++ + +H +
Sbjct: 20 LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79
Query: 399 LVTLLGACPEAWSL--VYEYLPNGSLQDRL-------------FRKSNVSPLLWKDRARI 443
++ LLG C + L + EY G+L++ L K L +KD
Sbjct: 80 IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139
Query: 444 AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHR 503
A ++A G+ +L S + +H DL +N+L+ + KI DFG+ R V + Y +
Sbjct: 140 AYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYY----KK 192
Query: 504 STAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 542
++ + + PE V T +SD +SFG+++ ++ T
Sbjct: 193 TSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 9e-12
Identities = 52/156 (33%), Positives = 83/156 (53%), Gaps = 17/156 (10%)
Query: 343 NFSESFKVGQGGFGCVYKGE--MLGRTVAIKML-YSHNMQGQLEFQ-QEVRVLSKLQHPH 398
NF + K+G+G +G VYK + G VA+K + +G +E+ +L +L HP+
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 399 LVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA---EIASGLCF 453
+V LL L V+E+L QD L + + SPL I + ++ GL F
Sbjct: 61 IVKLLDVIHTENKLYLVFEFLH----QD-LKKFMDASPLSGIPLPLIKSYLFQLLQGLAF 115
Query: 454 LHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
HS +++H DLKPQN+L+++E + K+ DFG+ R
Sbjct: 116 CHS---HRVLHRDLKPQNLLINTEGAIKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 1e-11
Identities = 66/206 (32%), Positives = 96/206 (46%), Gaps = 22/206 (10%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNM---QGQLEFQQEVRVLSK-LQHPHLVTLL 403
+G+G FG V K + G A+K+L + + Q E VL K L+HP LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 404 GA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPE 460
+ E V +Y+ G L L R+ + RAR AAE+AS + +LHS
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFL----EPRARFYAAEVASAIGYLHS---L 115
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 520
I++ DLKP+NILLDS+ + DFG+C+ E +F G+ Y PE R
Sbjct: 116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC------GTPEYLAPEVLR 169
Query: 521 TGVLTPKSDSYSFGLIILQLLTGRLP 546
D + G ++ ++L G P
Sbjct: 170 KEPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 1e-11
Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 37/221 (16%)
Query: 350 VGQGGFGCVYKGEMLG---------RTVAIKMLYSHNMQGQL-EFQQEVRVLSKL-QHPH 398
+G+G FG V E +G TVA+KML L + E+ ++ + +H +
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 399 LVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSP---------------LLWKDRA 441
++ LLGAC + L + EY G+L R + ++ P L +KD
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNL--REYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137
Query: 442 RIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 501
A ++A G+ +L S +K +H DL +N+L+ + KI DFG+ R D + +
Sbjct: 138 SCAYQVARGMEYLAS---QKCIHRDLAARNVLVTEDNVMKIADFGLAR----DVHNIDYY 190
Query: 502 HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 542
++T + + PE V T +SD +SFG+++ ++ T
Sbjct: 191 KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 231
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 1e-11
Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 24/207 (11%)
Query: 350 VGQGGFGCVYKGEM--LGRTVAIKMLYSHNMQGQLEFQ---QEVRVLS-KLQHPHLVTLL 403
+G+G FG V + GR A+K+L + + + E R+LS HP L T L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFL-TQL 61
Query: 404 GAC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKP 459
C P+ V E++ G L + + + RAR AAEI S L FLH
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFD----EARARFYAAEITSALMFLHD--- 114
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 519
+ I++ DLK N+LLD E K+ DFG+C+ + +F G+ Y PE
Sbjct: 115 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC------GTPDYIAPEIL 168
Query: 520 RTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ + P D ++ G+++ ++L G P
Sbjct: 169 QEMLYGPSVDWWAMGVLLYEMLCGHAP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 1e-11
Identities = 62/221 (28%), Positives = 97/221 (43%), Gaps = 49/221 (22%)
Query: 351 GQGGFGCVYK--GEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-------HPHLVT 401
G+G +G V K G +A+K ++ + Q++ R+L L P+ VT
Sbjct: 10 GRGAYGVVDKMRHVPTGTIMAVK-----RIRATVNSQEQKRLLMDLDISMRSVDCPYTVT 64
Query: 402 LLGA---------CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDR--ARIAAEIASG 450
GA C E + + SL D+ ++K L + +IA I
Sbjct: 65 FYGALFREGDVWICME--------VMDTSL-DKFYKKVYDKGLTIPEDILGKIAVSIVKA 115
Query: 451 LCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS 510
L +LHS ++H D+KP N+L++ K+CDFGI + YL T G
Sbjct: 116 LEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGI-------SGYLVDSVAKTIDAGC 166
Query: 511 FPYA-----DPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PY +PE ++ G KSD +S G+ +++L TGR P
Sbjct: 167 KPYMAPERINPELNQKG-YDVKSDVWSLGITMIELATGRFP 206
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 71/271 (26%), Positives = 121/271 (44%), Gaps = 34/271 (12%)
Query: 349 KVGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQ--LEFQQEVRVLSKLQHPHLVTLLG 404
K+G+G FG + K + G+ IK + M + E ++EV VLS ++HP++V
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 405 ACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIA--AEIASGLCFLHSSKPE 460
+ E +L V +Y G L ++ + V L+ + + +I L +H
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGV---LFPEDQILDWFVQICLALKHVHD---R 120
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 520
KI+H D+K QNI L + + K+ DFGI R V T+ L R+ G+ Y PE
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIAR-VLNSTVELA---RTCI--GTPYYLSPEICE 174
Query: 521 TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSS-ILDPLAGDWPTFVAR 579
KSD ++ G ++ ++ T ++ A G + + +L + G +P +
Sbjct: 175 NRPYNNKSDIWALGCVLYEMCT----------LKHAFEAGNMKNLVLKIIRGSYPPVSSH 224
Query: 580 RLVDLGLQCCELYGR---ERPDITPSLVKEL 607
DL +L+ R +RP + L K
Sbjct: 225 YSYDLRNLVSQLFKRNPRDRPSVNSILEKNF 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 2e-11
Identities = 69/205 (33%), Positives = 95/205 (46%), Gaps = 20/205 (9%)
Query: 350 VGQGGFGCVYKGEMLG--RTVAIKMLYSHN--MQGQLEFQQ-EVRVLS-KLQHPHLVTLL 403
+G+G FG V+ E+ G + AIK L M +E E RVLS +HP L L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 404 GA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
E V EYL G L +F + AAEI GL FLHS +
Sbjct: 63 CTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAEIICGLQFLHS---KG 116
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
IV+ DLK NILLD++ KI DFG+C+ E+ L ++ G+ Y PE
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCK---ENML---GDAKTCTFCGTPDYIAPEILLG 170
Query: 522 GVLTPKSDSYSFGLIILQLLTGRLP 546
D +SFG+++ ++L G+ P
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 2e-11
Identities = 65/209 (31%), Positives = 94/209 (44%), Gaps = 28/209 (13%)
Query: 350 VGQGGFGCVYKGEMLGRT--VAIKMLYSHN--MQGQLEFQQ-EVRVLS-KLQHPHLVTLL 403
+G+G FG V E+ G AIK L +E E RVL+ +HP L L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 404 GACP----EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSK 458
C E V EYL G L + + RAR AAEI GL FLH
Sbjct: 63 --CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFD----EARARFYAAEIICGLQFLHK-- 114
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRL-VTEDTLYLPSFHRSTAPKGSFPYADPE 517
+ I++ DLK N+LLD + KI DFG+C+ + + +++ G+ Y PE
Sbjct: 115 -KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEG-------KASTFCGTPDYIAPE 166
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ D +SFG+++ ++L G+ P
Sbjct: 167 ILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 54/195 (27%), Positives = 93/195 (47%), Gaps = 16/195 (8%)
Query: 349 KVGQGGFGCVYKGEMLGRT--VAIKMLYSHNMQGQLE--FQQEVRVLSKLQHPHLVTLLG 404
++G+G FG V+ G + VA+K + L+ F QE R+L + HP++V L+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSC-RETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 405 ACPEAWS--LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
C + +V E + G F ++ L K+ ++ A+G+ +L S +
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLT--FLRTEGPRLKVKELIQMVENAAAGMEYLES---KHC 115
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 522
+H DL +N L+ + KI DFG+ R ED +Y + P + PE G
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSR-EEEDGVYASTGGMKQIP---VKWTAPEALNYG 171
Query: 523 VLTPKSDSYSFGLII 537
+ +SD +SFG+++
Sbjct: 172 RYSSESDVWSFGILL 186
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 4e-11
Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 40/213 (18%)
Query: 351 GQGGFGCVYKGEMLGRT------------VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPH 398
GQG F +YKG + ++ V +K+L S + + L F + ++S+L H H
Sbjct: 4 GQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGS-DHRDSLAFFETASLMSQLSHKH 62
Query: 399 LVTLLGAC-PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
LV L G C + +V EY+ G L L R+ N L WK +A ++AS L +L
Sbjct: 63 LVKLYGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLED- 119
Query: 458 KPEKIVHGDLKPQNILLDSE-------LSSKICDFGICR-LVTEDTLYLPSFHRSTAPKG 509
+K+VHG++ +NIL+ K+ D GI +++ +
Sbjct: 120 --KKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERI--------- 168
Query: 510 SFPYADPEYHRTGV--LTPKSDSYSFGLIILQL 540
P+ PE R G LT +D +SFG +L++
Sbjct: 169 --PWIAPECIRNGQASLTIAADKWSFGTTLLEI 199
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 63.9 bits (156), Expect = 4e-11
Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 20/154 (12%)
Query: 349 KVGQGGFGCVYK--GEMLGRTVAIKMLYSHNMQGQLE--FQQEVRVLSKLQHPHLVTLLG 404
K+G+G +G V+K G+ VAIK ++ +E+R+L +L+HP+LV L+
Sbjct: 8 KIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLI- 66
Query: 405 ACPEAWS------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
E + LV+EY + L + V L K +I + + F H
Sbjct: 67 ---EVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIK---KIIWQTLQAVNFCHKHN 120
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 492
+H D+KP+NIL+ + K+CDFG R++T
Sbjct: 121 ---CIHRDVKPENILITKQGQIKLCDFGFARILT 151
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-11
Identities = 61/212 (28%), Positives = 96/212 (45%), Gaps = 20/212 (9%)
Query: 343 NFSESFKVGQGGFGCVYKGEMLG--RTVAIKMLYSHNMQGQLEFQ---QEVRVLSKLQHP 397
+F+ +G+G FG V E G AIK+L + + + E RVL+ P
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 398 HLVTLLGACPEAWSLVY---EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFL 454
+T L +C + +Y EY+ G L ++ V AAEI+ GL FL
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDL---MYHIQQVGKFKEPQAVFYAAEISVGLFFL 117
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 514
H I++ DLK N++LDSE KI DFG+C+ D + +F G+ Y
Sbjct: 118 HR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFC------GTPDYI 168
Query: 515 DPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PE D +++G+++ ++L G+ P
Sbjct: 169 APEIIAYQPYGKSVDWWAYGVLLYEMLAGQPP 200
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (156), Expect = 6e-11
Identities = 47/167 (28%), Positives = 74/167 (44%), Gaps = 35/167 (20%)
Query: 349 KVGQGGFGCVYKGEML----GRTVAIKMLYSHNMQGQLEFQ---QEVRVLSKLQHPHLVT 401
+G+G +G VYK + G+ AIK Q Q +E+ +L +L+H ++V+
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVS 66
Query: 402 LLGACPEAW----SLVYEYLPNGSLQ---------DRLFRKSNVSPLLWKDRARIAAEIA 448
L+ E L+++Y + Q S V LLW +I
Sbjct: 67 LVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW--------QIL 118
Query: 449 SGLCFLHSSKPEKIVHGDLKPQNILLDSELSS----KICDFGICRLV 491
+G+ +LHS+ ++H DLKP NIL+ E KI D G+ RL
Sbjct: 119 NGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 6e-11
Identities = 79/298 (26%), Positives = 122/298 (40%), Gaps = 63/298 (21%)
Query: 349 KVGQGGFGCVYKGEML---GRTVAIKMLYSHNMQGQLEFQ--QEVRVLSKLQ---HPHLV 400
++G+G +G V+K L GR VA+K + + + +EV VL L+ HP++V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 401 TLLGACPEA-------WSLVYEYLPNGSLQDRLFR--KSNVSPLLWKDRARIAAEIASGL 451
L C + +LV+E++ + L L + + V KD + ++ GL
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKD---MMFQLLRGL 123
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 511
FLHS ++VH DLKPQNIL+ S K+ DFG+ R+ + T+ +
Sbjct: 124 DFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA-------LTSVVVTL 173
Query: 512 PYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILD---- 567
Y PE D +S G I ++ R P+ R + +L ILD
Sbjct: 174 WYRAPEVLLQSSYATPVDLWSVGCIFAEMFR-RKPL-----FRGSSDVDQLGKILDVIGL 227
Query: 568 PLAGDWPTFVA--------------RRLV--------DLGLQCCELYGRERPDITPSL 603
P DWP VA + V DL L+C +R +L
Sbjct: 228 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 7e-11
Identities = 54/203 (26%), Positives = 100/203 (49%), Gaps = 19/203 (9%)
Query: 349 KVGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
K+G+G G C+ + + GR VA+KM+ Q + EV ++ QH ++V + +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 407 ---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
E W L+ E+L G+L D + S L + A + + LC+LHS + ++
Sbjct: 88 LVGEELWVLM-EFLQGGALTDIV---SQTR-LNEEQIATVCESVLQALCYLHS---QGVI 139
Query: 464 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV 523
H D+K +ILL + K+ DFG C +++D +P + + G+ + PE
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCAQISKD---VP---KRKSLVGTPYWMAPEVISRTP 193
Query: 524 LTPKSDSYSFGLIILQLLTGRLP 546
+ D +S G+++++++ G P
Sbjct: 194 YGTEVDIWSLGIMVIEMVDGEPP 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 66/243 (27%), Positives = 103/243 (42%), Gaps = 62/243 (25%)
Query: 332 FSLADLQTATCNFSESFKVGQGGFGCVYKGEML----GRTVAIKMLYSHNMQ-GQLEFQQ 386
F+ DL+ + ++G+G FG V K ML G +A+K + S + Q
Sbjct: 1 FTAEDLK-------DLGEIGRGAFGTVNK--MLHKPSGTIMAVKRIRSTVDEKEQKRLLM 51
Query: 387 EVRVLSKLQH-PHLVTLLGA---------CPEA--------WSLVYEYLPNGSLQDRLFR 428
++ V+ + P++V GA C E + VYE L + + +
Sbjct: 52 DLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVYEVL-KSVIPEEILG 110
Query: 429 KSNVSPLLWKDRARIAAEIASGLCFLHSSKPE-KIVHGDLKPQNILLDSELSSKICDFGI 487
K V+ + +A L+ K E KI+H D+KP NILLD + K+CDFGI
Sbjct: 111 KIAVATV----KA------------LNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGI 154
Query: 488 C-RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTP---KSDSYSFGLIILQLLTG 543
+LV S + T G PY PE +SD +S G+ + ++ TG
Sbjct: 155 SGQLVD-------SIAK-TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATG 206
Query: 544 RLP 546
+ P
Sbjct: 207 KFP 209
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 72/226 (31%), Positives = 98/226 (43%), Gaps = 52/226 (23%)
Query: 344 FSESFKVGQGGFGCVY--KGEMLGRTVAIK-MLYSHNMQGQLEFQ---QEVRVLSKLQHP 397
F++ ++G G FG VY + VAIK M YS Q ++Q +EVR L +L+HP
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYS-GKQSNEKWQDIIKEVRFLQQLRHP 75
Query: 398 HLVTLLGAC----PEAWSLVYEYLPNGSLQDRL--FRKSNVSPLLWKDRARIAAEIASGL 451
+ + G C AW LV EY GS D L +K PL + A I GL
Sbjct: 76 NTIEYKG-CYLREHTAW-LVMEYCL-GSASDILEVHKK----PLQEVEIAAICHGALQGL 128
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 511
+LHS + +H D+K NILL + K+ DFG LV +P SF
Sbjct: 129 AYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLV--------------SPANSF 171
Query: 512 ---PY--------ADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PY A E G K D +S G+ ++L + P
Sbjct: 172 VGTPYWMAPEVILAMDEGQYDG----KVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 1e-10
Identities = 53/203 (26%), Positives = 97/203 (47%), Gaps = 19/203 (9%)
Query: 349 KVGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
K+G+G G C+ + GR VA+K + Q + EV ++ QHP++V + +
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85
Query: 407 ---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
E W +V E+L G+L D + + A + + L FLH+ + ++
Sbjct: 86 LVGDELW-VVMEFLEGGALTDIVTHTRMNEEQI----ATVCLAVLKALSFLHA---QGVI 137
Query: 464 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV 523
H D+K +ILL S+ K+ DFG C V+++ +P R + G+ + PE
Sbjct: 138 HRDIKSDSILLTSDGRVKLSDFGFCAQVSKE---VP---RRKSLVGTPYWMAPEVISRLP 191
Query: 524 LTPKSDSYSFGLIILQLLTGRLP 546
+ D +S G+++++++ G P
Sbjct: 192 YGTEVDIWSLGIMVIEMVDGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 55/205 (26%), Positives = 87/205 (42%), Gaps = 24/205 (11%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNMQGQ---LEFQQEVRVL-SKLQHPHLVTLL 403
+ +G FG VY K G AIK+L +M + + E ++ + + P++ L
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 404 GA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
+ + LV EYL G L + P W + AE+ G+ LH
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCAS-LIKTLGGLPEDWA--KQYIAEVVLGVEDLHQ---RG 117
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
I+H D+KP+N+L+D K+ DFG+ R E+ ++ G+ Y PE
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFV----------GTPDYLAPETILG 167
Query: 522 GVLTPKSDSYSFGLIILQLLTGRLP 546
SD +S G +I + L G P
Sbjct: 168 VGDDKMSDWWSLGCVIFEFLFGYPP 192
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 55/213 (25%), Positives = 107/213 (50%), Gaps = 24/213 (11%)
Query: 343 NFSESFKVGQGGFGCVYK------GEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQH 396
+F + ++G G G V+K G ++ R + I + ++ Q+ +E++VL +
Sbjct: 6 DFEKISELGAGNGGVVFKVSHKPSGLIMARKL-IHLEIKPAIRNQI--IRELQVLHECNS 62
Query: 397 PHLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFL 454
P++V GA S+ E++ GSL D++ +K+ P + +++ + GL +L
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIP--EQILGKVSIAVIKGLTYL 119
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 514
+ KI+H D+KP NIL++S K+CDFG+ + + + + G+ Y
Sbjct: 120 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM--------ANSFVGTRSYM 169
Query: 515 DPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPV 547
PE + + +SD +S GL ++++ GR P+
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-10
Identities = 78/254 (30%), Positives = 116/254 (45%), Gaps = 38/254 (14%)
Query: 343 NFSESFKV-GQGGFGCVY-----KGEMLGRTVAIKMLYSHNMQGQLEFQQEVR----VLS 392
NF E KV G G +G V+ G G+ A+K+L + + + + R VL
Sbjct: 1 NF-ELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLE 59
Query: 393 KL-QHPHLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIA 448
+ Q P LVTL A L+ +Y+ G + L+++ N S +D R + EI
Sbjct: 60 HVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFS----EDEVRFYSGEII 115
Query: 449 SGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR-LVTEDTLYLPSFHRSTAP 507
L LH IV+ D+K +NILLDSE + DFG+ + ++E+ R+ +
Sbjct: 116 LALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK------ERTYSF 166
Query: 508 KGSFPYADPEYHRTGVLTPKS-DSYSFGLIILQLLTGRLPVGLAGE-------VRRAVSC 559
G+ Y PE R K+ D +S G++I +LLTG P L GE RR + C
Sbjct: 167 CGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC 226
Query: 560 G-KLSSILDPLAGD 572
S + P A D
Sbjct: 227 DPPFPSFIGPEAQD 240
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 59/219 (26%), Positives = 100/219 (45%), Gaps = 39/219 (17%)
Query: 341 TCNFSESFKVGQGGFG--CVYKGEMLGRTVAIKML---YSHNMQGQLEFQQEVRVLSKLQ 395
T + + VG G FG C + ++ G+ VAIK + +S + + + +E+++L L+
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY-RELKLLKHLR 67
Query: 396 HPHLVTL--LGACP-EAWSLVYEYLP---NGSLQDRLFRKSNVSPLLWKDRARIAAEIAS 449
H ++++L + P E V E L + L R K + L+ +I
Sbjct: 68 HENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLY--------QILR 119
Query: 450 GLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKG 509
GL ++HS+ +VH DLKP NIL++ KICDFG+ R + T
Sbjct: 120 GLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLAR---------IQDPQMTGYVS 167
Query: 510 SFPYADPE----YHRTGVLTPKSDSYSFGLIILQLLTGR 544
+ Y PE + + V + D +S G I ++L G+
Sbjct: 168 TRYYRAPEIMLTWQKYDV---EVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 2e-10
Identities = 60/205 (29%), Positives = 94/205 (45%), Gaps = 20/205 (9%)
Query: 350 VGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLG 404
+G+GGFG C + G+ A K L ++ G+ E ++L K+ +V+L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 67
Query: 405 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 461
A +A LV + G L+ ++ N P ++RA AAEI GL LH E+
Sbjct: 68 AYETKDALCLVLTLMNGGDLKFHIYNMGN--PGFDEERAVFYAAEITCGLEDLHR---ER 122
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
IV+ DLKP+NILLD +I D G+ + +P G+ Y PE +
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGL-------AVEIPEGETIRGRVGTVGYMAPEVVKN 175
Query: 522 GVLTPKSDSYSFGLIILQLLTGRLP 546
T D + G +I +++ G+ P
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 3e-10
Identities = 62/231 (26%), Positives = 97/231 (41%), Gaps = 42/231 (18%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKML---YSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
+G+GG G VY + R VA+K + S N + F +E ++ + L HP +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 404 GACPEAWSLVYEYLP----------------NGSLQDRLFRKSNVSPLLWKDRARIAAEI 447
C + VY +P SL L K++V L I +I
Sbjct: 69 SICSDG-DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFL-----SIFHKI 122
Query: 448 ASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI---CRLVTEDTLYL------ 498
+ + ++HS + ++H DLKP NILL I D+G +L ED L +
Sbjct: 123 CATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 499 PSFHRSTAPK---GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ T P G+ Y PE + +D Y+ G+I+ Q+LT P
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 59/205 (28%), Positives = 91/205 (44%), Gaps = 20/205 (9%)
Query: 350 VGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLG 404
+G+GGFG C + G+ A K L ++ G+ E R+L K+ +V+L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAY 67
Query: 405 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 461
A +A LV + G L+ ++ N P + RA AAE+ GL L E+
Sbjct: 68 AYETKDALCLVLTIMNGGDLKFHIYNMGN--PGFDEQRAIFYAAELCCGLEDLQR---ER 122
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
IV+ DLKP+NILLD +I D G+ + +P G+ Y PE
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGL-------AVQIPEGETVRGRVGTVGYMAPEVINN 175
Query: 522 GVLTPKSDSYSFGLIILQLLTGRLP 546
T D + G +I +++ G+ P
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 49/201 (24%), Positives = 92/201 (45%), Gaps = 20/201 (9%)
Query: 350 VGQGGFG--CVYKGEMLGRTVAIKM--LYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGA 405
+G+G FG +Y+ V K L + + + + E+ +LS LQHP+++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 406 CPEAWSLV--YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA--EIASGLCFLHSSKPEK 461
+ +L+ EY G+L D++ R+ L+++ + +I S + ++H
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKG---QLFEEEMVLWYLFQIVSAVSYIHK---AG 121
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
I+H D+K NI L K+ DFGI +++ + + G+ Y PE +
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV------VGTPYYMSPELCQG 175
Query: 522 GVLTPKSDSYSFGLIILQLLT 542
KSD ++ G ++ +LLT
Sbjct: 176 VKYNFKSDIWALGCVLYELLT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-10
Identities = 65/210 (30%), Positives = 99/210 (47%), Gaps = 30/210 (14%)
Query: 350 VGQGGFGCVYKGEMLGRTVAIKMLYSHNM---QGQLEFQQEVRVLSK-------LQHPHL 399
+G+G FG V +L R A + Y+ + + L+ ++E ++S+ ++HP L
Sbjct: 3 IGKGSFGKV----LLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFL 58
Query: 400 VTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHS 456
V L + A L V +Y+ G L L R+ + RAR AAEIAS L +LHS
Sbjct: 59 VGLHFSFQTADKLYFVLDYINGGELFYHLQRER----CFLEPRARFYAAEIASALGYLHS 114
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 516
IV+ DLKP+NILLDS+ + DFG+C+ E +F G+ Y P
Sbjct: 115 LN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC------GTPEYLAP 165
Query: 517 EYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
E D + G ++ ++L G P
Sbjct: 166 EVLHKQPYDRTVDWWCLGAVLYEMLYGLPP 195
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (147), Expect = 5e-10
Identities = 60/214 (28%), Positives = 93/214 (43%), Gaps = 36/214 (16%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNM-QGQLE--FQQEVRVLSKLQHPHLVTLLG 404
+G GGFG V K + RT A+K + ++ + + E +L + HP +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 405 ACPEAWSLVY---EYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKPE 460
+ +Y EY G L L + L + AR A + +LH+
Sbjct: 61 TFKDKKY-IYMLMEYCLGGELWTILRDRG----LFDEYTARFYIACVVLAFEYLHN---R 112
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE--- 517
I++ DLKP+N+LLDS K+ DFG + L S ++ G+ Y PE
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAK-------KLKSGQKTWTFCGTPEYVAPEIIL 165
Query: 518 ---YHRTGVLTPKSDSYSFGLIILQLLTGRLPVG 548
Y + D +S G+++ +LLTGR P G
Sbjct: 166 NKGYDFS------VDYWSLGILLYELLTGRPPFG 193
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 6e-10
Identities = 51/174 (29%), Positives = 81/174 (46%), Gaps = 22/174 (12%)
Query: 387 EVRVLSKLQH-PHLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI 443
E +VL ++ P LVTL A L+ +Y+ G L L+++ + + + R+
Sbjct: 54 ERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFT----ESEVRV 109
Query: 444 -AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 502
AEI L LH I++ D+K +NILLDSE + DFG+ + +
Sbjct: 110 YIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE----- 161
Query: 503 RSTAPKGSFPYADPEYHRTGVLTPKSDS----YSFGLIILQLLTGRLPVGLAGE 552
R+ + G+ Y PE R G + D +S G++ +LLTG P + GE
Sbjct: 162 RAYSFCGTIEYMAPEVIRGG--SGGHDKAVDWWSLGVLTFELLTGASPFTVDGE 213
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 7e-10
Identities = 66/249 (26%), Positives = 104/249 (41%), Gaps = 39/249 (15%)
Query: 315 NYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLY 374
N D F+ E E + L+ +F +G+G FG V L R + K +Y
Sbjct: 20 NIDNFLSRYEKAAEK----ITKLRMKAEDFDVIKVIGRGAFGEVQ----LVRHKSSKQVY 71
Query: 375 SHNMQGQLE---------FQQEVRVLSKLQHPHLVTLLGACPEAWSL--VYEYLPNGSLQ 423
+ + + E F +E +++ +V L A + L V EY+P G L
Sbjct: 72 AMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLV 131
Query: 424 DRLFRKSNVS-PLLWKDRARI-AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSK 481
+ + SN P W AR AE+ L +HS +H D+KP N+LLD K
Sbjct: 132 NLM---SNYDIPEKW---ARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLK 182
Query: 482 ICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT----GVLTPKSDSYSFGLII 537
+ DFG C + + + TA G+ Y PE ++ G + D +S G+ +
Sbjct: 183 LADFGTCMKMDANGM----VRCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFL 237
Query: 538 LQLLTGRLP 546
++L G P
Sbjct: 238 YEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|238947 cd01989, STK_N, The N-terminal domain of Eukaryotic Serine Threonine kinases | Back alignment and domain information |
|---|
Score = 57.7 bits (140), Expect = 7e-10
Identities = 23/45 (51%), Positives = 27/45 (60%), Gaps = 1/45 (2%)
Query: 4 HGIQKLVMGAFPDNCMKVKM-GSRKASYAAKNAPMFCEIWFVNKG 47
HGI KLVMGA DN +K S AS K AP FC ++ V+KG
Sbjct: 102 HGITKLVMGASSDNHFSMKFKKSDVASSVLKEAPDFCTVYVVSKG 146
|
The Serine Threonine kinases are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. The N-terminal domain is homologous to the USP family which has a ATP binding fold. The N-terminal domain is predicted to be involved in ATP binding. Length = 146 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 7e-10
Identities = 43/177 (24%), Positives = 81/177 (45%), Gaps = 36/177 (20%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQ--QEVRVLSKLQHPHLVTLLG 404
K+GQG FG V+K + VA+K + N + +E+++L L+H ++V L+
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 78
Query: 405 AC---PEAWS-------LVYEYLPN---GSLQDRLFRKSNVSPLLWKDRARIAAEIASGL 451
C ++ LV+E+ + G L ++ + + + ++ + +GL
Sbjct: 79 ICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLS------EIKKVMKMLLNGL 132
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK 508
++H +K I+H D+K NIL+ + K+ DFG+ R +F S K
Sbjct: 133 YYIHRNK---ILHRDMKAANILITKDGILKLADFGLAR----------AFSLSKNSK 176
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 8e-10
Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 30/210 (14%)
Query: 350 VGQGGFGCVYKGEMLG--RTVAIKMLYSHNMQGQLEFQ---QEVRVLS-KLQHPHLVTLL 403
+G+G FG V E+ G AIK+L + + E R+L+ +HP L T L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFL-TAL 61
Query: 404 GAC---PEAWSLVYEYLPNGSL--QDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSS 457
C + V EY+ G L Q + RK + R+R AAE+ L FLH
Sbjct: 62 HCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEP------RSRFYAAEVTLALMFLHR- 114
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRL-VTEDTLYLPSFHRSTAPKGSFPYADP 516
+++ DLK NILLD+E K+ DFG+C+ + +T G+ Y P
Sbjct: 115 --HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT-------TTTFCGTPDYIAP 165
Query: 517 EYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
E + P D ++ G+++ +++ G+ P
Sbjct: 166 EILQELEYGPSVDWWALGVLMYEMMAGQPP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 9e-10
Identities = 60/211 (28%), Positives = 92/211 (43%), Gaps = 20/211 (9%)
Query: 344 FSESFKVGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPH 398
F + +G+GGFG C + G+ A K L ++ G+ E ++L K+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 399 LVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLH 455
+V L A +A LV + G L+ ++ N P ++RA AAEI GL LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN--PGFEEERALFYAAEILCGLEDLH 119
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 515
E V+ DLKP+NILLD +I D G+ + +P G+ Y
Sbjct: 120 R---ENTVYRDLKPENILLDDYGHIRISDLGL-------AVKIPEGESIRGRVGTVGYMA 169
Query: 516 PEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PE T D + G +I +++ G+ P
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 64/221 (28%), Positives = 100/221 (45%), Gaps = 41/221 (18%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG--QLEFQQEVRVLSKL-QHPHLVTLLG 404
VG G +G VYKG + G+ AIK++ ++ G + E +QE+ +L K H ++ T G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSHHRNIATYYG 70
Query: 405 AC---------PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLH 455
A + W LV E+ GS+ D L + + + L + A I EI GL LH
Sbjct: 71 AFIKKNPPGMDDQLW-LVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLSHLH 128
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF---P 512
K++H D+K QN+LL K+ DFG+ R+ + +F P
Sbjct: 129 Q---HKVIHRDIKGQNVLLTENAEVKLVDFGVS----------AQLDRTVGRRNTFIGTP 175
Query: 513 Y-ADPEY-----HRTGVLTPKSDSYSFGLIILQLLTGRLPV 547
Y PE + KSD +S G+ +++ G P+
Sbjct: 176 YWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 22/206 (10%)
Query: 350 VGQGGFGCVYKGEMLGRT--VAIKMLYSHN--MQGQLEFQQ-EVRVLS-KLQHPHLVTLL 403
+G+G FG V E+ G+ A+K L + +E E RVL+ ++P L L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 404 GA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPE 460
E V E+L G L + K L+ RA AAEI GL FLHS +
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFD--LY--RATFYAAEIVCGLQFLHS---K 115
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 520
I++ DLK N++LD + KI DFG+C+ + ++ + R++ G+ Y PE +
Sbjct: 116 GIIYRDLKLDNVMLDRDGHIKIADFGMCK----ENVFGDN--RASTFCGTPDYIAPEILQ 169
Query: 521 TGVLTPKSDSYSFGLIILQLLTGRLP 546
T D +SFG+++ ++L G+ P
Sbjct: 170 GLKYTFSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 46/164 (28%), Positives = 84/164 (51%), Gaps = 15/164 (9%)
Query: 386 QEVRVLSKLQHPHLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI 443
+E++VL + P++V GA S+ E++ GSL D++ +++ P + I
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKEAKRIPEEILGKVSI 110
Query: 444 AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHR 503
A + GL +L + +I+H D+KP NIL++S K+CDFG+ + +
Sbjct: 111 A--VLRGLAYLR--EKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-------- 158
Query: 504 STAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPV 547
+ + G+ Y PE + + +SD +S GL +++L GR P+
Sbjct: 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-09
Identities = 50/150 (33%), Positives = 75/150 (50%), Gaps = 18/150 (12%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGA- 405
VG G +G VYKG + G+ AIK++ + + E + E+ +L K H ++ T GA
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEE-EIKLEINMLKKYSHHRNIATYYGAF 82
Query: 406 ---CP-----EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
P + W LV E+ GS+ D L + + + L A I EI GL LH+
Sbjct: 83 IKKSPPGHDDQLW-LVMEFCGAGSVTD-LVKNTKGNALKEDWIAYICREILRGLAHLHA- 139
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGI 487
K++H D+K QN+LL K+ DFG+
Sbjct: 140 --HKVIHRDIKGQNVLLTENAEVKLVDFGV 167
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 2e-09
Identities = 60/264 (22%), Positives = 108/264 (40%), Gaps = 60/264 (22%)
Query: 350 VGQGGFGCVYKGE--MLGRTVAIKML----YSHNMQGQLEF----------QQEVRVLSK 393
+G+G +G V K + G+ VAIK + S+++ + +E++++++
Sbjct: 17 LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76
Query: 394 LQHPHLVTLLGA-CPEAW-SLVYEYLPNGSLQDRLFRK-----SNVSPLLWKDRARIAAE 446
++H +++ L+ + +LV + + L+ + RK S V +L +
Sbjct: 77 IKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILL--------Q 127
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTA 506
I +GL LH +H DL P NI ++S+ KI DFG+ R T
Sbjct: 128 ILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184
Query: 507 PKG--------SFPYADPE-------YHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG 551
+ + Y PE YH D +S G I +LLTG+
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFA------VDMWSVGCIFAELLTGKPLFPGEN 238
Query: 552 EVRRAVSCGKLSSIL-DPLAGDWP 574
E+ + G++ +L P +WP
Sbjct: 239 EIDQ---LGRIFELLGTPNEDNWP 259
|
Length = 335 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 58/211 (27%), Positives = 95/211 (45%), Gaps = 20/211 (9%)
Query: 344 FSESFKVGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPH 398
F + +G+GGFG C + G+ A K L ++ G+ E ++L K+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 399 LVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLH 455
+V+L A +A LV + G L+ ++ + RA AAEI GL LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG--FEEGRAVFYAAEICCGLEDLH 119
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 515
E+IV+ DLKP+NILLD +I D G+ +++P G+ Y
Sbjct: 120 Q---ERIVYRDLKPENILLDDHGHIRISDLGL-------AVHVPEGQTIKGRVGTVGYMA 169
Query: 516 PEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PE + T D ++ G ++ +++ G+ P
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 20/208 (9%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLY----SHNMQGQLE-FQQEVRVLSKLQHPHLVTL 402
+GQG FG VY GR +A+K + S ++ + E+++L L H +V
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 403 LGAC---PE-AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
G E S+ E++P GS++D+L + L + +I G+ +LHS+
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQL---KSYGALTENVTRKYTRQILEGVSYLHSNM 126
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 518
IVH D+K NIL DS + K+ DFG + + L T G+ + PE
Sbjct: 127 ---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT---GTPYWMSPEV 180
Query: 519 HRTGVLTPKSDSYSFGLIILQLLTGRLP 546
K+D +S G ++++LT + P
Sbjct: 181 ISGEGYGRKADIWSVGCTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 43/150 (28%), Positives = 74/150 (49%), Gaps = 23/150 (15%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
++G G FG VYK + G A K++ + + + ++ E+ +L+ HP++V LLGA
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 407 ---PEAWSLVYEYLPNGSLQ------DRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
+ W ++ E+ P G++ DR + + I ++ L +LHS
Sbjct: 79 YWDGKLWIMI-EFCPGGAVDAIMLELDRGLTEPQIQV--------ICRQMLEALQYLHS- 128
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGI 487
KI+H DLK N+LL + K+ DFG+
Sbjct: 129 --MKIIHRDLKAGNVLLTLDGDIKLADFGV 156
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 48/157 (30%), Positives = 72/157 (45%), Gaps = 10/157 (6%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGA- 405
+VG G +G VYK L G A+K++ QQE+ ++ + +H ++V G+
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSY 75
Query: 406 -CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
E + EY GSLQD ++ + PL A + E GL +LHS +H
Sbjct: 76 LSREKLWICMEYCGGGSLQD-IYHVT--GPLSELQIAYVCRETLQGLAYLHSKGK---MH 129
Query: 465 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 501
D+K NILL K+ DFG+ +T SF
Sbjct: 130 RDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF 166
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 67/272 (24%), Positives = 114/272 (41%), Gaps = 26/272 (9%)
Query: 350 VGQGGFGCVY-------KGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTL 402
+GQG FG VY E+ + V + + E+++L LQH +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 403 LGACPE----AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
G + ++ EY+P GS++D+L ++ + + R +I G+ +LHS+
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR---QILEGMSYLHSNM 126
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 518
IVH D+K NIL DS + K+ DFG + + + T G+ + PE
Sbjct: 127 ---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVT---GTPYWMSPEV 180
Query: 519 HRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVA 578
K+D +S G ++++LT + P E + K+++ P P+ ++
Sbjct: 181 ISGEGYGRKADVWSLGCTVVEMLTEKPP---WAEYEAMAAIFKIAT--QPTNPQLPSHIS 235
Query: 579 RRLVDLGLQCCELYGRERPDITPSLVKELEQL 610
D L C + R RP L QL
Sbjct: 236 EHARDF-LGCIFVEARHRPSAEELLRHPFAQL 266
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 46/147 (31%), Positives = 76/147 (51%), Gaps = 13/147 (8%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVTL--L 403
K+G+G + V+KG ++ VA+K + H +EV +L L+H ++VTL +
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 404 GACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA-EIASGLCFLHSSKPEKI 462
+LV+EYL + L+ L N L+ +I ++ GL + H KI
Sbjct: 72 IHTERCLTLVFEYLDS-DLKQYL---DNCGNLMSMHNVKIFMFQLLRGLSYCHK---RKI 124
Query: 463 VHGDLKPQNILLDSELSSKICDFGICR 489
+H DLKPQN+L++ + K+ DFG+ R
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 46/143 (32%), Positives = 71/143 (49%), Gaps = 13/143 (9%)
Query: 351 GQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGAC- 406
G G FG VYK + G A K++ + +LE F E+ +LS+ +HP++V L A
Sbjct: 14 GDGAFGKVYKAQHKETGLFAAAKII-QIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72
Query: 407 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
+ W L+ E+ G+L D + + L + ++ L FLHS K++H
Sbjct: 73 YENKLWILI-EFCDGGAL-DSIMLELE-RGLTEPQIRYVCRQMLEALNFLHS---HKVIH 126
Query: 465 GDLKPQNILLDSELSSKICDFGI 487
DLK NILL + K+ DFG+
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGV 149
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 58.7 bits (143), Expect = 3e-09
Identities = 62/227 (27%), Positives = 101/227 (44%), Gaps = 61/227 (26%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKMLYS--HNMQ-GQLEFQQEVRVLSKL-QHPHLVTL 402
K+G+G +G V+K VA+K ++ N Q F+ E+ L +L HP++V L
Sbjct: 14 KLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVKL 72
Query: 403 LGACPEA----WSLVYEYLPN--------GSLQDRLFRKSNVSPLLWKDRARIAAEIASG 450
L LV+EY+ L+D + ++ + LL +A
Sbjct: 73 LNVIKAENDKDIYLVFEYMETDLHAVIRANILED-VHKRYIMYQLL---KA--------- 119
Query: 451 LCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS---------- 500
L ++HS ++H DLKP NILL+S+ K+ DFG+ R ++E +
Sbjct: 120 LKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATR 176
Query: 501 FHRSTAPK---GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 544
++R AP+ GS Y GV D +S G I+ ++L G+
Sbjct: 177 WYR--APEILLGSTRYT------KGV-----DMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 40/139 (28%), Positives = 66/139 (47%), Gaps = 16/139 (11%)
Query: 350 VGQGGFGCVYKG---------EMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLV 400
+GQG F ++KG E+ V +K+L + F + ++S+L H HLV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 401 TLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
G C + +V EY+ GSL L + N+ + WK +A ++A L FL
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWK--LEVAKQLAWALHFLED-- 118
Query: 459 PEKIVHGDLKPQNILLDSE 477
+ + HG++ +N+LL E
Sbjct: 119 -KGLTHGNVCAKNVLLIRE 136
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 3e-09
Identities = 47/159 (29%), Positives = 80/159 (50%), Gaps = 34/159 (21%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQ---------QEVRVLSKLQHP 397
K+G+G +G VYK + T+A+K + +LE + +E+ +L ++QH
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKI-------RLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 398 HLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKS-NVSPLLWKDRARIAA---EIASGL 451
++V L + LV+EYL D +K + SP K+ I +I G+
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYL------DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGI 115
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSS-KICDFGICR 489
+ HS +++H DLKPQN+L+D ++ K+ DFG+ R
Sbjct: 116 AYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
|
Length = 294 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 58.0 bits (140), Expect = 3e-09
Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 24/207 (11%)
Query: 350 VGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLG 404
+G+GGFG C + + G+ A K L ++ G+ E +L K+ P +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 405 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI---AAEIASGLCFLHSSKP 459
A LV + G L+ ++ + R+ +A+I G+ LHS
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERG----LEMERVIHYSAQITCGILHLHSMD- 115
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 519
IV+ D+KP+N+LLD + + ++ D G+ + L T G+ Y PE
Sbjct: 116 --IVYRDMKPENVLLDDQGNCRLSDLGL-------AVELKDGKTITQRAGTNGYMAPEIL 166
Query: 520 RTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ + D ++ G I +++ GR P
Sbjct: 167 KEEPYSYPVDWFAMGCSIYEMVAGRTP 193
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 62/211 (29%), Positives = 92/211 (43%), Gaps = 34/211 (16%)
Query: 349 KVGQGGFGCVY--KGEMLGRTVAIKMLYSHNMQGQLEFQ--------QEVRVLSKLQHPH 398
+VGQGG+G V+ K + G VA+K M+ L F+ E +L+ +
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKR-----MKKSLLFKLNEVRHVLTERDILTTTKSEW 62
Query: 399 LVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLH 455
LV LL A E L EY+P G + L N +L +D AR AE+ + LH
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLL----NNLGVLSEDHARFYMAEMFEAVDALH 118
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 515
+H DLKP+N L+D+ K+ DFG+ + + + + GS Y
Sbjct: 119 ELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT---------YANSVVGSPDYMA 166
Query: 516 PEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PE R D +S G ++ + L G P
Sbjct: 167 PEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 5e-09
Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 19/204 (9%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTLLG 404
+G+G FG V + R A+K + ++ + E E VL+++ P +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 405 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
+ PE LV ++ G L L R+ D +R A LC L + +
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRF------DLSRARFYTAELLCALENLHKFNV 114
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 522
++ DLKP+NILLD + +CDFG+C+L +D ++ G+ Y PE
Sbjct: 115 IYRDLKPENILLDYQGHIALCDFGLCKLNMKDD------DKTNTFCGTPEYLAPELLLGH 168
Query: 523 VLTPKSDSYSFGLIILQLLTGRLP 546
T D ++ G+++ ++LTG P
Sbjct: 169 GYTKAVDWWTLGVLLYEMLTGLPP 192
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 49/203 (24%), Positives = 95/203 (46%), Gaps = 19/203 (9%)
Query: 349 KVGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
K+G+G G C+ + G+ VA+K + Q + EV ++ QH ++V + +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 407 ---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
E W +V E+L G+L D + + + + A + + L LH+ + ++
Sbjct: 87 LVGDELW-VVMEFLEGGALTDIVTH----TRMNEEQIAAVCLAVLKALSVLHA---QGVI 138
Query: 464 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV 523
H D+K +ILL + K+ DFG C V+++ R + G+ + PE
Sbjct: 139 HRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV------PRRKSLVGTPYWMAPELISRLP 192
Query: 524 LTPKSDSYSFGLIILQLLTGRLP 546
P+ D +S G+++++++ G P
Sbjct: 193 YGPEVDIWSLGIMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 8e-09
Identities = 66/269 (24%), Positives = 118/269 (43%), Gaps = 26/269 (9%)
Query: 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHP 397
NF K+G+G F VY+ L G VA+K + ++ + + + +E+ +L +L HP
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 398 HLVTLLGACPE--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRA--RIAAEIASGLCF 453
+++ + E ++V E G L R+ + L ++ + ++ S L
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLS-RMIKHFKKQKRLIPEKTVWKYFVQLCSALEH 121
Query: 454 LHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY 513
+HS +++H D+KP N+ + + K+ D G+ R + T S G+ Y
Sbjct: 122 MHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL------VGTPYY 172
Query: 514 ADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS-CGKLSSI-LDPLAG 571
PE KSD +S G ++ ++ + P G+ S C K+ PL
Sbjct: 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FYGDKMNLYSLCKKIEQCDYPPLPS 230
Query: 572 DWPTFVARRLVDLGLQCCELYGRERPDIT 600
D + R+LV++ C +RPDIT
Sbjct: 231 DHYSEELRQLVNM---CINPDPEKRPDIT 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 9e-09
Identities = 66/277 (23%), Positives = 114/277 (41%), Gaps = 51/277 (18%)
Query: 350 VGQGGFGCVY---KGEMLGRTVAIKMLYSHNM---QGQLEFQQEVR--------VLSKLQ 395
+G G FGCVY K +A+K + HN + + E + + + +L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 396 HPHLVTLLGACPEAWSL--VYEYLPNGSLQDRLF----RKSNVSP-LLWKDRARIAAEIA 448
HP++V E L V + + L + +K + +W I ++
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN----IFVQMV 123
Query: 449 SGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK 508
L +LH K ++IVH DL P NI+L + I DFG+ + ++ + T+
Sbjct: 124 LALRYLH--KEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES-------KLTSVV 174
Query: 509 GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP------VGLAGEVRRAVSCGKL 562
G+ Y+ PE + K+D ++FG I+ Q+ T + P + LA ++ AV
Sbjct: 175 GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV----- 229
Query: 563 SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDI 599
+PL + + D+ C RPDI
Sbjct: 230 ---YEPLPEG---MYSEDVTDVITSCLTPDAEARPDI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 9e-09
Identities = 59/211 (27%), Positives = 92/211 (43%), Gaps = 25/211 (11%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNMQGQLE---FQQEVRVLSKLQHPHLVTLLG 404
VG+G FG V + + G A+K++ + Q F++E +LS P + L
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 405 ACPEAWS--LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 461
A + + LV EY P G L L R + +D A+ AE+ + HS
Sbjct: 69 AFQDKDNLYLVMEYQPGGDLLSLLNRYEDQ---FDEDMAQFYLAELVLAI---HSVHQMG 122
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
VH D+KP+N+L+D K+ DFG +T + + P G+ Y PE T
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS-----KLPVGTPDYIAPEVLTT 177
Query: 522 ------GVLTPKSDSYSFGLIILQLLTGRLP 546
G + D +S G+I +++ GR P
Sbjct: 178 MNGDGKGTYGVECDWWSLGVIAYEMIYGRSP 208
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 59/221 (26%), Positives = 89/221 (40%), Gaps = 50/221 (22%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIK-MLYSHNMQGQLEFQQEVRVLSKLQH--PHLVTLLG 404
+G G G VYK G +A+K M + N + ++ V+ K H P++V G
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLK-SHDCPYIVKCYG 81
Query: 405 A---------CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFL- 454
C E S D+L ++ P+ ++ I L +L
Sbjct: 82 YFITDSDVFICMELMSTCL---------DKLLKRIQ-GPIPEDILGKMTVAIVKALHYLK 131
Query: 455 --HSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC-RLVTEDTLYLPSFHRSTAPKGSF 511
H ++H D+KP NILLD+ + K+CDFGI RLV T G
Sbjct: 132 EKHG-----VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA--------KTRSAGCA 178
Query: 512 PYADPEYHRTGVLTPK------SDSYSFGLIILQLLTGRLP 546
Y PE R P +D +S G+ +++L TG+ P
Sbjct: 179 AYMAPE--RIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-08
Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 25/209 (11%)
Query: 350 VGQGGFGCV--YKGEMLGRTVAIKMLYSHNMQGQLE---FQQEVRVLSKLQHPHLVTLLG 404
+G+G FG V + + + A+K+L M + + F +E +++ P +V L
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 110
Query: 405 ACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 461
A + L V EY+P G L + L +V P W AR AE+ L +HS
Sbjct: 111 AFQDDRYLYMVMEYMPGGDLVN-LMSNYDV-PEKW---ARFYTAEVVLALDAIHSMG--- 162
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
+H D+KP N+LLD K+ DFG C + ++ + R G+ Y PE ++
Sbjct: 163 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-----RCDTAVGTPDYISPEVLKS 217
Query: 522 ----GVLTPKSDSYSFGLIILQLLTGRLP 546
G + D +S G+ + ++L G P
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 45/151 (29%), Positives = 74/151 (49%), Gaps = 21/151 (13%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVTL--L 403
K+G+G + V+KG ++ VA+K + H +EV +L L+H ++VTL +
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 404 GACPEAWSLVYEYLPNGSLQ-----DRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
++ +LV+EYL Q + NV L+ +I GL + H
Sbjct: 73 VHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLY--------QILRGLAYCHR-- 122
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICR 489
K++H DLKPQN+L++ K+ DFG+ R
Sbjct: 123 -RKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 36/110 (32%), Positives = 58/110 (52%), Gaps = 7/110 (6%)
Query: 433 SPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 492
SPL +D + ++A G+ FL S K +H DL +NILL KICDFG+ R +
Sbjct: 169 SPLTMEDLICYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIY 225
Query: 493 EDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 542
+D P + R + + + PE V T +SD +SFG+++ ++ +
Sbjct: 226 KD----PDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 271
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 45/151 (29%), Positives = 73/151 (48%), Gaps = 21/151 (13%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVTL--L 403
K+G+G + VYKG ++ VA+K + H +EV +L L+H ++VTL +
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 404 GACPEAWSLVYEYLPNGSLQ-----DRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
++ +LV+EYL Q NV L+ ++ GL + H
Sbjct: 73 IHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLF--------QLLRGLNYCHR-- 122
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICR 489
K++H DLKPQN+L++ K+ DFG+ R
Sbjct: 123 -RKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 59/219 (26%), Positives = 97/219 (44%), Gaps = 37/219 (16%)
Query: 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQ--QEVRVLSKLQHPH 398
F + ++G+G +G VY+ G VA+K + N + + +E+ +L L+HP+
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 399 LVTLL----GACPEAWSLVYEYLPN--GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLC 452
+V L G ++ LV EY SL D + +P + ++ GL
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQDLASLLD-----NMPTPFSESQVKCLMLQLLRGLQ 122
Query: 453 FLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK-GSF 511
+LH I+H DLK N+LL + KI DFG+ R T LP+ + PK +
Sbjct: 123 YLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLAR-----TYGLPAKPMT--PKVVTL 172
Query: 512 PYADPEY------HRTGVLTPKSDSYSFGLIILQLLTGR 544
Y PE + T + D ++ G I+ +LL +
Sbjct: 173 WYRAPELLLGCTTYTTAI-----DMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 2e-08
Identities = 69/282 (24%), Positives = 120/282 (42%), Gaps = 31/282 (10%)
Query: 344 FSESFKVGQGGFGCVY--KGEMLGRTVAIKMLYSHNMQGQLEFQ---QEVRVLSKLQHPH 398
F++ ++G G FG VY + VAIK + Q ++Q +EV+ L +++HP+
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 399 LVTLLGACPE---AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLH 455
+ G AW LV EY GS D L + + PL + A I GL +LH
Sbjct: 87 SIEYKGCYLREHTAW-LVMEYCL-GSASDLL--EVHKKPLQEVEIAAITHGALQGLAYLH 142
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 515
S ++H D+K NILL K+ DFG + + ++ + + AP+ +
Sbjct: 143 S---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPYW-MAPEVILAMDE 198
Query: 516 PEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPT 575
+Y K D +S G+ ++L + P+ + +S++ + PT
Sbjct: 199 GQY------DGKVDVWSLGITCIELAERKPPL---------FNMNAMSALYHIAQNESPT 243
Query: 576 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEERP 617
+ D + ++ P P+ + L+ + V ERP
Sbjct: 244 LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 59/208 (28%), Positives = 99/208 (47%), Gaps = 20/208 (9%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKML-YSHNMQGQLE----FQQEVRVLSKLQHPHLVTL 402
+G+G FG VY GR +A+K + + + Q + + E+++L L+H +V
Sbjct: 10 LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69
Query: 403 LGAC--PE--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
G PE S+ EY+P GS++D+L L R +I G+ +LHS+
Sbjct: 70 YGCLRDPEEKKLSIFVEYMPGGSIKDQL---KAYGALTENVTRRYTRQILQGVSYLHSNM 126
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 518
IVH D+K NIL DS + K+ DFG + + T+ + S + G+ + PE
Sbjct: 127 ---IVHRDIKGANILRDSAGNVKLGDFGASKRI--QTICM-SGTGIKSVTGTPYWMSPEV 180
Query: 519 HRTGVLTPKSDSYSFGLIILQLLTGRLP 546
K+D +S ++++LT + P
Sbjct: 181 ISGEGYGRKADVWSVACTVVEMLTEKPP 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 70/236 (29%), Positives = 99/236 (41%), Gaps = 38/236 (16%)
Query: 327 PESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEF 384
P+ AE D FS+ ++G G FG VY + VAIK + Q ++
Sbjct: 2 PDVAELFFKDDPEKL--FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKW 59
Query: 385 Q---QEVRVLSKLQHPHLVTLLGACPE---AWSLVYEYLPNGSLQDRLFRKSNVSPLLWK 438
Q +EVR L KL+HP+ + G AW LV EY GS D L + + PL
Sbjct: 60 QDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW-LVMEYCL-GSASDLL--EVHKKPLQEV 115
Query: 439 DRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498
+ A + GL +LHS ++H D+K NILL K+ DFG ++
Sbjct: 116 EIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------- 165
Query: 499 PSFHRSTAPKGSF---PY-ADPEY---HRTGVLTPKSDSYSFGLIILQLLTGRLPV 547
AP F PY PE G K D +S G+ ++L + P+
Sbjct: 166 -------APANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 2e-08
Identities = 48/168 (28%), Positives = 77/168 (45%), Gaps = 21/168 (12%)
Query: 346 ESFKV-GQGGFGCV--YKGEMLGRTVAIKMLYSHNM--QGQLE-FQQEVRVLSKLQHPHL 399
ES KV G+G FG V + + G A+K L M + Q+ + E +L++ +P +
Sbjct: 4 ESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWV 63
Query: 400 VTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
V L + L+ EYLP G + L +K + ++ R IA + + S
Sbjct: 64 VKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFT----EEETRFY--IAETILAIDSI 117
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST 505
+H D+KP N+LLD++ K+ DFG+C L HR+
Sbjct: 118 HKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCT-------GLKKSHRTE 158
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 46/158 (29%), Positives = 74/158 (46%), Gaps = 12/158 (7%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
++G G +G VYK + G AIK++ + QQE+ ++ +H ++V G+
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSY 75
Query: 407 ---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
+ W + E+ GSLQD ++ + PL A ++ E GL +LHS +
Sbjct: 76 LRRDKLW-ICMEFCGGGSLQD-IYHVT--GPLSESQIAYVSRETLQGLYYLHSKGK---M 128
Query: 464 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 501
H D+K NILL K+ DFG+ +T SF
Sbjct: 129 HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF 166
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 3e-08
Identities = 48/162 (29%), Positives = 79/162 (48%), Gaps = 22/162 (13%)
Query: 396 HPHLVTLLGACPEAWS---LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGL 451
HP LV L +C + S V E++ G L + R+ L ++ AR +AEI+ L
Sbjct: 55 HPFLVGL-HSCFQTESRLFFVIEFVSGGDLMFHMQRQRK----LPEEHARFYSAEISLAL 109
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR--LVTEDTLYLPSFHRSTAPKG 509
FLH I++ DLK N+LLD+E K+ D+G+C+ + DT ++ G
Sbjct: 110 NFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDT--------TSTFCG 158
Query: 510 SFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG 551
+ Y PE R D ++ G+++ +++ GR P + G
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 200
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 35/110 (31%), Positives = 56/110 (50%), Gaps = 7/110 (6%)
Query: 433 SPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 492
PL +D + ++A G+ FL S K +H DL +NILL KICDFG+ R +
Sbjct: 168 EPLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIY 224
Query: 493 EDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 542
+D P + R + + PE V T +SD +SFG+++ ++ +
Sbjct: 225 KD----PDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFS 270
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 64/243 (26%), Positives = 105/243 (43%), Gaps = 27/243 (11%)
Query: 315 NYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCV--YKGEMLGRTVAIKM 372
N D F+ E + + LQ ++ +G+G FG V + + + A+K+
Sbjct: 20 NIDNFLNRYEKIVRK----IRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKL 75
Query: 373 LYSHNMQGQLE---FQQEVRVLSKLQHPHLVTLLGACPEAWSL--VYEYLPNGSLQDRLF 427
L M + + F +E +++ P +V L A + L V EY+P G L + L
Sbjct: 76 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LM 134
Query: 428 RKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 487
+V P W AE+ L +HS ++H D+KP N+LLD K+ DFG
Sbjct: 135 SNYDV-PEKWAKF--YTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGT 188
Query: 488 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT----GVLTPKSDSYSFGLIILQLLTG 543
C + E + TA G+ Y PE ++ G + D +S G+ + ++L G
Sbjct: 189 CMKMDETGM----VRCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
Query: 544 RLP 546
P
Sbjct: 244 DTP 246
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 54.9 bits (133), Expect = 4e-08
Identities = 48/154 (31%), Positives = 82/154 (53%), Gaps = 24/154 (15%)
Query: 349 KVGQGGFGCVYKG-EML-GRTVAIKML-YSHNMQG-QLEFQQEVRVLSKLQHPHLVTL-- 402
++ +G +G VY+ + G VA+K L +G + +E+ +L KLQHP++VT+
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKE 71
Query: 403 --LGACPEAWSLVYEYLPNG--SLQDRL---FRKSNVSPLLWKDRARIAAEIASGLCFLH 455
+G+ + +V EY+ + SL + + F +S V L+ ++ SG+ LH
Sbjct: 72 VVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLM--------LQLLSGVAHLH 123
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
+ I+H DLK N+LL++ KICDFG+ R
Sbjct: 124 DN---WILHRDLKTSNLLLNNRGILKICDFGLAR 154
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 4e-08
Identities = 67/230 (29%), Positives = 96/230 (41%), Gaps = 74/230 (32%)
Query: 350 VGQGGFGCVYKGEM--LGRTVAIKMLYSHNMQGQLEFQ---------QEVRVLSKLQHPH 398
VG G +G V GR VAIK L FQ +E+R+L + H +
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSR-------PFQSAIHAKRTYRELRLLKHMDHEN 75
Query: 399 LVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSN-VSPLLWKDRARIAA------------ 445
++ LL + P SL+D F+ V+ L+ D I
Sbjct: 76 VIGLLDV----------FTPASSLED--FQDVYLVTHLMGADLNNIVKCQKLSDDHIQFL 123
Query: 446 --EIASGLCFLHSSKPEKIVHGDLKPQNILL--DSELSSKICDFGICRLVTEDTLYLPSF 501
+I GL ++HS+ I+H DLKP NI + D EL KI DFG+ R T+D +
Sbjct: 124 VYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCEL--KILDFGLARH-TDDEM----- 172
Query: 502 HRSTAPKGSFPYADPE-------YHRTGVLTPKSDSYSFGLIILQLLTGR 544
T + Y PE Y++T D +S G I+ +LLTG+
Sbjct: 173 ---TGYVATRWYRAPEIMLNWMHYNQT------VDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 60/209 (28%), Positives = 92/209 (44%), Gaps = 22/209 (10%)
Query: 350 VGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQLE---FQQEVRVLSKLQHPHLVTLLG 404
+G+G FG V K + R A+K+L M + E F++E VL + TL
Sbjct: 9 IGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHY 68
Query: 405 ACPEA--WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
A + LV +Y G L L + + P +D AR IA + +HS
Sbjct: 69 AFQDENYLYLVMDYYVGGDLLTLLSKFEDRLP---EDMARFY--IAEMVLAIHSIHQLHY 123
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT- 521
VH D+KP N+LLD ++ DFG C + +D +S+ G+ Y PE +
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-----QSSVAVGTPDYISPEILQAM 178
Query: 522 ----GVLTPKSDSYSFGLIILQLLTGRLP 546
G P+ D +S G+ + ++L G P
Sbjct: 179 EDGMGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 4e-08
Identities = 54/214 (25%), Positives = 97/214 (45%), Gaps = 35/214 (16%)
Query: 350 VGQGGFG--CVYKGEMLGRTVAIKMLYS--HNMQGQLEFQQEVRVLSKLQHPHLV----T 401
+G+G +G C G VAIK + ++ +E+++L L+HP +V
Sbjct: 8 IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67
Query: 402 LLGACPEAWS---LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
+L + +V+E L L + +++P + ++ L ++H++
Sbjct: 68 MLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTP---EHHQFFLYQLLRALKYIHTAN 123
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED-------TLYLPS-FHRSTAPKGS 510
+ H DLKP+NIL +++ KICDFG+ R+ D T Y+ + ++R+ GS
Sbjct: 124 ---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGS 180
Query: 511 FPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 544
F TP D +S G I ++LTG+
Sbjct: 181 F---------FSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 5e-08
Identities = 41/152 (26%), Positives = 74/152 (48%), Gaps = 9/152 (5%)
Query: 343 NFSESFKVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEFQ-QEVRVLSKLQHPHL 399
NF + K+G+G + VYKG G VA+K ++ +G +E+ ++ +L+H ++
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 400 VTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
V L LV+EY+ + L+ + L ++ G+ F H +
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
+ ++H DLKPQN+L++ K+ DFG+ R
Sbjct: 120 R---VLHRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 5e-08
Identities = 85/319 (26%), Positives = 125/319 (39%), Gaps = 62/319 (19%)
Query: 321 GLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVY--KGEMLGRTVAIKMLYSHNM 378
G+V+D PE A+ D F ++G G FG VY VA+K +
Sbjct: 3 GVVKD-PEIADLFYKDDPEEI--FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGK 59
Query: 379 QGQLEFQ---QEVRVLSKLQHPHLVTLLGACPE---AWSLVYEYLPNGSLQDRLFRKSNV 432
Q ++Q +EV+ L +L+HP+ + G + AW LV EY GS D L + +
Sbjct: 60 QTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAW-LVMEYCL-GSASDLL--EVHK 115
Query: 433 SPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 492
PL + A I GL +LHS ++H D+K NILL K+ DFG +
Sbjct: 116 KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSS 172
Query: 493 EDTLYLPSFHRSTAPKGSF---PY-ADPEY---HRTGVLTPKSDSYSFGLIILQLLTGRL 545
P SF PY PE G K D +S G+ ++L +
Sbjct: 173 --------------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 218
Query: 546 PVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVA-------RRLVDLGLQCCELYGRERPD 598
P+ + +S++ D PT + R VD LQ + P
Sbjct: 219 PL---------FNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQ-------KIPQ 262
Query: 599 ITPSLVKELEQLHVAEERP 617
P+ + L V +RP
Sbjct: 263 ERPASAELLRHDFVRRDRP 281
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 6e-08
Identities = 50/162 (30%), Positives = 79/162 (48%), Gaps = 22/162 (13%)
Query: 396 HPHLVTLLGACPEAWS---LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGL 451
HP LV L +C + S V EY+ G L + R+ L ++ AR +AEI+ L
Sbjct: 55 HPFLVGL-HSCFQTESRLFFVIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEISLAL 109
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR--LVTEDTLYLPSFHRSTAPKG 509
+LH I++ DLK N+LLDSE K+ D+G+C+ L DT ++ G
Sbjct: 110 NYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT--------TSTFCG 158
Query: 510 SFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG 551
+ Y PE R D ++ G+++ +++ GR P + G
Sbjct: 159 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG 200
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 6e-08
Identities = 67/281 (23%), Positives = 124/281 (44%), Gaps = 38/281 (13%)
Query: 350 VGQGGFGCVYKGEMLGR----TVAIK-MLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLL 403
+G+G FG V +G++ VA+K M + + ++E F E + + HP+++ L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 404 GACPE--------AWSLVYEYLPNGSLQD-RLFRKSNVSPLLWKDR--ARIAAEIASGLC 452
G C + + ++ ++ +G L L+ + P + + +IASG+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 453 FLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP 512
+L S + +H DL +N +L+ ++ + DFG+ + + Y + K
Sbjct: 127 YLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYY----RQGRIAKMPVK 179
Query: 513 YADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPV-GLA-GEVRRAVSCG-KLSSILDP 568
+ E V T KSD +SFG+ + ++ T G+ P G+ E+ + G +L D
Sbjct: 180 WIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDC 239
Query: 569 LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609
L G L L C L ++RP +L ELE+
Sbjct: 240 LDG---------LYSLMSSCWLLNPKDRPSFE-TLRCELEK 270
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 7e-08
Identities = 61/209 (29%), Positives = 97/209 (46%), Gaps = 26/209 (12%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLYS--HNMQGQLEFQQEVRVLSKLQHPHLVTLLGA 405
+G G FG V+ G+ VA+K + + N+ +E+++L +H ++++ L
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 406 CPEAWSLVYE--YLPNGSLQDRLFRKSNVSPL-LWKDRARI-AAEIASGLCFLHSSKPEK 461
+E Y+ +Q L K VSP L D ++ +I GL +LHS+
Sbjct: 68 LQPPHIDPFEEIYVVTELMQSDL-HKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG--- 123
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY--- 518
I+H D+KP N+L++S KICDFG+ R+ D S H T + Y PE
Sbjct: 124 ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD----ESKHM-TQEVVTQYYRAPEILMG 178
Query: 519 --HRTGVLTPKSDSYSFGLIILQLLTGRL 545
H T + D +S G I +LL R+
Sbjct: 179 SRHYTSAV----DIWSVGCIFAELLGRRI 203
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 9e-08
Identities = 42/147 (28%), Positives = 74/147 (50%), Gaps = 13/147 (8%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQ-LEFQQEVRVLSKLQHPHLVTL--L 403
K+G+G + VYKG+ + G+ VA+K++ +G +E +L L+H ++V L +
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDI 71
Query: 404 GACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA-EIASGLCFLHSSKPEKI 462
E +LV+EY+ Q + P + ++ ++ GL ++H I
Sbjct: 72 IHTKETLTLVFEYVHTDLCQYMDKHPGGLHP----ENVKLFLFQLLRGLSYIHQ---RYI 124
Query: 463 VHGDLKPQNILLDSELSSKICDFGICR 489
+H DLKPQN+L+ K+ DFG+ R
Sbjct: 125 LHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 60/209 (28%), Positives = 90/209 (43%), Gaps = 27/209 (12%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQH---PHLVT 401
+G+GGFG VY + G+ A+K L + QG+ E +LS + P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 402 LLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 459
+ A P+ + + + G L L + S K+ A EI GL +H+
Sbjct: 62 MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSE---KEMRFYATEIILGLEHMHN--- 115
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGI-CRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 518
+V+ DLKP NILLD +I D G+ C S + A G+ Y PE
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDF---------SKKKPHASVGTHGYMAPEV 166
Query: 519 HRTGVLTPKS-DSYSFGLIILQLLTGRLP 546
+ G S D +S G ++ +LL G P
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 46/207 (22%), Positives = 80/207 (38%), Gaps = 19/207 (9%)
Query: 351 GQGGFGCVYKGEMLGRTVAIKM--LYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE 408
+ K + VA+K L S + + QQE+ +LQHP+++ + +
Sbjct: 11 EDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV 70
Query: 409 AWSL--VYEYLPNGSLQDRLFR--KSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
L V + GS +D L + L A I ++ + L ++HS + +H
Sbjct: 71 DSELYVVSPLMAYGSCEDLLKTHFPEGLPELAI---AFILKDVLNALDYIHS---KGFIH 124
Query: 465 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS---FPYADPEYHRT 521
+K +ILL + + + + H PK S P+ PE +
Sbjct: 125 RSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF--PKSSVKNLPWLSPEVLQQ 182
Query: 522 GVL--TPKSDSYSFGLIILQLLTGRLP 546
+ KSD YS G+ +L G +P
Sbjct: 183 NLQGYNEKSDIYSVGITACELANGHVP 209
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 41/153 (26%), Positives = 72/153 (47%), Gaps = 18/153 (11%)
Query: 352 QGGFGCVYKGEMLG------RTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLG 404
+G FG ++ G ++ V +K + H + Q+ QE +L L H +++ +L
Sbjct: 16 EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75
Query: 405 AC---PEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 456
C E ++Y Y+ G+L Q RL +N L + +A +IA G+ +LH
Sbjct: 76 VCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK 135
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
++H D+ +N ++D EL KI D + R
Sbjct: 136 ---RGVIHKDIAARNCVIDEELQVKITDNALSR 165
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 45/209 (21%), Positives = 85/209 (40%), Gaps = 43/209 (20%)
Query: 358 VYKGEMLGRTVAIKML--YSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLG-------ACP 407
+YKG + V I+ + + ++ + E++ L ++ +++ + G P
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 408 EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS--SKPEKIVHG 465
SL+ EY G L++ L ++ + L +K + +A + GL L+ +KP +
Sbjct: 96 RL-SLILEYCTRGYLREVLDKEKD---LSFKTKLDMAIDCCKGLYNLYKYTNKP----YK 147
Query: 466 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP--------E 517
+L + L+ KI G+ E L P F Y E
Sbjct: 148 NLTSVSFLVTENYKLKIICHGL-----EKILSSPPFKNVNF----MVYFSYKMLNDIFSE 198
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
Y T K D YS G+++ ++ TG++P
Sbjct: 199 Y------TIKDDIYSLGVVLWEIFTGKIP 221
|
Length = 283 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 62/215 (28%), Positives = 94/215 (43%), Gaps = 25/215 (11%)
Query: 346 ESFKV-GQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQLE---FQQEVRVLSKLQHPHL 399
E KV G+G FG V K + G+ A+K+L M + E F++E VL +
Sbjct: 4 EILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWI 63
Query: 400 VTLLGACP--EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
L A LV +Y G L L + + P +D AR +A + + S
Sbjct: 64 TNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLP---EDMARFY--LAEMVLAIDSV 118
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGIC-RLVTEDTLYLPSFHRSTAPKGSFPYADP 516
VH D+KP N+LLD ++ DFG C RL+ + T+ +S G+ Y P
Sbjct: 119 HQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV------QSNVAVGTPDYISP 172
Query: 517 EYHR-----TGVLTPKSDSYSFGLIILQLLTGRLP 546
E + G P+ D +S G+ + ++L G P
Sbjct: 173 EILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 62/209 (29%), Positives = 92/209 (44%), Gaps = 27/209 (12%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQH---PHLVT 401
+G+GGFG VY + G+ A+K L + QG+ E +LS + P +V
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61
Query: 402 LLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 459
+ A P+ S + + + G L L + S + AAEI GL +H+
Sbjct: 62 MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSE---AEMRFYAAEIILGLEHMHN--- 115
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGI-CRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 518
+V+ DLKP NILLD +I D G+ C S + A G+ Y PE
Sbjct: 116 RFVVYRDLKPANILLDEHGHVRISDLGLACDF---------SKKKPHASVGTHGYMAPEV 166
Query: 519 HRTGVLTPKS-DSYSFGLIILQLLTGRLP 546
+ GV S D +S G ++ +LL G P
Sbjct: 167 LQKGVAYDSSADWFSLGCMLFKLLRGHSP 195
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 48/209 (22%), Positives = 95/209 (45%), Gaps = 29/209 (13%)
Query: 348 FKVGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGA 405
K+G+G G C+ + G+ VA+K + Q + EV ++ H ++V + +
Sbjct: 28 IKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNS 87
Query: 406 C---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
E W +V E+L G+L D + + + + A + + L +LH+ + +
Sbjct: 88 YLVGDELW-VVMEFLEGGALTDIVTH----TRMNEEQIATVCLSVLRALSYLHN---QGV 139
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 522
+H D+K +ILL S+ K+ DFG C V+++ PK P +
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-----------PKRKSLVGTPYWMAPE 188
Query: 523 VLT-----PKSDSYSFGLIILQLLTGRLP 546
V++ + D +S G+++++++ G P
Sbjct: 189 VISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 44/146 (30%), Positives = 75/146 (51%), Gaps = 11/146 (7%)
Query: 350 VGQGGFGCVYKGEM--LGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTLLG 404
+G+GGFG V +M G+ A K L ++ + ++ E R+L+K+ +V+L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 405 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 461
A LV + G L+ ++ +P + RA A+I SGL LH +
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQ---RR 117
Query: 462 IVHGDLKPQNILLDSELSSKICDFGI 487
I++ DLKP+N+LLD++ + +I D G+
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGL 143
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 22/209 (10%)
Query: 350 VGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQLE---FQQEVRVLSKLQHPHLVTLLG 404
+G+G FG V K + + A+K+L M + E F++E VL + + TL
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHY 68
Query: 405 ACPE--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
A + LV +Y G L L + + P +D AR +A + + S
Sbjct: 69 AFQDENNLYLVMDYYVGGDLLTLLSKFEDRLP---EDMARFY--LAEMVIAIDSVHQLHY 123
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT- 521
VH D+KP NIL+D ++ DFG C + ED +S+ G+ Y PE +
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-----QSSVAVGTPDYISPEILQAM 178
Query: 522 ----GVLTPKSDSYSFGLIILQLLTGRLP 546
G P+ D +S G+ + ++L G P
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGETP 207
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 2e-07
Identities = 47/167 (28%), Positives = 73/167 (43%), Gaps = 35/167 (20%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQE------VRVLSKLQ----H 396
K+G+G +G VYK G+ VA+K + +LE +E +R +S LQ
Sbjct: 8 KIGEGTYGKVYKARDKNTGKLVALK-------KTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 397 PHLVTLL--------GACPEAWSLVYEYLPNG--SLQDRLFRKSNVSPLLWKDRARIAAE 446
++V LL P + LV+EYL + D + PL K +
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLY-LVFEYLDSDLKKFMDS-NGRGPGRPLPAKTIKSFMYQ 118
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS-KICDFGICRLVT 492
+ G+ H ++H DLKPQN+L+D + KI D G+ R +
Sbjct: 119 LLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS 162
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 34/109 (31%), Positives = 55/109 (50%), Gaps = 7/109 (6%)
Query: 434 PLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493
L +D + ++A G+ FL S K +H DL +NILL KICDFG+ R + +
Sbjct: 175 VLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYK 231
Query: 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 542
D P + R + + PE V T +SD +SFG+++ ++ +
Sbjct: 232 D----PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 276
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-07
Identities = 55/225 (24%), Positives = 102/225 (45%), Gaps = 51/225 (22%)
Query: 350 VGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
+G G G V+ + VA+K + + Q +E++++ +L H ++V
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK------ 66
Query: 408 EAWSLVYEYL-PNGS-LQDRLFRKSNVSPL-------------------LWKDRARI-AA 445
VYE L P+GS L + + + ++ + L ++ AR+
Sbjct: 67 -----VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMY 121
Query: 446 EIASGLCFLHSSKPEKIVHGDLKPQNILLDSE-LSSKICDFGICRLVTEDTLYLPSFHRS 504
++ GL ++HS+ ++H DLKP N+ +++E L KI DFG+ R+V D Y + S
Sbjct: 122 QLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIV--DPHYSHKGYLS 176
Query: 505 TAPKGSFPYADPEYHRTGVLTPKS-----DSYSFGLIILQLLTGR 544
+ Y P +L+P + D ++ G I ++LTG+
Sbjct: 177 EGLVTKW-YRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 3e-07
Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 35/158 (22%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEFQ--QEVRVLSKLQHPHLVTL-- 402
K+G+G + VYKG ++ G+ VA+K + + +G F +E +L L+H ++VTL
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHD 70
Query: 403 LGACPEAWSLVYEYL-----------PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGL 451
+ + +LV+EYL G NV L+ ++ GL
Sbjct: 71 IIHTKKTLTLVFEYLDTDLKQYMDDCGGG------LSMHNVRLFLF--------QLLRGL 116
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
+ H +++H DLKPQN+L+ K+ DFG+ R
Sbjct: 117 AYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 4e-07
Identities = 32/147 (21%), Positives = 56/147 (38%), Gaps = 18/147 (12%)
Query: 349 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQH-----PHLVTLL 403
+ G VY +K+ + + + + ++EV +L L P ++
Sbjct: 5 LLKGGLTNRVYLLGTKDEDYVLKI--NPSREKGADREREVAILQLLARKGLPVPKVLASG 62
Query: 404 GACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
+ ++ L+ E++ +L VS +D A AE+ L LH +
Sbjct: 63 ESDGWSY-LLMEWIEGETL-------DEVSEEEKEDIAEQLAEL---LAKLHQLPLLVLC 111
Query: 464 HGDLKPQNILLDSELSSKICDFGICRL 490
HGDL P NIL+D I D+
Sbjct: 112 HGDLHPGNILVDDGKILGIIDWEYAGY 138
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 4e-07
Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 27/205 (13%)
Query: 350 VGQGGFGCV--YKGEMLGRTVAIKMLYSHNMQGQLE--FQQEVRVLSKLQHPHLVTLLGA 405
VG+G +G V + G+ IK L N + +QE ++LS+L+HP++V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY--- 64
Query: 406 CPEAWS-------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRA-RIAAEIASGLCFLHSS 457
E+W +V + G L +L K LL +++ +IA L +LH
Sbjct: 65 -RESWEGEDGLLYIVMGFCEGGDLYHKL--KEQKGKLLPENQVVEWFVQIAMALQYLHE- 120
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 517
+ I+H DLK QN+ L K+ D GI R++ ++ G+ Y PE
Sbjct: 121 --KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN------QCDMASTLIGTPYYMSPE 172
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLT 542
KSD ++ G + ++ T
Sbjct: 173 LFSNKPYNYKSDVWALGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 6e-07
Identities = 57/202 (28%), Positives = 92/202 (45%), Gaps = 20/202 (9%)
Query: 349 KVGQGGFGCVY--KGEMLGRTVAIKMLYS-----HNMQGQLEFQQEVRVLSKLQHPHLVT 401
++G+G FG VY K + +K+L N ++ QE ++LSKL HP +V
Sbjct: 7 RLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVK 66
Query: 402 LLGACPE--AWSLVYEYLPNGSLQDRLFR-KSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
+ E A+ ++ EY L +L K L ++ G+ ++H
Sbjct: 67 FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ-- 124
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 518
+I+H DLK +NI L + L KI DFG+ RL+ + S +T G+ Y PE
Sbjct: 125 -RRILHRDLKAKNIFLKNNL-LKIGDFGVSRLL------MGSCDLATTFTGTPYYMSPEA 176
Query: 519 HRTGVLTPKSDSYSFGLIILQL 540
+ KSD +S G I+ ++
Sbjct: 177 LKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 6e-07
Identities = 43/160 (26%), Positives = 79/160 (49%), Gaps = 26/160 (16%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKML--YSHNMQGQLEFQQEVRVLSKLQHPHLVTLLG 404
+G+G +G V G VAIK + + H Q + E+++L + +H +++ +L
Sbjct: 12 YIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR-EIKILRRFKHENIIGILD 70
Query: 405 ACP----EAWSLVY---EYLPNGSLQD--RLFRKSNVSPLLWKDRAR-IAAEIASGLCFL 454
E+++ VY E + D +L + ++S D + +I GL ++
Sbjct: 71 IIRPPSFESFNDVYIVQELMET----DLYKLIKTQHLS----NDHIQYFLYQILRGLKYI 122
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494
HS+ ++H DLKP N+LL++ KICDFG+ R+ +
Sbjct: 123 HSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 7e-07
Identities = 66/271 (24%), Positives = 114/271 (42%), Gaps = 32/271 (11%)
Query: 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQ---QEVRVLSKLQHP 397
NF K+G+G F VY+ L + VA+K + M Q +E+ +L +L HP
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 398 HLVTLLGACPE--AWSLVYEYLPNGSLQDRLF---RKSNVSP--LLWKDRARIAAEIASG 450
+++ L + E ++V E G L + ++ + P +WK ++ S
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWK----YFVQLCSA 118
Query: 451 LCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS 510
+ +HS +++H D+KP N+ + + K+ D G+ R + T S G+
Sbjct: 119 VEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL------VGT 169
Query: 511 FPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS-CGKLSSI-LDP 568
Y PE KSD +S G ++ ++ + P G+ S C K+ P
Sbjct: 170 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP--FYGDKMNLFSLCQKIEQCDYPP 227
Query: 569 LAGDWPTFVARRLVDLGLQCCELYGRERPDI 599
L + + R LV + C +RPDI
Sbjct: 228 LPTEHYSEKLRELVSM---CIYPDPDQRPDI 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 9e-07
Identities = 49/168 (29%), Positives = 78/168 (46%), Gaps = 21/168 (12%)
Query: 385 QQEVRVLSKLQHPHLVTLLGACPEAWS---LVYEYLPNGSLQDRLFRKSNVSPLLWKDRA 441
Q E V + + L +C + S LV EY+ G L + R+ L ++ A
Sbjct: 43 QTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRK----LPEEHA 98
Query: 442 RI-AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR--LVTEDTLYL 498
R AAEI L FLH I++ DLK N+LLD++ K+ D+G+C+ L DT
Sbjct: 99 RFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDT--- 152
Query: 499 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
++ G+ Y PE R D ++ G+++ +++ GR P
Sbjct: 153 -----TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSP 195
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 40/144 (27%), Positives = 68/144 (47%), Gaps = 11/144 (7%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
++G G FG VYK + G A K++ + + + ++ E+ +L+ HP++V LL A
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 407 ---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
W L+ E+ G++ + PL + + L +LH +K I+
Sbjct: 72 YYENNLWILI-EFCAGGAVDAVMLELER--PLTEPQIRVVCKQTLEALNYLHENK---II 125
Query: 464 HGDLKPQNILLDSELSSKICDFGI 487
H DLK NIL + K+ DFG+
Sbjct: 126 HRDLKAGNILFTLDGDIKLADFGV 149
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 1e-06
Identities = 41/133 (30%), Positives = 66/133 (49%), Gaps = 16/133 (12%)
Query: 415 EYLPNGSLQDRLFRKSNVSPLL-WKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNIL 473
+YLP+ + R N SP L + D + ++A+G+ FL S + VH DL +N+L
Sbjct: 215 QYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVL 271
Query: 474 LDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS----FPYADPEYHRTGVLTPKSD 529
+ KICDFG+ R + D+ Y+ KGS + PE + T SD
Sbjct: 272 ICEGKLVKICDFGLARDIMRDSNYI--------SKGSTFLPLKWMAPESIFNNLYTTLSD 323
Query: 530 SYSFGLIILQLLT 542
+SFG+++ ++ T
Sbjct: 324 VWSFGILLWEIFT 336
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-06
Identities = 49/201 (24%), Positives = 89/201 (44%), Gaps = 18/201 (8%)
Query: 350 VGQGGFGCVYKG--EMLGRT---VAIKMLY-SHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
+G G FG + +G ++ + VAI L + + + F E L + H ++V L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 404 GACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
G ++ V EY+ NG+L D RK L+ + +ASG+ +L
Sbjct: 73 GVITRGNTMMIVTEYMSNGAL-DSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMG--- 127
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
VH L +L++S+L KI F + + +Y +S +A PE +
Sbjct: 128 YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVL-----WAAPEAIQY 182
Query: 522 GVLTPKSDSYSFGLIILQLLT 542
+ SD +SFG+++ ++++
Sbjct: 183 HHFSSASDVWSFGIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 35/212 (16%)
Query: 350 VGQGGFG--CVYKGEMLGRTVAIKML----YSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
VG+G FG + + + A+K + S ++ ++E +L+K++HP++V
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDS---RKEAVLLAKMKHPNIVAFK 64
Query: 404 GACPEAWSL--VYEYLPNGSL-------QDRLFRKSNVSPLLWKDRARIAAEIASGLCFL 454
+ L V EY G L + +LF + + L W ++ G+ +
Sbjct: 65 ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI--LQW------FVQMCLGVQHI 116
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 514
H ++++H D+K +NI L K+ DFG RL+T Y ++ G+ Y
Sbjct: 117 HE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY------VGTPYYV 167
Query: 515 DPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PE KSD +S G I+ +L T + P
Sbjct: 168 PPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 42/147 (28%), Positives = 74/147 (50%), Gaps = 13/147 (8%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEFQ--QEVRVLSKLQHPHLVTL-- 402
K+G+G + VYKG + G+ VA+K++ +G + F +E +L L+H ++V L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIVLLHD 70
Query: 403 LGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
+ E + V+EY+ Q + + P + ++ GL ++H + I
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPY---NVRLFMFQLLRGLAYIHG---QHI 124
Query: 463 VHGDLKPQNILLDSELSSKICDFGICR 489
+H DLKPQN+L+ K+ DFG+ R
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 2e-06
Identities = 61/234 (26%), Positives = 99/234 (42%), Gaps = 50/234 (21%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNM--QGQ-LEFQQEVRVLSKLQHPHLVTLLG 404
+G+G FG V+ + + G+ A+K+L +M + Q + E +L+ P +V L
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY- 67
Query: 405 ACPEAWS--------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLH 455
+S LV EY+P G L + L RK + AR AE+ L +H
Sbjct: 68 -----YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPE----ETARFYIAELVLALDSVH 118
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGIC--------RLVTEDTLYLPSF------ 501
+H D+KP NIL+D++ K+ DFG+C R + + F
Sbjct: 119 K---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175
Query: 502 ---------HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
R+ + G+ Y PE R + D +S G+I+ ++L G P
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPP 229
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 2e-06
Identities = 64/225 (28%), Positives = 100/225 (44%), Gaps = 27/225 (12%)
Query: 343 NFSESFKV-GQGGFGCVY-----KGEMLGRTVAIKMLYSHNMQGQLEFQQEVR----VLS 392
NF E KV G G +G V+ G G+ A+K+L + + + + R VL
Sbjct: 1 NF-ELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 59
Query: 393 KL-QHPHLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIAS 449
+ Q P LVTL A L+ +Y+ G L L ++ ++ + EI
Sbjct: 60 HIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKE---QEVQIYSGEIVL 116
Query: 450 GLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKG 509
L LH I++ D+K +NILLDS + DFG+ + ED + R+ + G
Sbjct: 117 ALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV-----ERAYSFCG 168
Query: 510 SFPYADPEYHRTGVL--TPKSDSYSFGLIILQLLTGRLPVGLAGE 552
+ Y P+ R G D +S G+++ +LLTG P + GE
Sbjct: 169 TIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGE 213
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-06
Identities = 45/157 (28%), Positives = 77/157 (49%), Gaps = 20/157 (12%)
Query: 350 VGQGGFG--CVYKGEMLGRTVAIKMLYS--HNMQGQLEFQQEVRVLSKLQHPHLVTL--- 402
+G+G +G C K VAIK + + N +E+++L L H +++ +
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI 72
Query: 403 -LGACPEAWS---LVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSS 457
EA++ +VYE L + L ++ R S L D + ++ GL ++HS+
Sbjct: 73 MPPPHREAFNDVYIVYE-LMDTDLH-QIIRSSQT---LSDDHCQYFLYQLLRGLKYIHSA 127
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494
++H DLKP N+LL++ KICDFG+ R +E
Sbjct: 128 N---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEK 161
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 3e-06
Identities = 60/215 (27%), Positives = 106/215 (49%), Gaps = 32/215 (14%)
Query: 344 FSESFKVGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQL---EFQQEVRVLSKLQHPH 398
+ + +VG G +G C G VAIK LY Q +L +E+R+L ++H +
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLY-RPFQSELFAKRAYRELRLLKHMKHEN 75
Query: 399 LVTLLGACPEAWSL-----VYEYLP-NGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGL 451
++ LL SL Y +P G+ +L + +S +DR + + ++ GL
Sbjct: 76 VIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLS----EDRIQFLVYQMLKGL 131
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV-TEDTLYLPS-FHRSTAPKG 509
++H++ I+H DLKP N+ ++ + KI DFG+ R +E T Y+ + ++R AP+
Sbjct: 132 KYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRWYR--APEV 186
Query: 510 SFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 544
+ Y +T D +S G I+ ++LTG+
Sbjct: 187 ILNWM--HYTQT------VDIWSVGCIMAEMLTGK 213
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 3e-06
Identities = 55/214 (25%), Positives = 89/214 (41%), Gaps = 45/214 (21%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSH-NMQGQLEFQQEVRVLSKLQ-HPHLVTL-- 402
K+G+G F V K + G+ AIK + H Q+ +E++ L +L HP+++ L
Sbjct: 6 KIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65
Query: 403 --LGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460
+LV+E L + +L + K PL K ++ L +H +
Sbjct: 66 VLFDRKTGRLALVFE-LMDMNLYE--LIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG-- 120
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 520
I H D+KP+NIL+ ++ K+ DFG C R K PY EY
Sbjct: 121 -IFHRDIKPENILIKDDI-LKLADFGSC--------------RGIYSKP--PYT--EYIS 160
Query: 521 T------------GVLTPKSDSYSFGLIILQLLT 542
T G PK D ++ G + ++L+
Sbjct: 161 TRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-06
Identities = 49/216 (22%), Positives = 97/216 (44%), Gaps = 26/216 (12%)
Query: 350 VGQGGFGCVYKGEM-----LGRTVAIKMLYSH-NMQGQLE-FQQEVRVLSKLQHPHLVTL 402
+G+G FG V + ++ + VA+KML + +E F +E + + HP+++ L
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 403 LGACPEAWS--------LVYEYLPNGSLQDRLFRK---SNVSPLLWKDRARIAAEIASGL 451
+G + + ++ ++ +G L L L + R +IASG+
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGM 126
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 511
+L S + +H DL +N +L+ ++ + DFG+ + + Y + A K
Sbjct: 127 EYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYY----RQGCASKLPV 179
Query: 512 PYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP 546
+ E V T SD ++FG+ + +++T G+ P
Sbjct: 180 KWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTP 215
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.8 bits (117), Expect = 4e-06
Identities = 49/144 (34%), Positives = 67/144 (46%), Gaps = 25/144 (17%)
Query: 347 SFKV----GQGGFGCVY----KGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQ 395
FK G+G G V+ KG G+ A+K+L M + + ++ E +L+ L
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGT--GKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD 59
Query: 396 HPHLVTLLG--ACPEAWSLVYEYLPNGSLQDRLFRKSNVSP--LLWKDRARI-AAEIASG 450
HP L TL LV +Y P G L FR P L ++ AR AAE+
Sbjct: 60 HPFLPTLYASFQTETYLCLVMDYCPGGEL----FRLLQRQPGKCLSEEVARFYAAEVLLA 115
Query: 451 LCFLHSSKPEKIVHGDLKPQNILL 474
L +LH IV+ DLKP+NILL
Sbjct: 116 LEYLHL---LGIVYRDLKPENILL 136
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 43/152 (28%), Positives = 73/152 (48%), Gaps = 22/152 (14%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKML-YSHNMQGQLEFQ-QEVRVLSKLQHPHLVTLLG 404
K+G+G +G V+K VA+K + + +G +E+ +L +L+H ++V L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 405 A--CPEAWSLVYEYLPNGSLQD--RLFRKSNVSPLLWKDRARIAA---EIASGLCFLHSS 457
+ +LV+EY QD + F N D + + ++ GL F HS
Sbjct: 67 VLHSDKKLTLVFEYCD----QDLKKYFDSCNGDI----DPEIVKSFMFQLLKGLAFCHS- 117
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
++H DLKPQN+L++ K+ DFG+ R
Sbjct: 118 --HNVLHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 5e-06
Identities = 34/114 (29%), Positives = 61/114 (53%), Gaps = 8/114 (7%)
Query: 434 PLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493
PL D R ++++A G+ FL S + +H D+ +N+LL +KICDFG+ R +
Sbjct: 208 PLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264
Query: 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP 546
D+ Y+ + K + PE V T +SD +S+G+++ ++ + G+ P
Sbjct: 265 DSNYVVKGNARLPVK----WMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 5e-06
Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 36/211 (17%)
Query: 350 VGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTLLG 404
VG G +G C G VA+K L S Q + ++ E+R+L ++H +++ LL
Sbjct: 25 VGSGAYGSVCAAFDTKTGLRVAVKKL-SRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 83
Query: 405 ACPEAWSL-----VY--EYLPNGSLQD----RLFRKSNVSPLLWKDRARIAAEIASGLCF 453
A SL VY +L L + + +V L++ +I GL +
Sbjct: 84 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIY--------QILRGLKY 135
Query: 454 LHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY 513
+HS+ I+H DLKP N+ ++ + KI DFG+ R ++ + AP+ +
Sbjct: 136 IHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNW 192
Query: 514 ADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 544
Y++T D +S G I+ +LLTGR
Sbjct: 193 M--HYNQT------VDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 5e-06
Identities = 58/220 (26%), Positives = 92/220 (41%), Gaps = 36/220 (16%)
Query: 350 VGQGGFGCVYK--GEMLGRTVAIKMLYS-HNMQGQLEFQQEVRVLSKLQ-HPHLVTLLGA 405
+G+G +G V+K + G A+K+L H++ ++E E +L L HP++V G
Sbjct: 26 IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIE--AEYNILKALSDHPNVVKFYGM 83
Query: 406 C--------PEAWSLVYEYLPNGSLQDR----LFRKSNVSPLLWKDRARIAAEIASGLCF 453
+ W LV E GS+ D L R + + A I E GL
Sbjct: 84 YYKKDVKNGDQLW-LVLELCNGGSVTDLVKGFLKRGERMEEPII---AYILHEALMGLQH 139
Query: 454 LHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY 513
LH +K +H D+K NILL +E K+ DFG+ +T + R G+ +
Sbjct: 140 LHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS------TRLRRNTSVGTPFW 190
Query: 514 ADPEY-----HRTGVLTPKSDSYSFGLIILQLLTGRLPVG 548
PE + D +S G+ ++L G P+
Sbjct: 191 MAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA 230
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 6e-06
Identities = 42/166 (25%), Positives = 77/166 (46%), Gaps = 32/166 (19%)
Query: 350 VGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEFQ--QEVRVLSKLQHPHLVTLLGA 405
+G+G +G VYK + G VA+K + N + +E+++L +L H ++V L
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEI 74
Query: 406 C------------PEAWSLVYEYLPN---GSLQDRL--FRKSNVSPLLWKDRARIAAEIA 448
A+ LV+EY+ + G L+ L F + ++ + ++
Sbjct: 75 VTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM--------KQLL 126
Query: 449 SGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494
GL + H + +H D+K NILL+++ K+ DFG+ RL +
Sbjct: 127 EGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSE 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 7e-06
Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 7/97 (7%)
Query: 446 EIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST 505
++A G+ FL S + +H DL +NILL +KICDFG+ R + D+ Y+ +
Sbjct: 222 QVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARL 278
Query: 506 APKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 542
K + PE V T +SD +S+G+++ ++ +
Sbjct: 279 PVK----WMAPESIFNCVYTFESDVWSYGILLWEIFS 311
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 47/166 (28%), Positives = 73/166 (43%), Gaps = 33/166 (19%)
Query: 351 GQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVR--VLSKL-QHPHLVTLLGACP 407
G G C + G+ VAIK L S Q ++ R VL KL H +++ LL
Sbjct: 27 GAQGIVCAAYDTVTGQNVAIKKL-SRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNV-- 83
Query: 408 EAWSLVYEYLPNGSLQDRLFRK---------SNVSPLLWK--DRARIAAEIASGLC---F 453
+ P SL++ F+ +N+ ++ D R++ + LC
Sbjct: 84 --------FTPQKSLEE--FQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKH 133
Query: 454 LHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499
LHS+ I+H DLKP NI++ S+ + KI DFG+ R + P
Sbjct: 134 LHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 176
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 1e-05
Identities = 34/112 (30%), Positives = 58/112 (51%), Gaps = 7/112 (6%)
Query: 368 VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWS--LVYEYLPNGSLQDR 425
V +K+L + L F + ++ ++ H H+V L G C +V E++ G L
Sbjct: 35 VILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLF 94
Query: 426 LFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE 477
+ RKS+V WK ++A ++AS L +L + +VHG++ +NILL E
Sbjct: 95 MHRKSDVLTTPWK--FKVAKQLASALSYLED---KDLVHGNVCTKNILLARE 141
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 47.6 bits (113), Expect = 2e-05
Identities = 44/151 (29%), Positives = 76/151 (50%), Gaps = 19/151 (12%)
Query: 350 VGQGGFGCVYKGE--MLGRTVAIKM-----LYSHNMQGQLEFQQEVRVLSKLQHPHLVTL 402
+ +G FG VY G + A+K+ + + NM Q++ +++ LSK P +V L
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK--SPFIVHL 69
Query: 403 LGACPEAWS--LVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKP 459
+ A + LV EYL G ++ L ++ ++ A +E+A L +LH
Sbjct: 70 YYSLQSANNVYLVMEYLIGGDVKSLL----HIYGYFDEEMAVKYISEVALALDYLHR--- 122
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRL 490
I+H DLKP N+L+ +E K+ DFG+ ++
Sbjct: 123 HGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 66/247 (26%), Positives = 107/247 (43%), Gaps = 37/247 (14%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVL---SKLQHPHLVT 401
+G+G FG VY + + R A+K+L + + E E +L + P +V
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 402 LLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSK 458
L + LV +Y+ G L L ++ S +DRA+ AE+ L LH
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFS----EDRAKFYIAELVLALEHLHKYD 116
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 518
IV+ DLKP+NILLD+ +CDFG+ + D +F G+ Y PE
Sbjct: 117 ---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC------GTTEYLAPE- 166
Query: 519 HRTGVL------TPKSDSYSFGLIILQLLTGRLP--VGLAGEVRRAVSCGKLSSILDPLA 570
VL T D +S G+++ ++ G P ++ R ++ GK+ + L+
Sbjct: 167 ----VLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLS 222
Query: 571 GDWPTFV 577
+ FV
Sbjct: 223 DEGRQFV 229
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 53/196 (27%), Positives = 83/196 (42%), Gaps = 25/196 (12%)
Query: 342 CNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHN--------MQGQL-EFQQEVRVLS 392
F + +G G FG V L R V K LY+ ++ Q+ + E +L+
Sbjct: 1 SMFVKIKTLGIGAFGEV----CLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILA 56
Query: 393 KLQHPHLVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASG 450
+ + +V L + + +L V +Y+P G + L R + +D AR IA
Sbjct: 57 EADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG----IFPEDLARFY--IAEL 110
Query: 451 LCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC---RLVTEDTLYLPSFH-RSTA 506
C + S +H D+KP NIL+D + K+ DFG+C R + Y H R +
Sbjct: 111 TCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDS 170
Query: 507 PKGSFPYADPEYHRTG 522
S + DP R G
Sbjct: 171 MDFSNEWGDPANCRCG 186
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 60/207 (28%), Positives = 89/207 (42%), Gaps = 27/207 (13%)
Query: 350 VGQGGFGCV----YKGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTL 402
+G G FG V YK E VAIK + Q + E ++L+ + HP V L
Sbjct: 38 LGTGSFGRVILATYKNEDF-PPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNL 96
Query: 403 LGACPEA--WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKP 459
G+ + LV E++ G L R++ P D AA+I +L S
Sbjct: 97 YGSFKDESYLYLVLEFVIGGEFFTFL-RRNKRFP---NDVGCFYAAQIVLIFEYLQSLN- 151
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 519
IV+ DLKP+N+LLD + K+ DFG ++V T L G+ Y PE
Sbjct: 152 --IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC---------GTPEYIAPEIL 200
Query: 520 RTGVLTPKSDSYSFGLIILQLLTGRLP 546
+D ++ G+ I ++L G P
Sbjct: 201 LNVGHGKAADWWTLGIFIYEILVGCPP 227
|
Length = 340 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 3e-05
Identities = 19/44 (43%), Positives = 31/44 (70%), Gaps = 3/44 (6%)
Query: 446 EIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
+I GL ++HS+ ++H DLKP N+L++++ KICDFG+ R
Sbjct: 113 QILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 45.6 bits (109), Expect = 4e-05
Identities = 39/154 (25%), Positives = 71/154 (46%), Gaps = 19/154 (12%)
Query: 396 HPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCF 453
+P+ + L + + L+ +Y+ +G L D L ++ +S K +I ++ L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVK---KIIRQLVEALND 124
Query: 454 LHSSKPEKIVHGDLKPQNILLDSELSS-KICDFGICRLVTEDTLYLPSFHRSTAPKGSFP 512
LH I+H D+K +N+L D +CD+G+C+ T PS + G+
Sbjct: 125 LHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCK--IIGT---PSCYD-----GTLD 171
Query: 513 YADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
Y PE + D ++ G++ +LLTG+ P
Sbjct: 172 YFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHP 205
|
Length = 267 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 35/133 (26%), Positives = 58/133 (43%), Gaps = 16/133 (12%)
Query: 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNIL 473
Y+ + + L L D ++A G+ FL S + VH DL +N+L
Sbjct: 214 YKGSNDSEV-KNLLSDDGSEGLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVL 269
Query: 474 LDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS----FPYADPEYHRTGVLTPKSD 529
L KICDFG+ R + D+ Y+ KGS + PE + T SD
Sbjct: 270 LAQGKIVKICDFGLARDIMHDSNYV--------SKGSTFLPVKWMAPESIFDNLYTTLSD 321
Query: 530 SYSFGLIILQLLT 542
+S+G+++ ++ +
Sbjct: 322 VWSYGILLWEIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 6e-05
Identities = 44/154 (28%), Positives = 72/154 (46%), Gaps = 20/154 (12%)
Query: 346 ESFKV-GQGGFGCV--YKGEMLGRTVAIKMLYSHNMQGQLEFQQ------EVRVLSKLQH 396
ES KV G+G FG V + + G A+K+L +M LE +Q E +L +
Sbjct: 4 ESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADM---LEKEQVGHIRAERDILVEADS 60
Query: 397 PHLVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFL 454
+V + + + +L + E+LP G + L +K ++ IA + +
Sbjct: 61 LWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLT------EEETQFYIAETVLAI 114
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 488
S +H D+KP N+LLDS+ K+ DFG+C
Sbjct: 115 DSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLC 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 45.5 bits (107), Expect = 6e-05
Identities = 44/161 (27%), Positives = 70/161 (43%), Gaps = 23/161 (14%)
Query: 351 GQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVR--VLSK-LQHPHLVTLLGACP 407
G G C +L R VAIK L S Q Q ++ R VL K + H ++++LL
Sbjct: 28 GAQGIVCAAYDAVLDRNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV-- 84
Query: 408 EAWSLVYEYLPNGSLQD-------RLFRKSNVSPLLWK--DRARIAAEIASGLCFLHSSK 458
+ P SL++ +N+ ++ D R++ + LC +
Sbjct: 85 --------FTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 136
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499
I+H DLKP NI++ S+ + KI DFG+ R + P
Sbjct: 137 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 177
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 6e-05
Identities = 44/169 (26%), Positives = 74/169 (43%), Gaps = 46/169 (27%)
Query: 350 VGQGGFGCVYK--GEMLGRTVAIKMLYSHNMQGQLEFQQ----EVRVLSKLQHPHLVTLL 403
VG+G +G V K + VAIK + + E ++ E+++L L+ ++V L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKF--KDSEENEEVKETTLRELKMLRTLKQENIVEL- 65
Query: 404 GACPEAWS------LVYEY-----------LPNGSLQDRLFRKSNVSPLLWKDRARIAAE 446
EA+ LV+EY +PNG +++ R+ I
Sbjct: 66 ---KEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKV-------------RSYIYQL 109
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495
I + +H IVH D+KP+N+L+ K+CDFG R ++E +
Sbjct: 110 IKA----IHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 42/145 (28%), Positives = 64/145 (44%), Gaps = 23/145 (15%)
Query: 438 KDRARIA---AEIASGLCFL------HSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 488
K RA+ E +GL F+ H + ++H D+K NILL S K+ DFG
Sbjct: 131 KSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFS 190
Query: 489 RL----VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 544
++ V++D G+ Y PE R + K+D +S G+++ +LLT +
Sbjct: 191 KMYAATVSDDV--------GRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLK 242
Query: 545 LPVGLAGEVRRAVSCGKLSSILDPL 569
P GE V L+ DPL
Sbjct: 243 RP--FDGENMEEVMHKTLAGRYDPL 265
|
Length = 496 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 56/219 (25%), Positives = 96/219 (43%), Gaps = 36/219 (16%)
Query: 345 SESFK----VGQGGFGCVYKGEMLGRT--VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPH 398
++S+K +G G FG VY+ + + VAIK + +Q +E+ ++ L H +
Sbjct: 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV----LQDPQYKNRELLIMKNLNHIN 120
Query: 399 LVTL----LGACPEA------WSLVYEYLPNG--SLQDRLFRKSNVSPLLWKDRARIAAE 446
++ L C + ++V E++P R ++ PL + +
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKL--YSYQ 178
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS-KICDFGICRLVTEDTLYLPSFHRST 505
+ L ++HS + I H DLKPQN+L+D + K+CDFG + L + RS
Sbjct: 179 LCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAK-------NLLAGQRSV 228
Query: 506 APKGSFPYADPEYHRTGV-LTPKSDSYSFGLIILQLLTG 543
+ S Y PE T D +S G II +++ G
Sbjct: 229 SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 26/76 (34%), Positives = 38/76 (50%), Gaps = 6/76 (7%)
Query: 413 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNI 472
V +Y+P G + L R + +D AR IA C + S +H D+KP NI
Sbjct: 79 VMDYIPGGDMMSLLIRLG----IFEEDLARFY--IAELTCAIESVHKMGFIHRDIKPDNI 132
Query: 473 LLDSELSSKICDFGIC 488
L+D + K+ DFG+C
Sbjct: 133 LIDRDGHIKLTDFGLC 148
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-04
Identities = 62/216 (28%), Positives = 98/216 (45%), Gaps = 28/216 (12%)
Query: 350 VGQGGFGCVY---KGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTLL 403
+ G +G VY E R A+K + N+ + + QQ E +L+ ++P +V++
Sbjct: 9 ISNGAYGAVYLVRHKETRQR-FAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMF 67
Query: 404 GA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIA-AEIASGLCFLHSSKPE 460
+ +V EY+ G L N+ L D AR+ AE L +LH+
Sbjct: 68 CSFETKRHLCMVMEYVEGGDCATLL---KNIGALP-VDMARMYFAETVLALEYLHNYG-- 121
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICR--LVTEDT-LYLPSFHRSTAP------KGSF 511
IVH DLKP N+L+ S K+ DFG+ + L++ T LY + T G+
Sbjct: 122 -IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTP 180
Query: 512 PYADPEY-HRTGVLTPKSDSYSFGLIILQLLTGRLP 546
Y PE R G P D ++ G+I+ + L G +P
Sbjct: 181 EYIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVP 215
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 52/202 (25%), Positives = 87/202 (43%), Gaps = 44/202 (21%)
Query: 368 VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC---PEAWSLVYEYLPNGSLQD 424
V +K+L + L F + ++S++ H HL + G C E +V E++ +G L
Sbjct: 47 VVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSEN-IMVEEFVEHGPLDV 105
Query: 425 RLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICD 484
L ++ P+ WK +A ++AS L +L + +VHG++ +NILL
Sbjct: 106 CLRKEKGRVPVAWK--ITVAQQLASALSYLED---KNLVHGNVCAKNILLARL------- 153
Query: 485 FGICRLVTEDTLYLPSFHRSTAPKGSF------------PYADPEYHRTGV-LTPKSDSY 531
G+ E T F + + P SF P+ PE G L+ +D +
Sbjct: 154 -GLA----EGTS---PFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKW 205
Query: 532 SFGLIILQL-------LTGRLP 546
SFG +L++ L R P
Sbjct: 206 SFGTTLLEICFDGEVPLKERTP 227
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 2e-04
Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 20/154 (12%)
Query: 346 ESFKV-GQGGFGCV--YKGEMLGRTVAIKMLYSHNMQGQLEFQQ------EVRVLSKLQH 396
ES KV G+G FG V + + G A+K+L +M LE +Q E +L +
Sbjct: 4 ESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADM---LEKEQVAHIRAERDILVEADG 60
Query: 397 PHLVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFL 454
+V + + + +L + E+LP G + L +K +S IA + +
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLS------EEATQFYIAETVLAI 114
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 488
+ +H D+KP N+LLD++ K+ DFG+C
Sbjct: 115 DAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLC 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 2e-04
Identities = 28/135 (20%), Positives = 56/135 (41%), Gaps = 2/135 (1%)
Query: 175 KAEELRNSAFAEFLRRKKLESEAMEAIGKVKAFESAYAREMHLRK-EAEDALQTTIQDQE 233
+ EEL+ ++L +E E K++ E+ E + L +
Sbjct: 240 ELEELQEELKEAEEELEELTAELQELEEKLEELRLEV-SELEEEIEELQKELYALANEIS 298
Query: 234 KLKQEKAFVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRR 293
+L+Q+K + + L R + L ++ +E + DE EL ++ + L++E + +
Sbjct: 299 RLEQQKQILRERLANLERQLEELEAQLEELESKLDELAEELAELEEKLEELKEELESLEA 358
Query: 294 QKVEAVRWLERWRSR 308
+ E LE SR
Sbjct: 359 ELEELEAELEELESR 373
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 59/215 (27%), Positives = 96/215 (44%), Gaps = 45/215 (20%)
Query: 350 VGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQL---EFQQEVRVLSKLQHPHLVTLLG 404
VG G +G C + G VAIK L S Q ++ +E+ +L +QH +++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKL-SRPFQSEIFAKRAYRELTLLKHMQHENVIGLLD 81
Query: 405 ACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA-------------EIASGL 451
A S QD V P + D +I ++ GL
Sbjct: 82 VFTSAVSG-------DEFQDFYL----VMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGL 130
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV-TEDTLYLPS-FHRSTAPKG 509
++HS+ I+H DLKP N+ ++ + KI DFG+ R E T Y+ + ++R AP+
Sbjct: 131 KYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYR--APEV 185
Query: 510 SFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 544
+ Y++T D +S G I+ ++LTG+
Sbjct: 186 ILNWM--HYNQT------VDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 43/151 (28%), Positives = 67/151 (44%), Gaps = 23/151 (15%)
Query: 351 GQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVR--VLSK-LQHPHLVTLLGACP 407
G G C +L R VAIK L S Q Q ++ R VL K + H +++ LL
Sbjct: 35 GAQGIVCAAYDAILERNVAIKKL-SRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV-- 91
Query: 408 EAWSLVYEYLPNGSLQD-------RLFRKSNVSPLLWK--DRARIAAEIASGLCFLHSSK 458
+ P SL++ +N+ ++ D R++ + LC +
Sbjct: 92 --------FTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLH 143
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICR 489
I+H DLKP NI++ S+ + KI DFG+ R
Sbjct: 144 SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 174
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 2e-04
Identities = 59/217 (27%), Positives = 91/217 (41%), Gaps = 32/217 (14%)
Query: 350 VGQGGFGCVYK--GEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGAC 406
+G+G +G VYK + G A+K+L + + E + E +L L HP++V G
Sbjct: 30 IGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDE-EIEAEYNILQSLPNHPNVVKFYGMF 88
Query: 407 PEA--------WSLVYEYLPNGSLQDRLFRKSNVSPLLWK----DRARIAAEIASGLCFL 454
+A W LV E GS+ + V LL D A I+ + L L
Sbjct: 89 YKADKLVGGQLW-LVLELCNGGSVTEL------VKGLLICGQRLDEAMISYILYGALLGL 141
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 514
+I+H D+K NILL +E K+ DFG+ +T L R+T+ F A
Sbjct: 142 QHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL-----RRNTSVGTPFWMA 196
Query: 515 DP----EYHRTGVLTPKSDSYSFGLIILQLLTGRLPV 547
E + D +S G+ ++L G P+
Sbjct: 197 PEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 42/161 (26%), Positives = 70/161 (43%), Gaps = 23/161 (14%)
Query: 351 GQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ---HPHLVTLLGACP 407
G G C +LG VA+K L S Q Q ++ R L L+ H ++++LL
Sbjct: 32 GAQGIVCAAFDTVLGINVAVKKL-SRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNV-- 88
Query: 408 EAWSLVYEYLPNGSLQD-------RLFRKSNVSPLLWK--DRARIAAEIASGLCFLHSSK 458
+ P SL++ +N+ ++ D R++ + LC +
Sbjct: 89 --------FTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH 140
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499
I+H DLKP NI++ S+ + KI DFG+ R + + P
Sbjct: 141 SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTP 181
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 3e-04
Identities = 16/46 (34%), Positives = 30/46 (65%), Gaps = 3/46 (6%)
Query: 446 EIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491
++ GL ++HS+ ++H DLKP N+L++ + +I DFG+ R +
Sbjct: 115 QLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 5e-04
Identities = 48/205 (23%), Positives = 87/205 (42%), Gaps = 45/205 (21%)
Query: 387 EVRVLSKLQHPHLVT----LLGACPEAWSLVYEYLPNGSLQD------RLFRKSNVSPLL 436
EV V+ +L+H ++V L + ++ E+ G L ++F K ++
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121
Query: 437 WKDRARIAAEIASGLCFLHSSKP----EKIVHGDLKPQNILLDSELS------------- 479
I ++ L + H+ K E+++H DLKPQNI L + +
Sbjct: 122 -----DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLN 176
Query: 480 ----SKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE--YHRTGVLTPKSDSYSF 533
+KI DFG+ + + +++ + + G+ Y PE H T KSD ++
Sbjct: 177 GRPIAKIGDFGLSKNIGIESM-------AHSCVGTPYYWSPELLLHETKSYDDKSDMWAL 229
Query: 534 GLIILQLLTGRLPVGLAGEVRRAVS 558
G II +L +G+ P A + +S
Sbjct: 230 GCIIYELCSGKTPFHKANNFSQLIS 254
|
Length = 1021 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 5e-04
Identities = 46/221 (20%), Positives = 89/221 (40%), Gaps = 32/221 (14%)
Query: 350 VGQGGFGCVYK-----GEMLGRTVAIKMLYSHNMQGQLEF-----QQEVRVLSKLQHPHL 399
+G GGFGCVY+ + K+ N +E ++ ++ ++ H
Sbjct: 20 IGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHN 79
Query: 400 VTLLGACPEAW--------SLVYEYLPNGSLQDRLFRKSN--VSPLLWKDR---ARIAAE 446
+ LG P+ + + Y ++ L ++L + + K++ I +
Sbjct: 80 IDHLG-IPKYYGCGSFKRCRMYYRFI----LLEKLVENTKEIFKRIKCKNKKLIKNIMKD 134
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTA 506
+ + L ++H I HGD+KP+NI++D I D+GI ++
Sbjct: 135 MLTTLEYIHE---HGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKD 191
Query: 507 -PKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+G+ YA + H +T + D S G +L+ +LP
Sbjct: 192 LHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLP 232
|
Length = 294 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 45/153 (29%), Positives = 70/153 (45%), Gaps = 15/153 (9%)
Query: 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQL-EFQQEVRVLSKLQHP 397
+F +G+G FG V + G+ A+K L M + QL + E VL++ P
Sbjct: 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSP 61
Query: 398 HLVTLLGACPEA--WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFL 454
+V+L + +A L+ E+LP G L L + S +D R AE + +
Sbjct: 62 WVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFS----EDVTRFYMAECVLAIEAV 117
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 487
H +H D+KP NIL+D K+ DFG+
Sbjct: 118 HKLG---FIHRDIKPDNILIDRGGHIKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 8e-04
Identities = 35/173 (20%), Positives = 73/173 (42%), Gaps = 16/173 (9%)
Query: 148 SEKRESTDSDSKVEEDPLYVQHREVSIKA--EELRNSAFAEFLRRKKLESEAMEAIGKVK 205
E E + ++EE+ ++ +K EEL A ++LE E EA ++
Sbjct: 751 EELEELQERLEELEEELESLEEALAKLKEEIEELEEKRQALQEELEELEEELEEAERRLD 810
Query: 206 AFESAYAREMHLRKEAEDALQTTIQDQEKLKQEKAFVTQELHRTMRNVALLNSRAQEANR 265
A E R+ E ++ ++ E+L+++ + +EL + + L +E
Sbjct: 811 ALERELESLEQRRERLEQEIEELEEEIEELEEKLDELEEELEELEKELEELKEELEELEA 870
Query: 266 R--------------RDEATGELKLIQASIATLQQEKQRIRRQKVEAVRWLER 304
++E EL+ +++ +A L++E +++R + E LER
Sbjct: 871 EKEELEDELKELEEEKEELEEELRELESELAELKEEIEKLRERLEELEAKLER 923
|
Length = 1163 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 0.001
Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 38/221 (17%)
Query: 346 ESFKVGQGGFGCVYKGEMLG----RTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVT 401
E KVG+G +G VYK + R A+K + + + +E+ +L +L+HP++++
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS--MSACREIALLRELKHPNVIS 62
Query: 402 LLG-----ACPEAWSLVYEYLPNGSLQDRLFR---KSNVSPLLWKDRARIAA---EIASG 450
L A + W L+++Y + F K+N P+ R + + +I G
Sbjct: 63 LQKVFLSHADRKVW-LLFDYAEHDLWHIIKFHRASKANKKPVQLP-RGMVKSLLYQILDG 120
Query: 451 LCFLHSSKPEKIVHGDLKPQNILLDSELSS----KICDFGICRLVTEDTLYLPSFHRSTA 506
+ +LH++ ++H DLKP NIL+ E KI D G RL L
Sbjct: 121 IHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 507 PKGSFPYADPEY-----HRTGVLTPKSDSYSFGLIILQLLT 542
+F Y PE H T + D ++ G I +LLT
Sbjct: 178 ---TFWYRAPELLLGARHYTKAI----DIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 34/157 (21%), Positives = 62/157 (39%), Gaps = 15/157 (9%)
Query: 387 EVRVLSKLQHPHLVTLLG--ACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIA 444
E +L + HP ++ + +V LP+ S + PL I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 445 AEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRS 504
+I GL +LH+ ++I+H D+K +NI ++ I D G + +L
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL------ 214
Query: 505 TAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLL 541
G+ PE K+D +S G+++ ++L
Sbjct: 215 -GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 43/150 (28%), Positives = 61/150 (40%), Gaps = 17/150 (11%)
Query: 397 PHLVTLLG--ACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFL 454
P++V L ++ LV ++ G L + + N+ K R AAE+ L L
Sbjct: 45 PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVK---RWAAEMVVALDAL 101
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 514
H E IV DL P NILLD ++ F V ED+ + Y
Sbjct: 102 HR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEV-EDSCDGEAVENM--------YC 149
Query: 515 DPEYHRTGVLTPKSDSYSFGLIILQLLTGR 544
PE T D +S G I+ +LLTG+
Sbjct: 150 APEVGGISEETEACDWWSLGAILFELLTGK 179
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 41.7 bits (98), Expect = 0.001
Identities = 64/247 (25%), Positives = 87/247 (35%), Gaps = 68/247 (27%)
Query: 349 KVGQGGFGCVYKGEMLGRTVAIK---MLYSHNMQGQLEFQQEVRV-------LSKLQHPH 398
K+G+G FG VYK ++ + + +L G +E RV + +
Sbjct: 139 KLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGF 198
Query: 399 LVTLLG-ACPEAWSLVYEYLPNGSLQDRLFRKS---NVSPLLWKDR-------------- 440
L + E W LV+ Y +L D + K NV P L
Sbjct: 199 LEPVSSKKEDEYW-LVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKII 257
Query: 441 ARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS-KICDFGICRLVTEDTLYLP 499
I +I L LHS+ IVH D+KPQNI+ S KI D G + Y+P
Sbjct: 258 QTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIP 314
Query: 500 SFHRSTAPKGSF---P-YADPEYHRTGVLTPKS----------------------DSYSF 533
F P YA PE + TP + D YS
Sbjct: 315 K---------EFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA 365
Query: 534 GLIILQL 540
GLI LQ+
Sbjct: 366 GLIFLQM 372
|
Length = 566 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 52/215 (24%), Positives = 95/215 (44%), Gaps = 44/215 (20%)
Query: 350 VGQGGFG--CVYKGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTLLG 404
VG G +G C L + VA+K L S Q + ++ E+R+L ++H +++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKL-SRPFQSLIHARRTYRELRLLKHMKHENVIGLLD 81
Query: 405 ACPEAWSLVYEYLPNGSLQDRLFRKSN-VSPLLWKDRARIAA--------------EIAS 449
+ P S+++ F + V+ L+ D I ++
Sbjct: 82 V----------FTPATSIEN--FNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLR 129
Query: 450 GLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKG 509
GL ++HS+ I+H DLKP N+ ++ + +I DFG+ R ++ + AP+
Sbjct: 130 GLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRWYRAPEI 186
Query: 510 SFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 544
+ Y++T D +S G I+ +LL G+
Sbjct: 187 MLNWM--HYNQT------VDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|233757 TIGR02168, SMC_prok_B, chromosome segregation protein SMC, common bacterial type | Back alignment and domain information |
|---|
Score = 41.2 bits (97), Expect = 0.002
Identities = 20/86 (23%), Positives = 38/86 (44%)
Query: 219 KEAEDALQTTIQDQEKLKQEKAFVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLIQ 278
+E + L+ ++ ++ ++E +T EL + L E +E EL +
Sbjct: 235 EELREELEELQEELKEAEEELEELTAELQELEEKLEELRLEVSELEEEIEELQKELYALA 294
Query: 279 ASIATLQQEKQRIRRQKVEAVRWLER 304
I+ L+Q+KQ +R + R LE
Sbjct: 295 NEISRLEQQKQILRERLANLERQLEE 320
|
SMC (structural maintenance of chromosomes) proteins bind DNA and act in organizing and segregating chromosomes for partition. SMC proteins are found in bacteria, archaea, and eukaryotes. This family represents the SMC protein of most bacteria. The smc gene is often associated with scpB (TIGR00281) and scpA genes, where scp stands for segregation and condensation protein. SMC was shown (in Caulobacter crescentus) to be induced early in S phase but present and bound to DNA throughout the cell cycle [Cellular processes, Cell division, DNA metabolism, Chromosome-associated proteins]. Length = 1179 |
| >gnl|CDD|222135 pfam13445, zf-RING_LisH, RING-type zinc-finger, LisH dimerisation motif | Back alignment and domain information |
|---|
Score = 36.5 bits (85), Expect = 0.002
Identities = 15/50 (30%), Positives = 23/50 (46%), Gaps = 4/50 (8%)
Query: 612 VAEERPVPSFFLCPILQEIMHD----PQVAADGFTYEGKAIRDWLENGRE 657
+ S F+CPI +E+M D P + G Y KA+ +NG +
Sbjct: 1 LPYAHHFHSIFVCPISKEVMTDEENPPVMLPCGHVYSRKALEKLAKNGGK 50
|
This zinc-finger is the dimerisation motif for LisH proteins, and is also a typical RING-type of plant ubiquitin ligases. Length = 55 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.002
Identities = 57/220 (25%), Positives = 95/220 (43%), Gaps = 36/220 (16%)
Query: 346 ESFKVGQGGFGCVYKGEMLG----RTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVT 401
E KVG+G +G VYK + + A+K + + + +E+ +L +L+HP+++
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS--MSACREIALLRELKHPNVIA 62
Query: 402 L----LGACPEAWSLVYEYLPNGSLQDRLFR---KSNVSPLLWKDRARIAA---EIASGL 451
L L L+++Y + F K+N P+ R+ + + +I G+
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLP-RSMVKSLLYQILDGI 121
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSS----KICDFGICRLVTEDTLYLPSFHRSTAP 507
+LH++ ++H DLKP NIL+ E KI D G RL L
Sbjct: 122 HYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV- 177
Query: 508 KGSFPYADPEY-----HRTGVLTPKSDSYSFGLIILQLLT 542
+F Y PE H T + D ++ G I +LLT
Sbjct: 178 --TFWYRAPELLLGARHYTKAI----DIWAIGCIFAELLT 211
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|100796 PRK01156, PRK01156, chromosome segregation protein; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 16/119 (13%), Positives = 48/119 (40%), Gaps = 4/119 (3%)
Query: 175 KAEELRNSAFAEFLRRKKLESEAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQDQEK 234
K L+ + +++++K + I +++ +E Y K E + + +
Sbjct: 330 KLSVLQ-KDYNDYIKKKSRYDDLNNQILELEGYEMDY---NSYLKSIESLKKKIEEYSKN 385
Query: 235 LKQEKAFVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRR 293
+++ AF+++ L + + E N + + + ++ + I L++ + R
Sbjct: 386 IERMSAFISEILKIQEIDPDAIKKELNEINVKLQDISSKVSSLNQRIRALRENLDELSR 444
|
Length = 895 |
| >gnl|CDD|224117 COG1196, Smc, Chromosome segregation ATPases [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 0.003
Identities = 32/159 (20%), Positives = 62/159 (38%), Gaps = 5/159 (3%)
Query: 138 RSSSAGSGYMSEKRESTDSDSKVEE-----DPLYVQHREVSIKAEELRNSAFAEFLRRKK 192
+ + + E S++EE + L + E+ + EEL + K
Sbjct: 717 QLEELKRELAALEEELEQLQSRLEELEEELEELEEELEELQERLEELEEELESLEEALAK 776
Query: 193 LESEAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQDQEKLKQEKAFVTQELHRTMRN 252
L+ E E K +A + +EAE L ++ E L+Q + + QE+
Sbjct: 777 LKEEIEELEEKRQALQEELEELEEELEEAERRLDALERELESLEQRRERLEQEIEELEEE 836
Query: 253 VALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRI 291
+ L + E +E EL+ ++ + L+ EK+ +
Sbjct: 837 IEELEEKLDELEEELEELEKELEELKEELEELEAEKEEL 875
|
Length = 1163 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 30/137 (21%), Positives = 57/137 (41%), Gaps = 16/137 (11%)
Query: 413 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNI 472
+Y ++ + + + PLL + R I ++ + ++H +K++H D+K +NI
Sbjct: 249 LYSFMYDEAFDWK------DRPLLKQTR-AIMKQLLCAVEYIHD---KKLIHRDIKLENI 298
Query: 473 LLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYS 532
L+ + + DFG T G+ PE +D +S
Sbjct: 299 FLNCDGKIVLGDFG-----TAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWS 353
Query: 533 FGLIILQLLTGRL-PVG 548
GLI+L +L+ P+G
Sbjct: 354 CGLILLDMLSHDFCPIG 370
|
Length = 501 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 33/128 (25%), Positives = 51/128 (39%), Gaps = 27/128 (21%)
Query: 434 PLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS------------- 480
P + A+I + L + H+ ++H DLKP+NIL+++ +
Sbjct: 227 PFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284
Query: 481 ---KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLII 537
+ICD G C H TA + Y PE +D +S G II
Sbjct: 285 CRVRICDLGGC---------CDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCII 335
Query: 538 LQLLTGRL 545
+L TG+L
Sbjct: 336 YELYTGKL 343
|
Length = 467 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 688 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.98 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.96 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.96 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.96 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.96 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.96 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.95 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.95 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.94 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.94 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.94 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.93 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.92 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.91 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.89 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.86 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.83 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.82 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.82 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.81 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.8 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.75 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.75 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.71 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.71 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.69 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.69 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.69 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.69 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.68 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.68 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.54 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.48 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.4 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.39 | |
| PF04564 | 73 | U-box: U-box domain; InterPro: IPR003613 Quality c | 99.32 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.22 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.18 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.16 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.16 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.13 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.08 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.06 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.06 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.0 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.93 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.91 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.75 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.7 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.62 | |
| smart00504 | 63 | Ubox Modified RING finger domain. Modified RING fi | 98.5 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.45 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.44 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.42 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.39 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.36 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.28 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.24 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.22 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.16 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.14 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.07 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 97.99 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 97.96 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.94 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.85 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.81 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.77 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.69 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.69 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.68 | |
| KOG4642 | 284 | consensus Chaperone-dependent E3 ubiquitin protein | 97.59 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.55 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.55 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.42 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.41 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.4 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.32 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.24 | |
| PLN02236 | 344 | choline kinase | 97.01 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.87 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.72 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.7 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.63 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 96.44 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.42 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.38 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.37 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.34 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.27 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.18 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.0 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.99 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.69 | |
| KOG1029 | 1118 | consensus Endocytic adaptor protein intersectin [S | 95.59 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.38 | |
| PF04655 | 253 | APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r | 95.03 | |
| KOG1029 | 1118 | consensus Endocytic adaptor protein intersectin [S | 94.97 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.84 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-54 Score=465.54 Aligned_cols=274 Identities=47% Similarity=0.790 Sum_probs=241.5
Q ss_pred CCcccCHHHHHHHhcCcccceeeeccCceEEEEEEEC-CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEeccc
Q 005617 328 ESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406 (688)
Q Consensus 328 ~~~~~~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~-g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~ 406 (688)
....|++.+|..||++|+..+.||+||||.||+|.+. |..||||++.........+|.+|+.+|++++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 4677999999999999999999999999999999998 489999988766544245599999999999999999999999
Q ss_pred CC--C-ceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEe
Q 005617 407 PE--A-WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKIC 483 (688)
Q Consensus 407 ~~--~-~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLs 483 (688)
.+ . .+||||||++|+|.++|+..... +++|..|++|+.++|+||.|||..++++||||||||+|||||.++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 53 2 79999999999999999987654 89999999999999999999999998899999999999999999999999
Q ss_pred ecCccccccC-CCCcCCCccccCCC-CCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCC---------Chhh
Q 005617 484 DFGICRLVTE-DTLYLPSFHRSTAP-KGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVG---------LAGE 552 (688)
Q Consensus 484 DFGla~~~~~-~~~~~~~~~~~~~~-~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~---------~~~~ 552 (688)
|||+|+..+. .... ... .||.+|+||||+..+.++.|+|||||||+|+||+||+.|.. ...|
T Consensus 220 DFGLa~~~~~~~~~~-------~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w 292 (361)
T KOG1187|consen 220 DFGLAKLGPEGDTSV-------STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEW 292 (361)
T ss_pred CccCcccCCccccce-------eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHH
Confidence 9999977654 2211 111 89999999999999999999999999999999999998875 3456
Q ss_pred HHHHhhcCccccccCCCC--CCCCH-HHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHh
Q 005617 553 VRRAVSCGKLSSILDPLA--GDWPT-FVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 553 ~~~~~~~g~l~~~ld~~~--~~~~~-~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l 610 (688)
++..+..+.+.+++||.. +.++. .....+..++.+|++.+|.+||+|. .|++.|+.+
T Consensus 293 ~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~-~Vv~~L~~~ 352 (361)
T KOG1187|consen 293 AKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMS-QVVKELEGI 352 (361)
T ss_pred HHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHH-HHHHHHHhh
Confidence 677888899999999985 45664 6788899999999999999999999 567777554
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-46 Score=401.46 Aligned_cols=248 Identities=37% Similarity=0.600 Sum_probs=208.7
Q ss_pred eeeeccCceEEEEEEECCeE-EEEEEEecCCccc--hHHHHHHHHHHHcCCCCceeeEecccCCC---ceeEEecCCCCc
Q 005617 348 FKVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQG--QLEFQQEVRVLSKLQHPHLVTLLGACPEA---WSLVYEYLPNGS 421 (688)
Q Consensus 348 ~~LG~G~fG~Vykg~~~g~~-vAIK~l~~~~~~~--~~~f~~E~~iL~~l~HpnIV~l~g~~~~~---~~LV~E~~~~gs 421 (688)
..||.|+||+||+|.+.|.. ||||++....... ...|.+|+.+|.+++|||||+++|+|.+. .+||||||++|+
T Consensus 47 ~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~Gs 126 (362)
T KOG0192|consen 47 EVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGS 126 (362)
T ss_pred hhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCc
Confidence 45999999999999999988 9999998654433 45899999999999999999999999664 689999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCC-CeEEeecCccccccCCCCcCCC
Q 005617 422 LQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL-SSKICDFGICRLVTEDTLYLPS 500 (688)
Q Consensus 422 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~-~vKLsDFGla~~~~~~~~~~~~ 500 (688)
|.++|+.. ....+++..+++|+.+||+|+.|||+.++ ||||||||+||||+.++ ++||+|||+++......
T Consensus 127 L~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~----- 198 (362)
T KOG0192|consen 127 LSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK----- 198 (362)
T ss_pred HHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc-----
Confidence 99999885 33679999999999999999999999774 99999999999999998 99999999998775432
Q ss_pred ccccCCCCCCCCCCChhhhc--cCCCCCcchHhHHHHHHHHHHhCCCCCCChhhH--HHHhhcCccccccCCCCCCCCHH
Q 005617 501 FHRSTAPKGSFPYADPEYHR--TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGDWPTF 576 (688)
Q Consensus 501 ~~~~~~~~GT~~Y~APE~~~--~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~~~~g~l~~~ld~~~~~~~~~ 576 (688)
...+...||+.|||||++. ...|+.|+|||||||+||||+||+.||.....+ ...+..+.. ....|..
T Consensus 199 -~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~-------Rp~~p~~ 270 (362)
T KOG0192|consen 199 -TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGL-------RPPIPKE 270 (362)
T ss_pred -ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCC-------CCCCCcc
Confidence 1234478999999999999 669999999999999999999999999866542 222222211 1123333
Q ss_pred HHHHHHHHHHHccccCCCCCCCCchHHHHHHHHhhh
Q 005617 577 VARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 577 ~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l~~ 612 (688)
....+..|+.+||+.||..||++. +++..|+.+..
T Consensus 271 ~~~~l~~l~~~CW~~dp~~RP~f~-ei~~~l~~~~~ 305 (362)
T KOG0192|consen 271 CPPHLSSLMERCWLVDPSRRPSFL-EIVSRLESIMS 305 (362)
T ss_pred CCHHHHHHHHHhCCCCCCcCCCHH-HHHHHHHHHHH
Confidence 667899999999999999999999 78888887644
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=373.58 Aligned_cols=245 Identities=30% Similarity=0.420 Sum_probs=204.7
Q ss_pred cCHHHHHHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC-ccchHHHHHHHHHHHcCCCCceeeEecccC-
Q 005617 332 FSLADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACP- 407 (688)
Q Consensus 332 ~~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~-~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~- 407 (688)
+++.||+.. ..||+|..|+||++++. +..+|+|++.... ...+.++.+|++++...+|||||.+||+|.
T Consensus 76 i~~~dle~~-------~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~ 148 (364)
T KOG0581|consen 76 ISLSDLERL-------GVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYS 148 (364)
T ss_pred cCHHHhhhh-------hhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEe
Confidence 455565544 56999999999999997 8899999995443 345668999999999999999999999994
Q ss_pred -C-CceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeec
Q 005617 408 -E-AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDF 485 (688)
Q Consensus 408 -~-~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDF 485 (688)
. ...|+||||++|||++++... +.+++....+|+.+|++||.|||.. ..||||||||+|||++..|.+|||||
T Consensus 149 ~~~~isI~mEYMDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDF 223 (364)
T KOG0581|consen 149 NGEEISICMEYMDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDF 223 (364)
T ss_pred CCceEEeehhhcCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccc
Confidence 3 378999999999999999765 4588999999999999999999963 24999999999999999999999999
Q ss_pred CccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCCh-----hh--HHHHhh
Q 005617 486 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLA-----GE--VRRAVS 558 (688)
Q Consensus 486 Gla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~-----~~--~~~~~~ 558 (688)
|.++.+.+.. ..+.+||..|||||.+.+..|+.++||||||++++||.+|+.||... .+ ...++.
T Consensus 224 GVS~~lvnS~--------a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv 295 (364)
T KOG0581|consen 224 GVSGILVNSI--------ANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV 295 (364)
T ss_pred cccHHhhhhh--------cccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh
Confidence 9999876542 35778999999999999999999999999999999999999999753 11 223333
Q ss_pred cCccccccCCCCCCCCHH-HHHHHHHHHHHccccCCCCCCCCchHHH
Q 005617 559 CGKLSSILDPLAGDWPTF-VARRLVDLGLQCCELYGRERPDITPSLV 604 (688)
Q Consensus 559 ~g~l~~~ld~~~~~~~~~-~~~~l~~L~~~Cl~~dP~~RPs~~~~l~ 604 (688)
.+ .....|.. ++.++..++..||+.||.+||++.+.+.
T Consensus 296 ~~--------ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 296 DE--------PPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred cC--------CCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 22 22334443 7889999999999999999999985443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=389.22 Aligned_cols=246 Identities=26% Similarity=0.388 Sum_probs=212.9
Q ss_pred cCcccceeeeccCceEEEEEEE-C-CeEEEEEEEecCCcc---chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEM-L-GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~-~-g~~vAIK~l~~~~~~---~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
..|...+.||+|||+.||.++. . |..||+|++.+.... ....+.+|++|.+.|+|||||+++++|.+ +.|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688899999999999999988 3 999999999876443 34568899999999999999999999976 589999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
|+|++|+|..++... .++++.++..++.||+.||.|||+.+ |||||||..|+||+++.++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~Krr---k~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR---KPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHHhc---CCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 999999999998743 57999999999999999999999976 999999999999999999999999999988754
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCCh--hhHHHHhhcCccccccCCCCCC
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLA--GEVRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 495 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~--~~~~~~~~~g~l~~~ld~~~~~ 572 (688)
. .+..+.+|||.|+|||++....++..+||||+|||||.||+|++||... .+....+..... .
T Consensus 172 ~------Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y---------~ 236 (592)
T KOG0575|consen 172 G------ERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY---------S 236 (592)
T ss_pred c------cccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc---------c
Confidence 3 2457889999999999999999999999999999999999999999743 344455544432 3
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHH
Q 005617 573 WPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 573 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le 608 (688)
.|...+....+|+.++|+.||.+|||+.+++.+.+=
T Consensus 237 ~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff 272 (592)
T KOG0575|consen 237 MPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFF 272 (592)
T ss_pred cccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhh
Confidence 455677889999999999999999999976655443
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=373.75 Aligned_cols=246 Identities=24% Similarity=0.284 Sum_probs=198.0
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccc---hHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG---QLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~---~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|.....||+|+||.||+++-. |..+|+|++++..+.. ...+..|.++|....+|+||+||..|++ .+||||
T Consensus 141 ~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiM 220 (550)
T KOG0605|consen 141 DDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIM 220 (550)
T ss_pred ccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEE
Confidence 56777889999999999999765 9999999999887643 4568899999999999999999999965 589999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
||++||++..+|...+ .|+...+..++.+++.|+..||..| ||||||||+|+|||..|++||+||||+.-+...
T Consensus 221 EylPGGD~mTLL~~~~---~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 221 EYLPGGDMMTLLMRKD---TLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EecCCccHHHHHHhcC---cCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhh
Confidence 9999999999998764 6888999999999999999999977 999999999999999999999999999643210
Q ss_pred C-----------------CcCCCcc------------------------ccCCCCCCCCCCChhhhccCCCCCcchHhHH
Q 005617 495 T-----------------LYLPSFH------------------------RSTAPKGSFPYADPEYHRTGVLTPKSDSYSF 533 (688)
Q Consensus 495 ~-----------------~~~~~~~------------------------~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSf 533 (688)
. ...+... .....+|||.|||||++.+..|+..||+|||
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 0 0000000 1125689999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCChh--hHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCC
Q 005617 534 GLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDI 599 (688)
Q Consensus 534 GviL~ELltG~~Pf~~~~--~~~~~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~ 599 (688)
||||||||.|.+||.... ..+..+...+.. +.. .-....+.+..+||.+||. ||..|...
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~--l~f---P~~~~~s~eA~DLI~rll~-d~~~RLG~ 436 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRET--LKF---PEEVDLSDEAKDLITRLLC-DPENRLGS 436 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh--ccC---CCcCcccHHHHHHHHHHhc-CHHHhcCc
Confidence 999999999999997543 333333322210 100 0011234788999999999 99999983
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=358.65 Aligned_cols=254 Identities=24% Similarity=0.364 Sum_probs=211.5
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc--chHHHHHHHHHHHcCCCCceeeEec-ccCC---CceeEE
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLG-ACPE---AWSLVY 414 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g-~~~~---~~~LV~ 414 (688)
+|.+..+||+|.||+||+++.. |..||.|.++...+. .......|+.+|++|+|||||++|+ .|.+ -.+|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 3556678999999999999764 899999999866554 3446889999999999999999999 4533 278999
Q ss_pred ecCCCCcHHHHhccc-CCCCCCCHHHHHHHHHHHHHHHHHHhccCCC-ceEeCCCCCCceeeCCCCCeEEeecCcccccc
Q 005617 415 EYLPNGSLQDRLFRK-SNVSPLLWKDRARIAAEIASGLCFLHSSKPE-KIVHGDLKPQNILLDSELSSKICDFGICRLVT 492 (688)
Q Consensus 415 E~~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~-~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~ 492 (688)
|||..|+|...+... .....+++..+++++.|+|.||..+|+.-+. .|+||||||.||+|+.+|.+||+|||+++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 999999999988654 3346789999999999999999999995432 49999999999999999999999999999987
Q ss_pred CCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh--hHHHHhhcCccccccCCCC
Q 005617 493 EDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 493 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~--~~~~~~~~g~l~~~ld~~~ 570 (688)
.... ...+.+|||.||+||.+...+|++|+||||+||++|||+.-++||.+.. .....+..|.+..+
T Consensus 180 s~~t------fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~----- 248 (375)
T KOG0591|consen 180 SKTT------FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPL----- 248 (375)
T ss_pred chhH------HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCC-----
Confidence 6543 3467899999999999999999999999999999999999999997653 34455666654322
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHH
Q 005617 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 571 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~ 609 (688)
+....+..+..|+..|+..||..||+....+.+....
T Consensus 249 --p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~~~ 285 (375)
T KOG0591|consen 249 --PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQSE 285 (375)
T ss_pred --cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHHHH
Confidence 1256788999999999999999999976555554443
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-44 Score=372.38 Aligned_cols=246 Identities=25% Similarity=0.350 Sum_probs=203.2
Q ss_pred HhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc-------chHHHHHHHHHHHcCCCCceeeEecccC--C
Q 005617 340 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-------GQLEFQQEVRVLSKLQHPHLVTLLGACP--E 408 (688)
Q Consensus 340 at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~-------~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~ 408 (688)
..+.|...+.||+|+||.|-+|... |+.||||++++.... ....+.+|++||.+|+|||||+++++|. +
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 3456677899999999999999775 999999999875332 2234679999999999999999999994 4
Q ss_pred CceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCC---CCeEEeec
Q 005617 409 AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE---LSSKICDF 485 (688)
Q Consensus 409 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~---~~vKLsDF 485 (688)
..|||||||.||.|.+.+.... .+....-.-++.|++.|+.|||+.| |+||||||+||||..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk---~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANK---YLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHhcc---ccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 5799999999999999997664 3455666779999999999999976 9999999999999776 78999999
Q ss_pred CccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCC--C-CcchHhHHHHHHHHHHhCCCCCCCh---hhHHHHhhc
Q 005617 486 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVL--T-PKSDSYSFGLIILQLLTGRLPVGLA---GEVRRAVSC 559 (688)
Q Consensus 486 Gla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~--s-~ksDVwSfGviL~ELltG~~Pf~~~---~~~~~~~~~ 559 (688)
|+|+...... ...+.+|||.|.|||++.+..+ . .++|+||+|||||-+|+|.+||... ......+..
T Consensus 324 GlAK~~g~~s-------fm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~ 396 (475)
T KOG0615|consen 324 GLAKVSGEGS-------FMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK 396 (475)
T ss_pred chhhccccce-------ehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc
Confidence 9999886443 4578899999999999977653 3 4889999999999999999999732 225667777
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 560 GKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 560 g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
|++... ......++.+..+|+.+||..||+.||++.+.+
T Consensus 397 G~y~f~-----p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL 435 (475)
T KOG0615|consen 397 GRYAFG-----PLQWDRISEEALDLINWMLVVDPENRPSADEAL 435 (475)
T ss_pred Cccccc-----ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHh
Confidence 776432 122346788999999999999999999998443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=365.72 Aligned_cols=240 Identities=31% Similarity=0.448 Sum_probs=194.3
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecC--CccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEe
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSH--NMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYE 415 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~--~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E 415 (688)
.+|.....||.|+||+||+|++. +..||||.+.+. ....++-+..|+.+|+.++|||||.|++++. +..+||||
T Consensus 10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVME 89 (429)
T KOG0595|consen 10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVME 89 (429)
T ss_pred ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEE
Confidence 57888888999999999999986 889999999776 3445566889999999999999999999984 46889999
Q ss_pred cCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCC------CCeEEeecCccc
Q 005617 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE------LSSKICDFGICR 489 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~------~~vKLsDFGla~ 489 (688)
||.||+|.+++...+ .++...+..++.|+|.||.+||+.+ ||||||||.||||+.. -.+||+|||+|+
T Consensus 90 yC~gGDLs~yi~~~~---~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR 163 (429)
T KOG0595|consen 90 YCNGGDLSDYIRRRG---RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR 163 (429)
T ss_pred eCCCCCHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence 999999999998765 5888999999999999999999976 9999999999999865 458999999999
Q ss_pred cccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh--hHHHHhhcCccccccC
Q 005617 490 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSILD 567 (688)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~--~~~~~~~~g~l~~~ld 567 (688)
.+.++. ...+.+|+|-|||||++...+|+-|+|+||+|+|||+|++|++||.... +....++.++-.-
T Consensus 164 ~L~~~~-------~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~--- 233 (429)
T KOG0595|consen 164 FLQPGS-------MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIV--- 233 (429)
T ss_pred hCCchh-------HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcccccc---
Confidence 987654 2357799999999999999999999999999999999999999997433 3333343332111
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCCc
Q 005617 568 PLAGDWPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 568 ~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~ 600 (688)
...+...+..+.+|....+..+|.+|-+..
T Consensus 234 ---~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~ 263 (429)
T KOG0595|consen 234 ---PVLPAELSNPLRELLISLLQRNPKDRISFE 263 (429)
T ss_pred ---CchhhhccCchhhhhhHHHhcCccccCchH
Confidence 112223333444555556666666665544
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=364.15 Aligned_cols=238 Identities=29% Similarity=0.393 Sum_probs=204.0
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHcCCCCceeeEecccCC--CceeE
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLV 413 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~---~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV 413 (688)
-.+|...+.||+|+||.||.++.. ++.+|+|++++.... ......+|..||..++||+||+++..|++ .+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 367889999999999999999775 889999999887553 34568899999999999999999999965 58999
Q ss_pred EecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccC
Q 005617 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~ 493 (688)
++|+.||.|..+|.+.. .+++..+..++.+|+.||.|||+.+ ||||||||+|||||.+|+++|+|||+++....
T Consensus 104 ld~~~GGeLf~hL~~eg---~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG---RFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHHhcC---CcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999998664 4777888899999999999999966 99999999999999999999999999997654
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh--hHHHHhhcCccccccCCCCC
Q 005617 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSILDPLAG 571 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~--~~~~~~~~g~l~~~ld~~~~ 571 (688)
... .+.+.+||+.|||||++....|+..+|+|||||++|||+||.+||...+ .+...+..+++.
T Consensus 178 ~~~------~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~-------- 243 (357)
T KOG0598|consen 178 DGD------ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLP-------- 243 (357)
T ss_pred CCC------ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCC--------
Confidence 432 3456899999999999999999999999999999999999999997544 344555555422
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC
Q 005617 572 DWPTFVARRLVDLGLQCCELYGRERPD 598 (688)
Q Consensus 572 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs 598 (688)
..|...+....+|+...+..||.+|-.
T Consensus 244 ~~p~~ls~~ardll~~LL~rdp~~RLg 270 (357)
T KOG0598|consen 244 LPPGYLSEEARDLLKKLLKRDPRQRLG 270 (357)
T ss_pred CCCccCCHHHHHHHHHHhccCHHHhcC
Confidence 233345678899999999999999974
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-43 Score=376.35 Aligned_cols=249 Identities=33% Similarity=0.515 Sum_probs=209.4
Q ss_pred ccceeeeccCceEEEEEEECCe-EEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecCCCCc
Q 005617 345 SESFKVGQGGFGCVYKGEMLGR-TVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGS 421 (688)
Q Consensus 345 ~~~~~LG~G~fG~Vykg~~~g~-~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gs 421 (688)
...+.||+|-||.||.|.++|. .||+|.++...+ ....|.+|+.+|.+|+|+|||+|+|+|.. ..+||||||+.|+
T Consensus 209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m-~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~Gs 287 (468)
T KOG0197|consen 209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSM-SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGS 287 (468)
T ss_pred HHHHHhcCCccceEEEEEEcCCCcccceEEecccc-ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCc
Confidence 3446799999999999999976 899999987643 34578899999999999999999999954 4799999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCCc
Q 005617 422 LQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 501 (688)
Q Consensus 422 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~~ 501 (688)
|.++|... ....+...+.+.++.|||+|++||++.+ +|||||-..||||+++..+||+|||||+...++...
T Consensus 288 Ll~yLr~~-~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~---- 359 (468)
T KOG0197|consen 288 LLDYLRTR-EGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT---- 359 (468)
T ss_pred HHHHhhhc-CCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCcee----
Confidence 99999873 3356788999999999999999999976 999999999999999999999999999955443321
Q ss_pred cccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--hHHHHhhcCccccccCCCCCCCCHHHH
Q 005617 502 HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLAGDWPTFVA 578 (688)
Q Consensus 502 ~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~~~~g~l~~~ld~~~~~~~~~~~ 578 (688)
......-..-|.|||.+..+.++.|||||||||+||||+| |+.||.... ++...+..|... ..|..++
T Consensus 360 -~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRl--------p~P~~CP 430 (468)
T KOG0197|consen 360 -ASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRL--------PRPEGCP 430 (468)
T ss_pred -ecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcC--------CCCCCCC
Confidence 2233334557999999999999999999999999999999 999987544 456667666432 3455677
Q ss_pred HHHHHHHHHccccCCCCCCCCchHHHHHHHHhhh
Q 005617 579 RRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 579 ~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l~~ 612 (688)
..+.+|+..||+.+|++|||+. .+...|+.+..
T Consensus 431 ~~vY~lM~~CW~~~P~~RPtF~-~L~~~l~~~~~ 463 (468)
T KOG0197|consen 431 DEVYELMKSCWHEDPEDRPTFE-TLREVLEDFFT 463 (468)
T ss_pred HHHHHHHHHHhhCCcccCCCHH-HHHHHHHHhhh
Confidence 8899999999999999999998 77777776543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=338.57 Aligned_cols=230 Identities=29% Similarity=0.410 Sum_probs=203.2
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEe
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~---~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E 415 (688)
+|.....||.|+||.|.+++.. |..+|+|++.+.... ..+...+|..+|+.+.||++|+|++.|.+ ..+||||
T Consensus 45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme 124 (355)
T KOG0616|consen 45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME 124 (355)
T ss_pred hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence 4666688999999999999886 889999999877543 34468899999999999999999999865 4889999
Q ss_pred cCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCC
Q 005617 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~ 495 (688)
|++||.|..+|.+.+ .++.+.+..++.+|+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+.+...
T Consensus 125 yv~GGElFS~Lrk~~---rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 125 YVPGGELFSYLRKSG---RFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred ccCCccHHHHHHhcC---CCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 999999999998765 5788999999999999999999976 999999999999999999999999999988653
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh--hHHHHhhcCccccccCCCCCCC
Q 005617 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 496 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~--~~~~~~~~g~l~~~ld~~~~~~ 573 (688)
+.+.+|||.|+|||++....|+..+|+|||||++|||+.|.+||.... .+...+..|++ .+
T Consensus 198 --------T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v---------~f 260 (355)
T KOG0616|consen 198 --------TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV---------KF 260 (355)
T ss_pred --------EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc---------cC
Confidence 457799999999999999999999999999999999999999997544 34555666654 56
Q ss_pred CHHHHHHHHHHHHHccccCCCCC
Q 005617 574 PTFVARRLVDLGLQCCELYGRER 596 (688)
Q Consensus 574 ~~~~~~~l~~L~~~Cl~~dP~~R 596 (688)
|...+..+.+|+...++.|-.+|
T Consensus 261 P~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 261 PSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred CcccCHHHHHHHHHHHhhhhHhh
Confidence 77788899999999999999888
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=362.98 Aligned_cols=246 Identities=28% Similarity=0.389 Sum_probs=207.1
Q ss_pred HhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcC-CCCceeeEecccCC--Cce
Q 005617 340 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWS 411 (688)
Q Consensus 340 at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~~~ 411 (688)
.-++|.+++.||.|+|++||+|+.. ++.||||++.+... .....+..|-.+|.+| .||.||+||..|.+ .+|
T Consensus 71 ~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLY 150 (604)
T KOG0592|consen 71 TPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLY 150 (604)
T ss_pred ChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceE
Confidence 3468899999999999999999875 89999999976543 2334577899999999 89999999999976 489
Q ss_pred eEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccc
Q 005617 412 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~ 491 (688)
+|+||+++|+|.++|.+.+ .|+......++.+|+.||+|||+.| ||||||||+|||||.+|++||+|||.|+.+
T Consensus 151 FvLe~A~nGdll~~i~K~G---sfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l 224 (604)
T KOG0592|consen 151 FVLEYAPNGDLLDLIKKYG---SFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKIL 224 (604)
T ss_pred EEEEecCCCcHHHHHHHhC---cchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccC
Confidence 9999999999999998764 5788888999999999999999977 999999999999999999999999999998
Q ss_pred cCCCCc-----CCCc--cccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHH--HHhhcCcc
Q 005617 492 TEDTLY-----LPSF--HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKL 562 (688)
Q Consensus 492 ~~~~~~-----~~~~--~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~--~~~~~g~l 562 (688)
++.... .+.. .....++||..|++||++..+..++.+|+|+||||||+||.|++||....+.. +.+..
T Consensus 225 ~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~--- 301 (604)
T KOG0592|consen 225 SPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQA--- 301 (604)
T ss_pred ChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHH---
Confidence 754322 1111 11256899999999999999999999999999999999999999998665421 21111
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCc
Q 005617 563 SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 563 ~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~ 600 (688)
..-+||...++.+.+|+.+.|..||.+|++..
T Consensus 302 ------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~ 333 (604)
T KOG0592|consen 302 ------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQ 333 (604)
T ss_pred ------hcccCCCCCCHHHHHHHHHHHccCccccccHH
Confidence 12356677778999999999999999999986
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=345.40 Aligned_cols=257 Identities=18% Similarity=0.261 Sum_probs=207.8
Q ss_pred CCcccCHHHHHHHhcCcccceeeeccCceEEEEEEECCeEEEEEEEecCCccc---hHHHHHHHHHHHcCCCCceeeEec
Q 005617 328 ESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQG---QLEFQQEVRVLSKLQHPHLVTLLG 404 (688)
Q Consensus 328 ~~~~~~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~g~~vAIK~l~~~~~~~---~~~f~~E~~iL~~l~HpnIV~l~g 404 (688)
....++.++| ++.....||+|++|.||+|.+.|..||||++....... ...|.+|+.+|.+++|||||+++|
T Consensus 11 ~~~~i~~~~i-----~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g 85 (283)
T PHA02988 11 DIKCIESDDI-----DKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYG 85 (283)
T ss_pred cceecCHHHc-----CCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEee
Confidence 3455666676 33334689999999999999999999999997654433 356889999999999999999999
Q ss_pred ccCC------CceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCC
Q 005617 405 ACPE------AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL 478 (688)
Q Consensus 405 ~~~~------~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~ 478 (688)
+|.+ ..++||||+++|+|.+++... ..++|...+.++.+++.||.|||... +++||||||+|||++.++
T Consensus 86 ~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrdlkp~nill~~~~ 160 (283)
T PHA02988 86 FIIDIVDDLPRLSLILEYCTRGYLREVLDKE---KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKNLTSVSFLVTENY 160 (283)
T ss_pred eEEecccCCCceEEEEEeCCCCcHHHHHhhC---CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCcCChhhEEECCCC
Confidence 9854 367999999999999999764 35889999999999999999999842 378999999999999999
Q ss_pred CeEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhcc--CCCCCcchHhHHHHHHHHHHhCCCCCCChh--hHH
Q 005617 479 SSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT--GVLTPKSDSYSFGLIILQLLTGRLPVGLAG--EVR 554 (688)
Q Consensus 479 ~vKLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDVwSfGviL~ELltG~~Pf~~~~--~~~ 554 (688)
.+||+|||+++...... ....||+.|+|||++.+ ..++.++|||||||++|||+||+.||.... .+.
T Consensus 161 ~~kl~dfg~~~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~ 231 (283)
T PHA02988 161 KLKIICHGLEKILSSPP---------FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY 231 (283)
T ss_pred cEEEcccchHhhhcccc---------ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 99999999998764322 23468999999999876 689999999999999999999999997543 223
Q ss_pred HHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHhh
Q 005617 555 RAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 555 ~~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l~ 611 (688)
..+..+.... ..+...+..+.+|+.+||+.||.+||++. +++..|+.+.
T Consensus 232 ~~i~~~~~~~-------~~~~~~~~~l~~li~~cl~~dp~~Rps~~-ell~~l~~~~ 280 (283)
T PHA02988 232 DLIINKNNSL-------KLPLDCPLEIKCIVEACTSHDSIKRPNIK-EILYNLSLYK 280 (283)
T ss_pred HHHHhcCCCC-------CCCCcCcHHHHHHHHHHhcCCcccCcCHH-HHHHHHHHHH
Confidence 3332221111 12223466899999999999999999998 7888887764
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=356.36 Aligned_cols=255 Identities=29% Similarity=0.458 Sum_probs=203.3
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCc-cchHHHHHHHHHHHcC-CCCceeeEecccCC--
Q 005617 340 ATCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE-- 408 (688)
Q Consensus 340 at~~f~~~~~LG~G~fG~Vykg~~~-------g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~-- 408 (688)
..++|...+.||+|+||.||+|.+. +..||||++..... .....+.+|+.++..+ +|||||+++|+|..
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~ 84 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPN 84 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCC
Confidence 3467888899999999999999752 46799999975433 2345689999999999 89999999998853
Q ss_pred -CceeEEecCCCCcHHHHhcccCC--------------------------------------------------------
Q 005617 409 -AWSLVYEYLPNGSLQDRLFRKSN-------------------------------------------------------- 431 (688)
Q Consensus 409 -~~~LV~E~~~~gsL~~~L~~~~~-------------------------------------------------------- 431 (688)
..++||||+++|+|.+++.....
T Consensus 85 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (338)
T cd05102 85 GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETD 164 (338)
T ss_pred CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhcc
Confidence 36899999999999998865321
Q ss_pred ---CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCCccccCCCC
Q 005617 432 ---VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK 508 (688)
Q Consensus 432 ---~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~~~~~ 508 (688)
..++++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++........ .......
T Consensus 165 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~----~~~~~~~ 237 (338)
T cd05102 165 DLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY----VRKGSAR 237 (338)
T ss_pred ccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcch----hcccCCC
Confidence 135888999999999999999999965 999999999999999999999999999876433211 1223445
Q ss_pred CCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh---hHHHHhhcCccccccCCCCCCCCHHHHHHHHHH
Q 005617 509 GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG---EVRRAVSCGKLSSILDPLAGDWPTFVARRLVDL 584 (688)
Q Consensus 509 GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~---~~~~~~~~g~l~~~ld~~~~~~~~~~~~~l~~L 584 (688)
+++.|+|||++.+..++.++|||||||+||||++ |..||.... .....+..+... ..+...+..+.+|
T Consensus 238 ~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~l~~l 309 (338)
T cd05102 238 LPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM--------RAPENATPEIYRI 309 (338)
T ss_pred CCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC--------CCCCCCCHHHHHH
Confidence 6789999999999999999999999999999997 999997532 222333333211 1123345678999
Q ss_pred HHHccccCCCCCCCCchHHHHHHHHh
Q 005617 585 GLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 585 ~~~Cl~~dP~~RPs~~~~l~~~Le~l 610 (688)
+.+||+.||.+||++. ++++.|+.+
T Consensus 310 i~~cl~~dp~~RPs~~-el~~~l~~~ 334 (338)
T cd05102 310 MLACWQGDPKERPTFS-ALVEILGDL 334 (338)
T ss_pred HHHHccCChhhCcCHH-HHHHHHHHH
Confidence 9999999999999998 777888765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=348.40 Aligned_cols=253 Identities=30% Similarity=0.476 Sum_probs=204.2
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEeccc--CC--CceeEEe
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC--PE--AWSLVYE 415 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~--~~--~~~LV~E 415 (688)
.++...+.||+|+||+||++... |...|||............+.+|+.+|.+++|||||+++|.. .+ .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 45677789999999999999886 799999998766433355689999999999999999999963 34 4889999
Q ss_pred cCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCC-CCCeEEeecCccccccCC
Q 005617 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS-ELSSKICDFGICRLVTED 494 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~-~~~vKLsDFGla~~~~~~ 494 (688)
|+++|+|.+++.+.+. .|+...+..+..||+.||.|||+.+ ||||||||+||||+. +|.+||+|||+++.....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999987664 6899999999999999999999855 999999999999999 799999999999877641
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCCh-hhHHHHhhcCccccccCCCCCC
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLA-GEVRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 495 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~-~~~~~~~~~g~l~~~ld~~~~~ 572 (688)
.. .........||+.|||||++..+ ...+++|||||||+++||+||++||... ......+..+.-. ....
T Consensus 172 ~~---~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~-----~~P~ 243 (313)
T KOG0198|consen 172 GT---KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED-----SLPE 243 (313)
T ss_pred cc---cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC-----CCCC
Confidence 11 11224567899999999999864 3446999999999999999999999762 2222222222111 1225
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHH
Q 005617 573 WPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 573 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~L 607 (688)
+|...+....+++.+|+..+|..|||+.+.+.+.+
T Consensus 244 ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf 278 (313)
T KOG0198|consen 244 IPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPF 278 (313)
T ss_pred CCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChh
Confidence 66678889999999999999999999996554433
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=355.91 Aligned_cols=244 Identities=27% Similarity=0.423 Sum_probs=207.4
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEeccc--CCCceeEEecCC
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLP 418 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~--~~~~~LV~E~~~ 418 (688)
.|....+||+|+.|.||.+... +..||||++........+-+.+|+.+|+..+|+|||.++..| .+.+++|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 3455578999999999999775 788999999887777777789999999999999999999887 467999999999
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcC
Q 005617 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~ 498 (688)
||+|.+.+... .+++.++..|+.+++.||.|||..+ |||||||.+||||+.+|.+||+|||+|..+.....
T Consensus 354 ggsLTDvVt~~----~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-- 424 (550)
T KOG0578|consen 354 GGSLTDVVTKT----RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-- 424 (550)
T ss_pred CCchhhhhhcc----cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC--
Confidence 99999998653 4889999999999999999999966 99999999999999999999999999998865542
Q ss_pred CCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHH--HhhcCccccccCCCCCCCCHH
Q 005617 499 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR--AVSCGKLSSILDPLAGDWPTF 576 (688)
Q Consensus 499 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~--~~~~g~l~~~ld~~~~~~~~~ 576 (688)
.....+|||.|||||+.....|++|+||||||++++||+-|.+||-....++. .+......+ -..+..
T Consensus 425 ----KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~------lk~~~k 494 (550)
T KOG0578|consen 425 ----KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPK------LKNPEK 494 (550)
T ss_pred ----ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCC------cCCccc
Confidence 45778999999999999999999999999999999999999999965443322 222222111 134556
Q ss_pred HHHHHHHHHHHccccCCCCCCCCchHHHH
Q 005617 577 VARRLVDLGLQCCELYGRERPDITPSLVK 605 (688)
Q Consensus 577 ~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~ 605 (688)
.+..|.+++.+||+.|+.+||++.+.|.+
T Consensus 495 lS~~~kdFL~~cL~~dv~~RasA~eLL~H 523 (550)
T KOG0578|consen 495 LSPELKDFLDRCLVVDVEQRASAKELLEH 523 (550)
T ss_pred cCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence 78899999999999999999999955533
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=358.13 Aligned_cols=261 Identities=29% Similarity=0.475 Sum_probs=205.3
Q ss_pred HHHHHHhcCcccceeeeccCceEEEEEEECCeEEEEEEEecCCcc--chHHHHHHHHHHHcCCCCceeeEecccCC-Cce
Q 005617 335 ADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWS 411 (688)
Q Consensus 335 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~g~~vAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~ 411 (688)
.+....-+.+.....||+|.||+||+|.+.| .||||+++..... ..+.|.+|+.+|++-+|.||+-++|||-. ...
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~A 463 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPLA 463 (678)
T ss_pred cccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCcee
Confidence 3333444445566789999999999999988 4899999877654 34579999999999999999999999954 568
Q ss_pred eEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccc
Q 005617 412 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~ 491 (688)
||..||.|-+|+.+|+... ..|.....+.|+.|||.|+.|||..+ |||||||..||+|.+++.|||+||||+...
T Consensus 464 IiTqwCeGsSLY~hlHv~e--tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk 538 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQE--TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVK 538 (678)
T ss_pred eeehhccCchhhhhccchh--hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeee
Confidence 9999999999999998766 46888999999999999999999954 999999999999999999999999999765
Q ss_pred cCCCCcCCCccccCCCCCCCCCCChhhhc---cCCCCCcchHhHHHHHHHHHHhCCCCCCCh--hhHHHHhhcCcccccc
Q 005617 492 TEDTLYLPSFHRSTAPKGSFPYADPEYHR---TGVLTPKSDSYSFGLIILQLLTGRLPVGLA--GEVRRAVSCGKLSSIL 566 (688)
Q Consensus 492 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSfGviL~ELltG~~Pf~~~--~~~~~~~~~g~l~~~l 566 (688)
.... ..+......|...|||||++. ..+|++.+||||||||+|||+||..||... +.+.-++..|.+. .
T Consensus 539 ~~w~----g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~--p 612 (678)
T KOG0193|consen 539 TRWS----GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLM--P 612 (678)
T ss_pred eeec----cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccC--c
Confidence 4221 112234556888999999986 347899999999999999999999999721 2233333344221 1
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHH
Q 005617 567 DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 567 d~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~ 609 (688)
|. ..........+.+|+..||..++++||.+.+++...++.
T Consensus 613 d~--s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l 653 (678)
T KOG0193|consen 613 DL--SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEEL 653 (678)
T ss_pred cc--hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHh
Confidence 11 112234566899999999999999999999544434443
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=339.43 Aligned_cols=242 Identities=25% Similarity=0.337 Sum_probs=195.3
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEe
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E 415 (688)
.|...+.||+|+||.||+|... |..||||.+..... .....+.+|+.++..++|+||++++++|.+ ..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3677889999999999999874 88999999875432 233457899999999999999999998843 5789999
Q ss_pred cCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCC
Q 005617 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~ 495 (688)
|+++|+|..++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGN-PGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE 156 (285)
T ss_pred ecCCCcHHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC
Confidence 9999999988865432 35899999999999999999999965 9999999999999999999999999998764322
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhH--HHHhhcCccccccCCCCCCC
Q 005617 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 496 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~~~~g~l~~~ld~~~~~~ 573 (688)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+... +......+
T Consensus 157 -------~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~-----~~~~~~~~ 224 (285)
T cd05631 157 -------TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRR-----VKEDQEEY 224 (285)
T ss_pred -------eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHH-----hhcccccC
Confidence 123457999999999999999999999999999999999999999753321 1111100 00111233
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCCc
Q 005617 574 PTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 574 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~ 600 (688)
+...+..+.+|+.+||+.||.+||+..
T Consensus 225 ~~~~s~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05631 225 SEKFSEDAKSICRMLLTKNPKERLGCR 251 (285)
T ss_pred CccCCHHHHHHHHHHhhcCHHHhcCCC
Confidence 444567899999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=329.42 Aligned_cols=248 Identities=24% Similarity=0.343 Sum_probs=197.6
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEec
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 416 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~ 416 (688)
.|....++|+|+||+||+++.. |+.||||++..... .-.+-..+|+++|.+++|+|+|.|+.+|. ..++||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 4566678999999999999886 99999999976543 23345789999999999999999999994 458999999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCC
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~ 496 (688)
|+..-|.+.-... ..++...+.+++.|++.|+.|+|+++ +|||||||+||||..+|.+||||||+|+.+.....
T Consensus 83 ~dhTvL~eLe~~p---~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd 156 (396)
T KOG0593|consen 83 CDHTVLHELERYP---NGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD 156 (396)
T ss_pred cchHHHHHHHhcc---CCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCcc
Confidence 9876665543322 35788899999999999999999977 99999999999999999999999999999874322
Q ss_pred cCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhc----Ccc---------
Q 005617 497 YLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC----GKL--------- 562 (688)
Q Consensus 497 ~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~----g~l--------- 562 (688)
..+..+.|.+|.|||.+.+ ..|++.+||||+||++.||++|.+.|.+..++.+.... |.+
T Consensus 157 ------~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~ 230 (396)
T KOG0593|consen 157 ------NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFS 230 (396)
T ss_pred ------hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhc
Confidence 2367789999999998877 68999999999999999999999999877665443211 111
Q ss_pred -----ccccCCCC-------CCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 563 -----SSILDPLA-------GDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 563 -----~~~ld~~~-------~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
..+--|.. ..+| ..+.-+++|+..|++.||++|++-.+.+
T Consensus 231 ~N~~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll 282 (396)
T KOG0593|consen 231 SNPFFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLL 282 (396)
T ss_pred cCCceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHh
Confidence 11111111 1122 3455789999999999999999987544
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=356.01 Aligned_cols=234 Identities=28% Similarity=0.462 Sum_probs=197.1
Q ss_pred cceeeeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecCCCCcHH
Q 005617 346 ESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSLQ 423 (688)
Q Consensus 346 ~~~~LG~G~fG~Vykg~~~g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gsL~ 423 (688)
+...||.|+-|-||.|++.+..||||+++.-. ..+++-|++|+|||||.+.|+|.. .+|||||||+.|-|.
T Consensus 128 ELeWlGSGaQGAVF~Grl~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~ 200 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLHNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLY 200 (904)
T ss_pred hhhhhccCcccceeeeeccCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHH
Confidence 34689999999999999999999999875322 347888999999999999999965 478999999999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCCccc
Q 005617 424 DRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHR 503 (688)
Q Consensus 424 ~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~ 503 (688)
.+|.... +++-.....|..+||.|+.|||.+. |||||||+-||||..+..|||+|||.++...+.. .
T Consensus 201 ~VLka~~---~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~S-------T 267 (904)
T KOG4721|consen 201 EVLKAGR---PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKS-------T 267 (904)
T ss_pred HHHhccC---ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhh-------h
Confidence 9997654 4666778899999999999999977 9999999999999999999999999999876543 2
Q ss_pred cCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCccccccCCCCCCCCHHHHHHHHH
Q 005617 504 STAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVD 583 (688)
Q Consensus 504 ~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~l~~~ld~~~~~~~~~~~~~l~~ 583 (688)
...++||..|||||++.+.+.+.|+|||||||||||||||..||..++..--.|..|. ..+ .-..|..++..|.-
T Consensus 268 kMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGs--NsL---~LpvPstcP~Gfkl 342 (904)
T KOG4721|consen 268 KMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGS--NSL---HLPVPSTCPDGFKL 342 (904)
T ss_pred hhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccC--Ccc---cccCcccCchHHHH
Confidence 4578999999999999999999999999999999999999999986665322222221 111 12345566778999
Q ss_pred HHHHccccCCCCCCCCchHHH
Q 005617 584 LGLQCCELYGRERPDITPSLV 604 (688)
Q Consensus 584 L~~~Cl~~dP~~RPs~~~~l~ 604 (688)
|+.+||+..|..||++++++.
T Consensus 343 L~Kqcw~sKpRNRPSFrqil~ 363 (904)
T KOG4721|consen 343 LLKQCWNSKPRNRPSFRQILL 363 (904)
T ss_pred HHHHHHhcCCCCCccHHHHHH
Confidence 999999999999999996553
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-39 Score=354.36 Aligned_cols=239 Identities=26% Similarity=0.380 Sum_probs=204.0
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcC-CCCceeeEecccC--CCc
Q 005617 339 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKL-QHPHLVTLLGACP--EAW 410 (688)
Q Consensus 339 ~at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~--~~~ 410 (688)
..-.+|....+||+|+||.|+++.+. +..+|||++++..+ ...+....|..|+... +||.++.|+.+|+ +..
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34478999999999999999999987 67899999998865 3445578899998888 5999999999995 468
Q ss_pred eeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCcccc
Q 005617 411 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~ 490 (688)
++||||+.||++..+.+ ...++...+..++..|+.||.|||+++ ||+||||.+|||||.+|++||+|||+++.
T Consensus 445 ~fvmey~~Ggdm~~~~~----~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIH----TDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEecCCCcEEEEEe----cccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence 99999999999544433 245888999999999999999999976 99999999999999999999999999997
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCC
Q 005617 491 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDP 568 (688)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~ 568 (688)
..... ..+.+.+|||.|||||++.+..|+..+|+|||||+|||||+|..||.+.++ +...+...
T Consensus 518 ~m~~g------~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d-------- 583 (694)
T KOG0694|consen 518 GMGQG------DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND-------- 583 (694)
T ss_pred cCCCC------CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--------
Confidence 65332 246789999999999999999999999999999999999999999986543 33333222
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCC
Q 005617 569 LAGDWPTFVARRLVDLGLQCCELYGRERPDI 599 (688)
Q Consensus 569 ~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~ 599 (688)
..-+|...+.+.+.++.+++..+|.+|.-+
T Consensus 584 -~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 584 -EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred -CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 124777889999999999999999999988
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-39 Score=339.16 Aligned_cols=258 Identities=28% Similarity=0.409 Sum_probs=196.8
Q ss_pred cCcccceeeeccCceEEEEEEEC------------------CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML------------------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTL 402 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~------------------g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l 402 (688)
++|...+.||+|+||.||+|.+. +..||||.+..... .....|.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 46778889999999999999752 34699999876533 334579999999999999999999
Q ss_pred ecccC--CCceeEEecCCCCcHHHHhcccC----------------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEe
Q 005617 403 LGACP--EAWSLVYEYLPNGSLQDRLFRKS----------------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464 (688)
Q Consensus 403 ~g~~~--~~~~LV~E~~~~gsL~~~L~~~~----------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiH 464 (688)
+|+|. +..++||||+++|+|.+++.... ....++|..+++++.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 99985 35789999999999999885432 1235788999999999999999999966 999
Q ss_pred CCCCCCceeeCCCCCeEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh--
Q 005617 465 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-- 542 (688)
Q Consensus 465 rDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-- 542 (688)
|||||+|||++.++.+||+|||+++........ .......++..|+|||++..+.++.++|||||||++|||++
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYY----RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCcee----EecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 999999999999999999999999866433211 12234456889999999998999999999999999999987
Q ss_pred CCCCCCChhh--HHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHH
Q 005617 543 GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 543 G~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le 608 (688)
|..||..... +...+... +...........+...+..+.+|+.+||+.+|.+||++. ++...|+
T Consensus 238 ~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~-~i~~~l~ 303 (304)
T cd05096 238 KEQPYGELTDEQVIENAGEF-FRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFS-DIHAFLT 303 (304)
T ss_pred CCCCCCcCCHHHHHHHHHHH-hhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHH-HHHHHHh
Confidence 5677764332 11111100 000000000111223456789999999999999999998 5666554
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=348.05 Aligned_cols=243 Identities=28% Similarity=0.426 Sum_probs=203.2
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC----c-cchHHHHHHHHHHHcCC-CCceeeEeccc--CC
Q 005617 339 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN----M-QGQLEFQQEVRVLSKLQ-HPHLVTLLGAC--PE 408 (688)
Q Consensus 339 ~at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~----~-~~~~~f~~E~~iL~~l~-HpnIV~l~g~~--~~ 408 (688)
...++|...+.||+|+||.||.|... |..||||++.... . .....+.+|+.+++.++ ||||++++.++ ..
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 44578999999999999999999875 8999999776541 1 23345678999999998 99999999998 44
Q ss_pred CceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCC-CCeEEeecCc
Q 005617 409 AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE-LSSKICDFGI 487 (688)
Q Consensus 409 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~-~~vKLsDFGl 487 (688)
..++||||+.||+|.+.+... .++.+.....++.|++.|+.|||+.+ |+||||||+|||||.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~---g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNK---GRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHHc---CCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 689999999999999999873 46778999999999999999999976 9999999999999999 9999999999
Q ss_pred ccccc-CCCCcCCCccccCCCCCCCCCCChhhhccCC-CC-CcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCcc
Q 005617 488 CRLVT-EDTLYLPSFHRSTAPKGSFPYADPEYHRTGV-LT-PKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKL 562 (688)
Q Consensus 488 a~~~~-~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s-~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l 562 (688)
+.... .+. .....+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||..... ....+..+.+
T Consensus 168 s~~~~~~~~-------~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~ 240 (370)
T KOG0583|consen 168 SAISPGEDG-------LLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEF 240 (370)
T ss_pred ccccCCCCC-------cccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCc
Confidence 99874 222 346789999999999999877 85 799999999999999999999986332 2222333322
Q ss_pred ccccCCCCCCCCHHH-HHHHHHHHHHccccCCCCCCCCchHH
Q 005617 563 SSILDPLAGDWPTFV-ARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 563 ~~~ld~~~~~~~~~~-~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
.+|... +..+..|+.+|+..||..|+++.+.+
T Consensus 241 ---------~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 241 ---------KIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred ---------cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 344444 78999999999999999999998544
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=336.35 Aligned_cols=233 Identities=26% Similarity=0.359 Sum_probs=195.7
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|...+.||+|+||.||+|... |..||||++..... .....+.+|+.++..++||||+++++++.+ ..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36788899999999999999886 88999999975432 234468899999999999999999998854 478999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.+|.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRNS---GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 999999999998654 35788999999999999999999966 999999999999999999999999999876432
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCCCCC
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 495 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~ 572 (688)
.....||+.|+|||++.+..++.++|||||||++|+|+||+.||..... +...+..+.. .
T Consensus 155 ---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~---------~ 216 (291)
T cd05612 155 ---------TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL---------E 216 (291)
T ss_pred ---------cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc---------C
Confidence 1345799999999999999999999999999999999999999975432 2333333321 2
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCC
Q 005617 573 WPTFVARRLVDLGLQCCELYGRERPD 598 (688)
Q Consensus 573 ~~~~~~~~l~~L~~~Cl~~dP~~RPs 598 (688)
++......+.+|+.+||+.||.+||+
T Consensus 217 ~~~~~~~~~~~li~~~l~~dp~~R~~ 242 (291)
T cd05612 217 FPRHLDLYAKDLIKKLLVVDRTRRLG 242 (291)
T ss_pred CCccCCHHHHHHHHHHcCCCHHHccC
Confidence 34445668899999999999999996
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=367.30 Aligned_cols=254 Identities=30% Similarity=0.511 Sum_probs=214.7
Q ss_pred CcccceeeeccCceEEEEEEECC-------eEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccCC--Ccee
Q 005617 343 NFSESFKVGQGGFGCVYKGEMLG-------RTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSL 412 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~g-------~~vAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~L 412 (688)
+......||+|.||.||+|+..| ..||||.++..... .+.+|++|+++|+.|+|||||+|+|+|.+ ..+|
T Consensus 487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 33445679999999999998752 46999999987765 77899999999999999999999999954 5899
Q ss_pred EEecCCCCcHHHHhcccCC-----------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeE
Q 005617 413 VYEYLPNGSLQDRLFRKSN-----------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSK 481 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~~-----------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vK 481 (688)
|+|||..|+|..+|..... ..+|+-.+.+.||.|||.|+.||-+.. +|||||-..|+||.++..||
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VK 643 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVK 643 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEE
Confidence 9999999999999964321 234889999999999999999999977 99999999999999999999
Q ss_pred EeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCCh--hhHHHHhh
Q 005617 482 ICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLA--GEVRRAVS 558 (688)
Q Consensus 482 LsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~--~~~~~~~~ 558 (688)
|+|||+++.+-..+.+. ......-...||+||.+..+++|++||||||||+|||+++ |+.||.+. .++...+.
T Consensus 644 IsDfGLsRdiYssDYYk----~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~ 719 (774)
T KOG1026|consen 644 ISDFGLSRDIYSSDYYK----VRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIR 719 (774)
T ss_pred ecccccchhhhhhhhhc----ccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHH
Confidence 99999999765443221 1113334568999999999999999999999999999999 99998754 35788888
Q ss_pred cCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHhhh
Q 005617 559 CGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 559 ~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l~~ 612 (688)
.|++. ..|...+..+..|+..||+.+|.+||+++ ++-..|+....
T Consensus 720 ~g~lL--------~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~-eI~~~L~~~~~ 764 (774)
T KOG1026|consen 720 AGQLL--------SCPENCPTEVYSLMLECWNENPKRRPSFK-EIHSRLQAWAQ 764 (774)
T ss_pred cCCcc--------cCCCCCCHHHHHHHHHHhhcCcccCCCHH-HHHHHHHHHHh
Confidence 88774 34566778999999999999999999999 78888887654
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-39 Score=343.87 Aligned_cols=234 Identities=24% Similarity=0.369 Sum_probs=196.4
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|...+.||+|+||.||+|+.. |..||||++..... .....+.+|+.++.+++||||+++++++.+ ..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 56888899999999999999985 78899999975432 334568899999999999999999999843 578999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 999999999998754 35788899999999999999999966 999999999999999999999999999876432
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCCCCC
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 495 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~ 572 (688)
. ....||+.|+|||++.+..++.++|||||||++|||+||+.||..... ....+..+.+ .
T Consensus 172 ~---------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~---------~ 233 (329)
T PTZ00263 172 T---------FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRL---------K 233 (329)
T ss_pred c---------ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCc---------C
Confidence 2 245799999999999999999999999999999999999999975433 2233333322 2
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCC
Q 005617 573 WPTFVARRLVDLGLQCCELYGRERPDI 599 (688)
Q Consensus 573 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~ 599 (688)
+|......+.+|+.+||+.||.+||+.
T Consensus 234 ~p~~~~~~~~~li~~~L~~dP~~R~~~ 260 (329)
T PTZ00263 234 FPNWFDGRARDLVKGLLQTDHTKRLGT 260 (329)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 233345678999999999999999985
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=343.48 Aligned_cols=246 Identities=29% Similarity=0.393 Sum_probs=207.3
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc--chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEe
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E 415 (688)
++|.....||+|+||.||||+.. .+.||||.+.+.... ....+.+|++|++.++|||||.++.+|.. ..++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 46777788999999999999876 688999999766443 34568999999999999999999999964 5889999
Q ss_pred cCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCC
Q 005617 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~ 495 (688)
|+.| +|..+|.... .++++.+..|+.+++.||.|||++. |+|||+||.||||+.+|.+|+||||+|+.+..+.
T Consensus 82 ~a~g-~L~~il~~d~---~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQDG---KLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9987 9999997654 5889999999999999999999976 9999999999999999999999999999887654
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCccccccCCCCCCCCH
Q 005617 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPT 575 (688)
Q Consensus 496 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~l~~~ld~~~~~~~~ 575 (688)
. ..+...|||.|||||+..+..|+..+|.||+|||+|||.+|++||... .+...+.. +-.....||.
T Consensus 155 ~------vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~-si~~Lv~~------I~~d~v~~p~ 221 (808)
T KOG0597|consen 155 S------VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR-SITQLVKS------ILKDPVKPPS 221 (808)
T ss_pred e------eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH-HHHHHHHH------HhcCCCCCcc
Confidence 3 346778999999999999999999999999999999999999999532 22222211 1111235777
Q ss_pred HHHHHHHHHHHHccccCCCCCCCCchHHHHHH
Q 005617 576 FVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 576 ~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~L 607 (688)
..+..+..++...+..||..|.+-.+.+-+.+
T Consensus 222 ~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF 253 (808)
T KOG0597|consen 222 TASSSFVNFLQGLLIKDPAQRLTWTDLLGHPF 253 (808)
T ss_pred cccHHHHHHHHHHhhcChhhcccHHHHhcChH
Confidence 88999999999999999999998775554443
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=334.30 Aligned_cols=260 Identities=22% Similarity=0.271 Sum_probs=208.3
Q ss_pred HhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccch-HHHHHHHHHHHcCCCCceeeEeccc--CCCceeEE
Q 005617 340 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQ-LEFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVY 414 (688)
Q Consensus 340 at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~-~~f~~E~~iL~~l~HpnIV~l~g~~--~~~~~LV~ 414 (688)
..++|.....||.|..++||+|+.. +..||||++........ ..+.+|+..++.++|||||+++.+| .+.+++||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 3467888999999999999999885 89999999987766554 6789999999999999999999988 45689999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
.||.+||+.+++...-. ..+++..+..|+.++++||.|||.+| .||||||+.|||||.+|.|||+|||.+..+...
T Consensus 104 pfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 99999999999876543 34888999999999999999999977 999999999999999999999999988776554
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhc--cCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHH--hhcCccccccCCC-
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHR--TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VSCGKLSSILDPL- 569 (688)
Q Consensus 495 ~~~~~~~~~~~~~~GT~~Y~APE~~~--~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~--~~~g~l~~~ld~~- 569 (688)
.. ...... ...+||+.|||||++. ...|+.|+||||||++.+||.+|..||.-...+... .-.+.....+-..
T Consensus 180 G~-R~~~rf-~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~ 257 (516)
T KOG0582|consen 180 GD-RQVTRF-NTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGL 257 (516)
T ss_pred Cc-eeeEee-ccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccC
Confidence 31 111112 6779999999999954 347999999999999999999999999755543322 2223222221000
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHH
Q 005617 570 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 605 (688)
Q Consensus 570 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~ 605 (688)
..+........+.+++..|++.||.+|||+.+.+-.
T Consensus 258 ~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh 293 (516)
T KOG0582|consen 258 DKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH 293 (516)
T ss_pred ChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence 112223355689999999999999999999855543
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=337.40 Aligned_cols=229 Identities=26% Similarity=0.331 Sum_probs=189.3
Q ss_pred eeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecCCCCc
Q 005617 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGS 421 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gs 421 (688)
.||+|+||.||++... |..||||++..... .....+.+|+.++..++||||++++++|.+ ..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~ 81 (323)
T cd05571 2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence 6999999999999875 88999999976432 233467889999999999999999998844 4789999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCCc
Q 005617 422 LQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 501 (688)
Q Consensus 422 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~~ 501 (688)
|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 82 L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~------ 149 (323)
T cd05571 82 LFFHLSRE---RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG------ 149 (323)
T ss_pred HHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC------
Confidence 99988654 35789999999999999999999966 9999999999999999999999999987543221
Q ss_pred cccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCCCCCCCHHHHH
Q 005617 502 HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVAR 579 (688)
Q Consensus 502 ~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~~~~~~ 579 (688)
.......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ....+..+. ..+|...+.
T Consensus 150 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~---------~~~p~~~~~ 220 (323)
T cd05571 150 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE---------IRFPRTLSP 220 (323)
T ss_pred CcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC---------CCCCCCCCH
Confidence 122456799999999999999999999999999999999999999965432 222222221 133445567
Q ss_pred HHHHHHHHccccCCCCCCC
Q 005617 580 RLVDLGLQCCELYGRERPD 598 (688)
Q Consensus 580 ~l~~L~~~Cl~~dP~~RPs 598 (688)
.+.+|+.+||+.||.+||+
T Consensus 221 ~~~~li~~~L~~dP~~R~~ 239 (323)
T cd05571 221 EAKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred HHHHHHHHHccCCHHHcCC
Confidence 8999999999999999995
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=336.11 Aligned_cols=230 Identities=25% Similarity=0.336 Sum_probs=189.8
Q ss_pred eeccCceEEEEEEEC--CeEEEEEEEecCC---ccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecCCCCcH
Q 005617 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHN---MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSL 422 (688)
Q Consensus 350 LG~G~fG~Vykg~~~--g~~vAIK~l~~~~---~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gsL 422 (688)
||+|+||.||+|... +..||||++.... ......+.+|+.++.+++|||||+++++|.+ ..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999885 7889999997542 2334568899999999999999999998854 57899999999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCCcc
Q 005617 423 QDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 502 (688)
Q Consensus 423 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~~~ 502 (688)
.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...... .
T Consensus 81 ~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~------~ 148 (312)
T cd05585 81 FHHLQRE---GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD------D 148 (312)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC------C
Confidence 9998654 35789999999999999999999966 9999999999999999999999999998643222 1
Q ss_pred ccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCCCCCCCHHHHHH
Q 005617 503 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVARR 580 (688)
Q Consensus 503 ~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~~~~~~~ 580 (688)
......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ....+..+. ..++......
T Consensus 149 ~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~---------~~~~~~~~~~ 219 (312)
T cd05585 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEP---------LRFPDGFDRD 219 (312)
T ss_pred ccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCC---------CCCCCcCCHH
Confidence 23456799999999999999999999999999999999999999964332 222222211 1234445678
Q ss_pred HHHHHHHccccCCCCCCCCc
Q 005617 581 LVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 581 l~~L~~~Cl~~dP~~RPs~~ 600 (688)
+.+|+.+||+.||.+||++.
T Consensus 220 ~~~li~~~L~~dp~~R~~~~ 239 (312)
T cd05585 220 AKDLLIGLLSRDPTRRLGYN 239 (312)
T ss_pred HHHHHHHHcCCCHHHcCCCC
Confidence 89999999999999999875
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=325.62 Aligned_cols=249 Identities=24% Similarity=0.350 Sum_probs=199.4
Q ss_pred cCcccceeeeccCceEEEEEEEC-----CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML-----GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~-----g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV 413 (688)
++|...+.||+|+||.||+|.+. +..||+|+++.... .....|.+|+.++.+++||||++++|++.. ..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46788899999999999999763 56899999976533 234568999999999999999999999843 58899
Q ss_pred EecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccC
Q 005617 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~ 493 (688)
|||+++|+|.+++.... ..++|..++.++.+++.||.|||+.+ ++||||||+|||++.++.+|++|||.+.....
T Consensus 85 ~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRKHE--GQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 99999999999987543 46899999999999999999999865 99999999999999999999999998765432
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHHHhhcCccccccCCCC
Q 005617 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~~~~g~l~~~ld~~~ 570 (688)
... .......++..|+|||++.+..++.++|||||||++|||++ |..||..... ....+..+...
T Consensus 160 ~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~------- 227 (266)
T cd05064 160 EAI-----YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL------- 227 (266)
T ss_pred cch-----hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC-------
Confidence 211 11223446678999999999999999999999999999775 9999964432 22333333211
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHH
Q 005617 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 571 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~ 609 (688)
..+...+..+.+++.+||+.+|.+||++. .+.+.|..
T Consensus 228 -~~~~~~~~~~~~li~~c~~~~p~~RP~~~-~i~~~l~~ 264 (266)
T cd05064 228 -PAPRNCPNLLHQLMLDCWQKERGERPRFS-QIHSILSK 264 (266)
T ss_pred -CCCCCCCHHHHHHHHHHcCCCchhCCCHH-HHHHHHHh
Confidence 12233456789999999999999999998 66666654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=344.05 Aligned_cols=253 Identities=29% Similarity=0.420 Sum_probs=199.9
Q ss_pred hcCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCc-cchHHHHHHHHHHHcC-CCCceeeEecccCC--C
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--A 409 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~-------g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~ 409 (688)
.++|...+.||+|+||.||+|... +..||||+++.... .....+.+|+.+|..+ +|||||+++|+|.+ .
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 457888899999999999999742 45799999975432 3345688999999999 89999999999954 5
Q ss_pred ceeEEecCCCCcHHHHhcccCC----------------------------------------------------------
Q 005617 410 WSLVYEYLPNGSLQDRLFRKSN---------------------------------------------------------- 431 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~~---------------------------------------------------------- 431 (688)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 7899999999999998864321
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCc
Q 005617 432 --------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 432 --------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~ 497 (688)
...++|..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 125789999999999999999999965 999999999999999999999999999876543211
Q ss_pred CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh---hHHHHhhcCccccccCCCCCCC
Q 005617 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG---EVRRAVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 498 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~---~~~~~~~~g~l~~~ld~~~~~~ 573 (688)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.... .....+..+... ..
T Consensus 271 ----~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~--------~~ 338 (375)
T cd05104 271 ----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM--------LS 338 (375)
T ss_pred ----cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC--------CC
Confidence 11223446678999999999999999999999999999998 889986432 223333333211 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHH
Q 005617 574 PTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 574 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~ 609 (688)
+...+..+.+|+.+||+.||.+||++. +++..|+.
T Consensus 339 ~~~~~~~l~~li~~cl~~dP~~RPs~~-eil~~l~~ 373 (375)
T cd05104 339 PECAPSEMYDIMKSCWDADPLKRPTFK-QIVQLIEQ 373 (375)
T ss_pred CCCCCHHHHHHHHHHccCChhHCcCHH-HHHHHHHh
Confidence 222346789999999999999999999 66666664
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=333.98 Aligned_cols=252 Identities=25% Similarity=0.433 Sum_probs=200.6
Q ss_pred cCcccceeeeccCceEEEEEEEC--Ce----EEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC-CceeE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GR----TVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~----~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV 413 (688)
.+|...+.||+|+||.||+|.+. |. .||||++..... .....|.+|+.+++.++||||++++|+|.. ..++|
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v 86 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 86 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceee
Confidence 46888899999999999999863 33 489999875433 345678999999999999999999999854 57899
Q ss_pred EecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccC
Q 005617 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~ 493 (688)
++|+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~e~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 87 TQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred eecCCCCCHHHHHHhcc--ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccC
Confidence 99999999999987643 45789999999999999999999965 99999999999999999999999999987754
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHHHhhcCccccccCCCC
Q 005617 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~~~~g~l~~~ld~~~ 570 (688)
..... ......++..|+|||++....++.++|||||||++|||++ |..||..... +...+..+...
T Consensus 162 ~~~~~----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~------- 230 (316)
T cd05108 162 DEKEY----HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL------- 230 (316)
T ss_pred CCcce----eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCC-------
Confidence 32111 1123345778999999999999999999999999999998 9999975432 22222222111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHhh
Q 005617 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 571 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l~ 611 (688)
..+......+..++.+||..+|.+||++. .+...|..+.
T Consensus 231 -~~~~~~~~~~~~li~~cl~~~p~~Rps~~-~l~~~l~~~~ 269 (316)
T cd05108 231 -PQPPICTIDVYMIMVKCWMIDADSRPKFR-ELIIEFSKMA 269 (316)
T ss_pred -CCCCCCCHHHHHHHHHHccCChhhCcCHH-HHHHHHHHHH
Confidence 11222345789999999999999999999 5555666553
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=339.22 Aligned_cols=245 Identities=25% Similarity=0.297 Sum_probs=198.3
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|.....||+|+||.||+|... |..||||++..... .....+.+|+.++..++||||+++++++.+ ..+|||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46888999999999999999985 78999999976432 234568899999999999999999999854 478999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL---GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 999999999999654 35788999999999999999999966 99999999999999999999999999986543
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccC-CCCC
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILD-PLAG 571 (688)
Q Consensus 495 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld-~~~~ 571 (688)
......||+.|+|||++.+..++.++|||||||++|||++|..||..... ....+.... ..+. +...
T Consensus 154 --------~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~ 223 (333)
T cd05600 154 --------YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWK--ETLQRPVYD 223 (333)
T ss_pred --------ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcc--ccccCCCCC
Confidence 12456799999999999999999999999999999999999999975432 222222111 1111 1111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 572 DWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 572 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
+.....+..+.+|+.+||..+|.+||++.+.+
T Consensus 224 ~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll 255 (333)
T cd05600 224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIK 255 (333)
T ss_pred ccccccCHHHHHHHHHHhhChhhhcCCHHHHH
Confidence 11123467889999999999999999987443
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=334.17 Aligned_cols=249 Identities=23% Similarity=0.339 Sum_probs=197.3
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEec
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 416 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~ 416 (688)
++|.....||+|+||.||+++.. |..||+|.+..... .....|.+|+.+|.+++||||++++++|. +..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 84 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 84 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeec
Confidence 67888999999999999999986 78899999876532 23456999999999999999999999984 357899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCC
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~ 496 (688)
+++|+|.+++.... .+++..+..++.+++.||.|||+.+ +|+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 158 (331)
T cd06649 85 MDGGSLDQVLKEAK---RIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 158 (331)
T ss_pred CCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccc-
Confidence 99999999986543 5788999999999999999999853 49999999999999999999999999998664322
Q ss_pred cCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCc-------cc----
Q 005617 497 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGK-------LS---- 563 (688)
Q Consensus 497 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~-------l~---- 563 (688)
.....||+.|+|||++.+..++.++|||||||++|||+||+.||..... +...+.... ..
T Consensus 159 -------~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (331)
T cd06649 159 -------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISP 231 (331)
T ss_pred -------cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCc
Confidence 2345799999999999999999999999999999999999999964332 111111000 00
Q ss_pred -----------------------c----ccCCCCCCC-CHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 564 -----------------------S----ILDPLAGDW-PTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 564 -----------------------~----~ld~~~~~~-~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
. +........ .......+.+|+.+||+.||.+||++.+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell 299 (331)
T cd06649 232 RPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLM 299 (331)
T ss_pred ccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHh
Confidence 0 000000000 112456799999999999999999998544
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=334.36 Aligned_cols=229 Identities=26% Similarity=0.334 Sum_probs=188.1
Q ss_pred eeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecCCCCc
Q 005617 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGS 421 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gs 421 (688)
.||+|+||.||++... |..||+|++..... .....+.+|+.++..++||||++++++|.. ..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (323)
T cd05595 2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE 81 (323)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence 6999999999999875 88999999976432 233457789999999999999999998843 5789999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCCc
Q 005617 422 LQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 501 (688)
Q Consensus 422 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~~ 501 (688)
|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~----- 150 (323)
T cd05595 82 LFFHLSRE---RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA----- 150 (323)
T ss_pred HHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCC-----
Confidence 99888654 35789999999999999999999965 99999999999999999999999999875432211
Q ss_pred cccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCCCCCCCHHHHH
Q 005617 502 HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVAR 579 (688)
Q Consensus 502 ~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~~~~~~ 579 (688)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+..+. ..+|...+.
T Consensus 151 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~---------~~~p~~~~~ 220 (323)
T cd05595 151 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE---------IRFPRTLSP 220 (323)
T ss_pred -ccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC---------CCCCCCCCH
Confidence 12345799999999999999999999999999999999999999965432 222222111 123444567
Q ss_pred HHHHHHHHccccCCCCCCC
Q 005617 580 RLVDLGLQCCELYGRERPD 598 (688)
Q Consensus 580 ~l~~L~~~Cl~~dP~~RPs 598 (688)
.+.+|+.+||+.||.+||+
T Consensus 221 ~~~~li~~~L~~dP~~R~~ 239 (323)
T cd05595 221 EAKSLLAGLLKKDPKQRLG 239 (323)
T ss_pred HHHHHHHHHccCCHHHhCC
Confidence 8899999999999999994
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=327.39 Aligned_cols=249 Identities=22% Similarity=0.274 Sum_probs=194.6
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEe
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E 415 (688)
++|...+.||+|+||.||+|+.. +..||||++..... .....+.+|+.++..++||||++++++|.+ ..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888999999999999999986 78899999976532 234568899999999999999999999854 4789999
Q ss_pred cCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCC
Q 005617 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~ 495 (688)
|++++++..+.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEEMP---NGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 99998877654322 45889999999999999999999965 9999999999999999999999999998764332
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhh----cCc----------
Q 005617 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS----CGK---------- 561 (688)
Q Consensus 496 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~----~g~---------- 561 (688)
.. ......||+.|+|||++.+..++.++|||||||++|||++|++||........... .+.
T Consensus 155 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07848 155 NA-----NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFY 229 (287)
T ss_pred cc-----cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhh
Confidence 11 12345789999999999998999999999999999999999999975432211110 000
Q ss_pred ----cccccCCCC-------CCCCHHHHHHHHHHHHHccccCCCCCCCCch
Q 005617 562 ----LSSILDPLA-------GDWPTFVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 562 ----l~~~ld~~~-------~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~ 601 (688)
.....-+.. ..+....+..+.+|+.+||+.||.+||++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~ 280 (287)
T cd07848 230 SNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQ 280 (287)
T ss_pred ccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHH
Confidence 000000000 0111224567999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=346.61 Aligned_cols=244 Identities=29% Similarity=0.452 Sum_probs=209.4
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
+-|..++.||.|+-|.|.+|++. |+.+|||++.+... .....+.+|+-||+.+.|||+++||+++.+ .+|||.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 34677889999999999999885 99999999976632 234468899999999999999999999955 589999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
||++||.|.++|..++ +++..++++++.||+.|+.|+|..+ |+||||||+|+|||..+++||+|||+|.+...+
T Consensus 92 Eyv~gGELFdylv~kG---~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~g 165 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKG---PLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPG 165 (786)
T ss_pred EecCCchhHHHHHhhC---CCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCC
Confidence 9999999999998775 6888999999999999999999977 999999999999999999999999999987665
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCC-CCcchHhHHHHHHHHHHhCCCCCCChh--hHHHHhhcCccccccCCCCC
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVL-TPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSILDPLAG 571 (688)
Q Consensus 495 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDVwSfGviL~ELltG~~Pf~~~~--~~~~~~~~g~l~~~ld~~~~ 571 (688)
... .+-+|+|.|.|||++.+.+| +.++||||+|||||.||||+.||+... .+...+..|.+
T Consensus 166 klL-------eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f--------- 229 (786)
T KOG0588|consen 166 KLL-------ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVF--------- 229 (786)
T ss_pred ccc-------cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcc---------
Confidence 532 45689999999999999998 579999999999999999999998322 23344555654
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHH
Q 005617 572 DWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 572 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~L 607 (688)
+.|.+++.+..+|+.+|+..||..|.|+.+++-+-+
T Consensus 230 ~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~ 265 (786)
T KOG0588|consen 230 EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF 265 (786)
T ss_pred cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence 456678889999999999999999999986554443
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-38 Score=336.37 Aligned_cols=229 Identities=27% Similarity=0.325 Sum_probs=188.7
Q ss_pred eeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecCCCCc
Q 005617 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGS 421 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gs 421 (688)
.||+|+||.||++... |..||||++..... .....+.+|+.++..++||||+++++++.+ ..++||||+++|+
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~ 81 (328)
T cd05593 2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE 81 (328)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence 6999999999999875 78999999976432 234568899999999999999999998843 5789999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCCc
Q 005617 422 LQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 501 (688)
Q Consensus 422 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~~ 501 (688)
|...+... ..+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.......
T Consensus 82 L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~----- 150 (328)
T cd05593 82 LFFHLSRE---RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA----- 150 (328)
T ss_pred HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCccc-----
Confidence 99888654 35889999999999999999999966 99999999999999999999999999876432211
Q ss_pred cccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhH--HHHhhcCccccccCCCCCCCCHHHHH
Q 005617 502 HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGDWPTFVAR 579 (688)
Q Consensus 502 ~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~~~~g~l~~~ld~~~~~~~~~~~~ 579 (688)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... ...+..+. ..+|...+.
T Consensus 151 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~---------~~~p~~~~~ 220 (328)
T cd05593 151 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMED---------IKFPRTLSA 220 (328)
T ss_pred -ccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCC---------ccCCCCCCH
Confidence 123457999999999999999999999999999999999999999654332 12221111 123445567
Q ss_pred HHHHHHHHccccCCCCCCC
Q 005617 580 RLVDLGLQCCELYGRERPD 598 (688)
Q Consensus 580 ~l~~L~~~Cl~~dP~~RPs 598 (688)
.+.+|+.+||+.||.+||+
T Consensus 221 ~~~~li~~~L~~dP~~R~~ 239 (328)
T cd05593 221 DAKSLLSGLLIKDPNKRLG 239 (328)
T ss_pred HHHHHHHHHcCCCHHHcCC
Confidence 8899999999999999984
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=343.36 Aligned_cols=255 Identities=28% Similarity=0.450 Sum_probs=200.9
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCcc-chHHHHHHHHHHHcC-CCCceeeEecccCC--
Q 005617 340 ATCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKL-QHPHLVTLLGACPE-- 408 (688)
Q Consensus 340 at~~f~~~~~LG~G~fG~Vykg~~~-------g~~vAIK~l~~~~~~-~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~-- 408 (688)
..++|...+.||+|+||.||+|... +..||||++...... ....+.+|+.+++.+ +|||||+++|+|.+
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~ 115 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG 115 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence 3457888899999999999998753 247999999765432 345688999999999 89999999999854
Q ss_pred CceeEEecCCCCcHHHHhcccC----------------------------------------------------------
Q 005617 409 AWSLVYEYLPNGSLQDRLFRKS---------------------------------------------------------- 430 (688)
Q Consensus 409 ~~~LV~E~~~~gsL~~~L~~~~---------------------------------------------------------- 430 (688)
..++||||+++|+|.+++....
T Consensus 116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (374)
T cd05106 116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS 195 (374)
T ss_pred CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence 4789999999999999885421
Q ss_pred ---------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCCc
Q 005617 431 ---------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 501 (688)
Q Consensus 431 ---------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~~ 501 (688)
...++++..+++|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~---- 268 (374)
T cd05106 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY---- 268 (374)
T ss_pred cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcce----
Confidence 1135788999999999999999999965 999999999999999999999999999876433211
Q ss_pred cccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh---HHHHhhcCccccccCCCCCCCCHHH
Q 005617 502 HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE---VRRAVSCGKLSSILDPLAGDWPTFV 577 (688)
Q Consensus 502 ~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~---~~~~~~~g~l~~~ld~~~~~~~~~~ 577 (688)
.......+++.|+|||++....++.++|||||||++|||++ |+.||..... ....+..+. . ...+...
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~-----~---~~~~~~~ 340 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY-----Q---MSRPDFA 340 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHccc-----C---ccCCCCC
Confidence 11223346678999999999999999999999999999997 9999964332 122222221 0 1112223
Q ss_pred HHHHHHHHHHccccCCCCCCCCchHHHHHHHHh
Q 005617 578 ARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 578 ~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l 610 (688)
+..+.+++.+||+.||.+||++. .+++.|+.+
T Consensus 341 ~~~l~~li~~cl~~dp~~RPs~~-~l~~~l~~~ 372 (374)
T cd05106 341 PPEIYSIMKMCWNLEPTERPTFS-QISQLIQRQ 372 (374)
T ss_pred CHHHHHHHHHHcCCChhhCcCHH-HHHHHHHHH
Confidence 56889999999999999999999 777887764
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=337.68 Aligned_cols=252 Identities=26% Similarity=0.367 Sum_probs=200.2
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc--chHHHHHHHHHHHcCCCCceeeEecccCC----CceeE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACPE----AWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~~~----~~~LV 413 (688)
+.|....+||+|.||.||+++.. |+.||+|++...... ...-..+||.||++|+|||||+|.+...+ ..|||
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 45666788999999999999885 889999999877643 33456799999999999999999998733 48999
Q ss_pred EecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccC
Q 005617 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~ 493 (688)
+|||+. +|.-++.... -.|+..++..++.|++.||.|+|..+ |+|||||.+|||||++|.+||+|||||+++..
T Consensus 197 FeYMdh-DL~GLl~~p~--vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~ 270 (560)
T KOG0600|consen 197 FEYMDH-DLSGLLSSPG--VKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTP 270 (560)
T ss_pred Eecccc-hhhhhhcCCC--cccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccC
Confidence 999964 6777665433 35888999999999999999999976 99999999999999999999999999998865
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhc----C--------
Q 005617 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC----G-------- 560 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~----g-------- 560 (688)
.... ..+..+.|..|.|||++.+. .|++.+|+||.||||.||++|++.|.+..++.+.-.. |
T Consensus 271 ~~~~-----~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~ 345 (560)
T KOG0600|consen 271 SGSA-----PYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP 345 (560)
T ss_pred CCCc-----ccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc
Confidence 4422 25778899999999988764 7999999999999999999999999877665443211 1
Q ss_pred --ccc--cccCCCCCCCCH-------HHHHHHHHHHHHccccCCCCCCCCchHHHH
Q 005617 561 --KLS--SILDPLAGDWPT-------FVARRLVDLGLQCCELYGRERPDITPSLVK 605 (688)
Q Consensus 561 --~l~--~~ld~~~~~~~~-------~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~ 605 (688)
++. ..+.+ ...+.. ..+...++|+..+|..||.+|.|+.+.+..
T Consensus 346 ~~kLP~~~~~kp-~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s 400 (560)
T KOG0600|consen 346 VSKLPHATIFKP-QQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS 400 (560)
T ss_pred cccCCcccccCC-CCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence 111 11111 011121 234567899999999999999998855543
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=320.45 Aligned_cols=249 Identities=28% Similarity=0.454 Sum_probs=201.3
Q ss_pred cCcccceeeeccCceEEEEEEEC-CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecCC
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLP 418 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~-g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~ 418 (688)
++|...++||+|+||.||+|... +..||+|.+..... ....|.+|+.++..++||||+++++++.+ ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 56788899999999999999876 67799999865432 35678999999999999999999988743 4789999999
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcC
Q 005617 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~ 498 (688)
+|+|.+++.... ...+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++.........
T Consensus 85 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~- 159 (261)
T cd05072 85 KGSLLDFLKSDE-GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT- 159 (261)
T ss_pred CCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee-
Confidence 999999986543 246789999999999999999999965 999999999999999999999999999876543211
Q ss_pred CCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--hHHHHhhcCccccccCCCCCCCCH
Q 005617 499 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLAGDWPT 575 (688)
Q Consensus 499 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~~~~g~l~~~ld~~~~~~~~ 575 (688)
......++..|+|||++..+.+++++|||||||++|+|+| |..||.... .....+..+... +.. .
T Consensus 160 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~----~~~----~ 227 (261)
T cd05072 160 ----AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM----PRM----E 227 (261)
T ss_pred ----ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC----CCC----C
Confidence 1223456788999999998999999999999999999998 999996432 223333222111 111 1
Q ss_pred HHHHHHHHHHHHccccCCCCCCCCchHHHHHHHH
Q 005617 576 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 576 ~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~ 609 (688)
..+..+.+++.+|++.+|++||++. ++.+.|+.
T Consensus 228 ~~~~~~~~li~~~l~~~p~~Rp~~~-~i~~~l~~ 260 (261)
T cd05072 228 NCPDELYDIMKTCWKEKAEERPTFD-YLQSVLDD 260 (261)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHH-HHHHHHhc
Confidence 2346789999999999999999998 78777764
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=351.14 Aligned_cols=248 Identities=21% Similarity=0.251 Sum_probs=201.8
Q ss_pred CcccceeeeccCceEEEEEEEC---CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEecC
Q 005617 343 NFSESFKVGQGGFGCVYKGEML---GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 417 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~---g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~ 417 (688)
.|...+.||+|+||.||++... +..||+|.+..........+.+|+.+|+.++|||||+++++|. +..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3888899999999999999764 5678999876555444556889999999999999999999984 4589999999
Q ss_pred CCCcHHHHhccc-CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCC
Q 005617 418 PNGSLQDRLFRK-SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 418 ~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~ 496 (688)
++|+|.++|... ....++++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999988643 23356889999999999999999999965 99999999999999999999999999987654321
Q ss_pred cCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCCCCCCC
Q 005617 497 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWP 574 (688)
Q Consensus 497 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~ 574 (688)
. .......||+.|+|||++.+..++.++|||||||++|||+||+.||..... +...+..+... ..+
T Consensus 225 ~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~--------~~~ 292 (478)
T PTZ00267 225 L----DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD--------PFP 292 (478)
T ss_pred c----ccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------CCC
Confidence 1 123456799999999999999999999999999999999999999975432 22223223221 123
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCCchHHHH
Q 005617 575 TFVARRLVDLGLQCCELYGRERPDITPSLVK 605 (688)
Q Consensus 575 ~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~ 605 (688)
...+..+.+|+.+||+.+|..||++.+.+..
T Consensus 293 ~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~ 323 (478)
T PTZ00267 293 CPVSSGMKALLDPLLSKNPALRPTTQQLLHT 323 (478)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence 3445679999999999999999999865543
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=327.34 Aligned_cols=242 Identities=25% Similarity=0.313 Sum_probs=195.9
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEe
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYE 415 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~---~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E 415 (688)
+|...+.||+|+||.||++... +..||||.+...... ....+.+|+.++..++||||++++++|. +..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4777889999999999999875 789999999764332 2345788999999999999999999885 35889999
Q ss_pred cCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCC
Q 005617 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~ 495 (688)
|+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNMG-NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 999999998886543 246899999999999999999999966 9999999999999999999999999998764322
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHH--HHhhcCccccccCCCCCCC
Q 005617 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 496 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~--~~~~~g~l~~~ld~~~~~~ 573 (688)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..+.. .+......+
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~-----~~~~~~~~~ 224 (285)
T cd05605 157 -------TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVER-----RVKEDQEEY 224 (285)
T ss_pred -------ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHH-----Hhhhccccc
Confidence 1234579999999999999999999999999999999999999997543211 11110 011112234
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCCc
Q 005617 574 PTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 574 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~ 600 (688)
+...+..+.+|+.+||+.||.+||+..
T Consensus 225 ~~~~~~~~~~li~~~l~~~P~~R~~~~ 251 (285)
T cd05605 225 SEKFSEAARSICRQLLTKDPGFRLGCR 251 (285)
T ss_pred CcccCHHHHHHHHHHccCCHHHhcCCC
Confidence 445677899999999999999999655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=338.14 Aligned_cols=233 Identities=25% Similarity=0.303 Sum_probs=194.0
Q ss_pred cCcccceeeeccCceEEEEEEEC---CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML---GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~---g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV 413 (688)
++|.....||+|+||.||+|.+. +..||||++..... .....+.+|+.++..++|||||+++++|.+ ..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 46888899999999999999864 35799999865432 234568899999999999999999999854 47899
Q ss_pred EecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccC
Q 005617 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~ 493 (688)
|||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 110 ~Ey~~~g~L~~~i~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRRNK---RFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999987543 5789999999999999999999966 99999999999999999999999999987543
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhH--HHHhhcCccccccCCCCC
Q 005617 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAG 571 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~~~~g~l~~~ld~~~~ 571 (688)
. .....||+.|+|||++.+..++.++|||||||++|||+||..||...... ...+..+..
T Consensus 184 ~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~--------- 245 (340)
T PTZ00426 184 R---------TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGII--------- 245 (340)
T ss_pred C---------cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCC---------
Confidence 2 13457999999999999999999999999999999999999999755432 233332221
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCC
Q 005617 572 DWPTFVARRLVDLGLQCCELYGRERPD 598 (688)
Q Consensus 572 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs 598 (688)
.+|...+..+.+++.+|++.||.+|++
T Consensus 246 ~~p~~~~~~~~~li~~~l~~dp~~R~~ 272 (340)
T PTZ00426 246 YFPKFLDNNCKHLMKKLLSHDLTKRYG 272 (340)
T ss_pred CCCCCCCHHHHHHHHHHcccCHHHcCC
Confidence 233344567889999999999999974
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=324.27 Aligned_cols=250 Identities=33% Similarity=0.522 Sum_probs=201.2
Q ss_pred CcccceeeeccCceEEEEEEECC-------eEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--Ccee
Q 005617 343 NFSESFKVGQGGFGCVYKGEMLG-------RTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSL 412 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~g-------~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~L 412 (688)
+|...+.||+|+||.||+|...+ ..||+|.+..... .....|.+|+.++..++||||+++++++.+ ..++
T Consensus 6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 85 (283)
T cd05048 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM 85 (283)
T ss_pred HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEE
Confidence 56777889999999999998752 5699999875433 234568999999999999999999999854 4789
Q ss_pred EEecCCCCcHHHHhcccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCC
Q 005617 413 VYEYLPNGSLQDRLFRKSN-------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELS 479 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~ 479 (688)
+|||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+|+||||+||+++.++.
T Consensus 86 ~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 86 LFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLT 162 (283)
T ss_pred EEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCc
Confidence 9999999999999865421 145889999999999999999999966 999999999999999999
Q ss_pred eEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--hHHHH
Q 005617 480 SKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRA 556 (688)
Q Consensus 480 vKLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~ 556 (688)
+||+|||+++........ .......+++.|+|||++..+.++.++|||||||++|||++ |..||.... .+...
T Consensus 163 ~~L~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~ 238 (283)
T cd05048 163 VKISDFGLSRDIYSADYY----RVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM 238 (283)
T ss_pred EEECCCcceeeccccccc----cccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 999999999865432211 12344567889999999998999999999999999999998 999986432 23333
Q ss_pred hhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHH
Q 005617 557 VSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 557 ~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le 608 (688)
+..+... ..+...+..+.+|+.+||+.||.+||++. ++...|+
T Consensus 239 i~~~~~~--------~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~-~i~~~l~ 281 (283)
T cd05048 239 IRSRQLL--------PCPEDCPARVYALMIECWNEIPARRPRFK-DIHTRLR 281 (283)
T ss_pred HHcCCcC--------CCcccCCHHHHHHHHHHccCChhhCcCHH-HHHHHHh
Confidence 3333221 22344567899999999999999999998 6666655
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=318.81 Aligned_cols=245 Identities=27% Similarity=0.456 Sum_probs=196.8
Q ss_pred cCcccceeeeccCceEEEEEEEC-CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecCC
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLP 418 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~-g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~ 418 (688)
++|...+.||+|+||.||+|.+. +..+|+|.+.... .....|.+|+.++.+++||||++++++|.+ ..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 35777789999999999999886 5689999886443 334678999999999999999999999854 4789999999
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcC
Q 005617 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~ 498 (688)
+|+|.+++.... ..++|..+..++.+++.||.|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~- 156 (256)
T cd05114 83 NGCLLNYLRQRQ--GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT- 156 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCcee-
Confidence 999999886543 35889999999999999999999966 999999999999999999999999999865432211
Q ss_pred CCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHHHhhcCccccccCCCCCCCCH
Q 005617 499 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPT 575 (688)
Q Consensus 499 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~~ 575 (688)
......++..|+|||++....++.++||||||+++|||++ |+.||..... ....+..+... ..+.
T Consensus 157 ----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~--------~~~~ 224 (256)
T cd05114 157 ----SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRL--------YRPK 224 (256)
T ss_pred ----ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCC--------CCCC
Confidence 1223346678999999988899999999999999999999 9999975432 22333333211 1122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCCchHHHHH
Q 005617 576 FVARRLVDLGLQCCELYGRERPDITPSLVKE 606 (688)
Q Consensus 576 ~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~ 606 (688)
..+..+.+|+.+||+.+|.+||++. +++..
T Consensus 225 ~~~~~~~~li~~c~~~~p~~Rps~~-~l~~~ 254 (256)
T cd05114 225 LASMTVYEVMYSCWHEKPEGRPTFA-ELLRA 254 (256)
T ss_pred CCCHHHHHHHHHHccCCcccCcCHH-HHHHh
Confidence 2345789999999999999999998 45443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=325.28 Aligned_cols=249 Identities=26% Similarity=0.376 Sum_probs=190.6
Q ss_pred CcccceeeeccCceEEEEEEEC---CeEEEEEEEecCCcc--chHHHHHHHHHHHcC---CCCceeeEecccC-------
Q 005617 343 NFSESFKVGQGGFGCVYKGEML---GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKL---QHPHLVTLLGACP------- 407 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~---g~~vAIK~l~~~~~~--~~~~f~~E~~iL~~l---~HpnIV~l~g~~~------- 407 (688)
+|...+.||+|+||.||+|+.. |..||||++...... ....+.+|+.++..+ +||||++++++|.
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~ 81 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE 81 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence 6788899999999999999873 678999998754332 234566788877766 6999999999873
Q ss_pred CCceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCc
Q 005617 408 EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 487 (688)
Q Consensus 408 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGl 487 (688)
...++||||++ ++|.+++..... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 82 ~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 82 TKLTLVFEHVD-QDLTTYLDKVPE-PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CcEEEEEccCC-CCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence 23789999996 688888865432 45899999999999999999999966 99999999999999999999999999
Q ss_pred cccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHH--HhhcC-----
Q 005617 488 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR--AVSCG----- 560 (688)
Q Consensus 488 a~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~--~~~~g----- 560 (688)
++...... ......||+.|+|||++....++.++|||||||++|||++|++||........ .+...
T Consensus 157 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~ 229 (290)
T cd07862 157 ARIYSFQM-------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 229 (290)
T ss_pred eEeccCCc-------ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCC
Confidence 98764331 23456799999999999989999999999999999999999999975433211 11000
Q ss_pred --ccc-------cccCCCCC----CCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 561 --KLS-------SILDPLAG----DWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 561 --~l~-------~~ld~~~~----~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
... ..+.+... .........+.+|+.+||+.||++||++.+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 285 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 285 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHh
Confidence 000 00000000 01112455778999999999999999988443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=329.08 Aligned_cols=242 Identities=26% Similarity=0.366 Sum_probs=192.9
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHH---HcCCCCceeeEecccCC--CceeE
Q 005617 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVL---SKLQHPHLVTLLGACPE--AWSLV 413 (688)
Q Consensus 344 f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL---~~l~HpnIV~l~g~~~~--~~~LV 413 (688)
|.....||+|+||.||+|... |..||||++..... .....+.+|+.++ +.++||||+++++++.+ ..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 556789999999999999885 78999999975432 2234566776665 56689999999999843 58899
Q ss_pred EecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccC
Q 005617 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~ 493 (688)
|||+++|+|...+.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~~----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT----DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 999999999988754 35899999999999999999999966 99999999999999999999999999875432
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCCCC
Q 005617 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAG 571 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~ 571 (688)
.. .......||+.|+|||++.+..++.++|||||||++|||++|+.||..... +...+..+..
T Consensus 154 ~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~--------- 218 (324)
T cd05589 154 FG------DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV--------- 218 (324)
T ss_pred CC------CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---------
Confidence 21 122456799999999999999999999999999999999999999975432 2222222211
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHH
Q 005617 572 DWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 572 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~L 607 (688)
.+|...+..+.+++.+||+.||.+||++.+..+..+
T Consensus 219 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l 254 (324)
T cd05589 219 RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDV 254 (324)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHH
Confidence 233345677899999999999999998765433333
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=331.66 Aligned_cols=251 Identities=24% Similarity=0.322 Sum_probs=190.8
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC--ccchHHHHHHHHHHHcCCCCceeeEecccCC-------Cce
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-------AWS 411 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~--~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-------~~~ 411 (688)
+|.....||+|+||.||+|... |..||||++.... ......+.+|+.+++.++||||+++++++.. ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4777899999999999999875 7899999987532 2334568899999999999999999998721 268
Q ss_pred eEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccc
Q 005617 412 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~ 491 (688)
+||||+. ++|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKAN---DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHhc---ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 6888888644 35889999999999999999999966 999999999999999999999999999865
Q ss_pred cCCCCcCCCccccCCCCCCCCCCChhhhcc--CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHH--------------
Q 005617 492 TEDTLYLPSFHRSTAPKGSFPYADPEYHRT--GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR-------------- 555 (688)
Q Consensus 492 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~-------------- 555 (688)
...... ........||+.|+|||++.+ ..++.++|||||||++|||+||++||........
T Consensus 154 ~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 230 (338)
T cd07859 154 FNDTPT---AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE 230 (338)
T ss_pred ccccCc---cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 332211 011235679999999999866 6789999999999999999999999964332110
Q ss_pred ---HhhcCccccccC---C-CCCCC---CHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 556 ---AVSCGKLSSILD---P-LAGDW---PTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 556 ---~~~~g~l~~~ld---~-~~~~~---~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
.+........+. . ....+ .......+.+|+.+||+.||.+||++.+.+
T Consensus 231 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l 288 (338)
T cd07859 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEAL 288 (338)
T ss_pred HHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHh
Confidence 111110000000 0 00000 011345678999999999999999988544
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=331.62 Aligned_cols=237 Identities=27% Similarity=0.342 Sum_probs=193.8
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcC-CCCceeeEecccCC--CceeEE
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~~~LV~ 414 (688)
+|.....||+|+||.||+|... +..||||++..... .....+..|..++..+ +||+|+++++++.+ ..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5778899999999999999886 67899999976432 2234567788888887 58999999998843 578999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
||+++|+|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQV---GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 999999999988654 35788999999999999999999965 999999999999999999999999999764322
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCCCCC
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 495 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~ 572 (688)
.. ......||+.|+|||++....++.++|||||||++|||+||+.||..... ....+..+. ..
T Consensus 155 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~---------~~ 219 (323)
T cd05616 155 GV------TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN---------VA 219 (323)
T ss_pred CC------ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------CC
Confidence 21 22456799999999999999999999999999999999999999975442 222232222 12
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCCc
Q 005617 573 WPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 573 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~~ 600 (688)
+|...+..+.+|+.+|++.+|.+|++..
T Consensus 220 ~p~~~s~~~~~li~~~l~~~p~~R~~~~ 247 (323)
T cd05616 220 YPKSMSKEAVAICKGLMTKHPGKRLGCG 247 (323)
T ss_pred CCCcCCHHHHHHHHHHcccCHHhcCCCC
Confidence 3445567889999999999999999974
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=324.30 Aligned_cols=255 Identities=29% Similarity=0.470 Sum_probs=206.4
Q ss_pred cCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--Ccee
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSL 412 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~-------g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~L 412 (688)
.+|.....||+|+||.||+|... +..|++|.+..........|.+|+.++++++||||++++++|.+ ..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35777789999999999999753 35689999876665556779999999999999999999999854 4789
Q ss_pred EEecCCCCcHHHHhcccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCC
Q 005617 413 VYEYLPNGSLQDRLFRKSN-------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELS 479 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~ 479 (688)
||||+++++|.+++..... ...++|..++.++.+|+.||.|||+.+ |+||||||+|||++.++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 9999999999999865321 234899999999999999999999966 999999999999999999
Q ss_pred eEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--hHHHH
Q 005617 480 SKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRA 556 (688)
Q Consensus 480 vKLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~ 556 (688)
++|+|||++......... .......|+..|+|||++.+..++.++|||||||++|||+| |+.||.... .....
T Consensus 162 ~~l~dfg~a~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~ 237 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYY----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC 237 (291)
T ss_pred EEECCCCcccccCCCcee----ecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999765433211 12234567889999999999999999999999999999999 999985433 23333
Q ss_pred hhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHhhh
Q 005617 557 VSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 557 ~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l~~ 612 (688)
+..+.... .+...+..+.+|+.+||+.+|.+||++. .+.+.|+.+..
T Consensus 238 ~~~~~~~~--------~~~~~~~~~~~li~~~l~~~P~~Rpt~~-~v~~~l~~~~~ 284 (291)
T cd05094 238 ITQGRVLE--------RPRVCPKEVYDIMLGCWQREPQQRLNIK-EIYKILHALGK 284 (291)
T ss_pred HhCCCCCC--------CCccCCHHHHHHHHHHcccChhhCcCHH-HHHHHHHHHHh
Confidence 33332221 2223456789999999999999999999 78888888754
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=318.93 Aligned_cols=250 Identities=26% Similarity=0.431 Sum_probs=201.3
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecC
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 417 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~ 417 (688)
.+|...+.||.|+||.||+|... +..||+|.+.... .....+.+|+.++..++||||++++++|.. ..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 35777889999999999999875 7889999987543 345678999999999999999999999843 478999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCc
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~ 497 (688)
++++|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLRECN-RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 9999999986543 245899999999999999999999965 999999999999999999999999999876543211
Q ss_pred CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHHHhhcCccccccCCCCCCCC
Q 005617 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWP 574 (688)
Q Consensus 498 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~ 574 (688)
......+++.|+|||++.+..++.++|||||||++|||++ |..||..... ....+..+. ....+
T Consensus 161 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~--------~~~~~ 227 (263)
T cd05052 161 -----AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY--------RMERP 227 (263)
T ss_pred -----ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC--------CCCCC
Confidence 1122345678999999999999999999999999999998 9999864332 222222211 11223
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHh
Q 005617 575 TFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 575 ~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l 610 (688)
...+..+.+++.+||+.+|.+||++. .+.+.|+.+
T Consensus 228 ~~~~~~~~~li~~cl~~~p~~Rp~~~-~l~~~l~~~ 262 (263)
T cd05052 228 EGCPPKVYELMRACWQWNPSDRPSFA-EIHQAFETM 262 (263)
T ss_pred CCCCHHHHHHHHHHccCCcccCCCHH-HHHHHHHhh
Confidence 33457899999999999999999999 677777653
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=317.94 Aligned_cols=250 Identities=28% Similarity=0.448 Sum_probs=201.3
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecC
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 417 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~-g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~ 417 (688)
+++|...+.||+|+||.||+|.+. +..||||.++... .....|.+|+.++.+++||||+++++++.. ..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 456888899999999999999875 6789999987544 345679999999999999999999998854 478999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCc
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~ 497 (688)
++++|.+++.... ...++|..+..++.+++.||.|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999986543 346899999999999999999999965 999999999999999999999999999877532211
Q ss_pred CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHHHhhcCccccccCCCCCCCC
Q 005617 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWP 574 (688)
Q Consensus 498 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~ 574 (688)
......++..|+|||++.+..++.++||||||+++|||+| |+.||..... ....+..+.. ...+
T Consensus 160 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--------~~~~ 226 (261)
T cd05068 160 -----AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR--------MPCP 226 (261)
T ss_pred -----ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC--------CCCC
Confidence 1112233468999999999999999999999999999999 9999965432 2222222110 0112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHH
Q 005617 575 TFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 575 ~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~ 609 (688)
...+..+.+++.+|++.+|.+||++. .+...|+.
T Consensus 227 ~~~~~~~~~li~~~l~~~P~~Rp~~~-~l~~~l~~ 260 (261)
T cd05068 227 PGCPKELYDIMLDCWKEDPDDRPTFE-TLQWKLED 260 (261)
T ss_pred CcCCHHHHHHHHHHhhcCcccCCCHH-HHHHHHhc
Confidence 23456789999999999999999998 67766653
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=325.93 Aligned_cols=238 Identities=23% Similarity=0.338 Sum_probs=190.8
Q ss_pred eeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecCCCCcH
Q 005617 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSL 422 (688)
Q Consensus 350 LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~---~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gsL 422 (688)
||+|+||+||++... |..||||.+...... ....+..|+.++..++||||++++++|.. ..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999875 789999999754332 23457889999999999999999998744 47899999999999
Q ss_pred HHHhcccC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCCc
Q 005617 423 QDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 501 (688)
Q Consensus 423 ~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~~ 501 (688)
...+.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++..+.....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~----- 152 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS----- 152 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-----
Confidence 98875432 2356899999999999999999999965 99999999999999999999999999987654321
Q ss_pred cccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhH--HHHhhcCccccccCCCCCCCCHHHHH
Q 005617 502 HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGDWPTFVAR 579 (688)
Q Consensus 502 ~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~~~~g~l~~~ld~~~~~~~~~~~~ 579 (688)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+.... +.. ...++...+.
T Consensus 153 -~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~----~~~-~~~~~~~~~~ 226 (280)
T cd05608 153 -KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI----LND-SVTYPDKFSP 226 (280)
T ss_pred -cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhh----ccc-CCCCcccCCH
Confidence 123457999999999999999999999999999999999999999643221 11111110 110 1123445667
Q ss_pred HHHHHHHHccccCCCCCCCCch
Q 005617 580 RLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 580 ~l~~L~~~Cl~~dP~~RPs~~~ 601 (688)
.+.+++.+||+.||.+||++.+
T Consensus 227 ~~~~li~~~l~~~P~~R~~~~~ 248 (280)
T cd05608 227 ASKSFCEALLAKDPEKRLGFRD 248 (280)
T ss_pred HHHHHHHHHhcCCHHHhcCCCC
Confidence 8999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=321.84 Aligned_cols=253 Identities=29% Similarity=0.463 Sum_probs=200.0
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--C
Q 005617 340 ATCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--A 409 (688)
Q Consensus 340 at~~f~~~~~LG~G~fG~Vykg~~~-------g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~ 409 (688)
++++|...+.||+|+||.||+|.+. +..||||++..... .....|.+|+.++..++||||++++++|.+ .
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 5678999999999999999999764 35799999865432 334568999999999999999999999854 4
Q ss_pred ceeEEecCCCCcHHHHhcccCC-------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEE
Q 005617 410 WSLVYEYLPNGSLQDRLFRKSN-------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKI 482 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~~-------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL 482 (688)
.++||||+++|+|.+++..... ...++|..++.++.+++.||.|||+.+ ++|+||||+|||++.++.++|
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 7899999999999999865321 234688999999999999999999965 999999999999999999999
Q ss_pred eecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHHHhhc
Q 005617 483 CDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSC 559 (688)
Q Consensus 483 sDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~~~~ 559 (688)
+|||+++........ .......+++.|+|||++.++.++.++|||||||++|||++ |..||..... ....+..
T Consensus 161 ~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (277)
T cd05062 161 GDFGMTRDIYETDYY----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME 236 (277)
T ss_pred CCCCCccccCCccee----ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999865433211 11223456788999999999999999999999999999999 7889864432 2222222
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHH
Q 005617 560 GKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 560 g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le 608 (688)
+... ..+...+..+.+++.+||+.+|.+||++. +++..|+
T Consensus 237 ~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~-e~l~~l~ 276 (277)
T cd05062 237 GGLL--------DKPDNCPDMLFELMRMCWQYNPKMRPSFL-EIISSIK 276 (277)
T ss_pred CCcC--------CCCCCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHhh
Confidence 2221 12223456789999999999999999998 5555443
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=331.79 Aligned_cols=238 Identities=26% Similarity=0.339 Sum_probs=192.9
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC---ccchHHHHHHHHHHHcCCCC-ceeeEecccC--CCceeEE
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN---MQGQLEFQQEVRVLSKLQHP-HLVTLLGACP--EAWSLVY 414 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~---~~~~~~f~~E~~iL~~l~Hp-nIV~l~g~~~--~~~~LV~ 414 (688)
+|...+.||+|+||.||+|... +..||||++.... ......+..|+.++..+.|+ +|+++++++. +..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999886 6789999997642 23345688899999999765 5778888774 4588999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQV---GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 999999999988654 35789999999999999999999965 999999999999999999999999998753221
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCCCCC
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 495 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~ 572 (688)
. .......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ....+..+. ..
T Consensus 155 ~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~---------~~ 219 (324)
T cd05587 155 G------KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHN---------VS 219 (324)
T ss_pred C------CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC---------CC
Confidence 1 112345799999999999999999999999999999999999999975443 222222221 12
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCCch
Q 005617 573 WPTFVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 573 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~ 601 (688)
++...+..+.+|+.+||+.||.+||+...
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~ 248 (324)
T cd05587 220 YPKSLSKEAVSICKGLLTKHPAKRLGCGP 248 (324)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCCCC
Confidence 33445678899999999999999998753
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=330.81 Aligned_cols=234 Identities=27% Similarity=0.369 Sum_probs=188.6
Q ss_pred eeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcC-CCCceeeEecccCC--CceeEEecCCCC
Q 005617 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWSLVYEYLPNG 420 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~~~LV~E~~~~g 420 (688)
.||+|+||.||+|... +..||||+++.... .....+..|..++..+ +||||+++++++.. ..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg 81 (316)
T cd05592 2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 6999999999999886 67899999976432 2334466677777654 89999999998843 578999999999
Q ss_pred cHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCC
Q 005617 421 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 500 (688)
Q Consensus 421 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~ 500 (688)
+|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~L~~~~~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~----- 150 (316)
T cd05592 82 DLMFHIQSS---GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE----- 150 (316)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-----
Confidence 999988654 35788999999999999999999965 9999999999999999999999999998653322
Q ss_pred ccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCCCCCCCHHHH
Q 005617 501 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVA 578 (688)
Q Consensus 501 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~~~~~ 578 (688)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... +...+... ....|...+
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~---------~~~~~~~~~ 220 (316)
T cd05592 151 -GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND---------RPHFPRWIS 220 (316)
T ss_pred -CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC---------CCCCCCCCC
Confidence 122456799999999999999999999999999999999999999975443 22222111 112334456
Q ss_pred HHHHHHHHHccccCCCCCCCCchHH
Q 005617 579 RRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 579 ~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
..+.+|+.+||+.||.+||++.+.+
T Consensus 221 ~~~~~ll~~~l~~~P~~R~~~~~~l 245 (316)
T cd05592 221 KEAKDCLSKLFERDPTKRLGVDGDI 245 (316)
T ss_pred HHHHHHHHHHccCCHHHcCCChHHH
Confidence 6788999999999999999986444
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=336.04 Aligned_cols=252 Identities=26% Similarity=0.331 Sum_probs=203.5
Q ss_pred HhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccch-HHHHHHHHHHHcCC-CCceeeEecccCC---Ccee
Q 005617 340 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQ-LEFQQEVRVLSKLQ-HPHLVTLLGACPE---AWSL 412 (688)
Q Consensus 340 at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~-~~f~~E~~iL~~l~-HpnIV~l~g~~~~---~~~L 412 (688)
.-++|...++||.|.||.||+|+.. |..||||.++..-.... ..-.+|+..|.+|+ |||||+|..++.+ .+++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 3467888899999999999999875 88999999876543322 23568999999998 9999999999844 4789
Q ss_pred EEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCcccccc
Q 005617 413 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 492 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~ 492 (688)
|||||+ .+|..++..+ ..+|+...+..|+.||++||+|+|.+| +.|||+||+|||+..+..+||+|||+|+.+.
T Consensus 88 VfE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 999995 6899988776 378999999999999999999999977 9999999999999999999999999999886
Q ss_pred CCCCcCCCccccCCCCCCCCCCChhhh-ccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhc----C-------
Q 005617 493 EDTLYLPSFHRSTAPKGSFPYADPEYH-RTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC----G------- 560 (688)
Q Consensus 493 ~~~~~~~~~~~~~~~~GT~~Y~APE~~-~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~----g------- 560 (688)
... ..+..+.|.+|.|||++ ..+.|+.+.|+||+|||++|+.+-++-|.+..++.+.+.. |
T Consensus 162 Skp-------PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~ 234 (538)
T KOG0661|consen 162 SKP-------PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSW 234 (538)
T ss_pred cCC-------CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccc
Confidence 543 34677899999999976 5678999999999999999999999999877765544321 1
Q ss_pred ----ccccccCCC--------CCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHH
Q 005617 561 ----KLSSILDPL--------AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 604 (688)
Q Consensus 561 ----~l~~~ld~~--------~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~ 604 (688)
.+...+... ....-+..+.++++|+.+||.+||.+|||+.+.+.
T Consensus 235 ~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~ 290 (538)
T KOG0661|consen 235 PEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ 290 (538)
T ss_pred hhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence 011111110 11111236778999999999999999999985543
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=324.71 Aligned_cols=245 Identities=37% Similarity=0.625 Sum_probs=191.6
Q ss_pred cceeeeccCceEEEEEEEC------CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEec
Q 005617 346 ESFKVGQGGFGCVYKGEML------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 416 (688)
Q Consensus 346 ~~~~LG~G~fG~Vykg~~~------g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~ 416 (688)
....||.|.||.||+|.+. +..|+||.++.... .....|.+|+.++.+++||||++++|+|. +..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3468999999999999987 67899999966433 34678999999999999999999999995 347899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCC
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~ 496 (688)
+++|+|.++|.... ...+++..++.|+.||+.||.|||+.+ |+|+||+++|||++.++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~~-~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSKN-KEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHTC-TTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred cccccccccccccc-ccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 99999999998762 256899999999999999999999965 99999999999999999999999999987732221
Q ss_pred cCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--hHHHHhhcCccccccCCCCCCC
Q 005617 497 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 497 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~~~~g~l~~~ld~~~~~~ 573 (688)
. .......+...|+|||.+....++.++||||||+++|||+| |+.||.... .+...+..+... ..
T Consensus 159 ~----~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~--------~~ 226 (259)
T PF07714_consen 159 Y----KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRL--------PI 226 (259)
T ss_dssp E----EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEET--------TS
T ss_pred c----ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--------ee
Confidence 1 12344557788999999999999999999999999999999 789986433 223334333321 12
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCCchHHHHHH
Q 005617 574 PTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 574 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~L 607 (688)
+...+..+.+++..||..+|.+||++. ++++.|
T Consensus 227 ~~~~~~~~~~li~~C~~~~p~~RPs~~-~i~~~L 259 (259)
T PF07714_consen 227 PDNCPKDIYSLIQQCWSHDPEKRPSFQ-EILQEL 259 (259)
T ss_dssp BTTSBHHHHHHHHHHT-SSGGGS--HH-HHHHHH
T ss_pred ccchhHHHHHHHHHHcCCChhhCcCHH-HHHhcC
Confidence 233456788999999999999999998 555443
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=309.46 Aligned_cols=241 Identities=25% Similarity=0.372 Sum_probs=204.6
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|..++.||+|-||.||.|+.+ +..||+|++.+... ....++.+|++|-+.|+||||+++||+|-+ ..||++
T Consensus 22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLil 101 (281)
T KOG0580|consen 22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLIL 101 (281)
T ss_pred hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEE
Confidence 56788899999999999999886 67899999987643 334578999999999999999999999965 489999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
||.++|+|...|..... ..++......++.|+|.||.|+|..+ ||||||||+|+|++..+.+||+|||.+...+.+
T Consensus 102 Eya~~gel~k~L~~~~~-~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~ 177 (281)
T KOG0580|consen 102 EYAPRGELYKDLQEGRM-KRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSN 177 (281)
T ss_pred EecCCchHHHHHHhccc-ccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCCC
Confidence 99999999999974432 45777888999999999999999955 999999999999999999999999999876532
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh--hHHHHhhcCccccccCCCCCC
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 495 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~--~~~~~~~~g~l~~~ld~~~~~ 572 (688)
+..+.+||..|.+||...+..++..+|+|++|++.||++.|.+||.... +....+..- ...
T Consensus 178 --------kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~---------~~~ 240 (281)
T KOG0580|consen 178 --------KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV---------DLK 240 (281)
T ss_pred --------CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc---------ccc
Confidence 3567899999999999999999999999999999999999999997443 222333222 124
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 573 WPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 573 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
+|..++....+|+.+|+..+|.+|....+.+
T Consensus 241 ~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~ 271 (281)
T KOG0580|consen 241 FPSTISGGAADLISRLLVKNPIERLALTEVM 271 (281)
T ss_pred CCcccChhHHHHHHHHhccCccccccHHHHh
Confidence 4567788999999999999999999887443
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=335.50 Aligned_cols=248 Identities=25% Similarity=0.339 Sum_probs=197.2
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|...+.||+|+||.||+|... |..||||++..... .....+..|+.++..++||||+++++++.+ ..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888899999999999999986 89999999976432 334568899999999999999999999854 478999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
||+++|+|.+++... ..+++..+..|+.||+.||.|||..+ |+||||||+||||+.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999999765 46889999999999999999999965 999999999999999999999999999876543
Q ss_pred CCc-----------------------CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh
Q 005617 495 TLY-----------------------LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG 551 (688)
Q Consensus 495 ~~~-----------------------~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~ 551 (688)
... ...........||+.|+|||++.+..++.++|||||||+||||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 200 000012345679999999999999999999999999999999999999997554
Q ss_pred hHH--HHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCC-Cch
Q 005617 552 EVR--RAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPD-ITP 601 (688)
Q Consensus 552 ~~~--~~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs-~~~ 601 (688)
... ..+.... ....-+.. ...+..+.+|+.+|+. +|.+||+ +.+
T Consensus 235 ~~~~~~~i~~~~-~~~~~p~~----~~~~~~~~~li~~ll~-dp~~R~~s~~~ 281 (350)
T cd05573 235 LQETYNKIINWK-ESLRFPPD----PPVSPEAIDLICRLLC-DPEDRLGSFEE 281 (350)
T ss_pred HHHHHHHHhccC-CcccCCCC----CCCCHHHHHHHHHHcc-ChhhcCCCHHH
Confidence 322 1121100 00000111 1146678899999997 9999999 663
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=321.77 Aligned_cols=251 Identities=30% Similarity=0.526 Sum_probs=206.7
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEec
Q 005617 340 ATCNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 340 at~~f~~~~~LG~G~fG~Vykg~~~-g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
...+|...+.||.|+||.||+|... +..||+|.+..........+..|+.++..++||||+++++++.+ ..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 3457888899999999999999886 68899999987766566789999999999999999999998844 47899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCC
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~ 496 (688)
+++|+|.+++..... ..+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 84 MEKGSLLAFLRSPEG-QVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred cccCCHHHHHhcCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 999999999976532 46899999999999999999999966 99999999999999999999999999987654321
Q ss_pred cCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--hHHHHhhcCccccccCCCCCCC
Q 005617 497 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 497 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~~~~g~l~~~ld~~~~~~ 573 (688)
......++..|++||++....++.++||||||+++|+|++ |+.||.... .....+..+.. ...
T Consensus 160 ------~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------~~~ 225 (261)
T cd05148 160 ------LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR--------MPC 225 (261)
T ss_pred ------cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc--------CCC
Confidence 1224456788999999998999999999999999999998 899996533 22222222111 112
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHH
Q 005617 574 PTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 574 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~ 609 (688)
+...+..+.+++.+||+.+|.+||++. ++.+.|+.
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~-~l~~~L~~ 260 (261)
T cd05148 226 PAKCPQEIYKIMLECWAAEPEDRPSFK-ALREELDN 260 (261)
T ss_pred CCCCCHHHHHHHHHHcCCCchhCcCHH-HHHHHHhc
Confidence 234456789999999999999999999 77777764
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=337.68 Aligned_cols=245 Identities=24% Similarity=0.322 Sum_probs=192.0
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|...+.||+|+||.||+|+.. |..||||++..... .....+.+|+.++..++||||++++++|.+ ..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47888999999999999999885 78999999976432 233457889999999999999999999854 488999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
||+++|+|.+++.... .+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~~g~L~~~l~~~~---~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMKKD---TFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 9999999999987543 5889999999999999999999966 999999999999999999999999999765322
Q ss_pred CCcCC--------------------------------CccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh
Q 005617 495 TLYLP--------------------------------SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 542 (688)
Q Consensus 495 ~~~~~--------------------------------~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt 542 (688)
..... ........+||+.|+|||++....++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 10000 0001123579999999999999999999999999999999999
Q ss_pred CCCCCCChhhHH--HHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 005617 543 GRLPVGLAGEVR--RAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPD 598 (688)
Q Consensus 543 G~~Pf~~~~~~~--~~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs 598 (688)
|..||....... ..+..... ...-+. ....+..+.+|+.+|+. +|.+|++
T Consensus 235 G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~----~~~~s~~~~~li~~ll~-~p~~R~~ 286 (364)
T cd05599 235 GYPPFCSDNPQETYRKIINWKE-TLQFPD----EVPLSPEAKDLIKRLCC-EAERRLG 286 (364)
T ss_pred CCCCCCCCCHHHHHHHHHcCCC-ccCCCC----CCCCCHHHHHHHHHHcc-CHhhcCC
Confidence 999997544322 11211110 000011 11235577889999996 9999998
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=340.12 Aligned_cols=256 Identities=26% Similarity=0.399 Sum_probs=203.8
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCcc-chHHHHHHHHHHHcCC-CCceeeEecccCC-
Q 005617 339 TATCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQ-HPHLVTLLGACPE- 408 (688)
Q Consensus 339 ~at~~f~~~~~LG~G~fG~Vykg~~~-------g~~vAIK~l~~~~~~-~~~~f~~E~~iL~~l~-HpnIV~l~g~~~~- 408 (688)
...++|...+.||+|+||.||+|... +..||||++...... ....|.+|+.+|.++. |||||+++|+|.+
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 33578888999999999999999863 246999999754332 3456999999999996 9999999999954
Q ss_pred -CceeEEecCCCCcHHHHhcccC---------------------------------------------------------
Q 005617 409 -AWSLVYEYLPNGSLQDRLFRKS--------------------------------------------------------- 430 (688)
Q Consensus 409 -~~~LV~E~~~~gsL~~~L~~~~--------------------------------------------------------- 430 (688)
..+|||||+++|+|.++|....
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 4889999999999999886431
Q ss_pred ------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceee
Q 005617 431 ------------------------------------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL 474 (688)
Q Consensus 431 ------------------------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILL 474 (688)
....+++..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill 270 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEE
Confidence 0134788999999999999999999965 9999999999999
Q ss_pred CCCCCeEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--
Q 005617 475 DSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG-- 551 (688)
Q Consensus 475 d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~-- 551 (688)
+.++.+||+|||+++........ .......|++.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~ 346 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNY----VSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVD 346 (400)
T ss_pred eCCCEEEEEeCCcceeccccccc----cccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence 99999999999999876433211 12234457889999999999999999999999999999997 999986432
Q ss_pred -hHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHh
Q 005617 552 -EVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 552 -~~~~~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l 610 (688)
.....+..+.. ...+...+..+.+|+.+||+.+|++||++. .|.+.|+.+
T Consensus 347 ~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~-~l~~~l~~l 397 (400)
T cd05105 347 STFYNKIKSGYR--------MAKPDHATQEVYDIMVKCWNSEPEKRPSFL-HLSDIVESL 397 (400)
T ss_pred HHHHHHHhcCCC--------CCCCccCCHHHHHHHHHHCccCHhHCcCHH-HHHHHHHHH
Confidence 22222222211 112234456889999999999999999998 788888765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=362.87 Aligned_cols=250 Identities=31% Similarity=0.533 Sum_probs=205.9
Q ss_pred cccceeeeccCceEEEEEEEC---Ce----EEEEEEEecCC-ccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeE
Q 005617 344 FSESFKVGQGGFGCVYKGEML---GR----TVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLV 413 (688)
Q Consensus 344 f~~~~~LG~G~fG~Vykg~~~---g~----~vAIK~l~~~~-~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV 413 (688)
......||+|.||.||.|... |. .||||.++... .+...+|.+|..+|++++|||||+++|+|.+ ..+|+
T Consensus 694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~ 773 (1025)
T KOG1095|consen 694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLIL 773 (1025)
T ss_pred eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEE
Confidence 345678999999999999885 33 39999997664 4566789999999999999999999999954 47899
Q ss_pred EecCCCCcHHHHhcccC----CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccc
Q 005617 414 YEYLPNGSLQDRLFRKS----NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~----~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~ 489 (688)
+|||.+|+|..+|.+.. ....++..+.+.|+.+||+|+.||++.+ +|||||...|+||+....|||+|||+|+
T Consensus 774 leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlAr 850 (1025)
T KOG1095|consen 774 LEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLAR 850 (1025)
T ss_pred ehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchhH
Confidence 99999999999998762 1356889999999999999999999966 9999999999999999999999999999
Q ss_pred cccCCCCcCCCccccCCC-CCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHH-HhhcCcccc
Q 005617 490 LVTEDTLYLPSFHRSTAP-KGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRR-AVSCGKLSS 564 (688)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~-~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~-~~~~g~l~~ 564 (688)
.+-....+ +.... .-...|||||.+..+.++.|+|||||||+|||++| |..||....+ +.. ....|++
T Consensus 851 Diy~~~yy-----r~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL-- 923 (1025)
T KOG1095|consen 851 DIYDKDYY-----RKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRL-- 923 (1025)
T ss_pred hhhhchhe-----eccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCcc--
Confidence 55443322 11111 22347999999999999999999999999999999 9999986654 333 2334422
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHhh
Q 005617 565 ILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 565 ~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l~ 611 (688)
+.|..++..+.+|+++||+.+|++||+++ .+++.+..+.
T Consensus 924 -------~~P~~CP~~ly~lM~~CW~~~pe~RP~F~-~i~~q~~~i~ 962 (1025)
T KOG1095|consen 924 -------DPPSYCPEKLYQLMLQCWKHDPEDRPSFR-TIVEQDPAIS 962 (1025)
T ss_pred -------CCCCCCChHHHHHHHHHccCChhhCccHH-HHHhhhhhhh
Confidence 44666778899999999999999999999 6666666553
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=317.34 Aligned_cols=251 Identities=27% Similarity=0.436 Sum_probs=201.4
Q ss_pred cCcccceeeeccCceEEEEEEEC-----CeEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccCC--CceeE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML-----GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~-----g~~vAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV 413 (688)
++|...+.||+|+||.||+|.+. ...||||.+...... ....|.+|+.++..++||||+++++++.+ ..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 56888899999999999999874 347999998755433 34578999999999999999999998844 47899
Q ss_pred EecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccC
Q 005617 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~ 493 (688)
|||+++++|.+++.... ..+++..++.++.+++.||.|||+.+ |+|+||||+|||++.++.++|+|||+++....
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREND--GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 99999999999986643 36899999999999999999999966 99999999999999999999999999998752
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHHHhhcCccccccCCCC
Q 005617 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~~~~g~l~~~ld~~~ 570 (688)
.... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||..... ....+..+...
T Consensus 159 ~~~~----~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~------- 227 (266)
T cd05033 159 SEAT----YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRL------- 227 (266)
T ss_pred cccc----eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-------
Confidence 2211 11223446788999999999999999999999999999998 9999864332 22333222111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHh
Q 005617 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 571 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l 610 (688)
..+...+..+.+|+.+||+.+|.+||++. ++...|+.+
T Consensus 228 -~~~~~~~~~l~~li~~cl~~~p~~Rp~~~-ei~~~l~~~ 265 (266)
T cd05033 228 -PPPMDCPSALYQLMLDCWQKDRNERPTFS-QIVSTLDKM 265 (266)
T ss_pred -CCCCCCCHHHHHHHHHHcCCCcccCcCHH-HHHHHHHhh
Confidence 11223456789999999999999999998 677776643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=319.84 Aligned_cols=252 Identities=26% Similarity=0.397 Sum_probs=198.8
Q ss_pred cCcccceeeeccCceEEEEEEEC--Ce----EEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC-CceeE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GR----TVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~----~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV 413 (688)
.+|...+.||.|+||.||+|.+. |. .|++|.+..... ....++..|+.+++.+.||||++++|++.. ..++|
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i 86 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLV 86 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEE
Confidence 35666788999999999999874 44 477887754322 223467888889999999999999999854 46799
Q ss_pred EecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccC
Q 005617 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~ 493 (688)
+||+++|+|.+++.... ..++|..+..|+.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++....
T Consensus 87 ~e~~~~gsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 87 TQLSPLGSLLDHVRQHR--DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred EEeCCCCcHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 99999999999997543 46899999999999999999999965 99999999999999999999999999987643
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHHHhhcCccccccCCCC
Q 005617 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~~~~g~l~~~ld~~~ 570 (688)
.... .......|+..|+|||++.++.++.++|||||||++|||+| |..||..... ....+..+....
T Consensus 162 ~~~~----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~------ 231 (279)
T cd05111 162 DDKK----YFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLA------ 231 (279)
T ss_pred CCcc----cccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCC------
Confidence 3211 11234567889999999999999999999999999999998 9999965432 233333332211
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHhh
Q 005617 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 571 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l~ 611 (688)
.+......+..++.+||..+|..||++. ++...|..+.
T Consensus 232 --~~~~~~~~~~~li~~c~~~~p~~Rps~~-el~~~l~~~~ 269 (279)
T cd05111 232 --QPQICTIDVYMVMVKCWMIDENVRPTFK-ELANEFTRMA 269 (279)
T ss_pred --CCCCCCHHHHHHHHHHcCCCcccCcCHH-HHHHHHHHHH
Confidence 1112234678899999999999999998 6777776654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=348.31 Aligned_cols=255 Identities=21% Similarity=0.283 Sum_probs=205.6
Q ss_pred HHHHHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC--
Q 005617 335 ADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE-- 408 (688)
Q Consensus 335 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-- 408 (688)
.++....++|...+.||+|+||+||+|... |..||||++..... .....+.+|+.++..++|+||+++++.+..
T Consensus 25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~ 104 (496)
T PTZ00283 25 ATAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD 104 (496)
T ss_pred ccccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence 445556789999999999999999999874 89999999976543 334568899999999999999999876621
Q ss_pred --------CceeEEecCCCCcHHHHhcccC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCC
Q 005617 409 --------AWSLVYEYLPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELS 479 (688)
Q Consensus 409 --------~~~LV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~ 479 (688)
..++||||+++|+|.+++.... ....+++..+..|+.|++.||.|||+.+ |+||||||+||||+.++.
T Consensus 105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~ 181 (496)
T PTZ00283 105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGL 181 (496)
T ss_pred ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCC
Confidence 1568999999999999886532 3357899999999999999999999965 999999999999999999
Q ss_pred eEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHh
Q 005617 480 SKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAV 557 (688)
Q Consensus 480 vKLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~ 557 (688)
+||+|||+++.+...... .......||+.|+|||++.+..++.++|||||||+||||++|+.||..... +...+
T Consensus 182 vkL~DFGls~~~~~~~~~----~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~ 257 (496)
T PTZ00283 182 VKLGDFGFSKMYAATVSD----DVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT 257 (496)
T ss_pred EEEEecccCeeccccccc----cccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 999999999876432211 123456799999999999999999999999999999999999999975432 22222
Q ss_pred hcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHH
Q 005617 558 SCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 604 (688)
Q Consensus 558 ~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~ 604 (688)
..+... ..+...+..+.+|+.+||+.||.+||++.+.+.
T Consensus 258 ~~~~~~--------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~ 296 (496)
T PTZ00283 258 LAGRYD--------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLN 296 (496)
T ss_pred hcCCCC--------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHh
Confidence 222211 123345678999999999999999999986543
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=330.56 Aligned_cols=231 Identities=27% Similarity=0.406 Sum_probs=188.4
Q ss_pred eeeeccCceEEEEEEE-----CCeEEEEEEEecCCc----cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEec
Q 005617 348 FKVGQGGFGCVYKGEM-----LGRTVAIKMLYSHNM----QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 348 ~~LG~G~fG~Vykg~~-----~g~~vAIK~l~~~~~----~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
+.||+|+||.||++.. .+..||||++..... .....+.+|+.+|..++||||++++++|.. ..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 5799999999999975 378899999975422 223457889999999999999999998844 47899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCC
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~ 496 (688)
+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLERE---GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 9999999988654 35778889999999999999999966 99999999999999999999999999875432221
Q ss_pred cCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhH--HHHhhcCccccccCCCCCCCC
Q 005617 497 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGDWP 574 (688)
Q Consensus 497 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~~~~g~l~~~ld~~~~~~~ 574 (688)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+..+.. ..+
T Consensus 156 ------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~---------~~~ 220 (323)
T cd05584 156 ------VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKL---------NLP 220 (323)
T ss_pred ------cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---------CCC
Confidence 123457999999999999989999999999999999999999999754432 222222221 233
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCC
Q 005617 575 TFVARRLVDLGLQCCELYGRERPDI 599 (688)
Q Consensus 575 ~~~~~~l~~L~~~Cl~~dP~~RPs~ 599 (688)
...+..+.+|+.+||+.+|.+||+.
T Consensus 221 ~~~~~~~~~li~~~l~~~p~~R~~~ 245 (323)
T cd05584 221 PYLTPEARDLLKKLLKRNPSSRLGA 245 (323)
T ss_pred CCCCHHHHHHHHHHcccCHhHcCCC
Confidence 3456788999999999999999953
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=321.49 Aligned_cols=255 Identities=28% Similarity=0.449 Sum_probs=205.5
Q ss_pred cCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCcee
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSL 412 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~-------g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~L 412 (688)
.+|...+.||.|+||.||++... +..||+|.+..........|.+|+.++.+++||||++++++|. +..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 56788899999999999999752 3568999987665555667999999999999999999999985 45889
Q ss_pred EEecCCCCcHHHHhcccC----------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEE
Q 005617 413 VYEYLPNGSLQDRLFRKS----------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKI 482 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~----------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL 482 (688)
||||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ ++||||||+|||++.++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999886432 1235899999999999999999999965 999999999999999999999
Q ss_pred eecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--hHHHHhhc
Q 005617 483 CDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSC 559 (688)
Q Consensus 483 sDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~~~~ 559 (688)
+|||+++........ .......+++.|+|||++.+..++.++|||||||++|+|+| |.+||.... .....+..
T Consensus 162 ~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~ 237 (288)
T cd05093 162 GDFGMSRDVYSTDYY----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ 237 (288)
T ss_pred ccCCccccccCCcee----ecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 999999865432211 11234456789999999999999999999999999999999 999986543 23334444
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHhhh
Q 005617 560 GKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 560 g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l~~ 612 (688)
+.... .+...+..+.+|+.+||+.||.+||++. ++...|+.+..
T Consensus 238 ~~~~~--------~~~~~~~~l~~li~~~l~~~p~~Rpt~~-~v~~~l~~~~~ 281 (288)
T cd05093 238 GRVLQ--------RPRTCPKEVYDLMLGCWQREPHMRLNIK-EIHSLLQNLAK 281 (288)
T ss_pred CCcCC--------CCCCCCHHHHHHHHHHccCChhhCCCHH-HHHHHHHHHHH
Confidence 43221 1122345789999999999999999998 77788887653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=324.70 Aligned_cols=250 Identities=21% Similarity=0.335 Sum_probs=190.8
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEe
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E 415 (688)
.++|...+.||.|+||.||+|... |..||||++..... .....+.+|+.+++.++||||+++++++.+ ..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467889999999999999999885 78999999875543 233467889999999999999999999843 5789999
Q ss_pred cCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCC
Q 005617 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~ 495 (688)
|+. ++|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDKHP--GGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 57777665432 45788999999999999999999966 9999999999999999999999999987543221
Q ss_pred CcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhh-----cCccc------
Q 005617 496 LYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS-----CGKLS------ 563 (688)
Q Consensus 496 ~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~-----~g~l~------ 563 (688)
. ......||+.|+|||++.+ ..++.++|||||||++|+|+||..||.........+. .+...
T Consensus 158 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 231 (303)
T cd07869 158 H------TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPG 231 (303)
T ss_pred c------cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccc
Confidence 1 1234568999999998865 4588999999999999999999999975433221110 00000
Q ss_pred --c--ccCCCC-C-CCCH---------HHHHHHHHHHHHccccCCCCCCCCchH
Q 005617 564 --S--ILDPLA-G-DWPT---------FVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 564 --~--~ld~~~-~-~~~~---------~~~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
. .+++.. . ..+. .....+.+|+.+|++.||.+|||+.+.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~ 285 (303)
T cd07869 232 VHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAA 285 (303)
T ss_pred hhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHH
Confidence 0 000000 0 0000 123467899999999999999998743
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=324.08 Aligned_cols=249 Identities=23% Similarity=0.301 Sum_probs=191.4
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEec
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
.+|...+.||.|+||.||+|... +..||+|++..... .....+.+|+.++.+++||||+++++++.+ ..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888899999999999999875 78999999875433 234467899999999999999999999854 47899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCC
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~ 496 (688)
+++ +|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDNCG--NLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 985 8888876543 35788999999999999999999965 99999999999999999999999999976543221
Q ss_pred cCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHH---Hhh-cC-----------
Q 005617 497 YLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR---AVS-CG----------- 560 (688)
Q Consensus 497 ~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~---~~~-~g----------- 560 (688)
......||+.|+|||++.+ ..++.++|||||||++|+|+||++||........ ... .+
T Consensus 159 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (288)
T cd07871 159 ------TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGIT 232 (288)
T ss_pred ------cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccc
Confidence 1234578999999998865 5689999999999999999999999964332110 000 00
Q ss_pred ---ccccccCCCC-----CCCCHHHHHHHHHHHHHccccCCCCCCCCchH
Q 005617 561 ---KLSSILDPLA-----GDWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 561 ---~l~~~ld~~~-----~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
.+...+.+.. ..........+.+|+.+|++.||.+|||+.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~ 282 (288)
T cd07871 233 SNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAA 282 (288)
T ss_pred cchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHH
Confidence 0000010100 00011234578899999999999999998844
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=315.48 Aligned_cols=243 Identities=28% Similarity=0.472 Sum_probs=195.9
Q ss_pred eeeccCceEEEEEEEC----CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccC-CCceeEEecCCCCc
Q 005617 349 KVGQGGFGCVYKGEML----GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACP-EAWSLVYEYLPNGS 421 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~----g~~vAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~-~~~~LV~E~~~~gs 421 (688)
.||+|+||.||+|.+. +..||+|++..... .....|.+|+.++..+.||||++++|++. +..++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~ 81 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGP 81 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCc
Confidence 5899999999999753 67899999865433 23457899999999999999999999985 45789999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCCc
Q 005617 422 LQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 501 (688)
Q Consensus 422 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~~ 501 (688)
|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||.|||++.++.+||+|||++..........
T Consensus 82 L~~~l~~~---~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~--- 152 (257)
T cd05116 82 LNKFLQKN---KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY--- 152 (257)
T ss_pred HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCee---
Confidence 99998653 35789999999999999999999965 9999999999999999999999999998765432110
Q ss_pred cccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--hHHHHhhcCccccccCCCCCCCCHHHH
Q 005617 502 HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLAGDWPTFVA 578 (688)
Q Consensus 502 ~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~~~~g~l~~~ld~~~~~~~~~~~ 578 (688)
.......++..|+|||.+....++.++|||||||++|||++ |..||.... .+...+..+... ..|...+
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~--------~~~~~~~ 224 (257)
T cd05116 153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERM--------ECPQRCP 224 (257)
T ss_pred eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCC--------CCCCCCC
Confidence 11223345689999999988889999999999999999998 999997432 233334333211 2333456
Q ss_pred HHHHHHHHHccccCCCCCCCCchHHHHHHHH
Q 005617 579 RRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 579 ~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~ 609 (688)
..+.+|+.+||+.||.+||++. .|+..|+.
T Consensus 225 ~~l~~li~~~~~~~p~~Rp~~~-~i~~~l~~ 254 (257)
T cd05116 225 PEMYDLMKLCWTYGVDERPGFA-VVELRLRN 254 (257)
T ss_pred HHHHHHHHHHhccCchhCcCHH-HHHHHHhc
Confidence 7889999999999999999998 77777764
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-37 Score=329.22 Aligned_cols=253 Identities=25% Similarity=0.380 Sum_probs=197.4
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEe
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYE 415 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E 415 (688)
.++|...+.||.|+||.||++.+. |..||+|.+..... .....+.+|+.++..++|||||+++++|. +..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367888999999999999999886 78899998876432 23456899999999999999999999984 35889999
Q ss_pred cCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCC
Q 005617 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~ 495 (688)
|+++|+|.+++... ..+++..+..++.+++.||.|||+.+ +|+||||||+|||++.++.+||+|||++.......
T Consensus 84 ~~~~~~L~~~l~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~ 158 (333)
T cd06650 84 HMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 158 (333)
T ss_pred cCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence 99999999998654 35788999999999999999999843 49999999999999999999999999997654321
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhh---cCccccc-----
Q 005617 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVS---CGKLSSI----- 565 (688)
Q Consensus 496 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~---~g~l~~~----- 565 (688)
.....||..|+|||++.+..++.++|||||||++|+|++|+.||..... ....+. .+.....
T Consensus 159 --------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (333)
T cd06650 159 --------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPR 230 (333)
T ss_pred --------cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcc
Confidence 2345699999999999988999999999999999999999999964332 111110 0000000
Q ss_pred ------------------------cC----CCCCCCC-HHHHHHHHHHHHHccccCCCCCCCCchHHHHH
Q 005617 566 ------------------------LD----PLAGDWP-TFVARRLVDLGLQCCELYGRERPDITPSLVKE 606 (688)
Q Consensus 566 ------------------------ld----~~~~~~~-~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~ 606 (688)
.+ ......+ ......+.+|+.+||+.||.+||++.+.+.+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~ 300 (333)
T cd06650 231 PRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHA 300 (333)
T ss_pred cCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCH
Confidence 00 0000000 01345789999999999999999998655433
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=306.98 Aligned_cols=249 Identities=26% Similarity=0.363 Sum_probs=199.5
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccc--hHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEec
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG--QLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~--~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
.|...+.||+|.||.||+|++. |+.||||+++.....+ .....+|++.|+.++|+|||.|+++|.+ +..||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 4666688999999999999986 8999999998764432 2357899999999999999999999965 57899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCC
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~ 496 (688)
|+ .+|+..+.... ..++-.++..++.++++||+|||... |+||||||.|+|++.+|.+||+|||+|+.+.....
T Consensus 83 m~-tdLe~vIkd~~--i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~ 156 (318)
T KOG0659|consen 83 MP-TDLEVVIKDKN--IILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR 156 (318)
T ss_pred cc-ccHHHHhcccc--cccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence 96 58999887655 56788899999999999999999977 99999999999999999999999999999875442
Q ss_pred cCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhc------C------ccc
Q 005617 497 YLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC------G------KLS 563 (688)
Q Consensus 497 ~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~------g------~l~ 563 (688)
. .+..+-|-.|.|||.+.+ ..|+..+|+||.|||+.||+-|.+-|.+..++.+.... . .+.
T Consensus 157 ~------~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~ 230 (318)
T KOG0659|consen 157 I------QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMT 230 (318)
T ss_pred c------cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCcccc
Confidence 2 233478999999997755 57999999999999999999999988777665543211 0 111
Q ss_pred cccC---------CCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 564 SILD---------PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 564 ~~ld---------~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
.+.| +.....-+..+..+++|+..++..||.+|+++.+.+
T Consensus 231 ~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL 279 (318)
T KOG0659|consen 231 SLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQAL 279 (318)
T ss_pred ccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHh
Confidence 1111 111111223456789999999999999999988544
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=327.06 Aligned_cols=239 Identities=26% Similarity=0.338 Sum_probs=190.3
Q ss_pred eeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHH-HHHcCCCCceeeEecccCC--CceeEEecCCCC
Q 005617 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVR-VLSKLQHPHLVTLLGACPE--AWSLVYEYLPNG 420 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~-iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~g 420 (688)
.||+|+||.||+|... |..||||++..... .....+..|.. ++..++||||+++++++.+ ..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g 81 (323)
T cd05575 2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG 81 (323)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence 6999999999999985 88999999975432 22334555555 4678999999999998843 578999999999
Q ss_pred cHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCC
Q 005617 421 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 500 (688)
Q Consensus 421 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~ 500 (688)
+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~----- 150 (323)
T cd05575 82 ELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS----- 150 (323)
T ss_pred CHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-----
Confidence 999988654 35788999999999999999999966 9999999999999999999999999987543221
Q ss_pred ccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCCCCCCCHHHH
Q 005617 501 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVA 578 (688)
Q Consensus 501 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~~~~~ 578 (688)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+..+.. ..+...+
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---------~~~~~~~ 220 (323)
T cd05575 151 -KTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPL---------RLKPNIS 220 (323)
T ss_pred -CccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCC---------CCCCCCC
Confidence 123455799999999999999999999999999999999999999975432 2222222211 1222346
Q ss_pred HHHHHHHHHccccCCCCCCCCchHHHHHHH
Q 005617 579 RRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 579 ~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le 608 (688)
..+.+|+.+|++.||.+||++.+.+.+.++
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~~~~~il~ 250 (323)
T cd05575 221 VSARHLLEGLLQKDRTKRLGAKDDFLEIKN 250 (323)
T ss_pred HHHHHHHHHHhhcCHHhCCCCCCCHHHHHc
Confidence 678999999999999999999755544444
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=328.76 Aligned_cols=244 Identities=25% Similarity=0.349 Sum_probs=195.4
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCC-CCceeeEecccC--CCceeEE
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQ-HPHLVTLLGACP--EAWSLVY 414 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~-HpnIV~l~g~~~--~~~~LV~ 414 (688)
+|...+.||+|+||.||+|... |..||||++..... .....+..|..++..+. |++|+++++++. +..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4677889999999999999875 78999999975422 23345778999998885 567778888874 3578999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
||+++|+|.+++... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQV---GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 999999999988654 35889999999999999999999965 999999999999999999999999998764322
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCCCCC
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 495 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~ 572 (688)
.. ......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ....+..+. ..
T Consensus 155 ~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~---------~~ 219 (323)
T cd05615 155 GV------TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN---------VS 219 (323)
T ss_pred Cc------cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------CC
Confidence 21 12345699999999999999999999999999999999999999975432 222222221 12
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHH
Q 005617 573 WPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 573 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~L 607 (688)
+|...+..+.+|+.+||+.+|.+|++..+.....+
T Consensus 220 ~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i 254 (323)
T cd05615 220 YPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDI 254 (323)
T ss_pred CCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHH
Confidence 34445678899999999999999999764443333
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=314.90 Aligned_cols=248 Identities=32% Similarity=0.467 Sum_probs=199.9
Q ss_pred cCcccceeeeccCceEEEEEEEC-CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC-CceeEEecCCC
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYEYLPN 419 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~-g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV~E~~~~ 419 (688)
++|...+.||+|+||.||+|... +..||+|.+..... ....|.+|+.++++++|||++++++++.+ ..++||||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~ 84 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMSK 84 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecCC
Confidence 35777789999999999999876 67899999876443 34579999999999999999999998844 57899999999
Q ss_pred CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCC
Q 005617 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 420 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~ 499 (688)
++|.+++.... ...+++..+..++.+++.||.|||+.+ |+||||||+||+++.++.++|+|||++.........
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-- 158 (260)
T cd05070 85 GSLLDFLKDGE-GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-- 158 (260)
T ss_pred CcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc--
Confidence 99999986543 245899999999999999999999966 999999999999999999999999999876433211
Q ss_pred CccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHHHhhcCccccccCCCCCCCCHH
Q 005617 500 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTF 576 (688)
Q Consensus 500 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~~~ 576 (688)
......++..|+|||++....++.++||||||+++|+|++ |.+||..... ....+..+. ....+..
T Consensus 159 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~--------~~~~~~~ 227 (260)
T cd05070 159 ---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGY--------RMPCPQD 227 (260)
T ss_pred ---cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------CCCCCCc
Confidence 1123346678999999998899999999999999999999 8999965332 222222111 1122334
Q ss_pred HHHHHHHHHHHccccCCCCCCCCchHHHHHHH
Q 005617 577 VARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 577 ~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le 608 (688)
.+..+.+|+.+|+..+|.+||++. .+...|+
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rpt~~-~l~~~l~ 258 (260)
T cd05070 228 CPISLHELMLQCWKKDPEERPTFE-YLQSFLE 258 (260)
T ss_pred CCHHHHHHHHHHcccCcccCcCHH-HHHHHHh
Confidence 456799999999999999999998 6666665
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-37 Score=319.97 Aligned_cols=251 Identities=30% Similarity=0.444 Sum_probs=198.6
Q ss_pred cCcccceeeeccCceEEEEEEE------CCeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccC--CCcee
Q 005617 342 CNFSESFKVGQGGFGCVYKGEM------LGRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSL 412 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~------~g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~L 412 (688)
.+|.....||+|+||.||+|.+ .+..||+|.+..... .....|.+|+.+++.++||||+++++++. +..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3567778999999999999985 257899999975433 33457889999999999999999999874 45789
Q ss_pred EEecCCCCcHHHHhcccCC--------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCC
Q 005617 413 VYEYLPNGSLQDRLFRKSN--------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL 478 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~~--------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~ 478 (688)
||||+++|+|.+++..... ...+++..++.++.+++.||.|||+.+ |+||||||+|||++.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999999853221 235789999999999999999999965 99999999999999999
Q ss_pred CeEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--hHHH
Q 005617 479 SSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRR 555 (688)
Q Consensus 479 ~vKLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~ 555 (688)
.+||+|||+++........ .......++..|+|||++.+..++.++|||||||++|||++ |..||.... .+..
T Consensus 162 ~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~ 237 (283)
T cd05090 162 HVKISDLGLSREIYSADYY----RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIE 237 (283)
T ss_pred cEEeccccccccccCCcce----ecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999876433211 12234456788999999988899999999999999999999 999986433 2333
Q ss_pred HhhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHH
Q 005617 556 AVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 556 ~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le 608 (688)
.+..+... ..+...+..+.+++.+||+.+|.+||++. .+.+.|.
T Consensus 238 ~~~~~~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~-~i~~~l~ 281 (283)
T cd05090 238 MVRKRQLL--------PCSEDCPPRMYSLMTECWQEGPSRRPRFK-DIHTRLR 281 (283)
T ss_pred HHHcCCcC--------CCCCCCCHHHHHHHHHHcccCcccCcCHH-HHHHHhh
Confidence 33332221 12223456789999999999999999998 5655554
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=330.17 Aligned_cols=238 Identities=29% Similarity=0.387 Sum_probs=190.7
Q ss_pred CcccceeeeccCceEEEEEEE-----CCeEEEEEEEecCCc----cchHHHHHHHHHHHcC-CCCceeeEecccCC--Cc
Q 005617 343 NFSESFKVGQGGFGCVYKGEM-----LGRTVAIKMLYSHNM----QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AW 410 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~-----~g~~vAIK~l~~~~~----~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~~ 410 (688)
+|...+.||+|+||.||+++. .|..||+|++..... .....+..|+.++..+ +||||+++++++.+ ..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 477889999999999999876 378899999975322 2334578899999999 59999999998854 47
Q ss_pred eeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCcccc
Q 005617 411 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~ 490 (688)
++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR---DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 8999999999999998654 35788999999999999999999966 99999999999999999999999999986
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChh------hHHHHhhcCccc
Q 005617 491 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAG------EVRRAVSCGKLS 563 (688)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~------~~~~~~~~g~l~ 563 (688)
....... ......||+.|+|||++.+. .++.++|||||||++|||+||+.||.... .+...+...
T Consensus 155 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~--- 226 (332)
T cd05614 155 FLSEEKE-----RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKC--- 226 (332)
T ss_pred ccccCCC-----ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcC---
Confidence 5432211 22345799999999998765 47899999999999999999999996322 111111111
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCc
Q 005617 564 SILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 564 ~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~ 600 (688)
....+...+..+.+|+.+||+.||.+||++.
T Consensus 227 ------~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~ 257 (332)
T cd05614 227 ------DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAG 257 (332)
T ss_pred ------CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCC
Confidence 1123334566789999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=314.42 Aligned_cols=244 Identities=28% Similarity=0.439 Sum_probs=198.9
Q ss_pred cCcccceeeeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC---CCceeEEecCC
Q 005617 342 CNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP---EAWSLVYEYLP 418 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~---~~~~LV~E~~~ 418 (688)
.+|.....||+|+||.||+|...|..||+|.+.... ....|.+|+.++++++|+|++++++++. +..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~ 83 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 83 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCC
Confidence 367778899999999999999999999999986433 3457899999999999999999999752 34789999999
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcC
Q 005617 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~ 498 (688)
+|+|.+++..... ..+++..++.++.+++.||.|||+.+ |+||||||+||+++.++.+||+|||+++......
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--- 156 (256)
T cd05082 84 KGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 156 (256)
T ss_pred CCcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC---
Confidence 9999999865432 45889999999999999999999965 9999999999999999999999999987653321
Q ss_pred CCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--hHHHHhhcCccccccCCCCCCCCH
Q 005617 499 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLAGDWPT 575 (688)
Q Consensus 499 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~~~~g~l~~~ld~~~~~~~~ 575 (688)
....++..|+|||++....++.++|||||||++|+|++ |+.||.... .+...+..+.. ...+.
T Consensus 157 ------~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~ 222 (256)
T cd05082 157 ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK--------MDAPD 222 (256)
T ss_pred ------CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC--------CCCCC
Confidence 23345678999999999999999999999999999998 999986432 22233322211 12223
Q ss_pred HHHHHHHHHHHHccccCCCCCCCCchHHHHHHHH
Q 005617 576 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 576 ~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~ 609 (688)
..+..+.+++.+|++.+|.+||++. .+.+.|+.
T Consensus 223 ~~~~~~~~li~~~l~~~p~~Rpt~~-~l~~~l~~ 255 (256)
T cd05082 223 GCPPVVYDVMKQCWHLDAATRPSFL-QLREQLEH 255 (256)
T ss_pred CCCHHHHHHHHHHhcCChhhCcCHH-HHHHHHhc
Confidence 4456889999999999999999998 66666654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=334.81 Aligned_cols=230 Identities=26% Similarity=0.331 Sum_probs=187.3
Q ss_pred eeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecCCCCc
Q 005617 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGS 421 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gs 421 (688)
.||+|+||.||++... |..||+|++..... .....+..|+.++..++||||++++++|.+ ..++||||+++|+
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~ 81 (325)
T cd05594 2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE 81 (325)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence 6999999999999874 88999999976432 234467889999999999999999998843 4789999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCCc
Q 005617 422 LQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 501 (688)
Q Consensus 422 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~~ 501 (688)
|..++... ..+++..+..++.||+.||.|||+. .+|+||||||+|||++.++.+||+|||+++.......
T Consensus 82 L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~----- 151 (325)
T cd05594 82 LFFHLSRE---RVFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA----- 151 (325)
T ss_pred HHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-----
Confidence 99888654 3588999999999999999999973 2499999999999999999999999999875432221
Q ss_pred cccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCCCCCCCHHHHH
Q 005617 502 HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVAR 579 (688)
Q Consensus 502 ~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~~~~~~ 579 (688)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||..... ....+..+. ..+|.....
T Consensus 152 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~---------~~~p~~~~~ 221 (325)
T cd05594 152 -TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE---------IRFPRTLSP 221 (325)
T ss_pred -ccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCC---------CCCCCCCCH
Confidence 12345799999999999999999999999999999999999999965432 222222111 123334566
Q ss_pred HHHHHHHHccccCCCCCCC
Q 005617 580 RLVDLGLQCCELYGRERPD 598 (688)
Q Consensus 580 ~l~~L~~~Cl~~dP~~RPs 598 (688)
.+.+|+.+||+.||.+|++
T Consensus 222 ~~~~li~~~L~~dP~~R~~ 240 (325)
T cd05594 222 EAKSLLSGLLKKDPKQRLG 240 (325)
T ss_pred HHHHHHHHHhhcCHHHhCC
Confidence 8899999999999999984
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=328.77 Aligned_cols=231 Identities=27% Similarity=0.371 Sum_probs=189.3
Q ss_pred eeeccCceEEEEEEEC--CeEEEEEEEecCC---ccchHHHHHHHHHHHcC-CCCceeeEecccCC--CceeEEecCCCC
Q 005617 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHN---MQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWSLVYEYLPNG 420 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~---~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~~~LV~E~~~~g 420 (688)
.||+|+||.||+|... +..||||++.... ......+..|..++..+ +||||+++++++.+ ..++||||+++|
T Consensus 2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g 81 (320)
T cd05590 2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG 81 (320)
T ss_pred eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence 6999999999999885 7889999997542 23345677899998877 69999999999854 478999999999
Q ss_pred cHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCC
Q 005617 421 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 500 (688)
Q Consensus 421 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~ 500 (688)
+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~i~~~~---~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~---- 151 (320)
T cd05590 82 DLMFHIQKSR---RFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK---- 151 (320)
T ss_pred hHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC----
Confidence 9999886543 5788999999999999999999966 99999999999999999999999999876432211
Q ss_pred ccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCCCCCCCHHHH
Q 005617 501 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVA 578 (688)
Q Consensus 501 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~~~~~ 578 (688)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... +...+..+.. ..+...+
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~---------~~~~~~~ 220 (320)
T cd05590 152 --TTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEV---------VYPTWLS 220 (320)
T ss_pred --cccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCC---------CCCCCCC
Confidence 22345799999999999999999999999999999999999999975442 2233322221 2233356
Q ss_pred HHHHHHHHHccccCCCCCCCCc
Q 005617 579 RRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 579 ~~l~~L~~~Cl~~dP~~RPs~~ 600 (688)
..+.+|+.+||+.||.+||++.
T Consensus 221 ~~~~~li~~~L~~dP~~R~~~~ 242 (320)
T cd05590 221 QDAVDILKAFMTKNPTMRLGSL 242 (320)
T ss_pred HHHHHHHHHHcccCHHHCCCCC
Confidence 6789999999999999999984
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=318.93 Aligned_cols=251 Identities=29% Similarity=0.469 Sum_probs=201.0
Q ss_pred cCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccCC--Cce
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWS 411 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~-------g~~vAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~ 411 (688)
.+|...+.||+|+||.||+|... +..||||.+...... ....|.+|+.+|..++||||+++++++.. ..+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 45777789999999999999763 367999999765444 45679999999999999999999999854 588
Q ss_pred eEEecCCCCcHHHHhcccC-----------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCe
Q 005617 412 LVYEYLPNGSLQDRLFRKS-----------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS 480 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~~-----------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~v 480 (688)
+||||+++|+|.+++.... ....+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999986542 1245789999999999999999999965 9999999999999999999
Q ss_pred EEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--hHHHHh
Q 005617 481 KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAV 557 (688)
Q Consensus 481 KLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~~ 557 (688)
||+|||++......... .......+++.|+|||++.+..+++++|||||||++|||++ |..||.... .....+
T Consensus 162 kl~d~g~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05049 162 KIGDFGMSRDVYTTDYY----RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECI 237 (280)
T ss_pred EECCcccceecccCcce----ecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 99999999765332211 11234456789999999999999999999999999999999 999986433 222333
Q ss_pred hcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHH
Q 005617 558 SCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 558 ~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le 608 (688)
..+.... .+...+..+.+++.+||+.||.+||++. ++++.|+
T Consensus 238 ~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~Rp~~~-eil~~l~ 279 (280)
T cd05049 238 TQGRLLQ--------RPRTCPSEVYDIMLGCWKRDPQQRINIK-DIHERLQ 279 (280)
T ss_pred HcCCcCC--------CCCCCCHHHHHHHHHHcCCCcccCCCHH-HHHHHhh
Confidence 3332221 1223456789999999999999999998 5655553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=333.05 Aligned_cols=239 Identities=28% Similarity=0.389 Sum_probs=194.3
Q ss_pred eeeeccCceEEEEEEE-----CCeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecCC
Q 005617 348 FKVGQGGFGCVYKGEM-----LGRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLP 418 (688)
Q Consensus 348 ~~LG~G~fG~Vykg~~-----~g~~vAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~ 418 (688)
+.||+|+||.||++.. .|..||||++..... .....+..|+.+|.+++||||++++++|.+ ..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 4699999999999865 378999999976432 233457789999999999999999999854 4789999999
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcC
Q 005617 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~ 498 (688)
+|+|.+++... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-- 153 (318)
T cd05582 82 GGDLFTRLSKE---VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-- 153 (318)
T ss_pred CCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--
Confidence 99999998654 35889999999999999999999966 99999999999999999999999999986543321
Q ss_pred CCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhH--HHHhhcCccccccCCCCCCCCHH
Q 005617 499 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGDWPTF 576 (688)
Q Consensus 499 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~~~~g~l~~~ld~~~~~~~~~ 576 (688)
......||+.|+|||++....++.++|||||||++|||+||+.||...... ...+..+. ...|..
T Consensus 154 ----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~---------~~~p~~ 220 (318)
T cd05582 154 ----KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK---------LGMPQF 220 (318)
T ss_pred ----ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC---------CCCCCC
Confidence 223467999999999999889999999999999999999999999754432 22222221 123344
Q ss_pred HHHHHHHHHHHccccCCCCCCCCchHHHHHH
Q 005617 577 VARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 577 ~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~L 607 (688)
.+..+.+|+.+||+.||.+||++.+.++..+
T Consensus 221 ~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~ 251 (318)
T cd05582 221 LSPEAQSLLRALFKRNPANRLGAGPDGVEEI 251 (318)
T ss_pred CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHH
Confidence 5677899999999999999999875444333
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=331.05 Aligned_cols=253 Identities=30% Similarity=0.483 Sum_probs=200.3
Q ss_pred cCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCcc-chHHHHHHHHHHHcC-CCCceeeEecccCC---C
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKL-QHPHLVTLLGACPE---A 409 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~-------g~~vAIK~l~~~~~~-~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~---~ 409 (688)
++|...+.||.|+||.||+|... ++.||+|++...... ....+..|+.++.++ +||||++++++|.. .
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 46888899999999999999653 367999998754322 234578899999999 89999999998843 4
Q ss_pred ceeEEecCCCCcHHHHhcccCC----------------------------------------------------------
Q 005617 410 WSLVYEYLPNGSLQDRLFRKSN---------------------------------------------------------- 431 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~~---------------------------------------------------------- 431 (688)
.++||||+++|+|.+++.....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 6789999999999998854321
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCCccccCCCCCCC
Q 005617 432 VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 511 (688)
Q Consensus 432 ~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~~~~~GT~ 511 (688)
..+++|..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...... .......++.
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~----~~~~~~~~~~ 239 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY----VRKGDARLPL 239 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcch----hhccCCCCCc
Confidence 136899999999999999999999965 999999999999999999999999999876433211 1223456678
Q ss_pred CCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh---hHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHH
Q 005617 512 PYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG---EVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQ 587 (688)
Q Consensus 512 ~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~---~~~~~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~ 587 (688)
.|+|||++.+..++.++|||||||+||||++ |..||.... .....+..+... ..+......+.+++.+
T Consensus 240 ~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~l~~~ 311 (337)
T cd05054 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM--------RAPEYATPEIYSIMLD 311 (337)
T ss_pred cccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC--------CCCccCCHHHHHHHHH
Confidence 8999999999999999999999999999998 999996422 222223222211 1122345678999999
Q ss_pred ccccCCCCCCCCchHHHHHHHHh
Q 005617 588 CCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 588 Cl~~dP~~RPs~~~~l~~~Le~l 610 (688)
||+.+|.+||++. ++++.|+.+
T Consensus 312 cl~~~p~~RPs~~-ell~~l~~~ 333 (337)
T cd05054 312 CWHNNPEDRPTFS-ELVEILGDL 333 (337)
T ss_pred HccCChhhCcCHH-HHHHHHHHH
Confidence 9999999999998 777777764
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-37 Score=330.22 Aligned_cols=232 Identities=24% Similarity=0.310 Sum_probs=187.7
Q ss_pred eeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcC-CCCceeeEecccC--CCceeEEecCCC
Q 005617 348 FKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKL-QHPHLVTLLGACP--EAWSLVYEYLPN 419 (688)
Q Consensus 348 ~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~--~~~~LV~E~~~~ 419 (688)
+.||+|+||.||+|... +..||+|++..... .....+..|+.++.++ +||||+++++++. +..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 36999999999999885 78899999986432 2334577899998877 8999999999884 358899999999
Q ss_pred CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCC
Q 005617 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 420 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~ 499 (688)
|+|..++... ..+++..+..|+.+|+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~L~~~~~~~---~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--- 151 (329)
T cd05618 81 GDLMFHMQRQ---RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--- 151 (329)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC---
Confidence 9999887654 35889999999999999999999966 99999999999999999999999999875432211
Q ss_pred CccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh-----------hHHHHhhcCccccccCC
Q 005617 500 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG-----------EVRRAVSCGKLSSILDP 568 (688)
Q Consensus 500 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~-----------~~~~~~~~g~l~~~ld~ 568 (688)
......||+.|+|||++.+..++.++|||||||++|||+||+.||.... .+...+..+
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~-------- 220 (329)
T cd05618 152 ---TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK-------- 220 (329)
T ss_pred ---ccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC--------
Confidence 1234679999999999999999999999999999999999999995211 111111111
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCCc
Q 005617 569 LAGDWPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 569 ~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~ 600 (688)
....|...+..+.+|+.+||+.||.+||+..
T Consensus 221 -~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~ 251 (329)
T cd05618 221 -QIRIPRSLSVKAASVLKSFLNKDPKERLGCH 251 (329)
T ss_pred -CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCC
Confidence 1123445567889999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=315.18 Aligned_cols=251 Identities=24% Similarity=0.401 Sum_probs=198.9
Q ss_pred cccceeeeccCceEEEEEEEC-----CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC--------
Q 005617 344 FSESFKVGQGGFGCVYKGEML-----GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE-------- 408 (688)
Q Consensus 344 f~~~~~LG~G~fG~Vykg~~~-----g~~vAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-------- 408 (688)
|...+.||+|+||.||+|.+. +..||||+++.... .....+.+|+.++..++||||+++++++..
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 455678999999999999874 36799999876433 234578999999999999999999998732
Q ss_pred CceeEEecCCCCcHHHHhcccC---CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeec
Q 005617 409 AWSLVYEYLPNGSLQDRLFRKS---NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDF 485 (688)
Q Consensus 409 ~~~LV~E~~~~gsL~~~L~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDF 485 (688)
..++||||+++|+|..++.... ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 2589999999999999885432 2246899999999999999999999965 999999999999999999999999
Q ss_pred CccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHHHhhcCcc
Q 005617 486 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKL 562 (688)
Q Consensus 486 Gla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~~~~g~l 562 (688)
|+++......... ......++..|+|||++....++.++|||||||++|||++ |..||..... ....+..+..
T Consensus 158 g~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 233 (273)
T cd05035 158 GLSKKIYSGDYYR----QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR 233 (273)
T ss_pred cceeecccccccc----ccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 9998765433211 1223345778999999988899999999999999999999 8899865433 2223332221
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHh
Q 005617 563 SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 563 ~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l 610 (688)
. ..+...+..+.+++.+||+.||.+||++. ++.+.|+.+
T Consensus 234 ~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~-e~~~~l~~~ 272 (273)
T cd05035 234 L--------KQPEDCLDELYDLMYSCWRADPKDRPTFT-KLREVLENI 272 (273)
T ss_pred C--------CCCcCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHhh
Confidence 1 12334566899999999999999999998 677777654
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=316.22 Aligned_cols=249 Identities=24% Similarity=0.402 Sum_probs=195.9
Q ss_pred ccceeeeccCceEEEEEEEC--C--eEEEEEEEecCC--ccchHHHHHHHHHHHcCCCCceeeEecccCC--------Cc
Q 005617 345 SESFKVGQGGFGCVYKGEML--G--RTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--------AW 410 (688)
Q Consensus 345 ~~~~~LG~G~fG~Vykg~~~--g--~~vAIK~l~~~~--~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--------~~ 410 (688)
.....||+|+||.||+|.+. + ..||||.++... ......|..|+.++..++||||++++++|.. ..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 45678999999999999886 3 269999887543 2334568899999999999999999997621 35
Q ss_pred eeEEecCCCCcHHHHhccc---CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCc
Q 005617 411 SLVYEYLPNGSLQDRLFRK---SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 487 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~---~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGl 487 (688)
++||||+++|+|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 7999999999999887432 12345899999999999999999999965 99999999999999999999999999
Q ss_pred cccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHHHhhcCcccc
Q 005617 488 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSS 564 (688)
Q Consensus 488 a~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~~~~g~l~~ 564 (688)
++........ .......+++.|++||++....+++++|||||||++|||++ |+.||..... ....+..+....
T Consensus 159 ~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 234 (272)
T cd05075 159 SKKIYNGDYY----RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLK 234 (272)
T ss_pred ccccCcccce----ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9876543211 11233456778999999999999999999999999999999 8899864332 333333332211
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHH
Q 005617 565 ILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 565 ~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~ 609 (688)
.+...+..+.+++.+||+.+|.+||++. ++...|+.
T Consensus 235 --------~~~~~~~~~~~li~~~l~~~p~~Rps~~-~l~~~l~~ 270 (272)
T cd05075 235 --------QPPDCLDGLYSLMSSCWLLNPKDRPSFE-TLRCELEK 270 (272)
T ss_pred --------CCCCCCHHHHHHHHHHcCCCcccCcCHH-HHHHHHHh
Confidence 1223455789999999999999999998 66666664
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-37 Score=320.22 Aligned_cols=239 Identities=23% Similarity=0.332 Sum_probs=188.9
Q ss_pred eeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecCCCCcH
Q 005617 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSL 422 (688)
Q Consensus 350 LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~---~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gsL 422 (688)
||+|+||.||++... |..||+|.+...... ....+..|+.++.+++||||+++++++.+ ..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 799999999999875 899999998654322 23346679999999999999999998854 47899999999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCCcc
Q 005617 423 QDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 502 (688)
Q Consensus 423 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~~~ 502 (688)
.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~------- 149 (277)
T cd05607 81 KYHIYNVGE-RGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK------- 149 (277)
T ss_pred HHHHHhccc-cCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-------
Confidence 988865432 45889999999999999999999965 9999999999999999999999999998765332
Q ss_pred ccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh-H-HHHhhcCccccccCCCCCCCCHHHHHH
Q 005617 503 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE-V-RRAVSCGKLSSILDPLAGDWPTFVARR 580 (688)
Q Consensus 503 ~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~-~-~~~~~~g~l~~~ld~~~~~~~~~~~~~ 580 (688)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... . ...+....+...+.. .....+..
T Consensus 150 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~ 225 (277)
T cd05607 150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF----EHQNFTEE 225 (277)
T ss_pred eeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc----ccccCCHH
Confidence 12345699999999999999999999999999999999999999964321 0 111111111111100 11134567
Q ss_pred HHHHHHHccccCCCCCCCCchHH
Q 005617 581 LVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 581 l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
+.+|+.+||+.||.+||++.+.+
T Consensus 226 ~~~li~~~L~~~P~~R~~~~~~~ 248 (277)
T cd05607 226 SKDICRLFLAKKPEDRLGSREKN 248 (277)
T ss_pred HHHHHHHHhccCHhhCCCCccch
Confidence 89999999999999999998544
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=317.26 Aligned_cols=252 Identities=27% Similarity=0.428 Sum_probs=201.3
Q ss_pred cCcccceeeeccCceEEEEEEEC--Ce----EEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC-CceeE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GR----TVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~----~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV 413 (688)
.+|...+.||.|+||+||+|.+. |. .||||++..... .....+.+|+.++..+.||||++++++|.. ..+++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l~ 86 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLV 86 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEEE
Confidence 56777889999999999999863 43 489999875433 334578899999999999999999999854 57899
Q ss_pred EecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccC
Q 005617 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~ 493 (688)
|+|+++|+|.+++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~~~~~~g~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 87 TQLMPYGCLLDYVRENK--DRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred EEcCCCCCHHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 99999999999986543 46899999999999999999999965 99999999999999999999999999987753
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--hHHHHhhcCccccccCCCC
Q 005617 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~~~~g~l~~~ld~~~ 570 (688)
.... .......+++.|+|||.+.+..++.++|||||||++|||+| |..||.... .....+..+...
T Consensus 162 ~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~------- 230 (279)
T cd05109 162 DETE----YHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERL------- 230 (279)
T ss_pred ccce----eecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcC-------
Confidence 3211 11223346778999999999999999999999999999998 999986433 222333333211
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHhh
Q 005617 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 571 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l~ 611 (688)
..+...+..+.+++.+||+.||..||++. ++.+.|+.+.
T Consensus 231 -~~~~~~~~~~~~li~~~l~~dp~~Rp~~~-~l~~~l~~~~ 269 (279)
T cd05109 231 -PQPPICTIDVYMIMVKCWMIDSECRPRFR-ELVDEFSRMA 269 (279)
T ss_pred -CCCccCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHHhh
Confidence 11223456789999999999999999999 5667776654
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=335.90 Aligned_cols=252 Identities=21% Similarity=0.246 Sum_probs=191.1
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEe
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E 415 (688)
.|.....||+|+||+||+|... +..||||++..... .....+.+|+.++..++|||||+++++|.+ ..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999885 78999999976532 233468899999999999999999999854 5789999
Q ss_pred cCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCC
Q 005617 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~ 495 (688)
|+++|+|.+++.... .+++..+..++.||+.||.|||..+ |+||||||+||||+.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIRME---VFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 999999999987543 5788899999999999999999965 9999999999999999999999999986432110
Q ss_pred Cc-----------------------------------------CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHH
Q 005617 496 LY-----------------------------------------LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFG 534 (688)
Q Consensus 496 ~~-----------------------------------------~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfG 534 (688)
.. ...........||+.|+|||++....++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 00 0000011345799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCChhhHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHH--ccccCCCCCCCCchHH
Q 005617 535 LIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQ--CCELYGRERPDITPSL 603 (688)
Q Consensus 535 viL~ELltG~~Pf~~~~~~~~~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~--Cl~~dP~~RPs~~~~l 603 (688)
|++|||+||+.||..................+ ........+..+.+|+.+ |+..+|..||++.+.+
T Consensus 236 ~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l 303 (381)
T cd05626 236 VILFEMLVGQPPFLAPTPTETQLKVINWENTL---HIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIK 303 (381)
T ss_pred hHHHHHHhCCCCCcCCCHHHHHHHHHcccccc---CCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHh
Confidence 99999999999997544322111110000000 000111234567778877 5566777799987544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=318.88 Aligned_cols=260 Identities=27% Similarity=0.401 Sum_probs=199.3
Q ss_pred cCcccceeeeccCceEEEEEEE------CCeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC----CCce
Q 005617 342 CNFSESFKVGQGGFGCVYKGEM------LGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP----EAWS 411 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~------~g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~----~~~~ 411 (688)
.+|.....||+|+||.||+|.. .+..||||.+..........|.+|+.++..++||||+++++++. ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 4677788999999999999974 26789999987766555667999999999999999999999763 2478
Q ss_pred eEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccc
Q 005617 412 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~ 491 (688)
+||||+++|+|.+++.... ..++|..+..++.+++.||.|||+.+ |+||||||+||+++.++.+||+|||++...
T Consensus 84 lv~e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhcC--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 9999999999999986543 35899999999999999999999965 999999999999999999999999999876
Q ss_pred cCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhH-HHHhhcCcc--------
Q 005617 492 TEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV-RRAVSCGKL-------- 562 (688)
Q Consensus 492 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~-~~~~~~g~l-------- 562 (688)
....... .......++..|+|||++.+..++.++|||||||++|||++|..|+...... ...+.....
T Consensus 159 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05081 159 PQDKEYY---KVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHL 235 (284)
T ss_pred cCCCcce---eecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHH
Confidence 5432110 0112223455699999999999999999999999999999998776432211 111111100
Q ss_pred ccccCC-CCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHh
Q 005617 563 SSILDP-LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 563 ~~~ld~-~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l 610 (688)
.+.+.. .....+...+..+.+|+.+||..+|.+|||+. ++...|+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~-ei~~~l~~~ 283 (284)
T cd05081 236 IELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFS-ELALQVEAI 283 (284)
T ss_pred HHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHH-HHHHHHHhc
Confidence 001100 00111223456799999999999999999998 677777653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=314.34 Aligned_cols=244 Identities=27% Similarity=0.454 Sum_probs=195.6
Q ss_pred eeccCceEEEEEEEC----CeEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccCC-CceeEEecCCCCcHH
Q 005617 350 VGQGGFGCVYKGEML----GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYEYLPNGSLQ 423 (688)
Q Consensus 350 LG~G~fG~Vykg~~~----g~~vAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV~E~~~~gsL~ 423 (688)
||+|+||.||+|.+. +..||+|++...... ....|.+|+.++.+++||||++++++|.. ..++||||+++|+|.
T Consensus 3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L~ 82 (257)
T cd05115 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPLN 82 (257)
T ss_pred cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCHH
Confidence 899999999999764 456999998765432 34569999999999999999999999854 578999999999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCCccc
Q 005617 424 DRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHR 503 (688)
Q Consensus 424 ~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~ 503 (688)
+++.... ..+++..+++++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||++.......... ..
T Consensus 83 ~~l~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~---~~ 154 (257)
T cd05115 83 KFLSGKK--DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY---KA 154 (257)
T ss_pred HHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccce---ec
Confidence 9986533 46899999999999999999999965 9999999999999999999999999998654332211 11
Q ss_pred cCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--hHHHHhhcCccccccCCCCCCCCHHHHHH
Q 005617 504 STAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLAGDWPTFVARR 580 (688)
Q Consensus 504 ~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~~~~g~l~~~ld~~~~~~~~~~~~~ 580 (688)
.....+++.|+|||++....++.++|||||||++|||++ |..||.... .+...+..+.. ...+...+..
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~ 226 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR--------LDCPAECPPE 226 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC--------CCCCCCCCHH
Confidence 122344678999999988889999999999999999996 999996433 23333333322 1233345678
Q ss_pred HHHHHHHccccCCCCCCCCchHHHHHHHHh
Q 005617 581 LVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 581 l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l 610 (688)
+.+++.+||..+|++||++. .+.+.|+.+
T Consensus 227 l~~li~~c~~~~~~~Rp~~~-~i~~~l~~~ 255 (257)
T cd05115 227 MYALMKDCWIYKWEDRPNFA-KVEERMRTY 255 (257)
T ss_pred HHHHHHHHcCCChhhCcCHH-HHHHHHhhh
Confidence 88999999999999999998 677776643
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=326.28 Aligned_cols=234 Identities=29% Similarity=0.374 Sum_probs=188.8
Q ss_pred eeeccCceEEEEEEEC--CeEEEEEEEecCC---ccchHHHHHHHHHHHcC-CCCceeeEecccCC--CceeEEecCCCC
Q 005617 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHN---MQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWSLVYEYLPNG 420 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~---~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~~~LV~E~~~~g 420 (688)
.||+|+||.||+|+.. +..||||+++... ......+..|..++..+ +||||+++++++.+ ..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g 81 (316)
T cd05619 2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG 81 (316)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence 6999999999999986 6789999997642 22334567788888765 89999999999844 478999999999
Q ss_pred cHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCC
Q 005617 421 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 500 (688)
Q Consensus 421 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~ 500 (688)
+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---- 151 (316)
T cd05619 82 DLMFHIQSC---HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA---- 151 (316)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC----
Confidence 999988654 35789999999999999999999966 99999999999999999999999999875422211
Q ss_pred ccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCCCCCCCHHHH
Q 005617 501 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVA 578 (688)
Q Consensus 501 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~~~~~ 578 (688)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+..+. ..++....
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~---------~~~~~~~~ 220 (316)
T cd05619 152 --KTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDN---------PCYPRWLT 220 (316)
T ss_pred --ceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------CCCCccCC
Confidence 12345799999999999999999999999999999999999999975432 222222211 11233345
Q ss_pred HHHHHHHHHccccCCCCCCCCchHH
Q 005617 579 RRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 579 ~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
..+.+|+.+||+.||.+||++.+++
T Consensus 221 ~~~~~li~~~l~~~P~~R~~~~~~l 245 (316)
T cd05619 221 REAKDILVKLFVREPERRLGVKGDI 245 (316)
T ss_pred HHHHHHHHHHhccCHhhcCCChHHH
Confidence 6788999999999999999997433
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=319.84 Aligned_cols=253 Identities=28% Similarity=0.440 Sum_probs=200.4
Q ss_pred CcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccC--CCcee
Q 005617 343 NFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSL 412 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~-------g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~L 412 (688)
+|.....||+|+||.||+|... ...||+|.+..... .....+.+|+.+++.++||||++++++|. +..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4667789999999999999864 25689998875543 23456889999999999999999999984 35789
Q ss_pred EEecCCCCcHHHHhcccC---------------------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCc
Q 005617 413 VYEYLPNGSLQDRLFRKS---------------------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQN 471 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~---------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~N 471 (688)
||||+++|+|.+++.... ...++++..++.++.+++.||.|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999876421 1245889999999999999999999865 9999999999
Q ss_pred eeeCCCCCeEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCCh
Q 005617 472 ILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLA 550 (688)
Q Consensus 472 ILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~ 550 (688)
||++.++.+||+|||+++........ .......++..|+|||++.+..++.++||||||+++|||+| |..||...
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 233 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSY----VKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGI 233 (290)
T ss_pred EEEcCCCcEEeccccccccccCccch----hcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence 99999999999999999865433211 11233456778999999998899999999999999999999 99999643
Q ss_pred h--hHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHhh
Q 005617 551 G--EVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 551 ~--~~~~~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l~ 611 (688)
. .+...+..+.. ...+...+..+.+++.+|++.+|.+||++. ++...|+.+.
T Consensus 234 ~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~-~i~~~l~~~~ 287 (290)
T cd05045 234 APERLFNLLKTGYR--------MERPENCSEEMYNLMLTCWKQEPDKRPTFA-DISKELEKMM 287 (290)
T ss_pred CHHHHHHHHhCCCC--------CCCCCCCCHHHHHHHHHHccCCcccCCCHH-HHHHHHHHHH
Confidence 3 22333322211 112233456789999999999999999999 7777877653
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=322.47 Aligned_cols=239 Identities=26% Similarity=0.415 Sum_probs=206.8
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccch---HHHHHHHHHHHcCCCCceeeEecccCC--CceeE
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQ---LEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLV 413 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~---~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV 413 (688)
..+|.....||+|.||.|-++... |+.||||.+++..+.+. ..+.+|++||+.|+||||+.+|.+|.+ ...||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 346777789999999999999774 99999999988876554 358899999999999999999999954 58899
Q ss_pred EecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccC
Q 005617 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~ 493 (688)
|||..+|.|++++...+ .|+..+...|+.||..|+.|+|.++ ++|||||.+|||||.|+++||+|||++.++..
T Consensus 132 MEYaS~GeLYDYiSer~---~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 132 MEYASGGELYDYISERG---SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEecCCccHHHHHHHhc---cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 99999999999998765 5889999999999999999999976 99999999999999999999999999998876
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCC-CCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCCC
Q 005617 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVL-TPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~~ 570 (688)
... -.+++|+|-|.+||++.+.+| ++.+|-|||||+||.|+.|..||++.+. +...+..|.+.+.-
T Consensus 206 ~kf-------LqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~---- 274 (668)
T KOG0611|consen 206 KKF-------LQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE---- 274 (668)
T ss_pred ccH-------HHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC----
Confidence 552 357899999999999999988 6899999999999999999999987653 45566667665432
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCCchH
Q 005617 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 571 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
.+....-||.+||-.||+.|.|+.++
T Consensus 275 ------~PSdA~gLIRwmLmVNP~RRATieDi 300 (668)
T KOG0611|consen 275 ------TPSDASGLIRWMLMVNPERRATIEDI 300 (668)
T ss_pred ------CCchHHHHHHHHHhcCcccchhHHHH
Confidence 23356678999999999999998743
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=332.54 Aligned_cols=231 Identities=24% Similarity=0.325 Sum_probs=188.1
Q ss_pred eeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcC-CCCceeeEecccCC--CceeEEecCCCC
Q 005617 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWSLVYEYLPNG 420 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~~~LV~E~~~~g 420 (688)
.||+|+||.||++... +..||||+++.... .....+..|..++..+ +||||++++++|.+ ..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g 81 (329)
T cd05588 2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG 81 (329)
T ss_pred eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 6999999999999885 78999999986432 2334588999999998 79999999999854 478999999999
Q ss_pred cHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCC
Q 005617 421 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 500 (688)
Q Consensus 421 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~ 500 (688)
+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~----- 150 (329)
T cd05588 82 DLMFHMQRQ---RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG----- 150 (329)
T ss_pred CHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC-----
Confidence 999888654 35899999999999999999999965 9999999999999999999999999987532211
Q ss_pred ccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh-----------hHHHHhhcCccccccCCC
Q 005617 501 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG-----------EVRRAVSCGKLSSILDPL 569 (688)
Q Consensus 501 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~-----------~~~~~~~~g~l~~~ld~~ 569 (688)
.......||+.|+|||++.+..++.++|||||||++|+|+||+.||.... .....+..+.
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-------- 221 (329)
T cd05588 151 -DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ-------- 221 (329)
T ss_pred -CccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--------
Confidence 12234679999999999999999999999999999999999999996321 1111121111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCCc
Q 005617 570 AGDWPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 570 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~ 600 (688)
...|...+..+.+|+.+||+.||.+||+..
T Consensus 222 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 251 (329)
T cd05588 222 -IRIPRSLSVKASSVLKGFLNKDPKERLGCH 251 (329)
T ss_pred -CCCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 123334566789999999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=334.59 Aligned_cols=240 Identities=25% Similarity=0.410 Sum_probs=186.2
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecC
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 417 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~ 417 (688)
+|...+.||+|+||.||+|.+. |+.||||++...... ....|.+|+.++..++|+||++++++|.+ ..++||||+
T Consensus 75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 154 (353)
T PLN00034 75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFM 154 (353)
T ss_pred HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecC
Confidence 3455678999999999999885 789999999755332 34568999999999999999999999854 478999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCc
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~ 497 (688)
++|+|.... .+.+..+..|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+.....
T Consensus 155 ~~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~- 223 (353)
T PLN00034 155 DGGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD- 223 (353)
T ss_pred CCCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence 999986532 3456778899999999999999966 99999999999999999999999999987643221
Q ss_pred CCCccccCCCCCCCCCCChhhhcc-----CCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCCC
Q 005617 498 LPSFHRSTAPKGSFPYADPEYHRT-----GVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 498 ~~~~~~~~~~~GT~~Y~APE~~~~-----~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~~ 570 (688)
......||..|+|||++.. ...+.++|||||||++|||++|+.||..... .......... ...
T Consensus 224 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~-----~~~ 293 (353)
T PLN00034 224 -----PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICM-----SQP 293 (353)
T ss_pred -----cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhc-----cCC
Confidence 1234579999999998743 2345689999999999999999999963221 1111100000 001
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 571 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
...+......+.+|+.+||+.||.+||++.+.+
T Consensus 294 ~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell 326 (353)
T PLN00034 294 PEAPATASREFRHFISCCLQREPAKRWSAMQLL 326 (353)
T ss_pred CCCCCccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 122334567899999999999999999988443
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=332.62 Aligned_cols=246 Identities=25% Similarity=0.299 Sum_probs=195.9
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|.....||+|+||.||++... |..||||+++.... .....+.+|+.++..++||||+++++++.+ ..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888899999999999999875 88999999976432 234568899999999999999999998854 478999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
||+++|+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRYE--DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 9999999999987653 36889999999999999999999966 999999999999999999999999999876543
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhc------cCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHH--HHhhcCcccccc
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHR------TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSIL 566 (688)
Q Consensus 495 ~~~~~~~~~~~~~~GT~~Y~APE~~~------~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~--~~~~~g~l~~~l 566 (688)
... ......||+.|+|||++. ...++.++|||||||++|||++|+.||....... ..+.... ..+
T Consensus 156 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~--~~~ 228 (330)
T cd05601 156 KMV-----NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQ--RFL 228 (330)
T ss_pred Cce-----eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCC--Ccc
Confidence 211 123457999999999986 4567899999999999999999999997543322 1121111 111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 567 DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 567 d~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
.. ......+..+.+|+..|+. +|.+||++.+.+
T Consensus 229 ~~---~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~ 261 (330)
T cd05601 229 KF---PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLC 261 (330)
T ss_pred CC---CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHh
Confidence 00 0111245678899999998 999999988443
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=313.94 Aligned_cols=244 Identities=28% Similarity=0.469 Sum_probs=194.8
Q ss_pred CcccceeeeccCceEEEEEEEC-CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecCCC
Q 005617 343 NFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPN 419 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~-g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~ 419 (688)
+|...+.||+|+||.||+|.+. +..+|+|++..... ....|.+|+.++..++||||+++++++.+ ..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 4667788999999999999886 45799999864432 34568899999999999999999998854 47899999999
Q ss_pred CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCC
Q 005617 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 420 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~ 499 (688)
++|.+++.... ..++|..+..|+.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++........
T Consensus 84 ~~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-- 156 (256)
T cd05059 84 GCLLNYLRERK--GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-- 156 (256)
T ss_pred CCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceeccccccc--
Confidence 99999987543 36899999999999999999999966 999999999999999999999999999866432211
Q ss_pred CccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHHHhhcCccccccCCCCCCCCHH
Q 005617 500 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTF 576 (688)
Q Consensus 500 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~~~ 576 (688)
......++..|+|||++.+..++.++|||||||++|+|+| |+.||..... ....+..+. . ...+..
T Consensus 157 ---~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-----~---~~~~~~ 225 (256)
T cd05059 157 ---SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGY-----R---LYRPKL 225 (256)
T ss_pred ---ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCC-----c---CCCCCC
Confidence 1122334568999999999999999999999999999999 8999864432 222222221 0 112233
Q ss_pred HHHHHHHHHHHccccCCCCCCCCchHHHHH
Q 005617 577 VARRLVDLGLQCCELYGRERPDITPSLVKE 606 (688)
Q Consensus 577 ~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~ 606 (688)
.+..+.+|+.+||..+|++||++. ++...
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rpt~~-~~l~~ 254 (256)
T cd05059 226 APTEVYTIMYSCWHEKPEDRPAFK-KLLSQ 254 (256)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHH-HHHHH
Confidence 566899999999999999999998 44443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=314.41 Aligned_cols=244 Identities=27% Similarity=0.475 Sum_probs=196.4
Q ss_pred CcccceeeeccCceEEEEEEECC-eEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecCCC
Q 005617 343 NFSESFKVGQGGFGCVYKGEMLG-RTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPN 419 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~g-~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~ 419 (688)
+|.....||+|+||.||+|...+ ..||||.+.... .....|.+|+.++.+++||||++++++|.+ ..++||||+.+
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 46777889999999999998874 469999987543 334679999999999999999999999854 47899999999
Q ss_pred CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCC
Q 005617 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 420 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~ 499 (688)
|+|.+++.... ..+++..++.++.+|+.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.......
T Consensus 84 ~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~--- 155 (256)
T cd05113 84 GCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY--- 155 (256)
T ss_pred CcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCce---
Confidence 99999986543 36899999999999999999999965 99999999999999999999999999987643321
Q ss_pred CccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHHHhhcCccccccCCCCCCCCHH
Q 005617 500 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTF 576 (688)
Q Consensus 500 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~~~ 576 (688)
.......++..|++||++.+..++.++|||||||++|+|+| |..||..... +...+..+... ..+..
T Consensus 156 --~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~ 225 (256)
T cd05113 156 --TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL--------YRPHL 225 (256)
T ss_pred --eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC--------CCCCC
Confidence 11223346778999999998899999999999999999999 9999964432 22333222211 11222
Q ss_pred HHHHHHHHHHHccccCCCCCCCCchHHHHH
Q 005617 577 VARRLVDLGLQCCELYGRERPDITPSLVKE 606 (688)
Q Consensus 577 ~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~ 606 (688)
.+..+.+++.+||+.+|.+||++. .++..
T Consensus 226 ~~~~~~~li~~cl~~~p~~Rp~~~-~ll~~ 254 (256)
T cd05113 226 ASEKVYAIMYSCWHEKAEERPTFQ-QLLSS 254 (256)
T ss_pred CCHHHHHHHHHHcCCCcccCCCHH-HHHHh
Confidence 357889999999999999999998 44443
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=324.18 Aligned_cols=239 Identities=27% Similarity=0.337 Sum_probs=189.5
Q ss_pred eeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHH-HHHcCCCCceeeEecccCC--CceeEEecCCCC
Q 005617 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVR-VLSKLQHPHLVTLLGACPE--AWSLVYEYLPNG 420 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~-iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~g 420 (688)
.||+|+||.||+|+.. |..||||++..... .....+..|.. ++..++||||++++++|.+ ..++||||+++|
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (321)
T cd05603 2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81 (321)
T ss_pred eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 6999999999999985 78999999975432 22334555654 5788999999999998843 588999999999
Q ss_pred cHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCC
Q 005617 421 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 500 (688)
Q Consensus 421 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~ 500 (688)
+|...+... ..++...+..++.||+.||.|||+.+ |+||||||+||||+.+|.+||+|||+++.......
T Consensus 82 ~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---- 151 (321)
T cd05603 82 ELFFHLQRE---RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE---- 151 (321)
T ss_pred CHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC----
Confidence 999888653 35778889999999999999999965 99999999999999999999999999875422211
Q ss_pred ccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCCCCCCCHHHH
Q 005617 501 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVA 578 (688)
Q Consensus 501 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~~~~~ 578 (688)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...+. ....+..+. ...+....
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~---------~~~~~~~~ 220 (321)
T cd05603 152 --TTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKP---------LQLPGGKT 220 (321)
T ss_pred --ccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCC---------CCCCCCCC
Confidence 12345799999999999999999999999999999999999999975432 222222211 12333445
Q ss_pred HHHHHHHHHccccCCCCCCCCchHHHHHHH
Q 005617 579 RRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 579 ~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le 608 (688)
..+.+++.+|++.+|.+||+....+.+.++
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~~~~~~~~ 250 (321)
T cd05603 221 VAACDLLVGLLHKDQRRRLGAKADFLEIKN 250 (321)
T ss_pred HHHHHHHHHHccCCHhhcCCCCCCHHHHhC
Confidence 678999999999999999998755544443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=340.31 Aligned_cols=250 Identities=29% Similarity=0.471 Sum_probs=203.9
Q ss_pred cccceeeeccCceEEEEEEEC---C--eE-EEEEEEecC---CccchHHHHHHHHHHHcCCCCceeeEecccC--CCcee
Q 005617 344 FSESFKVGQGGFGCVYKGEML---G--RT-VAIKMLYSH---NMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSL 412 (688)
Q Consensus 344 f~~~~~LG~G~fG~Vykg~~~---g--~~-vAIK~l~~~---~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~L 412 (688)
....++||+|+||.||+|.+. + .. ||||..+.. ......+|.+|.+++.+++|||||++||++. ...+|
T Consensus 159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~i 238 (474)
T KOG0194|consen 159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLML 238 (474)
T ss_pred ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEE
Confidence 334478999999999999885 2 23 899998853 3456678999999999999999999999984 46899
Q ss_pred EEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCcccccc
Q 005617 413 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 492 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~ 492 (688)
|||+|+||+|.++|.+... .++..+++.++.+.|.||+|||+.+ +|||||-..|+|++.++.+||+|||+++...
T Consensus 239 vmEl~~gGsL~~~L~k~~~--~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~ 313 (474)
T KOG0194|consen 239 VMELCNGGSLDDYLKKNKK--SLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGS 313 (474)
T ss_pred EEEecCCCcHHHHHHhCCC--CCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCCc
Confidence 9999999999999987653 6899999999999999999999966 9999999999999999999999999987654
Q ss_pred CCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHHHh-hcCccccccCC
Q 005617 493 EDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAV-SCGKLSSILDP 568 (688)
Q Consensus 493 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~~-~~g~l~~~ld~ 568 (688)
.-.. ......-...|+|||.+..+.|++++|||||||++||+++ |..||.+... +...+ ..+..
T Consensus 314 ~~~~------~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r------ 381 (474)
T KOG0194|consen 314 QYVM------KKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYR------ 381 (474)
T ss_pred ceee------ccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCcc------
Confidence 1110 0112235578999999999999999999999999999999 8889986654 44444 22221
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHhhhc
Q 005617 569 LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVA 613 (688)
Q Consensus 569 ~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l~~~ 613 (688)
...|...+..+..++.+||..+|.+||+|. .+.+.|+.+...
T Consensus 382 --~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~-~i~~~l~~~~~~ 423 (474)
T KOG0194|consen 382 --MPIPSKTPKELAKVMKQCWKKDPEDRPTMS-TIKKKLEALEKK 423 (474)
T ss_pred --CCCCCCCHHHHHHHHHHhccCChhhccCHH-HHHHHHHHHHhc
Confidence 123335567888899999999999999999 788888877544
|
|
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=328.52 Aligned_cols=235 Identities=27% Similarity=0.371 Sum_probs=189.1
Q ss_pred eeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcC-CCCceeeEecccCC--CceeEEecCCC
Q 005617 348 FKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWSLVYEYLPN 419 (688)
Q Consensus 348 ~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~~~LV~E~~~~ 419 (688)
+.||+|+||.||+|... |..||||.++.... .....+..|..++..+ +||||+++++++.+ ..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 36999999999999885 78999999976422 2334567788888765 89999999999854 47899999999
Q ss_pred CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCC
Q 005617 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 420 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~ 499 (688)
|+|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 81 g~L~~~i~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---- 150 (316)
T cd05620 81 GDLMFHIQDK---GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD---- 150 (316)
T ss_pred CcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC----
Confidence 9999988654 35788999999999999999999966 9999999999999999999999999987532211
Q ss_pred CccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCCCCCCCHHH
Q 005617 500 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFV 577 (688)
Q Consensus 500 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~~~~ 577 (688)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+..+. ...+...
T Consensus 151 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~---------~~~~~~~ 219 (316)
T cd05620 151 --NRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDT---------PHYPRWI 219 (316)
T ss_pred --CceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC---------CCCCCCC
Confidence 122456799999999999999999999999999999999999999975432 222222111 1223334
Q ss_pred HHHHHHHHHHccccCCCCCCCCchHH
Q 005617 578 ARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 578 ~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
...+.+|+.+||+.||.+||++.+++
T Consensus 220 ~~~~~~li~~~l~~dP~~R~~~~~~~ 245 (316)
T cd05620 220 TKESKDILEKLFERDPTRRLGVVGNI 245 (316)
T ss_pred CHHHHHHHHHHccCCHHHcCCChHHH
Confidence 56789999999999999999986443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=317.27 Aligned_cols=249 Identities=26% Similarity=0.350 Sum_probs=197.2
Q ss_pred HHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcC-CCCceeeEecccCC------
Q 005617 338 QTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE------ 408 (688)
Q Consensus 338 ~~at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~------ 408 (688)
+.+++.|...+.||.|+||.||+|... +..||||++.... .....+.+|+.++.++ +||||++++++|..
T Consensus 2 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 2 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred CChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 356778888899999999999999885 7889999987543 3456788999999999 79999999998842
Q ss_pred --CceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecC
Q 005617 409 --AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFG 486 (688)
Q Consensus 409 --~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFG 486 (688)
..++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg 156 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG 156 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCC
Confidence 3679999999999999987532 246889999999999999999999965 9999999999999999999999999
Q ss_pred ccccccCCCCcCCCccccCCCCCCCCCCChhhhc-----cCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCc
Q 005617 487 ICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR-----TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGK 561 (688)
Q Consensus 487 la~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~ 561 (688)
++....... .......|++.|+|||++. ...++.++|||||||++|||++|+.||..............
T Consensus 157 ~~~~~~~~~------~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~ 230 (272)
T cd06637 157 VSAQLDRTV------GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 230 (272)
T ss_pred Cceeccccc------ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhc
Confidence 998654322 1234567999999999886 34688899999999999999999999965433222211110
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchH
Q 005617 562 LSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 562 l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
. ..+ ...+...+..+.+|+.+||..+|.+||++.+.
T Consensus 231 ~---~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i 266 (272)
T cd06637 231 N---PAP--RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQL 266 (272)
T ss_pred C---CCC--CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 0 000 01111234578999999999999999998743
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=313.15 Aligned_cols=250 Identities=31% Similarity=0.468 Sum_probs=202.0
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC-CceeEEecCC
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYEYLP 418 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~-g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV~E~~~ 418 (688)
.++|...++||+|+||.||+|... +..||+|.+..... ....|.+|+.++++++||||+++++++.+ ..++||||++
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~ 83 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYME 83 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcCC
Confidence 356788899999999999999875 78899999875443 35678999999999999999999998744 5789999999
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcC
Q 005617 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~ 498 (688)
+|+|.+++..... ..+++..+..++.+++.||.|||+.+ ++||||||+||+++.++.++|+|||++........
T Consensus 84 ~~~L~~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-- 157 (260)
T cd05067 84 NGSLVDFLKTPEG-IKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY-- 157 (260)
T ss_pred CCCHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc--
Confidence 9999998865432 46899999999999999999999965 99999999999999999999999999987653221
Q ss_pred CCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHHHhhcCccccccCCCCCCCCH
Q 005617 499 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPT 575 (688)
Q Consensus 499 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~~ 575 (688)
.......++..|+|||++....++.++|||||||++|||++ |+.||..... ....+..+... ..+.
T Consensus 158 ---~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~ 226 (260)
T cd05067 158 ---TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM--------PRPD 226 (260)
T ss_pred ---ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC--------CCCC
Confidence 11233456788999999999999999999999999999999 9999964432 22222222111 1122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCCchHHHHHHHH
Q 005617 576 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 576 ~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~ 609 (688)
..+..+.+++.+|++.+|++||++. .+...|+.
T Consensus 227 ~~~~~~~~li~~~l~~~p~~Rp~~~-~l~~~l~~ 259 (260)
T cd05067 227 NCPEELYELMRLCWKEKPEERPTFE-YLRSVLED 259 (260)
T ss_pred CCCHHHHHHHHHHccCChhhCCCHH-HHHHHhhc
Confidence 3346799999999999999999998 67666653
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=315.61 Aligned_cols=253 Identities=26% Similarity=0.367 Sum_probs=200.6
Q ss_pred HHHHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--Cce
Q 005617 336 DLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWS 411 (688)
Q Consensus 336 el~~at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~ 411 (688)
|++.+++++.....||+|+||.||+|.+. +..||+|.+..........+.+|+.+++.++||||++++++|.. ..+
T Consensus 2 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 2 EYEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred CcccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 45567888888899999999999999875 67899999887666666789999999999999999999999854 478
Q ss_pred eEEecCCCCcHHHHhcccCCCCCC--CHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCC-CCCeEEeecCcc
Q 005617 412 LVYEYLPNGSLQDRLFRKSNVSPL--LWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS-ELSSKICDFGIC 488 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~~~~~~l--~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~-~~~vKLsDFGla 488 (688)
+||||+++++|.+++.... ..+ ++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.++|+|||++
T Consensus 82 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~ 156 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKW--GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTS 156 (268)
T ss_pred EEEecCCCCCHHHHHHHhc--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhh
Confidence 9999999999999987543 234 78888999999999999999865 999999999999986 679999999998
Q ss_pred ccccCCCCcCCCccccCCCCCCCCCCChhhhccCC--CCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCcccccc
Q 005617 489 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV--LTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSIL 566 (688)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~--~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~l~~~l 566 (688)
........ ......|++.|+|||++.... ++.++|||||||++|+|++|+.||................
T Consensus 157 ~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~--- 227 (268)
T cd06624 157 KRLAGINP------CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMF--- 227 (268)
T ss_pred eecccCCC------ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhh---
Confidence 76543221 122346899999999986644 7899999999999999999999996433211111000000
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 567 DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 567 d~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
......+......+.+++.+||+.+|.+||++.+.+
T Consensus 228 -~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll 263 (268)
T cd06624 228 -KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLL 263 (268)
T ss_pred -ccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHH
Confidence 111234445667899999999999999999998443
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-38 Score=330.31 Aligned_cols=246 Identities=26% Similarity=0.338 Sum_probs=203.2
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEecC
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 417 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~ 417 (688)
.|+....||+|.||.||+|.+. ++.||||++...... ...++.+|+.+|+.++++||.++||.+. ..+.++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 4555678999999999999986 889999999876544 4567899999999999999999999874 4578999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCc
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~ 497 (688)
.||++.+.|.... .+.+..+.-|+.++..||.|||..+ .+|||||+.||||..+|.+||+|||.+..+.....
T Consensus 94 ~gGsv~~lL~~~~---~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~- 166 (467)
T KOG0201|consen 94 GGGSVLDLLKSGN---ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK- 166 (467)
T ss_pred cCcchhhhhccCC---CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh-
Confidence 9999999986543 3466677788999999999999976 99999999999999999999999999988876542
Q ss_pred CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCccccccCCCCCCCCHHH
Q 005617 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFV 577 (688)
Q Consensus 498 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~l~~~ld~~~~~~~~~~ 577 (688)
+..+++|||.|||||++....|+.|+||||||++.+||.+|.+|+.....++-.+ -+............
T Consensus 167 -----rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf------lIpk~~PP~L~~~~ 235 (467)
T KOG0201|consen 167 -----RRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF------LIPKSAPPRLDGDF 235 (467)
T ss_pred -----ccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE------eccCCCCCcccccc
Confidence 3478899999999999998899999999999999999999999997655422111 11111122233356
Q ss_pred HHHHHHHHHHccccCCCCCCCCchHHHHH
Q 005617 578 ARRLVDLGLQCCELYGRERPDITPSLVKE 606 (688)
Q Consensus 578 ~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~ 606 (688)
+..+.+++..||+.||+.||++.+.+-+.
T Consensus 236 S~~~kEFV~~CL~k~P~~RpsA~~LLKh~ 264 (467)
T KOG0201|consen 236 SPPFKEFVEACLDKNPEFRPSAKELLKHK 264 (467)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhhhH
Confidence 77899999999999999999999655443
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=355.71 Aligned_cols=264 Identities=22% Similarity=0.253 Sum_probs=204.7
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~---~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|...++||+|+||.||+|... |..||||++...... ....|.+|+.++++++|||||+++++|.+ ..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47888999999999999999885 789999999754322 24568999999999999999999999854 478999
Q ss_pred ecCCCCcHHHHhcccC--------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecC
Q 005617 415 EYLPNGSLQDRLFRKS--------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFG 486 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~--------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFG 486 (688)
||++||+|.+++.... ....+++..++.++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999886421 1234677888999999999999999965 9999999999999999999999999
Q ss_pred ccccccCCCCc------------CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHH
Q 005617 487 ICRLVTEDTLY------------LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR 554 (688)
Q Consensus 487 la~~~~~~~~~------------~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~ 554 (688)
+++........ ...........||+.|+|||++.+..++.++|||||||++|||+||+.||.......
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~k 238 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRK 238 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 99876211100 001111234579999999999999999999999999999999999999996533211
Q ss_pred HHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHhhh
Q 005617 555 RAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 555 ~~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l~~ 612 (688)
.. ....+ .++.........+..+.+++.+|+..||++||+..+++...|+....
T Consensus 239 i~-~~~~i---~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq 292 (932)
T PRK13184 239 IS-YRDVI---LSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ 292 (932)
T ss_pred hh-hhhhc---cChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 11 11111 11111011123456788999999999999999988889888887643
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=313.42 Aligned_cols=249 Identities=34% Similarity=0.457 Sum_probs=200.7
Q ss_pred cCcccceeeeccCceEEEEEEEC-CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC-CCceeEEecCCC
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP-EAWSLVYEYLPN 419 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~-g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~-~~~~LV~E~~~~ 419 (688)
++|....+||+|+||.||+|.+. +..||||.+..... ....|.+|+.++..++||||+++++++. +..++||||+++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~ 84 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSK 84 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCCC
Confidence 56888899999999999999886 45799999875432 3457899999999999999999999874 457899999999
Q ss_pred CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCC
Q 005617 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 420 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~ 499 (688)
|+|.+++.... ...+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.........
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~-- 158 (262)
T cd05071 85 GSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-- 158 (262)
T ss_pred CcHHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc--
Confidence 99999996532 245789999999999999999999966 999999999999999999999999999876533211
Q ss_pred CccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHHHhhcCccccccCCCCCCCCHH
Q 005617 500 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTF 576 (688)
Q Consensus 500 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~~~ 576 (688)
......++..|+|||+..+..++.++|||||||++|+|+| |..||..... ....+..+.. ...+..
T Consensus 159 ---~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~ 227 (262)
T cd05071 159 ---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--------MPCPPE 227 (262)
T ss_pred ---cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC--------CCCccc
Confidence 1123456778999999998999999999999999999999 8889864332 2222222110 112234
Q ss_pred HHHHHHHHHHHccccCCCCCCCCchHHHHHHHH
Q 005617 577 VARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 577 ~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~ 609 (688)
.+..+.+|+.+|++.+|.+||++. .+...|+.
T Consensus 228 ~~~~l~~li~~~l~~~p~~Rp~~~-~~~~~l~~ 259 (262)
T cd05071 228 CPESLHDLMCQCWRKEPEERPTFE-YLQAFLED 259 (262)
T ss_pred cCHHHHHHHHHHccCCcccCCCHH-HHHHHHHH
Confidence 566789999999999999999998 67777764
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=330.64 Aligned_cols=204 Identities=25% Similarity=0.381 Sum_probs=171.5
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|...+.||+|+||+||++... +..||||++..... .....+..|+.++..++||||+++++++.+ ..+|||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888899999999999999875 78999999975432 223467889999999999999999999854 478999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMKK---DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 999999999999764 35889999999999999999999966 999999999999999999999999999865321
Q ss_pred CCcC---------C--------------------CccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCC
Q 005617 495 TLYL---------P--------------------SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRL 545 (688)
Q Consensus 495 ~~~~---------~--------------------~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~ 545 (688)
.... + ........+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 1000 0 0001134579999999999999999999999999999999999999
Q ss_pred CCCChh
Q 005617 546 PVGLAG 551 (688)
Q Consensus 546 Pf~~~~ 551 (688)
||....
T Consensus 235 Pf~~~~ 240 (363)
T cd05628 235 PFCSET 240 (363)
T ss_pred CCCCCC
Confidence 997543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-37 Score=327.86 Aligned_cols=231 Identities=25% Similarity=0.367 Sum_probs=188.4
Q ss_pred eeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcC-CCCceeeEecccCC--CceeEEecCCCC
Q 005617 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWSLVYEYLPNG 420 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~~~LV~E~~~~g 420 (688)
.||+|+||.||+|+.. |..||||++..... .....+..|..++..+ +||||++++++|.+ ..++||||+++|
T Consensus 2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 81 (321)
T cd05591 2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG 81 (321)
T ss_pred ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence 5999999999999886 67899999976432 2334577899999876 79999999999854 478999999999
Q ss_pred cHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCC
Q 005617 421 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 500 (688)
Q Consensus 421 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~ 500 (688)
+|...+... ..+++..+..++.+|+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~---- 151 (321)
T cd05591 82 DLMFQIQRS---RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV---- 151 (321)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCc----
Confidence 999888654 35788999999999999999999966 99999999999999999999999999876432221
Q ss_pred ccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCCCCCCCHHHH
Q 005617 501 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVA 578 (688)
Q Consensus 501 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~~~~~ 578 (688)
......||+.|+|||++.+..++.++|||||||++|||+||+.||..... ....+..+.. ..|...+
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~---------~~p~~~~ 220 (321)
T cd05591 152 --TTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDV---------LYPVWLS 220 (321)
T ss_pred --cccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---------CCCCCCC
Confidence 12345799999999999999999999999999999999999999975443 2222222221 1233345
Q ss_pred HHHHHHHHHccccCCCCCCCCc
Q 005617 579 RRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 579 ~~l~~L~~~Cl~~dP~~RPs~~ 600 (688)
..+.+|+.+||+.||.+||+..
T Consensus 221 ~~~~~ll~~~L~~dp~~R~~~~ 242 (321)
T cd05591 221 KEAVSILKAFMTKNPNKRLGCV 242 (321)
T ss_pred HHHHHHHHHHhccCHHHcCCCC
Confidence 6789999999999999999654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=312.41 Aligned_cols=242 Identities=26% Similarity=0.450 Sum_probs=191.8
Q ss_pred eeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecCCCCcHH
Q 005617 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSLQ 423 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gsL~ 423 (688)
.||+|+||.||+|.+. +..||+|.+..... .....|.+|+.++..++||||++++++|.. ..++||||+++++|.
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 81 (252)
T cd05084 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFL 81 (252)
T ss_pred ccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHH
Confidence 5999999999999884 88899998765432 334569999999999999999999999844 478999999999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCCccc
Q 005617 424 DRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHR 503 (688)
Q Consensus 424 ~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~ 503 (688)
+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......... .
T Consensus 82 ~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~----~ 152 (252)
T cd05084 82 TFLRTEG--PRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAS----T 152 (252)
T ss_pred HHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccc----c
Confidence 9986543 45889999999999999999999966 9999999999999999999999999987654322110 0
Q ss_pred cCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHHHhhcCccccccCCCCCCCCHHHHHH
Q 005617 504 STAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVARR 580 (688)
Q Consensus 504 ~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~~~~~~~ 580 (688)
.....++..|+|||++.++.++.++|||||||++|||++ |..||..... ....+..+. ....+...+..
T Consensus 153 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~ 224 (252)
T cd05084 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV--------RLPCPELCPDA 224 (252)
T ss_pred CCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCC--------CCCCcccCCHH
Confidence 112233567999999999999999999999999999998 8899864332 222222211 11223344668
Q ss_pred HHHHHHHccccCCCCCCCCchHHHHHHH
Q 005617 581 LVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 581 l~~L~~~Cl~~dP~~RPs~~~~l~~~Le 608 (688)
+.+|+.+|++.+|.+||++. ++.+.|+
T Consensus 225 ~~~li~~~l~~~p~~Rps~~-~~~~~l~ 251 (252)
T cd05084 225 VYRLMERCWEYDPGQRPSFS-TVHQELQ 251 (252)
T ss_pred HHHHHHHHcCCChhhCcCHH-HHHHHHh
Confidence 99999999999999999998 5655553
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=312.02 Aligned_cols=245 Identities=28% Similarity=0.480 Sum_probs=202.2
Q ss_pred cCcccceeeeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEecCCC
Q 005617 342 CNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLPN 419 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~~~ 419 (688)
++|.....||.|+||.||+|...|+.||||.+..... ....+.+|+.++..++|+||+++++++. +..++||||+++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 84 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAK 84 (256)
T ss_pred hhccceeeeecCCCceEEEEEecCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCC
Confidence 4677788999999999999999999999999976654 4567999999999999999999999885 457899999999
Q ss_pred CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCC
Q 005617 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 420 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~ 499 (688)
++|.+++..... ..++|..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++......
T Consensus 85 ~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~---- 156 (256)
T cd05039 85 GSLVDYLRSRGR-AVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ---- 156 (256)
T ss_pred CcHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEccccccccccccc----
Confidence 999999865432 36899999999999999999999966 9999999999999999999999999998764322
Q ss_pred CccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--hHHHHhhcCccccccCCCCCCCCHH
Q 005617 500 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLAGDWPTF 576 (688)
Q Consensus 500 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~~~~g~l~~~ld~~~~~~~~~ 576 (688)
....++..|+|||++..+.++.++||||||+++|+|++ |..||.... .+...+..+... ..+..
T Consensus 157 -----~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~ 223 (256)
T cd05039 157 -----DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRM--------EAPEG 223 (256)
T ss_pred -----ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCC--------CCccC
Confidence 13345678999999998899999999999999999997 999986443 222223222111 12223
Q ss_pred HHHHHHHHHHHccccCCCCCCCCchHHHHHHHH
Q 005617 577 VARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 577 ~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~ 609 (688)
.+..+.+++.+||..+|.+||++. ++...|+.
T Consensus 224 ~~~~~~~li~~~l~~~p~~Rp~~~-~l~~~l~~ 255 (256)
T cd05039 224 CPPEVYKVMKDCWELDPAKRPTFK-QLREQLAL 255 (256)
T ss_pred CCHHHHHHHHHHhccChhhCcCHH-HHHHHHhc
Confidence 457889999999999999999998 67666653
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=325.46 Aligned_cols=252 Identities=24% Similarity=0.307 Sum_probs=197.3
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--------------cchHHHHHHHHHHHcCCCCceeeE
Q 005617 339 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--------------QGQLEFQQEVRVLSKLQHPHLVTL 402 (688)
Q Consensus 339 ~at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~--------------~~~~~f~~E~~iL~~l~HpnIV~l 402 (688)
..-|.|.....||+|.||.|-+|+.. ++.||||++.+... ...+...+|+.||++++|||||+|
T Consensus 94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L 173 (576)
T KOG0585|consen 94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL 173 (576)
T ss_pred eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence 34478999999999999999999886 88999999965432 123468899999999999999999
Q ss_pred ecccC----CCceeEEecCCCCcHHHHhcccCCCCC-CCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCC
Q 005617 403 LGACP----EAWSLVYEYLPNGSLQDRLFRKSNVSP-LLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE 477 (688)
Q Consensus 403 ~g~~~----~~~~LV~E~~~~gsL~~~L~~~~~~~~-l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~ 477 (688)
+.+.. +..|||+|||..|.+...-. ..+ ++..++.+++.++..||.|||..+ ||||||||+|+||+.+
T Consensus 174 iEvLDDP~s~~~YlVley~s~G~v~w~p~----d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~ 246 (576)
T KOG0585|consen 174 IEVLDDPESDKLYLVLEYCSKGEVKWCPP----DKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSD 246 (576)
T ss_pred EEeecCcccCceEEEEEeccCCccccCCC----CcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCC
Confidence 99874 35899999999998754322 233 889999999999999999999966 9999999999999999
Q ss_pred CCeEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCC----CCCcchHhHHHHHHHHHHhCCCCCCChhhH
Q 005617 478 LSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV----LTPKSDSYSFGLIILQLLTGRLPVGLAGEV 553 (688)
Q Consensus 478 ~~vKLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~----~s~ksDVwSfGviL~ELltG~~Pf~~~~~~ 553 (688)
|++||+|||.+.....+..... ...-...+|||.|||||...++. .+.+.||||+||+||.|+.|+.||......
T Consensus 247 g~VKIsDFGVs~~~~~~~~~~~-d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~ 325 (576)
T KOG0585|consen 247 GTVKISDFGVSNEFPQGSDEGS-DDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL 325 (576)
T ss_pred CcEEeeccceeeecccCCcccc-HHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence 9999999999987744321111 11123478999999999887743 357899999999999999999999754432
Q ss_pred --HHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHH
Q 005617 554 --RRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 605 (688)
Q Consensus 554 --~~~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~ 605 (688)
...+... |..-.-.+++...+.+|++++|+.||..|.++.++.++
T Consensus 326 ~l~~KIvn~-------pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H 372 (576)
T KOG0585|consen 326 ELFDKIVND-------PLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH 372 (576)
T ss_pred HHHHHHhcC-------cccCCCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence 1222221 11111122467889999999999999999998854433
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=318.72 Aligned_cols=257 Identities=27% Similarity=0.398 Sum_probs=199.9
Q ss_pred cCcccceeeeccCceEEEEEEECC------------------eEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEMLG------------------RTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTL 402 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~g------------------~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l 402 (688)
.+|.....||+|+||.||++...+ ..||+|.+..... .....|.+|+.++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~ 84 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARL 84 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 567888999999999999987642 4589999876543 345678999999999999999999
Q ss_pred ecccCC--CceeEEecCCCCcHHHHhcccC--------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCce
Q 005617 403 LGACPE--AWSLVYEYLPNGSLQDRLFRKS--------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNI 472 (688)
Q Consensus 403 ~g~~~~--~~~LV~E~~~~gsL~~~L~~~~--------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NI 472 (688)
+++|.. ..++||||+++++|.+++.... ....+++..++.++.+++.||.|||+.+ |+||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Ni 161 (296)
T cd05051 85 LGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhce
Confidence 999854 5889999999999999987543 1236899999999999999999999965 99999999999
Q ss_pred eeCCCCCeEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh--CCCCCCCh
Q 005617 473 LLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT--GRLPVGLA 550 (688)
Q Consensus 473 LLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt--G~~Pf~~~ 550 (688)
+++.++.++|+|||+++........ .......+++.|+|||++....++.++|||||||++|||++ |..||...
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYY----RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHL 237 (296)
T ss_pred eecCCCceEEccccceeecccCcce----eecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence 9999999999999999865433211 12335567889999999998899999999999999999998 77888643
Q ss_pred hh--HHHHhhcCccccccC-CCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHH
Q 005617 551 GE--VRRAVSCGKLSSILD-PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 551 ~~--~~~~~~~g~l~~~ld-~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le 608 (688)
.. +....... ....+ ......+...+..+.+|+.+||+.||.+||++. ++...|+
T Consensus 238 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~-el~~~L~ 295 (296)
T cd05051 238 TDQQVIENAGHF--FRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFR-EIHLFLQ 295 (296)
T ss_pred ChHHHHHHHHhc--cccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHH-HHHHHhc
Confidence 32 22221111 00000 001112333456899999999999999999998 5655553
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=311.43 Aligned_cols=249 Identities=31% Similarity=0.434 Sum_probs=199.8
Q ss_pred cCcccceeeeccCceEEEEEEEC-CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC-CceeEEecCCC
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYEYLPN 419 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~-g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV~E~~~~ 419 (688)
++|.....||+|+||.||+|.+. +..||+|.+.... .....|.+|+.+++.++|||++++++++.. ..++||||+++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~ 84 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGK 84 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCC
Confidence 45777889999999999999886 4579999886543 234578899999999999999999998854 47899999999
Q ss_pred CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCC
Q 005617 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 420 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~ 499 (688)
|+|.+++.... ...++|..+..++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.........
T Consensus 85 ~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-- 158 (260)
T cd05069 85 GSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-- 158 (260)
T ss_pred CCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc--
Confidence 99999997543 245799999999999999999999965 999999999999999999999999999876433211
Q ss_pred CccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHHHhhcCccccccCCCCCCCCHH
Q 005617 500 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTF 576 (688)
Q Consensus 500 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~~~ 576 (688)
......++..|+|||+..+..++.++|||||||++|||+| |..||..... ....+..+.. ...+..
T Consensus 159 ---~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~ 227 (260)
T cd05069 159 ---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR--------MPCPQG 227 (260)
T ss_pred ---ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC--------CCCCcc
Confidence 1123346788999999998999999999999999999999 8999965432 2222222110 112334
Q ss_pred HHHHHHHHHHHccccCCCCCCCCchHHHHHHHH
Q 005617 577 VARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 577 ~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~ 609 (688)
.+..+.+++.+||..+|.+||++. .+.+.|+.
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rp~~~-~i~~~l~~ 259 (260)
T cd05069 228 CPESLHELMKLCWKKDPDERPTFE-YIQSFLED 259 (260)
T ss_pred cCHHHHHHHHHHccCCcccCcCHH-HHHHHHhc
Confidence 567899999999999999999998 67776653
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=312.11 Aligned_cols=252 Identities=21% Similarity=0.327 Sum_probs=202.3
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~ 414 (688)
++|...+.||.|+||.||+|+.. +..||||.+..... .....|.+|+.+++.++||||+++++++. +..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 47888899999999999999874 88999998865432 23346889999999999999999999874 4578999
Q ss_pred ecCCCCcHHHHhcccC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccC
Q 005617 415 EYLPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~ 493 (688)
||+++|+|.+++.... ....++...+..++.+++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998885432 2245788999999999999999999965 99999999999999999999999999987654
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh----hHHHHhhcCccccccCCC
Q 005617 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG----EVRRAVSCGKLSSILDPL 569 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~----~~~~~~~~g~l~~~ld~~ 569 (688)
... ......|++.|+|||++.+..++.++||||||+++|||++|+.||.... .....+..+....
T Consensus 159 ~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~----- 227 (267)
T cd08228 159 KTT------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP----- 227 (267)
T ss_pred hhH------HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC-----
Confidence 321 1234568899999999998889999999999999999999999985332 1112222111110
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHh
Q 005617 570 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 570 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l 610 (688)
..+...+..+.+++.+||+.+|.+||++. ++.+.|+.+
T Consensus 228 --~~~~~~~~~~~~li~~cl~~~p~~Rp~~~-~vl~~~~~~ 265 (267)
T cd08228 228 --LPTEHYSEKLRELVSMCIYPDPDQRPDIG-YVHQIAKQM 265 (267)
T ss_pred --CChhhcCHHHHHHHHHHCCCCcccCcCHH-HHHHHHHHh
Confidence 11223456799999999999999999999 777777765
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=312.03 Aligned_cols=243 Identities=29% Similarity=0.401 Sum_probs=199.7
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEec
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
+|...+.||+|+||.||+|... |..|++|.+..... .....+.+|+.+++.++||||+++++++.+ ..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4777889999999999999885 78999999875432 345578999999999999999999999854 47899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCC
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~ 496 (688)
+++++|.+++.... ...+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~l~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQR-GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 99999999987642 256899999999999999999999865 99999999999999999999999999987654321
Q ss_pred cCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhH--HHHhhcCccccccCCCCCCCC
Q 005617 497 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGDWP 574 (688)
Q Consensus 497 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~~~~g~l~~~ld~~~~~~~ 574 (688)
......|++.|+|||++.+..++.++|||||||++|+|+||+.||...... ...+..+... ..+
T Consensus 157 ------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~ 222 (256)
T cd08529 157 ------FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFP--------PVS 222 (256)
T ss_pred ------hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC--------CCc
Confidence 123456889999999999999999999999999999999999999755432 1222222111 222
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 575 TFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 575 ~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
......+.+++.+||+.+|++||++.+.+
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll 251 (256)
T cd08529 223 QMYSQQLAQLIDQCLTKDYRQRPDTFQLL 251 (256)
T ss_pred cccCHHHHHHHHHHccCCcccCcCHHHHh
Confidence 24567899999999999999999998433
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=311.82 Aligned_cols=244 Identities=30% Similarity=0.516 Sum_probs=197.1
Q ss_pred eeeccCceEEEEEEEC--C---eEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccCC-CceeEEecCCCCc
Q 005617 349 KVGQGGFGCVYKGEML--G---RTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYEYLPNGS 421 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~--g---~~vAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV~E~~~~gs 421 (688)
.||+|+||.||+|... + ..||+|.+...... ....+.+|+.+++.+.|||||++++++.. ..++||||+++|+
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~ 81 (257)
T cd05060 2 ELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLGP 81 (257)
T ss_pred ccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCCc
Confidence 6999999999999764 2 67999999766543 45579999999999999999999998854 5789999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCCc
Q 005617 422 LQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 501 (688)
Q Consensus 422 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~~ 501 (688)
|.+++.... .+++..+..++.|++.||.|||..+ ++|+||||+|||++.++.+||+|||+++.........
T Consensus 82 L~~~l~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~--- 152 (257)
T cd05060 82 LLKYLKKRR---EIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY--- 152 (257)
T ss_pred HHHHHHhCC---CCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccc---
Confidence 999997643 5789999999999999999999966 9999999999999999999999999998765433211
Q ss_pred cccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHHHhhcCccccccCCCCCCCCHHHH
Q 005617 502 HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVA 578 (688)
Q Consensus 502 ~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~~~~~ 578 (688)
.......++..|+|||.+.+..++.++|||||||++|+|++ |.+||..... +...+..+... ..+...+
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~~ 224 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL--------PRPEECP 224 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC--------CCCCCCC
Confidence 11222335678999999999999999999999999999998 9999975432 22333332211 1223345
Q ss_pred HHHHHHHHHccccCCCCCCCCchHHHHHHHHh
Q 005617 579 RRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 579 ~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l 610 (688)
..+.+++.+||..+|.+||++. .+...|+.+
T Consensus 225 ~~l~~li~~cl~~~p~~Rp~~~-~l~~~l~~~ 255 (257)
T cd05060 225 QEIYSIMLSCWKYRPEDRPTFS-ELESTFRRD 255 (257)
T ss_pred HHHHHHHHHHhcCChhhCcCHH-HHHHHHHhc
Confidence 6889999999999999999998 677777653
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=325.23 Aligned_cols=231 Identities=26% Similarity=0.368 Sum_probs=189.3
Q ss_pred eeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcC-CCCceeeEecccC--CCceeEEecCCCC
Q 005617 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKL-QHPHLVTLLGACP--EAWSLVYEYLPNG 420 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~--~~~~LV~E~~~~g 420 (688)
.||+|+||.||+|... +..||||++..... .....+..|..++..+ +||||+++++++. +..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (318)
T cd05570 2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG 81 (318)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence 6999999999999886 67899999986432 3344577899999888 7999999999884 3588999999999
Q ss_pred cHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCC
Q 005617 421 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 500 (688)
Q Consensus 421 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~ 500 (688)
+|..++... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---- 151 (318)
T cd05570 82 DLMFHIQRS---GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV---- 151 (318)
T ss_pred CHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCC----
Confidence 999888654 35899999999999999999999965 99999999999999999999999999875322211
Q ss_pred ccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCCCCCCCHHHH
Q 005617 501 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVA 578 (688)
Q Consensus 501 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~~~~~ 578 (688)
......||+.|+|||++.+..++.++|||||||++|+|+||+.||..... +...+..+.. .++...+
T Consensus 152 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~---------~~~~~~~ 220 (318)
T cd05570 152 --TTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEV---------RYPRWLS 220 (318)
T ss_pred --cccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC---------CCCCcCC
Confidence 12345699999999999999999999999999999999999999975432 2222222211 2233456
Q ss_pred HHHHHHHHHccccCCCCCCCCc
Q 005617 579 RRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 579 ~~l~~L~~~Cl~~dP~~RPs~~ 600 (688)
..+.+|+.+||+.||.+||++.
T Consensus 221 ~~~~~li~~~l~~dP~~R~s~~ 242 (318)
T cd05570 221 KEAKSILKSFLTKNPEKRLGCL 242 (318)
T ss_pred HHHHHHHHHHccCCHHHcCCCC
Confidence 7889999999999999999994
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=336.49 Aligned_cols=245 Identities=22% Similarity=0.293 Sum_probs=188.4
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|...+.||+|+||.||+++.. +..||||++..... .....+.+|+.+|..++||||+++++.|.+ ..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36888999999999999999875 78999999865422 234568899999999999999999999854 478999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
||+++|+|.+++... ..++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|..+...
T Consensus 81 E~~~~g~L~~~i~~~---~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~ 154 (376)
T cd05598 81 DYIPGGDMMSLLIRL---GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 154 (376)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccc
Confidence 999999999998654 35788888999999999999999966 999999999999999999999999998543210
Q ss_pred CCc-------------------------------------CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHH
Q 005617 495 TLY-------------------------------------LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLII 537 (688)
Q Consensus 495 ~~~-------------------------------------~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL 537 (688)
... ...........||+.|+|||++.+..++.++|||||||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil 234 (376)
T cd05598 155 HDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 234 (376)
T ss_pred ccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeecccee
Confidence 000 0000011245799999999999999999999999999999
Q ss_pred HHHHhCCCCCCChhhHHH--HhhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 005617 538 LQLLTGRLPVGLAGEVRR--AVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPD 598 (688)
Q Consensus 538 ~ELltG~~Pf~~~~~~~~--~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs 598 (688)
|||++|+.||........ .+..... ....+. ....+..+.+++.+|+ .+|.+|+.
T Consensus 235 yell~G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~----~~~~s~~~~~li~~l~-~~p~~R~~ 291 (376)
T cd05598 235 YEMLVGQPPFLADTPAETQLKVINWET-TLHIPS----QAKLSREASDLILRLC-CGAEDRLG 291 (376)
T ss_pred eehhhCCCCCCCCCHHHHHHHHhccCc-cccCCC----CCCCCHHHHHHHHHHh-cCHhhcCC
Confidence 999999999975543221 1211110 000111 1123456777888866 49999994
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=318.42 Aligned_cols=243 Identities=24% Similarity=0.313 Sum_probs=194.7
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEec
Q 005617 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 344 f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~---~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
|...+.||.|+||+||+|... ++.||+|.+...... ....+.+|+.++..++|+||+++++++.. ..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 666788999999999999885 789999999765432 23457889999999999999999988743 47899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCC
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~ 496 (688)
+++|+|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNMGN-PGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 999999988865432 46899999999999999999999965 9999999999999999999999999987654322
Q ss_pred cCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHH--HHhhcCccccccCCCCCCCC
Q 005617 497 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSILDPLAGDWP 574 (688)
Q Consensus 497 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~--~~~~~g~l~~~ld~~~~~~~ 574 (688)
......|++.|+|||++.+..++.++|||||||++|+|++|..||....... ..+. ..+... ...++
T Consensus 157 ------~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~-~~~~~~----~~~~~ 225 (285)
T cd05632 157 ------SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD-RRVLET----EEVYS 225 (285)
T ss_pred ------cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-Hhhhcc----ccccC
Confidence 1234579999999999999999999999999999999999999997543211 1111 111110 11223
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCCchH
Q 005617 575 TFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 575 ~~~~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
...+..+.+|+..|++.||.+||++.+.
T Consensus 226 ~~~~~~~~~li~~~l~~~P~~R~~~~~~ 253 (285)
T cd05632 226 AKFSEEAKSICKMLLTKDPKQRLGCQEE 253 (285)
T ss_pred ccCCHHHHHHHHHHccCCHhHcCCCccc
Confidence 3455678999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=335.43 Aligned_cols=246 Identities=21% Similarity=0.270 Sum_probs=188.2
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEe
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E 415 (688)
.|...+.||+|+||.||+|+.. +..||||++..... .....+.+|+.+++.++|||||+++++|.+ ..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788899999999999999885 78899999975432 233468899999999999999999999854 4789999
Q ss_pred cCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCC
Q 005617 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~ 495 (688)
|+++|+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.+|.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~~---~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 99999999998654 35788889999999999999999966 9999999999999999999999999986432100
Q ss_pred Cc-----------------------------------------CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHH
Q 005617 496 LY-----------------------------------------LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFG 534 (688)
Q Consensus 496 ~~-----------------------------------------~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfG 534 (688)
.. ..........+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 00 0000011245799999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCChhhHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 005617 535 LIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPD 598 (688)
Q Consensus 535 viL~ELltG~~Pf~~~~~~~~~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs 598 (688)
|+||||++|++||..................+ ........+..+.+++.+++ .+|.+|++
T Consensus 236 vil~elltG~~Pf~~~~~~~~~~~i~~~~~~~---~~p~~~~~s~~~~~li~~l~-~~p~~R~~ 295 (382)
T cd05625 236 VILYEMLVGQPPFLAQTPLETQMKVINWQTSL---HIPPQAKLSPEASDLIIKLC-RGPEDRLG 295 (382)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHccCCCc---CCCCcccCCHHHHHHHHHHc-cCHhHcCC
Confidence 99999999999997654322221111100000 00111223456777777766 49999998
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=318.24 Aligned_cols=249 Identities=28% Similarity=0.436 Sum_probs=197.3
Q ss_pred cccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccCC--CceeE
Q 005617 344 FSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLV 413 (688)
Q Consensus 344 f~~~~~LG~G~fG~Vykg~~~-------g~~vAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV 413 (688)
|...+.||.|+||.||+|... +..||||++...... ....|.+|+.++..++||||+++++++.+ ..+++
T Consensus 7 ~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~ 86 (283)
T cd05091 7 VRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMI 86 (283)
T ss_pred HHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEE
Confidence 555678999999999999864 367999999755432 23568899999999999999999999854 57899
Q ss_pred EecCCCCcHHHHhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCe
Q 005617 414 YEYLPNGSLQDRLFRKS-------------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS 480 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~v 480 (688)
++|+++++|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 87 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 87 FSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCce
Confidence 99999999999985321 1235888999999999999999999965 9999999999999999999
Q ss_pred EEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--hHHHHh
Q 005617 481 KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAV 557 (688)
Q Consensus 481 KLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~~ 557 (688)
||+|||+++........ .......+++.|+|||++..+.++.++|||||||++|||+| |..||.... .+...+
T Consensus 164 kl~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i 239 (283)
T cd05091 164 KISDLGLFREVYAADYY----KLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239 (283)
T ss_pred Eecccccccccccchhe----eeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 99999998876433211 11234456789999999998999999999999999999998 888886432 233333
Q ss_pred hcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHH
Q 005617 558 SCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 558 ~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le 608 (688)
..+... ..+...+..+.+|+..||+.+|.+||++. ++...|+
T Consensus 240 ~~~~~~--------~~~~~~~~~~~~li~~cl~~~p~~RP~~~-~i~~~l~ 281 (283)
T cd05091 240 RNRQVL--------PCPDDCPAWVYTLMLECWNEFPSRRPRFK-DIHSRLR 281 (283)
T ss_pred HcCCcC--------CCCCCCCHHHHHHHHHHhCCCcccCCCHH-HHHHHhh
Confidence 333221 22334556789999999999999999998 6666554
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=331.00 Aligned_cols=231 Identities=23% Similarity=0.315 Sum_probs=188.2
Q ss_pred eeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcC-CCCceeeEecccC--CCceeEEecCCCC
Q 005617 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKL-QHPHLVTLLGACP--EAWSLVYEYLPNG 420 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~--~~~~LV~E~~~~g 420 (688)
.||+|+||.||+|... +..||||++..... .....+..|+.++.++ +||||+.+++++. +..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (327)
T cd05617 2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG 81 (327)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence 6999999999999885 78899999986533 2334588999999888 6999999999884 3578999999999
Q ss_pred cHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCC
Q 005617 421 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 500 (688)
Q Consensus 421 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~ 500 (688)
+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~L~~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~----- 150 (327)
T cd05617 82 DLMFHMQRQ---RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG----- 150 (327)
T ss_pred cHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC-----
Confidence 999888654 35899999999999999999999965 9999999999999999999999999987532211
Q ss_pred ccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh---------hHHHHhhcCccccccCCCCC
Q 005617 501 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG---------EVRRAVSCGKLSSILDPLAG 571 (688)
Q Consensus 501 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~---------~~~~~~~~g~l~~~ld~~~~ 571 (688)
.......||+.|+|||++.+..++.++|||||||+||||+||+.||.... .....+..+ ..
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~---------~~ 220 (327)
T cd05617 151 -DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK---------PI 220 (327)
T ss_pred -CceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC---------CC
Confidence 11235679999999999999999999999999999999999999995321 111211111 11
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCCc
Q 005617 572 DWPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 572 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~ 600 (688)
..|...+..+.+++.+||+.||.+||++.
T Consensus 221 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 221 RIPRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred CCCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 23444567789999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=317.49 Aligned_cols=255 Identities=27% Similarity=0.399 Sum_probs=197.4
Q ss_pred ccceeeeccCceEEEEEEE------CCeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC----CceeE
Q 005617 345 SESFKVGQGGFGCVYKGEM------LGRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE----AWSLV 413 (688)
Q Consensus 345 ~~~~~LG~G~fG~Vykg~~------~g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~----~~~LV 413 (688)
.....||+|+||+||++.. .+..||+|.+..... .....|.+|+.+|+.++||||++++++|.. ..++|
T Consensus 7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (283)
T cd05080 7 KKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLI 86 (283)
T ss_pred eeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEE
Confidence 6778999999999988653 267899999876533 345578899999999999999999998742 36899
Q ss_pred EecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccC
Q 005617 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~ 493 (688)
|||+++|+|.+++... .+++..++.++.+++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~e~~~~~~l~~~~~~~----~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 87 MEYVPLGSLRDYLPKH----KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred ecCCCCCCHHHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence 9999999999998653 4899999999999999999999965 99999999999999999999999999987654
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh-HHHHhh--c-----Cccccc
Q 005617 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE-VRRAVS--C-----GKLSSI 565 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~-~~~~~~--~-----g~l~~~ 565 (688)
..... .......++..|+|||++....++.++|||||||++|||+||..||..... ...... . ..+...
T Consensus 160 ~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05080 160 GHEYY---RVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIEL 236 (283)
T ss_pred cchhh---ccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhh
Confidence 32110 011233456779999999988999999999999999999999999864322 111110 0 011111
Q ss_pred cCCC-CCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHh
Q 005617 566 LDPL-AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 566 ld~~-~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l 610 (688)
++.. ....+...+..+.+++.+||+.+|.+||++. .++..|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~-~i~~~l~~~ 281 (283)
T cd05080 237 LERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFR-SLIPILKEM 281 (283)
T ss_pred hhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHH-HHHHHHHHh
Confidence 1111 1112334567899999999999999999999 677777754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=328.28 Aligned_cols=239 Identities=27% Similarity=0.331 Sum_probs=190.1
Q ss_pred eeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHH-HHHcCCCCceeeEecccC--CCceeEEecCCCC
Q 005617 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVR-VLSKLQHPHLVTLLGACP--EAWSLVYEYLPNG 420 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~-iL~~l~HpnIV~l~g~~~--~~~~LV~E~~~~g 420 (688)
.||+|+||.||+|... |..||||++..... .....+..|.. +++.++||||+++++++. +..++||||+++|
T Consensus 2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05604 2 VIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81 (325)
T ss_pred ceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCC
Confidence 5999999999999875 88999999975422 23345566655 467789999999999884 4588999999999
Q ss_pred cHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCC
Q 005617 421 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 500 (688)
Q Consensus 421 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~ 500 (688)
+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 82 ~L~~~l~~~---~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~----- 150 (325)
T cd05604 82 ELFFHLQRE---RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS----- 150 (325)
T ss_pred CHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCC-----
Confidence 999888654 35889999999999999999999966 9999999999999999999999999987543221
Q ss_pred ccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCCCCCCCHHHH
Q 005617 501 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVA 578 (688)
Q Consensus 501 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~~~~~ 578 (688)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||..... +...+..+.+ ..+...+
T Consensus 151 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~---------~~~~~~~ 220 (325)
T cd05604 151 -DTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPL---------VLRPGAS 220 (325)
T ss_pred -CCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCc---------cCCCCCC
Confidence 122456799999999999999999999999999999999999999975432 2222222211 1122345
Q ss_pred HHHHHHHHHccccCCCCCCCCchHHHHHHH
Q 005617 579 RRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 579 ~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le 608 (688)
..+.+++.+|++.+|.+||++.+.+.+.++
T Consensus 221 ~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05604 221 LTAWSILEELLEKDRQRRLGAKEDFLEIQE 250 (325)
T ss_pred HHHHHHHHHHhccCHHhcCCCCCCHHHHhc
Confidence 678899999999999999999855544444
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=312.47 Aligned_cols=253 Identities=26% Similarity=0.431 Sum_probs=199.6
Q ss_pred hcCcccceeeeccCceEEEEEEEC--C---eEEEEEEEecCC-ccchHHHHHHHHHHHcCCCCceeeEecccCC--Ccee
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML--G---RTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSL 412 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g---~~vAIK~l~~~~-~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~L 412 (688)
+++|...+.||+|+||.||+|.+. + ..||||.+.... ......|.+|+.++..++||||+++++++.+ ..++
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 457888899999999999999874 3 369999987553 2334578999999999999999999999854 5789
Q ss_pred EEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCcccccc
Q 005617 413 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 492 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~ 492 (688)
||||+++++|.+++.... ..+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 84 v~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~ 158 (268)
T cd05063 84 ITEYMENGALDKYLRDHD--GEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLE 158 (268)
T ss_pred EEEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecc
Confidence 999999999999986543 46899999999999999999999966 9999999999999999999999999998664
Q ss_pred CCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--hHHHHhhcCccccccCCC
Q 005617 493 EDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPL 569 (688)
Q Consensus 493 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~~~~g~l~~~ld~~ 569 (688)
...... .......+++.|+|||++....++.++|||||||++|||++ |+.||.... .....+..+.. .
T Consensus 159 ~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~----~-- 229 (268)
T cd05063 159 DDPEGT---YTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFR----L-- 229 (268)
T ss_pred cccccc---eeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCC----C--
Confidence 322111 11122234567999999998899999999999999999998 999985432 22233322210 1
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHh
Q 005617 570 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 570 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l 610 (688)
..+...+..+.+++.+||+.+|.+||++. .+...|+.+
T Consensus 230 --~~~~~~~~~~~~li~~c~~~~p~~Rp~~~-~i~~~l~~~ 267 (268)
T cd05063 230 --PAPMDCPSAVYQLMLQCWQQDRARRPRFV-DIVNLLDKL 267 (268)
T ss_pred --CCCCCCCHHHHHHHHHHcCCCcccCcCHH-HHHHHHHhh
Confidence 11223356789999999999999999998 677776643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=317.18 Aligned_cols=251 Identities=27% Similarity=0.434 Sum_probs=199.4
Q ss_pred cCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--Ccee
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSL 412 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~-------g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~L 412 (688)
.+|....+||+|+||.||++... +..||+|.+..........|.+|+.++..++||||+++++++.+ ..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 35666789999999999999642 56799999876665666789999999999999999999998854 4789
Q ss_pred EEecCCCCcHHHHhcccCC------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCe
Q 005617 413 VYEYLPNGSLQDRLFRKSN------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS 480 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~~------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~v 480 (688)
||||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999865421 135889999999999999999999965 9999999999999999999
Q ss_pred EEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHHHh
Q 005617 481 KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAV 557 (688)
Q Consensus 481 KLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~~ 557 (688)
||+|||++......... .......+++.|+|||++.+..++.++|||||||++|||++ |.+||..... ....+
T Consensus 162 kL~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 237 (280)
T cd05092 162 KIGDFGMSRDIYSTDYY----RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI 237 (280)
T ss_pred EECCCCceeEcCCCcee----ecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH
Confidence 99999999865432211 11233446788999999999999999999999999999998 9999854332 22222
Q ss_pred hcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHH
Q 005617 558 SCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 558 ~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le 608 (688)
..+... ..+...+..+.+|+.+||+.||.+||++. ++...|+
T Consensus 238 ~~~~~~--------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~-~l~~~l~ 279 (280)
T cd05092 238 TQGREL--------ERPRTCPPEVYAIMQGCWQREPQQRMVIK-DIHSRLQ 279 (280)
T ss_pred HcCccC--------CCCCCCCHHHHHHHHHHccCChhhCCCHH-HHHHHHh
Confidence 222111 11223456788999999999999999998 5655553
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=319.32 Aligned_cols=257 Identities=28% Similarity=0.459 Sum_probs=203.7
Q ss_pred HHHhcCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCc-cchHHHHHHHHHHHcC-CCCceeeEecccCC
Q 005617 338 QTATCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE 408 (688)
Q Consensus 338 ~~at~~f~~~~~LG~G~fG~Vykg~~~-------g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~ 408 (688)
....++|...+.||+|+||.||+|... ...||+|.+..... .....+.+|+.++.++ +||||++++++|..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 334567888899999999999999864 25799999875432 3345688999999999 89999999999854
Q ss_pred --CceeEEecCCCCcHHHHhccc-------------CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCcee
Q 005617 409 --AWSLVYEYLPNGSLQDRLFRK-------------SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNIL 473 (688)
Q Consensus 409 --~~~LV~E~~~~gsL~~~L~~~-------------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NIL 473 (688)
..++||||+++|+|..++... .....+++..++.++.|++.||.|||+.+ |+||||||+|||
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil 164 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVL 164 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEE
Confidence 478999999999999998643 22356899999999999999999999865 999999999999
Q ss_pred eCCCCCeEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh-
Q 005617 474 LDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG- 551 (688)
Q Consensus 474 Ld~~~~vKLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~- 551 (688)
++.++.+||+|||+++.+...... .......++..|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus 165 ~~~~~~~kL~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 240 (293)
T cd05053 165 VTEDHVMKIADFGLARDIHHIDYY----RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 240 (293)
T ss_pred EcCCCeEEeCccccccccccccce----eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence 999999999999999876543211 11223346678999999999999999999999999999998 999986433
Q ss_pred -hHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHh
Q 005617 552 -EVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 552 -~~~~~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l 610 (688)
.+...+..+... ..+......+.+|+.+||..+|.+|||+. +++..|+.+
T Consensus 241 ~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~-eil~~l~~~ 291 (293)
T cd05053 241 EELFKLLKEGYRM--------EKPQNCTQELYHLMRDCWHEVPSQRPTFK-QLVEDLDRM 291 (293)
T ss_pred HHHHHHHHcCCcC--------CCCCCCCHHHHHHHHHHcccCcccCcCHH-HHHHHHHHh
Confidence 233333322211 22334456899999999999999999998 677776654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=334.17 Aligned_cols=245 Identities=23% Similarity=0.286 Sum_probs=189.5
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|...+.||.|+||.||++... |..||||++..... .....+.+|+.++..++|||||+++++|.+ ..+|||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888899999999999999875 88999999865432 233468899999999999999999999854 488999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIKY---DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999998654 35788899999999999999999966 999999999999999999999999999643211
Q ss_pred CCc------------CCC-----------------------------ccccCCCCCCCCCCChhhhccCCCCCcchHhHH
Q 005617 495 TLY------------LPS-----------------------------FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSF 533 (688)
Q Consensus 495 ~~~------------~~~-----------------------------~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSf 533 (688)
... ... .......+||+.|+|||++....++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 000 000113579999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCChhhH--HHHhhcCccccccCCCCCCCC--HHHHHHHHHHHHHccccCCCCCC---CCc
Q 005617 534 GLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGDWP--TFVARRLVDLGLQCCELYGRERP---DIT 600 (688)
Q Consensus 534 GviL~ELltG~~Pf~~~~~~--~~~~~~g~l~~~ld~~~~~~~--~~~~~~l~~L~~~Cl~~dP~~RP---s~~ 600 (688)
||+||||+||.+||...... ...+.... ..+ .+| ...+..+.+|+.+|+. +|.+|+ ++.
T Consensus 235 Gvil~elltG~~Pf~~~~~~~~~~~i~~~~--~~~-----~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 235 GAIMFECLIGWPPFCSENSHETYRKIINWR--ETL-----YFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred chhhhhhhcCCCCCCCCCHHHHHHHHHccC--Ccc-----CCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 99999999999999654332 12221110 000 111 1245678899999997 777765 555
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=342.64 Aligned_cols=252 Identities=23% Similarity=0.315 Sum_probs=189.5
Q ss_pred HhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC---------
Q 005617 340 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--------- 408 (688)
Q Consensus 340 at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--------- 408 (688)
.+.+|...+.||+|+||.||+|... +..||||++.... ....+|+.+|+.++|||||++++++..
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999884 7899999885432 234579999999999999999887521
Q ss_pred -CceeEEecCCCCcHHHHhccc-CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCC-CeEEeec
Q 005617 409 -AWSLVYEYLPNGSLQDRLFRK-SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL-SSKICDF 485 (688)
Q Consensus 409 -~~~LV~E~~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~-~vKLsDF 485 (688)
..++||||+++ +|.+.+... .....+++..+..++.||+.||.|||+.+ |+||||||+||||+.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 14589999985 565555432 23356899999999999999999999966 99999999999999665 6999999
Q ss_pred CccccccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHH---Hhh-cC
Q 005617 486 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR---AVS-CG 560 (688)
Q Consensus 486 Gla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~---~~~-~g 560 (688)
|+++.+.... ......||+.|+|||++.+ ..++.++|||||||+||||+||.+||........ .+. .|
T Consensus 216 Gla~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~ 288 (440)
T PTZ00036 216 GSAKNLLAGQ-------RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLG 288 (440)
T ss_pred ccchhccCCC-------CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 9998765332 1234578999999998865 4689999999999999999999999975432211 110 00
Q ss_pred c------------cccccCCC------CCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHH
Q 005617 561 K------------LSSILDPL------AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKE 606 (688)
Q Consensus 561 ~------------l~~~ld~~------~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~ 606 (688)
. +..+--+. ...+|...+..+.+|+.+||+.||.+||++.+.+.+.
T Consensus 289 ~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp 352 (440)
T PTZ00036 289 TPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADP 352 (440)
T ss_pred CCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCCh
Confidence 0 00000000 0012223456899999999999999999998655443
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=315.21 Aligned_cols=252 Identities=30% Similarity=0.475 Sum_probs=201.1
Q ss_pred hcCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--Cc
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AW 410 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~-------g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~ 410 (688)
.++|.....||.|+||.||+|... +..||+|.+..... .....|.+|+.++..++||||+++++++.. ..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 357788899999999999999875 26799999865532 334578899999999999999999999844 57
Q ss_pred eeEEecCCCCcHHHHhcccCC-------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEe
Q 005617 411 SLVYEYLPNGSLQDRLFRKSN-------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKIC 483 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~~-------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLs 483 (688)
++||||+++|+|.+++..... ...++|..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 899999999999999865321 234789999999999999999999965 9999999999999999999999
Q ss_pred ecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--hHHHHhhcC
Q 005617 484 DFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCG 560 (688)
Q Consensus 484 DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~~~~g 560 (688)
|||+++.+...... .......+|..|+|||.+..+.++.++|||||||++|||+| |..||.... .....+..+
T Consensus 162 dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~ 237 (277)
T cd05032 162 DFGMTRDIYETDYY----RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDG 237 (277)
T ss_pred CcccchhhccCccc----ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcC
Confidence 99999876543211 12234557889999999998899999999999999999998 999986433 233333332
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHH
Q 005617 561 KLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 561 ~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le 608 (688)
... ..+...+..+.+++.+||+.+|.+|||+. .+...|+
T Consensus 238 ~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~-~l~~~l~ 276 (277)
T cd05032 238 GHL--------DLPENCPDKLLELMRMCWQYNPKMRPTFL-EIVSSLK 276 (277)
T ss_pred CCC--------CCCCCCCHHHHHHHHHHcCCChhhCCCHH-HHHHHhc
Confidence 221 12223367899999999999999999998 5555443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=312.90 Aligned_cols=246 Identities=25% Similarity=0.313 Sum_probs=194.8
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEecC
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 417 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~ 417 (688)
++|...+.||+|+||.||+|... |..||+|++..........+.+|+.++..++||||++++++|. +..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 56888899999999999999874 7889999997665555567889999999999999999999884 3578999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCc
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~ 497 (688)
++++|.+++... .++++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 89 ~~~~L~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06646 89 GGGSLQDIYHVT---GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA- 161 (267)
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence 999999988643 35789999999999999999999965 99999999999999999999999999987643221
Q ss_pred CCCccccCCCCCCCCCCChhhhc---cCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCccccccCCCCCCCC
Q 005617 498 LPSFHRSTAPKGSFPYADPEYHR---TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWP 574 (688)
Q Consensus 498 ~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~l~~~ld~~~~~~~ 574 (688)
......|++.|+|||++. ...++.++|||||||++|||++|+.||.............. ..+.+.....+
T Consensus 162 -----~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~ 234 (267)
T cd06646 162 -----KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK--SNFQPPKLKDK 234 (267)
T ss_pred -----ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec--CCCCCCCCccc
Confidence 123456899999999874 45578899999999999999999999854332211111000 00011111111
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCCch
Q 005617 575 TFVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 575 ~~~~~~l~~L~~~Cl~~dP~~RPs~~~ 601 (688)
...+..+.+|+.+||+.+|.+||++.+
T Consensus 235 ~~~~~~~~~li~~~l~~~P~~Rp~~~~ 261 (267)
T cd06646 235 TKWSSTFHNFVKISLTKNPKKRPTAER 261 (267)
T ss_pred cccCHHHHHHHHHHhhCChhhCcCHHH
Confidence 234568899999999999999999884
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=309.11 Aligned_cols=251 Identities=24% Similarity=0.383 Sum_probs=203.3
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|...+.||.|+||.||+|... |..||+|.++.... .....+.+|+.++++++|+||+++++++.+ ..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999885 88999999865332 234578999999999999999999999854 478999
Q ss_pred ecCCCCcHHHHhcccC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccC
Q 005617 415 EYLPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~ 493 (688)
||+++|+|.+++.... ....+++..+..++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999886532 2356899999999999999999999966 99999999999999999999999999886643
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh----HHHHhhcCccccccCCC
Q 005617 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE----VRRAVSCGKLSSILDPL 569 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~----~~~~~~~g~l~~~ld~~ 569 (688)
... ......|++.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+..+...
T Consensus 159 ~~~------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 226 (267)
T cd08224 159 KTT------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYP------ 226 (267)
T ss_pred CCc------ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCC------
Confidence 221 12345689999999999988999999999999999999999999854321 11112222111
Q ss_pred CCCCCH-HHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHh
Q 005617 570 AGDWPT-FVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 570 ~~~~~~-~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l 610 (688)
..+. .....+.+++.+||..+|.+||++. .+...|+.+
T Consensus 227 --~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~-~il~~~~~~ 265 (267)
T cd08224 227 --PLPADHYSEELRDLVSRCINPDPEKRPDIS-YVLQVAKEM 265 (267)
T ss_pred --CCChhhcCHHHHHHHHHHcCCCcccCCCHH-HHHHHHHHh
Confidence 1122 4556889999999999999999998 677777654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=315.24 Aligned_cols=252 Identities=26% Similarity=0.418 Sum_probs=197.8
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--C
Q 005617 340 ATCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--A 409 (688)
Q Consensus 340 at~~f~~~~~LG~G~fG~Vykg~~~-------g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~ 409 (688)
.+++|...+.||+|+||.||+|.+. +..||+|.+..... .....|.+|+.+++.++||||+++++++.+ .
T Consensus 4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (277)
T cd05036 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP 83 (277)
T ss_pred CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 3567888999999999999999884 36789998865432 334569999999999999999999998743 5
Q ss_pred ceeEEecCCCCcHHHHhcccCC----CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCC---CeEE
Q 005617 410 WSLVYEYLPNGSLQDRLFRKSN----VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL---SSKI 482 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~~----~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~---~vKL 482 (688)
.++||||+++|+|.+++..... ...++|..++.++.+|+.||.|||+.+ ++||||||+|||++.++ .+||
T Consensus 84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl 160 (277)
T cd05036 84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI 160 (277)
T ss_pred cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence 7899999999999999876532 235899999999999999999999966 99999999999998765 5999
Q ss_pred eecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--hHHHHhhc
Q 005617 483 CDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSC 559 (688)
Q Consensus 483 sDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~~~~ 559 (688)
+|||+++........ .......+++.|+|||++.+..++.++|||||||++|||++ |..||.... .....+..
T Consensus 161 ~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~ 236 (277)
T cd05036 161 ADFGMARDIYRASYY----RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTG 236 (277)
T ss_pred ccCccccccCCccce----ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999876432211 01122334568999999999999999999999999999997 999996533 22222222
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHH
Q 005617 560 GKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 560 g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~L 607 (688)
+. ...++...+..+.+++.+|++.+|++||++. +|++.|
T Consensus 237 ~~--------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~-~vl~~l 275 (277)
T cd05036 237 GG--------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFA-TILERI 275 (277)
T ss_pred CC--------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHH-HHHHHh
Confidence 11 1123344567889999999999999999998 454444
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=326.32 Aligned_cols=239 Identities=26% Similarity=0.325 Sum_probs=189.3
Q ss_pred eeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHH-HHHcCCCCceeeEecccC--CCceeEEecCCCC
Q 005617 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVR-VLSKLQHPHLVTLLGACP--EAWSLVYEYLPNG 420 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~-iL~~l~HpnIV~l~g~~~--~~~~LV~E~~~~g 420 (688)
.||+|+||.||+|+.. +..||+|++..... .....+..|.. ++..++||||+++++++. +..++||||+++|
T Consensus 2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~ 81 (325)
T cd05602 2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG 81 (325)
T ss_pred eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence 6999999999999886 67899999975432 22234444544 567889999999999884 4578999999999
Q ss_pred cHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCC
Q 005617 421 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 500 (688)
Q Consensus 421 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~ 500 (688)
+|.+++.... .++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~L~~~~~~~~---~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~---- 151 (325)
T cd05602 82 ELFYHLQRER---CFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG---- 151 (325)
T ss_pred cHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCC----
Confidence 9999886543 4677888899999999999999966 99999999999999999999999999975432211
Q ss_pred ccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhH--HHHhhcCccccccCCCCCCCCHHHH
Q 005617 501 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGDWPTFVA 578 (688)
Q Consensus 501 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~~~~g~l~~~ld~~~~~~~~~~~ 578 (688)
......||+.|+|||++.+..++.++|||||||++|+|++|++||...... ...+..+.. ..+...+
T Consensus 152 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~---------~~~~~~~ 220 (325)
T cd05602 152 --TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPL---------QLKPNIT 220 (325)
T ss_pred --CcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCc---------CCCCCCC
Confidence 234567999999999999999999999999999999999999999754332 222222111 1223456
Q ss_pred HHHHHHHHHccccCCCCCCCCchHHHHHHH
Q 005617 579 RRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 579 ~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le 608 (688)
..+.+|+.+|++.||.+||++.+.+.+.++
T Consensus 221 ~~~~~li~~~l~~~p~~R~~~~~~~~~i~~ 250 (325)
T cd05602 221 NSARHLLEGLLQKDRTKRLGAKDDFMEIKN 250 (325)
T ss_pred HHHHHHHHHHcccCHHHCCCCCCCHHHHhc
Confidence 678999999999999999999866555444
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=328.20 Aligned_cols=250 Identities=21% Similarity=0.251 Sum_probs=192.0
Q ss_pred HhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC--ccchHHHHHHHHHHHcCCCCceeeEecccCC-------
Q 005617 340 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE------- 408 (688)
Q Consensus 340 at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~--~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~------- 408 (688)
..++|...+.||+|+||.||++... |..||||++.... ......+.+|+.++..++||||+++++++..
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3578999999999999999999875 8899999986542 2334568899999999999999999998732
Q ss_pred -CceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCc
Q 005617 409 -AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 487 (688)
Q Consensus 409 -~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGl 487 (688)
..++||||+.++ |...+. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 258999999764 555443 24778889999999999999999966 99999999999999999999999999
Q ss_pred cccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHH---h-------
Q 005617 488 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA---V------- 557 (688)
Q Consensus 488 a~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~---~------- 557 (688)
++...... ......||+.|+|||++.+..++.++|||||||++|+|+||+.||...+..... +
T Consensus 170 a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 242 (359)
T cd07876 170 ARTACTNF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS 242 (359)
T ss_pred ccccccCc-------cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 97653322 123457899999999999999999999999999999999999999754321100 0
Q ss_pred ---------------hc-Ccc-----ccc----cCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHH
Q 005617 558 ---------------SC-GKL-----SSI----LDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 605 (688)
Q Consensus 558 ---------------~~-g~l-----~~~----ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~ 605 (688)
.. ... .+. ..+.....+......+.+|+.+||+.||.+|||+.+.+.+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 243 AEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 00 000 000 0000001111234578999999999999999999865543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=344.85 Aligned_cols=260 Identities=23% Similarity=0.316 Sum_probs=208.0
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCC-CCceeeEeccc-----CC--
Q 005617 339 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLLGAC-----PE-- 408 (688)
Q Consensus 339 ~at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~-HpnIV~l~g~~-----~~-- 408 (688)
....++.+.+.|.+|||+.||.+++. |..||+|++...+......+.+|+.+|++|+ |+|||.+++.. .+
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 34566778899999999999999997 4899999998888788888999999999997 99999999943 11
Q ss_pred --CceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecC
Q 005617 409 --AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFG 486 (688)
Q Consensus 409 --~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFG 486 (688)
+.+|.||||.||+|-+++....... |++.++++|+.++|+|+.+||... .||||||||-+||||+.+|+.||||||
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFG 191 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFG 191 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCccc
Confidence 2568999999999999998665433 999999999999999999999987 689999999999999999999999999
Q ss_pred ccccccCCCCcCC---CccccCCCCCCCCCCChhhh---ccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcC
Q 005617 487 ICRLVTEDTLYLP---SFHRSTAPKGSFPYADPEYH---RTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCG 560 (688)
Q Consensus 487 la~~~~~~~~~~~---~~~~~~~~~GT~~Y~APE~~---~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g 560 (688)
.|........... .....-...-|+.|.|||.+ .+...+.|+|||+|||+||-|+....||+..+. -+|..|
T Consensus 192 Satt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~--laIlng 269 (738)
T KOG1989|consen 192 SATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK--LAILNG 269 (738)
T ss_pred ccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--eeEEec
Confidence 9875432221000 00011223468999999965 667899999999999999999999999986543 233344
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHH
Q 005617 561 KLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 561 ~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~ 609 (688)
++.- .-.+.++..|.+||..||+.||.+||++.+.+...++.
T Consensus 270 ~Y~~-------P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l 311 (738)
T KOG1989|consen 270 NYSF-------PPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFEL 311 (738)
T ss_pred cccC-------CCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHH
Confidence 3321 11236788999999999999999999999655444443
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=319.47 Aligned_cols=257 Identities=25% Similarity=0.414 Sum_probs=195.7
Q ss_pred cCcccceeeeccCceEEEEEEECC----------------eEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEec
Q 005617 342 CNFSESFKVGQGGFGCVYKGEMLG----------------RTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLG 404 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~g----------------~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g 404 (688)
++|...+.||+|+||.||++...+ ..||||.+..... .....|.+|+.++.+++||||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 467788899999999999987632 2489999876432 23456999999999999999999999
Q ss_pred ccC--CCceeEEecCCCCcHHHHhcccC---------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCcee
Q 005617 405 ACP--EAWSLVYEYLPNGSLQDRLFRKS---------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNIL 473 (688)
Q Consensus 405 ~~~--~~~~LV~E~~~~gsL~~~L~~~~---------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NIL 473 (688)
+|. +..++||||+++++|.+++.... ....++|..++.++.+++.||.|||+.+ ++||||||+|||
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 984 35889999999999999886432 1134789999999999999999999965 999999999999
Q ss_pred eCCCCCeEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh--CCCCCCChh
Q 005617 474 LDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT--GRLPVGLAG 551 (688)
Q Consensus 474 Ld~~~~vKLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt--G~~Pf~~~~ 551 (688)
++.++.+||+|||++......... .......+++.|+|||++..+.++.++|||||||++|+|++ |..||....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYY----RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred EcCCCcEEecccccccccccCcce----eccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence 999999999999999865432211 11233456789999999999999999999999999999998 667876432
Q ss_pred h--HHHHhhcCcccccc-CCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHH
Q 005617 552 E--VRRAVSCGKLSSIL-DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 552 ~--~~~~~~~g~l~~~l-d~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le 608 (688)
. +...+. ...... .......+...+..+.+|+.+||+.+|.+||++. .+.+.|+
T Consensus 238 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~-~i~~~l~ 294 (295)
T cd05097 238 DEQVIENTG--EFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFN-KIHHFLR 294 (295)
T ss_pred hHHHHHHHH--HhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHH-HHHHHHh
Confidence 2 111110 000000 0000111223456899999999999999999998 6666654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=314.55 Aligned_cols=255 Identities=24% Similarity=0.321 Sum_probs=203.1
Q ss_pred hcCcccceeeeccCceEEEEEEEC------CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccC---CCc
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP---EAW 410 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~------g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~---~~~ 410 (688)
.++|.....||+|+||.||+|... +..|++|++..... .....+.+|+.++.+++||||+++++++. ...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 467888899999999999999875 37799998875432 33456889999999999999999999874 357
Q ss_pred eeEEecCCCCcHHHHhcccCCC-----CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeec
Q 005617 411 SLVYEYLPNGSLQDRLFRKSNV-----SPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDF 485 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~~~-----~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDF 485 (688)
+++++|+++|+|.+++...... ..+++..++.++.+++.||.|||+.+ ++||||||+||+++.++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 8999999999999998654322 56899999999999999999999865 999999999999999999999999
Q ss_pred CccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHHHhhcCcc
Q 005617 486 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKL 562 (688)
Q Consensus 486 Gla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~~~~g~l 562 (688)
|+++.+....... ......++..|+|||++....++.++|||||||++||+++ |+.||..... ....+..+..
T Consensus 162 g~~~~~~~~~~~~----~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 237 (280)
T cd05043 162 ALSRDLFPMDYHC----LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYR 237 (280)
T ss_pred CCcccccCCceEE----eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCC
Confidence 9998664332110 1123456778999999998899999999999999999999 9999975432 2222222211
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHhh
Q 005617 563 SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 563 ~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l~ 611 (688)
...+...+..+.+++.+||..+|++||++. ++...|+.+.
T Consensus 238 --------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~~~~~l~~~~ 277 (280)
T cd05043 238 --------LAQPINCPDELFAVMACCWALDPEERPSFS-QLVQCLTDFH 277 (280)
T ss_pred --------CCCCCcCCHHHHHHHHHHcCCChhhCCCHH-HHHHHHHHHH
Confidence 011223456789999999999999999998 7777777654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=311.41 Aligned_cols=255 Identities=22% Similarity=0.330 Sum_probs=201.4
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~ 414 (688)
++|...+.||.|+||.||+|... |..||||.+..... .....|.+|+.++..++||||++++++|. +..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 35777788999999999999864 88999998865432 23357889999999999999999999884 3578999
Q ss_pred ecCCCCcHHHHhcccC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccC
Q 005617 415 EYLPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~ 493 (688)
||+++++|.+++.... ....+++..+..++.+|+.||.|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 9999999999886432 2346899999999999999999999966 99999999999999999999999999887643
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh-HHHHhhcCccccccCCCCCC
Q 005617 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE-VRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~-~~~~~~~g~l~~~ld~~~~~ 572 (688)
... ......|+..|+|||++.+..++.++||||||+++|+|++|..||..... ...... .+.....+ ..
T Consensus 159 ~~~------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~--~~~~~~~~--~~ 228 (267)
T cd08229 159 KTT------AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK--KIEQCDYP--PL 228 (267)
T ss_pred CCc------ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhh--hhhcCCCC--CC
Confidence 321 12345689999999999988999999999999999999999999864321 111110 01010001 01
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHh
Q 005617 573 WPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 573 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l 610 (688)
.+...+..+.+++.+||+.+|.+|||+. .|.+.+..+
T Consensus 229 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~-~i~~~~~~~ 265 (267)
T cd08229 229 PSDHYSEELRQLVNMCINPDPEKRPDIT-YVYDVAKRM 265 (267)
T ss_pred CcccccHHHHHHHHHhcCCCcccCCCHH-HHHHHHhhh
Confidence 1123567899999999999999999998 677776654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=318.04 Aligned_cols=246 Identities=25% Similarity=0.383 Sum_probs=200.1
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEecC
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 417 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~ 417 (688)
.+|.....||.|+||.||+|... +..||+|.+..........+.+|+.++..++||||++++++|. ...++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 57888899999999999999874 7899999998766666677999999999999999999999884 4588999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCc
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~ 497 (688)
++++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 100 ~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~- 171 (296)
T cd06654 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (296)
T ss_pred CCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc-
Confidence 99999998853 34789999999999999999999966 99999999999999999999999999886543221
Q ss_pred CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCccccccCCCCCCCCHHH
Q 005617 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFV 577 (688)
Q Consensus 498 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~l~~~ld~~~~~~~~~~ 577 (688)
......|++.|+|||++.+..++.++|||||||++|+|++|+.||................ .+ ....+...
T Consensus 172 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~---~~-~~~~~~~~ 242 (296)
T cd06654 172 -----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG---TP-ELQNPEKL 242 (296)
T ss_pred -----ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCC---CC-CCCCcccc
Confidence 1234568999999999998889999999999999999999999997544322111110000 00 11123345
Q ss_pred HHHHHHHHHHccccCCCCCCCCchHHH
Q 005617 578 ARRLVDLGLQCCELYGRERPDITPSLV 604 (688)
Q Consensus 578 ~~~l~~L~~~Cl~~dP~~RPs~~~~l~ 604 (688)
...+.+|+.+||..+|.+||++.+.+.
T Consensus 243 ~~~l~~li~~~l~~~p~~Rpt~~eil~ 269 (296)
T cd06654 243 SAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (296)
T ss_pred CHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence 677899999999999999999985443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=320.26 Aligned_cols=255 Identities=26% Similarity=0.436 Sum_probs=202.2
Q ss_pred hcCcccceeeeccCceEEEEEEEC---------CeEEEEEEEecCC-ccchHHHHHHHHHHHcC-CCCceeeEecccCC-
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML---------GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE- 408 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~---------g~~vAIK~l~~~~-~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~- 408 (688)
.++|...+.||+|+||.||++... +..||+|.+.... ......+..|+.++..+ +||||++++++|.+
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 357889999999999999999763 2469999997643 23345688999999999 79999999999854
Q ss_pred -CceeEEecCCCCcHHHHhcccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceee
Q 005617 409 -AWSLVYEYLPNGSLQDRLFRKSN-------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL 474 (688)
Q Consensus 409 -~~~LV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILL 474 (688)
..++||||+++|+|.+++..... ...++|..++.++.|++.||.|||+.+ ++||||||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill 173 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 173 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEE
Confidence 57899999999999999976431 135899999999999999999999865 9999999999999
Q ss_pred CCCCCeEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh-
Q 005617 475 DSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE- 552 (688)
Q Consensus 475 d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~- 552 (688)
+.++.+||+|||+++........ .......+++.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYY----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred cCCCcEEECCCcccccccccchh----hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 99999999999998866432211 11223345678999999999999999999999999999998 8889864332
Q ss_pred -HHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHhh
Q 005617 553 -VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 553 -~~~~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l~ 611 (688)
+...+..+.. .+.+...+..+.+|+.+||..+|.+||++. +++..|+.+.
T Consensus 250 ~~~~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-evl~~l~~~~ 300 (307)
T cd05098 250 ELFKLLKEGHR--------MDKPSNCTNELYMMMRDCWHAVPSQRPTFK-QLVEDLDRIL 300 (307)
T ss_pred HHHHHHHcCCC--------CCCCCcCCHHHHHHHHHHcccChhhCcCHH-HHHHHHHHHH
Confidence 2223332221 122334456888999999999999999998 7777777654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=310.38 Aligned_cols=246 Identities=26% Similarity=0.427 Sum_probs=196.0
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccc---------hHHHHHHHHHHHcCCCCceeeEecccC--CCc
Q 005617 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG---------QLEFQQEVRVLSKLQHPHLVTLLGACP--EAW 410 (688)
Q Consensus 344 f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~---------~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~ 410 (688)
|.....||.|+||.||+|... +..||+|.+....... ...+.+|+.++++++||||+++++++. +..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 566788999999999999874 7889999886543322 245889999999999999999999984 357
Q ss_pred eeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCcccc
Q 005617 411 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~ 490 (688)
++||||+++++|.+++... ..+++..+..++.+++.||.|||+.+ ++||||+|+||+++.++.+||+|||+++.
T Consensus 82 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 82 NIFLEYVPGGSVAALLNNY---GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EEEEEecCCCCHHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 8999999999999999654 35788999999999999999999965 99999999999999999999999999987
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCccccccCCCC
Q 005617 491 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~l~~~ld~~~ 570 (688)
..................|++.|+|||++.+..++.++|||||||++|+|++|+.||............... ..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~------~~ 229 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN------AS 229 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc------CC
Confidence 753221111111122346889999999999989999999999999999999999999765443222211110 11
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCCch
Q 005617 571 GDWPTFVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 571 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~ 601 (688)
...+...+..+.+++.+||+.+|.+||++.+
T Consensus 230 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 260 (267)
T cd06628 230 PEIPSNISSEAIDFLEKTFEIDHNKRPTAAE 260 (267)
T ss_pred CcCCcccCHHHHHHHHHHccCCchhCcCHHH
Confidence 1233345678899999999999999999874
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=311.62 Aligned_cols=251 Identities=25% Similarity=0.402 Sum_probs=201.2
Q ss_pred cCcccceeeeccCceEEEEEEECC-----eEEEEEEEecCC-ccchHHHHHHHHHHHcCCCCceeeEecccCC-CceeEE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEMLG-----RTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~g-----~~vAIK~l~~~~-~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV~ 414 (688)
++|.....||.|+||.||+|...+ ..||||...... ......|.+|+.++..++||||++++++|.+ ..++||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~ 85 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVM 85 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEE
Confidence 457778899999999999998742 368999887654 3445579999999999999999999998854 478999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
||+++|+|.+++.... ..+++..++.++.+++.||.|||+.+ ++|+||||+|||++.++.+||+|||+++.....
T Consensus 86 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 160 (270)
T cd05056 86 ELAPLGELRSYLQVNK--YSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE 160 (270)
T ss_pred EcCCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccc
Confidence 9999999999996543 35899999999999999999999965 999999999999999999999999999876543
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhhH--HHHhhcCccccccCCCCC
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEV--RRAVSCGKLSSILDPLAG 571 (688)
Q Consensus 495 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~~--~~~~~~g~l~~~ld~~~~ 571 (688)
... ......+++.|+|||++....++.++|||||||++|||++ |..||...... ...+..+...
T Consensus 161 ~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~-------- 227 (270)
T cd05056 161 SYY-----KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL-------- 227 (270)
T ss_pred cce-----ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC--------
Confidence 211 1223345678999999988899999999999999999996 99999754432 1222222111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHhh
Q 005617 572 DWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 572 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l~ 611 (688)
..+...+..+.+++.+|+..+|.+||++. .+...|+.+.
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~P~~Rpt~~-~~~~~l~~~~ 266 (270)
T cd05056 228 PMPPNCPPTLYSLMTKCWAYDPSKRPRFT-ELKAQLSDIL 266 (270)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHHHH
Confidence 11223456799999999999999999998 6777777654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=317.50 Aligned_cols=252 Identities=28% Similarity=0.440 Sum_probs=196.8
Q ss_pred cCcccceeeeccCceEEEEEEEC--C--eEEEEEEEecCC-ccchHHHHHHHHHHHcC-CCCceeeEecccCC--CceeE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--G--RTVAIKMLYSHN-MQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g--~~vAIK~l~~~~-~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~~~LV 413 (688)
++|.....||+|+||.||+|.+. + ..+++|.++... ......|.+|+.++.++ +||||+++++++.+ ..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 46788889999999999999875 3 247888887432 23345689999999999 79999999999854 47899
Q ss_pred EecCCCCcHHHHhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCe
Q 005617 414 YEYLPNGSLQDRLFRKS-------------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS 480 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~v 480 (688)
|||+++|+|.+++.... ....+++..++.|+.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999986532 1235889999999999999999999965 9999999999999999999
Q ss_pred EEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHHHh
Q 005617 481 KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAV 557 (688)
Q Consensus 481 KLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~~ 557 (688)
||+|||++....... ......++..|+|||++....++.++|||||||++|||+| |..||..... +...+
T Consensus 159 kl~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~ 231 (297)
T cd05089 159 KIADFGLSRGEEVYV-------KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231 (297)
T ss_pred EECCcCCCcccccee-------ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 999999986432111 1122234567999999998899999999999999999998 9999964332 22222
Q ss_pred hcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHhhh
Q 005617 558 SCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 558 ~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l~~ 612 (688)
..+. ....+...+..+.+|+.+||+.+|.+||++. .++..|+.+..
T Consensus 232 ~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~-~i~~~l~~~~~ 277 (297)
T cd05089 232 PQGY--------RMEKPRNCDDEVYELMRQCWRDRPYERPPFA-QISVQLSRMLE 277 (297)
T ss_pred hcCC--------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHHHHH
Confidence 2221 1112233456789999999999999999999 56666666543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=332.75 Aligned_cols=244 Identities=24% Similarity=0.313 Sum_probs=194.2
Q ss_pred HhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--Ccee
Q 005617 340 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSL 412 (688)
Q Consensus 340 at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~L 412 (688)
..++|...+.||+|+||.||+++.. +..||||++..... .....+.+|+.+++.++||||+++++++.+ ..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 4567888999999999999999885 78999999975322 233457899999999999999999998854 4789
Q ss_pred EEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCcccccc
Q 005617 413 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 492 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~ 492 (688)
||||+++|+|.+++... .++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~~----~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY----DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 99999999999988543 4677888999999999999999965 9999999999999999999999999998764
Q ss_pred CCCCcCCCccccCCCCCCCCCCChhhhccC----CCCCcchHhHHHHHHHHHHhCCCCCCChhhH--HHHhhcCcccccc
Q 005617 493 EDTLYLPSFHRSTAPKGSFPYADPEYHRTG----VLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSIL 566 (688)
Q Consensus 493 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~----~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~~~~g~l~~~l 566 (688)
.... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||...... ...+..+.. .
T Consensus 194 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~-~-- 265 (370)
T cd05596 194 ANGM-----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN-S-- 265 (370)
T ss_pred CCCc-----ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC-c--
Confidence 3221 122356799999999988653 4789999999999999999999999754432 222222110 0
Q ss_pred CCCCCCCCH--HHHHHHHHHHHHccccCCCC--CCCCchH
Q 005617 567 DPLAGDWPT--FVARRLVDLGLQCCELYGRE--RPDITPS 602 (688)
Q Consensus 567 d~~~~~~~~--~~~~~l~~L~~~Cl~~dP~~--RPs~~~~ 602 (688)
..+|. ..+..+.+|+.+|++.+|.+ ||++.+.
T Consensus 266 ----~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~el 301 (370)
T cd05596 266 ----LTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEI 301 (370)
T ss_pred ----CCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHH
Confidence 01121 24678899999999999987 9988743
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=307.39 Aligned_cols=240 Identities=28% Similarity=0.463 Sum_probs=192.4
Q ss_pred eeeccCceEEEEEEEC-CeEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecCCCCcHHH
Q 005617 349 KVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSLQD 424 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~-g~~vAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gsL~~ 424 (688)
+||.|+||.||+|... +..||+|.+...... ....|.+|+.++..++||||++++++|.+ ..++||||+++++|.+
T Consensus 2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 81 (250)
T cd05085 2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLS 81 (250)
T ss_pred ccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHH
Confidence 6999999999999875 778999998765432 23468899999999999999999999854 5789999999999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCCcccc
Q 005617 425 RLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRS 504 (688)
Q Consensus 425 ~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~ 504 (688)
++.... ..+++..+..++.+++.||.|||..+ ++|+||||+||+++.++.+||+|||++......... ..
T Consensus 82 ~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-----~~ 151 (250)
T cd05085 82 FLRKKK--DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-----SS 151 (250)
T ss_pred HHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccc-----cC
Confidence 886543 35789999999999999999999965 999999999999999999999999998765432211 11
Q ss_pred CCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHHHhhcCccccccCCCCCCCCHHHHHHH
Q 005617 505 TAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVARRL 581 (688)
Q Consensus 505 ~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~~~~~~~l 581 (688)
....+++.|+|||++.++.++.++|||||||++|+|++ |..||..... ....+..+.. ...+...+..+
T Consensus 152 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~ 223 (250)
T cd05085 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYR--------MSCPQKCPDDV 223 (250)
T ss_pred CCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCC--------CCCCCCCCHHH
Confidence 23345678999999999999999999999999999999 9999964432 2222222211 11223345789
Q ss_pred HHHHHHccccCCCCCCCCchHHHHHH
Q 005617 582 VDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 582 ~~L~~~Cl~~dP~~RPs~~~~l~~~L 607 (688)
.+++.+|++.+|.+||++. ++.+.|
T Consensus 224 ~~li~~~l~~~p~~Rp~~~-~l~~~l 248 (250)
T cd05085 224 YKVMQRCWDYKPENRPKFS-ELQKEL 248 (250)
T ss_pred HHHHHHHcccCcccCCCHH-HHHHHh
Confidence 9999999999999999998 555554
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=332.08 Aligned_cols=244 Identities=19% Similarity=0.239 Sum_probs=188.3
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEecC
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 417 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~ 417 (688)
++|...+.||+|+||.||++... +..||||... ...+.+|+.+|++++|||||+++++|. ...++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 67999999999999999999885 7899999753 234778999999999999999999884 4578999998
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCc
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~ 497 (688)
. ++|..++... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 166 ~-~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~- 237 (391)
T PHA03212 166 K-TDLYCYLAAK---RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA- 237 (391)
T ss_pred C-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCcccccccccc-
Confidence 5 6888877554 35789999999999999999999965 99999999999999999999999999975432211
Q ss_pred CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh----------hHHHHhh-cCccc---
Q 005617 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG----------EVRRAVS-CGKLS--- 563 (688)
Q Consensus 498 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~----------~~~~~~~-~g~l~--- 563 (688)
.......||+.|+|||++....+++++|||||||++|||+||+.||.... .+...+. .|...
T Consensus 238 ----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 238 ----NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred ----cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 12235679999999999999999999999999999999999998864211 0000000 00000
Q ss_pred ---------cc---------cCCC-CCCCC--HHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 564 ---------SI---------LDPL-AGDWP--TFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 564 ---------~~---------ld~~-~~~~~--~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
.. ..+. ...|. ...+..+.+|+.+||+.||.+|||+.+.+
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL 374 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALL 374 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHh
Confidence 00 0000 00111 12456789999999999999999998543
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=317.16 Aligned_cols=252 Identities=28% Similarity=0.469 Sum_probs=199.6
Q ss_pred cCcccceeeeccCceEEEEEEEC--Ce----EEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC-CceeE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GR----TVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~----~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV 413 (688)
.+|...+.||+|+||.||+|.+. |. .||+|.+..... .....|.+|+.++..++||||++++|+|.. ..++|
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v 86 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLV 86 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCCCceee
Confidence 45667788999999999999873 43 579998875433 223468899999999999999999999854 46799
Q ss_pred EecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccC
Q 005617 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~ 493 (688)
++|+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~e~~~~g~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 87 TQLMPHGCLLDYVHEHK--DNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred ehhcCCCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccC
Confidence 99999999999986543 35789999999999999999999965 99999999999999999999999999987653
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCCh--hhHHHHhhcCccccccCCCC
Q 005617 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLA--GEVRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~--~~~~~~~~~g~l~~~ld~~~ 570 (688)
.... .......++..|+|||++.+..++.++|||||||++|||++ |..||... ......+..+...
T Consensus 162 ~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~------- 230 (303)
T cd05110 162 DEKE----YNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERL------- 230 (303)
T ss_pred cccc----cccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCC-------
Confidence 3211 11223456788999999999999999999999999999997 99999643 2333333332211
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHhh
Q 005617 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 571 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l~ 611 (688)
..+......+.+++..||..+|.+||++. .++..|..+.
T Consensus 231 -~~~~~~~~~~~~li~~c~~~~p~~Rp~~~-~l~~~l~~~~ 269 (303)
T cd05110 231 -PQPPICTIDVYMVMVKCWMIDADSRPKFK-ELAAEFSRMA 269 (303)
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHHHH
Confidence 01122345788999999999999999998 6777777654
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=306.92 Aligned_cols=243 Identities=37% Similarity=0.596 Sum_probs=199.6
Q ss_pred eeeccCceEEEEEEEC-----CeEEEEEEEecCCccc-hHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecCCCC
Q 005617 349 KVGQGGFGCVYKGEML-----GRTVAIKMLYSHNMQG-QLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNG 420 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~-----g~~vAIK~l~~~~~~~-~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~g 420 (688)
.||+|+||.||+|... +..||||.+....... ...+.+|+.++..++|+||+++++++.+ ..++||||++++
T Consensus 2 ~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~ 81 (262)
T cd00192 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGG 81 (262)
T ss_pred ccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCC
Confidence 6999999999999886 6789999998765443 5679999999999999999999999854 478999999999
Q ss_pred cHHHHhcccCC------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 421 SLQDRLFRKSN------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 421 sL~~~L~~~~~------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
+|.+++..... ...+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.+||+|||.+......
T Consensus 82 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 82 DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEcccccccccccc
Confidence 99999977521 267899999999999999999999965 999999999999999999999999999887654
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHHHhhcCccccccCCCCC
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAG 571 (688)
Q Consensus 495 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~ 571 (688)
.. ........+++.|+|||.+....++.++|||||||++|+|++ |..||..... +...+..+. ..
T Consensus 159 ~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--------~~ 226 (262)
T cd00192 159 DY----YRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGY--------RL 226 (262)
T ss_pred cc----cccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--------CC
Confidence 32 122345668899999999998899999999999999999999 6999975432 223333221 11
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHH
Q 005617 572 DWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 572 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~L 607 (688)
..+...+..+.+++.+||+.+|.+||++. .++..|
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~l~~~l 261 (262)
T cd00192 227 PKPEYCPDELYELMLSCWQLDPEDRPTFS-ELVERL 261 (262)
T ss_pred CCCccCChHHHHHHHHHccCCcccCcCHH-HHHHhh
Confidence 23334467899999999999999999998 454443
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=330.22 Aligned_cols=246 Identities=22% Similarity=0.307 Sum_probs=207.7
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccc--hHHHHHHHHHHHcCCCCceeeEecccCC--C-ceeEE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG--QLEFQQEVRVLSKLQHPHLVTLLGACPE--A-WSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~--~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~-~~LV~ 414 (688)
++|...++||+|+||.++..+.. +..|++|.+....... .....+|+.++++++|||||.+++.|.+ . .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 46778889999999999987765 7889999998765433 3357899999999999999999999954 3 68999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
+|++||+|.+.+.+.. ...++.+.+..|+.|++.|+.|||+.. |+|||||+.|||+..++.|||+|||+|+.+...
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999998766 456899999999999999999999755 999999999999999999999999999998765
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCCCCC
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 495 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~ 572 (688)
.. ...+.+||+.||+||++.+.+|+.|+|||||||++|||++-+++|...+. ....+..+. +.|
T Consensus 160 ~~------~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~----~~P---- 225 (426)
T KOG0589|consen 160 DS------LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL----YSP---- 225 (426)
T ss_pred hh------hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc----CCC----
Confidence 42 23578999999999999999999999999999999999999999975443 222232222 233
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCCchHHHH
Q 005617 573 WPTFVARRLVDLGLQCCELYGRERPDITPSLVK 605 (688)
Q Consensus 573 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~ 605 (688)
.|...+..+..|+..|+..+|..||++.+.+.+
T Consensus 226 lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 226 LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 344567789999999999999999999966554
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=318.01 Aligned_cols=255 Identities=27% Similarity=0.448 Sum_probs=202.6
Q ss_pred hcCcccceeeeccCceEEEEEEEC---------CeEEEEEEEecCC-ccchHHHHHHHHHHHcC-CCCceeeEecccCC-
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML---------GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE- 408 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~---------g~~vAIK~l~~~~-~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~- 408 (688)
..+|.....||+|+||.||+|+.. +..||+|.+.... ......+.+|+.++..+ +||||++++++|..
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 467788899999999999999752 3479999987543 23345789999999999 89999999999854
Q ss_pred -CceeEEecCCCCcHHHHhcccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceee
Q 005617 409 -AWSLVYEYLPNGSLQDRLFRKSN-------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL 474 (688)
Q Consensus 409 -~~~LV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILL 474 (688)
..++||||+++|+|.+++..... ...++|..++.++.||+.||.|||+.+ |+||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 47899999999999999876421 235789999999999999999999965 9999999999999
Q ss_pred CCCCCeEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--
Q 005617 475 DSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG-- 551 (688)
Q Consensus 475 d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~-- 551 (688)
+.++.+||+|||+++........ .......+++.|+|||++.+..++.++||||||+++|+|++ |..||....
T Consensus 171 ~~~~~~kl~D~g~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 246 (304)
T cd05101 171 TENNVMKIADFGLARDVNNIDYY----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246 (304)
T ss_pred cCCCcEEECCCccceeccccccc----ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 99999999999999876543211 12234456788999999998899999999999999999998 788886432
Q ss_pred hHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHhh
Q 005617 552 EVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 552 ~~~~~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l~ 611 (688)
.+...+..+... ..+...+..+.+|+.+||+.+|.+||++. ++++.|+.+.
T Consensus 247 ~~~~~~~~~~~~--------~~~~~~~~~~~~li~~cl~~~p~~Rps~~-e~l~~l~~~~ 297 (304)
T cd05101 247 ELFKLLKEGHRM--------DKPANCTNELYMMMRDCWHAIPSHRPTFK-QLVEDLDRIL 297 (304)
T ss_pred HHHHHHHcCCcC--------CCCCCCCHHHHHHHHHHcccChhhCCCHH-HHHHHHHHHH
Confidence 233333332211 11223456789999999999999999998 7777777654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=309.16 Aligned_cols=243 Identities=28% Similarity=0.444 Sum_probs=197.5
Q ss_pred cCcccceeeeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC-CCceeEEecCCCC
Q 005617 342 CNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP-EAWSLVYEYLPNG 420 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~-~~~~LV~E~~~~g 420 (688)
++|...+.||+|+||.||+|...+..||+|.+.... ....|.+|+.++..++||||+++++++. +..++||||+++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~~ 83 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKG 83 (254)
T ss_pred HHceeeeeeccCCCCceEecccCCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCCC
Confidence 357778899999999999999889999999986532 3457899999999999999999999884 4588999999999
Q ss_pred cHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCC
Q 005617 421 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 500 (688)
Q Consensus 421 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~ 500 (688)
+|.+++.... ...+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----- 154 (254)
T cd05083 84 NLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----- 154 (254)
T ss_pred CHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC-----
Confidence 9999987543 245789999999999999999999965 9999999999999999999999999987643221
Q ss_pred ccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHHHhhcCccccccCCCCCCCCHHH
Q 005617 501 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFV 577 (688)
Q Consensus 501 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~~~~ 577 (688)
....++..|+|||++.++.++.++|||||||++|+|++ |+.||..... ....+..+... ..+...
T Consensus 155 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~~~ 222 (254)
T cd05083 155 ----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM--------EPPEGC 222 (254)
T ss_pred ----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCC--------CCCCcC
Confidence 22334578999999998999999999999999999998 9999864432 22333322111 112234
Q ss_pred HHHHHHHHHHccccCCCCCCCCchHHHHHHH
Q 005617 578 ARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 578 ~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le 608 (688)
+..+.+++.+||+.+|..||++. .+...|+
T Consensus 223 ~~~~~~li~~~l~~~p~~Rp~~~-~l~~~l~ 252 (254)
T cd05083 223 PADVYVLMTSCWETEPKKRPSFH-KLREKLE 252 (254)
T ss_pred CHHHHHHHHHHcCCChhhCcCHH-HHHHHHc
Confidence 56788999999999999999998 5555543
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=314.26 Aligned_cols=252 Identities=29% Similarity=0.478 Sum_probs=200.3
Q ss_pred hcCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--Cc
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AW 410 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~-------g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~ 410 (688)
.++|.....||.|+||.||+|... +..||||++..... .....|.+|+.+++.++||||++++++|.+ ..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 467888899999999999999863 57899999875433 334569999999999999999999999854 47
Q ss_pred eeEEecCCCCcHHHHhcccC-------------------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCc
Q 005617 411 SLVYEYLPNGSLQDRLFRKS-------------------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQN 471 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~-------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~N 471 (688)
++||||+++|+|.+++.... ....+++..++.++.+++.||.|||..+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 89999999999999986431 1235789999999999999999999965 9999999999
Q ss_pred eeeCCCCCeEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCCh
Q 005617 472 ILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLA 550 (688)
Q Consensus 472 ILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~ 550 (688)
||++.++.++|+|||++......... .......+++.|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~ 236 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYY----KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGM 236 (288)
T ss_pred eEecCCCceEECccccceecccCccc----cccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999998765432211 11223345678999999998999999999999999999998 88888533
Q ss_pred h--hHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHH
Q 005617 551 G--EVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 551 ~--~~~~~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le 608 (688)
. .....+..+... ..+...+..+.+|+.+||+.+|.+||++. ++.+.|+
T Consensus 237 ~~~~~~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~-el~~~l~ 287 (288)
T cd05050 237 AHEEVIYYVRDGNVL--------SCPDNCPLELYNLMRLCWSKLPSDRPSFA-SINRILQ 287 (288)
T ss_pred CHHHHHHHHhcCCCC--------CCCCCCCHHHHHHHHHHcccCcccCCCHH-HHHHHhh
Confidence 2 233333333322 12223456899999999999999999998 6766665
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=313.57 Aligned_cols=248 Identities=25% Similarity=0.352 Sum_probs=189.0
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc--chHHHHHHHHHHHcC---CCCceeeEecccCC-------
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKL---QHPHLVTLLGACPE------- 408 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~--~~~~f~~E~~iL~~l---~HpnIV~l~g~~~~------- 408 (688)
+|...+.||+|+||.||+|... |..||||.+...... ....+.+|+.++..+ +||||++++++|..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4777889999999999999885 788999998754322 233566788777766 69999999998742
Q ss_pred CceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCcc
Q 005617 409 AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 488 (688)
Q Consensus 409 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla 488 (688)
..++||||+++ +|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPP-PGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 26899999985 78887765432 45899999999999999999999966 999999999999999999999999999
Q ss_pred ccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHH---Hhhc-C----
Q 005617 489 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR---AVSC-G---- 560 (688)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~---~~~~-g---- 560 (688)
....... ......||+.|+|||++.+..++.++|||||||++|+|++|++||........ .... +
T Consensus 156 ~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07863 156 RIYSCQM-------ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 228 (288)
T ss_pred ccccCcc-------cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCCh
Confidence 8764322 12345689999999999999999999999999999999999999964432111 1100 0
Q ss_pred -cccc-------ccCCCC----CCCCHHHHHHHHHHHHHccccCCCCCCCCchH
Q 005617 561 -KLSS-------ILDPLA----GDWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 561 -~l~~-------~ld~~~----~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
.+.. .+.+.. ..........+.+|+.+||+.||.+||++.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~ 282 (288)
T cd07863 229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRA 282 (288)
T ss_pred hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHH
Confidence 0000 000000 01112345678999999999999999998743
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=339.75 Aligned_cols=253 Identities=23% Similarity=0.301 Sum_probs=188.4
Q ss_pred HHHHHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCC------CceeeEeccc
Q 005617 335 ADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQH------PHLVTLLGAC 406 (688)
Q Consensus 335 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~H------pnIV~l~g~~ 406 (688)
+++...+++|...+.||+|+||+||+|.+. +..||||+++... .....+..|+.++..++| +++++++++|
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344456789999999999999999999875 7889999996432 223345667777777654 4588888887
Q ss_pred CC---CceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCC-----
Q 005617 407 PE---AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL----- 478 (688)
Q Consensus 407 ~~---~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~----- 478 (688)
.. ..++||+++ +++|.+++... ..+++..+..|+.||+.||.|||+.. +||||||||+||||+.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMKH---GPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCHHHEEEecCCccccc
Confidence 43 478899988 77888887654 36899999999999999999999731 499999999999998765
Q ss_pred -----------CeEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCC
Q 005617 479 -----------SSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPV 547 (688)
Q Consensus 479 -----------~vKLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf 547 (688)
.+||+|||++..... .....+||+.|+|||++.+..++.++|||||||+||||+||++||
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~---------~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf 345 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERH---------SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY 345 (467)
T ss_pred ccccccCCCCceEEECCCCccccCcc---------ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCC
Confidence 499999998764322 224568999999999999999999999999999999999999999
Q ss_pred CChhhHHHH--hh--cCccc-----------------------cccCCC-----C--CCC-CHHHHHHHHHHHHHccccC
Q 005617 548 GLAGEVRRA--VS--CGKLS-----------------------SILDPL-----A--GDW-PTFVARRLVDLGLQCCELY 592 (688)
Q Consensus 548 ~~~~~~~~~--~~--~g~l~-----------------------~~ld~~-----~--~~~-~~~~~~~l~~L~~~Cl~~d 592 (688)
......... +. .|.+. ...++. . ... .......+.+|+.+||+.|
T Consensus 346 ~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d 425 (467)
T PTZ00284 346 DTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYD 425 (467)
T ss_pred CCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcC
Confidence 754332110 00 01000 000000 0 000 0012346789999999999
Q ss_pred CCCCCCCchHH
Q 005617 593 GRERPDITPSL 603 (688)
Q Consensus 593 P~~RPs~~~~l 603 (688)
|.+||++.+.+
T Consensus 426 P~~R~ta~e~L 436 (467)
T PTZ00284 426 RQKRLNARQMT 436 (467)
T ss_pred hhhCCCHHHHh
Confidence 99999998554
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=318.70 Aligned_cols=250 Identities=28% Similarity=0.431 Sum_probs=194.5
Q ss_pred cCcccceeeeccCceEEEEEEEC--Ce--EEEEEEEecCCc-cchHHHHHHHHHHHcC-CCCceeeEecccCC--CceeE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GR--TVAIKMLYSHNM-QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~--~vAIK~l~~~~~-~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~~~LV 413 (688)
++|.....||+|+||.||+|.+. |. .+|+|.+..... .....|.+|+.++.++ +||||++++++|.+ ..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 56778889999999999999874 44 467777764332 3345788999999999 89999999999854 48899
Q ss_pred EecCCCCcHHHHhcccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCe
Q 005617 414 YEYLPNGSLQDRLFRKSN-------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS 480 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~v 480 (688)
|||+++|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 999999999999875431 235889999999999999999999965 9999999999999999999
Q ss_pred EEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHHHh
Q 005617 481 KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAV 557 (688)
Q Consensus 481 KLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~~ 557 (688)
||+|||++....... ......++..|+|||++....++.++|||||||++|||+| |..||..... ....+
T Consensus 164 kl~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~ 236 (303)
T cd05088 164 KIADFGLSRGQEVYV-------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236 (303)
T ss_pred EeCccccCcccchhh-------hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH
Confidence 999999986432111 1122345678999999988889999999999999999998 9999964332 11111
Q ss_pred hcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHh
Q 005617 558 SCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 558 ~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l 610 (688)
..+. ....+...+..+.+|+.+||+.+|.+||++. .++..|..+
T Consensus 237 ~~~~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~-~il~~l~~~ 280 (303)
T cd05088 237 PQGY--------RLEKPLNCDDEVYDLMRQCWREKPYERPSFA-QILVSLNRM 280 (303)
T ss_pred hcCC--------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHHH
Confidence 1110 1112223456789999999999999999999 455556554
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=308.06 Aligned_cols=247 Identities=25% Similarity=0.343 Sum_probs=197.5
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc-----chHHHHHHHHHHHcCCCCceeeEecccCC--Ccee
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-----GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSL 412 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~-----~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~L 412 (688)
++|...+.||.|+||.||+|... +..||+|.+...... ....+.+|+.++.+++||||+++++++.+ ..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57888999999999999999874 889999998754321 23468899999999999999999999854 5789
Q ss_pred EEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCcccccc
Q 005617 413 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 492 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~ 492 (688)
||||+++++|.+.+... ..+++..+..++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY---GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 99999999999988654 35788999999999999999999966 9999999999999999999999999997654
Q ss_pred CCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCccccccCCCCCC
Q 005617 493 EDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 493 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~l~~~ld~~~~~ 572 (688)
...... .......|+..|+|||++.+..++.++||||||+++|||++|+.||.............. ......
T Consensus 156 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~-----~~~~~~ 227 (263)
T cd06625 156 TICSSG---TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT-----QPTNPQ 227 (263)
T ss_pred cccccc---ccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhc-----cCCCCC
Confidence 322110 011345688999999999999999999999999999999999999965433222111110 011122
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCCchH
Q 005617 573 WPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 573 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
.+......+.+++.+||..+|.+||++.+.
T Consensus 228 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l 257 (263)
T cd06625 228 LPSHVSPDARNFLRRTFVENAKKRPSAEEL 257 (263)
T ss_pred CCccCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 344556788999999999999999998743
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-36 Score=313.87 Aligned_cols=258 Identities=24% Similarity=0.333 Sum_probs=202.5
Q ss_pred cCHHHHHHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcC-CCCceeeEecccC-
Q 005617 332 FSLADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACP- 407 (688)
Q Consensus 332 ~~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~- 407 (688)
+.++.+..++++|.....||+|+||.||++... +..||+|++.... .....+.+|+.++..+ +||||++++++|.
T Consensus 8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 86 (286)
T cd06638 8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYK 86 (286)
T ss_pred EEeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeee
Confidence 556777888999999999999999999999885 7899999886532 2235688999999999 6999999999872
Q ss_pred ------CCceeEEecCCCCcHHHHhccc-CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCe
Q 005617 408 ------EAWSLVYEYLPNGSLQDRLFRK-SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS 480 (688)
Q Consensus 408 ------~~~~LV~E~~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~v 480 (688)
+..++||||+++|+|.+++... .....+++..+..++.+++.||.|||+.+ |+||||||+||+++.++.+
T Consensus 87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~ 163 (286)
T cd06638 87 KDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGV 163 (286)
T ss_pred cccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCE
Confidence 2378999999999999987542 22346889999999999999999999965 9999999999999999999
Q ss_pred EEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhc-----cCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHH
Q 005617 481 KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR-----TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR 555 (688)
Q Consensus 481 KLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~ 555 (688)
||+|||++........ ......|++.|+|||++. ...++.++|||||||++|||++|+.||........
T Consensus 164 kl~dfg~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~ 237 (286)
T cd06638 164 KLVDFGVSAQLTSTRL------RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA 237 (286)
T ss_pred EEccCCceeecccCCC------ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH
Confidence 9999999987643221 223457999999999875 34578999999999999999999999875543332
Q ss_pred HhhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 556 AVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 556 ~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
........ .+.. ..+......+.+|+.+||+.+|++||++.+.+
T Consensus 238 ~~~~~~~~---~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell 281 (286)
T cd06638 238 LFKIPRNP---PPTL-HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLL 281 (286)
T ss_pred HhhccccC---CCcc-cCCCCcCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 22111110 0000 11222345789999999999999999998543
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=313.50 Aligned_cols=241 Identities=23% Similarity=0.342 Sum_probs=193.5
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEecCCC
Q 005617 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLPN 419 (688)
Q Consensus 344 f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~~~ 419 (688)
|.....||.|+||.||+|... +..+++|.+..........|.+|+.++..++||||++++++|. +..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 455678999999999999986 6788999987665555667899999999999999999999884 357899999999
Q ss_pred CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCC
Q 005617 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 420 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~ 499 (688)
|+|..++.... .++++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++.......
T Consensus 87 ~~l~~~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~---- 157 (282)
T cd06643 87 GAVDAVMLELE--RPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI---- 157 (282)
T ss_pred CcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc----
Confidence 99998876533 46899999999999999999999965 9999999999999999999999999987654322
Q ss_pred CccccCCCCCCCCCCChhhhc-----cCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHH--hhcCccccccCCCCCC
Q 005617 500 SFHRSTAPKGSFPYADPEYHR-----TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VSCGKLSSILDPLAGD 572 (688)
Q Consensus 500 ~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~--~~~g~l~~~ld~~~~~ 572 (688)
.......||+.|+|||++. ...++.++|||||||++|||++|++||......... +..+....+ .
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------~ 229 (282)
T cd06643 158 --QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL------A 229 (282)
T ss_pred --cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCC------C
Confidence 1223456899999999874 445788999999999999999999999754432221 111111111 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCCch
Q 005617 573 WPTFVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 573 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~ 601 (688)
.+...+..+.+|+.+||+.+|.+||++.+
T Consensus 230 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ 258 (282)
T cd06643 230 QPSRWSSEFKDFLKKCLEKNVDARWTTTQ 258 (282)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHH
Confidence 22234567899999999999999999874
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=308.18 Aligned_cols=246 Identities=28% Similarity=0.488 Sum_probs=190.4
Q ss_pred eeeccCceEEEEEEEC-----CeEEEEEEEecCC-ccchHHHHHHHHHHHcCCCCceeeEecccC--C-CceeEEecCCC
Q 005617 349 KVGQGGFGCVYKGEML-----GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACP--E-AWSLVYEYLPN 419 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~-----g~~vAIK~l~~~~-~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~-~~~LV~E~~~~ 419 (688)
.||+|+||.||+|.+. +..||||.+.... ......|.+|+.+++.++||||++++++|. + ..++||||+.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~ 81 (262)
T cd05058 2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKH 81 (262)
T ss_pred cccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCC
Confidence 5899999999999863 3579999985432 234557889999999999999999999763 2 37899999999
Q ss_pred CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCC
Q 005617 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 420 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~ 499 (688)
|+|.+++.... ..+++..++.++.+++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..........
T Consensus 82 ~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~ 156 (262)
T cd05058 82 GDLRNFIRSET--HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156 (262)
T ss_pred CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence 99999986543 34678888999999999999999965 99999999999999999999999999986543221110
Q ss_pred CccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhC-CCCCCChhh--HHHHhhcCccccccCCCCCCCCHH
Q 005617 500 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTG-RLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTF 576 (688)
Q Consensus 500 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG-~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~~~ 576 (688)
.......+++.|+|||++.+..++.++|||||||++|||++| .+||..... ....+..+.. ...+..
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~ 226 (262)
T cd05058 157 --HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRR--------LLQPEY 226 (262)
T ss_pred --cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC--------CCCCCc
Confidence 112344567889999999889999999999999999999995 566653322 2222222211 111223
Q ss_pred HHHHHHHHHHHccccCCCCCCCCchHHHHHHHHh
Q 005617 577 VARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 577 ~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l 610 (688)
.+..+.+++.+||+.+|.+||++. .++..|+.+
T Consensus 227 ~~~~~~~li~~cl~~~p~~Rp~~~-~il~~l~~~ 259 (262)
T cd05058 227 CPDPLYEVMLSCWHPKPEMRPTFS-ELVSRIEQI 259 (262)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHH-HHHHHHHHH
Confidence 356789999999999999999998 677777654
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=310.54 Aligned_cols=251 Identities=27% Similarity=0.417 Sum_probs=198.8
Q ss_pred cCcccceeeeccCceEEEEEEEC-----CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccC--CCceeE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML-----GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~-----g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV 413 (688)
.+|...+.||+|+||.||+|.+. +..||+|.+..... .....|.+|+.++..++||||+++++++. +..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46777899999999999999873 33799999865432 23457899999999999999999999984 357899
Q ss_pred EecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccC
Q 005617 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~ 493 (688)
|||+++|+|.+++.... ..+++..++.|+.+++.||.|||+.+ ++||||||+|||++.++.++|+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKHD--GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 99999999999997543 45899999999999999999999965 99999999999999999999999999987654
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHHHhhcCccccccCCCC
Q 005617 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~~~~g~l~~~ld~~~ 570 (688)
..... .......++..|+|||++.+..++.++|||||||++||+++ |..||..... ....+..+..
T Consensus 159 ~~~~~---~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-------- 227 (267)
T cd05066 159 DPEAA---YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR-------- 227 (267)
T ss_pred cccee---eecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc--------
Confidence 32111 11122334678999999999999999999999999999887 9999864332 2222322210
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHH
Q 005617 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 571 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~ 609 (688)
...+...+..+.+++.+|++.+|.+||++. .+.+.|+.
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~-~i~~~l~~ 265 (267)
T cd05066 228 LPAPMDCPAALHQLMLDCWQKDRNERPKFE-QIVSILDK 265 (267)
T ss_pred CCCCCCCCHHHHHHHHHHcccCchhCCCHH-HHHHHHHh
Confidence 011223456789999999999999999998 67676664
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=306.14 Aligned_cols=245 Identities=27% Similarity=0.360 Sum_probs=200.0
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecC
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 417 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~ 417 (688)
++|.....||.|+||.||+|... +..|++|.+..... ...|.+|+.++++++||||+++++++.+ ..++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 57888889999999999999886 68899999875433 6689999999999999999999999854 478999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCc
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~ 497 (688)
++++|.+++.... ..+++..+..++.+++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 9999999986533 46899999999999999999999966 99999999999999999999999999987654321
Q ss_pred CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCccccccCCCCCCCCHHH
Q 005617 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFV 577 (688)
Q Consensus 498 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~l~~~ld~~~~~~~~~~ 577 (688)
......|+..|+|||++.+..++.++|||||||++|+|++|+.||................ +.....+...
T Consensus 155 -----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 225 (256)
T cd06612 155 -----KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKP----PPTLSDPEKW 225 (256)
T ss_pred -----ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCC----CCCCCchhhc
Confidence 1234568899999999999999999999999999999999999997544332221111100 0011123345
Q ss_pred HHHHHHHHHHccccCCCCCCCCchHH
Q 005617 578 ARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 578 ~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
...+.+++.+||+.+|.+||++.+.+
T Consensus 226 ~~~~~~~i~~~l~~~P~~Rps~~~il 251 (256)
T cd06612 226 SPEFNDFVKKCLVKDPEERPSAIQLL 251 (256)
T ss_pred CHHHHHHHHHHHhcChhhCcCHHHHh
Confidence 56899999999999999999998433
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=317.19 Aligned_cols=240 Identities=25% Similarity=0.346 Sum_probs=192.1
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccc---hHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEec
Q 005617 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG---QLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 416 (688)
Q Consensus 344 f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~---~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~ 416 (688)
|...+.||+|+||.||++... +..||||.+....... ...+.+|+.++.+++|+||+++++.+. +..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 667789999999999999886 7899999987654322 345778999999999999999999884 357899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCC
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~ 496 (688)
+++|+|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 82 MNGGDLKFHIYHMGE-AGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred cCCCcHHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence 999999998865432 45889999999999999999999965 9999999999999999999999999987654322
Q ss_pred cCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhH--HHHhhcCccccccCCCCCCCC
Q 005617 497 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGDWP 574 (688)
Q Consensus 497 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~~~~g~l~~~ld~~~~~~~ 574 (688)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .... ...++.....++
T Consensus 157 ------~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~-----~~~~~~~~~~~~ 225 (285)
T cd05630 157 ------TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEV-----ERLVKEVQEEYS 225 (285)
T ss_pred ------cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHH-----HhhhhhhhhhcC
Confidence 112447999999999999999999999999999999999999999743211 0000 001111111223
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCC
Q 005617 575 TFVARRLVDLGLQCCELYGRERPDI 599 (688)
Q Consensus 575 ~~~~~~l~~L~~~Cl~~dP~~RPs~ 599 (688)
......+.+|+.+||+.||.+||++
T Consensus 226 ~~~~~~~~~li~~~l~~~p~~R~s~ 250 (285)
T cd05630 226 EKFSPDARSLCKMLLCKDPKERLGC 250 (285)
T ss_pred ccCCHHHHHHHHHHhhcCHHHccCC
Confidence 3445678999999999999999995
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=310.51 Aligned_cols=233 Identities=25% Similarity=0.392 Sum_probs=183.3
Q ss_pred eeeccCceEEEEEEEC--------------CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--Ccee
Q 005617 349 KVGQGGFGCVYKGEML--------------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSL 412 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~--------------g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~L 412 (688)
.||+|+||.||+|... ...||+|.+..........|..|+.++..++||||++++++|.. ..++
T Consensus 2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~l 81 (262)
T cd05077 2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIM 81 (262)
T ss_pred ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEE
Confidence 5899999999999753 23589998876655555678999999999999999999999854 5789
Q ss_pred EEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCC-------eEEeec
Q 005617 413 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELS-------SKICDF 485 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~-------vKLsDF 485 (688)
||||+++|+|..++.... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++. ++++||
T Consensus 82 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 82 VEEFVEFGPLDLFMHRKS--DVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred EEecccCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999998886543 45899999999999999999999965 999999999999987664 899999
Q ss_pred CccccccCCCCcCCCccccCCCCCCCCCCChhhhc-cCCCCCcchHhHHHHHHHHHH-hCCCCCCChhhHHH-HhhcCcc
Q 005617 486 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR-TGVLTPKSDSYSFGLIILQLL-TGRLPVGLAGEVRR-AVSCGKL 562 (688)
Q Consensus 486 Gla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~s~ksDVwSfGviL~ELl-tG~~Pf~~~~~~~~-~~~~g~l 562 (688)
|++...... ....|+..|+|||++. ...++.++|||||||++|||+ +|..||........ ....+..
T Consensus 157 g~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 226 (262)
T cd05077 157 GIPITVLSR----------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYEGQC 226 (262)
T ss_pred CCCccccCc----------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHhcCc
Confidence 998755321 2345888999999886 567899999999999999998 58888864332111 1111111
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHH
Q 005617 563 SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKE 606 (688)
Q Consensus 563 ~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~ 606 (688)
.. .......+.+|+.+||+.||.+||++. +++..
T Consensus 227 -~~--------~~~~~~~~~~li~~cl~~dp~~Rp~~~-~il~~ 260 (262)
T cd05077 227 -ML--------VTPSCKELADLMTHCMNYDPNQRPFFR-AIMRD 260 (262)
T ss_pred -cC--------CCCChHHHHHHHHHHcCCChhhCcCHH-HHHHh
Confidence 00 111235788999999999999999998 44433
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=330.82 Aligned_cols=258 Identities=28% Similarity=0.432 Sum_probs=203.0
Q ss_pred HHHHhcCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCccc-hHHHHHHHHHHHcCC-CCceeeEecccC
Q 005617 337 LQTATCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQG-QLEFQQEVRVLSKLQ-HPHLVTLLGACP 407 (688)
Q Consensus 337 l~~at~~f~~~~~LG~G~fG~Vykg~~~-------g~~vAIK~l~~~~~~~-~~~f~~E~~iL~~l~-HpnIV~l~g~~~ 407 (688)
.....++|...+.||+|+||.||+|.+. +..||||+++...... ...+.+|+.+|.++. |||||+++|+|.
T Consensus 32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 3344456778889999999999999864 3579999997653332 346889999999997 999999999995
Q ss_pred C--CceeEEecCCCCcHHHHhcccC-------------------------------------------------------
Q 005617 408 E--AWSLVYEYLPNGSLQDRLFRKS------------------------------------------------------- 430 (688)
Q Consensus 408 ~--~~~LV~E~~~~gsL~~~L~~~~------------------------------------------------------- 430 (688)
. ..++||||+++|+|.+++....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 4 4789999999999999986532
Q ss_pred ----------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCC
Q 005617 431 ----------------------------------------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQ 470 (688)
Q Consensus 431 ----------------------------------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~ 470 (688)
....++|..++.|+.+++.||.|||+.+ |+||||||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~ 268 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAAR 268 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcc
Confidence 1124788889999999999999999855 999999999
Q ss_pred ceeeCCCCCeEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCC
Q 005617 471 NILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGL 549 (688)
Q Consensus 471 NILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~ 549 (688)
|||++.++.+||+|||+++........ .......|++.|+|||++....+++++|||||||++|||++ |..||..
T Consensus 269 NiLl~~~~~~kL~DfGla~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~ 344 (401)
T cd05107 269 NVLICEGKLVKICDFGLARDIMRDSNY----ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE 344 (401)
T ss_pred eEEEeCCCEEEEEecCcceeccccccc----ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCC
Confidence 999999999999999999875432211 11233457889999999998899999999999999999998 8999864
Q ss_pred hhh---HHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHh
Q 005617 550 AGE---VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 550 ~~~---~~~~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l 610 (688)
... ....+..+.. ...+...+..+.+|+.+||+.+|..||++. +++..|+.+
T Consensus 345 ~~~~~~~~~~~~~~~~--------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~-ell~~L~~~ 399 (401)
T cd05107 345 LPMNEQFYNAIKRGYR--------MAKPAHASDEIYEIMQKCWEEKFEIRPDFS-QLVHLVGDL 399 (401)
T ss_pred CCchHHHHHHHHcCCC--------CCCCCCCCHHHHHHHHHHcCCChhHCcCHH-HHHHHHHHH
Confidence 332 1222222211 112233457899999999999999999999 777777754
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=329.75 Aligned_cols=244 Identities=23% Similarity=0.330 Sum_probs=190.6
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--Cce
Q 005617 339 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWS 411 (688)
Q Consensus 339 ~at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~ 411 (688)
...++|...+.||+|+||.||++... +..||+|++..... .....+.+|+.+++.++||||+++++++.+ ..+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 34567899999999999999999886 78899999965322 233458899999999999999999999854 478
Q ss_pred eEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccc
Q 005617 412 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~ 491 (688)
+||||+++|+|.+++... .+++..+..++.||+.||.|||+.+ |+||||||+||||+.++.+||+|||++...
T Consensus 120 lv~Ey~~gg~L~~~l~~~----~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 120 MVMEYMPGGDLVNLMSNY----DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 999999999999988542 4788889999999999999999966 999999999999999999999999999876
Q ss_pred cCCCCcCCCccccCCCCCCCCCCChhhhccC----CCCCcchHhHHHHHHHHHHhCCCCCCChhhH--HHHhhcCccccc
Q 005617 492 TEDTLYLPSFHRSTAPKGSFPYADPEYHRTG----VLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSI 565 (688)
Q Consensus 492 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~----~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~~~~g~l~~~ 565 (688)
..... .......||+.|+|||++... .++.++|||||||+||||+||+.||...... ...+.....
T Consensus 193 ~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~--- 264 (370)
T cd05621 193 DETGM-----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKN--- 264 (370)
T ss_pred ccCCc-----eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc---
Confidence 43221 122456799999999998654 3789999999999999999999999754332 122211110
Q ss_pred cCCCCCCCCH--HHHHHHHHHHHHccccCCCC--CCCCch
Q 005617 566 LDPLAGDWPT--FVARRLVDLGLQCCELYGRE--RPDITP 601 (688)
Q Consensus 566 ld~~~~~~~~--~~~~~l~~L~~~Cl~~dP~~--RPs~~~ 601 (688)
...+|. ..+..+.+++..|+..++.. ||++.+
T Consensus 265 ----~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e 300 (370)
T cd05621 265 ----SLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEE 300 (370)
T ss_pred ----ccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHH
Confidence 011221 34667888899999754433 667663
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=324.08 Aligned_cols=246 Identities=25% Similarity=0.335 Sum_probs=205.7
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEeccc--CCCceeEE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~--~~~~~LV~ 414 (688)
+.|+.-++||+||||.||-++.. |+-+|.|.+.+... .+..-..+|-.||.+++.|.||.|-.+| .+.+|||+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 67888899999999999988764 89999999866544 3344578999999999999999998887 46799999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
..|+||+|.-+|...++ ..+++..++.++.+|+.||.+||... ||.||+||+|||||+.|+++|+|.|||..+..+
T Consensus 265 tlMNGGDLkfHiyn~g~-~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGN-PGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EeecCCceeEEeeccCC-CCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 99999999999988765 67899999999999999999999976 999999999999999999999999999988766
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCccccccCCCCCCCC
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWP 574 (688)
Q Consensus 495 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~l~~~ld~~~~~~~ 574 (688)
. .....+||.||||||++.+..|+...|+|||||+||||+.|+.||.....- +....+...+-.....++
T Consensus 341 ~-------~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK---vk~eEvdrr~~~~~~ey~ 410 (591)
T KOG0986|consen 341 K-------PIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK---VKREEVDRRTLEDPEEYS 410 (591)
T ss_pred C-------ccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh---hhHHHHHHHHhcchhhcc
Confidence 5 234569999999999999999999999999999999999999999643221 000011111111233567
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCCch
Q 005617 575 TFVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 575 ~~~~~~l~~L~~~Cl~~dP~~RPs~~~ 601 (688)
...+++...|....|..||.+|...+.
T Consensus 411 ~kFS~eakslc~~LL~Kdp~~RLGcrg 437 (591)
T KOG0986|consen 411 DKFSEEAKSLCEGLLTKDPEKRLGCRG 437 (591)
T ss_pred cccCHHHHHHHHHHHccCHHHhccCCC
Confidence 778889999999999999999987763
|
|
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=310.63 Aligned_cols=252 Identities=27% Similarity=0.430 Sum_probs=196.7
Q ss_pred CcccceeeeccCceEEEEEEEC--C---eEEEEEEEecCC-ccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--G---RTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g---~~vAIK~l~~~~-~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
+|...+.||+|+||.||+|.+. + ..||||.+.... ......|..|+.++..++||||+++++++.+ ..++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4677889999999999999875 3 369999987543 2345679999999999999999999999854 478999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~~~~--~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 85 EFMENGALDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred ecCCCCcHHHHHhhCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 9999999999986543 45899999999999999999999965 999999999999999999999999999876443
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHHHhhcCccccccCCCCC
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAG 571 (688)
Q Consensus 495 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~ 571 (688)
... +.........++..|+|||++....++.++|||||||++|||++ |..||..... +...+..+. . .
T Consensus 160 ~~~-~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~--~------~ 230 (269)
T cd05065 160 TSD-PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY--R------L 230 (269)
T ss_pred ccc-cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC--c------C
Confidence 211 11111111123457999999999999999999999999999887 9999964332 222222111 0 0
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHH
Q 005617 572 DWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 572 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~ 609 (688)
..+...+..+.+++.+||..+|.+||++. .+...|+.
T Consensus 231 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~-~i~~~l~~ 267 (269)
T cd05065 231 PPPMDCPTALHQLMLDCWQKDRNARPKFG-QIVSTLDK 267 (269)
T ss_pred CCcccCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHh
Confidence 11223455788999999999999999998 66666654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=314.67 Aligned_cols=255 Identities=28% Similarity=0.453 Sum_probs=200.1
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--C
Q 005617 340 ATCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--A 409 (688)
Q Consensus 340 at~~f~~~~~LG~G~fG~Vykg~~~-------g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~ 409 (688)
.+++|.....||+|+||.||+|... +..||+|.+..... .....+.+|+.++..++||||+++++++.+ .
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567888999999999999998653 35799998865432 233468899999999999999999998843 5
Q ss_pred ceeEEecCCCCcHHHHhcccC-------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEE
Q 005617 410 WSLVYEYLPNGSLQDRLFRKS-------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKI 482 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~-------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL 482 (688)
.++||||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.++|
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 789999999999999996532 1245678889999999999999999965 999999999999999999999
Q ss_pred eecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHHHhhc
Q 005617 483 CDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSC 559 (688)
Q Consensus 483 sDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~~~~ 559 (688)
+|||+++........ .......++..|+|||.+..+.++.++|||||||++|||++ |..||..... +...+..
T Consensus 161 ~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 236 (288)
T cd05061 161 GDFGMTRDIYETDYY----RKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD 236 (288)
T ss_pred CcCCccccccccccc----cccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence 999999865432211 11223446778999999999999999999999999999999 7889865432 2222222
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHh
Q 005617 560 GKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 560 g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l 610 (688)
+... ..+...+..+.+++.+|++.+|.+||++. .+++.|+..
T Consensus 237 ~~~~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~ll~~l~~~ 278 (288)
T cd05061 237 GGYL--------DQPDNCPERVTDLMRMCWQFNPKMRPTFL-EIVNLLKDD 278 (288)
T ss_pred CCCC--------CCCCCCCHHHHHHHHHHcCCChhHCcCHH-HHHHHHHhh
Confidence 2211 12223356899999999999999999998 566666543
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=301.91 Aligned_cols=263 Identities=22% Similarity=0.288 Sum_probs=208.1
Q ss_pred HHhcCcccceeeeccCceEEEEEEE--CCeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC-------CC
Q 005617 339 TATCNFSESFKVGQGGFGCVYKGEM--LGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP-------EA 409 (688)
Q Consensus 339 ~at~~f~~~~~LG~G~fG~Vykg~~--~g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~-------~~ 409 (688)
...++|...+.||+|||+.||.++. .+..||+|++.....++.+...+|++..++++|||++++++++. +.
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~ 97 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHE 97 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCcee
Confidence 3457899999999999999999885 37889999998888888888999999999999999999998872 23
Q ss_pred ceeEEecCCCCcHHHHhcccC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCcc
Q 005617 410 WSLVYEYLPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 488 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla 488 (688)
.||+++|...|||.+.+.... ....+++.+++.|+.+|++||.+||...| +++||||||.|||+.+.+.++|.|||.+
T Consensus 98 ~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 98 AYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred EEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEEEeccCc
Confidence 799999999999999987654 33478999999999999999999999884 8999999999999999999999999999
Q ss_pred ccccCCCCc---CCCccccCCCCCCCCCCChhhhc---cCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCcc
Q 005617 489 RLVTEDTLY---LPSFHRSTAPKGSFPYADPEYHR---TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKL 562 (688)
Q Consensus 489 ~~~~~~~~~---~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~l 562 (688)
....-.... ....+....-..|..|.|||.+. +...+.++|||||||+||+|+.|..||...-. ..|.+
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-----~GgSl 251 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-----QGGSL 251 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-----cCCeE
Confidence 876422111 01112233446788999999874 55678999999999999999999999963211 12222
Q ss_pred ccccCCCCCCCC--HHHHHHHHHHHHHccccCCCCCCCCchHHHHHHH
Q 005617 563 SSILDPLAGDWP--TFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 563 ~~~ld~~~~~~~--~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le 608 (688)
.-.+......+| ...++.+.+|+.+|++.||.+||++. +++..++
T Consensus 252 aLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~-~ll~~~d 298 (302)
T KOG2345|consen 252 ALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIP-ELLSKLD 298 (302)
T ss_pred EEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHH-HHHHHHH
Confidence 221111111111 12678999999999999999999998 4544444
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=306.72 Aligned_cols=250 Identities=25% Similarity=0.391 Sum_probs=196.5
Q ss_pred CcccceeeeccCceEEEEEEEC-CeEEEEEEEecCCc------cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeE
Q 005617 343 NFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNM------QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLV 413 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~-g~~vAIK~l~~~~~------~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV 413 (688)
+|.....||.|+||.||+|... |..+|||.+..... .....+.+|+.+++.++|+||++++++|.+ ..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 3667788999999999999875 78899999865432 122458899999999999999999999854 47899
Q ss_pred EecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccC
Q 005617 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~ 493 (688)
|||+++++|.+++... .++++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNRF---GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 9999999999998654 35788999999999999999999966 99999999999999999999999999986542
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCccccccCCCCCCC
Q 005617 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~l~~~ld~~~~~~ 573 (688)
...............|+..|+|||++.+..++.++|||||||++|+|++|..||..................+ ...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~ 230 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLM----PRL 230 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCC----CCC
Confidence 2111111112234568999999999999999999999999999999999999997544332221111111111 112
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCCchH
Q 005617 574 PTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 574 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
+......+.+++.+||+.+|.+||++.+.
T Consensus 231 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~ 259 (265)
T cd06631 231 PDSFSAAAIDFVTSCLTRDQHERPSALQL 259 (265)
T ss_pred CCCCCHHHHHHHHHHhcCCcccCCCHHHH
Confidence 33456678999999999999999999843
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=320.83 Aligned_cols=245 Identities=26% Similarity=0.296 Sum_probs=186.8
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|...+.||+|+||.||++... +..||||++..... .....|.+|+.++..++||||++++++|.+ ..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888899999999999999885 78999999975322 233458899999999999999999999854 478999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
||+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 9999999999986533 35788999999999999999999966 999999999999999999999999998765432
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhcc-----CCCCCcchHhHHHHHHHHHHhCCCCCCChhhH--HHHhhcCccccccC
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRT-----GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILD 567 (688)
Q Consensus 495 ~~~~~~~~~~~~~~GT~~Y~APE~~~~-----~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~~~~g~l~~~ld 567 (688)
... ......||+.|+|||++.. ..++.++|||||||++|+|++|+.||...... ...+........+.
T Consensus 156 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 230 (331)
T cd05597 156 GTV-----QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFP 230 (331)
T ss_pred CCc-----cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCC
Confidence 211 1233569999999999863 46788999999999999999999999654322 11121111000011
Q ss_pred CCCCCCCHHHHHHHHHHHHHcccc--CCCCCCCCc
Q 005617 568 PLAGDWPTFVARRLVDLGLQCCEL--YGRERPDIT 600 (688)
Q Consensus 568 ~~~~~~~~~~~~~l~~L~~~Cl~~--dP~~RPs~~ 600 (688)
+ .....+..+.+|+.+|+.. ++..||++.
T Consensus 231 ~----~~~~~~~~~~~li~~ll~~~~~r~~r~~~~ 261 (331)
T cd05597 231 P----DVTDVSEEAKDLIRRLICSPETRLGRNGLQ 261 (331)
T ss_pred C----ccCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence 1 1112455678888887754 333366665
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=325.49 Aligned_cols=249 Identities=22% Similarity=0.247 Sum_probs=192.0
Q ss_pred HhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC-------
Q 005617 340 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE------- 408 (688)
Q Consensus 340 at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~------- 408 (688)
..++|...+.||+|+||.||++... +..||||++..... .....+.+|+.+++.++||||+++++++..
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999875 88999999875432 234567889999999999999999998732
Q ss_pred -CceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCc
Q 005617 409 -AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 487 (688)
Q Consensus 409 -~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGl 487 (688)
..++||||+++ +|...+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 25899999976 5555553 24788899999999999999999966 99999999999999999999999999
Q ss_pred cccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHH---hh------
Q 005617 488 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA---VS------ 558 (688)
Q Consensus 488 a~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~---~~------ 558 (688)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... +.
T Consensus 166 ~~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (355)
T cd07874 166 ARTAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238 (355)
T ss_pred cccCCCcc-------ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 98654322 123457899999999999999999999999999999999999999654321110 00
Q ss_pred ----------------c-Ccccccc------C---CCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHH
Q 005617 559 ----------------C-GKLSSIL------D---PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 604 (688)
Q Consensus 559 ----------------~-g~l~~~l------d---~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~ 604 (688)
. .....+. + +.....+......+.+|+.+|++.||.+|||+.+.+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~ 310 (355)
T cd07874 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQ 310 (355)
T ss_pred HHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhc
Confidence 0 0000000 0 0001112223567899999999999999999985543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=327.67 Aligned_cols=249 Identities=23% Similarity=0.315 Sum_probs=190.3
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC--ccchHHHHHHHHHHHcCCCCceeeEecccCC-------Cce
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-------AWS 411 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~--~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-------~~~ 411 (688)
+|+..+.||+|+||.||+|... |..||||++.... ......+.+|+.++..++||||+++++++.. ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4778899999999999999874 8999999986532 2334568899999999999999999998843 468
Q ss_pred eEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccc
Q 005617 412 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~ 491 (688)
+||||+. ++|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVSP---QPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 5777776543 36889999999999999999999966 999999999999999999999999999875
Q ss_pred cCCCCcCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHH--h----hcCcc--
Q 005617 492 TEDTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--V----SCGKL-- 562 (688)
Q Consensus 492 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~--~----~~g~l-- 562 (688)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......... + .....
T Consensus 154 ~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~ 228 (372)
T cd07853 154 EPDESK-----HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEA 228 (372)
T ss_pred ccCccc-----cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence 433211 12345689999999998764 5799999999999999999999999644321110 0 00000
Q ss_pred -------------ccccCCC----CCCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 563 -------------SSILDPL----AGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 563 -------------~~~ld~~----~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
.....+. ...........+.+|+.+||+.||.+||++.+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l 286 (372)
T cd07853 229 MRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADAL 286 (372)
T ss_pred HHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHh
Confidence 0000000 0011122356789999999999999999998544
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=315.24 Aligned_cols=248 Identities=25% Similarity=0.383 Sum_probs=203.1
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEecC
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 417 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~ 417 (688)
.+|.....||.|+||.||+|... |..||||.+..........+.+|+.+++.++||||++++++|. +..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 46888899999999999999864 8899999997766555677899999999999999999999984 3588999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCc
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~ 497 (688)
++++|..++.. ..+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~- 170 (296)
T cd06655 99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS- 170 (296)
T ss_pred CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccc-
Confidence 99999998854 35789999999999999999999966 99999999999999999999999999887643321
Q ss_pred CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHh--hcCccccccCCCCCCCCH
Q 005617 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAV--SCGKLSSILDPLAGDWPT 575 (688)
Q Consensus 498 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~--~~g~l~~~ld~~~~~~~~ 575 (688)
......|++.|+|||.+.+..++.++|||||||++|+|++|+.||.......... ....... ...+.
T Consensus 171 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~------~~~~~ 239 (296)
T cd06655 171 -----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE------LQNPE 239 (296)
T ss_pred -----cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcc------cCCcc
Confidence 1234568999999999998899999999999999999999999997654432221 1111111 11223
Q ss_pred HHHHHHHHHHHHccccCCCCCCCCchHHHHHHH
Q 005617 576 FVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 576 ~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le 608 (688)
..+..+.+++.+||..+|.+||++.+.+...+-
T Consensus 240 ~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~ 272 (296)
T cd06655 240 KLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272 (296)
T ss_pred cCCHHHHHHHHHHhhcChhhCCCHHHHhhChHh
Confidence 345678899999999999999999866654444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=318.54 Aligned_cols=250 Identities=22% Similarity=0.320 Sum_probs=191.1
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEec
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 416 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~ 416 (688)
++|...+.||+|+||.||+|... +..||||.+...... ....+.+|+.++.+++||||+++++++. +..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46888899999999999999875 788999998755432 3346788999999999999999999984 458899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCC
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~ 496 (688)
+++ +|...+.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 86 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDCG--NIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 985 7777775543 35788999999999999999999965 99999999999999999999999999976533221
Q ss_pred cCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHH---HHhh-cCc-----cccc-
Q 005617 497 YLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR---RAVS-CGK-----LSSI- 565 (688)
Q Consensus 497 ~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~---~~~~-~g~-----l~~~- 565 (688)
......||+.|+|||++.+ ..++.++|||||||++|+|+||++||....... .... .+. ...+
T Consensus 160 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (309)
T cd07872 160 ------TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGIS 233 (309)
T ss_pred ------ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhc
Confidence 1234568999999998865 568999999999999999999999996433211 0000 000 0000
Q ss_pred -------cC-CC-----CCCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 566 -------LD-PL-----AGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 566 -------ld-~~-----~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
.+ +. ........+..+.+|+.+|++.||.+|||+.+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 284 (309)
T cd07872 234 SNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAM 284 (309)
T ss_pred chhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHh
Confidence 00 00 0001112456788999999999999999988544
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=328.34 Aligned_cols=247 Identities=23% Similarity=0.346 Sum_probs=191.3
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|...+.||+|+||.||++... +..||||++..... .....+..|+.++..++||||+++++++.+ ..+|||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888899999999999999885 78999999975432 234468889999999999999999999854 478999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ |+||||||+||||+.+|.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~~---~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMKK---DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 999999999998654 35788999999999999999999966 999999999999999999999999998755321
Q ss_pred CCcC-----------------------------CCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCC
Q 005617 495 TLYL-----------------------------PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRL 545 (688)
Q Consensus 495 ~~~~-----------------------------~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~ 545 (688)
.... .........+||+.|+|||++.+..++.++|||||||++|||+||+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 1000 00001224579999999999999999999999999999999999999
Q ss_pred CCCChhh--HHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCc
Q 005617 546 PVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 546 Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~ 600 (688)
||..... ....+......-.+ |. . ...+..+.+|+.+|+. ||.+|++..
T Consensus 235 Pf~~~~~~~~~~~i~~~~~~~~~-p~--~--~~~s~~~~~li~~l~~-~p~~R~~~~ 285 (360)
T cd05627 235 PFCSETPQETYRKVMNWKETLVF-PP--E--VPISEKAKDLILRFCT-DSENRIGSN 285 (360)
T ss_pred CCCCCCHHHHHHHHHcCCCceec-CC--C--CCCCHHHHHHHHHhcc-ChhhcCCCC
Confidence 9975433 22222211100000 10 0 1134567888888774 999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=323.45 Aligned_cols=253 Identities=29% Similarity=0.459 Sum_probs=198.2
Q ss_pred cCcccceeeeccCceEEEEEEE-------CCeEEEEEEEecCCcc-chHHHHHHHHHHHcC-CCCceeeEecccCC---C
Q 005617 342 CNFSESFKVGQGGFGCVYKGEM-------LGRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKL-QHPHLVTLLGACPE---A 409 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~-------~g~~vAIK~l~~~~~~-~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~---~ 409 (688)
++|...+.||+|+||.||+|.. .++.||||++...... ....+.+|+.++.++ +|||||+++++|.. .
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 4688889999999999999974 2578999999764432 334688999999999 68999999998843 4
Q ss_pred ceeEEecCCCCcHHHHhcccCC----------------------------------------------------------
Q 005617 410 WSLVYEYLPNGSLQDRLFRKSN---------------------------------------------------------- 431 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~~---------------------------------------------------------- 431 (688)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 6899999999999998864321
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCCccccC
Q 005617 432 ------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST 505 (688)
Q Consensus 432 ------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~~ 505 (688)
...++|..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++......... ....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~----~~~~ 239 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY----VRKG 239 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcch----hhcC
Confidence 124788999999999999999999965 999999999999999999999999999876432211 1122
Q ss_pred CCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh---hHHHHhhcCccccccCCCCCCCCHHHHHHH
Q 005617 506 APKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG---EVRRAVSCGKLSSILDPLAGDWPTFVARRL 581 (688)
Q Consensus 506 ~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~---~~~~~~~~g~l~~~ld~~~~~~~~~~~~~l 581 (688)
...+++.|+|||++.+..++.++|||||||++|+|++ |..||.... .....+..+.... .+......+
T Consensus 240 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~ 311 (343)
T cd05103 240 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR--------APDYTTPEM 311 (343)
T ss_pred CCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCC--------CCCCCCHHH
Confidence 3456778999999988999999999999999999997 999986432 2222222222111 111234578
Q ss_pred HHHHHHccccCCCCCCCCchHHHHHHHHh
Q 005617 582 VDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 582 ~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l 610 (688)
.+++.+||+.+|.+||++. ++++.|+.+
T Consensus 312 ~~~~~~cl~~~p~~Rps~~-eil~~l~~~ 339 (343)
T cd05103 312 YQTMLDCWHGEPSQRPTFS-ELVEHLGNL 339 (343)
T ss_pred HHHHHHHccCChhhCcCHH-HHHHHHHHH
Confidence 9999999999999999999 676777765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=315.35 Aligned_cols=259 Identities=26% Similarity=0.404 Sum_probs=195.8
Q ss_pred cCcccceeeeccCceEEEEEEEC------------------CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML------------------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTL 402 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~------------------g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l 402 (688)
++|...+.||+|+||.||++... +..||+|++..... .....|.+|+.++..++||||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56888899999999999998532 34689999875533 344679999999999999999999
Q ss_pred ecccC--CCceeEEecCCCCcHHHHhcccCC--------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCce
Q 005617 403 LGACP--EAWSLVYEYLPNGSLQDRLFRKSN--------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNI 472 (688)
Q Consensus 403 ~g~~~--~~~~LV~E~~~~gsL~~~L~~~~~--------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NI 472 (688)
++++. +..++||||+++|+|.+++..... ...+++..++.++.+++.||.|||+.+ |+|+||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 99984 458899999999999999875431 134788899999999999999999966 99999999999
Q ss_pred eeCCCCCeEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh--CCCCCCCh
Q 005617 473 LLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT--GRLPVGLA 550 (688)
Q Consensus 473 LLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt--G~~Pf~~~ 550 (688)
|++.++.++|+|||+++.+...... .......+++.|++||+...+.++.++|||||||++|||+| |..||...
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYY----RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcce----eccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 9999999999999999865433211 11223345678999999888899999999999999999998 77888643
Q ss_pred hhHHHHhhcCcccccc-CCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHH
Q 005617 551 GEVRRAVSCGKLSSIL-DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 551 ~~~~~~~~~g~l~~~l-d~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le 608 (688)
.........+...... .......+...+..+.+|+.+||+.||.+||++. ++.+.|+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~-~i~~~l~ 295 (296)
T cd05095 238 SDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQ-EIHATLL 295 (296)
T ss_pred ChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHH-HHHHHHh
Confidence 2211110001000000 0000011223446889999999999999999998 5655554
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=325.47 Aligned_cols=248 Identities=23% Similarity=0.265 Sum_probs=191.4
Q ss_pred HhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC--ccchHHHHHHHHHHHcCCCCceeeEecccCC-------
Q 005617 340 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE------- 408 (688)
Q Consensus 340 at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~--~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~------- 408 (688)
..++|...+.||+|+||.||++... +..||||++.... ......+.+|+.+++.++||||+++++++..
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4578999999999999999999875 7889999987543 2334568899999999999999999988732
Q ss_pred -CceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCc
Q 005617 409 -AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 487 (688)
Q Consensus 409 -~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGl 487 (688)
..++||||+++ +|.+.+. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 25899999975 5666553 24788899999999999999999965 99999999999999999999999999
Q ss_pred cccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHH--Hhhc--C---
Q 005617 488 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR--AVSC--G--- 560 (688)
Q Consensus 488 a~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~--~~~~--g--- 560 (688)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||........ .+.. +
T Consensus 173 a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (364)
T cd07875 173 ARTAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245 (364)
T ss_pred ccccCCCC-------cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 98654322 12345789999999999999999999999999999999999999965432111 0000 0
Q ss_pred -------------------cc---------ccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 561 -------------------KL---------SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 561 -------------------~l---------~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
.. ...+-+.....+......+.+|+.+|++.||.+|||+.+.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L 316 (364)
T cd07875 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316 (364)
T ss_pred HHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHh
Confidence 00 00000000111112345789999999999999999998544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=312.03 Aligned_cols=249 Identities=23% Similarity=0.281 Sum_probs=191.6
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEec
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 416 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~ 416 (688)
+|...+.||.|+||.||+|... |..||||.+..... .....+.+|+.++..++||||+++++++. ...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4777889999999999999885 78999999865432 23456889999999999999999999985 357899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCC
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~ 496 (688)
+. ++|.+++........+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 688888765544457899999999999999999999965 99999999999999999999999999976543221
Q ss_pred cCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhc----Ccc---------
Q 005617 497 YLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC----GKL--------- 562 (688)
Q Consensus 497 ~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~----g~l--------- 562 (688)
......|++.|+|||++.+. .++.++|||||||++|+|+||++||............ +..
T Consensus 157 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (285)
T cd07861 157 ------VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVT 230 (285)
T ss_pred ------cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcch
Confidence 12344678999999988654 5789999999999999999999999754322111100 000
Q ss_pred -----ccccC----CCCCCCCHHHHHHHHHHHHHccccCCCCCCCCch
Q 005617 563 -----SSILD----PLAGDWPTFVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 563 -----~~~ld----~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~ 601 (688)
...++ ..........+..+.+|+.+||+.||.+|||+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ 278 (285)
T cd07861 231 SLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKK 278 (285)
T ss_pred hhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHH
Confidence 00000 0000011124567889999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=354.88 Aligned_cols=254 Identities=23% Similarity=0.313 Sum_probs=198.5
Q ss_pred HHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC----C
Q 005617 338 QTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE----A 409 (688)
Q Consensus 338 ~~at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~----~ 409 (688)
....++|.....||.|+||+||++... +..||+|.+..... .....|..|+.+|..|+|||||+++++|.+ .
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 344578999999999999999999886 67899999876533 234568999999999999999999998732 3
Q ss_pred ceeEEecCCCCcHHHHhcccC-CCCCCCHHHHHHHHHHHHHHHHHHhccCC----CceEeCCCCCCceeeCC--------
Q 005617 410 WSLVYEYLPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKP----EKIVHGDLKPQNILLDS-------- 476 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~----~~IiHrDIKp~NILLd~-------- 476 (688)
++|||||+++|+|.++|.... ....+++..++.|+.||+.||.|||..++ ++||||||||+||||+.
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 789999999999999987532 23568999999999999999999998652 45999999999999964
Q ss_pred ---------CCCeEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhcc--CCCCCcchHhHHHHHHHHHHhCCC
Q 005617 477 ---------ELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT--GVLTPKSDSYSFGLIILQLLTGRL 545 (688)
Q Consensus 477 ---------~~~vKLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDVwSfGviL~ELltG~~ 545 (688)
.+.+||+|||++..+.... ......||+.|+|||++.. ..+++++||||||||||||+||+.
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s-------~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~ 241 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGIES-------MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT 241 (1021)
T ss_pred cccccccCCCCceEEccCCccccccccc-------cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC
Confidence 3458999999998764322 1234579999999999854 458999999999999999999999
Q ss_pred CCCChhhHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHH
Q 005617 546 PVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 604 (688)
Q Consensus 546 Pf~~~~~~~~~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~ 604 (688)
||.........+..-. ...+... ...+..+.+|+..||+.+|.+||++.+.+.
T Consensus 242 PF~~~~~~~qli~~lk--~~p~lpi----~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 242 PFHKANNFSQLISELK--RGPDLPI----KGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCCcCCcHHHHHHHHh--cCCCCCc----CCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 9975443222211100 0000001 123567899999999999999999986553
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=307.29 Aligned_cols=244 Identities=30% Similarity=0.449 Sum_probs=195.7
Q ss_pred eeeccCceEEEEEEEC---C--eEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC-CceeEEecCCCCc
Q 005617 349 KVGQGGFGCVYKGEML---G--RTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYEYLPNGS 421 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~---g--~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV~E~~~~gs 421 (688)
.||+|+||.||+|.+. + ..||||.+..... .....|.+|+.++++++||||+++++++.+ ..++||||+++|+
T Consensus 2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~ 81 (257)
T cd05040 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLGS 81 (257)
T ss_pred cCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCCc
Confidence 5899999999999874 2 3699999987766 455679999999999999999999998754 5789999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCCc
Q 005617 422 LQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 501 (688)
Q Consensus 422 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~~ 501 (688)
|.+.+..... ..++|..+..++.|++.||.|||..+ ++|+||||+||+++.++.+||+|||+++.+...... .
T Consensus 82 L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~---~ 154 (257)
T cd05040 82 LLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH---Y 154 (257)
T ss_pred HHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccc---e
Confidence 9999876543 56899999999999999999999965 999999999999999999999999999887543211 1
Q ss_pred cccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhhH--HHHhhcCccccccCCCCCCCCHHHH
Q 005617 502 HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEV--RRAVSCGKLSSILDPLAGDWPTFVA 578 (688)
Q Consensus 502 ~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~~--~~~~~~g~l~~~ld~~~~~~~~~~~ 578 (688)
.......++..|+|||++.+..++.++|||||||++|||+| |..||...... ...+... . .....+...+
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~------~~~~~~~~~~ 227 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKE-G------ERLERPEACP 227 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc-C------CcCCCCccCC
Confidence 11234567889999999999999999999999999999999 99999643322 1222110 0 0111222345
Q ss_pred HHHHHHHHHccccCCCCCCCCchHHHHHH
Q 005617 579 RRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 579 ~~l~~L~~~Cl~~dP~~RPs~~~~l~~~L 607 (688)
..+.+++.+|++.+|.+||++. .+...|
T Consensus 228 ~~~~~li~~~l~~~p~~Rps~~-~~~~~l 255 (257)
T cd05040 228 QDIYNVMLQCWAHNPADRPTFA-ALREFL 255 (257)
T ss_pred HHHHHHHHHHCCCCcccCCCHH-HHHHHh
Confidence 6899999999999999999998 454443
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=314.31 Aligned_cols=241 Identities=26% Similarity=0.383 Sum_probs=188.8
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC-ccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEecC
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 417 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~-~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~ 417 (688)
+|.....||+|+||.||+|... +..||||++.... ......|.+|+.++.+++||||++++++|. +..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 5667789999999999999874 7889999987543 233456899999999999999999999984 4578999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCc
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~ 497 (688)
++|+|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.++|+|||++.......
T Consensus 82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~-- 149 (279)
T cd06619 82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI-- 149 (279)
T ss_pred CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccccc--
Confidence 999996542 4678889999999999999999965 9999999999999999999999999998654322
Q ss_pred CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHh-hcCccccccCCCCCCC-CH
Q 005617 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAV-SCGKLSSILDPLAGDW-PT 575 (688)
Q Consensus 498 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~-~~g~l~~~ld~~~~~~-~~ 575 (688)
.....||..|+|||++.+..++.++|||||||++|+|++|+.||.......... ..+....+.+...... ..
T Consensus 150 ------~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (279)
T cd06619 150 ------AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVG 223 (279)
T ss_pred ------ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCC
Confidence 234579999999999999999999999999999999999999996322100000 0000000001100111 11
Q ss_pred HHHHHHHHHHHHccccCCCCCCCCch
Q 005617 576 FVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 576 ~~~~~l~~L~~~Cl~~dP~~RPs~~~ 601 (688)
..+..+.+++.+|++.+|..||++.+
T Consensus 224 ~~~~~~~~li~~~l~~~P~~Rp~~~e 249 (279)
T cd06619 224 QFSEKFVHFITQCMRKQPKERPAPEN 249 (279)
T ss_pred cCCHHHHHHHHHHhhCChhhCCCHHH
Confidence 23457899999999999999999874
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-36 Score=316.17 Aligned_cols=253 Identities=27% Similarity=0.416 Sum_probs=200.8
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCc-cchHHHHHHHHHHHcC-CCCceeeEecccCC--
Q 005617 340 ATCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE-- 408 (688)
Q Consensus 340 at~~f~~~~~LG~G~fG~Vykg~~~-------g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~-- 408 (688)
..++|...+.||+|+||.||+|... +..||||+++.... .....|.+|+.+++++ +||||++++++|..
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 112 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG 112 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence 3467889999999999999999752 45799999876533 2345689999999999 79999999999843
Q ss_pred CceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCcc
Q 005617 409 AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 488 (688)
Q Consensus 409 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla 488 (688)
..++||||+++|+|.+++..... ..+++..+..++.+++.||.|||+.+ |+|+||||+|||++.++.++|+|||++
T Consensus 113 ~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~ 188 (302)
T cd05055 113 PILVITEYCCYGDLLNFLRRKRE-SFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLA 188 (302)
T ss_pred ceEEEEEcCCCCcHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccc
Confidence 57899999999999999865432 34899999999999999999999965 999999999999999999999999999
Q ss_pred ccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh---HHHHhhcCcccc
Q 005617 489 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE---VRRAVSCGKLSS 564 (688)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~---~~~~~~~g~l~~ 564 (688)
+........ .......++..|+|||++....++.++|||||||++|||+| |..||..... ....+..+..
T Consensus 189 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~-- 262 (302)
T cd05055 189 RDIMNDSNY----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYR-- 262 (302)
T ss_pred ccccCCCce----eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCc--
Confidence 866443211 11223456788999999999999999999999999999998 9999864332 2222222211
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHH
Q 005617 565 ILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 565 ~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~ 609 (688)
...+...+..+.+++.+||+.+|++||++. +++..|+.
T Consensus 263 ------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~-ell~~l~~ 300 (302)
T cd05055 263 ------MAQPEHAPAEIYDIMKTCWDADPLKRPTFK-QIVQLIGK 300 (302)
T ss_pred ------CCCCCCCCHHHHHHHHHHcCCCchhCcCHH-HHHHHHHh
Confidence 011223456799999999999999999999 66666664
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=314.09 Aligned_cols=246 Identities=27% Similarity=0.381 Sum_probs=195.8
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC-ccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEecC
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 417 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~-~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~ 417 (688)
+|...+.||+|+||.||++... |..||+|.+.... ......+.+|+.++.+++||||+++++++. ...++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5677789999999999999986 8899999987542 233457889999999999999999999884 4578999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCc
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~ 497 (688)
++++|..++........+++..+..++.+++.||.|||+.. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-- 157 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-- 157 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc--
Confidence 99999988876433457899999999999999999999742 49999999999999999999999999997654322
Q ss_pred CCCccccCCCCCCCCCCChhhhccCC------CCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCC
Q 005617 498 LPSFHRSTAPKGSFPYADPEYHRTGV------LTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPL 569 (688)
Q Consensus 498 ~~~~~~~~~~~GT~~Y~APE~~~~~~------~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~ 569 (688)
.....|++.|+|||++.+.. ++.++|||||||++|+|++|+.||..... ....+ ..+.+..
T Consensus 158 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~-----~~~~~~~ 226 (286)
T cd06622 158 ------AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL-----SAIVDGD 226 (286)
T ss_pred ------cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHH-----HHHhhcC
Confidence 23456889999999885543 58899999999999999999999964322 11111 1111111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 570 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 570 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
....+..+...+.+++.+||+.+|.+||++.+.+
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~ 260 (286)
T cd06622 227 PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLL 260 (286)
T ss_pred CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHh
Confidence 1233445677899999999999999999987433
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=308.72 Aligned_cols=247 Identities=27% Similarity=0.382 Sum_probs=186.6
Q ss_pred eeeccCceEEEEEEEC----CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecCCCCc
Q 005617 349 KVGQGGFGCVYKGEML----GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGS 421 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~----g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gs 421 (688)
.||+|+||.||+|... +..+|+|.+..... .....|.+|+.++..++||||++++|+|.+ ..++||||+++|+
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 5899999999999864 35799998876543 334578899999999999999999999854 4789999999999
Q ss_pred HHHHhcccC--CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCC
Q 005617 422 LQDRLFRKS--NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 422 L~~~L~~~~--~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~ 499 (688)
|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~-- 156 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY-- 156 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCccee--
Confidence 999987543 2234677888899999999999999965 999999999999999999999999999765432211
Q ss_pred CccccCCCCCCCCCCChhhhccC-------CCCCcchHhHHHHHHHHHHh-CCCCCCChhhHH--HHhhcCccccccCCC
Q 005617 500 SFHRSTAPKGSFPYADPEYHRTG-------VLTPKSDSYSFGLIILQLLT-GRLPVGLAGEVR--RAVSCGKLSSILDPL 569 (688)
Q Consensus 500 ~~~~~~~~~GT~~Y~APE~~~~~-------~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~~~--~~~~~g~l~~~ld~~ 569 (688)
.......|++.|+|||++... .++.++|||||||++|||++ |..||....... .....+......++.
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (269)
T cd05087 157 --VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPR 234 (269)
T ss_pred --ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCc
Confidence 112345678899999988532 35889999999999999996 999996543221 111111111121221
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHH
Q 005617 570 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 570 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~L 607 (688)
........+.+++..|+ .+|.+||++. +|+..|
T Consensus 235 ---~~~~~~~~~~~l~~~c~-~~P~~Rpt~~-~l~~~l 267 (269)
T cd05087 235 ---LKLPLSDRWYEVMQFCW-LQPEQRPSAE-EVHLLL 267 (269)
T ss_pred ---cCCCCChHHHHHHHHHh-cCcccCCCHH-HHHHHh
Confidence 11123456788999998 6899999998 555544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=304.90 Aligned_cols=248 Identities=26% Similarity=0.340 Sum_probs=200.6
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEecC
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 417 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~ 417 (688)
++|.....||.|+||.||+|... +..+++|.+..........+.+|+.++++++||||++++|++. +..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888899999999999999875 6889999998766566678999999999999999999999884 3578999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCc
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~ 497 (688)
++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.......
T Consensus 83 ~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-- 155 (262)
T cd06613 83 GGGSLQDIYQVTR--GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-- 155 (262)
T ss_pred CCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh--
Confidence 9999999886542 35889999999999999999999966 9999999999999999999999999998764322
Q ss_pred CCCccccCCCCCCCCCCChhhhccC---CCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCccccccCCCCCCCC
Q 005617 498 LPSFHRSTAPKGSFPYADPEYHRTG---VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWP 574 (688)
Q Consensus 498 ~~~~~~~~~~~GT~~Y~APE~~~~~---~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~l~~~ld~~~~~~~ 574 (688)
.......|+..|+|||.+... .++.++|||||||++|+|+||++||.............. ..+.+.....+
T Consensus 156 ----~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~--~~~~~~~~~~~ 229 (262)
T cd06613 156 ----AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK--SNFPPPKLKDK 229 (262)
T ss_pred ----hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCCCccccch
Confidence 122345789999999998776 889999999999999999999999975443222211110 00111111223
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCCchH
Q 005617 575 TFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 575 ~~~~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
...+..+.+++.+||..+|.+||++.+.
T Consensus 230 ~~~~~~~~~li~~~l~~~p~~Rpt~~~i 257 (262)
T cd06613 230 EKWSPVFHDFIKKCLTKDPKKRPTATKL 257 (262)
T ss_pred hhhhHHHHHHHHHHcCCChhhCCCHHHH
Confidence 3456789999999999999999999743
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=305.65 Aligned_cols=250 Identities=34% Similarity=0.501 Sum_probs=201.1
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecC
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 417 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~-g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~ 417 (688)
.++|...+.||.|+||.||+|.+. +..||||.+..... ....+.+|+.++++++||||+++++++.. ..++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 467888899999999999999876 57799999875443 45679999999999999999999999854 588999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCc
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~ 497 (688)
++++|.+++.... ...+++..+..++.+++.||.|||..+ |+|+||||+||+++.++.+||+|||++........
T Consensus 84 ~~~~L~~~i~~~~-~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (261)
T cd05034 84 SKGSLLDFLKSGE-GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEY- 158 (261)
T ss_pred CCCCHHHHHhccc-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhh-
Confidence 9999999997643 246899999999999999999999976 99999999999999999999999999987653221
Q ss_pred CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHHHhhcCccccccCCCCCCCC
Q 005617 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWP 574 (688)
Q Consensus 498 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~ 574 (688)
.......++..|+|||.+.+..+++++|||||||++|+|+| |+.||..... ....+..+. . ...+
T Consensus 159 ----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~-~-------~~~~ 226 (261)
T cd05034 159 ----TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGY-R-------MPRP 226 (261)
T ss_pred ----hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-C-------CCCC
Confidence 11123345678999999999999999999999999999999 9999965332 222222111 0 0112
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHH
Q 005617 575 TFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 575 ~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~ 609 (688)
...+..+.+++.+|++.+|.+||++. .+...|+.
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rp~~~-~l~~~l~~ 260 (261)
T cd05034 227 PNCPEELYDLMLQCWDKDPEERPTFE-YLQSFLED 260 (261)
T ss_pred CCCCHHHHHHHHHHcccCcccCCCHH-HHHHHHhc
Confidence 22356789999999999999999998 67666653
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=312.25 Aligned_cols=251 Identities=27% Similarity=0.410 Sum_probs=197.1
Q ss_pred cCcccceeeeccCceEEEEEEE------CCeEEEEEEEecCC-ccchHHHHHHHHHHHcCCCCceeeEecccCC----Cc
Q 005617 342 CNFSESFKVGQGGFGCVYKGEM------LGRTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE----AW 410 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~------~g~~vAIK~l~~~~-~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~----~~ 410 (688)
..|...+.||+|+||.||++.. .+..||+|.++... ......|.+|+.+++.++||||++++++|.+ ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467788999999999999974 26789999987553 2334579999999999999999999998843 36
Q ss_pred eeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCcccc
Q 005617 411 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~ 490 (688)
++||||+++++|.+++.... ..++|..++.++.+++.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~--~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNK--NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 89999999999999986543 35899999999999999999999965 99999999999999999999999999987
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhH-----------------
Q 005617 491 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV----------------- 553 (688)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~----------------- 553 (688)
........ .......|+..|+|||++.+..++.++|||||||++|||+||+.|+......
T Consensus 159 ~~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd05079 159 IETDKEYY---TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRL 235 (284)
T ss_pred cccCccce---eecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHH
Confidence 65432211 1123455778899999999889999999999999999999988765321110
Q ss_pred HHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHH
Q 005617 554 RRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 554 ~~~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~ 609 (688)
...+..+.. ...+...+..+.+|+.+||+.+|.+||++. .++..|+.
T Consensus 236 ~~~~~~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~-~il~~l~~ 282 (284)
T cd05079 236 VRVLEEGKR--------LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQ-NLIEGFEA 282 (284)
T ss_pred HHHHHcCcc--------CCCCCCCCHHHHHHHHHHccCCcccCcCHH-HHHHHHHh
Confidence 001111110 111223567899999999999999999998 66666664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=315.65 Aligned_cols=245 Identities=26% Similarity=0.366 Sum_probs=199.9
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecC
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 417 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~ 417 (688)
.+|...+.||.|+||.||+|... |..||||.+..........+.+|+.+++.++||||++++++|.. ..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 67888899999999999999874 88999999987666666778999999999999999999999843 578999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCc
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~ 497 (688)
++++|.+++.. ..+++..+..++.+++.||.|||+.+ |+||||||+|||++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~- 170 (297)
T cd06656 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (297)
T ss_pred CCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc-
Confidence 99999998854 34788999999999999999999965 99999999999999999999999999986543321
Q ss_pred CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCccccccCCCCCCCCHHH
Q 005617 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFV 577 (688)
Q Consensus 498 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~l~~~ld~~~~~~~~~~ 577 (688)
......|++.|+|||.+.+..++.++|||||||++|+|++|+.||............... .......+...
T Consensus 171 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~----~~~~~~~~~~~ 241 (297)
T cd06656 171 -----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN----GTPELQNPERL 241 (297)
T ss_pred -----CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccC----CCCCCCCcccc
Confidence 123456899999999999999999999999999999999999999654432211111000 00011223345
Q ss_pred HHHHHHHHHHccccCCCCCCCCchHH
Q 005617 578 ARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 578 ~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
...+.+|+.+||..+|.+||++.+.+
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il 267 (297)
T cd06656 242 SAVFRDFLNRCLEMDVDRRGSAKELL 267 (297)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHh
Confidence 66788999999999999999998544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=308.58 Aligned_cols=243 Identities=29% Similarity=0.454 Sum_probs=190.0
Q ss_pred eeeccCceEEEEEEEC--Ce--EEEEEEEecCC-ccchHHHHHHHHHHHcC-CCCceeeEecccCC--CceeEEecCCCC
Q 005617 349 KVGQGGFGCVYKGEML--GR--TVAIKMLYSHN-MQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWSLVYEYLPNG 420 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~--g~--~vAIK~l~~~~-~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~~~LV~E~~~~g 420 (688)
.||+|+||.||+|.+. |. .+|+|.++... ......|.+|+.++.++ +||||++++++|.. ..++||||+++|
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 81 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHG 81 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCC
Confidence 5899999999999885 33 47888887543 23445788999999999 89999999999854 478999999999
Q ss_pred cHHHHhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCc
Q 005617 421 SLQDRLFRKS-------------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 487 (688)
Q Consensus 421 sL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGl 487 (688)
+|.+++.... ....+++..+..++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||+
T Consensus 82 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 82 NLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred cHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCCC
Confidence 9999986542 1235789999999999999999999965 99999999999999999999999999
Q ss_pred cccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHHHhhcCcccc
Q 005617 488 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSS 564 (688)
Q Consensus 488 a~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~~~~g~l~~ 564 (688)
+....... ......+++.|+|||++....++.++|||||||++|||++ |..||..... ....+..+..
T Consensus 159 ~~~~~~~~-------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~-- 229 (270)
T cd05047 159 SRGQEVYV-------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR-- 229 (270)
T ss_pred ccccchhh-------hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCC--
Confidence 86432111 1122334678999999998899999999999999999997 9999964322 2222222111
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHh
Q 005617 565 ILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 565 ~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l 610 (688)
.+.+......+.+|+.+|+..+|.+||++. +++..|+.+
T Consensus 230 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~il~~l~~~ 268 (270)
T cd05047 230 ------LEKPLNCDDEVYDLMRQCWREKPYERPSFA-QILVSLNRM 268 (270)
T ss_pred ------CCCCCcCCHHHHHHHHHHcccChhhCCCHH-HHHHHHHHh
Confidence 112223456789999999999999999999 666666543
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=306.17 Aligned_cols=250 Identities=28% Similarity=0.439 Sum_probs=201.1
Q ss_pred hcCcccceeeeccCceEEEEEEEC-CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC-CceeEEecCC
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYEYLP 418 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~-g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV~E~~~ 418 (688)
..+|...+.||+|+||.||+|.+. +..||+|.+.... .....|.+|+.+++.++|+||+++++++.+ ..++||||++
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~~ 83 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMA 83 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeCC
Confidence 356788899999999999999875 6779999887543 234578899999999999999999998754 4689999999
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcC
Q 005617 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~ 498 (688)
+|+|.+++.... ...+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||++.........
T Consensus 84 ~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~- 158 (260)
T cd05073 84 KGSLLDFLKSDE-GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT- 158 (260)
T ss_pred CCcHHHHHHhCC-ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc-
Confidence 999999987643 245789999999999999999999865 999999999999999999999999999876433211
Q ss_pred CCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHHHhhcCccccccCCCCCCCCH
Q 005617 499 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPT 575 (688)
Q Consensus 499 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~~ 575 (688)
......++..|+|||++..+.++.++|||||||++|+|+| |..||..... ....+..+... ..+.
T Consensus 159 ----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~ 226 (260)
T cd05073 159 ----AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM--------PRPE 226 (260)
T ss_pred ----cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC--------CCcc
Confidence 1223446778999999998899999999999999999999 9999975432 23333222111 1122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCCchHHHHHHHH
Q 005617 576 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609 (688)
Q Consensus 576 ~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~ 609 (688)
..+..+.+++.+|++.+|.+||++. .+...|+.
T Consensus 227 ~~~~~~~~~i~~~l~~~p~~Rp~~~-~l~~~L~~ 259 (260)
T cd05073 227 NCPEELYNIMMRCWKNRPEERPTFE-YIQSVLDD 259 (260)
T ss_pred cCCHHHHHHHHHHcccCcccCcCHH-HHHHHHhc
Confidence 3456789999999999999999998 77777764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=312.30 Aligned_cols=244 Identities=23% Similarity=0.318 Sum_probs=195.6
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEecC
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 417 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~ 417 (688)
++|...+.||.|+||.||+|... +..||+|.+..........+.+|+.+++.++||||++++++|. ...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 46777889999999999999885 7889999998766556677899999999999999999999873 4588999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCc
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~ 497 (688)
++++|..++.... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 92 ~~~~l~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-- 164 (292)
T cd06644 92 PGGAVDAIMLELD--RGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-- 164 (292)
T ss_pred CCCcHHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc--
Confidence 9999988875543 45899999999999999999999965 9999999999999999999999999987543221
Q ss_pred CCCccccCCCCCCCCCCChhhhc-----cCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHH--hhcCccccccCCCC
Q 005617 498 LPSFHRSTAPKGSFPYADPEYHR-----TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VSCGKLSSILDPLA 570 (688)
Q Consensus 498 ~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~--~~~g~l~~~ld~~~ 570 (688)
.......|++.|+|||++. ...++.++|||||||++|||++|.+||......... +..+....
T Consensus 165 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~------ 234 (292)
T cd06644 165 ----QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT------ 234 (292)
T ss_pred ----cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCcc------
Confidence 1223456889999999884 345788999999999999999999999654332211 11111111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCCchH
Q 005617 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 571 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
...+...+..+.+++.+||+.+|.+||++.+.
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i 266 (292)
T cd06644 235 LSQPSKWSMEFRDFLKTALDKHPETRPSAAQL 266 (292)
T ss_pred CCCCcccCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 11223445678999999999999999998743
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=306.29 Aligned_cols=243 Identities=23% Similarity=0.308 Sum_probs=197.4
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC-ccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecC
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 417 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~-~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~ 417 (688)
+|...+.||.|+||.||++... +..||+|.+.... ......+.+|+.+++.++||||+++++++.+ ..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677889999999999999875 7889999986543 2344568899999999999999999999854 578999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCc
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~ 497 (688)
++|+|.+++.... ...+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQR-GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 9999999886432 245788999999999999999999966 99999999999999999999999999986643221
Q ss_pred CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhH--HHHhhcCccccccCCCCCCCCH
Q 005617 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGDWPT 575 (688)
Q Consensus 498 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~~~~g~l~~~ld~~~~~~~~ 575 (688)
......|++.|+|||++....++.++||||||+++|+|++|..||...... ...+..+... ..+.
T Consensus 156 -----~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~~~~ 222 (255)
T cd08219 156 -----YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK--------PLPS 222 (255)
T ss_pred -----ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC--------CCCc
Confidence 123456899999999999889999999999999999999999999754432 2222222221 1223
Q ss_pred HHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 576 FVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 576 ~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
..+..+.+|+.+||+.||.+||++.+.+
T Consensus 223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il 250 (255)
T cd08219 223 HYSYELRSLIKQMFKRNPRSRPSATTIL 250 (255)
T ss_pred ccCHHHHHHHHHHHhCCcccCCCHHHHh
Confidence 3456788999999999999999998433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=312.31 Aligned_cols=245 Identities=24% Similarity=0.315 Sum_probs=198.4
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecC
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 417 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~ 417 (688)
++|.....||.|+||.||+|... +..||+|++..........|..|+.++++++||||+++++++.. ..++||||+
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFC 84 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeecc
Confidence 56888889999999999999885 78899999987665666779999999999999999999999843 478999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCc
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~ 497 (688)
++++|.+++.... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~~~~~~--~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~- 158 (280)
T cd06611 85 DGGALDSIMLELE--RGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ- 158 (280)
T ss_pred CCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence 9999999886543 46899999999999999999999976 99999999999999999999999999876543221
Q ss_pred CCCccccCCCCCCCCCCChhhhc-----cCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHH--hhcCccccccCCCC
Q 005617 498 LPSFHRSTAPKGSFPYADPEYHR-----TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VSCGKLSSILDPLA 570 (688)
Q Consensus 498 ~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~--~~~g~l~~~ld~~~ 570 (688)
......||+.|+|||++. ...++.++|||||||++|+|++|+.||......... +..+....
T Consensus 159 -----~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------ 227 (280)
T cd06611 159 -----KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPT------ 227 (280)
T ss_pred -----ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCC------
Confidence 223456899999999874 345778999999999999999999999755432221 11111110
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 571 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
...+...+..+.+++.+||+.+|.+||++.+.+
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 260 (280)
T cd06611 228 LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELL 260 (280)
T ss_pred cCCcccCCHHHHHHHHHHhccChhhCcCHHHHh
Confidence 112233456788999999999999999988543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-36 Score=308.94 Aligned_cols=244 Identities=23% Similarity=0.315 Sum_probs=194.1
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEecC
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 417 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~ 417 (688)
++|...+.||+|+||.||+|... +..||+|.++.........+.+|+.++..++||||+++++++. +..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46777888999999999999874 7889999998765555566889999999999999999999884 4578999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCc
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~ 497 (688)
++++|.+++... ..+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 89 ~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06645 89 GGGSLQDIYHVT---GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-- 160 (267)
T ss_pred CCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence 999999988654 35889999999999999999999976 9999999999999999999999999987664322
Q ss_pred CCCccccCCCCCCCCCCChhhhc---cCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHH--hhcCccccccCCCCCC
Q 005617 498 LPSFHRSTAPKGSFPYADPEYHR---TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VSCGKLSSILDPLAGD 572 (688)
Q Consensus 498 ~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~--~~~g~l~~~ld~~~~~ 572 (688)
.......|++.|+|||++. ...++.++|||||||++|+|++|..||......... ....... +....
T Consensus 161 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~----~~~~~ 232 (267)
T cd06645 161 ----AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQ----PPKLK 232 (267)
T ss_pred ----cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCC----CCccc
Confidence 1224457999999999874 456889999999999999999999998543321111 1111111 10000
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCCch
Q 005617 573 WPTFVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 573 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~ 601 (688)
.....+..+.+++.+|+..+|.+||++.+
T Consensus 233 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~ 261 (267)
T cd06645 233 DKMKWSNSFHHFVKMALTKNPKKRPTAEK 261 (267)
T ss_pred ccCCCCHHHHHHHHHHccCCchhCcCHHH
Confidence 01123456889999999999999999873
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=314.24 Aligned_cols=248 Identities=25% Similarity=0.344 Sum_probs=194.1
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEec
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 416 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~ 416 (688)
++|...+.||+|+||.||++... |..||+|.+..... .....+.+|+.++.+++||||++++++|. +..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888899999999999999885 77899998875432 23456889999999999999999999984 458899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCC
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~ 496 (688)
+++++|.+++... ..+++..+..++.|++.||.|||+.. +++|+||||+|||++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 154 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM- 154 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence 9999999998654 45788999999999999999999842 49999999999999999999999999987654321
Q ss_pred cCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhH--HHHhhcCccccccC-------
Q 005617 497 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILD------- 567 (688)
Q Consensus 497 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~~~~g~l~~~ld------- 567 (688)
.....|++.|+|||++.+..++.++|||||||++|+|+||+.||...... ...+.. .......
T Consensus 155 -------~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 226 (308)
T cd06615 155 -------ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGR-PVSEGEAKESHRPV 226 (308)
T ss_pred -------cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcC-ccccccccCCcccc
Confidence 23457899999999998888999999999999999999999998533211 111100 0000000
Q ss_pred ----------------------CCCCCCC-HHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 568 ----------------------PLAGDWP-TFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 568 ----------------------~~~~~~~-~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
......+ ......+.+|+.+||..+|++||++.+.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll 285 (308)
T cd06615 227 SGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELT 285 (308)
T ss_pred cCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 0000000 12455789999999999999999988433
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=309.18 Aligned_cols=241 Identities=27% Similarity=0.342 Sum_probs=197.3
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC-ccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEec
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~-~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
++|.....||.|+||.||+|... +..||+|.+.... ......+.+|+.+++.++||||+++++++.+ ..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 35777889999999999999885 7899999987654 3344568899999999999999999998854 47899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCC
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~ 496 (688)
+++++|.+++... ++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~~~~~----~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 81 CGGGSCLDLLKPG----KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eCCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 9999999998653 6899999999999999999999965 99999999999999999999999999988754321
Q ss_pred cCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHH--HHhhcCccccccCCCCCCCC
Q 005617 497 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSILDPLAGDWP 574 (688)
Q Consensus 497 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~--~~~~~g~l~~~ld~~~~~~~ 574 (688)
......|++.|+|||++.+..++.++|||||||++|+|+||+.||....... ..+..+.. + ..+
T Consensus 154 ------~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-----~---~~~ 219 (274)
T cd06609 154 ------KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP-----P---SLE 219 (274)
T ss_pred ------ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCC-----C---CCc
Confidence 2244578999999999999899999999999999999999999997543221 11111111 1 111
Q ss_pred HH-HHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 575 TF-VARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 575 ~~-~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
.. .+..+.+++.+||..+|++||++.+.+
T Consensus 220 ~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il 249 (274)
T cd06609 220 GNKFSKPFKDFVSLCLNKDPKERPSAKELL 249 (274)
T ss_pred ccccCHHHHHHHHHHhhCChhhCcCHHHHh
Confidence 11 456789999999999999999988443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=301.88 Aligned_cols=243 Identities=24% Similarity=0.311 Sum_probs=198.2
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC---CceeEEe
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE---AWSLVYE 415 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~---~~~LV~E 415 (688)
+|...+.||.|+||.||++... +..||+|.+..... .....+.+|+.++++++|||++++++.+.. ..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778899999999999999875 78899999875433 334568899999999999999999988742 2679999
Q ss_pred cCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCC
Q 005617 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~ 495 (688)
|+++++|.+++.... ...+++.++..++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQK-GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 999999999987542 246899999999999999999999966 9999999999999999999999999998764322
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCCCCCC
Q 005617 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 496 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~ 573 (688)
. ......|++.|+|||++.+..++.++|||||||++|+|++|+.||..... ....+..+.+. ..
T Consensus 157 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~--------~~ 222 (257)
T cd08223 157 D------MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP--------PM 222 (257)
T ss_pred C------ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC--------CC
Confidence 1 22345689999999999999999999999999999999999999975432 11222222221 22
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 574 PTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 574 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
+......+.+++.+|++.+|.+||++.+.+
T Consensus 223 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l 252 (257)
T cd08223 223 PKDYSPELGELIATMLSKRPEKRPSVKSIL 252 (257)
T ss_pred ccccCHHHHHHHHHHhccCcccCCCHHHHh
Confidence 334567899999999999999999988433
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-36 Score=310.45 Aligned_cols=242 Identities=27% Similarity=0.384 Sum_probs=195.8
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecC
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 417 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~ 417 (688)
.|+..+.||.|+||.||+|.+. +..||||.+..... .....+.+|+.++++++||||++++++|.. ..++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 3556678999999999999875 78899999875543 334568999999999999999999999854 488999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCc
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~ 497 (688)
++++|.+++.. ..+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 85 ~~~~L~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 85 GGGSALDLLKP----GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 99999998853 35789999999999999999999965 99999999999999999999999999987643221
Q ss_pred CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHH--HHhhcCccccccCCCCCCCCH
Q 005617 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSILDPLAGDWPT 575 (688)
Q Consensus 498 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~--~~~~~g~l~~~ld~~~~~~~~ 575 (688)
......|+..|+|||++.+..++.++|||||||++|||+||+.||....... ..+..+. ....+.
T Consensus 157 -----~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~--------~~~~~~ 223 (277)
T cd06642 157 -----KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNS--------PPTLEG 223 (277)
T ss_pred -----hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCC--------CCCCCc
Confidence 1233568999999999999999999999999999999999999986433211 1111111 112233
Q ss_pred HHHHHHHHHHHHccccCCCCCCCCchHHHH
Q 005617 576 FVARRLVDLGLQCCELYGRERPDITPSLVK 605 (688)
Q Consensus 576 ~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~ 605 (688)
..+..+.+++.+||+.+|.+||++.+.+.+
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 224 QYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred ccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 456678999999999999999999966544
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=315.03 Aligned_cols=255 Identities=27% Similarity=0.448 Sum_probs=201.5
Q ss_pred cCcccceeeeccCceEEEEEEEC---------CeEEEEEEEecCCc-cchHHHHHHHHHHHcC-CCCceeeEecccCC--
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML---------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE-- 408 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~---------g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~-- 408 (688)
.+|...+.||+|+||.||+|+.. +..||+|.+..... .....+..|+.++..+ +||||++++++|.+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46778899999999999999752 35699999875432 3345688999999999 69999999999854
Q ss_pred CceeEEecCCCCcHHHHhcccCC-------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeC
Q 005617 409 AWSLVYEYLPNGSLQDRLFRKSN-------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD 475 (688)
Q Consensus 409 ~~~LV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd 475 (688)
..++||||+++|+|.+++..... ...++|..+..++.|++.||.|||+.+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 47899999999999999865321 245899999999999999999999865 99999999999999
Q ss_pred CCCCeEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--h
Q 005617 476 SELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--E 552 (688)
Q Consensus 476 ~~~~vKLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~ 552 (688)
.++.+||+|||+++........ .......+++.|+|||++.+..++.++|||||||++|+|++ |..||.... .
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~ 244 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYY----KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE 244 (314)
T ss_pred CCCcEEEccccccccccccccc----cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999876432211 11122335568999999999999999999999999999999 889986433 2
Q ss_pred HHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHhhh
Q 005617 553 VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 553 ~~~~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l~~ 612 (688)
+...+..+... +.+...+..+.+|+.+||+.+|.+||++. .+...|..+..
T Consensus 245 ~~~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~~p~~Rps~~-~ll~~l~~~~~ 295 (314)
T cd05099 245 LFKLLREGHRM--------DKPSNCTHELYMLMRECWHAVPTQRPTFK-QLVEALDKVLA 295 (314)
T ss_pred HHHHHHcCCCC--------CCCCCCCHHHHHHHHHHcCCCcccCcCHH-HHHHHHHHHHH
Confidence 33333333211 12233456788999999999999999998 67788877654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=310.17 Aligned_cols=255 Identities=26% Similarity=0.355 Sum_probs=201.4
Q ss_pred cCHHHHHHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcC-CCCceeeEecccC-
Q 005617 332 FSLADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACP- 407 (688)
Q Consensus 332 ~~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~- 407 (688)
.++.++..+.+.|.....||.|+||.||+|... +..||+|++.... .....+..|+.++.++ +||||++++++|.
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 84 (282)
T cd06636 6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIK 84 (282)
T ss_pred hhhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhc
Confidence 466777778899999999999999999999985 7889999986543 2345688999999999 7999999999983
Q ss_pred -------CCceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCe
Q 005617 408 -------EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS 480 (688)
Q Consensus 408 -------~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~v 480 (688)
+..++||||+++|+|.+++..... ..+++..+..++.||+.||.|||+.+ |+|+||+|+||+++.++.+
T Consensus 85 ~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~ 160 (282)
T cd06636 85 KSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-NALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEV 160 (282)
T ss_pred ccccCCCCEEEEEEEeCCCCcHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCE
Confidence 236899999999999998865432 45788889999999999999999966 9999999999999999999
Q ss_pred EEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhc-----cCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHH
Q 005617 481 KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR-----TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR 555 (688)
Q Consensus 481 KLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~ 555 (688)
+|+|||++........ ......|++.|+|||.+. ...++.++|||||||++|||++|..||........
T Consensus 161 ~l~dfg~~~~~~~~~~------~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~ 234 (282)
T cd06636 161 KLVDFGVSAQLDRTVG------RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA 234 (282)
T ss_pred EEeeCcchhhhhcccc------CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh
Confidence 9999999886542211 123457999999999875 35688899999999999999999999965433222
Q ss_pred HhhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchH
Q 005617 556 AVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 556 ~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
....... ..+. ......+..+.+|+.+||+.||.+||++.+.
T Consensus 235 ~~~~~~~---~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~el 276 (282)
T cd06636 235 LFLIPRN---PPPK--LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQL 276 (282)
T ss_pred hhhHhhC---CCCC--CcccccCHHHHHHHHHHhCCChhhCcCHHHH
Confidence 2111110 0000 1112345679999999999999999998743
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=305.89 Aligned_cols=249 Identities=24% Similarity=0.309 Sum_probs=196.1
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccc--hHHHHHHHHHHHcCCCCceeeEecc----cCCCceeEE
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG--QLEFQQEVRVLSKLQHPHLVTLLGA----CPEAWSLVY 414 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~--~~~f~~E~~iL~~l~HpnIV~l~g~----~~~~~~LV~ 414 (688)
+|...+.|++|.||.||+|++. +..||+|+++...... ...-.+|+.+|.+++|||||.+-.+ -.+..||||
T Consensus 77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VM 156 (419)
T KOG0663|consen 77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVM 156 (419)
T ss_pred HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeH
Confidence 4566688999999999999986 7889999998664322 2245799999999999999998654 456799999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
|||+ .+|...+.... .+|...++.-+..|+++||.|||.+. |+||||||+|+|+.+.|.+||+|||+|+.+...
T Consensus 157 e~~E-hDLksl~d~m~--q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp 230 (419)
T KOG0663|consen 157 EYVE-HDLKSLMETMK--QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP 230 (419)
T ss_pred HHHH-hhHHHHHHhcc--CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCC
Confidence 9996 47877776654 57888999999999999999999987 999999999999999999999999999998765
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhc----CccccccCC-
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC----GKLSSILDP- 568 (688)
Q Consensus 495 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~----g~l~~~ld~- 568 (688)
.. ..+..+.|..|.|||.+.+. .|++.+|+||+|||+.||+++++-|.+..++.+.-.. |.-.+.+-|
T Consensus 231 ~k------~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg 304 (419)
T KOG0663|consen 231 LK------PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPG 304 (419)
T ss_pred cc------cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCC
Confidence 32 34677899999999987664 6999999999999999999999999766554332110 110110000
Q ss_pred -------------------CCCCCCHH-HHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 569 -------------------LAGDWPTF-VARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 569 -------------------~~~~~~~~-~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
..+.++.. .+..-++|+...+.+||.+|.|+.+.+
T Consensus 305 ~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L 359 (419)
T KOG0663|consen 305 YSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGL 359 (419)
T ss_pred ccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhh
Confidence 01111111 446778999999999999999998544
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=311.47 Aligned_cols=259 Identities=28% Similarity=0.442 Sum_probs=200.0
Q ss_pred CcccceeeeccCceEEEEEEEC------CeEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccCC----Cce
Q 005617 343 NFSESFKVGQGGFGCVYKGEML------GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE----AWS 411 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~------g~~vAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~----~~~ 411 (688)
.|...+.||+|+||.||+|.+. +..||||++...... ....|.+|+.+++.++||||+++++++.. ..+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4566688999999999999864 578999999766543 45679999999999999999999998854 478
Q ss_pred eEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccc
Q 005617 412 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~ 491 (688)
+||||+++++|.+++.... ..+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||++...
T Consensus 85 lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 9999999999999997643 35899999999999999999999965 999999999999999999999999999887
Q ss_pred cCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHH-h-------hcCccc
Q 005617 492 TEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA-V-------SCGKLS 563 (688)
Q Consensus 492 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~-~-------~~g~l~ 563 (688)
....... .......++..|++||++.+..++.++||||||+++|||+||..|+......... . ....+.
T Consensus 160 ~~~~~~~---~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd05038 160 PEDKDYY---YVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLL 236 (284)
T ss_pred ccCCcce---eccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHH
Confidence 6332211 1122334566799999999899999999999999999999999998532211000 0 000000
Q ss_pred cccCC-CCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHh
Q 005617 564 SILDP-LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 564 ~~ld~-~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l 610 (688)
..+.. .....+...+..+.+|+.+||+.+|.+||++. +++..|+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~-ei~~~l~~i 283 (284)
T cd05038 237 ELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFA-DLILIVDRL 283 (284)
T ss_pred HHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHH-HHHHHHhhc
Confidence 00100 00111223346799999999999999999998 677777654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=307.18 Aligned_cols=244 Identities=27% Similarity=0.442 Sum_probs=193.4
Q ss_pred eeeccCceEEEEEEECC--------eEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecC
Q 005617 349 KVGQGGFGCVYKGEMLG--------RTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 417 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~g--------~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~ 417 (688)
.||.|+||.||+|+... ..||||.+..... .....|.+|+.+++.++||||++++++|.. ..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 59999999999998742 5799998865432 345678999999999999999999998843 578999999
Q ss_pred CCCcHHHHhcccC----CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCC-----CeEEeecCcc
Q 005617 418 PNGSLQDRLFRKS----NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL-----SSKICDFGIC 488 (688)
Q Consensus 418 ~~gsL~~~L~~~~----~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~-----~vKLsDFGla 488 (688)
++|+|.+++.... ....++|..++.++.+++.||.|||+.+ ++|+||||+||+++.++ .++|+|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999986532 2235789999999999999999999865 99999999999999887 8999999999
Q ss_pred ccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhhH--HHHhhcCccccc
Q 005617 489 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEV--RRAVSCGKLSSI 565 (688)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~~--~~~~~~g~l~~~ 565 (688)
+........ .......++..|+|||++.++.++.++|||||||++|||+| |..||...... ...+..+..
T Consensus 159 ~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~--- 231 (269)
T cd05044 159 RDIYKSDYY----RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGR--- 231 (269)
T ss_pred ccccccccc----ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCc---
Confidence 866433211 11233456789999999999999999999999999999998 99998644322 222222111
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHH
Q 005617 566 LDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 566 ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le 608 (688)
...+...+..+.+++.+||..+|.+||++. .+.+.|+
T Consensus 232 -----~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~-~i~~~l~ 268 (269)
T cd05044 232 -----LQKPENCPDKIYQLMTNCWAQDPSERPTFD-RIQEILQ 268 (269)
T ss_pred -----cCCcccchHHHHHHHHHHcCCCcccCCCHH-HHHHHHh
Confidence 122334567889999999999999999998 5666554
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=325.69 Aligned_cols=246 Identities=23% Similarity=0.316 Sum_probs=191.9
Q ss_pred HHHHHHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC
Q 005617 334 LADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE 408 (688)
Q Consensus 334 ~~el~~at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~ 408 (688)
+.++....++|...+.||+|+||.||++... +..||+|++..... .....+.+|+.++..++||||+++++++.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3445556689999999999999999999886 78899999865322 233457899999999999999999999854
Q ss_pred --CceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecC
Q 005617 409 --AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFG 486 (688)
Q Consensus 409 --~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFG 486 (688)
..++||||+++|+|.+++... .++...+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSNY----DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHhc----CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence 478999999999999988543 4678888999999999999999966 9999999999999999999999999
Q ss_pred ccccccCCCCcCCCccccCCCCCCCCCCChhhhccC----CCCCcchHhHHHHHHHHHHhCCCCCCChhhH--HHHhhcC
Q 005617 487 ICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG----VLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCG 560 (688)
Q Consensus 487 la~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~----~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~~~~g 560 (688)
+++....... .......||+.|+|||++... .++.++|||||||++|||++|+.||...... ...+...
T Consensus 188 ~a~~~~~~~~-----~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~ 262 (371)
T cd05622 188 TCMKMNKEGM-----VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH 262 (371)
T ss_pred ceeEcCcCCc-----ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence 9987643221 122456799999999998653 3789999999999999999999999754432 2222211
Q ss_pred c-cccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 005617 561 K-LSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPD 598 (688)
Q Consensus 561 ~-l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs 598 (688)
. .... ..+...+..+.+|+..|+. +|..|++
T Consensus 263 ~~~~~~------~~~~~~s~~~~~li~~~L~-~~~~r~~ 294 (371)
T cd05622 263 KNSLTF------PDDNDISKEAKNLICAFLT-DREVRLG 294 (371)
T ss_pred CCcccC------CCcCCCCHHHHHHHHHHcC-ChhhhcC
Confidence 1 1110 1112356678899999998 5655443
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=307.13 Aligned_cols=247 Identities=28% Similarity=0.396 Sum_probs=185.0
Q ss_pred eeeccCceEEEEEEEC----CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecCCCCc
Q 005617 349 KVGQGGFGCVYKGEML----GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGS 421 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~----g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gs 421 (688)
.||+|+||.||+|... ...+|+|.+..... .....|.+|+.+++.++||||++++|+|.+ ..++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 5899999999999753 35688888764432 234568899999999999999999999854 4889999999999
Q ss_pred HHHHhcccCC--CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCC
Q 005617 422 LQDRLFRKSN--VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 422 L~~~L~~~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~ 499 (688)
|.+++..... ....++.....++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++.........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-- 156 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY-- 156 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhe--
Confidence 9999876532 233567888999999999999999965 999999999999999999999999998764332211
Q ss_pred CccccCCCCCCCCCCChhhhcc-------CCCCCcchHhHHHHHHHHHHh-CCCCCCChhhH--HHHhhcCccccccCCC
Q 005617 500 SFHRSTAPKGSFPYADPEYHRT-------GVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEV--RRAVSCGKLSSILDPL 569 (688)
Q Consensus 500 ~~~~~~~~~GT~~Y~APE~~~~-------~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~~--~~~~~~g~l~~~ld~~ 569 (688)
.......+++.|+|||++.. ..++.++|||||||++|||++ |..||...... ...........+.++
T Consensus 157 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~- 233 (269)
T cd05042 157 --ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKP- 233 (269)
T ss_pred --eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCC-
Confidence 11234456788999998743 456889999999999999999 78888654321 111111111111111
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHH
Q 005617 570 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 570 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~L 607 (688)
..+...+..+.+++..|+ .||.+||++. +|...|
T Consensus 234 --~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~-~v~~~l 267 (269)
T cd05042 234 --QLDLKYSDRWYEVMQFCW-LDPETRPTAE-EVHELL 267 (269)
T ss_pred --cccccCCHHHHHHHHHHh-cCcccccCHH-HHHHHh
Confidence 223344566777888888 5999999988 555443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-36 Score=321.49 Aligned_cols=247 Identities=21% Similarity=0.289 Sum_probs=190.1
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC------
Q 005617 339 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE------ 408 (688)
Q Consensus 339 ~at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~------ 408 (688)
...++|.....||.|+||.||+|... +..||||.+..... .....+.+|+.+|..++||||++++++|..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 34578888999999999999999875 78899999875432 233457799999999999999999988732
Q ss_pred --CceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecC
Q 005617 409 --AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFG 486 (688)
Q Consensus 409 --~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFG 486 (688)
..+++++++ +++|.+++.. ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKC----QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 257899987 7899887743 35889999999999999999999966 9999999999999999999999999
Q ss_pred ccccccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHH--h-h-cCc
Q 005617 487 ICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--V-S-CGK 561 (688)
Q Consensus 487 la~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~--~-~-~g~ 561 (688)
+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... + . .+.
T Consensus 164 ~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 234 (343)
T cd07878 164 LARQADDE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGT 234 (343)
T ss_pred cceecCCC---------cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCC
Confidence 99875432 234578999999999876 57899999999999999999999999643321110 0 0 000
Q ss_pred -------------cccccCCCCCCCC--------HHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 562 -------------LSSILDPLAGDWP--------TFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 562 -------------l~~~ld~~~~~~~--------~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
....+.. ....+ ......+.+|+.+|++.||.+|||+.+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell 296 (343)
T cd07878 235 PSPEVLKKISSEHARKYIQS-LPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEAL 296 (343)
T ss_pred CCHHHHHhcchhhHHHHhhc-cccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence 0000000 00000 01234578999999999999999988544
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=310.87 Aligned_cols=257 Identities=26% Similarity=0.327 Sum_probs=203.5
Q ss_pred ccCHHHHHHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcC-CCCceeeEecccC
Q 005617 331 EFSLADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACP 407 (688)
Q Consensus 331 ~~~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~ 407 (688)
-+.+.++..++++|.....||+|+||.||++... +..||+|++.... .....+.+|+.++.++ +|||+++++++|.
T Consensus 11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~ 89 (291)
T cd06639 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFY 89 (291)
T ss_pred hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEE
Confidence 3666778888999999999999999999999884 7899999986542 2245678899999999 8999999999873
Q ss_pred C-------CceeEEecCCCCcHHHHhccc-CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCC
Q 005617 408 E-------AWSLVYEYLPNGSLQDRLFRK-SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELS 479 (688)
Q Consensus 408 ~-------~~~LV~E~~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~ 479 (688)
. ..++||||+++|+|.+++... .....+++..+..++.+++.||.|||..+ |+|+||||+||+++.++.
T Consensus 90 ~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~ 166 (291)
T cd06639 90 KADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGG 166 (291)
T ss_pred eccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCC
Confidence 2 368999999999999988642 22356899999999999999999999965 999999999999999999
Q ss_pred eEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccC-----CCCCcchHhHHHHHHHHHHhCCCCCCChhhHH
Q 005617 480 SKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG-----VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR 554 (688)
Q Consensus 480 vKLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-----~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~ 554 (688)
+||+|||++........ ......|+..|+|||++... .++.++|||||||++|||++|+.||.......
T Consensus 167 ~kl~dfg~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~ 240 (291)
T cd06639 167 VKLVDFGVSAQLTSTRL------RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK 240 (291)
T ss_pred EEEeecccchhcccccc------cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHH
Confidence 99999999987643221 12345689999999987644 36899999999999999999999997544322
Q ss_pred HH--hhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 555 RA--VSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 555 ~~--~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
.. +..+....+. .+......+.+|+.+||+.+|.+||++.+.+
T Consensus 241 ~~~~~~~~~~~~~~------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il 285 (291)
T cd06639 241 TLFKIPRNPPPTLL------HPEKWCRSFNHFISQCLIKDFEARPSVTHLL 285 (291)
T ss_pred HHHHHhcCCCCCCC------cccccCHHHHHHHHHHhhcChhhCcCHHHHh
Confidence 22 1111111111 1223445799999999999999999988443
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-36 Score=311.88 Aligned_cols=231 Identities=24% Similarity=0.383 Sum_probs=180.6
Q ss_pred eeeccCceEEEEEEEC--------------------------CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeE
Q 005617 349 KVGQGGFGCVYKGEML--------------------------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTL 402 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~--------------------------g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l 402 (688)
.||+|+||.||+|.+. ...||+|++..........|.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 5999999999999752 13589999876554445578899999999999999999
Q ss_pred ecccCC--CceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCC--
Q 005617 403 LGACPE--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL-- 478 (688)
Q Consensus 403 ~g~~~~--~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~-- 478 (688)
+|+|.+ ..++||||+++|+|..++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++..+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKEK--GRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 999854 4789999999999999886533 46789999999999999999999865 99999999999997654
Q ss_pred -----CeEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHH-hCCCCCCChh
Q 005617 479 -----SSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLL-TGRLPVGLAG 551 (688)
Q Consensus 479 -----~vKLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELl-tG~~Pf~~~~ 551 (688)
.+|++|||++...... ....|++.|+|||++.+ ..+++++|||||||++|||+ +|+.||....
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~----------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR----------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred cCccceeeecCCccccccccc----------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 3899999987654221 23357888999998865 56899999999999999984 7999986433
Q ss_pred hHH--HHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHH
Q 005617 552 EVR--RAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 605 (688)
Q Consensus 552 ~~~--~~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~ 605 (688)
... ....... ..+......+.+++.+||+.+|.+||++. .+++
T Consensus 227 ~~~~~~~~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rps~~-~il~ 271 (274)
T cd05076 227 PSEKERFYEKKH----------RLPEPSCKELATLISQCLTYEPTQRPSFR-TILR 271 (274)
T ss_pred hHHHHHHHHhcc----------CCCCCCChHHHHHHHHHcccChhhCcCHH-HHHH
Confidence 211 1111100 11111234689999999999999999998 4443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=304.92 Aligned_cols=231 Identities=29% Similarity=0.455 Sum_probs=184.4
Q ss_pred eeeccCceEEEEEEECCe------------EEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC-CCceeEEe
Q 005617 349 KVGQGGFGCVYKGEMLGR------------TVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP-EAWSLVYE 415 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~g~------------~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~-~~~~LV~E 415 (688)
.||+|+||.||+|.+.+. .|++|.+...... ...|.+|+.+++.++||||++++|+|. ...++|||
T Consensus 2 ~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e 80 (259)
T cd05037 2 HLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVEE 80 (259)
T ss_pred cccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEecCCcEEEEE
Confidence 599999999999988632 4888887655433 678999999999999999999999874 45789999
Q ss_pred cCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCC-------CeEEeecCcc
Q 005617 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL-------SSKICDFGIC 488 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~-------~vKLsDFGla 488 (688)
|+++|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||++
T Consensus 81 ~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 81 YVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred cCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 999999999987654 26889999999999999999999865 99999999999999888 7999999999
Q ss_pred ccccCCCCcCCCccccCCCCCCCCCCChhhhccC--CCCCcchHhHHHHHHHHHHh-CCCCCCChhhH--HHHhhcCccc
Q 005617 489 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG--VLTPKSDSYSFGLIILQLLT-GRLPVGLAGEV--RRAVSCGKLS 563 (688)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~--~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~~--~~~~~~g~l~ 563 (688)
...... ....++..|+|||++... .++.++|||||||++|+|++ |..||...... ...+....
T Consensus 156 ~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~-- 223 (259)
T cd05037 156 ITVLSR----------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH-- 223 (259)
T ss_pred cccccc----------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCC--
Confidence 865431 234577889999998776 78999999999999999999 57777544221 11111110
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHH
Q 005617 564 SILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKE 606 (688)
Q Consensus 564 ~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~ 606 (688)
..+......+.+++.+||..+|.+||++. ++++.
T Consensus 224 --------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~-~il~~ 257 (259)
T cd05037 224 --------RLPMPDCAELANLINQCWTYDPTKRPSFR-AILRD 257 (259)
T ss_pred --------CCCCCCchHHHHHHHHHhccChhhCCCHH-HHHHh
Confidence 01111126889999999999999999998 44443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=322.42 Aligned_cols=245 Identities=29% Similarity=0.441 Sum_probs=209.6
Q ss_pred HhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccch---HHHHHHHHHHHcCC-CCceeeEecccCC--Cce
Q 005617 340 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQ---LEFQQEVRVLSKLQ-HPHLVTLLGACPE--AWS 411 (688)
Q Consensus 340 at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~---~~f~~E~~iL~~l~-HpnIV~l~g~~~~--~~~ 411 (688)
....|.....||.|.||.||+++.. |..+|+|++.+....+. ..+.+|+.||+++. |||||.++++|.+ ..+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3456888899999999999999886 88999999988766543 57999999999998 9999999999955 579
Q ss_pred eEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCC----CCeEEeecCc
Q 005617 412 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE----LSSKICDFGI 487 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~----~~vKLsDFGl 487 (688)
+|||++.||.|.+.+... .++..++..++.+++.++.|||+.+ |+||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999999876 2899999999999999999999966 9999999999999643 5799999999
Q ss_pred cccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh--hHHHHhhcCccccc
Q 005617 488 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSI 565 (688)
Q Consensus 488 a~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~--~~~~~~~~g~l~~~ 565 (688)
+.....+. .....+||+.|+|||++....|+..+||||+||++|.|++|.+||.... .....+..|++
T Consensus 186 a~~~~~~~-------~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~--- 255 (382)
T KOG0032|consen 186 AKFIKPGE-------RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF--- 255 (382)
T ss_pred ceEccCCc-------eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC---
Confidence 99887632 3467899999999999999999999999999999999999999997655 34445556655
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 566 LDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 566 ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
+.....|+ ..+..+.+++..|+..||..|+++.+.+
T Consensus 256 -~f~~~~w~-~is~~akd~i~~ll~~dp~~R~ta~~~L 291 (382)
T KOG0032|consen 256 -DFTSEPWD-DISESAKDFIRKLLEFDPRKRLTAAQAL 291 (382)
T ss_pred -CCCCCCcc-ccCHHHHHHHHHhcccCcccCCCHHHHh
Confidence 22233454 4588999999999999999999998544
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=307.01 Aligned_cols=252 Identities=27% Similarity=0.448 Sum_probs=201.2
Q ss_pred cCcccceeeeccCceEEEEEEEC--C----eEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccC-CCceeE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--G----RTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP-EAWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g----~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~-~~~~LV 413 (688)
.+|...+.||+|+||.||+|.+. | ..||+|.+..... .....+.+|+.++..++||||++++++|. ...++|
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v 86 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLSSQVQLI 86 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCceEEE
Confidence 45677789999999999999864 3 2589998876543 23457889999999999999999999985 457899
Q ss_pred EecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccC
Q 005617 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~ 493 (688)
|||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 87 ~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 87 TQLMPLGCLLDYVRNHK--DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred EecCCCCcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 99999999999987643 35899999999999999999999965 99999999999999999999999999987653
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--hHHHHhhcCccccccCCCC
Q 005617 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~~~~g~l~~~ld~~~ 570 (688)
..... ......++..|+|||.+....++.++|||||||++|||+| |+.||.... .+...+..+...
T Consensus 162 ~~~~~----~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~------- 230 (279)
T cd05057 162 DEKEY----HAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERL------- 230 (279)
T ss_pred cccce----ecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCC-------
Confidence 32111 1122334678999999988899999999999999999999 999997543 233333332211
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHhh
Q 005617 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 571 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l~ 611 (688)
..+......+.+++.+||..+|..||++. .+...|..+.
T Consensus 231 -~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~-~l~~~l~~~~ 269 (279)
T cd05057 231 -PQPPICTIDVYMVLVKCWMIDAESRPTFK-ELINEFSKMA 269 (279)
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhhCCCHH-HHHHHHHHHH
Confidence 11222345788999999999999999998 6777777653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=300.81 Aligned_cols=245 Identities=29% Similarity=0.545 Sum_probs=196.1
Q ss_pred cCcccceeeeccCceEEEEEEEC-CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecCC
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLP 418 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~-g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~ 418 (688)
.+|.....||.|+||.||+|.+. +..+|+|.+..... ....|.+|+.++.+++||||+++++++.. ..++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAM-SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCC-CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 35677789999999999999876 78899998865432 34578999999999999999999999844 5789999999
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcC
Q 005617 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~ 498 (688)
+++|.+++.... ..+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 83 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-- 155 (256)
T cd05112 83 HGCLSDYLRAQR--GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-- 155 (256)
T ss_pred CCcHHHHHHhCc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcc--
Confidence 999999986543 35789999999999999999999966 99999999999999999999999999986543221
Q ss_pred CCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--hHHHHhhcCccccccCCCCCCCCH
Q 005617 499 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLAGDWPT 575 (688)
Q Consensus 499 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~~~~g~l~~~ld~~~~~~~~ 575 (688)
.......++.+|+|||++.++.++.++||||||+++|||++ |..||.... .....+..+. .... +.
T Consensus 156 ---~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~~~~------~~ 224 (256)
T cd05112 156 ---TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGF--RLYK------PR 224 (256)
T ss_pred ---cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCC--CCCC------CC
Confidence 11223345678999999998999999999999999999998 999996433 2222222221 1111 11
Q ss_pred HHHHHHHHHHHHccccCCCCCCCCchHHHHH
Q 005617 576 FVARRLVDLGLQCCELYGRERPDITPSLVKE 606 (688)
Q Consensus 576 ~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~ 606 (688)
..+..+.+|+.+||+.+|++||++. ++++.
T Consensus 225 ~~~~~~~~l~~~~l~~~p~~Rp~~~-~~l~~ 254 (256)
T cd05112 225 LASQSVYELMQHCWKERPEDRPSFS-LLLHQ 254 (256)
T ss_pred CCCHHHHHHHHHHcccChhhCCCHH-HHHHh
Confidence 2346799999999999999999998 45443
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=315.24 Aligned_cols=193 Identities=26% Similarity=0.356 Sum_probs=157.0
Q ss_pred ceeeeccCceEEEEEEEC----CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC----CceeEEecCC
Q 005617 347 SFKVGQGGFGCVYKGEML----GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE----AWSLVYEYLP 418 (688)
Q Consensus 347 ~~~LG~G~fG~Vykg~~~----g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~----~~~LV~E~~~ 418 (688)
+.+||+|+||.||+|... +..||||.+.... ....+.+|+.+|++++||||+++++++.. ..++||||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 468999999999999863 5789999986543 23457889999999999999999998732 3679999986
Q ss_pred CCcHHHHhcccC------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceee----CCCCCeEEeecCcc
Q 005617 419 NGSLQDRLFRKS------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL----DSELSSKICDFGIC 488 (688)
Q Consensus 419 ~gsL~~~L~~~~------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILL----d~~~~vKLsDFGla 488 (688)
++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 47777664321 1235889999999999999999999966 9999999999999 45688999999999
Q ss_pred ccccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCC
Q 005617 489 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVG 548 (688)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~ 548 (688)
+........ ........||+.|+|||++.+ ..++.++|||||||++|||++|++||.
T Consensus 160 ~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~ 217 (317)
T cd07868 160 RLFNSPLKP---LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFH 217 (317)
T ss_pred eccCCCCcc---ccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCcc
Confidence 876543211 112345678999999999876 458999999999999999999999995
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=301.31 Aligned_cols=249 Identities=25% Similarity=0.387 Sum_probs=208.0
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc----c----hHHHHHHHHHHHcC-CCCceeeEecccCCC
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ----G----QLEFQQEVRVLSKL-QHPHLVTLLGACPEA 409 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~----~----~~~f~~E~~iL~~l-~HpnIV~l~g~~~~~ 409 (688)
-++|.....||.|+.++|.++... |..+|+|++...... . .+.-..|+.||+++ -||||+++.+++...
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 356777888999999999988775 889999998654321 1 23466899999999 599999999999665
Q ss_pred --ceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCc
Q 005617 410 --WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 487 (688)
Q Consensus 410 --~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGl 487 (688)
.++|+|.|+.|.|.|+|...- .++.....+|+.|+..|+.|||..+ ||||||||+|||+|++.++||+|||+
T Consensus 96 sF~FlVFdl~prGELFDyLts~V---tlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 96 AFVFLVFDLMPRGELFDYLTSKV---TLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred chhhhhhhhcccchHHHHhhhhe---eecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccce
Confidence 678999999999999997654 5788999999999999999999966 99999999999999999999999999
Q ss_pred cccccCCCCcCCCccccCCCCCCCCCCChhhhc------cCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhc
Q 005617 488 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR------TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSC 559 (688)
Q Consensus 488 a~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~------~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~ 559 (688)
+..+..+. +-...+|||+|+|||.+. ...|+..+|+||+|||||.||.|.+||-.... +..++..
T Consensus 170 a~~l~~Ge-------kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Ime 242 (411)
T KOG0599|consen 170 ACQLEPGE-------KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIME 242 (411)
T ss_pred eeccCCch-------hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHh
Confidence 99987765 346789999999999763 34688999999999999999999999976555 3456777
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHH
Q 005617 560 GKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 560 g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~L 607 (688)
|++.- ...+|. +.+....+|+.+||+.||..|.|..+.+.+.+
T Consensus 243 GkyqF----~speWa-dis~~~KdLIsrlLqVdp~~Ritake~LaHpf 285 (411)
T KOG0599|consen 243 GKYQF----RSPEWA-DISATVKDLISRLLQVDPTKRITAKEALAHPF 285 (411)
T ss_pred ccccc----CCcchh-hccccHHHHHHHHHeeCchhcccHHHHhcChH
Confidence 77642 233454 46778999999999999999999997776554
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=311.46 Aligned_cols=248 Identities=26% Similarity=0.291 Sum_probs=200.4
Q ss_pred cCcccceeeeccCceEEEEEEECC--eEEEEEEEecCCccc---hHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEMLG--RTVAIKMLYSHNMQG---QLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~g--~~vAIK~l~~~~~~~---~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|...+.||.|.-|+||++++.| ..+|+|++.+..... ......|-+||+.++||.++.||..|.. ..||||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 445666789999999999999985 789999998776543 3457789999999999999999999954 478999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
|||+||+|...+.+.. ...++...+..++.+|+.||+|||..| ||.|||||+||||.++|++.|+||.|+....-.
T Consensus 157 eyCpGGdL~~LrqkQp-~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQKQP-GKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhhCC-CCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 9999999998887654 367899999999999999999999977 999999999999999999999999997544210
Q ss_pred CC--------------------------------c------------------CCCccccCCCCCCCCCCChhhhccCCC
Q 005617 495 TL--------------------------------Y------------------LPSFHRSTAPKGSFPYADPEYHRTGVL 524 (688)
Q Consensus 495 ~~--------------------------------~------------------~~~~~~~~~~~GT~~Y~APE~~~~~~~ 524 (688)
.. . .+...++...+||-.|+|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 00 0 111223456789999999999999999
Q ss_pred CCcchHhHHHHHHHHHHhCCCCCCChhhHHH--HhhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCc
Q 005617 525 TPKSDSYSFGLIILQLLTGRLPVGLAGEVRR--AVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 525 s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~--~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~ 600 (688)
+..+|||+|||+|||||.|..||.+...-.. .+....+ ...+.+ .++..+.+||.+.|..||.+|....
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l------~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~ 383 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPL------KFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSK 383 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCC------cCCCCC-cchhHHHHHHHHHhccChhhhhccc
Confidence 9999999999999999999999976554222 1211111 112222 5678899999999999999999854
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=316.60 Aligned_cols=255 Identities=27% Similarity=0.455 Sum_probs=201.6
Q ss_pred cCcccceeeeccCceEEEEEEEC---------CeEEEEEEEecCCc-cchHHHHHHHHHHHcC-CCCceeeEecccCC--
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML---------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE-- 408 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~---------g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~-- 408 (688)
.+|...+.||+|+||.||++... +..||+|.+..... .....+.+|+.++.++ +||||++++++|.+
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 46788899999999999999753 23689998875432 2345789999999999 79999999999854
Q ss_pred CceeEEecCCCCcHHHHhcccC-------------CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeC
Q 005617 409 AWSLVYEYLPNGSLQDRLFRKS-------------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD 475 (688)
Q Consensus 409 ~~~LV~E~~~~gsL~~~L~~~~-------------~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd 475 (688)
..++||||+++|+|.+++.... ....++|..++.++.|++.||.|||..+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 4789999999999999987532 1235889999999999999999999965 99999999999999
Q ss_pred CCCCeEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--h
Q 005617 476 SELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--E 552 (688)
Q Consensus 476 ~~~~vKLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~ 552 (688)
.++.+||+|||+++........ .......++..|+|||++....++.++|||||||++|||++ |..||.... .
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 244 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYY----KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE 244 (334)
T ss_pred CCCcEEECCcccceeccccccc----ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999876432211 11233445678999999999999999999999999999998 889986433 2
Q ss_pred HHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHhhh
Q 005617 553 VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 553 ~~~~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l~~ 612 (688)
....+..+... +.+...+..+.+|+.+||+.+|.+||++. +++..|+.+..
T Consensus 245 ~~~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~~p~~Rps~~-ell~~l~~~~~ 295 (334)
T cd05100 245 LFKLLKEGHRM--------DKPANCTHELYMIMRECWHAVPSQRPTFK-QLVEDLDRVLT 295 (334)
T ss_pred HHHHHHcCCCC--------CCCCCCCHHHHHHHHHHcccChhhCcCHH-HHHHHHHHHhh
Confidence 33333322211 12223456789999999999999999998 67777877654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=322.33 Aligned_cols=239 Identities=24% Similarity=0.314 Sum_probs=187.5
Q ss_pred eeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHcC---CCCceeeEecccCC--CceeEEecCCC
Q 005617 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKL---QHPHLVTLLGACPE--AWSLVYEYLPN 419 (688)
Q Consensus 350 LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~---~~~~f~~E~~iL~~l---~HpnIV~l~g~~~~--~~~LV~E~~~~ 419 (688)
||+|+||+||+|+.. |..||||++...... ....+..|..++..+ .||||+++++++.+ ..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999885 889999999654322 223455677777665 69999999998843 58999999999
Q ss_pred CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCC
Q 005617 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 420 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~ 499 (688)
|+|..++... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 81 g~L~~~l~~~---~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--- 151 (330)
T cd05586 81 GELFWHLQKE---GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--- 151 (330)
T ss_pred ChHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC---
Confidence 9999888654 35788999999999999999999966 99999999999999999999999999876432221
Q ss_pred CccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCCCCCCCHH
Q 005617 500 SFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTF 576 (688)
Q Consensus 500 ~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~~~ 576 (688)
......||+.|+|||++.+. .++.++|||||||++|+|+||+.||..... ....+..+...- . ...
T Consensus 152 ---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~-----~---~~~ 220 (330)
T cd05586 152 ---TTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRF-----P---KNV 220 (330)
T ss_pred ---CccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCC-----C---Ccc
Confidence 12456799999999998754 489999999999999999999999965432 233333332210 0 112
Q ss_pred HHHHHHHHHHHccccCCCCCCCCchHHHHHHH
Q 005617 577 VARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 577 ~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le 608 (688)
.+..+.+|+.+||+.||.+||+..+.+.+.++
T Consensus 221 ~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 221 LSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred CCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 35678899999999999999987655544444
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=310.62 Aligned_cols=235 Identities=25% Similarity=0.381 Sum_probs=184.9
Q ss_pred eeeccCceEEEEEEEC---------CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEecC
Q 005617 349 KVGQGGFGCVYKGEML---------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 417 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~---------g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~ 417 (688)
.||.|+||.||+|... ...||+|.+..........|.+|+.++..++|||||++++++. +..++||||+
T Consensus 2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (258)
T cd05078 2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYV 81 (258)
T ss_pred CCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecC
Confidence 5999999999999764 2348889886655555567899999999999999999999984 4588999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCC--------eEEeecCccc
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELS--------SKICDFGICR 489 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~--------vKLsDFGla~ 489 (688)
++|+|..++.... ..+++..++.++.||+.||.|||+.+ |+||||||+|||++.++. ++++|||++.
T Consensus 82 ~~g~L~~~l~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 82 KFGSLDTYLKKNK--NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred CCCcHHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 9999999987654 36789999999999999999999965 999999999999987765 6899999886
Q ss_pred cccCCCCcCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCC-CCCCChhhHHHHhhcCccccccC
Q 005617 490 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGR-LPVGLAGEVRRAVSCGKLSSILD 567 (688)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~-~Pf~~~~~~~~~~~~g~l~~~ld 567 (688)
..... ....|++.|+|||++.+. .++.++|||||||++|||++|. .||..............
T Consensus 157 ~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~------ 220 (258)
T cd05078 157 TVLPK----------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED------ 220 (258)
T ss_pred ccCCc----------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc------
Confidence 54321 234688899999998764 5799999999999999999985 66654333211110010
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHH
Q 005617 568 PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 568 ~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~L 607 (688)
....|......+.+|+.+||+.+|++||++. ++++.|
T Consensus 221 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~il~~l 257 (258)
T cd05078 221 --RHQLPAPKWTELANLINQCMDYEPDFRPSFR-AIIRDL 257 (258)
T ss_pred --cccCCCCCcHHHHHHHHHHhccChhhCCCHH-HHHHhc
Confidence 0122223346789999999999999999998 455443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=313.70 Aligned_cols=242 Identities=21% Similarity=0.311 Sum_probs=193.5
Q ss_pred ceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEecCCCCcH
Q 005617 347 SFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLPNGSL 422 (688)
Q Consensus 347 ~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~~~gsL 422 (688)
...||.|+||.||++... +..||||.+..........+.+|+.++..++||||+++++.|. +..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 456999999999999874 7899999987655555667899999999999999999999874 458899999999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCCcc
Q 005617 423 QDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 502 (688)
Q Consensus 423 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~~~ 502 (688)
.+++.. ..+++..+..++.+|+.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 107 ~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~------ 173 (292)
T cd06658 107 TDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP------ 173 (292)
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc------
Confidence 998743 34789999999999999999999965 99999999999999999999999999876543221
Q ss_pred ccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCccccccCCCCCCCCHHHHHHHH
Q 005617 503 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLV 582 (688)
Q Consensus 503 ~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~l~~~ld~~~~~~~~~~~~~l~ 582 (688)
......|++.|+|||++....++.++|||||||++|||++|+.||........... +...+.+.. ......+..+.
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~---~~~~~~~~~-~~~~~~~~~~~ 249 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR---IRDNLPPRV-KDSHKVSSVLR 249 (292)
T ss_pred cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhcCCCcc-ccccccCHHHH
Confidence 12345689999999999988999999999999999999999999965433211110 001111111 11123455788
Q ss_pred HHHHHccccCCCCCCCCchHHHH
Q 005617 583 DLGLQCCELYGRERPDITPSLVK 605 (688)
Q Consensus 583 ~L~~~Cl~~dP~~RPs~~~~l~~ 605 (688)
.++.+|+..||.+||++.+.+.+
T Consensus 250 ~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 250 GFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred HHHHHHccCChhHCcCHHHHhhC
Confidence 99999999999999999865543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=303.77 Aligned_cols=246 Identities=26% Similarity=0.382 Sum_probs=193.2
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-----cchHHHHHHHHHHHcCCCCceeeEecccCC----Cc
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-----QGQLEFQQEVRVLSKLQHPHLVTLLGACPE----AW 410 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~-----~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~----~~ 410 (688)
.+|.....||+|+||.||+|... +..||+|.+..... .....+.+|+.+++.++||||+++++++.+ ..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47888999999999999999874 78999999865432 223458899999999999999999998743 36
Q ss_pred eeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCcccc
Q 005617 411 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~ 490 (688)
+++|||+++++|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYG---ALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 78999999999999986543 4788999999999999999999865 99999999999999999999999999986
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCccccccCCCC
Q 005617 491 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~l~~~ld~~~ 570 (688)
........ .......|+..|+|||++.+..++.++|||||||++|||++|+.||.............. .+..
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~-----~~~~ 227 (266)
T cd06651 156 LQTICMSG---TGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIAT-----QPTN 227 (266)
T ss_pred cccccccC---CccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhc-----CCCC
Confidence 54321110 011235689999999999988999999999999999999999999975433222111110 0111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCCchH
Q 005617 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 571 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
...+......+..++ +||..+|.+||++.+.
T Consensus 228 ~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~ei 258 (266)
T cd06651 228 PQLPSHISEHARDFL-GCIFVEARHRPSAEEL 258 (266)
T ss_pred CCCchhcCHHHHHHH-HHhcCChhhCcCHHHH
Confidence 233444556667776 7888999999998843
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=300.67 Aligned_cols=242 Identities=29% Similarity=0.470 Sum_probs=193.8
Q ss_pred eeeccCceEEEEEEEC-CeEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecCCCCcHHH
Q 005617 349 KVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSLQD 424 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~-g~~vAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gsL~~ 424 (688)
+||.|+||.||++.+. ++.||+|.+...... ....|.+|+.++++++||||+++++++.+ ..++||||+++++|.+
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~ 81 (251)
T cd05041 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLT 81 (251)
T ss_pred ccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHH
Confidence 6999999999999886 899999998765443 45679999999999999999999999854 4789999999999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCCcccc
Q 005617 425 RLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRS 504 (688)
Q Consensus 425 ~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~ 504 (688)
++.... ..+++..++.++.+++.||.|||+.+ ++||||||+|||++.++.+||+|||++.......... ..
T Consensus 82 ~l~~~~--~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~----~~ 152 (251)
T cd05041 82 FLRKKK--NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTV----SD 152 (251)
T ss_pred HHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCccee----cc
Confidence 986543 35789999999999999999999966 9999999999999999999999999998654322110 11
Q ss_pred CCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHHHhhcCccccccCCCCCCCCHHHHHHH
Q 005617 505 TAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVARRL 581 (688)
Q Consensus 505 ~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~~~~~~~l 581 (688)
....++..|+|||++.++.++.++|||||||++|||+| |..||..... ....+..+. ....+...+..+
T Consensus 153 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~ 224 (251)
T cd05041 153 GLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY--------RMPAPQLCPEEI 224 (251)
T ss_pred ccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC--------CCCCCccCCHHH
Confidence 22334677999999998999999999999999999999 8889865432 222222211 011233445689
Q ss_pred HHHHHHccccCCCCCCCCchHHHHHHH
Q 005617 582 VDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 582 ~~L~~~Cl~~dP~~RPs~~~~l~~~Le 608 (688)
.+++.+|+..+|.+||++. +++..|+
T Consensus 225 ~~li~~~l~~~p~~Rp~~~-ell~~l~ 250 (251)
T cd05041 225 YRLMLQCWAYDPENRPSFS-EIYNELQ 250 (251)
T ss_pred HHHHHHHhccChhhCcCHH-HHHHHhh
Confidence 9999999999999999998 5555543
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=336.89 Aligned_cols=250 Identities=28% Similarity=0.444 Sum_probs=210.7
Q ss_pred ccceeeeccCceEEEEEEEC--C---eEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEec
Q 005617 345 SESFKVGQGGFGCVYKGEML--G---RTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 345 ~~~~~LG~G~fG~Vykg~~~--g---~~vAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
.+.++||.|-||.||+|++. | ..||||.|+..... .+.+|..|..||.++.||||++|-|+... ..+||.||
T Consensus 632 ~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEy 711 (996)
T KOG0196|consen 632 KIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEY 711 (996)
T ss_pred EEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhh
Confidence 34678999999999999986 4 46999999987654 45579999999999999999999999854 47889999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCC
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~ 496 (688)
|+||+|+.+|..+. ..|++-+..-++.+||.|+.||-+++ +|||||...|||++.+..+|++|||+++.+.++.
T Consensus 712 MENGsLDsFLR~~D--GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~- 785 (996)
T KOG0196|consen 712 MENGSLDSFLRQND--GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP- 785 (996)
T ss_pred hhCCcHHHHHhhcC--CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC-
Confidence 99999999998776 45889999999999999999999987 9999999999999999999999999999886654
Q ss_pred cCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCCh--hhHHHHhhcCccccccCCCCCCC
Q 005617 497 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLA--GEVRRAVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 497 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~--~~~~~~~~~g~l~~~ld~~~~~~ 573 (688)
+....+....-...|.|||.+...+++..+|||||||+|||.++ |..||-.. .++.+++..|--. ..
T Consensus 786 --~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRL--------Pp 855 (996)
T KOG0196|consen 786 --EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRL--------PP 855 (996)
T ss_pred --CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCC--------CC
Confidence 12223344444678999999999999999999999999999887 99998533 3466777666321 33
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHhh
Q 005617 574 PTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 574 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l~ 611 (688)
|.+++..|.+|++.||++|..+||.+. .++..|+.+-
T Consensus 856 PmDCP~aL~qLMldCWqkdR~~RP~F~-qiV~~lDklI 892 (996)
T KOG0196|consen 856 PMDCPAALYQLMLDCWQKDRNRRPKFA-QIVSTLDKLI 892 (996)
T ss_pred CCCCcHHHHHHHHHHHHHHhhcCCCHH-HHHHHHHHHh
Confidence 555677899999999999999999999 6777887763
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=311.58 Aligned_cols=250 Identities=23% Similarity=0.316 Sum_probs=191.1
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEec
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
++|.....||.|+||.||+|... +..||+|.+..... .....+.+|+.++..++||||+++++++.+ ..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46788899999999999999875 78899999875433 233467889999999999999999999843 57899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCC
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~ 496 (688)
++ ++|...+.... ..+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDCG--NSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 58888876543 35789999999999999999999966 99999999999999999999999999976533221
Q ss_pred cCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHH--hh-------cCcccccc
Q 005617 497 YLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VS-------CGKLSSIL 566 (688)
Q Consensus 497 ~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~--~~-------~g~l~~~l 566 (688)
......+++.|+|||++.+ ..++.++|||||||++|+|+||++||......... +. ...+..++
T Consensus 160 ------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (301)
T cd07873 160 ------TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGIL 233 (301)
T ss_pred ------cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhh
Confidence 1234467899999998765 45789999999999999999999999643321110 00 00000000
Q ss_pred C---------CC-----CCCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 567 D---------PL-----AGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 567 d---------~~-----~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
+ +. ........+..+.+|+.+|++.||.+|||+.+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil 284 (301)
T cd07873 234 SNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAM 284 (301)
T ss_pred ccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 0 00 0001123455788999999999999999987433
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=310.23 Aligned_cols=242 Identities=25% Similarity=0.396 Sum_probs=194.4
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC-ccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEec
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~-~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
++|...+.||+|+||+||++... |..||+|++.... ......|.+|+.++..++||||++++++|.. ..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45677788999999999999886 8899999987543 2345679999999999999999999999854 57899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCC
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~ 496 (688)
+++|+|.+++... .++++..+..++.+++.||.|||+.. +++||||+|+||+++.++.++|+|||++.......
T Consensus 85 ~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 85 MDCGSLDRIYKKG---GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred CCCCCHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 9999999988653 35899999999999999999999742 49999999999999999999999999987553221
Q ss_pred cCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhH----------HHHhhcCcccccc
Q 005617 497 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV----------RRAVSCGKLSSIL 566 (688)
Q Consensus 497 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~----------~~~~~~g~l~~~l 566 (688)
.....|+..|+|||++.+..++.++|||||||++|+|+||+.||...... ...+. .++
T Consensus 159 -------~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~ 226 (284)
T cd06620 159 -------ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQ-----QIV 226 (284)
T ss_pred -------cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHH-----HHh
Confidence 23457899999999998889999999999999999999999999743220 11111 111
Q ss_pred CCCCCCCCH-HHHHHHHHHHHHccccCCCCCCCCch
Q 005617 567 DPLAGDWPT-FVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 567 d~~~~~~~~-~~~~~l~~L~~~Cl~~dP~~RPs~~~ 601 (688)
.......+. ..+..+.+|+.+|++.||.+||++.+
T Consensus 227 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e 262 (284)
T cd06620 227 QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQ 262 (284)
T ss_pred hccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHH
Confidence 111111111 25567999999999999999999983
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=312.62 Aligned_cols=194 Identities=25% Similarity=0.351 Sum_probs=157.0
Q ss_pred ceeeeccCceEEEEEEEC----CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC----CCceeEEecCC
Q 005617 347 SFKVGQGGFGCVYKGEML----GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP----EAWSLVYEYLP 418 (688)
Q Consensus 347 ~~~LG~G~fG~Vykg~~~----g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~----~~~~LV~E~~~ 418 (688)
+.+||+|+||.||+|... +..||+|.+.... ....+.+|+.+++.++||||++++++|. ...++||||+.
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 468999999999999864 4679999986543 2345788999999999999999999873 24689999987
Q ss_pred CCcHHHHhccc------CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceee----CCCCCeEEeecCcc
Q 005617 419 NGSLQDRLFRK------SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL----DSELSSKICDFGIC 488 (688)
Q Consensus 419 ~gsL~~~L~~~------~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILL----d~~~~vKLsDFGla 488 (688)
+ +|.+.+... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 5 666665321 12235889999999999999999999965 9999999999999 56789999999999
Q ss_pred ccccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCC
Q 005617 489 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGL 549 (688)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~ 549 (688)
+........ ........||+.|+|||++.+ ..++.++|||||||++|||+||++||..
T Consensus 160 ~~~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~ 218 (317)
T cd07867 160 RLFNSPLKP---LADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC 218 (317)
T ss_pred eccCCCccc---ccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence 876543211 112245578999999999876 4589999999999999999999999963
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=305.13 Aligned_cols=241 Identities=26% Similarity=0.370 Sum_probs=197.1
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecC
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 417 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~ 417 (688)
.|...+.||.|+||.||+|.+. +..||||++..... .....+.+|+.+++.++||||++++++|.+ ..++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4666788999999999999874 78999999875532 334568999999999999999999999854 488999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCc
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~ 497 (688)
++|+|.+++.. .++++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 85 GGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 99999998854 35788999999999999999999965 99999999999999999999999999987643321
Q ss_pred CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHH--hhcCccccccCCCCCCCCH
Q 005617 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VSCGKLSSILDPLAGDWPT 575 (688)
Q Consensus 498 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~--~~~g~l~~~ld~~~~~~~~ 575 (688)
......|+..|+|||++.+..++.++|||||||++|||+||..||......... +..+ .....+.
T Consensus 157 -----~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--------~~~~~~~ 223 (277)
T cd06640 157 -----KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN--------NPPTLTG 223 (277)
T ss_pred -----ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC--------CCCCCch
Confidence 123456889999999999889999999999999999999999999744322111 1111 0122344
Q ss_pred HHHHHHHHHHHHccccCCCCCCCCchHHH
Q 005617 576 FVARRLVDLGLQCCELYGRERPDITPSLV 604 (688)
Q Consensus 576 ~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~ 604 (688)
..+..+.+++.+||+.+|.+||++.+.+.
T Consensus 224 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 252 (277)
T cd06640 224 EFSKPFKEFIDACLNKDPSFRPTAKELLK 252 (277)
T ss_pred hhhHHHHHHHHHHcccCcccCcCHHHHHh
Confidence 56778999999999999999999985543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=310.69 Aligned_cols=239 Identities=23% Similarity=0.363 Sum_probs=193.3
Q ss_pred cceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEecCCCCc
Q 005617 346 ESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLPNGS 421 (688)
Q Consensus 346 ~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~~~gs 421 (688)
....||.|+||.||++... +..||||.+..........+.+|+.++..++||||++++++|. +..++||||+++++
T Consensus 25 ~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~ 104 (297)
T cd06659 25 NYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGA 104 (297)
T ss_pred hhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCC
Confidence 3457999999999999874 8899999997665555667889999999999999999999884 45889999999999
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCCc
Q 005617 422 LQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 501 (688)
Q Consensus 422 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~~ 501 (688)
|..++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 105 L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~----- 172 (297)
T cd06659 105 LTDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP----- 172 (297)
T ss_pred HHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc-----
Confidence 9987744 35789999999999999999999966 99999999999999999999999999976543221
Q ss_pred cccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHH--HhhcCccccccCCCCCCCCHHHHH
Q 005617 502 HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR--AVSCGKLSSILDPLAGDWPTFVAR 579 (688)
Q Consensus 502 ~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~--~~~~g~l~~~ld~~~~~~~~~~~~ 579 (688)
......|++.|+|||++.+..++.++|||||||++|||++|+.||........ .+....... . ..+.....
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-----~-~~~~~~~~ 245 (297)
T cd06659 173 -KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK-----L-KNAHKISP 245 (297)
T ss_pred -cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCC-----c-cccCCCCH
Confidence 12345689999999999988999999999999999999999999964433221 111111100 0 11112345
Q ss_pred HHHHHHHHccccCCCCCCCCchHH
Q 005617 580 RLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 580 ~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
.+.+++.+||+.+|.+||++.+.+
T Consensus 246 ~l~~~i~~~l~~~P~~Rps~~~ll 269 (297)
T cd06659 246 VLRDFLERMLTREPQERATAQELL 269 (297)
T ss_pred HHHHHHHHHhcCCcccCcCHHHHh
Confidence 788999999999999999988444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-36 Score=311.26 Aligned_cols=252 Identities=25% Similarity=0.341 Sum_probs=190.9
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC----C---Cce
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP----E---AWS 411 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~----~---~~~ 411 (688)
+-.|...+++|.|+||.||+|.+. +..||||+.-.+.. .-.+|+.+|+++.|||||+|+.+|. . ...
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 345667789999999999999986 68899998754432 2236999999999999999998872 2 245
Q ss_pred eEEecCCCCcHHHHhccc-CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCC-CCeEEeecCccc
Q 005617 412 LVYEYLPNGSLQDRLFRK-SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE-LSSKICDFGICR 489 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~-~~vKLsDFGla~ 489 (688)
|||||||. +|...+... .....++...+.-+..||++||.|||+.+ |+||||||.|||+|.+ |.+||||||.|+
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcce
Confidence 89999975 677766532 12245666677888999999999999965 9999999999999976 999999999999
Q ss_pred cccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhh----------
Q 005617 490 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS---------- 558 (688)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~---------- 558 (688)
.+..+... .....|-.|.|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+.+.+.+...
T Consensus 175 ~L~~~epn-------iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~ 247 (364)
T KOG0658|consen 175 VLVKGEPN-------ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTR 247 (364)
T ss_pred eeccCCCc-------eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCH
Confidence 98765422 34456778999997765 4799999999999999999999999976554332211
Q ss_pred ----cCccc--cccCCC--CCC----CCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHH
Q 005617 559 ----CGKLS--SILDPL--AGD----WPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 559 ----~g~l~--~~ld~~--~~~----~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~L 607 (688)
..+.. +.-.|. ... +......+.++|+.+++.++|.+|.+..+.+.+.+
T Consensus 248 e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~f 308 (364)
T KOG0658|consen 248 EDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPF 308 (364)
T ss_pred HHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchh
Confidence 11110 111111 111 23446778999999999999999999886665433
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=317.11 Aligned_cols=245 Identities=25% Similarity=0.296 Sum_probs=188.3
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|...+.||+|+||.||++... +..||+|++..... .....|..|+.++..++|+||+++++++.+ ..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36888899999999999999886 67899999865322 223358899999999999999999998844 578999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
||+++|+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 9999999999997543 35889999999999999999999966 999999999999999999999999999765432
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhc-----cCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHH--HHhhcCccccccC
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHR-----TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSILD 567 (688)
Q Consensus 495 ~~~~~~~~~~~~~~GT~~Y~APE~~~-----~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~--~~~~~g~l~~~ld 567 (688)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.||....... ..+........+
T Consensus 156 ~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~- 229 (332)
T cd05623 156 GT-----VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQF- 229 (332)
T ss_pred Cc-----ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccC-
Confidence 21 1223457999999999986 3568999999999999999999999997544322 222111100000
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCC--CCCCc
Q 005617 568 PLAGDWPTFVARRLVDLGLQCCELYGRE--RPDIT 600 (688)
Q Consensus 568 ~~~~~~~~~~~~~l~~L~~~Cl~~dP~~--RPs~~ 600 (688)
.......+..+.+|+.+|+..++.. ||++.
T Consensus 230 ---p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~ 261 (332)
T cd05623 230 ---PAQVTDVSEDAKDLIRRLICSREHRLGQNGIE 261 (332)
T ss_pred ---CCccccCCHHHHHHHHHHccChhhhcCCCCHH
Confidence 0111234567888899988654433 45554
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=327.95 Aligned_cols=247 Identities=19% Similarity=0.217 Sum_probs=189.4
Q ss_pred hcCcccceeeeccCceEEEEEEEC----CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML----GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~----g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
..+|.....||.|+||.||++... +..||||.+... ..+.+|+.+|..++|||||++++++.. ..++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 457999999999999999999764 467999987643 245689999999999999999998853 578999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
+++. ++|.+++... ..+++..++.|+.||+.||.|||..+ |+||||||+|||++.++.+||+|||++......
T Consensus 166 e~~~-~~l~~~l~~~---~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9986 6788877332 46899999999999999999999965 999999999999999999999999999866543
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh------HHHHhh---cCccc--
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE------VRRAVS---CGKLS-- 563 (688)
Q Consensus 495 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~------~~~~~~---~g~l~-- 563 (688)
... .......||+.|+|||++....++.++|||||||++|||++|+.||..... +...+. .....
T Consensus 239 ~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~ 314 (392)
T PHA03207 239 PDT----PQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFP 314 (392)
T ss_pred ccc----ccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccC
Confidence 211 122356799999999999999999999999999999999999999853211 111111 00000
Q ss_pred ------------cccCCCCCC--CC-----HHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 564 ------------SILDPLAGD--WP-----TFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 564 ------------~~ld~~~~~--~~-----~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
......... .+ ......+.+++.+||..||.+||++.+.+
T Consensus 315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l 373 (392)
T PHA03207 315 QNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDIL 373 (392)
T ss_pred CccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHh
Confidence 000000000 01 11245688899999999999999998544
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=326.06 Aligned_cols=246 Identities=27% Similarity=0.393 Sum_probs=202.1
Q ss_pred eeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCCCc--eeEEecCCCCcHHH
Q 005617 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAW--SLVYEYLPNGSLQD 424 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~~~--~LV~E~~~~gsL~~ 424 (688)
+||+|.||+||-|++. ...+|||-+.........-+..|+.+-+.|+|.|||+++|+|.++. -+.||-++||||.+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs 661 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS 661 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence 6999999999999987 4568999997766666666889999999999999999999997653 37899999999999
Q ss_pred HhcccCCCCCC--CHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeC-CCCCeEEeecCccccccCCCCcCCCc
Q 005617 425 RLFRKSNVSPL--LWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD-SELSSKICDFGICRLVTEDTLYLPSF 501 (688)
Q Consensus 425 ~L~~~~~~~~l--~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd-~~~~vKLsDFGla~~~~~~~~~~~~~ 501 (688)
.|...= +|+ ++...-.+..||+.||.|||.+. |||||||-+|||++ -.|.+||+|||-++.+..-.
T Consensus 662 LLrskW--GPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin------ 730 (1226)
T KOG4279|consen 662 LLRSKW--GPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN------ 730 (1226)
T ss_pred HHHhcc--CCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC------
Confidence 997543 345 67778889999999999999977 99999999999997 46899999999999875322
Q ss_pred cccCCCCCCCCCCChhhhccC--CCCCcchHhHHHHHHHHHHhCCCCCCChhhHHH-HhhcCccccccCCCCCCCCHHHH
Q 005617 502 HRSTAPKGSFPYADPEYHRTG--VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR-AVSCGKLSSILDPLAGDWPTFVA 578 (688)
Q Consensus 502 ~~~~~~~GT~~Y~APE~~~~~--~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~-~~~~g~l~~~ld~~~~~~~~~~~ 578 (688)
..+.++.||..|||||++..+ .|+..+|||||||.+.||.||++||-..+.... +..-|.+.. -.+.|...+
T Consensus 731 P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKv-----HP~iPeels 805 (1226)
T KOG4279|consen 731 PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKV-----HPPIPEELS 805 (1226)
T ss_pred ccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceec-----CCCCcHHHH
Confidence 134567899999999999765 689999999999999999999999965443322 233343221 235788899
Q ss_pred HHHHHHHHHccccCCCCCCCCchHHHHHHHHh
Q 005617 579 RRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 579 ~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l 610 (688)
.+...++++|+.++|.+||++.+.+.+.+-..
T Consensus 806 aeak~FilrcFepd~~~R~sA~~LL~DpFlq~ 837 (1226)
T KOG4279|consen 806 AEAKNFILRCFEPDPCDRPSAKDLLQDPFLQH 837 (1226)
T ss_pred HHHHHHHHHHcCCCcccCccHHHhccCccccc
Confidence 99999999999999999999997766555433
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=344.08 Aligned_cols=248 Identities=27% Similarity=0.308 Sum_probs=201.4
Q ss_pred HHHHHHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHcCCCCceeeEecccCC
Q 005617 334 LADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACPE 408 (688)
Q Consensus 334 ~~el~~at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~---~~~~f~~E~~iL~~l~HpnIV~l~g~~~~ 408 (688)
..+++.-..+|.+.++||+|+||.|..++.. ++.||+|++++..+- ...-|..|.+||..-+.++||.|..+|++
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 3455566678999999999999999999886 788999999885543 34459999999999999999999999976
Q ss_pred --CceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecC
Q 005617 409 --AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFG 486 (688)
Q Consensus 409 --~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFG 486 (688)
++|||||||+||+|-.++.+.. +++...+..++..|+.||.-||+.| +|||||||+|||||..|++||+|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~~---~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKFD---RLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhcC---CChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 4889999999999999997654 6888999999999999999999987 9999999999999999999999999
Q ss_pred ccccccCCCCcCCCccccCCCCCCCCCCChhhhc----c-CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCc
Q 005617 487 ICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR----T-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGK 561 (688)
Q Consensus 487 la~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~----~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~ 561 (688)
.|-.+..+... .....+|||.|++||++. + +.|++.||+||+||++||||.|..||....-+...-..-+
T Consensus 221 sClkm~~dG~V-----~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~ 295 (1317)
T KOG0612|consen 221 SCLKMDADGTV-----RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMN 295 (1317)
T ss_pred hHHhcCCCCcE-----EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhc
Confidence 99888754432 456789999999999884 2 6799999999999999999999999964443332211111
Q ss_pred cccccCCCCCCCC--HHHHHHHHHHHHHccccCCCCCCC
Q 005617 562 LSSILDPLAGDWP--TFVARRLVDLGLQCCELYGRERPD 598 (688)
Q Consensus 562 l~~~ld~~~~~~~--~~~~~~l~~L~~~Cl~~dP~~RPs 598 (688)
..+.+ .+| ..++....+||.+.+. +|..|-.
T Consensus 296 hk~~l-----~FP~~~~VSeeakdLI~~ll~-~~e~RLg 328 (1317)
T KOG0612|consen 296 HKESL-----SFPDETDVSEEAKDLIEALLC-DREVRLG 328 (1317)
T ss_pred hhhhc-----CCCcccccCHHHHHHHHHHhc-Chhhhcc
Confidence 11111 233 3467788888887665 5677765
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=309.20 Aligned_cols=256 Identities=23% Similarity=0.252 Sum_probs=200.4
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~---~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|...+.||.|+||.||+|... +..||||.+...... ....+..|+.++..++||||+++++.+.+ ..++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36888899999999999999885 789999999765443 34468899999999999999999999854 478999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
||+.+++|.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQP-GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhCC-CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 9999999999886432 256899999999999999999999966 999999999999999999999999998765432
Q ss_pred CCcC-----------------------CCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh
Q 005617 495 TLYL-----------------------PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG 551 (688)
Q Consensus 495 ~~~~-----------------------~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~ 551 (688)
.... ..........||..|+|||++.+..++.++||||||+++|+|++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 1100 00011224578999999999999999999999999999999999999997554
Q ss_pred hHHHHh--hcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHH
Q 005617 552 EVRRAV--SCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 552 ~~~~~~--~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le 608 (688)
...... ...... . ......+..+.+++.+||..+|.+||+....+.+.|.
T Consensus 237 ~~~~~~~~~~~~~~------~-~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 237 RDETFSNILKKEVT------F-PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred hHHHHHHHhcCCcc------C-CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 322211 111110 0 0111156789999999999999999996644443433
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-35 Score=300.19 Aligned_cols=247 Identities=24% Similarity=0.340 Sum_probs=200.1
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC----CceeEE
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE----AWSLVY 414 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~----~~~LV~ 414 (688)
+|...+.||.|+||.||++... |..||+|++..... .....+..|+.+++.++||||+++++++.. ..+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4677789999999999999875 78899999876543 234568899999999999999999997732 368999
Q ss_pred ecCCCCcHHHHhccc-CCCCCCCHHHHHHHHHHHHHHHHHHhccC--CCceEeCCCCCCceeeCCCCCeEEeecCccccc
Q 005617 415 EYLPNGSLQDRLFRK-SNVSPLLWKDRARIAAEIASGLCFLHSSK--PEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491 (688)
Q Consensus 415 E~~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~--~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~ 491 (688)
||+++++|.+++... ....++++..++.++.+++.||.|||..+ ..+|+|+||+|+||+++.++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998654 22357899999999999999999999432 245999999999999999999999999999877
Q ss_pred cCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCC
Q 005617 492 TEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPL 569 (688)
Q Consensus 492 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~ 569 (688)
..... ......|++.|+|||++....++.++||||||+++|+|++|+.||..... ....+..+..
T Consensus 161 ~~~~~------~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------- 227 (265)
T cd08217 161 GHDSS------FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKF------- 227 (265)
T ss_pred cCCcc------cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCC-------
Confidence 54331 12345689999999999998999999999999999999999999975432 2222222221
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 570 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 570 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
...+...+..+.+++.+|++.+|.+||++.+.+
T Consensus 228 -~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il 260 (265)
T cd08217 228 -RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELL 260 (265)
T ss_pred -CCCccccCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 233445667899999999999999999998543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=300.16 Aligned_cols=242 Identities=29% Similarity=0.400 Sum_probs=196.3
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-----cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeE
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-----QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLV 413 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~-----~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV 413 (688)
+|.....||+|+||.||+|... +..|++|.+..... .....+.+|+.+++.++||||+++++++.+ ..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3666788999999999999885 88999999865432 234568899999999999999999999854 47899
Q ss_pred EecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccC
Q 005617 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~ 493 (688)
|||+++++|.+++... ..+++..+..++.+++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKKY---GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 9999999999998654 35789999999999999999999966 99999999999999999999999999887643
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCC-CCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCccccccCCCCCC
Q 005617 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGV-LTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~l~~~ld~~~~~ 572 (688)
.. ......|++.|++||.+.... ++.++|+|||||++|+|++|+.||............+.... ...
T Consensus 155 ~~-------~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-----~~~ 222 (258)
T cd06632 155 FS-------FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE-----LPP 222 (258)
T ss_pred cc-------cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc-----CCC
Confidence 32 123456899999999987766 89999999999999999999999975543322222221111 112
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCCchH
Q 005617 573 WPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 573 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
.+......+.+++.+||+.+|.+||++.+.
T Consensus 223 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~ 252 (258)
T cd06632 223 IPDHLSDEAKDFILKCLQRDPSLRPTAAEL 252 (258)
T ss_pred cCCCcCHHHHHHHHHHhhcCcccCcCHHHH
Confidence 233456788999999999999999998843
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=307.18 Aligned_cols=254 Identities=21% Similarity=0.236 Sum_probs=197.0
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|...+.||.|+||.||++... +..||||.+..... .....+.+|+.++..++||||+++++++.. ..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888899999999999999886 68899999876543 233468899999999999999999998854 368999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
||++|++|.+++... ..+++..+..++.+++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKNI---GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 999999999998654 35889999999999999999999965 999999999999999999999999998743211
Q ss_pred CCc---------CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh--hHHHHhhcCccc
Q 005617 495 TLY---------LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLS 563 (688)
Q Consensus 495 ~~~---------~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~--~~~~~~~~g~l~ 563 (688)
... ...........|+..|+|||++....++.++|||||||++|||++|..||.... .+......+...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~ 234 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE 234 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC
Confidence 100 000011123468889999999988899999999999999999999999996432 222222222211
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHH
Q 005617 564 SILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 564 ~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le 608 (688)
.+.. +...+..+.+++.+||+.+|.+||+.. .+.+.|+
T Consensus 235 ---~~~~---~~~~~~~~~~li~~~l~~~P~~R~~~~-~~~~ll~ 272 (305)
T cd05609 235 ---WPEG---DEALPADAQDLISRLLRQNPLERLGTG-GAFEVKQ 272 (305)
T ss_pred ---CCCc---cccCCHHHHHHHHHHhccChhhccCcc-CHHHHHh
Confidence 1111 113456789999999999999999986 3444444
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=303.37 Aligned_cols=251 Identities=24% Similarity=0.411 Sum_probs=196.3
Q ss_pred cccceeeeccCceEEEEEEEC-----CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC--------
Q 005617 344 FSESFKVGQGGFGCVYKGEML-----GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE-------- 408 (688)
Q Consensus 344 f~~~~~LG~G~fG~Vykg~~~-----g~~vAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-------- 408 (688)
|...+.||+|+||.||+|.+. +..||||++..... .....+.+|+.+++.++||||+++++++..
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 455678999999999999863 57899999876432 335568899999999999999999998732
Q ss_pred CceeEEecCCCCcHHHHhcccC---CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeec
Q 005617 409 AWSLVYEYLPNGSLQDRLFRKS---NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDF 485 (688)
Q Consensus 409 ~~~LV~E~~~~gsL~~~L~~~~---~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDF 485 (688)
..+++++|+++|+|.+++.... ....+++.....++.|++.||.|||+.+ |+||||||+||+++.++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 1368899999999998875321 2235789999999999999999999965 999999999999999999999999
Q ss_pred CccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHHHhhcCcc
Q 005617 486 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKL 562 (688)
Q Consensus 486 Gla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~~~~g~l 562 (688)
|+++........ .......+++.|++||.+....++.++|||||||++|+|++ |++||..... ....+..+..
T Consensus 158 g~~~~~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 233 (273)
T cd05074 158 GLSKKIYSGDYY----RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNR 233 (273)
T ss_pred cccccccCCcce----ecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCc
Confidence 999876433211 11223446678999999999999999999999999999999 8899864432 2222322221
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHh
Q 005617 563 SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 563 ~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l 610 (688)
. ..+......+.+++.+||+.+|.+||++. ++...|+.+
T Consensus 234 ~--------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~-~~~~~l~~~ 272 (273)
T cd05074 234 L--------KQPPDCLEDVYELMCQCWSPEPKCRPSFQ-HLRDQLELI 272 (273)
T ss_pred C--------CCCCCCCHHHHHHHHHHcCCChhhCcCHH-HHHHHHHhh
Confidence 1 11223456899999999999999999998 677777643
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=315.97 Aligned_cols=242 Identities=24% Similarity=0.361 Sum_probs=205.8
Q ss_pred CcccceeeeccCceEEEEEEE--CCeEEEEEEEecCCccch--HHHHHHHHHHHcCCCCceeeEecccC--CCceeEEec
Q 005617 343 NFSESFKVGQGGFGCVYKGEM--LGRTVAIKMLYSHNMQGQ--LEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 416 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~--~g~~vAIK~l~~~~~~~~--~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~ 416 (688)
=|...+.||+|.|+.|-++++ .|..||||++.+...... ..+.+|+..|..++|||||+||.+.. ..+|||+|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 356667899999999999876 599999999988776543 46889999999999999999999974 469999999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceee-CCCCCeEEeecCccccccCCC
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL-DSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILL-d~~~~vKLsDFGla~~~~~~~ 495 (688)
-++|+|.+++.+.. ..+.+....+++.||+.|+.|+|..+ +|||||||+||.+ ..-|-|||+|||++..+.++.
T Consensus 99 GD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred cCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 99999999998876 46888999999999999999999987 9999999999876 567899999999998887665
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCCCC-CcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCccccccCCCCCCCC
Q 005617 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLT-PKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWP 574 (688)
Q Consensus 496 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s-~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~l~~~ld~~~~~~~ 574 (688)
.-...+|+..|.|||++.+..|+ |.+||||||||||-|++|++||....+.+.. .-++|- ....|
T Consensus 174 -------kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL------TmImDC-KYtvP 239 (864)
T KOG4717|consen 174 -------KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL------TMIMDC-KYTVP 239 (864)
T ss_pred -------hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh------hhhhcc-cccCc
Confidence 33577899999999999999886 7899999999999999999999755443221 111221 22467
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 575 TFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 575 ~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
..++.++.+||..||..||++|.++.+++
T Consensus 240 shvS~eCrdLI~sMLvRdPkkRAslEeI~ 268 (864)
T KOG4717|consen 240 SHVSKECRDLIQSMLVRDPKKRASLEEIV 268 (864)
T ss_pred hhhhHHHHHHHHHHHhcCchhhccHHHHh
Confidence 88999999999999999999999987444
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=317.03 Aligned_cols=241 Identities=26% Similarity=0.298 Sum_probs=187.2
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|...+.||+|+||.||+++.. +..||||++..... .....+.+|+.++..++|+||+++++++.+ ..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888899999999999999885 78899999875322 223458889999999999999999999854 478999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
||++||+|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 81 Ey~~gg~L~~~l~~~~--~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKFE--DRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999997643 35788999999999999999999965 999999999999999999999999999876543
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhcc-----CCCCCcchHhHHHHHHHHHHhCCCCCCChhhH--HHHhhcCccccccC
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRT-----GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILD 567 (688)
Q Consensus 495 ~~~~~~~~~~~~~~GT~~Y~APE~~~~-----~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~~~~g~l~~~ld 567 (688)
... ......||+.|+|||++.+ +.++.++|||||||+||||++|+.||...... ...+......-.+.
T Consensus 156 ~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p 230 (331)
T cd05624 156 GTV-----QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFP 230 (331)
T ss_pred Cce-----eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCC
Confidence 211 1234579999999999875 56889999999999999999999999654322 12221111000000
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCC
Q 005617 568 PLAGDWPTFVARRLVDLGLQCCELYGRERP 597 (688)
Q Consensus 568 ~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RP 597 (688)
......+..+.+|+.+|+..++ +|+
T Consensus 231 ----~~~~~~~~~~~~li~~ll~~~~-~~~ 255 (331)
T cd05624 231 ----SHITDVSEEAKDLIQRLICSRE-RRL 255 (331)
T ss_pred ----CccccCCHHHHHHHHHHccCch-hhc
Confidence 1111245678889999988654 444
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-36 Score=307.26 Aligned_cols=245 Identities=32% Similarity=0.478 Sum_probs=194.0
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchH--HHHHHHHHHHcCCCCceeeEecccC--CCceeEEecC
Q 005617 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 417 (688)
Q Consensus 344 f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~--~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~ 417 (688)
|...+.||+|+||+||++... +..||+|++......... ...+|+.++.+++||||+++++++. ...++||+|+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 456789999999999999997 678999999887654433 3456999999999999999999984 4578999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCc
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~ 497 (688)
++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~~L~~~l~~~---~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~-- 152 (260)
T PF00069_consen 81 PGGSLQDYLQKN---KPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSENN-- 152 (260)
T ss_dssp TTEBHHHHHHHH---SSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTSTT--
T ss_pred cccccccccccc---cccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc--
Confidence 999999999732 46799999999999999999999965 9999999999999999999999999997642111
Q ss_pred CCCccccCCCCCCCCCCChhhhc-cCCCCCcchHhHHHHHHHHHHhCCCCCCChh--hHHHHhhcCccccccCCCCCCCC
Q 005617 498 LPSFHRSTAPKGSFPYADPEYHR-TGVLTPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSILDPLAGDWP 574 (688)
Q Consensus 498 ~~~~~~~~~~~GT~~Y~APE~~~-~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~--~~~~~~~~g~l~~~ld~~~~~~~ 574 (688)
.......||+.|+|||++. +..++.++||||||+++|+|++|..||.... .....+............ ...
T Consensus 153 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~--~~~ 226 (260)
T PF00069_consen 153 ----ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSS--QQS 226 (260)
T ss_dssp ----SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHT--TSH
T ss_pred ----cccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccc--ccc
Confidence 1235667899999999998 8889999999999999999999999998651 111111111000000000 000
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCCchH
Q 005617 575 TFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 575 ~~~~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
......+.+++.+||+.||.+||++.+.
T Consensus 227 ~~~~~~l~~li~~~l~~~p~~R~~~~~l 254 (260)
T PF00069_consen 227 REKSEELRDLIKKMLSKDPEQRPSAEEL 254 (260)
T ss_dssp TTSHHHHHHHHHHHSSSSGGGSTTHHHH
T ss_pred chhHHHHHHHHHHHccCChhHCcCHHHH
Confidence 0113789999999999999999998843
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=300.04 Aligned_cols=253 Identities=25% Similarity=0.285 Sum_probs=200.2
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEec
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 416 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~ 416 (688)
++|...+.||.|+||+||+|... +..||+|++..... .....+.+|+.+++.++|+||+++++.+. +..++||||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888899999999999999874 78899999975543 34567899999999999999999999874 357899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCC
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~ 496 (688)
+++++|.+++........+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999976543356899999999999999999999866 99999999999999999999999999987764432
Q ss_pred cCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHh--hcCccccccCCCCCCC
Q 005617 497 YLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAV--SCGKLSSILDPLAGDW 573 (688)
Q Consensus 497 ~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~--~~g~l~~~ld~~~~~~ 573 (688)
.. ........|+..|+|||++... .++.++|||||||++|+|++|+.||.......... ..+... .+.. ...
T Consensus 158 ~~--~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~--~~~ 232 (267)
T cd06610 158 RT--RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPP-SLET--GAD 232 (267)
T ss_pred cc--ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCC-CcCC--ccc
Confidence 11 0122445689999999998877 78999999999999999999999997543321111 111100 0000 001
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCCchH
Q 005617 574 PTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 574 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
....+..+.+++.+||..||.+||++.+.
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l 261 (267)
T cd06610 233 YKKYSKSFRKMISLCLQKDPSKRPTAEEL 261 (267)
T ss_pred cccccHHHHHHHHHHcCCChhhCcCHHHH
Confidence 12456788999999999999999998743
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=300.07 Aligned_cols=245 Identities=25% Similarity=0.329 Sum_probs=194.7
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-----cchHHHHHHHHHHHcCCCCceeeEecccCC----Cc
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-----QGQLEFQQEVRVLSKLQHPHLVTLLGACPE----AW 410 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~-----~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~----~~ 410 (688)
.+|...+.||+|+||.||+|... |..||||.+..... .....+.+|+.++.+++||||+++++++.+ ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888899999999999999875 78999998864321 123468899999999999999999998854 36
Q ss_pred eeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCcccc
Q 005617 411 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~ 490 (688)
++||||+++++|.+++.... .+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG---ALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 78999999999999886543 4788889999999999999999966 99999999999999999999999999986
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCccccccCCCC
Q 005617 491 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~l~~~ld~~~ 570 (688)
....... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||............. ..+..
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~-----~~~~~ 227 (265)
T cd06652 156 LQTICLS---GTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA-----TQPTN 227 (265)
T ss_pred ccccccc---ccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh-----cCCCC
Confidence 5432111 011234568999999999988889999999999999999999999997543322211110 11112
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCCch
Q 005617 571 GDWPTFVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 571 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~ 601 (688)
...|......+.+++.+|+. +|..||++.+
T Consensus 228 ~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~ 257 (265)
T cd06652 228 PVLPPHVSDHCRDFLKRIFV-EAKLRPSADE 257 (265)
T ss_pred CCCchhhCHHHHHHHHHHhc-ChhhCCCHHH
Confidence 23455667788899999994 9999999874
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=303.36 Aligned_cols=249 Identities=26% Similarity=0.347 Sum_probs=196.2
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC----CceeEE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE----AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~----~~~LV~ 414 (688)
++|...+.||.|++|.||+|.+. +..||+|.+..... .....+.+|+.++++++||||++++++|.+ ..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 46788899999999999999985 78899999875433 345568999999999999999999998843 368999
Q ss_pred ecCCCCcHHHHhccc-CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccC
Q 005617 415 EYLPNGSLQDRLFRK-SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 415 E~~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~ 493 (688)
||+++++|.+++... .....+++..+..|+.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 999999999887542 22356788999999999999999999965 99999999999999999999999999876543
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh-------hHHHHhhcCcccccc
Q 005617 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG-------EVRRAVSCGKLSSIL 566 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~-------~~~~~~~~g~l~~~l 566 (688)
.. .....++..|+|||.+.+..++.++|||||||++|+|++|+.||.... .....+.......+.
T Consensus 158 ~~--------~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd06621 158 SL--------AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELK 229 (287)
T ss_pred cc--------cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhc
Confidence 22 123457889999999999999999999999999999999999997541 111111111111111
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 567 DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 567 d~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
+... .....+..+.+++.+||..+|.+||++.+.+
T Consensus 230 ~~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil 264 (287)
T cd06621 230 DEPG--NGIKWSEEFKDFIKQCLEKDPTRRPTPWDML 264 (287)
T ss_pred cCCC--CCCchHHHHHHHHHHHcCCCcccCCCHHHHH
Confidence 1101 0012456789999999999999999998443
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=298.53 Aligned_cols=242 Identities=21% Similarity=0.280 Sum_probs=197.8
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC--ccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEec
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~--~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
+|+..+.||.|+||.||.++.. +..|++|.+.... ......+.+|+.++++++|+||+++++++.+ ..++||||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4788899999999999888764 8889999986543 3345578899999999999999999999854 47889999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCC
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~ 496 (688)
+++|+|.+++.... ...+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999987653 246899999999999999999999966 99999999999999999999999999987654331
Q ss_pred cCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCCCCCCC
Q 005617 497 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWP 574 (688)
Q Consensus 497 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~ 574 (688)
......|++.|+|||++.+..++.++||||||+++|+|++|..||..... ....+..+.... .+
T Consensus 157 ------~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~--------~~ 222 (256)
T cd08221 157 ------MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP--------VV 222 (256)
T ss_pred ------cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC--------Cc
Confidence 12345689999999999888899999999999999999999999975332 122222332221 12
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCCchH
Q 005617 575 TFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 575 ~~~~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
...+..+.+++.+||+.+|.+||++.+.
T Consensus 223 ~~~~~~~~~~i~~~l~~~p~~R~s~~~l 250 (256)
T cd08221 223 SVYSSELISLVHSLLQQDPEKRPTADEV 250 (256)
T ss_pred cccCHHHHHHHHHHcccCcccCCCHHHH
Confidence 3345678999999999999999998843
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=300.32 Aligned_cols=242 Identities=26% Similarity=0.379 Sum_probs=196.0
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEec
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 416 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~ 416 (688)
+|.....||.|+||.||++... +..||||.+..... .....+.+|+.+++.++||||+++++.+. +..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4777889999999999998874 78899999876543 23457899999999999999999999874 347899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCC-CCeEEeecCccccccCCC
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE-LSSKICDFGICRLVTEDT 495 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~-~~vKLsDFGla~~~~~~~ 495 (688)
+++++|.+++.... ...+++..+..++.+++.||.|||+.+ |+|+||+|+||+++.+ +.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKRC-NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999997643 245889999999999999999999965 9999999999999855 468999999998765432
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHH--HhhcCccccccCCCCCCC
Q 005617 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR--AVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 496 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~--~~~~g~l~~~ld~~~~~~ 573 (688)
......|+..|+|||.+....++.++||||||+++|+|++|+.||........ .+..+.. ...
T Consensus 157 -------~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~--------~~~ 221 (256)
T cd08220 157 -------KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF--------API 221 (256)
T ss_pred -------cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC--------CCC
Confidence 12345689999999999988899999999999999999999999975432111 1111111 122
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 574 PTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 574 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
+...+..+.+++.+||+.+|.+||++.+.+
T Consensus 222 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll 251 (256)
T cd08220 222 SDRYSPDLRQLILSMLNLDPSKRPQLSQIM 251 (256)
T ss_pred CCCcCHHHHHHHHHHccCChhhCCCHHHHh
Confidence 333566789999999999999999998544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=303.38 Aligned_cols=250 Identities=28% Similarity=0.439 Sum_probs=198.5
Q ss_pred cCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccCC--Cce
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWS 411 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~-------g~~vAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~ 411 (688)
.+|.....||.|+||.||+|+.. ...|++|.+...... ....|.+|+.++.+++||||++++++|.+ ..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46778889999999999999863 356999988665443 34679999999999999999999999854 578
Q ss_pred eEEecCCCCcHHHHhcccCCC------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeec
Q 005617 412 LVYEYLPNGSLQDRLFRKSNV------SPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDF 485 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~~~~------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDF 485 (688)
+||||+++|+|.+++...... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998755421 26899999999999999999999966 999999999999999999999999
Q ss_pred CccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHHHhhcCcc
Q 005617 486 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKL 562 (688)
Q Consensus 486 Gla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~~~~g~l 562 (688)
|++........ .......+++.|+|||.+.+..+++++|||||||++|+|++ |..||..... +......+.+
T Consensus 162 ~~~~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~ 236 (275)
T cd05046 162 SLSKDVYNSEY-----YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL 236 (275)
T ss_pred ccccccCcccc-----cccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCc
Confidence 99875432211 12234456788999999988889999999999999999999 8889864322 2233333322
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHH
Q 005617 563 SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 563 ~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~L 607 (688)
... .+...+..+.+++.+||+.+|.+||++. +++..|
T Consensus 237 ~~~-------~~~~~~~~l~~~i~~~l~~~p~~Rp~~~-~~l~~l 273 (275)
T cd05046 237 ELP-------VPEGCPSRLYKLMTRCWAVNPKDRPSFS-ELVSAL 273 (275)
T ss_pred CCC-------CCCCCCHHHHHHHHHHcCCCcccCCCHH-HHHHHh
Confidence 211 1223456899999999999999999998 455444
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=302.96 Aligned_cols=248 Identities=27% Similarity=0.354 Sum_probs=197.6
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcC-CCCceeeEecccCC-------
Q 005617 339 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE------- 408 (688)
Q Consensus 339 ~at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~------- 408 (688)
.++++|.....||.|+||.||+|... +..|++|++..... ....|.+|+.++.++ .||||++++++|.+
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 45789999999999999999999985 68899999876543 346789999999999 79999999999832
Q ss_pred -CceeEEecCCCCcHHHHhcccC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecC
Q 005617 409 -AWSLVYEYLPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFG 486 (688)
Q Consensus 409 -~~~LV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFG 486 (688)
..++||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 2589999999999999886532 2356899999999999999999999966 9999999999999999999999999
Q ss_pred ccccccCCCCcCCCccccCCCCCCCCCCChhhhcc-----CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHH--hhc
Q 005617 487 ICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-----GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VSC 559 (688)
Q Consensus 487 la~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-----~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~--~~~ 559 (688)
++....... .......|++.|+|||++.. ..++.++|||||||+||+|+||+.||......... +..
T Consensus 159 ~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 232 (275)
T cd06608 159 VSAQLDSTL------GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPR 232 (275)
T ss_pred cceecccch------hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhc
Confidence 987654322 12234568999999998753 34678999999999999999999999643322111 111
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchH
Q 005617 560 GKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 560 g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
+... ....+...+..+.+|+.+||..||.+|||+.+.
T Consensus 233 ~~~~------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~l 269 (275)
T cd06608 233 NPPP------TLKSPENWSKKFNDFISECLIKNYEQRPFMEEL 269 (275)
T ss_pred cCCC------CCCchhhcCHHHHHHHHHHhhcChhhCcCHHHH
Confidence 1111 111223356688999999999999999999843
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=303.55 Aligned_cols=249 Identities=24% Similarity=0.319 Sum_probs=193.2
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEe
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E 415 (688)
++|.....||+|+||.||+|.+. |..||+|++..... .....+.+|+.++..++||||++++++|.. ..++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36788889999999999999885 78999999865432 234568899999999999999999999854 4789999
Q ss_pred cCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCC
Q 005617 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~ 495 (688)
|+++++|..++... ..+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEKNP---RGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHhCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 99999988876543 35899999999999999999999965 9999999999999999999999999998765432
Q ss_pred CcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhh----cCc---------
Q 005617 496 LYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS----CGK--------- 561 (688)
Q Consensus 496 ~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~----~g~--------- 561 (688)
. ......|+..|+|||++.+ ..++.++|||||||++|+|++|++||........... .+.
T Consensus 155 ~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07847 155 D------DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIF 228 (286)
T ss_pred c------cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhc
Confidence 1 1234468889999998865 5678999999999999999999999975433211110 000
Q ss_pred ----c-ccccCCCCCC-C-----CHHHHHHHHHHHHHccccCCCCCCCCchH
Q 005617 562 ----L-SSILDPLAGD-W-----PTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 562 ----l-~~~ld~~~~~-~-----~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
. .....+.... . -...+..+.+|+.+||+.+|++||++.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ei 280 (286)
T cd07847 229 STNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEEL 280 (286)
T ss_pred ccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHH
Confidence 0 0000010000 0 01235678999999999999999998843
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-35 Score=327.80 Aligned_cols=248 Identities=21% Similarity=0.290 Sum_probs=190.1
Q ss_pred HhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEe
Q 005617 340 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYE 415 (688)
Q Consensus 340 at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E 415 (688)
...+|.....||+|+||.||++.+. +..||||.... ..+.+|+.+|++++|||||++++++. ...+|||+
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 3567999999999999999999986 68899996432 24678999999999999999999874 35789999
Q ss_pred cCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCC
Q 005617 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~ 495 (688)
++. ++|..++.... ..++|..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+++......
T Consensus 241 ~~~-~~L~~~l~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 241 KYR-SDLYTYLGARL--RPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred ccC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 995 68888775432 36899999999999999999999966 9999999999999999999999999998764322
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCCh----------hhHHHHhhcCcccc-
Q 005617 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLA----------GEVRRAVSCGKLSS- 564 (688)
Q Consensus 496 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~----------~~~~~~~~~g~l~~- 564 (688)
.. .......||+.|+|||++.+..++.++|||||||+||||++|..|+... ..+...+.......
T Consensus 315 ~~----~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~ 390 (461)
T PHA03211 315 ST----PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVD 390 (461)
T ss_pred cc----ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccc
Confidence 11 1123467999999999999999999999999999999999988664211 12222222221110
Q ss_pred ccC--------------------C--CCCCCCH--HHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 565 ILD--------------------P--LAGDWPT--FVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 565 ~ld--------------------~--~~~~~~~--~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
.+. + ....|.. .....+.+|+.+||+.||.+|||+.+.+
T Consensus 391 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL 453 (461)
T PHA03211 391 EFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELL 453 (461)
T ss_pred cCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHh
Confidence 000 0 0011111 1234688999999999999999988443
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-35 Score=311.79 Aligned_cols=253 Identities=18% Similarity=0.210 Sum_probs=188.6
Q ss_pred ceeeecc--CceEEEEEEEC--CeEEEEEEEecCCcc--chHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEecCC
Q 005617 347 SFKVGQG--GFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLP 418 (688)
Q Consensus 347 ~~~LG~G--~fG~Vykg~~~--g~~vAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~~ 418 (688)
..+||+| +||+||++... |..||||++...... ....+.+|+.+++.++|||||+++++|. +..++||||++
T Consensus 3 ~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~ 82 (327)
T cd08227 3 LTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82 (327)
T ss_pred hhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccC
Confidence 3579999 78999999875 889999999765332 2345778999999999999999999984 45889999999
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcC
Q 005617 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~ 498 (688)
+|+|.+++..... ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.++++|||.+..........
T Consensus 83 ~~~l~~~~~~~~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~ 158 (327)
T cd08227 83 YGSAKDLICTHFM-DGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL 158 (327)
T ss_pred CCcHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence 9999999865422 35899999999999999999999966 9999999999999999999999998765443211100
Q ss_pred -CCccccCCCCCCCCCCChhhhcc--CCCCCcchHhHHHHHHHHHHhCCCCCCChhhH--HHHhhcCccccccCCC----
Q 005617 499 -PSFHRSTAPKGSFPYADPEYHRT--GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPL---- 569 (688)
Q Consensus 499 -~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~~~~g~l~~~ld~~---- 569 (688)
..........++..|+|||++.+ ..++.++|||||||++|||++|+.||...... ......+.+...++..
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence 00011223457888999999876 46899999999999999999999999643221 1111111111111100
Q ss_pred ---------------------------------CCCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 570 ---------------------------------AGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 570 ---------------------------------~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
...+.......+.+|+.+||+.||.+|||+.+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell 305 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLL 305 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHh
Confidence 0011223456889999999999999999998443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-35 Score=301.15 Aligned_cols=247 Identities=23% Similarity=0.399 Sum_probs=196.3
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc------chHHHHHHHHHHHcCCCCceeeEecccCC--Ccee
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ------GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSL 412 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~------~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~L 412 (688)
+|.....||+|+||.||+|... +..||+|++...... ....+.+|+.++++++||||++++++|.+ ..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4777889999999999999874 889999998754321 23568899999999999999999999854 4789
Q ss_pred EEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCC-CeEEeecCccccc
Q 005617 413 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL-SSKICDFGICRLV 491 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~-~vKLsDFGla~~~ 491 (688)
||||+++++|.+++... .++++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY---GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 99999999999998653 36889999999999999999999965 99999999999998776 5999999999877
Q ss_pred cCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh---HHHHhhcCccccccCC
Q 005617 492 TEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE---VRRAVSCGKLSSILDP 568 (688)
Q Consensus 492 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~---~~~~~~~g~l~~~ld~ 568 (688)
........ .......||..|+|||++.+..++.++||||||+++|+|++|..||..... .......... .
T Consensus 155 ~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~ 227 (268)
T cd06630 155 AAKGTGAG--EFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA-----T 227 (268)
T ss_pred ccccccCC--ccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc-----C
Confidence 54321110 112345689999999999888999999999999999999999999963221 1111111000 0
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCCchH
Q 005617 569 LAGDWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 569 ~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
.....+......+.+++.+|+..+|.+||++.+.
T Consensus 228 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~l 261 (268)
T cd06630 228 TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSREL 261 (268)
T ss_pred CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHH
Confidence 1224455667889999999999999999999843
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-35 Score=299.88 Aligned_cols=243 Identities=24% Similarity=0.342 Sum_probs=197.5
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEec
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
+|...+.||+|+||.||++... |..||||.+..... .....+.+|+.++++++||||+++++++.+ ..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999874 78999999875432 334578999999999999999999999854 47899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCC
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~ 496 (688)
+++++|.+.+..... ..+++..++.|+.|++.||.|||+.+ ++|+||+|+|||++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQRG-VLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 999999998865432 35789999999999999999999965 99999999999999999999999999987643221
Q ss_pred cCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCCCCCCC
Q 005617 497 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWP 574 (688)
Q Consensus 497 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~ 574 (688)
......|++.|+|||++.+..++.++|||||||++|+|+||+.||..... ....+..+... ..+
T Consensus 157 ------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~--------~~~ 222 (256)
T cd08218 157 ------LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYP--------PVS 222 (256)
T ss_pred ------hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCC--------CCc
Confidence 12344688999999999999999999999999999999999999864332 11112222211 123
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 575 TFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 575 ~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
......+.+++.+||+.+|.+||++.+.+
T Consensus 223 ~~~~~~~~~li~~~l~~~p~~Rp~~~~vl 251 (256)
T cd08218 223 SHYSYDLRNLVSQLFKRNPRDRPSVNSIL 251 (256)
T ss_pred ccCCHHHHHHHHHHhhCChhhCcCHHHHh
Confidence 34566899999999999999999998544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=301.17 Aligned_cols=247 Identities=24% Similarity=0.359 Sum_probs=193.3
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--c--------chHHHHHHHHHHHcCCCCceeeEecccC--C
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--Q--------GQLEFQQEVRVLSKLQHPHLVTLLGACP--E 408 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~--~--------~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~ 408 (688)
+|...+.||.|+||.||+|... |..||||.+..... . ....+..|+.++..++||||+++++++. +
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4666789999999999999764 88999998854211 1 1235788999999999999999999984 4
Q ss_pred CceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCcc
Q 005617 409 AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 488 (688)
Q Consensus 409 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla 488 (688)
..++||||+++|+|.+++... ..+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 578999999999999998765 46889999999999999999999965 999999999999999999999999999
Q ss_pred ccccCCCCcCCCccccCCCCCCCCCCChhhhccCC--CCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhc--Ccccc
Q 005617 489 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV--LTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC--GKLSS 564 (688)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~--~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~--g~l~~ 564 (688)
+........ .......|+..|+|||++.... ++.++||||||+++|+|++|..||............ .....
T Consensus 156 ~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 231 (272)
T cd06629 156 KKSDDIYDN----DQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAP 231 (272)
T ss_pred ccccccccc----cccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCC
Confidence 765432110 1223456899999999987654 899999999999999999999999654433222211 11111
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchH
Q 005617 565 ILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 565 ~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
.+ .......++..+.+++.+||..+|..||++.+.
T Consensus 232 ~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 266 (272)
T cd06629 232 PI---PPDVSMNLSPVALDFLNACFTINPDNRPTAREL 266 (272)
T ss_pred cC---CccccccCCHHHHHHHHHHhcCChhhCCCHHHH
Confidence 11 111222346789999999999999999998743
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=304.97 Aligned_cols=249 Identities=24% Similarity=0.293 Sum_probs=190.9
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEec
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
+|.....||.|+||.||+|... |..||||.+..... .....+.+|+.++++++||||+++++++.+ ..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 5788899999999999999885 88999999865432 233568899999999999999999999854 57899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCC
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~ 496 (688)
+. ++|..++..... ..+++..+..++.+++.||.|||..+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDASPL-SGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 688888765432 46899999999999999999999965 99999999999999999999999999886543221
Q ss_pred cCCCccccCCCCCCCCCCChhhhccCC-CCCcchHhHHHHHHHHHHhCCCCCCChhhHHHH---hhcCc-ccc-------
Q 005617 497 YLPSFHRSTAPKGSFPYADPEYHRTGV-LTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA---VSCGK-LSS------- 564 (688)
Q Consensus 497 ~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~---~~~g~-l~~------- 564 (688)
......+++.|+|||++.+.. ++.++|||||||++|+|+||+.||......... +.... ...
T Consensus 156 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (284)
T cd07860 156 ------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT 229 (284)
T ss_pred ------ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhh
Confidence 123345789999999886644 688999999999999999999999654332111 11000 000
Q ss_pred -----------ccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchH
Q 005617 565 -----------ILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 565 -----------~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
................+.+++.+||+.||.+||++.+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~ 278 (284)
T cd07860 230 SLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAA 278 (284)
T ss_pred HHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHH
Confidence 00000001111234567899999999999999998743
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=319.47 Aligned_cols=258 Identities=27% Similarity=0.426 Sum_probs=203.1
Q ss_pred cCcccceeeeccCceEEEEEEECC-eEEEEEEEecCCccch-HHHHHHHHHHHcCCCCceeeEeccc--CCCceeEEecC
Q 005617 342 CNFSESFKVGQGGFGCVYKGEMLG-RTVAIKMLYSHNMQGQ-LEFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYL 417 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~g-~~vAIK~l~~~~~~~~-~~f~~E~~iL~~l~HpnIV~l~g~~--~~~~~LV~E~~ 417 (688)
......++||+|-||.|.++...| ..||||+++.....+. .+|..|+++|.+++|||||.|+|+| .+.+++|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 334556789999999999999986 8999999998766554 7899999999999999999999999 45689999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCc
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~ 497 (688)
++|+|..+|....... +.-....+|+.||+.|++||.+.+ +|||||.+.|+|+|.++++||+|||+++.+-.+..+
T Consensus 618 EnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred hcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCce
Confidence 9999999998774322 344556789999999999999976 999999999999999999999999999976554422
Q ss_pred CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh--CCCCCCChhhHHHHhhcCccccccCC-CCCCCC
Q 005617 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT--GRLPVGLAGEVRRAVSCGKLSSILDP-LAGDWP 574 (688)
Q Consensus 498 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt--G~~Pf~~~~~~~~~~~~g~l~~~ld~-~~~~~~ 574 (688)
+.....+-.+.|||||.+..++++.++|||+|||+|||+++ ...||....+-.---+.+.+..-..+ .....|
T Consensus 694 ----~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P 769 (807)
T KOG1094|consen 694 ----RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRP 769 (807)
T ss_pred ----eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCC
Confidence 22334455678999999999999999999999999999765 77899754331111111111111000 112345
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCCchHHHHHHH
Q 005617 575 TFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 575 ~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le 608 (688)
.-++..+.+|+++||..+-.+||++. .+...|.
T Consensus 770 ~~cp~~lyelml~Cw~~es~~RPsFe-~lh~~lq 802 (807)
T KOG1094|consen 770 PACPQGLYELMLRCWRRESEQRPSFE-QLHLFLQ 802 (807)
T ss_pred CcCcHHHHHHHHHHhchhhhcCCCHH-HHHHHHH
Confidence 56777899999999999999999998 4444444
|
|
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=307.25 Aligned_cols=250 Identities=25% Similarity=0.349 Sum_probs=193.3
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc--chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEe
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E 415 (688)
++|...+.||.|+||.||+|.+. +..||+|++...... ....+.+|+.++..++||||++++++|.+ ..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 36788899999999999999985 789999998654332 34568899999999999999999999954 4789999
Q ss_pred cCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCC
Q 005617 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~ 495 (688)
|+++++|..+.... ..++|..+..++.+|+.||.|||+.+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKYP---NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 99999998876543 34899999999999999999999965 9999999999999999999999999998764332
Q ss_pred CcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHH---hh-cCccc-------
Q 005617 496 LYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA---VS-CGKLS------- 563 (688)
Q Consensus 496 ~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~---~~-~g~l~------- 563 (688)
. ......|+..|+|||++.+ ..++.++|||||||++|||++|++||......... .. .+.+.
T Consensus 155 ~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (286)
T cd07846 155 E------VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIF 228 (286)
T ss_pred c------ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHh
Confidence 1 1234568899999998865 45788999999999999999999998643322110 00 00000
Q ss_pred -------cccCCCCC------CCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 564 -------SILDPLAG------DWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 564 -------~~ld~~~~------~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
....+... ......+..+.+|+.+||+.+|.+||++.+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il 281 (286)
T cd07846 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLL 281 (286)
T ss_pred ccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHh
Confidence 00000000 01123456799999999999999999998433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=298.49 Aligned_cols=245 Identities=27% Similarity=0.396 Sum_probs=200.8
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEec
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
++|...+.||.|++|.||+|... +..||||++..... .....|.+|+.++.+++||||+++++++.. ..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999886 88999999876654 345679999999999999999999999854 57899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhc-cCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCC
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS-SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~ 495 (688)
+++++|.+++... ..+++..++.++.+++.||.|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999999754 468899999999999999999999 76 9999999999999999999999999998765433
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh--hHHHHhhcCccccccCCCCCCC
Q 005617 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 496 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~--~~~~~~~~g~l~~~ld~~~~~~ 573 (688)
. ......|+..|+|||.+.+..++.++||||||+++|+|+||+.||.... .....+..- ........
T Consensus 155 ~------~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~-----~~~~~~~~ 223 (264)
T cd06623 155 D------QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI-----CDGPPPSL 223 (264)
T ss_pred C------cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHH-----hcCCCCCC
Confidence 1 1124568899999999999999999999999999999999999997553 211111110 01111122
Q ss_pred CHH-HHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 574 PTF-VARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 574 ~~~-~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
+.. .+..+.+++.+||..+|.+||++.+.+
T Consensus 224 ~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll 254 (264)
T cd06623 224 PAEEFSPEFRDFISACLQKDPKKRPSAAELL 254 (264)
T ss_pred CcccCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 333 567899999999999999999998544
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=297.15 Aligned_cols=240 Identities=34% Similarity=0.542 Sum_probs=195.4
Q ss_pred ccceeeeccCceEEEEEEECC------eEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEe
Q 005617 345 SESFKVGQGGFGCVYKGEMLG------RTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 345 ~~~~~LG~G~fG~Vykg~~~g------~~vAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E 415 (688)
.....||.|+||.||++...+ ..||+|++...... ....+..|+.++..++||||+++++++.+ ..++|||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456789999999999998863 78999999766544 45679999999999999999999999854 5889999
Q ss_pred cCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCC
Q 005617 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~ 495 (688)
|+++++|.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 82 YMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred ccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999875432 12899999999999999999999965 9999999999999999999999999998776542
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--hHHHHhhcCccccccCCCCCC
Q 005617 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 496 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~~~~g~l~~~ld~~~~~ 572 (688)
.. ......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||.... .....+..+... .
T Consensus 158 ~~-----~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--------~ 224 (258)
T smart00219 158 YY-----KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRL--------P 224 (258)
T ss_pred cc-----ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC--------C
Confidence 21 1112347889999999988899999999999999999998 888886432 233333333221 1
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCCch
Q 005617 573 WPTFVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 573 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~ 601 (688)
.+...+..+.+++.+|+..+|.+|||+.+
T Consensus 225 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ 253 (258)
T smart00219 225 KPENCPPEIYKLMLQCWAEDPEDRPTFSE 253 (258)
T ss_pred CCCcCCHHHHHHHHHHCcCChhhCcCHHH
Confidence 12235668999999999999999999884
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=320.36 Aligned_cols=257 Identities=27% Similarity=0.433 Sum_probs=214.2
Q ss_pred HHHHHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--Cc
Q 005617 335 ADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AW 410 (688)
Q Consensus 335 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~ 410 (688)
++++-..-+..-.++||.|-||.||.|.|. .-.||||.++.+.+ ...+|..|..+|..++|||+|+|+|+|.. ..
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 334444445566789999999999999997 67899999987665 36689999999999999999999999965 47
Q ss_pred eeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCcccc
Q 005617 411 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~ 490 (688)
|||.|||..|+|.++|..+.. ..++-...+.++.||+.|+.||...+ +|||||...|.|+.++..+||+||||+++
T Consensus 339 YIiTEfM~yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred EEEEecccCccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence 999999999999999987754 44666677889999999999999955 99999999999999999999999999999
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChh--hHHHHhhcCccccccC
Q 005617 491 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILD 567 (688)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~--~~~~~~~~g~l~~~ld 567 (688)
+..+.... .....-.+-|.|||-+..+.++.|+|||+|||+|||+.| |-.||.+.+ .+...+..|-
T Consensus 415 MtgDTYTA-----HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy------ 483 (1157)
T KOG4278|consen 415 MTGDTYTA-----HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY------ 483 (1157)
T ss_pred hcCCceec-----ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc------
Confidence 97665321 122334567999999999999999999999999999999 889997654 4566665552
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHh
Q 005617 568 PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 568 ~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l 610 (688)
..+.|..++..+.+|++.||+.+|.+||+++ ++-..++.+
T Consensus 484 --RM~~PeGCPpkVYeLMraCW~WsPsDRPsFa-eiHqafEtm 523 (1157)
T KOG4278|consen 484 --RMDGPEGCPPKVYELMRACWNWSPSDRPSFA-EIHQAFETM 523 (1157)
T ss_pred --cccCCCCCCHHHHHHHHHHhcCCcccCccHH-HHHHHHHHH
Confidence 2245667788999999999999999999999 677777665
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=298.51 Aligned_cols=245 Identities=24% Similarity=0.373 Sum_probs=202.0
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC--ccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~--~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
+++|+.-..||+|.|+.||++... |+.+|+|+++... ..+-+.+.+|+.|-..|+|||||+|.....+ ..+||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 456677778999999999998764 8899999886442 2355678899999999999999999998854 378999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeC---CCCCeEEeecCccccc
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD---SELSSKICDFGICRLV 491 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd---~~~~vKLsDFGla~~~ 491 (688)
|+|.|++|..-+... ..+++..+-..+.||+.+|.|+|.++ |||||+||.|+||- ...-+||+|||+|..+
T Consensus 90 e~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 999999997766544 23566778889999999999999977 99999999999995 3456999999999998
Q ss_pred cCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCC--hhhHHHHhhcCccccccCCC
Q 005617 492 TEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGL--AGEVRRAVSCGKLSSILDPL 569 (688)
Q Consensus 492 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~--~~~~~~~~~~g~l~~~ld~~ 569 (688)
..+. .....+|||+|||||++...+|+..+|||+.|||||-||.|++||.. ...+...+..|... -.
T Consensus 164 ~~g~-------~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd----~~ 232 (355)
T KOG0033|consen 164 NDGE-------AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYD----YP 232 (355)
T ss_pred CCcc-------ccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccC----CC
Confidence 8443 34578999999999999999999999999999999999999999976 33466667666542 11
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 570 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 570 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
...|+ .+++...+|+.+||..||.+|.|+.+.+
T Consensus 233 ~~~w~-~is~~Ak~LvrrML~~dP~kRIta~EAL 265 (355)
T KOG0033|consen 233 SPEWD-TVTPEAKSLIRRMLTVNPKKRITADEAL 265 (355)
T ss_pred CcccC-cCCHHHHHHHHHHhccChhhhccHHHHh
Confidence 22444 4677899999999999999999988544
|
|
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=301.42 Aligned_cols=240 Identities=28% Similarity=0.389 Sum_probs=194.5
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecCC
Q 005617 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLP 418 (688)
Q Consensus 344 f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~ 418 (688)
|.....||.|+||.||+|... +..||||.+..... .....|.+|+.++.+++||||++++++|.+ ..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 566788999999999999874 78999999865433 334568899999999999999999999843 5889999999
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcC
Q 005617 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~ 498 (688)
+++|..++.. ..+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 86 ~~~l~~~i~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-- 156 (277)
T cd06641 86 GGSALDLLEP----GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-- 156 (277)
T ss_pred CCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh--
Confidence 9999998854 35789999999999999999999965 99999999999999999999999999876643221
Q ss_pred CCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHH--HHhhcCccccccCCCCCCCCHH
Q 005617 499 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSILDPLAGDWPTF 576 (688)
Q Consensus 499 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~--~~~~~g~l~~~ld~~~~~~~~~ 576 (688)
......|+..|+|||++.+..++.++|||||||++|+|++|..||....... ..+..+.. ...+..
T Consensus 157 ----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~~~~ 224 (277)
T cd06641 157 ----KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP--------PTLEGN 224 (277)
T ss_pred ----hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCC--------CCCCcc
Confidence 1234568899999999988889999999999999999999999997543221 11111111 122334
Q ss_pred HHHHHHHHHHHccccCCCCCCCCchHHH
Q 005617 577 VARRLVDLGLQCCELYGRERPDITPSLV 604 (688)
Q Consensus 577 ~~~~l~~L~~~Cl~~dP~~RPs~~~~l~ 604 (688)
.+..+.+++.+||+.+|.+||++.+.+.
T Consensus 225 ~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 252 (277)
T cd06641 225 YSKPLKEFVEACLNKEPSFRPTAKELLK 252 (277)
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 4567899999999999999999985443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=303.38 Aligned_cols=251 Identities=24% Similarity=0.334 Sum_probs=194.5
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc--chHHHHHHHHHHHcCCCCc-eeeEecccCC--------
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPH-LVTLLGACPE-------- 408 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~--~~~~f~~E~~iL~~l~Hpn-IV~l~g~~~~-------- 408 (688)
..|....+||+|.||+||+|+.. |+.||+|++...... ......+|+.+|..++|+| ||.|++++..
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34555678999999999999875 899999999876542 2334679999999999999 9999999832
Q ss_pred CceeEEecCCCCcHHHHhcccCCC-CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCc
Q 005617 409 AWSLVYEYLPNGSLQDRLFRKSNV-SPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 487 (688)
Q Consensus 409 ~~~LV~E~~~~gsL~~~L~~~~~~-~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGl 487 (688)
..+||+||++ .+|..++...... ..++-..+..++.||+.||+|||+++ |+||||||.||||+.+|.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 4679999995 5788888665422 34666889999999999999999976 99999999999999999999999999
Q ss_pred cccccCCCCcCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCccc---
Q 005617 488 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLS--- 563 (688)
Q Consensus 488 a~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~l~--- 563 (688)
|+...-+.. ..+..++|..|.|||++.+. .|++..||||+|||+.||+++++-|.+..++........+.
T Consensus 167 Ara~~ip~~------~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP 240 (323)
T KOG0594|consen 167 ARAFSIPMR------TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTP 240 (323)
T ss_pred HHHhcCCcc------cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCC
Confidence 997653321 24567899999999998876 79999999999999999999999997666544332211110
Q ss_pred ------cc---cC--CCCCCCC------HHH---HHHHHHHHHHccccCCCCCCCCchH
Q 005617 564 ------SI---LD--PLAGDWP------TFV---ARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 564 ------~~---ld--~~~~~~~------~~~---~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
.+ .+ +....|. ..+ .....+|+.+|++++|..|.++...
T Consensus 241 ~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~a 299 (323)
T KOG0594|consen 241 NEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGA 299 (323)
T ss_pred CccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHH
Confidence 00 00 0001111 111 1378999999999999999998843
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=292.14 Aligned_cols=242 Identities=27% Similarity=0.425 Sum_probs=199.5
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEecCC
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLP 418 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~~ 418 (688)
+|...+.||.|++|.||++... +..|++|++..........+.+|+.+++.++||||+++++++. ...++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 4677789999999999999986 7889999998766556678999999999999999999999884 45889999999
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcC
Q 005617 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~ 498 (688)
+++|.+++.... ..+++..+..++.+++.||.|||..+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999987653 46899999999999999999999965 99999999999999999999999999987654321
Q ss_pred CCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHH--hhcCccccccCCCCCCCCHH
Q 005617 499 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VSCGKLSSILDPLAGDWPTF 576 (688)
Q Consensus 499 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~--~~~g~l~~~ld~~~~~~~~~ 576 (688)
.....|+..|++||++....++.++||||||+++|+|++|+.||......... ......... ..+..
T Consensus 154 -----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~ 222 (253)
T cd05122 154 -----RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGL------RNPEK 222 (253)
T ss_pred -----ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCc------Ccccc
Confidence 23456899999999998888999999999999999999999999755322221 111111111 11112
Q ss_pred HHHHHHHHHHHccccCCCCCCCCchH
Q 005617 577 VARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 577 ~~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
.+..+.+++.+||+.||.+||++.+.
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~t~~~~ 248 (253)
T cd05122 223 WSDEFKDFLKKCLQKNPEKRPTAEQL 248 (253)
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHH
Confidence 35679999999999999999999743
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=306.10 Aligned_cols=256 Identities=23% Similarity=0.316 Sum_probs=200.4
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEe--cCCccchHHHHHHHHHHHcCCCCceeeEecccC-------
Q 005617 339 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLY--SHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP------- 407 (688)
Q Consensus 339 ~at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~--~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~------- 407 (688)
.....|.....||.|+||.|..+... |..||||++. ..+....+...+|+.+|+.++|+|||.+++.+.
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f 98 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKF 98 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccc
Confidence 34456666788999999999999885 8999999997 445555667889999999999999999998873
Q ss_pred CCceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCc
Q 005617 408 EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 487 (688)
Q Consensus 408 ~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGl 487 (688)
.+.|+|+|+| +.+|...+.... .|+...+..++.|+++||.|+|+.+ |+||||||+|+|++.+..+||+|||+
T Consensus 99 ~DvYiV~elM-etDL~~iik~~~---~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGL 171 (359)
T KOG0660|consen 99 NDVYLVFELM-ETDLHQIIKSQQ---DLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGL 171 (359)
T ss_pred ceeEEehhHH-hhHHHHHHHcCc---cccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccc
Confidence 2478999999 678888886543 4788889999999999999999987 99999999999999999999999999
Q ss_pred cccccCCCCcCCCccccCCCCCCCCCCChhhhc-cCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHH----------
Q 005617 488 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR-TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA---------- 556 (688)
Q Consensus 488 a~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~---------- 556 (688)
|+..... ......+..+.|-.|.|||++. ...|+...||||.||||.||++|++-|.+.+.+.+.
T Consensus 172 AR~~~~~----~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP 247 (359)
T KOG0660|consen 172 ARYLDKF----FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP 247 (359)
T ss_pred eeecccc----CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC
Confidence 9988643 1122456778999999999764 568999999999999999999999998654433211
Q ss_pred -------hhcCccccccCCC----CCCC---CHHHHHHHHHHHHHccccCCCCCCCCchHHHH
Q 005617 557 -------VSCGKLSSILDPL----AGDW---PTFVARRLVDLGLQCCELYGRERPDITPSLVK 605 (688)
Q Consensus 557 -------~~~g~l~~~ld~~----~~~~---~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~ 605 (688)
+...+....+... ...| -+......++|+.+||..||.+|+|+.+.+.+
T Consensus 248 ~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h 310 (359)
T KOG0660|consen 248 SEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH 310 (359)
T ss_pred CHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence 1111111111110 0011 11345678999999999999999999866543
|
|
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=301.30 Aligned_cols=242 Identities=25% Similarity=0.419 Sum_probs=193.7
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCC---CCceeeEecccCC--CceeEE
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQ---HPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~---HpnIV~l~g~~~~--~~~LV~ 414 (688)
.|...+.||.|+||.||+|... +..||||.+..... .....+.+|+.+++.++ |||+++++++|.+ ..++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4667788999999999999974 78999999875433 34457889999999997 9999999999854 478999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
||+++++|.+++... .+++..++.++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~----~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKAG----PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHcc----CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 999999999988542 6889999999999999999999966 999999999999999999999999999876543
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCccccccCCCCCCC
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 495 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~l~~~ld~~~~~~ 573 (688)
.. ......|+..|+|||++.++ .++.++|||||||++|+|++|..||............... . ....
T Consensus 155 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~---~---~~~~ 222 (277)
T cd06917 155 SS------KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS---K---PPRL 222 (277)
T ss_pred cc------ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC---C---CCCC
Confidence 31 12345689999999988754 4689999999999999999999999754432211111100 0 0111
Q ss_pred CH-HHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 574 PT-FVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 574 ~~-~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
+. .....+.+++.+||+.||.+||++.+.+
T Consensus 223 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il 253 (277)
T cd06917 223 EDNGYSKLLREFVAACLDEEPKERLSAEELL 253 (277)
T ss_pred CcccCCHHHHHHHHHHcCCCcccCcCHHHHh
Confidence 11 1456789999999999999999988544
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=305.13 Aligned_cols=247 Identities=26% Similarity=0.374 Sum_probs=199.4
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEecC
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 417 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~ 417 (688)
++|...+.||.|+||.||+|... +..||+|.+..........+.+|+.++..++||||++++++|. +..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 67888899999999999999864 7889999987655555667899999999999999999999984 4588999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCc
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~ 497 (688)
++++|.+++... .+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.++|+|||++........
T Consensus 99 ~~~~L~~~~~~~----~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~- 170 (293)
T cd06647 99 AGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 170 (293)
T ss_pred CCCcHHHHHhhc----CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc-
Confidence 999999988643 4788999999999999999999966 99999999999999999999999999876543321
Q ss_pred CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCccccccCCCCCCCCHHH
Q 005617 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFV 577 (688)
Q Consensus 498 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~l~~~ld~~~~~~~~~~ 577 (688)
......|++.|+|||++....++.++|||||||++|+|++|+.||............+... ......+...
T Consensus 171 -----~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~----~~~~~~~~~~ 241 (293)
T cd06647 171 -----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG----TPELQNPEKL 241 (293)
T ss_pred -----ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCC----CCCCCCcccc
Confidence 1234468999999999988889999999999999999999999997543322111111000 0001122335
Q ss_pred HHHHHHHHHHccccCCCCCCCCchHHHH
Q 005617 578 ARRLVDLGLQCCELYGRERPDITPSLVK 605 (688)
Q Consensus 578 ~~~l~~L~~~Cl~~dP~~RPs~~~~l~~ 605 (688)
...+.+++.+||..+|.+||++.+.+.+
T Consensus 242 ~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 242 SAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 5678999999999999999999865544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=318.41 Aligned_cols=190 Identities=21% Similarity=0.304 Sum_probs=160.6
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005617 339 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 339 ~at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
....+|...+.||+|+||.||+|... +..||+|+.... .+..|+.++.+++|||||+++++|.. ..++||
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34568999999999999999999986 578999975332 23569999999999999999999854 478999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
+|+. |+|.+++.... ..++|..+..|+.||+.||.|||..+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 137 e~~~-~~l~~~l~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 210 (357)
T PHA03209 137 PHYS-SDLYTYLTKRS--RPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA 210 (357)
T ss_pred EccC-CcHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC
Confidence 9995 67888775533 46899999999999999999999966 999999999999999999999999999754322
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCC
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPV 547 (688)
Q Consensus 495 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf 547 (688)
. ......||+.|+|||++.+..++.++|||||||++|||+++..|+
T Consensus 211 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 P-------AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred c-------ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1 123457999999999999999999999999999999999965544
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=300.48 Aligned_cols=247 Identities=25% Similarity=0.369 Sum_probs=184.4
Q ss_pred eeeccCceEEEEEEEC-C---eEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecCCCCc
Q 005617 349 KVGQGGFGCVYKGEML-G---RTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGS 421 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~-g---~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gs 421 (688)
.||+|+||.||+|... + ..+++|.+..... .....|.+|+.+++.++||||++++++|.+ ..++||||+++|+
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 5999999999999754 2 3466777654432 345679999999999999999999999854 4789999999999
Q ss_pred HHHHhcccC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCC
Q 005617 422 LQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 500 (688)
Q Consensus 422 L~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~ 500 (688)
|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~---- 154 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDY---- 154 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchh----
Confidence 999987643 2345677778899999999999999965 99999999999999999999999999864322111
Q ss_pred ccccCCCCCCCCCCChhhhcc-------CCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHHHhhcCccccccCCCC
Q 005617 501 FHRSTAPKGSFPYADPEYHRT-------GVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 501 ~~~~~~~~GT~~Y~APE~~~~-------~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~~~~g~l~~~ld~~~ 570 (688)
........|+..|+|||++.. ..++.++|||||||++|||++ |..||..... ....+..+....+.++..
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (268)
T cd05086 155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQL 234 (268)
T ss_pred hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCcc
Confidence 011234568899999998743 345789999999999999997 5778864332 222222222233333322
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHH
Q 005617 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 571 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~L 607 (688)
+......+.+++..|| .+|++||++. ++++.|
T Consensus 235 ---~~~~~~~~~~l~~~c~-~~P~~Rp~~~-~i~~~l 266 (268)
T cd05086 235 ---ELPYSERWYEVLQFCW-LSPEKRATAE-EVHRLL 266 (268)
T ss_pred ---CCCCcHHHHHHHHHHh-hCcccCCCHH-HHHHHh
Confidence 2224567788999999 6799999998 555544
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=304.15 Aligned_cols=235 Identities=29% Similarity=0.388 Sum_probs=195.3
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|.....||.|+||.||++... +..||+|++..... .....+.+|+.++.+++||||+++++++.+ ..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888899999999999999885 78999999875432 234568899999999999999999999854 478999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
||+++++|.+++... ..+++..+..++.|++.||.|||+.+ |+|+||+|+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~~---~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRKS---GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 999999999998665 35788999999999999999999965 999999999999999999999999999876543
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCCCCC
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 495 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~ 572 (688)
.....|++.|+|||.+.+...+.++||||||+++|+|++|+.||..... ....+..+.. .
T Consensus 155 ---------~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---------~ 216 (290)
T cd05580 155 ---------TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKV---------R 216 (290)
T ss_pred ---------CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc---------c
Confidence 2345689999999999888899999999999999999999999975442 2222222221 2
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCCc
Q 005617 573 WPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 573 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~~ 600 (688)
.+......+.+++.+||..+|.+||+..
T Consensus 217 ~~~~~~~~l~~li~~~l~~~p~~R~~~~ 244 (290)
T cd05580 217 FPSFFSPDAKDLIRNLLQVDLTKRLGNL 244 (290)
T ss_pred CCccCCHHHHHHHHHHccCCHHHccCcc
Confidence 2333467889999999999999999543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=305.02 Aligned_cols=249 Identities=25% Similarity=0.324 Sum_probs=192.6
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc-----chHHHHHHHHHHHcCCCCceeeEecccCC--CceeE
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-----GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLV 413 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~-----~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV 413 (688)
+|...+.||.|+||.||+|... |..||||.+...... ....+..|+.++..++||||+++++++.+ ..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4677789999999999999875 789999999765433 23357789999999999999999999854 47899
Q ss_pred EecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccC
Q 005617 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~ 493 (688)
|||+ +|+|.+++.... ..+++..+..++.||+.||.|||+.+ |+|+||+|+|||++.++.++|+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 999999986543 36899999999999999999999966 99999999999999999999999999987654
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHH---hhc-C--------
Q 005617 494 DTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA---VSC-G-------- 560 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~---~~~-g-------- 560 (688)
... ......+++.|+|||++.+ ..++.++|||||||++|||++|.+||......... ... +
T Consensus 155 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (298)
T cd07841 155 PNR------KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWP 228 (298)
T ss_pred CCc------cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhh
Confidence 321 1233457889999998854 46789999999999999999998887543322110 000 0
Q ss_pred ---ccccccCCC------CCCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 561 ---KLSSILDPL------AGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 561 ---~l~~~ld~~------~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
.+....... ........+..+.+++.+||+.+|.+||++.+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l 280 (298)
T cd07841 229 GVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQAL 280 (298)
T ss_pred hcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 000000000 0011123467899999999999999999988433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-36 Score=320.65 Aligned_cols=236 Identities=27% Similarity=0.368 Sum_probs=194.3
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEe
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYE 415 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~---~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E 415 (688)
-|...+-||.|+||-||-+++. ...||||.+.....+ ...++..|+..|.+++|||+|.+-|||. ...+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 4666788999999999999875 678999999876554 3457899999999999999999999994 34789999
Q ss_pred cCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCC
Q 005617 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~ 495 (688)
||- ||-.|+|.-.. .++-..++.-|+.+.+.||.|||+.+ .||||||..||||.+.|.|||+|||.|....+.
T Consensus 107 YCl-GSAsDlleVhk--KplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA- 179 (948)
T KOG0577|consen 107 YCL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA- 179 (948)
T ss_pred HHh-ccHHHHHHHHh--ccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch-
Confidence 994 56677665443 57888999999999999999999976 999999999999999999999999999887543
Q ss_pred CcCCCccccCCCCCCCCCCChhhh---ccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHH--hhcCccccccCCCC
Q 005617 496 LYLPSFHRSTAPKGSFPYADPEYH---RTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VSCGKLSSILDPLA 570 (688)
Q Consensus 496 ~~~~~~~~~~~~~GT~~Y~APE~~---~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~--~~~g~l~~~ld~~~ 570 (688)
..++|||.|||||++ ..|.|+-|+||||||++-.||.-.++|+.....+... +....- |.+
T Consensus 180 ---------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNes-----PtL 245 (948)
T KOG0577|consen 180 ---------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-----PTL 245 (948)
T ss_pred ---------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCC-----CCC
Confidence 467899999999987 4678999999999999999999999997544432222 222111 111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCCch
Q 005617 571 GDWPTFVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 571 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~ 601 (688)
...+.+..+..++..||+.-|.+|||...
T Consensus 246 --qs~eWS~~F~~Fvd~CLqKipqeRptse~ 274 (948)
T KOG0577|consen 246 --QSNEWSDYFRNFVDSCLQKIPQERPTSEE 274 (948)
T ss_pred --CCchhHHHHHHHHHHHHhhCcccCCcHHH
Confidence 13456788999999999999999999874
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=301.95 Aligned_cols=245 Identities=24% Similarity=0.349 Sum_probs=188.5
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHH-HHcCCCCceeeEecccC--CCceeEEe
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRV-LSKLQHPHLVTLLGACP--EAWSLVYE 415 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~-~~~~~f~~E~~i-L~~l~HpnIV~l~g~~~--~~~~LV~E 415 (688)
++|.....||+|+||.||+|... |..||||++..... .....+..|+.+ ++.++||||+++++++. ...++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888899999999999999885 88999999876532 334456667665 55668999999999984 45889999
Q ss_pred cCCCCcHHHHhccc-CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 416 YLPNGSLQDRLFRK-SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 416 ~~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
|++ |+|.+++... .....+++..+..++.||+.||.|||+.. +++||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 996 6787777543 22356899999999999999999999852 4999999999999999999999999999876432
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhcc----CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHH---HhhcCccccccC
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRT----GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR---AVSCGKLSSILD 567 (688)
Q Consensus 495 ~~~~~~~~~~~~~~GT~~Y~APE~~~~----~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~---~~~~g~l~~~ld 567 (688)
. ......|+..|+|||++.+ ..++.++|||||||++|+|++|+.||........ .+..+....+
T Consensus 158 ~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 228 (283)
T cd06617 158 V-------AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQL-- 228 (283)
T ss_pred c-------ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCC--
Confidence 2 1233568999999998754 4568999999999999999999999964322111 1111111110
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 568 PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 568 ~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
.....+..+.+++.+||..+|.+||++.+.+
T Consensus 229 -----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il 259 (283)
T cd06617 229 -----PAEKFSPEFQDFVNKCLKKNYKERPNYPELL 259 (283)
T ss_pred -----CccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 0112456789999999999999999997443
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=299.04 Aligned_cols=248 Identities=24% Similarity=0.400 Sum_probs=194.5
Q ss_pred CcccceeeeccCceEEEEEEEC---CeEEEEEEEecCCc----------cchHHHHHHHHHHHc-CCCCceeeEecccCC
Q 005617 343 NFSESFKVGQGGFGCVYKGEML---GRTVAIKMLYSHNM----------QGQLEFQQEVRVLSK-LQHPHLVTLLGACPE 408 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~---g~~vAIK~l~~~~~----------~~~~~f~~E~~iL~~-l~HpnIV~l~g~~~~ 408 (688)
+|.....||+|+||.||+|.+. +..+|||.+..... .....+..|+.++.+ ++||||++++++|.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4677788999999999999985 47899998864321 123457789988875 799999999998854
Q ss_pred --CceeEEecCCCCcHHHHhccc-CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeec
Q 005617 409 --AWSLVYEYLPNGSLQDRLFRK-SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDF 485 (688)
Q Consensus 409 --~~~LV~E~~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDF 485 (688)
..++||||+++++|.+.+... .....+++..++.++.+++.||.|||+.+ +++|+||+|+|||++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 478999999999999987542 22356889999999999999999999632 4999999999999999999999999
Q ss_pred CccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhH--HHHhhcCccc
Q 005617 486 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLS 563 (688)
Q Consensus 486 Gla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~~~~g~l~ 563 (688)
|++....... ......|+..|++||++.+..++.++||||||+++|+|++|++||...... ...+..+...
T Consensus 159 g~~~~~~~~~-------~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 231 (269)
T cd08528 159 GLAKQKQPES-------KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYE 231 (269)
T ss_pred cceeeccccc-------ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCC
Confidence 9998765432 123556899999999999989999999999999999999999999654332 1222222211
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHH
Q 005617 564 SILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 564 ~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~L 607 (688)
+.. ....+..+.+++.+||+.||.+||++. ++...+
T Consensus 232 ----~~~---~~~~~~~l~~li~~cl~~~p~~Rp~~~-e~~~~~ 267 (269)
T cd08528 232 ----PLP---EGMYSEDVTDVITSCLTPDAEARPDII-QVSAMI 267 (269)
T ss_pred ----cCC---cccCCHHHHHHHHHHCCCCCccCCCHH-HHHHHh
Confidence 111 112346789999999999999999998 454443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=302.17 Aligned_cols=241 Identities=23% Similarity=0.341 Sum_probs=194.7
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEecCCC
Q 005617 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLPN 419 (688)
Q Consensus 344 f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~~~ 419 (688)
|.....||.|++|.||+|... +..||||++..........+.+|+.++..++||||+++++++. +..++|+||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444578999999999999874 7889999987655555567889999999999999999999874 468899999999
Q ss_pred CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCC
Q 005617 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 420 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~ 499 (688)
++|.+++.. ..+++..+..++.+++.||.|||+.+ |+||||+|+||+++.++.++|+|||++........
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--- 170 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--- 170 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc---
Confidence 999998865 35788999999999999999999966 99999999999999999999999999876543221
Q ss_pred CccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHH--HHhhcCccccccCCCCCCCCHHH
Q 005617 500 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSILDPLAGDWPTFV 577 (688)
Q Consensus 500 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~--~~~~~g~l~~~ld~~~~~~~~~~ 577 (688)
......|++.|+|||.+.+..++.++|||||||++|+|++|+.||....... ..+..+.. +. ...+...
T Consensus 171 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~-----~~-~~~~~~~ 241 (285)
T cd06648 171 ---RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLP-----PK-LKNLHKV 241 (285)
T ss_pred ---ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCC-----CC-CcccccC
Confidence 1234568999999999998889999999999999999999999986543221 11222111 11 1112224
Q ss_pred HHHHHHHHHHccccCCCCCCCCchHH
Q 005617 578 ARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 578 ~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
+..+.+++.+||+.+|.+||++.+.+
T Consensus 242 ~~~l~~li~~~l~~~p~~Rpt~~~il 267 (285)
T cd06648 242 SPRLRSFLDRMLVRDPAQRATAAELL 267 (285)
T ss_pred CHHHHHHHHHHcccChhhCcCHHHHc
Confidence 56899999999999999999988443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=301.39 Aligned_cols=250 Identities=22% Similarity=0.291 Sum_probs=193.0
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecC
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 417 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~ 417 (688)
+|...+.||.|++|.||+|... |..||||.+...... ....+.+|+.++++++||||++++++|.+ ..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 5778899999999999999985 889999999765433 34567889999999999999999999854 478999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCc
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~ 497 (688)
++ +|.+++........+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.++|+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 78887765544456899999999999999999999965 99999999999999999999999999976543221
Q ss_pred CCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHH---hhcC------------c
Q 005617 498 LPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA---VSCG------------K 561 (688)
Q Consensus 498 ~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~---~~~g------------~ 561 (688)
......+|+.|++||++.+. .++.++|||||||++|+|++|+.||......... .... .
T Consensus 156 -----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (284)
T cd07836 156 -----TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230 (284)
T ss_pred -----ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhc
Confidence 12345678999999988654 5789999999999999999999999644321110 0000 0
Q ss_pred cccccC-------CCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchH
Q 005617 562 LSSILD-------PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 562 l~~~ld-------~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
...... ..........+..+.+++.+|++.||.+||++.+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~ 278 (284)
T cd07836 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDA 278 (284)
T ss_pred CchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHH
Confidence 000000 00011112345678899999999999999998743
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=351.92 Aligned_cols=255 Identities=30% Similarity=0.462 Sum_probs=202.0
Q ss_pred cCHHHHHHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC-
Q 005617 332 FSLADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE- 408 (688)
Q Consensus 332 ~~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~- 408 (688)
+++.++. ..|.....||+|+||.||+|... |..||||++...... ...|+.++++++|||||+++|+|.+
T Consensus 683 ~~~~~~~---~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~ 755 (968)
T PLN00113 683 ITINDIL---SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSE 755 (968)
T ss_pred hhHHHHH---hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcC
Confidence 4444443 45777889999999999999874 889999998654322 2346889999999999999999943
Q ss_pred -CceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCc
Q 005617 409 -AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 487 (688)
Q Consensus 409 -~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGl 487 (688)
..++||||+++|+|.+++. .++|..+.+|+.|+|.||.|||..+.++|+||||||+||+++.++.+++. ||.
T Consensus 756 ~~~~lv~Ey~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~ 828 (968)
T PLN00113 756 KGAYLIHEYIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSL 828 (968)
T ss_pred CCCEEEEeCCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecc
Confidence 5789999999999999994 37999999999999999999997765789999999999999999988886 666
Q ss_pred cccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCCh--------hhHHHHhhc
Q 005617 488 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLA--------GEVRRAVSC 559 (688)
Q Consensus 488 a~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~--------~~~~~~~~~ 559 (688)
+..... .....||+.|+|||++.+..++.++|||||||++|||+||+.||... .+.......
T Consensus 829 ~~~~~~----------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~ 898 (968)
T PLN00113 829 PGLLCT----------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSD 898 (968)
T ss_pred cccccc----------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCc
Confidence 544321 12346899999999999999999999999999999999999998521 122222223
Q ss_pred CccccccCCCCC---CCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHhh
Q 005617 560 GKLSSILDPLAG---DWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 560 g~l~~~ld~~~~---~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l~ 611 (688)
......+|+... ..+......+.+++.+||+.+|.+||+|. ++++.|+.+.
T Consensus 899 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~-evl~~L~~~~ 952 (968)
T PLN00113 899 CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCAN-DVLKTLESAS 952 (968)
T ss_pred cchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHH-HHHHHHHHhh
Confidence 334445555431 23455677899999999999999999999 6777787653
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=301.69 Aligned_cols=248 Identities=22% Similarity=0.279 Sum_probs=188.1
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc--chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEec
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
+|...+.||.|+||.||+|... |..||+|++...... ....+.+|+.++++++||||+++++++.+ ..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4677789999999999999885 889999998754322 23457889999999999999999999854 47899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCC
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~ 496 (688)
+.+ +|.+++.... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~-~l~~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CDQ-DLKKYFDSCN--GDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CCC-CHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 974 7777765432 45899999999999999999999966 99999999999999999999999999986543221
Q ss_pred cCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhc-----C--------cc
Q 005617 497 YLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC-----G--------KL 562 (688)
Q Consensus 497 ~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~-----g--------~l 562 (688)
......+++.|+|||++.+. .++.++|||||||++|+|+||..|+............ + .+
T Consensus 155 ------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (284)
T cd07839 155 ------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGV 228 (284)
T ss_pred ------CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHh
Confidence 12345678999999988764 4799999999999999999999886432211111000 0 00
Q ss_pred ccccCC-----CCC-----CCCHHHHHHHHHHHHHccccCCCCCCCCchH
Q 005617 563 SSILDP-----LAG-----DWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 563 ~~~ld~-----~~~-----~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
....+. ... ......+..+.+|+.+||+.||.+|||+.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~i 278 (284)
T cd07839 229 SKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEA 278 (284)
T ss_pred hhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHH
Confidence 000000 000 0112345688899999999999999998843
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=302.47 Aligned_cols=250 Identities=26% Similarity=0.368 Sum_probs=194.3
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEec
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
+|...+.||.|+||.||+|... |..||||++..... .....+.+|+.++++++||||+++++++.+ ..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4677889999999999999874 78999999976553 234578999999999999999999999854 47899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCC
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~ 496 (688)
+ +++|.+++.... .++++..+..++.||+.||.|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999999886544 56899999999999999999999966 99999999999999999999999999987654321
Q ss_pred cCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHH---hhc-Cc--------cc
Q 005617 497 YLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA---VSC-GK--------LS 563 (688)
Q Consensus 497 ~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~---~~~-g~--------l~ 563 (688)
.......|+..|+|||++.+. .++.++|||||||++|||+||.+||......... +.. +. +.
T Consensus 155 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T cd07832 155 -----RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT 229 (286)
T ss_pred -----CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhcc
Confidence 112345689999999988654 4689999999999999999998888644321110 000 00 00
Q ss_pred c------ccCCCC-----CCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 564 S------ILDPLA-----GDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 564 ~------~ld~~~-----~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
. +..+.. ..........+.+|+.+|++.+|.+||++.+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l 280 (286)
T cd07832 230 SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEAL 280 (286)
T ss_pred CcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHh
Confidence 0 000000 011113357899999999999999999998443
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=298.14 Aligned_cols=238 Identities=26% Similarity=0.308 Sum_probs=196.6
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEe
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E 415 (688)
+|...+.||.|+||.||+|... +..||+|.+..... .....+.+|+.++++++||||+++++++.+ ..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 5778899999999999999886 88999999976543 335678999999999999999999998844 5889999
Q ss_pred cCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCC
Q 005617 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~ 495 (688)
|+.+++|.+++... .++++..+..|+.+++.||.|||..+ |+|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999998654 36889999999999999999999966 9999999999999999999999999988765432
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCCCCCC
Q 005617 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 496 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~ 573 (688)
......|+..|+|||++.+..++.++||||||+++|+|++|..||..... .......... .....
T Consensus 155 -------~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~------~~~~~ 221 (258)
T cd05578 155 -------LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET------ADVLY 221 (258)
T ss_pred -------cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc------ccccC
Confidence 12345688999999999988899999999999999999999999975432 1111111110 11123
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCC
Q 005617 574 PTFVARRLVDLGLQCCELYGRERPDI 599 (688)
Q Consensus 574 ~~~~~~~l~~L~~~Cl~~dP~~RPs~ 599 (688)
+...+..+.+++.+||+.||.+||++
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~R~~~ 247 (258)
T cd05578 222 PATWSTEAIDAINKLLERDPQKRLGD 247 (258)
T ss_pred cccCcHHHHHHHHHHccCChhHcCCc
Confidence 33455789999999999999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=313.22 Aligned_cols=244 Identities=23% Similarity=0.344 Sum_probs=185.2
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEe
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~---~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E 415 (688)
-|..++.||-|+||.|.+++-. ...||+|.|.+.+.- ....+..|.+||+...+++||+||..|.+ .+|+||+
T Consensus 630 mFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMd 709 (1034)
T KOG0608|consen 630 MFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 709 (1034)
T ss_pred ceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEe
Confidence 4666788999999999998654 567999999776542 23458899999999999999999999965 5899999
Q ss_pred cCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccC--
Q 005617 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE-- 493 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~-- 493 (688)
|++||++..+|.+.+ .|.+..+..++.++.+|+++.|..| +|||||||+|||||.+|++||+|||||.-+..
T Consensus 710 YIPGGDmMSLLIrmg---IFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 710 YIPGGDMMSLLIRMG---IFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred ccCCccHHHHHHHhc---cCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999999998765 4677888889999999999999987 99999999999999999999999999975531
Q ss_pred CCCcCCC--------c--------------------------cccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHH
Q 005617 494 DTLYLPS--------F--------------------------HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQ 539 (688)
Q Consensus 494 ~~~~~~~--------~--------------------------~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~E 539 (688)
+..+... . ......+||+.|+|||++....|+..||+||.||||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 1100000 0 01124589999999999999999999999999999999
Q ss_pred HHhCCCCCCChhhHHHHhhcCccccccCC-CCCCCCHHHHHHHHHHHHH-ccccCCCCCCC
Q 005617 540 LLTGRLPVGLAGEVRRAVSCGKLSSILDP-LAGDWPTFVARRLVDLGLQ-CCELYGRERPD 598 (688)
Q Consensus 540 LltG~~Pf~~~~~~~~~~~~g~l~~~ld~-~~~~~~~~~~~~l~~L~~~-Cl~~dP~~RPs 598 (688)
|+.|++||-............++...++. ..++. +.+..+||.+ |+. ++.|..
T Consensus 864 m~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~l----s~e~~~li~kLc~s--ad~RLG 918 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNL----SKEALDLIQKLCCS--ADSRLG 918 (1034)
T ss_pred HhhCCCCccCCCCCcceeeeeehhhcccccccccc----CHHHHHHHHHHhcC--hhhhhc
Confidence 99999999543332222222233333332 23333 4444555544 443 455543
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=302.92 Aligned_cols=249 Identities=24% Similarity=0.316 Sum_probs=195.3
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC--ccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEe
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~--~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E 415 (688)
++|...+.||.|+||.||+|... +..||||+++... ......+.+|+.+++.++||||++++++|.+ ..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888899999999999999885 7889999986543 2334678999999999999999999999843 4789999
Q ss_pred cCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCC
Q 005617 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~ 495 (688)
|++++.+..++... ..+++..+..++.+|+.||.|||..+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEASP---GGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 99998877665432 34789999999999999999999966 9999999999999999999999999998765433
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhc----Cc---------
Q 005617 496 LYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC----GK--------- 561 (688)
Q Consensus 496 ~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~----g~--------- 561 (688)
. .......|+..|+|||++.+. .++.++||||||+++|+|++|++||............ +.
T Consensus 155 ~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (288)
T cd07833 155 A-----SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELF 229 (288)
T ss_pred c-----ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhc
Confidence 1 112345688999999999888 8899999999999999999999999754332111100 00
Q ss_pred ----------cccccCCC--CCCCCHHHHHHHHHHHHHccccCCCCCCCCch
Q 005617 562 ----------LSSILDPL--AGDWPTFVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 562 ----------l~~~ld~~--~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~ 601 (688)
+....++. ...++..++..+.+|+.+||..+|.+||++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 281 (288)
T cd07833 230 SSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDE 281 (288)
T ss_pred ccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHH
Confidence 00000000 00122334678999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=301.68 Aligned_cols=248 Identities=22% Similarity=0.330 Sum_probs=188.9
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEec
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
++|.....||.|+||.||+|... +..||||.+...... ....+.+|+.+++.++||||+++++++.+ ..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 57888899999999999999875 789999998754322 23457789999999999999999999854 47899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCC
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~ 496 (688)
+++ +|.+++.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDCG--GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 985 8988886543 36789999999999999999999966 99999999999999999999999999875432111
Q ss_pred cCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHH----hh---cC---ccccc
Q 005617 497 YLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA----VS---CG---KLSSI 565 (688)
Q Consensus 497 ~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~----~~---~g---~l~~~ 565 (688)
......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||......... +. .. .....
T Consensus 159 ------~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (291)
T cd07844 159 ------TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGV 232 (291)
T ss_pred ------cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhh
Confidence 1123457889999998865 46899999999999999999999999644311111 00 00 00000
Q ss_pred -------------cCCC-CCCCCHHH--HHHHHHHHHHccccCCCCCCCCch
Q 005617 566 -------------LDPL-AGDWPTFV--ARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 566 -------------ld~~-~~~~~~~~--~~~l~~L~~~Cl~~dP~~RPs~~~ 601 (688)
..+. ........ ...+.+++.+||+.+|.+||++.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e 284 (291)
T cd07844 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAE 284 (291)
T ss_pred hhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHH
Confidence 0000 00000011 267789999999999999999874
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=301.68 Aligned_cols=242 Identities=28% Similarity=0.396 Sum_probs=196.0
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecC
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 417 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~ 417 (688)
+|...+.||.|+||.||++... +..||+|.+..... .....+.+|+.+++.++||||++++++|.. ..++|+||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5677788999999999999986 78999999876543 344578999999999999999999998844 578999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhc-cCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCC
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS-SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~ 496 (688)
++++|.+++.... ..+++..+..++.+++.||.|||+ .+ ++|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~- 155 (265)
T cd06605 82 DGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL- 155 (265)
T ss_pred CCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH-
Confidence 9999999987643 568889999999999999999999 55 9999999999999999999999999987664322
Q ss_pred cCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh----hHHHHhhcCccccccCCCCCC
Q 005617 497 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG----EVRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 497 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~----~~~~~~~~g~l~~~ld~~~~~ 572 (688)
.....|+..|+|||++.+..++.++||||||+++|+|++|+.||.... ........ .+......
T Consensus 156 -------~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-----~~~~~~~~ 223 (265)
T cd06605 156 -------AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQY-----IVNEPPPR 223 (265)
T ss_pred -------hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHH-----HhcCCCCC
Confidence 112678899999999999999999999999999999999999996542 11111110 01111111
Q ss_pred CCHH-HHHHHHHHHHHccccCCCCCCCCchH
Q 005617 573 WPTF-VARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 573 ~~~~-~~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
.+.. .+..+.+++.+||..+|.+||++.+.
T Consensus 224 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l 254 (265)
T cd06605 224 LPSGKFSPDFQDFVNLCLIKDPRERPSYKEL 254 (265)
T ss_pred CChhhcCHHHHHHHHHHcCCCchhCcCHHHH
Confidence 2222 56779999999999999999998843
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=301.56 Aligned_cols=247 Identities=24% Similarity=0.372 Sum_probs=201.7
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEE
Q 005617 339 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVY 414 (688)
Q Consensus 339 ~at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~ 414 (688)
..+++|.....||.|+||.||+|.+. +..||+|++..... ....+.+|+.++..++|+||++++++|. +..++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 45677888889999999999999986 88999999976554 5667899999999999999999999884 4588999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
||+++++|.+++.... ..+++..+..++.+++.||.|||+.+ |+|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 9999999999997654 46899999999999999999999965 999999999999999999999999998765432
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHH--hhcCccccccCCCCCC
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VSCGKLSSILDPLAGD 572 (688)
Q Consensus 495 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~--~~~g~l~~~ld~~~~~ 572 (688)
.. ......|++.|++||++.+..++.++|||||||++|+|++|+.||......... +..+.... ..
T Consensus 170 ~~------~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~------~~ 237 (286)
T cd06614 170 KS------KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPP------LK 237 (286)
T ss_pred hh------hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC------Cc
Confidence 21 123445889999999998888999999999999999999999999755433222 11111111 11
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 573 WPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 573 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
.+...+..+.+++.+|++.+|..||++.+.+
T Consensus 238 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il 268 (286)
T cd06614 238 NPEKWSPEFKDFLNKCLVKDPEKRPSAEELL 268 (286)
T ss_pred chhhCCHHHHHHHHHHhccChhhCcCHHHHh
Confidence 1222456789999999999999999998543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=296.04 Aligned_cols=242 Identities=27% Similarity=0.382 Sum_probs=195.4
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEec
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
+|...+.||.|+||.||+|... |..||+|.+..... .....+.+|+.+++.++||||++++++|.+ ..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4777889999999999999885 78899999876432 334568899999999999999999999854 47899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCC-CeEEeecCccccccCCC
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL-SSKICDFGICRLVTEDT 495 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~-~vKLsDFGla~~~~~~~ 495 (688)
+++++|.+++..... ..+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQRG-VLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 999999999875432 35799999999999999999999966 99999999999999886 46999999998765432
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHH--HhhcCccccccCCCCCCC
Q 005617 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR--AVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 496 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~--~~~~g~l~~~ld~~~~~~ 573 (688)
. ......|++.|+|||++....++.++|||||||++|+|++|..||........ ....+.+ . ..
T Consensus 157 ~------~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----~----~~ 222 (257)
T cd08225 157 E------LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYF----A----PI 222 (257)
T ss_pred c------cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccC----C----CC
Confidence 1 12334689999999999888999999999999999999999999975432111 1111111 1 11
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCCchH
Q 005617 574 PTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 574 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
+...+..+.+++.+||..+|.+||++.+.
T Consensus 223 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l 251 (257)
T cd08225 223 SPNFSRDLRSLISQLFKVSPRDRPSITSI 251 (257)
T ss_pred CCCCCHHHHHHHHHHhccChhhCcCHHHH
Confidence 22345679999999999999999998843
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=301.24 Aligned_cols=248 Identities=23% Similarity=0.295 Sum_probs=190.3
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecC
Q 005617 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 417 (688)
Q Consensus 344 f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~ 417 (688)
|...+.||.|++|.||+|... |..||||++..... .....+.+|+.+++.++|||++++++++.+ ..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 456688999999999999874 89999999875532 223568899999999999999999999854 478999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCc
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~ 497 (688)
+ ++|.+++..... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||++........
T Consensus 81 ~-~~l~~~~~~~~~-~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 81 D-LDLKKYMDSSPL-TGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred C-cCHHHHHhhCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 5 689988865432 45899999999999999999999965 99999999999999999999999999976543221
Q ss_pred CCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhh---c-Cc-----------
Q 005617 498 LPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS---C-GK----------- 561 (688)
Q Consensus 498 ~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~---~-g~----------- 561 (688)
......+++.|+|||++.+. .++.++|||||||++|+|+||++||........... . +.
T Consensus 155 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd07835 155 -----TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS 229 (283)
T ss_pred -----ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhh
Confidence 11334578999999987654 578999999999999999999999965443221111 0 00
Q ss_pred -------cccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchH
Q 005617 562 -------LSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 562 -------l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
+.....+.........+..+.+++.+|++.+|.+||++.+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~i 277 (283)
T cd07835 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAA 277 (283)
T ss_pred chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 00000000111122344678999999999999999998743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=294.92 Aligned_cols=246 Identities=28% Similarity=0.402 Sum_probs=196.1
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc--chHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEec
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 416 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~ 416 (688)
+|...+.||+|+||.||+|... +..||+|.+...... ....+.+|+.++..++|+||+++++++. +..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4677789999999999999874 789999999876553 4567999999999999999999999874 357899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCC
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~ 496 (688)
+++++|.+++... ..+++..+..|+.+++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhhc---CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 9999999998754 34788999999999999999999966 99999999999999999999999999987754332
Q ss_pred cCCCccccCCCCCCCCCCChhhhccCC---CCCcchHhHHHHHHHHHHhCCCCCCChhhHHH---HhhcCccccccCCCC
Q 005617 497 YLPSFHRSTAPKGSFPYADPEYHRTGV---LTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR---AVSCGKLSSILDPLA 570 (688)
Q Consensus 497 ~~~~~~~~~~~~GT~~Y~APE~~~~~~---~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~---~~~~g~l~~~ld~~~ 570 (688)
... .......|++.|+|||++.... ++.++||||||+++|+|++|+.||........ .+..+. .+..
T Consensus 155 ~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-----~~~~ 227 (264)
T cd06626 155 TMG--EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGH-----KPPI 227 (264)
T ss_pred ccc--ccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCC-----CCCC
Confidence 110 0012456889999999998766 89999999999999999999999964422111 111111 1111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCCchH
Q 005617 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 571 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
.. .......+.+++.+||+.+|.+||++.+.
T Consensus 228 ~~-~~~~~~~~~~li~~~l~~~p~~R~~~~~i 258 (264)
T cd06626 228 PD-SLQLSPEGKDFLDRCLESDPKKRPTASEL 258 (264)
T ss_pred Cc-ccccCHHHHHHHHHHccCCcccCCCHHHH
Confidence 11 11236678899999999999999999843
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=300.83 Aligned_cols=252 Identities=22% Similarity=0.338 Sum_probs=190.4
Q ss_pred HhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005617 340 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 340 at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++++|...+.||+|+||.||+|... |..||||++...... ....+.+|+.++..++|+||+++++++.+ ..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4678999999999999999999875 889999998755433 23467899999999999999999999854 478999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
||+. ++|.+.+.... ..+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQHP--GGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 66666654432 35788889999999999999999966 999999999999999999999999999764322
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhc-----C--------
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC-----G-------- 560 (688)
Q Consensus 495 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~-----g-------- 560 (688)
.. ......+++.|+|||++.+. .++.++|||||||++|+|+||..||.........+.. +
T Consensus 157 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (291)
T cd07870 157 SQ------TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWP 230 (291)
T ss_pred CC------CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhh
Confidence 11 12344578999999988754 5789999999999999999999999754332111100 0
Q ss_pred ---ccccccCCC-----CCCC-----CHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 561 ---KLSSILDPL-----AGDW-----PTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 561 ---~l~~~ld~~-----~~~~-----~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
.+....... .... .......+.+++.+|+..||.+|||+.+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l 286 (291)
T cd07870 231 GVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDAL 286 (291)
T ss_pred hhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHh
Confidence 000000000 0000 001245788999999999999999988543
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=301.46 Aligned_cols=236 Identities=25% Similarity=0.363 Sum_probs=190.3
Q ss_pred eeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEecCCCCcH
Q 005617 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLPNGSL 422 (688)
Q Consensus 350 LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~~~gsL 422 (688)
||+|+||+||++... |..||+|.+..... .....+..|+.+++.++||||+++++++. +..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 699999999999775 88999999875432 23345778999999999999999999884 458899999999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCCcc
Q 005617 423 QDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 502 (688)
Q Consensus 423 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~~~ 502 (688)
.+++..... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~l~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~------- 149 (277)
T cd05577 81 KYHIYNVGE-PGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK------- 149 (277)
T ss_pred HHHHHHcCc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCC-------
Confidence 999876543 46899999999999999999999966 9999999999999999999999999988664322
Q ss_pred ccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCCCCCCCHHHHHH
Q 005617 503 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVARR 580 (688)
Q Consensus 503 ~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~~~~~~~ 580 (688)
......|+..|+|||++.++.++.++|||||||++|+|++|+.||..... ....+...... .....+...+..
T Consensus 150 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~ 224 (277)
T cd05577 150 KIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE-----MAVEYPDKFSPE 224 (277)
T ss_pred ccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc-----ccccCCccCCHH
Confidence 12345688899999999888899999999999999999999999964432 11111111111 111233345678
Q ss_pred HHHHHHHccccCCCCCCCCch
Q 005617 581 LVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 581 l~~L~~~Cl~~dP~~RPs~~~ 601 (688)
+.+++.+||+.+|.+||+..+
T Consensus 225 ~~~li~~~l~~~p~~R~~~~~ 245 (277)
T cd05577 225 AKDLCEALLQKDPEKRLGCRG 245 (277)
T ss_pred HHHHHHHHccCChhHccCCCc
Confidence 899999999999999998875
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=303.50 Aligned_cols=239 Identities=27% Similarity=0.356 Sum_probs=190.1
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHcCCCCceeeEecccC--CCceeEE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~---~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~ 414 (688)
..|...+.||+|+||.||+|... |..||+|.+...... ....+.+|+.++..++||||++++++|. +..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45778889999999999999874 889999998754332 2346889999999999999999999984 4578999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
||+. |+|.+.+.... ..+++..+..++.|++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~~~--~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEVHK--KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHHcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9997 56666664332 35899999999999999999999966 999999999999999999999999998765422
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhc---cCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHh--hcCccccccCCC
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHR---TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAV--SCGKLSSILDPL 569 (688)
Q Consensus 495 ~~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~--~~g~l~~~ld~~ 569 (688)
....|++.|+|||++. .+.++.++||||||+++|||+||++||.......... ..+.. +.
T Consensus 169 ----------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~-----~~ 233 (307)
T cd06607 169 ----------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS-----PT 233 (307)
T ss_pred ----------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC-----CC
Confidence 2346888999999874 4668899999999999999999999997544322211 11111 00
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 570 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 570 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
-.+...+..+.+++.+||+.+|.+||++.+.+
T Consensus 234 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 265 (307)
T cd06607 234 --LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELL 265 (307)
T ss_pred --CCchhhCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 01223456799999999999999999998544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=302.80 Aligned_cols=246 Identities=25% Similarity=0.346 Sum_probs=188.6
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCC-CCceeeEecccC--CCceeEEec
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQ-HPHLVTLLGACP--EAWSLVYEY 416 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~-HpnIV~l~g~~~--~~~~LV~E~ 416 (688)
+|.....||+|+||.||++... |..||||.+..... .....+.+|+.++.++. ||||+++++++. ...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3445567999999999999885 78999999875433 34456889999999996 999999999874 347899999
Q ss_pred CCCCcHHHH---hcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccC
Q 005617 417 LPNGSLQDR---LFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 417 ~~~gsL~~~---L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~ 493 (688)
+.. +|.++ +... ....+++..+..++.+++.||.|||+.. +|+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~~~-~l~~l~~~~~~~-~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 85 MDI-SLDKFYKYVYEV-LKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred ccC-CHHHHHHHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 864 54443 2222 2256899999999999999999999742 499999999999999999999999999986543
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccC---CCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhh---cCccccccC
Q 005617 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTG---VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS---CGKLSSILD 567 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~---~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~---~g~l~~~ld 567 (688)
.. ......|++.|+|||++.+. .++.++|||||||++|+|++|+.||.........+. .+....+
T Consensus 161 ~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-- 231 (288)
T cd06616 161 SI-------AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPIL-- 231 (288)
T ss_pred CC-------ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcC--
Confidence 22 11334689999999998776 689999999999999999999999975433222211 1111111
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 568 PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 568 ~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
....+...+..+.+|+.+||+.+|.+||++.+.+
T Consensus 232 --~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~ 265 (288)
T cd06616 232 --SNSEEREFSPSFVNFINLCLIKDESKRPKYKELL 265 (288)
T ss_pred --CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 1112233567899999999999999999998544
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=301.91 Aligned_cols=252 Identities=23% Similarity=0.242 Sum_probs=190.8
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCC-CCceeeEecccCC--C-----
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQ-HPHLVTLLGACPE--A----- 409 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~--~~~~~f~~E~~iL~~l~-HpnIV~l~g~~~~--~----- 409 (688)
++|...+.||.|+||.||+|.+. |..||||.+..... .....+.+|+.++..++ ||||+++++++.. .
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888899999999999999885 78999998865432 23356888999999995 6999999998732 2
Q ss_pred ceeEEecCCCCcHHHHhcccCC--CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCC-CCCeEEeecC
Q 005617 410 WSLVYEYLPNGSLQDRLFRKSN--VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS-ELSSKICDFG 486 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~-~~~vKLsDFG 486 (688)
.++||||+++ +|.+++..... ...+++..+..++.||+.||.|||..+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 5899999986 78887765432 356899999999999999999999965 999999999999998 8999999999
Q ss_pred ccccccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhc------
Q 005617 487 ICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC------ 559 (688)
Q Consensus 487 la~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~------ 559 (688)
++....... .......+++.|+|||++.+ ..++.++|||||||++|+|++|..||............
T Consensus 157 ~~~~~~~~~------~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~ 230 (295)
T cd07837 157 LGRAFSIPV------KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGT 230 (295)
T ss_pred cceecCCCc------cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCC
Confidence 998654321 11233467889999998865 45799999999999999999999999754433221110
Q ss_pred Ccc---cccc---C----C-----CCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 560 GKL---SSIL---D----P-----LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 560 g~l---~~~l---d----~-----~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
... .... + + .........+..+.+++.+||..||.+||++.+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil 289 (295)
T cd07837 231 PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAAL 289 (295)
T ss_pred CChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHh
Confidence 000 0000 0 0 00000113456789999999999999999987433
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=296.33 Aligned_cols=235 Identities=26% Similarity=0.339 Sum_probs=192.7
Q ss_pred eeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecCCCCcH
Q 005617 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSL 422 (688)
Q Consensus 350 LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gsL 422 (688)
||.|+||.||++... +..||+|++..... .....+.+|+.+++.++||||+++++++.+ ..++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 799999999999997 88999999976543 234569999999999999999999998844 48899999999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCCcc
Q 005617 423 QDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 502 (688)
Q Consensus 423 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~~~ 502 (688)
.+++.... .+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~------- 147 (262)
T cd05572 81 WTILRDRG---LFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ------- 147 (262)
T ss_pred HHHHhhcC---CCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-------
Confidence 99997643 4788999999999999999999965 9999999999999999999999999998765432
Q ss_pred ccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh--h--HHHHhhcCccccccCCCCCCCCHHHH
Q 005617 503 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG--E--VRRAVSCGKLSSILDPLAGDWPTFVA 578 (688)
Q Consensus 503 ~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~--~--~~~~~~~g~l~~~ld~~~~~~~~~~~ 578 (688)
......|++.|++||++....++.++|+||||+++|+|++|..||.... . ....+..+ .....+|....
T Consensus 148 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~ 220 (262)
T cd05572 148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKG-------NGKLEFPNYID 220 (262)
T ss_pred ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhcc-------CCCCCCCcccC
Confidence 1234568999999999988889999999999999999999999997544 1 11111111 11223344446
Q ss_pred HHHHHHHHHccccCCCCCCCCchHHH
Q 005617 579 RRLVDLGLQCCELYGRERPDITPSLV 604 (688)
Q Consensus 579 ~~l~~L~~~Cl~~dP~~RPs~~~~l~ 604 (688)
..+.+++.+||+.+|.+||++.+..+
T Consensus 221 ~~~~~~i~~~l~~~p~~R~~~~~~~~ 246 (262)
T cd05572 221 KAAKDLIKQLLRRNPEERLGNLKGGI 246 (262)
T ss_pred HHHHHHHHHHccCChhhCcCCcccCH
Confidence 78999999999999999999654333
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=289.11 Aligned_cols=246 Identities=26% Similarity=0.401 Sum_probs=201.0
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC----CceeEE
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE----AWSLVY 414 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~----~~~LV~ 414 (688)
+|...+.||+|++|.||+|... +..|++|++..... .....+.+|+.++++++||||+++++.+.+ ..++||
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4677789999999999999986 88999999876653 345678999999999999999999998853 478999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
||+++++|.+++.... .+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKFG---KLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 9999999999987643 7899999999999999999999965 999999999999999999999999999887654
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhH-HHHhhcCccccccCCCCCCC
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV-RRAVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 495 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~-~~~~~~g~l~~~ld~~~~~~ 573 (688)
... .......++..|++||.+.....+.++||||||+++|+|++|..||...... ........ . ......
T Consensus 155 ~~~----~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~----~~~~~~ 225 (260)
T cd06606 155 ETG----EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS-S----GEPPEI 225 (260)
T ss_pred ccc----ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc-c----CCCcCC
Confidence 321 0123457899999999999888999999999999999999999999755421 11111110 0 011233
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 574 PTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 574 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
+......+.+++.+|++.+|.+||++.+.+
T Consensus 226 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll 255 (260)
T cd06606 226 PEHLSEEAKDFLRKCLRRDPKKRPTADELL 255 (260)
T ss_pred CcccCHHHHHHHHHhCcCChhhCCCHHHHh
Confidence 444577899999999999999999998544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-35 Score=320.36 Aligned_cols=240 Identities=23% Similarity=0.368 Sum_probs=197.7
Q ss_pred ceeeeccCceEEEEEEEC--CeEEEEEEEecC----CccchHHHHHHHHHHHcCCCCceeeEecccCC----CceeEEec
Q 005617 347 SFKVGQGGFGCVYKGEML--GRTVAIKMLYSH----NMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE----AWSLVYEY 416 (688)
Q Consensus 347 ~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~----~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~----~~~LV~E~ 416 (688)
...||+|+|-+||+|.+. |-.||---++.. .......|..|+.+|+.|+|||||++|.+|.+ ...+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 346999999999999886 666764433222 22334679999999999999999999999844 26689999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCC-CCeEEeecCccccccCCC
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE-LSSKICDFGICRLVTEDT 495 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~-~~vKLsDFGla~~~~~~~ 495 (688)
|..|+|..++.+.. .++...+..|+.||++||.|||+.. +||||||||.+||+|+.+ |.|||+|+|||.......
T Consensus 125 ~TSGtLr~Y~kk~~---~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 125 FTSGTLREYRKKHR---RVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred ccCCcHHHHHHHhc---cCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 99999999997764 4677889999999999999999988 589999999999999865 899999999999886543
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCC---hhhHHHHhhcCccccccCCCCCC
Q 005617 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGL---AGEVRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 496 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~---~~~~~~~~~~g~l~~~ld~~~~~ 572 (688)
...+.|||.|||||.+- ..|+..+||||||++|+||+|+..||.. ...+.+.+..|.....+...
T Consensus 201 --------aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV--- 268 (632)
T KOG0584|consen 201 --------AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKV--- 268 (632)
T ss_pred --------cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhcc---
Confidence 34579999999999876 7899999999999999999999999974 44677778777655443322
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHH
Q 005617 573 WPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 573 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~L 607 (688)
-..++.++|.+|+.. ..+||++.+.+.+.+
T Consensus 269 ----~dPevr~fIekCl~~-~~~R~sa~eLL~d~F 298 (632)
T KOG0584|consen 269 ----KDPEVREFIEKCLAT-KSERLSAKELLKDPF 298 (632)
T ss_pred ----CCHHHHHHHHHHhcC-chhccCHHHHhhChh
Confidence 134788999999999 999999986665544
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-34 Score=302.61 Aligned_cols=200 Identities=25% Similarity=0.302 Sum_probs=163.7
Q ss_pred CcccceeeeccCceEEEEEEE----CCeEEEEEEEecCC---ccchHHHHHHHHHHHcCCCCceeeEecccCC----Cce
Q 005617 343 NFSESFKVGQGGFGCVYKGEM----LGRTVAIKMLYSHN---MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE----AWS 411 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~----~g~~vAIK~l~~~~---~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~----~~~ 411 (688)
.|.....||+|+||.||+|.. .+..||||.+.... ......+.+|+.++..++||||++++++|.+ ..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 367778999999999999988 46899999998743 2334567889999999999999999999843 378
Q ss_pred eEEecCCCCcHHHHhccc-C-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCC----CCCeEEeec
Q 005617 412 LVYEYLPNGSLQDRLFRK-S-NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS----ELSSKICDF 485 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~-~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~----~~~vKLsDF 485 (688)
+||||+++ +|.+.+... . ....++...+..|+.||+.||.|||+.+ |+||||||+|||++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999976 565555322 1 2236889999999999999999999966 999999999999999 999999999
Q ss_pred CccccccCCCCcCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCC
Q 005617 486 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGL 549 (688)
Q Consensus 486 Gla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~ 549 (688)
|++......... ........||+.|+|||++.+. .++.++|||||||++|+|++|++||..
T Consensus 157 g~~~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~ 218 (316)
T cd07842 157 GLARLFNAPLKP---LADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKG 218 (316)
T ss_pred ccccccCCCccc---ccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence 999876543211 1123455789999999988664 579999999999999999999999963
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=299.94 Aligned_cols=250 Identities=24% Similarity=0.332 Sum_probs=192.4
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc--chHHHHHHHHHHHcCCCCceeeEecccC----CCceeE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACP----EAWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~~----~~~~LV 413 (688)
++|...+.||.|+||.||+|... +..||||.++..... ....+.+|+.++.+++||||+++++++. ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46777889999999999999986 788999999755432 2235778999999999999999999873 458999
Q ss_pred EecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccC
Q 005617 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~ 493 (688)
|||+. ++|.+.+.... ..+++..+..++.||+.||.|||+.+ |+|+||||+|||++.++.+||+|||++.....
T Consensus 85 ~e~~~-~~L~~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETMK--QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 48988886543 36899999999999999999999966 99999999999999999999999999987654
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHH--hh------------
Q 005617 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VS------------ 558 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~--~~------------ 558 (688)
... ......+++.|+|||++.+. .++.++||||||+++|+|++|.+||......... +.
T Consensus 159 ~~~------~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (293)
T cd07843 159 PLK------PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP 232 (293)
T ss_pred Ccc------ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHH
Confidence 321 12344678999999988654 4689999999999999999999999643321110 00
Q ss_pred ---c------CccccccC-CCCCCCCHH-HHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 559 ---C------GKLSSILD-PLAGDWPTF-VARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 559 ---~------g~l~~~ld-~~~~~~~~~-~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
. ........ .....++.. +...+.+++.+||+.+|++||++.+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell 288 (293)
T cd07843 233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDAL 288 (293)
T ss_pred HhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHh
Confidence 0 00000000 001112222 467789999999999999999988443
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=292.63 Aligned_cols=245 Identities=25% Similarity=0.330 Sum_probs=195.3
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC-----ccchHHHHHHHHHHHcCCCCceeeEecccCC----Cc
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN-----MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE----AW 410 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~-----~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~----~~ 410 (688)
.+|...+.||+|+||.||+|.+. |..||+|.+.... ......|.+|+.++++++||||+++++++.+ ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47888999999999999999874 7899999885431 1233468899999999999999999998843 36
Q ss_pred eeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCcccc
Q 005617 411 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~ 490 (688)
++|+||+++++|.+.+... ..+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY---GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 7899999999999988654 34788999999999999999999866 99999999999999999999999999986
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCccccccCCCC
Q 005617 491 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~l~~~ld~~~ 570 (688)
....... ........|+..|+|||++.+..++.++|||||||++|+|++|+.||.............. .+..
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-----~~~~ 227 (264)
T cd06653 156 IQTICMS---GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIAT-----QPTK 227 (264)
T ss_pred ccccccc---CccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHc-----CCCC
Confidence 5432110 0112345689999999999988899999999999999999999999975443322211110 0112
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCCch
Q 005617 571 GDWPTFVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 571 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~ 601 (688)
...|......+.+++.+||+ +|..||+..+
T Consensus 228 ~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~ 257 (264)
T cd06653 228 PMLPDGVSDACRDFLKQIFV-EEKRRPTAEF 257 (264)
T ss_pred CCCCcccCHHHHHHHHHHhc-CcccCccHHH
Confidence 23455677889999999999 5799999873
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-35 Score=315.03 Aligned_cols=248 Identities=27% Similarity=0.463 Sum_probs=206.1
Q ss_pred cccceeeeccCceEEEEEEEC----C--eEEEEEEEecCC-ccchHHHHHHHHHHHcCCCCceeeEecccCC-CceeEEe
Q 005617 344 FSESFKVGQGGFGCVYKGEML----G--RTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYE 415 (688)
Q Consensus 344 f~~~~~LG~G~fG~Vykg~~~----g--~~vAIK~l~~~~-~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV~E 415 (688)
....++||.|-||.||+|... | -.||||..+.+. ....+.|..|..++++++|||||+|+|+|.+ ..+||||
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~WivmE 470 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIVME 470 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEEEe
Confidence 344678999999999999875 3 249999998754 4556679999999999999999999999976 4789999
Q ss_pred cCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCC
Q 005617 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~ 495 (688)
.++-|.|..+|.... ..|+......++.||+.||.|||+.. +|||||...|||+...--+||+|||+++.+.++.
T Consensus 471 L~~~GELr~yLq~nk--~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 471 LAPLGELREYLQQNK--DSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred cccchhHHHHHHhcc--ccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 999999999997765 46777888999999999999999955 9999999999999999999999999999988765
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHHHhhcCccccccCCCCCC
Q 005617 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 496 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~ 572 (688)
.+ ......-.+-|||||.+....++..+|||-|||+|||++. |..||.+..+ +.-.+..|. ...
T Consensus 546 yY-----kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGe--------RlP 612 (974)
T KOG4257|consen 546 YY-----KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGE--------RLP 612 (974)
T ss_pred hh-----hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCC--------CCC
Confidence 43 3334445667999999999999999999999999999988 9999986553 222233332 224
Q ss_pred CCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHh
Q 005617 573 WPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 573 ~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l 610 (688)
.|+.++..|..|+.+||.++|.+||.+. ++...|..+
T Consensus 613 ~P~nCPp~LYslmskcWayeP~kRPrft-ei~~~lsdv 649 (974)
T KOG4257|consen 613 CPPNCPPALYSLMSKCWAYEPSKRPRFT-EIKAILSDV 649 (974)
T ss_pred CCCCCChHHHHHHHHHhccCcccCCcHH-HHHHHHHHH
Confidence 5667788999999999999999999998 555555444
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=289.10 Aligned_cols=242 Identities=26% Similarity=0.401 Sum_probs=198.6
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEec
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
+|.....||+|++|.||++... +..||+|.+..... .....+.+|+.++.+++|||++++++++.+ ..++||+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677889999999999999875 78899999977654 344579999999999999999999998854 47899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCC
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~ 496 (688)
+++++|.+++... ..+++..+..++.+++.||.|||+.+ |+||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~~---~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKKF---GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 9999999998654 46899999999999999999999966 99999999999999999999999999987754332
Q ss_pred cCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCccccccCCCCCCCCHH
Q 005617 497 YLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTF 576 (688)
Q Consensus 497 ~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~l~~~ld~~~~~~~~~ 576 (688)
. .....|+..|+|||+.....++.++||||||+++|+|++|..||.............. ......+..
T Consensus 155 ~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~------~~~~~~~~~ 222 (254)
T cd06627 155 D------DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ------DDHPPLPEG 222 (254)
T ss_pred c------ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhc------cCCCCCCCC
Confidence 1 2345689999999999888899999999999999999999999975443322222110 001123334
Q ss_pred HHHHHHHHHHHccccCCCCCCCCchH
Q 005617 577 VARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 577 ~~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
....+.+++.+||..+|++||++.+.
T Consensus 223 ~~~~~~~~i~~~l~~~p~~R~~~~~~ 248 (254)
T cd06627 223 ISPELKDFLMQCFQKDPNLRPTAKQL 248 (254)
T ss_pred CCHHHHHHHHHHHhCChhhCcCHHHH
Confidence 56788999999999999999998743
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=300.94 Aligned_cols=244 Identities=23% Similarity=0.325 Sum_probs=205.7
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEeccc--CCCceeEEecCCC
Q 005617 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPN 419 (688)
Q Consensus 344 f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~--~~~~~LV~E~~~~ 419 (688)
|....+||+|+||.||++.+. |..||||.+... .+..++..|+.|+.+.+.|++|++||.+ ..++++|||||-.
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 566778999999999999775 999999988653 3567899999999999999999999976 3468999999999
Q ss_pred CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCC
Q 005617 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 420 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~ 499 (688)
||..+++.-.. .+|+..++..|+...+.||.|||... -||||||..||||+.+|++||+|||.|..+.+..
T Consensus 113 GSiSDI~R~R~--K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM---- 183 (502)
T KOG0574|consen 113 GSISDIMRARR--KPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM---- 183 (502)
T ss_pred CcHHHHHHHhc--CCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH----
Confidence 99999987654 68999999999999999999999976 7999999999999999999999999998876543
Q ss_pred CccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCccccccCCCC-CCCCHHHH
Q 005617 500 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLA-GDWPTFVA 578 (688)
Q Consensus 500 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~l~~~ld~~~-~~~~~~~~ 578 (688)
.....+.|||-|||||++..-.|+.++||||||+...||..|++||.....++...... -.|.. -.-|...+
T Consensus 184 --AKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIP-----T~PPPTF~KPE~WS 256 (502)
T KOG0574|consen 184 --AKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIP-----TKPPPTFKKPEEWS 256 (502)
T ss_pred --HhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEecc-----CCCCCCCCChHhhh
Confidence 24567889999999999999999999999999999999999999998666543321110 01111 12356778
Q ss_pred HHHHHHHHHccccCCCCCCCCchHHHH
Q 005617 579 RRLVDLGLQCCELYGRERPDITPSLVK 605 (688)
Q Consensus 579 ~~l~~L~~~Cl~~dP~~RPs~~~~l~~ 605 (688)
.++-+++..||-.+|++|-|+.+.+.+
T Consensus 257 ~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 257 SEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred hHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 899999999999999999987754433
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=299.95 Aligned_cols=252 Identities=19% Similarity=0.217 Sum_probs=190.8
Q ss_pred eeeeccCceEEEEEEECCeEEEEEEEecCC--ccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecCCCCcHH
Q 005617 348 FKVGQGGFGCVYKGEMLGRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSLQ 423 (688)
Q Consensus 348 ~~LG~G~fG~Vykg~~~g~~vAIK~l~~~~--~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gsL~ 423 (688)
+.+|.|+++.||++...|..||||++.... ......+.+|+.+++.++||||+++++++.+ ..+++|||+++|+|.
T Consensus 8 ~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 87 (314)
T cd08216 8 KCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCE 87 (314)
T ss_pred HhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHH
Confidence 445666777777777789999999997652 3345579999999999999999999998843 578999999999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcC-CCcc
Q 005617 424 DRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL-PSFH 502 (688)
Q Consensus 424 ~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~-~~~~ 502 (688)
+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||.+.......... ....
T Consensus 88 ~~l~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 88 DLLKTHFP-EGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred HHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 99875432 35788999999999999999999966 9999999999999999999999999987654322110 0111
Q ss_pred ccCCCCCCCCCCChhhhcc--CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhh--cCccccccC-----------
Q 005617 503 RSTAPKGSFPYADPEYHRT--GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS--CGKLSSILD----------- 567 (688)
Q Consensus 503 ~~~~~~GT~~Y~APE~~~~--~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~--~g~l~~~ld----------- 567 (688)
......++..|+|||++.. ..+++++|||||||++|||++|+.||.........+. .+.....++
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSM 243 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCc
Confidence 2234567889999999866 3588999999999999999999999975443222211 111111110
Q ss_pred ---------C-----CCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 568 ---------P-----LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 568 ---------~-----~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
+ .....+......+.+|+.+||+.||.+||++.+.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll 293 (314)
T cd08216 244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLL 293 (314)
T ss_pred CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHh
Confidence 0 01112334567899999999999999999988544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=300.56 Aligned_cols=237 Identities=25% Similarity=0.351 Sum_probs=188.3
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEec
Q 005617 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 344 f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~---~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
|...+.||+|+||.||+|... |..||||.+...... ....+.+|+.+++.++|||+++++++|.+ ..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 667788999999999999874 789999998754332 23468899999999999999999999854 47899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCC
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~ 496 (688)
+++ +|.+.+.... .+++|..+..++.+++.||.|||+.+ |+||||+|+||+++.++.+||+|||++......
T Consensus 107 ~~g-~l~~~~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-- 178 (317)
T cd06635 107 CLG-SASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA-- 178 (317)
T ss_pred CCC-CHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence 975 7777665432 46899999999999999999999966 999999999999999999999999998754321
Q ss_pred cCCCccccCCCCCCCCCCChhhhc---cCCCCCcchHhHHHHHHHHHHhCCCCCCChhhH--HHHhhcCccccccCCCCC
Q 005617 497 YLPSFHRSTAPKGSFPYADPEYHR---TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAG 571 (688)
Q Consensus 497 ~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~~~~g~l~~~ld~~~~ 571 (688)
....|++.|+|||++. .+.++.++|||||||++|||++|+.||...... ...+..+....
T Consensus 179 --------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~------- 243 (317)
T cd06635 179 --------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT------- 243 (317)
T ss_pred --------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC-------
Confidence 2446889999999873 467899999999999999999999998654321 11221111110
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 572 DWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 572 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
..+...+..+.+|+.+||+.+|.+||++.+.+
T Consensus 244 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il 275 (317)
T cd06635 244 LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELL 275 (317)
T ss_pred CCCccccHHHHHHHHHHccCCcccCcCHHHHH
Confidence 11123456789999999999999999998544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=306.10 Aligned_cols=250 Identities=22% Similarity=0.272 Sum_probs=193.2
Q ss_pred HhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC--ccchHHHHHHHHHHHcCCCCceeeEecccCC-------
Q 005617 340 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE------- 408 (688)
Q Consensus 340 at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~--~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~------- 408 (688)
..++|...+.||+|+||.||+|... |..||||.+.... ......+.+|+.++.+++||||++++++|..
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4578999999999999999999875 8899999986432 2334567789999999999999999998732
Q ss_pred -CceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCc
Q 005617 409 -AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 487 (688)
Q Consensus 409 -~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGl 487 (688)
..++||||+. ++|.+.+.. .+++..+..++.|++.||.|||..+ |+||||||+|||++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 2589999996 477777643 2788899999999999999999966 99999999999999999999999999
Q ss_pred cccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHH--Hh-h-cCc--
Q 005617 488 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR--AV-S-CGK-- 561 (688)
Q Consensus 488 a~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~--~~-~-~g~-- 561 (688)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.... .+ . .+.
T Consensus 165 ~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 237 (353)
T cd07850 165 ARTAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS 237 (353)
T ss_pred ceeCCCCC-------CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 98764322 12345688999999999999999999999999999999999999964332110 00 0 000
Q ss_pred -------------------------cccccC----CC-CCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHH
Q 005617 562 -------------------------LSSILD----PL-AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 605 (688)
Q Consensus 562 -------------------------l~~~ld----~~-~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~ 605 (688)
+...+. +. ....+......+.+|+.+||+.||.+||++.+.+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000 00 001122346678999999999999999999865543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=297.87 Aligned_cols=251 Identities=23% Similarity=0.274 Sum_probs=188.7
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEe
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E 415 (688)
++|.....||.|+||.||+|... |+.||||.+..... .....+.+|+.+++.++||||+++++++.+ ..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999875 78899999865433 233568899999999999999999999854 5889999
Q ss_pred cCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCC-CCCeEEeecCccccccCC
Q 005617 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS-ELSSKICDFGICRLVTED 494 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~-~~~vKLsDFGla~~~~~~ 494 (688)
|++ ++|.+++..... ..+++..+..++.+|+.||.|||+.+ |+|+||+|+||+++. ++.+||+|||++......
T Consensus 82 ~~~-~~l~~~~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLD-LDLKKHMDSSPD-FAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred ccc-ccHHHHHHhCCC-CCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 996 577777654332 34678888999999999999999965 999999999999985 567999999999765432
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHH---hhc-Cc-cccc---
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA---VSC-GK-LSSI--- 565 (688)
Q Consensus 495 ~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~---~~~-g~-l~~~--- 565 (688)
.. ......|++.|+|||++.+ ..++.++|||||||++|+|+||++||......... ... +. ....
T Consensus 157 ~~------~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (294)
T PLN00009 157 VR------TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPG 230 (294)
T ss_pred cc------ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 21 1234467899999998865 45789999999999999999999999644322111 100 00 0000
Q ss_pred ----cC----------CCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 566 ----LD----------PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 566 ----ld----------~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
.+ ..........+..+.+++.+|++.+|.+||++.+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l 282 (294)
T PLN00009 231 VTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAAL 282 (294)
T ss_pred cccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHh
Confidence 00 000001122456789999999999999999988544
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=300.08 Aligned_cols=246 Identities=22% Similarity=0.328 Sum_probs=189.7
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCC-CCceeeEecccCC--CceeEEe
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQ-HPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~-HpnIV~l~g~~~~--~~~LV~E 415 (688)
++|.....||.|+||.||+|... +..||||.+..... .....+..|+.++.+.. ||||++++++|.+ ..++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 56777889999999999999987 88999999976543 23445777887777775 9999999999854 4789999
Q ss_pred cCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCC
Q 005617 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~ 495 (688)
|+. ++|.+.+.... .++++..+..++.+++.||.|||+.+ +|+||||+|+||+++.++.+||+|||++..+....
T Consensus 95 ~~~-~~l~~l~~~~~--~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~ 169 (296)
T cd06618 95 LMS-TCLDKLLKRIQ--GPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK 169 (296)
T ss_pred ccC-cCHHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence 985 46776665433 37899999999999999999999742 49999999999999999999999999987664322
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCC----CCCcchHhHHHHHHHHHHhCCCCCCChhhH---HHHhhcCccccccCC
Q 005617 496 LYLPSFHRSTAPKGSFPYADPEYHRTGV----LTPKSDSYSFGLIILQLLTGRLPVGLAGEV---RRAVSCGKLSSILDP 568 (688)
Q Consensus 496 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~----~s~ksDVwSfGviL~ELltG~~Pf~~~~~~---~~~~~~g~l~~~ld~ 568 (688)
. .....|++.|+|||++.+.. ++.++||||||+++|+|++|+.||...... ...+..+.....
T Consensus 170 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--- 239 (296)
T cd06618 170 A-------KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL--- 239 (296)
T ss_pred c-------ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCC---
Confidence 1 12345888999999986553 789999999999999999999999653221 111111111110
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHH
Q 005617 569 LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 605 (688)
Q Consensus 569 ~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~ 605 (688)
.........+.+|+.+||+.||.+||++.+.+..
T Consensus 240 ---~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 240 ---PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ---CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 1111245678999999999999999999855543
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=298.20 Aligned_cols=256 Identities=21% Similarity=0.274 Sum_probs=179.6
Q ss_pred cCcccceeeeccCceEEEEEEECC-----eEEEEEEEecCCccch-----------HHHHHHHHHHHcCCCCceeeEecc
Q 005617 342 CNFSESFKVGQGGFGCVYKGEMLG-----RTVAIKMLYSHNMQGQ-----------LEFQQEVRVLSKLQHPHLVTLLGA 405 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~g-----~~vAIK~l~~~~~~~~-----------~~f~~E~~iL~~l~HpnIV~l~g~ 405 (688)
+.|...+.||+|+||.||+|...+ ..+|+|+......... .....+...+..+.|+||++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 678899999999999999998763 3567776433322111 112234445667789999999987
Q ss_pred cCCC------ceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCC
Q 005617 406 CPEA------WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELS 479 (688)
Q Consensus 406 ~~~~------~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~ 479 (688)
+... .+++++++.. ++.+.+... ...++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVE-NTKEIFKRI---KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeEecCCceEEEEEEehhcc-CHHHHHHhh---ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCc
Confidence 6332 3567776643 555555332 23578889999999999999999965 999999999999999999
Q ss_pred eEEeecCccccccCCCCcC-CCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh---HHH
Q 005617 480 SKICDFGICRLVTEDTLYL-PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE---VRR 555 (688)
Q Consensus 480 vKLsDFGla~~~~~~~~~~-~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~---~~~ 555 (688)
++|+|||+|+.+....... ..........||+.|+|||++.+..++.++|||||||+||||++|+.||..... ...
T Consensus 165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~ 244 (294)
T PHA02882 165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIH 244 (294)
T ss_pred EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHH
Confidence 9999999998764322111 011122345799999999999999999999999999999999999999975421 111
Q ss_pred HhhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHH
Q 005617 556 AVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 556 ~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~L 607 (688)
....+-+..+..+. .. ....+..+.+++..|+..+|.+||++. .+.+.|
T Consensus 245 ~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~rp~~~-~l~~~~ 293 (294)
T PHA02882 245 AAKCDFIKRLHEGK-IK-IKNANKFIYDFIECVTKLSYEEKPDYD-ALIKIF 293 (294)
T ss_pred HhHHHHHHHhhhhh-hc-cCCCCHHHHHHHHHHHhCCCCCCCCHH-HHHHhh
Confidence 11111011111110 00 112356789999999999999999998 555443
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-34 Score=304.89 Aligned_cols=252 Identities=22% Similarity=0.307 Sum_probs=190.6
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC-------Cc
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE-------AW 410 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-------~~ 410 (688)
+++|...+.||+|+||.||+|... |..||||.+..... .....+.+|+.++.+++||||+++++++.. ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 578999999999999999999875 88999999864332 234568889999999999999999987632 36
Q ss_pred eeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCcccc
Q 005617 411 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~ 490 (688)
++|+||+.+ +|...+.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~-~l~~~~~~----~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIKT----QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 899999974 77777643 35899999999999999999999966 99999999999999999999999999987
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHH------hhcC---
Q 005617 491 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA------VSCG--- 560 (688)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~------~~~g--- 560 (688)
........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......... +...
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~ 232 (336)
T cd07849 156 ADPEHDHT---GFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQE 232 (336)
T ss_pred cccccccc---CCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 64322111 11234578999999998754 56899999999999999999999999643221100 0000
Q ss_pred ccccccCC----------C--CCCC---CHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 561 KLSSILDP----------L--AGDW---PTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 561 ~l~~~ld~----------~--~~~~---~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
.+..+.+. . ...+ ....+..+.+++.+||+.+|.+||++.+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l 290 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEAL 290 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHh
Confidence 00000000 0 0000 112356789999999999999999998443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=290.21 Aligned_cols=243 Identities=28% Similarity=0.348 Sum_probs=193.3
Q ss_pred eeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecCCCCcH
Q 005617 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSL 422 (688)
Q Consensus 350 LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gsL 422 (688)
||.|+||.||++... |..||+|++..... .....+.+|+.++.+++||||+++++++.. ..++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999986 88999999976544 344568899999999999999999998854 47899999999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcC--CC
Q 005617 423 QDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL--PS 500 (688)
Q Consensus 423 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~--~~ 500 (688)
.+++.... .+++..+..++.||+.||.|||..+ ++|+||+|+||+++.++.++|+|||++.......... ..
T Consensus 81 ~~~l~~~~---~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENVG---SLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 99987543 6899999999999999999999965 9999999999999999999999999988654321100 00
Q ss_pred ccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCCCCCCCHH--
Q 005617 501 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTF-- 576 (688)
Q Consensus 501 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~~~-- 576 (688)
........++..|++||.+....++.++||||||+++|+|++|..||..... ....+..+.. .++..
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~---------~~~~~~~ 225 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI---------EWPEDVE 225 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc---------CCCcccc
Confidence 1122345688999999999888899999999999999999999999964432 2222222221 12222
Q ss_pred HHHHHHHHHHHccccCCCCCCCCchHHHHHHH
Q 005617 577 VARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 577 ~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le 608 (688)
.+..+.+++.+||+.+|.+||++. .+.+.|+
T Consensus 226 ~~~~~~~~i~~~l~~~p~~Rpt~~-~~~~~l~ 256 (265)
T cd05579 226 VSDEAIDLISKLLVPDPEKRLGAK-SIEEIKN 256 (265)
T ss_pred CCHHHHHHHHHHhcCCHhhcCCCc-cHHHHhc
Confidence 267889999999999999999996 4444443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=305.18 Aligned_cols=257 Identities=24% Similarity=0.320 Sum_probs=193.7
Q ss_pred HhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecC--CccchHHHHHHHHHHHcC-CCCceeeEecccCC----Cc
Q 005617 340 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSH--NMQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE----AW 410 (688)
Q Consensus 340 at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~--~~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~----~~ 410 (688)
..++|.....||.|+||.||+|.+. |..||||++... .......+..|+.++.++ +||||++++++|.. ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 4567888899999999999999875 788999988643 223345677899999999 99999999998742 36
Q ss_pred eeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCcccc
Q 005617 411 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~ 490 (688)
++||||++ ++|..++... .++|..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~~----~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN----ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 89999997 5888887543 5789999999999999999999965 99999999999999999999999999987
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHH---Hhhc-Cc----
Q 005617 491 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR---AVSC-GK---- 561 (688)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~---~~~~-g~---- 561 (688)
........ .........||+.|+|||++.. ..++.++|||||||++|+|+||+.||........ .... +.
T Consensus 157 ~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~ 235 (337)
T cd07852 157 LSELEENP-ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAE 235 (337)
T ss_pred cccccccc-cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 65433210 0012234568999999998754 5678999999999999999999999964332111 0000 00
Q ss_pred ---------cccccCC-------CCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHH
Q 005617 562 ---------LSSILDP-------LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 605 (688)
Q Consensus 562 ---------l~~~ld~-------~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~ 605 (688)
...+++. .........+..+.+++.+||+.+|.+||++.+.+..
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 0000100 0011111245688999999999999999999865543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=294.49 Aligned_cols=247 Identities=25% Similarity=0.370 Sum_probs=189.7
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCC--ccchHHHHHHHHHHHcCCCCceeeEecccCC----CceeEEe
Q 005617 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE----AWSLVYE 415 (688)
Q Consensus 344 f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~--~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~----~~~LV~E 415 (688)
|.....||.|+||.||+|... |..||+|++.... ......+.+|+.++..++|||++++++++.+ ..++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 456688999999999999886 6899999998764 2334568899999999999999999999843 4889999
Q ss_pred cCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCC
Q 005617 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~ 495 (688)
|+++ +|..++.... ..+++..++.++.+|+.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSPE--VKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9975 8888876543 46899999999999999999999965 9999999999999999999999999998765432
Q ss_pred CcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHH---hhc-C-----ccc--
Q 005617 496 LYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA---VSC-G-----KLS-- 563 (688)
Q Consensus 496 ~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~---~~~-g-----~l~-- 563 (688)
.. ......++..|+|||.+.+ ..+++++||||||+++|||+||+.||......... ... + ...
T Consensus 155 ~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (287)
T cd07840 155 SA-----DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGV 229 (287)
T ss_pred cc-----cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhcccc
Confidence 10 1234467889999997754 46799999999999999999999999643321110 000 0 000
Q ss_pred -cc-----cCCCC------CC-CCHHHHHHHHHHHHHccccCCCCCCCCch
Q 005617 564 -SI-----LDPLA------GD-WPTFVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 564 -~~-----ld~~~------~~-~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~ 601 (688)
.+ +.+.. .+ +...++..+.+++.+||+.+|.+||++.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ 280 (287)
T cd07840 230 SKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQ 280 (287)
T ss_pred ccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHH
Confidence 00 00000 00 01112668899999999999999999884
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=294.25 Aligned_cols=245 Identities=24% Similarity=0.298 Sum_probs=185.3
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCC-CCceeeEecccC----CCceeEEe
Q 005617 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQ-HPHLVTLLGACP----EAWSLVYE 415 (688)
Q Consensus 344 f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~-HpnIV~l~g~~~----~~~~LV~E 415 (688)
|...+.||.|+||.||+|... +..||+|.++.... .......+|+.++.++. ||||++++++|. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 456678999999999999874 78999999875432 22334567899999985 999999999884 34789999
Q ss_pred cCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCC
Q 005617 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~ 495 (688)
|++ |+|.+.+.... ..++|..+..++.|++.||.|||+.+ ++||||+|+||+++. +.+||+|||++.......
T Consensus 81 ~~~-~~l~~~l~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMD-MNLYELIKGRK--RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCC-ccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 997 57777775433 46899999999999999999999965 999999999999999 999999999998764332
Q ss_pred CcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHH---HHhh-------------
Q 005617 496 LYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR---RAVS------------- 558 (688)
Q Consensus 496 ~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~---~~~~------------- 558 (688)
. .....+++.|+|||++.. +.++.++|||||||++|||++|.+||...+... ....
T Consensus 154 ~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (282)
T cd07831 154 P-------YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKF 226 (282)
T ss_pred C-------cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhh
Confidence 1 123458899999997654 567899999999999999999999996443211 0000
Q ss_pred -cCccccccCCC-CC----CCCHHHHHHHHHHHHHccccCCCCCCCCchH
Q 005617 559 -CGKLSSILDPL-AG----DWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 559 -~g~l~~~ld~~-~~----~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
.........+. .. ......+..+.+|+.+||+.+|.+||++.+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~ 276 (282)
T cd07831 227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQA 276 (282)
T ss_pred cccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHH
Confidence 00000000000 00 0112346789999999999999999998743
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=293.37 Aligned_cols=239 Identities=21% Similarity=0.307 Sum_probs=185.9
Q ss_pred HHHHHHHhcCcccceee--eccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcC-CCCceeeEecccC-
Q 005617 334 LADLQTATCNFSESFKV--GQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACP- 407 (688)
Q Consensus 334 ~~el~~at~~f~~~~~L--G~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~- 407 (688)
..++....++|...+.+ |.|+||.||++... +..+|+|.+........ |+.+...+ +||||++++++|.
T Consensus 6 ~~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 6 LSELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEec
Confidence 34455555677776666 99999999999875 78899999875432211 22233223 7999999999883
Q ss_pred -CCceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCC-CeEEeec
Q 005617 408 -EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL-SSKICDF 485 (688)
Q Consensus 408 -~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~-~vKLsDF 485 (688)
+..++||||+++|+|.+++.... +++|..+..++.|++.||.|||+.+ ++||||||+||+++.++ .++|+||
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~df 154 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDY 154 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecC
Confidence 45889999999999999986543 7899999999999999999999966 99999999999999998 9999999
Q ss_pred CccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHH---HHhhcCcc
Q 005617 486 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR---RAVSCGKL 562 (688)
Q Consensus 486 Gla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~---~~~~~g~l 562 (688)
|++...... ....|+..|+|||++.+..+++++|||||||++|+|++|+.||....... ..+... .
T Consensus 155 g~~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~ 223 (267)
T PHA03390 155 GLCKIIGTP----------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKR-Q 223 (267)
T ss_pred ccceecCCC----------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHh-h
Confidence 998765432 23468999999999999999999999999999999999999996432210 111100 0
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCC
Q 005617 563 SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDI 599 (688)
Q Consensus 563 ~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~ 599 (688)
. .....+...+..+.+++.+||+.+|.+||+.
T Consensus 224 ~-----~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~ 255 (267)
T PHA03390 224 Q-----KKLPFIKNVSKNANDFVQSMLKYNINYRLTN 255 (267)
T ss_pred c-----ccCCcccccCHHHHHHHHHHhccChhhCCch
Confidence 1 0112233566789999999999999999974
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=296.60 Aligned_cols=253 Identities=23% Similarity=0.319 Sum_probs=192.7
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC------
Q 005617 339 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE------ 408 (688)
Q Consensus 339 ~at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~------ 408 (688)
.+.++|.....||.|+||.||+|... |..||||++..... .....+.+|+.++..++||||+++++++.+
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 35578888999999999999999985 78999999975432 233467889999999999999999998743
Q ss_pred ------CceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEE
Q 005617 409 ------AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKI 482 (688)
Q Consensus 409 ------~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL 482 (688)
..++|+||+++ +|...+... ...+++..+..|+.|++.||.|||+.+ |+|+||||+||+++.++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESG--LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 46899999986 666666543 246899999999999999999999976 999999999999999999999
Q ss_pred eecCccccccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHH-----
Q 005617 483 CDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA----- 556 (688)
Q Consensus 483 sDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~----- 556 (688)
+|||++......... ......+++.|+|||++.+ ..++.++|||||||++|+|++|++||.........
T Consensus 158 ~dfg~~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~ 232 (302)
T cd07864 158 ADFGLARLYNSEESR-----PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232 (302)
T ss_pred CcccccccccCCccc-----ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 999999876543211 1123456888999998764 45789999999999999999999999754432211
Q ss_pred hhcCcc----ccc--------cCCCC------CCCCHHHHHHHHHHHHHccccCCCCCCCCchH
Q 005617 557 VSCGKL----SSI--------LDPLA------GDWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 557 ~~~g~l----~~~--------ld~~~------~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
...+.. ..+ .++.. .......+..+.+++.+||+.+|.+||++.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~i 296 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEA 296 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHH
Confidence 000000 000 00000 00011235689999999999999999998743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-34 Score=304.69 Aligned_cols=254 Identities=20% Similarity=0.265 Sum_probs=194.1
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccC------CCc
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACP------EAW 410 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~------~~~ 410 (688)
..+|...+.||.|+||.||+|... |..||+|++..... .....+.+|+.+|..++||||++++++|. ...
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 468888899999999999999875 88999999876432 33456788999999999999999998873 236
Q ss_pred eeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCcccc
Q 005617 411 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~ 490 (688)
++||||+. |+|.+++... ..+++..+..++.||+.||.|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIHSD---QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 89999995 6888888654 34899999999999999999999965 99999999999999999999999999987
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHH--------------
Q 005617 491 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR-------------- 555 (688)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~-------------- 555 (688)
....... .........|+..|+|||++.. ..++.++|||||||++|||++|+.||........
T Consensus 157 ~~~~~~~--~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~ 234 (334)
T cd07855 157 LSSSPTE--HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEE 234 (334)
T ss_pred ecccCcC--CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhH
Confidence 6433211 0111234578999999998765 4689999999999999999999999964332110
Q ss_pred ---HhhcCccccccCC--CC--CC---CCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 556 ---AVSCGKLSSILDP--LA--GD---WPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 556 ---~~~~g~l~~~ld~--~~--~~---~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
.+....+...++. .. .. .....+..+.+++.+||+.+|.+||++.+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l 292 (334)
T cd07855 235 VLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQAL 292 (334)
T ss_pred hhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 0000111111100 00 01 1123467899999999999999999988544
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=295.37 Aligned_cols=253 Identities=25% Similarity=0.357 Sum_probs=188.3
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc--chHHHHHHHHHHHcCCCCceeeEecccCC---------
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACPE--------- 408 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--------- 408 (688)
++|.....||.|+||.||+|... +..||||.+...... ....+.+|+.++++++||||++++++|..
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46888999999999999999885 789999998654322 23356789999999999999999998732
Q ss_pred -CceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCc
Q 005617 409 -AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 487 (688)
Q Consensus 409 -~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGl 487 (688)
..++||||+.+ +|.+.+.... ..+++..+..++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+
T Consensus 92 ~~~~lv~e~~~~-~l~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCEH-DLAGLLSNKN--VKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCCc-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 24899999964 7877775433 35899999999999999999999965 99999999999999999999999999
Q ss_pred cccccCCCCcCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhhHHH--Hhh--cCcc
Q 005617 488 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR--AVS--CGKL 562 (688)
Q Consensus 488 a~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~--~~~--~g~l 562 (688)
+.......... ........++..|+|||++.+. .++.++||||||+++|||+||.+||........ .+. .|.+
T Consensus 166 ~~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~ 243 (310)
T cd07865 166 ARAFSLSKNSK--PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSI 243 (310)
T ss_pred cccccCCcccC--CCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 98764332111 0112345678899999988654 478999999999999999999999964432111 000 0110
Q ss_pred ccccCCC------------CCC---------CCHHHHHHHHHHHHHccccCCCCCCCCchH
Q 005617 563 SSILDPL------------AGD---------WPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 563 ~~~ld~~------------~~~---------~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
...+-+. ... .+......+.+|+.+||..||.+||++.+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~ 304 (310)
T cd07865 244 TPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTA 304 (310)
T ss_pred ChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHH
Confidence 0000000 000 011123467899999999999999998743
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=286.93 Aligned_cols=241 Identities=27% Similarity=0.404 Sum_probs=198.5
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEec
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
+|.....||.|+||.||++... +..+|||.+..... .....+..|+.+++.++||||+++++++.+ ..++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4777889999999999999875 78899999876543 234468899999999999999999988744 47899999
Q ss_pred CCCCcHHHHhcccC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCC
Q 005617 417 LPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 417 ~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~ 495 (688)
+++++|..++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 157 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNM 157 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCC
Confidence 99999999886632 2356899999999999999999999966 9999999999999999999999999998775431
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCCCCCC
Q 005617 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 496 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~ 573 (688)
.....|++.|++||.+.+..++.++|+||||+++|+|++|+.||...+. ....+..+... ..
T Consensus 158 --------~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------~~ 221 (256)
T cd08530 158 --------AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP--------PI 221 (256)
T ss_pred --------cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC--------CC
Confidence 1234688999999999999999999999999999999999999975443 22222222221 22
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCCchH
Q 005617 574 PTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 574 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
+......+.+++.+|++.+|.+||++.+.
T Consensus 222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~~ 250 (256)
T cd08530 222 PPIYSQDLQNFIRSMLQVKPKLRPNCDKI 250 (256)
T ss_pred chhhCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 33566789999999999999999999843
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-35 Score=296.71 Aligned_cols=241 Identities=27% Similarity=0.320 Sum_probs=200.9
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchH---HHHHHHHHHHcCCCCceeeEecccC--CCceeEE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL---EFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~---~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~ 414 (688)
++|...++||+|.||.|-+++-. |+.+|||++++...-... .-..|-++|...+||.+..|-..|+ +.+|+||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 67888899999999999999875 899999999887654443 4567999999999999999988884 4689999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
||..||.|.-+|.+.. .++......+...|+.||.|||+.+ ||.||||.+|+|||.+|++||+|||+++.-...
T Consensus 248 eyanGGeLf~HLsrer---~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 248 EYANGGELFFHLSRER---VFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred EEccCceEeeehhhhh---cccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcccc
Confidence 9999999999887754 4666777778999999999999965 999999999999999999999999999875433
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCccccccCCCCCCCC
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWP 574 (688)
Q Consensus 495 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~l~~~ld~~~~~~~ 574 (688)
. ..+...+|||.|+|||++....|+..+|+|.+||+||||++|+.||...+. +++.+++--....+|
T Consensus 322 g------~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh-------~kLFeLIl~ed~kFP 388 (516)
T KOG0690|consen 322 G------DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH-------EKLFELILMEDLKFP 388 (516)
T ss_pred c------ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch-------hHHHHHHHhhhccCC
Confidence 2 245788999999999999999999999999999999999999999965432 112222211122567
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCCch
Q 005617 575 TFVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 575 ~~~~~~l~~L~~~Cl~~dP~~RPs~~~ 601 (688)
...+.+...|+...|..||.+|..-..
T Consensus 389 r~ls~eAktLLsGLL~kdP~kRLGgGp 415 (516)
T KOG0690|consen 389 RTLSPEAKTLLSGLLKKDPKKRLGGGP 415 (516)
T ss_pred ccCCHHHHHHHHHHhhcChHhhcCCCc
Confidence 777888899999999999999976543
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=292.37 Aligned_cols=246 Identities=29% Similarity=0.371 Sum_probs=198.5
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCC-CCceeeEecccCC--CceeE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQ-HPHLVTLLGACPE--AWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~-HpnIV~l~g~~~~--~~~LV 413 (688)
++|.....||.|+||.||+|... |..||+|++..... .....+..|+.++.+++ ||||+++++++.+ ..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999885 88999999876432 23456889999999998 9999999999854 58899
Q ss_pred EecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccC
Q 005617 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~ 493 (688)
|||+++++|.+++.... .+++..+..|+.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~~~---~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRKYG---SLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 99999999999987543 6899999999999999999999966 99999999999999999999999999987654
Q ss_pred CCCcCC--------------CccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhc
Q 005617 494 DTLYLP--------------SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC 559 (688)
Q Consensus 494 ~~~~~~--------------~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~ 559 (688)
...... .........|+..|+|||.+....++.++||||||+++++|++|..||............
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 234 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKI 234 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence 321100 011234456889999999998888999999999999999999999999765432211110
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCc
Q 005617 560 GKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 560 g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~ 600 (688)
. .....++...+..+.+++.+||+.+|.+||++.
T Consensus 235 ~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~ 268 (280)
T cd05581 235 L-------KLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVN 268 (280)
T ss_pred H-------hcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcc
Confidence 0 011123444567899999999999999999994
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=295.32 Aligned_cols=231 Identities=25% Similarity=0.344 Sum_probs=178.8
Q ss_pred eeeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHc---CCCCceeeEecccC--CCceeEEecCC
Q 005617 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSK---LQHPHLVTLLGACP--EAWSLVYEYLP 418 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~---~~~~f~~E~~iL~~---l~HpnIV~l~g~~~--~~~~LV~E~~~ 418 (688)
.||+|+||.||++... |..||||.+...... ....+.+|..++.. .+||||+.+++++. +..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 789999998764332 12234455544443 47999999998884 45789999999
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcC
Q 005617 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~ 498 (688)
+|+|.+++... ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.++|+|||++.......
T Consensus 81 ~~~L~~~i~~~---~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQH---GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 99999988654 35899999999999999999999966 9999999999999999999999999987553221
Q ss_pred CCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhh-HHHHhhcCccccccCCCCCCCCHH
Q 005617 499 PSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGE-VRRAVSCGKLSSILDPLAGDWPTF 576 (688)
Q Consensus 499 ~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~-~~~~~~~g~l~~~ld~~~~~~~~~ 576 (688)
.....||+.|+|||.+.+ ..++.++|||||||++|+|++|..||..... ....+..... ......+..
T Consensus 152 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-----~~~~~~~~~ 221 (279)
T cd05633 152 -----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL-----TVNVELPDS 221 (279)
T ss_pred -----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh-----cCCcCCccc
Confidence 123469999999998864 5689999999999999999999999964321 1111111110 001123344
Q ss_pred HHHHHHHHHHHccccCCCCCCC
Q 005617 577 VARRLVDLGLQCCELYGRERPD 598 (688)
Q Consensus 577 ~~~~l~~L~~~Cl~~dP~~RPs 598 (688)
.+..+.+++.+||+.||.+||+
T Consensus 222 ~~~~~~~li~~~l~~~p~~R~~ 243 (279)
T cd05633 222 FSPELKSLLEGLLQRDVSKRLG 243 (279)
T ss_pred cCHHHHHHHHHHhcCCHHHhcC
Confidence 5678999999999999999996
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=296.65 Aligned_cols=237 Identities=22% Similarity=0.343 Sum_probs=190.9
Q ss_pred eeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEecCCCCcHH
Q 005617 348 FKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLPNGSLQ 423 (688)
Q Consensus 348 ~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~~~gsL~ 423 (688)
.+||+|+||.||+|... |..||||.+..........+.+|+.+++.++||||++++++|. +..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 56999999999999884 7899999986554445567899999999999999999999884 4688999999999999
Q ss_pred HHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCCccc
Q 005617 424 DRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHR 503 (688)
Q Consensus 424 ~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~ 503 (688)
+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 106 ~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~------~~ 172 (292)
T cd06657 106 DIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV------PR 172 (292)
T ss_pred HHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc------cc
Confidence 98743 34789999999999999999999965 9999999999999999999999999987654322 11
Q ss_pred cCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHH--HHhhcCccccccCCCCCCCCHHHHHHH
Q 005617 504 STAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSILDPLAGDWPTFVARRL 581 (688)
Q Consensus 504 ~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~--~~~~~g~l~~~ld~~~~~~~~~~~~~l 581 (688)
.....|++.|++||++....++.++|||||||++|+|++|..||....... ..+..+ +.. .... .......+
T Consensus 173 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~-~~~----~~~~-~~~~~~~l 246 (292)
T cd06657 173 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN-LPP----KLKN-LHKVSPSL 246 (292)
T ss_pred ccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhh-CCc----ccCC-cccCCHHH
Confidence 234568999999999988889999999999999999999999997543321 112111 111 0001 11235578
Q ss_pred HHHHHHccccCCCCCCCCchHH
Q 005617 582 VDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 582 ~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
.+++.+||+.+|.+||++.+.+
T Consensus 247 ~~li~~~l~~~P~~R~~~~~ll 268 (292)
T cd06657 247 KGFLDRLLVRDPAQRATAAELL 268 (292)
T ss_pred HHHHHHHHhCCcccCcCHHHHh
Confidence 8999999999999999998544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=287.64 Aligned_cols=244 Identities=26% Similarity=0.388 Sum_probs=200.1
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEec
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 416 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~ 416 (688)
+|...+.||.|+||.||++... +..||+|++..... .....+.+|+.++..++|||++++++.+. +..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777889999999999999986 88999999976544 44567889999999999999999998874 357899999
Q ss_pred CCCCcHHHHhcccC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCC
Q 005617 417 LPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 417 ~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~ 495 (688)
+++++|.+++.... ....+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999887642 2357899999999999999999999965 9999999999999999999999999998765432
Q ss_pred CcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCCCCCC
Q 005617 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 496 ~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~ 573 (688)
. ......|++.|+|||.+....++.++||||||+++|+|++|+.||..... +......+.. ...
T Consensus 158 ~------~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~--------~~~ 223 (258)
T cd08215 158 D------LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQY--------PPI 223 (258)
T ss_pred c------eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCC--------CCC
Confidence 1 12345789999999999988999999999999999999999999965432 1122211111 122
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 574 PTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 574 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
+......+.+++.+||..+|.+||++.+.+
T Consensus 224 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll 253 (258)
T cd08215 224 PSQYSSELRNLVSSLLQKDPEERPSIAQIL 253 (258)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 334456789999999999999999998533
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=308.57 Aligned_cols=248 Identities=26% Similarity=0.330 Sum_probs=194.5
Q ss_pred HhcCcccceeeeccCceEEEEEEEC-CeEEEEEEEecC--CccchHHHHHHHHHHHcCC-CCceeeEeccc--CCCceeE
Q 005617 340 ATCNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSH--NMQGQLEFQQEVRVLSKLQ-HPHLVTLLGAC--PEAWSLV 413 (688)
Q Consensus 340 at~~f~~~~~LG~G~fG~Vykg~~~-g~~vAIK~l~~~--~~~~~~~f~~E~~iL~~l~-HpnIV~l~g~~--~~~~~LV 413 (688)
....|...++||.||.+.||++... ...||+|++... +.+....|.+|+..|.+|+ |.+||+||+|- .+.+|||
T Consensus 359 kg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 359 KGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred CcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 3456788899999999999999887 456788876543 3344567999999999995 99999999986 3458899
Q ss_pred EecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccC
Q 005617 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~ 493 (688)
|||- ..+|..+|...... ...| .+..+..|++.|+.++|..+ |||.||||.|+||-. |.+||+|||+|..+..
T Consensus 439 mE~G-d~DL~kiL~k~~~~-~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~ 511 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKKSI-DPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQP 511 (677)
T ss_pred eecc-cccHHHHHHhccCC-CchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCc
Confidence 9986 56899999776542 3345 57788899999999999976 999999999999964 6899999999999887
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccC-----------CCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCcc
Q 005617 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTG-----------VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKL 562 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-----------~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~l 562 (688)
+.... .....+||+.||+||.+... +.++++||||||||||+|+.|++||+.....+. ++
T Consensus 512 DTTsI----~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~a-----Kl 582 (677)
T KOG0596|consen 512 DTTSI----VKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIA-----KL 582 (677)
T ss_pred cccce----eeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHH-----HH
Confidence 66443 34567899999999987533 256899999999999999999999986554333 33
Q ss_pred ccccCCC-CCCCCHHHHH-HHHHHHHHccccCCCCCCCCchHH
Q 005617 563 SSILDPL-AGDWPTFVAR-RLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 563 ~~~ld~~-~~~~~~~~~~-~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
..+.||. ..+||..-.. .+++++..||..||++||+..+.+
T Consensus 583 ~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLL 625 (677)
T KOG0596|consen 583 HAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELL 625 (677)
T ss_pred HhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHh
Confidence 4455552 2233322112 299999999999999999998433
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=297.89 Aligned_cols=250 Identities=23% Similarity=0.307 Sum_probs=191.0
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc--chHHHHHHHHHHHcCCCCceeeEecccCC----CceeE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACPE----AWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~~~----~~~LV 413 (688)
++|...+.||.|+||.||+|... |..||+|.+...... ....+.+|+.++.+++|+||+++++++.+ ..++|
T Consensus 7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv 86 (309)
T cd07845 7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLV 86 (309)
T ss_pred cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEE
Confidence 57888899999999999999885 889999998754332 23356789999999999999999998742 37899
Q ss_pred EecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccC
Q 005617 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~ 493 (688)
|||+.+ +|.+.+.... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 87 ~e~~~~-~l~~~l~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~ 160 (309)
T cd07845 87 MEYCEQ-DLASLLDNMP--TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGL 160 (309)
T ss_pred EecCCC-CHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCC
Confidence 999974 7888776543 46899999999999999999999976 99999999999999999999999999987654
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHH--Hhhc--C----ccc-
Q 005617 494 DTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR--AVSC--G----KLS- 563 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~--~~~~--g----~l~- 563 (688)
... ......+++.|+|||++.+ ..++.++|||||||++|||++|++||........ .+.. + ...
T Consensus 161 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (309)
T cd07845 161 PAK------PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWP 234 (309)
T ss_pred ccC------CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhch
Confidence 321 1223456888999998865 5679999999999999999999999965433211 1110 0 000
Q ss_pred --------cccCCCCCCC------CHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 564 --------SILDPLAGDW------PTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 564 --------~~ld~~~~~~------~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
..+.-....+ ....+..+.+|+.+|++.||.+||++.+.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il 288 (309)
T cd07845 235 GFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEAL 288 (309)
T ss_pred hhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 0000000000 011356788999999999999999988443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=307.28 Aligned_cols=240 Identities=30% Similarity=0.488 Sum_probs=202.9
Q ss_pred eeeeccCceEEEEEEEC---Ce--EEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccCC-CceeEEecCCCC
Q 005617 348 FKVGQGGFGCVYKGEML---GR--TVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYEYLPNG 420 (688)
Q Consensus 348 ~~LG~G~fG~Vykg~~~---g~--~vAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV~E~~~~g 420 (688)
++||+|.||.|++|.|+ |+ .||||.+...... ...+|.+|+.+|.+|+|||+|+|||+..+ ...||+|+++.|
T Consensus 116 e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~ELaplG 195 (1039)
T KOG0199|consen 116 ELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFELAPLG 195 (1039)
T ss_pred HHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhhcccc
Confidence 56999999999999996 43 4899999887665 56689999999999999999999999875 578999999999
Q ss_pred cHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCC
Q 005617 421 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 500 (688)
Q Consensus 421 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~ 500 (688)
||.+.|.+ .....|.......++.|||.|+.||.+.+ +|||||-..||||-..-.+|||||||.+-+..+....
T Consensus 196 SLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Y-- 269 (1039)
T KOG0199|consen 196 SLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMY-- 269 (1039)
T ss_pred hHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCcce--
Confidence 99999988 33456777888899999999999999955 9999999999999999999999999999887655332
Q ss_pred ccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--HHHHhhcCccccccCCCCCCCCHHH
Q 005617 501 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFV 577 (688)
Q Consensus 501 ~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~~~~ 577 (688)
.......-.+.|.|||.+....++.++|||+|||+||||+| |..||.+... +...+..|.. -..|..+
T Consensus 270 -vm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~er--------LpRPk~c 340 (1039)
T KOG0199|consen 270 -VMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGER--------LPRPKYC 340 (1039)
T ss_pred -EecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccccc--------CCCCCCC
Confidence 22334456778999999999999999999999999999999 8899976553 4444544432 2345667
Q ss_pred HHHHHHHHHHccccCCCCCCCCchH
Q 005617 578 ARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 578 ~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
++.+.+++..||..+|.+||++..+
T Consensus 341 sedIY~imk~cWah~paDRptFsai 365 (1039)
T KOG0199|consen 341 SEDIYQIMKNCWAHNPADRPTFSAI 365 (1039)
T ss_pred hHHHHHHHHHhccCCccccccHHHH
Confidence 8899999999999999999999943
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=302.13 Aligned_cols=245 Identities=26% Similarity=0.324 Sum_probs=187.4
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC--------
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE-------- 408 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-------- 408 (688)
.++|.....||+|+||.||+|... |..||||++..... .....+.+|+.++..++||||++++++|..
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 378999999999999999999874 88999999865322 223458899999999999999999998742
Q ss_pred CceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCcc
Q 005617 409 AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 488 (688)
Q Consensus 409 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla 488 (688)
..++|++|+.+ +|...+. ..+++..+..++.|++.||.|||..+ |+||||||+|||++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIMG-----HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 25899999964 6766542 35789999999999999999999966 999999999999999999999999998
Q ss_pred ccccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHH---HhhcC----
Q 005617 489 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR---AVSCG---- 560 (688)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~---~~~~g---- 560 (688)
+..... .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .+...
T Consensus 165 ~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (342)
T cd07879 165 RHADAE---------MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPG 235 (342)
T ss_pred cCCCCC---------CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 764321 134467899999998876 4689999999999999999999999975432111 11100
Q ss_pred ----------ccccccC--CC--CCCC---CHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 561 ----------KLSSILD--PL--AGDW---PTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 561 ----------~l~~~ld--~~--~~~~---~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
.....+. +. ...+ .......+.+|+.+||+.||.+||++.+.+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l 295 (342)
T cd07879 236 PEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEAL 295 (342)
T ss_pred HHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHh
Confidence 0000000 00 0000 012345688999999999999999998544
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=314.67 Aligned_cols=247 Identities=22% Similarity=0.330 Sum_probs=202.7
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEeccc--CCCceeEEecCCC
Q 005617 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPN 419 (688)
Q Consensus 344 f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~--~~~~~LV~E~~~~ 419 (688)
|.+..-||-|+||.||++... +-..|-|++.........+|.-|++||+...||+||+|++.| .+.++++.|||.|
T Consensus 34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~G 113 (1187)
T KOG0579|consen 34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGG 113 (1187)
T ss_pred HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCC
Confidence 344556999999999999886 445688888877777778899999999999999999999865 5678999999999
Q ss_pred CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCC
Q 005617 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 420 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~ 499 (688)
|-.+.++..-+ .+|+..++.-++.+++.||.|||+.+ |||||||..|||+.-+|.++|+|||.+.....
T Consensus 114 GAVDaimlEL~--r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~------ 182 (1187)
T KOG0579|consen 114 GAVDAIMLELG--RVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKS------ 182 (1187)
T ss_pred chHhHHHHHhc--cccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchh------
Confidence 99999887655 57899999999999999999999966 99999999999999999999999998765432
Q ss_pred CccccCCCCCCCCCCChhhh-----ccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCccccccCCCCCCCC
Q 005617 500 SFHRSTAPKGSFPYADPEYH-----RTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWP 574 (688)
Q Consensus 500 ~~~~~~~~~GT~~Y~APE~~-----~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~l~~~ld~~~~~~~ 574 (688)
.......+.|||.|||||+. ...+|+.++||||||+.|.||.-+.+|-.....++-.+...+- +|.---.|
T Consensus 183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS----ePPTLlqP 258 (1187)
T KOG0579|consen 183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS----EPPTLLQP 258 (1187)
T ss_pred HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc----CCCcccCc
Confidence 12345678999999999976 4568999999999999999999999998766655544433221 11111235
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCCchHHHH
Q 005617 575 TFVARRLVDLGLQCCELYGRERPDITPSLVK 605 (688)
Q Consensus 575 ~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~ 605 (688)
...+..+.+++.+||..||..||++.+.+.+
T Consensus 259 S~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H 289 (1187)
T KOG0579|consen 259 SHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH 289 (1187)
T ss_pred chhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence 5677889999999999999999999865543
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=295.45 Aligned_cols=255 Identities=25% Similarity=0.330 Sum_probs=189.9
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccc--hHHHHHHHHHHHcCCCCceeeEecccCC--------
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG--QLEFQQEVRVLSKLQHPHLVTLLGACPE-------- 408 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~--~~~f~~E~~iL~~l~HpnIV~l~g~~~~-------- 408 (688)
.++|.....||.|+||.||+|... +..||||++....... ...+.+|+.++..++||||+++++++.+
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999885 7889999986554322 3457889999999999999999987632
Q ss_pred --CceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecC
Q 005617 409 --AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFG 486 (688)
Q Consensus 409 --~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFG 486 (688)
..++||+|+.+ +|...+.... ..+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~--~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPS--VKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 25899999975 5666665432 46899999999999999999999966 9999999999999999999999999
Q ss_pred ccccccCCCCcCC-----CccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhhHH---HHh
Q 005617 487 ICRLVTEDTLYLP-----SFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR---RAV 557 (688)
Q Consensus 487 la~~~~~~~~~~~-----~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~---~~~ 557 (688)
++........... .....+...|++.|+|||++.+. .++.++|||||||++|||++|++||....... ..+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9987643321111 11122345678999999987654 58999999999999999999999996433211 000
Q ss_pred hc-C-----------ccccccC-CCCCCCC-------HHHHHHHHHHHHHccccCCCCCCCCch
Q 005617 558 SC-G-----------KLSSILD-PLAGDWP-------TFVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 558 ~~-g-----------~l~~~ld-~~~~~~~-------~~~~~~l~~L~~~Cl~~dP~~RPs~~~ 601 (688)
.. + .+....+ ......+ ......+.+++.+||+.+|.+|||+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~e 304 (311)
T cd07866 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASD 304 (311)
T ss_pred HHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHH
Confidence 00 0 0000000 0000111 112357889999999999999999874
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=295.90 Aligned_cols=241 Identities=27% Similarity=0.357 Sum_probs=189.3
Q ss_pred CcccceeeeccCceEEEEEEE-----CCeEEEEEEEecCCc----cchHHHHHHHHHHHcC-CCCceeeEecccCC--Cc
Q 005617 343 NFSESFKVGQGGFGCVYKGEM-----LGRTVAIKMLYSHNM----QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AW 410 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~-----~g~~vAIK~l~~~~~----~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~~ 410 (688)
+|.....||.|+||.||++.. .|..||+|++..... .....+.+|+.++.++ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467788999999999999986 478899999975432 2345688999999999 59999999988854 36
Q ss_pred eeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCcccc
Q 005617 411 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~ 490 (688)
++||||+++++|.+++... .++++..+..++.|++.||.|||+.+ ++||||+|+|||++.++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQR---ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 7999999999999998654 35788999999999999999999965 99999999999999999999999999987
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCChhhhccC--CCCCcchHhHHHHHHHHHHhCCCCCCChhhH--HHHhhcCcccccc
Q 005617 491 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG--VLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSIL 566 (688)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~--~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~~~~g~l~~~l 566 (688)
....... ......|+..|+|||++... .++.++||||||+++|+|+||..||...... ...+.. .+
T Consensus 155 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~-----~~ 224 (290)
T cd05613 155 FHEDEVE-----RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR-----RI 224 (290)
T ss_pred ccccccc-----ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHH-----Hh
Confidence 6433211 12345689999999988653 4788999999999999999999999632210 011100 00
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccccCCCCCCCC
Q 005617 567 DPLAGDWPTFVARRLVDLGLQCCELYGRERPDI 599 (688)
Q Consensus 567 d~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~ 599 (688)
......++......+.+++.+|++.+|.+||+.
T Consensus 225 ~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~ 257 (290)
T cd05613 225 LKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGC 257 (290)
T ss_pred hccCCCCCccCCHHHHHHHHHHhcCCHHHhcCC
Confidence 001112344456788999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=290.86 Aligned_cols=248 Identities=24% Similarity=0.290 Sum_probs=193.1
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc--chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecC
Q 005617 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 417 (688)
Q Consensus 344 f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~ 417 (688)
|.....||.|++|.||+|... |..+++|.+...... ....+..|+.++++++||||+++++++.+ ..++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 445678999999999999875 888999998765433 34568899999999999999999998844 578999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCc
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~ 497 (688)
++ +|.+++.... ..+++..+..++.+++.||.|||..+ |+|+||||+||+++.++.++|+|||.+........
T Consensus 81 ~~-~l~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~- 153 (283)
T cd05118 81 DT-DLYKLIKDRQ--RGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR- 153 (283)
T ss_pred CC-CHHHHHHhhc--ccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence 75 8888776543 46899999999999999999999966 99999999999999999999999999987754331
Q ss_pred CCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHH---hh---cC---ccccccC
Q 005617 498 LPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA---VS---CG---KLSSILD 567 (688)
Q Consensus 498 ~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~---~~---~g---~l~~~ld 567 (688)
......++..|+|||.+.+. .++.++||||||+++|+|+||+.||......... .. .. .+....+
T Consensus 154 -----~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd05118 154 -----PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTS 228 (283)
T ss_pred -----cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchh
Confidence 12334688899999998776 7899999999999999999999999654432211 00 00 0000000
Q ss_pred --------------CCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 568 --------------PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 568 --------------~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
..........+..+.+++.+||+.||.+||++.+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll 278 (283)
T cd05118 229 LARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQAL 278 (283)
T ss_pred hhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHh
Confidence 000111223567899999999999999999998543
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-33 Score=302.20 Aligned_cols=249 Identities=22% Similarity=0.280 Sum_probs=192.1
Q ss_pred HHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC-----
Q 005617 338 QTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE----- 408 (688)
Q Consensus 338 ~~at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~----- 408 (688)
-..+++|...+.||+|+||.||+|... |..||||++..... .....+.+|+.++..++||||++++++|..
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 345678999999999999999999875 88999999864322 223468899999999999999999998742
Q ss_pred ---CceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeec
Q 005617 409 ---AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDF 485 (688)
Q Consensus 409 ---~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDF 485 (688)
..++||+|+ +++|.+++.. ..+++..+..++.|++.||.|||..+ |+||||||+||+++.++.+||+||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence 247999999 7899888753 35889999999999999999999966 999999999999999999999999
Q ss_pred CccccccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHH---hhc--
Q 005617 486 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA---VSC-- 559 (688)
Q Consensus 486 Gla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~---~~~-- 559 (688)
|++...... .....|++.|+|||++.+ ..++.++|||||||++|+|++|+.||......... ...
T Consensus 163 g~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~ 233 (343)
T cd07880 163 GLARQTDSE---------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTG 233 (343)
T ss_pred ccccccccC---------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 999865432 134467899999998876 45889999999999999999999999754321111 000
Q ss_pred ------------CccccccCCC-------CCCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 560 ------------GKLSSILDPL-------AGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 560 ------------g~l~~~ld~~-------~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
......+... ...........+.+++.+|++.||.+||++.+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l 296 (343)
T cd07880 234 TPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEAL 296 (343)
T ss_pred CCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHh
Confidence 0000000000 0011122345688999999999999999988544
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-33 Score=302.17 Aligned_cols=256 Identities=23% Similarity=0.268 Sum_probs=195.4
Q ss_pred ccCHHHHHHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC--ccchHHHHHHHHHHHcCCCCceeeEeccc
Q 005617 331 EFSLADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406 (688)
Q Consensus 331 ~~~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~--~~~~~~f~~E~~iL~~l~HpnIV~l~g~~ 406 (688)
.....++..++++|.....||+|+||.||+|... |..||||++.... ......+.+|+.++.+++||||+++++++
T Consensus 6 ~~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~ 85 (345)
T cd07877 6 QELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVF 85 (345)
T ss_pred hhHHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeee
Confidence 3445677888999999999999999999999864 8899999987542 22345688899999999999999999987
Q ss_pred CC--------CceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCC
Q 005617 407 PE--------AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL 478 (688)
Q Consensus 407 ~~--------~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~ 478 (688)
.. ..+++++++ +++|.+++.. ..+++..+..++.|++.||.|||+.+ |+||||||+||+++.++
T Consensus 86 ~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~ 157 (345)
T cd07877 86 TPARSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDC 157 (345)
T ss_pred eecccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCC
Confidence 32 256777776 8899887754 34889999999999999999999966 99999999999999999
Q ss_pred CeEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHH--
Q 005617 479 SSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR-- 555 (688)
Q Consensus 479 ~vKLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~-- 555 (688)
.+||+|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........
T Consensus 158 ~~kl~dfg~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~ 228 (345)
T cd07877 158 ELKILDFGLARHTDDE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 228 (345)
T ss_pred CEEEeccccccccccc---------ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999999998764322 234568899999998866 5688999999999999999999999964322111
Q ss_pred -Hhhc-Cc-cccc---------------cCC----CCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 556 -AVSC-GK-LSSI---------------LDP----LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 556 -~~~~-g~-l~~~---------------ld~----~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
.... +. ...+ +.. ...+........+.+|+.+|++.||.+||++.+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l 298 (345)
T cd07877 229 LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 298 (345)
T ss_pred HHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHh
Confidence 0000 00 0000 000 00000011345788999999999999999987444
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-33 Score=289.05 Aligned_cols=248 Identities=27% Similarity=0.378 Sum_probs=189.1
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc--chHHHHHHHHHHHcC---CCCceeeEecccCC--C-----
Q 005617 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKL---QHPHLVTLLGACPE--A----- 409 (688)
Q Consensus 344 f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~--~~~~f~~E~~iL~~l---~HpnIV~l~g~~~~--~----- 409 (688)
|.....||.|+||.||+|... +..||||++...... ....+.+|+.++.++ +||||++++++|.+ .
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 556789999999999999985 789999999754332 233566788877666 59999999999842 3
Q ss_pred ceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccc
Q 005617 410 WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~ 489 (688)
.+++|||+.+ +|.+++..... ..+++..+..++.+++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~-~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPK-PGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHccC-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 7899999975 78888765432 35899999999999999999999966 9999999999999999999999999998
Q ss_pred cccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHH---HhhcC----cc
Q 005617 490 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR---AVSCG----KL 562 (688)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~---~~~~g----~l 562 (688)
....... .....+++.|+|||++.+..++.++|||||||++|+|++|.+||........ ....- ..
T Consensus 156 ~~~~~~~-------~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07838 156 IYSFEMA-------LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEE 228 (287)
T ss_pred eccCCcc-------cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChH
Confidence 7644321 1234578999999999999999999999999999999999999875432211 11100 00
Q ss_pred c---------cccCCC----CCCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 563 S---------SILDPL----AGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 563 ~---------~~ld~~----~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
. ..+... ...........+.+++.+||+.||.+||++.+.+
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il 282 (287)
T cd07838 229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEAL 282 (287)
T ss_pred hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHh
Confidence 0 000000 0111123457789999999999999999988443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=316.40 Aligned_cols=196 Identities=32% Similarity=0.483 Sum_probs=172.6
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC-ccchHHHHHHHHHHHcCCCCceeeEecccCC--------Cce
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--------AWS 411 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~-~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--------~~~ 411 (688)
.|.....||+||||.||+|+.. |..||||.++... ....+...+|+++|++++|||||++++.-.+ ...
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~v 93 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPV 93 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccce
Confidence 3445577999999999999975 9999999998754 4456678899999999999999999987532 357
Q ss_pred eEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeC--CCC--CeEEeecCc
Q 005617 412 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD--SEL--SSKICDFGI 487 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd--~~~--~vKLsDFGl 487 (688)
+|||||.||||...|....+...|+..+.+.++.+++.||.|||.++ ||||||||.||++- .+| ..||+|||.
T Consensus 94 lvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 94 LVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred EEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 99999999999999999888889999999999999999999999876 99999999999984 223 489999999
Q ss_pred cccccCCCCcCCCccccCCCCCCCCCCChhhhc-cCCCCCcchHhHHHHHHHHHHhCCCCCC
Q 005617 488 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR-TGVLTPKSDSYSFGLIILQLLTGRLPVG 548 (688)
Q Consensus 488 a~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~-~~~~s~ksDVwSfGviL~ELltG~~Pf~ 548 (688)
|+.+.++. .....+||..|++||.+. ...|+.-+|.|||||++|+++||..||.
T Consensus 171 Arel~d~s-------~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~ 225 (732)
T KOG4250|consen 171 ARELDDNS-------LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFI 225 (732)
T ss_pred cccCCCCC-------eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCC
Confidence 99988765 236789999999999988 5889999999999999999999999995
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=297.01 Aligned_cols=292 Identities=27% Similarity=0.392 Sum_probs=217.4
Q ss_pred HHHHHHHHHHHHHHHHHHHHHHHHHHhhccCCCCCCCCccccccCCCCCcccCHHHHHHHhcCcccceeeeccCceEEEE
Q 005617 281 IATLQQEKQRIRRQKVEAVRWLERWRSRGQAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYK 360 (688)
Q Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~el~~at~~f~~~~~LG~G~fG~Vyk 360 (688)
.+.++-+++++.+.+..-+|.+.|....... .|.|-....++|-..++||+|||+.||+
T Consensus 423 EaeiqaElERLErvrnlHiRELKRi~NEdnS---------------------QFkDHptLn~RYLlLhLLGrGGFSEVyK 481 (775)
T KOG1151|consen 423 EAEIQAELERLERVRNLHIRELKRIHNEDNS---------------------QFKDHPTLNDRYLLLHLLGRGGFSEVYK 481 (775)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHhhcccchh---------------------hhccCcchHHHHHHHHHhccccHHHHHH
Confidence 3344555666666666666666654211100 1122233456777788999999999999
Q ss_pred EEEC--CeEEEEEEEecC-Cccc------hHHHHHHHHHHHcCCCCceeeEeccc---CCCceeEEecCCCCcHHHHhcc
Q 005617 361 GEML--GRTVAIKMLYSH-NMQG------QLEFQQEVRVLSKLQHPHLVTLLGAC---PEAWSLVYEYLPNGSLQDRLFR 428 (688)
Q Consensus 361 g~~~--g~~vAIK~l~~~-~~~~------~~~f~~E~~iL~~l~HpnIV~l~g~~---~~~~~LV~E~~~~gsL~~~L~~ 428 (688)
+.+. .+.||||+-..+ ++.+ .+...+|.+|-..|.||.||++|++| .+.+|-|+|||+|.+|+-+|..
T Consensus 482 AFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQ 561 (775)
T KOG1151|consen 482 AFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQ 561 (775)
T ss_pred hcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHh
Confidence 9775 788999987543 2221 23467899999999999999999999 3568899999999999999865
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCC---CCCeEEeecCccccccCCCCc-CCCcccc
Q 005617 429 KSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS---ELSSKICDFGICRLVTEDTLY-LPSFHRS 504 (688)
Q Consensus 429 ~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~---~~~vKLsDFGla~~~~~~~~~-~~~~~~~ 504 (688)
.. .++..++..|+.||+.||.||.... .||||-||||.||||-+ .|.+||+|||+++.+.++... .....-+
T Consensus 562 hk---lmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLT 637 (775)
T KOG1151|consen 562 HK---LMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELT 637 (775)
T ss_pred hh---hhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeee
Confidence 53 5788999999999999999999988 58999999999999954 478999999999998765543 2233346
Q ss_pred CCCCCCCCCCChhhhccC----CCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCccccccCCCCCCC--CHHHH
Q 005617 505 TAPKGSFPYADPEYHRTG----VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDW--PTFVA 578 (688)
Q Consensus 505 ~~~~GT~~Y~APE~~~~~----~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~l~~~ld~~~~~~--~~~~~ 578 (688)
....||.+|++||.|.-+ ..+.|+||||+|||+|.+|.|+.||+....-...+....+ +......+ .+.++
T Consensus 638 SQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTI---lkAtEVqFP~KPvVs 714 (775)
T KOG1151|consen 638 SQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTI---LKATEVQFPPKPVVS 714 (775)
T ss_pred cccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhch---hcceeccCCCCCccC
Confidence 678999999999977433 5788999999999999999999999865443333332222 11111122 23467
Q ss_pred HHHHHHHHHccccCCCCCCCCc
Q 005617 579 RRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 579 ~~l~~L~~~Cl~~dP~~RPs~~ 600 (688)
.....+|.+||.+.-.+|.+.-
T Consensus 715 seAkaFIRRCLaYRKeDR~DV~ 736 (775)
T KOG1151|consen 715 SEAKAFIRRCLAYRKEDRIDVQ 736 (775)
T ss_pred HHHHHHHHHHHHhhhhhhhhHH
Confidence 7889999999999999998654
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=302.27 Aligned_cols=251 Identities=22% Similarity=0.282 Sum_probs=192.9
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC--ccchHHHHHHHHHHHcCCCCceeeEecccCC-------C
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-------A 409 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~--~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-------~ 409 (688)
.++|.....||.|+||+||+|... |..||||.+.... ......+.+|+.++..++||||+++++++.. .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 457888999999999999999875 8899999987542 2334567789999999999999999998742 2
Q ss_pred ceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccc
Q 005617 410 WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~ 489 (688)
.++||||+. ++|.+++... ..+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRSS---QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 689999996 6888877543 35889999999999999999999965 9999999999999999999999999998
Q ss_pred cccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHH------H-------
Q 005617 490 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR------R------- 555 (688)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~------~------- 555 (688)
....... ......|+..|+|||++.. ..++.++|||||||++|+|++|++||....... .
T Consensus 157 ~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 230 (337)
T cd07858 157 TTSEKGD------FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSE 230 (337)
T ss_pred ccCCCcc------cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 7643321 1234568899999998765 568999999999999999999999996432210 0
Q ss_pred ----HhhcCcccccc-------CCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHH
Q 005617 556 ----AVSCGKLSSIL-------DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 604 (688)
Q Consensus 556 ----~~~~g~l~~~l-------d~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~ 604 (688)
.+..+.....+ ++.........+..+.+|+.+||+.+|.+||++.+.+.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~ 290 (337)
T cd07858 231 EDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALA 290 (337)
T ss_pred HHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHc
Confidence 00000000000 00001111235667899999999999999999885543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=292.00 Aligned_cols=247 Identities=25% Similarity=0.332 Sum_probs=188.7
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCC-CCceeeEecccCC--CceeEEecC
Q 005617 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQ-HPHLVTLLGACPE--AWSLVYEYL 417 (688)
Q Consensus 344 f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~-HpnIV~l~g~~~~--~~~LV~E~~ 417 (688)
|...+.||.|+||.||+|... +..||||++..... .......+|+..+.+++ ||||++++++|.+ ..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 456788999999999999985 78899999865433 22334567999999999 9999999999844 578999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCc
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~ 497 (688)
+|+|.+.+.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 889988886654 246899999999999999999999966 99999999999999999999999999986643321
Q ss_pred CCCccccCCCCCCCCCCChhhhc-cCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhc-----------------
Q 005617 498 LPSFHRSTAPKGSFPYADPEYHR-TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC----------------- 559 (688)
Q Consensus 498 ~~~~~~~~~~~GT~~Y~APE~~~-~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~----------------- 559 (688)
.....|+..|+|||++. ...++.++||||||+++++|++|++||............
T Consensus 155 ------~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (283)
T cd07830 155 ------YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYK 228 (283)
T ss_pred ------cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhh
Confidence 12346889999999874 456799999999999999999999999644322111000
Q ss_pred --CccccccCCC----CCCCCHHHHHHHHHHHHHccccCCCCCCCCchH
Q 005617 560 --GKLSSILDPL----AGDWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 560 --g~l~~~ld~~----~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
......+... ..+........+.+++.+||+.+|.+||++.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei 277 (283)
T cd07830 229 LASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQA 277 (283)
T ss_pred hhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHH
Confidence 0000000000 001111124679999999999999999998743
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-33 Score=286.90 Aligned_cols=232 Identities=25% Similarity=0.292 Sum_probs=183.5
Q ss_pred eeeeccCceEEEEEEEC--CeEEEEEEEecCCccc---hHHHHHHHHHH-HcCCCCceeeEecccCC--CceeEEecCCC
Q 005617 348 FKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG---QLEFQQEVRVL-SKLQHPHLVTLLGACPE--AWSLVYEYLPN 419 (688)
Q Consensus 348 ~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~---~~~f~~E~~iL-~~l~HpnIV~l~g~~~~--~~~LV~E~~~~ 419 (688)
+.||.|+||.||+|... |..||||++....... ...+..|..++ ...+|||+++++++|.+ ..++||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46999999999999884 7899999987554322 22345555544 44589999999999854 58899999999
Q ss_pred CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCC
Q 005617 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 420 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~ 499 (688)
++|.+++... ..+++..+..++.|++.||.|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 82 ~~L~~~l~~~---~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKTL---GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 9999998654 35788999999999999999999965 99999999999999999999999999876432
Q ss_pred CccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCCCCCCCHHH
Q 005617 500 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFV 577 (688)
Q Consensus 500 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~~~~ 577 (688)
.....|++.|+|||.+.+..++.++||||||+++|+|+||..||..... ....+..+.... ........
T Consensus 150 ----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~ 220 (260)
T cd05611 150 ----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINW-----PEEVKEFC 220 (260)
T ss_pred ----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCC-----CCcccccC
Confidence 1344688999999999888899999999999999999999999965432 222222222110 00112234
Q ss_pred HHHHHHHHHHccccCCCCCCCCc
Q 005617 578 ARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 578 ~~~l~~L~~~Cl~~dP~~RPs~~ 600 (688)
+..+.+++.+||+.+|++||++.
T Consensus 221 ~~~~~~~i~~~l~~~p~~R~~~~ 243 (260)
T cd05611 221 SPEAVDLINRLLCMDPAKRLGAN 243 (260)
T ss_pred CHHHHHHHHHHccCCHHHccCCC
Confidence 57899999999999999999886
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=285.83 Aligned_cols=238 Identities=24% Similarity=0.347 Sum_probs=185.8
Q ss_pred eeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCC-CCceeeEecccC--CCceeEEecCCCCc
Q 005617 348 FKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQ-HPHLVTLLGACP--EAWSLVYEYLPNGS 421 (688)
Q Consensus 348 ~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~-HpnIV~l~g~~~--~~~~LV~E~~~~gs 421 (688)
..||.|..|.|++++.. |...|||.+..... ...+.+...++++.+-+ .|+||+.+|||. ....+.||.|. .-
T Consensus 98 ~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs-~C 176 (391)
T KOG0983|consen 98 GDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS-TC 176 (391)
T ss_pred HhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH-HH
Confidence 34999999999999987 68999999976644 34556778888877765 999999999994 35778888873 33
Q ss_pred HHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCCc
Q 005617 422 LQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 501 (688)
Q Consensus 422 L~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~~ 501 (688)
++.+|.... .++++...-++...++.||.||-..+ +||||||||+|||||..|++||||||++..+.+...
T Consensus 177 ~ekLlkrik--~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA----- 247 (391)
T KOG0983|consen 177 AEKLLKRIK--GPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA----- 247 (391)
T ss_pred HHHHHHHhc--CCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc-----
Confidence 444444333 46788878889999999999999854 799999999999999999999999999988765542
Q ss_pred cccCCCCCCCCCCChhhhc---cCCCCCcchHhHHHHHHHHHHhCCCCCCChhh---HHHHhhcCccccccCCCCCCCCH
Q 005617 502 HRSTAPKGSFPYADPEYHR---TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE---VRRAVSCGKLSSILDPLAGDWPT 575 (688)
Q Consensus 502 ~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~---~~~~~~~g~l~~~ld~~~~~~~~ 575 (688)
.+..+|-+.|||||.+. ...|+.++||||||+.|+||.||+.||.+... +...+-.. .. |.+ ....
T Consensus 248 --htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~-eP----P~L-~~~~ 319 (391)
T KOG0983|consen 248 --HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE-EP----PLL-PGHM 319 (391)
T ss_pred --cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc-CC----CCC-Cccc
Confidence 24567999999999875 44789999999999999999999999986432 22222221 11 111 1122
Q ss_pred HHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 576 FVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 576 ~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
.++..+.+++..||..|+.+||...+.+
T Consensus 320 gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll 347 (391)
T KOG0983|consen 320 GFSPDFQSFVKDCLTKDHRKRPKYNKLL 347 (391)
T ss_pred CcCHHHHHHHHHHhhcCcccCcchHHHh
Confidence 2678899999999999999999988443
|
|
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=292.98 Aligned_cols=249 Identities=27% Similarity=0.355 Sum_probs=193.2
Q ss_pred CcccceeeeccCceEEEEEEEC-----CeEEEEEEEecCCc----cchHHHHHHHHHHHcC-CCCceeeEecccCC--Cc
Q 005617 343 NFSESFKVGQGGFGCVYKGEML-----GRTVAIKMLYSHNM----QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AW 410 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~-----g~~vAIK~l~~~~~----~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~~ 410 (688)
+|.....||.|+||.||++... +..||||++..... .....+.+|+.++.++ +||||+++++++.. ..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4677789999999999998753 57899999875432 2334688999999999 59999999988854 47
Q ss_pred eeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCcccc
Q 005617 411 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~ 490 (688)
++||||+++|+|.+++... ..+++..+..++.|++.||.|||+.+ ++||||+|+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR---EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhhc---CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 8999999999999988654 35788999999999999999999865 99999999999999999999999999887
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCChhhhccCC--CCCcchHhHHHHHHHHHHhCCCCCCChhhH--HHHhhcCcccccc
Q 005617 491 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV--LTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSIL 566 (688)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~--~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~~~~g~l~~~l 566 (688)
....... ......|++.|+|||.+.+.. .+.++||||||+++|+|+||..||...... ...+......
T Consensus 155 ~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~--- 226 (288)
T cd05583 155 FLAEEEE-----RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILK--- 226 (288)
T ss_pred ccccccc-----ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHc---
Confidence 6433211 123456899999999987665 788999999999999999999999632211 0111100000
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHH
Q 005617 567 DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 567 d~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le 608 (688)
.....+......+.+++.+||+.+|+.|||+. .+...|+
T Consensus 227 --~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~-~~~~~l~ 265 (288)
T cd05583 227 --SKPPFPKTMSAEARDFIQKLLEKDPKKRLGAN-GADEIKN 265 (288)
T ss_pred --cCCCCCcccCHHHHHHHHHHhcCCHhhccCcc-hHHHHhc
Confidence 01122334556789999999999999999987 4544444
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-33 Score=291.02 Aligned_cols=231 Identities=26% Similarity=0.341 Sum_probs=178.6
Q ss_pred eeeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHH---HHcCCCCceeeEecccCC--CceeEEecCC
Q 005617 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRV---LSKLQHPHLVTLLGACPE--AWSLVYEYLP 418 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~---~~~~f~~E~~i---L~~l~HpnIV~l~g~~~~--~~~LV~E~~~ 418 (688)
.||+|+||.||++... |+.||||.+...... ....+..|..+ ++...||||+.+++++.+ ..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 3899999999999874 789999998765332 12234445444 444579999999998843 5789999999
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcC
Q 005617 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~ 498 (688)
||+|..++... ..+++..+..|+.|++.||.|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 g~~L~~~l~~~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQH---GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 99999888643 46899999999999999999999966 9999999999999999999999999987653221
Q ss_pred CCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhhHH-HHhhcCccccccCCCCCCCCHH
Q 005617 499 PSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR-RAVSCGKLSSILDPLAGDWPTF 576 (688)
Q Consensus 499 ~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~-~~~~~g~l~~~ld~~~~~~~~~ 576 (688)
.....|+..|+|||++.++ .++.++|||||||++|+|++|+.||....... ....... ......++..
T Consensus 152 -----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~-----~~~~~~~~~~ 221 (278)
T cd05606 152 -----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT-----LTMAVELPDS 221 (278)
T ss_pred -----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHh-----hccCCCCCCc
Confidence 2344699999999998754 68999999999999999999999996542110 0000000 0011123334
Q ss_pred HHHHHHHHHHHccccCCCCCCC
Q 005617 577 VARRLVDLGLQCCELYGRERPD 598 (688)
Q Consensus 577 ~~~~l~~L~~~Cl~~dP~~RPs 598 (688)
.+..+.+++.+|+..+|.+||.
T Consensus 222 ~s~~~~~li~~~l~~~p~~R~~ 243 (278)
T cd05606 222 FSPELRSLLEGLLQRDVNRRLG 243 (278)
T ss_pred CCHHHHHHHHHHhhcCHHhccC
Confidence 5678999999999999999993
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-34 Score=321.48 Aligned_cols=255 Identities=16% Similarity=0.251 Sum_probs=179.3
Q ss_pred HhcCcccceeeeccCceEEEEEEEC---CeEEEEEEEe--------------c---CCccchHHHHHHHHHHHcCCCCce
Q 005617 340 ATCNFSESFKVGQGGFGCVYKGEML---GRTVAIKMLY--------------S---HNMQGQLEFQQEVRVLSKLQHPHL 399 (688)
Q Consensus 340 at~~f~~~~~LG~G~fG~Vykg~~~---g~~vAIK~l~--------------~---~~~~~~~~f~~E~~iL~~l~HpnI 399 (688)
..++|.....||+|+||.||++... +..+++|.+. + ........|.+|+.+|.+++||||
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnI 225 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENI 225 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCc
Confidence 4578999999999999999998764 2222222111 0 011123458899999999999999
Q ss_pred eeEecccC--CCceeEEecCCCCcHHHHhcccCC--CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeC
Q 005617 400 VTLLGACP--EAWSLVYEYLPNGSLQDRLFRKSN--VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD 475 (688)
Q Consensus 400 V~l~g~~~--~~~~LV~E~~~~gsL~~~L~~~~~--~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd 475 (688)
|++++++. +..++|++++. ++|..++..... ........+..|+.||+.||.|||+.+ ||||||||+||||+
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~ 301 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLN 301 (501)
T ss_pred CcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEC
Confidence 99999984 45789999985 566666543221 122345667889999999999999965 99999999999999
Q ss_pred CCCCeEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCC-CCCChh---
Q 005617 476 SELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRL-PVGLAG--- 551 (688)
Q Consensus 476 ~~~~vKLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~-Pf~~~~--- 551 (688)
.++.+||+|||+++.+..... .......||+.|+|||++.+..++.++|||||||+||||++|.. |+....
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~ 376 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKERE-----AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP 376 (501)
T ss_pred CCCCEEEEeCCCceecCcccc-----cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCH
Confidence 999999999999987654321 12234679999999999999999999999999999999999875 443211
Q ss_pred --hHHHHhhc-----Ccc-------ccccCC-----CCCCCCH-----HHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 552 --EVRRAVSC-----GKL-------SSILDP-----LAGDWPT-----FVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 552 --~~~~~~~~-----g~l-------~~~ld~-----~~~~~~~-----~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
.+...+.. ..+ ...++. .....+. .....+.+++.+||+.||.+||++.+.+
T Consensus 377 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL 452 (501)
T PHA03210 377 GKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELL 452 (501)
T ss_pred HHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHh
Confidence 11111110 000 000000 0000010 1234577889999999999999998544
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=295.42 Aligned_cols=238 Identities=28% Similarity=0.355 Sum_probs=200.1
Q ss_pred cCcccceeeeccCceEEEEEEECC--eEEEEEEEecCCccc---hHHHHHHHHHHHcC-CCCceeeEecccC--CCceeE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEMLG--RTVAIKMLYSHNMQG---QLEFQQEVRVLSKL-QHPHLVTLLGACP--EAWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~g--~~vAIK~l~~~~~~~---~~~f~~E~~iL~~l-~HpnIV~l~g~~~--~~~~LV 413 (688)
.+|....+||+|+||.|.++...| ..+|||++++...-. .+--..|-++|+.. +-|.+++|..+|+ +.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 468888999999999999998875 469999998875422 22245678888877 6789999999885 579999
Q ss_pred EecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccC
Q 005617 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~ 493 (688)
|||+.||+|.-++...+. +-++.+..++.+||-||-|||+.+ ||.||||.+|||||.+|++||+|||+++.-.-
T Consensus 429 MEyvnGGDLMyhiQQ~Gk---FKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGK---FKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEecCchhhhHHHHhcc---cCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc
Confidence 999999999999876553 556778899999999999999965 99999999999999999999999999986433
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCCCC
Q 005617 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAG 571 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~ 571 (688)
+. ..+.+.+|||.|+|||++...+|+..+|+|||||+||||+.|++||.+.++ +..++...+.
T Consensus 503 ~~------~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnv--------- 567 (683)
T KOG0696|consen 503 DG------VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNV--------- 567 (683)
T ss_pred CC------cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccC---------
Confidence 32 245788999999999999999999999999999999999999999987654 4455544432
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCCc
Q 005617 572 DWPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 572 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~ 600 (688)
.+|...+.+...++...+...|.+|....
T Consensus 568 syPKslSkEAv~ickg~ltK~P~kRLGcg 596 (683)
T KOG0696|consen 568 SYPKSLSKEAVAICKGLLTKHPGKRLGCG 596 (683)
T ss_pred cCcccccHHHHHHHHHHhhcCCccccCCC
Confidence 57788899999999999999999996544
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-33 Score=298.54 Aligned_cols=250 Identities=25% Similarity=0.321 Sum_probs=192.3
Q ss_pred HHHHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccC---C
Q 005617 336 DLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACP---E 408 (688)
Q Consensus 336 el~~at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~---~ 408 (688)
++...+++|.....||.|+||.||++... |..||||++..... .....+..|+.++..++||||++++++|. .
T Consensus 4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~ 83 (328)
T cd07856 4 TVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLE 83 (328)
T ss_pred ceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCC
Confidence 34557889999999999999999999875 78999998864322 23456889999999999999999999873 3
Q ss_pred CceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCcc
Q 005617 409 AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 488 (688)
Q Consensus 409 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla 488 (688)
..++||||+ +++|..++.. .++++..+..++.|++.||.|||+.+ |+||||+|+|||++.++.+||+|||++
T Consensus 84 ~~~lv~e~~-~~~L~~~~~~----~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~ 155 (328)
T cd07856 84 DIYFVTELL-GTDLHRLLTS----RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLA 155 (328)
T ss_pred cEEEEeehh-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccc
Confidence 478999998 5688887753 35788888999999999999999966 999999999999999999999999998
Q ss_pred ccccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHH-------------
Q 005617 489 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR------------- 554 (688)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~------------- 554 (688)
...... .....+++.|+|||++.+ ..++.++|||||||++|+|+||++||.......
T Consensus 156 ~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~ 226 (328)
T cd07856 156 RIQDPQ---------MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPP 226 (328)
T ss_pred cccCCC---------cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 754321 123467889999998766 568999999999999999999999996433211
Q ss_pred ----HHhhcCccccccCCC--CCCCC-----HHHHHHHHHHHHHccccCCCCCCCCchH
Q 005617 555 ----RAVSCGKLSSILDPL--AGDWP-----TFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 555 ----~~~~~g~l~~~ld~~--~~~~~-----~~~~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
..+..+.....+... ....+ ...+..+.+++.+||+.+|.+||++.+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~el 285 (328)
T cd07856 227 DDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEA 285 (328)
T ss_pred HHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence 000011100110000 00111 1235689999999999999999998743
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-32 Score=292.85 Aligned_cols=237 Identities=26% Similarity=0.355 Sum_probs=186.6
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEec
Q 005617 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 344 f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~---~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
|.....||+|+||.||+|... |..||||.+...... ....+.+|+.++..++|||+++++++|.+ ..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999874 889999998754332 23468889999999999999999999854 47899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCC
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~ 496 (688)
+. |+|.+.+.... .++++..+..++.+++.||.|||+.+ |+|+||+|+||+++.++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~~~--~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 96 57777665433 46899999999999999999999966 99999999999999999999999999864321
Q ss_pred cCCCccccCCCCCCCCCCChhhhc---cCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHH--hhcCccccccCCCCC
Q 005617 497 YLPSFHRSTAPKGSFPYADPEYHR---TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VSCGKLSSILDPLAG 571 (688)
Q Consensus 497 ~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~--~~~g~l~~~ld~~~~ 571 (688)
.....|+..|+|||++. .+.++.++|||||||++|+|++|.+||......... ...+.....
T Consensus 174 -------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~------ 240 (313)
T cd06633 174 -------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL------ 240 (313)
T ss_pred -------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC------
Confidence 23456899999999874 466889999999999999999999998654332211 111111111
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 572 DWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 572 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
.....+..+.+|+.+||+.+|.+||++.+.+
T Consensus 241 -~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l 271 (313)
T cd06633 241 -QSNEWTDSFRGFVDYCLQKIPQERPASAELL 271 (313)
T ss_pred -CccccCHHHHHHHHHHccCChhhCcCHHHHh
Confidence 1112345688999999999999999988444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=293.28 Aligned_cols=238 Identities=26% Similarity=0.351 Sum_probs=187.8
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEe
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYE 415 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E 415 (688)
.|...+.||.|+||.||+|+.. +..||||.+..... .....+.+|+.+++.++|||++++++++. +..++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3666688999999999999885 78899999865322 23346889999999999999999999874 35789999
Q ss_pred cCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCC
Q 005617 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~ 495 (688)
|+. |+|.+.+.... .++++..+..++.+++.||.|||+.+ ++||||+|+|||++.++.++|+|||++......
T Consensus 96 ~~~-~~l~~~~~~~~--~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 96 YCL-GSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred ccC-CCHHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 996 57777665432 45789999999999999999999965 999999999999999999999999998765432
Q ss_pred CcCCCccccCCCCCCCCCCChhhhc---cCCCCCcchHhHHHHHHHHHHhCCCCCCChhhH--HHHhhcCccccccCCCC
Q 005617 496 LYLPSFHRSTAPKGSFPYADPEYHR---TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLA 570 (688)
Q Consensus 496 ~~~~~~~~~~~~~GT~~Y~APE~~~---~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~~~~g~l~~~ld~~~ 570 (688)
....|++.|+|||++. .+.++.++|||||||++|+|++|..||...... ...+..+....
T Consensus 169 ---------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~------ 233 (308)
T cd06634 169 ---------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPA------ 233 (308)
T ss_pred ---------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCC------
Confidence 2346889999999874 456889999999999999999999998644322 11122221111
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 571 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
..+......+.+|+.+||+.+|.+||++.+.+
T Consensus 234 -~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll 265 (308)
T cd06634 234 -LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLL 265 (308)
T ss_pred -cCcccccHHHHHHHHHHhhCCcccCCCHHHHh
Confidence 01223456789999999999999999987433
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=284.64 Aligned_cols=243 Identities=24% Similarity=0.311 Sum_probs=191.0
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC-----ccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeE
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN-----MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLV 413 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~-----~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV 413 (688)
+|...+.||+|+||.||++... +..+++|+++... ......+..|+.++..++||||+++++++.+ ..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 3667789999999999999876 4556666665322 1233457789999999999999999999843 57899
Q ss_pred EecCCCCcHHHHhccc-CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCcccccc
Q 005617 414 YEYLPNGSLQDRLFRK-SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 492 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~ 492 (688)
|||+++++|.+.+... .....+++..+..++.|++.||.|||+.+ ++|+||+|+||+++. +.++|+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988643 22356899999999999999999999965 999999999999975 569999999998764
Q ss_pred CCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHH--HhhcCccccccCCCC
Q 005617 493 EDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR--AVSCGKLSSILDPLA 570 (688)
Q Consensus 493 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~--~~~~g~l~~~ld~~~ 570 (688)
.... ......|++.|+|||++....++.++||||||+++|+|++|..||........ .+..+. .
T Consensus 157 ~~~~------~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~--------~ 222 (260)
T cd08222 157 GSCD------LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGP--------T 222 (260)
T ss_pred CCcc------cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCC--------C
Confidence 3321 12345688999999999888899999999999999999999999964332211 111111 1
Q ss_pred CCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 571 ~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
...+...+..+.+++.+||+.+|.+||++.+.+
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il 255 (260)
T cd08222 223 PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEIL 255 (260)
T ss_pred CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHh
Confidence 123445667899999999999999999988443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-33 Score=296.69 Aligned_cols=251 Identities=26% Similarity=0.309 Sum_probs=194.5
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC--ccchHHHHHHHHHHHcCCCCceeeEecccCC-------Cce
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-------AWS 411 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~--~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-------~~~ 411 (688)
+|.....||.|+||.||+|... |..||||.+.... ......+.+|+.++..++||||+++++++.. ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4777889999999999999985 7899999987654 3344578999999999999999999998843 368
Q ss_pred eEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccc
Q 005617 412 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~ 491 (688)
+||+|++ ++|.+++.... ++++..+..++.+++.||.|||+.+ |+|+||||.|||++.++.++|+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~~~---~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKSPQ---PLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhCCC---CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999998 47888876533 6899999999999999999999966 999999999999999999999999999887
Q ss_pred cCCCCcCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhhHHH--H-hhc-C------
Q 005617 492 TEDTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR--A-VSC-G------ 560 (688)
Q Consensus 492 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~--~-~~~-g------ 560 (688)
....... .......||+.|+|||++.+. .++.++||||||+++|+|++|++||........ . ... +
T Consensus 154 ~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 230 (330)
T cd07834 154 DPDEDEK---GFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEED 230 (330)
T ss_pred ccccccc---ccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhH
Confidence 5442100 112345688999999999887 899999999999999999999999965432111 0 000 0
Q ss_pred -------ccccccC---CC----CCCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 561 -------KLSSILD---PL----AGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 561 -------~l~~~ld---~~----~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
.....+. .. ........+..+.+++.+||+.+|.+||++.+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll 287 (330)
T cd07834 231 LKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEAL 287 (330)
T ss_pred hhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHH
Confidence 0000000 00 0001122456789999999999999999988544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=294.00 Aligned_cols=253 Identities=18% Similarity=0.234 Sum_probs=186.9
Q ss_pred eeecc--CceEEEEEEE--CCeEEEEEEEecCCcc--chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecCCCC
Q 005617 349 KVGQG--GFGCVYKGEM--LGRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNG 420 (688)
Q Consensus 349 ~LG~G--~fG~Vykg~~--~g~~vAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~g 420 (688)
.||+| +||+||++.+ .|+.||||++...... ....+.+|+.++..++||||++++++|.. ..++||||+.+|
T Consensus 5 ~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~ 84 (328)
T cd08226 5 EIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYG 84 (328)
T ss_pred HhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCC
Confidence 46666 9999999988 4899999998754332 33568899999999999999999999854 578999999999
Q ss_pred cHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCC-
Q 005617 421 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP- 499 (688)
Q Consensus 421 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~- 499 (688)
+|.+++..... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.++++|||.+...........
T Consensus 85 ~l~~~l~~~~~-~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (328)
T cd08226 85 SANSLLKTYFP-EGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV 160 (328)
T ss_pred CHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence 99998876432 35889999999999999999999865 99999999999999999999999986644322111100
Q ss_pred CccccCCCCCCCCCCChhhhccC--CCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhh--cCccc------------
Q 005617 500 SFHRSTAPKGSFPYADPEYHRTG--VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS--CGKLS------------ 563 (688)
Q Consensus 500 ~~~~~~~~~GT~~Y~APE~~~~~--~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~--~g~l~------------ 563 (688)
.........++..|+|||++.+. .++.++|||||||++|+|++|+.||........... .+...
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (328)
T cd08226 161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEE 240 (328)
T ss_pred cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhh
Confidence 00011223456789999998763 578999999999999999999999964432111110 00000
Q ss_pred -------------------------cccCCC-CCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHH
Q 005617 564 -------------------------SILDPL-AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 605 (688)
Q Consensus 564 -------------------------~~ld~~-~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~ 605 (688)
.+.+.. ....+..+...+.+|+.+||+.||.+|||+.+.+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~ 308 (328)
T cd08226 241 SRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH 308 (328)
T ss_pred hhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 000000 011123466789999999999999999999865533
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=286.70 Aligned_cols=247 Identities=26% Similarity=0.337 Sum_probs=191.5
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCC--ccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecC
Q 005617 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 417 (688)
Q Consensus 344 f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~--~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~ 417 (688)
|.....||.|+||.||+|... +..||+|++.... ......+..|+.+++.++||||+++++++.+ ..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 445678999999999999886 7899999998754 2334568899999999999999999999854 588999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCc
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~ 497 (688)
+ ++|.+++.... ..+++..+..++.+++.||.|||+.+ |+||||+|+||+++.++.+||+|||++........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 8 58999987653 36899999999999999999999966 99999999999999999999999999987654321
Q ss_pred CCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhc---------------Cc
Q 005617 498 LPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC---------------GK 561 (688)
Q Consensus 498 ~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~---------------g~ 561 (688)
......++..|+|||++.+. .++.++|||||||++|||++|++||............ ..
T Consensus 154 -----~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (282)
T cd07829 154 -----TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK 228 (282)
T ss_pred -----ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcc
Confidence 12234567889999998776 8899999999999999999999999754332111000 00
Q ss_pred c---ccccCC----CCCCCCHHHHHHHHHHHHHccccCCCCCCCCchH
Q 005617 562 L---SSILDP----LAGDWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 562 l---~~~ld~----~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
+ ...+.. ............+.+++.+||..+|.+||++.+.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~ 276 (282)
T cd07829 229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEA 276 (282)
T ss_pred cccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHH
Confidence 0 000000 0000011235689999999999999999998843
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-33 Score=298.94 Aligned_cols=252 Identities=22% Similarity=0.283 Sum_probs=190.3
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC----------
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE---------- 408 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~---------- 408 (688)
..+|...+.||.|+||.||+|... |..||+|.+..........+.+|+.++..++||||+++++++..
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 367889999999999999999885 78999999977666666778999999999999999999987632
Q ss_pred ------CceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCC-CCCeE
Q 005617 409 ------AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS-ELSSK 481 (688)
Q Consensus 409 ------~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~-~~~vK 481 (688)
..++||||+. ++|.+.+.. ..+++..+..++.||+.||.|||+.+ |+||||||+||+++. ++.+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLEQ----GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 2579999997 588887743 35789999999999999999999966 999999999999974 56789
Q ss_pred EeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhc-
Q 005617 482 ICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC- 559 (688)
Q Consensus 482 LsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~- 559 (688)
|+|||++.......... .......|+..|+|||++.. ..++.++|||||||++|+|++|+.||............
T Consensus 156 l~dfg~~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~ 232 (342)
T cd07854 156 IGDFGLARIVDPHYSHK---GYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLIL 232 (342)
T ss_pred ECCcccceecCCccccc---cccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999998664321110 01123468899999997654 56889999999999999999999999644322111100
Q ss_pred --Cc-------------cccccC--CCCC-----CCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 560 --GK-------------LSSILD--PLAG-----DWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 560 --g~-------------l~~~ld--~~~~-----~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
.. +...+. .... .........+.+|+.+||+.||.+||++.+.+
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell 298 (342)
T cd07854 233 ESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEAL 298 (342)
T ss_pred HhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHh
Confidence 00 000000 0000 01112446788999999999999999988433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=334.52 Aligned_cols=249 Identities=27% Similarity=0.334 Sum_probs=201.9
Q ss_pred HHHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccC--CCc
Q 005617 337 LQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAW 410 (688)
Q Consensus 337 l~~at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~ 410 (688)
+...+-++..+..||.|.||.||.|... |...|+|-++.... .....+.+|+.+|..|+|||+|++||+-. +..
T Consensus 1230 lsnV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1230 LSNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred hccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 5566778888899999999999999875 88899998765443 33345789999999999999999999864 468
Q ss_pred eeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCcccc
Q 005617 411 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~ 490 (688)
+|.||||.+|+|.+.+.... ..++.....+..|++.|+.|||+.+ ||||||||.||||+.+|.+|++|||.|..
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gr---i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~k 1383 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGR---IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVK 1383 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcc---hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeE
Confidence 99999999999999987653 2344555567899999999999976 99999999999999999999999999998
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCChhhhccC---CCCCcchHhHHHHHHHHHHhCCCCCCChhhH---HHHhhcCcccc
Q 005617 491 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG---VLTPKSDSYSFGLIILQLLTGRLPVGLAGEV---RRAVSCGKLSS 564 (688)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~---~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~---~~~~~~g~l~~ 564 (688)
+..+....+ ..-....||+.|||||++.+. ....+.||||+|||++||+||+.||...+.- ...+..|...
T Consensus 1384 i~~~~~~~~--~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~P- 1460 (1509)
T KOG4645|consen 1384 IKNNAQTMP--GELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKP- 1460 (1509)
T ss_pred ecCchhcCC--HHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCC-
Confidence 876542222 123467899999999999654 4567899999999999999999999755432 2234445433
Q ss_pred ccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCch
Q 005617 565 ILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 565 ~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~ 601 (688)
..|...+..-.+++.+|+..||+.|.++.|
T Consensus 1461 -------q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~q 1490 (1509)
T KOG4645|consen 1461 -------QIPERLSSEGRDFLEHCLEQDPKMRWTASQ 1490 (1509)
T ss_pred -------CCchhhhHhHHHHHHHHHhcCchhhhHHHH
Confidence 456668888999999999999999976553
|
|
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-33 Score=306.17 Aligned_cols=194 Identities=29% Similarity=0.356 Sum_probs=165.1
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCC-CC-----ceeeEeccc--CCCcee
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HP-----HLVTLLGAC--PEAWSL 412 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~-Hp-----nIV~l~g~~--~~~~~L 412 (688)
+|.+...||+|.||.|-+|.+. ++.||||+++.... -..+-..|+.+|..|+ |. |+|+++++| .+..||
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~-f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR-FLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH-HHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 7888999999999999999886 78999999986532 2234557999999997 43 899999998 567999
Q ss_pred EEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCC--CCeEEeecCcccc
Q 005617 413 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE--LSSKICDFGICRL 490 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~--~~vKLsDFGla~~ 490 (688)
|+|.+ ..+|.++|... .+.+|+...+..|+.||+.||.+||..+ |||+||||+||||..- ..+||+|||.+..
T Consensus 266 VfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 99998 56999998654 4577999999999999999999999976 9999999999999654 3699999999988
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh
Q 005617 491 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG 551 (688)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~ 551 (688)
..... ....-+..|.|||++.+.+|+.+.||||||||+.||+||.+.|.+..
T Consensus 341 ~~q~v---------ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 341 ESQRV---------YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred cCCcc---------eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 76433 23456678999999999999999999999999999999988886443
|
|
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=305.06 Aligned_cols=248 Identities=28% Similarity=0.420 Sum_probs=207.2
Q ss_pred HHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc--chHHHHHHHHHHHcCCCCceeeEeccc--CCCce
Q 005617 338 QTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGAC--PEAWS 411 (688)
Q Consensus 338 ~~at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~--~~~~~ 411 (688)
..-.+.|.....||+|.|+.|..|+.. |..||||.+.+.... ....+.+|+.+|..++|||||+|+++. ...+|
T Consensus 52 ~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~ly 131 (596)
T KOG0586|consen 52 SNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLY 131 (596)
T ss_pred cccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeE
Confidence 345678899999999999999999875 899999999876443 334588999999999999999999987 45699
Q ss_pred eEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccc
Q 005617 412 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~ 491 (688)
+||||..+|.+.++|.+.+. +....+..++.|+..|++|||+.+ |||||||.+||||+.+.++||+|||++..+
T Consensus 132 lV~eya~~ge~~~yl~~~gr---~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~ 205 (596)
T KOG0586|consen 132 LVMEYASGGELFDYLVKHGR---MKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFF 205 (596)
T ss_pred EEEEeccCchhHHHHHhccc---chhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceee
Confidence 99999999999999987763 334778889999999999999965 999999999999999999999999999988
Q ss_pred cCCCCcCCCccccCCCCCCCCCCChhhhccCCC-CCcchHhHHHHHHHHHHhCCCCCCChh--hHHHHhhcCccccccCC
Q 005617 492 TEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVL-TPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSILDP 568 (688)
Q Consensus 492 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDVwSfGviL~ELltG~~Pf~~~~--~~~~~~~~g~l~~~ld~ 568 (688)
..+. ...+.+|++.|.|||++.+..| ++.+|+||+|++||-|+.|..||.+.. .....+..|++
T Consensus 206 ~~~~-------~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~------ 272 (596)
T KOG0586|consen 206 DYGL-------MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKY------ 272 (596)
T ss_pred cccc-------cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeee------
Confidence 7544 3357899999999999998877 689999999999999999999997432 23333333322
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHH
Q 005617 569 LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 569 ~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~L 607 (688)
..|..++.++.+|+.+++..+|.+|+++.+...+.+
T Consensus 273 ---rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W 308 (596)
T KOG0586|consen 273 ---RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRW 308 (596)
T ss_pred ---cccceeechhHHHHHHhhccCccccCCHHHhhhhcc
Confidence 234456778899999999999999999986655544
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=304.11 Aligned_cols=233 Identities=23% Similarity=0.310 Sum_probs=202.6
Q ss_pred cceeeeccCceEEEEEEECCeE--EEEEEEecCCcc---chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecCC
Q 005617 346 ESFKVGQGGFGCVYKGEMLGRT--VAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLP 418 (688)
Q Consensus 346 ~~~~LG~G~fG~Vykg~~~g~~--vAIK~l~~~~~~---~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~ 418 (688)
....||-||||.|-+++..+.. +|+|.+++.... .++.+..|-.||...+.|+||+||-.|.+ ..|++||-|-
T Consensus 424 ~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaCl 503 (732)
T KOG0614|consen 424 RIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACL 503 (732)
T ss_pred hhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhc
Confidence 3456999999999999988655 899999877553 44568899999999999999999999965 4789999999
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcC
Q 005617 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~ 498 (688)
||.|+..|.+.+ .|+......++.++..|+.|||..+ ||.|||||+|.+||.+|-+||.|||+|+.+..+.
T Consensus 504 GGElWTiLrdRg---~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~--- 574 (732)
T KOG0614|consen 504 GGELWTILRDRG---SFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR--- 574 (732)
T ss_pred CchhhhhhhhcC---CcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCC---
Confidence 999999998775 4666778889999999999999965 9999999999999999999999999999987654
Q ss_pred CCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHH--HHhhcCccccccCCCCCCCCHH
Q 005617 499 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSILDPLAGDWPTF 576 (688)
Q Consensus 499 ~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~--~~~~~g~l~~~ld~~~~~~~~~ 576 (688)
++.+++|||.|.|||++.+...+..+|.||||+++||||||.+||...+.+. +.+-.| +| ...||..
T Consensus 575 ----KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG-----id--~i~~Pr~ 643 (732)
T KOG0614|consen 575 ----KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG-----ID--KIEFPRR 643 (732)
T ss_pred ----ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh-----hh--hhhcccc
Confidence 5678999999999999999999999999999999999999999999887653 333333 11 2367888
Q ss_pred HHHHHHHHHHHccccCCCCCCC
Q 005617 577 VARRLVDLGLQCCELYGRERPD 598 (688)
Q Consensus 577 ~~~~l~~L~~~Cl~~dP~~RPs 598 (688)
+.....+|+.+.|..+|.+|..
T Consensus 644 I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 644 ITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred cchhHHHHHHHHHhcCcHhhhc
Confidence 8999999999999999999987
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-32 Score=277.66 Aligned_cols=230 Identities=28% Similarity=0.373 Sum_probs=190.9
Q ss_pred eeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecCCCCcH
Q 005617 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSL 422 (688)
Q Consensus 350 LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~---~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gsL 422 (688)
||.|+||.||++... +..||+|++...... ....+..|+.++++++||||+++++.+.+ ..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 699999999999886 789999998765443 34578899999999999999999998854 47899999999999
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCCcc
Q 005617 423 QDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 502 (688)
Q Consensus 423 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~~~ 502 (688)
.+++.... .+++..+..++.|++.||.|||..+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~l~~~~---~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~------ 148 (250)
T cd05123 81 FSHLSKEG---RFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS------ 148 (250)
T ss_pred HHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCC------
Confidence 99986543 5889999999999999999999965 99999999999999999999999999987644321
Q ss_pred ccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCCCCCCCHHHHHH
Q 005617 503 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVARR 580 (688)
Q Consensus 503 ~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~~~~~~~~~~ 580 (688)
......|+..|++||.+.+...+.++|+||||+++|+|++|..||..... ....+..+. ..++...+..
T Consensus 149 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~---------~~~~~~~~~~ 219 (250)
T cd05123 149 RTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDP---------LRFPEFLSPE 219 (250)
T ss_pred cccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC---------CCCCCCCCHH
Confidence 12455689999999999888899999999999999999999999975442 111121111 1233344678
Q ss_pred HHHHHHHccccCCCCCCCCc
Q 005617 581 LVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 581 l~~L~~~Cl~~dP~~RPs~~ 600 (688)
+.+++.+||..||++||++.
T Consensus 220 l~~~i~~~l~~~p~~R~~~~ 239 (250)
T cd05123 220 ARDLISGLLQKDPTKRLGSG 239 (250)
T ss_pred HHHHHHHHhcCCHhhCCCcc
Confidence 89999999999999999996
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-32 Score=294.18 Aligned_cols=255 Identities=23% Similarity=0.280 Sum_probs=188.1
Q ss_pred cCcc-cceeeeccCceEEEEEEEC--CeEEEEEEEecCCccc--------------hHHHHHHHHHHHcCCCCceeeEec
Q 005617 342 CNFS-ESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG--------------QLEFQQEVRVLSKLQHPHLVTLLG 404 (688)
Q Consensus 342 ~~f~-~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~--------------~~~f~~E~~iL~~l~HpnIV~l~g 404 (688)
++|. ....||.|+||.||+|.+. +..||||.+....... ...+.+|+.++..++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3454 3467999999999999875 8899999986543221 124778999999999999999999
Q ss_pred ccC--CCceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEE
Q 005617 405 ACP--EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKI 482 (688)
Q Consensus 405 ~~~--~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL 482 (688)
+|. +..++||||+. |+|.+++... ..+++.....++.|++.||.|||+.+ |+|+||+|+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK---IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 984 35789999997 6888888543 35788999999999999999999965 999999999999999999999
Q ss_pred eecCccccccCCCCcC--------CCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhhH
Q 005617 483 CDFGICRLVTEDTLYL--------PSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEV 553 (688)
Q Consensus 483 sDFGla~~~~~~~~~~--------~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~ 553 (688)
+|||++.......... ..........+++.|+|||++.+. .++.++|||||||++|+|+||++||......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999998765211100 001112234578899999988664 4789999999999999999999999755432
Q ss_pred HHH------hhcCc---cccc--------cCCC----CCCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 554 RRA------VSCGK---LSSI--------LDPL----AGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 554 ~~~------~~~g~---l~~~--------ld~~----~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
... +.... +... ..+. ........+..+.+++.+||+.+|.+||++.+.+
T Consensus 241 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l 311 (335)
T PTZ00024 241 DQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEAL 311 (335)
T ss_pred HHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHh
Confidence 211 10000 0000 0000 0000112356789999999999999999988544
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-33 Score=298.15 Aligned_cols=247 Identities=24% Similarity=0.302 Sum_probs=190.9
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC--ccchHHHHHHHHHHHcCCCCceeeEecccCC--C---
Q 005617 339 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--A--- 409 (688)
Q Consensus 339 ~at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~--~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~--- 409 (688)
...++|.....||.|+||.||+|... +..||||++.... ......+.+|+.+++.++||||+++++++.. .
T Consensus 12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence 34678999999999999999999985 7889999986532 2233557789999999999999999987732 2
Q ss_pred ---ceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecC
Q 005617 410 ---WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFG 486 (688)
Q Consensus 410 ---~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFG 486 (688)
.++|+||+ +++|.+++.. ..+++..+..++.+++.||.|||+.+ |+||||||+||+++.++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg 163 (343)
T cd07851 92 FQDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFG 163 (343)
T ss_pred cccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccc
Confidence 68999998 6799888864 35899999999999999999999966 9999999999999999999999999
Q ss_pred ccccccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHH--hhc--Cc
Q 005617 487 ICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VSC--GK 561 (688)
Q Consensus 487 la~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~--~~~--g~ 561 (688)
++...... .....+|+.|+|||.+.+ ..++.++|||||||++|+|+||+.||......... +.. +.
T Consensus 164 ~~~~~~~~---------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~ 234 (343)
T cd07851 164 LARHTDDE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGT 234 (343)
T ss_pred cccccccc---------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCC
Confidence 99865432 134468899999998865 46789999999999999999999999643322110 000 00
Q ss_pred c-------------ccccCCC----CCCC---CHHHHHHHHHHHHHccccCCCCCCCCchH
Q 005617 562 L-------------SSILDPL----AGDW---PTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 562 l-------------~~~ld~~----~~~~---~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
. ...+... ...+ ....+..+.+++.+||+.+|.+|||+.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~el 295 (343)
T cd07851 235 PDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEA 295 (343)
T ss_pred CCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHH
Confidence 0 0000000 0000 01235689999999999999999998843
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-32 Score=304.60 Aligned_cols=247 Identities=28% Similarity=0.450 Sum_probs=206.9
Q ss_pred cceeeeccCceEEEEEEEC------CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC-CceeEEecC
Q 005617 346 ESFKVGQGGFGCVYKGEML------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYEYL 417 (688)
Q Consensus 346 ~~~~LG~G~fG~Vykg~~~------g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV~E~~ 417 (688)
..++||.|+||+||+|.+- .-+||||++..... +.-.+|..|+-+|++++|||+++|+|+|.. ...||++||
T Consensus 700 k~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq~m 779 (1177)
T KOG1025|consen 700 KDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQLM 779 (1177)
T ss_pred hhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHHhc
Confidence 3478999999999999884 34799999876543 456789999999999999999999999954 578999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCc
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~ 497 (688)
+.|+|.+++.... ..+--+..+.|..|||+|+.|||... ++||||-..|||+..-.++||.|||+++.+..+...
T Consensus 780 P~G~LlDyvr~hr--~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 780 PLGCLLDYVREHR--DNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred ccchHHHHHHHhh--ccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 9999999997754 46777899999999999999999854 999999999999999999999999999998766533
Q ss_pred CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCCh--hhHHHHhhcCccccccCCCCCCCC
Q 005617 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLA--GEVRRAVSCGKLSSILDPLAGDWP 574 (688)
Q Consensus 498 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~--~~~~~~~~~g~l~~~ld~~~~~~~ 574 (688)
. ......-.+-|||-|.+....|+.++|||||||.+|||+| |..|+... .++...++.|.. -..|
T Consensus 855 y----~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR--------LsqP 922 (1177)
T KOG1025|consen 855 Y----SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER--------LSQP 922 (1177)
T ss_pred c----cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc--------CCCC
Confidence 2 2334445667999999999999999999999999999999 99998743 456666666543 2446
Q ss_pred HHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHh
Q 005617 575 TFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 575 ~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l 610 (688)
+....++..++.+||..|+..||+++ ++...+...
T Consensus 923 piCtiDVy~~mvkCwmid~~~rp~fk-el~~~fs~~ 957 (1177)
T KOG1025|consen 923 PICTIDVYMVMVKCWMIDADSRPTFK-ELAEEFSRM 957 (1177)
T ss_pred CCccHHHHHHHHHHhccCcccCccHH-HHHHHHHHH
Confidence 67788999999999999999999999 565555544
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=321.16 Aligned_cols=252 Identities=29% Similarity=0.366 Sum_probs=189.0
Q ss_pred HHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcCCCCceeeEecccCC-------
Q 005617 339 TATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE------- 408 (688)
Q Consensus 339 ~at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~------- 408 (688)
.--++|.+...||+||||.||+++.. |..||||++..... .....+.+|+.+|++|+|||||++|.++.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 45578888999999999999999875 99999999976642 223357899999999999999999653200
Q ss_pred --------------------------------------------------------------------------------
Q 005617 409 -------------------------------------------------------------------------------- 408 (688)
Q Consensus 409 -------------------------------------------------------------------------------- 408 (688)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHH
Q 005617 409 ----------------------------------AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFL 454 (688)
Q Consensus 409 ----------------------------------~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yL 454 (688)
.+||=||||+..+|.+++..+.... .-...++++.+|++||.|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence 0134567777766766665543211 2356789999999999999
Q ss_pred hccCCCceEeCCCCCCceeeCCCCCeEEeecCcccccc----C--------CCCcCCCccccCCCCCCCCCCChhhhccC
Q 005617 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT----E--------DTLYLPSFHRSTAPKGSFPYADPEYHRTG 522 (688)
Q Consensus 455 H~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~----~--------~~~~~~~~~~~~~~~GT~~Y~APE~~~~~ 522 (688)
|+.+ ||||||||.||+||.+..|||+|||+|+... . ...........+..+||.-|+|||++.+.
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9976 9999999999999999999999999998721 0 00011112234677999999999998655
Q ss_pred ---CCCCcchHhHHHHHHHHHHhCCCCCCChh---hHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCC
Q 005617 523 ---VLTPKSDSYSFGLIILQLLTGRLPVGLAG---EVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRER 596 (688)
Q Consensus 523 ---~~s~ksDVwSfGviL~ELltG~~Pf~~~~---~~~~~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~R 596 (688)
.|+.|+|+||||||||||+. ||+..- .+...++.|.+... .++.......-..++.++++.||.+|
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~-----~~f~~~~~~~e~slI~~Ll~hdP~kR 862 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP-----ADFFDPEHPEEASLIRWLLSHDPSKR 862 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC-----cccccccchHHHHHHHHHhcCCCccC
Confidence 49999999999999999986 565432 24445556655443 23334445566789999999999999
Q ss_pred CCCchHH
Q 005617 597 PDITPSL 603 (688)
Q Consensus 597 Ps~~~~l 603 (688)
||+.+.+
T Consensus 863 PtA~eLL 869 (1351)
T KOG1035|consen 863 PTATELL 869 (1351)
T ss_pred CCHHHHh
Confidence 9998544
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-32 Score=290.82 Aligned_cols=252 Identities=23% Similarity=0.245 Sum_probs=187.3
Q ss_pred CcccceeeeccCceEEEEEEEC----CeEEEEEEEecCCc--cchHHHHHHHHHHHcC-CCCceeeEecccC------CC
Q 005617 343 NFSESFKVGQGGFGCVYKGEML----GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKL-QHPHLVTLLGACP------EA 409 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~----g~~vAIK~l~~~~~--~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~------~~ 409 (688)
+|...+.||+|+||.||++... +..||||.+..... .....+.+|+.++.++ .||||+++++++. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4777889999999999999885 55899999865322 2345688899999999 5999999998642 23
Q ss_pred ceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccc
Q 005617 410 WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~ 489 (688)
.+++++|+. ++|.+.+... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~~---~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRSG---QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 577888885 6888887543 45889999999999999999999966 9999999999999999999999999998
Q ss_pred cccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHH--------------
Q 005617 490 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR-------------- 554 (688)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~-------------- 554 (688)
......... ........||+.|+|||++.+ ..++.++|||||||++|+|++|++||.......
T Consensus 154 ~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 231 (332)
T cd07857 154 GFSENPGEN--AGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE 231 (332)
T ss_pred ecccccccc--cccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCH
Confidence 765432211 111234578999999998765 468999999999999999999999996432110
Q ss_pred ---HHhhcCccccc---cCC----CCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 555 ---RAVSCGKLSSI---LDP----LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 555 ---~~~~~g~l~~~---ld~----~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
..+........ +.. ............+.+|+.+|++.||.+||++.+.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll 290 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEAL 290 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 00000000000 000 00000111356789999999999999999988544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=291.58 Aligned_cols=250 Identities=27% Similarity=0.443 Sum_probs=191.0
Q ss_pred cceeeeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcC--CCCceeeEecccC------CCceeEEecC
Q 005617 346 ESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKL--QHPHLVTLLGACP------EAWSLVYEYL 417 (688)
Q Consensus 346 ~~~~LG~G~fG~Vykg~~~g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l--~HpnIV~l~g~~~------~~~~LV~E~~ 417 (688)
...+||+|.||.||||++.++.||||++.. +....|.+|-+|.+.. +|+||++++++-. -++.||++|-
T Consensus 214 l~eli~~Grfg~V~KaqL~~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh 290 (534)
T KOG3653|consen 214 LLELIGRGRFGCVWKAQLDNRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFH 290 (534)
T ss_pred hHHHhhcCccceeehhhccCceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeec
Confidence 345699999999999999999999999964 4456788888888765 8999999999852 2578999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCC------CceEeCCCCCCceeeCCCCCeEEeecCccccc
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP------EKIVHGDLKPQNILLDSELSSKICDFGICRLV 491 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~------~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~ 491 (688)
+.|||.++|.. ..++|....+|+..+++||+|||...+ ++|+|||||+.||||.+|++..|+|||+|..+
T Consensus 291 ~kGsL~dyL~~----ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~ 366 (534)
T KOG3653|consen 291 PKGSLCDYLKA----NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL 366 (534)
T ss_pred cCCcHHHHHHh----ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence 99999999965 358999999999999999999998653 47999999999999999999999999999988
Q ss_pred cCCCCcCCCccccCCCCCCCCCCChhhhccCC-CC-----CcchHhHHHHHHHHHHhCCCCC------------C-----
Q 005617 492 TEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV-LT-----PKSDSYSFGLIILQLLTGRLPV------------G----- 548 (688)
Q Consensus 492 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~s-----~ksDVwSfGviL~ELltG~~Pf------------~----- 548 (688)
..+... ......+||..|||||++.+.. +. ...||||+|.|||||++...-+ .
T Consensus 367 ~p~~~~----~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~ 442 (534)
T KOG3653|consen 367 EPGKPQ----GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN 442 (534)
T ss_pred cCCCCC----cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence 755422 1234589999999999986542 22 3699999999999999975432 1
Q ss_pred --ChhhHHHHhhcCccccccCCCCCCCCH-HHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHh
Q 005617 549 --LAGEVRRAVSCGKLSSILDPLAGDWPT-FVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 549 --~~~~~~~~~~~g~l~~~ld~~~~~~~~-~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l 610 (688)
..++++..+...+....+. ..|-. ....-|.+.+..||+.||+-|.|+. =+.+.+..+
T Consensus 443 hPt~e~mq~~VV~kK~RP~~p---~~W~~h~~~~~l~et~EeCWDhDaeARLTA~-Cv~eR~~~l 503 (534)
T KOG3653|consen 443 HPTLEEMQELVVRKKQRPKIP---DAWRKHAGMAVLCETIEECWDHDAEARLTAG-CVEERMAEL 503 (534)
T ss_pred CCCHHHHHHHHHhhccCCCCh---hhhhcCccHHHHHHHHHHHcCCchhhhhhhH-HHHHHHHHH
Confidence 1122333332222111110 01111 2356789999999999999999986 444444433
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=283.15 Aligned_cols=250 Identities=28% Similarity=0.392 Sum_probs=196.5
Q ss_pred cccCHHHHHHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc-cchHHHHHHHHHHHcC-CCCceeeEecc
Q 005617 330 AEFSLADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKL-QHPHLVTLLGA 405 (688)
Q Consensus 330 ~~~~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l-~HpnIV~l~g~ 405 (688)
-.|+-++|+... .||.|+||+|+|-.+. |...|||++..... ..+.+|..|.++..+- +.||||++||+
T Consensus 59 ~~F~~~~Lqdlg-------~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa 131 (361)
T KOG1006|consen 59 HTFTSDNLQDLG-------EIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGA 131 (361)
T ss_pred cccccchHHHHH-------HhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhh
Confidence 456666666554 5999999999999886 89999999988766 5677899999887666 79999999998
Q ss_pred c-CC-CceeEEecCCCCcHHH---HhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCe
Q 005617 406 C-PE-AWSLVYEYLPNGSLQD---RLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS 480 (688)
Q Consensus 406 ~-~~-~~~LV~E~~~~gsL~~---~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~v 480 (688)
+ .+ ..++.||.|+ .||.. +.+... ...+++.-.-.|...++.||.||-... .||||||||+|||||..|.+
T Consensus 132 ~F~EGdcWiCMELMd-~SlDklYk~vy~vq-~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~v 207 (361)
T KOG1006|consen 132 LFSEGDCWICMELMD-ISLDKLYKRVYSVQ-KSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDV 207 (361)
T ss_pred hhcCCceeeeHHHHh-hhHHHHHHHHHHHH-hccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCE
Confidence 7 33 4778999995 45543 333222 245777888889999999999998864 59999999999999999999
Q ss_pred EEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhcc--CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHH--
Q 005617 481 KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT--GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA-- 556 (688)
Q Consensus 481 KLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~-- 556 (688)
||||||++..+.+... .+.-+|-..|||||-+.. ..|+.++||||||++|||+.||+.||..+..+...
T Consensus 208 KLCDFGIcGqLv~SiA-------kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~ 280 (361)
T KOG1006|consen 208 KLCDFGICGQLVDSIA-------KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLC 280 (361)
T ss_pred eeecccchHhHHHHHH-------hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHH
Confidence 9999999987765432 245578889999998743 35899999999999999999999999887766544
Q ss_pred -hhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCc
Q 005617 557 -VSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 557 -~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~ 600 (688)
+..|....++.+. -..+.+..+..++..|+..|-.+||...
T Consensus 281 ~Vv~gdpp~l~~~~---~~~~~s~~~~~fintCl~Kd~~~Rpky~ 322 (361)
T KOG1006|consen 281 QVVIGDPPILLFDK---ECVHYSFSMVRFINTCLIKDRSDRPKYD 322 (361)
T ss_pred HHHcCCCCeecCcc---cccccCHHHHHHHHHHhhcccccCcchh
Confidence 4455444332211 1123567899999999999999999987
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.8e-32 Score=285.77 Aligned_cols=261 Identities=26% Similarity=0.395 Sum_probs=201.2
Q ss_pred HHhcCcccceeeeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcC--CCCceeeEecccC--C----Cc
Q 005617 339 TATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKL--QHPHLVTLLGACP--E----AW 410 (688)
Q Consensus 339 ~at~~f~~~~~LG~G~fG~Vykg~~~g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l--~HpnIV~l~g~~~--~----~~ 410 (688)
+........+.||+|.||.||+|.++|..||||++.... ...+.+|.+|++.+ +|+||+.++++-. . .+
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hhhheeEEEEEecCccccceeeccccCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 334556677899999999999999999999999997643 34577788887664 9999999998852 1 37
Q ss_pred eeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhc-----cCCCceEeCCCCCCceeeCCCCCeEEeec
Q 005617 411 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS-----SKPEKIVHGDLKPQNILLDSELSSKICDF 485 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-----~~~~~IiHrDIKp~NILLd~~~~vKLsDF 485 (688)
+||.+|-+.|||.|+|.+ ..++-...++++..+|.||++||. .+.+.|.|||||+.|||+..+|..-|+|+
T Consensus 285 wLvTdYHe~GSL~DyL~r----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADL 360 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNR----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL 360 (513)
T ss_pred EEeeecccCCcHHHHHhh----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeec
Confidence 899999999999999976 468889999999999999999996 34567999999999999999999999999
Q ss_pred CccccccCCCCcCCCccccCCCCCCCCCCChhhhccCC----C--CCcchHhHHHHHHHHHHhC----------CCCCCC
Q 005617 486 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV----L--TPKSDSYSFGLIILQLLTG----------RLPVGL 549 (688)
Q Consensus 486 Gla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~----~--s~ksDVwSfGviL~ELltG----------~~Pf~~ 549 (688)
|||........... -.....+||..|||||++.... + -..+||||||.||||+.-. ++||..
T Consensus 361 GLAv~h~~~t~~id--i~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd 438 (513)
T KOG2052|consen 361 GLAVRHDSDTDTID--IPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD 438 (513)
T ss_pred eeeEEecccCCccc--CCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence 99987765533221 1345678999999999985432 1 1369999999999998763 356642
Q ss_pred h-------hhHHHHhhcCccccccCCCCCCC-CHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHhhh
Q 005617 550 A-------GEVRRAVSCGKLSSILDPLAGDW-PTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 550 ~-------~~~~~~~~~g~l~~~ld~~~~~~-~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l~~ 612 (688)
. .+++.-+...++...+++ .| .......+.+|+..||..||.-|-|+- -+.+.|..+..
T Consensus 439 ~Vp~DPs~eeMrkVVCv~~~RP~ipn---rW~s~~~l~~m~klMkeCW~~Np~aRltAL-riKKtl~~l~~ 505 (513)
T KOG2052|consen 439 VVPSDPSFEEMRKVVCVQKLRPNIPN---RWKSDPALRVMAKLMKECWYANPAARLTAL-RIKKTLAKLSN 505 (513)
T ss_pred CCCCCCCHHHHhcceeecccCCCCCc---ccccCHHHHHHHHHHHHhhcCCchhhhHHH-HHHHHHHHHhc
Confidence 1 123333333333332222 23 234677899999999999999999987 67777776653
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=277.75 Aligned_cols=241 Identities=25% Similarity=0.353 Sum_probs=197.6
Q ss_pred HhcCcccc-eeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcC-CCCceeeEecccCC------C
Q 005617 340 ATCNFSES-FKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE------A 409 (688)
Q Consensus 340 at~~f~~~-~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~------~ 409 (688)
.|++|+.. .+||-|-.|.|..+... |..+|+|++... ....+|+++--.. .|||||.+++++.+ .
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 56777654 57999999999988775 889999998643 2345777775555 59999999999843 3
Q ss_pred ceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCC---CCCeEEeecC
Q 005617 410 WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS---ELSSKICDFG 486 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~---~~~vKLsDFG 486 (688)
+.+|||+|+||.|...+...+. ..+++.++..|+.||+.|+.|||+.+ |.||||||+|+|... |..+||+|||
T Consensus 134 LLiVmE~meGGeLfsriq~~g~-~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGD-QAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHccc-ccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 5689999999999999987654 57999999999999999999999977 999999999999964 4579999999
Q ss_pred ccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCC------hhhHHHHhhcC
Q 005617 487 ICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGL------AGEVRRAVSCG 560 (688)
Q Consensus 487 la~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~------~~~~~~~~~~g 560 (688)
+|+.-.... ...+.+-||.|.|||++...+|+..+|+||+||++|-||+|.+||.. ...+...+..|
T Consensus 210 FAK~t~~~~-------~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~g 282 (400)
T KOG0604|consen 210 FAKETQEPG-------DLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTG 282 (400)
T ss_pred cccccCCCc-------cccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhcc
Confidence 999765332 23567889999999999999999999999999999999999999953 33456666666
Q ss_pred ccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCch
Q 005617 561 KLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 561 ~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~ 601 (688)
.+.-. ..+|. .+++...+++...|..+|.+|.|+.+
T Consensus 283 qy~FP----~pEWs-~VSe~aKdlIR~LLkt~PteRlTI~~ 318 (400)
T KOG0604|consen 283 QYEFP----EPEWS-CVSEAAKDLIRKLLKTEPTERLTIEE 318 (400)
T ss_pred CccCC----ChhHh-HHHHHHHHHHHHHhcCCchhheeHHH
Confidence 54321 22343 57888999999999999999999874
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.3e-32 Score=276.73 Aligned_cols=219 Identities=24% Similarity=0.207 Sum_probs=176.6
Q ss_pred cCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecCCCCcHHHHhcc
Q 005617 353 GGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSLQDRLFR 428 (688)
Q Consensus 353 G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gsL~~~L~~ 428 (688)
|.||.||++.+. |+.||+|++.... .+..|...+....||||+++++++.+ ..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 899999999885 8899999987643 33455566666679999999998854 58899999999999998865
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCCccccCCCC
Q 005617 429 KSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK 508 (688)
Q Consensus 429 ~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~~~~~ 508 (688)
.. .+++..+..++.|++.||.|||..+ |+||||||+||+++.++.++|+|||++....... ....
T Consensus 79 ~~---~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~---------~~~~ 143 (237)
T cd05576 79 FL---NIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC---------DGEA 143 (237)
T ss_pred hc---CCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc---------ccCC
Confidence 43 4899999999999999999999965 9999999999999999999999999887654321 2345
Q ss_pred CCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHc
Q 005617 509 GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQC 588 (688)
Q Consensus 509 GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~C 588 (688)
++..|+|||++....+++++|||||||++|||++|..|+...... +.. ......|......+.+++.+|
T Consensus 144 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~---~~~--------~~~~~~~~~~~~~~~~li~~~ 212 (237)
T cd05576 144 VENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG---INT--------HTTLNIPEWVSEEARSLLQQL 212 (237)
T ss_pred cCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh---ccc--------ccccCCcccCCHHHHHHHHHH
Confidence 677899999998888999999999999999999999887532211 000 001123344567889999999
Q ss_pred cccCCCCCCCCchH
Q 005617 589 CELYGRERPDITPS 602 (688)
Q Consensus 589 l~~dP~~RPs~~~~ 602 (688)
++.||.+||++.+.
T Consensus 213 l~~dp~~R~~~~~~ 226 (237)
T cd05576 213 LQFNPTERLGAGVA 226 (237)
T ss_pred ccCCHHHhcCCCcc
Confidence 99999999998643
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.8e-31 Score=312.44 Aligned_cols=143 Identities=29% Similarity=0.405 Sum_probs=126.3
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHcCCCCceeeEecccC--CCceeEE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~---~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~ 414 (688)
++|...++||+|+||.||+|.+. +..||||++...... ....+..|+.++..++||||+++++++. +..+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999987 889999999765432 2356889999999999999999998874 4589999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCcccc
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~ 490 (688)
||+.+++|.+++... ..+++..++.|+.||+.||.|||..+ ||||||||+||||+.++.+||+|||+++.
T Consensus 84 Ey~~g~~L~~li~~~---~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~ 153 (669)
T cd05610 84 EYLIGGDVKSLLHIY---GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153 (669)
T ss_pred eCCCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence 999999999998654 35788999999999999999999965 99999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-31 Score=308.14 Aligned_cols=253 Identities=31% Similarity=0.480 Sum_probs=206.6
Q ss_pred hcCcccceeeeccCceEEEEEEEC---------CeEEEEEEEecCCcc-chHHHHHHHHHHHcC-CCCceeeEecccCC-
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML---------GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKL-QHPHLVTLLGACPE- 408 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~---------g~~vAIK~l~~~~~~-~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~- 408 (688)
.++......||.|.||.|++|... ...||||+++..... ....+..|+.+|..+ +|||||.++|+|..
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 344445568999999999999764 246999999876544 456799999999999 69999999999965
Q ss_pred -CceeEEecCCCCcHHHHhcccC-----CC--------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceee
Q 005617 409 -AWSLVYEYLPNGSLQDRLFRKS-----NV--------SPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL 474 (688)
Q Consensus 409 -~~~LV~E~~~~gsL~~~L~~~~-----~~--------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILL 474 (688)
..++|+||+..|+|.++|.... .. ..++..+.+.++.|||.|++||++.. +|||||-..|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEe
Confidence 5789999999999999998765 01 23888999999999999999999955 9999999999999
Q ss_pred CCCCCeEEeecCccccccCCCCcCCCccccCCCCC--CCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCC--
Q 005617 475 DSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKG--SFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGL-- 549 (688)
Q Consensus 475 d~~~~vKLsDFGla~~~~~~~~~~~~~~~~~~~~G--T~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~-- 549 (688)
..+..+||+|||+|+...+.... ......| ...|||||.+....|+.++|||||||+||||+| |..||..
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y-----~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~ 526 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYY-----RTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIP 526 (609)
T ss_pred cCCCEEEEccccceeccCCCCce-----EecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCC
Confidence 99999999999999976554422 1122233 234999999999999999999999999999999 8899975
Q ss_pred -hhhHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHh
Q 005617 550 -AGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 550 -~~~~~~~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l 610 (688)
..++...+..|... +.|.....++.++++.||+.+|.+||++. +++..|+..
T Consensus 527 ~~~~l~~~l~~G~r~--------~~P~~c~~eiY~iM~~CW~~~p~~RP~F~-~~~~~~~~~ 579 (609)
T KOG0200|consen 527 PTEELLEFLKEGNRM--------EQPEHCSDEIYDLMKSCWNADPEDRPTFS-ECVEFFEKH 579 (609)
T ss_pred cHHHHHHHHhcCCCC--------CCCCCCCHHHHHHHHHHhCCCcccCCCHH-HHHHHHHHH
Confidence 34555566666543 33555678899999999999999999999 677777763
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-32 Score=275.86 Aligned_cols=252 Identities=25% Similarity=0.382 Sum_probs=198.2
Q ss_pred CHHHHHHHhcCcccceeeeccCceEEEEEEE--CCeEEEEEEEecCCccchHHHHHHHHHHHcCC-CCceeeEecccCC-
Q 005617 333 SLADLQTATCNFSESFKVGQGGFGCVYKGEM--LGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLLGACPE- 408 (688)
Q Consensus 333 ~~~el~~at~~f~~~~~LG~G~fG~Vykg~~--~g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~-HpnIV~l~g~~~~- 408 (688)
.+.|+-..|. ..||+|+|+.|-.+.. .|..||||++.+.....+..+.+|++++...+ |+||++|+.+|.+
T Consensus 74 ~F~d~YkLt~-----e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd 148 (463)
T KOG0607|consen 74 KFEDMYKLTS-----ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD 148 (463)
T ss_pred hHHHHHHhHH-----HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc
Confidence 3667777765 6799999999998765 48999999999887777888999999999995 9999999999965
Q ss_pred -CceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCC---CeEEee
Q 005617 409 -AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL---SSKICD 484 (688)
Q Consensus 409 -~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~---~vKLsD 484 (688)
..|||||.|.||+|..++.+.. .+++.++.++..+|+.||.|||..+ |.||||||+|||-.... -+||||
T Consensus 149 ~~FYLVfEKm~GGplLshI~~~~---~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCD 222 (463)
T KOG0607|consen 149 TRFYLVFEKMRGGPLLSHIQKRK---HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICD 222 (463)
T ss_pred ceEEEEEecccCchHHHHHHHhh---hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeec
Confidence 4899999999999999998764 4788999999999999999999955 99999999999986543 489999
Q ss_pred cCccccccCCCCcCC-CccccCCCCCCCCCCChhhh-----ccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh------
Q 005617 485 FGICRLVTEDTLYLP-SFHRSTAPKGSFPYADPEYH-----RTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE------ 552 (688)
Q Consensus 485 FGla~~~~~~~~~~~-~~~~~~~~~GT~~Y~APE~~-----~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~------ 552 (688)
|.+..-+.......+ +...-.+.+|+..|||||+. ....|+.++|.||||||||-||+|.+||.+.-.
T Consensus 223 fDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWd 302 (463)
T KOG0607|consen 223 FDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWD 302 (463)
T ss_pred cccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCcc
Confidence 988765543222111 22334578899999999965 234688999999999999999999999963221
Q ss_pred -----------HHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCc
Q 005617 553 -----------VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 553 -----------~~~~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~ 600 (688)
....+..|++.-. ..+|. .++....+|+...+..++.+|-++.
T Consensus 303 rGe~Cr~CQ~~LFesIQEGkYeFP----dkdWa-hIS~eakdlisnLlvrda~~rlsa~ 356 (463)
T KOG0607|consen 303 RGEVCRVCQNKLFESIQEGKYEFP----DKDWA-HISSEAKDLISNLLVRDAKQRLSAA 356 (463)
T ss_pred CCCccHHHHHHHHHHHhccCCcCC----hhhhH-HhhHHHHHHHHHHHhccHHhhhhhh
Confidence 2223344433210 11232 3677788889999999999998776
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=290.26 Aligned_cols=238 Identities=29% Similarity=0.437 Sum_probs=199.8
Q ss_pred ceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEeccc--CCCceeEEecCCCC
Q 005617 347 SFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNG 420 (688)
Q Consensus 347 ~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~--~~~~~LV~E~~~~g 420 (688)
.+.||+|-||+||-|+.+ |+.||||++.+..- .....+.+|+.||.+++||.||.|-..| ++..++|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 468999999999999876 99999999976543 3446799999999999999999998888 46689999999776
Q ss_pred cHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCC---CCeEEeecCccccccCCCCc
Q 005617 421 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE---LSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 421 sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~---~~vKLsDFGla~~~~~~~~~ 497 (688)
-|+-+|.... +.|+......++.||+.||.|||..+ |+|+||||+||||... -.+||||||+|+.+....
T Consensus 649 MLEMILSsEk--gRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-- 721 (888)
T KOG4236|consen 649 MLEMILSSEK--GRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-- 721 (888)
T ss_pred HHHHHHHhhc--ccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh--
Confidence 6666665443 56888878888999999999999955 9999999999999654 469999999999987654
Q ss_pred CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCccccccCCCCCCCCHHH
Q 005617 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFV 577 (688)
Q Consensus 498 ~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~l~~~ld~~~~~~~~~~ 577 (688)
....++|||.|+|||++....|...-|+||.|||+|--|+|..||+...++...+....+.-.- ..| .++
T Consensus 722 -----FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIndQIQNAaFMyPp----~PW-~ei 791 (888)
T KOG4236|consen 722 -----FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDINDQIQNAAFMYPP----NPW-SEI 791 (888)
T ss_pred -----hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhHHhhccccccCC----Cch-hhc
Confidence 3578899999999999999999999999999999999999999999888887777766543321 123 356
Q ss_pred HHHHHHHHHHccccCCCCCCCCch
Q 005617 578 ARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 578 ~~~l~~L~~~Cl~~dP~~RPs~~~ 601 (688)
+...++||...|+..-.+|-+...
T Consensus 792 s~~AidlIn~LLqVkm~kRysvdk 815 (888)
T KOG4236|consen 792 SPEAIDLINNLLQVKMRKRYSVDK 815 (888)
T ss_pred CHHHHHHHHHHHHHHHHHhcchHh
Confidence 778899999999998888877653
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-31 Score=295.98 Aligned_cols=255 Identities=26% Similarity=0.380 Sum_probs=211.9
Q ss_pred cCHHHHHHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcC-CCCceeeEeccc--
Q 005617 332 FSLADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGAC-- 406 (688)
Q Consensus 332 ~~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~-- 406 (688)
+.++.+..-++-|.+...||.|.+|.||+++.. |+.+|||++.... ....++..|.+||..+ .|||++.+||+|
T Consensus 9 ~~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~-d~deEiE~eynil~~~~~hpnv~~fyg~~~k 87 (953)
T KOG0587|consen 9 IDLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE-DEEEEIELEYNMLKKYSHHPNVATFYGAFIK 87 (953)
T ss_pred cchhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc-cccHHHHHHHHHHHhccCCCCcceEEEEEEE
Confidence 344555566788999999999999999988664 8999999987654 3455778899999998 699999999987
Q ss_pred -----CCCceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeE
Q 005617 407 -----PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSK 481 (688)
Q Consensus 407 -----~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vK 481 (688)
.+.++||||||.+||..|++..-. ...+.|..+..|+..++.||.+||.+. +||||||-.||||+.+|.||
T Consensus 88 ~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VK 163 (953)
T KOG0587|consen 88 KDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVK 163 (953)
T ss_pred ecCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEE
Confidence 356899999999999999987665 577999999999999999999999977 99999999999999999999
Q ss_pred EeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhcc-----CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHH
Q 005617 482 ICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-----GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA 556 (688)
Q Consensus 482 LsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-----~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~ 556 (688)
|+|||.+..+.... ....+..|||.|||||++.- ..|+..+|+||||++..||--|.+|+.....++.+
T Consensus 164 LvDFGvSaQldsT~------grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraL 237 (953)
T KOG0587|consen 164 LVDFGVSAQLDSTV------GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRAL 237 (953)
T ss_pred Eeeeeeeeeeeccc------ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhh
Confidence 99999998876432 35567899999999998853 35778999999999999999999999876666554
Q ss_pred hhcCccccccCCCC-CCCCHHHHHHHHHHHHHccccCCCCCCCCchH
Q 005617 557 VSCGKLSSILDPLA-GDWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 557 ~~~g~l~~~ld~~~-~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~ 602 (688)
+.... .|.. ...|...+.++.++|..|+..|...||++.+.
T Consensus 238 F~IpR-----NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~l 279 (953)
T KOG0587|consen 238 FLIPR-----NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEEL 279 (953)
T ss_pred ccCCC-----CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhh
Confidence 43221 1111 12356778899999999999999999998843
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=293.98 Aligned_cols=237 Identities=25% Similarity=0.331 Sum_probs=193.8
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcC-CCCceeeEecccCCC--ceeEEe
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACPEA--WSLVYE 415 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~~--~~LV~E 415 (688)
+..|.....+|.|+|+.|-.+... +...++|++...... ..+|+.++... +||||+++.+.|.+. .++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~----~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD----NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccccc----cccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 566777778999999999999875 788999999776322 33577777776 699999999999664 789999
Q ss_pred cCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceee-CCCCCeEEeecCccccccCC
Q 005617 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL-DSELSSKICDFGICRLVTED 494 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILL-d~~~~vKLsDFGla~~~~~~ 494 (688)
.+.||-|.+.+..... ....+..|+.+|+.|+.|||..+ ||||||||+|||+ +..|+++|+|||.++..+..
T Consensus 397 ~l~g~ell~ri~~~~~----~~~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRSKPE----FCSEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHhcch----hHHHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 9999998888866542 22677789999999999999955 9999999999999 68999999999999987654
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChh---hHHHHhhcCccccccCCCCC
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG---EVRRAVSCGKLSSILDPLAG 571 (688)
Q Consensus 495 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~---~~~~~~~~g~l~~~ld~~~~ 571 (688)
. ...+-|..|.|||+.....|++.|||||||++||+||+|+.||.... ++...+..+.+
T Consensus 470 ~---------~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~--------- 531 (612)
T KOG0603|consen 470 C---------DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKF--------- 531 (612)
T ss_pred h---------cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCcc---------
Confidence 1 34467889999999999999999999999999999999999996322 34444444433
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHH
Q 005617 572 DWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 572 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le 608 (688)
...++....+|+.+||+.||.+||+|.+...+.+-
T Consensus 532 --s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 532 --SECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred --ccccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 24567889999999999999999999965544443
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-30 Score=260.80 Aligned_cols=231 Identities=29% Similarity=0.380 Sum_probs=188.8
Q ss_pred CceEEEEEEEC--CeEEEEEEEecCCccc-hHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEecCCCCcHHHHhcc
Q 005617 354 GFGCVYKGEML--GRTVAIKMLYSHNMQG-QLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLPNGSLQDRLFR 428 (688)
Q Consensus 354 ~fG~Vykg~~~--g~~vAIK~l~~~~~~~-~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~~~gsL~~~L~~ 428 (688)
+||.||+|... |..||+|++....... ...|.+|+..+++++|+||+++++++. ...++||||+++++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 68999999986 6899999998766555 678999999999999999999999985 457899999999999999865
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCCccccCCCC
Q 005617 429 KSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK 508 (688)
Q Consensus 429 ~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~~~~~ 508 (688)
.. .+++..+..++.+++.+|.|||..+ ++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-------~~~~~~ 147 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-------LLTTFV 147 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc-------cccccc
Confidence 43 2789999999999999999999975 9999999999999999999999999998876432 124556
Q ss_pred CCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh---HHHHhhcCccccccCCCCCCCCHHHHHHHHHHH
Q 005617 509 GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE---VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLG 585 (688)
Q Consensus 509 GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~---~~~~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~ 585 (688)
|+..|++||.+....++.++||||||+++++|++|..||..... .......+..... .........+.+++
T Consensus 148 ~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~i 221 (244)
T smart00220 148 GTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFP------PPEWKISPEAKDLI 221 (244)
T ss_pred CCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc------cccccCCHHHHHHH
Confidence 88999999999988999999999999999999999999965222 2222222111100 00001456899999
Q ss_pred HHccccCCCCCCCCchHH
Q 005617 586 LQCCELYGRERPDITPSL 603 (688)
Q Consensus 586 ~~Cl~~dP~~RPs~~~~l 603 (688)
.+|+..+|.+||++.+.+
T Consensus 222 ~~~l~~~p~~Rp~~~~~~ 239 (244)
T smart00220 222 RKLLVKDPEKRLTAEEAL 239 (244)
T ss_pred HHHccCCchhccCHHHHh
Confidence 999999999999998433
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-31 Score=269.35 Aligned_cols=246 Identities=22% Similarity=0.275 Sum_probs=194.1
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc---chHHHHHHHHHHHcC-CCCceeeEecccCC--CceeE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---GQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~---~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~~~LV 413 (688)
++|....+||+|+|+.|..+++. .+.+|+|++++.-.. +..=...|-.+..+. +||.+|-|..+|+. .+++|
T Consensus 250 ~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffv 329 (593)
T KOG0695|consen 250 QDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFV 329 (593)
T ss_pred ccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEE
Confidence 67889999999999999999886 678999999765332 223356777787776 79999999999964 48899
Q ss_pred EecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccC
Q 005617 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~ 493 (688)
.||++||+|.-++.... .|+.+.+..+..+|+.||.|||+.+ ||.||||.+|||||..|++||+|+|+++.--.
T Consensus 330 ieyv~ggdlmfhmqrqr---klpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 330 IEYVNGGDLMFHMQRQR---KLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEecCcceeeehhhhh---cCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCC
Confidence 99999999987776543 5888999999999999999999966 99999999999999999999999999987543
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccCCCCC
Q 005617 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAG 571 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld~~~~ 571 (688)
+.. .+.+.+|||.|+|||++.+..|+..+|+|+|||+|+||+.|+.||..++. ....... -+..++-....
T Consensus 404 ~gd------~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~nted-ylfqvilekqi 476 (593)
T KOG0695|consen 404 PGD------TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTED-YLFQVILEKQI 476 (593)
T ss_pred CCc------ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhH-HHHHHHhhhcc
Confidence 332 34678999999999999999999999999999999999999999974431 0000000 01111111112
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCCc
Q 005617 572 DWPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 572 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~ 600 (688)
..|...+-+...++...++.||.+|..-.
T Consensus 477 riprslsvkas~vlkgflnkdp~erlgc~ 505 (593)
T KOG0695|consen 477 RIPRSLSVKASHVLKGFLNKDPKERLGCR 505 (593)
T ss_pred cccceeehhhHHHHHHhhcCCcHHhcCCC
Confidence 34555566778888899999999996543
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-31 Score=267.53 Aligned_cols=200 Identities=27% Similarity=0.357 Sum_probs=164.4
Q ss_pred cCcccceeeeccCceEEEEEEEC------CeEEEEEEEecCCcc-c-hHHHHHHHHHHHcCCCCceeeEecccCC---Cc
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML------GRTVAIKMLYSHNMQ-G-QLEFQQEVRVLSKLQHPHLVTLLGACPE---AW 410 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~------g~~vAIK~l~~~~~~-~-~~~f~~E~~iL~~l~HpnIV~l~g~~~~---~~ 410 (688)
..|.....||+|.||.||++... ...+|||.++..... + .....+|+.+++.++|||||.|..+|.. ..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v 103 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKV 103 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence 34666788999999999999543 236999999765332 1 2347799999999999999999998844 47
Q ss_pred eeEEecCCCCcHHHHhccc--CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCC----CCeEEee
Q 005617 411 SLVYEYLPNGSLQDRLFRK--SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE----LSSKICD 484 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~--~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~----~~vKLsD 484 (688)
+|++||.+. +|..++... .....++-..+..|+.||+.|+.|||++. |+||||||.|||+..+ |.|||+|
T Consensus 104 ~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD 179 (438)
T KOG0666|consen 104 WLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD 179 (438)
T ss_pred EEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence 899999864 777776543 23356888999999999999999999988 9999999999999887 8999999
Q ss_pred cCccccccCCCCcCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCC
Q 005617 485 FGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVG 548 (688)
Q Consensus 485 FGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~ 548 (688)
||+++.+.+..... .....++.|+.|.|||.+.+. .||+..||||.|||+.||||-.+-|.
T Consensus 180 lGlaR~~~~plkpl---~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~ 241 (438)
T KOG0666|consen 180 LGLARLFNNPLKPL---ASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFK 241 (438)
T ss_pred ccHHHHhhcccccc---ccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcccc
Confidence 99999987654322 234567889999999988765 68999999999999999999988774
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=285.04 Aligned_cols=256 Identities=21% Similarity=0.239 Sum_probs=178.7
Q ss_pred HhcCcccceeeeccCceEEEEEEE------------------CCeEEEEEEEecCCccchHH--------------HHHH
Q 005617 340 ATCNFSESFKVGQGGFGCVYKGEM------------------LGRTVAIKMLYSHNMQGQLE--------------FQQE 387 (688)
Q Consensus 340 at~~f~~~~~LG~G~fG~Vykg~~------------------~g~~vAIK~l~~~~~~~~~~--------------f~~E 387 (688)
.+++|...++||+|+||.||+|.+ .+..||||++.........+ +..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467999999999999999999964 24679999987544332233 3447
Q ss_pred HHHHHcCCCCce-----eeEecccC----------CCceeEEecCCCCcHHHHhcccCC---------------------
Q 005617 388 VRVLSKLQHPHL-----VTLLGACP----------EAWSLVYEYLPNGSLQDRLFRKSN--------------------- 431 (688)
Q Consensus 388 ~~iL~~l~HpnI-----V~l~g~~~----------~~~~LV~E~~~~gsL~~~L~~~~~--------------------- 431 (688)
+.++.+++|.|+ +.++|+|. ...+|||||+++|+|.++|+....
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777778876654 67777763 236899999999999999874321
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCCccccCCCCCCC
Q 005617 432 VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 511 (688)
Q Consensus 432 ~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~~~~~GT~ 511 (688)
...++|..+..|+.+++.||.|||..+ |+||||||+|||++.++.+||+|||++......... ......+|+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-----~~~~g~~tp 374 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-----NPLYGMLDP 374 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-----CccccCCCc
Confidence 123577889999999999999999965 999999999999999999999999999765433211 122334589
Q ss_pred CCCChhhhccCC----------------------CCCcchHhHHHHHHHHHHhCCC-CCCChhhHHHHhhc--Cccc--c
Q 005617 512 PYADPEYHRTGV----------------------LTPKSDSYSFGLIILQLLTGRL-PVGLAGEVRRAVSC--GKLS--S 564 (688)
Q Consensus 512 ~Y~APE~~~~~~----------------------~s~ksDVwSfGviL~ELltG~~-Pf~~~~~~~~~~~~--g~l~--~ 564 (688)
.|+|||.+.... ...+.||||+||++|+|++|.. ||............ ..+. .
T Consensus 375 ~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r 454 (507)
T PLN03224 375 RYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR 454 (507)
T ss_pred ceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH
Confidence 999999875432 1235799999999999999985 66532211111000 0000 0
Q ss_pred ccCCCCCCC--CHHHHHHHHHHHHHccccCC---CCCCCCchHH
Q 005617 565 ILDPLAGDW--PTFVARRLVDLGLQCCELYG---RERPDITPSL 603 (688)
Q Consensus 565 ~ld~~~~~~--~~~~~~~l~~L~~~Cl~~dP---~~RPs~~~~l 603 (688)
.......++ .........+|+.+++..+| .+|+|+.+.+
T Consensus 455 ~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL 498 (507)
T PLN03224 455 MYKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQAL 498 (507)
T ss_pred hhcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHh
Confidence 000000111 12345678899999999766 6899988543
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=290.00 Aligned_cols=252 Identities=25% Similarity=0.238 Sum_probs=165.4
Q ss_pred HhcCcccceeeeccCceEEEEEEEC------CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecc--------
Q 005617 340 ATCNFSESFKVGQGGFGCVYKGEML------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGA-------- 405 (688)
Q Consensus 340 at~~f~~~~~LG~G~fG~Vykg~~~------g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~-------- 405 (688)
..++|...+.||+|+||.||+|.+. +..||||++..... ...+..+ .+....+.+++.++..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 5678999999999999999999885 56899998764321 1111111 1222223333333222
Q ss_pred cCCCceeEEecCCCCcHHHHhcccCCC-----------------CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCC
Q 005617 406 CPEAWSLVYEYLPNGSLQDRLFRKSNV-----------------SPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLK 468 (688)
Q Consensus 406 ~~~~~~LV~E~~~~gsL~~~L~~~~~~-----------------~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIK 468 (688)
.....+|||||+.+++|.+++...... .......+..|+.||+.||.|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 123578999999999999988654210 01112345679999999999999965 9999999
Q ss_pred CCceeeCC-CCCeEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccC----------------------CCC
Q 005617 469 PQNILLDS-ELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG----------------------VLT 525 (688)
Q Consensus 469 p~NILLd~-~~~vKLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~----------------------~~s 525 (688)
|+||||+. ++.+||+|||+|+.+...... ......||+.|+|||.+... .++
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-----~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~ 357 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-----IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 357 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccccc-----CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence 99999986 689999999999876433221 23456799999999965322 234
Q ss_pred CcchHhHHHHHHHHHHhCCCCCCChhh-HHHHhhcCc-----cccccCCCC-CCC------CHHHHHHHHHHHHHccccC
Q 005617 526 PKSDSYSFGLIILQLLTGRLPVGLAGE-VRRAVSCGK-----LSSILDPLA-GDW------PTFVARRLVDLGLQCCELY 592 (688)
Q Consensus 526 ~ksDVwSfGviL~ELltG~~Pf~~~~~-~~~~~~~g~-----l~~~ld~~~-~~~------~~~~~~~l~~L~~~Cl~~d 592 (688)
.++|||||||+||||+++..|+..... ....+.... +...+.+.. .+. .........+|+.+||+.|
T Consensus 358 ~k~DVwSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d 437 (566)
T PLN03225 358 DRFDIYSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFK 437 (566)
T ss_pred CCcccHHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence 567999999999999998777643211 111111110 001111100 000 0001223558999999999
Q ss_pred CCCCCCCchHH
Q 005617 593 GRERPDITPSL 603 (688)
Q Consensus 593 P~~RPs~~~~l 603 (688)
|.+|||+.+.+
T Consensus 438 P~kR~ta~e~L 448 (566)
T PLN03225 438 GRQRISAKAAL 448 (566)
T ss_pred cccCCCHHHHh
Confidence 99999988544
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-30 Score=244.97 Aligned_cols=204 Identities=25% Similarity=0.394 Sum_probs=163.4
Q ss_pred HHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCC-ccchHHHHHHHHHHHcC-CCCceeeEecccC--CCce
Q 005617 338 QTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN-MQGQLEFQQEVRVLSKL-QHPHLVTLLGACP--EAWS 411 (688)
Q Consensus 338 ~~at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~-~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~--~~~~ 411 (688)
....++......||+|+||.|-+-++. |...|+|.+...- .+.+....+|+++..+. .+|.+|.+||... ...+
T Consensus 42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw 121 (282)
T KOG0984|consen 42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW 121 (282)
T ss_pred ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence 333344445567999999999877764 8999999997653 34566788999988776 7999999999863 3578
Q ss_pred eEEecCCCCcHHHHhccc-CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCcccc
Q 005617 412 LVYEYLPNGSLQDRLFRK-SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~ 490 (688)
+.||.|. .||..+-... .....+++...-+|+..|..||.|||+.- .+||||+||+||||+.+|.+|+||||++-.
T Consensus 122 IcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 122 ICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred EeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEccccccee
Confidence 9999984 5666543322 23356788888899999999999999964 699999999999999999999999999988
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCChhhhc----cCCCCCcchHhHHHHHHHHHHhCCCCCCChh
Q 005617 491 VTEDTLYLPSFHRSTAPKGSFPYADPEYHR----TGVLTPKSDSYSFGLIILQLLTGRLPVGLAG 551 (688)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~----~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~ 551 (688)
+.+... .+...|...|||||.+. ...|+.|+||||||+.++||.+++.||....
T Consensus 199 L~dSiA-------kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~ 256 (282)
T KOG0984|consen 199 LVDSIA-------KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG 256 (282)
T ss_pred ehhhhH-------HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence 866542 23356888999999764 3479999999999999999999999997544
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.5e-30 Score=285.96 Aligned_cols=245 Identities=31% Similarity=0.382 Sum_probs=188.9
Q ss_pred CcccceeeeccCce-EEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcC-CCCceeeEecccCCC--ceeEEecCC
Q 005617 343 NFSESFKVGQGGFG-CVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACPEA--WSLVYEYLP 418 (688)
Q Consensus 343 ~f~~~~~LG~G~fG-~Vykg~~~g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~~--~~LV~E~~~ 418 (688)
-|+..+.+|.|+.| .||+|...|+.||||++-... ..-..+|+..|..- .|||||++|+.-.+. .||..|.|
T Consensus 510 ~~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 510 FFSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eeccHHHcccCCCCcEEEEEeeCCceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 35556779999987 579999999999999985432 22356899999988 699999999887554 78899999
Q ss_pred CCcHHHHhccc-CCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCC---C--CCeEEeecCcccccc
Q 005617 419 NGSLQDRLFRK-SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS---E--LSSKICDFGICRLVT 492 (688)
Q Consensus 419 ~gsL~~~L~~~-~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~---~--~~vKLsDFGla~~~~ 492 (688)
..+|.+++... .......-...+.+..|++.||++||+.+ ||||||||.||||+. + ..++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 56899998763 11111111335678899999999999976 999999999999976 3 569999999999987
Q ss_pred CCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhC-CCCCCChhhHHHHhhcCccccccCCCCC
Q 005617 493 EDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTG-RLPVGLAGEVRRAVSCGKLSSILDPLAG 571 (688)
Q Consensus 493 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG-~~Pf~~~~~~~~~~~~g~l~~~ld~~~~ 571 (688)
.+... +.......||-||+|||++....-+..+||||||||+|+.++| ..||+..-.-...+..|...-..-....
T Consensus 663 ~~~sS---~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl~~~~~L~~L~~~~ 739 (903)
T KOG1027|consen 663 GGKSS---FSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANILTGNYTLVHLEPLP 739 (903)
T ss_pred CCcch---hhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhhcCccceeeeccCc
Confidence 66543 3346778999999999999999889999999999999999996 8999865554444544432211000011
Q ss_pred CCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 572 DWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 572 ~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
++ ...+||.+|++++|..||++.+.+
T Consensus 740 d~------eA~dLI~~ml~~dP~~RPsa~~VL 765 (903)
T KOG1027|consen 740 DC------EAKDLISRMLNPDPQLRPSATDVL 765 (903)
T ss_pred hH------HHHHHHHHhcCCCcccCCCHHHHh
Confidence 11 788999999999999999998654
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-29 Score=263.91 Aligned_cols=249 Identities=24% Similarity=0.297 Sum_probs=191.8
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCC--CC----ceeeEecccC--CCc
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ--HP----HLVTLLGACP--EAW 410 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~--Hp----nIV~l~g~~~--~~~ 410 (688)
+++|....++|+|.||.|-.+.+. +..||||+++.-. .-.+...-|+++|.++. -| -+|++.+||. ...
T Consensus 88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghi 166 (415)
T KOG0671|consen 88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHI 166 (415)
T ss_pred ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCce
Confidence 788999999999999999998776 6789999986432 22334567999999993 22 4788888884 457
Q ss_pred eeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCC--------------
Q 005617 411 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS-------------- 476 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~-------------- 476 (688)
|||+|.| |-|+.++|..+ +..+++...+..|+.|++.+++|||+++ ++|.||||+|||+-.
T Consensus 167 Civfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~~ 241 (415)
T KOG0671|consen 167 CIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKVC 241 (415)
T ss_pred EEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCccc
Confidence 8999988 66999999654 3467899999999999999999999987 999999999999932
Q ss_pred ------CCCeEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCCh
Q 005617 477 ------ELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLA 550 (688)
Q Consensus 477 ------~~~vKLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~ 550 (688)
+..++|+|||.|+.-.... ...+.|..|.|||++.+-+++.+|||||+||||+||.||...|..-
T Consensus 242 ~~r~~ks~~I~vIDFGsAtf~~e~h---------s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtH 312 (415)
T KOG0671|consen 242 FIRPLKSTAIKVIDFGSATFDHEHH---------STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTH 312 (415)
T ss_pred eeccCCCcceEEEecCCcceeccCc---------ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccC
Confidence 3458999999998765432 4567899999999999999999999999999999999999988644
Q ss_pred hhHHHH-----------------------hhcCcc-----------ccccCC---CC--CCCCHHHHHHHHHHHHHcccc
Q 005617 551 GEVRRA-----------------------VSCGKL-----------SSILDP---LA--GDWPTFVARRLVDLGLQCCEL 591 (688)
Q Consensus 551 ~~~~~~-----------------------~~~g~l-----------~~~ld~---~~--~~~~~~~~~~l~~L~~~Cl~~ 591 (688)
++.+.. ...|.+ ..+.++ .. ......+...|++|+.+||..
T Consensus 313 en~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~f 392 (415)
T KOG0671|consen 313 ENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEF 392 (415)
T ss_pred CcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHcc
Confidence 321110 111111 001111 00 011234566899999999999
Q ss_pred CCCCCCCCchHHH
Q 005617 592 YGRERPDITPSLV 604 (688)
Q Consensus 592 dP~~RPs~~~~l~ 604 (688)
||.+|+|+.+++.
T Consensus 393 DP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 393 DPARRITLREALS 405 (415)
T ss_pred CccccccHHHHhc
Confidence 9999999996554
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-30 Score=251.75 Aligned_cols=253 Identities=24% Similarity=0.354 Sum_probs=187.8
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccCC----------
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE---------- 408 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~---------- 408 (688)
.|....+||+|.||.||+++.. |+.||+|++...+. .-.....+|+++|..++|+|++.++..|..
T Consensus 18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~ 97 (376)
T KOG0669|consen 18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRA 97 (376)
T ss_pred HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccc
Confidence 4555578999999999999775 78899987644322 223456789999999999999999998821
Q ss_pred CceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCcc
Q 005617 409 AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 488 (688)
Q Consensus 409 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla 488 (688)
..+|||.+|+ .+|.-+|.... ..++...+.+++.++..||.|+|.+. |+|||+||.|+||+.+|.+||+|||++
T Consensus 98 t~ylVf~~ce-hDLaGlLsn~~--vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 98 TFYLVFDFCE-HDLAGLLSNRK--VRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred eeeeeHHHhh-hhHHHHhcCcc--ccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccc
Confidence 2689999996 46777665443 45778899999999999999999987 999999999999999999999999999
Q ss_pred ccccCCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHH------------
Q 005617 489 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR------------ 555 (688)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~------------ 555 (688)
+.+....... ....+..+.|..|.+||.+.+ ..|+++.|||+-||||.||.||.+-+.+..+...
T Consensus 172 r~fs~~~n~~--kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 172 RAFSTSKNVV--KPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cceecccccC--CCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 8775433221 123467778999999997765 5799999999999999999999988865433211
Q ss_pred -----HhhcCcccccc--CCCCC-CCC--HHH------HHHHHHHHHHccccCCCCCCCCchHH
Q 005617 556 -----AVSCGKLSSIL--DPLAG-DWP--TFV------ARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 556 -----~~~~g~l~~~l--d~~~~-~~~--~~~------~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
.+..-.+...+ .|... .+. .+. ....++|+.+++..||.+||+..+.+
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~al 313 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQAL 313 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhh
Confidence 11111111111 11110 000 011 22678999999999999999988543
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=230.38 Aligned_cols=246 Identities=22% Similarity=0.286 Sum_probs=182.9
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc--cchHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEec
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 416 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~ 416 (688)
+|...++||+|.||+||+|+.. +..||+|++..... .-.....+|+-+|+.++|.|||++++... ....||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 3555678999999999999875 78899999876543 23456789999999999999999999874 357899999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCC
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~ 496 (688)
|. .+|..+..... +.++...+..++.|+++||.|+|+.+ +.|||+||.|+||+.+|.+||+|||+++.+.-...
T Consensus 83 cd-qdlkkyfdsln--g~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CD-QDLKKYFDSLN--GDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hh-HHHHHHHHhcC--CcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 95 46766665443 45778889999999999999999976 99999999999999999999999999998764431
Q ss_pred cCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHh-CCCCCCChhh---HHHHh-hcCc--------c
Q 005617 497 YLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLT-GRLPVGLAGE---VRRAV-SCGK--------L 562 (688)
Q Consensus 497 ~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~---~~~~~-~~g~--------l 562 (688)
.....+.|..|.+|.++.+. -|++..|+||-|||+.|+.. |++.|.+.+- ..... .-|. +
T Consensus 157 ------cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~ 230 (292)
T KOG0662|consen 157 ------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSM 230 (292)
T ss_pred ------eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcc
Confidence 23456789999999988665 57999999999999999998 5554543321 11111 1111 1
Q ss_pred ccccCCCC-CCCCH---------HHHHHHHHHHHHccccCCCCCCCCc
Q 005617 563 SSILDPLA-GDWPT---------FVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 563 ~~~ld~~~-~~~~~---------~~~~~l~~L~~~Cl~~dP~~RPs~~ 600 (688)
..+-|... .-+|. .....-.+|.++.+.-+|..|.++.
T Consensus 231 t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisae 278 (292)
T KOG0662|consen 231 TKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAE 278 (292)
T ss_pred ccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHH
Confidence 11111110 00111 1222346788888888999999876
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=231.84 Aligned_cols=203 Identities=37% Similarity=0.551 Sum_probs=177.5
Q ss_pred eeccCceEEEEEEEC--CeEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccCC--CceeEEecCCCCcHHH
Q 005617 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSLQD 424 (688)
Q Consensus 350 LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gsL~~ 424 (688)
||.|++|.||++... |..+++|++...... ....+.+|+.++..++|++|+++++++.. ..+++|||+.+++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 689999999999997 899999999766543 34579999999999999999999999865 6889999999999999
Q ss_pred HhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCC-CCCeEEeecCccccccCCCCcCCCccc
Q 005617 425 RLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS-ELSSKICDFGICRLVTEDTLYLPSFHR 503 (688)
Q Consensus 425 ~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~-~~~vKLsDFGla~~~~~~~~~~~~~~~ 503 (688)
++.... ..+++..+..++.+++.+|.|||..+ ++|+||+|.||+++. ++.++|+|||.+........ .
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~------~ 149 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS------L 149 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc------h
Confidence 987643 35789999999999999999999975 999999999999999 89999999999987654321 1
Q ss_pred cCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCccccccCCCCCCCCHHHHHHHH
Q 005617 504 STAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLV 582 (688)
Q Consensus 504 ~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~l~~~ld~~~~~~~~~~~~~l~ 582 (688)
.....+...|++||.+... .++.++|+|+||+++++| ..+.
T Consensus 150 ~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------~~~~ 191 (215)
T cd00180 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------PELK 191 (215)
T ss_pred hhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------------HHHH
Confidence 2345688899999999887 889999999999999999 4688
Q ss_pred HHHHHccccCCCCCCCCch
Q 005617 583 DLGLQCCELYGRERPDITP 601 (688)
Q Consensus 583 ~L~~~Cl~~dP~~RPs~~~ 601 (688)
+++..|++.+|.+||++.+
T Consensus 192 ~~l~~~l~~~p~~R~~~~~ 210 (215)
T cd00180 192 DLIRKMLQKDPEKRPSAKE 210 (215)
T ss_pred HHHHHHhhCCcccCcCHHH
Confidence 9999999999999999873
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=252.51 Aligned_cols=263 Identities=24% Similarity=0.341 Sum_probs=212.5
Q ss_pred CHHHHHHHhcCcccceeeeccCceEEEEEEEC-------CeEEEEEEEecCCccc-hHHHHHHHHHHHcCCCCceeeEec
Q 005617 333 SLADLQTATCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQG-QLEFQQEVRVLSKLQHPHLVTLLG 404 (688)
Q Consensus 333 ~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~-------g~~vAIK~l~~~~~~~-~~~f~~E~~iL~~l~HpnIV~l~g 404 (688)
...+|..-.++|.....+-+|.||.||.|.+. .+.|-+|.++....+- ...|..|.-.|..+.|||+..+.|
T Consensus 275 r~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~ 354 (563)
T KOG1024|consen 275 RLQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLG 354 (563)
T ss_pred hHHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeE
Confidence 45677777888999999999999999999775 2447778776654433 345888999999999999999999
Q ss_pred ccCC---CceeEEecCCCCcHHHHhc-----ccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCC
Q 005617 405 ACPE---AWSLVYEYLPNGSLQDRLF-----RKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS 476 (688)
Q Consensus 405 ~~~~---~~~LV~E~~~~gsL~~~L~-----~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~ 476 (688)
++.+ ..+++|.++.-|+|..+|. +......++-.+...++.|++.|+.|||..+ |||.||...|.+||+
T Consensus 355 V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd 431 (563)
T KOG1024|consen 355 VSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDD 431 (563)
T ss_pred EEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehh
Confidence 9844 4788999999999999998 3334456777788889999999999999976 999999999999999
Q ss_pred CCCeEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhh--H
Q 005617 477 ELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--V 553 (688)
Q Consensus 477 ~~~vKLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~--~ 553 (688)
...+||+|=.+++.+-+.+... -.........||+||.+.+..|+..+|||||||+||||+| |+.|+...+. +
T Consensus 432 ~LqVkltDsaLSRDLFP~DYhc----LGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm 507 (563)
T KOG1024|consen 432 QLQVKLTDSALSRDLFPGDYHC----LGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM 507 (563)
T ss_pred heeEEeccchhccccCcccccc----cCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH
Confidence 9999999999998765544221 1122234557999999999999999999999999999999 9999986654 5
Q ss_pred HHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHhh
Q 005617 554 RRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 554 ~~~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l~ 611 (688)
...+.+|... ..|.+++.+|..++..||...|++||++. .++..|..+.
T Consensus 508 ~~ylkdGyRl--------aQP~NCPDeLf~vMacCWallpeeRPsf~-Qlv~cLseF~ 556 (563)
T KOG1024|consen 508 EHYLKDGYRL--------AQPFNCPDELFTVMACCWALLPEERPSFS-QLVICLSEFH 556 (563)
T ss_pred HHHHhcccee--------cCCCCCcHHHHHHHHHHHhcCcccCCCHH-HHHHHHHHHH
Confidence 5566666422 33556778999999999999999999998 5666766554
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-26 Score=231.41 Aligned_cols=196 Identities=36% Similarity=0.515 Sum_probs=169.2
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccC--CCceeEEecCC
Q 005617 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLP 418 (688)
Q Consensus 344 f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~~ 418 (688)
|.....||.|++|.||+|... +..+|||.+...... ....+.+|+..+.+++|+|++++++++. ...++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 456688999999999999986 688999999876555 5668999999999999999999999885 45889999999
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcC
Q 005617 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~ 498 (688)
+++|.+++..... .+++..+..++.+++.+|.|||..+ ++|+||+|.||+++.++.++|+|||++........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-- 153 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-- 153 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc--
Confidence 9999999876432 1789999999999999999999965 99999999999999999999999999988754320
Q ss_pred CCccccCCCCCCCCCCChhhh-ccCCCCCcchHhHHHHHHHHHHhCCCCCCC
Q 005617 499 PSFHRSTAPKGSFPYADPEYH-RTGVLTPKSDSYSFGLIILQLLTGRLPVGL 549 (688)
Q Consensus 499 ~~~~~~~~~~GT~~Y~APE~~-~~~~~s~ksDVwSfGviL~ELltG~~Pf~~ 549 (688)
.......++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus 154 ---~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 154 ---ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred ---ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 012345688899999998 777888899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-27 Score=230.29 Aligned_cols=244 Identities=21% Similarity=0.337 Sum_probs=188.7
Q ss_pred hcCcccceeeeccCceEEEEEEE--CCeEEEEEEEecCCccchHHHHHHHHHHHcCC-CCceeeEecccCCC----ceeE
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEM--LGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLLGACPEA----WSLV 413 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~--~g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~-HpnIV~l~g~~~~~----~~LV 413 (688)
.++|...+++|+|-|+.||.|.. +...++||++++-. .+.+.+|+.||..|+ |||||+|++...+. ..||
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi 113 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI 113 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence 36788889999999999999985 47889999997643 456889999999997 99999999998553 6799
Q ss_pred EecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCC-CCeEEeecCcccccc
Q 005617 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE-LSSKICDFGICRLVT 492 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~-~~vKLsDFGla~~~~ 492 (688)
+||+.+.+...+. +.|+..++..++.+++.||.|+|+.| |.|||+||.|++||.. -.++|+|+|+|.+..
T Consensus 114 FE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH 184 (338)
T KOG0668|consen 114 FEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH 184 (338)
T ss_pred hhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence 9999998887655 45677888999999999999999977 9999999999999965 569999999999987
Q ss_pred CCCCcCCCccccCCCCCCCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCCh-hhHHH---------------
Q 005617 493 EDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLA-GEVRR--------------- 555 (688)
Q Consensus 493 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~-~~~~~--------------- 555 (688)
++.. ....+.+..|--||.+.. ..|+..-|+|||||+|..|+..+.||-.. ++..+
T Consensus 185 p~~e-------YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~ 257 (338)
T KOG0668|consen 185 PGKE-------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYA 257 (338)
T ss_pred CCce-------eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHH
Confidence 6653 234566777889998754 46888999999999999999999998421 11111
Q ss_pred HhhcC------ccccccCC-CCCCCCH--------HHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 556 AVSCG------KLSSILDP-LAGDWPT--------FVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 556 ~~~~g------~l~~~ld~-~~~~~~~--------~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
.+..- .+..+++. ....|.. -..++.++|+.+.|..|-.+|||+.+.+
T Consensus 258 Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam 320 (338)
T KOG0668|consen 258 YLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAM 320 (338)
T ss_pred HHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHh
Confidence 11111 11111111 1112211 1346889999999999999999998543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-27 Score=262.46 Aligned_cols=249 Identities=25% Similarity=0.318 Sum_probs=204.8
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEeccc--CCCceeEEec
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEY 416 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~--~~~~~LV~E~ 416 (688)
..+|.....+|.|.||.|||+++. +...|||+++.....+......|+-++...+|||||.++|.+ .+.++++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 357888899999999999999886 889999999988777777788999999999999999999998 4679999999
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCC
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~ 496 (688)
|.+|+|.+.-+-. .+++..++..++.....||.|||+.+ =+|||||-.|||+.+.|.+|++|||.+..+....
T Consensus 94 cgggslQdiy~~T---gplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati- 166 (829)
T KOG0576|consen 94 CGGGSLQDIYHVT---GPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI- 166 (829)
T ss_pred cCCCcccceeeec---ccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh-
Confidence 9999999976543 47888889999999999999999976 7999999999999999999999999987765432
Q ss_pred cCCCccccCCCCCCCCCCChhhh---ccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCccccccCCCCCCC
Q 005617 497 YLPSFHRSTAPKGSFPYADPEYH---RTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDW 573 (688)
Q Consensus 497 ~~~~~~~~~~~~GT~~Y~APE~~---~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~l~~~ld~~~~~~ 573 (688)
.+.....||+.|||||+. ..+.|...||||++|+...|+---++|.......+...-- .....+|....-
T Consensus 167 -----~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~Lm--TkS~~qpp~lkD 239 (829)
T KOG0576|consen 167 -----AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLM--TKSGFQPPTLKD 239 (829)
T ss_pred -----hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHh--hccCCCCCcccC
Confidence 345788999999999965 5778999999999999999999988886544443332111 011223322222
Q ss_pred CHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 574 PTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 574 ~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
+......+.+++..|+..+|++||+....+
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL 269 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLL 269 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhhe
Confidence 334567889999999999999999987444
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-28 Score=241.33 Aligned_cols=246 Identities=25% Similarity=0.354 Sum_probs=181.5
Q ss_pred cccceeeeccCceEEEEEEEC--CeEEEEEEEecC--CccchHHHHHHHHHHHcCCCCceeeEecccC-------CCcee
Q 005617 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSH--NMQGQLEFQQEVRVLSKLQHPHLVTLLGACP-------EAWSL 412 (688)
Q Consensus 344 f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~--~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~-------~~~~L 412 (688)
...++.||-|+||.||.+.+. |+.||+|++..- +...-+.+.+|+++|.-++|.|++..++... .+.|+
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV 134 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYV 134 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHH
Confidence 345678999999999999885 899999988543 2234457889999999999999999887752 24677
Q ss_pred EEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCcccccc
Q 005617 413 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 492 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~ 492 (688)
|.|.|. .+|..++... .+++-..+.-+..||++||.|||+.+ |.||||||.|+|++.|..+||||||+++...
T Consensus 135 ~TELmQ-SDLHKIIVSP---Q~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 135 LTELMQ-SDLHKIIVSP---QALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHH-hhhhheeccC---CCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccc
Confidence 888874 5676666543 45666777778999999999999977 9999999999999999999999999999876
Q ss_pred CCCCcCCCccccCCCCCCCCCCChhhhccC-CCCCcchHhHHHHHHHHHHhCCCCCCChhhHH-----------------
Q 005617 493 EDTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR----------------- 554 (688)
Q Consensus 493 ~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~----------------- 554 (688)
.+... ..+..+.|..|.|||++++. .|+...||||.|||+.||+..+..|...+.+.
T Consensus 208 ~d~~~-----hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaM 282 (449)
T KOG0664|consen 208 QRDRL-----NMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAM 282 (449)
T ss_pred hhhhh-----hhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHH
Confidence 54422 23455678999999988765 68999999999999999999988774322211
Q ss_pred HHhhcCccccccCCC--CCCC--------CHHHHHHHHHHHHHccccCCCCCCCCch
Q 005617 555 RAVSCGKLSSILDPL--AGDW--------PTFVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 555 ~~~~~g~l~~~ld~~--~~~~--------~~~~~~~l~~L~~~Cl~~dP~~RPs~~~ 601 (688)
+....|.-.-++... ..+. +..-.-..+.+..+++..||+.|.+..+
T Consensus 283 r~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~ 339 (449)
T KOG0664|consen 283 KYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEE 339 (449)
T ss_pred HHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhh
Confidence 111222211122110 0011 1122335667788889999999987663
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=250.43 Aligned_cols=193 Identities=22% Similarity=0.330 Sum_probs=164.9
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc------c--hHHHHHHHHHHHcCC---CCceeeEecccCC
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ------G--QLEFQQEVRVLSKLQ---HPHLVTLLGACPE 408 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~------~--~~~f~~E~~iL~~l~---HpnIV~l~g~~~~ 408 (688)
.+|.....+|.|+||.|+.+.+. ...|+||.+++...- + .-.+--|+.||+.++ |+||++++++|.+
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 45777899999999999999986 677999999776431 1 112567999999997 9999999999965
Q ss_pred --CceeEEecC-CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeec
Q 005617 409 --AWSLVYEYL-PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDF 485 (688)
Q Consensus 409 --~~~LV~E~~-~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDF 485 (688)
.+||+||-- +|-+|.+++..+ +.+++.++.-|+.||+.|+++||+.+ |||||||-+||.+|.+|-+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~k---p~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFK---PRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhcc---CccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 477888864 556899998765 35788999999999999999999976 999999999999999999999999
Q ss_pred CccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCC-CCcchHhHHHHHHHHHHhCCCCCC
Q 005617 486 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVL-TPKSDSYSFGLIILQLLTGRLPVG 548 (688)
Q Consensus 486 Gla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-s~ksDVwSfGviL~ELltG~~Pf~ 548 (688)
|.|.....+. -...+||.+|.|||++.+..| +..-|||++|++||.++....||.
T Consensus 715 gsaa~~ksgp--------fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSGP--------FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCCC--------cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9998776543 246789999999999999887 667999999999999999999984
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-26 Score=232.81 Aligned_cols=246 Identities=24% Similarity=0.273 Sum_probs=184.9
Q ss_pred hcCcccceeeeccCceEEEEEEE--CCeEEEEEEEecC--CccchHHHHHHHHHHHcCCCCceeeEecccC--------C
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEM--LGRTVAIKMLYSH--NMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--------E 408 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~--~g~~vAIK~l~~~--~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--------~ 408 (688)
..+|.....+|.|.- .|--+-+ .+++||+|.+... .........+|..++..+.|+|||+++.+|. .
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 356677778888887 5554444 3899999987443 2334456789999999999999999999982 1
Q ss_pred CceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCcc
Q 005617 409 AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 488 (688)
Q Consensus 409 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla 488 (688)
+.|+|||+|. ++|...+.. .++-.....|+.|+++|+.|||+.+ |+||||||+||++..+..+||+|||+|
T Consensus 95 e~y~v~e~m~-~nl~~vi~~-----elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 95 EVYLVMELMD-ANLCQVILM-----ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred hHHHHHHhhh-hHHHHHHHH-----hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhh
Confidence 3789999994 577776652 2445678889999999999999977 999999999999999999999999999
Q ss_pred ccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhc---------
Q 005617 489 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC--------- 559 (688)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~--------- 559 (688)
+...... ..+..+.|-.|.|||++.+..|...+||||+||++.||++|..-|.+.+.+.+....
T Consensus 166 r~e~~~~-------~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~ 238 (369)
T KOG0665|consen 166 RTEDTDF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDP 238 (369)
T ss_pred cccCccc-------ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCH
Confidence 8765431 346678899999999999988999999999999999999999888643322111000
Q ss_pred ----------------------Ccccccc-CC---CCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 560 ----------------------GKLSSIL-DP---LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 560 ----------------------g~l~~~l-d~---~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
-.+.+.+ |. ...+.+......+.+|+.+||..||++|-+..+.+
T Consensus 239 ~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL 308 (369)
T KOG0665|consen 239 SFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDAL 308 (369)
T ss_pred HHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHh
Confidence 0111111 10 01111223455688999999999999999987544
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.5e-26 Score=244.30 Aligned_cols=210 Identities=24% Similarity=0.317 Sum_probs=169.6
Q ss_pred CCCCcccCHHHHHHHhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCC------CC
Q 005617 326 LPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ------HP 397 (688)
Q Consensus 326 ~~~~~~~~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~------Hp 397 (688)
....-.+.+-|+ ....|.+....|+|-|++|-.|.+. |..||||+|..+.... +.=..|+.||.+|+ --
T Consensus 418 aEGYYrv~igE~--LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~-KtGl~EleiLkKL~~AD~Edk~ 494 (752)
T KOG0670|consen 418 AEGYYRVRIGEL--LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH-KTGLKELEILKKLNDADPEDKF 494 (752)
T ss_pred ccceEEEehhhh--hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh-hhhhHHHHHHHHhhccCchhhh
Confidence 333334444444 4567888888999999999999886 8899999998764332 22357999999995 34
Q ss_pred ceeeEecccC--CCceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeC
Q 005617 398 HLVTLLGACP--EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD 475 (688)
Q Consensus 398 nIV~l~g~~~--~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd 475 (688)
++++|+..|. ..+|||+|-+ ..+|.++|.+.+..-.|....+..++.|+..||..|-..+ |+|.||||+|||++
T Consensus 495 Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVN 570 (752)
T KOG0670|consen 495 HCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVN 570 (752)
T ss_pred HHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEec
Confidence 8899988874 5689999987 5689999988776667888999999999999999999866 99999999999998
Q ss_pred CC-CCeEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCCh
Q 005617 476 SE-LSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLA 550 (688)
Q Consensus 476 ~~-~~vKLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~ 550 (688)
.+ ..+||||||.|.....+.. +....+--|.|||++.+-.|+...|+||.||+||||.||+..|.+.
T Consensus 571 E~k~iLKLCDfGSA~~~~enei--------tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~ 638 (752)
T KOG0670|consen 571 ESKNILKLCDFGSASFASENEI--------TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGR 638 (752)
T ss_pred cCcceeeeccCccccccccccc--------cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCC
Confidence 65 5689999999988765542 2223344699999999999999999999999999999999888543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.4e-25 Score=232.70 Aligned_cols=129 Identities=27% Similarity=0.379 Sum_probs=106.9
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCC-----CC---ceeeEecccCC--
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-----HP---HLVTLLGACPE-- 408 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~-----Hp---nIV~l~g~~~~-- 408 (688)
+++|...++||.|-|++||++.+. .+.||+|+.+... .-.+....|+.+|++++ |+ .||+|++.|..
T Consensus 77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq-hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsG 155 (590)
T KOG1290|consen 77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ-HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSG 155 (590)
T ss_pred CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh-HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecC
Confidence 367888999999999999999886 6789999987542 22234678999999984 33 69999999932
Q ss_pred ----CceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceee
Q 005617 409 ----AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL 474 (688)
Q Consensus 409 ----~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILL 474 (688)
..|||+|++ |.+|-.+|.... ...++...+.+|+.||+.||.|||..+ +|||.||||+||||
T Consensus 156 pNG~HVCMVfEvL-GdnLLklI~~s~-YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl 221 (590)
T KOG1290|consen 156 PNGQHVCMVFEVL-GDNLLKLIKYSN-YRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLL 221 (590)
T ss_pred CCCcEEEEEehhh-hhHHHHHHHHhC-CCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeee
Confidence 378999999 677777776543 356889999999999999999999988 79999999999999
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-25 Score=269.15 Aligned_cols=199 Identities=17% Similarity=0.129 Sum_probs=139.9
Q ss_pred HcCCC-CceeeEecccC---------CCceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCc
Q 005617 392 SKLQH-PHLVTLLGACP---------EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461 (688)
Q Consensus 392 ~~l~H-pnIV~l~g~~~---------~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~ 461 (688)
+.++| +||+.++++|. +..++++||+ +++|.++|.... ..+++..+..|+.||+.||.|||+.+
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~g--- 100 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQG--- 100 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhCC---
Confidence 34566 68888998871 1245678877 669999996532 46899999999999999999999965
Q ss_pred eEeCCCCCCceeeCCC-------------------CCeEEeecCccccccCCCC----------cCCCccccCCCCCCCC
Q 005617 462 IVHGDLKPQNILLDSE-------------------LSSKICDFGICRLVTEDTL----------YLPSFHRSTAPKGSFP 512 (688)
Q Consensus 462 IiHrDIKp~NILLd~~-------------------~~vKLsDFGla~~~~~~~~----------~~~~~~~~~~~~GT~~ 512 (688)
|+||||||+||||+.. +.+||+|||+++....... ..+.........||+.
T Consensus 101 IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 180 (793)
T PLN00181 101 IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSW 180 (793)
T ss_pred eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcc
Confidence 9999999999999654 4455666666553211000 0000001123468999
Q ss_pred CCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccccC
Q 005617 513 YADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELY 592 (688)
Q Consensus 513 Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~d 592 (688)
|||||++.+..++.++|||||||+||||++|.+|+.........+.... +.+. . .........++.+||+.+
T Consensus 181 Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~~~~~~~~~----~~~~---~-~~~~~~~~~~~~~~L~~~ 252 (793)
T PLN00181 181 YTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRTMSSLRHRV----LPPQ---I-LLNWPKEASFCLWLLHPE 252 (793)
T ss_pred eEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHHHHHHHHhh----cChh---h-hhcCHHHHHHHHHhCCCC
Confidence 9999999999999999999999999999999999764333222222111 1110 0 111334568889999999
Q ss_pred CCCCCCCchHHH
Q 005617 593 GRERPDITPSLV 604 (688)
Q Consensus 593 P~~RPs~~~~l~ 604 (688)
|.+||++.+.+.
T Consensus 253 P~~Rps~~eil~ 264 (793)
T PLN00181 253 PSCRPSMSELLQ 264 (793)
T ss_pred hhhCcChHHHhh
Confidence 999999996554
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-24 Score=229.97 Aligned_cols=256 Identities=25% Similarity=0.348 Sum_probs=189.6
Q ss_pred HHHHhcCcccceeeeccCceEEEEEEEC-----CeEEEEEEEecCCccchHHHHHHHHHHHcCC-CCceeeEeccc--CC
Q 005617 337 LQTATCNFSESFKVGQGGFGCVYKGEML-----GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLLGAC--PE 408 (688)
Q Consensus 337 l~~at~~f~~~~~LG~G~fG~Vykg~~~-----g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~-HpnIV~l~g~~--~~ 408 (688)
+....+.|...++||.|.|++||++.+. +..||+|.+.... ....+.+|+++|..+. +.||+++.+++ .+
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 3445577888999999999999999663 5679999986543 3345889999999995 99999999998 45
Q ss_pred CceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCC-CCCeEEeecCc
Q 005617 409 AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS-ELSSKICDFGI 487 (688)
Q Consensus 409 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~-~~~vKLsDFGl 487 (688)
..++|+||++.....++.. .++...+..++..+..||.++|..| ||||||||+|+|.+. .+.-.|.|||+
T Consensus 109 ~v~ivlp~~~H~~f~~l~~------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYR------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHh------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 6899999999999988874 3667889999999999999999976 999999999999985 46789999999
Q ss_pred cccccCCC-----------CcC-----------------CC----------ccccCCCCCCCCCCChhhhcc-CCCCCcc
Q 005617 488 CRLVTEDT-----------LYL-----------------PS----------FHRSTAPKGSFPYADPEYHRT-GVLTPKS 528 (688)
Q Consensus 488 a~~~~~~~-----------~~~-----------------~~----------~~~~~~~~GT~~Y~APE~~~~-~~~s~ks 528 (688)
|....... ... +. -......+||+||.|||++.. ...++++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 97221000 000 00 001124579999999998765 4578999
Q ss_pred hHhHHHHHHHHHHhCCCCCCCh----------------hhHHH-HhhcCc--ccc--------------------ccCC-
Q 005617 529 DSYSFGLIILQLLTGRLPVGLA----------------GEVRR-AVSCGK--LSS--------------------ILDP- 568 (688)
Q Consensus 529 DVwSfGviL~ELltG~~Pf~~~----------------~~~~~-~~~~g~--l~~--------------------~ld~- 568 (688)
||||.|||++-+++++.||... ..+++ +.-.|. +.+ .+.+
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 9999999999999999998311 11111 111122 111 0001
Q ss_pred -----CCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 569 -----LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 569 -----~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
...++....+..+++|+.+|+..||.+|.++.++|
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeAL 379 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDAL 379 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHh
Confidence 01122333455789999999999999999998554
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.5e-24 Score=209.30 Aligned_cols=158 Identities=23% Similarity=0.219 Sum_probs=121.6
Q ss_pred CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCC
Q 005617 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 420 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~ 499 (688)
|+|.+++.... .+++|..++.|+.||+.||.|||+.+ ||+|||++.++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~----- 62 (176)
T smart00750 1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE----- 62 (176)
T ss_pred CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc-----
Confidence 78999887543 46899999999999999999999954 999999999999999 9999876432
Q ss_pred CccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhH---HHHhhcCccccccCCCCCCCCHH
Q 005617 500 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV---RRAVSCGKLSSILDPLAGDWPTF 576 (688)
Q Consensus 500 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~---~~~~~~g~l~~~ld~~~~~~~~~ 576 (688)
...||+.|||||++.+..++.++|||||||++|||+||+.||...... ...+..+... .++.....+..
T Consensus 63 ------~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 134 (176)
T smart00750 63 ------QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPA--DDPRDRSNLES 134 (176)
T ss_pred ------cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhcc--CCccccccHHH
Confidence 225899999999999999999999999999999999999999644321 1111111111 11111112223
Q ss_pred HHH--HHHHHHHHccccCCCCCCCCchHH
Q 005617 577 VAR--RLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 577 ~~~--~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
... .+.+++.+||..+|.+||++.+.+
T Consensus 135 ~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll 163 (176)
T smart00750 135 VSAARSFADFMRVCASRLPQRREAANHYL 163 (176)
T ss_pred HHhhhhHHHHHHHHHhcccccccCHHHHH
Confidence 333 699999999999999999998444
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.5e-25 Score=218.69 Aligned_cols=237 Identities=24% Similarity=0.356 Sum_probs=177.6
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcC-CCCceeeEecc-cC--CCceeEEe
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGA-CP--EAWSLVYE 415 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l-~HpnIV~l~g~-~~--~~~~LV~E 415 (688)
+.|.+.+.||+|.||.+-++.++ .+.+++|.++.. ...+.+|.+|..---.| .|.|||.-|.. |+ +.+++++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 45788889999999999999998 567999987643 24567899998765555 59999998865 43 45778999
Q ss_pred cCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceee-CC-CCCeEEeecCccccccC
Q 005617 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL-DS-ELSSKICDFGICRLVTE 493 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILL-d~-~~~vKLsDFGla~~~~~ 493 (688)
|+|.|+|..-+... .+-+....+++.|+++||.|+|+.+ +||||||.+|||| +. ...+||||||+.+....
T Consensus 103 ~aP~gdL~snv~~~----GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~ 175 (378)
T KOG1345|consen 103 FAPRGDLRSNVEAA----GIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT 175 (378)
T ss_pred cCccchhhhhcCcc----cccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCc
Confidence 99999998877543 3566778899999999999999955 9999999999998 33 35799999999876543
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccC-----CCCCcchHhHHHHHHHHHHhCCCCCCChh------hHHHHhhcCcc
Q 005617 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTG-----VLTPKSDSYSFGLIILQLLTGRLPVGLAG------EVRRAVSCGKL 562 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-----~~s~ksDVwSfGviL~ELltG~~Pf~~~~------~~~~~~~~g~l 562 (688)
.. ....-+..|.+||..... ...+.+|||.||+++|.++||++||.-.. +-+..+..++.
T Consensus 176 tV---------~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~ 246 (378)
T KOG1345|consen 176 TV---------KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKN 246 (378)
T ss_pred ee---------hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccC
Confidence 21 223456679999976432 34789999999999999999999996211 22344544444
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCc
Q 005617 563 SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 563 ~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~ 600 (688)
..+.+ .+. ..+..+..+..+-+..+|++|--..
T Consensus 247 ~~~P~----~F~-~fs~~a~r~Fkk~lt~~~~drcki~ 279 (378)
T KOG1345|consen 247 PALPK----KFN-PFSEKALRLFKKSLTPRFKDRCKIW 279 (378)
T ss_pred ccCch----hhc-ccCHHHHHHHHHhcCCcccccchhH
Confidence 32211 111 2456788888899999999995444
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.6e-23 Score=224.94 Aligned_cols=172 Identities=19% Similarity=0.197 Sum_probs=132.4
Q ss_pred HHHHHhcCcccceeeeccCceEEEEEEEC---CeEEEEEEEecCC-----ccchHHHHHHHHHHHcCCCCceee-Eeccc
Q 005617 336 DLQTATCNFSESFKVGQGGFGCVYKGEML---GRTVAIKMLYSHN-----MQGQLEFQQEVRVLSKLQHPHLVT-LLGAC 406 (688)
Q Consensus 336 el~~at~~f~~~~~LG~G~fG~Vykg~~~---g~~vAIK~l~~~~-----~~~~~~f~~E~~iL~~l~HpnIV~-l~g~~ 406 (688)
......++|.....||+|+||+||+|.+. +..||||++.... ......|.+|+.+|.+++|+|+|+ ++++
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 34556678999999999999999999873 6778999876331 112446899999999999999995 5443
Q ss_pred CCCceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCC-CCCceeeCCCCCeEEeec
Q 005617 407 PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDL-KPQNILLDSELSSKICDF 485 (688)
Q Consensus 407 ~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDI-Kp~NILLd~~~~vKLsDF 485 (688)
...+|||||++|++|... . .. . ...++.+++.||.|||+.+ |+|||| ||+|||++.++.+||+||
T Consensus 91 -~~~~LVmE~~~G~~L~~~-~-~~--~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDF 156 (365)
T PRK09188 91 -GKDGLVRGWTEGVPLHLA-R-PH--G------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDF 156 (365)
T ss_pred -CCcEEEEEccCCCCHHHh-C-cc--c------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEEC
Confidence 457999999999999632 1 10 1 2467889999999999965 999999 999999999999999999
Q ss_pred CccccccCCCCcCC--CccccCCCCCCCCCCChhhhccC
Q 005617 486 GICRLVTEDTLYLP--SFHRSTAPKGSFPYADPEYHRTG 522 (688)
Q Consensus 486 Gla~~~~~~~~~~~--~~~~~~~~~GT~~Y~APE~~~~~ 522 (688)
|+|+.+........ ....-+...|++.|+|||++...
T Consensus 157 GlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 157 QLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 99998765432111 11112467789999999988644
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-21 Score=202.77 Aligned_cols=258 Identities=29% Similarity=0.404 Sum_probs=195.8
Q ss_pred cccceeeeccCceEEEEEEECCeEEEEEEEecCCccc---hHHHHHHHHHHHcCCCC-ceeeEecccCCC--ceeEEecC
Q 005617 344 FSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQG---QLEFQQEVRVLSKLQHP-HLVTLLGACPEA--WSLVYEYL 417 (688)
Q Consensus 344 f~~~~~LG~G~fG~Vykg~~~g~~vAIK~l~~~~~~~---~~~f~~E~~iL~~l~Hp-nIV~l~g~~~~~--~~LV~E~~ 417 (688)
|.....||.|+||.||++... ..+++|.+....... ...|.+|+.++..+.|+ +|+++++++... .+++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 556678999999999999988 889999997765543 56799999999999988 799999988543 48999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCC-CeEEeecCccccccCCCC
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL-SSKICDFGICRLVTEDTL 496 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~-~vKLsDFGla~~~~~~~~ 496 (688)
.++++.+.+........+.......++.+++.++.|+|..+ ++|||+||+||+++..+ .++++|||+++.......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 99999966654321125788899999999999999999976 99999999999999998 799999999986654332
Q ss_pred cCCCccccCCCCCCCCCCChhhhcc---CCCCCcchHhHHHHHHHHHHhCCCCCCChh------hHHHHhhcCccccccC
Q 005617 497 YLPSFHRSTAPKGSFPYADPEYHRT---GVLTPKSDSYSFGLIILQLLTGRLPVGLAG------EVRRAVSCGKLSSILD 567 (688)
Q Consensus 497 ~~~~~~~~~~~~GT~~Y~APE~~~~---~~~s~ksDVwSfGviL~ELltG~~Pf~~~~------~~~~~~~~g~l~~~ld 567 (688)
............||..|++||.+.. ..++...|+||+|++++++++|..||.... .....+..........
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence 1100012467789999999999987 688999999999999999999999986543 2222222221110000
Q ss_pred CCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHH
Q 005617 568 PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 605 (688)
Q Consensus 568 ~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~ 605 (688)
+.....+......+.+++..|+..+|..|.+.......
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 00011112223578899999999999999998855544
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.4e-22 Score=212.45 Aligned_cols=260 Identities=23% Similarity=0.270 Sum_probs=190.7
Q ss_pred CcccceeeeccCceEEEEEEECC---eEEEEEEEecCCccchHHHHHHHHHHHcCCC----CceeeEecccC-C--Ccee
Q 005617 343 NFSESFKVGQGGFGCVYKGEMLG---RTVAIKMLYSHNMQGQLEFQQEVRVLSKLQH----PHLVTLLGACP-E--AWSL 412 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~g---~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~H----pnIV~l~g~~~-~--~~~L 412 (688)
+|....+||+|+||.||.|.... ..+|+|............+..|+.++..+.. +++..+++... . ..++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 79999999999999999999863 4699998877654433367889999988863 57777777662 3 4688
Q ss_pred EEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCC-----CCeEEeecCc
Q 005617 413 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE-----LSSKICDFGI 487 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~-----~~vKLsDFGl 487 (688)
||+.+ |.+|.++..... ...++-.+++.|+.|++.+|.+||+.+ ++||||||+|+++... ..++|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 98887 889999775544 467889999999999999999999976 9999999999999865 4699999999
Q ss_pred cc--cccCCCCc--CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhH--HHHhhcCc
Q 005617 488 CR--LVTEDTLY--LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGK 561 (688)
Q Consensus 488 a~--~~~~~~~~--~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~--~~~~~~g~ 561 (688)
++ ........ .+.........||..|.++..+.+...+.+.|+||+++++.+++.|..||...... ...+....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 98 33222211 11111123566999999999999999999999999999999999999999644321 11111111
Q ss_pred cccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHhhh
Q 005617 562 LSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 562 l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l~~ 612 (688)
....... .....+..+..+...+-..+..++|... .+...|.....
T Consensus 254 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~-~~~~~l~~~~~ 299 (322)
T KOG1164|consen 254 RKLLTDR----FGDLKPEEFAKILEYIDSLDYEDKPDYE-KLAELLKDVFD 299 (322)
T ss_pred hhhcccc----ccCCChHHHHHHHHHhhccCCcCCCCHH-HHHHHHHHHHH
Confidence 1111111 1112234566666666668999999988 66666665544
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-23 Score=207.64 Aligned_cols=252 Identities=23% Similarity=0.413 Sum_probs=195.3
Q ss_pred cccCHHHHHHHhcCcccceeeeccCceEEEEEEECCeEEEEEEEecCCccch--HHHHHHHHHHHcCCCCceeeEecccC
Q 005617 330 AEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQ--LEFQQEVRVLSKLQHPHLVTLLGACP 407 (688)
Q Consensus 330 ~~~~~~el~~at~~f~~~~~LG~G~fG~Vykg~~~g~~vAIK~l~~~~~~~~--~~f~~E~~iL~~l~HpnIV~l~g~~~ 407 (688)
.-+++.+|...| +|.....|..|+|++.|..+++|+++....... .+|..|.-.|+.+.||||+.++|+|.
T Consensus 185 ~gid~~~lnl~t-------kl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacn 257 (448)
T KOG0195|consen 185 TGIDVSSLNLIT-------KLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACN 257 (448)
T ss_pred cCcchhhhhhhh-------hhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhcc
Confidence 344555655554 488999999999999999999999976654433 46999999999999999999999996
Q ss_pred C--CceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEe-CCCCCCceeeCCCCCeEEe-
Q 005617 408 E--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH-GDLKPQNILLDSELSSKIC- 483 (688)
Q Consensus 408 ~--~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiH-rDIKp~NILLd~~~~vKLs- 483 (688)
. .+.++..||+.|||...|+...+ -.++-.++.+++.+||+|++|||+..| ++- --|.+..|++|++.+++|+
T Consensus 258 sppnlv~isq~mp~gslynvlhe~t~-vvvd~sqav~faldiargmaflhslep--~ipr~~lns~hvmidedltarism 334 (448)
T KOG0195|consen 258 SPPNLVIISQYMPFGSLYNVLHEQTS-VVVDHSQAVRFALDIARGMAFLHSLEP--MIPRFYLNSKHVMIDEDLTARISM 334 (448)
T ss_pred CCCCceEeeeeccchHHHHHHhcCcc-EEEecchHHHHHHHHHhhHHHHhhcch--hhhhhhcccceEEecchhhhheec
Confidence 5 47789999999999999987653 234567889999999999999999873 444 4689999999999988876
Q ss_pred -ecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCC---CcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhc
Q 005617 484 -DFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLT---PKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC 559 (688)
Q Consensus 484 -DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s---~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~ 559 (688)
|--++- ......-.|.||+||.++..+-+ ..+|+|||.++||||.|...||.....++.-...
T Consensus 335 ad~kfsf-------------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmki 401 (448)
T KOG0195|consen 335 ADTKFSF-------------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKI 401 (448)
T ss_pred ccceeee-------------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhh
Confidence 211111 11223446889999998766543 5799999999999999999999866655433211
Q ss_pred CccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHh
Q 005617 560 GKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 560 g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l 610 (688)
.+.-.....|+..+..+..|+.-|++.||.+||.+. .++-.|+.+
T Consensus 402 -----aleglrv~ippgis~hm~klm~icmnedpgkrpkfd-mivpilekm 446 (448)
T KOG0195|consen 402 -----ALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFD-MIVPILEKM 446 (448)
T ss_pred -----hhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcc-eehhhHHHh
Confidence 112223356778899999999999999999999998 666666653
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.2e-22 Score=201.91 Aligned_cols=258 Identities=21% Similarity=0.261 Sum_probs=195.1
Q ss_pred HhcCcccceeeeccCceEEEEEEE--CCeEEEEEEEecCCccchHHHHHHHHHHHcC-CCCceeeEecccCCC--ceeEE
Q 005617 340 ATCNFSESFKVGQGGFGCVYKGEM--LGRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACPEA--WSLVY 414 (688)
Q Consensus 340 at~~f~~~~~LG~G~fG~Vykg~~--~g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~~--~~LV~ 414 (688)
..-+|.++++||.|+||.++.|.. ++..||||.-...+.. -++..|....+.| ..++|...|.+.+++ ..||+
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A--PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA--PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccccCCc--chHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 445899999999999999999976 4899999986544332 2456677777777 578888887776554 56999
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCC-----CeEEeecCccc
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL-----SSKICDFGICR 489 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~-----~vKLsDFGla~ 489 (688)
|.+ |.||+|++.-++ ..|+..+++.||.|++.-+.|+|+.. +|.|||||+|+||..-+ .+.|+|||+|+
T Consensus 104 dLL-GPSLEDLFD~Cg--R~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK 177 (449)
T KOG1165|consen 104 DLL-GPSLEDLFDLCG--RRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK 177 (449)
T ss_pred hhh-CcCHHHHHHHhc--CcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchh
Confidence 988 889999887665 46888999999999999999999965 99999999999997543 48999999999
Q ss_pred cccCCCCcCC-CccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh-----HHHHhhcCccc
Q 005617 490 LVTEDTLYLP-SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE-----VRRAVSCGKLS 563 (688)
Q Consensus 490 ~~~~~~~~~~-~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~-----~~~~~~~g~l~ 563 (688)
.+.+...... .+.......||..||+---..+...+.+.|.-|||-|++..|-|..||.+... -...+...+-.
T Consensus 178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~ 257 (449)
T KOG1165|consen 178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRS 257 (449)
T ss_pred hhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccccc
Confidence 9876554321 23346678899999999999999999999999999999999999999975432 12223333333
Q ss_pred cccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHh
Q 005617 564 SILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 564 ~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l 610 (688)
..+...+..+|. ++..-+.-.-..+..+-|+.. .+...+..+
T Consensus 258 T~i~~Lc~g~P~----efa~Yl~yvR~L~F~E~PDYd-ylr~Lf~dv 299 (449)
T KOG1165|consen 258 TPIEVLCEGFPE----EFATYLRYVRRLDFFETPDYD-YLRKLFDDV 299 (449)
T ss_pred CCHHHHHhcCHH----HHHHHHHHHHhcCcccCCCHH-HHHHHHHHH
Confidence 223223334444 444444455566778888876 555555544
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=192.31 Aligned_cols=257 Identities=23% Similarity=0.283 Sum_probs=198.7
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCC-CceeeEecccCC--CceeEEe
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQH-PHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~H-pnIV~l~g~~~~--~~~LV~E 415 (688)
.+.|...++||.|+||.+|.|..- |..||||+-...... -++..|..+...|++ ..|..+..+..+ ...|||+
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h--pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH--PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC--cchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 357999999999999999999774 899999997655433 346678999999975 456555555543 4679999
Q ss_pred cCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCC---CCeEEeecCcccccc
Q 005617 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE---LSSKICDFGICRLVT 492 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~---~~vKLsDFGla~~~~ 492 (688)
.+ |.||++.+.-+. ..++..+++-++.|++.-++|+|..+ +|||||||+|+|..-+ ..+.|+|||+|+.+.
T Consensus 92 LL-GPsLEdLfnfC~--R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFCS--RRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHHh--hhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 88 889999887665 46888999999999999999999966 9999999999998644 468999999999876
Q ss_pred CCCCcC-CCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhH-----HHHhhcCcccccc
Q 005617 493 EDTLYL-PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV-----RRAVSCGKLSSIL 566 (688)
Q Consensus 493 ~~~~~~-~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~-----~~~~~~g~l~~~l 566 (688)
+..... ..+.......||..|.+--...+...+.+.|+-|+|.+|..+.-|..||.+.... ...+...++...+
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~i 245 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPI 245 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCH
Confidence 533221 1233456788999999999888888999999999999999999999999765432 2234444444444
Q ss_pred CCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHh
Q 005617 567 DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 567 d~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l 610 (688)
...+..+|. ++.-.+.-|-....++-|+.. .+.+.+.-+
T Consensus 246 e~LC~G~P~----EF~myl~Y~R~L~F~E~Pdy~-ylrqlFriL 284 (341)
T KOG1163|consen 246 EVLCKGFPA----EFAMYLNYCRGLGFEEKPDYM-YLRQLFRIL 284 (341)
T ss_pred HHHhCCCcH----HHHHHHHHHhhcCCCCCCcHH-HHHHHHHHH
Confidence 444555554 566677789999999999986 565555544
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=1e-20 Score=191.70 Aligned_cols=169 Identities=14% Similarity=0.089 Sum_probs=134.3
Q ss_pred HhcCcccceeeeccCceEEEEEEECCeEEEEEEEecCCccchHH---------HHHHHHHHHcCCCCceeeEecccC---
Q 005617 340 ATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLE---------FQQEVRVLSKLQHPHLVTLLGACP--- 407 (688)
Q Consensus 340 at~~f~~~~~LG~G~fG~Vykg~~~g~~vAIK~l~~~~~~~~~~---------f~~E~~iL~~l~HpnIV~l~g~~~--- 407 (688)
..++|...+.||.|+||.||.....+..+|||++.......... |.+|+..+.++.||+|..+..++.
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 46899999999999999999987778899999997665443332 689999999999999999877642
Q ss_pred -------CCceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCe
Q 005617 408 -------EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS 480 (688)
Q Consensus 408 -------~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~v 480 (688)
...+|||||++|.+|.+... ++. ....+++.+|..||..+ ++|||+||+||+++.+| +
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i 173 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-L 173 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-E
Confidence 23789999999999988731 221 34569999999999976 99999999999999988 9
Q ss_pred EEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHH
Q 005617 481 KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLL 541 (688)
Q Consensus 481 KLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELl 541 (688)
+|+|||........... .-++....+..++|+|||||.+.-+.
T Consensus 174 ~liDfg~~~~~~e~~a~------------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 174 RIIDLSGKRCTAQRKAK------------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEECCCcccccchhhH------------------HHHHHHhHhcccccccceeEeehHHH
Confidence 99999988755322210 11555666778999999999887654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.9e-20 Score=184.66 Aligned_cols=137 Identities=19% Similarity=0.246 Sum_probs=106.8
Q ss_pred eeeeccCceEEEEEEEC-CeEEEEEEEecCCcc--c-------hHHH-----------------HHHHHHHHcCCCCcee
Q 005617 348 FKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQ--G-------QLEF-----------------QQEVRVLSKLQHPHLV 400 (688)
Q Consensus 348 ~~LG~G~fG~Vykg~~~-g~~vAIK~l~~~~~~--~-------~~~f-----------------~~E~~iL~~l~HpnIV 400 (688)
..||+|+||.||+|... |..||||+++..... . ...| ..|+.++.++.++++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~ 82 (190)
T cd05147 3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP 82 (190)
T ss_pred CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 57999999999999885 899999999765321 1 1122 3499999999877764
Q ss_pred eEecccCCCceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHH-hccCCCceEeCCCCCCceeeCCCCC
Q 005617 401 TLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFL-HSSKPEKIVHGDLKPQNILLDSELS 479 (688)
Q Consensus 401 ~l~g~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yL-H~~~~~~IiHrDIKp~NILLd~~~~ 479 (688)
....+.....+|||||++|+++...+... .++++.....++.|++.+|.|| |..+ |+||||||+|||++ ++.
T Consensus 83 ~p~~~~~~~~~iVmE~i~g~~l~~~~~~~---~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 83 CPEPILLKSHVLVMEFIGDDGWAAPRLKD---APLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCcEEEecCCEEEEEEeCCCCCcchhhhc---CCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCc
Confidence 33322233458999999998776543322 3578899999999999999999 6755 99999999999998 578
Q ss_pred eEEeecCccccc
Q 005617 480 SKICDFGICRLV 491 (688)
Q Consensus 480 vKLsDFGla~~~ 491 (688)
++|+|||+|...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999999754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.9e-20 Score=183.28 Aligned_cols=189 Identities=17% Similarity=0.100 Sum_probs=143.1
Q ss_pred ccceeeeccCceEEEEEEECCeEEEEEEEecCCccc----hHHHHHHHHHHHcCC-CCceeeEecccCCCceeEEecCCC
Q 005617 345 SESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQG----QLEFQQEVRVLSKLQ-HPHLVTLLGACPEAWSLVYEYLPN 419 (688)
Q Consensus 345 ~~~~~LG~G~fG~Vykg~~~g~~vAIK~l~~~~~~~----~~~f~~E~~iL~~l~-HpnIV~l~g~~~~~~~LV~E~~~~ 419 (688)
.....||+|+||+||.+...+.+++.+.+.....-. ...|.+|+.+|.+|. |+++++++++ +..+++|+|+.|
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~--~~~~lvmeyI~G 82 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW--DGRHLDRSYLAG 82 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE--cCEEEEEeeecC
Confidence 345789999999999888788999988887654411 224889999999995 5889999886 457999999999
Q ss_pred CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCC-CCCceeeCCCCCeEEeecCccccccCCCCcC
Q 005617 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDL-KPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 420 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDI-Kp~NILLd~~~~vKLsDFGla~~~~~~~~~~ 498 (688)
.+|...+.. ....++.+++.+|.++|..+ |+|||| ||+|||++.++.++|+|||+|..........
T Consensus 83 ~~L~~~~~~----------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 83 AAMYQRPPR----------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred ccHHhhhhh----------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 999764321 12457889999999999976 999999 7999999999999999999998654332100
Q ss_pred CCcc-------ccCCCCCCCCCCChhhhc--cCCCCCcchHhHHHHHHHHHHhCCCCCC
Q 005617 499 PSFH-------RSTAPKGSFPYADPEYHR--TGVLTPKSDSYSFGLIILQLLTGRLPVG 548 (688)
Q Consensus 499 ~~~~-------~~~~~~GT~~Y~APE~~~--~~~~s~ksDVwSfGviL~ELltG~~Pf~ 548 (688)
.-.. .......++.|++|+... ...--+..++++.|+.+|.++||..|.-
T Consensus 150 r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~ 208 (218)
T PRK12274 150 RLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHW 208 (218)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcc
Confidence 0000 011234789999998432 2233367899999999999999998863
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-20 Score=207.11 Aligned_cols=222 Identities=27% Similarity=0.342 Sum_probs=180.4
Q ss_pred eeccCceEEEEE-----EECCeEEEEEEEecCCccc--hHHHHHHHHHHHcCC-CCceeeEecccC--CCceeEEecCCC
Q 005617 350 VGQGGFGCVYKG-----EMLGRTVAIKMLYSHNMQG--QLEFQQEVRVLSKLQ-HPHLVTLLGACP--EAWSLVYEYLPN 419 (688)
Q Consensus 350 LG~G~fG~Vykg-----~~~g~~vAIK~l~~~~~~~--~~~f~~E~~iL~~l~-HpnIV~l~g~~~--~~~~LV~E~~~~ 419 (688)
+|.|.||.|+.+ ...|.-+|+|++++..... ......|..++..++ ||.+|.+..++. ...+++++|..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 799999999864 3347889999997764422 125667899999997 999999998884 458999999999
Q ss_pred CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCC
Q 005617 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 420 gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~ 499 (688)
|.|...+.... .+++.....+...++-++.++|..+ |+|||+|++||+++.+|++++.|||+++..-...
T Consensus 82 g~lft~l~~~~---~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---- 151 (612)
T KOG0603|consen 82 GDLFTRLSKEV---MFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---- 151 (612)
T ss_pred chhhhccccCC---chHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh----
Confidence 99988886654 3566777778889999999999977 9999999999999999999999999999875433
Q ss_pred CccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCccccccCCCCCCCCHHHHH
Q 005617 500 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVAR 579 (688)
Q Consensus 500 ~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~l~~~ld~~~~~~~~~~~~ 579 (688)
..+||..|||||++. .....+|+||||++++||+||-.||.. ++...+-.. ....|.+...
T Consensus 152 ------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~--~~~~~Il~~---------~~~~p~~l~~ 212 (612)
T KOG0603|consen 152 ------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG--DTMKRILKA---------ELEMPRELSA 212 (612)
T ss_pred ------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch--HHHHHHhhh---------ccCCchhhhH
Confidence 228999999999998 678899999999999999999999986 222222111 2245667778
Q ss_pred HHHHHHHHccccCCCCCCCCc
Q 005617 580 RLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 580 ~l~~L~~~Cl~~dP~~RPs~~ 600 (688)
....++..++..+|..|--..
T Consensus 213 ~a~~~~~~l~~r~p~nrLg~~ 233 (612)
T KOG0603|consen 213 EARSLFRQLFKRNPENRLGAG 233 (612)
T ss_pred HHHHHHHHHHhhCHHHHhccC
Confidence 888888889999999887764
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.4e-19 Score=177.94 Aligned_cols=139 Identities=19% Similarity=0.212 Sum_probs=109.9
Q ss_pred eeeeccCceEEEEEEEC-CeEEEEEEEecCCcc--c------------------------hHHHHHHHHHHHcCCCCcee
Q 005617 348 FKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQ--G------------------------QLEFQQEVRVLSKLQHPHLV 400 (688)
Q Consensus 348 ~~LG~G~fG~Vykg~~~-g~~vAIK~l~~~~~~--~------------------------~~~f~~E~~iL~~l~HpnIV 400 (688)
..||+|+||.||+|.+. |..||||+++..... . ...+..|...+.++.|+++.
T Consensus 3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 82 (190)
T cd05145 3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP 82 (190)
T ss_pred ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 57999999999999886 999999999865321 0 11245789999999999875
Q ss_pred eEecccCCCceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhc-cCCCceEeCCCCCCceeeCCCCC
Q 005617 401 TLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS-SKPEKIVHGDLKPQNILLDSELS 479 (688)
Q Consensus 401 ~l~g~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IiHrDIKp~NILLd~~~~ 479 (688)
....+.....+|||||++|+++....... ..++......++.+++.+|.+||+ .+ |+||||||+|||++ ++.
T Consensus 83 ~p~~~~~~~~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~ 155 (190)
T cd05145 83 VPEPILLKKNVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGK 155 (190)
T ss_pred CceEEEecCCEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCC
Confidence 44333333468999999998654432222 346778899999999999999999 66 99999999999999 899
Q ss_pred eEEeecCccccccC
Q 005617 480 SKICDFGICRLVTE 493 (688)
Q Consensus 480 vKLsDFGla~~~~~ 493 (688)
++|+|||++.....
T Consensus 156 ~~liDFG~a~~~~~ 169 (190)
T cd05145 156 PYIIDVSQAVELDH 169 (190)
T ss_pred EEEEEcccceecCC
Confidence 99999999987653
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.5e-20 Score=215.79 Aligned_cols=248 Identities=22% Similarity=0.277 Sum_probs=179.4
Q ss_pred ccceeeeccCceEEEEEEEC--CeEEEEEEEe----cCCc-cc-hHHHHHHHHHHHcCCCCceeeEecccCC--CceeEE
Q 005617 345 SESFKVGQGGFGCVYKGEML--GRTVAIKMLY----SHNM-QG-QLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 345 ~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~----~~~~-~~-~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
.....+|.|++|.|+..... ...++.|... .... .. ...+..|+-+-..++|||++..+..+.+ ...-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 34578999999988877553 3444444332 1111 11 1125567777888999999887766533 233459
Q ss_pred ecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCC
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~ 494 (688)
|||++ +|..++... ..+.-.++..++.|++.|+.|||+.+ |.||||||+|+++..+|.+||+|||.+..+..+
T Consensus 401 E~~~~-Dlf~~~~~~---~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN---GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred hcccH-HHHHHHhcc---cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 99999 999998765 24666788899999999999999977 999999999999999999999999999877543
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccCCCCC-cchHhHHHHHHHHHHhCCCCCCChhhHHHH----hhcCccccccCCC
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTP-KSDSYSFGLIILQLLTGRLPVGLAGEVRRA----VSCGKLSSILDPL 569 (688)
Q Consensus 495 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~-ksDVwSfGviL~ELltG~~Pf~~~~~~~~~----~~~g~l~~~ld~~ 569 (688)
... ........+|+..|+|||++....|.+ ..||||.|++++.|++|+.||.....-... ...+...... .
T Consensus 474 ~e~--~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~--~ 549 (601)
T KOG0590|consen 474 WEK--NIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFE--G 549 (601)
T ss_pred cch--hhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcccccccccc--C
Confidence 211 123457789999999999999999976 699999999999999999999643322111 1111111100 0
Q ss_pred CCCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 570 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 570 ~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
........+.....++.++|+.+|.+|-++.+++
T Consensus 550 ~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~ 583 (601)
T KOG0590|consen 550 PNRLLSLLPRETRIIIYRMLQLDPTKRITIEQIL 583 (601)
T ss_pred hHHHHHhchhhHHHHHHHHccCChhheecHHHHh
Confidence 1111234566788999999999999999998544
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.75 E-value=5e-18 Score=177.00 Aligned_cols=230 Identities=22% Similarity=0.324 Sum_probs=148.7
Q ss_pred CcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCC---C-------c------eee
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQH---P-------H------LVT 401 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~H---p-------n------IV~ 401 (688)
.+..+..||.|+|+.||.+++. |..+|||++..... ...+.+.+|.-....+.+ | . +++
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 3455678999999999999997 69999999865432 234567777665555432 1 1 122
Q ss_pred Eecc---c---C-------CCceeEEecCCCCcHHHHhc---ccCC-CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEe
Q 005617 402 LLGA---C---P-------EAWSLVYEYLPNGSLQDRLF---RKSN-VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464 (688)
Q Consensus 402 l~g~---~---~-------~~~~LV~E~~~~gsL~~~L~---~~~~-~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiH 464 (688)
+-+- + . -+.+++|+-+ -++|.+++. .... ...+....++.+..|+++.+++||..+ ++|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVH 168 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVH 168 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEe
Confidence 2110 0 0 0235677766 567776643 2222 123445566778899999999999976 999
Q ss_pred CCCCCCceeeCCCCCeEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhcc--------CCCCCcchHhHHHHH
Q 005617 465 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT--------GVLTPKSDSYSFGLI 536 (688)
Q Consensus 465 rDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~--------~~~s~ksDVwSfGvi 536 (688)
+||+|+|+|++.+|.++|+||+......... .....+..|.+||.... -.++.+.|.|+||++
T Consensus 169 gdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~---------~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ 239 (288)
T PF14531_consen 169 GDIKPENFLLDQDGGVFLGDFSSLVRAGTRY---------RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGIT 239 (288)
T ss_dssp ST-SGGGEEE-TTS-EEE--GGGEEETTEEE---------EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHH
T ss_pred cccceeeEEEcCCCCEEEcChHHHeecCcee---------eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHH
Confidence 9999999999999999999998876654321 11335578999997643 257889999999999
Q ss_pred HHHHHhCCCCCCChhhHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCC
Q 005617 537 ILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRER 596 (688)
Q Consensus 537 L~ELltG~~Pf~~~~~~~~~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~R 596 (688)
+|.|.+|..||+........ +.....+. .++..+..|+..+|+.||.+|
T Consensus 240 ly~lWC~~lPf~~~~~~~~~----------~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 240 LYSLWCGRLPFGLSSPEADP----------EWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHSS-STCCCGGGSTS----------GGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHHHccCCCCCCCccccc----------cccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 99999999999854431000 00122344 778899999999999999987
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=5.9e-18 Score=170.35 Aligned_cols=134 Identities=22% Similarity=0.302 Sum_probs=103.8
Q ss_pred ccceeeeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcC-----CCCceeeEecccCCC----c-e-eE
Q 005617 345 SESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-----QHPHLVTLLGACPEA----W-S-LV 413 (688)
Q Consensus 345 ~~~~~LG~G~fG~Vykg~~~g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l-----~HpnIV~l~g~~~~~----~-~-LV 413 (688)
+....||+|+||.||.....+.. +||++..........+.+|+.++..+ .||||++++|++.+. . + +|
T Consensus 5 ~~~~~LG~G~~~~Vy~hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 5 SEQSPLGTGRHRKCYAHPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CCcceecCCCceEEEECCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 34578999999999962222344 79998776555667799999999999 579999999998543 1 2 68
Q ss_pred Eec--CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHH-HHHhccCCCceEeCCCCCCceeeCC----CCCeEEeecC
Q 005617 414 YEY--LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGL-CFLHSSKPEKIVHGDLKPQNILLDS----ELSSKICDFG 486 (688)
Q Consensus 414 ~E~--~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL-~yLH~~~~~~IiHrDIKp~NILLd~----~~~vKLsDFG 486 (688)
+|| +++|+|.+++... .++.. ..++.+++.++ .|||+.+ |+||||||+|||++. ++.++|+||+
T Consensus 84 ~e~~G~~~~tL~~~l~~~----~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQC----RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred ecCCCCcchhHHHHHHcc----cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 999 6689999999552 24444 35678888887 8999976 999999999999974 3479999954
Q ss_pred cc
Q 005617 487 IC 488 (688)
Q Consensus 487 la 488 (688)
-+
T Consensus 155 G~ 156 (210)
T PRK10345 155 GE 156 (210)
T ss_pred CC
Confidence 33
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.4e-18 Score=200.10 Aligned_cols=246 Identities=23% Similarity=0.262 Sum_probs=170.6
Q ss_pred CcccceeeeccCceEEEEEEECCeEEEEEEEecCCcc-chHHHH---HHHHHHHcCCCCceeeEecccC--CCceeEEec
Q 005617 343 NFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQ-GQLEFQ---QEVRVLSKLQHPHLVTLLGACP--EAWSLVYEY 416 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~g~~vAIK~l~~~~~~-~~~~f~---~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~ 416 (688)
+|...+.||.+.|=.|.+|+++...|+||++.+.... ....|. .|++ ...++|||++++.-+-. ...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 5666788999999999999998666999999766532 333344 4444 55669999999876642 346788888
Q ss_pred CCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCcccc--ccCC
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL--VTED 494 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~--~~~~ 494 (688)
+ ..+|.|+|.-+ +.+..-+..-|+.|++.||.-+|..+ |+|||||.+||||..-.=+.|+||..-+- ++.+
T Consensus 103 v-khnLyDRlSTR---PFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 V-KHNLYDRLSTR---PFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred H-hhhhhhhhccc---hHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 7 45788887432 33455666778999999999999976 99999999999999988899999986653 2222
Q ss_pred CCcCCCccccCCCCCCCCCCChhhhccC----------C-CCCcchHhHHHHHHHHHHh-CCCCCCChhhHHHHhhcCcc
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRTG----------V-LTPKSDSYSFGLIILQLLT-GRLPVGLAGEVRRAVSCGKL 562 (688)
Q Consensus 495 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~----------~-~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~~~~~~~~g~l 562 (688)
......+...+.. .-..|+|||-|... . ++++.||||+||++.||++ |++||.+..-. +.+.|.
T Consensus 176 NPadf~fFFDTSr-RRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~--aYr~~~- 251 (1431)
T KOG1240|consen 176 NPADFTFFFDTSR-RRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLL--AYRSGN- 251 (1431)
T ss_pred CcccceEEEecCC-ceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHH--hHhccC-
Confidence 2111122222222 23469999976432 2 7889999999999999999 78888754322 122221
Q ss_pred ccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHH
Q 005617 563 SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 563 ~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l 603 (688)
.......+... +...+.+|++.|++.||..|-++.+.+
T Consensus 252 ~~~~e~~Le~I---ed~~~Rnlil~Mi~rdPs~RlSAedyL 289 (1431)
T KOG1240|consen 252 ADDPEQLLEKI---EDVSLRNLILSMIQRDPSKRLSAEDYL 289 (1431)
T ss_pred ccCHHHHHHhC---cCccHHHHHHHHHccCchhccCHHHHH
Confidence 00000000011 122688999999999999999998433
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.71 E-value=4.2e-17 Score=163.65 Aligned_cols=132 Identities=24% Similarity=0.392 Sum_probs=110.5
Q ss_pred eeeeccCceEEEEEEECCeEEEEEEEecCCccc--------hHHHHHHHHHHHcCCCCceeeEecc--cCCCceeEEecC
Q 005617 348 FKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQG--------QLEFQQEVRVLSKLQHPHLVTLLGA--CPEAWSLVYEYL 417 (688)
Q Consensus 348 ~~LG~G~fG~Vykg~~~g~~vAIK~l~~~~~~~--------~~~f~~E~~iL~~l~HpnIV~l~g~--~~~~~~LV~E~~ 417 (688)
+.||+|++|.||+|...|..|+||+........ ...+.+|+.++..++|+||+....+ ..+..++||||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 469999999999999999999999876543221 2357889999999999988665544 456688999999
Q ss_pred CCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCcccc
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~ 490 (688)
+|++|.+.+.... + .+..++.+++.+|.+||..+ ++|+|++|.|||++ ++.++|+|||++..
T Consensus 82 ~G~~L~~~~~~~~------~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 82 EGEPLKDLINSNG------M-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCcCHHHHHHhcc------H-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999885422 2 78899999999999999966 99999999999999 78999999998865
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=1.9e-17 Score=183.02 Aligned_cols=209 Identities=30% Similarity=0.417 Sum_probs=153.7
Q ss_pred HHcCCCCceeeEecccCC--CceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCC
Q 005617 391 LSKLQHPHLVTLLGACPE--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLK 468 (688)
Q Consensus 391 L~~l~HpnIV~l~g~~~~--~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIK 468 (688)
|..+.|.|+.+++|.|.+ ..+.|.+||..|+|.+.+.... ..++|.-...++.+|+.||.|||+.. -..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~--~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNED--IKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccc--cCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 356789999999999854 4678999999999999998743 56899999999999999999999954 23999999
Q ss_pred CCceeeCCCCCeEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccC-------CCCCcchHhHHHHHHHHHH
Q 005617 469 PQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG-------VLTPKSDSYSFGLIILQLL 541 (688)
Q Consensus 469 p~NILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-------~~s~ksDVwSfGviL~ELl 541 (688)
+.|.++|..+.+||+|||+.......... .......-..-|.|||.+... ..+.+.||||||++++|++
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~----~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~ 152 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEP----EAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL 152 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccc----cccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence 99999999999999999998876431100 001111234469999988653 1467899999999999999
Q ss_pred hCCCCCCChh------hHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHHHh
Q 005617 542 TGRLPVGLAG------EVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 542 tG~~Pf~~~~------~~~~~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le~l 610 (688)
+.+.||.... ++...+..+ -...+-|...... .....+..++..||..+|..||++. .+-..++.+
T Consensus 153 ~r~~~~~~~~~~~~~~eii~~~~~~-~~~~~rP~i~~~~-e~~~~l~~l~~~cw~e~P~~rPs~~-~i~~~~~~~ 224 (484)
T KOG1023|consen 153 FRSGPFDLRNLVEDPDEIILRVKKG-GSNPFRPSIELLN-ELPPELLLLVARCWEEIPEKRPSIE-QIRSKLLTI 224 (484)
T ss_pred hccCccccccccCChHHHHHHHHhc-CCCCcCcchhhhh-hcchHHHHHHHHhcccChhhCccHH-HHHhhhhhh
Confidence 9999996422 232333331 1111222211111 3444799999999999999999998 454444443
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=5.2e-17 Score=161.58 Aligned_cols=129 Identities=25% Similarity=0.412 Sum_probs=105.8
Q ss_pred eeeccCceEEEEEEECCeEEEEEEEecCCcc--------chHHHHHHHHHHHcCCCCce--eeEecccCCCceeEEecCC
Q 005617 349 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQ--------GQLEFQQEVRVLSKLQHPHL--VTLLGACPEAWSLVYEYLP 418 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~g~~vAIK~l~~~~~~--------~~~~f~~E~~iL~~l~HpnI--V~l~g~~~~~~~LV~E~~~ 418 (688)
.||+|+||.||+|.+.|..|++|........ ....+.+|+.++..++|+++ ..+++...+..++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 3899999999999999999999997543221 12457789999999988754 4455555666799999999
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccc
Q 005617 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~ 491 (688)
|++|.+.+.... ..++.+++.+|.+||..+ ++|+|++|.||+++ ++.++++|||++...
T Consensus 81 g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 81 GKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999998874421 178999999999999966 99999999999999 899999999998763
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.69 E-value=2.3e-17 Score=190.19 Aligned_cols=210 Identities=23% Similarity=0.284 Sum_probs=143.8
Q ss_pred hcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCCCceeEEecCC
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLP 418 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~~~~LV~E~~~ 418 (688)
..+|..++.|..|+||.||..++. -+.+|+|+ ++.+. ||+ | +.-|.+..+.|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l-----------ilR-----n----ilt~a~npfvv----- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL-----------ILR-----N----ILTFAGNPFVV----- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccch-----------hhh-----c----cccccCCccee-----
Confidence 368888999999999999999887 67899854 32221 111 1 22222333333
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCC-c
Q 005617 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL-Y 497 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~-~ 497 (688)
|+-...+.. .++++- +++.+++|||+.+ |+|||+||+|.||..-|++|++|||+.+...-... .
T Consensus 136 -gDc~tllk~---~g~lPv--------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 -GDCATLLKN---IGPLPV--------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred -chhhhhccc---CCCCcc--------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 333333322 233432 2378999999966 99999999999999999999999999976432110 0
Q ss_pred --------CCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCChhh--HHHHhhcCccccccC
Q 005617 498 --------LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILD 567 (688)
Q Consensus 498 --------~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~--~~~~~~~g~l~~~ld 567 (688)
.........++|||.|+|||++.-..|+..+|||++|+|+||.+.|+.||.+... ....+...
T Consensus 201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd------- 273 (1205)
T KOG0606|consen 201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISD------- 273 (1205)
T ss_pred hhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhh-------
Confidence 0011124567999999999999999999999999999999999999999975421 11111110
Q ss_pred CCCCCCC---HHHHHHHHHHHHHccccCCCCCCCCc
Q 005617 568 PLAGDWP---TFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 568 ~~~~~~~---~~~~~~l~~L~~~Cl~~dP~~RPs~~ 600 (688)
...|| .....++.+++.+.|+.+|.+|--..
T Consensus 274 --~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ 307 (1205)
T KOG0606|consen 274 --DIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTG 307 (1205)
T ss_pred --hccccccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence 01121 12356788999999999999997544
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.69 E-value=8.5e-17 Score=165.30 Aligned_cols=149 Identities=19% Similarity=0.192 Sum_probs=113.2
Q ss_pred HHHHHhcCcccceeeeccCceEEEEEE-E--CCeEEEEEEEecCCcc------------------------chHHHHHHH
Q 005617 336 DLQTATCNFSESFKVGQGGFGCVYKGE-M--LGRTVAIKMLYSHNMQ------------------------GQLEFQQEV 388 (688)
Q Consensus 336 el~~at~~f~~~~~LG~G~fG~Vykg~-~--~g~~vAIK~l~~~~~~------------------------~~~~f~~E~ 388 (688)
.+......|.....||+|+||.||+|. . .|..||||++...... ....+..|+
T Consensus 22 ~~~~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 101 (237)
T smart00090 22 SLLNRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEF 101 (237)
T ss_pred HHHhcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHH
Confidence 333444457888999999999999998 3 4899999998754311 012356899
Q ss_pred HHHHcCCCC--ceeeEecccCCCceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCC
Q 005617 389 RVLSKLQHP--HLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGD 466 (688)
Q Consensus 389 ~iL~~l~Hp--nIV~l~g~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrD 466 (688)
.++.++.+. .+..++++ ...+|||||++|++|...+... ..+.......++.+++.+|.+||..+ .|+|||
T Consensus 102 ~~L~~L~~~~i~~p~~~~~--~~~~lV~E~~~g~~L~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~D 174 (237)
T smart00090 102 RNLQRLYEAGVPVPKPIAW--RRNVLVMEFIGGDGLPAPRLKD---VEPEEEEEFELYDDILEEMRKLYKEG--ELVHGD 174 (237)
T ss_pred HHHHHHHhcCCCCCeeeEe--cCceEEEEEecCCccccccccc---CCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCC
Confidence 999999753 34445543 3458999999999887654322 23455567899999999999999954 399999
Q ss_pred CCCCceeeCCCCCeEEeecCcccccc
Q 005617 467 LKPQNILLDSELSSKICDFGICRLVT 492 (688)
Q Consensus 467 IKp~NILLd~~~~vKLsDFGla~~~~ 492 (688)
|||+||+++ ++.++|+|||++....
T Consensus 175 ikp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 175 LSEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred CChhhEEEE-CCCEEEEEChhhhccC
Confidence 999999999 8899999999987653
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.9e-16 Score=186.10 Aligned_cols=198 Identities=24% Similarity=0.293 Sum_probs=155.0
Q ss_pred HHHHHHhcCcccceeeeccCceEEEEEEEC-CeEEEEEEEecCCccchHHHHHHHHHHHcCC---CCceeeEecc--cCC
Q 005617 335 ADLQTATCNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ---HPHLVTLLGA--CPE 408 (688)
Q Consensus 335 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~-g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~---HpnIV~l~g~--~~~ 408 (688)
.+++.....|.+...||+|+||.||+|... |+.||||+-+.... -+|.-=..++.+|+ -+-|..+..+ |.+
T Consensus 691 ~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~ 767 (974)
T KOG1166|consen 691 TEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHISSAHVFQN 767 (974)
T ss_pred ceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHHHHHccCC
Confidence 345556678888999999999999999775 89999999765432 12222334555665 1223333332 467
Q ss_pred CceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCC-------CCCeE
Q 005617 409 AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS-------ELSSK 481 (688)
Q Consensus 409 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~-------~~~vK 481 (688)
..+||++|.+.|+|-+++. ....++|..+..|+.+++..+..||..+ |||+||||+|+||.. +..++
T Consensus 768 ~S~lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 768 ASVLVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred cceeeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceE
Confidence 8899999999999999997 3356899999999999999999999977 999999999999942 45699
Q ss_pred EeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCC
Q 005617 482 ICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRL 545 (688)
Q Consensus 482 LsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~ 545 (688)
|+|||-+-.+.--. ....-....+|-++-.+|...+..++..+|.|.|.-+++-||.|+.
T Consensus 842 lIDfG~siDm~lfp----~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFP----DGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EEecccceeeeEcC----CCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 99999986543111 1112356778999999999999999999999999999999999974
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.9e-16 Score=157.96 Aligned_cols=144 Identities=23% Similarity=0.212 Sum_probs=111.8
Q ss_pred HHHHHhcCcccceeeeccCceEEEEEEEC-CeEEEEEEEecCCcc----------------------chHHHHHHHHHHH
Q 005617 336 DLQTATCNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQ----------------------GQLEFQQEVRVLS 392 (688)
Q Consensus 336 el~~at~~f~~~~~LG~G~fG~Vykg~~~-g~~vAIK~l~~~~~~----------------------~~~~f~~E~~iL~ 392 (688)
++......|...+.||.|+||.||+|... |..||||++...... ....+..|..++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 44444445777889999999999999885 899999997653310 0113677899999
Q ss_pred cCCCC--ceeeEecccCCCceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCC
Q 005617 393 KLQHP--HLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQ 470 (688)
Q Consensus 393 ~l~Hp--nIV~l~g~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~ 470 (688)
.+.|+ +++..++. ...++||||++|++|...... .....++.+++.++.++|..+ |+||||||.
T Consensus 89 ~l~~~~i~v~~~~~~--~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~ 154 (198)
T cd05144 89 ALYEEGFPVPKPIDW--NRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEF 154 (198)
T ss_pred HHHHcCCCCCceeec--CCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcc
Confidence 99877 44555543 346899999999999765421 235678899999999999965 999999999
Q ss_pred ceeeCCCCCeEEeecCccccccC
Q 005617 471 NILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 471 NILLd~~~~vKLsDFGla~~~~~ 493 (688)
||+++.++.++|+|||++.....
T Consensus 155 Nill~~~~~~~liDfg~~~~~~~ 177 (198)
T cd05144 155 NILVDDDEKIYIIDWPQMVSTDH 177 (198)
T ss_pred cEEEcCCCcEEEEECCccccCCC
Confidence 99999999999999999966543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.8e-17 Score=180.23 Aligned_cols=175 Identities=25% Similarity=0.315 Sum_probs=138.4
Q ss_pred ceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccc
Q 005617 410 WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~ 489 (688)
+++.|++|.-.+|.++|.+.......+|...+.|+.|++.|+.| ++.+|||+||.||++..+..+||.|||+..
T Consensus 331 lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgDFgl~t 404 (516)
T KOG1033|consen 331 LYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT 404 (516)
T ss_pred hhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhhhhhee
Confidence 67899999999999999887777778899999999999999999 359999999999999999999999999998
Q ss_pred cccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHh-CCCCCCChhhHHHHhhcCccccccCC
Q 005617 490 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEVRRAVSCGKLSSILDP 568 (688)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~~~~~~~~g~l~~~ld~ 568 (688)
.........+.....+..+||..||+||.+.+..|+.|+||||||+||+||++ -..++.... ....++.|.+...
T Consensus 405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~~-t~~d~r~g~ip~~--- 480 (516)
T KOG1033|consen 405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERIA-TLTDIRDGIIPPE--- 480 (516)
T ss_pred ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHHH-hhhhhhcCCCChH---
Confidence 87766544445556778899999999999999999999999999999999998 333332111 1122333332210
Q ss_pred CCCCCCHHHHHHHHHHHHHccccCCCCCCCC
Q 005617 569 LAGDWPTFVARRLVDLGLQCCELYGRERPDI 599 (688)
Q Consensus 569 ~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~ 599 (688)
..-++| .-..|+++++.+.|.+||+.
T Consensus 481 ~~~d~p-----~e~~ll~~lls~~p~~RP~~ 506 (516)
T KOG1033|consen 481 FLQDYP-----EEYTLLQQLLSPSPEERPSA 506 (516)
T ss_pred HhhcCc-----HHHHHHHHhcCCCcccCchH
Confidence 011222 34578899999999999944
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.4e-16 Score=165.16 Aligned_cols=200 Identities=21% Similarity=0.270 Sum_probs=139.6
Q ss_pred CCCceeeEecccCCC-----------------------------ceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHH
Q 005617 395 QHPHLVTLLGACPEA-----------------------------WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA 445 (688)
Q Consensus 395 ~HpnIV~l~g~~~~~-----------------------------~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~ 445 (688)
+|||||.+.++|.+. .|+||.-.+ .+|..++.... .+.....-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~~----~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTRH----RSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcCC----CchHHHHHHHH
Confidence 699999999887321 246665553 46777775543 45567788899
Q ss_pred HHHHHHHHHhccCCCceEeCCCCCCceee--CCCC--CeEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhcc
Q 005617 446 EIASGLCFLHSSKPEKIVHGDLKPQNILL--DSEL--SSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521 (688)
Q Consensus 446 qia~aL~yLH~~~~~~IiHrDIKp~NILL--d~~~--~vKLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~ 521 (688)
|+++|+.|||..+ |.|||+|++|||| |+++ .+.|+|||++---.......+-....-...|...-||||++..
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999966 9999999999998 4444 4788999988543332222221122334567888999999865
Q ss_pred CCC------CCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCC
Q 005617 522 GVL------TPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRE 595 (688)
Q Consensus 522 ~~~------s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~ 595 (688)
.+- -.|+|.|+.|.+.||+++...||...+++.-. ...+.+ ..+...|..++..+.+|+...++.||.+
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~--~r~Yqe---~qLPalp~~vpp~~rqlV~~lL~r~psk 500 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD--TRTYQE---SQLPALPSRVPPVARQLVFDLLKRDPSK 500 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheec--hhhhhh---hhCCCCcccCChHHHHHHHHHhcCCccc
Confidence 431 24899999999999999999999753332110 001111 1123345566778889999999999999
Q ss_pred CCCCchHHHHHHH
Q 005617 596 RPDITPSLVKELE 608 (688)
Q Consensus 596 RPs~~~~l~~~Le 608 (688)
||+.. +....|.
T Consensus 501 Rvsp~-iAANvl~ 512 (598)
T KOG4158|consen 501 RVSPN-IAANVLN 512 (598)
T ss_pred cCCcc-HHHhHHH
Confidence 99987 6665555
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.3e-16 Score=182.94 Aligned_cols=141 Identities=25% Similarity=0.338 Sum_probs=114.0
Q ss_pred HHHHHhcCcccceeeeccCceEEEEEEECCeEEEEEEEecCCc--------cchHHHHHHHHHHHcCCCCceeeEeccc-
Q 005617 336 DLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNM--------QGQLEFQQEVRVLSKLQHPHLVTLLGAC- 406 (688)
Q Consensus 336 el~~at~~f~~~~~LG~G~fG~Vykg~~~g~~vAIK~l~~~~~--------~~~~~f~~E~~iL~~l~HpnIV~l~g~~- 406 (688)
........|...+.||+|+||+||+|.+.+..+++|+...... .....+.+|+.++..++|+|++..+.++
T Consensus 327 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~ 406 (535)
T PRK09605 327 KEEEVKRRKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDV 406 (535)
T ss_pred cccccccccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEE
Confidence 3344455667788999999999999999877777765432211 1124588999999999999988766554
Q ss_pred -CCCceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeec
Q 005617 407 -PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDF 485 (688)
Q Consensus 407 -~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDF 485 (688)
.+..++||||++|++|.+++. ....++.+++.+|.|||+.+ |+||||||+|||+ .++.++|+||
T Consensus 407 ~~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDF 471 (535)
T PRK09605 407 DPEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDF 471 (535)
T ss_pred eCCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeC
Confidence 446889999999999999874 35778999999999999966 9999999999999 6789999999
Q ss_pred Cccccc
Q 005617 486 GICRLV 491 (688)
Q Consensus 486 Gla~~~ 491 (688)
|+++..
T Consensus 472 Gla~~~ 477 (535)
T PRK09605 472 GLGKYS 477 (535)
T ss_pred cccccC
Confidence 999764
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.4e-15 Score=139.35 Aligned_cols=132 Identities=23% Similarity=0.230 Sum_probs=112.7
Q ss_pred ceeeeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcCCC--CceeeEecccCC--CceeEEecCCCCcH
Q 005617 347 SFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQH--PHLVTLLGACPE--AWSLVYEYLPNGSL 422 (688)
Q Consensus 347 ~~~LG~G~fG~Vykg~~~g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~H--pnIV~l~g~~~~--~~~LV~E~~~~gsL 422 (688)
.+.||.|+++.||++...+..++||....... ...+..|+.++..++| ++++++++++.. ..+++|||++++++
T Consensus 3 ~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~ 80 (155)
T cd05120 3 IKLLKGGLTNRVYLLGTKDEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETL 80 (155)
T ss_pred ceecccccccceEEEEecCCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeec
Confidence 46799999999999999888999999865543 5578899999999976 588888887754 68999999998877
Q ss_pred HHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCcccc
Q 005617 423 QDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 423 ~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~ 490 (688)
... +......++.+++.+|.+||.....+++|+|++|.||+++..+.++++|||.+..
T Consensus 81 ~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 81 DEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 543 4466778899999999999997656799999999999999999999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.3e-15 Score=146.15 Aligned_cols=136 Identities=23% Similarity=0.264 Sum_probs=97.0
Q ss_pred ceeeeccCceEEEEEEEC-CeEEEEEEEecCCccc--hHH----------------------HHHHHHHHHcCCCCc--e
Q 005617 347 SFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQG--QLE----------------------FQQEVRVLSKLQHPH--L 399 (688)
Q Consensus 347 ~~~LG~G~fG~Vykg~~~-g~~vAIK~l~~~~~~~--~~~----------------------f~~E~~iL~~l~Hpn--I 399 (688)
.+.||+|+||.||+|... |..||||++....... ... ...|...+..+.+.+ +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 357999999999999887 8999999987643211 111 134566666664432 3
Q ss_pred eeEecccCCCceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhc-cCCCceEeCCCCCCceeeCCCC
Q 005617 400 VTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS-SKPEKIVHGDLKPQNILLDSEL 478 (688)
Q Consensus 400 V~l~g~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~-~~~~~IiHrDIKp~NILLd~~~ 478 (688)
.+.+++ ...++||||++++.+......... .. .....++.+++.++.++|. .+ |+|+||||+||+++ ++
T Consensus 82 ~~~~~~--~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 82 PKPIDL--NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DG 151 (187)
T ss_pred CceEec--CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CC
Confidence 444433 346899999999544321111100 01 4578899999999999999 55 99999999999999 89
Q ss_pred CeEEeecCcccccc
Q 005617 479 SSKICDFGICRLVT 492 (688)
Q Consensus 479 ~vKLsDFGla~~~~ 492 (688)
.++|+|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 99999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.54 E-value=4e-14 Score=145.71 Aligned_cols=134 Identities=22% Similarity=0.219 Sum_probs=105.3
Q ss_pred ceeee-ccCceEEEEEEECCeEEEEEEEecCCc-------------cchHHHHHHHHHHHcCCCCce--eeEecccCC--
Q 005617 347 SFKVG-QGGFGCVYKGEMLGRTVAIKMLYSHNM-------------QGQLEFQQEVRVLSKLQHPHL--VTLLGACPE-- 408 (688)
Q Consensus 347 ~~~LG-~G~fG~Vykg~~~g~~vAIK~l~~~~~-------------~~~~~f~~E~~iL~~l~HpnI--V~l~g~~~~-- 408 (688)
...|| .||.|+||.+...+..++||.+..... .....+.+|+.++.+++|++| +..++++..
T Consensus 36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 35798 999999999999999999998854211 123457889999999998775 666665421
Q ss_pred ----CceeEEecCCC-CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEe
Q 005617 409 ----AWSLVYEYLPN-GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKIC 483 (688)
Q Consensus 409 ----~~~LV~E~~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLs 483 (688)
..++||||++| .+|.+++... +++.. .+.+++.+|.+||..+ |+||||||.|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~~----~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQEA----PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhcC----CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 13599999998 6898887542 34432 3678999999999976 9999999999999999999999
Q ss_pred ecCccccc
Q 005617 484 DFGICRLV 491 (688)
Q Consensus 484 DFGla~~~ 491 (688)
|||.+...
T Consensus 185 Dfg~~~~~ 192 (239)
T PRK01723 185 DFDRGELR 192 (239)
T ss_pred ECCCcccC
Confidence 99988653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.48 E-value=4.9e-15 Score=170.52 Aligned_cols=247 Identities=23% Similarity=0.314 Sum_probs=180.4
Q ss_pred cCcccceeeeccCceEEEEEEEC---CeEEEEEEEecCC--ccchHHHHHHHHHHHcCC-CCceeeEecccC--CCceeE
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML---GRTVAIKMLYSHN--MQGQLEFQQEVRVLSKLQ-HPHLVTLLGACP--EAWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~---g~~vAIK~l~~~~--~~~~~~f~~E~~iL~~l~-HpnIV~l~g~~~--~~~~LV 413 (688)
..|.....||+|+|+.|-..... ...+|+|.+.... .........|..+-..+. |+|++.+++... +..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 34566677999999999877664 4457777665443 122233445777777776 999999999874 457899
Q ss_pred EecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHh-ccCCCceEeCCCCCCceeeCCCC-CeEEeecCccccc
Q 005617 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLH-SSKPEKIVHGDLKPQNILLDSEL-SSKICDFGICRLV 491 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH-~~~~~~IiHrDIKp~NILLd~~~-~vKLsDFGla~~~ 491 (688)
.+|..+|++.+.+.... ....+-...-.++.|+..++.|+| ..+ +.||||||+|.+++..+ ..+++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~~~-~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHPD-STGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccccCC-ccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 99999999988884221 113444667788999999999999 644 99999999999999999 9999999999987
Q ss_pred cC-CCCcCCCccccCCCCC-CCCCCChhhhcc-CCCCCcchHhHHHHHHHHHHhCCCCCCChhhHHHHhhcCccccccCC
Q 005617 492 TE-DTLYLPSFHRSTAPKG-SFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDP 568 (688)
Q Consensus 492 ~~-~~~~~~~~~~~~~~~G-T~~Y~APE~~~~-~~~s~ksDVwSfGviL~ELltG~~Pf~~~~~~~~~~~~g~l~~~ld~ 568 (688)
.. .... ......+| ++.|+|||...+ ....+..|+||.|+++.-+++|..|+....... +........
T Consensus 176 ~~~~g~~----~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-----~~~~~~~~~ 246 (601)
T KOG0590|consen 176 RNKNGAE----RSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-----GRYSSWKSN 246 (601)
T ss_pred cccCCcc----eeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-----ccceeeccc
Confidence 66 3321 22345567 999999998877 456789999999999999999999987543321 111111111
Q ss_pred C---CCCCCHHHHHHHHHHHHHccccCCCCCCCCch
Q 005617 569 L---AGDWPTFVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 569 ~---~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~ 601 (688)
. ..............+..+++..+|..|.+..+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~ 282 (601)
T KOG0590|consen 247 KGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEE 282 (601)
T ss_pred ccccccCccccCChhhhhcccccccCCchhcccccc
Confidence 0 01112234567788888999999999999873
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.40 E-value=8.7e-13 Score=127.31 Aligned_cols=130 Identities=20% Similarity=0.151 Sum_probs=101.0
Q ss_pred eeeeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcCCCCce-eeEecccCCCceeEEecCCCCcHHHHh
Q 005617 348 FKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHL-VTLLGACPEAWSLVYEYLPNGSLQDRL 426 (688)
Q Consensus 348 ~~LG~G~fG~Vykg~~~g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnI-V~l~g~~~~~~~LV~E~~~~gsL~~~L 426 (688)
..|+.|.++.||++...|..|++|+...... ....+..|+.++..+.+.++ .++++++.+..++||||++|.++....
T Consensus 4 ~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~~~ 82 (170)
T cd05151 4 SPLKGGMTNKNYRVEVANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLTED 82 (170)
T ss_pred eecCCcccCceEEEEECCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCcccccc
Confidence 5689999999999999999999999765432 22356789999999865554 445666555678999999999876430
Q ss_pred cccCCCCCCCHHHHHHHHHHHHHHHHHHhccC--CCceEeCCCCCCceeeCCCCCeEEeecCcccc
Q 005617 427 FRKSNVSPLLWKDRARIAAEIASGLCFLHSSK--PEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 427 ~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~--~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~ 490 (688)
.....++.+++.+|..||..+ +..++|+|++|.||+++ ++.++++|||.+..
T Consensus 83 -----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 83 -----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred -----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 011345678999999999976 34579999999999999 67899999998754
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.39 E-value=8.7e-13 Score=147.28 Aligned_cols=137 Identities=23% Similarity=0.290 Sum_probs=98.6
Q ss_pred eeeeccCceEEEEEEEC-CeEEEEEEEecCCccc----------------------------------------hHHHHH
Q 005617 348 FKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQG----------------------------------------QLEFQQ 386 (688)
Q Consensus 348 ~~LG~G~fG~Vykg~~~-g~~vAIK~l~~~~~~~----------------------------------------~~~f~~ 386 (688)
..||.|++|.||+|++. |+.||||+.++..... ..+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 67999999999999985 9999999986542110 012556
Q ss_pred HHHHHHcCC-----CCce--eeEecccCCCceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHH-HHHHHhccC
Q 005617 387 EVRVLSKLQ-----HPHL--VTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIAS-GLCFLHSSK 458 (688)
Q Consensus 387 E~~iL~~l~-----HpnI--V~l~g~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~-aL~yLH~~~ 458 (688)
|...+.+++ ++++ .+++..+....+|||||++|++|.+....... .+ .+..++..++. .+..+|..+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhCC
Confidence 666666652 3332 23333334568999999999999887643211 11 23456666666 467888755
Q ss_pred CCceEeCCCCCCceeeCCCCCeEEeecCcccccc
Q 005617 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 492 (688)
Q Consensus 459 ~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~ 492 (688)
++|+|+||.||+++.++.++|+|||++..+.
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999987664
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PF04564 U-box: U-box domain; InterPro: IPR003613 Quality control of intracellular proteins is essential for cellular homeostasis | Back alignment and domain information |
|---|
Probab=99.32 E-value=5.5e-13 Score=111.39 Aligned_cols=70 Identities=46% Similarity=0.847 Sum_probs=61.8
Q ss_pred CCCcccchhhhhhhcCCCcCCCCccccccchhhhhccCCCCCCCcccccCCCCCCcchHHHHHHHHHhhh
Q 005617 618 VPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDWLCK 687 (688)
Q Consensus 618 ~Ps~~l~Pilqeim~dP~v~~dg~tye~~~I~~wl~~g~~~SPmtn~~l~~~~l~Pn~~lr~~~~~~~~~ 687 (688)
+|..|.||+..++|.||.+.++|.+|+..+|..|+..++.++|+|+..++..+|+||.+||++|++|+++
T Consensus 1 iP~~f~CpIt~~lM~dPVi~~~G~tyer~~I~~~l~~~~~~~P~t~~~l~~~~l~pn~~Lk~~I~~~~~~ 70 (73)
T PF04564_consen 1 IPDEFLCPITGELMRDPVILPSGHTYERSAIERWLEQNGGTDPFTRQPLSESDLIPNRALKSAIEEWCAE 70 (73)
T ss_dssp SSGGGB-TTTSSB-SSEEEETTSEEEEHHHHHHHHCTTSSB-TTT-SB-SGGGSEE-HHHHHHHHHHHHH
T ss_pred CCcccCCcCcCcHhhCceeCCcCCEEcHHHHHHHHHcCCCCCCCCCCcCCcccceECHHHHHHHHHHHHH
Confidence 5889999999999999999999999999999999999889999999999999999999999999999975
|
Molecular chaperones recognise and contribute to the refolding of misfolded or unfolded proteins, whereas the ubiquitin-proteasome system mediates the degradation of such abnormal proteins. Ubiquitin-protein ligases (E3s) determine the substrate specificity for ubiquitylation and have been classified into HECT and RING-finger families. More recently, however, U-box proteins, which contain a domain (the U box) of about 70 amino acids that is conserved from yeast to humans, have been identified as a new type of E3 []. Members of the U-box family of proteins constitute a class of ubiquitin-protein ligases (E3s) distinct from the HECT-type and RING finger-containing E3 families []. Using yeast two-hybrid technology, all mammalian U-box proteins have been reported to interact with molecular chaperones or co-chaperones, including Hsp90, Hsp70, DnaJc7, EKN1, CRN, and VCP. This suggests that the function of U box-type E3s is to mediate the degradation of unfolded or misfolded proteins in conjunction with molecular chaperones as receptors that recognise such abnormal proteins [, ]. Unlike the RING finger domain, IPR001841 from INTERPRO, that is stabilised by Zn2+ ions coordinated by the cysteines and a histidine, the U-box scaffold is probably stabilised by a system of salt-bridges and hydrogen bonds. The charged and polar residues that participate in this network of bonds are more strongly conserved in the U-box proteins than in classic RING fingers, which supports their role in maintaining the stability of the U box. Thus, the U box appears to have evolved from a RING finger domain by appropriation of a new set of residues required to stabilise its structure, concomitant with the loss of the original, metal-chelating residues [].; GO: 0004842 ubiquitin-protein ligase activity, 0016567 protein ubiquitination, 0000151 ubiquitin ligase complex; PDB: 1T1H_A 2C2L_D 2C2V_V 1WGM_A 2KR4_A 3L1Z_B 3L1X_A 2KRE_A 3M63_A 2QIZ_A .... |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.22 E-value=8.4e-12 Score=128.83 Aligned_cols=203 Identities=22% Similarity=0.259 Sum_probs=139.2
Q ss_pred HHHHcCCCCceeeEecccCCC-------ceeEEecCCCCcHHHHhcccC-CCCCCCHHHHHHHHHHHHHHHHHHhccCCC
Q 005617 389 RVLSKLQHPHLVTLLGACPEA-------WSLVYEYLPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKPE 460 (688)
Q Consensus 389 ~iL~~l~HpnIV~l~g~~~~~-------~~LV~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~i~~qia~aL~yLH~~~~~ 460 (688)
+-|-.+-|-|||++..|+.+. ..++.|||..|+|..+|.+.. ....+....-.+|+.||..||.|||+.. +
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~-P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCD-P 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccC-C
Confidence 345566799999999988542 468999999999999997643 3345666667789999999999999987 6
Q ss_pred ceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHH
Q 005617 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQL 540 (688)
Q Consensus 461 ~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~EL 540 (688)
+|+|+++..+-|++..+|-+|+.----.. ... ..............|-++|.+||+=.....+..+|||+||...+||
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~ap~s-~h~-s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDS-THP-SVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred ccccCCcchhheeecCCceEEecccCccc-cch-hhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 89999999999999999988886321111 000 0000011123344578899999998888888999999999999999
Q ss_pred HhCCCC-CCChhhHHHHhhcCc-cccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHH
Q 005617 541 LTGRLP-VGLAGEVRRAVSCGK-LSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 605 (688)
Q Consensus 541 ltG~~P-f~~~~~~~~~~~~g~-l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~ 605 (688)
-.|..- -.....+.......+ +..+-++ .-..++..|++..|..||+|+.++.+
T Consensus 276 ailEiq~tnseS~~~~ee~ia~~i~~len~-----------lqr~~i~kcl~~eP~~rp~ar~llfH 331 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEENIANVIIGLENG-----------LQRGSITKCLEGEPNGRPDARLLLFH 331 (458)
T ss_pred HHheeccCCCcceeehhhhhhhheeeccCc-----------cccCcCcccccCCCCCCcchhhhhcC
Confidence 887643 222111111111111 0011011 11345678999999999999965543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.9e-11 Score=135.86 Aligned_cols=243 Identities=25% Similarity=0.250 Sum_probs=168.5
Q ss_pred Ccccceeeec--cCceEEEEEEE--C--CeEEEEEEE--ecCCccchHHHHHHHHHHHcC-CCCceeeEecccCCC--ce
Q 005617 343 NFSESFKVGQ--GGFGCVYKGEM--L--GRTVAIKML--YSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACPEA--WS 411 (688)
Q Consensus 343 ~f~~~~~LG~--G~fG~Vykg~~--~--g~~vAIK~l--~~~~~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~~--~~ 411 (688)
.|.....+|. |.+|.||.+.. . +..+|+|.- ..........=.+|+....++ .|+|.|+.+..+.+. .+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3455677999 99999999877 3 788999973 333223333334566666667 499999988877543 44
Q ss_pred eEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHH----HHHHHhccCCCceEeCCCCCCceeeCCC-CCeEEeecC
Q 005617 412 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIAS----GLCFLHSSKPEKIVHGDLKPQNILLDSE-LSSKICDFG 486 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~----aL~yLH~~~~~~IiHrDIKp~NILLd~~-~~vKLsDFG 486 (688)
+-+|++ +.+|..+.+.... .++....+.+..+... ||.++|+.. ++|-|+||.||++..+ ...+++|||
T Consensus 195 iqtE~~-~~sl~~~~~~~~~--~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELC-GESLQSYCHTPCN--FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeeccc-cchhHHhhhcccc--cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence 555555 5777777665442 2444556666666666 999999966 9999999999999999 889999999
Q ss_pred ccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCCh-hhHHHHhhcCccccc
Q 005617 487 ICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLA-GEVRRAVSCGKLSSI 565 (688)
Q Consensus 487 la~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~~-~~~~~~~~~g~l~~~ 565 (688)
+...+.+..... .........|...|++||... +-++...|+|++|.++++..+|..+.... ...|..+..+-+..
T Consensus 269 ~v~~i~~~~~~~-~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~- 345 (524)
T KOG0601|consen 269 LVSKISDGNFSS-VFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPL- 345 (524)
T ss_pred eeEEccCCcccc-ceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCch-
Confidence 999887655322 222334457888999999764 56889999999999999999987665321 12222222222111
Q ss_pred cCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCc
Q 005617 566 LDPLAGDWPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 566 ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~ 600 (688)
++-......+..++.++++.+|..|++..
T Consensus 346 ------e~~~~~s~~l~~~~~~~~d~~~~~~~~~q 374 (524)
T KOG0601|consen 346 ------EFCEGGSSSLRSVTSQMLDEDPRLRLTAQ 374 (524)
T ss_pred ------hhhcCcchhhhhHHHHhcCcchhhhhHHH
Confidence 11112234555588999999999999876
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.16 E-value=7.2e-11 Score=133.94 Aligned_cols=141 Identities=17% Similarity=0.232 Sum_probs=92.4
Q ss_pred cCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCcc----------------------------------------
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ---------------------------------------- 379 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~~---------------------------------------- 379 (688)
..|+. ..||.|++|.||+|++. |+.||||++++....
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 44665 68999999999999985 899999999754210
Q ss_pred chHHHHHHHHHHHcCC----CCceee---EecccCCCceeEEecCCCCcHHHHh--cccC-CCCCCCHHHHHHHHHHHHH
Q 005617 380 GQLEFQQEVRVLSKLQ----HPHLVT---LLGACPEAWSLVYEYLPNGSLQDRL--FRKS-NVSPLLWKDRARIAAEIAS 449 (688)
Q Consensus 380 ~~~~f~~E~~iL~~l~----HpnIV~---l~g~~~~~~~LV~E~~~~gsL~~~L--~~~~-~~~~l~~~~~~~i~~qia~ 449 (688)
...+|.+|+..+.+++ +.+.|. +|.-+....+|||||+.|+.+.+.- ...+ ....+....+..++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH--
Confidence 0012455665555553 333333 3333345678999999999998742 2211 00112222222223333
Q ss_pred HHHHHhccCCCceEeCCCCCCceeeCCCC----CeEEeecCccccccC
Q 005617 450 GLCFLHSSKPEKIVHGDLKPQNILLDSEL----SSKICDFGICRLVTE 493 (688)
Q Consensus 450 aL~yLH~~~~~~IiHrDIKp~NILLd~~~----~vKLsDFGla~~~~~ 493 (688)
.. .+++|+|+||.||+++.+| .+++.|||++..++.
T Consensus 277 -----f~---~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 -----FR---DGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred -----Hh---CCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 23 3599999999999999888 999999999987754
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.6e-11 Score=142.75 Aligned_cols=249 Identities=21% Similarity=0.193 Sum_probs=173.7
Q ss_pred HhcCcccceeeeccCceEEEEEEEC--CeEEEEEEEecCCc---cchHHHHHHHHHHHcCCCCceeeEecc--cCCCcee
Q 005617 340 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGA--CPEAWSL 412 (688)
Q Consensus 340 at~~f~~~~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~--~~~~~~L 412 (688)
.-+.|...+-+-+|.+|.++.+.-. |...++|+.....+ ........+-.++-..++|-++..... |....+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 3356666677889999999977554 44555555433321 112223334444444567778777666 4667899
Q ss_pred EEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCcccccc
Q 005617 413 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 492 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~ 492 (688)
|++|+.+++|...|+... ..+.......+..+..+++|||... ++|+|++|.|+|...+|+.+++|||......
T Consensus 882 ~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence 999999999999987654 2333444556677889999999955 8999999999999999999999998443221
Q ss_pred CC---CCc-----------------CCC-----ccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCC
Q 005617 493 ED---TLY-----------------LPS-----FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPV 547 (688)
Q Consensus 493 ~~---~~~-----------------~~~-----~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf 547 (688)
.- ... .+. ........||+.|.+||...+......+|+|++|++++|.++|.+||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00 000 000 01234678999999999999999999999999999999999999999
Q ss_pred CChhh--HHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCc
Q 005617 548 GLAGE--VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 548 ~~~~~--~~~~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~ 600 (688)
..... +...+..+.+. ....+........+++...+..+|.+|-.+.
T Consensus 1036 na~tpq~~f~ni~~~~~~------~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRDIP------WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred CCcchhhhhhccccCCCC------CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 75432 22222222221 1223344566778888889999999998876
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.13 E-value=3.6e-10 Score=113.50 Aligned_cols=139 Identities=24% Similarity=0.338 Sum_probs=108.7
Q ss_pred eeeeccCceEEEEEEECC-eEEEEEEEecCCc-cchHHHHHHHHHHHcCCC--CceeeEecccCC-----CceeEEecCC
Q 005617 348 FKVGQGGFGCVYKGEMLG-RTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQH--PHLVTLLGACPE-----AWSLVYEYLP 418 (688)
Q Consensus 348 ~~LG~G~fG~Vykg~~~g-~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~H--pnIV~l~g~~~~-----~~~LV~E~~~ 418 (688)
..||.|.++.||++...+ ..+++|....... .....+..|+.++..+++ .++.++++++.+ ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 468999999999998875 8999999765432 234568899999999975 445667777754 4589999999
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccC----------------------------------------
Q 005617 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK---------------------------------------- 458 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~---------------------------------------- 458 (688)
|+++.+.+.. ..++......++.+++.+|.+||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988776532 24566777888888888888888531
Q ss_pred -------------CCceEeCCCCCCceeeCC--CCCeEEeecCcccc
Q 005617 459 -------------PEKIVHGDLKPQNILLDS--ELSSKICDFGICRL 490 (688)
Q Consensus 459 -------------~~~IiHrDIKp~NILLd~--~~~vKLsDFGla~~ 490 (688)
+..++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 246899999999999998 66789999998754
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.3e-09 Score=108.33 Aligned_cols=136 Identities=15% Similarity=0.115 Sum_probs=98.0
Q ss_pred eeeeccCceEEEEEEEC--------CeEEEEEEEecCCc----------------------cchHHHH----HHHHHHHc
Q 005617 348 FKVGQGGFGCVYKGEML--------GRTVAIKMLYSHNM----------------------QGQLEFQ----QEVRVLSK 393 (688)
Q Consensus 348 ~~LG~G~fG~Vykg~~~--------g~~vAIK~l~~~~~----------------------~~~~~f~----~E~~iL~~ 393 (688)
..||.|--+.||.|... +..+|||+.+.... .....+. +|...|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 46899999999999754 36899998753210 0012233 89999999
Q ss_pred CC--CCceeeEecccCCCceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHH-hccCCCceEeCCCCCC
Q 005617 394 LQ--HPHLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFL-HSSKPEKIVHGDLKPQ 470 (688)
Q Consensus 394 l~--HpnIV~l~g~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yL-H~~~~~~IiHrDIKp~ 470 (688)
+. .-++..++++ ...+|||||+.++.+....... ..++......+..+++.+|..| |..+ |||+||++.
T Consensus 83 l~~~Gv~vP~pi~~--~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs~~ 154 (197)
T cd05146 83 MQKAGIPCPEVVVL--KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLSEY 154 (197)
T ss_pred HHHcCCCCCeEEEe--cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHH
Confidence 85 3566666654 6788999999876443221111 1234455677889999999999 7755 999999999
Q ss_pred ceeeCCCCCeEEeecCcccccc
Q 005617 471 NILLDSELSSKICDFGICRLVT 492 (688)
Q Consensus 471 NILLd~~~~vKLsDFGla~~~~ 492 (688)
|||++ ++.++|+|||.+....
T Consensus 155 NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 155 NMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred HEEEE-CCcEEEEECCCceeCC
Confidence 99997 4689999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.3e-09 Score=105.56 Aligned_cols=129 Identities=26% Similarity=0.380 Sum_probs=103.8
Q ss_pred eeeccCceEEEEEEECCeEEEEEEEecCCc-c-c------hHHHHHHHHHHHcCC--CCceeeEecccCCCceeEEecCC
Q 005617 349 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNM-Q-G------QLEFQQEVRVLSKLQ--HPHLVTLLGACPEAWSLVYEYLP 418 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~g~~vAIK~l~~~~~-~-~------~~~f~~E~~iL~~l~--HpnIV~l~g~~~~~~~LV~E~~~ 418 (688)
.|++|+-+.+|.+.+.|..+++|.-.+... . . ...-.+|..+|++++ --+...+|.+.++...|+|||++
T Consensus 3 ~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~ 82 (204)
T COG3642 3 LIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIE 82 (204)
T ss_pred hhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeC
Confidence 588999999999988888888886433221 1 1 124678999999985 45666777777888999999999
Q ss_pred CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccc
Q 005617 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~ 491 (688)
|..|.+.+... ...++..|-.-+.-||..+ |||+||.++||++..++ +.++||||+..-
T Consensus 83 G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 83 GELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred ChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCccccc
Confidence 99999988653 3567788888899999977 99999999999998765 999999998753
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.2e-10 Score=129.47 Aligned_cols=246 Identities=22% Similarity=0.204 Sum_probs=171.5
Q ss_pred cccCHHH-HHHHhcCcccceeeeccCceEEEEEEEC---CeEEEEEEEecCCccchHH--HHHHHHHHHcC-CCCceeeE
Q 005617 330 AEFSLAD-LQTATCNFSESFKVGQGGFGCVYKGEML---GRTVAIKMLYSHNMQGQLE--FQQEVRVLSKL-QHPHLVTL 402 (688)
Q Consensus 330 ~~~~~~e-l~~at~~f~~~~~LG~G~fG~Vykg~~~---g~~vAIK~l~~~~~~~~~~--f~~E~~iL~~l-~HpnIV~l 402 (688)
..|...+ ...-+.+|.....||.|.|+.||....+ +..|++|.+.........+ -..|+-+...+ .|.+++..
T Consensus 252 ~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~ 331 (524)
T KOG0601|consen 252 NIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGK 331 (524)
T ss_pred heecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCC
Confidence 3344445 4555678999999999999999987654 6789999876543322222 23466666565 58888887
Q ss_pred eccc--CCCceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCC-CC
Q 005617 403 LGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE-LS 479 (688)
Q Consensus 403 ~g~~--~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~-~~ 479 (688)
+..+ ....++-.|||.++++...+.-. ..+....++++..+++.++.++|+.. ++|+|+||+||++..+ +.
T Consensus 332 ~~~W~~~r~~~ip~e~~~~~s~~l~~~~~---~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~ 405 (524)
T KOG0601|consen 332 NSSWSQLRQGYIPLEFCEGGSSSLRSVTS---QMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFF 405 (524)
T ss_pred CCCccccccccCchhhhcCcchhhhhHHH---HhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhh
Confidence 7655 34577899999999988766322 23455668899999999999999855 9999999999999886 88
Q ss_pred eEEeecCccccccCCCCcCCCccccCCCCCCCCC-CChhhhccCCCCCcchHhHHHHHHHHHHhCCCC-CCChhhHHHHh
Q 005617 480 SKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY-ADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP-VGLAGEVRRAV 557 (688)
Q Consensus 480 vKLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y-~APE~~~~~~~s~ksDVwSfGviL~ELltG~~P-f~~~~~~~~~~ 557 (688)
.+++|||++..+.-.. .....++..| .+|.......+..+.|+||||.-+.+.++|..- .....+ ..+
T Consensus 406 ~~~~~~~~~t~~~~~~--------~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~--~~i 475 (524)
T KOG0601|consen 406 SKLGDFGCWTRLAFSS--------GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS--LTI 475 (524)
T ss_pred hhccccccccccceec--------ccccccccccccchhhccccccccccccccccccccccccCcccCcccccc--eee
Confidence 9999999987532111 1112233334 355566677889999999999999999999753 222222 222
Q ss_pred hcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCc
Q 005617 558 SCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 558 ~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~ 600 (688)
..|.+. ..+. ....+..+...+...++..||.+.
T Consensus 476 ~~~~~p--------~~~~-~~~~~q~~~kv~~~~~~~~~~l~~ 509 (524)
T KOG0601|consen 476 RSGDTP--------NLPG-LKLQLQVLLKVMINPDRKRRPSAV 509 (524)
T ss_pred eccccc--------CCCc-hHHhhhhhhhhhcCCccccchhhh
Confidence 222221 1122 236778888889999999999876
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.1e-08 Score=109.17 Aligned_cols=251 Identities=20% Similarity=0.280 Sum_probs=164.1
Q ss_pred cceeeeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcC-CCCceee--------EecccCCC-ceeEEe
Q 005617 346 ESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVT--------LLGACPEA-WSLVYE 415 (688)
Q Consensus 346 ~~~~LG~G~fG~Vykg~~~g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l-~HpnIV~--------l~g~~~~~-~~LV~E 415 (688)
.+..||+||-+.+|-.---+..| -|+.+......+.+ .+..|... .||-+-. |+|--... ..+.|.
T Consensus 15 ~gr~LgqGgea~ly~l~e~~d~V-AKIYh~Pppa~~aq---k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP 90 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVRDQV-AKIYHAPPPAAQAQ---KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMP 90 (637)
T ss_pred CCccccCCccceeeecchhhchh-heeecCCCchHHHH---HHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecc
Confidence 34679999999999543323333 36665544433332 23334444 4554332 22222222 457777
Q ss_pred cCCCCcHHHHhc----ccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccc
Q 005617 416 YLPNGSLQDRLF----RKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491 (688)
Q Consensus 416 ~~~~gsL~~~L~----~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~ 491 (688)
.+++..--..+. +........|.-.++.+..+|.+.+.||..| .+-+|+.++|+|+.+++.+.|.|-..-...
T Consensus 91 ~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~ 167 (637)
T COG4248 91 KVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQIN 167 (637)
T ss_pred cCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeec
Confidence 777753222222 2334567899999999999999999999977 888999999999999999999974433222
Q ss_pred cCCCCcCCCccccCCCCCCCCCCChhhh-----ccCCCCCcchHhHHHHHHHHHHhC-CCCCCChh-------hHHHHhh
Q 005617 492 TEDTLYLPSFHRSTAPKGSFPYADPEYH-----RTGVLTPKSDSYSFGLIILQLLTG-RLPVGLAG-------EVRRAVS 558 (688)
Q Consensus 492 ~~~~~~~~~~~~~~~~~GT~~Y~APE~~-----~~~~~s~ksDVwSfGviL~ELltG-~~Pf~~~~-------~~~~~~~ 558 (688)
.++. .....+|...|.+||.- .+..-+...|.|.|||++|+||.| +.||.+.. ..+..+.
T Consensus 168 ~ng~-------~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia 240 (637)
T COG4248 168 ANGT-------LHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIA 240 (637)
T ss_pred cCCc-------eEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhh
Confidence 2222 23467899999999954 344567889999999999999997 99997432 2333455
Q ss_pred cCccccccC------CCCCCCCHH-HHHHHHHHHHHcccc--CCCCCCCCchHHHHHHHHhh
Q 005617 559 CGKLSSILD------PLAGDWPTF-VARRLVDLGLQCCEL--YGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 559 ~g~l~~~ld------~~~~~~~~~-~~~~l~~L~~~Cl~~--dP~~RPs~~~~l~~~Le~l~ 611 (688)
.|.+...-| +..+.||-. ....+..|..+|+.. ++.-||+.. ..+..|..+.
T Consensus 241 ~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~-aW~aAl~al~ 301 (637)
T COG4248 241 HGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK-AWVAALDALR 301 (637)
T ss_pred cceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH-HHHHHHHHHH
Confidence 555443333 223445443 355777888888874 367899987 6666665553
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.93 E-value=1.2e-08 Score=98.65 Aligned_cols=142 Identities=24% Similarity=0.310 Sum_probs=103.0
Q ss_pred cceeeeccCceEEEEEEECCeEEEEEEEecCCcc--------chHHHHHHHHHHHcCCCCce--eeEecccCCCceeEEe
Q 005617 346 ESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQ--------GQLEFQQEVRVLSKLQHPHL--VTLLGACPEAWSLVYE 415 (688)
Q Consensus 346 ~~~~LG~G~fG~Vykg~~~g~~vAIK~l~~~~~~--------~~~~f~~E~~iL~~l~HpnI--V~l~g~~~~~~~LV~E 415 (688)
....|-+|+-+.|+++.+.|+.++||--...... ......+|+++|.+++--.| ..++-+-.....|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 3467899999999999999999999864433211 12346789999999863333 2333223456789999
Q ss_pred cCCC-CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCC---eEEeecCccccc
Q 005617 416 YLPN-GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELS---SKICDFGICRLV 491 (688)
Q Consensus 416 ~~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~---vKLsDFGla~~~ 491 (688)
|++| .++.+++........ .-.....++..|-..+.-||.++ |||+||..+||+|..++. +.++|||++..-
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~-~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDES-EDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred eccchhHHHHHHHHHccCcc-cchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhcc
Confidence 9988 467777765432222 11223678899999999999977 999999999999976553 589999998643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.91 E-value=8.6e-09 Score=116.01 Aligned_cols=162 Identities=20% Similarity=0.232 Sum_probs=117.1
Q ss_pred CCeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCCC--ceeEEecCCCCcHHHHhcccCCCCCCCHHHHH
Q 005617 364 LGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEA--WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRA 441 (688)
Q Consensus 364 ~g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~~--~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~ 441 (688)
.+.+|.|...+...........+-++.|+.+|||||++++..+... .|||+|-+. .|...+... .-..+.
T Consensus 36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l------~~~~v~ 107 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL------GKEEVC 107 (690)
T ss_pred cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh------HHHHHH
Confidence 3778888887766553234467788899999999999999998554 699999874 344444322 223455
Q ss_pred HHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCCccccCCCCCCCCCCChhhhcc
Q 005617 442 RIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521 (688)
Q Consensus 442 ~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~ 521 (688)
-.+.||+.||.|||+.+ +++|++|.-+-|+++..|..||++|-++........ ......--..|..|+.+..
T Consensus 108 ~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~------~~~~~~~~~s~~~P~~~~~ 179 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA------PAKSLYLIESFDDPEEIDP 179 (690)
T ss_pred HHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc------ccccchhhhcccChhhcCc
Confidence 56899999999999876 699999999999999999999999998765432210 0011112224666765433
Q ss_pred CCCCCcchHhHHHHHHHHHHhC
Q 005617 522 GVLTPKSDSYSFGLIILQLLTG 543 (688)
Q Consensus 522 ~~~s~ksDVwSfGviL~ELltG 543 (688)
.. -..|.|-|||+++|++.|
T Consensus 180 s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 180 SE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cc--cchhhhhHHHHHHHHhCc
Confidence 22 346999999999999999
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.75 E-value=1.1e-07 Score=99.37 Aligned_cols=137 Identities=17% Similarity=0.116 Sum_probs=98.4
Q ss_pred eeccCceEEEEEEECCeEEEEEEEecCCcc-----------chHHHHHHHHHHHcCCCCc--eeeEeccc-------CCC
Q 005617 350 VGQGGFGCVYKGEMLGRTVAIKMLYSHNMQ-----------GQLEFQQEVRVLSKLQHPH--LVTLLGAC-------PEA 409 (688)
Q Consensus 350 LG~G~fG~Vykg~~~g~~vAIK~l~~~~~~-----------~~~~f~~E~~iL~~l~Hpn--IV~l~g~~-------~~~ 409 (688)
+-......|+++.+.|+.|.||........ ....+.+|...+.++..-+ .+.++++. ...
T Consensus 30 v~~~~~rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~ 109 (268)
T PRK15123 30 FRELEGRRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRT 109 (268)
T ss_pred EecCCCceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccce
Confidence 333344457788888999999977543321 1124789999998884332 33333333 123
Q ss_pred ceeEEecCCCC-cHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCC-------CCCeE
Q 005617 410 WSLVYEYLPNG-SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS-------ELSSK 481 (688)
Q Consensus 410 ~~LV~E~~~~g-sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~-------~~~vK 481 (688)
.+||+|++++. +|.+++..... .+.+...+..++.+++..+.-||..+ |+|+|+++.|||++. ++.+.
T Consensus 110 s~LVte~l~~~~sL~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~~~ 185 (268)
T PRK15123 110 SFIITEDLAPTISLEDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLKLS 185 (268)
T ss_pred eEEEEeeCCCCccHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCceEE
Confidence 67999999986 89888753221 23455677889999999999999976 999999999999985 46899
Q ss_pred EeecCcccc
Q 005617 482 ICDFGICRL 490 (688)
Q Consensus 482 LsDFGla~~ 490 (688)
|+||+.+..
T Consensus 186 LIDl~r~~~ 194 (268)
T PRK15123 186 VIDLHRAQI 194 (268)
T ss_pred EEECCcccc
Confidence 999998753
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.70 E-value=1.6e-07 Score=103.06 Aligned_cols=166 Identities=23% Similarity=0.289 Sum_probs=125.3
Q ss_pred ceEEEEEEEC--CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccC------CCceeEEecCCC-CcHHHH
Q 005617 355 FGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP------EAWSLVYEYLPN-GSLQDR 425 (688)
Q Consensus 355 fG~Vykg~~~--g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~------~~~~LV~E~~~~-gsL~~~ 425 (688)
..+.|++... |..|++|+++.........-..-+++++++.|+|+|++..+|. ...+|||+|.|+ ++|.+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 3577898764 9999999995544333323334578899999999999988773 237899999987 578776
Q ss_pred hcccCC------------CCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccC
Q 005617 426 LFRKSN------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 426 L~~~~~------------~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~ 493 (688)
.+.... ....++...+.++.|+..||.++|+.| +.-+-|.|.+||++.+..++|+..|+...+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 553321 123567889999999999999999977 88899999999999999999999998877654
Q ss_pred CCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCC
Q 005617 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~P 546 (688)
+.. +| + .--.+-|.=.||.+++.|.||..-
T Consensus 446 d~~------------------~~--l---e~~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT------------------EP--L---ESQQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC------------------cc--h---hHHhhhhHHHHHHHHHHHhhcccc
Confidence 320 00 0 011357889999999999999643
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.62 E-value=1.6e-07 Score=93.04 Aligned_cols=125 Identities=26% Similarity=0.278 Sum_probs=80.6
Q ss_pred EEEEEEEC-CeEEEEEEEecCCc---------------------cc-----hHHHHHHHHHHHcCCCC--ceeeEecccC
Q 005617 357 CVYKGEML-GRTVAIKMLYSHNM---------------------QG-----QLEFQQEVRVLSKLQHP--HLVTLLGACP 407 (688)
Q Consensus 357 ~Vykg~~~-g~~vAIK~l~~~~~---------------------~~-----~~~f~~E~~iL~~l~Hp--nIV~l~g~~~ 407 (688)
.||.|... |..+|||+...... .. .....+|...|.++..- ++.+++++
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 48999875 88999998754210 00 12366899999999755 45666644
Q ss_pred CCceeEEecCC--CCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHH-HhccCCCceEeCCCCCCceeeCCCCCeEEee
Q 005617 408 EAWSLVYEYLP--NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCF-LHSSKPEKIVHGDLKPQNILLDSELSSKICD 484 (688)
Q Consensus 408 ~~~~LV~E~~~--~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~y-LH~~~~~~IiHrDIKp~NILLd~~~~vKLsD 484 (688)
...+|||||+. |..+..+.... ++......++.+++..+.. +|..+ |+|+||.+.|||++.+ .+.|+|
T Consensus 79 ~~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~iID 149 (188)
T PF01163_consen 79 NRNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYIID 149 (188)
T ss_dssp ETTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE--
T ss_pred eCCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEEEe
Confidence 36789999999 65554433221 1123356677788886555 46755 9999999999999987 999999
Q ss_pred cCcccccc
Q 005617 485 FGICRLVT 492 (688)
Q Consensus 485 FGla~~~~ 492 (688)
||.+....
T Consensus 150 f~qav~~~ 157 (188)
T PF01163_consen 150 FGQAVDSS 157 (188)
T ss_dssp GTTEEETT
T ss_pred cCcceecC
Confidence 99887654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >smart00504 Ubox Modified RING finger domain | Back alignment and domain information |
|---|
Probab=98.50 E-value=5.8e-08 Score=78.42 Aligned_cols=62 Identities=50% Similarity=0.903 Sum_probs=59.4
Q ss_pred ccchhhhhhhcCCCcCCCCccccccchhhhhccCCCCCCCcccccCCCCCCcchHHHHHHHHH
Q 005617 622 FLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDW 684 (688)
Q Consensus 622 ~l~Pilqeim~dP~v~~dg~tye~~~I~~wl~~g~~~SPmtn~~l~~~~l~Pn~~lr~~~~~~ 684 (688)
+.||+..++|.+|.+.+.|++|+.+.|..|+.+ +.++|+++..++..+|+||.+||++|++|
T Consensus 2 ~~Cpi~~~~~~~Pv~~~~G~v~~~~~i~~~~~~-~~~cP~~~~~~~~~~l~~~~~l~~~i~~~ 63 (63)
T smart00504 2 FLCPISLEVMKDPVILPSGQTYERRAIEKWLLS-HGTDPVTGQPLTHEDLIPNLALKSAIQEW 63 (63)
T ss_pred cCCcCCCCcCCCCEECCCCCEEeHHHHHHHHHH-CCCCCCCcCCCChhhceeCHHHHHHHHhC
Confidence 679999999999999999999999999999988 67999999999999999999999999999
|
Modified RING finger domain, without the full complement of Zn2+-binding ligands. Probable involvement in E2-dependent ubiquitination. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=6.3e-08 Score=109.56 Aligned_cols=151 Identities=25% Similarity=0.377 Sum_probs=104.5
Q ss_pred HHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCC---ccccCCCCCCCCCCChhhhc
Q 005617 444 AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS---FHRSTAPKGSFPYADPEYHR 520 (688)
Q Consensus 444 ~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~---~~~~~~~~GT~~Y~APE~~~ 520 (688)
+.+++.|+.|+|..- .+||++|.|++|.++.+|..||+.|+++.....+..+... ........-...|.|||++.
T Consensus 105 l~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 345669999999964 6999999999999999999999999998776553221100 01112233456799999999
Q ss_pred cCCCCCcchHhHHHHHHHHHHh-CCCCCCChhhH-HHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCC
Q 005617 521 TGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEV-RRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPD 598 (688)
Q Consensus 521 ~~~~s~ksDVwSfGviL~ELlt-G~~Pf~~~~~~-~~~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs 598 (688)
....++++|+|||||++|.+.. |+.-+...+.. ......+ ..+...-.+...++.++.+=+.+.+..++..||+
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~----~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~ 258 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRN----LLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPT 258 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhc----ccccccccccccCcHHHHHHHHHHhcCCcccCcc
Confidence 9889999999999999999995 44444322111 1111100 0111112334566778888889999999999996
Q ss_pred Cc
Q 005617 599 IT 600 (688)
Q Consensus 599 ~~ 600 (688)
+.
T Consensus 259 ~~ 260 (700)
T KOG2137|consen 259 LD 260 (700)
T ss_pred hh
Confidence 54
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.44 E-value=8e-07 Score=89.47 Aligned_cols=124 Identities=26% Similarity=0.302 Sum_probs=89.4
Q ss_pred EECCeEEEEEEEecCCc-------cchHHHHHHHHHHHcCCCC--ceeeEecccC------CCceeEEecCCCC-cHHHH
Q 005617 362 EMLGRTVAIKMLYSHNM-------QGQLEFQQEVRVLSKLQHP--HLVTLLGACP------EAWSLVYEYLPNG-SLQDR 425 (688)
Q Consensus 362 ~~~g~~vAIK~l~~~~~-------~~~~~f~~E~~iL~~l~Hp--nIV~l~g~~~------~~~~LV~E~~~~g-sL~~~ 425 (688)
...++.+-+|.+..... -....+.+|...+..+..- .+...+++.. ...+||+|++++. +|.++
T Consensus 29 ~~~~~~y~~k~~~~~~~~~~~~~~~~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~ 108 (206)
T PF06293_consen 29 DLVGRRYYRKRLWNKLRRDRLRFPLRRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDL 108 (206)
T ss_pred cccceEEEECCeechhccchhhhcccchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHH
Confidence 34466777776432211 2344678898888888533 3344444432 1347999999985 79998
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCC---CeEEeecCccccc
Q 005617 426 LFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL---SSKICDFGICRLV 491 (688)
Q Consensus 426 L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~---~vKLsDFGla~~~ 491 (688)
+..... ++......++.+++..+.-||..+ |+|+|+++.|||++.++ .+.|+||+-++..
T Consensus 109 ~~~~~~---~~~~~~~~ll~~l~~~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 109 LQQWEQ---LDPSQRRELLRALARLIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHhhcc---cchhhHHHHHHHHHHHHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 865332 344567889999999999999977 99999999999999887 8999999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.42 E-value=5.9e-07 Score=101.67 Aligned_cols=138 Identities=20% Similarity=0.269 Sum_probs=92.9
Q ss_pred eeeeccCceEEEEEEEC-CeEEEEEEEecCCcc----------------------------------------chHHHHH
Q 005617 348 FKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQ----------------------------------------GQLEFQQ 386 (688)
Q Consensus 348 ~~LG~G~fG~Vykg~~~-g~~vAIK~l~~~~~~----------------------------------------~~~~f~~ 386 (688)
..|+.++-|.||+|++. |+.||||+.++.-.. ..-+|.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 57999999999999998 999999998654210 0112456
Q ss_pred HHHHHHcCC-----CCce--eeEecccCCCceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHH-HHHhccC
Q 005617 387 EVRVLSKLQ-----HPHL--VTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGL-CFLHSSK 458 (688)
Q Consensus 387 E~~iL~~l~-----HpnI--V~l~g~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL-~yLH~~~ 458 (688)
|...+.+++ .|++ .++|--+.....|+|||++|..+.+...... ..++-. .++..++.+. .-+-.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~k---~ia~~~~~~f~~q~~~-- 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDRK---ELAELLVRAFLRQLLR-- 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCHH---HHHHHHHHHHHHHHHh--
Confidence 666666652 3333 2333334567899999999999988753332 223322 3333333331 11222
Q ss_pred CCceEeCCCCCCceeeCCCCCeEEeecCccccccC
Q 005617 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 459 ~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~ 493 (688)
.+++|.|.+|.||+++.+|.+.+.|||+...+.+
T Consensus 284 -dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 -DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred -cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 2499999999999999999999999999876654
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.39 E-value=2.3e-06 Score=87.94 Aligned_cols=145 Identities=22% Similarity=0.206 Sum_probs=98.6
Q ss_pred HHHHHHHhcCcccceeeeccCceEEEEEEEC-CeEEEEEEEecCCc----------------------cchHHHHHHHHH
Q 005617 334 LADLQTATCNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNM----------------------QGQLEFQQEVRV 390 (688)
Q Consensus 334 ~~el~~at~~f~~~~~LG~G~fG~Vykg~~~-g~~vAIK~l~~~~~----------------------~~~~~f~~E~~i 390 (688)
+..+..-..-...+.+||-|--+.||.|... |.++|||.-..... -......+|..+
T Consensus 83 L~~l~~r~~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~ 162 (304)
T COG0478 83 LHALVKRGIVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEA 162 (304)
T ss_pred HHHHHHcChHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHH
Confidence 3344444444556789999999999999987 99999997532211 012235688999
Q ss_pred HHcCCCC--ceeeEecccCCCceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCC
Q 005617 391 LSKLQHP--HLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLK 468 (688)
Q Consensus 391 L~~l~Hp--nIV~l~g~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIK 468 (688)
|.+|... .+...+++ +...+||||++|-.|...-. +-...-.|+..|+.-+.-+-.. +|||+|++
T Consensus 163 L~~L~~~G~~VP~P~~~--nRHaVvMe~ieG~eL~~~r~--------~~en~~~il~~il~~~~~~~~~---GiVHGDlS 229 (304)
T COG0478 163 LQRLYPEGVKVPKPIAW--NRHAVVMEYIEGVELYRLRL--------DVENPDEILDKILEEVRKAYRR---GIVHGDLS 229 (304)
T ss_pred HHHhhhcCCCCCCcccc--ccceeeeehcccceeecccC--------cccCHHHHHHHHHHHHHHHHHc---CccccCCc
Confidence 9888544 55555543 34679999999977755331 1122333444455544444444 49999999
Q ss_pred CCceeeCCCCCeEEeecCccccc
Q 005617 469 PQNILLDSELSSKICDFGICRLV 491 (688)
Q Consensus 469 p~NILLd~~~~vKLsDFGla~~~ 491 (688)
+-|||++.+|.+.++||--+...
T Consensus 230 efNIlV~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 230 EFNILVTEDGDIVVIDWPQAVPI 252 (304)
T ss_pred hheEEEecCCCEEEEeCcccccC
Confidence 99999999999999999766543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.36 E-value=6.2e-06 Score=82.69 Aligned_cols=137 Identities=21% Similarity=0.195 Sum_probs=105.1
Q ss_pred eeeccCceEEEEEEECCeEEEEEEEecC---C---ccchHHHHHHHHHHHcCC--CCceeeEecccC---C----CceeE
Q 005617 349 KVGQGGFGCVYKGEMLGRTVAIKMLYSH---N---MQGQLEFQQEVRVLSKLQ--HPHLVTLLGACP---E----AWSLV 413 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~g~~vAIK~l~~~---~---~~~~~~f~~E~~iL~~l~--HpnIV~l~g~~~---~----~~~LV 413 (688)
.-|+||.+.|+.-.+.|..+-+|.-... + +.+...|.+|+..|.+|. .-++.+.+ ++. . ..+||
T Consensus 25 N~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 25 NYRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CcCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 3688999999999998888999986421 1 346678999999999995 33344444 331 1 25789
Q ss_pred EecCCC-CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCC--eEEeecCcccc
Q 005617 414 YEYLPN-GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELS--SKICDFGICRL 490 (688)
Q Consensus 414 ~E~~~~-gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~--vKLsDFGla~~ 490 (688)
+|-+.| -+|.+++.... ..+.+...+..++.+|+..+.-||..+ +.|+|+.+.|||++.+|. ++++||--++.
T Consensus 104 Te~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997765 58888875432 234566778899999999999999976 999999999999987777 99999986654
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.28 E-value=2.3e-06 Score=96.72 Aligned_cols=139 Identities=16% Similarity=0.220 Sum_probs=94.1
Q ss_pred eeeeccCceEEEEEEEC-CeEEEEEEEecCCcc-------------------------------------chHHHHHHHH
Q 005617 348 FKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQ-------------------------------------GQLEFQQEVR 389 (688)
Q Consensus 348 ~~LG~G~fG~Vykg~~~-g~~vAIK~l~~~~~~-------------------------------------~~~~f~~E~~ 389 (688)
..||.-+.|.||+|++. |..||||+-++.-.. ...+|.+|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 56999999999999997 889999997654210 0113556665
Q ss_pred HHHcC----CCCc------eeeEecccCCCceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCC
Q 005617 390 VLSKL----QHPH------LVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 459 (688)
Q Consensus 390 iL~~l----~Hpn------IV~l~g~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~ 459 (688)
-..++ .|-+ |.++|-.+.....|+||||+|..+.|.-.-.. ..++-. .|+..+.++. ++..-.
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~--~gi~~~---~i~~~l~~~~--~~qIf~ 319 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK--RGISPH---DILNKLVEAY--LEQIFK 319 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH--cCCCHH---HHHHHHHHHH--HHHHHh
Confidence 55444 4555 56666667778999999999998877543222 123323 3333333332 222212
Q ss_pred CceEeCCCCCCceeeC----CCCCeEEeecCccccccC
Q 005617 460 EKIVHGDLKPQNILLD----SELSSKICDFGICRLVTE 493 (688)
Q Consensus 460 ~~IiHrDIKp~NILLd----~~~~vKLsDFGla~~~~~ 493 (688)
.+++|.|-+|.||+++ .++.+.+-|||+...+..
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 3599999999999998 367899999999987654
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.24 E-value=9.2e-06 Score=83.04 Aligned_cols=138 Identities=14% Similarity=0.192 Sum_probs=82.6
Q ss_pred ceeeeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcCCCCc--eeeEeccc--CCCceeEEecCCCCc-
Q 005617 347 SFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPH--LVTLLGAC--PEAWSLVYEYLPNGS- 421 (688)
Q Consensus 347 ~~~LG~G~fG~Vykg~~~g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~Hpn--IV~l~g~~--~~~~~LV~E~~~~gs- 421 (688)
...||.|..+.||+. .|..+++|...... ......+|.+++..+..-+ +.+.++++ .+...+||++++|..
T Consensus 6 ~~~i~~G~t~~~y~~--~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 6 WTQTGEGGNGESYTH--KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred heeecCCCCcceeEe--cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 357999999999984 36678888876533 3345688999998885333 34555554 334678999999963
Q ss_pred HHHH---------------------hcccCCCCCCCHHHHHH-HHH----------HHHH-HHHHHhcc-CCCceEeCCC
Q 005617 422 LQDR---------------------LFRKSNVSPLLWKDRAR-IAA----------EIAS-GLCFLHSS-KPEKIVHGDL 467 (688)
Q Consensus 422 L~~~---------------------L~~~~~~~~l~~~~~~~-i~~----------qia~-aL~yLH~~-~~~~IiHrDI 467 (688)
+... |+... ........... +.. .+.. ...+|... .+..++|+|+
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~-~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTK-CDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCC-CCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 2111 11110 01111111110 000 0111 12222221 1245789999
Q ss_pred CCCceeeCCCCCeEEeecCcccc
Q 005617 468 KPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 468 Kp~NILLd~~~~vKLsDFGla~~ 490 (688)
.|.||+++.++ +.|+||+.+..
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCc
Confidence 99999999888 99999997754
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.22 E-value=1.1e-05 Score=81.31 Aligned_cols=141 Identities=25% Similarity=0.279 Sum_probs=85.5
Q ss_pred eeeeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcCCCC--ceeeEecccC-----CCceeEEecCCCC
Q 005617 348 FKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHP--HLVTLLGACP-----EAWSLVYEYLPNG 420 (688)
Q Consensus 348 ~~LG~G~fG~Vykg~~~g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~Hp--nIV~l~g~~~-----~~~~LV~E~~~~g 420 (688)
+.|+.|..+.||+....+..+++|..... .....+..|..++..+... .+.+++.++. ...+++|++++|.
T Consensus 3 ~~l~~G~~n~~~~v~~~~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~ 80 (239)
T PF01636_consen 3 RPLSGGFSNRVYRVTTDDGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGR 80 (239)
T ss_dssp EEEEESSSSEEEEEEETTSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSE
T ss_pred ccCCCCCeeeEEEEEECCcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccc
Confidence 57999999999999998889999997554 3445678899998888432 3456665431 1257899999999
Q ss_pred cHHH----------------Hh---ccc-CCCCCCCHHHH---------HHH------------HHHHHH-HHHHHhc--
Q 005617 421 SLQD----------------RL---FRK-SNVSPLLWKDR---------ARI------------AAEIAS-GLCFLHS-- 456 (688)
Q Consensus 421 sL~~----------------~L---~~~-~~~~~l~~~~~---------~~i------------~~qia~-aL~yLH~-- 456 (688)
.+.. .+ +.. ....++.+... ... ...+.. .+..++.
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (239)
T PF01636_consen 81 PLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEALL 160 (239)
T ss_dssp EHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhhh
Confidence 8877 11 111 11112222110 000 112222 3334443
Q ss_pred --cCCCceEeCCCCCCceeeC-CCCCeEEeecCcccc
Q 005617 457 --SKPEKIVHGDLKPQNILLD-SELSSKICDFGICRL 490 (688)
Q Consensus 457 --~~~~~IiHrDIKp~NILLd-~~~~vKLsDFGla~~ 490 (688)
..+..++|+|+.|.|||++ .++.+-|.||+.+..
T Consensus 161 ~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 161 PKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred ccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2346799999999999999 666668999987754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.16 E-value=4.3e-05 Score=75.84 Aligned_cols=106 Identities=25% Similarity=0.267 Sum_probs=84.4
Q ss_pred HHHHHHHHcCCC-CceeeEecccCCCceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceE
Q 005617 385 QQEVRVLSKLQH-PHLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463 (688)
Q Consensus 385 ~~E~~iL~~l~H-pnIV~l~g~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~Ii 463 (688)
..|.-++..+.+ +++++++|+|. .++|.||...+++...-..-.....-+|..+.+|+.+++..+.+|+......+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG--~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~ 84 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG--RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFY 84 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC--CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEE
Confidence 358888888876 69999999994 477999998876653211111112458999999999999999999997655688
Q ss_pred eCCCCCCceeeCCCCCeEEeecCcccccc
Q 005617 464 HGDLKPQNILLDSELSSKICDFGICRLVT 492 (688)
Q Consensus 464 HrDIKp~NILLd~~~~vKLsDFGla~~~~ 492 (688)
-.|++|+|+-++++|.+|+.|...+....
T Consensus 85 lcDv~~~nfgv~~~~~lk~iDld~v~~~~ 113 (188)
T PF12260_consen 85 LCDVSPDNFGVNDDGRLKLIDLDDVFVED 113 (188)
T ss_pred EeecchHHeEEeCCCcEEEEechhcchhH
Confidence 89999999999999999999998775543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.14 E-value=1.1e-05 Score=81.37 Aligned_cols=136 Identities=19% Similarity=0.179 Sum_probs=92.5
Q ss_pred HhcCcccceeeeccCceEEEEEEECCeEEEEEEEecCCccchHH---------HHHHHHHHHcCCC---CceeeEecc--
Q 005617 340 ATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLE---------FQQEVRVLSKLQH---PHLVTLLGA-- 405 (688)
Q Consensus 340 at~~f~~~~~LG~G~fG~Vykg~~~g~~vAIK~l~~~~~~~~~~---------f~~E~~iL~~l~H---pnIV~l~g~-- 405 (688)
..++|...+.+-......|.+-...|..+++|.........+.. ..+.+..+.+++. -....++.+
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 34677777777777788888888899999999987654332222 2244444444432 122222221
Q ss_pred -----cCCCceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCe
Q 005617 406 -----CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS 480 (688)
Q Consensus 406 -----~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~v 480 (688)
+....+|||||++|..|.+... ++. .++..+..++.-||..| ++|+|++|.|++++.++ +
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~-i 173 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG-I 173 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-E
Confidence 1344678999999988866542 111 24566778899999976 99999999999998655 9
Q ss_pred EEeecCcccc
Q 005617 481 KICDFGICRL 490 (688)
Q Consensus 481 KLsDFGla~~ 490 (688)
++.||+..+.
T Consensus 174 ~iID~~~k~~ 183 (229)
T PF06176_consen 174 RIIDTQGKRM 183 (229)
T ss_pred EEEECccccc
Confidence 9999986653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.07 E-value=3.1e-05 Score=79.68 Aligned_cols=139 Identities=18% Similarity=0.148 Sum_probs=85.0
Q ss_pred eeeccCc-eEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcCC-CCceeeEecccCC--CceeEEecCCCCcHHH
Q 005617 349 KVGQGGF-GCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLLGACPE--AWSLVYEYLPNGSLQD 424 (688)
Q Consensus 349 ~LG~G~f-G~Vykg~~~g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~-HpnIV~l~g~~~~--~~~LV~E~~~~gsL~~ 424 (688)
.|-.|.+ ..||+....+..+.||+..... ...+.+|+.++..+. +-.+.++++++.. ..++||++++|.+|..
T Consensus 5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~ 81 (244)
T cd05150 5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAA 81 (244)
T ss_pred ecCCCCCcCeEEEEcCCCCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhH
Confidence 3555555 7899998777788899876543 335678999988883 4445566776643 4789999999987764
Q ss_pred Hh-------------------cccCC-CCCCC--HHHHHHHHH--------------------HHHHHHHHHhc----cC
Q 005617 425 RL-------------------FRKSN-VSPLL--WKDRARIAA--------------------EIASGLCFLHS----SK 458 (688)
Q Consensus 425 ~L-------------------~~~~~-~~~l~--~~~~~~i~~--------------------qia~aL~yLH~----~~ 458 (688)
.. +.... ..++. +...+.... .+...+..|-. ..
T Consensus 82 ~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 161 (244)
T cd05150 82 LWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE 161 (244)
T ss_pred hhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence 32 11100 00111 001110000 01111222211 12
Q ss_pred CCceEeCCCCCCceeeCCCCCeEEeecCcccc
Q 005617 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 459 ~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~ 490 (688)
+..++|+|+.|.|||++.++.+.|+||+.+..
T Consensus 162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred ceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 34599999999999999988889999987653
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.99 E-value=1.2e-06 Score=98.34 Aligned_cols=192 Identities=20% Similarity=0.144 Sum_probs=133.8
Q ss_pred HHHHHhcCcccceeeeccCceEEEEEEECC-eEEEEEEEecCCccchHHHHHHHHHHHcCCCCc-eeeEecccCC--Cce
Q 005617 336 DLQTATCNFSESFKVGQGGFGCVYKGEMLG-RTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPH-LVTLLGACPE--AWS 411 (688)
Q Consensus 336 el~~at~~f~~~~~LG~G~fG~Vykg~~~g-~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~Hpn-IV~l~g~~~~--~~~ 411 (688)
.++..|.-+...+-+++|+++.+||.+... +....+.+.. .....-++++|.+++||| .+..++-+.. ...
T Consensus 236 ~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~-----~l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~ 310 (829)
T KOG0576|consen 236 TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ-----TLSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLW 310 (829)
T ss_pred cccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc-----chhhHHHHHHHHHccCCCCcccccccCCcccccc
Confidence 344445555555678999999999987653 2233444322 245566899999999999 6666666533 466
Q ss_pred eEEecCCCC-cHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCcccc
Q 005617 412 LVYEYLPNG-SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 412 LV~E~~~~g-sL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~ 490 (688)
++++++.+| +-........ ..+...+...+...-.++|+|||+.. =+|+| ||+..+ +..+..||+.+..
T Consensus 311 i~~~i~s~~rs~~~~~~~se--~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~ 380 (829)
T KOG0576|consen 311 IPMRICSTGRSSALEMTVSE--IALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQ 380 (829)
T ss_pred hhhhhhcCCccccccCChhh--Hhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcc
Confidence 899999887 2221111100 11222334455666778899999842 38888 777765 6899999999887
Q ss_pred ccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCCcchHhHHHHHHHHHHhCCCCCCC
Q 005617 491 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGL 549 (688)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~~ 549 (688)
+.... ......+|+.++|||+...+.+..+.|+|++|+--.++--|-+|-..
T Consensus 381 L~~~~-------~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~ 432 (829)
T KOG0576|consen 381 LTRTM-------KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS 432 (829)
T ss_pred cCccc-------ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC
Confidence 76433 34677899999999999999999999999999988888888777543
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.96 E-value=6.9e-05 Score=76.49 Aligned_cols=153 Identities=22% Similarity=0.226 Sum_probs=95.3
Q ss_pred cCHHHHHHHhcCcccce---eeeccCceEEEEEEEC-CeEEEEEEEecCCccchH---------H---------------
Q 005617 332 FSLADLQTATCNFSESF---KVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQL---------E--------------- 383 (688)
Q Consensus 332 ~~~~el~~at~~f~~~~---~LG~G~fG~Vykg~~~-g~~vAIK~l~~~~~~~~~---------~--------------- 383 (688)
.++..|...-....... .|+.|--+.||+|... +..||||+.......... .
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 34444554444444444 4556777899998764 899999998654321111 1
Q ss_pred HHHHHHHHHcCC--CCceeeEecccCCCceeEEecCCCCcH-HHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCC
Q 005617 384 FQQEVRVLSKLQ--HPHLVTLLGACPEAWSLVYEYLPNGSL-QDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460 (688)
Q Consensus 384 f~~E~~iL~~l~--HpnIV~l~g~~~~~~~LV~E~~~~gsL-~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~ 460 (688)
...|..-|.++. +-.+.+-+++. ...|||||+....+ .-.|.. -++...+...+..++++.+.-|-...
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~~--~nVLvMEfIg~~g~pAP~LkD----v~~e~~e~~~~~~~~v~~~~~l~~~a-- 186 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAFR--NNVLVMEFIGDDGLPAPRLKD----VPLELEEAEGLYEDVVEYMRRLYKEA-- 186 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceeec--CCeEEEEeccCCCCCCCCccc----CCcCchhHHHHHHHHHHHHHHHHHhc--
Confidence 224555555552 22333333332 45799999965421 111111 11222256677778888888777733
Q ss_pred ceEeCCCCCCceeeCCCCCeEEeecCccccccC
Q 005617 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 461 ~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~ 493 (688)
++||+||+.-|||+. ++.+.|+|||-|....+
T Consensus 187 ~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~h 218 (268)
T COG1718 187 GLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDH 218 (268)
T ss_pred CcccccchhhheEEE-CCeEEEEECccccccCC
Confidence 499999999999999 88999999998876543
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.94 E-value=6e-05 Score=77.25 Aligned_cols=138 Identities=22% Similarity=0.297 Sum_probs=77.3
Q ss_pred eeeeccCce-EEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcCCCC---ceeeEecccCC-----CceeEEecCC
Q 005617 348 FKVGQGGFG-CVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHP---HLVTLLGACPE-----AWSLVYEYLP 418 (688)
Q Consensus 348 ~~LG~G~fG-~Vykg~~~g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~Hp---nIV~l~g~~~~-----~~~LV~E~~~ 418 (688)
..|+.||.. .||+. +..+++|..+.. .....+.+|..+|..+... .+..+++.+.. ..++||++++
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~ 77 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE 77 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence 467877776 58975 446778875432 2344688999999887532 33444444322 2478999999
Q ss_pred CCcHHHH------------------hcccCCCC-C------------C-CHHHHH-----HHH----HHHHHH-HH-HHh
Q 005617 419 NGSLQDR------------------LFRKSNVS-P------------L-LWKDRA-----RIA----AEIASG-LC-FLH 455 (688)
Q Consensus 419 ~gsL~~~------------------L~~~~~~~-~------------l-~~~~~~-----~i~----~qia~a-L~-yLH 455 (688)
|.++... |+...... + + .|.... .+. .+.... +. +++
T Consensus 78 G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~ 157 (235)
T cd05155 78 GETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAALR 157 (235)
T ss_pred CCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHhc
Confidence 9766321 12111000 0 0 121110 000 011111 11 111
Q ss_pred cc--CCCceEeCCCCCCceeeCCCCCeEEeecCcccc
Q 005617 456 SS--KPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 456 ~~--~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~ 490 (688)
.. .+..++|+|+.|.|||++.++..-|.||+.+..
T Consensus 158 ~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 158 APWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 11 334599999999999999776667999998754
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00018 Score=87.19 Aligned_cols=146 Identities=19% Similarity=0.257 Sum_probs=93.3
Q ss_pred ceeeeccCceEEEEEEECC----eEEEEEEEecCCc-cchHHHHHHHHHHHcCC-CCce--eeEecccCC-----CceeE
Q 005617 347 SFKVGQGGFGCVYKGEMLG----RTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQ-HPHL--VTLLGACPE-----AWSLV 413 (688)
Q Consensus 347 ~~~LG~G~fG~Vykg~~~g----~~vAIK~l~~~~~-~~~~~f~~E~~iL~~l~-HpnI--V~l~g~~~~-----~~~LV 413 (688)
...|+.|.++.+|+....+ ..+++|+...... .....+.+|+.+|..+. |+++ .+++++|.+ ..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 4678999999999987763 4688887654332 23456889999999995 6655 777888754 37899
Q ss_pred EecCCCCcHHH--------------------H---hcccCC--------CCCCCHH--HHHHHH---------------H
Q 005617 414 YEYLPNGSLQD--------------------R---LFRKSN--------VSPLLWK--DRARIA---------------A 445 (688)
Q Consensus 414 ~E~~~~gsL~~--------------------~---L~~~~~--------~~~l~~~--~~~~i~---------------~ 445 (688)
|||++|..+.+ . |+.... ..+..+. .+..|. -
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 99999865321 1 111110 0111111 111111 1
Q ss_pred HHHHHHHHHhccCC--------CceEeCCCCCCceeeCCC-CC-eEEeecCcccccc
Q 005617 446 EIASGLCFLHSSKP--------EKIVHGDLKPQNILLDSE-LS-SKICDFGICRLVT 492 (688)
Q Consensus 446 qia~aL~yLH~~~~--------~~IiHrDIKp~NILLd~~-~~-vKLsDFGla~~~~ 492 (688)
.+...+.+|..+-| ..+||+|+++.|||++.+ +. +-|.||+++..-.
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 23344667755443 249999999999999853 33 5799999987654
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.81 E-value=6.8e-05 Score=77.83 Aligned_cols=138 Identities=17% Similarity=0.115 Sum_probs=81.9
Q ss_pred eeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcCCCCce-eeEecccCCCceeEEecCCCCcHHH----
Q 005617 350 VGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHL-VTLLGACPEAWSLVYEYLPNGSLQD---- 424 (688)
Q Consensus 350 LG~G~fG~Vykg~~~g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnI-V~l~g~~~~~~~LV~E~~~~gsL~~---- 424 (688)
+..|-.+.+|+....|..+++|+...........+.+|..++..+...++ .++++.+. ..+||+|++|..+..
T Consensus 4 ~~~G~tn~~y~~~~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~--~~~v~e~i~G~~~~~~~~~ 81 (256)
T TIGR02721 4 LSGGLTNRSWRIEHPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE--HWLLVEWLEGEVITLDQFV 81 (256)
T ss_pred CCCcCcCCeEEEEeCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC--CEEEEEeccCccccccccc
Confidence 56677889999887788999997654322211246789999988864333 33444433 478999999876532
Q ss_pred -------------HhcccCC-CCCCCHHHH-HHHHHH---------HHHHHHHHhcc-----CCCceEeCCCCCCceeeC
Q 005617 425 -------------RLFRKSN-VSPLLWKDR-ARIAAE---------IASGLCFLHSS-----KPEKIVHGDLKPQNILLD 475 (688)
Q Consensus 425 -------------~L~~~~~-~~~l~~~~~-~~i~~q---------ia~aL~yLH~~-----~~~~IiHrDIKp~NILLd 475 (688)
.|+.... ..+++.... ..+..+ +...+..+-.. .+..++|+|+.|.||+++
T Consensus 82 ~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~Nil~~ 161 (256)
T TIGR02721 82 ALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYNLVVT 161 (256)
T ss_pred CchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCcEEEe
Confidence 1222111 112222211 111111 11112222111 134689999999999999
Q ss_pred CCCCeEEeecCcccc
Q 005617 476 SELSSKICDFGICRL 490 (688)
Q Consensus 476 ~~~~vKLsDFGla~~ 490 (688)
.++ +.|.||..|..
T Consensus 162 ~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 162 PQG-LKLIDWEYASD 175 (256)
T ss_pred CCC-CEEEeccccCc
Confidence 877 78999987754
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.77 E-value=0.00015 Score=70.31 Aligned_cols=130 Identities=19% Similarity=0.202 Sum_probs=88.3
Q ss_pred cceeeeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcCCCCceeeEecccCCCceeEEecCCCCcHHHH
Q 005617 346 ESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDR 425 (688)
Q Consensus 346 ~~~~LG~G~fG~Vykg~~~g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~~~~LV~E~~~~gsL~~~ 425 (688)
....||+|++|.||+|.+.|..+|+|+-..++ ....+..|+++|..+.--++-+=+..+. ..++.|||+.|-.|.+.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg-~~~i~me~i~G~~L~~~ 102 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRGGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYG-EDFIRMEYIDGRPLGKL 102 (201)
T ss_pred hhhhhhcccccEEEEeeccCceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEec-hhhhhhhhhcCcchhhh
Confidence 34569999999999999999999999876544 3456888999999988666644332222 23345999999888776
Q ss_pred hcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCC-CCceeeCCCCCeEEeecCccccc
Q 005617 426 LFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLK-PQNILLDSELSSKICDFGICRLV 491 (688)
Q Consensus 426 L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIK-p~NILLd~~~~vKLsDFGla~~~ 491 (688)
-... + .+-...++..---|... +|-|..|. |..++|-+++.+.|+||..|+..
T Consensus 103 ~~~~------~----rk~l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 103 EIGG------D----RKHLLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhcc------c----HHHHHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 5321 1 12233444543344443 38888876 44444445559999999988743
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00044 Score=73.72 Aligned_cols=73 Identities=19% Similarity=0.050 Sum_probs=55.0
Q ss_pred eeeeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcCCC---CceeeEecccC-----CCceeEEecCCC
Q 005617 348 FKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQH---PHLVTLLGACP-----EAWSLVYEYLPN 419 (688)
Q Consensus 348 ~~LG~G~fG~Vykg~~~g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~H---pnIV~l~g~~~-----~~~~LV~E~~~~ 419 (688)
..||.|..+.||.....+..+.+|..+.. .....|..|...|..|.- ..+.+++++|. +..+||||+++|
T Consensus 20 ~~i~~G~~~~vy~~~~~~~~~~~k~~~~~--~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G 97 (297)
T PRK10593 20 ECISEQPYAALWALYDSQGNPMPLMARSF--STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRG 97 (297)
T ss_pred eecCCccceeEEEEEcCCCCEEEEEeccc--ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCC
Confidence 56999999999998877667788875431 123478899999998843 46777887763 347999999998
Q ss_pred CcH
Q 005617 420 GSL 422 (688)
Q Consensus 420 gsL 422 (688)
+++
T Consensus 98 ~~~ 100 (297)
T PRK10593 98 VSV 100 (297)
T ss_pred Eec
Confidence 764
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00025 Score=72.34 Aligned_cols=140 Identities=20% Similarity=0.278 Sum_probs=83.2
Q ss_pred eeeeccCceEEEEEEEC---CeEEEEEEEecCCccchHHHHHHHHHHHcCCC-CceeeEecccCCCceeEEecCCCCcHH
Q 005617 348 FKVGQGGFGCVYKGEML---GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQH-PHLVTLLGACPEAWSLVYEYLPNGSLQ 423 (688)
Q Consensus 348 ~~LG~G~fG~Vykg~~~---g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~H-pnIV~l~g~~~~~~~LV~E~~~~gsL~ 423 (688)
..|+.|-...+|+.... +..|++|+...... ......+|+.++..+.. .-..++++.+. ..+||||++|.++.
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~~~l~e~i~G~~l~ 80 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ--NGLIYEFIPGRTLE 80 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC--CcEEEEeeCCCcCC
Confidence 46778888999998876 57899997654322 11234578888888853 33444555443 35899999987653
Q ss_pred HH-----------------hcccCCC---------CCCCHHHHHHHHH----------------------HHH---HHH-
Q 005617 424 DR-----------------LFRKSNV---------SPLLWKDRARIAA----------------------EIA---SGL- 451 (688)
Q Consensus 424 ~~-----------------L~~~~~~---------~~l~~~~~~~i~~----------------------qia---~aL- 451 (688)
.. ++..... ..-.|..+..+.. .+. ..|
T Consensus 81 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~ 160 (235)
T cd05157 81 PEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISWLK 160 (235)
T ss_pred HHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHHHH
Confidence 11 1111111 1112322222211 111 111
Q ss_pred HHHhcc-CCCceEeCCCCCCceeeCC-CCCeEEeecCcccc
Q 005617 452 CFLHSS-KPEKIVHGDLKPQNILLDS-ELSSKICDFGICRL 490 (688)
Q Consensus 452 ~yLH~~-~~~~IiHrDIKp~NILLd~-~~~vKLsDFGla~~ 490 (688)
..+-.. .+..++|+|+.+.|||++. ++.+.|+||..|..
T Consensus 161 ~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 161 ELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 112221 3356999999999999998 57899999987653
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00028 Score=70.41 Aligned_cols=133 Identities=27% Similarity=0.403 Sum_probs=95.1
Q ss_pred CCCcccCHHHHHHHhcCcccceeeeccCc-eEEEEEEECCeEEEEEEEecC---Cc-------c-----------chHHH
Q 005617 327 PESAEFSLADLQTATCNFSESFKVGQGGF-GCVYKGEMLGRTVAIKMLYSH---NM-------Q-----------GQLEF 384 (688)
Q Consensus 327 ~~~~~~~~~el~~at~~f~~~~~LG~G~f-G~Vykg~~~g~~vAIK~l~~~---~~-------~-----------~~~~f 384 (688)
|....|+. -+.+|.....||.|.- |.||+++..|..+|||++... .. . ...-|
T Consensus 27 PKL~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF 101 (207)
T PF13095_consen 27 PKLEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPF 101 (207)
T ss_pred CCcCCcCC-----CCCcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChH
Confidence 33445555 3378899999999999 999999999999999994321 10 0 01238
Q ss_pred HHHHHHHHcCC---CCce--eeEeccc--C-C-----------------CceeEEecCCCCcHHHHhcccCCCCCCCHHH
Q 005617 385 QQEVRVLSKLQ---HPHL--VTLLGAC--P-E-----------------AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKD 439 (688)
Q Consensus 385 ~~E~~iL~~l~---HpnI--V~l~g~~--~-~-----------------~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~ 439 (688)
..|.+...+|+ +.++ |+.+||. . + -+.||.||++... .+
T Consensus 102 ~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~---- 165 (207)
T PF13095_consen 102 NCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PL---- 165 (207)
T ss_pred HHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------cc----
Confidence 89999999885 3344 9999986 1 0 0357888876543 11
Q ss_pred HHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCcc
Q 005617 440 RARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 488 (688)
Q Consensus 440 ~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGla 488 (688)
...-+.+|.+-|..+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 166 ~~~~~~~~~~dl~~~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 166 QIRDIPQMLRDLKILHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred chhHHHHHHHHHHHHHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 2233556777788899976 999999999975 3489999864
|
|
| >KOG4642 consensus Chaperone-dependent E3 ubiquitin protein ligase (contains TPR repeats) [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=97.59 E-value=4.1e-05 Score=76.76 Aligned_cols=73 Identities=30% Similarity=0.552 Sum_probs=69.0
Q ss_pred CCCCCCcccchhhhhhhcCCCcCCCCccccccchhhhhccCCCCCCCcccccCCCCCCcchHHHHHHHHHhhh
Q 005617 615 ERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDWLCK 687 (688)
Q Consensus 615 ~~~~Ps~~l~Pilqeim~dP~v~~dg~tye~~~I~~wl~~g~~~SPmtn~~l~~~~l~Pn~~lr~~~~~~~~~ 687 (688)
...+|.+..+.|.-++|++|++.++|.||++..|.+++...+...|.|.-+|..-+++||++|+-+|..|+..
T Consensus 205 ~rEvpd~lcgkIt~el~~~pvi~psgIty~ra~I~Ehl~rvghfdpvtr~~Lte~q~ipN~alkevIa~fl~~ 277 (284)
T KOG4642|consen 205 KREVPDYLCGKITLELMREPVITPSGITYDRADIEEHLQRVGHFDPVTRWPLTEYQLIPNLALKEVIAAFLKE 277 (284)
T ss_pred cccccchhhhhhhHHhhcCCccCccccchhHHHHHHHHHHhccCCchhcccCCHHhhccchHHHHHHHHHHHh
Confidence 4678999999999999999999999999999999999999999999999999999999999999999998863
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00044 Score=73.17 Aligned_cols=141 Identities=18% Similarity=0.184 Sum_probs=87.4
Q ss_pred ceeeeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcCCCC--ceeeEeccc--------CCCceeEEec
Q 005617 347 SFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHP--HLVTLLGAC--------PEAWSLVYEY 416 (688)
Q Consensus 347 ~~~LG~G~fG~Vykg~~~g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~Hp--nIV~l~g~~--------~~~~~LV~E~ 416 (688)
...|..|....+|+....+..+++|+... ........|+.++..+.+- .+.+++... .+..++|++|
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~ 95 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEF 95 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEe
Confidence 35677788889999888777899998764 2334566788888887432 344554432 2235789999
Q ss_pred CCCCcHHH--------------HhcccC-C-------CCCCCHHHHH----------HHHHHHHHHHHHHhc----cCCC
Q 005617 417 LPNGSLQD--------------RLFRKS-N-------VSPLLWKDRA----------RIAAEIASGLCFLHS----SKPE 460 (688)
Q Consensus 417 ~~~gsL~~--------------~L~~~~-~-------~~~l~~~~~~----------~i~~qia~aL~yLH~----~~~~ 460 (688)
++|..+.. .|+... . .....|.... .....+..++.++.. ..+.
T Consensus 96 i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~ 175 (296)
T cd05153 96 LAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPR 175 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCC
Confidence 99876421 111110 0 0112332221 011223344555543 2245
Q ss_pred ceEeCCCCCCceeeCCCCCeEEeecCcccc
Q 005617 461 KIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 461 ~IiHrDIKp~NILLd~~~~vKLsDFGla~~ 490 (688)
.++|+|+.|.|||++.++.+.|.||+.+..
T Consensus 176 ~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 176 GVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred cCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 699999999999999987789999987653
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.55 E-value=4.1e-05 Score=93.08 Aligned_cols=175 Identities=13% Similarity=-0.039 Sum_probs=126.1
Q ss_pred EEEEEEecCCccchHH-----HHHHHHHHHcCCCCceeeEecccC----CCceeEEecCCCCcHHHHhcccC-CCCCCCH
Q 005617 368 VAIKMLYSHNMQGQLE-----FQQEVRVLSKLQHPHLVTLLGACP----EAWSLVYEYLPNGSLQDRLFRKS-NVSPLLW 437 (688)
Q Consensus 368 vAIK~l~~~~~~~~~~-----f~~E~~iL~~l~HpnIV~l~g~~~----~~~~LV~E~~~~gsL~~~L~~~~-~~~~l~~ 437 (688)
+-+|+.+...-+...+ ...|++.++...|++++..+.-.+ ...+.+++|+.+|.+.+.|.+.. ..++++.
T Consensus 1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~ 1334 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDR 1334 (2724)
T ss_pred eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchh
Confidence 4555554443333222 334555566678999987765442 34678999999999999987663 3444444
Q ss_pred HHHHHHHHHHHHHHHHHhccC--CCceEeCCCCCCceeeCCCCCeEEeecCccccccCCCCcCCCccccCCCCCCCCCCC
Q 005617 438 KDRARIAAEIASGLCFLHSSK--PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 515 (688)
Q Consensus 438 ~~~~~i~~qia~aL~yLH~~~--~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~A 515 (688)
.-+.....+...+..-+|+.. ....+|+++|+-|.+|+.+.++|++++|+.+..++... ......+++.|+.
T Consensus 1335 ~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~s------f~Gl~l~sp~~v~ 1408 (2724)
T KOG1826|consen 1335 SPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLS------FFGLELCSPIYVL 1408 (2724)
T ss_pred chHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHh------hhhhhhCCHHHHH
Confidence 444444444355555555543 23478999999999999999999999999995544332 2356678889999
Q ss_pred hhhhccCCCCCcchHhHHHHHHHHHHhCCCCCC
Q 005617 516 PEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVG 548 (688)
Q Consensus 516 PE~~~~~~~s~ksDVwSfGviL~ELltG~~Pf~ 548 (688)
|++...-.++.++|+|..|+.+|++.-|..+|.
T Consensus 1409 qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1409 QLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred HHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence 999999999999999999999999999998874
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.002 Score=71.28 Aligned_cols=74 Identities=15% Similarity=0.082 Sum_probs=55.3
Q ss_pred eeeeccCceEEEEEEECC--eEEEEEEEecC------C-ccchHHHHHHHHHHHcCC---CCceeeEecccCCCceeEEe
Q 005617 348 FKVGQGGFGCVYKGEMLG--RTVAIKMLYSH------N-MQGQLEFQQEVRVLSKLQ---HPHLVTLLGACPEAWSLVYE 415 (688)
Q Consensus 348 ~~LG~G~fG~Vykg~~~g--~~vAIK~l~~~------~-~~~~~~f~~E~~iL~~l~---HpnIV~l~g~~~~~~~LV~E 415 (688)
..||.|.+..||++...+ +.|+||.-... . .-....+..|...|..+. ..++.+++.+..+..++|||
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D~~~~~lVME 111 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYDEELAVTVME 111 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEECCCCCEEEEe
Confidence 468999999999999874 48999985422 1 123456777888888763 34677888887878899999
Q ss_pred cCCCCc
Q 005617 416 YLPNGS 421 (688)
Q Consensus 416 ~~~~gs 421 (688)
|+++..
T Consensus 112 ~L~~~~ 117 (401)
T PRK09550 112 DLSDHK 117 (401)
T ss_pred cCCCcc
Confidence 998754
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.00078 Score=71.58 Aligned_cols=140 Identities=24% Similarity=0.337 Sum_probs=84.6
Q ss_pred eeeeccCceEEEEEEEC--------CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCc-eeeEecccCCCceeEEecCC
Q 005617 348 FKVGQGGFGCVYKGEML--------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPH-LVTLLGACPEAWSLVYEYLP 418 (688)
Q Consensus 348 ~~LG~G~fG~Vykg~~~--------g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~Hpn-IV~l~g~~~~~~~LV~E~~~ 418 (688)
..|..|-...||+.... +..|++|+..... .......+|..++..+...+ ..++++++.+ .+|++|++
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~--~~v~e~i~ 80 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN--GRIEEFIP 80 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC--CchhheeC
Confidence 45666777799988765 3789999965543 22345677888888885322 3455666543 46899998
Q ss_pred CCcHHHH-----------------hcccCCC--------CCCCHHHHHHH--------------------------HHHH
Q 005617 419 NGSLQDR-----------------LFRKSNV--------SPLLWKDRARI--------------------------AAEI 447 (688)
Q Consensus 419 ~gsL~~~-----------------L~~~~~~--------~~l~~~~~~~i--------------------------~~qi 447 (688)
|..+... |+..... .+.-|.....+ ...+
T Consensus 81 G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (302)
T cd05156 81 SRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLEDE 160 (302)
T ss_pred CCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHHHH
Confidence 8766421 1111110 01112111111 1122
Q ss_pred HHHHHHHhc------cCCCceEeCCCCCCceeeCCC----CCeEEeecCcccc
Q 005617 448 ASGLCFLHS------SKPEKIVHGDLKPQNILLDSE----LSSKICDFGICRL 490 (688)
Q Consensus 448 a~aL~yLH~------~~~~~IiHrDIKp~NILLd~~----~~vKLsDFGla~~ 490 (688)
...+.+|-. ..+..++|+|+.|.|||++.+ +.+.|+||..|..
T Consensus 161 ~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 161 AKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 223344432 244679999999999999985 8899999987753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0023 Score=68.61 Aligned_cols=155 Identities=14% Similarity=0.191 Sum_probs=84.3
Q ss_pred cCHHHHHHHhcCccc-----ceeeeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcCCC--CceeeEec
Q 005617 332 FSLADLQTATCNFSE-----SFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQH--PHLVTLLG 404 (688)
Q Consensus 332 ~~~~el~~at~~f~~-----~~~LG~G~fG~Vykg~~~g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~H--pnIV~l~g 404 (688)
++..++...-..|.. ...|+.|....+|+....+..+++|+.. .. .......|+.++..|.. -.+.+.+.
T Consensus 7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g~~vLK~~~-~~--~~~~l~~~~~~l~~L~~~glpvP~~i~ 83 (319)
T PRK05231 7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQGEYVLTLFE-RL--TAEDLPFFLGLMQHLAARGVPVPAPVA 83 (319)
T ss_pred CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCCcEEEEEec-cC--ChHHhHHHHHHHHHHHHCCCCCCccee
Confidence 445555554444533 2456677778999988776689999875 21 22333345555555521 11223332
Q ss_pred c--------cCCCceeEEecCCCCcHH-----------HH---hcccC-C-------CCCCCH-HHHHH-----------
Q 005617 405 A--------CPEAWSLVYEYLPNGSLQ-----------DR---LFRKS-N-------VSPLLW-KDRAR----------- 442 (688)
Q Consensus 405 ~--------~~~~~~LV~E~~~~gsL~-----------~~---L~~~~-~-------~~~l~~-~~~~~----------- 442 (688)
. ..+..+++++|++|..+. .. ++... . ...+.| .....
T Consensus 84 ~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (319)
T PRK05231 84 RRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQA 163 (319)
T ss_pred CCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHH
Confidence 1 133467999999987531 11 11111 0 011222 22111
Q ss_pred -HHHH-HHHHHHHHhcc----CCCceEeCCCCCCceeeCCCCCeEEeecCccc
Q 005617 443 -IAAE-IASGLCFLHSS----KPEKIVHGDLKPQNILLDSELSSKICDFGICR 489 (688)
Q Consensus 443 -i~~q-ia~aL~yLH~~----~~~~IiHrDIKp~NILLd~~~~vKLsDFGla~ 489 (688)
.+.. +...+..+... -+.++||+|++|.|||++.+...-|.||+.+.
T Consensus 164 ~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 164 ALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred HHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 1111 11222333311 35679999999999999976656899999764
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0027 Score=63.53 Aligned_cols=131 Identities=22% Similarity=0.278 Sum_probs=86.7
Q ss_pred ceeeeccCceEEEEEEECCeEEEEEEEecCC----------------ccchHHHHHHHHHHHcCC------CCceeeEec
Q 005617 347 SFKVGQGGFGCVYKGEMLGRTVAIKMLYSHN----------------MQGQLEFQQEVRVLSKLQ------HPHLVTLLG 404 (688)
Q Consensus 347 ~~~LG~G~fG~Vykg~~~g~~vAIK~l~~~~----------------~~~~~~f~~E~~iL~~l~------HpnIV~l~g 404 (688)
...||+|+.=.||.--. .....||+..... .....++.+|+.-...+. +.+|.+++|
T Consensus 6 ~~~i~~G~~R~cy~HP~-dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPD-DPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred CcccccCCCceEEECCC-CCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 45799999999996322 4456788887655 223456777877776665 788999999
Q ss_pred ccCC--CceeEEecCCC------CcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCC
Q 005617 405 ACPE--AWSLVYEYLPN------GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS 476 (688)
Q Consensus 405 ~~~~--~~~LV~E~~~~------gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~ 476 (688)
+... +..+|+|.+.+ .+|.+++... .++. . +...+-.-..||-..+ |+.+|++|.||++..
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~----~~~~-~---~~~~L~~f~~~l~~~~---Iv~~dl~~~NIv~~~ 153 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKEG----GLTE-E---LRQALDEFKRYLLDHH---IVIRDLNPHNIVVQR 153 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHcC----CccH-H---HHHHHHHHHHHHHHcC---CeecCCCcccEEEEe
Confidence 9854 46788887653 2577777432 2333 2 2333334455666654 999999999999964
Q ss_pred C--C--CeEEee-cCccc
Q 005617 477 E--L--SSKICD-FGICR 489 (688)
Q Consensus 477 ~--~--~vKLsD-FGla~ 489 (688)
. + .+.|+| ||-..
T Consensus 154 ~~~~~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 154 RDSGEFRLVLIDGLGEKE 171 (199)
T ss_pred cCCCceEEEEEeCCCCcc
Confidence 3 2 477777 45433
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.24 E-value=0.0045 Score=66.08 Aligned_cols=140 Identities=16% Similarity=0.192 Sum_probs=82.7
Q ss_pred eeeeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcCCCC--ceeeEeccc--------CCCceeEEecC
Q 005617 348 FKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHP--HLVTLLGAC--------PEAWSLVYEYL 417 (688)
Q Consensus 348 ~~LG~G~fG~Vykg~~~g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~Hp--nIV~l~g~~--------~~~~~LV~E~~ 417 (688)
..++.|-...+|+....+..+++|+..... .......|+.++..|... ++.+++... .+..++|++|+
T Consensus 28 ~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~i 105 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTDVGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEFL 105 (307)
T ss_pred cccCCccccceEEEEeCCCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEeC
Confidence 456677778999987776678899875432 233455677777777422 244444332 22357899999
Q ss_pred CCCcHH-----------H---HhcccC-CC--------CCCCHHHHHH------------HHHHHHHHHHHHhc----cC
Q 005617 418 PNGSLQ-----------D---RLFRKS-NV--------SPLLWKDRAR------------IAAEIASGLCFLHS----SK 458 (688)
Q Consensus 418 ~~gsL~-----------~---~L~~~~-~~--------~~l~~~~~~~------------i~~qia~aL~yLH~----~~ 458 (688)
+|..+. . .++... .. ..-.|..... ....+...+.++.. ..
T Consensus 106 ~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~~ 185 (307)
T TIGR00938 106 QGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRDL 185 (307)
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 986432 1 122111 00 0112222111 01123344555543 23
Q ss_pred CCceEeCCCCCCceeeCCCCCeEEeecCccc
Q 005617 459 PEKIVHGDLKPQNILLDSELSSKICDFGICR 489 (688)
Q Consensus 459 ~~~IiHrDIKp~NILLd~~~~vKLsDFGla~ 489 (688)
+.+++|+|+++.||+++.++.+.|.||+.+.
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 5679999999999999998877899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.0048 Score=67.18 Aligned_cols=140 Identities=19% Similarity=0.256 Sum_probs=84.6
Q ss_pred eeeeccCceEEEEEEEC------CeEEEEEEEecCCccchHHHHHHHHHHHcCCCCce-eeEecccCCCceeEEecCCCC
Q 005617 348 FKVGQGGFGCVYKGEML------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHL-VTLLGACPEAWSLVYEYLPNG 420 (688)
Q Consensus 348 ~~LG~G~fG~Vykg~~~------g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnI-V~l~g~~~~~~~LV~E~~~~g 420 (688)
..|-.|-...+|+.... +..|++|+...... ..-...+|..++..+..-++ .++++.+.++ .|++|+++.
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g--~v~efi~g~ 118 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFFDRDDEIRTFECMSRHGQGPRLLGRFPNG--RVEEFIHAR 118 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eeechHHHHHHHHHHHHcCCCCceEEEECCc--eEEEeeCCC
Confidence 44555777899998753 25799998765432 22234678999888854333 4556766554 689999887
Q ss_pred cHHHH-----------------hcccCC---CCCCCHHHHHHHHHHH-----------------HHHHHHH----hc-cC
Q 005617 421 SLQDR-----------------LFRKSN---VSPLLWKDRARIAAEI-----------------ASGLCFL----HS-SK 458 (688)
Q Consensus 421 sL~~~-----------------L~~~~~---~~~l~~~~~~~i~~qi-----------------a~aL~yL----H~-~~ 458 (688)
+|... ++.... ..+..|....++..++ ...+..| .. ..
T Consensus 119 ~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~~~ 198 (344)
T PLN02236 119 TLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGDDQ 198 (344)
T ss_pred CCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcccCC
Confidence 66421 222111 1122344444443222 1112222 22 22
Q ss_pred CCceEeCCCCCCceeeCC-CCCeEEeecCcccc
Q 005617 459 PEKIVHGDLKPQNILLDS-ELSSKICDFGICRL 490 (688)
Q Consensus 459 ~~~IiHrDIKp~NILLd~-~~~vKLsDFGla~~ 490 (688)
+..++|+|+++.|||++. ++.+.|+||..+..
T Consensus 199 ~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 199 EIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 346999999999999986 47899999987753
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.87 E-value=0.0031 Score=76.05 Aligned_cols=196 Identities=20% Similarity=0.190 Sum_probs=133.1
Q ss_pred HHHHHHHHHcCCCCceeeEecccCCC------ceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhcc
Q 005617 384 FQQEVRVLSKLQHPHLVTLLGACPEA------WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457 (688)
Q Consensus 384 f~~E~~iL~~l~HpnIV~l~g~~~~~------~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~ 457 (688)
..-|...+.++.|+|++.+++|..+. ..+.-+++..-++...+... ..++....+.+..++.+||.|+|..
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v---~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV---GSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc---cccCHHHHHHHHHHHhhhHHHHHHh
Confidence 44577778888999999999886332 12355778888887777554 3567788888999999999999997
Q ss_pred CCCceEeCCCCCC---ceeeCCCCCeEEe--ecCccccccCCCCcCCCccccCCCCCCCCCCChhhhccCCCCC--cchH
Q 005617 458 KPEKIVHGDLKPQ---NILLDSELSSKIC--DFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTP--KSDS 530 (688)
Q Consensus 458 ~~~~IiHrDIKp~---NILLd~~~~vKLs--DFGla~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~s~--ksDV 530 (688)
. ..|.-+..+ +...+..+.+.++ ||+..+....... .....-+..|.+||......+.. ..|+
T Consensus 306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~-------~~~~~~~~~~~~~e~~~~~~~~~~r~~dL 375 (1351)
T KOG1035|consen 306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK-------SFSDLLAEIRNADEDLKENTAKKSRLTDL 375 (1351)
T ss_pred c---cceeEEecccccccccCccceeecchhhhcccccCCCccc-------chhhcCccccccccccccccchhhhhhHH
Confidence 4 444444444 4455667777777 9998887665432 12333455688888776665554 4799
Q ss_pred hHHHHHHHHHHhCCCCCCChhhHHHHhhcCccccccCCCCCCCCHHHHHHHHHHHHHccccCCCCCCCCchHHHHHHH
Q 005617 531 YSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 531 wSfGviL~ELltG~~Pf~~~~~~~~~~~~g~l~~~ld~~~~~~~~~~~~~l~~L~~~Cl~~dP~~RPs~~~~l~~~Le 608 (688)
|.+|..+..+..|..+-.....+ ..+++. . ....+.+....|+..++++|++..+.+-..+.
T Consensus 376 ~~lgll~~~~~~~~~i~~~~~~~---------~~~l~~---~----~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~ 437 (1351)
T KOG1035|consen 376 WCLGLLLLQLSQGEDISEKSAVP---------VSLLDV---L----STSELLDALPKCLDEDSEERLSALELLTHPFL 437 (1351)
T ss_pred HHHHHHHhhhhhcCcccccccch---------hhhhcc---c----cchhhhhhhhhhcchhhhhccchhhhhhchhc
Confidence 99999999999987664321111 011111 0 11156677888999999999998865544443
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.0084 Score=66.25 Aligned_cols=72 Identities=17% Similarity=0.074 Sum_probs=52.9
Q ss_pred eeeeccCceEEEEEEECCeEEEEEEEecCCc-------cchHHHHHHHHHHHcCC---CCceeeEecccCCCceeEEecC
Q 005617 348 FKVGQGGFGCVYKGEMLGRTVAIKMLYSHNM-------QGQLEFQQEVRVLSKLQ---HPHLVTLLGACPEAWSLVYEYL 417 (688)
Q Consensus 348 ~~LG~G~fG~Vykg~~~g~~vAIK~l~~~~~-------~~~~~f~~E~~iL~~l~---HpnIV~l~g~~~~~~~LV~E~~ 417 (688)
+.||.|....||+....+..|+||.-..... .....-..|...|..+. ..++.++|.+|.+..++||||+
T Consensus 38 ~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded~~vlvME~L 117 (418)
T PLN02756 38 KEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRTMALIGMRYL 117 (418)
T ss_pred EEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCCCCEEEEeec
Confidence 5689999999999988777899997642211 12223334566666553 3578889999999999999999
Q ss_pred CC
Q 005617 418 PN 419 (688)
Q Consensus 418 ~~ 419 (688)
++
T Consensus 118 ~~ 119 (418)
T PLN02756 118 EP 119 (418)
T ss_pred CC
Confidence 87
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.70 E-value=0.016 Score=62.16 Aligned_cols=138 Identities=18% Similarity=0.318 Sum_probs=80.5
Q ss_pred ceEEEEEEECCeEEEEEEEec--CCccchHHHHHHHHHHHcCC--CCceeeEecccCCCc----eeEEecCCCCcHHHHh
Q 005617 355 FGCVYKGEMLGRTVAIKMLYS--HNMQGQLEFQQEVRVLSKLQ--HPHLVTLLGACPEAW----SLVYEYLPNGSLQDRL 426 (688)
Q Consensus 355 fG~Vykg~~~g~~vAIK~l~~--~~~~~~~~f~~E~~iL~~l~--HpnIV~l~g~~~~~~----~LV~E~~~~gsL~~~L 426 (688)
.-.+|.....++++++. ... ..........+|..+++.+. -.-+...+++|.++. +.||+|+.|..+.+.+
T Consensus 38 sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~ 116 (321)
T COG3173 38 SNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSAL 116 (321)
T ss_pred ccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcC
Confidence 33455555558888888 332 11223334567888888774 334556678887666 8999999984332211
Q ss_pred ccc---------------------CC--------------CCCCCHHHHHHH--------HHHHHHHHHHHhccC-----
Q 005617 427 FRK---------------------SN--------------VSPLLWKDRARI--------AAEIASGLCFLHSSK----- 458 (688)
Q Consensus 427 ~~~---------------------~~--------------~~~l~~~~~~~i--------~~qia~aL~yLH~~~----- 458 (688)
... .. .+...|....+. .-....-..||+.+.
T Consensus 117 ~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~ 196 (321)
T COG3173 117 PPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAG 196 (321)
T ss_pred CcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCC
Confidence 100 00 000112111110 011222344555443
Q ss_pred CCceEeCCCCCCceeeCCCCCeEEeecCccccccC
Q 005617 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 459 ~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~~~~ 493 (688)
+..++|+|+.+.||+++.++-+=|.||+++....+
T Consensus 197 ~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 197 PPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred CceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 35699999999999999998899999999876543
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.63 E-value=0.0022 Score=67.90 Aligned_cols=137 Identities=15% Similarity=0.156 Sum_probs=91.5
Q ss_pred cCcccceeeeccCceEEEEEEEC-CeEEEEEEEecCCc-----------------cc-----hHHHHHHHHHHHcCC-C-
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNM-----------------QG-----QLEFQQEVRVLSKLQ-H- 396 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~-g~~vAIK~l~~~~~-----------------~~-----~~~f~~E~~iL~~l~-H- 396 (688)
.-++.+++||-|--+.||.+-.. |++.++|.-..... .. .....+|...|+.|. |
T Consensus 92 ~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 92 SVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 34678899999999999999887 99999996422110 00 112446777777773 2
Q ss_pred CceeeEecccCCCceeEEecCCCCcHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCC
Q 005617 397 PHLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS 476 (688)
Q Consensus 397 pnIV~l~g~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~ 476 (688)
--+.+.++++ ..++|||++.|-.|...-+-.. ...+...+..-+.-|-.. ++||+|..--||+++.
T Consensus 172 fpVPkpiD~~--RH~Vvmelv~g~Pl~~v~~v~d---------~~~ly~~lm~~Iv~la~~---GlIHgDFNEFNimv~d 237 (465)
T KOG2268|consen 172 FPVPKPIDHN--RHCVVMELVDGYPLRQVRHVED---------PPTLYDDLMGLIVRLANH---GLIHGDFNEFNIMVKD 237 (465)
T ss_pred CCCCCccccc--ceeeHHHhhcccceeeeeecCC---------hHHHHHHHHHHHHHHHHc---CceecccchheeEEec
Confidence 2333444433 3578999998887765432211 223344444445555554 4999999999999999
Q ss_pred CCCeEEeecCcccccc
Q 005617 477 ELSSKICDFGICRLVT 492 (688)
Q Consensus 477 ~~~vKLsDFGla~~~~ 492 (688)
++.++++||--+....
T Consensus 238 d~~i~vIDFPQmvS~s 253 (465)
T KOG2268|consen 238 DDKIVVIDFPQMVSTS 253 (465)
T ss_pred CCCEEEeechHhhccC
Confidence 9999999997655443
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.012 Score=59.30 Aligned_cols=115 Identities=17% Similarity=0.192 Sum_probs=72.9
Q ss_pred CceEEEEEEECCeEEEEEEEecCCcc-chHHHHHHHHHHHcCCCCceeeEecccCCCceeEEecCCCCcHHHHhcccCCC
Q 005617 354 GFGCVYKGEMLGRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNV 432 (688)
Q Consensus 354 ~fG~Vykg~~~g~~vAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~~~~LV~E~~~~gsL~~~L~~~~~~ 432 (688)
|.++.-+|.-.=.+..+|++...... ...-|.++.+++++++ .|++|..--...+.++.|+|-....
T Consensus 74 gNsTl~~~kt~iG~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~NDn~~~yGvIlE~Cy~~~i---------- 141 (308)
T PF07387_consen 74 GNSTLLIGKTKIGPLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKNDNNYKYGVILERCYKIKI---------- 141 (308)
T ss_pred CceEEEEeccccchhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeecCCCceeEEEEeeccCccc----------
Confidence 33344343333234455666554444 4556788999998875 4777764322346688888842111
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCCeEEeecCc
Q 005617 433 SPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 487 (688)
Q Consensus 433 ~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKLsDFGl 487 (688)
.+ ..++.-=+.+|.-.|+.. .+.+|+|..|+||+-|..|.+||.|-+.
T Consensus 142 --~~----~N~i~agi~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 142 --NF----SNFITAGIKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred --ch----hHHHHHhHHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhh
Confidence 00 112222246678888665 5799999999999999999999999764
|
The function of this family is unknown. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.025 Score=61.61 Aligned_cols=71 Identities=18% Similarity=0.109 Sum_probs=48.4
Q ss_pred eeccCceEEEEEEECC--eEEEEEEEecC------C-ccchHHHHHHHHHHHcCC--CC-ceeeEecccCCCceeEEecC
Q 005617 350 VGQGGFGCVYKGEMLG--RTVAIKMLYSH------N-MQGQLEFQQEVRVLSKLQ--HP-HLVTLLGACPEAWSLVYEYL 417 (688)
Q Consensus 350 LG~G~fG~Vykg~~~g--~~vAIK~l~~~------~-~~~~~~f~~E~~iL~~l~--Hp-nIV~l~g~~~~~~~LV~E~~ 417 (688)
||.|....||++...+ +.|+||.-... . .-......-|...|.... -| .+.++|.+-.+...+|||++
T Consensus 3 igdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~D~e~~~~vMEdL 82 (370)
T TIGR01767 3 VGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHFDTEMAVTVMEDL 82 (370)
T ss_pred CCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEEccccceehHhhC
Confidence 7999999999999874 58999964221 1 223334456777776663 44 45556666677778999999
Q ss_pred CCC
Q 005617 418 PNG 420 (688)
Q Consensus 418 ~~g 420 (688)
+..
T Consensus 83 ~~~ 85 (370)
T TIGR01767 83 SHH 85 (370)
T ss_pred ccc
Confidence 654
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.022 Score=61.59 Aligned_cols=139 Identities=18% Similarity=0.283 Sum_probs=82.7
Q ss_pred eeeeccCceEEEEEEECC-----eEEEEEEEecCCccchHHHHHHHHHHHcCCCCce-eeEecccCCCceeEEecCCCCc
Q 005617 348 FKVGQGGFGCVYKGEMLG-----RTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHL-VTLLGACPEAWSLVYEYLPNGS 421 (688)
Q Consensus 348 ~~LG~G~fG~Vykg~~~g-----~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnI-V~l~g~~~~~~~LV~E~~~~gs 421 (688)
..|..|-...+|+....+ ..|++|+...... ......+|..++..+..-++ .++++++..+ +|.+|+++..
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G--~i~~fi~g~~ 96 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVFGNG--MIQSFINART 96 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEeCCc--EeehhhcCCC
Confidence 445557777899887653 2789998765432 22345678999988865444 4566666443 5899998765
Q ss_pred HHH-----------------HhcccCC---CCCCCHHHHHHHHHHH----------------------HHHHHH----Hh
Q 005617 422 LQD-----------------RLFRKSN---VSPLLWKDRARIAAEI----------------------ASGLCF----LH 455 (688)
Q Consensus 422 L~~-----------------~L~~~~~---~~~l~~~~~~~i~~qi----------------------a~aL~y----LH 455 (688)
|.. .|+.... ..+-.|....++..++ ..-+.. +.
T Consensus 97 l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~~~ 176 (330)
T PLN02421 97 LTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEITD 176 (330)
T ss_pred CChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHHhc
Confidence 521 1122111 0122344443333222 111221 21
Q ss_pred c-cCCCceEeCCCCCCceeeCC-CCCeEEeecCccc
Q 005617 456 S-SKPEKIVHGDLKPQNILLDS-ELSSKICDFGICR 489 (688)
Q Consensus 456 ~-~~~~~IiHrDIKp~NILLd~-~~~vKLsDFGla~ 489 (688)
. ..+..++|.|+.+.|||++. ++.++++||..|.
T Consensus 177 ~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 177 SLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred cCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 1 12345899999999999974 5789999998764
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.37 E-value=0.023 Score=59.96 Aligned_cols=31 Identities=32% Similarity=0.674 Sum_probs=25.8
Q ss_pred CceEeCCCCCCceeeCCCCC-eEEeecCcccc
Q 005617 460 EKIVHGDLKPQNILLDSELS-SKICDFGICRL 490 (688)
Q Consensus 460 ~~IiHrDIKp~NILLd~~~~-vKLsDFGla~~ 490 (688)
..++|+|++|.|||++.++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 35899999999999997555 56999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.34 E-value=0.015 Score=61.57 Aligned_cols=137 Identities=21% Similarity=0.271 Sum_probs=71.7
Q ss_pred ceeeeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcCC---CCceeeEeccc--CCCceeEEecCCCCc
Q 005617 347 SFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ---HPHLVTLLGAC--PEAWSLVYEYLPNGS 421 (688)
Q Consensus 347 ~~~LG~G~fG~Vykg~~~g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~---HpnIV~l~g~~--~~~~~LV~E~~~~gs 421 (688)
...||.|....+|+....+..+.||+-.. .....|..|..-|+.|. --.+.+.+++. .+..+|||||++.+.
T Consensus 22 ~~~v~GG~i~~a~~~~~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~~ 98 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLDTDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMGS 98 (288)
T ss_dssp EEEE--SSSSEEEEEETTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE------
T ss_pred eEecCCCChhheEEEECCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCCC
Confidence 46789999999999987789999998762 33446888888888883 33455666554 556799999998771
Q ss_pred --------HHH---Hhcc-cC--CC----------------CCCCHHH-----HHHHHH--------------HHHHHHH
Q 005617 422 --------LQD---RLFR-KS--NV----------------SPLLWKD-----RARIAA--------------EIASGLC 452 (688)
Q Consensus 422 --------L~~---~L~~-~~--~~----------------~~l~~~~-----~~~i~~--------------qia~aL~ 452 (688)
|.. .|+. .. .+ -.-+|.. |+.... .++..+.
T Consensus 99 ~~~~~~~~lg~~LA~LH~~~~~~~FGf~~~~~~G~~~q~N~w~~~W~~Ff~~~RL~~~l~~~~~~~~~~~~~~~l~~~~~ 178 (288)
T PF03881_consen 99 PSPPDWEELGRQLAALHQWSPAGKFGFPVDTYIGSLPQPNTWTDSWEEFFAEQRLRPQLELAREKGGLDAELERLVERLP 178 (288)
T ss_dssp --CCHHHHHHHHHHHHHH-T--SSBB-SS-EEETTEEE----BS-HHHHHHHHCCHHHHHHHHHCTSS-CHHHHHHHHHH
T ss_pred CCchhHHHHHHHHHHHhhhcCCCCcCCCcCCcccCcCCCCCCCCCHHHHHHHHHHHHHHHHHHhhCCchhHHHHHHHHHH
Confidence 111 2232 11 00 0123322 111111 1222221
Q ss_pred -HHhccC-CCceEeCCCCCCceeeCCCCCeEEeecC
Q 005617 453 -FLHSSK-PEKIVHGDLKPQNILLDSELSSKICDFG 486 (688)
Q Consensus 453 -yLH~~~-~~~IiHrDIKp~NILLd~~~~vKLsDFG 486 (688)
.|+... .+.++|+||.+.|++.+.+|.+.|.|=.
T Consensus 179 ~~l~~~~~~PsLlHGDLW~GN~~~~~~g~p~l~DPa 214 (288)
T PF03881_consen 179 SLLPGREPKPSLLHGDLWSGNVGFDADGEPVLFDPA 214 (288)
T ss_dssp HCCTTS----EEE-SS-SGGGEEEETTE-EEE-S--
T ss_pred HHhcCCCCCceeeEcCccccceeecCCCCceeeccc
Confidence 233222 2469999999999999999989998843
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.017 Score=62.27 Aligned_cols=138 Identities=20% Similarity=0.187 Sum_probs=91.8
Q ss_pred eeeeccCceEEEEEEEC-CeEEEEEEEecCCc---------cchHH-----------------HHHHHHHHHcCCCCcee
Q 005617 348 FKVGQGGFGCVYKGEML-GRTVAIKMLYSHNM---------QGQLE-----------------FQQEVRVLSKLQHPHLV 400 (688)
Q Consensus 348 ~~LG~G~fG~Vykg~~~-g~~vAIK~l~~~~~---------~~~~~-----------------f~~E~~iL~~l~HpnIV 400 (688)
..|..|--+.||.+.-. |..+|||+.+.... .+... ...|++-|.+|+...|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 35889999999999775 88999998754321 11111 23566667666544432
Q ss_pred eEecccCCCceeEEecCCCCcHHH-HhcccCCCCCCCHHHHHHHHHHHHHHHHHHhccCCCceEeCCCCCCceeeCCCCC
Q 005617 401 TLLGACPEAWSLVYEYLPNGSLQD-RLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELS 479 (688)
Q Consensus 401 ~l~g~~~~~~~LV~E~~~~gsL~~-~L~~~~~~~~l~~~~~~~i~~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~ 479 (688)
-.--.......|||+|+-...... .|. .-.++...+..+..+++.-+.-|...| .+||.||.--|+|+ .+|.
T Consensus 230 ~PePIlLk~hVLVM~FlGrdgw~aPkLK----d~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Ly-hdG~ 302 (520)
T KOG2270|consen 230 CPEPILLKNHVLVMEFLGRDGWAAPKLK----DASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLY-HDGK 302 (520)
T ss_pred CCCceeeecceEeeeeccCCCCcCcccc----cccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheE-ECCE
Confidence 111111224578999995322111 111 124555678888899999999998887 59999999999988 4578
Q ss_pred eEEeecCcccccc
Q 005617 480 SKICDFGICRLVT 492 (688)
Q Consensus 480 vKLsDFGla~~~~ 492 (688)
+.|+|.+-+....
T Consensus 303 lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 303 LYIIDVSQSVEHD 315 (520)
T ss_pred EEEEEccccccCC
Confidence 9999998775543
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.014 Score=58.78 Aligned_cols=123 Identities=19% Similarity=0.261 Sum_probs=62.7
Q ss_pred CeEEEEEEEecCCccchHHHHHHHHHHHcCCC-CceeeEecccCCCceeEEecCCCCcHHH-------H----------h
Q 005617 365 GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQH-PHLVTLLGACPEAWSLVYEYLPNGSLQD-------R----------L 426 (688)
Q Consensus 365 g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~H-pnIV~l~g~~~~~~~LV~E~~~~gsL~~-------~----------L 426 (688)
++.|+|++.... .........|..+++.+.. ..-.++++++.++ +|++|+++..|.. . +
T Consensus 2 ~~~~~~Ri~g~~-t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g--~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~~l 78 (211)
T PF01633_consen 2 PEKYLVRIPGEG-TENFIDRENENEALKLLSEAGLGPKIIYFFENG--RVEEFIEGRTLSPEDFRNPEILKRIAKLLAKL 78 (211)
T ss_dssp TSEEEEEEEESC-GCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE--EEEE--SSEE--CGGGGSHHHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCC-cccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC--cEEEEecccccChhhccChHHHHHHHHHHHHH
Confidence 356788877655 3344566789999988854 4445666766554 5779997765421 0 1
Q ss_pred ccc----CCCCCCCHHHHHHH----------------------HHHHHHHHHHHhc-----cCCCceEeCCCCCCceee-
Q 005617 427 FRK----SNVSPLLWKDRARI----------------------AAEIASGLCFLHS-----SKPEKIVHGDLKPQNILL- 474 (688)
Q Consensus 427 ~~~----~~~~~l~~~~~~~i----------------------~~qia~aL~yLH~-----~~~~~IiHrDIKp~NILL- 474 (688)
+.. .....-.|.....+ ...+..-+..+.. ..+..++|.|+.|.|||+
T Consensus 79 H~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil~~ 158 (211)
T PF01633_consen 79 HSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNILIN 158 (211)
T ss_dssp HTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEEET
T ss_pred hhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEEec
Confidence 111 01111123322222 1112222222221 123468999999999999
Q ss_pred CCCCCeEEeecCcccc
Q 005617 475 DSELSSKICDFGICRL 490 (688)
Q Consensus 475 d~~~~vKLsDFGla~~ 490 (688)
+.++.++|+||..|..
T Consensus 159 ~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 159 NKDGEVKLIDFEYAGY 174 (211)
T ss_dssp SSSSCEEE--GTT-EE
T ss_pred cCCCeEEEecHHHHhh
Confidence 8889999999988754
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.00 E-value=0.086 Score=55.97 Aligned_cols=30 Identities=30% Similarity=0.450 Sum_probs=25.8
Q ss_pred CCceEeCCCCCCceeeCCCCCeEEeecCccc
Q 005617 459 PEKIVHGDLKPQNILLDSELSSKICDFGICR 489 (688)
Q Consensus 459 ~~~IiHrDIKp~NILLd~~~~vKLsDFGla~ 489 (688)
+.+++|+|+++.||+++. +.+.|.||+.+.
T Consensus 186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred cCceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 357999999999999988 678999998654
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.99 E-value=0.027 Score=62.07 Aligned_cols=73 Identities=16% Similarity=0.091 Sum_probs=50.6
Q ss_pred eeeeccCceEEEEEEEC--CeEEEEEEEecC-----C-ccchHHHHHHHHHHHcCC--CC-ceeeEecccCCCceeEEec
Q 005617 348 FKVGQGGFGCVYKGEML--GRTVAIKMLYSH-----N-MQGQLEFQQEVRVLSKLQ--HP-HLVTLLGACPEAWSLVYEY 416 (688)
Q Consensus 348 ~~LG~G~fG~Vykg~~~--g~~vAIK~l~~~-----~-~~~~~~f~~E~~iL~~l~--Hp-nIV~l~g~~~~~~~LV~E~ 416 (688)
..||.|....||++.+. +..|+||.-... . .-...+..-|..+|..+. -| .+.++|.+-.+...+|||+
T Consensus 35 ~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D~e~~~~vMEd 114 (409)
T PRK12396 35 KEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFDSVMNCCVMED 114 (409)
T ss_pred eEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEECcHHhhHHHHh
Confidence 46899999999999985 678999964221 1 123445566777777663 45 4555666666777889999
Q ss_pred CCCC
Q 005617 417 LPNG 420 (688)
Q Consensus 417 ~~~g 420 (688)
++..
T Consensus 115 L~~~ 118 (409)
T PRK12396 115 LSDH 118 (409)
T ss_pred Cccc
Confidence 8653
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.69 E-value=0.13 Score=55.75 Aligned_cols=156 Identities=23% Similarity=0.334 Sum_probs=88.8
Q ss_pred ccCHHHHHHHhcCcccc-----eeeeccCceEEEEEEECCeEEEEEEEecCCccchHHHHHHHHHHHcCCC---Cc---e
Q 005617 331 EFSLADLQTATCNFSES-----FKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQH---PH---L 399 (688)
Q Consensus 331 ~~~~~el~~at~~f~~~-----~~LG~G~fG~Vykg~~~g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~H---pn---I 399 (688)
.+.-.++..+...|..+ ..|.+ .-..||+....+..+++|+.... ....+..-|...|..+.- |= +
T Consensus 10 ~~~~~~~~~~l~~~~~g~~~~~~~l~s-~eN~~f~~~~~~g~~iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl 86 (331)
T COG2334 10 PLTSDEAAAALEAYHYGLDGSLRGLNS-EENSNFRVQTEDGRYILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPL 86 (331)
T ss_pred CcChHHHHHHHHhcCcCcccccccccc-ccCceEEEEecCCCeEEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCc
Confidence 34444444444433322 23444 45678988888666799988765 344455567777776632 11 2
Q ss_pred eeEec----ccCC--CceeEEecCCCCcHHH---------------Hhccc---------CCCCCCCHHH----------
Q 005617 400 VTLLG----ACPE--AWSLVYEYLPNGSLQD---------------RLFRK---------SNVSPLLWKD---------- 439 (688)
Q Consensus 400 V~l~g----~~~~--~~~LV~E~~~~gsL~~---------------~L~~~---------~~~~~l~~~~---------- 439 (688)
..+=| .... ..+-|++|++|..+.. .|+.. .......|..
T Consensus 87 ~~~dG~~l~~~~~~~r~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~ 166 (331)
T COG2334 87 PSLDGELLEALSGGPRPAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLD 166 (331)
T ss_pred cCCCcchhhhccCCceeEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhc
Confidence 22222 2233 4567999999988772 11110 0111334531
Q ss_pred ---HHHHHHHHHHHHHHHhcc----CCCc---eEeCCCCCCceeeCCCCC-eEEeecCccc
Q 005617 440 ---RARIAAEIASGLCFLHSS----KPEK---IVHGDLKPQNILLDSELS-SKICDFGICR 489 (688)
Q Consensus 440 ---~~~i~~qia~aL~yLH~~----~~~~---IiHrDIKp~NILLd~~~~-vKLsDFGla~ 489 (688)
.......+...+..+... -|.. +||+|+.|.|||++.+.. +-+.|||-+.
T Consensus 167 ~~~~~~l~a~~~~~~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 167 LVEPEDLRAALLAALDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred ccCchhhHHHHHHHHHHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 011233344444444433 2333 999999999999999885 8999999765
|
|
| >KOG1029 consensus Endocytic adaptor protein intersectin [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=95.59 E-value=2.2 Score=49.70 Aligned_cols=17 Identities=29% Similarity=0.347 Sum_probs=7.5
Q ss_pred HHHHHHHHHHHHhHHHH
Q 005617 181 NSAFAEFLRRKKLESEA 197 (688)
Q Consensus 181 ~~~~~e~~rR~~~e~~~ 197 (688)
+.||+|--||.+.|...
T Consensus 333 Rq~leeqqqreree~eq 349 (1118)
T KOG1029|consen 333 RQALEEQQQREREEVEQ 349 (1118)
T ss_pred HHHHHHHHHHHHHHHHH
Confidence 44444444444444443
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.38 E-value=0.069 Score=57.11 Aligned_cols=32 Identities=22% Similarity=0.362 Sum_probs=28.6
Q ss_pred CCceEeCCCCCCceeeCCCCCeEEeecCcccc
Q 005617 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 459 ~~~IiHrDIKp~NILLd~~~~vKLsDFGla~~ 490 (688)
+.+++|+|+.++|||++.++.+.|+||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 45799999999999999999999999987754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties [] | Back alignment and domain information |
|---|
Probab=95.03 E-value=0.13 Score=53.48 Aligned_cols=73 Identities=26% Similarity=0.239 Sum_probs=55.5
Q ss_pred eeeccCceEEEEEEEC-CeEEEEEEEecCCccchHHHHHHH---HHHHcCCCCceeeEecccCCCceeEEecC-CCCcHH
Q 005617 349 KVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEV---RVLSKLQHPHLVTLLGACPEAWSLVYEYL-PNGSLQ 423 (688)
Q Consensus 349 ~LG~G~fG~Vykg~~~-g~~vAIK~l~~~~~~~~~~f~~E~---~iL~~l~HpnIV~l~g~~~~~~~LV~E~~-~~gsL~ 423 (688)
.+..|..+.|+.++.. |.++++|+...... +..|. ..|...+-...|+++..-.+...|++|.+ ++.+|.
T Consensus 9 ~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~-----~~~E~~g~~~L~~w~G~GaVrll~~d~~~~AlLLErl~~g~~L~ 83 (253)
T PF04655_consen 9 PPAHGSSSLVVPVRRADGTPAVLKLAPPHAE-----AEHEARGEAALRWWNGRGAVRLLAADPERGALLLERLDPGRSLA 83 (253)
T ss_pred CCCCCcceEEEEEEcCCCCeEEEEecCCccc-----chhhhhHHhHhheeCCCCceeeeccccccchhhhhhccCCCchh
Confidence 4567889999999764 89999999865432 22233 55888888889999999988899999999 555775
Q ss_pred HHh
Q 005617 424 DRL 426 (688)
Q Consensus 424 ~~L 426 (688)
+..
T Consensus 84 ~~~ 86 (253)
T PF04655_consen 84 SLP 86 (253)
T ss_pred hcc
Confidence 544
|
Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process |
| >KOG1029 consensus Endocytic adaptor protein intersectin [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=94.97 E-value=1.1 Score=52.02 Aligned_cols=27 Identities=22% Similarity=0.059 Sum_probs=18.5
Q ss_pred HHHhh-HHHHHHHHHHHHhHHHHHHHhh
Q 005617 176 AEELR-NSAFAEFLRRKKLESEAMEAIG 202 (688)
Q Consensus 176 ~~~~~-~~~~~e~~rR~~~e~~~~~~~~ 202 (688)
-|+|. |.|=+|-.|+.-.|+...++-+
T Consensus 319 keNy~kGqaELerRRq~leeqqqreree 346 (1118)
T KOG1029|consen 319 KENYEKGQAELERRRQALEEQQQREREE 346 (1118)
T ss_pred HHhHhhhhHHHHHHHHHHHHHHHHHHHH
Confidence 35665 8888887777777777666443
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.84 E-value=0.39 Score=51.84 Aligned_cols=92 Identities=13% Similarity=-0.002 Sum_probs=52.4
Q ss_pred CcccCHHHHHHHhcCcccc---e-eeeccCceEEEEEEEC-CeEEEEEEEecCCccchHHHHHHHHHHHcCCC--Cceee
Q 005617 329 SAEFSLADLQTATCNFSES---F-KVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQH--PHLVT 401 (688)
Q Consensus 329 ~~~~~~~el~~at~~f~~~---~-~LG~G~fG~Vykg~~~-g~~vAIK~l~~~~~~~~~~f~~E~~iL~~l~H--pnIV~ 401 (688)
+..++.+.+..+...+-.. . ..-.+.-..||+.... |..+++|+..... ....+...|+..+..|.. -.++.
T Consensus 8 ~~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv~~ 86 (325)
T PRK11768 8 FQTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPVVA 86 (325)
T ss_pred CCCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCCCC
Confidence 4556667666666544221 1 2223445689988775 6789999875432 234556677777776632 12222
Q ss_pred Ee---cc----cCCCceeEEecCCCCc
Q 005617 402 LL---GA----CPEAWSLVYEYLPNGS 421 (688)
Q Consensus 402 l~---g~----~~~~~~LV~E~~~~gs 421 (688)
.. |- +.+..+.|+++++|..
T Consensus 87 p~~~~G~~~~~~~g~~~~l~~~~~G~~ 113 (325)
T PRK11768 87 PLAFNGQTLHEHQGFRFALFPRRGGRA 113 (325)
T ss_pred CccCCCCEEEEECCEEEEEEeeeCCCC
Confidence 12 11 1223567889988764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 688 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-37 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-37 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 5e-37 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-36 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-35 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 4e-35 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-35 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 5e-34 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-29 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-29 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-23 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 7e-23 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 2e-22 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-21 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-21 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 5e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 5e-21 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 7e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-21 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-21 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 9e-21 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 9e-21 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 9e-21 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 9e-21 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-20 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-20 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-20 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-20 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-20 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-20 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-20 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-20 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-20 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-20 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 2e-20 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 2e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-20 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 3e-20 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 3e-20 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 3e-20 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 3e-20 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 3e-20 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 4e-20 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 7e-20 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-19 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-19 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 5e-19 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 8e-19 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-18 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-18 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-18 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-18 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-18 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-18 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-18 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 5e-18 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-18 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 5e-18 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-18 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 5e-18 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 5e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-18 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-18 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-18 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 9e-18 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-18 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-18 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 1e-17 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 1e-17 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-17 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 1e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 1e-17 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 1e-17 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-17 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 3e-17 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-17 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 3e-17 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-17 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-17 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-17 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 3e-17 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-17 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 3e-17 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-17 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-17 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 5e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-17 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 6e-17 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-17 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 8e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-17 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 9e-17 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-16 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-16 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-16 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-16 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-16 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 1e-16 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-16 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-16 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-16 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-16 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-16 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-16 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-16 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-16 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-16 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-16 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-16 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-16 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-16 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-16 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-16 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-16 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-16 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-16 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-16 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-16 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-16 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 4e-16 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 4e-16 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-16 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-16 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-16 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-16 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-16 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 5e-16 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-16 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-16 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 6e-16 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-16 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-16 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 7e-16 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 9e-16 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-15 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 1e-15 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-15 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-15 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-15 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-15 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-15 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-15 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-15 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 2e-15 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-15 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-15 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-15 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-15 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-15 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-15 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-15 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 4e-15 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-15 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 4e-15 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-15 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 4e-15 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-15 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 4e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-15 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-15 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 5e-15 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 5e-15 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-15 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-15 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 8e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 8e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 9e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-14 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-14 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-14 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-14 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-14 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-14 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-14 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-14 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-14 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-14 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 3e-14 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-14 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-14 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-14 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-14 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-14 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-14 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-14 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 3e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-14 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 4e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-14 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 4e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-14 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 5e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 5e-14 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 5e-14 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 6e-14 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 7e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-14 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-14 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-14 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 8e-14 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-14 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 9e-14 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 9e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 9e-14 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-14 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-13 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-13 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-13 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-13 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-13 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-13 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-13 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-13 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 2e-13 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-13 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-13 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-13 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-13 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-13 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-13 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 3e-13 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 3e-13 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 3e-13 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-13 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-13 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 5e-13 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-13 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-13 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-13 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 7e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 7e-13 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 7e-13 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 9e-13 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-13 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 9e-13 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 9e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-12 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-12 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-12 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-12 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-12 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-12 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-12 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-12 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 2e-12 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-12 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-12 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-12 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 2e-12 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-12 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-12 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-12 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-12 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 3e-12 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 3e-12 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-12 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-12 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-12 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-12 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-12 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-12 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-12 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-12 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-12 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 4e-12 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-12 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-12 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 4e-12 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-12 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-12 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-12 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 4e-12 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-12 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-12 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 4e-12 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 4e-12 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 5e-12 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-12 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-12 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 7e-12 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 7e-12 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 7e-12 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 7e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 8e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-12 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 1e-11 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 1e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 1e-11 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-11 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-11 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-11 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 1e-11 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-11 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 1e-11 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-11 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-11 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-11 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-11 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-11 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-11 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-11 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-11 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-11 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-11 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-11 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-11 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-11 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-11 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 3e-11 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-11 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-11 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-11 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 3e-11 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-11 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-11 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-11 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-11 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-11 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 3e-11 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-11 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-11 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 3e-11 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-11 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-11 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-11 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-11 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-11 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-11 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-11 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-11 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-11 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-11 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-11 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-11 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-11 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 4e-11 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 4e-11 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-11 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 4e-11 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 4e-11 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 4e-11 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 4e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-11 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-11 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 4e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 5e-11 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-11 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-11 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-11 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-11 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 6e-11 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-11 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-11 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 8e-11 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 8e-11 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-11 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 9e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-11 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 9e-11 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-10 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 1e-10 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 1e-10 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-10 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 1e-10 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-10 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-10 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-10 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-10 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-10 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-10 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 1e-10 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-10 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-10 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-10 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-10 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-10 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-10 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-10 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 1e-10 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-10 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-10 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-10 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-10 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-10 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-10 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-10 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-10 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-10 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-10 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-10 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-10 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-10 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-10 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-10 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-10 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-10 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-10 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-10 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-10 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-10 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-10 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-10 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 2e-10 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-10 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-10 | ||
| 1t1h_A | 78 | Nmr Solution Structure Of The U Box Domain From Atp | 3e-10 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-10 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 3e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-10 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-10 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-10 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-10 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-10 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 3e-10 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 3e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-10 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 4e-10 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-10 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-10 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-10 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-10 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-10 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 5e-10 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-10 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 5e-10 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-10 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-10 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-10 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 7e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 7e-10 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 7e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 7e-10 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-09 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 1e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-09 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-09 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-09 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 2e-09 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-09 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-09 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-09 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-09 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-09 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 3e-09 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-09 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 4e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-09 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-09 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 5e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-09 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 5e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 5e-09 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-09 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 6e-09 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 6e-09 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-09 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 6e-09 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 6e-09 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 6e-09 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 6e-09 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 6e-09 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-09 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 7e-09 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 7e-09 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-09 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 7e-09 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 7e-09 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 7e-09 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 9e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 9e-09 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-08 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-08 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-08 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-08 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-08 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-08 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-08 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-08 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-08 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 1e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-08 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-08 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-08 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-08 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-08 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-08 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-08 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 2e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-08 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-08 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 2e-08 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-08 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-08 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-08 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-08 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-08 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-08 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 3e-08 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-08 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-08 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 4e-08 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-08 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 4e-08 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-08 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 4e-08 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 4e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-08 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 4e-08 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 4e-08 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 4e-08 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 4e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-08 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-08 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-08 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 4e-08 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 4e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-08 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 4e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 5e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-08 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-08 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-08 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-08 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-08 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-08 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-08 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-08 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-08 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-08 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 5e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-08 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 5e-08 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-08 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 6e-08 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 6e-08 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 7e-08 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 7e-08 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 7e-08 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 7e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-08 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 7e-08 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 8e-08 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 8e-08 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 8e-08 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-08 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 9e-08 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 9e-08 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 9e-08 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 9e-08 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 9e-08 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 9e-08 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-07 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-07 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-07 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-07 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-07 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-07 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-07 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-07 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-07 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-07 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-07 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-07 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-07 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-07 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-07 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-07 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-07 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 3e-07 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 3e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-07 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 3e-07 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 3e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-07 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-07 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-07 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 3e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-07 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-07 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 3e-07 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-07 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 3e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 3e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-07 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 3e-07 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 3e-07 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 3e-07 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-07 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-07 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-07 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-07 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 4e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 4e-07 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-07 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-07 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-07 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-07 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-07 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-07 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-07 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 4e-07 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-07 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 4e-07 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-07 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-07 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-07 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 4e-07 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 4e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 4e-07 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-07 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-07 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-07 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 5e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-07 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-07 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-07 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-07 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 5e-07 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-07 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-07 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-07 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 5e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 5e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-07 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-07 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-07 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 6e-07 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 6e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-07 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 6e-07 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 6e-07 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 6e-07 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 6e-07 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 6e-07 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-07 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-07 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-07 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 6e-07 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 6e-07 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-07 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-07 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-07 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 6e-07 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-07 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 7e-07 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 7e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 7e-07 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 7e-07 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 7e-07 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 7e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 7e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 8e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 8e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 9e-07 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 9e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-07 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-07 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 9e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 9e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 9e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-06 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-06 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-06 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-06 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-06 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-06 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-06 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 1e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-06 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-06 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-06 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-06 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-06 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-06 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-06 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-06 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-06 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-06 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-06 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 2e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-06 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-06 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-06 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 2e-06 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-06 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 2e-06 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-06 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-06 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-06 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-06 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-06 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 3e-06 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-06 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-06 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 3e-06 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 3e-06 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 3e-06 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 3e-06 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 4e-06 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 4e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 5e-06 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-06 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-06 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 6e-06 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 7e-06 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-06 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 8e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-06 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 9e-06 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 1e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-05 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-05 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 1e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 1e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-05 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-05 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-05 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 3e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 4e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 4e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-05 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-05 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 7e-05 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 9e-05 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 9e-05 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-04 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-04 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 1e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-04 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-04 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-04 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-04 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-04 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-04 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-04 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-04 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-04 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-04 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-04 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-04 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-04 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-04 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-04 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-04 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-04 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-04 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-04 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-04 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-04 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 3e-04 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 3e-04 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 3e-04 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1T1H|A Chain A, Nmr Solution Structure Of The U Box Domain From Atpub14, An Armadillo Repeat Containing Protein From Arabidopsis Thaliana Length = 78 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 297 bits (762), Expect = 1e-95
Identities = 107/291 (36%), Positives = 149/291 (51%), Gaps = 22/291 (7%)
Query: 332 FSLADLQTATCNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRV 390
L DL+ AT NF F +G G FG VYKG + G VA+K + QG EF+ E+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 391 LSKLQHPHLVTLLGACPEAWS--LVYEYLPNGSLQDRLFRKSN-VSPLLWKDRARIAAEI 447
LS +HPHLV+L+G C E L+Y+Y+ NG+L+ L+ + W+ R I
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 448 ASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAP 507
A GL +LH+ I+H D+K NILLD KI DFGI + TE H ST
Sbjct: 149 ARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELD----QTHLSTVV 201
Query: 508 KGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPV---------GLAGEVRRAVS 558
KG+ Y DPEY G LT KSD YSFG+++ ++L R + LA + +
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261
Query: 559 CGKLSSILDP-LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608
G+L I+DP LA R+ D ++C L +RP + ++ +LE
Sbjct: 262 NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMG-DVLWKLE 311
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 276 bits (709), Expect = 5e-88
Identities = 99/302 (32%), Positives = 148/302 (49%), Gaps = 29/302 (9%)
Query: 332 FSLADLQTATCNFSESF------KVGQGGFGCVYKGEMLGRTVAIKMLYSHN----MQGQ 381
FS +L+ T NF E K+G+GGFG VYKG + TVA+K L + + +
Sbjct: 15 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELK 74
Query: 382 LEFQQEVRVLSKLQHPHLVTLLGACPEAWS--LVYEYLPNGSLQDRLFRKSNVSPLLWKD 439
+F QE++V++K QH +LV LLG + LVY Y+PNGSL DRL PL W
Sbjct: 75 QQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHM 134
Query: 440 RARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499
R +IA A+G+ FLH +H D+K NILLD ++KI DFG+ R +
Sbjct: 135 RCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA---- 187
Query: 500 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE----VRR 555
++ G+ Y PE G +TPKSD YSFG+++L+++TG V E +
Sbjct: 188 QTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246
Query: 556 A----VSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611
+ +D D + + + QC +RPDI + + L+++
Sbjct: 247 KEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIK-KVQQLLQEMT 305
Query: 612 VA 613
+
Sbjct: 306 AS 307
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 259 bits (665), Expect = 3e-81
Identities = 109/302 (36%), Positives = 163/302 (53%), Gaps = 27/302 (8%)
Query: 332 FSLADLQTATCNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQG-QLEFQQEVR 389
FSL +LQ A+ NFS +G+GGFG VYKG + G VA+K L QG +L+FQ EV
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 390 VLSKLQHPHLVTLLGACPEA--WSLVYEYLPNGSLQDRLFRKSNVSPLL-WKDRARIAAE 446
++S H +L+ L G C LVY Y+ NGS+ L + P L W R RIA
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 447 IASGLCFLH-SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE-DTLYLPSFHRS 504
A GL +LH P KI+H D+K NILLD E + + DFG+ +L+ DT H +
Sbjct: 140 SARGLAYLHDHCDP-KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT------HVT 192
Query: 505 TAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPV---GLAGE--------V 553
TA +G+ + PEY TG + K+D + +G+++L+L+TG+ LA + V
Sbjct: 193 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
Query: 554 RRAVSCGKLSSILDP-LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612
+ + KL +++D L G++ +L+ + L C + ERP ++ +V+ LE +
Sbjct: 253 KGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS-EVVRMLEGDGL 311
Query: 613 AE 614
AE
Sbjct: 312 AE 313
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 8e-63
Identities = 83/303 (27%), Positives = 130/303 (42%), Gaps = 30/303 (9%)
Query: 349 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE 408
VG+G FG V K + + VAIK + S + + F E+R LS++ HP++V L GAC
Sbjct: 15 VVGRGAFGVVCKAKWRAKDVAIKQIESESERK--AFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 409 AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLK 468
LV EY GSL + L + + + G+ +LHS +P+ ++H DLK
Sbjct: 73 PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLK 132
Query: 469 PQNILLDSELSS-KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPK 527
P N+LL + + KICDFG + T KGS + PE + K
Sbjct: 133 PPNLLLVAGGTVLKICDFGTACDIQTHM---------TNNKGSAAWMAPEVFEGSNYSEK 183
Query: 528 SDSYSFGLIILQLLTGRLP----VGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVD 583
D +S+G+I+ +++T R P G A + AV G + + + +
Sbjct: 184 CDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL--------IKNLPKPIES 235
Query: 584 LGLQCCELYGRERPDITPSLVKELEQLHVA-----EERPVPSFFLCPILQEIMHDPQVAA 638
L +C +RP + +VK + L E P P ++ +P V
Sbjct: 236 LMTRCWSKDPSQRPSME-EIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEPYVDF 294
Query: 639 DGF 641
F
Sbjct: 295 AEF 297
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 8e-62
Identities = 65/316 (20%), Positives = 114/316 (36%), Gaps = 39/316 (12%)
Query: 324 EDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLE 383
+ +L + +G FGCV+K ++L VA+K+ + Q +
Sbjct: 6 HHHSSGVDLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSW-Q 64
Query: 384 FQQEVRVLSKLQHPHLVTLLGACPEA------WSLVYEYLPNGSLQDRLFRKSNVSPLLW 437
+ EV L ++H +++ +GA L+ + GSL D L + W
Sbjct: 65 NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN----VVSW 120
Query: 438 KDRARIAAEIASGLCFLHS--------SKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
+ IA +A GL +LH KP I H D+K +N+LL + L++ I DFG+
Sbjct: 121 NELCHIAETMARGLAYLHEDIPGLKDGHKP-AISHRDIKSKNVLLKNNLTACIADFGLAL 179
Query: 490 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVL-----TPKSDSYSFGLIILQLLTGR 544
S + G+ Y PE + + D Y+ GL++ +L +
Sbjct: 180 KFEAGK----SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRC 235
Query: 545 LPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 604
+ ++ P D V + L + +++
Sbjct: 236 TAADGPVDEYMLPFEEEIGQ--HPSLEDMQEVVVHKKKRP-----VLRDYWQKHAGMAML 288
Query: 605 KELEQL---HVAEERP 617
E + H AE R
Sbjct: 289 CETIEECWDHDAEARL 304
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 1e-59
Identities = 82/268 (30%), Positives = 130/268 (48%), Gaps = 21/268 (7%)
Query: 349 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTLLGAC 406
K+G G FG V++ E G VA+K+L + + EF +EV ++ +L+HP++V +GA
Sbjct: 44 KIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 407 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
P S+V EYL GSL L + L + R +A ++A G+ +LH+ P IVH
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVH 162
Query: 465 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVL 524
+LK N+L+D + + K+CDFG+ RL L S + G+ + PE R
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS------SKSAAGTPEWMAPEVLRDEPS 216
Query: 525 TPKSDSYSFGLIILQLLTGRLP-VGL-AGEVRRAVSCGKLSSILDPLAGDWPTFVARRLV 582
KSD YSFG+I+ +L T + P L +V AV + P + ++
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEI-------PRNLNPQVA 269
Query: 583 DLGLQCCELYGRERPDITPSLVKELEQL 610
+ C +RP +++ L L
Sbjct: 270 AIIEGCWTNEPWKRPSFA-TIMDLLRPL 296
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 3e-56
Identities = 72/278 (25%), Positives = 119/278 (42%), Gaps = 36/278 (12%)
Query: 349 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQL----EFQQEVRVLSKLQHPHLVTLLG 404
+G GGFG VY+ +G VA+K + +QE ++ + L+HP+++ L G
Sbjct: 14 IIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 405 AC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
C LV E+ G L L K + A +IA G+ +LH I
Sbjct: 74 VCLKEPNLCLVMEFARGGPLNRVLSGK----RIPPDILVNWAVQIARGMNYLHDEAIVPI 129
Query: 463 VHGDLKPQNILLDSELSS--------KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 514
+H DLK NIL+ ++ + KI DFG+ R T + G++ +
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT--------KMSAAGAYAWM 181
Query: 515 DPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP-VGL-AGEVRRAVSCGKLSSILDPLAGD 572
PE R + + SD +S+G+++ +LLTG +P G+ V V+ KL+ +
Sbjct: 182 APEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI------ 235
Query: 573 WPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610
P+ L C RP T +++ +L +
Sbjct: 236 -PSTCPEPFAKLMEDCWNPDPHSRPSFT-NILDQLTTI 271
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 2e-55
Identities = 82/283 (28%), Positives = 133/283 (46%), Gaps = 42/283 (14%)
Query: 349 KVGQGGFGCVYKGEMLGR--TVAIKMLYSHNMQGQL-------EFQQEVRVLSKLQHPHL 399
++G+GGFG V+KG ++ VAIK L + +G+ EFQ+EV ++S L HP++
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 400 VTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 459
V L G +V E++P G L RL K++ P+ W + R+ +IA G+ ++ + P
Sbjct: 86 VKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQNQNP 143
Query: 460 EKIVHGDLKPQNILLDS-----ELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 514
IVH DL+ NI L S + +K+ DFG+ + + G+F +
Sbjct: 144 -PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS---------VSGLLGNFQWM 193
Query: 515 DPE--YHRTGVLTPKSDSYSFGLIILQLLTGRLP----VGLAGEVRRAVSCGKLS-SILD 567
PE T K+D+YSF +I+ +LTG P + + L +I
Sbjct: 194 APETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI-- 251
Query: 568 PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610
P RL ++ C ++RP + +VKEL +L
Sbjct: 252 ------PEDCPPRLRNVIELCWSGDPKKRPHFS-YIVKELSEL 287
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 3e-55
Identities = 77/271 (28%), Positives = 129/271 (47%), Gaps = 24/271 (8%)
Query: 349 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTLLGAC 406
++G G FG VYKG+ G VA+KML Q F+ EV VL K +H +++ +G
Sbjct: 31 RIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 407 -PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 465
++V ++ SL L ++ + K IA + A G+ +LH+ I+H
Sbjct: 90 TAPQLAIVTQWCEGSSLYHHL--HASETKFEMKKLIDIARQTARGMDYLHAKS---IIHR 144
Query: 466 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE---YHRTG 522
DLK NI L + + KI DFG+ + + H+ GS + PE +
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS----HQFEQLSGSILWMAPEVIRMQDSN 200
Query: 523 VLTPKSDSYSFGLIILQLLTGRLP---VGLAGEVRRAVSCGKLSSILDPLAGDWPTFVAR 579
+ +SD Y+FG+++ +L+TG+LP + ++ V G LS L + + P +
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCP----K 256
Query: 580 RLVDLGLQCCELYGRERPDITPSLVKELEQL 610
R+ L +C + ERP ++ E+E+L
Sbjct: 257 RMKRLMAECLKKKRDERPSFP-RILAEIEEL 286
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 185 bits (470), Expect = 5e-53
Identities = 58/237 (24%), Positives = 97/237 (40%), Gaps = 31/237 (13%)
Query: 331 EFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRV 390
E + ++ N +G+G +G VYKG + R VA+K+ N Q F E +
Sbjct: 2 EAAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQ---NFINEKNI 58
Query: 391 --LSKLQHPHLVTLLGAC-------PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRA 441
+ ++H ++ + + LV EY PNGSL L + W
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWVSSC 114
Query: 442 RIAAEIASGLCFLHSSKPE------KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495
R+A + GL +LH+ P I H DL +N+L+ ++ + I DFG+ +T +
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 496 LYLPSF--HRSTAPKGSFPYADPEY-------HRTGVLTPKSDSYSFGLIILQLLTG 543
L P + + + G+ Y PE + D Y+ GLI ++
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 6e-52
Identities = 42/207 (20%), Positives = 92/207 (44%), Gaps = 22/207 (10%)
Query: 349 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTLLGAC 406
K+ + G ++KG G + +K+L + + +F +E L HP+++ +LGAC
Sbjct: 17 KLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC 76
Query: 407 ----PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
+L+ ++P GSL + L + + + A ++A G+ FLH+ +P I
Sbjct: 77 QSPPAPHPTLITHWMPYGSLYNVL-HEGTNFVVDQSQAVKFALDMARGMAFLHTLEP-LI 134
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE---YH 519
L +++++D +++++I + +S + + PE
Sbjct: 135 PRHALNSRSVMIDEDMTARISMADVKF-----------SFQSPGRMYAPAWVAPEALQKK 183
Query: 520 RTGVLTPKSDSYSFGLIILQLLTGRLP 546
+D +SF +++ +L+T +P
Sbjct: 184 PEDTNRRSADMWSFAVLLWELVTREVP 210
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 1e-51
Identities = 63/277 (22%), Positives = 106/277 (38%), Gaps = 31/277 (11%)
Query: 349 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTLLGAC 406
+G+G FG VY G G VAI+++ F++EV + +H ++V +GAC
Sbjct: 40 LIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 407 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
P +++ +L + L +IA EI G+ +LH+ + I+H
Sbjct: 99 MSPPHLAIITSLCKGRTLYSVVRDAKI--VLDVNKTRQIAQEIVKGMGYLHA---KGILH 153
Query: 465 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVL 524
DLK +N+ D I DFG+ + + G + PE R
Sbjct: 154 KDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRRE-DKLRIQNGWLCHLAPEIIRQLSP 211
Query: 525 ---------TPKSDSYSFGLIILQLLTGRLP-VGL-AGEVRRAVSCGKLSSILDPLAGDW 573
+ SD ++ G I +L P A + + G ++
Sbjct: 212 DTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLS------- 264
Query: 574 PTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610
+ + + D+ L C ERP T L+ LE+L
Sbjct: 265 QIGMGKEISDILLFCWAFEQEERPTFT-KLMDMLEKL 300
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 9e-51
Identities = 68/286 (23%), Positives = 119/286 (41%), Gaps = 24/286 (8%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
+G+G FG K G + +K L + + Q F +EV+V+ L+HP+++ +G
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 407 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
+ + + EY+ G+L+ + KS S W R A +IASG+ +LHS I+H
Sbjct: 77 YKDKRLNFITEYIKGGTLRGII--KSMDSQYPWSQRVSFAKDIASGMAYLHSM---NIIH 131
Query: 465 GDLKPQNILLDSELSSKICDFGICRLVTEDT--------LYLPSFHRSTAPKGSFPYADP 516
DL N L+ + + DFG+ RL+ ++ L P + G+ + P
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 517 EYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTF 576
E K D +SFG+++ +++ + + P
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPNCPP- 250
Query: 577 VARRLVDLGLQCCELYGRERPDITPSLVKELEQL--HVAEERPVPS 620
+ ++CC+L +RP L LE L H+A P+
Sbjct: 251 ---SFFPITVRCCDLDPEKRPS-FVKLEHWLETLRMHLAGHLPLGP 292
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 5e-48
Identities = 53/225 (23%), Positives = 90/225 (40%), Gaps = 28/225 (12%)
Query: 349 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRV--LSKLQHPHLVTLLGAC 406
VG+G +G V++G G VA+K+ S + + + +E + L+H +++ + +
Sbjct: 15 CVGKGRYGEVWRGSWQGENVAVKIFSSRDEK---SWFRETELYNTVMLRHENILGFIASD 71
Query: 407 ------PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460
L+ Y GSL D L L RI IASGL LH
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQLT----TLDTVSCLRIVLSIASGLAHLHIEIFG 127
Query: 461 -----KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 515
I H DLK +NIL+ I D G+ + ++ T L + G+ Y
Sbjct: 128 TQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDV--GNNPRVGTKRYMA 185
Query: 516 PE------YHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR 554
PE + D ++FGL++ ++ + G+ + +
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYK 230
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 6e-47
Identities = 55/223 (24%), Positives = 90/223 (40%), Gaps = 24/223 (10%)
Query: 349 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC-- 406
++G+G +G V+ G+ G VA+K+ ++ + E+ ++H +++ + A
Sbjct: 44 QIGKGRYGEVWMGKWRGEKVAVKVFFTTEEA-SWFRETEIYQTVLMRHENILGFIAADIK 102
Query: 407 ----PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE-- 460
L+ +Y NGSL D L L K ++A SGLC LH+
Sbjct: 103 GTGSWTQLYLITDYHENGSLYDYLKST----TLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 461 ---KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 517
I H DLK +NIL+ + I D G+ DT G+ Y PE
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDT--NEVDIPPNTRVGTKRYMPPE 216
Query: 518 ------YHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR 554
+D YSFGLI+ ++ + G+ E +
Sbjct: 217 VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQ 259
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 2e-45
Identities = 55/227 (24%), Positives = 91/227 (40%), Gaps = 36/227 (15%)
Query: 349 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC-- 406
+G+G FG V++G+ G VA+K+ S + + E+ L+H +++ + A
Sbjct: 49 SIGKGRFGEVWRGKWRGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNK 107
Query: 407 -----PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE- 460
+ W LV +Y +GSL D L R + + ++A ASGL LH
Sbjct: 108 DNGTWTQLW-LVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGT 162
Query: 461 ----KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 516
I H DLK +NIL+ + I D G+ D+ G+ Y P
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR--HDSATDTIDIAPNHRVGTKRYMAP 220
Query: 517 EYHRTGVL-----------TPKSDSYSFGLIILQLLTGRLPVGLAGE 552
E VL ++D Y+ GL+ ++ G+ +
Sbjct: 221 E-----VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 262
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 5e-40
Identities = 66/274 (24%), Positives = 116/274 (42%), Gaps = 32/274 (11%)
Query: 349 KVGQGGFGCVYKGEMLGRT--VAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVTLLGA 405
++G+G FG V+ G + VA+K +F QE R+L + HP++V L+G
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 406 CPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
C + + V E + G L ++ + L K ++ + A+G+ +L S +
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFL--RTEGARLRVKTLLQMVGDAAAGMEYLESKC---CI 235
Query: 464 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY---ADPEYHR 520
H DL +N L+ + KI DFG+ R + ++ P A PE
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYA------ASGGLRQVPVKWTA-PEALN 288
Query: 521 TGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAGDWPTFV 577
G + +SD +SFG+++ + + G P L+ + R V G L P
Sbjct: 289 YGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG---RLPC-----PELC 340
Query: 578 ARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611
+ L QC +RP + ++ +EL+ +
Sbjct: 341 PDAVFRLMEQCWAYEPGQRPSFS-TIYQELQSIR 373
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 2e-37
Identities = 58/218 (26%), Positives = 90/218 (41%), Gaps = 31/218 (14%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGA 405
+GQG V++G G AIK+ + + ++ +E VL KL H ++V L A
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF-A 74
Query: 406 CPEAWS-----LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460
E + L+ E+ P GSL L SN L + + ++ G+ L
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---N 131
Query: 461 KIVHGDLKPQNILL----DSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 516
IVH ++KP NI+ D + K+ DFG R + +D S + G+ Y P
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVSLY------GTEEYLHP 184
Query: 517 EYHRTGVL--------TPKSDSYSFGLIILQLLTGRLP 546
+ + VL D +S G+ TG LP
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 61/208 (29%), Positives = 97/208 (46%), Gaps = 24/208 (11%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKML---YSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
K+G GG VY E +L VAIK + + F++EV S+L H ++V+++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 404 --GACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
+ + LV EY+ +L + + PL +I G+ H +
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHG---PLSVDTAINFTNQILDGIKHAHDMR--- 131
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK---GSFPYADPEY 518
IVH D+KPQNIL+DS + KI DFGI + ++E +L T G+ Y PE
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL--------TQTNHVLGTVQYFSPEQ 183
Query: 519 HRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ +D YS G+++ ++L G P
Sbjct: 184 AKGEATDECTDIYSIGIVLYEMLVGEPP 211
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 1e-36
Identities = 78/219 (35%), Positives = 106/219 (48%), Gaps = 19/219 (8%)
Query: 349 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
K+GQG FG V+ G G T VAIK L M + F QE +V+ KL+H LV L
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 408 EA-WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGD 466
E +V EY+ GSL D L + L +AA+IASG+ ++ VH D
Sbjct: 250 EEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 305
Query: 467 LKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY--ADPEYHRTGVL 524
L+ NIL+ L K+ DFG+ RL+ ++ FP PE G
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYT-------ARQGAKFPIKWTAPEAALYGRF 358
Query: 525 TPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCG 560
T KSD +SFG+++ +L T GR+P G+ EV V G
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 397
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 71/297 (23%), Positives = 113/297 (38%), Gaps = 33/297 (11%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
K+G+GGF V E L G A+K + H Q + E Q+E + HP+++ L+ C
Sbjct: 36 KLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYC 95
Query: 407 PEAWS------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRA-RIAAEIASGLCFLHSSKP 459
L+ + G+L + + R + L +D+ + I GL +H+
Sbjct: 96 LRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA--- 152
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRS---TAPKGSFPYADP 516
+ H DLKP NILL E + D G A + + Y P
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 517 E---YHRTGVLTPKSDSYSFGLIILQLLTGRLP---VGLAGEVRRAVSCGKLSSILDPLA 570
E V+ ++D +S G ++ ++ G P V G+ +LS P
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSP-- 270
Query: 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEERPVPSFFLCPIL 627
+ L L + +RP I P L+ +LE L + P P IL
Sbjct: 271 -----RHSSALWQLLNSMMTVDPHQRPHI-PLLLSQLEAL----QPPAPGQHTTQIL 317
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-36
Identities = 63/221 (28%), Positives = 106/221 (47%), Gaps = 21/221 (9%)
Query: 349 KVGQGGFGCVYKGEMLGRT--VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
K+G G +G VY+G + VA+K L M+ + EF +E V+ +++HP+LV LLG C
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 407 PEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
+ E++ G+L D L R+ N + +A +I+S + +L + +H
Sbjct: 286 TREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYLEK---KNFIH 341
Query: 465 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY--ADPEYHRTG 522
+L +N L+ K+ DFG+ RL+T DT Y FP PE
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAH------AGAKFPIKWTAPESLAYN 394
Query: 523 VLTPKSDSYSFGLIILQLLT-GRLPV-GLAG-EVRRAVSCG 560
+ KSD ++FG+++ ++ T G P G+ +V +
Sbjct: 395 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD 435
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 3e-36
Identities = 58/218 (26%), Positives = 90/218 (41%), Gaps = 31/218 (14%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGA 405
+GQG V++G G AIK+ + + ++ +E VL KL H ++V L A
Sbjct: 16 ILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF-A 74
Query: 406 CPEAWS-----LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460
E + L+ E+ P GSL L SN L + + ++ G+ L
Sbjct: 75 IEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---N 131
Query: 461 KIVHGDLKPQNILL----DSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 516
IVH ++KP NI+ D + K+ DFG R + +D S + G+ Y P
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVSLY------GTEEYLHP 184
Query: 517 EYHRTGVL--------TPKSDSYSFGLIILQLLTGRLP 546
+ + VL D +S G+ TG LP
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-35
Identities = 78/219 (35%), Positives = 106/219 (48%), Gaps = 19/219 (8%)
Query: 349 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
K+GQG FG V+ G G T VAIK L M + F QE +V+ KL+H LV L
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 408 EA-WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGD 466
E +V EY+ GSL D L + L +AA+IASG+ ++ VH D
Sbjct: 333 EEPIYIVTEYMSKGSLLDFL-KGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 388
Query: 467 LKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY--ADPEYHRTGVL 524
L+ NIL+ L K+ DFG+ RL+ ++ FP PE G
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYT-------ARQGAKFPIKWTAPEAALYGRF 441
Query: 525 TPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCG 560
T KSD +SFG+++ +L T GR+P G+ EV V G
Sbjct: 442 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG 480
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-35
Identities = 71/311 (22%), Positives = 125/311 (40%), Gaps = 57/311 (18%)
Query: 349 KVGQGGFGCVYKGEMLGR------TVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTL 402
++G+G FG V VA+K L + +F++E+ +L LQH ++V
Sbjct: 17 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 76
Query: 403 LGACPEAWS----LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
G C A L+ EYLP GSL+D L + + + + ++I G+ +L +
Sbjct: 77 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT-- 132
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YAD 515
++ +H DL +NIL+++E KI DFG+ +++ +D + + P G P YA
Sbjct: 133 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEF----FKVKEP-GESPIFWYA- 185
Query: 516 PEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPT 575
PE + SD +SFG+++ +L T + + G+
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFT------------YIEKSKSPPAEFMRMIGNDK- 232
Query: 576 FVARRLVDLGLQCCELYGR-------ERPDITPSLVKELEQL---HVAEERPVPSF-FLC 624
+ L RPD P + + + +R PSF L
Sbjct: 233 -------QGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQR--PSFRDLA 283
Query: 625 PILQEIMHDPQ 635
+ +I +
Sbjct: 284 LRVDQIRDNMA 294
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-35
Identities = 72/308 (23%), Positives = 120/308 (38%), Gaps = 69/308 (22%)
Query: 349 KVGQGGFGCVYKGEMLGR------TVAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVT 401
+G G FG VYKG + VAIK L E E V++ + +PH+
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 402 LLGACP-EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460
LLG C L+ + +P G L D + + + + + +IA G+ +L +
Sbjct: 82 LLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYL-EDR-- 136
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPE 517
++VH DL +N+L+ + KI DFG+ +L+ + A G P A E
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE------YHAEGGKVPIKWMA-LE 189
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAGDWP 574
+ T +SD +S+G+ + +L+T G P G+ E+ + G+
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE------------- 236
Query: 575 TFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL------HVAEERPVPSF-FLCPIL 627
RL +P I ++ + A+ R P F L
Sbjct: 237 -----RL-------------PQPPICT---IDVYMIMRKCWMIDADSR--PKFRELIIEF 273
Query: 628 QEIMHDPQ 635
++ DPQ
Sbjct: 274 SKMARDPQ 281
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-35
Identities = 86/282 (30%), Positives = 125/282 (44%), Gaps = 33/282 (11%)
Query: 349 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
++G G FG V+ G G T VA+K L +M F E ++ +LQH LV L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 408 -EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGD 466
E ++ EY+ NGSL D L + + L +AA+IA G+ F+ +H D
Sbjct: 79 QEPIYIITEYMENGSLVDFL-KTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRD 134
Query: 467 LKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY---ADPEYHRTGV 523
L+ NIL+ LS KI DFG+ RL+ ++ FP A PE G
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEYT-------AREGAKFPIKWTA-PEAINYGT 186
Query: 524 LTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAGDWPTFVARR 580
T KSD +SFG+++ +++T GR+P G+ EV + + G + P
Sbjct: 187 FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY---RMVR-----PDNCPEE 238
Query: 581 LVDLGLQCCELYGRERPDITPSLVKELEQLHVAEE---RPVP 619
L L C + +RP L LE A E +P P
Sbjct: 239 LYQLMRLCWKERPEDRPTFD-YLRSVLEDFFTATEGQYQPQP 279
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-35
Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 24/199 (12%)
Query: 349 KVGQGGFGCVYKGEMLGR------TVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTL 402
++G+G FG V VA+K L + +F++E+ +L LQH ++V
Sbjct: 48 QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKY 107
Query: 403 LGAC----PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
G C L+ EYLP GSL+D L + + + + ++I G+ +L +
Sbjct: 108 KGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT-- 163
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YAD 515
++ +H DL +NIL+++E KI DFG+ +++ +D Y ++ P G P YA
Sbjct: 164 -KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY----YKVKEP-GESPIFWYA- 216
Query: 516 PEYHRTGVLTPKSDSYSFG 534
PE + SD +SFG
Sbjct: 217 PESLTESKFSVASDVWSFG 235
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 28/211 (13%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIK-MLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLG 404
++G+G F VYKG VA + + + + F++E +L LQHP++V
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 405 AC------PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
+ + LV E + +G+L+ L R + + + +I GL FLH+
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLR---SWCRQILKGLQFLHTRT 149
Query: 459 PEKIVHGDLKPQNILLDSELSS-KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY--AD 515
P I+H DLK NI + S KI D G+ L + + P A
Sbjct: 150 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVIGT-------PEFMA- 198
Query: 516 PEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PE + D Y+FG+ +L++ T P
Sbjct: 199 PEMYEEKY-DESVDVYAFGMCMLEMATSEYP 228
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 83/305 (27%), Positives = 131/305 (42%), Gaps = 46/305 (15%)
Query: 349 KVGQGGFGCVYKGEMLGR------TVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTL 402
++G+G FG V VA+K L Q +FQ+E+++L L +V
Sbjct: 30 QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 403 LGACPEAWS----LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
G LV EYLP+G L+D L + + + L +++I G+ +L S
Sbjct: 90 RGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS-- 145
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YAD 515
+ VH DL +NIL++SE KI DFG+ +L+ D Y + P G P YA
Sbjct: 146 -RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDY----YVVREP-GQSPIFWYA- 198
Query: 516 PEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEVRRAVSCGKLSSILDPLAGDWP 574
PE + + +SD +SFG+++ +L T C + L + +
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKS------------CSPSAEFLRMMGCERD 246
Query: 575 TFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL---HVAEERPVPSF-FLCPILQEI 630
RL++L L+ E P P+ V EL +L ++R PSF L P L +
Sbjct: 247 VPALSRLLEL-LE--EGQRLPAPPACPAEVHELMKLCWAPSPQDR--PSFSALGPQLDML 301
Query: 631 MHDPQ 635
+
Sbjct: 302 WSGSR 306
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-35
Identities = 68/295 (23%), Positives = 114/295 (38%), Gaps = 36/295 (12%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLLGA 405
+ +GGF VY+ + + GR A+K L S+ + QEV + KL HP++V A
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 406 CPEAWS---------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 456
L+ L G L + L + + PL +I + + +H
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK------GS 510
KP I+H DLK +N+LL ++ + K+CDFG ++ Y S R + +
Sbjct: 155 QKP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 511 FPYADPE---YHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILD 567
Y PE + + K D ++ G I+ L + P + + GK S
Sbjct: 214 PMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE--DGAKLRIVNGKYS---- 267
Query: 568 PLAGDWPTFVAR--RLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEERPVPS 620
P + L ++ ER I +V +L+++ A S
Sbjct: 268 -----IPPHDTQYTVFHSLIRAMLQVNPEERLSI-AEVVHQLQEIAAARNVNPKS 316
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-35
Identities = 64/271 (23%), Positives = 110/271 (40%), Gaps = 38/271 (14%)
Query: 349 KVGQGGFGCVYKGE-MLGRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHP--HLVTLL 403
++G GG V++ + AIK + Q ++ E+ L+KLQ ++ L
Sbjct: 16 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 404 GAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
+ +V E N L L +K ++ P +R + + +H
Sbjct: 76 DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP---WERKSYWKNMLEAVHTIHQ---HG 128
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE---- 517
IVH DLKP N L+ + K+ DFGI + DT S + + G+ Y PE
Sbjct: 129 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT---TSVVKDS-QVGTVNYMPPEAIKD 183
Query: 518 -------YHRTGVLTPKSDSYSFGLIILQLLTGRLP-VGLAGEVRRAVSCGKLSSILDP- 568
++PKSD +S G I+ + G+ P + ++ KL +I+DP
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS------KLHAIIDPN 237
Query: 569 LAGDWPTFVARRLVDLGLQCCELYGRERPDI 599
++P + L D+ C + ++R I
Sbjct: 238 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 268
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 5e-35
Identities = 72/301 (23%), Positives = 117/301 (38%), Gaps = 45/301 (14%)
Query: 349 KVGQGGFGCVYKGEMLGR------TVAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVT 401
+G+G FG V VA+K L + + + ++E+ +L L H ++V
Sbjct: 28 DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 87
Query: 402 LLGACPEAWS----LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
G C E L+ E+LP+GSL++ L N + + K + + A +I G+ +L S
Sbjct: 88 YKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGS- 144
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YA 514
+ VH DL +N+L++SE KI DFG+ + + D Y + P YA
Sbjct: 145 --RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY----YTVKDD-RDSPVFWYA 197
Query: 515 DPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWP 574
PE SD +SFG+ + +LLT + + L I G
Sbjct: 198 -PECLMQSKFYIASDVWSFGVTLHELLTY-------CDSDSSPMALFLKMIGPTH-GQMT 248
Query: 575 TFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL---HVAEERPVPSF-FLCPILQEI 630
+ G P P V +L + R SF L + +
Sbjct: 249 VTRLVNTLKEG------KRLPCPPNCPDEVYQLMRKCWEFQPSNR--TSFQNLIEGFEAL 300
Query: 631 M 631
+
Sbjct: 301 L 301
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-35
Identities = 64/271 (23%), Positives = 110/271 (40%), Gaps = 38/271 (14%)
Query: 349 KVGQGGFGCVYKG-EMLGRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHP--HLVTLL 403
++G GG V++ + AIK + Q ++ E+ L+KLQ ++ L
Sbjct: 35 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 94
Query: 404 GAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
+ +V E N L L +K ++ P +R + + +H
Sbjct: 95 DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP---WERKSYWKNMLEAVHTIHQ---HG 147
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE---- 517
IVH DLKP N L+ + K+ DFGI + DT S + + G+ Y PE
Sbjct: 148 IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT---TSVVKDS-QVGTVNYMPPEAIKD 202
Query: 518 -------YHRTGVLTPKSDSYSFGLIILQLLTGRLP-VGLAGEVRRAVSCGKLSSILDP- 568
++PKSD +S G I+ + G+ P + ++ KL +I+DP
Sbjct: 203 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS------KLHAIIDPN 256
Query: 569 LAGDWPTFVARRLVDLGLQCCELYGRERPDI 599
++P + L D+ C + ++R I
Sbjct: 257 HEIEFPDIPEKDLQDVLKCCLKRDPKQRISI 287
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 6e-35
Identities = 78/303 (25%), Positives = 124/303 (40%), Gaps = 53/303 (17%)
Query: 349 KVGQGGFGCVYKGEMLGR------TVAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVT 401
+G+G FG V VA+K L + ++QE+ +L L H H++
Sbjct: 38 DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIK 97
Query: 402 LLGACPEAWS----LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
G C +A + LV EY+P GSL+D L + ++ A +I G+ +LH+
Sbjct: 98 YKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGL---AQLLLFAQQICEGMAYLHA- 152
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YA 514
+ +H DL +N+LLD++ KI DFG+ + V E Y +R G P YA
Sbjct: 153 --QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEY----YRVRED-GDSPVFWYA 205
Query: 515 DPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWP 574
PE + SD +SFG+ + +LLT + ++ L I
Sbjct: 206 -PECLKEYKFYYASDVWSFGVTLYELLTH-------CDSSQSPPTKFLELIGIAQGQ-MT 256
Query: 575 TFVARRLVDLG--LQC---C--ELYG----------RERPDITPSLVKELEQLHVAEERP 617
L++ G L C E+Y RP +L+ L+ +H +
Sbjct: 257 VLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFE-NLIPILKTVHEKYQGQ 315
Query: 618 VPS 620
PS
Sbjct: 316 APS 318
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 9e-35
Identities = 65/261 (24%), Positives = 108/261 (41%), Gaps = 39/261 (14%)
Query: 349 KVGQGGFGCVYKGEML-GRTVAIKM--LYSHNMQGQLEFQQEVRVLSKLQHP--HLVTLL 403
++G GG V++ + AIK L + Q ++ E+ L+KLQ ++ L
Sbjct: 63 QIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 404 GAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
+ +V E N L L +K ++ P +R + + +H
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP---WERKSYWKNMLEAVHTIHQ---HG 175
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE---- 517
IVH DLKP N L+ K+ DFGI + DT S + + G+ Y PE
Sbjct: 176 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDT---TSVVKDS-QVGAVNYMPPEAIKD 230
Query: 518 -------YHRTGVLTPKSDSYSFGLIILQLLTGRLP-VGLAGEVRRAVSCGKLSSILDP- 568
++PKSD +S G I+ + G+ P + ++ KL +I+DP
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQIS------KLHAIIDPN 284
Query: 569 LAGDWPTFVARRLVDLGLQCC 589
++P + L D+ L+CC
Sbjct: 285 HEIEFPDIPEKDLQDV-LKCC 304
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-34
Identities = 72/220 (32%), Positives = 110/220 (50%), Gaps = 21/220 (9%)
Query: 349 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
K+G G FG V+ T VA+K + +M F E V+ LQH LV L
Sbjct: 195 KLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVT 253
Query: 408 -EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGD 466
E ++ E++ GSL D L + S +A+IA G+ F+ +H D
Sbjct: 254 KEPIYIITEFMAKGSLLDFL-KSDEGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRD 309
Query: 467 LKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS-FPY--ADPEYHRTGV 523
L+ NIL+ + L KI DFG+ R++ ++ Y TA +G+ FP PE G
Sbjct: 310 LRAANILVSASLVCKIADFGLARVIEDNE-Y-------TAREGAKFPIKWTAPEAINFGS 361
Query: 524 LTPKSDSYSFGLIILQLLT-GRLPV-GLAG-EVRRAVSCG 560
T KSD +SFG+++++++T GR+P G++ EV RA+ G
Sbjct: 362 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG 401
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 1e-34
Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 25/220 (11%)
Query: 349 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE 408
+G+G FG V G+ G VA+K + + F E V+++L+H +LV LLG E
Sbjct: 200 TIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQ--AFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 409 AWSLVY---EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 465
+Y EY+ GSL D L R S L + + ++ + +L VH
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHR 313
Query: 466 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY--ADPEYHRTGV 523
DL +N+L+ + +K+ DFG+ + + G P PE R
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----------GKLPVKWTAPEALREKK 362
Query: 524 LTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCG 560
+ KSD +SFG+++ ++ + GR+P + +V V G
Sbjct: 363 FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG 402
|
| >1t1h_A Gspef-atpub14, armadillo repeat containing protein; ubiquitin ligase, E3 ligase, U-BOX,; NMR {Arabidopsis thaliana} SCOP: g.44.1.2 Length = 78 | Back alignment and structure |
|---|
Score = 124 bits (315), Expect = 1e-34
Identities = 28/68 (41%), Positives = 39/68 (57%)
Query: 618 VPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHAL 677
P +F CPI E+M DP + + G TYE +I+ WL+ G +T P + L H LTPN+ L
Sbjct: 5 FPEYFRCPISLELMKDPVIVSTGQTYERSSIQKWLDAGHKTCPKSQETLLHAGLTPNYVL 64
Query: 678 RHAIQDWL 685
+ I W
Sbjct: 65 KSLIALWC 72
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-34
Identities = 79/283 (27%), Positives = 123/283 (43%), Gaps = 34/283 (12%)
Query: 349 KVGQGGFGCVYKGEMLGR-----TVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVTL 402
+G+G FG VY GE + + AIK L MQ F +E ++ L HP+++ L
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 403 LGACPEAWSLVY---EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 459
+G L + Y+ +G L F +S KD ++A G+ +L + +
Sbjct: 88 IGIMLPPEGLPHVLLPYMCHGDLLQ--FIRSPQRNPTVKDLISFGLQVARGMEYL-AEQ- 143
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADP 516
K VH DL +N +LD + K+ DFG+ R + + Y HR P A
Sbjct: 144 -KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHR----HARLPVKWTA-L 197
Query: 517 EYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAGDW 573
E +T T KSD +SFG+++ +LLT G P + ++ ++ G+ L
Sbjct: 198 ESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR---RLPQ----- 249
Query: 574 PTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEER 616
P + L + QC E RP LV E+EQ+ A
Sbjct: 250 PEYCPDSLYQVMQQCWEADPAVRPTFR-VLVGEVEQIVSALLG 291
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 3e-34
Identities = 71/276 (25%), Positives = 122/276 (44%), Gaps = 30/276 (10%)
Query: 349 KVGQGGFGCVYKGEMLGRT--VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
K+G G +G VY+G + VA+K L M+ + EF +E V+ +++HP+LV LLG C
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 407 PEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
+ E++ G+L D L R+ N + +A +I+S + +L K +H
Sbjct: 79 TREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL-EKK--NFIH 134
Query: 465 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY--ADPEYHRTG 522
DL +N L+ K+ DFG+ RL+T DT Y FP PE
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDT-YTAH------AGAKFPIKWTAPESLAYN 187
Query: 523 VLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAGDWPTFVAR 579
+ KSD ++FG+++ ++ T G P G+ +V + ++ P
Sbjct: 188 KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---RMER-----PEGCPE 239
Query: 580 RLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEE 615
++ +L C + +RP + + E +
Sbjct: 240 KVYELMRACWQWNPSDRPSFA-EIHQAFETMFQESS 274
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-34
Identities = 75/275 (27%), Positives = 125/275 (45%), Gaps = 30/275 (10%)
Query: 349 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
++G G FG V G+ G+ VA+KM+ +M EF QE + + KL HP LV G C
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED-EFFQEAQTMMKLSHPKLVKFYGVCS 73
Query: 408 EAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 465
+ + + V EY+ NG L + L +S+ L + ++ G+ FL S + +H
Sbjct: 74 KEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFIHR 128
Query: 466 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY--ADPEYHRTGV 523
DL +N L+D +L K+ DFG+ R V +D ++ FP + PE
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV-------SSVGTKFPVKWSAPEVFHYFK 181
Query: 524 LTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAGDWPTFVARR 580
+ KSD ++FG+++ ++ + G++P EV VS G L P +
Sbjct: 182 YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH---RLYR-----PHLASDT 233
Query: 581 LVDLGLQCCELYGRERPDITPSLVKELEQLHVAEE 615
+ + C +RP L+ +E L ++
Sbjct: 234 IYQIMYSCWHELPEKRPTFQ-QLLSSIEPLREKDK 267
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 3e-34
Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 20/209 (9%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKML---YSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
+G GG V+ R VA+K+L + + L F++E + + L HP +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 404 ------GACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
+V EY+ +L+D + + P+ K + A+ L F H +
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN 135
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 517
I+H D+KP NI++ + + K+ DFGI R + + S ++ A G+ Y PE
Sbjct: 136 G---IIHRDVKPANIMISATNAVKVMDFGIARAIADSG---NSVTQTAAVIGTAQYLSPE 189
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
R + +SD YS G ++ ++LTG P
Sbjct: 190 QARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 26/209 (12%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKML---YSHNMQGQLEFQQEVRVLSKLQHPHLVTL- 402
VG+GG G VY+ E + R VA+K++ S + + Q+E R +LQ PH+V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 403 -LGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRA-RIAAEIASGLCFLHSSKPE 460
G + + L L R+ ++P RA I +I S L H++
Sbjct: 101 DFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAP----PRAVAIVRQIGSALDAAHAAG-- 154
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK---GSFPYADPE 517
H D+KP+NIL+ ++ + + DFGI T++ L T G+ Y PE
Sbjct: 155 -ATHRDVKPENILVSADDFAYLVDFGIASATTDEKL--------TQLGNTVGTLYYMAPE 205
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
T ++D Y+ ++ + LTG P
Sbjct: 206 RFSESHATYRADIYALTCVLYECLTGSPP 234
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-34
Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 25/205 (12%)
Query: 349 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE 408
+G+G FG V G+ G VA+K + + F E V+++L+H +LV LLG E
Sbjct: 28 TIGKGEFGDVMLGDYRGNKVAVKCIKNDAT--AQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 409 AWSLVY---EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 465
+Y EY+ GSL D L R S L + + ++ + +L VH
Sbjct: 86 EKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGDCLLKFSLDVCEAMEYL-EGN--NFVHR 141
Query: 466 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY---ADPEYHRTG 522
DL +N+L+ + +K+ DFG+ + + T G P A PE R
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTKEASS-----------TQDTGKLPVKWTA-PEALREK 189
Query: 523 VLTPKSDSYSFGLIILQLLT-GRLP 546
+ KSD +SFG+++ ++ + GR+P
Sbjct: 190 KFSTKSDVWSFGILLWEIYSFGRVP 214
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 5e-34
Identities = 59/212 (27%), Positives = 89/212 (41%), Gaps = 26/212 (12%)
Query: 351 GQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGACP 407
G GGFG V + G VAIK E + E++++ KL HP++V+ P
Sbjct: 23 GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAR-EVP 81
Query: 408 EAWS---------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
+ L EY G L+ L + N L + ++I+S L +LH ++
Sbjct: 82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR 141
Query: 459 PEKIVHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 515
I+H DLKP+NI+L KI D G + + + L F G+ Y
Sbjct: 142 ---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL-CTEF------VGTLQYLA 191
Query: 516 PEYHRTGVLTPKSDSYSFGLIILQLLTGRLPV 547
PE T D +SFG + + +TG P
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPF 223
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-34
Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 23/221 (10%)
Query: 349 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC- 406
++G G FG V+ G L + VAIK + M + +F +E V+ KL HP LV L G C
Sbjct: 15 EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE-DFIEEAEVMMKLSHPKLVQLYGVCL 73
Query: 407 -PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 465
LV E++ +G L D + ++ + + ++ G+ +L + ++H
Sbjct: 74 EQAPICLVTEFMEHGCLSD--YLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 128
Query: 466 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPEYHRTG 522
DL +N L+ K+ DFG+ R V +D ++ FP + PE
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-------SSTGTKFPVKWAS-PEVFSFS 180
Query: 523 VLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCG 560
+ KSD +SFG+++ ++ + G++P + EV +S G
Sbjct: 181 RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG 221
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-34
Identities = 56/220 (25%), Positives = 103/220 (46%), Gaps = 21/220 (9%)
Query: 349 KVGQGGFGCVYKGEMLGRT-VAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC- 406
++G G FG V G+ G+ VAIKM+ +M EF +E +V+ L H LV L G C
Sbjct: 31 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED-EFIEEAKVMMNLSHEKLVQLYGVCT 89
Query: 407 -PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 465
++ EY+ NG L + + + + + ++ + +L S ++ +H
Sbjct: 90 KQRPIFIITEYMANGCLLN--YLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHR 144
Query: 466 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY--ADPEYHRTGV 523
DL +N L++ + K+ DFG+ R V +D ++ FP + PE
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-------SSVGSKFPVRWSPPEVLMYSK 197
Query: 524 LTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCG 560
+ KSD ++FG+++ ++ + G++P E ++ G
Sbjct: 198 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG 237
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 57/225 (25%), Positives = 92/225 (40%), Gaps = 26/225 (11%)
Query: 349 KVGQGGFGCVYKGEMLGRT-----VAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVTL 402
+G+G FG VY+G VA+K +F E ++ L HPH+V L
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKL 78
Query: 403 LGACP-EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
+G E ++ E P G L L + N + L + +I + +L S
Sbjct: 79 IGIIEEEPTWIIMELYPYGELGHYL--ERNKNSLKVLTLVLYSLQICKAMAYLES---IN 133
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPEY 518
VH D+ +NIL+ S K+ DFG+ R + ++ Y A P + PE
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY-------KASVTRLPIKWMS-PES 185
Query: 519 HRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCG 560
T SD + F + + ++L+ G+ P L +V + G
Sbjct: 186 INFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG 230
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 2e-33
Identities = 71/281 (25%), Positives = 113/281 (40%), Gaps = 35/281 (12%)
Query: 349 KVGQGGFGCVYKGEMLGR-----TVAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVTL 402
+G+G FG V++G + VAIK + +F QE + + HPH+V L
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 81
Query: 403 LGACP-EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
+G ++ E G L+ L + L A ++++ L +L SK +
Sbjct: 82 IGVITENPVWIIMELCTLGELRSFL--QVRKYSLDLASLILYAYQLSTALAYL-ESK--R 136
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPEY 518
VH D+ +N+L+ S K+ DFG+ R + + T Y A KG P A PE
Sbjct: 137 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-------KASKGKLPIKWMA-PES 188
Query: 519 HRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAGDWPT 575
T SD + FG+ + ++L G P G+ +V + G+ L P
Sbjct: 189 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE---RLPM-----PP 240
Query: 576 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEER 616
L L +C RP T L +L + E+
Sbjct: 241 NCPPTLYSLMTKCWAYDPSRRPRFT-ELKAQLSTILEEEKA 280
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 80/292 (27%), Positives = 130/292 (44%), Gaps = 45/292 (15%)
Query: 349 KVGQGGFGCVYKGEMLG-------RTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVT 401
++G+G FG V+ E VA+K L + + +FQ+E +L+ LQH H+V
Sbjct: 22 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVK 81
Query: 402 LLGACPEA--WSLVYEYLPNGSLQDRL-------------FRKSNVSPLLWKDRARIAAE 446
G C + +V+EY+ +G L L + L IA++
Sbjct: 82 FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 141
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTA 506
IASG+ +L +S+ VH DL +N L+ + L KI DFG+ R V Y R
Sbjct: 142 IASGMVYL-ASQ--HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY-----RVGG 193
Query: 507 PKGSFP--YADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGK 561
P + PE T +SD +SFG+I+ ++ T G+ P L+ EV ++ G+
Sbjct: 194 -HTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGR 252
Query: 562 LSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVA 613
+L+ P + + D+ L C + ++R +I + K L L A
Sbjct: 253 ---VLER-----PRVCPKEVYDVMLGCWQREPQQRLNIK-EIYKILHALGKA 295
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 62/290 (21%), Positives = 114/290 (39%), Gaps = 42/290 (14%)
Query: 349 KVGQGGFGCVYKGEMLGR-----TVAIKML--YSHNMQGQLEFQQEVRVLSKLQHPHLVT 401
+G+G FG V +G + VA+K + + + + EF E + HP+++
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 402 LLGAC----PEAWSLVY---EYLPNGSLQD--RLFR-KSNVSPLLWKDRARIAAEIASGL 451
LLG C + ++ G L R ++ + + + +IA G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 511
+L S++ +H DL +N +L +++ + DFG+ + + Y R
Sbjct: 161 EYL-SNR--NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYY-----RQGR-IAKM 211
Query: 512 P---YADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSI 565
P A E V T KSD ++FG+ + ++ T G P G+ E+ + G
Sbjct: 212 PVKWIA-IESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR--- 267
Query: 566 LDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEE 615
L P L ++ C +RP + L +LE+L +
Sbjct: 268 LKQ-----PEDCLDELYEIMYSCWRTDPLDRPTFS-VLRLQLEKLLESLP 311
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 58/223 (26%), Positives = 97/223 (43%), Gaps = 38/223 (17%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGA 405
+G+GGFG V++ + + AIK + N + E +EV+ L+KL+HP +V A
Sbjct: 12 CLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA 71
Query: 406 CPEAWS--------------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGL 451
E + + + +L+D + + + I +IA +
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAV 131
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT------LYLPSFHRST 505
FLHS + ++H DLKP NI + K+ DFG+ + +D +P++ R T
Sbjct: 132 EFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHT 188
Query: 506 APKGSFPYADPE------YHRTGVLTPKSDSYSFGLIILQLLT 542
G+ Y PE Y + K D +S GLI+ +LL
Sbjct: 189 GQVGTKLYMSPEQIHGNSY------SHKVDIFSLGLILFELLY 225
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 72/294 (24%), Positives = 121/294 (41%), Gaps = 46/294 (15%)
Query: 349 KVGQGGFGCVYKGEMLGR-------TVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVT 401
++G+G FG V+ E VA+K L + + +FQ+E +L+ LQH H+V
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 402 LLGACPEA--WSLVYEYLPNGSLQDRL------------FRKSNVSPLLWKDRARIAAEI 447
G C E +V+EY+ +G L L PL +A+++
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 448 ASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAP 507
A+G+ +L + VH DL +N L+ L KI DFG+ R + Y R
Sbjct: 168 AAGMVYL-AGL--HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYY-----RVGG- 218
Query: 508 KGSFP---YADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGK 561
+ P PE T +SD +SFG+++ ++ T G+ P L+ E ++ G+
Sbjct: 219 RTMLPIRWMP-PESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR 277
Query: 562 LSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEE 615
L+ P + + C + ++R I + L+ L A
Sbjct: 278 ---ELER-----PRACPPEVYAIMRGCWQREPQQRHSIK-DVHARLQALAQAPP 322
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-33
Identities = 64/215 (29%), Positives = 95/215 (44%), Gaps = 39/215 (18%)
Query: 349 KVGQGGFGCVYKGEMLG-------RTVAIKMLY-SHNMQGQLEFQQEVRVLSKL-QHPHL 399
+G G FG V + G TVA+KML S ++ + E++VLS L H ++
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 400 VTLLGAC--PEAWSLVYEYLPNGSLQDRL---------------FRKSNVSPLLWKDRAR 442
V LLGAC ++ EY G L + L + + L +D
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 443 IAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 502
+ ++A G+ FL +SK +H DL +NILL +KICDFG+ R + D+ Y+
Sbjct: 150 FSYQVAKGMAFL-ASK--NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVK-- 204
Query: 503 RSTAPKGSFPY---ADPEYHRTGVLTPKSDSYSFG 534
P A PE V T +SD +S+G
Sbjct: 205 ----GNARLPVKWMA-PESIFNCVYTFESDVWSYG 234
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 9e-33
Identities = 60/228 (26%), Positives = 93/228 (40%), Gaps = 34/228 (14%)
Query: 343 NFSESFKVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLV 400
+F E +GQG FG V K + R AIK + + EV +L+ L H ++V
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLS-TILSEVMLLASLNHQYVV 65
Query: 401 TLLGACPEAWS---------------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRA-RIA 444
A E + + EY NG+L D + ++ +D R+
Sbjct: 66 RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQ---RDEYWRLF 122
Query: 445 AEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRS 504
+I L ++HS + I+H DLKP NI +D + KI DFG+ + V L ++
Sbjct: 123 RQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179
Query: 505 TAPK--------GSFPYADPE-YHRTGVLTPKSDSYSFGLIILQLLTG 543
G+ Y E TG K D YS G+I +++
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 60/226 (26%), Positives = 99/226 (43%), Gaps = 26/226 (11%)
Query: 349 KVGQGGFGCVYKGEMLGR------TVAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVT 401
+G G FG VYKG + VAIK L E E V++ + +PH+
Sbjct: 22 VLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCR 81
Query: 402 LLGACP-EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460
LLG C L+ + +P G L D + + + + + +IA G+ +L
Sbjct: 82 LLGICLTSTVQLITQLMPFGCLLDYV--REHKDNIGSQYLLNWCVQIAKGMNYLED---R 136
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPE 517
++VH DL +N+L+ + KI DFG+ +L+ + A G P A E
Sbjct: 137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY------HAEGGKVPIKWMA-LE 189
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCG 560
+ T +SD +S+G+ + +L+T G P G+ E+ + G
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG 235
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 1e-32
Identities = 62/211 (29%), Positives = 97/211 (45%), Gaps = 35/211 (16%)
Query: 349 KVGQGGFGCVYKGEMLG-------RTVAIKMLY-SHNMQGQLEFQQEVRVLSKL-QHPHL 399
+G G FG V + G VA+KML + + + E++++S L QH ++
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENI 112
Query: 400 VTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNV-----------SPLLWKDRARIAAE 446
V LLGAC ++ EY G L + L RKS V S +D +++
Sbjct: 113 VNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQ 172
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTA 506
+A G+ FL +SK +H D+ +N+LL + +KI DFG+ R + D+ Y+
Sbjct: 173 VAQGMAFL-ASK--NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVK------ 223
Query: 507 PKGSFPY---ADPEYHRTGVLTPKSDSYSFG 534
P A PE V T +SD +S+G
Sbjct: 224 GNARLPVKWMA-PESIFDCVYTVQSDVWSYG 253
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 65/285 (22%), Positives = 113/285 (39%), Gaps = 40/285 (14%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLG 404
+G G +G K G+ + K L +M + EV +L +L+HP++V
Sbjct: 13 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 72
Query: 405 ACPEAWS----LVYEYLPNGSLQDRLFRKSNVSPLLWKDRA-RIAAEIASGLCFLHSSKP 459
+ + +V EY G L + + + L ++ R+ ++ L H
Sbjct: 73 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 132
Query: 460 E--KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 517
++H DLKP N+ LD + + K+ DFG+ R++ DT + +F G+ Y PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF------VGTPYYMSPE 186
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLTGRLP------VGLAGEVRRAVSCGKLSSILDPLAG 571
KSD +S G ++ +L P LAG++R GK I
Sbjct: 187 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE----GKFRRI------ 236
Query: 572 DWPTFVARRLVDLGLQCCELYGRERPDIT-----PSLVKELEQLH 611
P + L ++ + L RP + P +++ H
Sbjct: 237 --PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHHHHH 279
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 78/320 (24%), Positives = 125/320 (39%), Gaps = 50/320 (15%)
Query: 349 KVGQGGFGCVYKGEMLGR------TVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVT 401
+G G FG V+KG + V IK++ Q + + L H H+V
Sbjct: 20 VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVR 79
Query: 402 LLGACP-EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460
LLG CP + LV +YLP GSL D + + + L + +IA G+ +L
Sbjct: 80 LLGLCPGSSLQLVTQYLPLGSLLDHV--RQHRGALGPQLLLNWGVQIAKGMYYLEE---H 134
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPE 517
+VH +L +N+LL S ++ DFG+ L+ D + P A E
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQ------LLYSEAKTPIKWMA-LE 187
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAGDWP 574
G T +SD +S+G+ + +L+T G P GL EV + G+ L P
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE---RLAQ-----P 239
Query: 575 TFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEER---------------PVP 619
+ + ++C + RP L E ++ R P P
Sbjct: 240 QICTIDVYMVMVKCWMIDENIRPTFK-ELANEFTRMARDPPRYLVIKRESGPGIAPGPEP 298
Query: 620 SFFLCPILQEIMHDPQVAAD 639
L+E+ +P++ D
Sbjct: 299 HGLTNKKLEEVELEPELDLD 318
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 70/278 (25%), Positives = 122/278 (43%), Gaps = 34/278 (12%)
Query: 349 KVGQGGFGCVYKGEMLGR-----TVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVTL 402
+G+G FGCVY G +L A+K L ++ +F E ++ HP++++L
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSL 91
Query: 403 LGACPEAWSLVY---EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 459
LG C + Y+ +G L++ F ++ KD ++A G+ +L +SK
Sbjct: 92 LGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHNPTVKDLIGFGLQVAKGMKYL-ASK- 147
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADP 516
K VH DL +N +LD + + K+ DFG+ R + + Y P A
Sbjct: 148 -KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKT----GAKLPVKWMA-L 201
Query: 517 EYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAGDW 573
E +T T KSD +SFG+++ +L+T G P + ++ + G+ L
Sbjct: 202 ESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR---LLQ----- 253
Query: 574 PTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611
P + L ++ L+C RP + LV + +
Sbjct: 254 PEYCPDPLYEVMLKCWHPKAEMRPSFS-ELVSRISAIF 290
|
| >2f42_A STIP1 homology and U-box containing protein 1; chaperone; 2.50A {Danio rerio} PDB: 2c2v_S 2oxq_C Length = 179 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-32
Identities = 24/139 (17%), Positives = 53/139 (38%), Gaps = 5/139 (3%)
Query: 552 EVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL- 610
E R + + + + + + R+ + + ++++L
Sbjct: 32 EKRISQENELHAYLSKLILAEKERELDDRVKQSDDSQNGGDISKMKSKHDKYLMDMDELF 91
Query: 611 ----HVAEERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRL 666
++R +P + I E+M +P + G TY+ K I + L+ P+T L
Sbjct: 92 SQVDEKRKKREIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFDPVTRSPL 151
Query: 667 SHLHLTPNHALRHAIQDWL 685
+ L PN A++ I ++
Sbjct: 152 TQDQLIPNLAMKEVIDAFI 170
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 3e-32
Identities = 68/291 (23%), Positives = 117/291 (40%), Gaps = 43/291 (14%)
Query: 349 KVGQGGFGCVYKGEMLGR-----TVAIKMLYSHNMQGQ--LEFQQEVRVLSKLQHPHLVT 401
+G+G FG V + ++ VA+KML + + EF +E + + HPH+
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 402 LLGAC----PEAWS----LVYEYLPNGSLQD--RLFRKS-NVSPLLWKDRARIAAEIASG 450
L+G + ++ ++ +G L R N L + R +IA G
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 451 LCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS 510
+ +L SS+ +H DL +N +L +++ + DFG+ R + Y R
Sbjct: 150 MEYL-SSR--NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYY-----RQGC-ASK 200
Query: 511 FP---YADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSS 564
P A E + T SD ++FG+ + +++T G+ P G+ E+ + G
Sbjct: 201 LPVKWLA-LESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR-- 257
Query: 565 ILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEE 615
L P + DL QC ++RP T L ELE +
Sbjct: 258 -LKQ-----PPECMEEVYDLMYQCWSADPKQRPSFT-CLRMELENILGHLS 301
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 72/305 (23%), Positives = 128/305 (41%), Gaps = 42/305 (13%)
Query: 349 KVGQGGFGCVYKGEMLGR-------TVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLV 400
+G G FG VY+G++ G VA+K L + Q +L+F E ++SK H ++V
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 96
Query: 401 TLLGACPEA--WSLVYEYLPNGSLQD----RLFRKSNVSPLLWKDRARIAAEIASGLCFL 454
+G ++ ++ E + G L+ R S S L D +A +IA G +L
Sbjct: 97 RCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYL 156
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHRSTAPKGSF 511
+H D+ +N LL KI DFG+ R + + Y
Sbjct: 157 -EEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYY------RKGGCAML 207
Query: 512 P--YADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSIL 566
P + PE G+ T K+D++SFG+++ ++ + G +P + EV V+ G +
Sbjct: 208 PVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR---M 264
Query: 567 DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEE--RPVPSFFLC 624
DP P + + QC + +RP+ +++ +E +
Sbjct: 265 DP-----PKNCPGPVYRIMTQCWQHQPEDRPNFA-IILERIEYCTQDPDVINTALPIEYG 318
Query: 625 PILQE 629
P+++E
Sbjct: 319 PLVEE 323
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 5e-32
Identities = 60/214 (28%), Positives = 92/214 (42%), Gaps = 38/214 (17%)
Query: 349 KVGQGGFGCVYKGEMLG-------RTVAIKMLYSHNMQGQL-EFQQEVRVLSKL-QHPHL 399
+G+G FG V + + G RTVA+KML + E+++L + H ++
Sbjct: 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 93
Query: 400 VTLLGACPEA---WSLVYEYLPNGSLQDRL-------------FRKSNVSPLLWKDRARI 443
V LLGAC + ++ E+ G+L L L +
Sbjct: 94 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 153
Query: 444 AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHR 503
+ ++A G+ FL +S+ K +H DL +NILL + KICDFG+ R + +D Y
Sbjct: 154 SFQVAKGMEFL-ASR--KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY-----V 205
Query: 504 STAPKGSFPY---ADPEYHRTGVLTPKSDSYSFG 534
P A PE V T +SD +SFG
Sbjct: 206 RKG-DARLPLKWMA-PETIFDRVYTIQSDVWSFG 237
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-32
Identities = 72/281 (25%), Positives = 115/281 (40%), Gaps = 34/281 (12%)
Query: 349 KVGQGGFGCVYKGEMLGR-----TVAIKMLYSHNMQGQ-LEFQQEVRVLSKLQHPHLVTL 402
+G G G V G + VAIK L + + Q +F E ++ + HP+++ L
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRL 115
Query: 403 LGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460
G V EY+ NGSL F +++ + + +G+ +L S
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDT--FLRTHDGQFTIMQLVGMLRGVGAGMRYL-SDL-- 170
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPE 517
VH DL +N+L+DS L K+ DFG+ R++ +D T G P A PE
Sbjct: 171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA-----YTTTGGKIPIRWTA-PE 224
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAGDWP 574
+ SD +SFG+++ ++L G P + +V +V G L P
Sbjct: 225 AIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGY---RLPA-----P 276
Query: 575 TFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEE 615
L L L C +RP + +V L+ L + E
Sbjct: 277 MGCPHALHQLMLDCWHKDRAQRPRFS-QIVSVLDALIRSPE 316
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-32
Identities = 66/225 (29%), Positives = 108/225 (48%), Gaps = 25/225 (11%)
Query: 349 KVGQGGFGCVYKGEMLGR----TVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTL 402
++G G FG V KG + TVA+K+L + L E E V+ +L +P++V +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 403 LGACP-EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
+G C E+W LV E G L L + +V K+ + +++ G+ +L
Sbjct: 84 IGICEAESWMLVMEMAELGPLNKYLQQNRHVKD---KNIIELVHQVSMGMKYL-EES--N 137
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPEY 518
VH DL +N+LL ++ +KI DFG+ + + D Y G +P YA PE
Sbjct: 138 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY-----KAQTHGKWPVKWYA-PEC 191
Query: 519 HRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCG 560
+ KSD +SFG+++ + + G+ P G+ G EV + G
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 236
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 63/220 (28%), Positives = 91/220 (41%), Gaps = 44/220 (20%)
Query: 349 KVGQGGFGCVYKGEMLG-------RTVAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLV 400
+G+G FG V K TVA+KML + +L + E VL ++ HPH++
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVI 89
Query: 401 TLLGAC--PEAWSLVYEYLPNGSLQDRL---------------------FRKSNVSPLLW 437
L GAC L+ EY GSL+ L + L
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTM 149
Query: 438 KDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497
D A +I+ G+ +L + K+VH DL +NIL+ KI DFG+ R V E+ Y
Sbjct: 150 GDLISFAWQISQGMQYL-AEM--KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206
Query: 498 LPSFHRSTAPKGSFP---YADPEYHRTGVLTPKSDSYSFG 534
+ +G P A E + T +SD +SFG
Sbjct: 207 -----VKRS-QGRIPVKWMA-IESLFDHIYTTQSDVWSFG 239
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-31
Identities = 71/305 (23%), Positives = 115/305 (37%), Gaps = 63/305 (20%)
Query: 349 KVGQGGFGCVYKGEMLGR-----TVAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVTL 402
+G+G FG V++G + VAIK + +F QE + + HPH+V L
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 403 LGACP-EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
+G ++ E G L+ L + L A ++++ L +L SK +
Sbjct: 457 IGVITENPVWIIMELCTLGELRSFL--QVRKFSLDLASLILYAYQLSTALAYL-ESK--R 511
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPEY 518
VH D+ +N+L+ S K+ DFG+ R + + T Y A KG P A PE
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-------KASKGKLPIKWMA-PES 563
Query: 519 HRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAGDWPT 575
T SD + FG+ + ++L G P G+ +V + G+
Sbjct: 564 INFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-------------- 609
Query: 576 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQL---HVAEERPVPSF-FLCPILQEIM 631
RL P P + L + R P F L L I+
Sbjct: 610 ----RL-------------PMPPNCPPTLYSLMTKCWAYDPSRR--PRFTELKAQLSTIL 650
Query: 632 HDPQV 636
+ ++
Sbjct: 651 EEEKL 655
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 63/224 (28%), Positives = 105/224 (46%), Gaps = 23/224 (10%)
Query: 349 KVGQGGFGCVYKGEMLGRT----VAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVTLL 403
++G G FG V +G R VAIK+L + E +E +++ +L +P++V L+
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 404 GACP-EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
G C EA LV E G L L + + A + +++ G+ +L K
Sbjct: 77 GVCQAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL-EEK--NF 131
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPEYH 519
VH DL +N+LL + +KI DFG+ + + D Y + G +P YA PE
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY-----TARSAGKWPLKWYA-PECI 185
Query: 520 RTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCG 560
+ +SD +S+G+ + + L+ G+ P + G EV + G
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 229
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 1e-31
Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 26/212 (12%)
Query: 349 KVGQGGFGCVYKGEMLGRT-----VAIKMLYSHNMQGQL---EFQQEVRVLSKLQHPHLV 400
K+G G FG V +GE + VA+K L + +F +EV + L H +L+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 401 TLLGACP-EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 459
L G +V E P GSL DRL + + L +R A ++A G+ +L S
Sbjct: 85 RLYGVVLTPPMKMVTELAPLGSLLDRL--RKHQGHFLLGTLSRYAVQVAEGMGYLES--- 139
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLV-TEDTLYLPSFHRSTAPKGSFP---YAD 515
++ +H DL +N+LL + KI DFG+ R + D Y P A
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHY------VMQEHRKVPFAWCA- 192
Query: 516 PEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP 546
PE +T + SD++ FG+ + ++ T G+ P
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 72/302 (23%), Positives = 126/302 (41%), Gaps = 51/302 (16%)
Query: 349 KVGQGGFGCVYKGEMLG---------RTVAIKMLY-SHNMQGQLEFQQEVRVLSKL-QHP 397
+G+G FG V E +G TVA+KML + + E+ ++ + +H
Sbjct: 42 PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 101
Query: 398 HLVTLLGAC--PEAWSLVYEYLPNGSLQDRL-------------FRKSNVSPLLWKDRAR 442
+++ LLGAC ++ EY G+L++ L + + +KD
Sbjct: 102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 161
Query: 443 IAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 502
++A G+ +L +S+ K +H DL +N+L+ KI DFG+ R + Y
Sbjct: 162 CTYQLARGMEYL-ASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY----- 213
Query: 503 RSTAPKGSFPY---ADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRA 556
+ T G P A PE V T +SD +SFG+++ ++ T G P G+ E+ +
Sbjct: 214 KKTT-NGRLPVKWMA-PEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL 271
Query: 557 VSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEER 616
+ G +D P L + C +RP LV++L+++
Sbjct: 272 LKEGHR---MDK-----PANCTNELYMMMRDCWHAVPSQRPTFK-QLVEDLDRILTLTTN 322
Query: 617 PV 618
Sbjct: 323 EE 324
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-31
Identities = 61/206 (29%), Positives = 98/206 (47%), Gaps = 30/206 (14%)
Query: 349 KVGQGGFGCVYKGEMLG-------RTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLV 400
++GQG FG VY+G G VAIK + + +M+ ++EF E V+ + H+V
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 91
Query: 401 TLLGACPEA--WSLVYEYLPNGSLQD-------RLFRKSNVSPLLWKDRARIAAEIASGL 451
LLG + ++ E + G L+ + ++P ++A EIA G+
Sbjct: 92 RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGM 151
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 511
+L+++ K VH DL +N ++ + + KI DFG+ R + E Y R KG
Sbjct: 152 AYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY-----RKGG-KGLL 202
Query: 512 PY---ADPEYHRTGVLTPKSDSYSFG 534
P + PE + GV T SD +SFG
Sbjct: 203 PVRWMS-PESLKDGVFTTYSDVWSFG 227
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 59/206 (28%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 351 GQGGFGCVYKGEML--GRTVAIKMLY-----SHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
G+G FG VY +A+K+L+ ++ QL ++EV + S L+HP+++ L
Sbjct: 18 GKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL--RREVEIQSHLRHPNILRLY 75
Query: 404 G--ACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKPE 460
G L+ EY P G++ L + S R E+A+ L + HS +
Sbjct: 76 GYFHDATRVYLILEYAPLGTVYRELQKLSKFDE----QRTATYITELANALSYCHS---K 128
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 520
+++H D+KP+N+LL S KI DFG ++ PS R+ G+ Y PE
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRTDLC-GTLDYLPPEMIE 180
Query: 521 TGVLTPKSDSYSFGLIILQLLTGRLP 546
+ K D +S G++ + L G+ P
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPP 206
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 52/212 (24%), Positives = 85/212 (40%), Gaps = 37/212 (17%)
Query: 351 GQGGFGCVYKGEML--GRTVAIKMLY-----SHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
G+GGF ++ A K++ + + ++ E+ + L H H+V
Sbjct: 24 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKM--SMEISIHRSLAHQHVVGFH 81
Query: 404 GACPEAWSLVY---EYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKP 459
G E V+ E SL + R+ ++ AR +I G +LH
Sbjct: 82 G-FFEDNDFVFVVLELCRRRSLLELHKRRKALTE----PEARYYLRQIVLGCQYLHR--- 133
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 519
+++H DLK N+ L+ +L KI DFG+ V D + G+ Y PE
Sbjct: 134 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG----ERKKVLC--GTPNYIAPE-- 185
Query: 520 RTGVLT-----PKSDSYSFGLIILQLLTGRLP 546
VL+ + D +S G I+ LL G+ P
Sbjct: 186 ---VLSKKGHSFEVDVWSIGCIMYTLLVGKPP 214
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 4e-31
Identities = 52/235 (22%), Positives = 88/235 (37%), Gaps = 38/235 (16%)
Query: 349 KVGQGGFGCVYKGEMLGR---------TVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHL 399
+GQG F ++KG V +K+L + F + ++SKL H HL
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 400 VTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
V G C + LV E++ GSL + K N + + + +A ++A+ + FL
Sbjct: 75 VLNYGVCVCGDENILVQEFVKFGSLDT--YLKKNKNCINILWKLEVAKQLAAAMHFL-EE 131
Query: 458 KPEKIVHGDLKPQNILLDSELSS--------KICDFGICRLVTEDTLY-LPSFHRSTAPK 508
++HG++ +NILL E K+ D GI V + P+
Sbjct: 132 N--TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERI--PWVPPE 187
Query: 509 GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCG 560
L +D +SFG + ++ + G P L +
Sbjct: 188 -CIEN-------PKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR 234
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 5e-31
Identities = 72/306 (23%), Positives = 129/306 (42%), Gaps = 44/306 (14%)
Query: 349 KVGQGGFGCVYKGEMLGR-------TVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLV 400
+G G FG VY+G++ G VA+K L + Q +L+F E ++SK H ++V
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIV 137
Query: 401 TLLGACPEA--WSLVYEYLPNGSLQDRLFRKS-----NVSPLLWKDRARIAAEIASGLCF 453
+G ++ ++ E + G L+ L R++ S L D +A +IA G +
Sbjct: 138 RCIGVSLQSLPRFILLELMAGGDLKSFL-RETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 454 LHSSKPEKIVHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHRSTAPKGS 510
L +H D+ +N LL KI DFG+ R + Y
Sbjct: 197 L-EEN--HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYY------RKGGCAM 247
Query: 511 FP--YADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSI 565
P + PE G+ T K+D++SFG+++ ++ + G +P + EV V+ G
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR--- 304
Query: 566 LDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEE--RPVPSFFL 623
+DP P + + QC + +RP+ +++ +E +
Sbjct: 305 MDP-----PKNCPGPVYRIMTQCWQHQPEDRPNFA-IILERIEYCTQDPDVINTALPIEY 358
Query: 624 CPILQE 629
P+++E
Sbjct: 359 GPLVEE 364
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 5e-31
Identities = 81/382 (21%), Positives = 151/382 (39%), Gaps = 38/382 (9%)
Query: 250 MRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVRWLERWRSRG 309
M + + RRR + + + S I +
Sbjct: 1 MSPIDPMGHHHHHHGRRRASVAAGILVPRGSPGLDGI--CSIEELSTSLYKKAGSENLYF 58
Query: 310 QAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEMLGR--- 366
Q + L +L ++ + + + +F+E +G+G FGCVY G +L
Sbjct: 59 QGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNE--VIGRGHFGCVYHGTLLDNDGK 116
Query: 367 --TVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVY---EYLPNG 420
A+K L ++ +F E ++ HP++++LLG C + Y+ +G
Sbjct: 117 KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG 176
Query: 421 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS 480
L++ F ++ KD ++A G+ FL +SK K VH DL +N +LD + +
Sbjct: 177 DLRN--FIRNETHNPTVKDLIGFGLQVAKGMKFL-ASK--KFVHRDLAARNCMLDEKFTV 231
Query: 481 KICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPEYHRTGVLTPKSDSYSFGLII 537
K+ DFG+ R + + + +++ P A E +T T KSD +SFG+++
Sbjct: 232 KVADFGLARDMYDKE-FDSVHNKT---GAKLPVKWMA-LESLQTQKFTTKSDVWSFGVLL 286
Query: 538 LQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGR 594
+L+T G P + ++ + G+ L P + L ++ L+C
Sbjct: 287 WELMTRGAPPYPDVNTFDITVYLLQGRR---LLQ-----PEYCPDPLYEVMLKCWHPKAE 338
Query: 595 ERPDITPSLVKELEQLHVAEER 616
RP + LV + +
Sbjct: 339 MRPSFS-ELVSRISAIFSTFIG 359
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 6e-31
Identities = 61/220 (27%), Positives = 95/220 (43%), Gaps = 44/220 (20%)
Query: 349 KVGQGGFGCVYKGEMLG-------RTVAIKMLY-SHNMQGQLEFQQEVRVLSKL-QHPHL 399
+G G FG V G VA+KML + + E++++++L H ++
Sbjct: 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 111
Query: 400 VTLLGAC--PEAWSLVYEYLPNGSLQD--------------------RLFRKSNVSPLLW 437
V LLGAC L++EY G L + RL + +++ L +
Sbjct: 112 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 171
Query: 438 KDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497
+D A ++A G+ FL K VH DL +N+L+ KICDFG+ R + D+ Y
Sbjct: 172 EDLLCFAYQVAKGMEFL-EFK--SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 228
Query: 498 LPSFHRSTAPKGSFPY---ADPEYHRTGVLTPKSDSYSFG 534
+ P A PE G+ T KSD +S+G
Sbjct: 229 VVR------GNARLPVKWMA-PESLFEGIYTIKSDVWSYG 261
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 8e-31
Identities = 50/216 (23%), Positives = 87/216 (40%), Gaps = 24/216 (11%)
Query: 343 NFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLV 400
+F +G G G + M R VA+K + +EV++L + +HP+++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSF---ADREVQLLRESDEHPNVI 81
Query: 401 TLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
+ + E +LQ+ + +K L + + + SGL LHS
Sbjct: 82 RYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDF--AHLGLEPITLLQQTTSGLAHLHSLN 138
Query: 459 PEKIVHGDLKPQNILL-----DSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY 513
IVH DLKP NIL+ ++ + I DFG+C+ + SF R + G+ +
Sbjct: 139 ---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR---HSFSRRSGVPGTEGW 192
Query: 514 ADPEY---HRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PE T D +S G + +++
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSH 228
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 1e-30
Identities = 54/210 (25%), Positives = 88/210 (41%), Gaps = 28/210 (13%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLG 404
K+G+G FG + GR IK + M + + E ++EV VL+ ++HP++V
Sbjct: 31 KIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRE 90
Query: 405 ACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
+ E SL V +Y G L R+ +I L +H KI
Sbjct: 91 SFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVHD---RKI 146
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE----- 517
+H D+K QNI L + + ++ DFGI R++ + G+ Y PE
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC------IGTPYYLSPEICENK 200
Query: 518 -YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
Y KSD ++ G ++ +L T +
Sbjct: 201 PY------NNKSDIWALGCVLYELCTLKHA 224
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 75/306 (24%), Positives = 132/306 (43%), Gaps = 51/306 (16%)
Query: 349 KVGQGGFGCVYKGEMLG---------RTVAIKMLYSHNMQGQL-EFQQEVRVLSKL-QHP 397
+G+G FG V E +G VA+KML S + L + E+ ++ + +H
Sbjct: 76 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 135
Query: 398 HLVTLLGAC--PEAWSLVYEYLPNGSLQD--RLFRKSNV-----------SPLLWKDRAR 442
+++ LLGAC ++ EY G+L++ + R + L KD
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 443 IAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 502
A ++A G+ +L +SK K +H DL +N+L+ + KI DFG+ R + Y
Sbjct: 196 CAYQVARGMEYL-ASK--KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY----- 247
Query: 503 RSTAPKGSFPY---ADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRA 556
+ T G P A PE + T +SD +SFG+++ ++ T G P G+ E+ +
Sbjct: 248 KKTT-NGRLPVKWMA-PEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 305
Query: 557 VSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEER 616
+ G +D P+ L + C +RP LV++L+++
Sbjct: 306 LKEGHR---MDK-----PSNCTNELYMMMRDCWHAVPSQRPTFK-QLVEDLDRIVALTSN 356
Query: 617 PVPSFF 622
++
Sbjct: 357 QEMGYY 362
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 76/285 (26%), Positives = 127/285 (44%), Gaps = 39/285 (13%)
Query: 349 KVGQGGFGCVYKGEMLGRT------VAIKMLYSHNMQGQ-LEFQQEVRVLSKLQHPHLVT 401
+G G FG VYKG + + VAIK L + + Q ++F E ++ + H +++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIR 110
Query: 402 LLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 459
L G + + + EY+ NG+L F + + IA+G+ +L ++
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDK--FLREKDGEFSVLQLVGMLRGIAAGMKYL-ANM- 166
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTED--TLYLPSFHRSTAPKGSFP---YA 514
VH DL +NIL++S L K+ DFG+ R++ +D Y T G P A
Sbjct: 167 -NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY-------TTSGGKIPIRWTA 218
Query: 515 DPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGKLSSILDPLAG 571
PE T SD +SFG+++ +++T G P L+ EV +A++ G L
Sbjct: 219 -PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF---RLPT--- 271
Query: 572 DWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEER 616
P + L +QC + RP +V L++L A +
Sbjct: 272 --PMDCPSAIYQLMMQCWQQERARRPKFA-DIVSILDKLIRAPDS 313
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 1e-30
Identities = 53/206 (25%), Positives = 88/206 (42%), Gaps = 27/206 (13%)
Query: 351 GQGGFGCVYKGEML--GRTVAIKMLY-----SHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
G+G FG VY +A+K+L+ ++ QL ++E+ + S L+HP+++ +
Sbjct: 23 GKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQL--RREIEIQSHLRHPNILRMY 80
Query: 404 G--ACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKPE 460
+ L+ E+ P G L L + R+ E+A L + H
Sbjct: 81 NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDE----QRSATFMEELADALHYCHE---R 133
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 520
K++H D+KP+N+L+ + KI DFG PS R T G+ Y PE
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWSVHA-------PSLRRRTMC-GTLDYLPPEMIE 185
Query: 521 TGVLTPKSDSYSFGLIILQLLTGRLP 546
K D + G++ + L G P
Sbjct: 186 GKTHDEKVDLWCAGVLCYEFLVGMPP 211
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 60/240 (25%), Positives = 100/240 (41%), Gaps = 35/240 (14%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
+G GGFG V+K + G+T IK + +N + ++EV+ L+KL H ++V G
Sbjct: 18 LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE----KAEREVKALAKLDHVNIVHYNGCW 73
Query: 407 PEAWS------------------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIA 448
+ E+ G+L+ + K L + +I
Sbjct: 74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALELFEQIT 132
Query: 449 SGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK 508
G+ ++HS +K+++ DLKP NI L KI DFG+ + D R+ + K
Sbjct: 133 KGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK------RTRS-K 182
Query: 509 GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDP 568
G+ Y PE + + D Y+ GLI+ +LL + + G +S I D
Sbjct: 183 GTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDK 242
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 36/212 (16%)
Query: 349 KVGQGGFGCVYKGEMLGR-------TVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLV 400
++G+ FG VYKG + G VAIK L + EF+ E + ++LQHP++V
Sbjct: 16 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 401 TLLGACPEA--WSLVYEYLPNGSLQDRL-------------FRKSNVSPLLWKDRARIAA 445
LLG + S+++ Y +G L + L ++ S L D + A
Sbjct: 76 CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 446 EIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST 505
+IA+G+ +L SS +VH DL +N+L+ +L+ KI D G+ R V Y +
Sbjct: 136 QIAAGMEYL-SSH--HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYY-----KLL 187
Query: 506 APKGSFP---YADPEYHRTGVLTPKSDSYSFG 534
P A PE G + SD +S+G
Sbjct: 188 G-NSLLPIRWMA-PEAIMYGKFSIDSDIWSYG 217
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 53/212 (25%), Positives = 85/212 (40%), Gaps = 37/212 (17%)
Query: 351 GQGGFGCVYKGEML--GRTVAIKM-----LYSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
G+GGF ++ A K+ L + + ++ E+ + L H H+V
Sbjct: 50 GKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKM--SMEISIHRSLAHQHVVGFH 107
Query: 404 GACPEAWSLVY---EYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKP 459
G E V+ E SL + R+ ++ AR +I G +LH
Sbjct: 108 G-FFEDNDFVFVVLELCRRRSLLELHKRRKALTE----PEARYYLRQIVLGCQYLHR--- 159
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 519
+++H DLK N+ L+ +L KI DFG+ V D + G+ Y PE
Sbjct: 160 NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG----ERKKVLC--GTPNYIAPE-- 211
Query: 520 RTGVLT-----PKSDSYSFGLIILQLLTGRLP 546
VL+ + D +S G I+ LL G+ P
Sbjct: 212 ---VLSKKGHSFEVDVWSIGCIMYTLLVGKPP 240
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 2e-30
Identities = 52/210 (24%), Positives = 83/210 (39%), Gaps = 33/210 (15%)
Query: 349 KVGQGGFGCVYKGE---MLGRTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVTL-- 402
+ GG G +Y + GR V +K L +S + + Q E + L+++ HP +V +
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 403 ------LGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 456
P + +V EY+ SL+ + L + EI L +LHS
Sbjct: 147 FVEHTDRHGDPVGY-IVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHS 200
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 516
+V+ DLKP+NI+L E K+ D G + G+ + P
Sbjct: 201 ---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLY----------GTPGFQAP 246
Query: 517 EYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
E RTG T +D Y+ G + L
Sbjct: 247 EIVRTGP-TVATDIYTVGRTLAALTLDLPT 275
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 39/215 (18%)
Query: 349 KVGQGGFGCVYKGEMLG---------RTVAIKMLYSHNMQGQL-EFQQEVRVLSKL-QHP 397
+G+G FG V E +G TVA+KML + L + E+ ++ + +H
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHK 147
Query: 398 HLVTLLGAC--PEAWSLVYEYLPNGSLQDRL-------------FRKSNVSPLLWKDRAR 442
+++ LLGAC ++ EY G+L++ L + + +KD
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 443 IAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 502
++A G+ +L +S+ K +H DL +N+L+ KI DFG+ R + Y
Sbjct: 208 CTYQLARGMEYL-ASQ--KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYY----- 259
Query: 503 RSTAPKGSFPY---ADPEYHRTGVLTPKSDSYSFG 534
+ T G P A PE V T +SD +SFG
Sbjct: 260 KKTT-NGRLPVKWMA-PEALFDRVYTHQSDVWSFG 292
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 64/226 (28%), Positives = 106/226 (46%), Gaps = 25/226 (11%)
Query: 349 KVGQGGFGCVYKGEMLGRT-----VAIKMLYSHNMQGQ-LEFQQEVRVLSKLQHPHLVTL 402
VG G FG V G + + VAIK L + Q +F E ++ + HP+++ L
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRL 111
Query: 403 LGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460
G ++ + V EY+ NGSL F + + + + IASG+ +L S
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDS--FLRKHDAQFTVIQLVGMLRGIASGMKYL-SDM-- 166
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPE 517
VH DL +NIL++S L K+ DFG+ R++ +D T G P + PE
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA-----YTTRGGKIPIRWTS-PE 220
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCG 560
T SD +S+G+++ ++++ G P ++ +V +AV G
Sbjct: 221 AIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG 266
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 3e-30
Identities = 63/225 (28%), Positives = 106/225 (47%), Gaps = 23/225 (10%)
Query: 349 KVGQGGFGCVYKGEMLGRT----VAIKMLYSHNMQGQL-EFQQEVRVLSKLQHPHLVTLL 403
++G G FG V +G R VAIK+L + E +E +++ +L +P++V L+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 404 GAC-PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
G C EA LV E G L L + + A + +++ G+ +L K
Sbjct: 403 GVCQAEALMLVMEMAGGGPLHKFL--VGKREEIPVSNVAELLHQVSMGMKYL-EEK--NF 457
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP---YADPEYH 519
VH +L +N+LL + +KI DFG+ + + D Y + G +P YA PE
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYY-----TARSAGKWPLKWYA-PECI 511
Query: 520 RTGVLTPKSDSYSFGLIILQLLT-GRLP-VGLAG-EVRRAVSCGK 561
+ +SD +S+G+ + + L+ G+ P + G EV + GK
Sbjct: 512 NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK 556
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 5e-30
Identities = 38/228 (16%), Positives = 84/228 (36%), Gaps = 48/228 (21%)
Query: 351 GQGGFGCVYKGEMLGRTVAIKMLY-------------------SHNMQGQLEFQQEVRVL 391
QG F + E + A+K + + E++++
Sbjct: 40 NQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFK--NELQII 97
Query: 392 SKLQHPHLVTLLGACPEAWS------LVYEYLPNGSLQDRL-----FRKSNVSPLLWKDR 440
+ +++ + +T + ++YEY+ N S+ K+ + +
Sbjct: 98 TDIKNEYCLTCE----GIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVI 153
Query: 441 ARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 500
I + + ++H+ K I H D+KP NIL+D K+ DFG + + +
Sbjct: 154 KCIIKSVLNSFSYIHNEK--NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK--- 208
Query: 501 FHRSTAPKGSFPYADPE--YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ +G++ + PE + + K D +S G+ + + +P
Sbjct: 209 ----GS-RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 60/212 (28%), Positives = 94/212 (44%), Gaps = 36/212 (16%)
Query: 351 GQGGFGCVYKGEML--GRTVAIKMLY-----SHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
G+G F VY+ E + G VAIKM+ M +++ EV++ +L+HP ++ L
Sbjct: 20 GKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQ--NEVKIHCQLKHPSILELY 77
Query: 404 GACPEAWSLVY---EYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKP 459
E + VY E NG + L + ++ AR +I +G+ +LHS
Sbjct: 78 N-YFEDSNYVYLVLEMCHNGEMNRYLKNRVKP---FSENEARHFMHQIITGMLYLHS--- 130
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 519
I+H DL N+LL ++ KI DFG+ + H + G+ Y PE
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH----EKHYTLC--GTPNYISPE-- 182
Query: 520 RTGVLT-----PKSDSYSFGLIILQLLTGRLP 546
+ T +SD +S G + LL GR P
Sbjct: 183 ---IATRSAHGLESDVWSLGCMFYTLLIGRPP 211
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 54/213 (25%), Positives = 85/213 (39%), Gaps = 37/213 (17%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE--FQQEVRVLSKLQHPHLVTLLG 404
+VG+G FG V++ + G A+K + +LE +E+ + L P +V L G
Sbjct: 65 RVGRGSFGEVHRMKDKQTGFQCAVK-------KVRLEVFRVEELVACAGLSSPRIVPLYG 117
Query: 405 ACPEAWSL--VYEYLPNGSLQDRL-----FRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
A E + E L GSL + + + GL +LH+
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRA--------LYYLGQALEGLEYLHT- 168
Query: 458 KPEKIVHGDLKPQNILLDSE-LSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY--A 514
+I+HGD+K N+LL S+ + +CDFG + D L G+ A
Sbjct: 169 --RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYI-PGT-ETHMA 224
Query: 515 DPE-YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PE K D +S ++L +L G P
Sbjct: 225 -PEVVMGKPC-DAKVDIWSSCCMMLHMLNGCHP 255
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-29
Identities = 52/216 (24%), Positives = 90/216 (41%), Gaps = 37/216 (17%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE---FQQEVRVLSKLQHPHLVTLL 403
K+G+G F VY+ L G VA+K + ++ +E+ +L +L HP+++
Sbjct: 39 KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98
Query: 404 GACPEAWSL--VYEYLPNGSLQDRL--FRKSNVS---PLLWKDRARIAAEIASGLCFLHS 456
+ E L V E G L + F+K +WK ++ S L +HS
Sbjct: 99 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWK----YFVQLCSALEHMHS 154
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 516
+++H D+KP N+ + + K+ D G+ R + T S G+ Y P
Sbjct: 155 ---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL------VGTPYYMSP 205
Query: 517 E------YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
E Y KSD +S G ++ ++ + P
Sbjct: 206 ERIHENGY------NFKSDIWSLGCLLYEMAALQSP 235
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-29
Identities = 56/220 (25%), Positives = 95/220 (43%), Gaps = 44/220 (20%)
Query: 349 KVGQGGFGCVYKGEMLG-------RTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLV 400
+G+G FG V++ G VA+KML + Q +FQ+E ++++ +P++V
Sbjct: 54 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 401 TLLGACPEA--WSLVYEYLPNGSLQDRL---------------------FRKSNVSPLLW 437
LLG C L++EY+ G L + L PL
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 438 KDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497
++ IA ++A+G+ +L S + K VH DL +N L+ + KI DFG+ R + Y
Sbjct: 174 AEQLCIARQVAAGMAYL-SER--KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 230
Query: 498 LPSFHRSTAPKGSFP---YADPEYHRTGVLTPKSDSYSFG 534
++ + P PE T +SD +++G
Sbjct: 231 -----KADG-NDAIPIRWMP-PESIFYNRYTTESDVWAYG 263
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 6e-29
Identities = 63/211 (29%), Positives = 96/211 (45%), Gaps = 36/211 (17%)
Query: 351 GQGGFGCVYKGE--MLGRTVAIKML----YSHNMQGQLEFQQEVRVLSKLQHPHLVTLLG 404
G+G F V + GR VAIK++ + +L +EVR++ L HP++V L
Sbjct: 24 GKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKL--FREVRIMKILNHPNIVKLFE 81
Query: 405 --ACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKPEK 461
+ L+ EY G + D L + AR +I S + + H ++
Sbjct: 82 VIETEKTLYLIMEYASGGEVFDYLVAHGRMKE----KEARSKFRQIVSAVQYCHQ---KR 134
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE---- 517
IVH DLK +N+LLD++++ KI DFG T G+ PYA PE
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK----LDAFC---GAPPYAAPELFQG 187
Query: 518 --YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
Y G P+ D +S G+I+ L++G LP
Sbjct: 188 KKYD--G---PEVDVWSLGVILYTLVSGSLP 213
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 54/205 (26%), Positives = 89/205 (43%), Gaps = 18/205 (8%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
+G+G +G VY G L +AIK + + + +E+ + L+H ++V LG+
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 408 EAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 465
E + E +P GSL L K + +I GL +LH +IVH
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHR 146
Query: 466 DLKPQNILLDSELSS-KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE---YHRT 521
D+K N+L+++ KI DFG + + +F G+ Y PE
Sbjct: 147 DIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF------TGTLQYMAPEIIDKGPR 200
Query: 522 GVLTPKSDSYSFGLIILQLLTGRLP 546
G +D +S G I+++ TG+ P
Sbjct: 201 GY-GKAADIWSLGCTIIEMATGKPP 224
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-28
Identities = 56/216 (25%), Positives = 78/216 (36%), Gaps = 29/216 (13%)
Query: 344 FSESF----KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKL- 394
F +SF ++G G +G V+K GR A+K S + + EV K+
Sbjct: 55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVG 114
Query: 395 QHPHLVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSP--LLWKDRARIAAEIASG 450
QHP V L A E L E SLQ P +W +
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWG----YLRDTLLA 169
Query: 451 LCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS 510
L LHS +VH D+KP NI L K+ DFG+ + +G
Sbjct: 170 LAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA-------GEVQEGD 219
Query: 511 FPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
Y PE + +D +S GL IL++
Sbjct: 220 PRYMAPELLQGS-YGTAADVFSLGLTILEVACNMEL 254
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-28
Identities = 63/265 (23%), Positives = 100/265 (37%), Gaps = 40/265 (15%)
Query: 349 KVGQGGFGCV-YKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGAC 406
+G G G V ++G GR VA+K + E+++L++ HP+++ +
Sbjct: 22 ILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCD---IALMEIKLLTESDDHPNVIRYYCSE 78
Query: 407 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAE----IASGLCFLHSSKPE 460
+ E N +LQD + K+ L + IASG+ LHS
Sbjct: 79 TTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---L 134
Query: 461 KIVHGDLKPQNILLDSELSS-------------KICDFGICRLVTEDTLYLPSFHRSTAP 507
KI+H DLKPQNIL+ + I DFG+C+ + + P
Sbjct: 135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT--NLNNP 192
Query: 508 KGSFPYADPE-------YHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEVRRAVSC 559
G+ + PE LT D +S G + +L+ G+ P G +
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNIIR 252
Query: 560 GKLSSILDPLAGDWPTFVARRLVDL 584
G S LD + + DL
Sbjct: 253 GIFS--LDEMKCLHDRSLIAEATDL 275
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 2e-28
Identities = 65/228 (28%), Positives = 107/228 (46%), Gaps = 36/228 (15%)
Query: 337 LQTATCNFSESFKV----GQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE---FQQE 387
+Q +T FS+ +K G+G FG V + G+ A+K++ ++ + + +E
Sbjct: 17 VQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLRE 76
Query: 388 VRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA 445
V++L +L HP+++ L + LV E G L D + + S D ARI
Sbjct: 77 VQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSE---VDAARIIR 133
Query: 446 EIASGLCFLHSSKPEKIVHGDLKPQNILLDS---ELSSKICDFGICRLVTEDTLYLPSFH 502
++ SG+ ++H KIVH DLKP+N+LL+S + + +I DFG+
Sbjct: 134 QVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS-------K 183
Query: 503 RSTAPKGSFPYADPEYHRTGVL----TPKSDSYSFGLIILQLLTGRLP 546
+ G+ Y PE VL K D +S G+I+ LL+G P
Sbjct: 184 KMKDKIGTAYYIAPE-----VLHGTYDEKCDVWSTGVILYILLSGCPP 226
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-28
Identities = 35/220 (15%), Positives = 65/220 (29%), Gaps = 29/220 (13%)
Query: 349 KVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVT 401
+G+G F VY+ + +K+ N Q + L +
Sbjct: 72 LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMK 131
Query: 402 LLGAC--PEAWSLVYEYLPNGSLQDRL--FRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
A LV E G+L + + ++ + + A + + +H
Sbjct: 132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC 191
Query: 458 KPEKIVHGDLKPQNILLDSELSS-----------KICDFGICRLVTEDTLYLPSFHRSTA 506
+ I+HGD+KP N +L + + D G D P TA
Sbjct: 192 E---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI----DMKLFPKGTIFTA 244
Query: 507 PKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ + E + D + + +L G
Sbjct: 245 KCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 65/211 (30%), Positives = 92/211 (43%), Gaps = 39/211 (18%)
Query: 349 KVGQGGFGCVYKGEMLG----RTVAIKMLYSHNMQGQL-EFQQEVRVLSKL-QHPHLVTL 402
+G+G FG V K + AIK + + + +F E+ VL KL HP+++ L
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 403 LGACPEAWSL--VYEYLPNGSLQDRLFRKSNV--------------SPLLWKDRARIAAE 446
LGAC L EY P+G+L D L RKS V S L + AA+
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTA 506
+A G+ +L S K + +H DL +NIL+ +KI DFG+ R +
Sbjct: 151 VARGMDYL-SQK--QFIHRDLAARNILVGENYVAKIADFGLSR----GQEV----YVKKT 199
Query: 507 PKGSFPY---ADPEYHRTGVLTPKSDSYSFG 534
G P A E V T SD +S+G
Sbjct: 200 -MGRLPVRWMA-IESLNYSVYTTNSDVWSYG 228
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-28
Identities = 37/244 (15%), Positives = 70/244 (28%), Gaps = 60/244 (24%)
Query: 350 VGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQG---QLEFQQEVRVLSKLQ--------- 395
+GQ + + G + + + Y + ++EV L L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 396 ----------------HPHLVTLLGACPEAWSLVY---EYLPNGSLQDRLF----RKSNV 432
++ + + W L +LQ S
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 433 SPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 492
L+ R ++ ++ L LH +VH L+P +I+LD + F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 493 EDTLYLPSFHRSTAPKGSFPYADPEY----------HRTGVLTPKSDSYSFGLIILQLLT 542
+ +A PE H ++T D+++ GL I +
Sbjct: 263 ASAV----------SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312
Query: 543 GRLP 546
LP
Sbjct: 313 ADLP 316
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 4e-28
Identities = 68/258 (26%), Positives = 103/258 (39%), Gaps = 41/258 (15%)
Query: 337 LQTATCNFSESFKV----GQGGFGCVYKGEML--GRTVAIKMLYSHNMQG--QLEFQQEV 388
+ + + SE ++ G G +G V AIK++ ++ + +EV
Sbjct: 28 ITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEV 87
Query: 389 RVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAE 446
VL L HP+++ L + LV E G L D + + + D A I +
Sbjct: 88 AVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNE---VDAAVIIKQ 144
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDS---ELSSKICDFGICRLVTEDTLYLPSFHR 503
+ SG+ +LH IVH DLKP+N+LL+S + KI DFG+ +
Sbjct: 145 VLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKM------ 195
Query: 504 STAPKGSFPYADPEYHRTGVL----TPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAV 557
G+ Y PE VL K D +S G+I+ LL G P G E+ R V
Sbjct: 196 -KERLGTAYYIAPE-----VLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKV 249
Query: 558 SCGKLSSILDPLAGDWPT 575
GK + W
Sbjct: 250 EKGKYTFDSPE----WKN 263
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 4e-28
Identities = 67/212 (31%), Positives = 107/212 (50%), Gaps = 37/212 (17%)
Query: 351 GQGGFGCVYKGE--MLGRTVAIKML-----YSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
G G FG V GE + G VA+K+L S ++ G+++ +E++ L +HPH++ L
Sbjct: 20 GVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK--REIQNLKLFRHPHIIKLY 77
Query: 404 G--ACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKPE 460
+ P + +V EY+ G L D + + V AR + +I S + + H
Sbjct: 78 QVISTPTDFFMVMEYVSGGELFDYICKHGRVEE----MEARRLFQQILSAVDYCHR---H 130
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE--- 517
+VH DLKP+N+LLD+ +++KI DFG+ ++++ S GS YA PE
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF----LRTSC---GSPNYAAPEVIS 183
Query: 518 ---YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
Y G P+ D +S G+I+ LL G LP
Sbjct: 184 GRLYA--G---PEVDIWSCGVILYALLCGTLP 210
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 2e-27
Identities = 34/276 (12%), Positives = 66/276 (23%), Gaps = 57/276 (20%)
Query: 351 GQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLE---FQQEVRVLSKLQHPHLVTLLGA 405
G V+ A+K+ + E + ++L
Sbjct: 71 RVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDR 130
Query: 406 CPEAWS----------------------------LVYEYLPNGSLQDRL----FRKSNVS 433
L+ + L+ F
Sbjct: 131 RRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMP-AASVDLELLFSTLDFVYVFRG 189
Query: 434 PLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493
+ A++ L S + +VHG P N+ + + + D V
Sbjct: 190 DEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246
Query: 494 DTLYLPSFHRSTAPKGSFPYADPEY--HRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG 551
R A YA E+ T T +++ GL I ++ LP GL
Sbjct: 247 ---------RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 552 EVRRAVSCGKLSSILDPLAGDWPTFV-----ARRLV 582
+ + + + + + L+
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLI 333
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 3e-27
Identities = 62/238 (26%), Positives = 98/238 (41%), Gaps = 46/238 (19%)
Query: 337 LQTATCNFSESFKV----GQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL-------- 382
++ ES+ G G +G V + AIK++
Sbjct: 27 VRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNI 86
Query: 383 -----EFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPL 435
E E+ +L L HP+++ L + + LV E+ G L +++ +
Sbjct: 87 EKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDE- 145
Query: 436 LWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS---ELSSKICDFGICRLVT 492
D A I +I SG+C+LH IVH D+KP+NILL++ L+ KI DFG+ +
Sbjct: 146 --CDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFS 200
Query: 493 EDTLYLPSFHRSTAPKGSFPYADPEYHRTGVL----TPKSDSYSFGLIILQLLTGRLP 546
+D ++ G+ Y PE VL K D +S G+I+ LL G P
Sbjct: 201 KD-------YKLRDRLGTAYYIAPE-----VLKKKYNEKCDVWSCGVIMYILLCGYPP 246
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-27
Identities = 61/211 (28%), Positives = 99/211 (46%), Gaps = 31/211 (14%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQ--LEFQQEVRVLSKLQHPHLVTLLG 404
+G+G FG V K + + A+K++ + + + +EV +L KL HP+++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 405 AC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
++ +V E G L D + ++ S D ARI ++ SG+ ++H I
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSE---HDAARIIKQVFSGITYMHK---HNI 142
Query: 463 VHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 519
VH DLKP+NILL+S+ KI DFG+ ++ + G+ Y PE
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN-------TKMKDRIGTAYYIAPE-- 193
Query: 520 RTGVL----TPKSDSYSFGLIILQLLTGRLP 546
VL K D +S G+I+ LL+G P
Sbjct: 194 ---VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 50/209 (23%), Positives = 84/209 (40%), Gaps = 29/209 (13%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
+G+G +G V A K + + ++ F+QE+ ++ L HP+++ L
Sbjct: 16 TIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF 75
Query: 407 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
LV E G L +R+ K D ARI ++ S + + H + H
Sbjct: 76 EDNTDIYLVMELCTGGELFERVVHKRVFRE---SDAARIMKDVLSAVAYCHK---LNVAH 129
Query: 465 GDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
DLKP+N L ++ K+ DFG+ + G+ Y P+
Sbjct: 130 RDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM-------RTKVGTPYYVSPQ---- 178
Query: 522 GVL----TPKSDSYSFGLIILQLLTGRLP 546
VL P+ D +S G+++ LL G P
Sbjct: 179 -VLEGLYGPECDEWSAGVMMYVLLCGYPP 206
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-26
Identities = 57/215 (26%), Positives = 89/215 (41%), Gaps = 27/215 (12%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGA 405
+G G V VAIK + Q ++ +E++ +S+ HP++V+ +
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 406 ---CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWK--DRARIAA---EIASGLCFLHSS 457
E W LV + L GS+ D + D + IA E+ GL +LH
Sbjct: 82 FVVKDELW-LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHK- 139
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF---PY- 513
+H D+K NILL + S +I DFG+ + + R T F P
Sbjct: 140 --NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT-----FVGTPCW 192
Query: 514 -ADPE-YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
A PE + K+D +SFG+ ++L TG P
Sbjct: 193 MA-PEVMEQVRGYDFKADIWSFGITAIELATGAAP 226
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIK-MLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGA 405
++G G G V+K G +A K + + + +E++VL + P++V GA
Sbjct: 40 ELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGA 99
Query: 406 --CPEAWSLVYEYLPNGSLQDRLFRKSNVS-PLLWKDRARIAAEIASGLCFLHSSKPEKI 462
S+ E++ GSL L + + +L +++ + GL +L KI
Sbjct: 100 FYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL----GKVSIAVIKGLTYLREKH--KI 153
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 522
+H D+KP NIL++S K+CDFG+ + + S S G+ Y PE +
Sbjct: 154 MHRDVKPSNILVNSRGEIKLCDFGVSGQLID------SMANSFV--GTRSYMSPERLQGT 205
Query: 523 VLTPKSDSYSFGLIILQLLTGRLP 546
+ +SD +S GL ++++ GR P
Sbjct: 206 HYSVQSDIWSMGLSLVEMAVGRYP 229
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 1e-25
Identities = 37/244 (15%), Positives = 68/244 (27%), Gaps = 61/244 (25%)
Query: 351 GQGGFGCVYKGE--MLGRTVAIKMLYS----------------------------HNMQG 380
GQ + G + + + Y +
Sbjct: 82 GQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKV 141
Query: 381 QLEFQQEVRVLSKLQHPHLVTLLGACPEAWSLVY---EYLPNGSLQDR---LFRKSNVSP 434
L F ++ Q ++ + + W L +LQ L S+
Sbjct: 142 HLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHK 201
Query: 435 LL-WKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493
L R ++ ++ L LH +VH L+P +I+LD + F
Sbjct: 202 SLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 258
Query: 494 DTLYLPSFHRSTAPKGSFPYADPEY-----------HRTGVLTPKSDSYSFGLIILQLLT 542
+ S + PE R ++T D+++ GL+I +
Sbjct: 259 RVV----------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308
Query: 543 GRLP 546
LP
Sbjct: 309 ADLP 312
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-25
Identities = 63/211 (29%), Positives = 104/211 (49%), Gaps = 35/211 (16%)
Query: 351 GQGGFGCVYKGE--MLGRTVAIKML-----YSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
G G FG V G+ + G VA+K+L S ++ G++ +E++ L +HPH++ L
Sbjct: 25 GVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR--REIQNLKLFRHPHIIKLY 82
Query: 404 GACPEAWS------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHS 456
+ S +V EY+ G L D + + + +R + +I SG+ + H
Sbjct: 83 ----QVISTPSDIFMVMEYVSGGELFDYICKNGRLDE----KESRRLFQQILSGVDYCHR 134
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 516
+VH DLKP+N+LLD+ +++KI DFG+ ++++ S GS YA P
Sbjct: 135 ---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF----LRTSC---GSPNYAAP 184
Query: 517 E-YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
E P+ D +S G+I+ LL G LP
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGTLP 215
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-25
Identities = 66/216 (30%), Positives = 99/216 (45%), Gaps = 46/216 (21%)
Query: 351 GQGGFGCVYKGE--MLGRTVAIKM-----LYSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
G+G FG V + VA+K L +M ++E +E+ L L+HPH++ L
Sbjct: 18 GEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE--REISYLKLLRHPHIIKLY 75
Query: 404 GACPEAWS------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHS 456
+ + +V EY G L D + K ++ D R +I + + H
Sbjct: 76 ----DVITTPTDIVMVIEYA-GGELFDYIVEKKRMTE----DEGRRFFQQIICAIEYCHR 126
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 516
KIVH DLKP+N+LLD L+ KI DFG+ ++T+ S GS YA P
Sbjct: 127 ---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF----LKTSC---GSPNYAAP 176
Query: 517 E------YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
E Y G P+ D +S G+++ +L GRLP
Sbjct: 177 EVINGKLYA--G---PEVDVWSCGIVLYVMLVGRLP 207
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 49/242 (20%), Positives = 85/242 (35%), Gaps = 61/242 (25%)
Query: 343 NFSESF----KVGQGGFGCVYKGEML--GRTVAIK--MLYSHNMQGQLEFQQEVRVLSKL 394
++ F K+G G FG V+K G AIK + +EV + L
Sbjct: 8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVL 67
Query: 395 -QHPHLVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDR-ARIAAEIASG 450
QH H+V A E + EY GSL D + + + + ++ G
Sbjct: 68 GQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127
Query: 451 LCFLHSSKPEKIVHGDLKPQNILLD-------------------SELSSKICDFGICRLV 491
L ++HS +VH D+KP NI + +++ KI D G +
Sbjct: 128 LRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI 184
Query: 492 TE------DTLYLPSFHRSTAP---KGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT 542
+ D+ +L A + ++ + PK+D ++ L ++
Sbjct: 185 SSPQVEEGDSRFL-------ANEVLQENYTH-----------LPKADIFALALTVVCAAG 226
Query: 543 GR 544
Sbjct: 227 AE 228
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-25
Identities = 61/211 (28%), Positives = 88/211 (41%), Gaps = 28/211 (13%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGA 405
K+G G FG V+ E G IK + Q +E + E+ VL L HP+++ +
Sbjct: 29 KLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEV 88
Query: 406 C--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLW-KDRARIAAEIASGLCFLHSSKPEKI 462
+V E G L +R+ L A + ++ + L + HS + +
Sbjct: 89 FEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHV 145
Query: 463 VHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 519
VH DLKP+NIL KI DFG+ L D T G+ Y PE
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS-------TNAAGTALYMAPE-- 196
Query: 520 RTGVL----TPKSDSYSFGLIILQLLTGRLP 546
V T K D +S G+++ LLTG LP
Sbjct: 197 ---VFKRDVTFKCDIWSAGVVMYFLLTGCLP 224
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 49/233 (21%), Positives = 97/233 (41%), Gaps = 22/233 (9%)
Query: 324 EDLPESAEFSLADLQTATCNFSESFKV----GQGGFGCVYKGE--MLGRTVAIKMLYSHN 377
++ ++ + + + + G G FG V++ GR K + +
Sbjct: 29 FYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY 88
Query: 378 MQGQLEFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPL 435
+ + E+ ++++L HP L+ L A L+ E+L G L DR+ + +
Sbjct: 89 PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK--M 146
Query: 436 LWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS--KICDFGICRLVTE 493
+ + GL +H IVH D+KP+NI+ +++ +S KI DFG+ +
Sbjct: 147 SEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203
Query: 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
D + + + +A PE + +D ++ G++ LL+G P
Sbjct: 204 DEIVKVTT-------ATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-25
Identities = 50/204 (24%), Positives = 95/204 (46%), Gaps = 18/204 (8%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
++G G FG V++ G A K + + + + ++E++ +S L+HP LV L A
Sbjct: 164 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 223
Query: 407 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
++YE++ G L +++ + N + + ++ GLC +H + VH
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNK--MSEDEAVEYMRQVCKGLCHMHEN---NYVH 278
Query: 465 GDLKPQNILLDSELSS--KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 522
DLKP+NI+ ++ S+ K+ DFG+ + + G+ +A PE
Sbjct: 279 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT-------GTAEFAAPEVAEGK 331
Query: 523 VLTPKSDSYSFGLIILQLLTGRLP 546
+ +D +S G++ LL+G P
Sbjct: 332 PVGYYTDMWSVGVLSYILLSGLSP 355
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 69/229 (30%), Positives = 106/229 (46%), Gaps = 34/229 (14%)
Query: 333 SLADLQTATCNFSESF----KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE-FQ 385
L +Q + E F K+G+G FG V+KG + VAIK++ + ++E Q
Sbjct: 9 GLPGMQNLKADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ 68
Query: 386 QEVRVLSKLQHPHLVTLLGA---CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR 442
QE+ VLS+ P++ G+ + W ++ EYL GS D L PL A
Sbjct: 69 QEITVLSQCDSPYVTKYYGSYLKDTKLW-IIMEYLGGGSALDLLEPG----PLDETQIAT 123
Query: 443 IAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 502
I EI GL +LHS EK +H D+K N+LL K+ DFG+ +T+
Sbjct: 124 ILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--------- 171
Query: 503 RSTAPKGSF---PY--ADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ + +F P+ A PE + K+D +S G+ ++L G P
Sbjct: 172 -TQIKRNTFVGTPFWMA-PEVIKQSAYDSKADIWSLGITAIELARGEPP 218
|
| >2kre_A Ubiquitin conjugation factor E4 B; U-box domain, E3 ubiquitin ligase, E4 polyubiquitin chain EL factor, phosphoprotein, UBL conjugation pathway; NMR {Homo sapiens} PDB: 3l1x_A 3l1z_B Length = 100 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 5e-25
Identities = 21/89 (23%), Positives = 33/89 (37%), Gaps = 7/89 (7%)
Query: 603 LVKELEQLHVAEERP------VPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGR 656
+++E++ R P F P++ +M DP G + I L N
Sbjct: 5 FAEKVEEIVAKNARAEIDYSDAPDEFRDPLMDTLMTDPVRLPSGTIMDRSIILRHLLNSP 64
Query: 657 ETSPMTNLRLSHLHLTPNHALRHAIQDWL 685
T P L+ L P L+ IQ W+
Sbjct: 65 -TDPFNRQTLTESMLEPVPELKEQIQAWM 92
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 31/211 (14%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE--FQQEVRVLSKLQHPHLVTLLG 404
+G+G FG V K + + A+K++ + + + +EV +L KL HP+++ L
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE 88
Query: 405 AC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
++ +V E G L D + ++ S D ARI ++ SG+ ++H I
Sbjct: 89 ILEDSSSFYIVGELYTGGELFDEIIKRKRFSE---HDAARIIKQVFSGITYMHK---HNI 142
Query: 463 VHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 519
VH DLKP+NILL+S+ KI DFG+ ++T G+ Y PE
Sbjct: 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKM-------KDRIGTAYYIAPE-- 193
Query: 520 RTGVL----TPKSDSYSFGLIILQLLTGRLP 546
VL K D +S G+I+ LL+G P
Sbjct: 194 ---VLRGTYDEKCDVWSAGVILYILLSGTPP 221
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 46/150 (30%), Positives = 72/150 (48%), Gaps = 13/150 (8%)
Query: 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVT 401
++ K+GQG G VY + G+ VAI+ + + E+ V+ + ++P++V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 402 LLGAC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
L + E W +V EYL GSL D + + A + E L FLHS
Sbjct: 82 YLDSYLVGDELW-VVMEYLAGGSLTDVVTET----CMDEGQIAAVCRECLQALEFLHS-- 134
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGIC 488
+++H D+K NILL + S K+ DFG C
Sbjct: 135 -NQVIHRDIKSDNILLGMDGSVKLTDFGFC 163
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 45/152 (29%), Positives = 75/152 (49%), Gaps = 15/152 (9%)
Query: 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHL 399
F K+G+G +G VYK G+ VAIK + ++ L+ +E+ ++ + PH+
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV---PVESDLQEIIKEISIMQQCDSPHV 86
Query: 400 VTLLGAC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 456
V G+ + W +V EY GS+ D + + L + A I GL +LH
Sbjct: 87 VKYYGSYFKNTDLW-IVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGIC 488
+ +H D+K NILL++E +K+ DFG+
Sbjct: 144 ---MRKIHRDIKAGNILLNTEGHAKLADFGVA 172
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 45/216 (20%), Positives = 85/216 (39%), Gaps = 39/216 (18%)
Query: 351 GQGGFGCVYKGE--MLGRTVAIKML--------YSHNMQGQLEFQQEVRVLSKLQHPHLV 400
G G FG V+ + V +K + + E+ +LS+++H +++
Sbjct: 33 GSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANII 92
Query: 401 TLLG--ACPEAWSLVYEYLPNGS-LQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHS 456
+L + LV E +G L + R + A I ++ S + +L
Sbjct: 93 KVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDE----PLASYIFRQLVSAVGYLRL 148
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 516
+ I+H D+K +NI++ + + K+ DFG + L F+ G+ Y P
Sbjct: 149 ---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL----FYTFC---GTIEYCAP 198
Query: 517 EYHRTGVLT------PKSDSYSFGLIILQLLTGRLP 546
E VL P+ + +S G+ + L+ P
Sbjct: 199 E-----VLMGNPYRGPELEMWSLGVTLYTLVFEENP 229
|
| >2kr4_A Ubiquitin conjugation factor E4 B; U-BOX, UFD2, ring, E3 ligase, UBL conjugation pathway; NMR {Mus musculus} Length = 85 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 8e-25
Identities = 19/73 (26%), Positives = 27/73 (36%), Gaps = 1/73 (1%)
Query: 613 AEERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLT 672
+ P F P++ +M DP G + I L N T P L+ L
Sbjct: 6 IDYSDAPDEFRDPLMDTLMTDPVRLPSGTVMDRSIILRHLLNSP-TDPFNRQMLTESMLE 64
Query: 673 PNHALRHAIQDWL 685
P L+ IQ W+
Sbjct: 65 PVPELKEQIQAWM 77
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 8e-25
Identities = 51/208 (24%), Positives = 85/208 (40%), Gaps = 28/208 (13%)
Query: 351 GQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLG--A 405
G+G +G V + VA+K++ E ++E+ + L H ++V G
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 406 CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKPEKIVH 464
L EY G L DR+ + A+ ++ +G+ +LH I H
Sbjct: 76 EGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHG---IGITH 128
Query: 465 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE------Y 518
D+KP+N+LLD + KI DFG+ + + G+ PY PE +
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNN--RERLLNKMC--GTLPYVAPELLKRREF 184
Query: 519 HRTGVLTPKSDSYSFGLIILQLLTGRLP 546
H D +S G+++ +L G LP
Sbjct: 185 H--A---EPVDVWSCGIVLTAMLAGELP 207
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 53/219 (24%), Positives = 91/219 (41%), Gaps = 45/219 (20%)
Query: 351 GQGGFGCVYKGEML--GRTVAIKML--------YSHNMQGQLEFQQEVRVLSKLQH--PH 398
G GGFG VY G + VAIK + ++ EV +L K+
Sbjct: 52 GSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP--MEVVLLKKVSSGFSG 109
Query: 399 LVTLLG--ACPEAWSLVYEY-LPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFL 454
++ LL P+++ L+ E P L D + + + + AR ++ +
Sbjct: 110 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQE----ELARSFFWQVLEAVRHC 165
Query: 455 HSSKPEKIVHGDLKPQNILLDSE-LSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY 513
H+ ++H D+K +NIL+D K+ DFG L+ DT+Y G+ Y
Sbjct: 166 HN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-DTVYTDF-------DGTRVY 214
Query: 514 ADPE------YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ PE YH G + +S G+++ ++ G +P
Sbjct: 215 SPPEWIRYHRYH--G---RSAAVWSLGILLYDMVCGDIP 248
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 40/150 (26%), Positives = 69/150 (46%), Gaps = 13/150 (8%)
Query: 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVT 401
K+G+G G V GR VA+KM+ Q + EV ++ QH ++V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 402 LLGAC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
+ + E W ++ E+L G+L D + + L + A + + L +LH+
Sbjct: 107 MYKSYLVGEELW-VLMEFLQGGALTDIV----SQVRLNEEQIATVCEAVLQALAYLHA-- 159
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGIC 488
+ ++H D+K +ILL + K+ DFG C
Sbjct: 160 -QGVIHRDIKSDSILLTLDGRVKLSDFGFC 188
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 68/271 (25%), Positives = 108/271 (39%), Gaps = 24/271 (8%)
Query: 288 KQRIRRQKVEAVRWLERWRSRGQAGAANYDGFIGLVEDLPESAEFSLADLQTATCNFSES 347
Q R EA + + V+ A F + +
Sbjct: 29 DQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSF 88
Query: 348 FKV------GQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHL 399
+ V G G FG V+K E G +A K++ + M+ + E + E+ V+++L H +L
Sbjct: 89 YTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANL 148
Query: 400 VTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
+ L A LV EY+ G L DR+ +S L D +I G+ +H
Sbjct: 149 IQLYDAFESKNDIVLVMEYVDGGELFDRIIDES--YNLTELDTILFMKQICEGIRHMHQM 206
Query: 458 KPEKIVHGDLKPQNILLDSELSS--KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 515
I+H DLKP+NIL + + KI DFG+ R +F G+ +
Sbjct: 207 ---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF-------GTPEFLA 256
Query: 516 PEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PE ++ +D +S G+I LL+G P
Sbjct: 257 PEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 52/207 (25%), Positives = 90/207 (43%), Gaps = 25/207 (12%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGA- 405
+G G F V+ + G+ A+K + + E+ VL K++H ++VTL
Sbjct: 16 VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIY 75
Query: 406 -CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
+ LV + + G L DR+ + + KD + + ++ S + +LH IVH
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRILERGVYTE---KDASLVIQQVLSAVKYLHE---NGIVH 129
Query: 465 GDLKPQNILL-----DSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 519
DLKP+N+L +S++ I DFG+ ++ + + G+ Y PE
Sbjct: 130 RDLKPENLLYLTPEENSKI--MITDFGLSKMEQNGIM--------STACGTPGYVAPEVL 179
Query: 520 RTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ D +S G+I LL G P
Sbjct: 180 AQKPYSKAVDCWSIGVITYILLCGYPP 206
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 57/219 (26%), Positives = 91/219 (41%), Gaps = 43/219 (19%)
Query: 351 GQGGFGCVYKGEML--GRTVAIKML------YSHNMQGQLEFQQEVRVLSKL----QHPH 398
G+GGFG V+ G L VAIK++ + + EV +L K+ HP
Sbjct: 40 GKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPG 99
Query: 399 LVTLLG--ACPEAWSLVYEY-LPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFL 454
++ LL E + LV E LP L D + K + +R ++ + +
Sbjct: 100 VIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGE----GPSRCFFGQVVAAIQHC 155
Query: 455 HSSKPEKIVHGDLKPQNILLDSE-LSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY 513
HS +VH D+K +NIL+D +K+ DFG L D Y G+ Y
Sbjct: 156 HSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGAL-LHDEPYTDF-------DGTRVY 204
Query: 514 ADPE------YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ PE YH + +S G+++ ++ G +P
Sbjct: 205 SPPEWISRHQYH--A---LPATVWSLGILLYDMVCGDIP 238
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 41/148 (27%), Positives = 72/148 (48%), Gaps = 17/148 (11%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE---FQQEVRVLSKLQHPHLVTLL 403
++G G FG VYK + G A K++ + + E + E+ +L+ HP++V LL
Sbjct: 26 ELGDGAFGKVYKAKNKETGALAAAKVI---ETKSEEELEDYIVEIEILATCDHPYIVKLL 82
Query: 404 GAC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460
GA + W ++ E+ P G++ + L + ++ L FLHS +
Sbjct: 83 GAYYHDGKLW-IMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQMLEALNFLHS---K 136
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGIC 488
+I+H DLK N+L+ E ++ DFG+
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVS 164
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 64/214 (29%), Positives = 97/214 (45%), Gaps = 37/214 (17%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNM--QGQLEF-QQEVRVLSKLQHPHLVTLLG 404
+G+G F V + R AIK+L ++ + ++ + +E V+S+L HP V L
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYF 97
Query: 405 ACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 461
+ L Y NG L + RK R AEI S L +LH +
Sbjct: 98 TFQDDEKLYFGLSYAKNGELLKYI-RKIGSFDE---TCTRFYTAEIVSALEYLHG---KG 150
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF---P-YADPE 517
I+H DLKP+NILL+ ++ +I DFG ++++ ++ A SF Y PE
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--------KQARANSFVGTAQYVSPE 202
Query: 518 YHRTGVLTPK-----SDSYSFGLIILQLLTGRLP 546
+LT K SD ++ G II QL+ G P
Sbjct: 203 -----LLTEKSACKSSDLWALGCIIYQLVAGLPP 231
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 51/159 (32%), Positives = 77/159 (48%), Gaps = 22/159 (13%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL--EFQQEVRVLSKL-QHPHLVTLL 403
VG G +G VYKG + G+ AIK++ ++ G E +QE+ +L K H ++ T
Sbjct: 31 LVGNGTYGQVYKGRHVKTGQLAAIKVM---DVTGDEEEEIKQEINMLKKYSHHRNIATYY 87
Query: 404 GA---------CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFL 454
GA + W LV E+ GS+ D L + + + L + A I EI GL L
Sbjct: 88 GAFIKKNPPGMDDQLW-LVMEFCGAGSVTD-LIKNTKGNTLKEEWIAYICREILRGLSHL 145
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493
H K++H D+K QN+LL K+ DFG+ +
Sbjct: 146 HQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 51/208 (24%), Positives = 85/208 (40%), Gaps = 28/208 (13%)
Query: 351 GQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLG--A 405
G+G +G V + VA+K++ E ++E+ + L H ++V G
Sbjct: 16 GEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 406 CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKPEKIVH 464
L EY G L DR+ + A+ ++ +G+ +LH I H
Sbjct: 76 EGNIQYLFLEYCSGGELFDRIEPDIGMPE----PDAQRFFHQLMAGVVYLHG---IGITH 128
Query: 465 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE------Y 518
D+KP+N+LLD + KI DFG+ + + G+ PY PE +
Sbjct: 129 RDIKPENLLLDERDNLKISDFGLATVFRYNN--RERLLNKMC--GTLPYVAPELLKRREF 184
Query: 519 HRTGVLTPKSDSYSFGLIILQLLTGRLP 546
H D +S G+++ +L G LP
Sbjct: 185 H--A---EPVDVWSCGIVLTAMLAGELP 207
|
| >1wgm_A Ubiquitin conjugation factor E4A; ubiquitinating enzyme, KIAA0126, structural genomics, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: g.44.1.2 Length = 98 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 8e-24
Identities = 24/85 (28%), Positives = 33/85 (38%), Gaps = 2/85 (2%)
Query: 602 SLVKELEQLHVAEERPVPSFFLCPILQEIMHDPQVAADG-FTYEGKAIRDWLENGRETSP 660
S L+Q FL PI+ +M DP V T + I L + +T P
Sbjct: 3 SGSSGLQQQEEETYADACDEFLDPIMSTLMCDPVVLPSSRVTVDRSTIARHLLSD-QTDP 61
Query: 661 MTNLRLSHLHLTPNHALRHAIQDWL 685
L+ + PN L+ IQ WL
Sbjct: 62 FNRSPLTMDQIRPNTELKEKIQRWL 86
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 27/205 (13%), Positives = 49/205 (23%), Gaps = 48/205 (23%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKML---YSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
G ++ L R VA+ + E LS++ P + +L
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 404 --GACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
+V E++ GSLQ+ + R +A+ H
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAAHR---AG 149
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
+ P + + + +
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPAT-----------------MPD-------------- 178
Query: 522 GVLTPKSDSYSFGLIILQLLTGRLP 546
P+ D G + LL R P
Sbjct: 179 --ANPQDDIRGIGASLYALLVNRWP 201
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-23
Identities = 54/224 (24%), Positives = 93/224 (41%), Gaps = 31/224 (13%)
Query: 341 TCNFSESFKV----GQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQL------EFQQEV 388
+ + + G G F V K G A K + + E ++EV
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREV 66
Query: 389 RVLSKLQHPHLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAE 446
+L ++ H +++TL L+ E + G L D L +K ++S ++ +
Sbjct: 67 SILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE---EEATSFIKQ 123
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS----KICDFGICRLVTEDTLYLPSFH 502
I G+ +LH+ K I H DLKP+NI+L + K+ DFG+ + + + F
Sbjct: 124 ILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF- 179
Query: 503 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
G+ + PE L ++D +S G+I LL+G P
Sbjct: 180 ------GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 1e-23
Identities = 53/237 (22%), Positives = 93/237 (39%), Gaps = 34/237 (14%)
Query: 331 EFSLADLQTATCNFSESFKV----GQGGFGCVYKGE--MLGRTVAIKML--------YSH 376
+ ++ D + + + G G G V + VAI+++ +
Sbjct: 120 DLTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAR 179
Query: 377 NMQGQLEFQQEVRVLSKLQHPHLVTLLGAC-PEAWSLVYEYLPNGSLQDRLFRKSNVSPL 435
L + E+ +L KL HP ++ + E + +V E + G L D++ +
Sbjct: 180 EADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKE- 238
Query: 436 LWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS---ELSSKICDFGICRLVT 492
++ + +LH I+H DLKP+N+LL S + KI DFG +++
Sbjct: 239 --ATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 293
Query: 493 EDTLYLPSFHRSTAPKGSFPYADPE---YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
E +L T G+ Y PE T D +S G+I+ L+G P
Sbjct: 294 ETSLM------RTLC-GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 57/224 (25%), Positives = 93/224 (41%), Gaps = 31/224 (13%)
Query: 341 TCNFSESFKV----GQGGFGCVYKGEML--GRTVAIK------MLYSHNMQGQLEFQQEV 388
N + + G G F V K G A K S + + ++EV
Sbjct: 6 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 65
Query: 389 RVLSKLQHPHLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAE 446
+L ++QHP+++TL L+ E + G L D L K +++ ++ +
Sbjct: 66 SILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTE---EEATEFLKQ 122
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS----KICDFGICRLVTEDTLYLPSFH 502
I +G+ +LHS + I H DLKP+NI+L KI DFG+ + + F
Sbjct: 123 ILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF- 178
Query: 503 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
G+ + PE L ++D +S G+I LL+G P
Sbjct: 179 ------GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 42/219 (19%), Positives = 72/219 (32%), Gaps = 35/219 (15%)
Query: 349 KVGQG--GFGCVYKGEML--GRTVAIKM--LYSHNMQGQLEFQQEVRVLSKLQHPHLVTL 402
+G+G V G V ++ L + + + Q E+ V HP++V
Sbjct: 32 VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91
Query: 403 LGA---CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA---EIASGLCFLHS 456
E W +V ++ GS +D L + + + IA + L ++H
Sbjct: 92 RATFIADNELW-VVTSFMAYGSAKD-LICTHFMDGM---NELAIAYILQGVLKALDYIHH 146
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY--A 514
VH +K +IL+ + + + H +
Sbjct: 147 ---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203
Query: 515 DPEYHRTGVLT-------PKSDSYSFGLIILQLLTGRLP 546
PE VL KSD YS G+ +L G +P
Sbjct: 204 -PE-----VLQQNLQGYDAKSDIYSVGITACELANGHVP 236
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 55/219 (25%), Positives = 95/219 (43%), Gaps = 31/219 (14%)
Query: 343 NFSESFKV----GQGGFGCVYKGE--MLGRTVAIK------MLYSHNMQGQLEFQQEVRV 390
+ +++ G G F V K G+ A K + S + E ++EV +
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 391 LSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIA 448
L +++HP+++TL L+ E + G L D L K +++ + + +I
Sbjct: 62 LREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTE---DEATQFLKQIL 118
Query: 449 SGLCFLHSSKPEKIVHGDLKPQNILLDSELSS----KICDFGICRLVTEDTLYLPSFHRS 504
G+ +LHS + I H DLKP+NI+L + K+ DFGI + + F
Sbjct: 119 DGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF--- 172
Query: 505 TAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTG 543
G+ + PE L ++D +S G+I LL+G
Sbjct: 173 ----GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-23
Identities = 55/219 (25%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 341 TCNFSESFKV----GQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQ--LEFQQEVRVLS 392
+ FS+++ V G+G F V + G A K++ + + + + ++E R+
Sbjct: 1 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICR 60
Query: 393 KLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASG 450
KLQHP++V L + LV++ + G L + + + S D + +I
Sbjct: 61 KLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE---ADASHCIQQILES 117
Query: 451 LCFLHSSKPEKIVHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHRSTAP 507
+ + HS+ IVH +LKP+N+LL S+ K+ DFG+ V + A
Sbjct: 118 IAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS-----EAWHGFA- 168
Query: 508 KGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
G+ Y PE + + D ++ G+I+ LL G P
Sbjct: 169 -GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 206
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 59/233 (25%), Positives = 98/233 (42%), Gaps = 41/233 (17%)
Query: 340 ATCNFSESFKV----GQGGFGCVYKGE--MLGRTVAIKML---------YSHNMQGQLEF 384
+T F E+++ G+G V + + A+K++ + +
Sbjct: 11 STHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREAT 70
Query: 385 QQEVRVLSKL-QHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRA 441
+EV +L K+ HP+++ L + LV++ + G L D L K +S K+
Sbjct: 71 LKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE---KETR 127
Query: 442 RIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL--- 498
+I + +C LH IVH DLKP+NILLD +++ K+ DFG +
Sbjct: 128 KIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVC 184
Query: 499 --PSFHRSTAP---KGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PS+ AP + S P Y + D +S G+I+ LL G P
Sbjct: 185 GTPSY---LAPEIIECSMNDNHPGY------GKEVDMWSTGVIMYTLLAGSPP 228
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-23
Identities = 46/204 (22%), Positives = 92/204 (45%), Gaps = 19/204 (9%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
+G+G FG V++ +T K + ++E+ +L+ +H +++ L +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV-LVKKEISILNIARHRNILHLHESF 70
Query: 407 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
E +++E++ + +R+ + L ++ ++ L FLHS I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERINTSAFE--LNEREIVSYVHQVCEALQFLHSHN---IGH 125
Query: 465 GDLKPQNILLDSELSS--KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 522
D++P+NI+ + SS KI +FG R + + F + Y PE H+
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF-------TAPEYYAPEVHQHD 178
Query: 523 VLTPKSDSYSFGLIILQLLTGRLP 546
V++ +D +S G ++ LL+G P
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINP 202
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-23
Identities = 56/224 (25%), Positives = 95/224 (42%), Gaps = 31/224 (13%)
Query: 341 TCNFSESFKV----GQGGFGCVYKGE--MLGRTVAIKML------YSHNMQGQLEFQQEV 388
+ + + G G F V K G A K + S + E ++EV
Sbjct: 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREV 66
Query: 389 RVLSKLQHPHLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAE 446
+L ++ HP+++TL L+ E + G L D L +K ++S ++ +
Sbjct: 67 SILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSE---EEATSFIKQ 123
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS----KICDFGICRLVTEDTLYLPSFH 502
I G+ +LH+ K I H DLKP+NI+L + K+ DFG+ + + + F
Sbjct: 124 ILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIF- 179
Query: 503 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
G+ + PE L ++D +S G+I LL+G P
Sbjct: 180 ------GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 4e-23
Identities = 53/238 (22%), Positives = 89/238 (37%), Gaps = 62/238 (26%)
Query: 351 GQGGFGCVYKG--EMLGRTVAIKML----------------------------YSHNMQG 380
G+G +G V E A+K+L
Sbjct: 22 GKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIE 81
Query: 381 QLEFQQEVRVLSKLQHPHLVTLLGACPEAWS--------LVYEYLPNGSLQDRLFRKSNV 432
Q+ QE+ +L KL HP++V L+ E +V+E + G + + K
Sbjct: 82 QVY--QEIAILKKLDHPNVVKLV----EVLDDPNEDHLYMVFELVNQGPVMEVPTLKP-- 133
Query: 433 SPLLWKDRAR-IAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491
L +D+AR ++ G+ +LH +KI+H D+KP N+L+ + KI DFG+
Sbjct: 134 ---LSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF 187
Query: 492 TEDTLYLPSFHRSTAPKGSFPYADPE---YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
L S G+ + PE R D ++ G+ + + G+ P
Sbjct: 188 KGSDALL-----SNTV-GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 49/228 (21%), Positives = 94/228 (41%), Gaps = 26/228 (11%)
Query: 336 DLQTATCNFSESFKV----GQGGFGCVYKGEML--GRTVAIKM-----LYSHNMQGQLEF 384
D+ F + +++ G+G F V + G+ A+K+ S +
Sbjct: 14 DMADDDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDL 73
Query: 385 QQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLW-KDRA 441
++E + L+HPH+V LL +V+E++ L + ++++ + +
Sbjct: 74 KREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVAS 133
Query: 442 RIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYL 498
+I L + H + I+H D+KP +LL S+ +S K+ FG+ + E L
Sbjct: 134 HYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVA 190
Query: 499 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
G+ + PE + D + G+I+ LL+G LP
Sbjct: 191 ------GGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLP 232
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 6e-23
Identities = 53/215 (24%), Positives = 88/215 (40%), Gaps = 30/215 (13%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKML--------YSHNMQGQLEFQQEVRVLSKLQHPH 398
+G G G V + VAIK++ + L + E+ +L KL HP
Sbjct: 17 TLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPC 76
Query: 399 LVTLLGAC-PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
++ + E + +V E + G L D++ + ++ + +LH +
Sbjct: 77 IIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKE---ATCKLYFYQMLLAVQYLHEN 133
Query: 458 KPEKIVHGDLKPQNILLDS---ELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 514
I+H DLKP+N+LL S + KI DFG +++ E S R+ G+ Y
Sbjct: 134 G---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-----SLMRTLC--GTPTYL 183
Query: 515 DPE---YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
PE T D +S G+I+ L+G P
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 2e-22
Identities = 54/229 (23%), Positives = 98/229 (42%), Gaps = 36/229 (15%)
Query: 337 LQTATC-NFSESFKV----GQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLE--FQQE 387
+ T TC F+E +++ G+G F V + + G+ A ++ + + + ++E
Sbjct: 1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLERE 60
Query: 388 VRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA 445
R+ L+HP++V L + L+++ + G L + + + S D +
Sbjct: 61 ARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSE---ADASHCIQ 117
Query: 446 EIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFH 502
+I + H +VH +LKP+N+LL S+L K+ DFG+ V + F
Sbjct: 118 QILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF- 173
Query: 503 RSTAPKGSFPYADPEYHRTGVL-----TPKSDSYSFGLIILQLLTGRLP 546
G+ Y PE VL D ++ G+I+ LL G P
Sbjct: 174 -----AGTPGYLSPE-----VLRKDPYGKPVDLWACGVILYILLVGYPP 212
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 55/230 (23%), Positives = 102/230 (44%), Gaps = 35/230 (15%)
Query: 341 TCNFSESFKV-----GQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSK 393
+ F + +++ G+G V L + A+K++ + +EV +L +
Sbjct: 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ 66
Query: 394 LQ-HPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASG 450
Q H +++ L+ + + LV+E + GS+ + ++ + + + + + ++AS
Sbjct: 67 CQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNE---LEASVVVQDVASA 123
Query: 451 LCFLHSSKPEKIVHGDLKPQNILLDS--ELSS-KICDFGICRLVTEDTLYLPSFHRS-TA 506
L FLH+ I H DLKP+NIL + ++S KICDF + + + P
Sbjct: 124 LDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLT 180
Query: 507 PKGSFPYADPEYHRTGVL----------TPKSDSYSFGLIILQLLTGRLP 546
P GS Y PE V+ + D +S G+I+ LL+G P
Sbjct: 181 PCGSAEYMAPE-----VVEAFSEEASIYDKRCDLWSLGVILYILLSGYPP 225
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 2e-22
Identities = 55/212 (25%), Positives = 95/212 (44%), Gaps = 26/212 (12%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIK-MLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLG 404
++G+G +G V K + G+ +A+K + + + + Q + ++ V+ + P++V G
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 405 AC---PEAWSLVYEYLPNGSLQD--RLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 459
A + W + E + + S + + + +I L L +
Sbjct: 89 ALFREGDCW-ICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENL- 145
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGIC-RLVTEDTLYLPSFHRSTAPKGSFPYADPE- 517
KI+H D+KP NILLD + K+CDFGI +LV D++ A G PY PE
Sbjct: 146 -KIIHRDIKPSNILLDRSGNIKLCDFGISGQLV--DSI----AKTRDA--GCRPYMAPER 196
Query: 518 ---YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+SD +S G+ + +L TGR P
Sbjct: 197 IDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 2e-22
Identities = 49/151 (32%), Positives = 69/151 (45%), Gaps = 21/151 (13%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQ------LEFQQEVRVLSKLQHPHLV 400
++G G FG VY + VAIK + + G+ + +EVR L KL+HP+ +
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKM---SYSGKQSNEKWQDIIKEVRFLQKLRHPNTI 117
Query: 401 TLLGAC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
G AW LV EY GS D L + + PL + A + GL +LHS
Sbjct: 118 QYRGCYLREHTAW-LVMEYCL-GSASDLL--EVHKKPLQEVEIAAVTHGALQGLAYLHS- 172
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGIC 488
++H D+K NILL K+ DFG
Sbjct: 173 --HNMIHRDVKAGNILLSEPGLVKLGDFGSA 201
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 2e-22
Identities = 51/213 (23%), Positives = 95/213 (44%), Gaps = 35/213 (16%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHN--MQGQLEF-QQEVRVLSKLQHPHLVTLLG 404
+G+G FG V + + A+K + + ++ +E++++ L+HP LV L
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 405 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 461
+ E +V + L G L+ L + + ++ ++ E+ L +L + ++
Sbjct: 83 SFQDEEDMFMVVDLLLGGDLRYHLQQNVHFK----EETVKLFICELVMALDYLQN---QR 135
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
I+H D+KP NILLD I DF I ++ +T + + G+ PY PE
Sbjct: 136 IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ-ITTM------AGTKPYMAPE---- 184
Query: 522 GVLTPKS--------DSYSFGLIILQLLTGRLP 546
+ + + D +S G+ +LL GR P
Sbjct: 185 -MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 59/231 (25%), Positives = 98/231 (42%), Gaps = 32/231 (13%)
Query: 329 SAEFSLADLQTATCNFSESFKVGQGGFGCVYKG--EMLGRTVAIK-MLYSHNMQGQLEFQ 385
S E DL+ ++G+G +G V K G+ +A+K + + N Q Q
Sbjct: 1 SMEVKADDLEPIM-------ELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLL 53
Query: 386 QEVRV-LSKLQHPHLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDR-- 440
++ + + + P VT GA + E + + SL D+ +++ +
Sbjct: 54 MDLDISMRTVDCPFTVTFYGALFREGDVWICMELM-DTSL-DKFYKQVIDKGQTIPEDIL 111
Query: 441 ARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC-RLVTEDTLYLP 499
+IA I L LHS ++H D+KP N+L+++ K+CDFGI LV D +
Sbjct: 112 GKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGYLV--DDVAKD 167
Query: 500 SFHRSTAPKGSFPYADPE----YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
G PY PE + KSD +S G+ +++L R P
Sbjct: 168 ID------AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFP 212
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 3e-22
Identities = 57/210 (27%), Positives = 88/210 (41%), Gaps = 35/210 (16%)
Query: 351 GQGGFGCVYKGE--MLGRTVAIKMLY-SHNMQGQLEFQQEVRVLSKLQHPHLVTL--LGA 405
G G FG + VA+K + + + Q+E+ L+HP++V +
Sbjct: 29 GSGNFGVARLMRDKLTKELVAVKYIERGAAIDENV--QREIINHRSLRHPNIVRFKEVIL 86
Query: 406 CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKPEKIVH 464
P +++ EY G L +R+ S D AR ++ SG+ + HS +I H
Sbjct: 87 TPTHLAIIMEYASGGELYERICNAGRFSE----DEARFFFQQLLSGVSYCHS---MQICH 139
Query: 465 GDLKPQNILLDSELSS--KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 522
DLK +N LLD + KICDFG + S +ST G+ Y PE
Sbjct: 140 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-----SQPKSTV--GTPAYIAPE----- 187
Query: 523 VLT------PKSDSYSFGLIILQLLTGRLP 546
VL +D +S G+ + +L G P
Sbjct: 188 VLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 3e-22
Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 26/223 (11%)
Query: 337 LQTATCNFSESFKV----GQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE--FQQEV 388
+ A+ FS+++ V G+G F V + G A K++ + + + ++E
Sbjct: 20 MMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREA 79
Query: 389 RVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAE 446
R+ KLQHP++V L + LV++ + G L + + + S D + +
Sbjct: 80 RICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSE---ADASHCIQQ 136
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHR 503
I + + HS+ IVH +LKP+N+LL S+ K+ DFG+ V + +
Sbjct: 137 ILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAW-----H 188
Query: 504 STAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
A G+ Y PE + + D ++ G+I+ LL G P
Sbjct: 189 GFA--GTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP 229
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 3e-22
Identities = 55/219 (25%), Positives = 91/219 (41%), Gaps = 36/219 (16%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKML--------YSHNMQGQLEFQQEVRVLSKL-QHP 397
+G+G V + G A+K++ + + ++E +L ++ HP
Sbjct: 101 VIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHP 160
Query: 398 HLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLH 455
H++TL+ + LV++ + G L D L K +S K+ I + + FLH
Sbjct: 161 HIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSE---KETRSIMRSLLEAVSFLH 217
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL-----PSFHRSTAP--- 507
+ IVH DLKP+NILLD + ++ DFG + P + AP
Sbjct: 218 A---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGY---LAPEIL 271
Query: 508 KGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
K S P Y + D ++ G+I+ LL G P
Sbjct: 272 KCSMDETHPGY------GKEVDLWACGVILFTLLAGSPP 304
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 4e-22
Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 33/211 (15%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLLGA 405
+G+G F K + A+K++ Q+E+ L + HP++V L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEA---NTQKEITALKLCEGHPNIVKLHEV 74
Query: 406 C--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
LV E L G L +R+ +K + S + + I ++ S + +H +V
Sbjct: 75 FHDQLHTFLVMELLNGGELFERIKKKKHFSE---TEASYIMRKLVSAVSHMHD---VGVV 128
Query: 464 HGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 520
H DLKP+N+L E + KI DFG RL D L P + YA PE
Sbjct: 129 HRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL------KTPCFTLHYAAPE--- 179
Query: 521 TGVLT-----PKSDSYSFGLIILQLLTGRLP 546
+L D +S G+I+ +L+G++P
Sbjct: 180 --LLNQNGYDESCDLWSLGVILYTMLSGQVP 208
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 4e-22
Identities = 47/215 (21%), Positives = 87/215 (40%), Gaps = 35/215 (16%)
Query: 351 GQGGFGCVYKGEML--GRTVAIKML------YSHNMQGQLEFQQEVRVLSKLQHPHLVTL 402
G+G +G V + A+K+L N + ++ +E+++L +L+H +++ L
Sbjct: 14 GEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVK--KEIQLLRRLRHKNVIQL 71
Query: 403 ----LGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
+ +V EY G + + ++ GL +LHS
Sbjct: 72 VDVLYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLEYLHS-- 127
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE- 517
+ IVH D+KP N+LL + + KI G+ + + T+ +GS + PE
Sbjct: 128 -QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP---FAADDTCRTS-QGSPAFQPPEI 182
Query: 518 ------YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ G K D +S G+ + + TG P
Sbjct: 183 ANGLDTFS--G---FKVDIWSAGVTLYNITTGLYP 212
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 4e-22
Identities = 58/253 (22%), Positives = 92/253 (36%), Gaps = 65/253 (25%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKM-----LYSHNMQGQLEFQQEVRVLSKLQHPHLVT 401
+GQG +G V AIK+ + N + + EVR++ KL HP++
Sbjct: 33 AIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIAR 92
Query: 402 LLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLW---------------------- 437
L + LV E G L D+L + S
Sbjct: 93 LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 438 ---------------KDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS-- 480
K + I +I S L +LH+ + I H D+KP+N L + S
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEI 209
Query: 481 KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSY-------SF 533
K+ DFG+ + + + A G+ + PE VL ++SY S
Sbjct: 210 KLVDFGLSKEFYKLNNGEYYGMTTKA--GTPYFVAPE-----VLNTTNESYGPKCDAWSA 262
Query: 534 GLIILQLLTGRLP 546
G+++ LL G +P
Sbjct: 263 GVLLHLLLMGAVP 275
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 96.5 bits (240), Expect = 6e-22
Identities = 40/175 (22%), Positives = 70/175 (40%), Gaps = 11/175 (6%)
Query: 377 NMQGQLEFQQEVRVLSKLQHPHLVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSP 434
+ ++R + + V L L + +L+D + R+ ++
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160
Query: 435 LLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494
I +IA + FLHS + ++H DLKP NI + K+ DFG+ + +D
Sbjct: 161 REHGVCLHIFIQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217
Query: 495 T------LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTG 543
+P++ T G+ Y PE + K D +S GLI+ +LL
Sbjct: 218 EEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYS 272
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 51/212 (24%), Positives = 87/212 (41%), Gaps = 29/212 (13%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIK-MLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLG 404
++G G G V+K G +A+K M S N + ++ V+ K P++V G
Sbjct: 32 EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91
Query: 405 AC---PEAWSLVYEYLPNGSLQDRLFRKSNVS-PLLWKDRARIAAEIASGLCFLHSSKPE 460
+ + + E + + + + + + +L ++ I L +L
Sbjct: 92 TFITNTDVF-IAMELMGTCAEKLKKRMQGPIPERIL----GKMTVAIVKALYYLKEKH-- 144
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGIC-RLVTEDTLYLPSFHRSTAPKGSFPYADPE-- 517
++H D+KP NILLD K+CDFGI RLV D G Y PE
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISGRLV--DDKAKDRS------AGCAAYMAPERI 196
Query: 518 ---YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
++D +S G+ +++L TG+ P
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 57/241 (23%), Positives = 95/241 (39%), Gaps = 44/241 (18%)
Query: 328 ESAEFSLADLQTATCNFSESFKV-----GQGGFGCVYKGEML--GRTVAIKMLYSHNMQG 380
E + ++ +++ G G G V + G+ A+K+LY
Sbjct: 10 SGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-- 67
Query: 381 QLEFQQEVRVLSKLQ-HPHLVTLLGACPEAWS------LVYEYLPNGSLQDRLFRKSNVS 433
+QEV + PH+V +L ++ E + G L R+ + +
Sbjct: 68 ---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGD-Q 123
Query: 434 PLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS---KICDFGICRL 490
++ A I +I + + FLHS I H D+KP+N+L S+ K+ DFG +
Sbjct: 124 AFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180
Query: 491 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKS-----DSYSFGLIILQLLTGRL 545
T++ L P + Y PE VL P+ D +S G+I+ LL G
Sbjct: 181 TTQNAL--------QTPCYTPYYVAPE-----VLGPEKYDKSCDMWSLGVIMYILLCGFP 227
Query: 546 P 546
P
Sbjct: 228 P 228
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 66/233 (28%), Positives = 99/233 (42%), Gaps = 30/233 (12%)
Query: 327 PESAEFSLADLQTATCNFSESFKV----GQGGFGCVYKGE--MLGRTVAIKMLYSHNMQG 380
S + S+ F+V G+G VY+ + + A+K+L +
Sbjct: 34 TASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKK 93
Query: 381 QLEFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWK 438
+ E+ VL +L HP+++ L P SLV E + G L DR+ K S +
Sbjct: 94 IVR--TEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSE---R 148
Query: 439 DRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL-----DSELSSKICDFGICRLVTE 493
D A +I + +LH + IVH DLKP+N+L D+ L KI DFG+ ++V
Sbjct: 149 DAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPL--KIADFGLSKIVEH 203
Query: 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
L G+ Y PE R P+ D +S G+I LL G P
Sbjct: 204 QVLM-------KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEP 249
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 52/228 (22%), Positives = 100/228 (43%), Gaps = 39/228 (17%)
Query: 337 LQTATCNFSESFKV----GQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRV 390
L + F++ ++V G G + + A+K++ + + + +E+ +
Sbjct: 13 LHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIID----KSKRDPTEEIEI 68
Query: 391 LSKL-QHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEI 447
L + QHP+++TL + +V E + G L D++ R+ S ++ + + I
Sbjct: 69 LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSE---REASAVLFTI 125
Query: 448 ASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS----KICDFGICRLVTEDTLYLPSFHR 503
+ +LH+ + +VH DLKP NIL E + +ICDFG + + + L
Sbjct: 126 TKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL----- 177
Query: 504 STAPKGSFPYADPEYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 546
P + + PE VL + D +S G+++ +LTG P
Sbjct: 178 -MTPCYTANFVAPE-----VLERQGYDAACDIWSLGVLLYTMLTGYTP 219
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 5e-21
Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 24/210 (11%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLE-FQQEVRVLSKLQHPHLVTLLG 404
+G+G FG V ++ + A+K+L M + + F++E VL + TL
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHY 141
Query: 405 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 461
A LV +Y G L L S L ++ AR AE+ + +H
Sbjct: 142 AFQDDNNLYLVMDYYVGGDL---LTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ---LH 195
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE---- 517
VH D+KP NIL+D ++ DFG C + ED +S+ G+ Y PE
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-----QSSVAVGTPDYISPEILQA 250
Query: 518 -YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
G P+ D +S G+ + ++L G P
Sbjct: 251 MEGGKGRYGPECDWWSLGVCMYEMLYGETP 280
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 6e-21
Identities = 57/219 (26%), Positives = 84/219 (38%), Gaps = 26/219 (11%)
Query: 343 NFSESFKV-----GQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQL--EFQQEVRVLSK 393
NF+ + + G+G F V + G+ A K L E E+ VL
Sbjct: 25 NFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLEL 84
Query: 394 LQH-PHLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASG 450
+ P ++ L L+ EY G + + + D R+ +I G
Sbjct: 85 AKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEM-VSENDVIRLIKQILEG 143
Query: 451 LCFLHSSKPEKIVHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHRSTAP 507
+ +LH + IVH DLKPQNILL S KI DFG+ R +
Sbjct: 144 VYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM------ 194
Query: 508 KGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
G+ Y PE +T +D ++ G+I LLT P
Sbjct: 195 -GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 9e-21
Identities = 54/220 (24%), Positives = 94/220 (42%), Gaps = 42/220 (19%)
Query: 348 FKV-GQGGFGCVYKGEM--LGRTVAIKML----------YSHNMQGQLEFQQEVRVLSKL 394
F+V G+GGFG V+ +M G+ A K L Y M E ++L+K+
Sbjct: 190 FRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMV-------EKKILAKV 242
Query: 395 QHPHLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGL 451
+V+L A LV + G ++ ++ +P + RA A+I SGL
Sbjct: 243 HSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 511
LH I++ DLKP+N+LLD + + +I D G+ + + G+
Sbjct: 303 EHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY------AGTP 353
Query: 512 PYADPEYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 546
+ PE +L + D ++ G+ + +++ R P
Sbjct: 354 GFMAPE-----LLLGEEYDFSVDYFALGVTLYEMIAARGP 388
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 57/212 (26%), Positives = 87/212 (41%), Gaps = 26/212 (12%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLE-FQQEVRVLSKLQHPHLVTLLG 404
+G+G F V +M G+ A+K++ +M +G++ F++E VL + L
Sbjct: 69 IGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHF 128
Query: 405 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 461
A LV EY G L L S + + AR AEI + +H
Sbjct: 129 AFQDENYLYLVMEYYVGGDL---LTLLSKFGERIPAEMARFYLAEIVMAIDSVHR---LG 182
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
VH D+KP NILLD ++ DFG C + D RS G+ Y PE +
Sbjct: 183 YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV-----RSLVAVGTPDYLSPEILQA 237
Query: 522 GVLTPKSDSY-------SFGLIILQLLTGRLP 546
P + SY + G+ ++ G+ P
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 9e-20
Identities = 67/215 (31%), Positives = 101/215 (46%), Gaps = 40/215 (18%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNMQGQLEFQQ---EVRVLSKLQHPHLVTLLG 404
+G+G FG V K + GR A+K+L + + E E RVL +HP L L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 215
Query: 405 A--CPEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHS 456
+ + V EY G L ++R+F + DRAR AEI S L +LHS
Sbjct: 216 SFQTHDRLCFVMEYANGGELFFHLSRERVFSE---------DRARFYGAEIVSALDYLHS 266
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 516
K +V+ DLK +N++LD + KI DFG+C+ +D + +F G+ P
Sbjct: 267 EK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTF------CGT-----P 313
Query: 517 EYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 546
EY VL D + G+++ +++ GRLP
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 2e-19
Identities = 58/210 (27%), Positives = 93/210 (44%), Gaps = 30/210 (14%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLG 404
+G+GGFG V ++ G+ A K L + +G+ E ++L K+ +V+L
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY 251
Query: 405 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 461
A +A LV + G L+ ++ + RA AAEI GL LH E+
Sbjct: 252 AYETKDALCLVLTLMNGGDLKFHIYHMGQ--AGFPEARAVFYAAEICCGLEDLHR---ER 306
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
IV+ DLKP+NILLD +I D G+ V E G+ Y PE
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-------TIKGRVGTVGYMAPE---- 355
Query: 522 GVLTPKS-----DSYSFGLIILQLLTGRLP 546
V+ + D ++ G ++ +++ G+ P
Sbjct: 356 -VVKNERYTFSPDWWALGCLLYEMIAGQSP 384
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 88.7 bits (221), Expect = 2e-19
Identities = 52/156 (33%), Positives = 78/156 (50%), Gaps = 19/156 (12%)
Query: 350 VGQGGFGCVY----KGEMLGRTVAIKMLYSHNM--QGQLE-FQQEVRVLSKLQHPHLVTL 402
+G G FG V+ + GR A+K+L + Q+E E +LS + HP ++ +
Sbjct: 14 LGTGSFGRVHLIRSRHN--GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 403 LGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKP 459
G +A + + +Y+ G L L RKS P A+ AAE+ L +LHS
Sbjct: 72 WGTFQDAQQIFMIMDYIEGGELFSLL-RKSQRFP---NPVAKFYAAEVCLALEYLHS--- 124
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495
+ I++ DLKP+NILLD KI DFG + V + T
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 160
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 3e-19
Identities = 58/232 (25%), Positives = 93/232 (40%), Gaps = 43/232 (18%)
Query: 337 LQTATCNFSESFKV-----GQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVR 389
LQ + +KV G G G V + A+KML Q + ++EV
Sbjct: 52 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVE 106
Query: 390 VLSKLQ-HPHLVTLLGACPEAWS------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR 442
+ + PH+V ++ ++ +V E L G L R+ + + ++ +
Sbjct: 107 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASE 165
Query: 443 IAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLP 499
I I + +LHS I H D+KP+N+L S+ + K+ DFG + T
Sbjct: 166 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL-- 220
Query: 500 SFHRSTAPKGSFPYADPEYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 546
T P + Y PE VL P+ D +S G+I+ LL G P
Sbjct: 221 -----TTPCYTPYYVAPE-----VLGPEKYDKSCDMWSLGVIMYILLCGYPP 262
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 87.7 bits (218), Expect = 6e-19
Identities = 58/217 (26%), Positives = 90/217 (41%), Gaps = 48/217 (22%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNM--QGQLE-FQQEVRVLSKLQHPHLVTLLG 404
+G G FG V K + G A+K+L + Q+E E R+L + P LV L
Sbjct: 49 LGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF 108
Query: 405 ACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 461
+ + +L V EY+ G + L R S AR AA+I +LHS
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSE----PHARFYAAQIVLTFEYLHS---LD 161
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL-------YLPSFHRSTAP-----KG 509
+++ DLKP+N+L+D + ++ DFG + V T L AP KG
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEAL-------APEIILSKG 214
Query: 510 SFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ V D ++ G++I ++ G P
Sbjct: 215 ---------YNKAV-----DWWALGVLIYEMAAGYPP 237
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 87.6 bits (218), Expect = 6e-19
Identities = 60/220 (27%), Positives = 99/220 (45%), Gaps = 49/220 (22%)
Query: 350 VGQGGFGCVY-----KGEMLGRTVAIKML-----YSHNMQGQLEFQQEVRVLSKLQHPHL 399
+GQG FG V+ G + A+K+L + ++ + E +L ++ HP +
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD---RVRTKMERDILVEVNHPFI 88
Query: 400 VTLLGA--CPEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARI-AAEIASGL 451
V L A L+ ++L G L ++ +F + + + AE+A L
Sbjct: 89 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTE---------EDVKFYLAELALAL 139
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 511
LHS I++ DLKP+NILLD E K+ DFG+ + + SF G+
Sbjct: 140 DHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF------CGTV 190
Query: 512 PYADPEYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 546
Y PE V+ + D +SFG+++ ++LTG LP
Sbjct: 191 EYMAPE-----VVNRRGHTQSADWWSFGVLMFEMLTGTLP 225
|
| >2c2l_A CHIP, carboxy terminus of HSP70-interacting protein; chaperone, E3 ligase, ubiquitinylation, TPR, heat-shock protein complex; 3.3A {Mus musculus} SCOP: a.118.8.1 g.44.1.2 Length = 281 | Back alignment and structure |
|---|
Score = 86.5 bits (214), Expect = 8e-19
Identities = 20/72 (27%), Positives = 37/72 (51%)
Query: 614 EERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTP 673
++R +P + I E+M +P + G TY+ K I + L+ +P+T L+ L P
Sbjct: 201 KKRDIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFNPVTRSPLTQEQLIP 260
Query: 674 NHALRHAIQDWL 685
N A++ I ++
Sbjct: 261 NLAMKEVIDAFI 272
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 9e-19
Identities = 47/154 (30%), Positives = 75/154 (48%), Gaps = 26/154 (16%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQ---------EVRVLSKLQHP 397
VG+G +G V K GR VAIK E+++L +L+H
Sbjct: 32 LVGEGSYGMVMKCRNKDTGRIVAIKKF-------LESDDDKMVKKIAMREIKLLKQLRHE 84
Query: 398 HLVTLLGACPE--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLH 455
+LV LL C + W LV+E++ + ++ D L + + L ++ + +I +G+ F H
Sbjct: 85 NLVNLLEVCKKKKRWYLVFEFVDH-TILDDL--ELFPNGLDYQVVQKYLFQIINGIGFCH 141
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
S I+H D+KP+NIL+ K+CDFG R
Sbjct: 142 SHN---IIHRDIKPENILVSQSGVVKLCDFGFAR 172
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 42/154 (27%), Positives = 64/154 (41%), Gaps = 26/154 (16%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQ---------EVRVLSKLQHP 397
K+G+G +G V+K G+ VAIK E+R+L +L+HP
Sbjct: 10 KIGEGSYGVVFKCRNRDTGQIVAIKKF-------LESEDDPVIKKIALREIRMLKQLKHP 62
Query: 398 HLVTLLGACPE--AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLH 455
+LV LL LV+EY + ++ L + I + + F H
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYCDH-TVLHEL--DRYQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
+H D+KP+NIL+ K+CDFG R
Sbjct: 120 KHN---CIHRDVKPENILITKHSVIKLCDFGFAR 150
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 86.4 bits (215), Expect = 1e-18
Identities = 58/219 (26%), Positives = 100/219 (45%), Gaps = 45/219 (20%)
Query: 350 VGQGGFGCVYKGEML-----GRTVAIKMLY-SHNMQGQLEFQQ---EVRVLSKLQHPHLV 400
+G+GG+G V++ + G+ A+K+L + ++ + E +L +++HP +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 401 TLLGA--CPEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARI-AAEIASGLC 452
L+ A L+ EYL G L ++ +F + D A AEI+ L
Sbjct: 85 DLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFME---------DTACFYLAEISMALG 135
Query: 453 FLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP 512
LH + I++ DLKP+NI+L+ + K+ DFG+C+ D +F G+
Sbjct: 136 HLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTF------CGTIE 186
Query: 513 YADPEYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 546
Y PE +L D +S G ++ +LTG P
Sbjct: 187 YMAPE-----ILMRSGHNRAVDWWSLGALMYDMLTGAPP 220
|
| >3m62_A Ubiquitin conjugation factor E4; armadillo-like repeats, UBL conjugation pathway, DNA damage, nucleus, phosphoprotein; HET: 1PE; 2.40A {Saccharomyces cerevisiae} PDB: 3m63_A* 2qiz_A 2qj0_A Length = 968 | Back alignment and structure |
|---|
Score = 89.4 bits (221), Expect = 1e-18
Identities = 22/82 (26%), Positives = 35/82 (42%), Gaps = 2/82 (2%)
Query: 605 KELEQLHVAEERPVPSFFLCPILQEIMHDPQV-AADGFTYEGKAIRDWLENGRETSPMTN 663
++ ++ E VP FL P++ IM DP + A + I+ L + T P
Sbjct: 875 RKADEEEDLEYGDVPDEFLDPLMYTIMKDPVILPASKMNIDRSTIKAHLLSDS-TDPFNR 933
Query: 664 LRLSHLHLTPNHALRHAIQDWL 685
+ L +TPN LR I +
Sbjct: 934 MPLKLEDVTPNEELRQKILCFK 955
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 64/222 (28%), Positives = 97/222 (43%), Gaps = 55/222 (24%)
Query: 350 VGQGGFGCVYKGEM--LGRTVAIKML----------YSHNMQGQLEFQQEVRVLSKLQHP 397
+G+G FG V GR A+K+L +H + E RVL +HP
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT-------ESRVLQNTRHP 65
Query: 398 HLVTLLGA--CPEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARI-AAEIAS 449
L L A + V EY G L ++R+F + +RAR AEI S
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTE---------ERARFYGAEIVS 116
Query: 450 GLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKG 509
L +LHS +V+ D+K +N++LD + KI DFG+C+ D + +F G
Sbjct: 117 ALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC------G 167
Query: 510 SFPYADPEYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 546
+ PEY VL D + G+++ +++ GRLP
Sbjct: 168 T-----PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 204
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 1e-18
Identities = 55/209 (26%), Positives = 88/209 (42%), Gaps = 25/209 (11%)
Query: 350 VGQGGFGCVY--KGEMLGRTVAIKMLYSHNM--QGQLE-FQQEVRVLSKLQHPHLVTLLG 404
+G+G FG V + + + A+K+L M + F +E +++ P +V L
Sbjct: 77 IGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFY 136
Query: 405 A--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHSSKPEK 461
A +V EY+P G L L +V AR AE+ L +HS
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPE----KWARFYTAEVVLALDAIHSMG--- 188
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE---- 517
+H D+KP N+LLD K+ DFG C + ++ + R G+ Y PE
Sbjct: 189 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-----RCDTAVGTPDYISPEVLKS 243
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
G + D +S G+ + ++L G P
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 2e-18
Identities = 59/219 (26%), Positives = 90/219 (41%), Gaps = 38/219 (17%)
Query: 346 ESFKV-GQGGFGCVYKGEML--GRTVAIKMLYSH---NMQGQLEFQQEVRVLSKL---QH 396
++ G+GGFG VY G+ A+K L QG+ E +LS +
Sbjct: 192 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 251
Query: 397 PHLVTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCF 453
P +V + A P+ S + + + G L L + S + R AAEI GL
Sbjct: 252 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFS----EADMRFYAAEIILGLEH 307
Query: 454 LHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY 513
+H+ +V+ DLKP NILLD +I D G+ ++ + + G+ Y
Sbjct: 308 MHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH--AS------VGTHGY 356
Query: 514 ADPEYHRTGVLTPKS------DSYSFGLIILQLLTGRLP 546
PE VL D +S G ++ +LL G P
Sbjct: 357 MAPE-----VLQKGVAYDSSADWFSLGCMLFKLLRGHSP 390
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 84.5 bits (210), Expect = 4e-18
Identities = 46/156 (29%), Positives = 77/156 (49%), Gaps = 29/156 (18%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQ---------EVRVLSKLQHP 397
K+G+G +G VYK G VA+K + +L+ + E+ +L +L HP
Sbjct: 10 KIGEGTYGVVYKARNKLTGEVVALKKI-------RLDTETEGVPSTAIREISLLKELNHP 62
Query: 398 HLVTLLGACPEAWS--LVYEYLPNGSLQD--RLFRKSNVSPLLWKDRARIAAEIASGLCF 453
++V LL LV+E+L QD + S ++ + ++ GL F
Sbjct: 63 NIVKLLDVIHTENKLYLVFEFLH----QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 454 LHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
HS + ++H DLKPQN+L+++E + K+ DFG+ R
Sbjct: 119 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 5e-18
Identities = 42/155 (27%), Positives = 70/155 (45%), Gaps = 24/155 (15%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQ--------EVRVLSKLQHPH 398
K+G G + VYKG G VA+K + +L+ ++ E+ ++ +L+H +
Sbjct: 12 KLGNGTYATVYKGLNKTTGVYVALKEV-------KLDSEEGTPSTAIREISLMKELKHEN 64
Query: 399 LVTLLGACPEAWS--LVYEYLPN--GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFL 454
+V L LV+E++ N D + L ++ GL F
Sbjct: 65 IVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
H +K I+H DLKPQN+L++ K+ DFG+ R
Sbjct: 125 HENK---ILHRDLKPQNLLINKRGQLKLGDFGLAR 156
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 37/149 (24%), Positives = 63/149 (42%), Gaps = 21/149 (14%)
Query: 351 GQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACP 407
G G G V + A+KML ++EV + + Q PH+V ++
Sbjct: 27 GLGINGKVLQIFNKRTQEKFALKMLQDCPK-----ARREVELHWRASQCPHIVRIVDVYE 81
Query: 408 EAWS------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
++ +V E L G L R+ + + ++ + I I + +LHS
Sbjct: 82 NLYAGRKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHS---IN 137
Query: 462 IVHGDLKPQNILLDSELSS---KICDFGI 487
I H D+KP+N+L S+ + K+ DFG
Sbjct: 138 IAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 3e-17
Identities = 43/154 (27%), Positives = 71/154 (46%), Gaps = 27/154 (17%)
Query: 349 KVGQGGFGCVYKG-EMLGRTVAIKMLYSHNMQGQLEFQQ---------EVRVLSKLQHPH 398
K+G+G +G VYK G T A+K + +LE + E+ +L +L+H +
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKI-------RLEKEDEGIPSTTIREISILKELKHSN 61
Query: 399 LVTLLGACPEAWS--LVYEYLPNGSLQD-RLFRKSNVSPLLWKDRARIAAEIASGLCFLH 455
+V L LV+E+L QD + L ++ +G+ + H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH 117
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
+ ++H DLKPQN+L++ E KI DFG+ R
Sbjct: 118 DRR---VLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 5e-17
Identities = 43/154 (27%), Positives = 69/154 (44%), Gaps = 23/154 (14%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQ--------EVRVLSKLQHPH 398
+G+G F VYK + VAIK + + + E + E+++L +L HP+
Sbjct: 17 FLGEGQFATVYKARDKNTNQIVAIKKI---KLGHRSEAKDGINRTALREIKLLQELSHPN 73
Query: 399 LVTLLGACPEAWS--LVYEYLPNGSLQD-RLFRKSNVSPLLWKDRARIAAEIASGLCFLH 455
++ LL A + LV++++ D + K N L GL +LH
Sbjct: 74 IIGLLDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
I+H DLKP N+LLD K+ DFG+ +
Sbjct: 130 QHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 6e-17
Identities = 41/170 (24%), Positives = 73/170 (42%), Gaps = 38/170 (22%)
Query: 346 ESFKVGQGGFGCVYKGEML----GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVT 401
E KVG+G +G VYK + + A+K + + + +E+ +L +L+HP++++
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--MSACREIALLRELKHPNVIS 82
Query: 402 LLGACPEAWS----LVYEYL-------------PNGSLQDRLFRKSNVSPLLWKDRARIA 444
L L+++Y + + + V LL+
Sbjct: 83 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY------- 135
Query: 445 AEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS----KICDFGICRL 490
+I G+ +LH++ ++H DLKP NIL+ E KI D G RL
Sbjct: 136 -QILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 6e-17
Identities = 44/154 (28%), Positives = 77/154 (50%), Gaps = 27/154 (17%)
Query: 349 KVGQGGFGCVYKG-EMLGRTVAIKMLYSHNMQGQLEFQQ---------EVRVLSKLQHPH 398
KVG+G +G VYK + GR VA+K + +L+ + E+ +L +L HP+
Sbjct: 28 KVGEGTYGVVYKAKDSQGRIVALKRI-------RLDAEDEGIPSTAIREISLLKELHHPN 80
Query: 399 LVTLLGACPEAWS--LVYEYLPNGSLQD-RLFRKSNVSPLLWKDRARIAAEIASGLCFLH 455
+V+L+ LV+E++ +D + N + L ++ G+ H
Sbjct: 81 IVSLIDVIHSERCLTLVFEFME----KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCH 136
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
+ I+H DLKPQN+L++S+ + K+ DFG+ R
Sbjct: 137 QHR---ILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 80.6 bits (200), Expect = 7e-17
Identities = 40/155 (25%), Positives = 70/155 (45%), Gaps = 28/155 (18%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQ---------EVRVLSKLQHP 397
K+G+G +G V+K + VA+K + +L+ E+ +L +L+H
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRV-------RLDDDDEGVPSSALREICLLKELKHK 61
Query: 398 HLVTLLGACPEAWS--LVYEYLPNGSLQD-RLFRKSNVSPLLWKDRARIAAEIASGLCFL 454
++V L LV+E+ QD + + S L + ++ GL F
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
HS ++H DLKPQN+L++ K+ +FG+ R
Sbjct: 118 HS---RNVLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 81.5 bits (202), Expect = 9e-17
Identities = 71/229 (31%), Positives = 98/229 (42%), Gaps = 68/229 (29%)
Query: 350 VGQGGFGCVY----KGEMLGRTVAIKML----------YSHNMQGQLEFQQEVRVLSK-L 394
+G+G FG V K E A+K+L H M E VL K +
Sbjct: 46 IGKGSFGKVLLARHKAE--EVFYAVKVLQKKAILKKKEEKHIMS-------ERNVLLKNV 96
Query: 395 QHPHLVTLLGA--CPEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARI-AAE 446
+HP LV L + + V +Y+ G L ++R F + RAR AAE
Sbjct: 97 KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLE---------PRARFYAAE 147
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTA 506
IAS L +LHS IV+ DLKP+NILLDS+ + DFG+C+ E ST
Sbjct: 148 IASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--------STT 196
Query: 507 PKGSF---P-YADPEYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 546
+F P Y PE VL + D + G ++ ++L G P
Sbjct: 197 --STFCGTPEYLAPE-----VLHKQPYDRTVDWWCLGAVLYEMLYGLPP 238
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 1e-16
Identities = 67/221 (30%), Positives = 94/221 (42%), Gaps = 49/221 (22%)
Query: 349 KV-GQGGFGCV----YKGEMLGRTVAIKMLYSHNMQGQLEF---QQEVRVLSK-LQHPHL 399
K+ G+G FG V +K + AIK L + + E RVLS +HP L
Sbjct: 23 KMLGKGSFGKVFLAEFKKT--NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 80
Query: 400 VTLLGA--CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLHS 456
+ E V EYL G L + RA AAEI GL FLHS
Sbjct: 81 THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFD----LSRATFYAAEIILGLQFLHS 136
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICR--LVTEDTLYLPSFHRSTAPKGSF--- 511
+ IV+ DLK NILLD + KI DFG+C+ ++ + +F
Sbjct: 137 ---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN------------TFCGT 181
Query: 512 P-YADPEYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 546
P Y PE +L + D +SFG+++ ++L G+ P
Sbjct: 182 PDYIAPE-----ILLGQKYNHSVDWWSFGVLLYEMLIGQSP 217
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 44/154 (28%), Positives = 74/154 (48%), Gaps = 27/154 (17%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQ--------EVRVLSKLQHPH 398
K+G+G + VYKG+ VA+K + +LE ++ EV +L L+H +
Sbjct: 9 KLGEGTYATVYKGKSKLTDNLVALKEI-------RLEHEEGAPCTAIREVSLLKDLKHAN 61
Query: 399 LVTLLGACPEAWS--LVYEYLPNGSLQD-RLFRKSNVSPLLWKDRARIAAEIASGLCFLH 455
+VTL S LV+EYL +D + + + + + ++ GL + H
Sbjct: 62 IVTLHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCH 117
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
K ++H DLKPQN+L++ K+ DFG+ R
Sbjct: 118 RQK---VLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 3e-16
Identities = 58/222 (26%), Positives = 93/222 (41%), Gaps = 57/222 (25%)
Query: 350 VGQGGFGCVYKG--EMLGRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQH------PH 398
+G+G FG V K + + VA+KM+ + Q E +R+L L+ +
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEE----IRILEHLRKQDKDNTMN 160
Query: 399 LVTLLGA-------CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGL 451
++ +L C + +E L + +L + L +K+ + A I L
Sbjct: 161 VIHMLENFTFRNHIC-----MTFELL-SMNLYE-LIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSS--KICDFG-ICRLVTEDTLYLPS-FHRSTAP 507
LH ++ I+H DLKP+NILL + S K+ DFG C Y+ S F+R+
Sbjct: 214 DALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRA--- 267
Query: 508 KGSFPYADPEYHRTGVL-----TPKSDSYSFGLIILQLLTGR 544
PE V+ D +S G I+ +LLTG
Sbjct: 268 --------PE-----VILGARYGMPIDMWSLGCILAELLTGY 296
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 3e-16
Identities = 63/223 (28%), Positives = 96/223 (43%), Gaps = 55/223 (24%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHP------ 397
+G+G FG V K VAIK++ + Q Q+E VR+L +
Sbjct: 61 LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIE----VRLLELMNKHDTEMKY 116
Query: 398 HLVTLLGA-------CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASG 450
++V L C LV+E L + +L D L R +N + + A ++ +
Sbjct: 117 YIVHLKRHFMFRNHLC-----LVFEML-SYNLYD-LLRNTNFRGVSLNLTRKFAQQMCTA 169
Query: 451 LCFLHSSKPEKIVHGDLKPQNILLDSELSS--KICDFGICRLVTED-TLYLPS-FHRSTA 506
L FL + + I+H DLKP+NILL + S KI DFG + + Y+ S F+RS
Sbjct: 170 LLFLATPEL-SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRS-- 226
Query: 507 PKGSFPYADPEYHRTGVL-----TPKSDSYSFGLIILQLLTGR 544
PE VL D +S G I++++ TG
Sbjct: 227 ---------PE-----VLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 3e-16
Identities = 61/216 (28%), Positives = 94/216 (43%), Gaps = 42/216 (19%)
Query: 350 VGQGGFGCVYKGEM--LGRTVAIKMLYSHNMQGQLEF---QQEVRVLSK-LQHPHLVTLL 403
+G+G FG V E A+K+L + + E RVL+ + P L L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 404 GA--CPEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLH 455
+ V EY+ G L Q F++ A AAEIA GL FL
Sbjct: 88 SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE---------PHAVFYAAEIAIGLFFLQ 138
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 515
S + I++ DLK N++LDSE KI DFG+C+ D + +F G+ Y
Sbjct: 139 S---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC------GTPDYIA 189
Query: 516 PEYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 546
PE ++ + D ++FG+++ ++L G+ P
Sbjct: 190 PE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 220
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-16
Identities = 54/217 (24%), Positives = 91/217 (41%), Gaps = 44/217 (20%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEF---QQEVRVLSK-LQHPHLVTLL 403
+G+G + V + R A+K++ + + Q E V + HP LV L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 76
Query: 404 GAC---PEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARI-AAEIASGLCFL 454
+C V EY+ G L + R + + AR +AEI+ L +L
Sbjct: 77 -SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE---------EHARFYSAEISLALNYL 126
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 514
H I++ DLK N+LLDSE K+ D+G+C+ +F G+ Y
Sbjct: 127 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC------GTPNYI 177
Query: 515 DPEYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 546
PE +L + D ++ G+++ +++ GR P
Sbjct: 178 APE-----ILRGEDYGFSVDWWALGVLMFEMMAGRSP 209
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 4e-16
Identities = 48/191 (25%), Positives = 81/191 (42%), Gaps = 44/191 (23%)
Query: 325 DLPESAEFSLADLQTATCNFSESF----KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNM 378
+ S++ + + + K+G+G +G VYK + TVAIK +
Sbjct: 13 EAQTQGPGSMSVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI----- 67
Query: 379 QGQLEFQQ---------EVRVLSKLQHPHLVTLLGACPEAWS--LVYEYLPN--GSLQDR 425
+LE ++ EV +L +LQH +++ L L++EY N D+
Sbjct: 68 --RLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDK 125
Query: 426 L--FRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS--- 480
+ L+ ++ +G+ F HS + +H DLKPQN+LL +S
Sbjct: 126 NPDVSMRVIKSFLY--------QLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETP 174
Query: 481 --KICDFGICR 489
KI DFG+ R
Sbjct: 175 VLKIGDFGLAR 185
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 5e-16
Identities = 56/223 (25%), Positives = 93/223 (41%), Gaps = 56/223 (25%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEF---QQEVRVLSK-LQHPHLVTLL 403
+G+G + V + R A++++ + + Q E V + HP LV L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 119
Query: 404 GAC---PEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARI-AAEIASGLCFL 454
+C V EY+ G L + R + + AR +AEI+ L +L
Sbjct: 120 -SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPE---------EHARFYSAEISLALNYL 169
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR--LVTEDTLYLPSFHRSTAPKGSF- 511
H I++ DLK N+LLDSE K+ D+G+C+ L DT +F
Sbjct: 170 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTS------------TFC 214
Query: 512 --P-YADPEYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 546
P Y PE +L + D ++ G+++ +++ GR P
Sbjct: 215 GTPNYIAPE-----ILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 5e-16
Identities = 50/153 (32%), Positives = 69/153 (45%), Gaps = 26/153 (16%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEF---QQEVRVLSK-LQHPHLVTLL 403
+G+G FG V + G A+K+L + + E R+LS HP L L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF 90
Query: 404 GAC--PEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARI-AAEIASGLCFLH 455
P+ V E++ G L + R F + RAR AAEI S L FLH
Sbjct: 91 CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDE---------ARARFYAAEIISALMFLH 141
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 488
+ I++ DLK N+LLD E K+ DFG+C
Sbjct: 142 D---KGIIYRDLKLDNVLLDHEGHCKLADFGMC 171
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 6e-16
Identities = 54/226 (23%), Positives = 87/226 (38%), Gaps = 55/226 (24%)
Query: 350 VGQGGFGCVY-----KGEMLGRTVAIKMLYSHNMQGQLEFQQ----EVRVLSKLQH-PHL 399
+G G +G V+ G G+ A+K+L + + + + E +VL ++ P L
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 121
Query: 400 VTLLGA--CPEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARI-AAEIASGL 451
VTL A L+ +Y+ G L Q F + +I EI L
Sbjct: 122 VTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE---------HEVQIYVGEIVLAL 172
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 511
LH I++ D+K +NILLDS + DFG+ + D A F
Sbjct: 173 EHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD-------ETERA--YDF 220
Query: 512 ---P-YADPEYHRTGVLTPKSDSY-------SFGLIILQLLTGRLP 546
Y P+ ++ + S G+++ +LLTG P
Sbjct: 221 CGTIEYMAPD-----IVRGGDSGHDKAVDWWSLGVLMYELLTGASP 261
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 7e-16
Identities = 42/165 (25%), Positives = 74/165 (44%), Gaps = 34/165 (20%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQ-EVRVLSKLQHPHLVTLLGA 405
+G G FG VY+ ++ G VAIK + F+ E++++ KL H ++V L
Sbjct: 61 VIGNGSFGVVYQAKLCDSGELVAIKKVLQDK-----RFKNRELQIMRKLDHCNIVRLRYF 115
Query: 406 CPEAWS--------LVYEYLPNGSLQD-----RLFRKSN--VSPLLWKDRARIAAEIASG 450
+ LV +Y+P + R + ++ + + K ++
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVP----ETVYRVARHYSRAKQTLPVIYVK---LYMYQLFRS 168
Query: 451 LCFLHSSKPEKIVHGDLKPQNILLDSELSS-KICDFGICRLVTED 494
L ++HS I H D+KPQN+LLD + + K+CDFG + +
Sbjct: 169 LAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG 210
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 79.3 bits (195), Expect = 2e-15
Identities = 62/223 (27%), Positives = 93/223 (41%), Gaps = 56/223 (25%)
Query: 350 VGQGGFGCVYKGEM--LGRTVAIKML----------YSHNMQGQLEFQQEVRVLSK-LQH 396
+G+G FG V E A+K+L M E RVL+ +
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMV-------EKRVLALPGKP 401
Query: 397 PHLVTLLGA--CPEAWSLVYEYLPNGSL-----QDRLFRKSNVSPLLWKDRARI-AAEIA 448
P L L + V EY+ G L Q F++ A AAEIA
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKE---------PHAVFYAAEIA 452
Query: 449 SGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPK 508
GL FL S + I++ DLK N++LDSE KI DFG+C+ D + +F
Sbjct: 453 IGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC------ 503
Query: 509 GSFPYADPEYHRTGVLTPKS-----DSYSFGLIILQLLTGRLP 546
G+ Y PE ++ + D ++FG+++ ++L G+ P
Sbjct: 504 GTPDYIAPE-----IIAYQPYGKSVDWWAFGVLLYEMLAGQAP 541
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 49/171 (28%), Positives = 78/171 (45%), Gaps = 30/171 (17%)
Query: 342 CNFSESF----KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-GQLEFQQ----EVRV 390
+ + ++G G +G VYK G VA+K + N G EV +
Sbjct: 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 391 LSKLQ---HPHLVTLLGACPEAWS-------LVYEYLPNGSLQD--RLFRKSNVSPLLWK 438
L +L+ HP++V L+ C + + LV+E++ QD K+ L +
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLPAE 120
Query: 439 DRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
+ + GL FLH++ IVH DLKP+NIL+ S + K+ DFG+ R
Sbjct: 121 TIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 3e-15
Identities = 54/222 (24%), Positives = 89/222 (40%), Gaps = 48/222 (21%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGA- 405
GQG FG V G+ G +VAIK + E Q ++ L+ L HP++V L
Sbjct: 30 MAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPNIVQLQSYF 88
Query: 406 CPEAWS--------LVYEYLPNGSLQD-----RLFRKSN--VSPLLWKDRARIAAEIASG 450
+V EY+P R + + P+L K ++
Sbjct: 89 YTLGERDRRDIYLNVVMEYVP----DTLHRCCRNYYRRQVAPPPILIK---VFLFQLIRS 141
Query: 451 LCFLHSSKPEKIVHGDLKPQNILLDSELSS-KICDFGICRLVTED---TLYLPS-FHRST 505
+ LH + H D+KP N+L++ + K+CDFG + ++ Y+ S ++R
Sbjct: 142 IGCLHLPSV-NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYR-- 198
Query: 506 APK---GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 544
AP+ G+ Y T D +S G I +++ G
Sbjct: 199 APELIFGNQHY-----------TTAVDIWSVGCIFAEMMLGE 229
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 8e-15
Identities = 45/171 (26%), Positives = 79/171 (46%), Gaps = 34/171 (19%)
Query: 342 CNFSESF----KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE-F----QQEVRV 390
C+ + K+GQG FG V+K G+ VA+K + M+ + E F +E+++
Sbjct: 13 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKV---LMENEKEGFPITALREIKI 69
Query: 391 LSKLQHPHLVTLLGACPEAWS----------LVYEYLPNGSLQD--RLFRKSNVSPLLWK 438
L L+H ++V L+ C S LV+++ D L V
Sbjct: 70 LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCE----HDLAGLLSNVLV-KFTLS 124
Query: 439 DRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
+ R+ + +GL ++H +K I+H D+K N+L+ + K+ DFG+ R
Sbjct: 125 EIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR 172
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 2e-14
Identities = 40/156 (25%), Positives = 70/156 (44%), Gaps = 33/156 (21%)
Query: 349 KVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP 407
+G G FG V++ +++ VAIK + +Q + +E++++ ++HP++V L
Sbjct: 47 VIGNGSFGVVFQAKLVESDEVAIKKV----LQDKRFKNRELQIMRIVKHPNVVDLKAFFY 102
Query: 408 EAWS--------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAE--------IASGL 451
LV EY+P + ++R S K + + + L
Sbjct: 103 SNGDKKDEVFLNLVLEYVP----ET-VYR---ASRHYAKLKQTMPMLLIKLYMYQLLRSL 154
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSS-KICDFG 486
++HS I H D+KPQN+LLD K+ DFG
Sbjct: 155 AYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFG 187
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 73.0 bits (180), Expect = 4e-14
Identities = 46/165 (27%), Positives = 77/165 (46%), Gaps = 38/165 (23%)
Query: 349 KVGQGGFGCVYKG---EMLGRTVAIKMLYSHNMQGQLEFQQE------------VRVLSK 393
++G+G +G V+K + GR VA+K + +++ +E +R L
Sbjct: 18 EIGEGAYGKVFKARDLKNGGRFVALKRV-------RVQTGEEGMPLSTIREVAVLRHLET 70
Query: 394 LQHPHLVTLLGACPEAWS-------LVYEYLPNGSLQD--RLFRKSNVSPLLWKDRARIA 444
+HP++V L C + + LV+E++ QD K + + +
Sbjct: 71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTETIKDMM 126
Query: 445 AEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
++ GL FLHS ++VH DLKPQNIL+ S K+ DFG+ R
Sbjct: 127 FQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 4e-14
Identities = 46/194 (23%), Positives = 80/194 (41%), Gaps = 29/194 (14%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEFQQ----EVRVLSKLQHPHLVTL 402
+G G +G V + ++ R VAIK + + L + E+ +L++L H H+V +
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKI--LRVFEDLIDCKRILREIAILNRLNHDHVVKV 117
Query: 403 LG-ACPEAWS------LVYEYLPNGSLQD--RLFRKSNVSPLLWKDRAR-IAAEIASGLC 452
L P+ +V E D +LFR L + + + + G+
Sbjct: 118 LDIVIPKDVEKFDELYVVLEIAD----SDFKKLFRTPVY---LTELHIKTLLYNLLVGVK 170
Query: 453 FLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV-TEDTLYLPSFHRSTAPKGSF 511
++HS+ I+H DLKP N L++ + S K+CDFG+ R V + +
Sbjct: 171 YVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 512 PYADPEYHRTGVLT 525
+ LT
Sbjct: 228 VTFPHTKNLKRQLT 241
|
| >2yu4_A E3 SUMO-protein ligase NSE2; SP-ring domain, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 94 | Back alignment and structure |
|---|
Score = 66.1 bits (161), Expect = 1e-13
Identities = 21/73 (28%), Positives = 32/73 (43%), Gaps = 9/73 (12%)
Query: 622 FLCPILQEIMHDP-QVAADGFTYEGKAIRDWLENGRETS-----PMT---NLRLSHLHLT 672
F CPI +E M P + G TYE AI +E+ ++ P + + L
Sbjct: 8 FTCPITKEEMKKPVKNKVCGHTYEEDAIVRMIESRQKRKKKAYCPQIGCSHTDIRKSDLI 67
Query: 673 PNHALRHAIQDWL 685
+ ALR AI++
Sbjct: 68 QDEALRRAIENHN 80
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 2e-13
Identities = 41/167 (24%), Positives = 61/167 (36%), Gaps = 27/167 (16%)
Query: 349 KVGQGGFGCVYKG-EMLGRTVAIKMLYSHNMQGQLE--FQQ---------EVRVLSKLQH 396
+ G +G V G + G VAIK +++ G+ E+R+L+ H
Sbjct: 29 FISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHH 88
Query: 397 PHLVTLLGA-CPEAWS------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIA 448
P+++ L LV E + L + + + I
Sbjct: 89 PNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI--HDQRIVIS-PQHIQYFMYHIL 144
Query: 449 SGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495
GL LH + +VH DL P NILL ICDF + R T D
Sbjct: 145 LGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADA 188
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 2e-13
Identities = 54/241 (22%), Positives = 93/241 (38%), Gaps = 45/241 (18%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKMLYSHNMQGQLEFQQ----EVRVLSKLQHPHLVTL 402
+G+G +G VY + + VAIK + + M L + E+ +L++L+ +++ L
Sbjct: 33 LIGRGSYGYVYLAYDKNTEKNVAIKKV--NRMFEDLIDCKRILREITILNRLKSDYIIRL 90
Query: 403 LGAC-PEAWS------LVYEYLPNGSLQD--RLFRKSNVSPLLWKDRAR-IAAEIASGLC 452
P+ +V E D +LF+ L ++ + I + G
Sbjct: 91 YDLIIPDDLLKFDELYIVLEIAD----SDLKKLFKTPIF---LTEEHIKTILYNLLLGEN 143
Query: 453 FLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP 512
F+H S I+H DLKP N LL+ + S K+CDFG+ R + + +
Sbjct: 144 FIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPH 200
Query: 513 YADPEYHRTG-VLT-----P----KSDSY-------SFGLIILQLLTGRLPVGLAGEVRR 555
+ + T V+T P ++Y S G I +LL R
Sbjct: 201 NKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRF 260
Query: 556 A 556
Sbjct: 261 P 261
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 5e-13
Identities = 50/231 (21%), Positives = 92/231 (39%), Gaps = 59/231 (25%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQ-------- 395
K+G G F V+ + + VA+K++ + + E +++L ++
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDE----IKLLQRVNDADNTKED 81
Query: 396 ---HPHLVTLL------GACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAE 446
H++ LL G +V+E L +L L +K + +I+ +
Sbjct: 82 SMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLA-LIKKYEHRGIPLIYVKQISKQ 139
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS------KICDFGICRLVTED-TLYLP 499
+ GL ++H + I+H D+KP+N+L++ S KI D G E T +
Sbjct: 140 LLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQ 197
Query: 500 S-FHRSTAPKGSFPYADPEYHRTGVL-----TPKSDSYSFGLIILQLLTGR 544
+ +RS PE VL +D +S +I +L+TG
Sbjct: 198 TREYRS-----------PE-----VLLGAPWGCGADIWSTACLIFELITGD 232
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 5e-13
Identities = 36/150 (24%), Positives = 54/150 (36%), Gaps = 22/150 (14%)
Query: 349 KVGQGGFGCVYKGEMLG-------RTVAIKMLY-SHNMQGQLEFQQEVRVLSKL-QHPHL 399
+G+G FG V + + G RTVA+KML E+++L + H ++
Sbjct: 29 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88
Query: 400 VTLLGAC---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 456
V LLGAC ++ E+ G+L L R G F
Sbjct: 89 VNLLGACTKPGGPLMVIVEFCKFGNLST----------YLRSKRNEFVPYKTKGARFRQG 138
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFG 486
+ DLK + + S SS F
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFV 168
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 36/118 (30%), Positives = 55/118 (46%), Gaps = 14/118 (11%)
Query: 433 SPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 492
L + + ++A G+ FL S K +H DL +NILL + KICDFG+ R +
Sbjct: 188 DFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIY 244
Query: 493 EDTLYLPSFHRSTAPKGSFPY---ADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLP 546
+D Y P A PE V T +SD +SFG+++ ++ + G P
Sbjct: 245 KDPDY-----VRKG-DARLPLKWMA-PETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 295
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 6e-13
Identities = 36/166 (21%), Positives = 70/166 (42%), Gaps = 27/166 (16%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKML-YSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGA 405
+G GG G V+ + VAIK + + + + E++++ +L H ++V +
Sbjct: 18 PLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALR-EIKIIRRLDHDNIVKVFEI 76
Query: 406 -CPEAWSLVYEYLPNGSLQD-------------RLFRKSNVSPLLWKDRAR-IAAEIASG 450
P L + L + + + + AR ++ G
Sbjct: 77 LGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLE----EHARLFMYQLLRG 132
Query: 451 LCFLHSSKPEKIVHGDLKPQNILLDSE-LSSKICDFGICRLVTEDT 495
L ++HS+ ++H DLKP N+ +++E L KI DFG+ R++
Sbjct: 133 LKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHY 175
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 7e-13
Identities = 37/158 (23%), Positives = 74/158 (46%), Gaps = 22/158 (13%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLLGA 405
K+G+G + V++ + V +K+L + + ++E+++L L+ P+++TL
Sbjct: 43 KLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLADI 99
Query: 406 CPEAWS----LVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLHSSKPE 460
+ S LV+E++ N + +L++ L R EI L + HS
Sbjct: 100 VKDPVSRTPALVFEHVNNTDFK-QLYQT------LTDYDIRFYMYEILKALDYCHSMG-- 150
Query: 461 KIVHGDLKPQNILLDSELSS-KICDFGICRLVTEDTLY 497
I+H D+KP N+++D E ++ D+G+ Y
Sbjct: 151 -IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 187
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 50/215 (23%), Positives = 93/215 (43%), Gaps = 44/215 (20%)
Query: 350 VGQGGFGCVYKG--EMLGRTVAIKMLY---SHNMQGQLEFQQEVRVLSKLQHPHLVTLLG 404
+G G G V +L R VAIK L + + ++ E+ ++ + H ++++LL
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLN 128
Query: 405 ACPEAWS--------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLH 455
+ LV E + +L ++ + L +R + ++ G+ LH
Sbjct: 129 VFTPQKTLEEFQDVYLVMELMDA-NLC-QVIQME-----LDHERMSYLLYQMLCGIKHLH 181
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED---TLYLPS-FHRSTAPK--G 509
S+ I+H DLKP NI++ S+ + KI DFG+ R T Y+ + ++R AP+
Sbjct: 182 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR--APEVIL 236
Query: 510 SFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 544
Y D +S G I+ +++ +
Sbjct: 237 GMGY-----------KENVDIWSVGCIMGEMVRHK 260
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 3e-12
Identities = 54/211 (25%), Positives = 86/211 (40%), Gaps = 25/211 (11%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQH-PHLVTLL-- 403
K+G G FG +Y G + G VAIK+ QL E ++ +Q + T+
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHI--ESKIYKMMQGGVGIPTIRWC 73
Query: 404 GACPEAWSLVYEYLPNG-SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
GA + +V E L G SL+D LF + L K +A ++ S + ++HS
Sbjct: 74 GAEGDYNVMVMELL--GPSLED-LFNFCSRKFSL-KTVLLLADQMISRIEYIHSK---NF 126
Query: 463 VHGDLKPQNILLDSELSSK---ICDFGICRLVTEDTLYLPSFHRSTAPKGSFP----YAD 515
+H D+KP N L+ I DFG+ + + + H + YA
Sbjct: 127 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ---HIPYRENKNLTGTARYAS 183
Query: 516 PEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
H + + D S G +++ G LP
Sbjct: 184 INTHLGIEQSRRDDLESLGYVLMYFNLGSLP 214
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 67.2 bits (163), Expect = 3e-12
Identities = 39/250 (15%), Positives = 66/250 (26%), Gaps = 61/250 (24%)
Query: 340 ATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHN--------MQGQLEFQQEVRVL 391
T K+G+G FG V++ VAIK++ + E E+ +
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 392 SKLQ---------HPHLVTLL------GACPEAWSLVYEYLP--NGSLQDRLFRKSNVSP 434
+L + L G+ P +++ GS DR +
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 435 LL--------------------WKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL 474
+ I ++ + L + H DL N+LL
Sbjct: 138 FIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAE--ASLRFEHRDLHWGNVLL 195
Query: 475 DSELSSKICD-----------FGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV 523
K+ G+ V+ L R D + TG
Sbjct: 196 KKTSLKKLHYTLNGKSSTIPSCGLQ--VSIIDYTLSRLERDGIVVFCDVSMDEDL-FTGD 252
Query: 524 LTPKSDSYSF 533
+ D Y
Sbjct: 253 GDYQFDIYRL 262
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 4e-12
Identities = 49/236 (20%), Positives = 85/236 (36%), Gaps = 55/236 (23%)
Query: 349 KVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHP---- 397
+GQGGFGC+Y +M +K+ S N G L E++ + P
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN--GPLFT--ELKFYQRAAKPEQIQ 97
Query: 398 -----HLVTLLGACPEAWS------------LVYEYLPNG-SLQDRLFRKSNVSPLLWKD 439
+ LG S ++ + G LQ ++ + K
Sbjct: 98 KWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF--GSDLQK-IYEANA-KRFSRKT 153
Query: 440 RARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKI--CDFGICRLVTEDTLY 497
+++ I L ++H + VHGD+K N+LL+ + ++ D+G+ Y
Sbjct: 154 VLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY------RY 204
Query: 498 LPS---FHRSTAPKGSFP----YADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
P + PK + + H + + D G ++Q LTG LP
Sbjct: 205 CPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 51/215 (23%), Positives = 93/215 (43%), Gaps = 44/215 (20%)
Query: 350 VGQGGFGCVYKG--EMLGRTVAIKML---YSHNMQGQLEFQQEVRVLSKLQHPHLVTLLG 404
+G G G V +L R VAIK L + + + ++ E+ ++ + H +++ LL
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLN 91
Query: 405 ACPEAWS--------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLH 455
S +V E + +L ++ + L +R + ++ G+ LH
Sbjct: 92 VFTPQKSLEEFQDVYIVMELMDA-NLC-QVIQME-----LDHERMSYLLYQMLCGIKHLH 144
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED---TLYLPS-FHRSTAPK--G 509
S+ I+H DLKP NI++ S+ + KI DFG+ R T Y+ + ++R AP+
Sbjct: 145 SAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYR--APEVIL 199
Query: 510 SFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 544
Y D +S G I+ +++ G
Sbjct: 200 GMGY-----------KENVDIWSVGCIMGEMIKGG 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 6e-12
Identities = 54/218 (24%), Positives = 93/218 (42%), Gaps = 49/218 (22%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKML---YSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
VG G +G V + G VAIK L + + + ++ E+ +L +QH +++ LL
Sbjct: 31 HVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLL 89
Query: 404 GACPEAWS--------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFL 454
A S LV ++ LQ + S ++ + + ++ GL ++
Sbjct: 90 DVFTPASSLRNFYDFYLVMPFMQT-DLQKIM--GLKFSE----EKIQYLVYQMLKGLKYI 142
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED-TLYLPSFHRST----APK- 508
HS+ +VH DLKP N+ ++ + KI DFG+ R + T Y+ T AP+
Sbjct: 143 HSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYV-----VTRWYRAPEV 194
Query: 509 --GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 544
Y D +S G I+ ++LTG+
Sbjct: 195 ILSWMHY-----------NQTVDIWSVGCIMAEMLTGK 221
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 9e-12
Identities = 52/251 (20%), Positives = 99/251 (39%), Gaps = 80/251 (31%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQ-EVRVLSKLQHPHLVTLL-- 403
+G G FG V + + G+ A+K + ++ E+ ++ L H +++ L+
Sbjct: 14 TLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLDHVNIIKLVDY 68
Query: 404 --------------------------------GACPEAWS------LVYEYLPNGSLQD- 424
+ S ++ EY+P+ +L
Sbjct: 69 FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKV 127
Query: 425 -RLFRKSN--VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS- 480
+ F +S + L ++ + F+HS I H D+KPQN+L++S+ ++
Sbjct: 128 LKSFIRSGRSIPMNLIS---IYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTL 181
Query: 481 KICDFGICRLVTED---TLYLPS-FHRSTAPK---GSFPYADPEYHRTGVLTPKSDSYSF 533
K+CDFG + + Y+ S F+R AP+ G+ Y TP D +S
Sbjct: 182 KLCDFGSAKKLIPSEPSVAYICSRFYR--APELMLGATEY-----------TPSIDLWSI 228
Query: 534 GLIILQLLTGR 544
G + +L+ G+
Sbjct: 229 GCVFGELILGK 239
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 45/190 (23%), Positives = 85/190 (44%), Gaps = 30/190 (15%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKMLY---SHNMQGQLEFQQEVRVLSKLQ-HPHLVTL 402
K+G+G +G V+K G VA+K ++ ++ Q F+ E+ +L++L H ++V L
Sbjct: 16 KLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNL 74
Query: 403 LGAC-PEAWS---LVYEYLPNGSLQD--RLFRKSNVSPLLWKDRAR-IAAEIASGLCFLH 455
L + LV++Y+ D + R + +L + + ++ + +LH
Sbjct: 75 LNVLRADNDRDVYLVFDYME----TDLHAVIR----ANILEPVHKQYVVYQLIKVIKYLH 126
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 515
S ++H D+KP NILL++E K+ DFG+ R + + P +
Sbjct: 127 SGG---LLHRDMKPSNILLNAECHVKVADFGLSR-----SFVNIRRVTNNIPLSINENTE 178
Query: 516 PEYHRTGVLT 525
+LT
Sbjct: 179 NFDDDQPILT 188
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 44/228 (19%), Positives = 83/228 (36%), Gaps = 42/228 (18%)
Query: 349 KVGQGGFGCVYKGEML--GRTVA---IKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
K+G GGFG +Y A +K+ Y N G L E++ ++ +
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN--GPLFS--ELKFYQRVAKKDCIKKW 99
Query: 404 GACPEA---------WS------------LVYEYLPNG-SLQDRLFRKSNVSPLLWKDRA 441
+ S +V E L G LQ + ++
Sbjct: 100 IERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL--GIDLQK-ISGQNGTFKK--STVL 154
Query: 442 RIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKI--CDFGICRLVTEDTLYLP 499
++ + L ++H ++ VHGD+K N+LL + ++ D+G+ + +
Sbjct: 155 QLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQ 211
Query: 500 SFHRSTAP-KGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
G+ + + H+ L+ +SD G +L+ L G+LP
Sbjct: 212 YQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 3e-11
Identities = 44/226 (19%), Positives = 77/226 (34%), Gaps = 35/226 (15%)
Query: 349 KVGQGGFGCVYKGEML----------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPH 398
+ G +Y+ + ++K L + + + E R LQ
Sbjct: 49 FQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVNK 107
Query: 399 LVTLLGACPEA-----WS---------LVYEYLPNG-SLQDRLFRKSNVSPLLWKDRARI 443
L A LV L G SLQ S L + ++
Sbjct: 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQS-ALDVSPKHVLSERSVLQV 164
Query: 444 AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKI--CDFGICRLVTEDTLYLP-S 500
A + L FLH ++ VHG++ +NI +D E S++ +G ++
Sbjct: 165 ACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYV 221
Query: 501 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ +G + + H+ + +SD S G +L+ L G LP
Sbjct: 222 EGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLP 267
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 39/160 (24%), Positives = 73/160 (45%), Gaps = 26/160 (16%)
Query: 350 VGQGGFGCVYKG--EMLGRTVAIKML--YSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGA 405
+G+G +G V + VAIK + + H Q + E+++L + +H +++ +
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLR-EIKILLRFRHENIIGINDI 93
Query: 406 -CPEAWS------LVYEYLPNGSLQD--RLFRKSNVSPLLWKDRAR-IAAEIASGLCFLH 455
+V + + D +L + ++S D +I GL ++H
Sbjct: 94 IRAPTIEQMKDVYIVQDLME----TDLYKLLKTQHLSN----DHICYFLYQILRGLKYIH 145
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495
S+ ++H DLKP N+LL++ KICDFG+ R+ D
Sbjct: 146 SAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 182
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 6e-11
Identities = 47/226 (20%), Positives = 89/226 (39%), Gaps = 53/226 (23%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKML--YSHNMQGQLEFQQEVRVLSKLQHPHLVTLLG 404
+G+G +G V + G VAIK + + + + E+++L +H +++T+
Sbjct: 18 LLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR-EIKILKHFKHENIITIFN 76
Query: 405 A-CPEAWS------LVYEYLPNGSLQD--RLFRKSNVSPLLWKDRAR-IAAEIASGLCFL 454
P+++ ++ E + D R+ + +L D + + + L
Sbjct: 77 IQRPDSFENFNEVYIIQELMQ----TDLHRVIS----TQMLSDDHIQYFIYQTLRAVKVL 128
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST--------- 505
H S ++H DLKP N+L++S K+CDFG+ R++ E
Sbjct: 129 HGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185
Query: 506 ----APK---GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 544
AP+ S Y + D +S G I+ +L R
Sbjct: 186 RWYRAPEVMLTSAKY-----------SRAMDVWSCGCILAELFLRR 220
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 6e-11
Identities = 46/239 (19%), Positives = 82/239 (34%), Gaps = 73/239 (30%)
Query: 349 KVGQGGFGCVYK---GEMLGRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHP----- 397
+G+G FG V + VA+K++ + +LE + VL K++
Sbjct: 26 NLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLE----INVLKKIKEKDKENK 81
Query: 398 -HLVTLLGA-------CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIAS 449
V + C + +E L + + +++N P +A ++
Sbjct: 82 FLCVLMSDWFNFHGHMC-----IAFELL-GKNTFE-FLKENNFQPYPLPHVRHMAYQLCH 134
Query: 450 GLCFLHSSKPEKIVHGDLKPQNILLDSELSS-------------------KICDFGICRL 490
L FLH ++ + H DLKP+NIL + ++ DFG
Sbjct: 135 ALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF 191
Query: 491 VTED-TLYLPS-FHRSTAPKGSFPYADPEYHRTGVL----TPKSDSYSFGLIILQLLTG 543
E T + + +R PE +L D +S G I+ + G
Sbjct: 192 DHEHHTTIVATRHYRP-----------PE----VILELGWAQPCDVWSIGCILFEYYRG 235
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 8e-11
Identities = 52/244 (21%), Positives = 88/244 (36%), Gaps = 79/244 (32%)
Query: 349 KVGQGGFGCVYKG--EMLGRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQH-----PH 398
K+G G FG V + A+K++ + ++E +L K+Q+ +
Sbjct: 42 KMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIE----ADILKKIQNDDINNNN 97
Query: 399 LVTLLGA-------CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGL 451
+V G C L++E L SL + + ++N + +D EI L
Sbjct: 98 IVKYHGKFMYYDHMC-----LIFEPL-GPSLYE-IITRNNYNGFHIEDIKLYCIEILKAL 150
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSS-------------------------KICDFG 486
+L + H DLKP+NILLD K+ DFG
Sbjct: 151 NYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG 207
Query: 487 ICRLVTED-TLYLPS-FHRSTAPKGSFPYADPEYHRTGVL-----TPKSDSYSFGLIILQ 539
++ + + +R+ PE V+ SD +SFG ++ +
Sbjct: 208 CATFKSDYHGSIINTRQYRA-----------PE-----VILNLGWDVSSDMWSFGCVLAE 251
Query: 540 LLTG 543
L TG
Sbjct: 252 LYTG 255
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 57/217 (26%), Positives = 94/217 (43%), Gaps = 48/217 (22%)
Query: 350 VGQGGFGCVYK--GEMLGRTVAIKML---YSHNMQGQLEFQQEVRVLSKLQHPHLVTLLG 404
VG G +G V G VA+K L + + + ++ E+R+L ++H +++ LL
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLD 95
Query: 405 ACPEAWS--------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRAR-IAAEIASGLCFLH 455
A S LV + L + + K L D + + +I GL ++H
Sbjct: 96 VFTPARSLEEFNDVYLVTHLMGA-DLNNIV--KCQK---LTDDHVQFLIYQILRGLKYIH 149
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED-TLYLPSFHRST----APK-- 508
S+ I+H DLKP N+ ++ + KI DFG+ R ++ T Y+ +T AP+
Sbjct: 150 SAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYV-----ATRWYRAPEIM 201
Query: 509 -GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 544
Y D +S G I+ +LLTGR
Sbjct: 202 LNWMHY-----------NQTVDIWSVGCIMAELLTGR 227
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 50/216 (23%), Positives = 89/216 (41%), Gaps = 46/216 (21%)
Query: 350 VGQGGFGCVYKG--EMLGRTVAIKML---YSHNMQGQLEFQQEVRVLSKLQHPHLVTLLG 404
VG G +G V G VAIK L + + + ++ E+R+L ++H +++ LL
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRHENVIGLLD 91
Query: 405 ACPEAWS--------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 456
+ LV ++ L + L + ++ GL ++H+
Sbjct: 92 VFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA 146
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED-TLYLPSFHRST----APK--- 508
+ I+H DLKP N+ ++ + KI DFG+ R + T Y+ T AP+
Sbjct: 147 AG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYV-----VTRWYRAPEVIL 198
Query: 509 GSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR 544
Y T D +S G I+ +++TG+
Sbjct: 199 NWMRY-----------TQTVDIWSVGCIMAEMITGK 223
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 52/239 (21%), Positives = 89/239 (37%), Gaps = 73/239 (30%)
Query: 349 KVGQGGFGCVYKG---EMLGRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHP----- 397
+G+G FG V + + GR VA+K++ + + + E ++VL L
Sbjct: 21 TLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSE----IQVLEHLNTTDPNST 76
Query: 398 -HLVTLLGA-------CPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIAS 449
V +L C +V+E L S D +++ P ++A +I
Sbjct: 77 FRCVQMLEWFEHHGHIC-----IVFELL-GLSTYD-FIKENGFLPFRLDHIRKMAYQICK 129
Query: 450 GLCFLHSSKPEKIVHGDLKPQNILLDSELSS-------------------KICDFGICRL 490
+ FLHS K+ H DLKP+NIL + K+ DFG
Sbjct: 130 SVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY 186
Query: 491 VTED-TLYLPS-FHRSTAPKGSFPYADPEYHRTGVL----TPKSDSYSFGLIILQLLTG 543
E + + + +R+ PE +L + D +S G I+++ G
Sbjct: 187 DDEHHSTLVSTRHYRA-----------PE----VILALGWSQPCDVWSIGCILIEYYLG 230
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 2e-10
Identities = 53/211 (25%), Positives = 87/211 (41%), Gaps = 25/211 (11%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLL-- 403
K+G G FG +Y G VAIK+ QL + E ++ LQ + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLY--ESKIYRILQGGTGIPNVRWF 71
Query: 404 GACPEAWSLVYEYLPNG-SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
G + LV + L G SL+D LF + L K +A ++ + + F+HS +
Sbjct: 72 GVEGDYNVLVMDLL--GPSLED-LFNFCSRKLSL-KTVLMLADQMINRVEFVHS---KSF 124
Query: 463 VHGDLKPQNILLDSELSSK---ICDFGICRLVTEDTLYLPSFHRSTAPKGSFP----YAD 515
+H D+KP N L+ + I DFG+ + + + + H + YA
Sbjct: 125 LHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQ---HIPYRENKNLTGTARYAS 181
Query: 516 PEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
H + + D S G +++ L G LP
Sbjct: 182 VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 62.9 bits (152), Expect = 2e-10
Identities = 99/616 (16%), Positives = 190/616 (30%), Gaps = 209/616 (33%)
Query: 207 FESAYAREMHL--RKEAEDALQTTIQDQEKLKQEKAFVTQELHRTMRNVALLNSRAQEAN 264
FE+ E + + + F +++ +++ L
Sbjct: 9 FETG---EHQYQYKDILSVFEDAFVDN---------FDCKDVQDMPKSI-LSKEEIDHII 55
Query: 265 RRRDEATGELKLIQASIATLQQEKQRIRRQKVEAV-----RWL-ERWRSRGQAGAANYDG 318
+D +G L+L TL +++ + ++ VE V ++L ++ + +
Sbjct: 56 MSKDAVSGTLRLFW----TLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRM 111
Query: 319 FIGLVEDLPESAE-FS---------LADLQTATCNFSESFKVG-QGGFGCVYKGEMLGRT 367
+I + L + F+ L+ A + V G G G+T
Sbjct: 112 YIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGS-------GKT 164
Query: 368 V-AIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC--PEA-----WSLVYEYLPN 419
A+ + S+ +Q +++F+ + + L C PE L+Y+ PN
Sbjct: 165 WVALDVCLSYKVQCKMDFK----I-------FWLNL-KNCNSPETVLEMLQKLLYQIDPN 212
Query: 420 GSLQDRLFRKSNVSPLL--WKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSE 477
R SN+ + + R L SKP + L ++L +
Sbjct: 213 --WTSRSDHSSNIKLRIHSIQAELRR----------LLKSKPYENC---L----LVLLNV 253
Query: 478 LSSKICD-FGI-CR-LVT----EDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDS 530
++K + F + C+ L+T + T +L + + H + LTP
Sbjct: 254 QNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHISLD---------HHSMTLTP---D 301
Query: 531 YSFGLI--ILQLLTGRLP----------VGLAGE-VR---------RAVSCGKLSSI--- 565
L+ L LP + + E +R + V+C KL++I
Sbjct: 302 EVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIES 361
Query: 566 -LDPLAGDWPTFVARRLVDLG------------LQCCELYGRERPDITPSLVKELEQLHV 612
L+ L P + L L ++ +V +L + +
Sbjct: 362 SLNVLE---PAEYRKMFDRLSVFPPSAHIPTILL--SLIWFDVIKSDVMVVVNKLHKYSL 416
Query: 613 AEERP------VPSFFL---CPILQEI-MHD-----------------PQVAADG--FTY 643
E++P +PS +L + E +H D +++
Sbjct: 417 VEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSH 476
Query: 644 EG---KAIR---------------DWLENG-RETSPMTNLRLSHL-----------HLTP 673
G K I +LE R S N S L ++
Sbjct: 477 IGHHLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFYKPYICD 536
Query: 674 NHALRH----AIQDWL 685
N AI D+L
Sbjct: 537 NDPKYERLVNAILDFL 552
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 55.6 bits (133), Expect = 5e-08
Identities = 63/430 (14%), Positives = 119/430 (27%), Gaps = 131/430 (30%)
Query: 3 IHGIQKLVMGAFPDNCMKVKMGSRK---ASYAAKNAP----MFCEIWFVNKGK------- 48
I G + GS K A + M +I+++N
Sbjct: 155 IDG-----VL-----------GSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETV 198
Query: 49 ------------HVWTKEASESPNSFLPFCGAETRSAKMLRSRSLENCNGTSLFNPESIL 96
WT + S N L + ++L+S+ ENC L +L
Sbjct: 199 LEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENC----LL----VL 250
Query: 97 SRSATTLTHVGITDWVQSDPVHMVFPSSPTISCSDMNLFSPRSSS----AGSGYMSEKRE 152
VQ+ F +SC L + R + +
Sbjct: 251 -------------LNVQNAKAWNAF----NLSCK--ILLTTRFKQVTDFLSAATTTHISL 291
Query: 153 STDSDSKVEEDPLYVQHREVSIKAEELRNSA----------FAEFLRR--------KKLE 194
S + ++ + + + + ++L AE +R K +
Sbjct: 292 DHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVN 351
Query: 195 SEAMEAIGK--VKAFESAYAREMH-----LRKEA---EDALQTTIQDQEKLKQEKAFVTQ 244
+ + I + + E A R+M A L + + +K + V
Sbjct: 352 CDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLS--LIWFDVIKSDVMVVVN 409
Query: 245 ELHRTMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQKVEAVRWLER 304
+LH+ +L+ ++ E+T + I + + + + R V+ +
Sbjct: 410 KLHKY----SLVE-------KQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKT 458
Query: 305 WRSRGQAGAANYDG----FIG----LVEDLPESAEFS--LADLQTATCNFSESFKVGQGG 354
+ S D IG +E F D F E K+
Sbjct: 459 FDSDD-LIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDF-----RFLEQ-KIRHDS 511
Query: 355 FGCVYKGEML 364
G +L
Sbjct: 512 TAWNASGSIL 521
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 60.1 bits (146), Expect = 6e-10
Identities = 49/217 (22%), Positives = 83/217 (38%), Gaps = 35/217 (16%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQH----PHLVTL 402
++G+G FG +++G + + VAIK + QL E R L P++
Sbjct: 17 RIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRD--EYRTYKLLAGCTGIPNVYY- 73
Query: 403 LGACPEAWSLVYEYLPNG-SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
G LV + L G SL+D L + K A A ++ + + +H +
Sbjct: 74 FGQEGLHNVLVIDLL--GPSLED-LLDLCGRKFSV-KTVAMAAKQMLARVQSIHE---KS 126
Query: 462 IVHGDLKPQNILLDSELSSK-----ICDFGICRLVTEDTLYLPSFHRSTAPK-------G 509
+V+ D+KP N L+ S + DFG+ + Y + P G
Sbjct: 127 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK------FYRDPVTKQHIPYREKKNLSG 180
Query: 510 SFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ Y H + + D + G + + L G LP
Sbjct: 181 TARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLP 217
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 3e-09
Identities = 54/217 (24%), Positives = 88/217 (40%), Gaps = 35/217 (16%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQH----PHLVTL 402
K+G G FG + G+ L VAIK+ + QL E R +L P +
Sbjct: 16 KIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHL--EYRFYKQLGSGDGIPQVYYF 73
Query: 403 LGACPEAWSLVYEYLPNG-SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
G C + ++V E L G SL+D LF + + L K IA ++ S + ++HS +
Sbjct: 74 -GPCGKYNAMVLELL--GPSLED-LFDLCDRTFSL-KTVLMIAIQLISRMEYVHS---KN 125
Query: 462 IVHGDLKPQNILLDSELSSK-----ICDFGICRLVTEDTLYLPSF---HRSTAPKGSFP- 512
+++ D+KP+N L+ + I DF + + Y+ H S
Sbjct: 126 LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK------EYIDPETKKHIPYREHKSLTG 179
Query: 513 ---YADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
Y H + + D + G + + L G LP
Sbjct: 180 TARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLP 216
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 40/151 (26%), Positives = 63/151 (41%), Gaps = 33/151 (21%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-----HP---H 398
K+G G F V+ + VA+K++ S + E+R+L ++ P
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETA-LDEIRLLKSVRNSDPNDPNREM 102
Query: 399 LVTLLGA-----------CPEAWSLVYEYLPNG-SLQDRLFRKSNVSPLLWKDRARIAAE 446
+V LL C +V+E L G L KSN L +I +
Sbjct: 103 VVQLLDDFKISGVNGTHIC-----MVFEVL--GHHLLK-WIIKSNYQGLPLPCVKKIIQQ 154
Query: 447 IASGLCFLHSSKPEKIVHGDLKPQNILLDSE 477
+ GL +LH+ +I+H D+KP+NILL
Sbjct: 155 VLQGLDYLHTKC--RIIHTDIKPENILLSVN 183
|
| >2bay_A PRE-mRNA splicing factor PRP19; U-BOX, ubiquitin ligase, E3 ligase; 1.50A {Saccharomyces cerevisiae} SCOP: g.44.1.2 PDB: 1n87_A Length = 61 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 2e-06
Identities = 11/55 (20%), Positives = 23/55 (41%), Gaps = 2/55 (3%)
Query: 620 SFFLCPILQEIMHDPQVA-ADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTP 673
S LC I ++ P ++ +E + ++++ P+TN LS +
Sbjct: 2 SHMLCAISGKVPRRPVLSPKSRTIFEKSLLEQYVKD-TGNDPITNEPLSIEEIVE 55
|
| >1i84_S Smooth muscle myosin heavy chain; muscle protein, myosin subfragment 2, heavy meromyosin, essential light chain, motor protein; HET: MLY; 20.00A {Gallus gallus} SCOP: i.15.1.1 PDB: 3j04_A 3dtp_B 3dtp_A Length = 1184 | Back alignment and structure |
|---|
Score = 47.9 bits (114), Expect = 1e-05
Identities = 30/148 (20%), Positives = 54/148 (36%), Gaps = 14/148 (9%)
Query: 175 KAEELRNSAFAEFLRRKKLESEAMEAIGKVKAFESAYA----------REMHLRKEAEDA 224
+ +L E R+KL+ E + A GK+K E +E L +E
Sbjct: 956 QMLDLEEQLEEEEAARQKLQLEKVTADGKIKKMEDDILIMEDQNNKLTKERKLLEERVSD 1015
Query: 225 LQTTIQDQE----KLKQEKAFVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLIQAS 280
L T + ++E L + K + + QE + + + GE +
Sbjct: 1016 LTTNLAEEEEKAKNLTKLKNKHESMISELEVRLKKEEKSRQELEKIKRKLEGESSDLHEQ 1075
Query: 281 IATLQQEKQRIRRQKVEAVRWLERWRSR 308
IA LQ + ++ Q + L+ +R
Sbjct: 1076 IAELQAQIAELKAQLAKKEEELQAALAR 1103
|
| >3htk_C E3 SUMO-protein ligase MMS21; SUMO E3 ligase, SPL-ring, ring, ATP-binding, chromosomal protein, coiled coil, DNA damage; 2.31A {Saccharomyces cerevisiae} Length = 267 | Back alignment and structure |
|---|
Score = 44.6 bits (104), Expect = 5e-05
Identities = 8/67 (11%), Positives = 22/67 (32%), Gaps = 4/67 (5%)
Query: 622 FLCPILQEIMHDPQVAAD-GFTYEGKAIRDWLENGRETS-PMT--NLRLSHLHLTPNHAL 677
CPI + P ++ ++ I+++L+ P + +S + +
Sbjct: 182 LTCPITCKPYEAPLISRKCNHVFDRDGIQNYLQGYTTRDCPQAACSQVVSMRDFVRDPIM 241
Query: 678 RHAIQDW 684
+
Sbjct: 242 ELRCKIA 248
|
| >1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284 | Back alignment and structure |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 22/124 (17%), Positives = 46/124 (37%), Gaps = 7/124 (5%)
Query: 175 KAEELRNSAFAEFLRRKKLESEAMEAIGKVKAFESAYAREMHLRKEAEDALQTTIQDQEK 234
+A+E A R K+LE E + K+KA E + +AL+ + E
Sbjct: 21 RADEAEADKKAAEDRSKQLEDELVSLQKKLKATEDE-------LDKYSEALKDAQEKLEL 73
Query: 235 LKQEKAFVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLIQASIATLQQEKQRIRRQ 294
+++ ++ R + L A R A +L+ + + ++ + I +
Sbjct: 74 AEKKATDAEADVASLNRRIQLFEEELDRAQERLATALQKLEEAEKAADESERGMKVIESR 133
Query: 295 KVEA 298
+
Sbjct: 134 AQKD 137
|
| >1c1g_A Tropomyosin; contractIle protein; 7.00A {Sus scrofa} SCOP: h.1.5.1 PDB: 2tma_A 2w49_A 2w4u_A Length = 284 | Back alignment and structure |
|---|
Score = 41.2 bits (96), Expect = 6e-04
Identities = 24/134 (17%), Positives = 48/134 (35%), Gaps = 7/134 (5%)
Query: 161 EEDPLYVQHREVSIKAEELRNSAFAEFLRRKKLESEAMEAIGKVKAFESAYAREMHLRKE 220
E D + K EE +A K +ES A + K++ E H+ ++
Sbjct: 98 ELDRAQERLATALQKLEEAEKAADESERGMKVIESRAQKDEEKMEIQEIQLKEAKHIAED 157
Query: 221 AEDALQTTIQDQEKLKQEKAFVTQELHRTMRNVALLNSRAQEANRRRDEATGELKLIQAS 280
A+ + E++ ++ + +L R L + E T LK ++A
Sbjct: 158 AD-------RKYEEVARKLVIIESDLERAEERAELSEGKCAELEEEIKTVTNNLKSLEAQ 210
Query: 281 IATLQQEKQRIRRQ 294
Q++ + +
Sbjct: 211 AEKYSQKEDKYEEE 224
|
| >2dfs_A Myosin-5A; myosin-V, inhibited state, cryoelectron tomograp contractIle protein-transport protein complex; 24.00A {Gallus gallus} Length = 1080 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 5e-04
Identities = 19/171 (11%), Positives = 53/171 (30%), Gaps = 18/171 (10%)
Query: 149 EKRESTDSDSKVEEDPLYVQHREVSIKAEELRNSAFAEFLRRKKLESEAMEAIGKVKAFE 208
K+ ++K+ + + I + + E + LE K+++
Sbjct: 919 YKKLHIGLENKIMQ-------LQRKIDEQNKEYKSLLE--KMNNLEITYSTETEKLRSDV 969
Query: 209 SAYAREM-------HLRKEAEDALQTTIQDQEKLKQEKAFVTQELHRTMRNVALLNSRAQ 261
+ ++ + ++ + + EK + + + L S +
Sbjct: 970 ERLRMSEEEAKNATNRVLSLQEEIAKLRKELHQTQTEKKTIEEWADKYKHETEQLVSELK 1029
Query: 262 EANRRRDEATGEL--KLIQASIATLQQEKQRIRRQKVEAVRWLERWRSRGQ 310
E N EL ++ + + ++++ + + L R R Q
Sbjct: 1030 EQNTLLKTEKEELNRRIHDQAKEITETMEKKLVEETKQLELDLNDERLRYQ 1080
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 688 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-63 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-56 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 9e-56 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-55 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 8e-55 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-54 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-54 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-53 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-53 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-53 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-53 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-52 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-52 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-51 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-51 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-50 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-50 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-49 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-49 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 8e-49 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-48 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-48 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-48 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-48 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-48 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-47 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 4e-47 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-47 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-46 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 1e-46 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-46 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-45 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-44 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-43 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 4e-43 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-42 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-41 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 4e-41 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 4e-40 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-40 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-38 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-38 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-38 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-35 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-35 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-35 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 4e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-35 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-34 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-33 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-33 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 7e-32 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 6e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-29 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 6e-29 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 7e-29 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-25 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-19 | |
| d1t1ha_ | 78 | g.44.1.2 (A:) E3 ubiquitin ligase PUB14 {Thale-cre | 9e-19 | |
| d2c2la2 | 80 | g.44.1.2 (A:225-304) STIP1 homology and U box-cont | 1e-14 | |
| d1wgma_ | 98 | g.44.1.2 (A:) Ubiquitin conjugation factor E4A {Hu | 3e-11 | |
| d1jm7a_ | 103 | g.44.1.1 (A:) brca1 RING domain {Human (Homo sapie | 2e-06 | |
| d2es4d1 | 280 | a.137.15.1 (D:53-332) Lipase chaperone LifO (LipB) | 0.004 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 1e-63
Identities = 75/271 (27%), Positives = 123/271 (45%), Gaps = 24/271 (8%)
Query: 349 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
++G G FG VYKG+ VA+KML Q F+ EV VL K +H +++ +G
Sbjct: 15 RIGSGSFGTVYKGK-WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 407 PEAW-SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 465
++V ++ SL L IA + A G+ +LH + I+H
Sbjct: 74 TAPQLAIVTQWCEGSSLYHHLHIIET--KFEMIKLIDIARQTAQGMDYLH---AKSIIHR 128
Query: 466 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT---G 522
DLK NI L +L+ KI DFG+ + + + H+ GS + PE R
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS----HQFEQLSGSILWMAPEVIRMQDKN 184
Query: 523 VLTPKSDSYSFGLIILQLLTGRLP---VGLAGEVRRAVSCGKLSSILDPLAGDWPTFVAR 579
+ +SD Y+FG+++ +L+TG+LP + ++ V G LS L + + P +
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP----K 240
Query: 580 RLVDLGLQCCELYGRERPDITPSLVKELEQL 610
+ L +C + ERP ++ +E L
Sbjct: 241 AMKRLMAECLKKKRDERPLFP-QILASIELL 270
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 2e-56
Identities = 74/269 (27%), Positives = 111/269 (41%), Gaps = 18/269 (6%)
Query: 349 KVGQGGFGCVYKGEM-LGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC- 406
++G G FG V+ G VA+K L +M F E ++ +LQH LV L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD-AFLAEANLMKQLQHQRLVRLYAVVT 78
Query: 407 PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGD 466
E ++ EY+ NGSL D L S + L +AA+IA G+ F+ +H D
Sbjct: 79 QEPIYIITEYMENGSLVDFLKTPSGI-KLTINKLLDMAAQIAEGMAFIEE---RNYIHRD 134
Query: 467 LKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTP 526
L+ NIL+ LS KI DFG+ RL+ ++ + K + PE G T
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNE-----YTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 527 KSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGL 586
KSD +SFG+++ +++T + ++ P L L
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEV-----IQNLERGYRMVRPDNCPEELYQLMR 244
Query: 587 QCCELYGRERPDITPSLVKELEQLHVAEE 615
C + +RP L LE A E
Sbjct: 245 LCWKERPEDRPTFD-YLRSVLEDFFTATE 272
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 9e-56
Identities = 62/265 (23%), Positives = 109/265 (41%), Gaps = 24/265 (9%)
Query: 349 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE 408
+G+G FG V G+ G VA+K + N F E V+++L+H +LV LLG E
Sbjct: 14 TIGKGEFGDVMLGDYRGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 71
Query: 409 AWS---LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 465
+V EY+ GSL D L + S L + + ++ + +L VH
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEG---NNFVHR 127
Query: 466 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLT 525
DL +N+L+ + +K+ DFG+ + + K + PE R +
Sbjct: 128 DLAARNVLVSEDNVAKVSDFGLTKEASSTQ---------DTGKLPVKWTAPEALREKKFS 178
Query: 526 PKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLG 585
KSD +SFG+++ ++ + ++ + + D P + ++
Sbjct: 179 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDV-----VPRVEKGYKMDAPDGCPPAVYEVM 233
Query: 586 LQCCELYGRERPDITPSLVKELEQL 610
C L RP L ++LE +
Sbjct: 234 KNCWHLDAAMRPSFL-QLREQLEHI 257
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 1e-55
Identities = 52/215 (24%), Positives = 99/215 (46%), Gaps = 18/215 (8%)
Query: 337 LQTATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE-FQQEVRVLSK 393
++ +F + ++G G G V+K G +A K+++ +E++VL +
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 394 LQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGL 451
P++V GA S+ E++ GSL L + + + +++ + GL
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGL 117
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 511
+L KI+H D+KP NIL++S K+CDFG+ + + + + G+
Sbjct: 118 TYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--------MANSFVGTR 167
Query: 512 PYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
Y PE + + +SD +S GL ++++ GR P
Sbjct: 168 SYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 8e-55
Identities = 60/266 (22%), Positives = 110/266 (41%), Gaps = 22/266 (8%)
Query: 349 KVGQGGFGCVYKGEM-LGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC- 406
++G G FG V G+ VAIKM+ + EF +E +V+ L H LV L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69
Query: 407 -PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 465
++ EY+ NG L + L + + + ++ + +L ++ +H
Sbjct: 70 KQRPIFIITEYMANGCLLNYLREMRH--RFQTQQLLEMCKDVCEAMEYLE---SKQFLHR 124
Query: 466 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLT 525
DL +N L++ + K+ DFG+ R V +D + S K ++ PE +
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDE-----YTSSVGSKFPVRWSPPEVLMYSKFS 179
Query: 526 PKSDSYSFGLIILQLLT-GRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDL 584
KSD ++FG+++ ++ + G++P I L P + ++ +
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMP--YERFTNSET----AEHIAQGLRLYRPHLASEKVYTI 233
Query: 585 GLQCCELYGRERPDITPSLVKELEQL 610
C ERP L+ + +
Sbjct: 234 MYSCWHEKADERPTFK-ILLSNILDV 258
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 1e-54
Identities = 63/265 (23%), Positives = 112/265 (42%), Gaps = 20/265 (7%)
Query: 349 KVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC- 406
++G G FG V+ G L VAIK + + +F +E V+ KL HP LV L G C
Sbjct: 12 EIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70
Query: 407 -PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHG 465
LV+E++ +G L D L + + + + ++ G+ +L ++H
Sbjct: 71 EQAPICLVFEFMEHGCLSDYLRTQRGLFA--AETLLGMCLDVCEGMAYLEE---ACVIHR 125
Query: 466 DLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLT 525
DL +N L+ K+ DFG+ R V +D + ST K +A PE +
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQ-----YTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 526 PKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLG 585
KSD +SFG+++ ++ + + I P + + +
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEV-----VEDISTGFRLYKPRLASTHVYQIM 235
Query: 586 LQCCELYGRERPDITPSLVKELEQL 610
C + +RP + L+++L ++
Sbjct: 236 NHCWKERPEDRPAFS-RLLRQLAEI 259
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 186 bits (472), Expect = 3e-54
Identities = 72/297 (24%), Positives = 124/297 (41%), Gaps = 31/297 (10%)
Query: 332 FSLADLQTATCNFSESF---------KVGQGGFGCVYKGEM-----LGRTVAIKMLYSHN 377
F+ D A F++ +G G FG V G + VAIK L S
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 378 MQGQL-EFQQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSP 434
+ Q +F E ++ + HP+++ L G ++ E++ NGSL F + N
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS--FLRQNDGQ 124
Query: 435 LLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494
+ IA+G+ +L VH DL +NIL++S L K+ DFG+ R + +D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEV 553
T P++ + K + PE + T SD +S+G+++ ++++ G P
Sbjct: 182 T-SDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP--YWDMT 238
Query: 554 RRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610
+ V +++I P L L L C + RP +V L+++
Sbjct: 239 NQDV----INAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFG-QIVNTLDKM 290
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 1e-53
Identities = 73/296 (24%), Positives = 129/296 (43%), Gaps = 24/296 (8%)
Query: 324 EDLPESAEFSLADLQTATCNFSESFKVGQGGFGCVYKGEML-----GRTVAIKMLYSHNM 378
+L ++ + + + +F+E +G+G FGCVY G +L A+K L
Sbjct: 11 PELVQAVQHVVIGPSSLIVHFNE--VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 68
Query: 379 QGQLE-FQQEVRVLSKLQHPHLVTLLGACPEAWS---LVYEYLPNGSLQDRLFRKSNVSP 434
G++ F E ++ HP++++LLG C + +V Y+ +G L++ F ++
Sbjct: 69 IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN--FIRNETHN 126
Query: 435 LLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494
KD ++A G+ FL +K VH DL +N +LD + + K+ DFG+ R + +
Sbjct: 127 PTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183
Query: 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR 554
S H T K + E +T T KSD +SFG+++ +L+T P
Sbjct: 184 EFD--SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTF 241
Query: 555 RAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610
+L P + L ++ L+C RP + LV + +
Sbjct: 242 DI-----TVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFS-ELVSRISAI 291
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 1e-53
Identities = 69/272 (25%), Positives = 116/272 (42%), Gaps = 24/272 (8%)
Query: 346 ESFKVGQGGFGCVYKGEM----LGRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHL 399
E ++G G FG V KG + +TVA+K+L + L E E V+ +L +P++
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 400 VTLLGAC-PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
V ++G C E+W LV E G L L + + K+ + +++ G+ +L
Sbjct: 71 VRMIGICEAESWMLVMEMAELGPLNKYLQQNR---HVKDKNIIELVHQVSMGMKYLE--- 124
Query: 459 PEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY 518
VH DL +N+LL ++ +KI DFG+ + + D Y + T K + PE
Sbjct: 125 ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY---YKAQTHGKWPVKWYAPEC 181
Query: 519 HRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFV 577
+ KSD +SFG+++ + + G+ P G V + + P
Sbjct: 182 INYYKFSSKSDVWSFGVLMWEAFSYGQKP--YRGMKGSEV----TAMLEKGERMGCPAGC 235
Query: 578 ARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609
R + DL C RP ++ L
Sbjct: 236 PREMYDLMNLCWTYDVENRPGFA-AVELRLRN 266
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 2e-53
Identities = 64/282 (22%), Positives = 115/282 (40%), Gaps = 22/282 (7%)
Query: 346 ESFKVGQGGFGCVYKGEML----GRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLV 400
++G G FG V +G VAIK+L + E +E +++ +L +P++V
Sbjct: 13 ADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIV 72
Query: 401 TLLGACPEA-WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 459
L+G C LV E G L L K + + A + +++ G+ +L
Sbjct: 73 RLIGVCQAEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVAELLHQVSMGMKYLE---E 127
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 519
+ VH DL +N+LL + +KI DFG+ + + D Y +A K + PE
Sbjct: 128 KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY---TARSAGKWPLKWYAPECI 184
Query: 520 RTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVA 578
+ +SD +S+G+ + + L+ G+ P V ++ I + P
Sbjct: 185 NFRKFSSRSDVWSYGVTMWEALSYGQKP--YKKMKGPEV----MAFIEQGKRMECPPECP 238
Query: 579 RRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEERPVPS 620
L L C +RPD ++ + + + + V
Sbjct: 239 PELYALMSDCWIYKWEDRPDFL-TVEQRMRACYYSLASKVEG 279
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 4e-53
Identities = 62/294 (21%), Positives = 105/294 (35%), Gaps = 40/294 (13%)
Query: 349 KVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE 408
+G+G FG V++G+ G VA+K+ S + + E+ L+H +++ + A +
Sbjct: 10 SIGKGRFGEVWRGKWRGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 409 AWS------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE-- 460
LV +Y +GSL D L R + + ++A ASGL LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 461 ---KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 517
I H DLK +NIL+ + I D G+ T + G+ Y PE
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID--IAPNHRVGTKRYMAPE 182
Query: 518 YHRTGV------LTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC------------ 559
+ ++D Y+ GL+ ++ G+ + +
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 560 -GKLSSILDPLAGDWPTF--VARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610
L P + R + + +C G R + K L QL
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL-RIKKTLSQL 295
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 181 bits (459), Expect = 2e-52
Identities = 64/267 (23%), Positives = 119/267 (44%), Gaps = 22/267 (8%)
Query: 349 KVGQGGFGCVYKGEM--LGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
K+G G +G VY+G TVA+K L M+ + EF +E V+ +++HP+LV LLG C
Sbjct: 24 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE-EFLKEAAVMKEIKHPNLVQLLGVC 82
Query: 407 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
+ ++ E++ G+L D L + + +A +I+S + +L +H
Sbjct: 83 TREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIH 138
Query: 465 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVL 524
DL +N L+ K+ DFG+ RL+T DT K + PE
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY-----TAHAGAKFPIKWTAPESLAYNKF 193
Query: 525 TPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDP-LAGDWPTFVARRLVD 583
+ KSD ++FG+++ ++ T + + ++ +L+ + P ++ +
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMS------PYPGIDLSQVYELLEKDYRMERPEGCPEKVYE 247
Query: 584 LGLQCCELYGRERPDITPSLVKELEQL 610
L C + +RP + + E +
Sbjct: 248 LMRACWQWNPSDRPSFA-EIHQAFETM 273
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (455), Expect = 4e-52
Identities = 83/271 (30%), Positives = 113/271 (41%), Gaps = 18/271 (6%)
Query: 349 KVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC- 406
K+GQG FG V+ G VAIK L M + F QE +V+ KL+H LV L
Sbjct: 24 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE-AFLQEAQVMKKLRHEKLVQLYAVVS 82
Query: 407 PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGD 466
E +V EY+ GSL + L +AA+IASG+ ++ VH D
Sbjct: 83 EEPIYIVTEYMSKGSL-LDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRD 138
Query: 467 LKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTP 526
L+ NIL+ L K+ DFG+ RL+ ++ + K + PE G T
Sbjct: 139 LRAANILVGENLVCKVADFGLARLIEDNE-----YTARQGAKFPIKWTAPEAALYGRFTI 193
Query: 527 KSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGL 586
KSD +SFG+++ +L T G V R V L + P L DL
Sbjct: 194 KSDVWSFGILLTELTTKGRVP-YPGMVNREV----LDQVERGYRMPCPPECPESLHDLMC 248
Query: 587 QCCELYGRERPDITPSLVKELEQLHVAEERP 617
QC ERP L LE + E
Sbjct: 249 QCWRKEPEERPTFE-YLQAFLEDYFTSTEPQ 278
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 2e-51
Identities = 64/262 (24%), Positives = 104/262 (39%), Gaps = 28/262 (10%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLG 404
++G+G F VYKG VA L + + F++E +L LQHP++V
Sbjct: 16 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 75
Query: 405 AC------PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
+ + LV E + +G+L+ L R + K +I GL FLH+
Sbjct: 76 SWESTVKGKKCIVLVTELMTSGTLKTYLKRF---KVMKIKVLRSWCRQILKGLQFLHTRT 132
Query: 459 PEKIVHGDLKPQNILLDSELSS-KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 517
P I+H DLK NI + S KI D G+ L + A G+ + PE
Sbjct: 133 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA--------SFAKAVIGTPEFMAPE 183
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFV 577
+ D Y+FG+ +L++ T P + A +++S + P +
Sbjct: 184 MYE-EKYDESVDVYAFGMCMLEMATSEYP--YSECQNAAQIYRRVTSGVKPA--SFDKVA 238
Query: 578 ARRLVDLGLQCCELYGRERPDI 599
+ ++ C ER I
Sbjct: 239 IPEVKEIIEGCIRQNKDERYSI 260
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 176 bits (448), Expect = 7e-51
Identities = 66/309 (21%), Positives = 118/309 (38%), Gaps = 44/309 (14%)
Query: 333 SLADLQTATCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQGQL-EF 384
L L+ N +G+G FG V++ VA+KML +F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 385 QQEVRVLSKLQHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKS------------ 430
Q+E ++++ +P++V LLG C + L++EY+ G L + L S
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 431 ---------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSK 481
PL ++ IA ++A+G+ +L K VH DL +N L+ + K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVK 180
Query: 482 ICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLL 541
I DFG+ R + Y + PE T +SD +++G+++ ++
Sbjct: 181 IADFGLSRNIYSADYY----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 236
Query: 542 TGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITP 601
+ L + + D P L +L C +RP
Sbjct: 237 SYGLQPYYGMAHEEV-----IYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFC- 290
Query: 602 SLVKELEQL 610
S+ + L+++
Sbjct: 291 SIHRILQRM 299
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 1e-50
Identities = 57/262 (21%), Positives = 102/262 (38%), Gaps = 23/262 (8%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTLLG 404
+G G +G K G+ + K L +M EV +L +L+HP++V
Sbjct: 11 TIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYD 70
Query: 405 ACPEAWS----LVYEYLPNGSLQDRLFRKSNVS-PLLWKDRARIAAEIASGLCFLH--SS 457
+ + +V EY G L + + + L + R+ ++ L H S
Sbjct: 71 RIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSD 130
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 517
++H DLKP N+ LD + + K+ DFG+ R++ DT + +F + Y PE
Sbjct: 131 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG------TPYYMSPE 184
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFV 577
KSD +S G ++ +L P ++ + I + P
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPP--FTAFSQKEL----AGKIREGKFRRIPYRY 238
Query: 578 ARRLVDLGLQCCELYGRERPDI 599
+ L ++ + L RP +
Sbjct: 239 SDELNEIITRMLNLKDYHRPSV 260
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 3e-50
Identities = 55/260 (21%), Positives = 98/260 (37%), Gaps = 24/260 (9%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
++G G FG VYK + A K++ + + + ++ E+ +L+ HP++V LL A
Sbjct: 19 ELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 78
Query: 407 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
++ E+ G++ + PL + + L +LH +K I+H
Sbjct: 79 YYENNLWILIEFCAGGAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHDNK---IIH 133
Query: 465 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEY-----H 519
DLK NIL + K+ DFG+ T R + G+ + PE
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTI------QRRDSFIGTPYWMAPEVVMCETS 187
Query: 520 RTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVAR 579
+ K+D +S G+ ++++ P V S L P+ +
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPP--HHELNPMRVLLKIAKSEPPTL--AQPSRWSS 243
Query: 580 RLVDLGLQCCELYGRERPDI 599
D +C E R
Sbjct: 244 NFKDFLKKCLEKNVDARWTT 263
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (436), Expect = 2e-49
Identities = 66/277 (23%), Positives = 115/277 (41%), Gaps = 23/277 (8%)
Query: 343 NFSESFKVGQGGFGCVYKGEM------LGRTVAIKMLYSHNMQGQL-EFQQEVRVLSKLQ 395
+ +G G FG VYKG + VAIK L + + Q +F E ++ +
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67
Query: 396 HPHLVTLLGACPEA--WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCF 453
H +++ L G + ++ EY+ NG+L L K + IA+G+ +
Sbjct: 68 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVGMLRGIAAGMKY 125
Query: 454 LHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY 513
L + VH DL +NIL++S L K+ DFG+ R++ +D + ++ K +
Sbjct: 126 LAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT---YTTSGGKIPIRW 179
Query: 514 ADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDW 573
PE T SD +SFG+++ +++T + +I D
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV-----MKAINDGFRLPT 234
Query: 574 PTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610
P + L +QC + RP +V L++L
Sbjct: 235 PMDCPSAIYQLMMQCWQQERARRPKFA-DIVSILDKL 270
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 3e-49
Identities = 65/261 (24%), Positives = 110/261 (42%), Gaps = 32/261 (12%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLL 403
+G+G FG VY +A+K+L+ + + + ++EV + S L+HP+++ L
Sbjct: 13 PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 72
Query: 404 GAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
G L+ EY P G++ L + S + A E+A+ L + HS +
Sbjct: 73 GYFHDATRVYLILEYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR--- 126
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
++H D+KP+N+LL S KI DFG R T G+ Y PE
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--------RRTTLCGTLDYLPPEMIEG 178
Query: 522 GVLTPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSILDPLAGDWPTFVAR 579
+ K D +S G++ + L G+ P E + +S + +P FV
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEF---------TFPDFVTE 229
Query: 580 RLVDLGLQCCELYGRERPDIT 600
DL + + +RP +
Sbjct: 230 GARDLISRLLKHNPSQRPMLR 250
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 8e-49
Identities = 61/255 (23%), Positives = 106/255 (41%), Gaps = 21/255 (8%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
K+GQG G VY + G+ VAI+ + + E+ V+ + ++P++V L +
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 407 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
+ +V EYL GSL D + A + E L FLHS +++H
Sbjct: 87 LVGDELWVVMEYLAGGSLTDVVTETCMD----EGQIAAVCRECLQALEFLHS---NQVIH 139
Query: 465 GDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVL 524
D+K NILL + S K+ DFG C +T + + + G+ + PE
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQ------SKRSTMVGTPYWMAPEVVTRKAY 193
Query: 525 TPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVDL 584
PK D +S G++ ++++ G P E ++ L P ++ D
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPP--YLNENPLRALYLIATNGTPEL--QNPEKLSAIFRDF 249
Query: 585 GLQCCELYGRERPDI 599
+C ++ +R
Sbjct: 250 LNRCLDMDVEKRGSA 264
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (430), Expect = 1e-48
Identities = 68/272 (25%), Positives = 117/272 (43%), Gaps = 24/272 (8%)
Query: 349 KVGQGGFGCVYKGEML-----GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLV 400
K+G G FG V +GE +VA+K L + + +F +EV + L H +L+
Sbjct: 15 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 401 TLLGACPEAW-SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 459
L G +V E P GSL DRL + L +R A ++A G+ +L S
Sbjct: 75 RLYGVVLTPPMKMVTELAPLGSLLDRLRKHQG--HFLLGTLSRYAVQVAEGMGYLES--- 129
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYH 519
++ +H DL +N+LL + KI DFG+ R + ++ + K F + PE
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND---DHYVMQEHRKVPFAWCAPESL 186
Query: 520 RTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVA 578
+T + SD++ FG+ + ++ T G+ P + K + P
Sbjct: 187 KTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK-----EGERLPRPEDCP 241
Query: 579 RRLVDLGLQCCELYGRERPDITPSLVKELEQL 610
+ + ++ +QC +RP +L L +
Sbjct: 242 QDIYNVMVQCWAHKPEDRPTFV-ALRDFLLEA 272
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (432), Expect = 2e-48
Identities = 71/288 (24%), Positives = 115/288 (39%), Gaps = 38/288 (13%)
Query: 349 KVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQGQLE-FQQEVRVLSKL-QHPHL 399
+G G FG V + TVA+KML + E E++VLS L H ++
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNI 89
Query: 400 VTLLGAC--PEAWSLVYEYLPNGSLQDRLFRK---------------SNVSPLLWKDRAR 442
V LLGAC ++ EY G L + L RK + L +D
Sbjct: 90 VNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLS 149
Query: 443 IAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 502
+ ++A G+ FL S + +H DL +NILL +KICDFG+ R + D+ ++
Sbjct: 150 FSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS----NYV 202
Query: 503 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKL 562
+ + PE V T +SD +S+G+ + +L + V
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF----Y 258
Query: 563 SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610
I + P + D+ C + +RP +V+ +E+
Sbjct: 259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFK-QIVQLIEKQ 305
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 170 bits (431), Expect = 2e-48
Identities = 61/267 (22%), Positives = 97/267 (36%), Gaps = 31/267 (11%)
Query: 344 FSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQ---LEFQQEVRVLSKLQHPH 398
FS+ ++G G FG VY + VAIK + Q + +EVR L KL+HP+
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 399 LVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 456
+ G LV EY + K PL + A + GL +LHS
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGLAYLHS 133
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 516
++H D+K NILL K+ DFG ++ ++ G+ + P
Sbjct: 134 ---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV----------GTPYWMAP 180
Query: 517 EY---HRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDW 573
E G K D +S G+ ++L + P L + + L
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPP--LFNMNAMSALYHIAQNESPALQ--- 235
Query: 574 PTFVARRLVDLGLQCCELYGRERPDIT 600
+ + C + ++RP
Sbjct: 236 SGHWSEYFRNFVDSCLQKIPQDRPTSE 262
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 170 bits (432), Expect = 5e-48
Identities = 56/257 (21%), Positives = 104/257 (40%), Gaps = 21/257 (8%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
++G G FG V++ G A K + + + + ++E++ +S L+HP LV L A
Sbjct: 33 ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF 92
Query: 407 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
++YE++ G L +++ + N + + ++ GLC +H VH
Sbjct: 93 EDDNEMVMIYEFMSGGELFEKVADEHN--KMSEDEAVEYMRQVCKGLCHMHE---NNYVH 147
Query: 465 GDLKPQNILLDSELSS--KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 522
DLKP+NI+ ++ S+ K+ DFG+ + G+ +A PE
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-------QSVKVTTGTAEFAAPEVAEGK 200
Query: 523 VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLV 582
+ +D +S G++ LL+G P GE S + + ++
Sbjct: 201 PVGYYTDMWSVGVLSYILLSGLSP--FGGENDDETLRNVKSCDWNMDDSAFSG-ISEDGK 257
Query: 583 DLGLQCCELYGRERPDI 599
D + R I
Sbjct: 258 DFIRKLLLADPNTRMTI 274
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 6e-48
Identities = 68/291 (23%), Positives = 117/291 (40%), Gaps = 43/291 (14%)
Query: 349 KVGQGGFGCVYKGEMLG-------RTVAIKMLYSHNMQGQLE-FQQEVRVLSKL-QHPHL 399
+G G FG V G VA+KML + E E++++++L H ++
Sbjct: 44 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENI 103
Query: 400 VTLLGAC--PEAWSLVYEYLPNGSLQDRLFRK--------------------SNVSPLLW 437
V LLGAC L++EY G L + L K +++ L +
Sbjct: 104 VNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTF 163
Query: 438 KDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497
+D A ++A G+ FL + VH DL +N+L+ KICDFG+ R + D+
Sbjct: 164 EDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS-- 218
Query: 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAV 557
++ + + PE G+ T KSD +S+G+++ ++ + + V
Sbjct: 219 --NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF 276
Query: 558 SCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608
I + D P + + + C R+RP +L L
Sbjct: 277 ----YKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFP-NLTSFLG 322
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (425), Expect = 2e-47
Identities = 65/282 (23%), Positives = 118/282 (41%), Gaps = 25/282 (8%)
Query: 344 FSESFKVGQGGFGCVYK------GEMLGRTVAIKMLY-SHNMQGQLEFQQEVRVLSKLQH 396
F + +G G FG VYK GE + VAIK L + + + E E V++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 397 PHLVTLLGACPEA-WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLH 455
PH+ LLG C + L+ + +P G L D + + + +IA G+ +L
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIG--SQYLLNWCVQIAKGMNYLE 128
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 515
++VH DL +N+L+ + KI DFG+ +L+ + + + K +
Sbjct: 129 ---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE----EKEYHAEGGKVPIKWMA 181
Query: 516 PEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEVRRAVSCGKLSSILDPLAGDWP 574
E + T +SD +S+G+ + +L+T G P G + S + P
Sbjct: 182 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD--GIPASEI----SSILEKGERLPQP 235
Query: 575 TFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEER 616
+ + ++C + RP L+ E ++ +R
Sbjct: 236 PICTIDVYMIMVKCWMIDADSRPKFR-ELIIEFSKMARDPQR 276
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 4e-47
Identities = 61/269 (22%), Positives = 108/269 (40%), Gaps = 23/269 (8%)
Query: 349 KVGQGGFGCVYKGEML-----GRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTL 402
+G+G FG V++G + VAIK + E F QE + + HPH+V L
Sbjct: 14 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 73
Query: 403 LGACPEAWS-LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
+G E ++ E G L+ F + L A ++++ L +L S ++
Sbjct: 74 IGVITENPVWIIMELCTLGELRS--FLQVRKYSLDLASLILYAYQLSTALAYLES---KR 128
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
VH D+ +N+L+ S K+ DFG+ R + + T +++++ K + PE
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST-----YYKASKGKLPIKWMAPESINF 183
Query: 522 GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRL 581
T SD + FG+ + ++L + + + I + P L
Sbjct: 184 RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV-----IGRIENGERLPMPPNCPPTL 238
Query: 582 VDLGLQCCELYGRERPDITPSLVKELEQL 610
L +C RP T L +L +
Sbjct: 239 YSLMTKCWAYDPSRRPRFT-ELKAQLSTI 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 166 bits (422), Expect = 5e-47
Identities = 67/289 (23%), Positives = 112/289 (38%), Gaps = 37/289 (12%)
Query: 343 NFSESFKVGQGGFGCVYKGEMLG----RTVAIKMLYSHNMQGQL-EFQQEVRVLSKL-QH 396
+ +G+G FG V K + AIK + + + +F E+ VL KL H
Sbjct: 11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70
Query: 397 PHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRK-------------SNVSPLLWKDRA 441
P+++ LLGAC L EY P+G+L D L + S S L +
Sbjct: 71 PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130
Query: 442 RIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSF 501
AA++A G+ +L + +H DL +NIL+ +KI DFG+ R
Sbjct: 131 HFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYV------ 181
Query: 502 HRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGK 561
+ T + + E V T SD +S+G+++ ++++
Sbjct: 182 -KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL----- 235
Query: 562 LSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610
+ + P + DL QC ERP ++ L ++
Sbjct: 236 YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFA-QILVSLNRM 283
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 1e-46
Identities = 69/297 (23%), Positives = 127/297 (42%), Gaps = 30/297 (10%)
Query: 343 NFSESFKVGQGGFGCVYKG-------EMLGRTVAIKMLY-SHNMQGQLEFQQEVRVLSKL 394
+ S ++GQG FG VY+G + VAIK + + +M+ ++EF E V+ +
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF 80
Query: 395 QHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLF-------RKSNVSPLLWKDRARIAA 445
H+V LLG + ++ E + G L+ L ++P ++A
Sbjct: 81 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 140
Query: 446 EIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST 505
EIA G+ +L+++K VH DL +N ++ + + KI DFG+ R + E Y +
Sbjct: 141 EIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY----RKGG 193
Query: 506 APKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSI 565
+ PE + GV T SD +SFG+++ ++ T + L +
Sbjct: 194 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV-----LRFV 248
Query: 566 LDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVAEERPVPSFF 622
++ D P L +L C + + RP ++ +++ R V ++
Sbjct: 249 MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFL-EIISSIKEEMEPGFREVSFYY 304
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 1e-46
Identities = 56/257 (21%), Positives = 94/257 (36%), Gaps = 20/257 (7%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGA 405
+G+G +G V VA+K++ E ++E+ + L H ++V G
Sbjct: 12 TLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGH 71
Query: 406 C--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
L EY G L DR+ + D R ++ +G+ +LH I
Sbjct: 72 RREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPDAQRFFHQLMAGVVYLHG---IGIT 125
Query: 464 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG- 522
H D+KP+N+LLD + KI DFG+ + + G+ PY PE +
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNN----RERLLNKMCGTLPYVAPELLKRRE 181
Query: 523 VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLV 582
D +S G+++ +L G LP + + S K + +
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP----WKKIDSAPL 237
Query: 583 DLGLQCCELYGRERPDI 599
L + R I
Sbjct: 238 ALLHKILVENPSARITI 254
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 162 bits (412), Expect = 5e-46
Identities = 65/274 (23%), Positives = 118/274 (43%), Gaps = 23/274 (8%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQ---LEFQQEVRVLSKLQHPHLVTLL 403
+G GG V+ L R VA+K+L + + L F++E + + L HP +V +
Sbjct: 14 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73
Query: 404 GACPEAWS------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
+V EY+ +L+D + + P+ K + A+ L F H +
Sbjct: 74 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQN 130
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 517
I+H D+KP NI++ + + K+ DFGI R + + S ++ A G+ Y PE
Sbjct: 131 G---IIHRDVKPANIMISATNAVKVMDFGIARAIADSG---NSVTQTAAVIGTAQYLSPE 184
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFV 577
R + +SD YS G ++ ++LTG P G+ +V+ + P + +
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPP--FTGDSPVSVAYQHVREDPIPPSARHEG-L 241
Query: 578 ARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611
+ L + L+ R + +L ++H
Sbjct: 242 SADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 2e-45
Identities = 67/270 (24%), Positives = 104/270 (38%), Gaps = 24/270 (8%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLL 403
+G+G F V L R AIK+L ++ +E V+S+L HP V L
Sbjct: 15 ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 74
Query: 404 GAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
E Y NG L + + AEI S L +LH +
Sbjct: 75 FTFQDDEKLYFGLSYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHG---KG 128
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
I+H DLKP+NILL+ ++ +I DFG ++++ ++ R+ + G+ Y PE
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPES----KQARANSFVGTAQYVSPELLTE 184
Query: 522 GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRL 581
SD ++ G II QL+ G P + I+ L D+P +
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLPP--FRAGNEYLI----FQKIIK-LEYDFPEKFFPKA 237
Query: 582 VDLGLQCCELYGRERPDITPSLVKELEQLH 611
DL + L +R + H
Sbjct: 238 RDLVEKLLVLDATKRLGCEEMEGYGPLKAH 267
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 161 bits (408), Expect = 1e-44
Identities = 56/257 (21%), Positives = 105/257 (40%), Gaps = 21/257 (8%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
++G G FG V++ GR K + + + + E+ ++++L HP L+ L A
Sbjct: 36 ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF 95
Query: 407 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
L+ E+L G L DR+ + + + + GL +H IVH
Sbjct: 96 EDKYEMVLILEFLSGGELFDRIAAEDY--KMSEAEVINYMRQACEGLKHMHEH---SIVH 150
Query: 465 GDLKPQNILLDSELSS--KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 522
D+KP+NI+ +++ +S KI DFG+ + D + + + +A PE
Sbjct: 151 LDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT-------TATAEFAAPEIVDRE 203
Query: 523 VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLV 582
+ +D ++ G++ LL+G P AGE + + + V+
Sbjct: 204 PVGFYTDMWAIGVLGYVLLSGLSP--FAGEDDLETLQNVKRCDWEFDEDAFSS-VSPEAK 260
Query: 583 DLGLQCCELYGRERPDI 599
D + R+R +
Sbjct: 261 DFIKNLLQKEPRKRLTV 277
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 1e-43
Identities = 49/258 (18%), Positives = 109/258 (42%), Gaps = 22/258 (8%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
+G+G FG V++ +T K + Q+ ++E+ +L+ +H +++ L +
Sbjct: 12 DLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESF 70
Query: 407 --PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVH 464
E +++E++ + +R+ ++ L ++ ++ L FLHS I H
Sbjct: 71 ESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHSHN---IGH 125
Query: 465 GDLKPQNILLDSELSS--KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 522
D++P+NI+ + SS KI +FG R + + + Y PE H+
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF-------RLLFTAPEYYAPEVHQHD 178
Query: 523 VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLV 582
V++ +D +S G ++ LL+G P E + + +++ + ++ +
Sbjct: 179 VVSTATDMWSLGTLVYVLLSGINP--FLAETNQQIIENIMNAEYTFDEEAFKE-ISIEAM 235
Query: 583 DLGLQCCELYGRERPDIT 600
D + + R +
Sbjct: 236 DFVDRLLVKERKSRMTAS 253
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 4e-43
Identities = 65/288 (22%), Positives = 122/288 (42%), Gaps = 39/288 (13%)
Query: 349 KVGQGGFGCVYKGEML---------GRTVAIKMLYSHNMQGQL-EFQQEVRVLSKL-QHP 397
+G+G FG V E + VA+KML S + L + E+ ++ + +H
Sbjct: 20 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHK 79
Query: 398 HLVTLLGACPEAWS--LVYEYLPNGSLQDRLFRK-------------SNVSPLLWKDRAR 442
+++ LLGAC + ++ EY G+L++ L + + L KD
Sbjct: 80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 139
Query: 443 IAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFH 502
A ++A G+ +L S +K +H DL +N+L+ + KI DFG+ R + +
Sbjct: 140 CAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID----YYK 192
Query: 503 RSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKL 562
++T + + PE + T +SD +SFG+++ ++ T V
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL--- 249
Query: 563 SSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610
+ + D P+ L + C +RP LV++L+++
Sbjct: 250 --LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFK-QLVEDLDRI 294
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 152 bits (385), Expect = 5e-42
Identities = 60/260 (23%), Positives = 103/260 (39%), Gaps = 24/260 (9%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGA 405
+G G F V E + VAIK + ++G+ + E+ VL K++HP++V L
Sbjct: 16 VLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDI 75
Query: 406 C--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
L+ + + G L DR+ K +D +R+ ++ + +LH IV
Sbjct: 76 YESGGHLYLIMQLVSGGELFDRIVEKG---FYTERDASRLIFQVLDAVKYLHD---LGIV 129
Query: 464 HGDLKPQNILL---DSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 520
H DLKP+N+L D + I DFG+ ++ ++ + G+ Y PE
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVL-------STACGTPGYVAPEVLA 182
Query: 521 TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARR 580
+ D +S G+I LL G P E + L + + + W ++
Sbjct: 183 QKPYSKAVDCWSIGVIAYILLCGYPP--FYDENDAKLFEQILKAEYEFDSPYWDD-ISDS 239
Query: 581 LVDLGLQCCELYGRERPDIT 600
D E +R
Sbjct: 240 AKDFIRHLMEKDPEKRFTCE 259
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 3e-41
Identities = 69/287 (24%), Positives = 116/287 (40%), Gaps = 37/287 (12%)
Query: 349 KVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQGQL-EFQQEVRVLSK-LQHPHL 399
+G+G FG V + + RTVA+KML + E+++L H ++
Sbjct: 20 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 79
Query: 400 VTLLGACPEAWS---LVYEYLPNGSLQDRLFRKSNV-------------SPLLWKDRARI 443
V LLGAC + ++ E+ G+L L K N L +
Sbjct: 80 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICY 139
Query: 444 AAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHR 503
+ ++A G+ FL S K +H DL +NILL + KICDFG+ R + +D P + R
Sbjct: 140 SFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD----PDYVR 192
Query: 504 STAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLS 563
+ + PE V T +SD +SFG+++ ++ + ++
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF----CR 248
Query: 564 SILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610
+ + P + + L C +RP + LV+ L L
Sbjct: 249 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS-ELVEHLGNL 294
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 151 bits (383), Expect = 4e-41
Identities = 64/278 (23%), Positives = 111/278 (39%), Gaps = 29/278 (10%)
Query: 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQ------LEFQQEVRVLSKL 394
+FS +G+GGFG VY G+ A+K L ++ + L + + ++S
Sbjct: 5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 395 QHPHLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLC 452
P +V + A P+ S + + + G L L + D AAEI GL
Sbjct: 65 DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLE 121
Query: 453 FLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFP 512
+H+ +V+ DLKP NILLD +I D G+ ++ + A G+
Sbjct: 122 HMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK--------KPHASVGTHG 170
Query: 513 YADPEYHRTGV-LTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAG 571
Y PE + GV +D +S G ++ +LL G P + ++ + +A
Sbjct: 171 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----EIDRMTLTMAV 226
Query: 572 DWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQ 609
+ P + L L + R +E+++
Sbjct: 227 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 148 bits (375), Expect = 7e-41
Identities = 60/280 (21%), Positives = 108/280 (38%), Gaps = 40/280 (14%)
Query: 344 FSESFKV----GQGGFGCVYKGEML--GRTVAIKML---------YSHNMQGQLEFQQEV 388
F E+++ G+G V + + A+K++ + + +EV
Sbjct: 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEV 60
Query: 389 RVLSKLQ-HPHLVTLLGACPEAWS--LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAA 445
+L K+ HP+++ L LV++ + G L D L K L K+ +I
Sbjct: 61 DILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMR 117
Query: 446 EIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRST 505
+ +C LH IVH DLKP+NILLD +++ K+ DFG + +
Sbjct: 118 ALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG-------EKLR 167
Query: 506 APKGSFPYADPEYHRTGVL------TPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC 559
G+ Y PE + + D +S G+I+ LL G P + +
Sbjct: 168 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP--FWHRKQMLMLR 225
Query: 560 GKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDI 599
+S + +W + + DL + + ++R
Sbjct: 226 MIMSGNYQFGSPEWDD-YSDTVKDLVSRFLVVQPQKRYTA 264
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 4e-40
Identities = 56/268 (20%), Positives = 99/268 (36%), Gaps = 14/268 (5%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE-FQQEVRVLSKLQHPHLVTLLGA 405
+G+G +G V VAIK + Q + +E+++L + +H +++ +
Sbjct: 15 YIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDI 74
Query: 406 C--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
P + YL + L++ L +I GL ++HS ++
Sbjct: 75 IRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVL 131
Query: 464 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV 523
H DLKP N+LL++ KICDFG+ R+ D T + Y PE
Sbjct: 132 HRDLKPSNLLLNTTCDLKICDFGLARVADPDH---DHTGFLTEYVATRWYRAPEIMLNSK 188
Query: 524 L-TPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLV 582
T D +S G I+ ++L+ R G+ L + P D + +
Sbjct: 189 GYTKSIDIWSVGCILAEMLSNRPI--FPGKHYLDQLNHILGILGSPSQEDLNCIINLKAR 246
Query: 583 DLGLQCCELYGRERPDITPSLVKELEQL 610
+ L + P+ + L
Sbjct: 247 NYLLSLPHKNKVPWNRLFPNADSKALDL 274
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 146 bits (370), Expect = 8e-40
Identities = 64/268 (23%), Positives = 106/268 (39%), Gaps = 29/268 (10%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKML---YSHNMQGQLEFQQEVRVLSKLQHPHLVTLL 403
+G G FG V+ GR A+K+L ++ E +LS + HP ++ +
Sbjct: 11 TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70
Query: 404 GACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
G +A + + +Y+ G L L + AAE+ L +LHS +
Sbjct: 71 GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFP---NPVAKFYAAEVCLALEYLHS---KD 124
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
I++ DLKP+NILLD KI DFG + V + + G+ Y PE T
Sbjct: 125 IIYRDLKPENILLDKNGHIKITDFGFAKYVPD---------VTYTLCGTPDYIAPEVVST 175
Query: 522 GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRL 581
D +SFG++I ++L G P IL+ +P F +
Sbjct: 176 KPYNKSIDWWSFGILIYEMLAGYTP--FYDSNTMKT----YEKILNA-ELRFPPFFNEDV 228
Query: 582 VDLGLQCCELYGRERPDITPSLVKELEQ 609
DL + +R + ++++
Sbjct: 229 KDLLSRLITRDLSQRLGNLQNGTEDVKN 256
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 1e-39
Identities = 67/265 (25%), Positives = 103/265 (38%), Gaps = 27/265 (10%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE---FQQEVRVLSK-LQHPHLVTL 402
+G+G FG V+ E + AIK L + + E RVLS +HP L +
Sbjct: 9 MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 68
Query: 403 LGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460
E V EYL G L + AAEI GL FLHS +
Sbjct: 69 FCTFQTKENLFFVMEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHS---K 122
Query: 461 KIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 520
IV+ DLK NILLD + KI DFG+C+ ++ G+ Y PE
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD------AKTNTFCGTPDYIAPEILL 176
Query: 521 TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARR 580
D +SFG+++ ++L G+ P +L + +P ++ +
Sbjct: 177 GQKYNHSVDWWSFGVLLYEMLIGQSP-------FHGQDEEELFHSIRMDNPFYPRWLEKE 229
Query: 581 LVDLGLQCCELYGRERPDITPSLVK 605
DL ++ +R + + +
Sbjct: 230 AKDLLVKLFVREPEKRLGVRGDIRQ 254
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 143 bits (362), Expect = 5e-39
Identities = 55/276 (19%), Positives = 98/276 (35%), Gaps = 27/276 (9%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
K+G G FG +Y G + G VAIK+ Q E ++ +Q + + C
Sbjct: 14 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVGIPTIRWC 71
Query: 407 ---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
+ +V E L F K +A ++ S + ++HS +
Sbjct: 72 GAEGDYNVMVMELLGPSLEDLFNFCS---RKFSLKTVLLLADQMISRIEYIHSK---NFI 125
Query: 464 HGDLKPQNILLDSELSSKIC---DFGICRLVTEDTLYLPSF-HRSTAPKGSFPYADPEYH 519
H D+KP N L+ + DFG+ + + + + G+ YA H
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185
Query: 520 RTGVLTPKSDSYSFGLIILQLLTGRLPVGL-----AGEVRRAVSCGKLSSILDPLAGDWP 574
+ + D S G +++ G LP + +S K+S+ ++ L +P
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYP 245
Query: 575 TFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610
C L ++PD + L + L
Sbjct: 246 ----SEFATYLNFCRSLRFDDKPDYS-YLRQLFRNL 276
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 1e-38
Identities = 49/215 (22%), Positives = 89/215 (41%), Gaps = 24/215 (11%)
Query: 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLV 400
+++++ +G G FG VY+ ++ G VAIK + +Q + +E++++ KL H ++V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLDHCNIV 76
Query: 401 TLLGACPEAWS--------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLC 452
L + LV +Y+P + L ++ L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 453 FLHSSKPEKIVHGDLKPQNILLDSE-LSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSF 511
++HS I H D+KPQN+LLD + K+CDFG + + + +
Sbjct: 137 YIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE------PNVSYICSRY 187
Query: 512 PYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
A T D +S G ++ +LL G+
Sbjct: 188 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPI 222
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 140 bits (354), Expect = 6e-38
Identities = 48/278 (17%), Positives = 86/278 (30%), Gaps = 29/278 (10%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
++G+G FG +++G L + VAIK + + E R L + +
Sbjct: 12 RIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69
Query: 407 ---PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
LV + L K A A ++ + + +H +V
Sbjct: 70 GQEGLHNVLVIDLLGPSLED---LLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LV 123
Query: 464 HGDLKPQNILLDSELSS-----KICDFGICRLVTED-TLYLPSFHRSTAPKGSFPYADPE 517
+ D+KP N L+ S + DFG+ + + T + G+ Y
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLTGR-----LPVGLAGEVRRAVSCGKLSSILDPLAGD 572
H + + D + G + + L G L + + K S+ L L
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG 243
Query: 573 WPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610
+P L PD L ++
Sbjct: 244 FP----EEFYKYMHYARNLAFDATPDYD-YLQGLFSKV 276
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 8e-38
Identities = 56/265 (21%), Positives = 98/265 (36%), Gaps = 31/265 (11%)
Query: 350 VGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGAC 406
+G G G V + A+KML Q + ++EV + + Q PH+V ++
Sbjct: 20 LGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVY 74
Query: 407 PEAWS------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPE 460
++ +V E L G L R+ + + ++ + I I + +LHS
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN-- 131
Query: 461 KIVHGDLKPQNILLDSELSS---KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 517
I H D+KP+N+L S+ + K+ DFG + T + + Y PE
Sbjct: 132 -IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY-------TPYYVAPE 183
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLTGRLPV--GLAGEVRRAVSCGKLSSILDPLAGDWPT 575
D +S G+I+ LL G P + + + +W
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 243
Query: 576 FVARRLVDLGLQCCELYGRERPDIT 600
V+ + L + +R IT
Sbjct: 244 -VSEEVKMLIRNLLKTEPTQRMTIT 267
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 9e-38
Identities = 69/286 (24%), Positives = 109/286 (38%), Gaps = 31/286 (10%)
Query: 349 KVGQGGFGCVYKGEML---GRTVAIKMLYSHNMQG--QLEFQQEVRVLSKL---QHPHLV 400
++G+G +G V+K L GR VA+K + + L +EV VL L +HP++V
Sbjct: 14 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73
Query: 401 TLLGACPEAWS-------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCF 453
L C + + LV+E++ K + + + ++ GL F
Sbjct: 74 RLFDVCTVSRTDRETKLTLVFEHVDQDLTT--YLDKVPEPGVPTETIKDMMFQLLRGLDF 131
Query: 454 LHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPY 513
LHS ++VH DLKPQNIL+ S K+ DFG+ R+ + T+ + Y
Sbjct: 132 LHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF-------QMALTSVVVTLWY 181
Query: 514 ADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDW 573
PE D +S G I ++ + G L I P DW
Sbjct: 182 RAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL--FRGSSDVDQLGKILDVIGLPGEEDW 239
Query: 574 PTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL--HVAEERP 617
P VA + + + DI L + +R
Sbjct: 240 PRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI 285
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 1e-35
Identities = 60/265 (22%), Positives = 106/265 (40%), Gaps = 30/265 (11%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL------EFQQEVRVLSKLQHPHLV 400
++G G F V K G A K + + + ++EV +L ++QHP+++
Sbjct: 17 ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 401 TLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK 458
TL L+ E + G L D L K L ++ +I +G+ +LHS
Sbjct: 77 TLHEVYENKTDVILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHS-- 131
Query: 459 PEKIVHGDLKPQNILLDSE----LSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 514
+I H DLKP+NI+L KI DFG+ + G+ +
Sbjct: 132 -LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-------EFKNIFGTPEFV 183
Query: 515 DPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWP 574
PE L ++D +S G+I LL+G P G+ ++ +S++ ++
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASP--FLGDTKQET-LANVSAVNYEFEDEYF 240
Query: 575 TFVARRLVDLGLQCCELYGRERPDI 599
+ + D + ++R I
Sbjct: 241 SNTSALAKDFIRRLLVKDPKKRMTI 265
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 133 bits (334), Expect = 2e-35
Identities = 54/269 (20%), Positives = 99/269 (36%), Gaps = 20/269 (7%)
Query: 349 KVGQGGFGCVYKGEM-LGRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTLLGA 405
K+G+G +G VYK + G T A+K + + +E+ +L +L+H ++V L
Sbjct: 9 KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 406 CPEAWS--LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463
LV+E+L + + L ++ +G+ + H + ++
Sbjct: 69 IHTKKRLVLVFEHLDQDLKKLLDVCEG---GLESVTAKSFLLQLLNGIAYCHDRR---VL 122
Query: 464 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV 523
H DLKPQN+L++ E KI DFG+ R + + A +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTL-----WYRAPDVLMGSKK 177
Query: 524 LTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRLVD 583
+ D +S G I +++ G G + P + +WP D
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTPL--FPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235
Query: 584 LGLQCCELYGRER--PDITPSLVKELEQL 610
E E + S + L ++
Sbjct: 236 PNFTVYEPLPWESFLKGLDESGIDLLSKM 264
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 3e-35
Identities = 53/210 (25%), Positives = 91/210 (43%), Gaps = 16/210 (7%)
Query: 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPH 398
NF + K+G+G +G VYK G VA+K + + +E+ +L +L HP+
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 399 LVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 456
+V LL LV+E+L + S ++ + ++ GL F HS
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLK--KFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 516
+++H DLKPQN+L+++E + K+ DFG+ R P + + A
Sbjct: 121 ---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-----PVRTYTHEVVTLWYRAPE 172
Query: 517 EYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
+ D +S G I +++T R
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRAL 202
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 3e-35
Identities = 55/269 (20%), Positives = 92/269 (34%), Gaps = 24/269 (8%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE-----FQQEVRVLSKLQHPHLVT 401
+G+G F VYK + VAIK + + + +E+++L +L HP+++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 402 LLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKP 459
LL A SLV++++ L GL +LH
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEVIIKDNSL---VLTPSHIKAYMLMTLQGLEYLHQ--- 118
Query: 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE-Y 518
I+H DLKP N+LLD K+ DFG+ + T + Y PE
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP------NRAYTHQVVTRWYRAPELL 172
Query: 519 HRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVA 578
+ D ++ G I+ +LL L G+ ++ P WP +
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRVPF--LPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230
Query: 579 RRLVDLGLQCCELYGRERPDITPSLVKEL 607
+ + +L
Sbjct: 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDL 259
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 4e-35
Identities = 48/213 (22%), Positives = 88/213 (41%), Gaps = 23/213 (10%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTLLG 404
K+GQG FG V+K G+ VA+K + N + +E+++L L+H ++V L+
Sbjct: 17 KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 76
Query: 405 ACPEAWS----------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFL 454
C S LV+++ + + R+ + +GL ++
Sbjct: 77 ICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV---KFTLSEIKRVMQMLLNGLYYI 133
Query: 455 HSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYA 514
H KI+H D+K N+L+ + K+ DFG+ R + P+ + + + Y
Sbjct: 134 HR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRV--VTLWYR 188
Query: 515 DPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLP 546
PE P D + G I+ ++ T
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 5e-35
Identities = 67/274 (24%), Positives = 109/274 (39%), Gaps = 30/274 (10%)
Query: 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE---FQQEVRVLSKLQHP 397
+F +G+G FG V GR A+K+L + + E E RVL +HP
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 398 HLVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLH 455
L L A + V EY G L L R+ + AEI S L +LH
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLH 122
Query: 456 SSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 515
S +V+ D+K +N++LD + KI DFG+C+ D + +F G+ Y
Sbjct: 123 S---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC------GTPEYLA 173
Query: 516 PEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAG--EVRRAVSCGKLSSILDPLAGDW 573
PE D + G+++ +++ GRLP + + ++ +
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEI---------RF 224
Query: 574 PTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607
P ++ L + ++R PS KE+
Sbjct: 225 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEV 258
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (329), Expect = 1e-34
Identities = 54/265 (20%), Positives = 95/265 (35%), Gaps = 40/265 (15%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE------FQQEVRVLSKLQHPH-- 398
+G GGFG VY G + VAIK + + E EV +L K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 399 LVTLLGAC--PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 456
++ LL P+++ L+ E + L + ++ + H+
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFITERG--ALQEELARSFFWQVLEAVRHCHN 128
Query: 457 SKPEKIVHGDLKPQNILLDSELSS-KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYAD 515
++H D+K +NIL+D K+ DFG L+ + T G+ Y+
Sbjct: 129 CG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKD--------TVYTDFDGTRVYSP 177
Query: 516 PEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWP 574
PE+ R + +S G+++ ++ G +P E+ R +
Sbjct: 178 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV-------------FFR 224
Query: 575 TFVARRLVDLGLQCCELYGRERPDI 599
V+ L C L +RP
Sbjct: 225 QRVSSECQHLIRWCLALRPSDRPTF 249
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 129 bits (326), Expect = 1e-33
Identities = 55/268 (20%), Positives = 102/268 (38%), Gaps = 29/268 (10%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLE---FQQEVRVLSKLQHPHLVTLL 403
+G G FG V + G A+K+L + + E R+L + P LV L
Sbjct: 48 TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107
Query: 404 GACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
+ + +L V EY+ G + L R AA+I +LHS
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHS---LD 161
Query: 462 IVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT 521
+++ DLKP+N+L+D + ++ DFG + R+ G+ PE +
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK---------RVKGRTWTLCGTPEALAPEIILS 212
Query: 522 GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWPTFVARRL 581
D ++ G++I ++ G P A ++ + +P+ + L
Sbjct: 213 KGYNKAVDWWALGVLIYEMAAGYPP-------FFADQPIQIYEKIVSGKVRFPSHFSSDL 265
Query: 582 VDLGLQCCELYGRERPDITPSLVKELEQ 609
DL ++ +R + V +++
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKN 293
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 3e-33
Identities = 42/204 (20%), Positives = 79/204 (38%), Gaps = 17/204 (8%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTLLG 404
K+G+G +G V+K + VA+K + + + +E+ +L +L+H ++V L
Sbjct: 9 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHD 68
Query: 405 ACPEAWS--LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKI 462
LV+E+ + ++ + ++ GL F H +
Sbjct: 69 VLHSDKKLTLVFEFCDQDLKKYFDSCNGDLD---PEIVKSFLFQLLKGLGFCH---SRNV 122
Query: 463 VHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG 522
+H DLKPQN+L++ K+ +FG+ R P S +
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGI-----PVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 523 VLTPKSDSYSFGLIILQLLTGRLP 546
+ + D +S G I +L P
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRP 201
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 7e-32
Identities = 54/295 (18%), Positives = 99/295 (33%), Gaps = 34/295 (11%)
Query: 332 FSLADLQTATCNFSESFKV----GQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL--E 383
F ++ ++ G G +G V G VAIK LY
Sbjct: 4 FYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR 63
Query: 384 FQQEVRVLSKLQHPHLVTLLGACPEAWS--------LVYEYLPNGSLQDRLFRKSNVSPL 435
+E+R+L ++H +++ LL + LV ++ G+ +L + L
Sbjct: 64 AYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHE---KL 118
Query: 436 LWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495
+ ++ GL ++H+ I+H DLKP N+ ++ + KI DFG+ R
Sbjct: 119 GEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS-- 173
Query: 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR 555
+ + A T D +S G I+ +++TG+ G
Sbjct: 174 ------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL--FKGSDHL 225
Query: 556 AVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610
+ P A + + EL ++ I + L
Sbjct: 226 DQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNL 280
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 118 bits (297), Expect = 6e-30
Identities = 42/207 (20%), Positives = 84/207 (40%), Gaps = 28/207 (13%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLLGA 405
K+G+G + V++ + V +K+L + + ++E+++L L+ P+++TL
Sbjct: 42 KLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGPNIITLADI 98
Query: 406 CPEAWS----LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEK 461
+ S LV+E++ N + L D EI L + HS
Sbjct: 99 VKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSM---G 149
Query: 462 IVHGDLKPQNILLDSELSS-KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHR 520
I+H D+KP N+++D E ++ D+G+ S + PE
Sbjct: 150 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-------EYNVRVASRYFKGPELLV 202
Query: 521 T-GVLTPKSDSYSFGLIILQLLTGRLP 546
+ D +S G ++ ++ + P
Sbjct: 203 DYQMYDYSLDMWSLGCMLASMIFRKEP 229
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 1e-29
Identities = 47/210 (22%), Positives = 80/210 (38%), Gaps = 28/210 (13%)
Query: 349 KVGQGGFGCVYKGE--MLGRTVAIKMLY--SHNMQGQLEFQQEVRVLSKLQHPHLVTLLG 404
+G G G V +L R VAIK L N +E+ ++ + H ++++LL
Sbjct: 24 PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN 83
Query: 405 ACPEAWS--------LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 456
+ LV E + Q + + + ++ G+ LHS
Sbjct: 84 VFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD------HERMSYLLYQMLCGIKHLHS 137
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 516
I+H DLKP NI++ S+ + KI DFG+ R T + Y P
Sbjct: 138 ---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-------FMMTPYVVTRYYRAP 187
Query: 517 EYHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
E D +S G I+ +++ ++
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKIL 217
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 6e-29
Identities = 49/209 (23%), Positives = 79/209 (37%), Gaps = 26/209 (12%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQL--EFQQEVRVLSKLQHPHLVTLLG 404
VG G +G V G VA+K L +E+R+L ++H +++ LL
Sbjct: 25 PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLD 84
Query: 405 ACPEAWSL-------VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
A SL + +L L + + + L + +I GL ++HS
Sbjct: 85 VFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQILRGLKYIHS- 139
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPE 517
I+H DLKP N+ ++ + KI DFG+ + + A
Sbjct: 140 --ADIIHRDLKPSNLAVNEDCELKILDFGLA--------RHTDDEMTGYVATRWYRAPEI 189
Query: 518 YHRTGVLTPKSDSYSFGLIILQLLTGRLP 546
D +S G I+ +LLTGR
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTL 218
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 7e-29
Identities = 64/273 (23%), Positives = 108/273 (39%), Gaps = 28/273 (10%)
Query: 349 KVGQGGFGCVYKGEML-----GRTVAIKML----YSHNMQGQLEFQQEVRVLSKLQH-PH 398
+G G +G V+ + G+ A+K+L + + E +VL ++ P
Sbjct: 31 VLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPF 90
Query: 399 LVTLLGACPEAWSL--VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS 456
LVTL A L + +Y+ G L L ++ + EI L LH
Sbjct: 91 LVTLHYAFQTETKLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHK 147
Query: 457 SKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADP 516
I++ D+K +NILLDS + DFG+ + D R+ G+ Y P
Sbjct: 148 ---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET-----ERAYDFCGTIEYMAP 199
Query: 517 EYHRTGV--LTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLAGDWP 574
+ R G D +S G+++ +LLTG P + GE S ++S + +P
Sbjct: 200 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN---SQAEISRRILKSEPPYP 256
Query: 575 TFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607
++ DL + ++R P E+
Sbjct: 257 QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEI 289
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 105 bits (261), Expect = 4e-25
Identities = 42/250 (16%), Positives = 89/250 (35%), Gaps = 26/250 (10%)
Query: 349 KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC 406
K+G G F V+ + + VA+K++ + + + E+++L ++
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE-AAEDEIKLLQRVNDADNTKEDSMG 78
Query: 407 ---------------PEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGL 451
P +V + G L +K + +I+ ++ GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 452 CFLHSSKPEKIVHGDLKPQNILLDSE-LSSKICDFGICRLVTEDTLYLPSFHRSTAPKGS 510
++H I+H D+KP+N+L++ + I L + +
Sbjct: 139 DYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS----IQT 192
Query: 511 FPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSILDPLA 570
Y PE +D +S +I +L+TG ++ I++ L
Sbjct: 193 REYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELL- 251
Query: 571 GDWPTFVARR 580
G+ P+++ R
Sbjct: 252 GELPSYLLRN 261
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 83.7 bits (206), Expect = 4e-19
Identities = 27/152 (17%), Positives = 45/152 (29%), Gaps = 19/152 (12%)
Query: 349 KVGQGGFGCVYKGEML-GRTVAIKML----------YSHNMQGQLEFQQEVRVLSKLQHP 397
+G+G V+ +K G L F ++ +
Sbjct: 7 LMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFR 66
Query: 398 HLVTLLGACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS 457
L L G Y + N L + L + + ++ + I + +
Sbjct: 67 ALQKLQGLAVPKV---YAWEGNAVLME-LIDAKELYRVRVENPDEVLDMILEEVAKFYH- 121
Query: 458 KPEKIVHGDLKPQNILLDSELSSKICDFGICR 489
IVHGDL N+L+ E I DF
Sbjct: 122 --RGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
| >d1t1ha_ g.44.1.2 (A:) E3 ubiquitin ligase PUB14 {Thale-cress (Arabidopsis thaliana) [TaxId: 3702]} Length = 78 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: E3 ubiquitin ligase PUB14 species: Thale-cress (Arabidopsis thaliana) [TaxId: 3702]
Score = 79.0 bits (194), Expect = 9e-19
Identities = 28/68 (41%), Positives = 39/68 (57%)
Query: 618 VPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHAL 677
P +F CPI E+M DP + + G TYE +I+ WL+ G +T P + L H LTPN+ L
Sbjct: 5 FPEYFRCPISLELMKDPVIVSTGQTYERSSIQKWLDAGHKTCPKSQETLLHAGLTPNYVL 64
Query: 678 RHAIQDWL 685
+ I W
Sbjct: 65 KSLIALWC 72
|
| >d2c2la2 g.44.1.2 (A:225-304) STIP1 homology and U box-containing protein 1, STUB1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 80 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: STIP1 homology and U box-containing protein 1, STUB1 species: Mouse (Mus musculus) [TaxId: 10090]
Score = 67.6 bits (164), Expect = 1e-14
Identities = 20/74 (27%), Positives = 38/74 (51%)
Query: 615 ERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPN 674
+R +P + I E+M +P + G TY+ K I + L+ +P+T L+ L PN
Sbjct: 1 KRDIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFNPVTRSPLTQEQLIPN 60
Query: 675 HALRHAIQDWLCKS 688
A++ I ++ ++
Sbjct: 61 LAMKEVIDAFISEN 74
|
| >d1wgma_ g.44.1.2 (A:) Ubiquitin conjugation factor E4A {Human (Homo sapiens) [TaxId: 9606]} Length = 98 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: Ubiquitin conjugation factor E4A species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.9 bits (139), Expect = 3e-11
Identities = 20/81 (24%), Positives = 29/81 (35%)
Query: 605 KELEQLHVAEERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNL 664
L+Q FL PI+ +M DP V ++ +T P
Sbjct: 6 SGLQQQEEETYADACDEFLDPIMSTLMCDPVVLPSSRVTVDRSTIARHLLSDQTDPFNRS 65
Query: 665 RLSHLHLTPNHALRHAIQDWL 685
L+ + PN L+ IQ WL
Sbjct: 66 PLTMDQIRPNTELKEKIQRWL 86
|
| >d1jm7a_ g.44.1.1 (A:) brca1 RING domain {Human (Homo sapiens) [TaxId: 9606]} Length = 103 | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: brca1 RING domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.7 bits (105), Expect = 2e-06
Identities = 13/90 (14%), Positives = 32/90 (35%), Gaps = 6/90 (6%)
Query: 598 DITPSLVKELEQLHVAEERPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLE--NG 655
D++ V+E++ + + CPI E++ +P + + L G
Sbjct: 2 DLSALRVEEVQNV----INAMQKILECPICLELIKEPVSTKCDHIFCKFCMLKLLNQKKG 57
Query: 656 RETSPMTNLRLSHLHLTPNHALRHAIQDWL 685
P+ ++ L + +++ L
Sbjct: 58 PSQCPLCKNDITKRSLQESTRFSQLVEELL 87
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 688 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.9 | |
| d1wgma_ | 98 | Ubiquitin conjugation factor E4A {Human (Homo sapi | 98.84 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.78 | |
| d1t1ha_ | 78 | E3 ubiquitin ligase PUB14 {Thale-cress (Arabidopsi | 98.72 | |
| d2c2la2 | 80 | STIP1 homology and U box-containing protein 1, STU | 98.67 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.27 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.0 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.76 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.48 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.26 | |
| d2baya1 | 56 | Pre-mRNA splicing factor Prp19 {Baker's yeast (Sac | 94.4 | |
| d1jm7b_ | 97 | bard1 RING domain {Human (Homo sapiens) [TaxId: 96 | 93.59 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=378.67 Aligned_cols=257 Identities=29% Similarity=0.452 Sum_probs=209.0
Q ss_pred HCCCCCCEEEECCCCEEEEEEEECCEEEEEEEEECCCC--CCHHHHHHHHHHHHCCCCCCEEEEECCCCC-CCEEEEECC
Q ss_conf 26953230340138658999999890999999723893--346999999999970799941247054478-742377607
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYEYL 417 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV~E~~ 417 (688)
.++|...+.||+|+||+||+|++.+ .||||+++.... .....|.+|+.++.+++|||||+++|++.+ ..++||||+
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~Ey~ 85 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWC 85 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECC
T ss_pred CCCEEEEEEEEECCCCEEEEEEECC-EEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCEEEEEEECC
T ss_conf 4518998898307885899999999-899999973469989999999999999847998786456797155899999658
Q ss_pred CCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 89967888612499998999999999999999999985069981571899999622079997699105731001578876
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~ 497 (688)
++|+|.+++.... ..+++..++.|+.|+|.||.|||+.+ |+||||||+|||++.++.+||+|||+|+........
T Consensus 86 ~~g~L~~~l~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~ 160 (276)
T d1uwha_ 86 EGSSLYHHLHIIE--TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGS 160 (276)
T ss_dssp CEEEHHHHHHTSC--CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-------
T ss_pred CCCCHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCHHHEEECCCCCEEECCCCCEEECCCCCCC
T ss_conf 9988899985235--78999999999999999988875099---951614789979818997887500221333556776
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHCC---CCCCCCCHHHHHHHHHHHHHHCCCCCCCHH---HHHHHHHCCCCCCCCCCCCC
Q ss_conf 777655689988988888120104---999982027679999999980999999815---68988521963223578889
Q 005617 498 LPSFHRSTAPKGSFPYADPEYHRT---GVLTPKSDSYSFGLIILQLLTGRLPVGLAG---EVRRAVSCGKLSSILDPLAG 571 (688)
Q Consensus 498 ~~~~~~~~~~~Gt~~Y~APE~~~~---~~~s~ksDVwSlGviL~ELltG~~Pf~~~~---~i~~~i~~~~l~~~ld~~~~ 571 (688)
.......||+.|||||++.+ ..|+.++|||||||+||||+||+.||.... .+...+..+... |...
T Consensus 161 ----~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~----p~~~ 232 (276)
T d1uwha_ 161 ----HQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS----PDLS 232 (276)
T ss_dssp ---------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCC----CCGG
T ss_pred ----CCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCC----CCCH
T ss_conf ----31256655743179999950568999953151635999999997889989989699999999658889----8600
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 99979999999999982126999999993689999998530
Q 005617 572 DWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 572 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~L~~l~~ 612 (688)
..+..++..+.+|+.+||+.||.+|||+. +++..|+.+..
T Consensus 233 ~~~~~~~~~l~~li~~cl~~dp~~RPt~~-~il~~Le~l~~ 272 (276)
T d1uwha_ 233 KVRSNCPKAMKRLMAECLKKKRDERPLFP-QILASIELLAR 272 (276)
T ss_dssp GSCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred HCCCCCHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHH
T ss_conf 03655549999999997588976892999-99999999997
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=376.30 Aligned_cols=265 Identities=26% Similarity=0.411 Sum_probs=210.5
Q ss_pred CCHHHHHHHHC---------CCCCCEEEECCCCEEEEEEEEC--C---EEEEEEEEECCCCC-CHHHHHHHHHHHHCCCC
Q ss_conf 49888998726---------9532303401386589999998--9---09999997238933-46999999999970799
Q 005617 332 FSLADLQTATC---------NFSESFKVGQGGFGCVYKGEML--G---RTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQH 396 (688)
Q Consensus 332 ~~~~el~~at~---------~f~~~~~LG~G~fG~Vykg~~~--g---~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l~H 396 (688)
|+++++..++. +|...+.||+|+||+||+|.+. | ..||||.+...... ....|.+|+.+|++++|
T Consensus 7 ~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~H 86 (299)
T d1jpaa_ 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86 (299)
T ss_dssp GGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCC
T ss_pred CCHHHHHHHHHHHCHHHCHHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCC
T ss_conf 88798999996046220800427856980278829999999579978899999997844598999999999999985799
Q ss_pred CCEEEEECCCC--CCCEEEEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEE
Q ss_conf 94124705447--8742377607899678886124999989999999999999999999850699815718999996220
Q 005617 397 PHLVTLLGACP--EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL 474 (688)
Q Consensus 397 pnIV~l~g~~~--~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILL 474 (688)
||||+++|+|. +..++||||+++|+|.+++.... ..++|..++.|+.|++.||.|||+.+ |+||||||+||||
T Consensus 87 pnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~--~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl 161 (299)
T d1jpaa_ 87 PNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQND--GQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILV 161 (299)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEE
T ss_pred CCCCCEEEEEEECCEEEEEEEECCCCCCEEEECCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEE
T ss_conf 888618999962887799997227985300210456--79999999999999999889885279---8357615044898
Q ss_pred CCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCHHH-
Q ss_conf 79997699105731001578876777655689988988888120104999982027679999999980-9999998156-
Q 005617 475 DSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE- 552 (688)
Q Consensus 475 d~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELlt-G~~Pf~~~~~- 552 (688)
+.++.+||+|||+++......... .........||+.|+|||++.+..++.++|||||||++|||+| |++||.....
T Consensus 162 ~~~~~~Kl~DFGla~~~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~ 240 (299)
T d1jpaa_ 162 NSNLVCKVSDFGLSRFLEDDTSDP-TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240 (299)
T ss_dssp CTTCCEEECCC------------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred CCCCCEEECCCCCCEECCCCCCCC-EEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHH
T ss_conf 899919988844315756777765-3650256668830038788836997861214453578999986799999999999
Q ss_pred -HHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf -89885219632235788899997999999999998212699999999368999999853
Q 005617 553 -VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 553 -i~~~i~~~~l~~~ld~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~L~~l~ 611 (688)
+...+..+.. ...+..++..+.+|+.+||+.||.+||++. +++..|+.+.
T Consensus 241 ~~~~~i~~~~~--------~~~~~~~~~~l~~li~~cl~~~P~~RPs~~-ei~~~L~~~l 291 (299)
T d1jpaa_ 241 DVINAIEQDYR--------LPPPMDCPSALHQLMLDCWQKDRNHRPKFG-QIVNTLDKMI 291 (299)
T ss_dssp HHHHHHHTTCC--------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHH-HHHHHHHHHH
T ss_pred HHHHHHHCCCC--------CCCCCCCHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHH
T ss_conf 99999973788--------999742269999999997587976892999-9999999984
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=371.14 Aligned_cols=252 Identities=29% Similarity=0.429 Sum_probs=207.0
Q ss_pred HCCCCCCEEEECCCCEEEEEEEEC-CEEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCEEEEECCCCC-CCEEEEECCC
Q ss_conf 269532303401386589999998-90999999723893346999999999970799941247054478-7423776078
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYEYLP 418 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~-g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV~E~~~ 418 (688)
.++|.....||+|+||.||+|.+. +..||||++.... .....|.+|+.++.+++|||||+++|+|.+ ..++||||++
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey~~ 90 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYME 90 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCT
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEECC
T ss_conf 89938867981079828999999999999999986476-88899999999998679998857873104597699999578
Q ss_pred CCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 99678886124999989999999999999999999850699815718999996220799976991057310015788767
Q 005617 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 498 (688)
+|+|.+++..... ..+++..++.|+.||+.||.|||+.+ |+||||||+||||+.++.+||+|||+|+.......
T Consensus 91 ~g~L~~~~~~~~~-~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-- 164 (272)
T d1qpca_ 91 NGSLVDFLKTPSG-IKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-- 164 (272)
T ss_dssp TCBHHHHTTSHHH-HTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE--
T ss_pred CCCHHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCEEECCCCCEEECCCCCC--
T ss_conf 9828888751478-98878899999999999999997489---54675642251562024404234101477358864--
Q ss_pred CCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCC-CCCCCHH--HHHHHHHCCCCCCCCCCCCCCCCH
Q ss_conf 7765568998898888812010499998202767999999998099-9999815--689885219632235788899997
Q 005617 499 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR-LPVGLAG--EVRRAVSCGKLSSILDPLAGDWPT 575 (688)
Q Consensus 499 ~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELltG~-~Pf~~~~--~i~~~i~~~~l~~~ld~~~~~~~~ 575 (688)
.......||+.|+|||++.+..++.++|||||||++|||+||. +|+.... .+...+..+. ....|.
T Consensus 165 ---~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~--------~~~~p~ 233 (272)
T d1qpca_ 165 ---TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY--------RMVRPD 233 (272)
T ss_dssp ---ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--------CCCCCT
T ss_pred ---CCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCC--------CCCCCC
T ss_conf ---420356774444582898379998245645257999999968988888889999999997068--------888965
Q ss_pred HHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 999999999998212699999999368999999853
Q 005617 576 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 576 ~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~L~~l~ 611 (688)
.++..+.+|+.+||+.||.+|||+. .+++.|+.+.
T Consensus 234 ~~~~~l~~li~~cl~~~P~~Rpt~~-ei~~~L~~~f 268 (272)
T d1qpca_ 234 NCPEELYQLMRLCWKERPEDRPTFD-YLRSVLEDFF 268 (272)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHH
T ss_pred CCHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHH
T ss_conf 5719999999997588976893999-9999861132
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=371.39 Aligned_cols=243 Identities=25% Similarity=0.391 Sum_probs=203.9
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCEEEEECCCC--CCCEEEEECC
Q ss_conf 69532303401386589999998--9099999972389334699999999997079994124705447--8742377607
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 417 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~ 417 (688)
.+|.....||+|+||.||+|... |..||||++..........+.+|+.++++++|||||++++++. +..++||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEEC
T ss_conf 05388789812858299999998999899999984301727999999999998679998805857798899989999703
Q ss_pred CCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 89967888612499998999999999999999999985069981571899999622079997699105731001578876
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~ 497 (688)
++|+|.+++.. ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+.....
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~- 171 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS- 171 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-
T ss_pred CCCCHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCC-
T ss_conf 79808988641----59999999999999999999999879---72267768886887899686425156413213666-
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHHHHHH--HHCCCCCCCCCCCCCCCCH
Q ss_conf 77765568998898888812010499998202767999999998099999981568988--5219632235788899997
Q 005617 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA--VSCGKLSSILDPLAGDWPT 575 (688)
Q Consensus 498 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELltG~~Pf~~~~~i~~~--i~~~~l~~~ld~~~~~~~~ 575 (688)
......||+.|+|||++.+..|+.++|||||||++|+|+||+.||......... +..+... ....+.
T Consensus 172 -----~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~------~~~~~~ 240 (293)
T d1yhwa1 172 -----KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP------ELQNPE 240 (293)
T ss_dssp -----CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC------CCSSGG
T ss_pred -----CCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCC------CCCCCC
T ss_conf -----444444477736826644799880120313729999980488998997999999999857999------888855
Q ss_pred HHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf 9999999999982126999999993689
Q 005617 576 FVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 576 ~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
.++..+.+|+.+||+.||.+|||+.+.+
T Consensus 241 ~~s~~~~~li~~~L~~dP~~R~s~~eil 268 (293)
T d1yhwa1 241 KLSAIFRDFLNRCLDMDVEKRGSAKELL 268 (293)
T ss_dssp GSCHHHHHHHHHHTCSSTTTSCCHHHHT
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 3799999999998669966890999996
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.62 Aligned_cols=251 Identities=27% Similarity=0.472 Sum_probs=207.8
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC-CEEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCEEEEECCCC--CCCEEEEECCC
Q ss_conf 69532303401386589999998-9099999972389334699999999997079994124705447--87423776078
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYLP 418 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~-g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~~ 418 (688)
++|.....||+|+||.||+|.+. +..||||++.... .....|.+|+.++.+++|||||+++|+|. +..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEECC
T ss_conf 9958888982088829999998899999999987886-768999999999996689975653524315993379998369
Q ss_pred CCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 99678886124999989999999999999999999850699815718999996220799976991057310015788767
Q 005617 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 498 (688)
+|+|.+++.... ..+++..++.|+.|+|.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 84 ~g~L~~~l~~~~--~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~- 157 (263)
T d1sm2a_ 84 HGCLSDYLRTQR--GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT- 157 (263)
T ss_dssp TCBHHHHHHTTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred CCCHHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCHHHEEECCCCCEEECCCCHHEECCCCCCE-
T ss_conf 991899752013--47889999999999999877653164---310443153266668877686553210023688733-
Q ss_pred CCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCHHH--HHHHHHCCCCCCCCCCCCCCCCH
Q ss_conf 77655689988988888120104999982027679999999980-9999998156--89885219632235788899997
Q 005617 499 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPT 575 (688)
Q Consensus 499 ~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELlt-G~~Pf~~~~~--i~~~i~~~~l~~~ld~~~~~~~~ 575 (688)
......||+.|+|||++.+..++.++|||||||++|||+| |.+||..... +...+..+.. ...|.
T Consensus 158 ----~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~--------~~~p~ 225 (263)
T d1sm2a_ 158 ----SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR--------LYKPR 225 (263)
T ss_dssp -----------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC--------CCCCT
T ss_pred ----EECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC--------CCCCC
T ss_conf ----504300176667857860799984033210599999998789888778999999999980688--------89954
Q ss_pred HHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 9999999999982126999999993689999998530
Q 005617 576 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 576 ~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~L~~l~~ 612 (688)
..+..+.+|+.+||+.||.+||++. ++++.|+.+..
T Consensus 226 ~~~~~l~~li~~cl~~~p~~Rps~~-~il~~L~~i~e 261 (263)
T d1sm2a_ 226 LASTHVYQIMNHCWKERPEDRPAFS-RLLRQLAEIAE 261 (263)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHH
T ss_conf 3679999999997657976891999-99999999985
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.46 Aligned_cols=254 Identities=27% Similarity=0.408 Sum_probs=207.9
Q ss_pred CCCCCCE-EEECCCCEEEEEEEEC----CEEEEEEEEECCCC-CCHHHHHHHHHHHHCCCCCCEEEEECCCC-CCCEEEE
Q ss_conf 6953230-3401386589999998----90999999723893-34699999999997079994124705447-8742377
Q 005617 342 CNFSESF-KVGQGGFGCVYKGEML----GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP-EAWSLVY 414 (688)
Q Consensus 342 ~~f~~~~-~LG~G~fG~Vykg~~~----g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~-~~~~LV~ 414 (688)
++|.... +||+|+||.||+|.+. +..||||+++.... .....|.+|+.++.+++|||||+++|+|. +..++||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvm 87 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVM 87 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEE
T ss_pred CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCEEEEEE
T ss_conf 47188784873060809999999608976899999988203978999999999999867998880686560368079999
Q ss_pred ECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 60789967888612499998999999999999999999985069981571899999622079997699105731001578
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 494 (688)
||+++|+|.+++.... ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 88 E~~~~g~L~~~l~~~~--~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~ 162 (285)
T d1u59a_ 88 EMAGGGPLHKFLVGKR--EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD 162 (285)
T ss_dssp ECCTTEEHHHHHTTCT--TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred EECCCCCHHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEECCCHHHHCCCCC
T ss_conf 8078996899752125--69999999999999999878998688---105767646604546885420331342115543
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCHH--HHHHHHHCCCCCCCCCCCCC
Q ss_conf 876777655689988988888120104999982027679999999980-999999815--68988521963223578889
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLAG 571 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELlt-G~~Pf~~~~--~i~~~i~~~~l~~~ld~~~~ 571 (688)
.... .......||+.|+|||++....++.++|||||||++|||+| |+.||.... .+...+..+.. .
T Consensus 163 ~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~--------~ 231 (285)
T d1u59a_ 163 DSYY---TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR--------M 231 (285)
T ss_dssp SCEE---CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC--------C
T ss_pred CCCC---CCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC--------C
T ss_conf 4321---1356211374335868872799995412322017899999389999999799999999981899--------9
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 99979999999999982126999999993689999998530
Q 005617 572 DWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 572 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~L~~l~~ 612 (688)
..|..++..+.+|+.+||+.+|.+||++. .+.+.|+....
T Consensus 232 ~~p~~~~~~l~~li~~cl~~~p~~RPs~~-~i~~~L~~~~~ 271 (285)
T d1u59a_ 232 ECPPECPPELYALMSDCWIYKWEDRPDFL-TVEQRMRACYY 271 (285)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHH
T ss_conf 99976789999999997577976890999-99999999999
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=371.94 Aligned_cols=253 Identities=25% Similarity=0.409 Sum_probs=208.5
Q ss_pred HHCCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCEEEEE
Q ss_conf 7269532303401386589999998--90999999723893346999999999970799941247054478--7423776
Q 005617 340 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 340 at~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E 415 (688)
..++|.....||+|+||+||+|.+. |..||||+++... .....|.+|+.++++++|||||+++|+|.+ ..++|||
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEEEE
T ss_conf 5799398659820888089999999999699999977761-039999999999986799988267752745785478763
Q ss_pred CCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 07899678886124999989999999999999999999850699815718999996220799976991057310015788
Q 005617 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 495 (688)
|+++|+|.+++..... ..+++..++.|+.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+|+......
T Consensus 94 ~~~~g~l~~~l~~~~~-~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 94 FMTYGNLLDYLRECNR-QEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp CCTTCBHHHHHHHSCT-TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred CCCCCCHHHHHHHCCC-CCHHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEEECCCCC
T ss_conf 1467606777530355-41579999999999999788898789---3057604576899899928983244546537887
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCC-CHH--HHHHHHHCCCCCCCCCCCCCC
Q ss_conf 76777655689988988888120104999982027679999999980999999-815--689885219632235788899
Q 005617 496 LYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVG-LAG--EVRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 496 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELltG~~Pf~-~~~--~i~~~i~~~~l~~~ld~~~~~ 572 (688)
.. ......|++.|+|||++.+..|+.++|||||||++|||++|..|+. ... .+...+..+. ...
T Consensus 170 ~~-----~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~--------~~~ 236 (287)
T d1opja_ 170 YT-----AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY--------RME 236 (287)
T ss_dssp SE-----EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC--------CCC
T ss_pred CE-----EECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCC--------CCC
T ss_conf 22-----10355665466692787279998104302178999999867998877425999999985588--------888
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 997999999999998212699999999368999999853
Q 005617 573 WPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~L~~l~ 611 (688)
.+..++..+.+|+.+||+.||.+|||+. ++.+.|+.+.
T Consensus 237 ~~~~~~~~l~~li~~cl~~dP~~Rps~~-ei~~~L~~~~ 274 (287)
T d1opja_ 237 RPEGCPEKVYELMRACWQWNPSDRPSFA-EIHQAFETMF 274 (287)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHTT
T ss_pred CCCCCHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHH
T ss_conf 8743309999999997577976893999-9999999998
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.49 Aligned_cols=244 Identities=22% Similarity=0.302 Sum_probs=202.5
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCEEEEECCCC--CCCEEEEECC
Q ss_conf 69532303401386589999998--9099999972389334699999999997079994124705447--8742377607
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAWSLVYEYL 417 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~~LV~E~~ 417 (688)
+.|.....||+|+||.||+|++. |..||+|++..........|.+|+.++++++|||||++++++. +..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf 37598479930778199999999999399999987289999999999999998679999884988980099589999627
Q ss_pred CCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 89967888612499998999999999999999999985069981571899999622079997699105731001578876
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~ 497 (688)
++|+|.+++.... ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+......
T Consensus 92 ~~g~L~~~~~~~~--~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-- 164 (288)
T d2jfla1 92 AGGAVDAVMLELE--RPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-- 164 (288)
T ss_dssp TTEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred CCCCHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEECCHHHEEECCCCCEEEEECHHHHCCCCCC--
T ss_conf 9981889998628--99999999999999999999999889---8871407003148789998997161230357786--
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHC-----CCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCCCCCCC
Q ss_conf 77765568998898888812010-----49999820276799999999809999998156--898852196322357888
Q 005617 498 LPSFHRSTAPKGSFPYADPEYHR-----TGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 498 ~~~~~~~~~~~Gt~~Y~APE~~~-----~~~~s~ksDVwSlGviL~ELltG~~Pf~~~~~--i~~~i~~~~l~~~ld~~~ 570 (688)
.......||+.|+|||++. ...|+.++|||||||++|||+||+.||..... +...+..+... .
T Consensus 165 ----~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~------~ 234 (288)
T d2jfla1 165 ----QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPP------T 234 (288)
T ss_dssp ----HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCC------C
T ss_pred ----CCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCC------C
T ss_conf ----410010256264799998320257888880665787899999982088999998999999999707998------7
Q ss_pred CCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHH
Q ss_conf 99997999999999998212699999999368
Q 005617 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 571 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~ 602 (688)
...+...+..+.+|+.+||+.||.+|||+.+.
T Consensus 235 ~~~~~~~s~~~~~li~~~L~~dp~~R~t~~el 266 (288)
T d2jfla1 235 LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQL 266 (288)
T ss_dssp CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf 77656699999999999766996689199999
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=366.11 Aligned_cols=252 Identities=28% Similarity=0.449 Sum_probs=205.1
Q ss_pred HCCCCCCEEEECCCCEEEEEEEECC-------EEEEEEEEECCC-CCCHHHHHHHHHHHHCC-CCCCEEEEECCCCC--C
Q ss_conf 2695323034013865899999989-------099999972389-33469999999999707-99941247054478--7
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEMLG-------RTVAIKMLYSHN-MQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--A 409 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~g-------~~VAIK~l~~~~-~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~ 409 (688)
.++|.+...||+|+||+||+|++.+ ..||+|.+.... ......|.+|+.++.++ +|||||+++|+|.+ .
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCE
T ss_conf 89939701983078819999998578855420499999966335878999999999999971589968687788862995
Q ss_pred CEEEEECCCCCCHHHHHCCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCC
Q ss_conf 4237760789967888612499--------------------99899999999999999999998506998157189999
Q 005617 410 WSLVYEYLPNGSLQDRLFRKSN--------------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKP 469 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~~--------------------~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp 469 (688)
.++||||+++|+|.++|..... ...+++..++.|+.|++.||.|||+.+ |+||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCH
T ss_conf 899997279995999998625777510221000012220012577899999999999999999997399---05052703
Q ss_pred CCEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHH-CCCCCC
Q ss_conf 9622079997699105731001578876777655689988988888120104999982027679999999980-999999
Q 005617 470 QNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVG 548 (688)
Q Consensus 470 ~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELlt-G~~Pf~ 548 (688)
+|||++.++.+||+|||+|+........ .......||+.|||||++.+..++.++|||||||++|||+| |++||.
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNY----VVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTS----EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred HCCCCCCCCEEEEEECCCCCCCCCCCCE----EEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCC
T ss_conf 2144345982898514222204577861----562343578765783887279999633030003999999838999999
Q ss_pred CHHH---HHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 8156---89885219632235788899997999999999998212699999999368999999
Q 005617 549 LAGE---VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 549 ~~~~---i~~~i~~~~l~~~ld~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~L~ 608 (688)
.... +...+..+. ..+.|..++..+.+|+.+||+.||.+|||+. ++++.|.
T Consensus 269 ~~~~~~~~~~~~~~~~--------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~-ei~~~L~ 322 (325)
T d1rjba_ 269 GIPVDANFYKLIQNGF--------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFP-NLTSFLG 322 (325)
T ss_dssp TCCCSHHHHHHHHTTC--------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHH
T ss_pred CCCHHHHHHHHHHCCC--------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHH
T ss_conf 9898999999985699--------8998876789999999997588966893999-9999974
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=365.22 Aligned_cols=246 Identities=22% Similarity=0.358 Sum_probs=204.0
Q ss_pred HCCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCEEEEEC
Q ss_conf 269532303401386589999998--90999999723893346999999999970799941247054478--74237760
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
-++|.+...||+|+||.||+|... |..||||++..........+.+|+.++.+++|||||++++++.+ ..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 65758988984076819999998899989999998452431699999999999867997999299999989999999985
Q ss_pred CCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEEC--CCCCEEEEECCCCCCCCCC
Q ss_conf 78996788861249999899999999999999999998506998157189999962207--9997699105731001578
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD--SELSSKICDFGICRLVTED 494 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd--~~~~vKL~DFGla~~~~~~ 494 (688)
++||+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+|+.+...
T Consensus 105 ~~gg~L~~~l~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVADEH--NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTCTT--SCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHHHC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CEEEEECHHHEEECCCCCCEEEEEECCHHEECCCC
T ss_conf 79988999997623--78999999999999999999997569---76000154673641688986999545210442565
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCCCCCCCCC
Q ss_conf 8767776556899889888881201049999820276799999999809999998156--89885219632235788899
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELltG~~Pf~~~~~--i~~~i~~~~l~~~ld~~~~~ 572 (688)
. ......||+.|||||++.+..++.++|||||||++|+|++|+.||..... +...+..+.... ...
T Consensus 180 ~-------~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~-----~~~ 247 (350)
T d1koaa2 180 Q-------SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNM-----DDS 247 (350)
T ss_dssp S-------CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCS-----CCG
T ss_pred C-------CCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCC-----CCC
T ss_conf 4-------3200068624218899758998726765546599999985989989979999999998478898-----942
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf 9979999999999982126999999993689
Q 005617 573 WPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
....++..+.+|+.+||..||.+|||+.+.+
T Consensus 248 ~~~~~s~~~~~li~~~L~~dP~~R~t~~eil 278 (350)
T d1koaa2 248 AFSGISEDGKDFIRKLLLADPNTRMTIHQAL 278 (350)
T ss_dssp GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 2358999999999997568966790899986
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.55 Aligned_cols=254 Identities=26% Similarity=0.398 Sum_probs=205.9
Q ss_pred CCCCCCEEEECCCCEEEEEEEECC------EEEEEEEEECCCCC-CHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCEE
Q ss_conf 695323034013865899999989------09999997238933-46999999999970799941247054478--7423
Q 005617 342 CNFSESFKVGQGGFGCVYKGEMLG------RTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSL 412 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~g------~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~L 412 (688)
..|...+.||+|+||.||+|.+.+ ..||||++...... ....|.+|+.++.+++|||||+++|+|.+ ..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEE
T ss_conf 99686159811779099999996899878799999998844596899999999999985689878323677833880389
Q ss_pred EEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 77607899678886124999989999999999999999999850699815718999996220799976991057310015
Q 005617 413 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 492 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 492 (688)
||||+.+|++.+.+.... ..++|..++.|+.|++.||.|||+.+ |+||||||+||||+.++.+||+|||+++...
T Consensus 87 v~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREKD--GEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHTT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEECCCCCCHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHCCCCC---CCCCCCCCCEEEECCCCEEEECCCCHHHCCC
T ss_conf 997213574022210234--54208999999999998541212123---4257656442788899849984551030035
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCC-CCHH--HHHHHHHCCCCCCCCCCC
Q ss_conf 7887677765568998898888812010499998202767999999998099999-9815--689885219632235788
Q 005617 493 EDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPV-GLAG--EVRRAVSCGKLSSILDPL 569 (688)
Q Consensus 493 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELltG~~Pf-~~~~--~i~~~i~~~~l~~~ld~~ 569 (688)
..... ........||+.|+|||++....++.++|||||||++|||++|..|+ .... .+...+..+.
T Consensus 162 ~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~-------- 230 (283)
T d1mqba_ 162 DDPEA---TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF-------- 230 (283)
T ss_dssp ---------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC--------
T ss_pred CCCCC---CEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC--------
T ss_conf 78765---2674267777343488887049999735563448989999967988655689999999986357--------
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 8999979999999999982126999999993689999998530
Q 005617 570 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 570 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~L~~l~~ 612 (688)
....+..++..+.+|+.+||+.+|.+||++. ++++.|+.+..
T Consensus 231 ~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~-eil~~L~~l~~ 272 (283)
T d1mqba_ 231 RLPTPMDCPSAIYQLMMQCWQQERARRPKFA-DIVSILDKLIR 272 (283)
T ss_dssp CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHH-HHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHH
T ss_conf 8998504579999999997767976893999-99999999866
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.55 Aligned_cols=245 Identities=28% Similarity=0.443 Sum_probs=202.1
Q ss_pred EEEECCCCEEEEEEEEC----CEEEEEEEEECCCCC--CHHHHHHHHHHHHCCCCCCEEEEECCCCC-CCEEEEECCCCC
Q ss_conf 03401386589999998----909999997238933--46999999999970799941247054478-742377607899
Q 005617 348 FKVGQGGFGCVYKGEML----GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYEYLPNG 420 (688)
Q Consensus 348 ~~LG~G~fG~Vykg~~~----g~~VAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV~E~~~~g 420 (688)
++||+|+||.||+|.+. +..||||+++..... ....|.+|+.++++++|||||+++|+|.+ ..++||||+++|
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g 92 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 92 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTE
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEEEEEECCCCC
T ss_conf 78345878299999981697385999999880108989999999999999867998985277775059779999747889
Q ss_pred CHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCCC
Q ss_conf 67888612499998999999999999999999985069981571899999622079997699105731001578876777
Q 005617 421 SLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPS 500 (688)
Q Consensus 421 sL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~ 500 (688)
+|.+++... ..+++..++.|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+......
T Consensus 93 ~L~~~l~~~---~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~--- 163 (277)
T d1xbba_ 93 PLNKYLQQN---RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY--- 163 (277)
T ss_dssp EHHHHHHHC---TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE---
T ss_pred CHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCC---
T ss_conf 689997522---57899999999999999976687479---556777611310235675123413453313432344---
Q ss_pred CCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCHH--HHHHHHHCCCCCCCCCCCCCCCCHHH
Q ss_conf 655689988988888120104999982027679999999980-999999815--68988521963223578889999799
Q 005617 501 FHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLAGDWPTFV 577 (688)
Q Consensus 501 ~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELlt-G~~Pf~~~~--~i~~~i~~~~l~~~ld~~~~~~~~~~ 577 (688)
........||+.|+|||++....++.++|||||||++|||+| |++||.... .+...+..+.. ...|..+
T Consensus 164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~--------~~~p~~~ 235 (277)
T d1xbba_ 164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER--------MGCPAGC 235 (277)
T ss_dssp EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC--------CCCCTTC
T ss_pred CCCCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC--------CCCCCCC
T ss_conf 32244567784203916653799984344303403132896589999999899999999982899--------9998656
Q ss_pred HHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 999999999821269999999936899999985
Q 005617 578 ARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 578 ~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~L~~l 610 (688)
+..+.+|+.+||+.||.+||++. ++...|+..
T Consensus 236 ~~~~~~li~~cl~~dp~~RPs~~-~i~~~L~~~ 267 (277)
T d1xbba_ 236 PREMYDLMNLCWTYDVENRPGFA-AVELRLRNY 267 (277)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHH-HHHHHHHHH
T ss_pred CHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHCH
T ss_conf 79999999997588976890989-999985288
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=368.48 Aligned_cols=254 Identities=24% Similarity=0.380 Sum_probs=201.6
Q ss_pred HHCCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCC-CCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCEEEE
Q ss_conf 7269532303401386589999998--90999999723893-346999999999970799941247054478--742377
Q 005617 340 ATCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 340 at~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
..++|....+||+|+||+||+|... |..||+|+++.... .....+.+|+.+++.++|||||+++++|.+ ..++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 75688897897127780999999989996999999875409789999999999998679999994999999899999999
Q ss_pred ECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCC-CCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 6078996788861249999899999999999999999998506-998157189999962207999769910573100157
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSS-KPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~-~~~~IiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 493 (688)
||+++|+|.+++.+.. .+++..+..++.|++.||.|||+. + |+||||||+|||++.++.+||+|||+|+...+
T Consensus 84 Ey~~gg~L~~~l~~~~---~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred ECCCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf 7679986899874249---99999999999999999999998599---97144577994687899899954877625678
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHHHHHHHH-----CCCCCC----
Q ss_conf 88767776556899889888881201049999820276799999999809999998156898852-----196322----
Q 005617 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS-----CGKLSS---- 564 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELltG~~Pf~~~~~i~~~i~-----~~~l~~---- 564 (688)
.. ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||........... .+....
T Consensus 158 ~~--------~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (322)
T d1s9ja_ 158 SM--------ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 229 (322)
T ss_dssp HT--------C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------
T ss_pred CC--------CCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCC
T ss_conf 86--------2111377141194687589989488899899999999988899899887899999988751775457742
Q ss_pred ---------------------------CCCCCCCCCC-HHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHH
Q ss_conf ---------------------------3578889999-799999999999821269999999936899999
Q 005617 565 ---------------------------ILDPLAGDWP-TFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 565 ---------------------------~ld~~~~~~~-~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~L 607 (688)
+........+ ...+..+.+|+.+||+.||.+|||+.+.+.+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf 300 (322)
T d1s9ja_ 230 PRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAF 300 (322)
T ss_dssp ----------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred CCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHCHH
T ss_conf 12333221111222354134778876650268766764448999999999986899467908999960986
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=363.41 Aligned_cols=246 Identities=23% Similarity=0.333 Sum_probs=205.1
Q ss_pred HCCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCEEEEEC
Q ss_conf 269532303401386589999998--90999999723893346999999999970799941247054478--74237760
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
.++|.+...||+|+||.||+|... |..||||++..........+.+|+.++.+++|||||++++++.+ ..++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 40359989993177829999999899979999998872646799999999999867997989199999989999999982
Q ss_pred CCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEEC--CCCCEEEEECCCCCCCCCC
Q ss_conf 78996788861249999899999999999999999998506998157189999962207--9997699105731001578
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD--SELSSKICDFGICRLVTED 494 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd--~~~~vKL~DFGla~~~~~~ 494 (688)
++||+|.+.+.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+|+.+...
T Consensus 108 ~~gg~L~~~~~~~~--~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIAAED--YKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTTCTT--CCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCC
T ss_conf 89980888898638--99899999999999999999999779---26513144553113467884899525630343788
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHHH--HHHHHCCCCCCCCCCCCCC
Q ss_conf 87677765568998898888812010499998202767999999998099999981568--9885219632235788899
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV--RRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELltG~~Pf~~~~~i--~~~i~~~~l~~~ld~~~~~ 572 (688)
. ......||+.|+|||++.+..++.++|||||||++|+|+||+.||...... ...+..+... ....
T Consensus 183 ~-------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-----~~~~ 250 (352)
T d1koba_ 183 E-------IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE-----FDED 250 (352)
T ss_dssp S-------CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC-----CCSS
T ss_pred C-------CEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCC-----CCCC
T ss_conf 7-------201004764534899974799897633389899999999688998997999999999847889-----8930
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf 9979999999999982126999999993689
Q 005617 573 WPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
.+..++..+.+|+.+||+.||.+|||+.+.+
T Consensus 251 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil 281 (352)
T d1koba_ 251 AFSSVSPEAKDFIKNLLQKEPRKRLTVHDAL 281 (352)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 0247999999999997569966891899996
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.58 Aligned_cols=243 Identities=23% Similarity=0.302 Sum_probs=198.6
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCC-CHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCEEEEEC
Q ss_conf 69532303401386589999998--909999997238933-46999999999970799941247054478--74237760
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
++|...+.||+|+||+||+|+.. |..||||++...... ....+.+|+.++++++|||||++++++.+ ..++||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEEC
T ss_conf 46089989721748099999999999799999984566412799999999999857998884696540467436798864
Q ss_pred CCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 78996788861249999899999999999999999998506998157189999962207999769910573100157887
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 496 (688)
+++|+|.+++... ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 85 ~~gg~L~~~l~~~---~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIEPD---IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSBTT---TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred CCCCCHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCC
T ss_conf 5898089997537---99999999999999999999999759---83575468997887899879832314224046886
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHCCCCC-CCCCHHHHHHHHHHHHHHCCCCCCCHHHH---HHHHHCCCCCCCCCCCCCC
Q ss_conf 6777655689988988888120104999-98202767999999998099999981568---9885219632235788899
Q 005617 497 YLPSFHRSTAPKGSFPYADPEYHRTGVL-TPKSDSYSFGLIILQLLTGRLPVGLAGEV---RRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~~~~~~~-s~ksDVwSlGviL~ELltG~~Pf~~~~~i---~~~i~~~~l~~~ld~~~~~ 572 (688)
. ......+||+.|+|||++.+..+ +.++|||||||++|||+||++||...... ......... ...
T Consensus 159 ~----~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~-------~~~ 227 (271)
T d1nvra_ 159 E----RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT-------YLN 227 (271)
T ss_dssp E----CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT-------TST
T ss_pred C----CCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCC-------CCC
T ss_conf 5----31113255747428728618999997101617379999998299788889859999999863888-------788
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCCCCCCCH
Q ss_conf 99799999999999821269999999936
Q 005617 573 WPTFVARRLVDLGLQCCELYGRERPDITP 601 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~ 601 (688)
....++..+.+|+.+||+.||.+|||+.+
T Consensus 228 ~~~~~s~~~~~li~~~L~~dP~~R~t~~e 256 (271)
T d1nvra_ 228 PWKKIDSAPLALLHKILVENPSARITIPD 256 (271)
T ss_dssp TGGGSCHHHHHHHHHHSCSSTTTSCCHHH
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHH
T ss_conf 64469999999999976799668909999
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=363.66 Aligned_cols=239 Identities=27% Similarity=0.418 Sum_probs=202.1
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCC---CCCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCEEEE
Q ss_conf 69532303401386589999998--9099999972389---3346999999999970799941247054478--742377
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN---MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~---~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|.+.+.||+|+||.||+|+.. |..||+|++.... ......+.+|+.++..++|||||++++++.+ ..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37699889851778589999998999499999981688567689999999999998568888885999999899989998
Q ss_pred ECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 60789967888612499998999999999999999999985069981571899999622079997699105731001578
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 494 (688)
||+++|+|.+++.... .+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~~~---~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS---KFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred EECCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCCEECCCCCEEECCCCEEEECCCC
T ss_conf 5047985898875048---9999999999999999999999889---465220234414668998711555633544888
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCCCCCCCCC
Q ss_conf 8767776556899889888881201049999820276799999999809999998156--89885219632235788899
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELltG~~Pf~~~~~--i~~~i~~~~l~~~ld~~~~~ 572 (688)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... +...+..+. ..
T Consensus 160 ~--------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~---------~~ 222 (263)
T d2j4za1 160 R--------RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE---------FT 222 (263)
T ss_dssp C--------CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC---------CC
T ss_pred C--------CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCC---------CC
T ss_conf 5--------235578876349999758998931440467599999832999988899999999997189---------99
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf 9979999999999982126999999993689
Q 005617 573 WPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
+|...+..+.+|+.+||+.||.+|||+.+.+
T Consensus 223 ~p~~~s~~~~~li~~~L~~dp~~R~t~~eil 253 (263)
T d2j4za1 223 FPDFVTEGARDLISRLLKHNPSQRPMLREVL 253 (263)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 9866899999999997647976890999997
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.14 Aligned_cols=252 Identities=25% Similarity=0.428 Sum_probs=207.8
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CE----EEEEEEEECCC-CCCHHHHHHHHHHHHCCCCCCEEEEECCCCC-CCEEE
Q ss_conf 69532303401386589999998--90----99999972389-3346999999999970799941247054478-74237
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GR----TVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~----~VAIK~l~~~~-~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV 413 (688)
.+|...+.||+|+||+||+|.+. |. .||+|.+.... ......|.+|+.++.+++|||||+++|+|.+ ..+++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v 88 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLI 88 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEE
T ss_conf 99978319820899299999995899889899999996513497999999999999986799888158999961983699
Q ss_pred EECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 76078996788861249999899999999999999999998506998157189999962207999769910573100157
Q 005617 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 493 (688)
++|+.+|+|.+.+.... ..+++..++.|+.|||.||.|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 89 ~e~~~~~~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 89 TQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EECCTTCBHHHHHHHTS--SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred EEECCCCCCCCCCCCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCHHHCCEECCCCCEEEECCCCCEECCC
T ss_conf 98426874010111334--57999999999999999999998769---50476212031167998758602552223354
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCHH--HHHHHHHCCCCCCCCCCCC
Q ss_conf 8876777655689988988888120104999982027679999999980-999999815--6898852196322357888
Q 005617 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELlt-G~~Pf~~~~--~i~~~i~~~~l~~~ld~~~ 570 (688)
.... .......||+.|+|||++.++.++.++|||||||++|||+| |.+||.... .+...+..+..
T Consensus 164 ~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~-------- 231 (317)
T d1xkka_ 164 EEKE----YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-------- 231 (317)
T ss_dssp TCC------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC--------
T ss_pred CCCC----CCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC--------
T ss_conf 4453----2236510586446708874699983565440799999999779999999998999999975998--------
Q ss_pred CCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 99997999999999998212699999999368999999853
Q 005617 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 571 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~L~~l~ 611 (688)
...|..++..+.+|+.+||+.||.+|||+. .++..|..+.
T Consensus 232 ~~~p~~~~~~~~~li~~cl~~dP~~RPs~~-eil~~l~~~~ 271 (317)
T d1xkka_ 232 LPQPPICTIDVYMIMVKCWMIDADSRPKFR-ELIIEFSKMA 271 (317)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHH
T ss_conf 999855689999999984789934691999-9999999987
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.66 Aligned_cols=248 Identities=24% Similarity=0.344 Sum_probs=205.0
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCC--CHHHHHHHHHHHHCCCCCCEEEEECCCCC----CCEEE
Q ss_conf 69532303401386589999998--909999997238933--46999999999970799941247054478----74237
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACPE----AWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~~~----~~~LV 413 (688)
++|...+.||+|+||.||+|+.. |..||+|.+...... ....|.+|+.++.+++|||||++++++.+ ..++|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
T ss_conf 33799679830889199999999999799999987465797999999999999997789998248999991789989999
Q ss_pred EECCCCCCHHHHHCCCC-CCCCCCHHHHHHHHHHHHHHHHHHHCCCC--CCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 76078996788861249-99989999999999999999999850699--8157189999962207999769910573100
Q 005617 414 YEYLPNGSLQDRLFRKS-NVSPLLWKDRARIAAEIASGLCFLHSSKP--EKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~-~~~~l~~~~~~~ia~qia~aL~yLH~~~~--~~IiHrDIKp~NILLd~~~~vKL~DFGla~~ 490 (688)
|||+++|+|.+++.... ....+++..++.|+.|++.||.|||+.++ .+|+||||||+|||++.++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEEE
T ss_conf 95689993899998515457899999999999999999999997167788788586765425747888579800100032
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCCCCC
Q ss_conf 15788767776556899889888881201049999820276799999999809999998156--8988521963223578
Q 005617 491 VTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDP 568 (688)
Q Consensus 491 ~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELltG~~Pf~~~~~--i~~~i~~~~l~~~ld~ 568 (688)
...... ......||+.|+|||++.+..|+.++|||||||++|||+||++||..... +...+..+...
T Consensus 164 ~~~~~~------~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~----- 232 (269)
T d2java1 164 LNHDTS------FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR----- 232 (269)
T ss_dssp C-----------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-----
T ss_pred CCCCCC------CCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCC-----
T ss_conf 245777------556677882327999983999993898875278999980188998998999999999718998-----
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf 88999979999999999982126999999993689
Q 005617 569 LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 569 ~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
..+...+..+.+|+.+||+.||.+|||+.+.+
T Consensus 233 ---~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell 264 (269)
T d2java1 233 ---RIPYRYSDELNEIITRMLNLKDYHRPSVEEIL 264 (269)
T ss_dssp ---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ---CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf ---89743599999999997679955791899997
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=361.86 Aligned_cols=242 Identities=27% Similarity=0.368 Sum_probs=203.6
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCC---CCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCEEEE
Q ss_conf 69532303401386589999998--90999999723893---346999999999970799941247054478--742377
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|.+...||+|+||.||+|... |..||||++..... .....+.+|+.++++++|||||++++++.+ ..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999998768888617999999899889999
Q ss_pred ECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 60789967888612499998999999999999999999985069981571899999622079997699105731001578
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 494 (688)
||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~~~---~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG---SFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred ECCCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCCCCCCCCCCCEEEECCCCCCEECCCC
T ss_conf 7048987777653159---9999999999999999997621650---884767741236688853886032102422567
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCCCCCCCCC
Q ss_conf 8767776556899889888881201049999820276799999999809999998156--89885219632235788899
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELltG~~Pf~~~~~--i~~~i~~~~l~~~ld~~~~~ 572 (688)
... ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||..... +...+..+.. .
T Consensus 162 ~~~----~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~---------~ 228 (288)
T d1uu3a_ 162 SKQ----ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEY---------D 228 (288)
T ss_dssp ------------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCC---------C
T ss_pred CCC----CCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC---------C
T ss_conf 764----333555677552584400268989666230456999998038899899599999999971899---------9
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCCCCCCCHH
Q ss_conf 997999999999998212699999999368
Q 005617 573 WPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~ 602 (688)
+|..++..+.+|+.+||+.||.+|||+.+.
T Consensus 229 ~p~~~s~~~~~li~~~L~~dP~~R~t~~e~ 258 (288)
T d1uu3a_ 229 FPEKFFPKARDLVEKLLVLDATKRLGCEEM 258 (288)
T ss_dssp CCTTCCHHHHHHHHTTSCSSGGGSTTSGGG
T ss_pred CCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf 985479999999999855797689197897
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=360.95 Aligned_cols=245 Identities=23% Similarity=0.309 Sum_probs=202.2
Q ss_pred HCCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCC-CHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCEEEEE
Q ss_conf 269532303401386589999998--909999997238933-46999999999970799941247054478--7423776
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E 415 (688)
.+.|.+...||+|+||+||+|+.. |..||||++...... ....+.+|+.++..++|||||++++++.+ ..++|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEE
T ss_conf 66669988994065839999999999989999998157731289999999999986799899919899998998889885
Q ss_pred CCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEEC---CCCCEEEEECCCCCCCC
Q ss_conf 078996788861249999899999999999999999998506998157189999962207---99976991057310015
Q 005617 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD---SELSSKICDFGICRLVT 492 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd---~~~~vKL~DFGla~~~~ 492 (688)
|++||+|.+++... ..+++..+..|+.|++.||.|||+.+ |+||||||+|||+. .++.+||+|||+|+...
T Consensus 88 ~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVEK---GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHTC---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred CCCCCCHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHHCE---EEEEEECCCCEEECCCCCCCEEEEECCCEEEECC
T ss_conf 26898488865303---67887899999999999987524130---5568704630011046888249983154358725
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCCCCCCC
Q ss_conf 788767776556899889888881201049999820276799999999809999998156--898852196322357888
Q 005617 493 EDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 493 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELltG~~Pf~~~~~--i~~~i~~~~l~~~ld~~~ 570 (688)
... .....+||+.|+|||++.+..|+.++|||||||++|||++|++||..... +...+..+.... .
T Consensus 162 ~~~-------~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~-----~ 229 (307)
T d1a06a_ 162 PGS-------VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEF-----D 229 (307)
T ss_dssp ------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCC-----C
T ss_pred CCC-------EEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCCCC-----C
T ss_conf 897-------0440032842259188737999807873451599999985979999989999999986168777-----8
Q ss_pred CCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf 999979999999999982126999999993689
Q 005617 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 571 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
...+..++..+.+|+.+||+.||.+|||+.+.+
T Consensus 230 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil 262 (307)
T d1a06a_ 230 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQAL 262 (307)
T ss_dssp TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 766667899999999997608975791899986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.19 Aligned_cols=247 Identities=24% Similarity=0.422 Sum_probs=205.6
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC-CEEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCEEEEECCC
Q ss_conf 69532303401386589999998-90999999723893346999999999970799941247054478--7423776078
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYLP 418 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~-g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~~ 418 (688)
++|...++||+|+||+||+|++. +..||||+++... .....|.+|+.++.+++|||||+++|+|.+ ..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECCC
T ss_conf 9979968982078839999998899899999987475-778999999999996689860158899850781699997048
Q ss_pred CCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 99678886124999989999999999999999999850699815718999996220799976991057310015788767
Q 005617 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 498 (688)
+|+|..++.... ..+++..+.+|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 83 ~g~l~~~~~~~~--~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~- 156 (258)
T d1k2pa_ 83 NGCLLNYLREMR--HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT- 156 (258)
T ss_dssp TEEHHHHHHSGG--GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC-
T ss_pred CCCHHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCCE-
T ss_conf 993888641024--67768999999999999999875468---434665413588769984798861442023578722-
Q ss_pred CCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCHHH--HHHHHHCCCCCCCCCCCCCCCCH
Q ss_conf 77655689988988888120104999982027679999999980-9999998156--89885219632235788899997
Q 005617 499 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGE--VRRAVSCGKLSSILDPLAGDWPT 575 (688)
Q Consensus 499 ~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELlt-G~~Pf~~~~~--i~~~i~~~~l~~~ld~~~~~~~~ 575 (688)
......||+.|+|||++....++.++|||||||++|||+| |+.||..... +...+..+.. ...|.
T Consensus 157 ----~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~--------~~~p~ 224 (258)
T d1k2pa_ 157 ----SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR--------LYRPH 224 (258)
T ss_dssp ----CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCC--------CCCCT
T ss_pred ----EECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC--------CCCCC
T ss_conf ----524657887757807863799885210336432467397559999889999999999980797--------89965
Q ss_pred HHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHH
Q ss_conf 999999999998212699999999368999999
Q 005617 576 FVARRLVDLGLQCCELYGRERPDITPSLVKELE 608 (688)
Q Consensus 576 ~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~L~ 608 (688)
..+..+.+|+.+||+.||.+|||+. +++..|.
T Consensus 225 ~~~~~l~~li~~cl~~dP~~RPt~~-eil~~L~ 256 (258)
T d1k2pa_ 225 LASEKVYTIMYSCWHEKADERPTFK-ILLSNIL 256 (258)
T ss_dssp TCCHHHHHHHHHTTCSSGGGSCCHH-HHHHHHH
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHH
T ss_conf 4659999999997668976893999-9998741
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=360.47 Aligned_cols=261 Identities=26% Similarity=0.446 Sum_probs=213.1
Q ss_pred HHHHHHHCCCCCCEEEECCCCEEEEEEEECC-------EEEEEEEEECCCCC-CHHHHHHHHHHHHCCCCCCEEEEECCC
Q ss_conf 8899872695323034013865899999989-------09999997238933-469999999999707999412470544
Q 005617 335 ADLQTATCNFSESFKVGQGGFGCVYKGEMLG-------RTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGAC 406 (688)
Q Consensus 335 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~g-------~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~ 406 (688)
.+++...++|.+.+.||+|+||+||+|++.| ..||||+++..... ....|.+|+.++++++||||++++++|
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred HHCCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEE
T ss_conf 31138988938867982078839999998887657788299999988210857999999999999966899765524666
Q ss_pred CC--CCEEEEECCCCCCHHHHHCCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEE
Q ss_conf 78--7423776078996788861249---------------------999899999999999999999998506998157
Q 005617 407 PE--AWSLVYEYLPNGSLQDRLFRKS---------------------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIV 463 (688)
Q Consensus 407 ~~--~~~LV~E~~~~gsL~~~L~~~~---------------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~Ii 463 (688)
.+ ..++||||+++|+|.+++.... ....+++..++.|+.|++.||.|||+.+ |+
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred CCCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCC---EE
T ss_conf 059803899981589929999985275542100001110012103467889899999999999999855413578---68
Q ss_pred ECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHC
Q ss_conf 18999996220799976991057310015788767776556899889888881201049999820276799999999809
Q 005617 464 HGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTG 543 (688)
Q Consensus 464 HrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELltG 543 (688)
||||||+|||+|.++.+||+|||+|+........ .......|++.|+|||++....|+.++|||||||++|||++|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~ 238 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYY----KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 238 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCB----C----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred EEEECCCCEEECCCCCEEECCCHHHEECCCCCCC----CCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCC
T ss_conf 5488401168989992898331442113677641----115777767676798997268898056302523629999806
Q ss_pred C-CCCCCHHH--HHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 9-99998156--89885219632235788899997999999999998212699999999368999999853
Q 005617 544 R-LPVGLAGE--VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 544 ~-~Pf~~~~~--i~~~i~~~~l~~~ld~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~L~~l~ 611 (688)
. +||..... +...+..+... ..|..++..+.+|+.+||+.+|++|||+. ++++.|+++.
T Consensus 239 ~~~p~~~~~~~e~~~~v~~~~~~--------~~p~~~~~~~~~li~~cl~~~P~~RPt~~-ev~~~L~~i~ 300 (301)
T d1lufa_ 239 GLQPYYGMAHEEVIYYVRDGNIL--------ACPENCPLELYNLMRLCWSKLPADRPSFC-SIHRILQRMC 300 (301)
T ss_dssp TCCTTTTSCHHHHHHHHHTTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHTT
T ss_pred CCCCCCCCCHHHHHHHHHCCCCC--------CCCCCCHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHC
T ss_conf 89999998999999999739978--------88732529999999997488965793999-9999999842
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.26 Aligned_cols=238 Identities=26% Similarity=0.308 Sum_probs=201.9
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCC---CCCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCEEEE
Q ss_conf 69532303401386589999998--9099999972389---3346999999999970799941247054478--742377
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN---MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~---~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|.+.+.||+|+||.||+|+.. |..||||++.+.. ......+.+|+.+|++++|||||++++++.+ ..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCE
T ss_conf 74289889831768499999998999899999981565449799999999999998679998877876403564211100
Q ss_pred ECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 60789967888612499998999999999999999999985069981571899999622079997699105731001578
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 494 (688)
||+++|+|.+++.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.+|.+||+|||+|+.....
T Consensus 85 ey~~gg~L~~~~~~~~---~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSRER---VFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred ECCCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEEEECCCCCCCCCC
T ss_conf 0357986055553256---7759999999999965211343159---622464777847658998888205652003567
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCCCCCCCCC
Q ss_conf 8767776556899889888881201049999820276799999999809999998156--89885219632235788899
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELltG~~Pf~~~~~--i~~~i~~~~l~~~ld~~~~~ 572 (688)
.. .....+||+.|+|||++.+..|+.++|||||||++|||++|++||..... +...+..+. ..
T Consensus 159 ~~------~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~---------~~ 223 (337)
T d1o6la_ 159 GA------TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE---------IR 223 (337)
T ss_dssp TC------CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------CC
T ss_pred CC------CCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCC---------CC
T ss_conf 86------2055100889966665048988833310223067889987899999969999999985289---------98
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 9979999999999982126999999993
Q 005617 573 WPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 600 (688)
+|..++..+.+|+.+||+.||.+||+..
T Consensus 224 ~p~~~s~~~~dli~~~L~~dP~~R~~~~ 251 (337)
T d1o6la_ 224 FPRTLSPEAKSLLAGLLKKDPKQRLGGG 251 (337)
T ss_dssp CCTTSCHHHHHHHHHHTCSSTTTSTTCS
T ss_pred CCCCCCHHHHHHHHHHCCCCCHHHCCCC
T ss_conf 9866899999999866638934422565
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.37 Aligned_cols=251 Identities=33% Similarity=0.422 Sum_probs=206.8
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC-CEEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCEEEEECCCCC-CCEEEEECCCC
Q ss_conf 69532303401386589999998-90999999723893346999999999970799941247054478-74237760789
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLVYEYLPN 419 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~-g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV~E~~~~ 419 (688)
++|.+...||+|+||.||+|.+. +..||||+++... .....|.+|+.++.+++|||||+++|+|.+ ..++||||+++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~-~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~~ 95 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSK 95 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTT
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCEEEEEEEEECCCEEEEEEECCC
T ss_conf 9979846993079809999999999999999988044-888999999999986666788689999823975999994479
Q ss_pred CCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCCC
Q ss_conf 96788861249999899999999999999999998506998157189999962207999769910573100157887677
Q 005617 420 GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYLP 499 (688)
Q Consensus 420 gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~~ 499 (688)
|+|..++..... ..++|..++.|+.+|+.||.|||..+ |+||||||+||||+.++.+||+|||+++........
T Consensus 96 g~l~~~~~~~~~-~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~-- 169 (285)
T d1fmka3 96 GSLLDFLKGETG-KYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-- 169 (285)
T ss_dssp CBHHHHHSHHHH-TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred CCHHHHHHHCCC-CCCHHHHHHHHHHHHHHHHHHHHHHH---EECCCCCCEEEEECCCCCEEECCCCHHHHCCCCCCE--
T ss_conf 943542000035-53059999999999999999875411---433531230799989992998442555425688733--
Q ss_pred CCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCC-CCHH--HHHHHHHCCCCCCCCCCCCCCCCHH
Q ss_conf 765568998898888812010499998202767999999998099999-9815--6898852196322357888999979
Q 005617 500 SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPV-GLAG--EVRRAVSCGKLSSILDPLAGDWPTF 576 (688)
Q Consensus 500 ~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELltG~~Pf-~~~~--~i~~~i~~~~l~~~ld~~~~~~~~~ 576 (688)
......||+.|+|||++....++.++||||||+++|||+||..|+ .... .+...+..+.. ...+..
T Consensus 170 ---~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~--------~~~~~~ 238 (285)
T d1fmka3 170 ---ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR--------MPCPPE 238 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC--------CCCCTT
T ss_pred ---EECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC--------CCCCCC
T ss_conf ---524545566545808983799891774132358999998689999988889999999982689--------999832
Q ss_pred HHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 99999999998212699999999368999999853
Q 005617 577 VARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 577 ~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~L~~l~ 611 (688)
++..+.+|+.+||+.||++||++. .|+..|+...
T Consensus 239 ~~~~l~~li~~cl~~dP~~Rps~~-~i~~~L~~~~ 272 (285)
T d1fmka3 239 CPESLHDLMCQCWRKEPEERPTFE-YLQAFLEDYF 272 (285)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHTTT
T ss_pred CCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHH
T ss_conf 379999999997566975891999-9999876662
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.92 Aligned_cols=239 Identities=27% Similarity=0.389 Sum_probs=193.7
Q ss_pred CCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCC--CCHHHHHHHHHHHHCCCCCCEEEEECCCCC------CCEEEE
Q ss_conf 32303401386589999998--90999999723893--346999999999970799941247054478------742377
Q 005617 345 SESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE------AWSLVY 414 (688)
Q Consensus 345 ~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~------~~~LV~ 414 (688)
....+||+|+||+||+|.+. +..||+|.+..... .....|.+|+.++++++|||||++++++.+ ..++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEEE
T ss_conf 85169700828499999999999599999985122798999999999999985799985069999840334588899999
Q ss_pred ECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEEC-CCCCEEEEECCCCCCCCC
Q ss_conf 6078996788861249999899999999999999999998506998157189999962207-999769910573100157
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD-SELSSKICDFGICRLVTE 493 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd-~~~~vKL~DFGla~~~~~ 493 (688)
||+++|+|.+++.... .+++..+..|+.|++.||.|||+.+ .+|+||||||+|||++ .++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~~~---~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKRFK---VMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred ECCCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHCC-CCEEECCCCHHHCEEECCCCCEEEEECCCCEECCC
T ss_conf 5789894899975135---5469999999999999999999789-97996876743511667999889800576542368
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHH---HHHHHHCCCCCCCCCCCC
Q ss_conf 88767776556899889888881201049999820276799999999809999998156---898852196322357888
Q 005617 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE---VRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELltG~~Pf~~~~~---i~~~i~~~~l~~~ld~~~ 570 (688)
.. .....||+.|+|||++.+ .++.++|||||||++|||++|+.||..... +...+..+...
T Consensus 168 ~~--------~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~------- 231 (270)
T d1t4ha_ 168 SF--------AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP------- 231 (270)
T ss_dssp TS--------BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC-------
T ss_pred CC--------CCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC-------
T ss_conf 76--------677553813008988478-99986711007999999987889998765599999999738998-------
Q ss_pred CCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf 999979999999999982126999999993689
Q 005617 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 571 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
..++...++.+.+|+.+||+.||++|||+.+.+
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell 264 (270)
T d1t4ha_ 232 ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLL 264 (270)
T ss_dssp GGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 656755789999999997637975892999996
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=358.74 Aligned_cols=241 Identities=25% Similarity=0.344 Sum_probs=196.6
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCCC---HHHHHHHHHHHHCCCCCCEEEEECCCCC--CCEEEE
Q ss_conf 69532303401386589999998--9099999972389334---6999999999970799941247054478--742377
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG---QLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~~---~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
..|...+.||+|+||.||+|+.. |..||||++....... ...|.+|+.++.+++|||||++++++.+ ..++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 85676279701888099999998999399999984444358899999999999999778999823899999899889999
Q ss_pred ECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 60789967888612499998999999999999999999985069981571899999622079997699105731001578
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 494 (688)
||+.+|+|..++... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 95 E~~~~g~l~~~~~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK---KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EECCCCCHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCCCEEEECCCCCEEEEECCCCCCCCC-
T ss_conf 806999457899737---99999999999999999999998689---76667884217987999789844365334677-
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCC---CCCCCCCHHHHHHHHHHHHHHCCCCCCCHHHHH--HHHHCCCCCCCCCCC
Q ss_conf 876777655689988988888120104---999982027679999999980999999815689--885219632235788
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRT---GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSILDPL 569 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~---~~~s~ksDVwSlGviL~ELltG~~Pf~~~~~i~--~~i~~~~l~~~ld~~ 569 (688)
.....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||....... ..+..+....+
T Consensus 168 ---------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~---- 234 (309)
T d1u5ra_ 168 ---------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL---- 234 (309)
T ss_dssp ---------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC----
T ss_pred ---------CCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCC----
T ss_conf ---------8731347663688998346788867214545589999999878899999799999999982899988----
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHH
Q ss_conf 899997999999999998212699999999368999
Q 005617 570 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVK 605 (688)
Q Consensus 570 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~ 605 (688)
.+...+..+.+|+.+||+.||.+|||+.+.+.+
T Consensus 235 ---~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H 267 (309)
T d1u5ra_ 235 ---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (309)
T ss_dssp ---SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred ---CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf ---878889999999999773796579189999719
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=350.76 Aligned_cols=233 Identities=27% Similarity=0.368 Sum_probs=197.5
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCC---CCCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCEEEE
Q ss_conf 69532303401386589999998--9099999972389---3346999999999970799941247054478--742377
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN---MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~---~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|.+.+.||+|+||+||+|+.. |..||||++.... ......+.+|+.+++.++|||||++++++.+ ..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf 47088889720768089999998999799999984577548899999999999998636967533035685288005676
Q ss_pred ECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 60789967888612499998999999999999999999985069981571899999622079997699105731001578
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 494 (688)
||+.||+|...+.... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ---RFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHHTS---SCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EECCCCCCCCCCCCCC---CCCCCHHHHHHHHHHHHHHHHCCCC---EECCCCCCHHEEECCCCCEEEECCCCCEEECCC
T ss_conf 5037863223432222---1110079999999987655412476---770556810503868998898317521671245
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCCCCCCCCC
Q ss_conf 8767776556899889888881201049999820276799999999809999998156--89885219632235788899
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELltG~~Pf~~~~~--i~~~i~~~~l~~~ld~~~~~ 572 (688)
....+||+.|+|||++.+..|+.++|||||||++|+|+||+.||..... +...+..+.. .
T Consensus 158 ---------~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~---------~ 219 (316)
T d1fota_ 158 ---------TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAEL---------R 219 (316)
T ss_dssp ---------BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCC---------C
T ss_pred ---------CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC---------C
T ss_conf ---------6434576343599998389998043046533368999759899999699999999970898---------8
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 99799999999999821269999999
Q 005617 573 WPTFVARRLVDLGLQCCELYGRERPD 598 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs 598 (688)
+|...+..+.+++.+||..||.+||+
T Consensus 220 ~p~~~s~~~~~li~~~L~~dp~~R~~ 245 (316)
T d1fota_ 220 FPPFFNEDVKDLLSRLITRDLSQRLG 245 (316)
T ss_dssp CCTTSCHHHHHHHHHHTCSCTTTCTT
T ss_pred CCCCCCHHHHHHHHHHHHHCHHHCCC
T ss_conf 99778999999999995449976664
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=351.18 Aligned_cols=232 Identities=24% Similarity=0.323 Sum_probs=197.4
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCC---CCCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCEEEE
Q ss_conf 69532303401386589999998--9099999972389---3346999999999970799941247054478--742377
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN---MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~---~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~ 414 (688)
++|...+.||+|+||.||+|++. |..||||++.... ......+.+|+.++..++|||||++++++.+ ..++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999999748772740344443222223222
Q ss_pred ECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCC
Q ss_conf 60789967888612499998999999999999999999985069981571899999622079997699105731001578
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTED 494 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~ 494 (688)
||+.+|+|...+.... .+++..+..|+.||+.||.|||+.+ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 121 e~~~~g~l~~~l~~~~---~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG---RFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred CCCCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHCCCCCCCCEEEEECEEEEECCCC
T ss_conf 2334662266675158---9899999999999999899998599---861767999936077897886101033322566
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCCCCCCCCC
Q ss_conf 8767776556899889888881201049999820276799999999809999998156--89885219632235788899
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELltG~~Pf~~~~~--i~~~i~~~~l~~~ld~~~~~ 572 (688)
.....||+.|||||++.+..++.++|||||||++|||+||+.||..... +...+..+.. .
T Consensus 195 ---------~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~---------~ 256 (350)
T d1rdqe_ 195 ---------TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV---------R 256 (350)
T ss_dssp ---------BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------C
T ss_pred ---------CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCCC---------C
T ss_conf ---------6433676356788997179988533114500789999758899899599999999861798---------8
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 9979999999999982126999999
Q 005617 573 WPTFVARRLVDLGLQCCELYGRERP 597 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RP 597 (688)
.+..++..+.+|+.+||+.||.+|+
T Consensus 257 ~p~~~s~~~~~li~~~L~~dP~kR~ 281 (350)
T d1rdqe_ 257 FPSHFSSDLKDLLRNLLQVDLTKRF 281 (350)
T ss_dssp CCTTCCHHHHHHHHHHSCSCTTTCT
T ss_pred CCCCCCHHHHHHHHHHHHHCHHHCC
T ss_conf 9766899999999998340998606
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=352.77 Aligned_cols=239 Identities=26% Similarity=0.319 Sum_probs=192.8
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCC---CCHHHHHH---HHHHHHCCCCCCEEEEECCCCC--CCE
Q ss_conf 69532303401386589999998--90999999723893---34699999---9999970799941247054478--742
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM---QGQLEFQQ---EVRVLSKLQHPHLVTLLGACPE--AWS 411 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~---~~~~~f~~---E~~iL~~l~HpnIV~l~g~~~~--~~~ 411 (688)
++|.+.+.||+|+||.||+|+.. |..||||++..... .....+.+ ++.++..++|||||++++++.+ ..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
T ss_conf 76851018842889099999999999799999984587542667999999999999985089985889999999899889
Q ss_pred EEEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 37760789967888612499998999999999999999999985069981571899999622079997699105731001
Q 005617 412 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~DFGla~~~ 491 (688)
+||||+++|+|.+++.... .+++..+..|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 84 ivmE~~~gg~L~~~l~~~~---~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG---VFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEECCCCCHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCEEECCCEEEECCCCCEEEEEECEEEEC
T ss_conf 9999148983899987325---5327899999999999999999779---622044422167858896798220102333
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCCCCC
Q ss_conf 578876777655689988988888120104-9999820276799999999809999998156--8988521963223578
Q 005617 492 TEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDP 568 (688)
Q Consensus 492 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~ELltG~~Pf~~~~~--i~~~i~~~~l~~~ld~ 568 (688)
.... .....||+.|+|||++.. ..|+.++|||||||+||||+||+.||..... ....... ...
T Consensus 158 ~~~~--------~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~------~~~ 223 (364)
T d1omwa3 158 SKKK--------PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM------TLT 223 (364)
T ss_dssp SSSC--------CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH------SSS
T ss_pred CCCC--------CCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH------CCC
T ss_conf 7886--------43311345542168760389998441046778999999859998888998999999986------046
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 88999979999999999982126999999993
Q 005617 569 LAGDWPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 569 ~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 600 (688)
....++..++..+.+|+.+||+.||.+||++.
T Consensus 224 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~ 255 (364)
T d1omwa3 224 MAVELPDSFSPELRSLLEGLLQRDVNRRLGCL 255 (364)
T ss_dssp CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTS
T ss_pred CCCCCCCCCCHHHHHHHHHHCCCCHHHHCCCC
T ss_conf 88878877899999999998566988808874
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.31 Aligned_cols=247 Identities=27% Similarity=0.438 Sum_probs=207.5
Q ss_pred CCCCCCEEEECCCCEEEEEEEECCEEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCEEEEECCCCC---CCEEEEECCC
Q ss_conf 6953230340138658999999890999999723893346999999999970799941247054478---7423776078
Q 005617 342 CNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE---AWSLVYEYLP 418 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~---~~~LV~E~~~ 418 (688)
++|.....||+|+||.||+|.+.|..||||+++.. .....|.+|+.++++++|||||+++|+|.+ ..++||||++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~ 84 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMA 84 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCT
T ss_pred HHEEEEEEEECCCCEEEEEEEECCEEEEEEEECCH--HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEECCC
T ss_conf 99488579820798089999999909999998857--7799999999999867898985498788723892899996369
Q ss_pred CCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCCC
Q ss_conf 99678886124999989999999999999999999850699815718999996220799976991057310015788767
Q 005617 419 NGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLYL 498 (688)
Q Consensus 419 ~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~~ 498 (688)
+|+|.++|..... ..++|..+++|+.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 85 ~g~L~~~l~~~~~-~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~--- 157 (262)
T d1byga_ 85 KGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 157 (262)
T ss_dssp TEEHHHHHHHHHH-HHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred CCCHHHHHHHCCC-CCCCHHHHHHHHHHHHHHCCCCCCCC---EECCCCCHHHHEECCCCCEEECCCCCCEECCCCC---
T ss_conf 9989999874578-88899999999999985232113376---5536665676014689977632456003447877---
Q ss_pred CCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCHH--HHHHHHHCCCCCCCCCCCCCCCCH
Q ss_conf 77655689988988888120104999982027679999999980-999999815--689885219632235788899997
Q 005617 499 PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLAGDWPT 575 (688)
Q Consensus 499 ~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELlt-G~~Pf~~~~--~i~~~i~~~~l~~~ld~~~~~~~~ 575 (688)
....+++.|+|||++.+..+++++||||||+++|||+| |++||.... .+...+..+.. ...+.
T Consensus 158 ------~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~--------~~~~~ 223 (262)
T d1byga_ 158 ------DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK--------MDAPD 223 (262)
T ss_dssp ----------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC--------CCCCT
T ss_pred ------CCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC--------CCCCC
T ss_conf ------6556664677817872798885887775799999999789999999999999999980899--------99976
Q ss_pred HHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 9999999999982126999999993689999998530
Q 005617 576 FVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 576 ~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~L~~l~~ 612 (688)
..+..+.+|+.+||+.||.+|||+. ++++.|+.+..
T Consensus 224 ~~~~~~~~li~~cl~~dP~~Rps~~-~l~~~L~~i~~ 259 (262)
T d1byga_ 224 GCPPAVYEVMKNCWHLDAAMRPSFL-QLREQLEHIKT 259 (262)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHH
T ss_conf 5799999999997566976893999-99999999986
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.28 Aligned_cols=245 Identities=25% Similarity=0.320 Sum_probs=201.1
Q ss_pred HCCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCC------CCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CC
Q ss_conf 269532303401386589999998--90999999723893------346999999999970799941247054478--74
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM------QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AW 410 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~------~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~ 410 (688)
.+.|.....||+|+||.||+|+.. |..||||++..... .....|.+|+.++++++|||||++++++.+ ..
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf 56779827981178959999999999989999998756632134068999999999999867998999388999979989
Q ss_pred EEEEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCC----CEEEEECC
Q ss_conf 23776078996788861249999899999999999999999998506998157189999962207999----76991057
Q 005617 411 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL----SSKICDFG 486 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~----~vKL~DFG 486 (688)
++||||+++|+|.+++.... .+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~---~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG 162 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE---SLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFG 162 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCT
T ss_pred EEEEECCCCCCCCCHHCCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEEECCCCCCCCEEECCHH
T ss_conf 99998677864310010356---4215578999999999987666254---22113330127982589866646964334
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCC
Q ss_conf 310015788767776556899889888881201049999820276799999999809999998156--898852196322
Q 005617 487 ICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSS 564 (688)
Q Consensus 487 la~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELltG~~Pf~~~~~--i~~~i~~~~l~~ 564 (688)
+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+..+....
T Consensus 163 ~a~~~~~~~-------~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1jksa_ 163 LAHKIDFGN-------EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 235 (293)
T ss_dssp TCEECTTSC-------BCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC
T ss_pred HHHHCCCCC-------CCCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCCCC
T ss_conf 421057776-------3122477774309999818999976652214099999970889988999999999998168888
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf 357888999979999999999982126999999993689
Q 005617 565 ILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 565 ~ld~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
....+...+..+.+|+.+||+.||.+|||+.+.+
T Consensus 236 -----~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil 269 (293)
T d1jksa_ 236 -----EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSL 269 (293)
T ss_dssp -----CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHH
T ss_pred -----CCHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf -----7010478899999999998638966891999996
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.33 Aligned_cols=252 Identities=25% Similarity=0.367 Sum_probs=207.4
Q ss_pred HCCCCCCEEEECCCCEEEEEEEEC-----CEEEEEEEEECCCCC-CHHHHHHHHHHHHCCCCCCEEEEECCCCC-CCEEE
Q ss_conf 269532303401386589999998-----909999997238933-46999999999970799941247054478-74237
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML-----GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSLV 413 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~-----g~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~LV 413 (688)
.++|.....||+|+||.||+|.+. +..||||.+...... ....|.+|+.++++++|||||+++|+|.+ ..++|
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv 85 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWII 85 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEE
T ss_pred HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCEEEEE
T ss_conf 89969877993078829999999369964499999993656687999999999999986899998569889953747999
Q ss_pred EECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 76078996788861249999899999999999999999998506998157189999962207999769910573100157
Q 005617 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 493 (688)
|||+++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 86 ~E~~~~g~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~ 160 (273)
T d1mp8a_ 86 MELCTLGELRSFLQVRK--YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 160 (273)
T ss_dssp EECCTTEEHHHHHHHTT--TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC---------
T ss_pred EEECCCCCHHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCHHHEEECCCCCEEECCCHHHEECCC
T ss_conf 98406980776542247--89999999999999987752302267---44141026553206789678765034213367
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCHH--HHHHHHHCCCCCCCCCCCC
Q ss_conf 8876777655689988988888120104999982027679999999980-999999815--6898852196322357888
Q 005617 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--EVRRAVSCGKLSSILDPLA 570 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELlt-G~~Pf~~~~--~i~~~i~~~~l~~~ld~~~ 570 (688)
... .......||+.|+|||++....++.++|||||||++|||+| |.+||.... .+...+..+...
T Consensus 161 ~~~-----~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~------- 228 (273)
T d1mp8a_ 161 STY-----YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL------- 228 (273)
T ss_dssp ---------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-------
T ss_pred CCC-----EECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCCC-------
T ss_conf 762-----33054005831032667516998874524442478999982699998889999999999818999-------
Q ss_pred CCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 99997999999999998212699999999368999999853
Q 005617 571 GDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 571 ~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~L~~l~ 611 (688)
..+..++..+.+|+.+||..||.+|||+. +++..|+.+.
T Consensus 229 -~~~~~~~~~~~~li~~cl~~dp~~Rps~~-ei~~~L~~i~ 267 (273)
T d1mp8a_ 229 -PMPPNCPPTLYSLMTKCWAYDPSRRPRFT-ELKAQLSTIL 267 (273)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHH
T ss_pred -CCCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHH
T ss_conf -89877799999999997687976892999-9999999997
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.89 Aligned_cols=250 Identities=28% Similarity=0.460 Sum_probs=201.7
Q ss_pred CEEEECCCCEEEEEEEECC-----EEEEEEEEECCC-CCCHHHHHHHHHHHHCCCCCCEEEEECCCCC---CCEEEEECC
Q ss_conf 3034013865899999989-----099999972389-3346999999999970799941247054478---742377607
Q 005617 347 SFKVGQGGFGCVYKGEMLG-----RTVAIKMLYSHN-MQGQLEFQQEVRVLSKLQHPHLVTLLGACPE---AWSLVYEYL 417 (688)
Q Consensus 347 ~~~LG~G~fG~Vykg~~~g-----~~VAIK~l~~~~-~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~---~~~LV~E~~ 417 (688)
..+||+|+||+||+|.+.. ..||||+++... ......|.+|+.++++++|||||+++|+|.+ ..++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEEE
T ss_conf 66981368809999999779987999999998843697899999999999986789998678678980699438999874
Q ss_pred CCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 89967888612499998999999999999999999985069981571899999622079997699105731001578876
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~ 497 (688)
++|+|.+++.... ..+++..++.++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~~~--~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHCTT--CCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ECCCHHHHHCCCC--CCCHHHHHHHHHHHHHHHHHHHCCCC---CCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCCC
T ss_conf 0674144210134--54048999999999887652003367---625776687576779998899106523225566555
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHH---HHHHHHCCCCCCCCCCCCCCCC
Q ss_conf 7776556899889888881201049999820276799999999809999998156---8988521963223578889999
Q 005617 498 LPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE---VRRAVSCGKLSSILDPLAGDWP 574 (688)
Q Consensus 498 ~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELltG~~Pf~~~~~---i~~~i~~~~l~~~ld~~~~~~~ 574 (688)
.........||+.|+|||++....++.++||||||+++|||+||..||..... +...+..+.. ...|
T Consensus 187 --~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~--------~~~p 256 (311)
T d1r0pa_ 187 --SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR--------LLQP 256 (311)
T ss_dssp --CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCC--------CCCC
T ss_pred --CCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHCCCC--------CCCC
T ss_conf --310025655564556768874379997457466199999999789999888999999999980898--------8996
Q ss_pred HHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 79999999999982126999999993689999998530
Q 005617 575 TFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 575 ~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~L~~l~~ 612 (688)
..++..+.+|+.+||+.||++||++. ++++.|+.+..
T Consensus 257 ~~~~~~l~~li~~cl~~dP~~RPs~~-ei~~~L~~i~~ 293 (311)
T d1r0pa_ 257 EYCPDPLYEVMLKCWHPKAEMRPSFS-ELVSRISAIFS 293 (311)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHH
T ss_conf 44759999999997688976893999-99999999997
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=344.68 Aligned_cols=241 Identities=28% Similarity=0.358 Sum_probs=199.9
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCC---CCCHHHHHHHHHHHH-CCCCCCEEEEECCCCC--CCEEE
Q ss_conf 69532303401386589999998--9099999972389---334699999999997-0799941247054478--74237
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHN---MQGQLEFQQEVRVLS-KLQHPHLVTLLGACPE--AWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~---~~~~~~f~~E~~iL~-~l~HpnIV~l~g~~~~--~~~LV 413 (688)
++|.+.+.||+|+||+||+|+.. |..||||++.+.. ......+..|..++. .++|||||++++++.+ ..++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCC
Q ss_conf 76078996788861249999899999999999999999998506998157189999962207999769910573100157
Q 005617 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTE 493 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~DFGla~~~~~ 493 (688)
|||+++|+|.+++.... .+++..+..++.||+.||.|||+.+ |+||||||+|||++.++++||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~~~---~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH---KFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEECCCCCHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCEEECCCCCEECCCCCHHHHCCC
T ss_conf 75037980899864047---8999999999999999999998689---34034765404444899630155530232356
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCCCCCCCC
Q ss_conf 88767776556899889888881201049999820276799999999809999998156--8988521963223578889
Q 005617 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAG 571 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELltG~~Pf~~~~~--i~~~i~~~~l~~~ld~~~~ 571 (688)
... ......||+.|+|||++.+..++.++|||||||++|||+||+.||..... +...+..+. .
T Consensus 156 ~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~---------~ 220 (320)
T d1xjda_ 156 GDA------KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN---------P 220 (320)
T ss_dssp TTC------CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC---------C
T ss_pred CCC------CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHCCC---------C
T ss_conf 653------3454578777689999827998832320112278989873889999989999999997189---------9
Q ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf 99979999999999982126999999993689
Q 005617 572 DWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 572 ~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
.+|..++..+.+|+.+||..||.+||++..++
T Consensus 221 ~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l 252 (320)
T d1xjda_ 221 FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDI 252 (320)
T ss_dssp CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCG
T ss_pred CCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHH
T ss_conf 89756799999999996544898783889999
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.36 Aligned_cols=255 Identities=29% Similarity=0.437 Sum_probs=204.0
Q ss_pred HCCCCCCEEEECCCCEEEEEEEEC-------CEEEEEEEEECCCCC-CHHHHHHHHHHHHCC-CCCCEEEEECCCCC---
Q ss_conf 269532303401386589999998-------909999997238933-469999999999707-99941247054478---
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKL-QHPHLVTLLGACPE--- 408 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~-------g~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--- 408 (688)
.++|.....||+|+||.||+|.+. ++.||||+++..... ....+.+|..++.++ +|+|||.+++++.+
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCC
T ss_conf 79979844984167839999998677755578399999986001717899999999998861499849974115404797
Q ss_pred CCEEEEECCCCCCHHHHHCCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEEC
Q ss_conf 74237760789967888612499-------------99899999999999999999998506998157189999962207
Q 005617 409 AWSLVYEYLPNGSLQDRLFRKSN-------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD 475 (688)
Q Consensus 409 ~~~LV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd 475 (688)
..++||||+++|+|.+++..... ...+++..+..|+.|++.||.|||+.+ |+||||||+|||++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~ 168 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLS 168 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEC
T ss_pred EEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEC
T ss_conf 579999845899299999853666665322202332146899999999999999999887379---71786773106577
Q ss_pred CCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHC-CCCCCCHH---
Q ss_conf 99976991057310015788767776556899889888881201049999820276799999999809-99999815---
Q 005617 476 SELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTG-RLPVGLAG--- 551 (688)
Q Consensus 476 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELltG-~~Pf~~~~--- 551 (688)
.++.+||+|||+|+........ .......||+.|+|||++.+..++.++|||||||++|||+|| .+||....
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~ 244 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDY----VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 244 (299)
T ss_dssp GGGCEEECC------CCSCTTS----CCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred CCCCEEECCCCCHHHCCCCCCC----CCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHHH
T ss_conf 9982898457520011356652----224751667210203686468899663221367899999868899998999899
Q ss_pred HHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 689885219632235788899997999999999998212699999999368999999853
Q 005617 552 EVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 552 ~i~~~i~~~~l~~~ld~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~L~~l~ 611 (688)
.+...+..+... ..|...+..+.+|+.+||+.||.+|||+. ++++.|+.+.
T Consensus 245 ~~~~~~~~~~~~--------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~-eil~~L~~il 295 (299)
T d1ywna1 245 EFCRRLKEGTRM--------RAPDYTTPEMYQTMLDCWHGEPSQRPTFS-ELVEHLGNLL 295 (299)
T ss_dssp HHHHHHHHTCCC--------CCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHH
T ss_pred HHHHHHHCCCCC--------CCCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHH
T ss_conf 999999638988--------88865789999999997677966791999-9999997998
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=343.69 Aligned_cols=256 Identities=25% Similarity=0.381 Sum_probs=207.9
Q ss_pred HCCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCCC---HHHHHHHHHHHHCCCCCCEEEEECCCCC------C
Q ss_conf 269532303401386589999998--9099999972389334---6999999999970799941247054478------7
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG---QLEFQQEVRVLSKLQHPHLVTLLGACPE------A 409 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~~---~~~f~~E~~iL~~l~HpnIV~l~g~~~~------~ 409 (688)
.++|.+...||+|+||.||+|... |..||||++....... ...|.+|+.+++.++|||||++++++.. .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf 62069868996089929999999999989999998556646989999999999999856999887311435432688766
Q ss_pred CEEEEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 42377607899678886124999989999999999999999999850699815718999996220799976991057310
Q 005617 410 WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~DFGla~ 489 (688)
.++||||++||+|.+++.... .+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++..+|+|||++.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~---~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG---PMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC---SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEEHHHHCCCC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCEEEHHHHHH
T ss_conf 999997788987101120358---9999999999999999999998579---5276346755665754320100344432
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHHHHH---HHHCCCCCCCC
Q ss_conf 015788767776556899889888881201049999820276799999999809999998156898---85219632235
Q 005617 490 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR---AVSCGKLSSIL 566 (688)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELltG~~Pf~~~~~i~~---~i~~~~l~~~l 566 (688)
........ ........||+.|+|||++.+..+++++|||||||++|||+||++||........ .+..+...
T Consensus 160 ~~~~~~~~---~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~--- 233 (277)
T d1o6ya_ 160 AIADSGNS---VTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP--- 233 (277)
T ss_dssp ECC-------------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC---
T ss_pred HHCCCCCC---CCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCC---
T ss_conf 21235443---333464257624369999839999966320265289999976979989969999999998469999---
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 788899997999999999998212699999999368999999853
Q 005617 567 DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLH 611 (688)
Q Consensus 567 d~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~L~~l~ 611 (688)
+ ......++..+.+|+.+||+.||.+||+..+++.+.|.++.
T Consensus 234 -~--~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~ 275 (277)
T d1o6ya_ 234 -P--SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 275 (277)
T ss_dssp -G--GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred -C--CHHCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHH
T ss_conf -7--10034789999999999866797677739999999999975
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.19 Aligned_cols=258 Identities=26% Similarity=0.351 Sum_probs=198.4
Q ss_pred CCCCCCEEEECCCCEEEEEEEECCEEEEEEEEECCCCCCHHHHH--HHHHHHHCCCCCCEEEEECCCCC------CCEEE
Q ss_conf 69532303401386589999998909999997238933469999--99999970799941247054478------74237
Q 005617 342 CNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQ--QEVRVLSKLQHPHLVTLLGACPE------AWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~g~~VAIK~l~~~~~~~~~~f~--~E~~iL~~l~HpnIV~l~g~~~~------~~~LV 413 (688)
.+|...+.||+|+||.||+|++.|..||||++.... ...+. .|+..+..++|||||+++|+|.+ ..++|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv 79 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEECCEEEEEEEECCCC---HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEEE
T ss_conf 689998898207881999999999899999987200---46799999999996279986832688998379860489999
Q ss_pred EECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC-----CCCEEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf 760789967888612499998999999999999999999985069-----981571899999622079997699105731
Q 005617 414 YEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK-----PEKIVHGDLKPQNILLDSELSSKICDFGIC 488 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~-----~~~IiHrDIKp~NILLd~~~~vKL~DFGla 488 (688)
|||+++|+|.++|... .++|..+++++.++|.||.|||... .++|+||||||+|||++.++.+||+|||++
T Consensus 80 ~Ey~~~g~L~~~l~~~----~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 80 SDYHEHGSLFDYLNRY----TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EECCTTCBHHHHHHHC----CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EECCCCCCHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCCC
T ss_conf 9646698989998658----999899999999999999998876652046898661531731357868877688763866
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCC------CCCCCHHHHHHHHHHHHHHCCCCCCCHH-----------
Q ss_conf 00157887677765568998898888812010499------9982027679999999980999999815-----------
Q 005617 489 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGV------LTPKSDSYSFGLIILQLLTGRLPVGLAG----------- 551 (688)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~------~s~ksDVwSlGviL~ELltG~~Pf~~~~----------- 551 (688)
+......... ........||+.|+|||++.... ++.++|||||||+||||+||.+|+....
T Consensus 156 ~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~ 233 (303)
T d1vjya_ 156 VRHDSATDTI--DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233 (303)
T ss_dssp EEEETTTTEE--CC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred CCCCCCCCCE--ECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHCCC
T ss_conf 2346777620--01355250354767822105654546777675012201599999996289988766311241012255
Q ss_pred ------HHHHHHHCCCCCCCCCCCCC-CC-CHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf ------68988521963223578889-99-9799999999999821269999999936899999985300
Q 005617 552 ------EVRRAVSCGKLSSILDPLAG-DW-PTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVA 613 (688)
Q Consensus 552 ------~i~~~i~~~~l~~~ld~~~~-~~-~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~L~~l~~~ 613 (688)
........+ .++|... .+ +......+.+|+.+||+.||.+|||+. ++++.|+.+...
T Consensus 234 ~~~~~~~~~~~~~~~----~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~-ei~~~L~~i~~~ 298 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQ----KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL-RIKKTLSQLSQQ 298 (303)
T ss_dssp SSCCHHHHHHHHTTS----CCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHH-HHHHHHHHHHHH
T ss_pred CCCHHHHHHHHHHCC----CCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHHH
T ss_conf 643099999987502----46888776557768999999999997606985895999-999999988886
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=347.27 Aligned_cols=252 Identities=28% Similarity=0.424 Sum_probs=205.2
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CE--EEEEEEEECCCC-CCHHHHHHHHHHHHCC-CCCCEEEEECCCCC--CCEEE
Q ss_conf 69532303401386589999998--90--999999723893-3469999999999707-99941247054478--74237
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GR--TVAIKMLYSHNM-QGQLEFQQEVRVLSKL-QHPHLVTLLGACPE--AWSLV 413 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~--~VAIK~l~~~~~-~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~~~LV 413 (688)
++|....+||+|+||.||+|.+. |. .||||++..... .....|.+|+.++.++ +|||||+++|+|.+ ..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf 99688779820788289999998999699999999782338579999999999998622899883678888418736999
Q ss_pred EECCCCCCHHHHHCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCE
Q ss_conf 7607899678886124-------------999989999999999999999999850699815718999996220799976
Q 005617 414 YEYLPNGSLQDRLFRK-------------SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSS 480 (688)
Q Consensus 414 ~E~~~~gsL~~~L~~~-------------~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~v 480 (688)
|||+++|+|.++|... .....+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCCEEEECCCCCE
T ss_conf 9802898699998640355555123101234578999999999999999987663089---5455505204898688763
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCC-CCCCCHH--HHHHHH
Q ss_conf 9910573100157887677765568998898888812010499998202767999999998099-9999815--689885
Q 005617 481 KICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGR-LPVGLAG--EVRRAV 557 (688)
Q Consensus 481 KL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELltG~-~Pf~~~~--~i~~~i 557 (688)
||+|||+++...... ......||..|+|||.+....++.++|||||||++|||++|. +||.... .+...+
T Consensus 167 kl~DfG~a~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i 239 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV-------KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 239 (309)
T ss_dssp EECCTTCEESSCEEC-------CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred EECCCCCCCCCCCCC-------CCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCCHHHHHHHH
T ss_conf 874344322444223-------4553013775555387526999962215313889999983689999999999999999
Q ss_pred HCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 2196322357888999979999999999982126999999993689999998530
Q 005617 558 SCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 558 ~~~~l~~~ld~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~L~~l~~ 612 (688)
..+. ....+..++..+.+|+.+||+.||++||++. ++++.|+.+..
T Consensus 240 ~~~~--------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~-eil~~L~~i~~ 285 (309)
T d1fvra_ 240 PQGY--------RLEKPLNCDDEVYDLMRQCWREKPYERPSFA-QILVSLNRMLE 285 (309)
T ss_dssp GGTC--------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred HHCC--------CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHH
T ss_conf 8268--------8888766789999999997678966894999-99999999986
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.56 Aligned_cols=249 Identities=22% Similarity=0.264 Sum_probs=195.4
Q ss_pred HCCCCCCE-EEECCCCEEEEEEEEC--CEEEEEEEEECCCCCCHHHHHHHHHHHHCC-CCCCEEEEECCCCC------CC
Q ss_conf 26953230-3401386589999998--909999997238933469999999999707-99941247054478------74
Q 005617 341 TCNFSESF-KVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKL-QHPHLVTLLGACPE------AW 410 (688)
Q Consensus 341 t~~f~~~~-~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~------~~ 410 (688)
.++|.+.. .||+|+||.||+|.+. |..||||++.. ...+.+|+.++.++ +|||||++++++.+ ..
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEE
T ss_conf 14879810796545486999999889998999999897-----4779999999998669999782989995034689789
Q ss_pred EEEEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECC---CCCEEEEECCC
Q ss_conf 237760789967888612499998999999999999999999985069981571899999622079---99769910573
Q 005617 411 SLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS---ELSSKICDFGI 487 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~---~~~vKL~DFGl 487 (688)
++|||||+||+|.+++..... ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++. .+.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDRGD-QAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSCSC-CCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCCHHHHHHHCCC-CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCE
T ss_conf 999977899849999986278-77579999999999999999999769---86444100220113555566311354551
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHHHH--HHHHCCCCCCC
Q ss_conf 1001578876777655689988988888120104999982027679999999980999999815689--88521963223
Q 005617 488 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVR--RAVSCGKLSSI 565 (688)
Q Consensus 488 a~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELltG~~Pf~~~~~i~--~~i~~~~l~~~ 565 (688)
|+...... ......||+.|+|||++.+..|+.++|||||||++|+|+||++||....... ..+........
T Consensus 161 a~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~ 233 (335)
T d2ozaa1 161 AKETTSHN-------SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 233 (335)
T ss_dssp CEECCCCC-------CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS
T ss_pred EEECCCCC-------CCCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHHCCC
T ss_conf 23336888-------64322677563792777489888888887645167788658899889887788999999985388
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHH
Q ss_conf 57888999979999999999982126999999993689999
Q 005617 566 LDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKE 606 (688)
Q Consensus 566 ld~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~ 606 (688)
.+ ........++..+.+|+.+||+.||.+||++.+.+.+.
T Consensus 234 ~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp 273 (335)
T d2ozaa1 234 YE-FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP 273 (335)
T ss_dssp SS-CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSH
T ss_pred CC-CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCH
T ss_conf 88-89854346999999999997569965790999997098
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=343.31 Aligned_cols=255 Identities=27% Similarity=0.452 Sum_probs=209.3
Q ss_pred CCCCCCEEEECCCCEEEEEEEECC---------EEEEEEEEECCCCC-CHHHHHHHHHHHHCC-CCCCEEEEECCCCC--
Q ss_conf 695323034013865899999989---------09999997238933-469999999999707-99941247054478--
Q 005617 342 CNFSESFKVGQGGFGCVYKGEMLG---------RTVAIKMLYSHNMQ-GQLEFQQEVRVLSKL-QHPHLVTLLGACPE-- 408 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~g---------~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~-- 408 (688)
++|.+.+.||+|+||.||+|+..+ ..||||+++..... ....+.+|...+.++ +|||||+++|+|.+
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~ 92 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 92 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCCCC
T ss_conf 99697009851678289999985787555667549999998811286889999999999998139996973465220188
Q ss_pred CCEEEEECCCCCCHHHHHCCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEEC
Q ss_conf 74237760789967888612499-------------99899999999999999999998506998157189999962207
Q 005617 409 AWSLVYEYLPNGSLQDRLFRKSN-------------VSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD 475 (688)
Q Consensus 409 ~~~LV~E~~~~gsL~~~L~~~~~-------------~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd 475 (688)
..++||||+.+|+|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+|||++
T Consensus 93 ~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 93 PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 169 (299)
T ss_dssp SCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred EEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCEEEC
T ss_conf 689999736999099999860677643222334574346799999999999999998766379---78630221022454
Q ss_pred CCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCHH--H
Q ss_conf 9997699105731001578876777655689988988888120104999982027679999999980-999999815--6
Q 005617 476 SELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG--E 552 (688)
Q Consensus 476 ~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELlt-G~~Pf~~~~--~ 552 (688)
.++.+||+|||+++........ .......|++.|+|||++.++.|+.++|||||||++|||++ |.+||.... .
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~----~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~ 245 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYY----KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 245 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTT----CCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred CCCCEEECCCHHHCCCCCCCCC----CCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHHH
T ss_conf 7897676221110113555554----314667888466326675179888255547758888874017989899999999
Q ss_pred HHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 898852196322357888999979999999999982126999999993689999998530
Q 005617 553 VRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 553 i~~~i~~~~l~~~ld~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~L~~l~~ 612 (688)
+...+..+.. ...|..++..+.+|+.+||+.||.+|||+. ++++.|+.+..
T Consensus 246 ~~~~i~~~~~--------~~~p~~~~~~l~~li~~cl~~dP~~Rps~~-eil~~L~~i~a 296 (299)
T d1fgka_ 246 LFKLLKEGHR--------MDKPSNCTNELYMMMRDCWHAVPSQRPTFK-QLVEDLDRIVA 296 (299)
T ss_dssp HHHHHHTTCC--------CCCCSSCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHHHH
T ss_pred HHHHHHCCCC--------CCCCCCCHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHH
T ss_conf 9999972888--------898743529999999997667976793999-99999988860
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=345.59 Aligned_cols=254 Identities=28% Similarity=0.447 Sum_probs=206.0
Q ss_pred HCCCCCCEEEECCCCEEEEEEEEC-------CEEEEEEEEECCCC-CCHHHHHHHHHHHHCCCCCCEEEEECCCC--CCC
Q ss_conf 269532303401386589999998-------90999999723893-34699999999997079994124705447--874
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACP--EAW 410 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~-------g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~--~~~ 410 (688)
-++|...++||+|+||+||+|.+. +..||||+++.... .....|.+|+.++.+++|||||+++|+|. +..
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCE
T ss_conf 89918835982078818999998786447789689999987012868999999999999976999884125478428810
Q ss_pred EEEEECCCCCCHHHHHCCC-------CCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEE
Q ss_conf 2377607899678886124-------999989999999999999999999850699815718999996220799976991
Q 005617 411 SLVYEYLPNGSLQDRLFRK-------SNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKIC 483 (688)
Q Consensus 411 ~LV~E~~~~gsL~~~L~~~-------~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~ 483 (688)
++||||+++|+|.+++... .....+++..+.+++.++|.||.|||..+ |+||||||+|||++.++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECEECCCCEEECCCCEEEEE
T ss_conf 6777604899889998750332113444688799999999999999999876479---6543286775403599649994
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHC-CCCCCCHHH--HHHHHHCC
Q ss_conf 057310015788767776556899889888881201049999820276799999999809-999998156--89885219
Q 005617 484 DFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTG-RLPVGLAGE--VRRAVSCG 560 (688)
Q Consensus 484 DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELltG-~~Pf~~~~~--i~~~i~~~ 560 (688)
|||+++........ .......||+.|+|||.+.+..++.++||||||+++|||+|| .+||..... +...+..+
T Consensus 176 DFGla~~~~~~~~~----~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~ 251 (308)
T d1p4oa_ 176 DFGMTRDIYETDYY----RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG 251 (308)
T ss_dssp CTTCCCGGGGGGCE----EGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred ECCCCEECCCCCCE----EECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHC
T ss_conf 24542023577630----31340231632378888736998833344437899999996899999998999999999808
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 63223578889999799999999999821269999999936899999985
Q 005617 561 KLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 561 ~l~~~ld~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~L~~l 610 (688)
.. ...+..++..+.+|+.+||+.+|.+|||+. .++..|+..
T Consensus 252 ~~--------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~-~il~~L~~~ 292 (308)
T d1p4oa_ 252 GL--------LDKPDNCPDMLFELMRMCWQYNPKMRPSFL-EIISSIKEE 292 (308)
T ss_dssp CC--------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHGGG
T ss_pred CC--------CCCCCCCHHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHH
T ss_conf 88--------888633539999999997577965893999-999997876
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=348.22 Aligned_cols=253 Identities=27% Similarity=0.409 Sum_probs=204.9
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC---C--EEEEEEEEECCCC---CCHHHHHHHHHHHHCCCCCCEEEEECCCCC-CCEE
Q ss_conf 69532303401386589999998---9--0999999723893---346999999999970799941247054478-7423
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML---G--RTVAIKMLYSHNM---QGQLEFQQEVRVLSKLQHPHLVTLLGACPE-AWSL 412 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~---g--~~VAIK~l~~~~~---~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-~~~L 412 (688)
.+|.+...||+|+||.||+|++. + ..||||++..... .....|.+|+.++.+++|||||+++|+|.+ ..++
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~l 87 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKM 87 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEE
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCHHE
T ss_conf 89199789803888399999998899907999999998355579899999999999998689999878987774010011
Q ss_pred EEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCC
Q ss_conf 77607899678886124999989999999999999999999850699815718999996220799976991057310015
Q 005617 413 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVT 492 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~DFGla~~~~ 492 (688)
||||+++|++.+.+.... ..+++..++.++.|+|.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~~~--~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 88 VTELAPLGSLLDRLRKHQ--GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp EEECCTTCBHHHHHHHHG--GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred EEEEECCCCHHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECHHHHCCCCCCCEEECCCHHHHHCC
T ss_conf 465423861254442126--89999999999999999998752178---7520566888156556543325611555303
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCHHHHH--HHHHCCCCCCCCCCC
Q ss_conf 78876777655689988988888120104999982027679999999980-999999815689--885219632235788
Q 005617 493 EDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAGEVR--RAVSCGKLSSILDPL 569 (688)
Q Consensus 493 ~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELlt-G~~Pf~~~~~i~--~~i~~~~l~~~ld~~ 569 (688)
...... .......|+..|+|||++.+..++.++|||||||++|||+| |+.||....... ..+.....
T Consensus 163 ~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~------- 232 (273)
T d1u46a_ 163 QNDDHY---VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGE------- 232 (273)
T ss_dssp C-CCEE---EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCC-------
T ss_pred CCCCCC---EECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHCCC-------
T ss_conf 588752---6547632573107999983799994215661489999999689999999699999999984799-------
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 89999799999999999821269999999936899999985
Q 005617 570 AGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 570 ~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~L~~l 610 (688)
..+.+..++..+.+|+.+||+.||.+|||+. .+.+.|+..
T Consensus 233 ~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~-ei~~~L~~~ 272 (273)
T d1u46a_ 233 RLPRPEDCPQDIYNVMVQCWAHKPEDRPTFV-ALRDFLLEA 272 (273)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHC
T ss_conf 9998544539999999997688966792999-999999964
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=340.84 Aligned_cols=249 Identities=18% Similarity=0.275 Sum_probs=201.4
Q ss_pred HCCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCEEEEEC
Q ss_conf 269532303401386589999998--90999999723893346999999999970799941247054478--74237760
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
.++|.+...||+|+||+||+|... |..||+|+++... .....+.+|+.+|..++|||||++++++.+ ..++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
T ss_conf 010588789831778399999998999699999975786-6599999999999857997989098999889988999953
Q ss_pred CCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECC--CCCEEEEECCCCCCCCCC
Q ss_conf 789967888612499998999999999999999999985069981571899999622079--997699105731001578
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS--ELSSKICDFGICRLVTED 494 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~--~~~vKL~DFGla~~~~~~ 494 (688)
++||+|.+++.... ..+++..+..|+.||+.||.|||+.+ |+||||||+|||++. .+.+||+|||+++.....
T Consensus 83 ~~gg~L~~~i~~~~--~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINTSA--FELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCCC
T ss_conf 89980889987538--99999999999999999999998769---97513554443443788518997644111003467
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCCCCCCCCC
Q ss_conf 8767776556899889888881201049999820276799999999809999998156--89885219632235788899
Q 005617 495 TLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSILDPLAGD 572 (688)
Q Consensus 495 ~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELltG~~Pf~~~~~--i~~~i~~~~l~~~ld~~~~~ 572 (688)
. ......||+.|+|||.+.+..++.++|||||||++|+|++|..||..... +...+..+...- ...
T Consensus 158 ~-------~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-----~~~ 225 (321)
T d1tkia_ 158 D-------NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTF-----DEE 225 (321)
T ss_dssp C-------EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCC-----CHH
T ss_pred C-------CCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCC-----CHH
T ss_conf 7-------5321223322234021048777840113027999999982899999989999999998389998-----802
Q ss_pred CCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHH
Q ss_conf 99799999999999821269999999936899999
Q 005617 573 WPTFVARRLVDLGLQCCELYGRERPDITPSLVKEL 607 (688)
Q Consensus 573 ~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~L 607 (688)
....++..+.+|+.+||..||.+||++.+.+.+.+
T Consensus 226 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~ 260 (321)
T d1tkia_ 226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPW 260 (321)
T ss_dssp HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred HCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCCHH
T ss_conf 23678999999999986699668909999963996
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=339.96 Aligned_cols=254 Identities=29% Similarity=0.411 Sum_probs=206.8
Q ss_pred HCCCCCCEEEECCCCEEEEEEEEC-------CEEEEEEEEECCCCC-CHHHHHHHHHHHHCC-CCCCEEEEECCCCC--C
Q ss_conf 269532303401386589999998-------909999997238933-469999999999707-99941247054478--7
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML-------GRTVAIKMLYSHNMQ-GQLEFQQEVRVLSKL-QHPHLVTLLGACPE--A 409 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~-------g~~VAIK~l~~~~~~-~~~~f~~E~~iL~~l-~HpnIV~l~g~~~~--~ 409 (688)
.++|.+.++||+|+||.||+|++. +..||||+++..... ....|.+|+.++.++ +|||||+++|+|.+ .
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCE
T ss_conf 89969854982068829999998066447788699999987424877999999999998762699988789989831997
Q ss_pred CEEEEECCCCCCHHHHHCCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEE
Q ss_conf 423776078996788861249---------------99989999999999999999999850699815718999996220
Q 005617 410 WSLVYEYLPNGSLQDRLFRKS---------------NVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILL 474 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~---------------~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILL 474 (688)
.++||||+++|+|.+++.... ....+++..+..|+.||+.||.|||+.+ ++||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCCC
T ss_conf 8999973799879999985356654444453322233458899999999999999999887579---2666241021000
Q ss_pred CCCCCEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHH-CCCCCCCHH--
Q ss_conf 79997699105731001578876777655689988988888120104999982027679999999980-999999815--
Q 005617 475 DSELSSKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLT-GRLPVGLAG-- 551 (688)
Q Consensus 475 d~~~~vKL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELlt-G~~Pf~~~~-- 551 (688)
+.++.+||+|||+++........ .......||+.|+|||++....++.++|||||||++|||+| |.+||....
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNY----VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTS----EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred CCCCCCCCCCCCHHEECCCCCCC----EEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHH
T ss_conf 02575210234010233678861----58620135968767788617999974001025899999985899887789989
Q ss_pred -HHHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHH
Q ss_conf -68988521963223578889999799999999999821269999999936899999985
Q 005617 552 -EVRRAVSCGKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQL 610 (688)
Q Consensus 552 -~i~~~i~~~~l~~~ld~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~L~~l 610 (688)
.+...+..+.. ...+...+..+.+|+.+||+.||.+||++. .+++.|+..
T Consensus 255 ~~~~~~i~~~~~--------~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~-~il~~L~~~ 305 (311)
T d1t46a_ 255 SKFYKMIKEGFR--------MLSPEHAPAEMYDIMKTCWDADPLKRPTFK-QIVQLIEKQ 305 (311)
T ss_dssp HHHHHHHHHTCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHH-HHHHHHHHH
T ss_pred HHHHHHHHCCCC--------CCCCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHH
T ss_conf 999999866898--------898543659999999997577965792999-999999876
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=334.41 Aligned_cols=243 Identities=24% Similarity=0.330 Sum_probs=200.2
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCCC---------HHHHHHHHHHHHCCC-CCCEEEEECCCCC-
Q ss_conf 69532303401386589999998--9099999972389334---------699999999997079-9941247054478-
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG---------QLEFQQEVRVLSKLQ-HPHLVTLLGACPE- 408 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~~---------~~~f~~E~~iL~~l~-HpnIV~l~g~~~~- 408 (688)
++|.....||+|+||+||+|+.. |..||||++....... ...+.+|+.++.+++ |||||++++++.+
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred CCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCC
T ss_conf 63888528841768499999999999899999996244641147888999999999999999850799747997621467
Q ss_pred -CCEEEEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCC
Q ss_conf -7423776078996788861249999899999999999999999998506998157189999962207999769910573
Q 005617 409 -AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 487 (688)
Q Consensus 409 -~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~DFGl 487 (688)
..++||||+++|+|.+++.... .+++..+..++.||+.||.|||..+ |+||||||+|||++.++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~---~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV---TLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS---SCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred CCEEEEEECCCCCHHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCHH
T ss_conf 60599997689866899998659---9999999999999999999998759---94323462548986899838712403
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCC------CCCCCCCHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHC
Q ss_conf 1001578876777655689988988888120104------9999820276799999999809999998156--8988521
Q 005617 488 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRT------GVLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSC 559 (688)
Q Consensus 488 a~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~------~~~s~ksDVwSlGviL~ELltG~~Pf~~~~~--i~~~i~~ 559 (688)
++...... ......||+.|+|||++.+ ..++.++||||+||++|+|++|+.||..... +...+..
T Consensus 157 a~~~~~~~-------~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~ 229 (277)
T d1phka_ 157 SCQLDPGE-------KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 229 (277)
T ss_dssp CEECCTTC-------CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred EEECCCCC-------CEEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHHHHHHHHH
T ss_conf 16726887-------21345246788898886053445678899233185656023103228889889999999999981
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHH
Q ss_conf 9632235788899997999999999998212699999999368
Q 005617 560 GKLSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPS 602 (688)
Q Consensus 560 ~~l~~~ld~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~ 602 (688)
+... . ........+..+.+|+.+||+.||.+||++.+.
T Consensus 230 ~~~~-~----~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~ei 267 (277)
T d1phka_ 230 GNYQ-F----GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEA 267 (277)
T ss_dssp TCCC-C----CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred CCCC-C----CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHH
T ss_conf 8988-8----985434689999999999765896689199999
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.15 Aligned_cols=245 Identities=24% Similarity=0.253 Sum_probs=190.1
Q ss_pred CEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCCC-----HHHHHHHHHHHHCCCCCCEEEEECCCCC--CCEEEEECC
Q ss_conf 303401386589999998--9099999972389334-----6999999999970799941247054478--742377607
Q 005617 347 SFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQG-----QLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEYL 417 (688)
Q Consensus 347 ~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~~-----~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~~ 417 (688)
..+||+|+||+||+|.+. |..||||++....... ...+.+|+.++.+++|||||++++++.+ ..++||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred CEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHHH
T ss_conf 63851272829999999999969999998420212456799999999999998679999868985422587402204553
Q ss_pred CCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCCC
Q ss_conf 89967888612499998999999999999999999985069981571899999622079997699105731001578876
Q 005617 418 PNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTLY 497 (688)
Q Consensus 418 ~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~~ 497 (688)
.++++....... ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.......
T Consensus 83 ~~~~~~~~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~- 155 (299)
T d1ua2a_ 83 ETDLEVIIKDNS---LVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR- 155 (299)
T ss_dssp SEEHHHHHTTCC---SSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC-
T ss_pred CCHHHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCC-
T ss_conf 450776554126---67789999999999999998863163---55035776258853778411465761000578755-
Q ss_pred CCCCCCCCCCCCCCCCCCHHHHCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHC----CC-----CCCCC-
Q ss_conf 7776556899889888881201049-9998202767999999998099999981568988521----96-----32235-
Q 005617 498 LPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC----GK-----LSSIL- 566 (688)
Q Consensus 498 ~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~ELltG~~Pf~~~~~i~~~i~~----~~-----l~~~l- 566 (688)
.....+||+.|+|||++... .|+.++|||||||++|||+||.+||............ +. .....
T Consensus 156 -----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~ 230 (299)
T d1ua2a_ 156 -----AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCS 230 (299)
T ss_dssp -----CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTS
T ss_pred -----CCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCHHC
T ss_conf -----433020473336399972677888056436304289999859699999999999999998518997254521000
Q ss_pred --CC----CCCCCC-----HHHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf --78----889999-----79999999999982126999999993689
Q 005617 567 --DP----LAGDWP-----TFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 567 --d~----~~~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
.. .....+ ...+..+.+|+.+||+.||++|||+.+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L 278 (299)
T d1ua2a_ 231 LPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278 (299)
T ss_dssp STTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHH
T ss_pred CCHHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 213443034789886785656899999999997638945690899996
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=332.55 Aligned_cols=251 Identities=26% Similarity=0.340 Sum_probs=193.2
Q ss_pred HCCCCCCEEEECCCCEEEEEEEEC---CEEEEEEEEECCCC--CCHHHHHHHHHHHHCC---CCCCEEEEECCCC-----
Q ss_conf 269532303401386589999998---90999999723893--3469999999999707---9994124705447-----
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML---GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKL---QHPHLVTLLGACP----- 407 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~---g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l---~HpnIV~l~g~~~----- 407 (688)
.++|....+||+|+||+||+|++. +..||||++..... .....+.+|+.++..+ +|||||+++++|.
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCC
T ss_conf 58979888992155869999999888998999999802324516799999999999987425898802366322146666
Q ss_pred --CCCEEEEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEEC
Q ss_conf --874237760789967888612499998999999999999999999985069981571899999622079997699105
Q 005617 408 --EAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDF 485 (688)
Q Consensus 408 --~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~DF 485 (688)
...+++|||+.++.+........ ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~--~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCT--TCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCEEEEEEEECCCCCHHHHHHCCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEECCCCCEEECCH
T ss_conf 6746999997405871444443037--89998999999999999999997588---983579862789858997542100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHHHHHHHH----CCC
Q ss_conf 7310015788767776556899889888881201049999820276799999999809999998156898852----196
Q 005617 486 GICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS----CGK 561 (688)
Q Consensus 486 Gla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELltG~~Pf~~~~~i~~~i~----~~~ 561 (688)
|+++...... ......||+.|+|||++.+..|+.++||||+||++|||++|++||........... .+.
T Consensus 161 g~~~~~~~~~-------~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~ 233 (305)
T d1blxa_ 161 GLARIYSFQM-------ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 233 (305)
T ss_dssp CSCCCCCGGG-------GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred HHHHHHCCCC-------CCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCC
T ss_conf 0101100234-------577765485114831001798881110003289999998787998998989999999984079
Q ss_pred -----------CC-----CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf -----------32-----2357888999979999999999982126999999993689
Q 005617 562 -----------LS-----SILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 562 -----------l~-----~~ld~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
.. .........++...+..+.+|+.+||+.||.+|||+.+.+
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L 291 (305)
T d1blxa_ 234 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291 (305)
T ss_dssp CCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CCHHCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 9611053211110333022345645440445899999999998748966791899996
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=332.49 Aligned_cols=251 Identities=25% Similarity=0.328 Sum_probs=194.2
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCC--CCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCEEEEE
Q ss_conf 69532303401386589999998--90999999723893--346999999999970799941247054478--7423776
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E 415 (688)
++|...++||+|+||+||+|.+. |..||||+++.... .....+.+|+.++++++|||||++++++.+ ..++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99776517723768099999999999799999980222575899999999999986799838874453322432037886
Q ss_pred CCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 07899678886124999989999999999999999999850699815718999996220799976991057310015788
Q 005617 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 495 (688)
|+.++.+. .+.... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|+......
T Consensus 82 ~~~~~~~~-~~~~~~-~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKK-FMDASA-LTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHH-HHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ECCCCHHH-HHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCHHEEECCCCCCEECCCCCCEECCCCC
T ss_conf 23774455-544202-568888999999999999999865288---9921357114011346762103578613436886
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHCCCC-CCCCCHHHHHHHHHHHHHHCCCCCCCHHHHHHHHH----CCCCCCC-----
Q ss_conf 7677765568998898888812010499-99820276799999999809999998156898852----1963223-----
Q 005617 496 LYLPSFHRSTAPKGSFPYADPEYHRTGV-LTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS----CGKLSSI----- 565 (688)
Q Consensus 496 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlGviL~ELltG~~Pf~~~~~i~~~i~----~~~l~~~----- 565 (688)
. ......||+.|+|||++.... ++.++|||||||++|+|++|+.||........... .+...+.
T Consensus 157 ~------~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 230 (298)
T d1gz8a_ 157 R------TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 230 (298)
T ss_dssp B------CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTG
T ss_pred C------CCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHCCCC
T ss_conf 4------1001036521541122136657774221033331342796687998988999999999983289833314442
Q ss_pred ---CCC--CCCCC--------CHHHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf ---578--88999--------979999999999982126999999993689
Q 005617 566 ---LDP--LAGDW--------PTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 566 ---ld~--~~~~~--------~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
.+. ....+ ....+..+.+|+.+||+.||.+|||+.+.+
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell 281 (298)
T d1gz8a_ 231 TSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281 (298)
T ss_dssp GGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred CCCCCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 224212434543222204441667899999999997639955791899996
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=327.94 Aligned_cols=247 Identities=24% Similarity=0.314 Sum_probs=189.3
Q ss_pred CCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCEEEEECCCCC--------CCEE
Q ss_conf 9532303401386589999998--90999999723893346999999999970799941247054478--------7423
Q 005617 343 NFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGACPE--------AWSL 412 (688)
Q Consensus 343 ~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--------~~~L 412 (688)
+|...++||+|+||+||+|++. |..||||++...... +.+|+.++.+++|||||+++++|.. ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCHH----HHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf 767516982176839999999999979999998816068----9999999986689898738789974476577318999
Q ss_pred EEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCC-CEEEEECCCCCCC
Q ss_conf 776078996788861249999899999999999999999998506998157189999962207999-7699105731001
Q 005617 413 VYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL-SSKICDFGICRLV 491 (688)
Q Consensus 413 V~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~-~vKL~DFGla~~~ 491 (688)
||||++++.+............+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++ .+||+|||+++..
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEEECCCCCEEEECCCCHHHC
T ss_conf 9841688607888863103689999999999999999999998668---7645788603787358971167336605440
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHHCCCCCCCHHHHHHHHH------------
Q ss_conf 578876777655689988988888120104-9999820276799999999809999998156898852------------
Q 005617 492 TEDTLYLPSFHRSTAPKGSFPYADPEYHRT-GVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS------------ 558 (688)
Q Consensus 492 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~-~~~s~ksDVwSlGviL~ELltG~~Pf~~~~~i~~~i~------------ 558 (688)
.... ......|++.|+|||.+.+ ..++.++||||+||++|||++|++||...........
T Consensus 174 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 246 (350)
T d1q5ka_ 174 VRGE-------PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246 (350)
T ss_dssp CTTS-------CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred CCCC-------CCCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHHHHHHHHHHHCCCHHHH
T ss_conf 4776-------532002555556827764046888210002465277855028799898799999999999748981776
Q ss_pred -----CC----CCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf -----19----6322357-888999979999999999982126999999993689
Q 005617 559 -----CG----KLSSILD-PLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 559 -----~~----~l~~~ld-~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
.. .+..... +.........+..+.+|+.+||..||.+|||+.+.+
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L 301 (350)
T d1q5ka_ 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301 (350)
T ss_dssp HHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHCCCHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 5430621011035544567444431568999999999997658955792999996
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=324.63 Aligned_cols=250 Identities=22% Similarity=0.310 Sum_probs=195.9
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC-CEEEEEEEEECCCC--CCHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCEEEEEC
Q ss_conf 69532303401386589999998-90999999723893--346999999999970799941247054478--74237760
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYEY 416 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~-g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E~ 416 (688)
++|...++||+|+||+||+|++. |..||||++..... .....+.+|+.++++++|||||++++++.+ ..++++++
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf 99634318722778189999968999999999812326858999999999999867998687660120467731589974
Q ss_pred CCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCCC
Q ss_conf 78996788861249999899999999999999999998506998157189999962207999769910573100157887
Q 005617 417 LPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDTL 496 (688)
Q Consensus 417 ~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~~ 496 (688)
+.++.+....... ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~~~~~~~~~~~---~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLDVCE---GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHHTST---TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EHHHHHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHCCCC---EEECCCCCCEEEECCCCCEEECCCCCCEECCCCCC
T ss_conf 0045678998604---77514456899999999999860574---88267877505686899787323664301146765
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCHHHHHHHHH----CCC--------CC
Q ss_conf 67776556899889888881201049-999820276799999999809999998156898852----196--------32
Q 005617 497 YLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS----CGK--------LS 563 (688)
Q Consensus 497 ~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~ELltG~~Pf~~~~~i~~~i~----~~~--------l~ 563 (688)
......|++.|+|||.+... .++.++|||||||++|||++|+.||........... .+. ..
T Consensus 156 ------~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 229 (286)
T d1ob3a_ 156 ------KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229 (286)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGG
T ss_pred ------CCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCHHHCCCHH
T ss_conf ------41010243110137887178888841002111758999977979989889899999999863899711042123
Q ss_pred CC------CC---CC-CCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf 23------57---88-8999979999999999982126999999993689
Q 005617 564 SI------LD---PL-AGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 564 ~~------ld---~~-~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
.. .. +. ........+..+.+|+.+||+.||++|||+.+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell 279 (286)
T d1ob3a_ 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279 (286)
T ss_dssp GSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred HHHHCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 33221433333567646665125899999999998668966890999985
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=332.69 Aligned_cols=236 Identities=23% Similarity=0.353 Sum_probs=192.1
Q ss_pred HCCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCC------CHHHHHHHHHHHHCCC--CCCEEEEECCCCC--
Q ss_conf 269532303401386589999998--909999997238933------4699999999997079--9941247054478--
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ------GQLEFQQEVRVLSKLQ--HPHLVTLLGACPE-- 408 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~------~~~~f~~E~~iL~~l~--HpnIV~l~g~~~~-- 408 (688)
.++|.+.+.||+|+||.||+|... |..||||++...... ....+.+|+.++.+++ |||||++++++.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf 88379967984087839999999999979999998568844334556799999999999974358988127999983099
Q ss_pred CCEEEEECCCC-CCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECC-CCCEEEEECC
Q ss_conf 74237760789-967888612499998999999999999999999985069981571899999622079-9976991057
Q 005617 409 AWSLVYEYLPN-GSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS-ELSSKICDFG 486 (688)
Q Consensus 409 ~~~LV~E~~~~-gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~-~~~vKL~DFG 486 (688)
..++||||+.+ +++.+++... ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~~---~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHHH---CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEEECCCCCHHHHHHHCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCCEEEECCCC
T ss_conf 6899998336862289998615---89999999999999999999998779---75566761114774478848977546
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCC-CCCCHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHCCCCCCC
Q ss_conf 31001578876777655689988988888120104999-98202767999999998099999981568988521963223
Q 005617 487 ICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVL-TPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSCGKLSSI 565 (688)
Q Consensus 487 la~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~-s~ksDVwSlGviL~ELltG~~Pf~~~~~i~~~i~~~~l~~~ 565 (688)
+|+...... .....||+.|+|||++.+..+ +.++|||||||++|||+||+.||.....+.. +..
T Consensus 157 ~a~~~~~~~--------~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~i~~----~~~--- 221 (273)
T d1xwsa_ 157 SGALLKDTV--------YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR----GQV--- 221 (273)
T ss_dssp TCEECCSSC--------BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHHHHH----CCC---
T ss_pred CCEECCCCC--------CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCHHHHH----CCC---
T ss_conf 535324445--------56656587747999984899788653325540345367568899887367761----544---
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf 57888999979999999999982126999999993689
Q 005617 566 LDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 566 ld~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
.++...+..+.+|+.+||..||.+|||+.+.+
T Consensus 222 ------~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil 253 (273)
T d1xwsa_ 222 ------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQ 253 (273)
T ss_dssp ------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred ------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf ------77877999999999997608975893999985
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=325.67 Aligned_cols=247 Identities=23% Similarity=0.295 Sum_probs=194.0
Q ss_pred HCCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCC--CHHHHHHHHHHHHCCCCCCEEEEECCCCC--------
Q ss_conf 269532303401386589999998--909999997238933--46999999999970799941247054478--------
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACPE-------- 408 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-------- 408 (688)
.++|....+||+|+||+||+|.+. |..||||+++..... ....+.+|+.+|+.++|||||+++++|..
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCC
T ss_conf 77189988980177819999999999989999998522259699999999999998668987547999863576555541
Q ss_pred CCEEEEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCC
Q ss_conf 74237760789967888612499998999999999999999999985069981571899999622079997699105731
Q 005617 409 AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGIC 488 (688)
Q Consensus 409 ~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~DFGla 488 (688)
..++||||+ +++|...+.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EEEEEEECC-CCCHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCHHHCCCCCCCCCCCCCCE
T ss_conf 599998405-5218999874----02269999999999999999987378---764566851111210012211343102
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCHHHHHHHHH----CCC--
Q ss_conf 0015788767776556899889888881201049-999820276799999999809999998156898852----196--
Q 005617 489 RLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS----CGK-- 561 (688)
Q Consensus 489 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~ELltG~~Pf~~~~~i~~~i~----~~~-- 561 (688)
+..... .+...||+.|+|||++.+. .++.++||||+||++|+|++|++||........... .+.
T Consensus 169 ~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 239 (346)
T d1cm8a_ 169 RQADSE---------MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPP 239 (346)
T ss_dssp EECCSS---------CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred ECCCCC---------CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCC
T ss_conf 206876---------31024553335889981787899650103003899999978699888976899999985037884
Q ss_pred ------------------CCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHH
Q ss_conf ------------------3223578889999799999999999821269999999936899
Q 005617 562 ------------------LSSILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLV 604 (688)
Q Consensus 562 ------------------l~~~ld~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~ 604 (688)
+...............+..+.+|+.+||..||.+|||+.+.+.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~ 300 (346)
T d1cm8a_ 240 AEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300 (346)
T ss_dssp HHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred HHHHHHHCCHHHHHHHCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 8888653000344331157866655667755689999999999977299557929999963
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=325.87 Aligned_cols=253 Identities=22% Similarity=0.267 Sum_probs=194.5
Q ss_pred HCCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCC-CCHHHHHHHHHHHHCCCCCCEEEEECCCCCC------CE
Q ss_conf 269532303401386589999998--90999999723893-3469999999999707999412470544787------42
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM-QGQLEFQQEVRVLSKLQHPHLVTLLGACPEA------WS 411 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~-~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~~------~~ 411 (688)
+.+|....+||+|+||+||+|... |..||||++..... .....+.+|+.+|..++|||||++++++... .+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEE
T ss_conf 89859978994064809999999999949999998031095899999999999997689898858889950564554149
Q ss_pred EEEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 37760789967888612499998999999999999999999985069981571899999622079997699105731001
Q 005617 412 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLV 491 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~DFGla~~~ 491 (688)
++++++.+|+|.+++... .+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 87 ~l~~~~~~g~L~~~l~~~----~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ----HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHHC----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEECCCCHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEEEC
T ss_conf 999962598656644058----9999999999999999999999789---867778764378879997787545705650
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHHH-CCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHC----CCCC---
Q ss_conf 5788767776556899889888881201-0499998202767999999998099999981568988521----9632---
Q 005617 492 TEDTLYLPSFHRSTAPKGSFPYADPEYH-RTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVSC----GKLS--- 563 (688)
Q Consensus 492 ~~~~~~~~~~~~~~~~~Gt~~Y~APE~~-~~~~~s~ksDVwSlGviL~ELltG~~Pf~~~~~i~~~i~~----~~l~--- 563 (688)
...... ........||+.|+|||++ ....++.++||||+||++|+|++|+.||............ ....
T Consensus 160 ~~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 236 (345)
T d1pmea_ 160 DPDHDH---TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED 236 (345)
T ss_dssp CGGGCB---CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred CCCCCC---CEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHH
T ss_conf 477764---10101102652000387860478887410100467013377669799788888999998765206997566
Q ss_pred ----------C--CCCCCCCCCC-----HHHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf ----------2--3578889999-----79999999999982126999999993689
Q 005617 564 ----------S--ILDPLAGDWP-----TFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 564 ----------~--~ld~~~~~~~-----~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
. ...+.....+ ...+..+.+|+.+||+.||.+|||+.+.+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L 293 (345)
T d1pmea_ 237 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293 (345)
T ss_dssp HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHHHHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 423433222202446775577877783789999999999997648956790899986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=321.49 Aligned_cols=254 Identities=22% Similarity=0.310 Sum_probs=193.8
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCC--CCHHHHHHHHHHHHCCCCCCEEEEECCCCC---------
Q ss_conf 69532303401386589999998--90999999723893--346999999999970799941247054478---------
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNM--QGQLEFQQEVRVLSKLQHPHLVTLLGACPE--------- 408 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~--~~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--------- 408 (688)
++|....+||+|+||+||+|++. |..||||++..... .....+.+|+.+|++++||||+++++++..
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCCC
T ss_conf 79889999722748299999998999799999984222463789999999999998359996606765402465444457
Q ss_pred -CCEEEEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCC
Q ss_conf -7423776078996788861249999899999999999999999998506998157189999962207999769910573
Q 005617 409 -AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGI 487 (688)
Q Consensus 409 -~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~DFGl 487 (688)
..++||||+.++.+....... ..++...+..|+.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~~~---~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSNVL---VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTCTT---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CEEEEEEECCCCCCCCHHHHCC---CCCCCHHHHHHHHHHHHHHHHHCCCC---EEECCCCCHHEEECCCCCEEEEECCE
T ss_conf 6389998535787410122203---44330899999999999998852299---88567672220366899687631350
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCHHHHHHHHH----CCCC
Q ss_conf 10015788767776556899889888881201049-999820276799999999809999998156898852----1963
Q 005617 488 CRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS----CGKL 562 (688)
Q Consensus 488 a~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~ELltG~~Pf~~~~~i~~~i~----~~~l 562 (688)
++......... .......+||+.|+|||++.+. .++.++|||||||++|||++|++||........... .+..
T Consensus 164 ~~~~~~~~~~~--~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 241 (318)
T d3blha1 164 ARAFSLAKNSQ--PNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241 (318)
T ss_dssp CEECCC-------CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred EEECCCCCCCC--CCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHHCCCC
T ss_conf 02235544432--1135660249787428997079998917870067864661744879989989999999999841899
Q ss_pred CCCC-------------CCCC-CCCCH-------HHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf 2235-------------7888-99997-------9999999999982126999999993689
Q 005617 563 SSIL-------------DPLA-GDWPT-------FVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 563 ~~~l-------------d~~~-~~~~~-------~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
.... .... ...+. .....+.+|+.+||+.||++|||+.+.+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL 303 (318)
T d3blha1 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303 (318)
T ss_dssp CTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred CHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 82553443203444332013344555033404445998999999998738965890999997
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=323.29 Aligned_cols=260 Identities=22% Similarity=0.292 Sum_probs=197.0
Q ss_pred HCCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCCEEEEECCC---CCCCEEEEE
Q ss_conf 269532303401386589999998--909999997238933469999999999707999412470544---787423776
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPHLVTLLGAC---PEAWSLVYE 415 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~HpnIV~l~g~~---~~~~~LV~E 415 (688)
.++|.....||+|+||.||+|++. |..||||++...... ..+..|+.++..++|+|+|..++.| .+..++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCCC--HHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEE
T ss_conf 88899968985078809999999889989999997210058--8899999999970389960179999951987789998
Q ss_pred CCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEEC---CCCCEEEEECCCCCCCC
Q ss_conf 078996788861249999899999999999999999998506998157189999962207---99976991057310015
Q 005617 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLD---SELSSKICDFGICRLVT 492 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd---~~~~vKL~DFGla~~~~ 492 (688)
|+ +|+|.+.+.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++ .+..+||+|||+|+...
T Consensus 84 ~~-~~~l~~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 84 LL-GPSLEDLFNFCS--RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred EC-CCCHHHHHHHCC--CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHCCCCCCCCCCEEEEECCCCCEECC
T ss_conf 73-871333244306--88768999999999999999999799---4426678766064335777615650467513425
Q ss_pred CCCCCCC-CCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHHHHHH-----HHCCCCCCCC
Q ss_conf 7887677-765568998898888812010499998202767999999998099999981568988-----5219632235
Q 005617 493 EDTLYLP-SFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA-----VSCGKLSSIL 566 (688)
Q Consensus 493 ~~~~~~~-~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELltG~~Pf~~~~~i~~~-----i~~~~l~~~l 566 (688)
....... .........||+.|+|||++.+..++.++|||||||++|||+||+.||......... ........
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-- 235 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-- 235 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS--
T ss_pred CCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCC--
T ss_conf 544554100013577678735329999918998983218861778999984987665530577999999852356789--
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHC
Q ss_conf 78889999799999999999821269999999936899999985300
Q 005617 567 DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHVA 613 (688)
Q Consensus 567 d~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~L~~l~~~ 613 (688)
+ ....+..++..+.+++..||..+|.+||++. .+.+.|+.+...
T Consensus 236 -~-~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~-~i~~~l~~~~~~ 279 (299)
T d1ckia_ 236 -P-IEVLCKGYPSEFATYLNFCRSLRFDDKPDYS-YLRQLFRNLFHR 279 (299)
T ss_dssp -C-HHHHTTTSCHHHHHHHHHHHHSCTTCCCCHH-HHHHHHHHHHHH
T ss_pred -C-HHHHCCCCCHHHHHHHHHHCCCCHHHCCCHH-HHHHHHHHHHHH
T ss_conf -8-3575347889999999998439955791999-999999999997
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=318.22 Aligned_cols=246 Identities=21% Similarity=0.238 Sum_probs=195.0
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCC--CHHHHHHHHHHHHCCCCCCEEEEECCCC--------CC
Q ss_conf 69532303401386589999998--909999997238933--4699999999997079994124705447--------87
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACP--------EA 409 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~~--------~~ 409 (688)
++|....+||+|+||+||+|.+. |..||||++...... ....+.+|+.++++++|||||+++++|. ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCCE
T ss_conf 77599889621758599999999999899999988233697999999999999986489876489989702564345762
Q ss_pred CEEEEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 42377607899678886124999989999999999999999999850699815718999996220799976991057310
Q 005617 410 WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~DFGla~ 489 (688)
.++||||+.++.+.. +. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~~-~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQV-IQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHHH-HT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEEEECCCHHHHHH-HH-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCEEEECHHHHH
T ss_conf 699984144677876-50-----38999999999999999998865221---1245677632113654431320102321
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHHHHHHHH-----------
Q ss_conf 015788767776556899889888881201049999820276799999999809999998156898852-----------
Q 005617 490 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS----------- 558 (688)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELltG~~Pf~~~~~i~~~i~----------- 558 (688)
...... ......||+.|+|||++.+..+++++||||+||++|+|++|++||...........
T Consensus 168 ~~~~~~-------~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~ 240 (355)
T d2b1pa1 168 TAGTSF-------MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 240 (355)
T ss_dssp --------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred CCCCCC-------CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHH
T ss_conf 146665-------5332214655558133147777877433356625789865989988897788999999720589879
Q ss_pred -------------CCC-------CCCCC----CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf -------------196-------32235----7888999979999999999982126999999993689
Q 005617 559 -------------CGK-------LSSIL----DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 559 -------------~~~-------l~~~l----d~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
.+. ..... .+.....+...+..+.+|+.+||..||++|||+.+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL 309 (355)
T d2b1pa1 241 FMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309 (355)
T ss_dssp HHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 998765667777641754356664212643335432101333799999999998769945790899996
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=317.97 Aligned_cols=259 Identities=19% Similarity=0.229 Sum_probs=199.4
Q ss_pred HCCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCCCHHHHHHHHHHHHCCCC-CCEEEEECCCCC--CCEEEEE
Q ss_conf 269532303401386589999998--90999999723893346999999999970799-941247054478--7423776
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQH-PHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~H-pnIV~l~g~~~~--~~~LV~E 415 (688)
.++|.+...||+|+||.||+|++. |..||||++..... ...+.+|+.++..+.| +|++.+++++.+ ..++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC--CHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 9806997998417882999999988997999999750258--29999999999996489998779999601881179999
Q ss_pred CCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECC-----CCCEEEEECCCCCC
Q ss_conf 0789967888612499998999999999999999999985069981571899999622079-----99769910573100
Q 005617 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDS-----ELSSKICDFGICRL 490 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~-----~~~vKL~DFGla~~ 490 (688)
|+ +|+|.+.+.... ..+++..+..++.+++.||.|||+.+ |+||||||+|||++. .+.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~~~--~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDLCG--RKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EC-CCCHHHHHHHHC--CCHHHHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEECCCCCCCCCCEEECCCCEEEE
T ss_conf 64-888799997520--31106899999999999999999779---6626677131523475434479568723660577
Q ss_pred CCCCCCCC-CCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHH-----HHHHHHCCCCCC
Q ss_conf 15788767-776556899889888881201049999820276799999999809999998156-----898852196322
Q 005617 491 VTEDTLYL-PSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGE-----VRRAVSCGKLSS 564 (688)
Q Consensus 491 ~~~~~~~~-~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELltG~~Pf~~~~~-----i~~~i~~~~l~~ 564 (688)
........ ..........||+.|||||++.+..+++++|||||||++|||+||+.||..... ....+.......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST 235 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS
T ss_pred CCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHHHHCCCCC
T ss_conf 14676654111024676277510267989648888869998983199999986987678853021999999997056799
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 357888999979999999999982126999999993689999998530
Q 005617 565 ILDPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSLVKELEQLHV 612 (688)
Q Consensus 565 ~ld~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i~~~L~~l~~ 612 (688)
... +.+..++..+.+++..|+..+|.+||++. .+...|+.+..
T Consensus 236 ~~~----~l~~~~p~~l~~ii~~~~~~~~~~rP~y~-~l~~~l~~~~~ 278 (293)
T d1csna_ 236 PLR----ELCAGFPEEFYKYMHYARNLAFDATPDYD-YLQGLFSKVLE 278 (293)
T ss_dssp CHH----HHTTTSCHHHHHHHHHHHHCCTTCCCCHH-HHHHHHHHHHH
T ss_pred CHH----HHCCCCCHHHHHHHHHHHCCCCCCCCCHH-HHHHHHHHHHH
T ss_conf 958----96579989999999998439930085999-99999999999
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=314.54 Aligned_cols=243 Identities=19% Similarity=0.288 Sum_probs=190.3
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCCCHHHHHHHHHHHHCCC-CCCEEEEECCCC----CCCEEEE
Q ss_conf 69532303401386589999998--9099999972389334699999999997079-994124705447----8742377
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLLGACP----EAWSLVY 414 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~-HpnIV~l~g~~~----~~~~LV~ 414 (688)
++|.+..+||+|+||+||+|+.. |..||||+++.. ....+.+|+.+|..++ ||||+++++++. ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEE
T ss_conf 6718978983174819999998899979999998889---9999999999998515799876799999816877126888
Q ss_pred ECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCC-CEEEEECCCCCCCCC
Q ss_conf 6078996788861249999899999999999999999998506998157189999962207999-769910573100157
Q 005617 415 EYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSEL-SSKICDFGICRLVTE 493 (688)
Q Consensus 415 E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~-~vKL~DFGla~~~~~ 493 (688)
||+.+|+|.... ..+++..+..++.||+.||.|||+.+ |+||||||+|||++.++ .+||+|||+|+....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EECCCCCHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEECCCCCCEECCC
T ss_conf 631798589974------68999999999999999998876433---443456441237748998366415654266468
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCHHHHHH----------------H
Q ss_conf 88767776556899889888881201049-999820276799999999809999998156898----------------8
Q 005617 494 DTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRR----------------A 556 (688)
Q Consensus 494 ~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~ELltG~~Pf~~~~~i~~----------------~ 556 (688)
.. ......||+.|+|||.+.+. .++.++||||+||++|+|++|+.||........ .
T Consensus 183 ~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~ 255 (328)
T d3bqca1 183 GQ-------EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY 255 (328)
T ss_dssp TC-------CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH
T ss_pred CC-------CCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHH
T ss_conf 87-------44432248642476102688888845232335455587604889998876018999999998788415555
Q ss_pred HHCCC------CCCCCCC---------CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf 52196------3223578---------88999979999999999982126999999993689
Q 005617 557 VSCGK------LSSILDP---------LAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 557 i~~~~------l~~~ld~---------~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
..... ....... .........+..+.+|+.+||..||.+|||+.+.+
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L 317 (328)
T d3bqca1 256 IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAM 317 (328)
T ss_dssp HHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 54225444743000003334331121155211244899999999998669956890899996
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=315.93 Aligned_cols=243 Identities=26% Similarity=0.348 Sum_probs=193.8
Q ss_pred CCCCCCEEEECCCCEEEEEEEE-----CCEEEEEEEEECCCC----CCHHHHHHHHHHHHCCCC-CCEEEEECCCCC--C
Q ss_conf 6953230340138658999999-----890999999723893----346999999999970799-941247054478--7
Q 005617 342 CNFSESFKVGQGGFGCVYKGEM-----LGRTVAIKMLYSHNM----QGQLEFQQEVRVLSKLQH-PHLVTLLGACPE--A 409 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~-----~g~~VAIK~l~~~~~----~~~~~f~~E~~iL~~l~H-pnIV~l~g~~~~--~ 409 (688)
++|.+.+.||+|+||+||+|.. .|..||||.+..... .....+.+|+.++.+++| |||+++++++.+ .
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024873
Q ss_pred CEEEEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 42377607899678886124999989999999999999999999850699815718999996220799976991057310
Q 005617 410 WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~DFGla~ 489 (688)
.++||||+.+|+|.+++.... .++...+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~---~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE---RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEEECCCCCHHHHHHHHCC---CCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCCCCEEECCCCCEEEEECCCHH
T ss_conf 001231234117999987304---5437888888999999998851499---8965477320124699988874132022
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCC--CCCCCCHHHHHHHHHHHHHHCCCCCCCHHH--HHHHHHCCCCCCC
Q ss_conf 015788767776556899889888881201049--999820276799999999809999998156--8988521963223
Q 005617 490 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG--VLTPKSDSYSFGLIILQLLTGRLPVGLAGE--VRRAVSCGKLSSI 565 (688)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~--~~s~ksDVwSlGviL~ELltG~~Pf~~~~~--i~~~i~~~~l~~~ 565 (688)
.+...... ......|++.|++||.+... .++.++|||||||+||+|++|+.||..... ....+..+...
T Consensus 178 ~~~~~~~~-----~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~-- 250 (322)
T d1vzoa_ 178 EFVADETE-----RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK-- 250 (322)
T ss_dssp ECCGGGGG-----GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH--
T ss_pred HHCCCCCC-----CCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCC--
T ss_conf 20344443-----22122233333106876057768871325177779999997689998888777799999983356--
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 57888999979999999999982126999999993
Q 005617 566 LDPLAGDWPTFVARRLVDLGLQCCELYGRERPDIT 600 (688)
Q Consensus 566 ld~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~ 600 (688)
.....+...+..+.+|+.+||+.||.+||++.
T Consensus 251 ---~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~ 282 (322)
T d1vzoa_ 251 ---SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCG 282 (322)
T ss_dssp ---CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSS
T ss_pred ---CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCCC
T ss_conf ---89988654799999999997445898819997
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-45 Score=307.72 Aligned_cols=250 Identities=20% Similarity=0.228 Sum_probs=195.2
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCC--CHHHHHHHHHHHHCCCCCCEEEEECCCCC--CCEEEEE
Q ss_conf 69532303401386589999998--909999997238933--46999999999970799941247054478--7423776
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACPE--AWSLVYE 415 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~~~--~~~LV~E 415 (688)
++|....+||+|+||+||+|++. |..||||+++..... ....+.+|+.+++.++|||||+++++|.+ ..++|++
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99786269712868199999999999699999980321786899999999999985675788821354444431158863
Q ss_pred CCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCCCCCCCC
Q ss_conf 07899678886124999989999999999999999999850699815718999996220799976991057310015788
Q 005617 416 YLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICRLVTEDT 495 (688)
Q Consensus 416 ~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~DFGla~~~~~~~ 495 (688)
++.+++|..++... ..+++..+..++.|++.||.|||..+ |+||||||+|||++.++.+||+|||.++......
T Consensus 82 ~~~~~~l~~~~~~~---~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDSCN---GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHHTT---TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ECCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHHHHHHCCC---EEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCC
T ss_conf 02332221121235---65403678999999999987743399---8600146761211337826652046011046887
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHCCCC-CCCCCHHHHHHHHHHHHHHCCCCCCCHHHHHHH---HH--CCCC-------
Q ss_conf 7677765568998898888812010499-998202767999999998099999981568988---52--1963-------
Q 005617 496 LYLPSFHRSTAPKGSFPYADPEYHRTGV-LTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRA---VS--CGKL------- 562 (688)
Q Consensus 496 ~~~~~~~~~~~~~Gt~~Y~APE~~~~~~-~s~ksDVwSlGviL~ELltG~~Pf~~~~~i~~~---i~--~~~l------- 562 (688)
. ......+++.|+|||++.... ++.++|||||||++|||++|+.||......... +. .+..
T Consensus 156 ~------~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (292)
T d1unla_ 156 R------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPS 229 (292)
T ss_dssp S------CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTT
T ss_pred C------CCEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHH
T ss_conf 5------1001034431014667506988880444026541889985189999889999999999986118997355134
Q ss_pred -CCC--------C--CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf -223--------5--7888999979999999999982126999999993689
Q 005617 563 -SSI--------L--DPLAGDWPTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 563 -~~~--------l--d~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
... . ...........+..+.+|+.+||+.||.+|||+.+.+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L 281 (292)
T d1unla_ 230 MTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEAL 281 (292)
T ss_dssp GGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred HHHCCCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 4322211334445443104330656899999999998649966890999996
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=313.55 Aligned_cols=247 Identities=23% Similarity=0.268 Sum_probs=193.1
Q ss_pred HCCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCC--CHHHHHHHHHHHHCCCCCCEEEEECCCCC-------C
Q ss_conf 269532303401386589999998--909999997238933--46999999999970799941247054478-------7
Q 005617 341 TCNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQ--GQLEFQQEVRVLSKLQHPHLVTLLGACPE-------A 409 (688)
Q Consensus 341 t~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~--~~~~f~~E~~iL~~l~HpnIV~l~g~~~~-------~ 409 (688)
+++|....+||+|+||+||+|+.. |..||||++...... ....+.+|+.+|..++|||+|++++++.. .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
T ss_conf 98718888983178839999999999979999998820028689999999999998668987425999996346456686
Q ss_pred CEEEEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEECCCCC
Q ss_conf 42377607899678886124999989999999999999999999850699815718999996220799976991057310
Q 005617 410 WSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICDFGICR 489 (688)
Q Consensus 410 ~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~DFGla~ 489 (688)
.+++++|+.+|+|.+++.. ..+++..+..|+.|++.||.|||+.+ |+||||||+|||++.++.+|++|||++.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred EEEEEEEECCCCHHHHCCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCHHC
T ss_conf 4999996258862320022----45309999999999999999997388---7651667763345543220013210001
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCC-CCCCCCHHHHHHHHHHHHHHCCCCCCCHHHHHHHHH----CCCCC-
Q ss_conf 015788767776556899889888881201049-999820276799999999809999998156898852----19632-
Q 005617 490 LVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTG-VLTPKSDSYSFGLIILQLLTGRLPVGLAGEVRRAVS----CGKLS- 563 (688)
Q Consensus 490 ~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~-~~s~ksDVwSlGviL~ELltG~~Pf~~~~~i~~~i~----~~~l~- 563 (688)
..... .....|++.|+|||++.+. .++.++|||||||++|+|++|++||........... .+...
T Consensus 170 ~~~~~---------~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~ 240 (348)
T d2gfsa1 170 HTDDE---------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 240 (348)
T ss_dssp CCTGG---------GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred CCCCC---------CCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCH
T ss_conf 25754---------444345435558355337756785512432058999997688997889889999999973079975
Q ss_pred CC------------CC--CCCCCC-----CHHHHHHHHHHHHHCCCCCCCCCCCCCHHH
Q ss_conf 23------------57--888999-----979999999999982126999999993689
Q 005617 564 SI------------LD--PLAGDW-----PTFVARRLVDLGLQCCELYGRERPDITPSL 603 (688)
Q Consensus 564 ~~------------ld--~~~~~~-----~~~~~~~l~~Li~~Cl~~dP~~RPs~~~~i 603 (688)
+. .. +..... ....+..+.+|+.+||..||.+|||+.+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL 299 (348)
T d2gfsa1 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQAL 299 (348)
T ss_dssp HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf 77320010244544430355787555662678999999999997758834593899985
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.4e-42 Score=291.29 Aligned_cols=250 Identities=21% Similarity=0.255 Sum_probs=187.0
Q ss_pred CCCCCCEEEECCCCEEEEEEEEC--CEEEEEEEEECCCCCCHHHHHHHHHHHHCCC-----------CCCEEEEECCCCC
Q ss_conf 69532303401386589999998--9099999972389334699999999997079-----------9941247054478
Q 005617 342 CNFSESFKVGQGGFGCVYKGEML--GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-----------HPHLVTLLGACPE 408 (688)
Q Consensus 342 ~~f~~~~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~-----------HpnIV~l~g~~~~ 408 (688)
++|.+..+||+|+||+||+|+.. |..||||+++.... ....+.+|+.++..++ |+|||++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCC-CHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 857998997507781899999999997999999834313-3689999999999840145555542276764789987631
Q ss_pred ----CCEEEEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCC-----
Q ss_conf ----74237760789967888612499998999999999999999999985069981571899999622079997-----
Q 005617 409 ----AWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELS----- 479 (688)
Q Consensus 409 ----~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~----- 479 (688)
..++++.++..+..............+++..+..++.+++.||.|||+.. +|+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~--~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEE
T ss_pred CCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHC--CCCCCCCCHHHEEEECCCCCCCCC
T ss_conf 256520234320003542000001223467868999999999999988876405--864656770570563057656443
Q ss_pred -EEEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCHHHHHHHHHHHHHHCCCCCCCHHHH-----
Q ss_conf -69910573100157887677765568998898888812010499998202767999999998099999981568-----
Q 005617 480 -SKICDFGICRLVTEDTLYLPSFHRSTAPKGSFPYADPEYHRTGVLTPKSDSYSFGLIILQLLTGRLPVGLAGEV----- 553 (688)
Q Consensus 480 -vKL~DFGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~APE~~~~~~~s~ksDVwSlGviL~ELltG~~Pf~~~~~i----- 553 (688)
+|++|||.+...... .....||+.|+|||++....++.++||||+||++++|++|+.||......
T Consensus 170 ~~kl~dfg~s~~~~~~---------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~ 240 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEH---------YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240 (362)
T ss_dssp EEEECCCTTCEETTBC---------CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred EEEEEECCCCCCCCCC---------CCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCH
T ss_conf 0567531442123445---------4223665210571321466777643201237899999878899898755432102
Q ss_pred ----HH-HHHCCC--------------------CCCCCC-----------CCCCCCCHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf ----98-852196--------------------322357-----------888999979999999999982126999999
Q 005617 554 ----RR-AVSCGK--------------------LSSILD-----------PLAGDWPTFVARRLVDLGLQCCELYGRERP 597 (688)
Q Consensus 554 ----~~-~i~~~~--------------------l~~~ld-----------~~~~~~~~~~~~~l~~Li~~Cl~~dP~~RP 597 (688)
.. ....|. ....+. +.....+...+..+.+|+.+||..||.+||
T Consensus 241 ~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp 320 (362)
T d1q8ya_ 241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 320 (362)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCC
T ss_conf 68999999983799878862453220001320122024323577644421000156743589999999998779945790
Q ss_pred CCCHHH
Q ss_conf 993689
Q 005617 598 DITPSL 603 (688)
Q Consensus 598 s~~~~i 603 (688)
|+.+.+
T Consensus 321 ta~e~L 326 (362)
T d1q8ya_ 321 DAGGLV 326 (362)
T ss_dssp CHHHHH
T ss_pred CHHHHH
T ss_conf 899996
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.90 E-value=2.3e-23 Score=166.26 Aligned_cols=164 Identities=20% Similarity=0.146 Sum_probs=119.2
Q ss_pred CCCCEEEECCCCEEEEEEEEC-CEEEEEEEEECCCCC------------------CHHHHHHHHHHHHCCCCCCEEEEEC
Q ss_conf 532303401386589999998-909999997238933------------------4699999999997079994124705
Q 005617 344 FSESFKVGQGGFGCVYKGEML-GRTVAIKMLYSHNMQ------------------GQLEFQQEVRVLSKLQHPHLVTLLG 404 (688)
Q Consensus 344 f~~~~~LG~G~fG~Vykg~~~-g~~VAIK~l~~~~~~------------------~~~~f~~E~~iL~~l~HpnIV~l~g 404 (688)
+.++++||+|+||.||+|... |..||||+++..... ....+..|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred CHHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEE
T ss_conf 02277802485659999997999999999986044346665565630008889999997789999999816999144998
Q ss_pred CCCCCCEEEEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCCCCEEECCCCCEEEEE
Q ss_conf 44787423776078996788861249999899999999999999999998506998157189999962207999769910
Q 005617 405 ACPEAWSLVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSKPEKIVHGDLKPQNILLDSELSSKICD 484 (688)
Q Consensus 405 ~~~~~~~LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~~~~IiHrDIKp~NILLd~~~~vKL~D 484 (688)
+. ..+++|||++++.+.. ++......++.+++.+|.|||..+ |+||||||+|||++.+ .++|+|
T Consensus 82 ~~--~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 82 WE--GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp EE--TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEECC
T ss_pred EC--CCEEEEEEECCCCCCC----------HHHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHEEEECC-CEEEEE
T ss_conf 62--8889999504565420----------015789999999999999982688---8983689036114289-899987
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCH------HHHCCCCCCCCCHHHHHHHHHH
Q ss_conf 57310015788767776556899889888881------2010499998202767999999
Q 005617 485 FGICRLVTEDTLYLPSFHRSTAPKGSFPYADP------EYHRTGVLTPKSDSYSFGLIIL 538 (688)
Q Consensus 485 FGla~~~~~~~~~~~~~~~~~~~~Gt~~Y~AP------E~~~~~~~s~ksDVwSlGviL~ 538 (688)
||+|........ ..|... +++ ...|+.++|+||..--++
T Consensus 146 FG~a~~~~~~~~--------------~~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 146 FPQSVEVGEEGW--------------REILERDVRNIITYF-SRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CTTCEETTSTTH--------------HHHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHHH
T ss_pred CCCCCCCCCCCC--------------HHHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHH
T ss_conf 788430899870--------------999987799999997-578998446899999874
|
| >d1wgma_ g.44.1.2 (A:) Ubiquitin conjugation factor E4A {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: Ubiquitin conjugation factor E4A species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.84 E-value=8.4e-10 Score=78.00 Aligned_cols=71 Identities=30% Similarity=0.482 Sum_probs=65.4
Q ss_pred CCCCCCCCCHHHHHHHCCCCCCCCC-CCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 8988865522356431498767898-42232011234204977888755556778899654789999998630
Q 005617 616 RPVPSFFLCPILQEIMHDPQVAADG-FTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDWLCK 687 (688)
Q Consensus 616 ~~~ps~~~~pi~~e~~~~p~~~~dg-~~ye~~~i~~wle~g~~~SP~tn~~l~~~~l~Pn~aLr~~~~~~~~~ 687 (688)
..+|..|.|||..++|.||.+.+.+ .+|+..+|..|+.. +.++|.++..+...+|+||.+||.+|++|+.+
T Consensus 17 ~~~P~~f~CPI~~~lm~dPV~~~~~~~ty~r~~I~~~l~~-~~~~P~~~~~l~~~~L~pN~~Lr~~I~~~~~~ 88 (98)
T d1wgma_ 17 ADACDEFLDPIMSTLMCDPVVLPSSRVTVDRSTIARHLLS-DQTDPFNRSPLTMDQIRPNTELKEKIQRWLAE 88 (98)
T ss_dssp CSCCTTTBCTTTCSBCSSEEECTTTCCEEEHHHHHHHTTT-SCBCTTTCSBCCTTTSEECHHHHHHHHHHHHH
T ss_pred CCCCHHHCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHH-CCCCCCCCCCCCCHHHCCHHHHHHHHHHHHHH
T ss_conf 5990774886734688777762355320149999999870-68766555666401120139999999999999
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.78 E-value=8.3e-08 Score=65.02 Aligned_cols=148 Identities=16% Similarity=0.088 Sum_probs=96.9
Q ss_pred HHHHHHHCCCCCCEEEECCCCEEEEEEEECCEEEEEEEEECCCCCCHHHHHHHHHHHHCCC-CCCEEEEECCCC--CCCE
Q ss_conf 8899872695323034013865899999989099999972389334699999999997079-994124705447--8742
Q 005617 335 ADLQTATCNFSESFKVGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLLGACP--EAWS 411 (688)
Q Consensus 335 ~el~~at~~f~~~~~LG~G~fG~Vykg~~~g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~-HpnIV~l~g~~~--~~~~ 411 (688)
.++...-..|......+.++.+.||+....+..+.+|+...........+.+|...+..+. +-.+.+++.++. +..+
T Consensus 7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 7 PELKKLIEKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHHTTSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHHHHHCEEEEECCCCCCCCCEEEEEECCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEE
T ss_conf 99997513527997678998771899990898699998488765325569999999998760699872899975089649
Q ss_pred EEEECCCCCCHHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC---------------------------------
Q ss_conf 37760789967888612499998999999999999999999985069---------------------------------
Q 005617 412 LVYEYLPNGSLQDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHSSK--------------------------------- 458 (688)
Q Consensus 412 LV~E~~~~gsL~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~~~--------------------------------- 458 (688)
+||++++|.++........ . ...++.+++..+..||...
T Consensus 87 lv~~~l~G~~~~~~~~~~~-----~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDEQ-----S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTTTCS-----C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEECCCCCCCCCCCCCC-----C---HHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCC
T ss_conf 9998604334354334402-----6---9999998999999985568421435764465655577899877655554303
Q ss_pred -----------------------CCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf -----------------------98157189999962207999769910573100
Q 005617 459 -----------------------PEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 459 -----------------------~~~IiHrDIKp~NILLd~~~~vKL~DFGla~~ 490 (688)
+..++|+|+.|.|||++.++.+-|.||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 3232005799999999844986781789860047642364996599960231441
|
| >d1t1ha_ g.44.1.2 (A:) E3 ubiquitin ligase PUB14 {Thale-cress (Arabidopsis thaliana) [TaxId: 3702]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: E3 ubiquitin ligase PUB14 species: Thale-cress (Arabidopsis thaliana) [TaxId: 3702]
Probab=98.72 E-value=3e-09 Score=74.46 Aligned_cols=73 Identities=38% Similarity=0.732 Sum_probs=68.8
Q ss_pred CCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHC
Q ss_conf 8988865522356431498767898422320112342049778887555567788996547899999986309
Q 005617 616 RPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDWLCKS 688 (688)
Q Consensus 616 ~~~ps~~~~pi~~e~~~~p~~~~dg~~ye~~~i~~wle~g~~~SP~tn~~l~~~~l~Pn~aLr~~~~~~~~~~ 688 (688)
+.+|+.|.|||-.++|.+|.+...|.+|....|..|+..+...+|.++.++...+++||++||++|++|+++.
T Consensus 3 peiP~~l~CpIc~~~m~dPV~~~cgh~fc~~ci~~~~~~~~~~cP~~~~~l~~~~l~pN~~L~~~I~~~~~~~ 75 (78)
T d1t1ha_ 3 PEFPEYFRCPISLELMKDPVIVSTGQTYERSSIQKWLDAGHKTCPKSQETLLHAGLTPNYVLKSLIALWCESN 75 (78)
T ss_dssp CCCSSSSSCTTTSCCCSSEEEETTTEEEEHHHHHHHHTTTCCBCTTTCCBCSSCCCEECTTTHHHHHHHHHHS
T ss_pred CCCCCCCCCCCCCCHHHCCEECCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHH
T ss_conf 9899627991718121083372677743399999999988887886556377565624699999999999995
|
| >d2c2la2 g.44.1.2 (A:225-304) STIP1 homology and U box-containing protein 1, STUB1 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: STIP1 homology and U box-containing protein 1, STUB1 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=98.67 E-value=5.4e-09 Score=72.75 Aligned_cols=72 Identities=28% Similarity=0.549 Sum_probs=68.2
Q ss_pred CCCCCCCCCHHHHHHHCCCCCCCCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 898886552235643149876789842232011234204977888755556778899654789999998630
Q 005617 616 RPVPSFFLCPILQEIMHDPQVAADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNHALRHAIQDWLCK 687 (688)
Q Consensus 616 ~~~ps~~~~pi~~e~~~~p~~~~dg~~ye~~~i~~wle~g~~~SP~tn~~l~~~~l~Pn~aLr~~~~~~~~~ 687 (688)
..+|..|.|||-.++|.+|.+.+.|.+|....|..|+..++.++|.++.++...+++||.+|+++|++|+++
T Consensus 2 ~eiP~~l~CpIc~~l~~dPv~~~cGhtfc~~ci~~~l~~~~~~cP~c~~~l~~~~l~pN~~L~~~I~~~l~~ 73 (80)
T d2c2la2 2 RDIPDYLCGKISFELMREPCITPSGITYDRKDIEEHLQRVGHFNPVTRSPLTQEQLIPNLAMKEVIDAFISE 73 (80)
T ss_dssp CCCCSTTBCTTTCSBCSSEEECSSCCEEETTHHHHHHHHTCSSCTTTCCCCCGGGCEECHHHHHHHHHHHTT
T ss_pred CCCCCCCCCCCCCCHHHHHCCCCCCCEECHHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHH
T ss_conf 989700118583732340330588685638899999863776578756665423555199999999999998
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.27 E-value=1.3e-05 Score=50.73 Aligned_cols=75 Identities=16% Similarity=0.069 Sum_probs=50.4
Q ss_pred EEEECCCCEEEEEEEEC--CEEEEEEEEECC------C-CCCHHHHHHHHHHHHCCC---CCCEEEEECCCCCCCEEEEE
Q ss_conf 03401386589999998--909999997238------9-334699999999997079---99412470544787423776
Q 005617 348 FKVGQGGFGCVYKGEML--GRTVAIKMLYSH------N-MQGQLEFQQEVRVLSKLQ---HPHLVTLLGACPEAWSLVYE 415 (688)
Q Consensus 348 ~~LG~G~fG~Vykg~~~--g~~VAIK~l~~~------~-~~~~~~f~~E~~iL~~l~---HpnIV~l~g~~~~~~~LV~E 415 (688)
..||.|....||+.... +..|++|.-... . .........|...|..+. ...+.+++++..+...+|||
T Consensus 32 ~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d~~~~~lvmE 111 (392)
T d2pula1 32 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSDTEMAVTVME 111 (392)
T ss_dssp EECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEETTTTEEEEC
T ss_pred EEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEECCCCCEEEEE
T ss_conf 98079852768999957998489996177130346777888778999999999986505798855289985988779871
Q ss_pred CCCCCCH
Q ss_conf 0789967
Q 005617 416 YLPNGSL 422 (688)
Q Consensus 416 ~~~~gsL 422 (688)
++.+..+
T Consensus 112 ~L~~~~~ 118 (392)
T d2pula1 112 DLSHLKI 118 (392)
T ss_dssp CCTTSEE
T ss_pred CCCCCCC
T ss_conf 3577653
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.00 E-value=1.9e-05 Score=49.69 Aligned_cols=128 Identities=21% Similarity=0.186 Sum_probs=76.8
Q ss_pred EEECCC-CEEEEEEEEC-CEEEEEEEEECCCCCCHHHHHHHHHHHHCCC--CCCEEEEECCCC--CCCEEEEECCCCCCH
Q ss_conf 340138-6589999998-9099999972389334699999999997079--994124705447--874237760789967
Q 005617 349 KVGQGG-FGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ--HPHLVTLLGACP--EAWSLVYEYLPNGSL 422 (688)
Q Consensus 349 ~LG~G~-fG~Vykg~~~-g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~--HpnIV~l~g~~~--~~~~LV~E~~~~gsL 422 (688)
.+..|. .+.||+.... +..+.+|........ .+..|...+..+. .-.+.++++++. ...++||++++|.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~---~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN---ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTTS---CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCCCHH---HHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCCC
T ss_conf 767865477589999389878999958966776---89999999999986599988613222456615999874413554
Q ss_pred HHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHC----------------------------------------------
Q ss_conf 8886124999989999999999999999999850----------------------------------------------
Q 005617 423 QDRLFRKSNVSPLLWKDRARIAAEIASGLCFLHS---------------------------------------------- 456 (688)
Q Consensus 423 ~~~L~~~~~~~~l~~~~~~~ia~qia~aL~yLH~---------------------------------------------- 456 (688)
.... +. ...++.+++..|.-||.
T Consensus 94 ~~~~--------~~---~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred CCCC--------CC---HHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHH
T ss_conf 3221--------26---899999999999987368854488755412468899999987541101134011213799999
Q ss_pred -----C----CCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf -----6----998157189999962207999769910573100
Q 005617 457 -----S----KPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 457 -----~----~~~~IiHrDIKp~NILLd~~~~vKL~DFGla~~ 490 (688)
. .+..++|+|+.|.|||++.+..+-|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 9998718765795678678887635773796589998533265
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.76 E-value=0.001 Score=38.39 Aligned_cols=157 Identities=11% Similarity=0.073 Sum_probs=81.4
Q ss_pred CCHHHHHHHHCCCCCCEE-----EECCCCEEEEEEEECCEEEEEEEEECCCCCCHHHHHHHHHHHHCCC-----CCCEEE
Q ss_conf 498889987269532303-----4013865899999989099999972389334699999999997079-----994124
Q 005617 332 FSLADLQTATCNFSESFK-----VGQGGFGCVYKGEMLGRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-----HPHLVT 401 (688)
Q Consensus 332 ~~~~el~~at~~f~~~~~-----LG~G~fG~Vykg~~~g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~-----HpnIV~ 401 (688)
.+.+++.....+|..+.. |..|.-.+.|.....+..+++|+........ .+..++.++..+. .|..+.
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~~~~--~l~~~~~~l~~L~~~g~pvp~pi~ 80 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDPLILTLYEKRVEKN--DLPFFLGLMQHLAAKGLSCPLPLP 80 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCCEEEEEECC---CC--HHHHHHHHHHHHHHTTCCCCCBCC
T ss_pred CCHHHHHHHHHHCCCCCCEEEECCCCCCCCCEEEEEECCCCEEEEECCCCCCHH--HHHHHHHHHHHHHHCCCCCCCCCE
T ss_conf 899999999986799985685237888526738999789728999807899988--999999998754302555455641
Q ss_pred EE-CCC----CCCCEEEEECCCCCCHH--------------HHHCCC----CC---CCCCCH-----------------H
Q ss_conf 70-544----78742377607899678--------------886124----99---998999-----------------9
Q 005617 402 LL-GAC----PEAWSLVYEYLPNGSLQ--------------DRLFRK----SN---VSPLLW-----------------K 438 (688)
Q Consensus 402 l~-g~~----~~~~~LV~E~~~~gsL~--------------~~L~~~----~~---~~~l~~-----------------~ 438 (688)
.. |.. ......++.++.+.... ..++.. .. .....+ .
T Consensus 81 ~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (316)
T d2ppqa1 81 RKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEK 160 (316)
T ss_dssp BTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTST
T ss_pred ECCCCCCEEEECCCCEEEEECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCH
T ss_conf 04897621341255024531146553332046788888998764544432024531011101200245677776531141
Q ss_pred HHHHHHHHHHHHHHHHHC-CCCCCEEECCCCCCCEEECCCCCEEEEECCCCCC
Q ss_conf 999999999999999850-6998157189999962207999769910573100
Q 005617 439 DRARIAAEIASGLCFLHS-SKPEKIVHGDLKPQNILLDSELSSKICDFGICRL 490 (688)
Q Consensus 439 ~~~~ia~qia~aL~yLH~-~~~~~IiHrDIKp~NILLd~~~~vKL~DFGla~~ 490 (688)
.....+......+..... .-|.++||+|+.++||+++.+...-|.||+.+..
T Consensus 161 ~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 161 GLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp THHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf 27999999987642048554545033378636564020454126742221236
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.48 E-value=0.00065 Score=39.71 Aligned_cols=71 Identities=14% Similarity=0.238 Sum_probs=48.0
Q ss_pred EEEECCCCEEEEEEEEC---------CEEEEEEEEECCCCCCHHHHHHHHHHHHCCC-CCCEEEEECCCCCCCEEEEECC
Q ss_conf 03401386589999998---------9099999972389334699999999997079-9941247054478742377607
Q 005617 348 FKVGQGGFGCVYKGEML---------GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQ-HPHLVTLLGACPEAWSLVYEYL 417 (688)
Q Consensus 348 ~~LG~G~fG~Vykg~~~---------g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~-HpnIV~l~g~~~~~~~LV~E~~ 417 (688)
..|+.|-.-.+|+.... ...|.+++.- . ........+|..++..+. +.-..+++++|.+ .+|++|+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~--g~I~efi 123 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG--GRLEEYI 123 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT--EEEECCC
T ss_pred EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECC-C-CCHHHHHHHHHHHHHHHHHCCCCCEEEEECCC--CEEEEEE
T ss_conf 991785334348999688775445789817999659-9-61165899999999999757999808998189--5699973
Q ss_pred CCCCH
Q ss_conf 89967
Q 005617 418 PNGSL 422 (688)
Q Consensus 418 ~~gsL 422 (688)
+|.++
T Consensus 124 ~g~~l 128 (395)
T d1nw1a_ 124 PSRPL 128 (395)
T ss_dssp CEEEC
T ss_pred CCCCC
T ss_conf 45548
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.26 E-value=0.0045 Score=34.26 Aligned_cols=136 Identities=13% Similarity=0.099 Sum_probs=73.4
Q ss_pred CCCEEEEEEEEC-CEEEEEEEEECCCCCCHHHHHHHHHHHHCCCCCC--EEEEECCC-------CCCCEEEEECCCCCCH
Q ss_conf 386589999998-9099999972389334699999999997079994--12470544-------7874237760789967
Q 005617 353 GGFGCVYKGEML-GRTVAIKMLYSHNMQGQLEFQQEVRVLSKLQHPH--LVTLLGAC-------PEAWSLVYEYLPNGSL 422 (688)
Q Consensus 353 G~fG~Vykg~~~-g~~VAIK~l~~~~~~~~~~f~~E~~iL~~l~Hpn--IV~l~g~~-------~~~~~LV~E~~~~gsL 422 (688)
+.-..||++... |..|++|+..... ....++..|...+..|...+ ++..+... ....+.++++++|..+
T Consensus 33 s~EN~vy~v~~~dg~~~VlK~~rp~~-~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 33 SYENRVYQFQDEDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp CSSSEEEEECCTTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred CCCCEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCC
T ss_conf 61202699983899979999847877-88999999999999998559987875206898056653479999865277688
Q ss_pred H--------------HHHCC----CC--CCCCCCHH----------------------HHHHHHHHHHHHHHHH-HCCCC
Q ss_conf 8--------------88612----49--99989999----------------------9999999999999998-50699
Q 005617 423 Q--------------DRLFR----KS--NVSPLLWK----------------------DRARIAAEIASGLCFL-HSSKP 459 (688)
Q Consensus 423 ~--------------~~L~~----~~--~~~~l~~~----------------------~~~~ia~qia~aL~yL-H~~~~ 459 (688)
. ..++. .. ....+++. .....+..+...+.-+ ....+
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_conf 99999999998999999886303578655677897887665689998747699889899999999999999984545687
Q ss_pred CCEEECCCCCCCEEECCCCCEEEEECCCCCCC
Q ss_conf 81571899999622079997699105731001
Q 005617 460 EKIVHGDLKPQNILLDSELSSKICDFGICRLV 491 (688)
Q Consensus 460 ~~IiHrDIKp~NILLd~~~~vKL~DFGla~~~ 491 (688)
.++||+|+.+.|||++.+ ..+.||+-+...
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~g 221 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDARNG 221 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCCEE
T ss_pred CEEECCCCCCCCEEEECC--CEEEECHHCCCC
T ss_conf 120247888042878389--358865201468
|
| >d2baya1 g.44.1.2 (A:1-56) Pre-mRNA splicing factor Prp19 {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: U-box domain: Pre-mRNA splicing factor Prp19 species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=94.40 E-value=0.0027 Score=35.71 Aligned_cols=52 Identities=19% Similarity=0.360 Sum_probs=46.9
Q ss_pred CCHHHHHHHCCCCCC-CCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCH
Q ss_conf 522356431498767-89842232011234204977888755556778899654
Q 005617 623 LCPILQEIMHDPQVA-ADGFTYEGKAIRDWLENGRETSPMTNLRLSHLHLTPNH 675 (688)
Q Consensus 623 ~~pi~~e~~~~p~~~-~dg~~ye~~~i~~wle~g~~~SP~tn~~l~~~~l~Pn~ 675 (688)
.|||-.+.|.+|.+. ..|.+|..+.|..|+.+ +.++|+++..+...+|+|..
T Consensus 2 ~C~Ic~~~~~~Pv~~~~cGh~fc~~cI~~~l~~-~~~CP~c~~~l~~~dLipik 54 (56)
T d2baya1 2 LCAISGKVPRRPVLSPKSRTIFEKSLLEQYVKD-TGNDPITNEPLSIEEIVEIV 54 (56)
T ss_dssp CCTTTCSCCSSEEEETTTTEEEEHHHHHHHHHH-HSBCTTTCCBCCGGGCEECC
T ss_pred CCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHH-CCCCCCCCCCCCHHHCEECC
T ss_conf 993678568865745789984559999998760-36798547818877536478
|
| >d1jm7b_ g.44.1.1 (B:) bard1 RING domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: RING/U-box superfamily: RING/U-box family: RING finger domain, C3HC4 domain: bard1 RING domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.59 E-value=0.15 Score=24.35 Aligned_cols=83 Identities=16% Similarity=0.156 Sum_probs=62.8
Q ss_pred CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHCCCCCC-CCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCC
Q ss_conf 9999999936899999985300578988865522356431498767-898422320112342049778887555567788
Q 005617 592 YGRERPDITPSLVKELEQLHVAEERPVPSFFLCPILQEIMHDPQVA-ADGFTYEGKAIRDWLENGRETSPMTNLRLSHLH 670 (688)
Q Consensus 592 dP~~RPs~~~~i~~~L~~l~~~~~~~~ps~~~~pi~~e~~~~p~~~-~dg~~ye~~~i~~wle~g~~~SP~tn~~l~~~~ 670 (688)
+|..+-.+. .....|+.+.. .+.|||=.+.+.+|... .=|.+|-...|..|+.+ .+|.-+..+....
T Consensus 2 ~p~~~~~~~-~~~~~l~~l~~--------~l~C~IC~~~~~~pv~~~~CgH~fC~~Ci~~~~~~---~CP~Cr~~~~~~~ 69 (97)
T d1jm7b_ 2 EPDGRGAWA-HSRAALDRLEK--------LLRCSRCTNILREPVCLGGCEHIFCSNCVSDCIGT---GCPVCYTPAWIQD 69 (97)
T ss_dssp CSSTTCCCH-HHHHHHHHHHH--------TTSCSSSCSCCSSCBCCCSSSCCBCTTTGGGGTTT---BCSSSCCBCSCSS
T ss_pred CCCCCCCCH-HHHHHHHHHHH--------CCCCCCCCCHHHCCCEECCCCCCHHHHHHHHHHHC---CCCCCCCCCCHHH
T ss_conf 988666507-67999996212--------28992587221127465889993029999999853---6662278676551
Q ss_pred CCCCHHHHHHHHHHHH
Q ss_conf 9965478999999863
Q 005617 671 LTPNHALRHAIQDWLC 686 (688)
Q Consensus 671 l~Pn~aLr~~~~~~~~ 686 (688)
+.||.+|..+++.+.+
T Consensus 70 l~~n~~l~~lv~~~~~ 85 (97)
T d1jm7b_ 70 LKINRQLDSMIQLCSK 85 (97)
T ss_dssp CCCCHHHHHHHHHHHH
T ss_pred CCCCHHHHHHHHHHHH
T ss_conf 8605899999999999
|